FN Clarivate Analytics Web of Science
VR 1.0
PT B
AU Walker, FL
   Thoma, GR
AF Walker, FL
   Thoma, GR
BE Nixon, C
   Dengler, H
TI Java-assisted Internet document delivery
SO 14TH ANNUAL COMPUTERS IN LIBRARIES '99 PROCEEDINGS: IN COOPERATION WITH
   THE SPECIAL LIBRARIES ASSOCIATION
LA English
DT Proceedings Paper
CT 14th Annual Conference on Computers in Libraries
CY MAR 08-10, 1999
CL ARLINGTON, VA
SP Informat Today Inc
DE Java; Internet; HotMed; MedJava; document delivery; email; MIME; Ariel;
   DocView; World Wide Web; interlibrary loan
AB An increasing number of libraries are using the Internet for document delivery, not only for interlibrary loan, but for delivering documents directly to the patron's desktop computer. This has been made possible through the widespread adoption of software such as Ariel and DocView. Ariel, a product of the Research Libraries Group, converts paper-based documents to bitmapped images, and delivers them over the Internet. The National Library of Medicine's DocView, released in January 1998 and now used by 2,000 people in over 70 countries, is primarily designed for library patrons to receive, display and manage documents received fr-om Ariel systems. Despite the relative effectiveness of such technologies, Internet document delivery to the patron's desktop remains a challenge to document delivery librarians for several reasons. First, the librarian may need to assist patrons in acquiring document-viewing software, and in helping them install it on a wide variety of computer platforms. The librarian may also need to help patrons upgrade their viewing software as new versions are released. Because a heterogeneous patron population may be expected to have a diverse range of computer skills, the document delivery librarian may indeed face the challenge of training this population in using the document viewing software. As if this were not enough, the potential problem of copyright abuse always exists when copyrighted material is distributed electronically. How does a library cope with the potential problems introduced with Internet document delivery to the patron's desktop? One potential solution to this dilemma is Java-assisted document delivery. The National Library of Medicine's Lister Hill National Center for Biomedical Communications is developing software code-named HotMed and MedJava, which provide a method of delivering library documents through the World Wide Web by using a Java applet. While HotMed is software that delivers multimedia information over the Internet, MedJava is a Java software applet that HotMed delivers with scanned documents. MedJava enables the recipient to view the documents using a Java-enabled web browser. This paper describes the prototype HotMed and MedJava software, and shows how they can significantly reduce or eliminate the problems described here that libraries face in adopting Internet document delivery to the patron's desktop.
C1 Natl Lib Med, Lister Hill Natl Ctr Biomed Commun, Bethesda, MD 20894 USA.
CR *ALD CORP, 1992, TIFF REV 6 0
   Berger M. A., 1996, College & Undergraduate Libraries, V3, P49, DOI 10.1300/J106v03n02_05
   BORENSTEIN N, 1992, MIME MULTIPURPOSE IN
   DELACRUZ I, 1996, INSIDE MAPI
   Postel J, 1985, FILE TRANSFER PROTOC
   Sessions R., 1997, COM DCOM MICROSOFTS
   Walker DW, 1995, CERN REPORT, V95, P165
   WALKER FL, 1996, P IOLS 96, P107
   WALKER FL, 1997, P IOLS 97, P145
NR 9
TC 0
Z9 0
U1 0
U2 0
PU INFORMATION TODAY INC
PI MEDFORD
PA 143 OLD MARLTON PIKE, MEDFORD, NJ 08055 USA
BN 1-57387-077-3
PY 1999
BP 181
EP 190
PG 10
WC Information Science & Library Science
SC Information Science & Library Science
GA BP68L
UT WOS:000085856800041
DA 2018-10-19
ER

PT S
AU Barroso, RC
   Lopes, RT
   de Jesus, EFO
   de Oliveira, LF
AF Barroso, RC
   Lopes, RT
   de Jesus, EFO
   de Oliveira, LF
GP IEEE
   IEEE
   IEEE
TI Synchrotron biomedical applications using X-ray diffraction tomography
SO 1999 IEEE NUCLEAR SCIENCE SYMPOSIUM - CONFERENCE RECORD, VOLS 1-3
SE IEEE NUCLEAR SCIENCE SYMPOSIUM - CONFERENCE RECORD
LA English
DT Proceedings Paper
CT 1999 IEEE Nuclear Science Symposium and Medical Imaging Conference
CY OCT 24-30, 1999
CL SEATTLE, WA
SP IEEE, Nucl & Plasma Sci Soc, Argonne Natl Labs, Bicron Inc, Brookhaven Natl Lab, CTI PET Syst Inc, Ernest Orlando Lawrence Berkeley Natl Lab, Fermi Natl Accelerator Lab, GE Med Syst, INFN Sezione Ferrara Italy, Lawrence Livermore Natl Lab, Los Alamos Natl Lab, NASA, Natl Inst Stand & Technol, Oak Ridge Natl Lab, Picker Int, Sandia Natl Labs, Stanford Linear Accelerator Ctr, Univ Calif Irvine, Univ Washington, Seattle, Univ Ferrara Italy, Univ Utah, US DOE
AB This work reports the feasibility of a non-destructive synchrotron radiation X-ray diffraction imaging technique. This research was performed at the X-ray Diffraction beam line of the National Synchrotron Light Laboratory (LNLS) in Brazil. The coherent scattering properties of different tissue (water, Lucite, nylon and polystyrene) and bone (hydroxyapatite) substitute materials were evaluated. Furthermore, diffraction patterns of some polycrystalline solids (lead, platinum, dysprosium and silicon) were studied due to industrial and environmental human exposure to these metals. The X-ray diffraction measurements were carried out with an 11.101 keV and the diffracted beam was detected by a fast scintillation detector. The obtained diffraction patterns form the basis of a selective tomography technique. Preliminary images are presented. The results encourage us to examine further the application of the two-dimensional selective method to biomedical imaging.
C1 Univ Estado Rio Janeiro, Inst Fis, BR-20550900 Rio De Janeiro, Brazil.
RP Barroso, RC (reprint author), Univ Estado Rio Janeiro, Inst Fis, Rua Sao Francisco Xavier 524 Sala 3001A, BR-20550900 Rio De Janeiro, Brazil.
CR Barroso RC, 1998, NUCL INSTRUM METH A, V418, P458, DOI 10.1016/S0168-9002(98)00759-1
   Barroso RC, 1999, NUCL INSTRUM METH A, V422, P718, DOI 10.1016/S0168-9002(98)01024-9
   Cusatis C, 1998, J SYNCHROTRON RADIAT, V5, P491, DOI 10.1107/S0909049598000685
   EVANS SH, 1991, PHYS MED BIOL, V36, P7, DOI 10.1088/0031-9155/36/1/002
   FOWLER BA, 1993, ENVIRON HEALTH PERSP, V100, P57, DOI 10.2307/3431521
   HARDING G, 1987, J OPT SOC AM A, V4, P933, DOI 10.1364/JOSAA.4.000933
   Shimojo N, 1997, LIFE SCI, V60, P2129, DOI 10.1016/S0024-3205(97)00222-1
   Westmore MS, 1996, MED PHYS, V23, P723, DOI 10.1118/1.597720
NR 8
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1082-3654
BN 0-7803-5697-7
J9 IEEE NUCL SCI CONF R
PY 1999
BP 855
EP 859
PG 3
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Engineering; Instruments & Instrumentation; Nuclear Science &
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA BQ74H
UT WOS:000089372200173
DA 2018-10-19
ER

PT S
AU Augier, A
   Mavilio, A
   Muniz, G
   Garcia, A
   Serra, R
AF Augier, A
   Mavilio, A
   Muniz, G
   Garcia, A
   Serra, R
BE Guzman, AM
TI Researches in optics and laser in the laboratory of coherent optics
SO 3RD IBEROAMERICAN OPTICS MEETING AND 6TH LATIN AMERICAN MEETING ON
   OPTICS, LASERS, AND THEIR APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd Iberoamerican Optics Meeting / 6th Latin American Meeting on Optics,
   Lasers, and Their Applications
CY SEP 28-OCT 02, 1998
CL CARTAGENA DE INDIAS, COLOMBIA
SP Colombian Network Opt, Univ Nacl Colombia, Univ Valle, Univ Ind Santander, Univ Antioquia, Univ Las Americas, Fundac Multitaller Univ Valle, Colciencias-Inst Colombiano Desarrollo Ciencia & Technol Francisco Jose Caldas, Acad Colombiana Ciencias, Exactas, Fisicas & Naturales, Fundac Promoc Investigac & Technol, Sociedad Colombiana Fisica, Fundac Alejandro Angel Escobar, Centro Latinoamer Fisica, UNESCO, Abdus Salam Int Ctr Tehoret Phys, Int Commiss for Opt, Opt Soc Amer, SPIE, AVIANCA-SAM
DE optics; speckle; velocimetry; particle analysis; laser heat treatment;
   image processing; texture; holography; Photomedicine and Photobiology
ID CW CO2-LASER
AB The Laboratory of Coherent Optics possesses the following lines of investigation: laser material processing, holography, image processing, biomedical applications of laser, speckle techniques and other optical measuring techniques. In the present paper, some of the most important results obtained in the last three years are described.
C1 Higher Polytech Inst Jose A Echeverria, ISPJAE, Fac Elect Engn, Dept Phys,Lab Coherent Opt, Havana 19390, Cuba.
RP Augier, A (reprint author), Higher Polytech Inst Jose A Echeverria, ISPJAE, Fac Elect Engn, Dept Phys,Lab Coherent Opt, Havana 19390, Cuba.
RI Serra Toledo, Rolando/A-7938-2013
OI Serra Toledo, Rolando/0000-0002-4008-1947
CR AUGIER AG, 1995, P 5 LAT AM M OPT LAS, P258
   AUGIER AG, 1997, IN PRESS P TECNOLASE
   AUGIER AG, 1995, P 5 LAT AM M OPT LAS, P254
   CEBALLOS J, 1998, P 1 IB M LAS SYNTH M
   GARCIA A, 1997, IN PRESS P TECNOLASE
   GARCIA A, 1993, REV CUBANA MED DEPOR
   MAVILIO A, 1996, MEMORIAS FORO IBEROA
   Muniz G, 1996, P SOC PHOTO-OPT INS, V2730, P550, DOI 10.1117/12.231042
   Muniz G, 1996, P SOC PHOTO-OPT INS, V2730, P558, DOI 10.1117/12.231016
   NUNEZ A, IN PRESS P TECN 97 2
   NUNEZ A, 1997, IN PRESS P TECHNOLAS
   SERRA R, 1995, MEMORIAS 1 FORO OPTI
   SERRA R, 1997, REV DIALOGO IBEROAME, P43
   TEJERA M, 1995, 5 ENC LAT OPT LAS AP
NR 14
TC 0
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3036-6
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3572
BP 564
EP 567
DI 10.1117/12.358434
PG 4
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BN39L
UT WOS:000081782700095
DA 2018-10-19
ER

PT S
AU Smith, TI
AF Smith, TI
BE Carr, GL
   Dumas, P
TI Research on picosecond processes in biological, chemical, and materials
   science systems using the infrared beam at the stanford free electron
   laser center
SO ACCELERATOR-BASED SOURCES OF INFRARED AND SPECTROSCOPIC APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Accelerator-Based Sources of Infrared and Spectroscopic
   Applications
CY JUL 19-20, 1999
CL DENVER, CO
DE free electron laser; infrared; laser; picosecond
ID PHOTON-ECHO EXPERIMENTS; VIBRATIONAL ECHO; MYOGLOBIN-CO; DYNAMICS;
   MICROSCOPY; LIQUIDS; GLASSES
AB The Stanford free electron laser center was established to support a broad range of biomedical and materials science research. This paper will begin with an introduction to the Center's capabilities, and then will present brief descriptions of some of the experiments utilizing the transform and diffraction limited tunable picosecond pulses of infrared light from the free electron lasers at the Center. The experiments share the common characteristic that they exploit unique aspects of the FEL beams and would be much more difficult to perform with any other light source.
C1 Stanford Univ, WW Hansen Expt Phys Labs, Stanford, CA 94305 USA.
RP Smith, TI (reprint author), Stanford Univ, WW Hansen Expt Phys Labs, Stanford, CA 94305 USA.
CR Crosson ER, 1999, REV SCI INSTRUM, V70, P4, DOI 10.1063/1.1149533
   Hill JR, 1996, BIOSPECTROSCOPY, V2, P277, DOI 10.1002/(SICI)1520-6343(1996)2:5<277::AID-BSPY2>3.0.CO;2-2
   KONO J, IN PRESS APPL PHYSIC
   LARECH A, 1996, OPT LETT, V21, P1315
   MITCHELL AP, 1999, SPIE P, V3617, P137
   OKEEFE A, 1988, REV SCI INSTRUM, V59, P2544, DOI 10.1063/1.1139895
   Palanker DV, 1998, OPT COMMUN, V148, P215, DOI 10.1016/S0030-4018(97)00702-5
   PARKER FS, 1971, APPL INFR SPECTR BIO
   Peterson KA, 1999, J PHYS CHEM B, V103, P557, DOI 10.1021/jp982398f
   Rector KD, 1997, J PHYS CHEM B, V101, P1468, DOI 10.1021/jp963226q
   Rella CW, 1996, J PHYS CHEM-US, V100, P15620, DOI 10.1021/jp961129r
   Stuart B., 1997, BIOL APPL INFRARED S
   TOKMAKOFF A, 1995, J PHYS CHEM-US, V99, P13310, DOI 10.1021/j100036a003
   TOKMAKOFF A, 1995, ACCOUNTS CHEM RES, V28, P437, DOI 10.1021/ar00059a001
   TREADO PJ, 1994, APPL SPECTROSC REV, V29, P1, DOI 10.1080/05704929408000896
   ZENHAUSERN F, 1995, SCIENCE, V269, P1083, DOI 10.1126/science.269.5227.1083
NR 16
TC 3
Z9 3
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3261-X
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3775
BP 46
EP 57
DI 10.1117/12.366651
PG 12
WC Instruments & Instrumentation; Microscopy; Optics; Physics,
   Multidisciplinary; Physics, Condensed Matter; Spectroscopy
SC Instruments & Instrumentation; Microscopy; Optics; Physics; Spectroscopy
GA BP12L
UT WOS:000084198100007
DA 2018-10-19
ER

PT J
AU Huang, ZM
   Ramakrishna, S
AF Huang, ZM
   Ramakrishna, S
TI Development of knitted fabric reinforced composite material for
   prosthetic application
SO ADVANCED COMPOSITES LETTERS
LA English
DT Letter
ID FIBER
AB This Letter reports the development of a knitted fabric composite material using Kevlar 49 fibres and ultraviolet (UV) curable resin for a biomedical device, prosthetic socket application. Material fabrication and mechanical characterisation are described. The mechanical properties of this new material are comparable with those of a currently used indirect socket material. Compared with other available direct sockets, this new material is capable of better conforming to patient's stump and has longer gel time for manual operations involved.
C1 Natl Univ Singapore, Dept Mech & Prod Engn, Polymer & Text Composite Lab, Singapore 119260, Singapore.
RP Huang, ZM (reprint author), Natl Univ Singapore, Dept Mech & Prod Engn, Polymer & Text Composite Lab, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
CR CHOU S, 1992, J REINF PLAST COMP, V11, P1239, DOI 10.1177/073168449201101102
   GOMMERS B, 1996, COMP SCI TECH, V56, P1391
   HORSTING K, 1993, SAMPE J, V29, P7
   Huang ZM, 1999, J COMPOS MATER, V33, P1758, DOI 10.1177/002199839903301901
   Karger-Kocsis J, 1996, PLAST RUBB COMPOS PR, V25, P109
   LEONG KH, IN PRESS COMPOSITE A
   MAYER J, 1993, INT TECHT S, V3, P1
   Ramakrishna S, 1997, COMPOS SCI TECHNOL, V57, P1, DOI 10.1016/S0266-3538(96)00098-X
   VARIN RR, 1982, P 27 NAT SAMPE S US, P659
NR 9
TC 11
Z9 11
U1 0
U2 2
PU WOODHEAD PUBL LIMITED
PI LETCHWORTH
PA BLACKHORSE RD, LETCHWORTH SG6 1HN, HERTS, ENGLAND
SN 0963-6935
J9 ADV COMPOS LETT
JI Adv. Compos. Lett.
PY 1999
VL 8
IS 6
BP 289
EP 294
PG 6
WC Materials Science, Composites
SC Materials Science
GA 293CX
UT WOS:000085834900003
DA 2018-10-19
ER

PT J
AU Larson, J
AF Larson, J
TI The animal welfare information center - a brief overview
SO ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN
LA English
DT Article
DE 3R; animal welfare information center; national agricultural library;
   information services; publications; electronic resources; user
   statistics
AB The Animal Welfare Information Center (AWIC) of USDA's National Agricultural Library was established by a mandate of the U.S. Congress in the 1985 Amendments of the Animal Welfare Act. The Act regulates how warm-blooded animals are treated as they ave in biomedical research, for toxicity testing, as specimens in higher education, or exhibited in circuses, zoos and aquaria. Large volume dog dealers also come under the Act.
   In the 1985 Amendments, the U.S. Congress instructs the Center fa provide information on topics such as: alternatives to painful procedures, anesthetics, analgesics, tranquilizers, improved methodologies, training materials for those who use animals, environmental enrichment for primates, and exercise for dogs. This overview of the AWIC program discusses the historical aspects of the Center, and will illustrate how the U.S. Congressional mandate is currently carried out via the Center's national and international activities, services, publications, and outreach to U.S. regulated community. Some data regarding the use of the Center's products and services is presented.
C1 USDA, Beltsville, MD 20705 USA.
RP Larson, J (reprint author), USDA, Beltsville, MD 20705 USA.
CR Russell WMS, 1992, PRINCIPLES HUMANE EX
NR 1
TC 0
Z9 0
U1 0
U2 1
PU SPEKTRUM AKADEMISCHER VERLAG
PI HEIDELBERG
PA VANGEROWSTR 20, D-69115 HEIDELBERG, GERMANY
SN 0946-7785
J9 ALTEX-ALTERN TIEREXP
JI Altex Altern. Tierexp.
PY 1999
VL 16
IS 3
BP 192
EP 195
PG 4
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 251VQ
UT WOS:000083467400032
DA 2018-10-19
ER

PT J
AU Langelier, E
   Rancourt, D
   Bouchard, S
   Lord, C
   Stevens, PP
   Germain, L
   Auger, FA
AF Langelier, E
   Rancourt, D
   Bouchard, S
   Lord, C
   Stevens, PP
   Germain, L
   Auger, FA
TI Cyclic traction machine for long-term culture of fibroblast-populated
   collagen gels
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE tissue engineering; collagen gels; fibroblasts; cyclic traction;
   traction machine; collagen fibers orientation
ID SMOOTH-MUSCLE CELLS; ORIENTATION
AB Our research group has been investigating the effect of cyclic deformations on the evolution of fibroblast populated collagen gels (FPCG). Since existing traction machines are not designed for such an application, we had to design a cyclic traction machine adapted to tissue culture inside an incubator over an extended period of time. Biocompatible materials were used for fabrication to allow for easy sterilization and to prevent any adverse reaction from the tissue. The traction machine is based on a computer-controlled stepping motor system for easy adjustment of the deformation amplitude and frequency. The maximum stretching speed achieved is around 1 mm/s. The traction machine can measure FPCG mechanical properties and perform rupture tests to determine its ultimate strength. Several FPCGs have been successfully cultured with the machine for up to four weeks without any adverse reaction. (C) 1999 Biomedical Engineering Society. [S0090-6964(99)00401-4].
C1 Univ Laval, Dept Chirurg, St Foy, PQ G1K 7P4, Canada.
   Hop St Sacrement, Lab Organogenese Expt, Quebec City, PQ G1S 4L8, Canada.
   Univ Laval, Dept Genie Mecan, St Foy, PQ G1K 7P4, Canada.
RP Rancourt, D (reprint author), Univ Laval, Dept Engn Mech, Room 1504,Pavillon Pouliot, St Foy, PQ G1K 7P4, Canada.
OI Lord, Christopher/0000-0002-3226-0515
CR BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5
   DARTSCH PC, 1986, ACTA ANAT, V125, P108
   GOULET F, 1996, TXB TISSUE ENG, P629
   GOULET F, 1996, LIGAMENTS LIGAMENTOP, P367
   HUANG D, 1993, ANN BIOMED ENG, V21, P289, DOI 10.1007/BF02368184
   IVES CL, 1986, IN VITRO CELL DEV B, V22, P500
   Kanda K, 1993, ASAIO J, V39, pM686
   KANDA K, 1994, CELL TRANSPLANT, V3, P537, DOI 10.1177/096368979400300611
   KANDA K, 1994, CELL TRANSPLANT, V3, P481, DOI 10.1177/096368979400300605
   Kanda K, 1992, ASAIO J, V38, pM382, DOI 10.1097/00002480-199207000-00060
   LABELLE S, 1988, THESIS ECOLE POLYTEC
   LEUNG DYM, 1977, EXP CELL RES, V109, P285, DOI 10.1016/0014-4827(77)90008-8
   LIGHT ND, 1982, METHOD ENZYMOL, V82, P360
   SHIRINSKY VP, 1989, J CELL BIOL, V109, P331, DOI 10.1083/jcb.109.1.331
   VALLE CAL, 1992, BRIT J DERMATOL, V127, P365, DOI 10.1111/j.1365-2133.1992.tb00455.x
   Yahia L H, 1991, Biomed Mater Eng, V1, P215
NR 16
TC 26
Z9 29
U1 0
U2 0
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
   USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JAN-FEB
PY 1999
VL 27
IS 1
BP 67
EP 72
DI 10.1114/1.166
PG 6
WC Engineering, Biomedical
SC Engineering
GA 153VJ
UT WOS:000077853400008
PM 9916762
DA 2018-10-19
ER

PT J
AU Suslick, KS
   Price, GJ
AF Suslick, KS
   Price, GJ
TI Applications of ultrasound to materials chemistry
SO ANNUAL REVIEW OF MATERIALS SCIENCE
LA English
DT Review
DE sonochemistry; cavitation; polymer chemistry; nanostructure;
   heterogeneous catalysis; biomaterials
ID HIGH-INTENSITY ULTRASOUND; NANOSTRUCTURED MOLYBDENUM CARBIDE;
   SONOCHEMICAL SYNTHESIS; AMORPHOUS IRON; CATALYTIC PROPERTIES;
   METHYL-METHACRYLATE; HIGH POLYMERS; SURFACE-AREA; POLYMERIZATION;
   NANOPARTICLES
AB The chemical effects of ultrasound derive primarily from acoustic cavitation. Bubble collapse in liquids results in an enormous concentration of energy from the conversion of the kinetic energy of the liquid motion into heating of the contents of the bubble. The high local temperatures and pressures, combined with extraordinarily rapid cooling, provide a unique means for driving chemical reactions under extreme conditions. A diverse set of applications of ultrasound to enhance chemical reactivity has been explored with important uses in synthetic materials chemistry. For example, the sonochemical decomposition of volatile organometallic precursors in low-volatility solvents produces nanostructured materials in various forms with high catalytic activities. Nanostructured metals, alloys, oxides, carbides and sulfides, nanometer colloids, and nanostructured supported catalysts can all be prepared by this general route. Another important application of sonochemistry in materials chemistry has been the preparation of biomaterials, most notably protein microspheres. Such microspheres have a wide range of biomedical applications, including their use in echo contrast agents for sonography, magnetic resonance imaging, contrast enhancement, and oxygen or drug delivery. Other applications include the modification of polymers and polymer surfaces.
C1 Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England.
RP Suslick, KS (reprint author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.
EM ksuslick@uiuc.edu; chsgjp@bath.ac.uk
RI Suslick, Kenneth/C-3281-2011; Price, Gareth/B-5293-2011
OI Suslick, Kenneth/0000-0001-5422-0701; Price, Gareth/0000-0003-4983-5722
CR BASEDOW AM, 1977, ADV POLYM SCI, V22, P83
   BELLISSENT R, 1993, PHYS REV B, V48, P15797, DOI 10.1103/PhysRevB.48.15797
   BELLISSENT R, 1995, PHYS SCRIPTA, VT57, P79, DOI 10.1088/0031-8949/1995/T57/012
   Bellissent R, 1996, J NON-CRYST SOLIDS, V207, P656
   Berkovsky B. M., 1993, MAGNETIC FLUIDS ENG
   BLANCO E, 1995, MATER LETT, V22, P265, DOI 10.1016/0167-577X(94)00253-3
   BOUDJOUK P, 1981, TETRAHEDRON LETT, V22, P3813, DOI 10.1016/S0040-4039(01)91315-2
   Cao X, 1997, J MATER RES, V12, P402, DOI 10.1557/JMR.1997.0058
   CARLI R, 1993, P EUR SON SOC 3 COIM
   CHATAKONDU K, 1987, J CHEM SOC CHEM COMM, P900, DOI 10.1039/c39870000900
   CHAUMONT D, 1992, J NON-CRYST SOLIDS, V147, P41, DOI 10.1016/S0022-3093(05)80590-3
   COOPER G, 1994, J COLLOID INTERF SCI, V184, P52
   CRUM LA, 1999, P NATO ADV STUDY I C, V524
   DELAROSAFOX N, 1990, J NON-CRYST SOLIDS, V121, P211, DOI 10.1016/0022-3093(90)90134-8
   DESAI NP, 1994, Patent No. 5362478
   DESAI NP, 1995, Patent No. 543686
   DESAI NP, 1996, Patent No. 5560933
   Dhas NA, 1998, CHEM MATER, V10, P1446, DOI 10.1021/cm9708269
   DOKTYCZ SJ, 1990, SCIENCE, V247, P1067, DOI 10.1126/science.2309118
   Eckburg JJ, 1996, J BIOMECH ENG-T ASME, V118, P193, DOI 10.1115/1.2795959
   ELPINER IE, 1964, ULTRASOUND PHYSICAL
   ENCINA MV, 1980, J POLYM SCI POL LETT, V18, P757, DOI 10.1002/pol.1980.130181201
   Esquivias L., 1986, Current Topics on Non-Crystalline Solids. Proceedings of the First Workshop on Non-Crystalline Solids, P409
   ESQUIVIAS L, 1988, ULTRASTRUCTURE PROCE, P255
   EXSTED BJ, 1994, POLYMER, V35, P5560
   FANG Y, 1992, J MATER RES, V7, P2294, DOI 10.1557/JMR.1992.2294
   FLINT EB, 1991, SCIENCE, V253, P1397, DOI 10.1126/science.253.5026.1397
   Flosdorf EW, 1933, J AM CHEM SOC, V55, P3051, DOI 10.1021/ja01334a509
   FREIFELDER D, 1962, BIOPHYS J, V2, P235, DOI 10.1016/S0006-3495(62)86852-0
   GASGNIER M, 1995, J SOLID STATE CHEM, V115, P532, DOI 10.1006/jssc.1995.1170
   GATES BC, 1992, CATALYTIC CHEM, P387
   Grieser F, 1996, ULTRASONICS, V34, P547, DOI 10.1016/0041-624X(96)00036-4
   GRINSTAFF MW, 1992, ULTRASONICS, V30, P168, DOI 10.1016/0041-624X(92)90068-W
   GRINSTAFF MW, 1993, PHYS REV B, V48, P269, DOI 10.1103/PhysRevB.48.269
   GRINSTAFF MW, 1991, P NATL ACAD SCI USA, V88, P7708, DOI 10.1073/pnas.88.17.7708
   GRINSTAFF MW, 1997, Patent No. 5635207
   GRINSTAFF MW, 1996, Patent No. 5512268
   GRINSTAFF MW, 1996, Patent No. 5508021
   GRINSTAFF MW, 1997, Patent No. 5639473
   GRINSTAFF MW, 1996, Patent No. 5505932
   GRINSTAFF MW, 1997, Patent No. 5650156
   Grinstaff MW, 1997, Methods for the preparation of pharmaceutically active agents for in vivo delivery, Patent No. [US5665382, 5665382]
   Grinstaff MW, 1996, Composition useful for in vivo delivery of biologics and methods employing same, Patent No. [5498421, US5498421]
   Grinstaff MW, 1997, US Patent, Patent No. [5,665,383, 5665383]
   Gyorgyi AS, 1933, NATURE, V131, P278, DOI 10.1038/131278a0
   HENGLEIN A, 1954, MAKROMOL CHEM, V14, P15
   Hyeon TH, 1996, J AM CHEM SOC, V118, P5492, DOI 10.1021/ja9538187
   Isayev AI, 1996, J APPL POLYM SCI, V59, P803, DOI 10.1002/(SICI)1097-4628(19960131)59:5<803::AID-APP7>3.0.CO;2-#
   Kataby G, 1997, LANGMUIR, V13, P6151, DOI 10.1021/la960929q
   Kataby G, 1998, LANGMUIR, V14, P1512, DOI 10.1021/la970978i
   KELLER MW, 1988, ECHOCARDIOGRAPHY COR
   KIM HK, 1988, J AM CHEM SOC, V110, P3321, DOI 10.1021/ja00218a064
   KLABUNDE KJ, 1993, ACS SYM SER, V517, P88
   KODA S, 1994, POLYMER, V35, P30, DOI 10.1016/0032-3861(94)90045-0
   Koltypin Y, 1997, J MATER CHEM, V7, P2453, DOI 10.1039/a704008c
   KRUUS P, 1985, J PHYS CHEM-US, V89, P3379, DOI 10.1021/j100261a044
   KRUUS P, 1991, ADV SONOCHEMISTRY, V2, P1
   LEDOUX MJ, 1992, J CATAL, V134, P383, DOI 10.1016/0021-9517(92)90329-G
   LEE JS, 1990, J CATAL, V125, P157, DOI 10.1016/0021-9517(90)90086-Y
   Leighton T., 1994, ACOUSTIC BUBBLE
   Litran R, 1997, J SOL-GEL SCI TECHN, V8, P985, DOI 10.1023/A:1018313819720
   LIU KJ, 1994, BIOPHYS J, V67, P896, DOI 10.1016/S0006-3495(94)80551-X
   LONG GB, 1967, Patent No. 3346472
   Long GJ, 1998, PHYS REV B, V57, P10716, DOI 10.1103/PhysRevB.57.10716
   LORIMER JP, 1991, J CHEM SOC CHEM COMM, P1217, DOI 10.1039/c39910001217
   Luche J.L, 1998, SYNTHETIC ORGANIC SO
   MALTSEV AN, 1976, ZH FIZ KHIM+, V50, P1641
   Mason TJ, 1996, CHEM ENG RES DES, V74, P511
   MASON TJ, 1988, CONOSCHEMISTRY THEOR
   MATYJASZEWSKI K, 1995, MACROMOLECULES, V28, P59, DOI 10.1021/ma00105a007
   McNamara W. B., 1999, P NATO ADV STUDY I C, V524
   Mdleleni MM, 1998, J AM CHEM SOC, V120, P6189, DOI 10.1021/ja9800333
   MILLER RD, 1991, J POLYM SCI POL CHEM, V29, P813, DOI 10.1002/pola.1991.080290604
   MILLER RD, 1989, CHEM REV, V89, P1359, DOI 10.1021/cr00096a006
   MIYATA T, 1975, J CHEM ENG JAPAN, V8, P469
   Moser W. R., 1996, ADV CATALYSTS NANOST
   Nagata Y, 1996, RADIAT RES, V146, P333, DOI 10.2307/3579465
   Nguyen TQ, 1997, POLYMER, V38, P3783, DOI 10.1016/S0032-3861(96)00950-0
   ODELL JA, 1990, MACROMOLECULES, V23, P3092, DOI 10.1021/ma00214a011
   OSHEA JM, 1973, AUST J BIOL SCI, V26, P583, DOI 10.1071/BI9730583
   OSTROSKI AS, 1950, J APPL PHYS, V21, P478, DOI 10.1063/1.1699689
   PECORARO TA, 1981, J CATAL, V67, P430, DOI 10.1016/0021-9517(81)90303-1
   Preece CM, 1981, ADV MECH PHYS SURF, V1, P199
   Price GJ, 1996, MACROMOLECULES, V29, P5664, DOI 10.1021/ma951812w
   PRICE GJ, 1992, MACROMOLECULES, V25, P6447, DOI 10.1021/ma00050a010
   PRICE GJ, 1990, BRIT POLYM J, V23, P63, DOI 10.1002/pi.4980230111
   Price GJ, 1997, EUR POLYM J, V33, P599, DOI 10.1016/S0014-3057(96)00239-X
   PRICE GJ, 1993, EUR POLYM J, V29, P419, DOI 10.1016/0014-3057(93)90114-U
   PRICE GJ, 1992, J CHEM SOC CHEM COMM, P1209, DOI 10.1039/c39920001209
   PRICE GJ, 1995, SILICON CONTAINING P, P147
   PRICE GJ, 1996, CHEM EXTREME NONCLAS
   PRICE GJ, 1990, ADV SONOCHEMISTRY, V1, P231
   RAGAINI V, 1990, Patent No. 20478
   Ramesh S, 1997, CHEM MATER, V9, P2996, DOI 10.1021/cm9703536
   RANHOTRA GS, 1987, J CATAL, V108, P40, DOI 10.1016/0021-9517(87)90153-9
   RIESZ P, 1985, ENVIRON HEALTH PERSP, V64, P233, DOI 10.2307/3430013
   SALENSA TK, 1971, ULTRASONICS, V13, P21
   SATO T, 1977, J COATING TECHNOL, V49, P45
   SCHULTZ DN, 1994, POLYM PREPR, V35, P514
   SENAPATI N, 1985, Patent No. 45489771
   Shafi KVPM, 1998, THIN SOLID FILMS, V318, P38, DOI 10.1016/S0040-6090(97)01135-8
   Shafi KVPM, 1997, J PHYS CHEM B, V101, P6409, DOI 10.1021/jp970893q
   Shafi KVPM, 1998, ADV MATER, V10, P590, DOI 10.1002/(SICI)1521-4095(199805)10:8<590::AID-ADMA590>3.0.CO;2-L
   Shafi KVPM, 1998, J MATER CHEM, V8, P769, DOI 10.1039/a706871i
   Shafi KVPM, 1997, J APPL PHYS, V81, P6901, DOI 10.1063/1.365250
   Sostaric JZ, 1997, J CHEM SOC FARADAY T, V93, P1791, DOI 10.1039/a608567i
   Suslick K.S., 1990, ADV SONOCHEMISTRY, V1, P197
   Suslick K. S., 1998, KIRKOTHMER ENCY CHEM, V26, P517
   Suslick K. S., 1989, CHEM MATER, V1, P6
   Suslick K.S, 1997, HDB HETEROGENEOUS CA, V3, P1350
   SUSLICK KS, 1990, J AM CHEM SOC, V112, P7807, DOI 10.1021/ja00177a058
   Suslick KS, 1996, CHEM MATER, V8, P2172, DOI 10.1021/cm960056l
   Suslick KS, 1996, MATER SCI FORUM, V225, P903, DOI 10.4028/www.scientific.net/MSF.225-227.903
   Suslick KS, 1996, J AM CHEM SOC, V118, P11960, DOI 10.1021/ja961807n
   SUSLICK KS, 1994, MATER RES SOC SYMP P, V351, P443
   SUSLICK KS, 1987, J AM CHEM SOC, V109, P3459, DOI 10.1021/ja00245a047
   SUSLICK KS, 1989, J AM CHEM SOC, V111, P2342, DOI 10.1021/ja00188a081
   SUSLICK KS, 1984, J AM CHEM SOC, V106, P6856, DOI 10.1021/ja00334a073
   SUSLICK KS, 1994, ULTRASON SONOCHEM, V1, pS65, DOI 10.1016/1350-4177(94)90030-2
   SUSLICK KS, 1986, J AM CHEM SOC, V108, P5641, DOI 10.1021/ja00278a055
   SUSLICK KS, 1989, SOLID STATE IONICS, V32-3, P444, DOI 10.1016/0167-2738(89)90254-3
   SUSLICK KS, 1991, NATURE, V353, P414, DOI 10.1038/353414a0
   Suslick KS, 1995, MAT SCI ENG A-STRUCT, V204, P186, DOI 10.1016/0921-5093(95)09958-1
   SUSLICK KS, 1987, ULTRASONICS, V25, P56, DOI 10.1016/0041-624X(87)90013-8
   SUSLICK KS, 1994, MATER RES SOC SYMP P, V351, P201
   SUSLICK KS, 1995, MRS BULL, V20, P29, DOI 10.1557/S088376940004464X
   Suslick KS, 1997, ENCY ACOUSTICS, V1, P271
   SUSLICK KS, 1999, IN PRESS PHILOS T A
   SUSLICK KS, 1993, ENCY MAT SCI ENG, P2093
   SUSLICK KS, 1988, ULTRASOUND ITS CHEM
   SUSLICK KS, 1996, ADV CATALYSTS NANOST, P197
   SUSLICK KS, 1994, ENCY INORGANIC CHEM, V7, P3890
   TABATA M, 1980, CHEM PHYS LETT, V73, P178, DOI 10.1016/0009-2614(80)85230-4
   URBAN MW, 1988, MACROMOLECULES, V21, P372, DOI 10.1021/ma00180a014
   van Eldik R., 1997, CHEM EXTREME NONCLAS
   VANDERHOFF BM, 1974, J MACROMOL SCI CHEM, VA  8, P429, DOI 10.1080/00222337408065839
   VANDERHOFF BME, 1977, J MACROMOL SCI CHEM, VA11, P1739, DOI 10.1080/00222337708063088
   VOLPE L, 1985, J SOLID STATE CHEM, V59, P332, DOI 10.1016/0022-4596(85)90301-9
   WATANABE O, 1985, PROG POLYM PHYS JAPA, V28, P285
   Webb AG, 1996, JMRI-J MAGN RESON IM, V6, P675, DOI 10.1002/jmri.1880060417
   WEIDMAN TW, 1990, ULTRASONICS, V28, P310, DOI 10.1016/0041-624X(90)90037-O
   WELLER H, 1993, ADV MATER, V5, P88, DOI 10.1002/adma.19930050204
   WONG M, 1995, MATER RES SOC SYMP P, V372, P89
NR 143
TC 1085
Z9 1114
U1 30
U2 443
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0084-6600
J9 ANNU REV MATER SCI
JI Annu. Rev. Mater. Sci.
PY 1999
VL 29
BP 295
EP 326
DI 10.1146/annurev.matsci.29.1.295
PG 32
WC Materials Science, Multidisciplinary
SC Materials Science
GA 235GR
UT WOS:000082534400010
DA 2018-10-19
ER

PT J
AU D'Alessio, L
   Teghil, R
   Zaccagnino, M
   Zaccardo, I
   Ferro, D
   Marotta, V
AF D'Alessio, L
   Teghil, R
   Zaccagnino, M
   Zaccardo, I
   Ferro, D
   Marotta, V
TI Pulsed laser ablation and deposition of bioactive glass as coating
   material for biomedical applications
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT Symposium on Surface Processing - Laser, Lamp, Plasma, at the Annual
   Spring Meeting of the European-Materials-Society (E-MRS 96)
CY JUN 16-19, 1996-1998
CL STRASBOURG, FRANCE
SP European Mat Soc
DE laser ablation; coatings; bioglass; biomaterials
ID HYDROXYAPATITE
AB A study of the laser ablation and deposition, on Ti-Al substrates, of a biologically active glass (Bioglass(R)) suitable for bone implants is reported. The analysis of the gaseous phase by emission spectroscopy and the characterisation of the films from a compositional and morphological point of view have been carried out. The mean chemical composition of the deposits obtained from Bioglass ablation is very close to the target composition and the morphology indicates that different mechanisms of material ejection are present. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Basilicata, Dipartimento Chim, I-85100 Potenza, Italy.
   CNR, Ctr Termodinamica Chim Alte Temp, I-00185 Rome, Italy.
   CNR, Ist Mat Speciali, Tito Scalo, PZ, Italy.
RP Teghil, R (reprint author), Univ Basilicata, Dipartimento Chim, Via N Sauro 85, I-85100 Potenza, Italy.
EM teghil@unibas.it
OI TEGHIL, ROBERTO/0000-0002-8528-8669
CR COOK SD, 1986, J DENT RES, V65, P222
   COTELL CM, 1993, APPL SURF SCI, V69, P140, DOI 10.1016/0169-4332(93)90495-W
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   FOTI G, 1992, LASER DEPOSITION ADV
   Hatton P. V, 1998, EUROP MICR ANAL  JAN, P39
   KOKUBO T, 1993, 3 EUROCERAMICS, V3, P1
   RUCKENSTEIN E, 1983, J COLLOID INTERF SCI, V96, P245, DOI 10.1016/0021-9797(83)90026-7
   Santagata A, 1997, APPL SURF SCI, V109, P376, DOI 10.1016/S0169-4332(96)00753-2
   Santos JD, 1996, J MATER SCI-MATER M, V7, P187, DOI 10.1007/BF00121259
   TEGHIL R, 1995, APPL SURF SCI, V90, P505, DOI 10.1016/0169-4332(95)00179-4
   Teghil R, 1997, APPL SURF SCI, V119, P34, DOI 10.1016/S0169-4332(97)00170-0
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
NR 12
TC 39
Z9 39
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN
PY 1999
VL 138
BP 527
EP 532
DI 10.1016/S0169-4332(98)00610-2
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 166KX
UT WOS:000078576400101
DA 2018-10-19
ER

PT J
AU Oktar, FN
   Kesenci, K
   Piskin, E
AF Oktar, FN
   Kesenci, K
   Piskin, E
TI Characterization of processed tooth hydroxyapatite for potential
   biomedical implant applications
SO ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY
LA English
DT Article
DE hydroxyapatite; enamel; dentine
ID CHEMICAL-COMPOSITION; BIOCERAMICS
AB In this study hydroxyapatite (HA) (100-150 mu m) derived from freshly-extracted human teeth in laboratory conditions was investigated. Scanning electron microscope (SEM), energy dispersive x-ray spectroscopy (EDXS), wet chemical, ion chromatographic peak method (ICP), atomic absorption, x-ray diffraction and infra-red (IR) were performed separately for HA obtained from dentine and enamel. This naturally derived HA did not differ from synthetic ones. Its production was simple when compared with other methods. Processed tooth HA could safely be used in animal subjects prior to human studies as a graft material after biocompatibility studies fully conducted.
C1 Bosphorus Univ, Inst Biomed Engn, Istanbul, Turkey.
   Hacettepe Univ, Dept Chem Engn, Bioengn Div, TR-06532 Ankara, Turkey.
RP Oktar, FN (reprint author), Bosphorus Univ, Inst Biomed Engn, Istanbul, Turkey.
CR ABDELFATTAH WI, 1994, BIOMATERIALS, V15, P609, DOI 10.1016/0142-9612(94)90211-9
   Anselme K, 1997, J BIOMED MATER RES, V34, P247, DOI 10.1002/(SICI)1097-4636(199702)34:2<247::AID-JBM14>3.0.CO;2-F
   AOKI H, 1991, SCI MED APPL HYDROXY
   *ASTM COMM, 1988, F118588 ASTM, P514
   AUGAT P, 1995, J APPL BIOMATER, V6, P99, DOI 10.1002/jab.770060203
   BERNT CC, 1992, P INT THERM SPRAYING
   Best S, 1997, J MATER SCI-MATER M, V8, P97, DOI 10.1023/A:1018558816871
   BORETOS JW, 1985, J CERAM B, V64, P1098
   FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   HENCH LL, 1993, AM CERAM SOC BULL, V72, P93
   ISHAWA K, 1993, J MAT SCI MAT MED, V4, P165
   ITOH H, 1990, J DEN MAT, V13, P25
   JARCO M, 1987, INT J ORAL MAXILLOF, V16, P642
   *JOINT COMM POWD D, 1975, 25167 JOINT COMM POW
   JOSHI SV, 1993, J MATER SCI-MATER M, V4, P251, DOI 10.1007/BF00122276
   KELLER L, 1995, J BIOMED MATER RES, V29, P14
   LUGSCHEIDER E, 1992, P INT THER SPRAY CON
   Oonishi H, 1997, J BONE JOINT SURG BR, V79B, P87, DOI 10.1302/0301-620X.79B1.1290
   RECKORT HP, 1988, ZAHN MITT, V78, P843
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   RUNNELLS RR, 1993, J AM DENT ASSOC, V124, P65, DOI 10.14219/jada.archive.1993.0017
   Spitzer W J, 1991, Dtsch Zahnarztl Z, V46, P436
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   VANDIJK K, 1995, J BIOMED MATER RES, V29, P369
   WACHTEL HC, 1990, DTSCH ZAHNAERZL Z, V8, P458
   Yubao L, 1993, Biomaterials, V14, P969
   Zhang S, 1997, J MATER SCI-MATER M, V8, P25, DOI 10.1023/A:1018586128257
   1988, ZAHN WOCHE, V26, P11
   1988, ZAHN MITT, V78, P862
   1988, STELLUNGSNAHME DTSCH, V78, P857
   1996, FDI WORLD, V5, P11
NR 31
TC 59
Z9 59
U1 0
U2 5
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1073-1199
J9 ARTIF CELL BLOOD SUB
JI Artif. Cells Blood Substit. Immobil. Biotechnol.
PY 1999
VL 27
IS 4
BP 367
EP 379
DI 10.3109/10731199909117706
PG 13
WC Biotechnology & Applied Microbiology; Engineering, Biomedical; Materials
   Science, Biomaterials
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA 217AT
UT WOS:000081477700004
PM 10427420
DA 2018-10-19
ER

PT J
AU Kokubo, T
AF Kokubo, T
TI Novel biomedical materials based on glasses
SO BIOCERAMICS
SE MATERIALS SCIENCE FORUM
LA English
DT Article
DE bioactive glasses; bioactive glass-ceramics; bone-bonding mechanism;
   bioactive metals; bioactive polymers; bioactive cements; hyperthermia
   treatment; radiotherapy
ID BIOACTIVE BONE-CEMENT; SIMULATED BODY-FLUID; BIOMIMETIC PROCESS; APATITE
   FORMATION; ORGANIC POLYMERS; SILICA-GEL; SUBSTRATE; CERAMICS; LAYER;
   KINDS
AB Some bioactive glasses and glass-ceramics have occupied important positions in bone-repairing materials. Fundamental studies on their bone-bonding mechanism indicate that Si-OH and Ti-OH group on their surfaces induce the nucleation of bonelike apatite which is resposible for bonding to living bone. These findings provide us techniques for forming the biologically active bonelike apatite even on metals and organic polymers. A bioactive composite cement also can be derived from bioactive glass-ceramics. Ferrimagnetic crystals-containing glass-ceramics are useful as thermoseeds for hyperthermia treatment of cancers. Chemically durable glasses containing Y or P at high level can play an important role in radiotherapy of cancers.
C1 Kyoto Univ, Fac Engn, Div Mat Chem, Sakyo Ku, Kyoto 60601, Japan.
RP Kokubo, T (reprint author), Kyoto Univ, Fac Engn, Div Mat Chem, Sakyo Ku, Kyoto 60601, Japan.
CR ANDERSSON OH, 1988, GLASTECH BER-GLASS, V61, P300
   BERGER G, 1989, P 15 INT C GLASS A, V3, P120
   Bromer H., 1973, German patent, Patent No. [2,326,100, 2326100]
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   CHO SB, 1995, BIOCERAMICS, V8, P493
   CHOW LC, 1991, NIPPON SERAM KYO GAK, V99, P954
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Day DE, 1993, INTRO BIOCERAMICS, P305
   EBISAWA Y, 1991, NIPPON SERAM KYO GAK, V99, P7
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   Hench LL., 1993, INTRO BIOCERAMICS, P239
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Holand W., 1983, Wissenschaftliche Zeitschrift der Friedrich-Schiller-Universitaet Jena, Mathematisch-Naturwissenschaftliche Reihe, V32, P571
   IKENAGA M, 1993, J ORTHOP RES, V11, P849, DOI 10.1002/jor.1100110611
   KAWANABE K, 1993, J APPL BIOMATER, V4, P135, DOI 10.1002/jab.770040204
   KAWASHITA M, 1995, BIOCERAMICS, V8, P501
   Kim H. C., UNPUB
   KIM HM, 1995, J AM CERAM SOC, V78, P2405, DOI 10.1111/j.1151-2916.1995.tb08677.x
   KOKUBO T, 1991, J AM CERAM SOC, V74, P1739, DOI 10.1111/j.1151-2916.1991.tb07176.x
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kokubo T., 1993, BONE BONDING BIOMATE, P31
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P1721
   KOKUBO T, 1987, YOGYO-KYOKAI-SHI, V95, P785
   Lacefield WR, 1993, INTRO BIOCERAMICS, P223
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   LUDERER AA, 1983, RADIAT RES, V94, P190, DOI 10.2307/3575874
   Miyaji F, 1994, BIOCERAMICS, V7, P119
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   Ohtsuki C., 1991, J CERAM SOC JPN, V99, P1
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   Otsuki C, 1992, J NONCRYST SOLIDS, V143, P84
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   TANAHASHI M, 1995, J BIOMED MATER RES, V29, P349, DOI 10.1002/jbm.820290310
   WILSON J, 1993, INTRO BIOCERAMICS, P63
   YAMAMURO T, 1993, INTRO BIOCERAMICS, P89
NR 38
TC 12
Z9 22
U1 0
U2 3
PU TRANSTEC PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 1999
VL 293
BP 65
EP 81
DI 10.4028/www.scientific.net/MSF.293.65
PG 17
WC Materials Science, Multidisciplinary
SC Materials Science
GA BM15E
UT WOS:000077814000005
DA 2018-10-19
ER

PT J
AU Shackelford, JF
AF Shackelford, JF
TI Bioceramics - Current status and future trends
SO BIOCERAMICS
SE MATERIALS SCIENCE FORUM
LA English
DT Article
DE bioceramics; biomaterials; biomimetics; ceramics; glasses;
   hydroxyapatite
ID BONE DEFECTS; REPAIR
AB A wide range of ceramic materials are currently used in biomedical applications, from chemically pure oxides, such as alumina, to the chemically and microstructurally complex ceramic-matrix composites. Among the most significant applications are the hydroxyapatite coatings on hip prostheses and the use of hydroxyapatite and/or related calcium salts for bone defect and fracture repair.;Increasing applications of ceramic and glass materials can be expected in both orthopaedics and dentistry. The use of these materials in cancer treatment also appears promising. The development of biomimetic processing techniques and protein delivery systems represent the cutting edge in bioceramics, involving the merger of materials science with the biological sciences.
C1 Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.
RP Shackelford, JF (reprint author), Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.
CR BUNKER BC, 1994, SCIENCE, V264, P48, DOI 10.1126/science.264.5155.48
   Chapman MW, 1993, OPERATIVE ORTHOPAEDI, V1, P355
   CLARK A, 1991, ENG MAT HDB, V4, P1091
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DAVIDSON J, OR906 SMITH NEPH RIC
   DAY D, 1995, AM CERAM SOC BULL, V74, P64
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   FRAKER AC, 1977, JOM-J MIN MET MAT S, V29, P22, DOI 10.1007/BF03354319
   HENCH LL, 1993, AM CERAM SOC BULL, V72, P93
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   Hulbert S. F., 1982, Ceramics International, V8, P131, DOI 10.1016/0272-8842(82)90003-7
   Hunt M. S., 1987, MAT DESIGN, V8, P113
   Ikenaga M., 1991, BIOCERAMICS, V4, P255
   Johnson KD, 1996, J ORTHOPAED RES, V14, P351, DOI 10.1002/jor.1100140304
   KAWANABE K, 1992, BIOCERAMICS, V5, P233
   KUMAR P, 1991, J BIOMED MATER RES, V25, P813, DOI 10.1002/jbm.820250703
   MCINTYRE JP, 1991, AM CERAM SOC BULL, V70, P1499
   OHGUSHI H, 1997, IN PRESS P 2 INT C B
   Reddi A. Hari, 1997, Cytokine and Growth Factor Reviews, V8, P11, DOI 10.1016/S1359-6101(96)00049-4
   Shackelford J.F., 1996, INTRO MAT SCI ENG
   SHACKELFORD JF, 1998, BIOCERAMICS
   WHITE JE, 1994, KEY ENG MAT, V94
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 23
TC 35
Z9 37
U1 1
U2 12
PU TRANSTEC PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 1999
VL 293
BP 99
EP 106
DI 10.4028/www.scientific.net/MSF.293.99
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BM15E
UT WOS:000077814000007
DA 2018-10-19
ER

PT S
AU McKelvey, AL
   Ritchie, RO
AF McKelvey, AL
   Ritchie, RO
BE Neenan, T
   Marcolongo, M
   Valentini, RF
TI Fatigue-crack growth in the superelastic endovascular stent material
   nitinol
SO BIOMEDICAL MATERIALS-DRUG DELIVERY, IMPLANTS AND TISSUE ENGINEERING
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Biomedical Materials-Drug Delivery, Implants and Tissue
   Engineering
CY NOV 30-DEC 01, 1998
CL BOSTON, MA
SP Mat Res Soc
ID PARTIALLY-STABILIZED ZIRCONIA; TRANSFORMATION; PROPAGATION; CERAMICS;
   MARTENSITES; MECHANISMS
AB This paper describes a study of fatigue-crack propagation behavior in the superelastic alloy Nitinol. This work is motivated by biomedical applications, and the current interest to improve the design and performance of medical stents for implantation in the human body. Specifically, the objective of this work is to study the effect of environment on cyclic crack-growth resistance in a similar to 50Ni-50Ti (at. %) alloy, and to provide the necessary data for the safe life predication of Nitinol endovascular stents. The material selected for this study has been heat treated such that it is superelastic at human body temperature. Characterization of fatigue-crack growth rates has been performed at 37 degrees C on disc-shaped compact-tension samples, in environments of air, aerated deionized water, and aerated Hank's solution. Results indicate that, in fact, Nitinol has the lowest fatigue-crack growth resistance of metallic alloys currently used for implant-applications.
C1 Univ Calif Berkeley, Dept Mat Sci & Mineral Engn, Berkeley, CA 94720 USA.
RP McKelvey, AL (reprint author), Univ Calif Berkeley, Dept Mat Sci & Mineral Engn, Berkeley, CA 94720 USA.
CR BRAMFITT JE, 1994, SMST 94, P435
   BUDIANSKY B, 1983, INT J SOLIDS STRUCT, V19, P337, DOI 10.1016/0020-7683(83)90031-8
   Buehler W., 1965, US Patent, Patent No. [3,174,851, 3174851]
   CHUTER TAM, 1995, ENDOLUMINAL VASCULAR
   DAUSKARDT RH, 1990, J AM CERAM SOC, V73, P893, DOI 10.1111/j.1151-2916.1990.tb05132.x
   DAUSKARDT RH, 1989, MRS INT M ADV MAT, V9, P243
   Duerig TW, 1996, METALL, V50, P569
   EVANS AG, 1986, ACTA METALL MATER, V34, P761, DOI 10.1016/0001-6160(86)90052-0
   Garvie R. C., 1980, Ceramurgia International, V6, P19, DOI 10.1016/0390-5519(80)90028-9
   HANNINK RHJ, 1978, J MATER SCI, V13, P2487, DOI 10.1007/BF00808066
   HEUER AH, 1982, J AM CERAM SOC, V65, P642, DOI 10.1111/j.1151-2916.1982.tb09946.x
   HORNBOGEN E, 1978, ACTA METALL MATER, V26, P147, DOI 10.1016/0001-6160(78)90211-0
   JACKSON CM, 1972, 5110 NASASP
   LANGE FF, 1982, J MATER SCI, V17, P225, DOI 10.1007/BF00809057
   MCMEEKING RM, 1982, J AM CERAM SOC, V65, P242, DOI 10.1111/j.1151-2916.1982.tb10426.x
   MEI Z, 1990, METALL TRANS A, V21, P3137, DOI 10.1007/BF02647310
   MELTON KN, 1979, ACTA METALL MATER, V27, P137, DOI 10.1016/0001-6160(79)90065-8
   MIYAZAKI S, 1989, MAT RES SOC P, V9, P263
   OLSON GB, 1976, METALL TRANS A, V7, P1897, DOI 10.1007/BF02659822
   PORTER DL, 1977, J AM CERAM SOC, V60, P183, DOI 10.1111/j.1151-2916.1977.tb15509.x
   RITCHIE RO, 1988, MAT SCI ENG A-STRUCT, V103, P15, DOI 10.1016/0025-5416(88)90547-2
   Ritchie RO, 1996, J HEART VALVE DIS, V5, pS9
   SABURI T, 1979, ACTA METALL MATER, V27, P979, DOI 10.1016/0001-6160(79)90186-X
   SURESH S, 1991, FATIGUE MAT, P356
   SWAIN MV, 1983, J AM CERAM SOC, V66, P358, DOI 10.1111/j.1151-2916.1983.tb10049.x
   Wayman CM, 1990, ENG ASPECTS SHAPE ME, P3
NR 26
TC 2
Z9 2
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-456-4
J9 MATER RES SOC SYMP P
PY 1999
VL 550
BP 281
EP 286
PG 6
WC Biotechnology & Applied Microbiology; Materials Science,
   Multidisciplinary; Materials Science, Biomaterials; Pharmacology &
   Pharmacy
SC Biotechnology & Applied Microbiology; Materials Science; Pharmacology &
   Pharmacy
GA BN11N
UT WOS:000080751700041
DA 2018-10-19
ER

PT S
AU Lezal, D
   Pedlikova, J
   Karel, M
   Horak, L
   Zavadil, J
AF Lezal, D
   Pedlikova, J
   Karel, M
   Horak, L
   Zavadil, J
BE Baldini, F
   Croitoru, NI
   Frenz, M
   Lundstrom, I
   Miyagi, M
   Pratesi, R
   Wolfbeis, OS
TI Special glasses for passive and active IR fibers for medical and
   biomedical applications
SO BIOMEDICAL SENSORS, FIBERS, AND OPTICAL DELIVERY SYSTEMS, PROCEEDINGS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Sensors, Fibers, and Optical Delivery Systems
CY SEP 08-10, 1998
CL STOCKHOLM, SWEDEN
SP EOS-European Opt Soc, SPIE-Int Soc Opt Engn, ELA-European Laser Assoc, SSL-Scandinavian Soc Laser Therapy, IBOS-Int Biomed Opt Soc, SOS-Swedish Opt Soc, Commiss European Communities
DE sulfides; tellurites; glasses; rare earth; active fibers
AB General chemical compositions of prepared glasses with low OH group concentrations are Ge0.25Ga0.10S0.65, Ge0.25Ga0.05As0.05S0.65, (TeO2)(x) - (PbCl2)(1-x) with x = 0.4 to 0.6 and (TeO2)(x) - (ZnO)(1-x) with x = 0.75 to 0.80. Samples doped with 500 to 12000 ppm rare earth in weight were prepared. Rare earth doped glasses are homogeneous when RE concentration is less than 3000 ppm. Heterogeneous inclusions arise beyond 1000 ppm RE when doping is made with chloride or oxide. Electron microscopy, absorption and fluorescence measurements have been made. YAG:Nd, Ar, He-Ne lasers were used for excitation of photoluminiscence.
   The color and the optical quality of the tellurite glasses depend on crucible materials. Rare earth doping results in visible defects or inhomogeneities when concentration is larger than 1000 ppm. The chemical composition and the optical absorption of doped and undoped samples was examined. Fluorescence intensity of Pr and Dy is smaller in these HMO glasses than in the sulfide glasses, this results from higher phonon energy and higher OH concentration. Further development is required for future applications.
C1 IIC AV, Lab Inorgan Mat, Prague 6, Czech Republic.
RP Lezal, D (reprint author), IIC AV, Lab Inorgan Mat, Pelleova 24, Prague 6, Czech Republic.
RI Zavadil, Jiri/G-1930-2014
OI Zavadil, Jiri/0000-0002-1746-4747
CR BERTHEREAU A, 1994, MATER RES BULL, V29, P933, DOI 10.1016/0025-5408(94)90053-1
   BRUCE GB, 1996, 10 INT S NON GLASS C, P302
   HEWAK DW, 1996, P 10 INT S NON GLASS, P157
   LEZAL D, 1996, P SPIE, V2928
   LEZAL D, 1996, CERAMICS SILIKATY, V40
   MacFarlane DR, 1996, CERAM INT, V22, P535, DOI 10.1016/0272-8842(95)00129-8
   McDougall J, 1996, PHYS CHEM GLASSES, V37, P254
   MORGAN SP, 1996, P 10 INT S NON GLASS
NR 8
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3032-3
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3570
BP 53
EP 61
DI 10.1117/12.336915
PG 9
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Microbiology; Optics
SC Biotechnology & Applied Microbiology; Engineering; Microbiology; Optics
GA BM45P
UT WOS:000078785700007
DA 2018-10-19
ER

PT S
AU Ebringerova, A
   Hromadkova, Z
AF Ebringerova, A
   Hromadkova, Z
BE Harding, SE
TI Xylans of industrial and biomedical importance
SO BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, VOL 16
SE Biotechnology & Genetic Engineering Reviews
LA English
DT Review
ID CELL-WALL MATERIAL; SODIUM PENTOSAN POLYSULFATE; MOLECULAR-WEIGHT
   DISTRIBUTION; RYE-BRAN ARABINOXYLAN; CORN COB HETEROXYLANS; LARGE-SCALE
   ISOLATION; PULP OLEA-EUROPAEA; PINE KRAFT PULP; PHASE-I TRIAL;
   WHEAT-FLOUR
C1 Slovak Acad Sci, Inst Chem, Bratislava 84238, Slovakia.
RP Ebringerova, A (reprint author), Slovak Acad Sci, Inst Chem, Dubravska Cesta 9, Bratislava 84238, Slovakia.
CR ADAMCZYK J, 1992, Patent No. 9221769
   Amash A, 1998, POLYM BULL, V40, P251, DOI 10.1007/s002890050249
   Anderson JM, 1997, CURR THER RES CLIN E, V58, P93, DOI 10.1016/S0011-393X(97)80118-X
   Anees M, 1996, J ENZYM INHIB, V10, P203, DOI 10.3109/14756369609030314
   ANNISON G, 1992, CARBOHYD POLYM, V19, P151, DOI 10.1016/0144-8617(92)90155-J
   Antal M, 1997, PAPIER, V51, P223
   ANTAL M, 1991, PAPIER, V45, P232
   AOE S, 1992, Patent No. 4360835
   AOYAMA M, 1994, HOLZ ROH WERKST, V52, P388, DOI 10.1007/BF02615390
   AOYAMA M, 1995, HOLZFORSCHUNG, V49, P193, DOI 10.1515/hfsg.1995.49.3.193
   ASP NG, 1993, CARBOHYD POLYM, V21, P183, DOI 10.1016/0144-8617(93)90016-W
   Aspinall G. O., 1983, POLYSACCHARIDES, P196
   ASPINALL GO, 1991, CARBOHYD RES, V214, P107, DOI 10.1016/S0008-6215(00)90534-2
   ATALLA RH, 1993, INT J BIOL MACROMOL, V15, P109, DOI 10.1016/0141-8130(93)90007-9
   ATKINS EDT, 1992, PROGR BIOTECHNOL, V7, P39
   Baghurst PA, 1996, FOOD AUST, V48, pS3
   Barroso NP, 1997, BOL SOC CHIL QUIM, V42, P301
   Bataillon M, 1998, IND CROP PROD, V8, P37, DOI 10.1016/S0926-6690(97)10002-4
   BAZUS A, 1993, CARBOHYD RES, V243, P323, DOI 10.1016/0008-6215(93)87036-R
   BAZUS A, 1992, BIOSCI BIOTECH BIOCH, V56, P508, DOI 10.1271/bbb.56.508
   BENTOULMOU N, 1997, REPRODUCTION NUTR DE, V37, P356
   BENTOULMOU N, 1997, REPRODUCTION NUTR DE, V37, P361
   BHADURI SK, 1995, IND CROP PROD, V4, P79, DOI 10.1016/0926-6690(95)00018-8
   Billa E, 1997, IND CROP PROD, V6, P297, DOI 10.1016/S0926-6690(97)00031-9
   Buchert J, 1997, TAPPI J, V80, P165
   BUCHERT J, 1995, TAPPI J, V78, P125
   Chan KL, 1997, J PEDIATR SURG, V32, P3, DOI 10.1016/S0022-3468(97)90079-8
   Chanliaud E, 1996, CARBOHYD POLYM, V31, P41, DOI 10.1016/S0144-8617(96)00032-X
   CHANLIAUD E, 1995, J CEREAL SCI, V21, P195, DOI 10.1016/0733-5210(95)90035-7
   CHEN P, 1995, ANAL BIOCHEM, V226, P186, DOI 10.1006/abio.1995.1209
   Chesson Andrew, 1995, V67, P547
   Cleemput G, 1997, J CEREAL SCI, V26, P55, DOI 10.1006/jcrs.1996.0099
   CLEEMPUT G, 1995, J CEREAL SCI, V22, P73, DOI 10.1016/S0733-5210(05)80009-8
   Coimbra MA, 1995, CARBOHYD POLYM, V27, P277, DOI 10.1016/0144-8617(95)00067-4
   COIMBRA MA, 1994, CARBOHYD RES, V252, P245, DOI 10.1016/0008-6215(94)84136-5
   Dace R, 1997, THROMB RES, V87, P113, DOI 10.1016/S0049-3848(97)00110-2
   Dhami R, 1995, CARBOHYD POLYM, V28, P113, DOI 10.1016/0144-8617(95)00099-2
   DIRINGER H, 1991, Patent No. 464759
   DOCTOR VM, 1991, THROMB RES, V64, P413, DOI 10.1016/0049-3848(91)90342-T
   DUDKIN MS, 1991, GEMICELLJULOZY
   EBRINGEROVA A, 1994, CARBOHYD POLYM, V24, P301, DOI 10.1016/0144-8617(94)90075-2
   Ebringerova A, 1996, J APPL POLYM SCI, V62, P1043
   Ebringerova A, 1998, J APPL POLYM SCI, V67, P1523
   Ebringerova A, 1996, ANGEW MAKROMOL CHEM, V242, P97, DOI 10.1002/apmc.1996.052420106
   EBRINGEROVA A, 1992, CARBOHYD POLYM, V19, P99, DOI 10.1016/0144-8617(92)90119-B
   EBRINGEROVA A, 1994, CARBOHYD RES, V264, P97, DOI 10.1016/0008-6215(94)00183-9
   Ebringerova A, 1997, ULTRASON SONOCHEM, V4, P305, DOI 10.1016/S1350-4177(97)00037-0
   EBRINGEROVA A, 1994, CARBOHYD POLYM, V24, P161, DOI 10.1016/0144-8617(94)90126-0
   EBRINGEROVA A, 1992, FOOD HYDROCOLLOID, V6, P437, DOI 10.1016/S0268-005X(09)80029-5
   Ebringerova A, 1995, INT J BIOL MACROMOL, V17, P327, DOI 10.1016/0141-8130(96)81840-X
   EBRINGEROVA A, 1992, PAPIER, V46, P726
   Ebringerova A, 1996, HOLZ ROH WERKST, V54, P127, DOI 10.1007/s001070050151
   EBRINGEROVA A, 1995, J MICROBIOL BIOTECHN, V10, P640
   EBRINGEROVA A, 1993, 7 EUR CARB S AUG 22, pD3
   EBRINGEROVA A, 1998, CARBOHYDRATE ORGANIC, V4, P118
   Elliot SJ, 1997, J AM SOC NEPHROL, V8, pA2388
   Este JA, 1996, ANTIVIR RES, V29, P297, DOI 10.1016/0166-3542(95)00936-1
   FAN YR, 1987, ACTA PHARMACOL SIN, V8, P166
   FAUROT AL, 1995, FOOD SCI TECHNOL-LEB, V28, P436
   Fengel D., 1984, WOOD CHEM ULTRASTRUC, P167
   FERRAO AV, 1993, BIOCHIM BIOPHYS ACTA, V1180, P225, DOI 10.1016/0925-4439(93)90042-Y
   FRANCIS DJ, 1993, RHEUMATOL INT, V13, P61, DOI 10.1007/BF00307735
   Fujisawa M, 1992, Nihon Hinyokika Gakkai Zasshi, V83, P1647
   FUKUSHI Y, 1988, CARBOHYD RES, V182, P313, DOI 10.1016/0008-6215(88)84014-X
   GarciaConesa MT, 1997, REDOX REP, V3, P239, DOI 10.1080/13510002.1997.11747116
   Ghosh P, 1996, OSTEOARTHR CARTILAGE, V4, P43, DOI 10.1016/S1063-4584(96)80006-9
   GILLESPIE L, 1991, Patent No. 466315
   GIRHAMMAR U, 1995, FOOD HYDROCOLLOID, V9, P133, DOI 10.1016/S0268-005X(09)80275-0
   GLASSER WG, 1996, BIOTECHNOL ADV, V14, P605
   GRABBER JH, 1995, PHYTOCHEMISTRY, V40, P1077, DOI 10.1016/0031-9422(95)00413-2
   GREENSHIELDS RN, 1992, Patent No. 2261671
   Gregory ACE, 1998, BIOTECHNOL GENET ENG, V15, P439, DOI 10.1080/02648725.1998.10647965
   GRUPPEN H, 1993, J CEREAL SCI, V18, P111, DOI 10.1006/jcrs.1993.1040
   GRUPPEN H, 1991, J CEREAL SCI, V13, P275, DOI 10.1016/S0733-5210(09)80006-4
   Han JY, 1996, J AM SOC BREW CHEM, V54, P216
   Harkonen H, 1997, J CEREAL SCI, V26, P95, DOI 10.1006/jcrs.1996.0106
   HASHI M, 1979, AGR BIOL CHEM TOKYO, V43, P961, DOI 10.1080/00021369.1979.10863565
   HAWKINS MJ, 1995, EUROPEAN J CANC A, V31, pS14
   HERATH HMTB, 1990, CARBOHYD RES, V198, P343, DOI 10.1016/0008-6215(90)84304-D
   Hoffmann P, 1997, THROMB RES, V86, P325, DOI 10.1016/S0049-3848(97)00075-3
   HOLMES H C, 1991, Antiviral Chemistry and Chemotherapy, V2, P287
   HROMADKOVA Z, 1995, CHEM PAP-CHEM ZVESTI, V49, P97
   Hromadkova Z, 1999, IND CROP PROD, V9, P101, DOI 10.1016/S0926-6690(98)00020-X
   Hromadkova Z, 1996, J WOOD CHEM TECHNOL, V16, P221, DOI 10.1080/02773819608545805
   HROMADKOVA Z, 1991, PAPIER, V45, P157
   HROMADKOVA Z, 1994, CHEM LISTY, V88, P591
   HROMADKOVA Z, 1993, PAPIER, V47, pA587
   HROMADKOVA Z, 1997, P 8 BRAT S SACCH SMO, P95
   Hwang P, 1997, UROLOGY, V50, P39, DOI 10.1016/S0090-4295(97)00110-6
   Imai T, 1997, MOKUZAI GAKKAISHI, V43, P241
   Ishihara M, 1996, MOKUZAI GAKKAISHI, V42, P1211
   Ishii T, 1997, PLANT SCI, V127, P111, DOI 10.1016/S0168-9452(97)00130-1
   Izydorczyk MS, 1995, CARBOHYD POLYM, V28, P33, DOI 10.1016/0144-8617(95)00077-1
   Jerez JR, 1997, CARBOHYD POLYM, V32, P155, DOI 10.1016/S0144-8617(96)00119-1
   KANARI M, 1989, CHEM PHARM BULL, V37, P3191
   Kardosova A, 1998, CARBOHYD RES, V308, P99, DOI 10.1016/S0008-6215(98)00072-X
   KARDOSOVA A, 1990, CHEM PAP-CHEM ZVESTI, V44, P111
   KAVITHA R, 1992, CEREAL CHEM, V69, P440
   KIESEL J, 1991, THROMB RES, V64, P301, DOI 10.1016/0049-3848(91)90001-D
   KINDEL PK, 1989, CARBOHYD RES, V187, P173, DOI 10.1016/0008-6215(89)80001-1
   KLOCKING HP, 1992, THROMB RES, V67, P41, DOI 10.1016/0049-3848(92)90256-A
   Koch P, 1996, CONTACT DERMATITIS, V34, P156, DOI 10.1111/j.1600-0536.1996.tb02162.x
   KOHN R, 1986, COLLECT CZECH CHEM C, V51, P2243, DOI 10.1135/cccc19862243
   KOLLAR L, 1994, PERFUSION, V7, P18
   KOSIKOVA B, 1991, APITTA, V45, P425
   KRONE V, 1991, Patent No. 4540044
   KWAN JS, 1995, CARBOHYD POLYM, V26, P99, DOI 10.1016/0144-8617(94)00098-E
   LAHAYE M, 1993, FOOD CHEM, V47, P29, DOI 10.1016/0308-8146(93)90298-T
   Lawther JM, 1996, J APPL POLYM SCI, V60, P1827, DOI 10.1002/(SICI)1097-4628(19960613)60:11<1827::AID-APP6>3.0.CO;2-N
   Lee ST, 1997, J MICROBIOL METH, V29, P1, DOI 10.1016/S0167-7012(97)00986-X
   Lempereur I, 1997, J CEREAL SCI, V25, P103, DOI 10.1006/jcrs.1996.0090
   LENZ J, 1984, RHEOL ACTA, V23, P570, DOI 10.1007/BF01329291
   Li JB, 1997, CARBOHYD RES, V302, P213, DOI 10.1016/S0008-6215(97)00125-0
   Lush RM, 1996, ANN ONCOL, V7, P939
   Marshall JL, 1997, CLIN CANCER RES, V3, P2347
   MATULEWICZ MC, 1992, INT J BIOL MACROMOL, V14, P29, DOI 10.1016/S0141-8130(05)80016-9
   MATULEWICZ MC, 1987, PHYTOCHEMISTRY, V26, P1033, DOI 10.1016/S0031-9422(00)82344-4
   MELLON JE, 1995, APPL ENVIRON MICROB, V61, P4409
   Methacanon Pawadee, 1997, Carbohydrate Polymers, V34, P435, DOI 10.1016/S0144-8617(97)87391-2
   Mohri T, 1995, J GEN PHYSIOL, V106, P28
   NDiaye S, 1996, BIORESOURCE TECHNOL, V57, P61, DOI 10.1016/0960-8524(96)00041-7
   NETHERY A, 1992, BIOCHEM PHARMACOL, V44, P1549, DOI 10.1016/0006-2952(92)90471-T
   Neto CP, 1997, IND CROP PROD, V6, P51, DOI 10.1016/S0926-6690(96)00205-1
   Neto CP, 1996, IND CROP PROD, V5, P189, DOI 10.1016/0926-6690(96)89448-9
   Ng A, 1997, CARBOHYD RES, V303, P459, DOI 10.1016/S0008-6215(97)00193-6
   NGUYEN NM, 1993, ANTICANCER RES, V13, P2143
   Nilsson M, 1996, CARBOHYD POLYM, V30, P229, DOI 10.1016/S0144-8617(96)00071-9
   Orme CE, 1997, ACTA PHYSIOL SCAND, V159, P179, DOI 10.1046/j.1365-201X.1997.504239000.x
   Papatheofanous MG, 1998, IND CROP PROD, V7, P249, DOI 10.1016/S0926-6690(97)00055-1
   PARISH CR, 1997, BIOTECHNOLOGY ADV, V15, P525
   PARSONS CL, 1992, Patent No. 5180715
   PIENTA KJ, 1992, PROSTATE, V20, P233, DOI 10.1002/pros.2990200308
   PROKSCH A, 1987, PHYTOCHEMISTRY, V26, P1989, DOI 10.1016/S0031-9422(00)81744-6
   PURINA L, 1991, WOOD CHEM KHIMIJA DR, P37
   RAISS R, 1992, Patent No. 9213541
   RALPH J, 1995, CARBOHYD RES, V275, P167, DOI 10.1016/0008-6215(95)00237-N
   Read RA, 1996, J SMALL ANIM PRACT, V37, P108, DOI 10.1111/j.1748-5827.1996.tb02355.x
   Renard CMGC, 1997, INT J BIOL MACROMOL, V21, P155, DOI 10.1016/S0141-8130(97)00055-X
   Rochet V, 1997, REPROD NUTR DEV, V37, P221, DOI 10.1051/rnd:19970210
   ROGACHEFSKY RA, 1994, ANN NY ACAD SCI, V732, P392, DOI 10.1111/j.1749-6632.1994.tb24763.x
   ROSNER H, 1992, CARBOHYD RES, V223, P329, DOI 10.1016/0008-6215(92)80032-V
   SAULNIER L, 1995, CARBOHYD RES, V272, P241, DOI 10.1016/0008-6215(95)00053-V
   SAULNIER L, 1995, CARBOHYD POLYM, V26, P279, DOI 10.1016/0144-8617(95)00020-8
   SAULNIER L, 1998, CARBOHYDRATES ORGANI, V4, P132
   SCHNABELRAUCH M, 1992, Patent No. 299312
   SCHOLS D, 1992, ANTIVIR CHEM CHEMOTH, V3, P23, DOI 10.1177/095632029200300104
   Schwartsmann G, 1996, TUMORI, V82, P360
   SCHWARZ PB, 1995, J AM SOC BREW CHEM, V53, P157
   Senthil D, 1996, MOL CELL BIOCHEM, V156, P31
   SHUBA K, 1992, BIOCH INT, V27, P1011
   SIMKOVIC I, 1992, CARBOHYD POLYM, V17, P285, DOI 10.1016/0144-8617(92)90171-L
   SIMKOVIC I, 1990, HOLZFORSCHUNG, V44, P113, DOI 10.1515/hfsg.1990.44.2.113
   SROKOVA I, 1997, P 8 BRAT S SACCH SEP, P97
   Stephen A.M., 1983, POLYSACCHARIDES, P98
   Stewart D, 1997, IND CROP PROD, V6, P17, DOI 10.1016/S0926-6690(96)00172-0
   STSCHERBINA D, 1991, ACTA POLYM, V42, P345, DOI 10.1002/actp.1991.010420801
   Sun RC, 1998, IND CROP PROD, V7, P121, DOI 10.1016/S0926-6690(97)00040-X
   SWAIN SM, 1995, INVEST NEW DRUG, V13, P55, DOI 10.1007/BF02614221
   SWAMY NR, 1990, CARBOHYD RES, V197, P327
   TAMAGAKI T, 1997, BIOSCIENCE BIOTECHNO, V61, P1077
   Teleman A, 1996, CARBOHYD RES, V293, P1, DOI 10.1016/0008-6215(96)00170-X
   TELEMAN A, 1995, CARBOHYD RES, V272, P55, DOI 10.1016/0008-6215(95)96873-M
   Thiebaud S, 1998, BIORESOURCE TECHNOL, V63, P139, DOI 10.1016/S0960-8524(97)00078-3
   THORMAR H, 1995, ANTIVIR RES, V27, P49, DOI 10.1016/0166-3542(94)00082-J
   vanHazendonk JM, 1996, CARBOHYD RES, V291, P141
   VERBRUGGEN MA, 1993, J CEREAL SCI, V17, P71, DOI 10.1006/jcrs.1993.1008
   VERBRUGGEN MA, 1995, J CEREAL SCI, V21, P271, DOI 10.1006/jcrs.1995.0030
   VIETOR RJ, 1992, J CEREAL SCI, V15, P213, DOI 10.1016/S0733-5210(09)80120-3
   VIETOR RJ, 1994, CARBOHYD POLYM, V24, P113, DOI 10.1016/0144-8617(94)90020-5
   VINCENDON M, 1993, MAKROMOL CHEM, V194, P321
   Vincendon M, 1998, J APPL POLYM SCI, V67, P455
   Vinkx CJA, 1996, J CEREAL SCI, V24, P1, DOI 10.1006/jcrs.1996.0032
   VISSER J, 1992, XYLAN XYLANASES
   VONBRIESEN H, 1990, RES VIROLOGY, V141, P251, DOI 10.1016/0923-2516(90)90029-I
   WAGENKNECHT W, 1992, Patent No. 298643
   WAGNER H, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1069
   WALLACE G, 1995, PHYTOCHEMISTRY, V39, P1293, DOI 10.1016/0031-9422(95)00048-C
   WALLACE G, 1995, CARBOHYD RES, V272, P41, DOI 10.1016/0008-6215(95)00036-S
   Wende G, 1997, PHYTOCHEMISTRY, V44, P1011, DOI 10.1016/S0031-9422(96)00648-6
   Wende G, 1997, PHYTOCHEMISTRY, V44, P1019, DOI 10.1016/S0031-9422(96)00649-8
   Whistler R L, 1976, Adv Carbohydr Chem Biochem, V32, P235
   WHISTLER RL, 1989, FRONTIERS CARBOHYDRA, V1, P289
   WILLIAMS RJ, 1992, THERMOCHIM ACTA, V212, P105, DOI 10.1016/0040-6031(92)80225-L
   WIMALASIRI KMS, 1995, CARBOHYD POLYM, V26, P19, DOI 10.1016/0144-8617(95)98829-6
   Wong KKY, 1995, ACS SYM SER, V618, P352
   WUN TC, 1992, BLOOD, V79, P430
   YAMADA H, 1985, CARBOHYD RES, V144, P101, DOI 10.1016/0008-6215(85)85011-4
   Yamagaki T, 1996, BIOSCI BIOTECH BIOCH, V60, P1222, DOI 10.1271/bbb.60.1222
   Yamagaki T, 1997, BIOSCI BIOTECH BIOCH, V61, P1281, DOI 10.1271/bbb.61.1281
   YOKOTA S, 1995, PULP PAP-CANADA, V96, P39
   YUI T, 1995, BIOSCI BIOTECH BIOCH, V59, P965, DOI 10.1271/bbb.59.965
NR 191
TC 73
Z9 74
U1 2
U2 24
PU INTERCEPT LTD SCIENTIFIC, TECHNICAL & MEDICAL PUBLISHERS
PI ANDOVER
PA PO BOX 716, ANDOVER SP10 1YG, HANTS, ENGLAND
SN 0264-8725
BN 1-898298-58-0
J9 BIOTECHNOL GENET ENG
JI Biotechnol. Genet. Eng. Rev.
PY 1999
VL 16
BP 325
EP 346
DI 10.1080/02648725.1999.10647982
PG 22
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology; Chemistry, Physical; Genetics &
   Heredity; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Genetics & Heredity; Pharmacology & Pharmacy
GA BN42Q
UT WOS:000081897100014
PM 10819084
OA Bronze
DA 2018-10-19
ER

PT J
AU Shen, WC
   Wen, SZ
   Cao, NZ
   Zheng, L
   Zhou, W
   Liu, YJ
   Gu, JL
AF Shen, WC
   Wen, SZ
   Cao, NZ
   Zheng, L
   Zhou, W
   Liu, YJ
   Gu, JL
TI Expanded graphite - A new kind of biomedical material
SO CARBON
LA English
DT Letter
DE exfoliated graphite; porosity; adsorption properties
C1 Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Shen, WC (reprint author), Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RI Zhou, Wei/C-6504-2008
OI Zhou, Wei/0000-0002-5461-3617
CR Cao N, 1996, CHEM B, V4, P37
   Cao N.Z., 1997, CHEM RES APPL, V9, P54
   Cao N.Z., 1997, CHINA ENV SCI, V17, P188
   Cao NZ, 1996, ACTA PHYS-CHIM SIN, V12, P766, DOI 10.3866/PKU.WHXB19960819
   CAO NJ, 1996, CHINESE J BIOMED ENG, V15, P287
   CAO NZ, 1996, P EUR CARB C ROY SOC, P114
   KABOVICH ZK, 1991, Patent No. 1697752
   KABOVICH ZK, 1994, Patent No. 1694124
   SHEN WC, 1996, P EUR CARB C ROY SOC, P348
NR 9
TC 20
Z9 24
U1 0
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0008-6223
J9 CARBON
JI Carbon
PY 1999
VL 37
IS 2
BP 356
EP 358
PG 3
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 169EG
UT WOS:000078734100026
DA 2018-10-19
ER

PT J
AU Chen, YL
   Mao, HB
   Zhang, XF
   Gong, YD
   Zhao, NM
AF Chen, YL
   Mao, HB
   Zhang, XF
   Gong, YD
   Zhao, NM
TI Increase in the transition enthalpy of fibrinogen upon adsorption onto
   hydroxyapatite
SO CHINESE PHYSICS LETTERS
LA English
DT Article
ID SOLID-LIQUID INTERFACES; CALCIUM; CALORIMETRY; PROTEINS
AB The increase of the protein transition enthalpy upon adsorption onto biomedical material surfaces was observed by measuring the differential scanning calorimetry (DSC) traces of bovine fibrinogen adsorbed onto a hydroxyapatite surface. The mechanism causing the transition enthalpy increase upon adsorption was clarified by using DSC measurements of bovine fibrinogen for different ionic strength and sodium dodecyl sulfate concentrations. The results suggest that the increased fibrinogen transition enthalpy may be attributed to the electrostatic interactions between the carboxyl of the D domains and the calcium loci of hydroxyapatite, which may result in a more compact protein structure.
C1 Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
RP Chen, YL (reprint author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
RI Mao, Haibin/B-7609-2011
CR DONOVAN JW, 1985, BIOCHEMISTRY-US, V24, P3434, DOI 10.1021/bi00335a007
   FENG L, 1994, J BIOMED MATER RES, V28, P735, DOI 10.1002/jbm.820280611
   FENG L, 1995, ACS SYM SER, V602, P68
   Giancola C, 1997, INT J BIOL MACROMOL, V20, P193, DOI 10.1016/S0141-8130(97)01159-8
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   MARGUERIE G, 1977, BIOCHIM BIOPHYS ACTA, V490, P94, DOI 10.1016/0005-2795(77)90109-X
   MIHALYI E, 1985, BIOCHEMISTRY-US, V24, P3443, DOI 10.1021/bi00335a008
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   PRIVALOV PL, 1982, J MOL BIOL, V159, P665, DOI 10.1016/0022-2836(82)90107-3
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   STEADMAN BL, 1992, BIOTECHNOL BIOENG, V40, P8, DOI 10.1002/bit.260400103
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   Yan GY, 1995, ACS SYM SER, V602, P256
NR 13
TC 1
Z9 1
U1 0
U2 1
PU ALLERTON PRESS INC
PI NEW YORK
PA 150 FIFTH AVE, NEW YORK, NY 10011 USA
SN 0256-307X
J9 CHINESE PHYS LETT
JI Chin. Phys. Lett.
PY 1999
VL 16
IS 6
BP 431
EP 433
DI 10.1088/0256-307X/16/6/016
PG 3
WC Physics, Multidisciplinary
SC Physics
GA 217DK
UT WOS:000081484400016
DA 2018-10-19
ER

PT S
AU Salinas-Rodriguez, A
AF Salinas-Rodriguez, A
BE Disegi, JA
   Kennedy, RL
   Pilliar, R
TI The role of the FCC-HCP phase transformation during the plastic
   deformation of Co-Cr-Mo-C alloys for biomedical applications
SO COBALT-BASE ALLOYS FOR BIOMEDICAL APPLICATIONS
SE AMERICAN SOCIETY FOR TESTING AND MATERIALS SPECIAL TECHNICAL PUBLICATION
LA English
DT Proceedings Paper
CT Symposium on Cobalt-Base Alloys for Biomedical Applications
CY NOV 03-04, 1998
CL NORFOLK, VA
SP ASTM Comm F 4, Med Surg Mat & Dev
DE plastic deformation; strain hardening; microstructure; cobalt-base
   alloys
ID MECHANISMS
AB The plastic deformation behavior of solution treated Co-27Cr-5Mo cast alloys with C contents up to 0.31 wt% were studied at 298 K by means of uniaxial tension and compression tests. In addition, the effect of initial grain size on the plastic flow behavior of annealed Co-27Cr-5Mo-0.05C wrought alloy was investigated. Optical and scanning electron microscopy and X-ray diffraction techniques were used to characterize the microstructures produced by plastic deformation.
   Carbon contents greater than 0.05 wt% and furnace cooling after solution treatments at 1250 degrees C were found to inhibit the occurrence of strain-induced fcc(metastable)double right arrow hcp phase transformation and lead to high strain hardening rate, high strength and low ductility. A similar behavior was found in annealed, 0.05 wt% C alloy for grain sizes smaller than 10 mu m. In contrast, a fast cooling rate after the solution treatment and grain sizes in the range 100-2000 mu m for this later alloy were found to promote phase transformation during deformation which lead to a rapid decrease of the rate of strain hardening. The yield strength and the strain hardening behavior of both cast-solution treated and wrought-annealed materials were found to depend on the type of loading during the tests.
   The results allowed to conclude that the strain-induced fcc(metastable)double right arrow hcp phase transformation plays an important role during large strain plastic deformation of low carbon Co-27Cr-5Mo implant alloys. However, when the carbon C in these alloys is larger than 0.05 wt%, the ductility and the fracture behavior are controlled by the size, morphology and distribution of secondary phase carbide particles in the microstructure.
C1 CINVESTAV, Unidad Saltillo, Coahuila 25000, Mexico.
RP Salinas-Rodriguez, A (reprint author), CINVESTAV, Unidad Saltillo, POB 663, Coahuila 25000, Mexico.
CR GRAHAM AH, 1970, METALL TRANS, V1, P423, DOI 10.1007/BF02811551
   KILNER T, 1986, J MATER SCI, V21, P1349, DOI 10.1007/BF00553274
   KILNER T, 1982, SCRIPTA METALL MATER, V16, P741, DOI 10.1016/0036-9748(82)90333-7
   OLSON GB, 1975, METALL TRANS, VA  6, P791, DOI 10.1007/BF02672301
   RAJAN K, 1982, J MATER SCI, V17, P769, DOI 10.1007/BF00540374
   RAJAN K, 1982, METALL TRANS A, V13, P1161, DOI 10.1007/BF02645497
   Sage M., 1950, REV MET, V47, P139
   SALDIVAR GA, 1998, THESIS CINVESTAV SAL
   SalinasRodriguez A, 1996, J BIOMED MATER RES, V31, P409, DOI 10.1002/(SICI)1097-4636(199607)31:3<409::AID-JBM16>3.0.CO;2-D
   VANDERSANDE JB, 1976, METALL TRANS A, V7, P389
NR 10
TC 4
Z9 4
U1 0
U2 2
PU AMERICAN SOCIETY TESTING AND MATERIALS
PI W CONSHOHOCKEN
PA 100 BARR HARBOR DRIVE, W CONSHOHOCKEN, PA 19428-2959 USA
SN 1040-1695
BN 0-8031-2608-5
J9 AM SOC TEST MATER
PY 1999
VL 1365
BP 108
EP 121
PG 14
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials
SC Engineering; Materials Science
GA BN93M
UT WOS:000083576900010
DA 2018-10-19
ER

PT S
AU Girkin, JM
   Burns, D
   Dawson, MD
AF Girkin, JM
   Burns, D
   Dawson, MD
BE Reed, MK
   Neev, J
TI Macroscopic multiphoton biomedical imaging using semiconductor saturable
   Bragg reflector modelocked Lasers
SO COMMERCIAL AND BIOMEDICAL APPLICATIONS OF ULTRAFAST LASERS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Commercial and Biomedical Applications of Ultrafast Lasers
CY JAN 28-29, 1999
CL SAN JOSE, CA
SP SPIE
DE diode pumped lasers; passive modelocking; semiconductor saturable
   absorber mirror; multiphoton imaging; detection of dental disease
ID FLUORESCENCE
AB We report on the development of practical and user friendly lasers for multiphoton imaging of biological material. The laser developed for the work is a laser diode pumped Cr:LiSAF source modelocked using a saturable Bragg reflector as the passive modelocking element. From this system we routinely obtain 100fs pulses at a repetition rate 200MHz with an average output power of 20mW. The laser has a single operator control and is particularly suitable for use by non-laser specialists.
   We have used the source developed to image a range of biologically significant samples. The initial work has centred on the imaging of intact human dental tissue. The first two-photon images of dental tissue are reported showing the development of early dental disease from depths up to 500 mu m into the tooth. These results demonstrate the detection of carious lesions before the more conventional techniques currently used by dental practitioners.
   Work on other living intact biological tissue is also reported, in particular plants containing a genetically bred fluorescent marker to enable the examination of complete and intact living plant tissue.
C1 Univ Strathclyde, Inst Photon, Glasgow G4 0NW, Lanark, Scotland.
RP Girkin, JM (reprint author), Univ Strathclyde, Inst Photon, Glasgow G4 0NW, Lanark, Scotland.
OI Girkin, John/0000-0003-2568-3576
CR DEJONG EDJ, 1995, CARIES RES, V29, P2, DOI 10.1159/000262032
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Goppert-Mayer M, 1931, ANN PHYS-BERLIN, V9, P273
   Keller U, 1996, IEEE J SEL TOP QUANT, V2, P435, DOI 10.1109/2944.571743
   ORGAARD B, 1994, AM J ORTHOD DENTOFAC, V106, P238
   SUNDSTROM F, 1985, SWED DENT J, V9, P71
NR 6
TC 2
Z9 2
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3086-2
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3616
BP 92
EP 98
DI 10.1117/12.351825
PG 3
WC Engineering, Biomedical; Optics; Radiology, Nuclear Medicine & Medical
   Imaging
SC Engineering; Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BN29H
UT WOS:000081442300011
DA 2018-10-19
ER

PT B
AU Donahue, CA
   Fairchild, RF
AF Donahue, CA
   Fairchild, RF
BE Hylko, JM
   Salyer, RL
TI Radiological considerations in the transport, use, and acceleration of
   isotopes for radioactive ion beams
SO CREATION AND FUTURE LEGACY OF STOCKPILE STEWARDSHIP: ISOTOPE PRODUCTION,
   APPLICATIONS, AND CONSUMPTION
LA English
DT Proceedings Paper
CT 32nd Annual Midyear Topical Meeting of the Health-Physics-Society
CY JAN 24-27, 1999
CL ALBUQUERQUE, NM
SP Hlth Phys Soc Rio Grande Chapter
AB Berkeley Experiments with Accelerated Radioactive Species (BEARS) is an initiative to develop Radioactive Ion Beams (RIBs) capabilities at the 88-Inch Cyclotron at Ernest Orlando Lawrence Berkeley National Laboratory (Berkeley Lab). RIBs offer new opportunities for research into nuclear structure, condensed matter physics, and nuclear astrophysics. The BEARS system in development involves the production of light-mass, proton-rich species using the 10-MeV proton beam of the Biomedical Positron Emission Tomography (PET) Cyclotron at Berkeley Lab. The radioactive material produced includes 20-minute C-11, IO-minute N-13, and 70-second O-14, which will be continually transported to the 88-Inch Cyclotron from the Biomedical Cyclotron via a gas-jet capillary. The transport line will be installed above ground for most of the 300-meter distance between the two facilities. This paper will provide an overview of the BEARS gas-jet transport technique focusing on the health physics concerns associated with this research. Health physics concerns include the shielding of the 0.511-MeV positron annihilation radiation; the containment of gaseous radioactive material produced; the design, shielding, and posting of the transport line; and the monitoring of the effluent.
C1 Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.
RP Donahue, CA (reprint author), Univ Calif Berkeley, Lawrence Berkeley Lab, 1 Cyclotron Rd, Berkeley, CA 94720 USA.
CR CASTEN RF, 1997, P WORKSH SCI ADV RAD
   POWELL J, 1998, P 15 INT C APPL ACC
   POWELL J, 1998, P 2 INT C EX NUCL AT
   XIE ZQ, 1998, P 8 INT C HEAV ION A
NR 4
TC 0
Z9 0
U1 0
U2 1
PU MEDICAL PHYSICS PUBLISHING
PI MADISON
PA 4513 VERNON BLVD, MADISON, WI 53705 USA
BN 0-944838-88-X
PY 1999
BP 59
EP 63
PG 5
WC Nuclear Science & Technology; Physics, Applied; Radiology, Nuclear
   Medicine & Medical Imaging
SC Nuclear Science & Technology; Physics; Radiology, Nuclear Medicine &
   Medical Imaging
GA BM63F
UT WOS:000079308800010
DA 2018-10-19
ER

PT J
AU De Corte, F
AF De Corte, F
TI Thirty years of NAA developments and applications at the THETIS reactor
   of the Institute for Nuclear Sciences, Gent
SO CZECHOSLOVAK JOURNAL OF PHYSICS
LA English
DT Article; Proceedings Paper
CT 13th Radiochemical Conference
CY APR 19-24, 1998
CL JACHYMOV, CZECH REPUBLIC
ID NEUTRON-ACTIVATION ANALYSIS; DATA COMPILATION; KO-MEASUREMENTS;
   TRACE-ELEMENTS; BRAIN
AB A survey is given of the past and present fundamental developments and practical applications of neutron activation analysis performed at the reactor THETIS of the Institute for Nuclear Sciences, Gent, which has already now for more than 30 years played an internationally appreciated pioneering role in this domain. Whereas the applications were mainly dealing with the analysis of semiconductor and high-purity materials, biomedical matrices, geological materials, environmental samples and artefacts, the developments were directed towards the elaboration of irradiation, separation and counting schemes, the determination of nuclear activation and decay constants, and especially towards the introduction of a modern (so-called k(0)-) standardization method which - especially combined with a dedicated software package such as KAYZERO/SOLCOI(C) issued by DSM Research - proved to make NAA to a manageable and competitive analytical tool, nowadays applied in more than 50 NAA-labs worldwide.
C1 State Univ Ghent, Inst Nucl Sci, Analyt Chem Lab, Fund Sci Res Flanders,INW, B-9000 Ghent, Belgium.
RP De Corte, F (reprint author), State Univ Ghent, Inst Nucl Sci, Analyt Chem Lab, Fund Sci Res Flanders,INW, Proeftuinstr 86, B-9000 Ghent, Belgium.
CR De-corte F., 1987, THESIS U GENT
   DECORTE F, 1993, J RADIOAN NUCL CH AR, V169, P125, DOI 10.1007/BF02046790
   DECORTE F, 1989, J RADIOAN NUCL CH AR, V133, P3, DOI 10.1007/BF02039969
   DECORTE F, 1989, J RADIOAN NUCL CH AR, V133, P43, DOI 10.1007/BF02039970
   DECORTE F, 1991, ANAL CHIM ACTA, V254, P127, DOI 10.1016/0003-2670(91)90019-2
   DECORTE F, 1983, J RADIOANAL CHEM, V79, P255
   DECORTE F, 1971, J RADIOANAL CHEM, V8, P287
   DECORTE F, 1971, J RADIOANAL CHEM, V9, P9
   DECORTE F, 1989, J RADIOAN NUCL CH AR, V133, P131, DOI 10.1007/BF02039971
   DECORTE F, 1992, P INT K0 US WORKSH G
   DECORTE F, 1988, NUCL DATA SCI TECHNO, P583
   DECORTE F, 1994, ACTA PHYS HUNGARICA, V75, P189
   DECORTE F, 1996, IN PRESS ADV FISSION
   DECORTE F, 1997, I J STEFAN, P41
   DECORTE F, 1988, NUCL DATA SCI TECHNO, P57
   *DSM RES, 1996, KAYZERO SOLCOI MAN V
   DUFLOU H, 1987, BIOL TRACE ELEM RES, V13, P1, DOI 10.1007/BF02796617
   GIJBELS R, 1983, 8871 EN EUR
   *I J STEF, 1996, P 2 INT K0 US WORKSH
   MAENHAUT W, 1989, ATMOS ENVIRON, V23, P2551, DOI 10.1016/0004-6981(89)90266-7
   SCHUTYSER P, 1978, ANAL CHIM ACTA, V100, P75, DOI 10.1016/S0003-2670(01)93305-7
   SIMONITS A, 1975, J RADIOANAL CHEM, V24, P31, DOI 10.1007/BF02514380
   STRIJCKMANS K, 1991, ANN REPORTS 1987 198
   VANCRAEYNEST L, 1998, THESIS U GENT
   VanLierde S, 1997, NUCL INSTRUM METH B, V130, P444, DOI 10.1016/S0168-583X(97)00237-1
   VANSCHANDEVIJL R, 1971, J RADIOANAL CHEM, V9, P55
NR 26
TC 0
Z9 0
U1 0
U2 0
PU CZECHOSLOVAK JNL OF PHYSICS
PI PRAGUE
PA FYZIKALNI USTAV AV NA SLOVANCE 2, PRAGUE 180 40, CZECH REPUBLIC
SN 0011-4626
J9 CZECH J PHYS
JI Czech. J. Phys.
PY 1999
VL 49
SU 1
BP 247
EP 254
DI 10.1007/s10582-999-0033-4
PN 1
PG 8
WC Physics, Multidisciplinary
SC Physics
GA 205WJ
UT WOS:000080843300033
DA 2018-10-19
ER

PT S
AU Mickan, S
   Abbott, D
   Munch, J
   Zhang, XC
   van Doorn, T
AF Mickan, S
   Abbott, D
   Munch, J
   Zhang, XC
   van Doorn, T
BE Bergmann, NW
   Reinhold, O
   Tien, NC
TI Analysis of system trade-offs for terahertz imaging
SO ELECTRONICS AND STRUCTURES FOR MEMS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT SPIE Conference on Electronics and Structures for MEMS
CY OCT 27-29, 1999
CL QUEENSLAND, AUSTRALIA
SP SPIE, IREE Soc, Queensland Govt State Dev, IEEE, Electron Devices Soc, Electrochem Soc, Griffith Univ Microelectr Engn Soc, Australia
DE terahertz; T-ray imaging; optoelectronics; wavelets
ID TIME-DOMAIN SPECTROSCOPY; QUANTUM-WELLS; OPTICAL RECTIFICATION;
   RADIATION; PULSES; GENERATION; ANTENNAS; EXCITONS; BAND; EXCITATION
AB The rapidly developing field of terahertz (or T-ray) imaging promises to provide a non-invasive method of identifying the composition of various objects. Biomedical diagnostics, semiconductor device diagnostics, trace gas analysis and moisture analysis for agriculture are among the growing number of important T-ray applications. We present results using an electro-optical sampling method and and discuss how this can be simplified by using a micro antenna array realised by MEMs technology. The challenges and advantages of both approaches are compared. In our set-up, sub-picosecond pulses of terahertz radiation are produced via optical rectification, using an LT gallium arsenide wafer. A coherent method is used, whereby both amplitude and phase of the THz beam are detected, providing an exact signature of the material under observation.(1) From the analysis of the amplitude and phase it is possible to tomographically reconstruct a terahertz-domain image of an object.(2) Current terahertz systems, however, remain too slow for many real-time applications and the need for high speed image processing is evident.(3-5) Previous systems have relied on simple signal processing algorithms, based on Fourier transformations, for de-convolving the system response and extracting phase/amplitude information. We discuss enhanced processing based on wavelet transforms. Wavelet techniques for signal analysis provide near optimal thresholding for signal recovery and are computationally inexpensive for pulsed waveforms.(6) The improved signal characterisation and speed of wavelet analysis over Fourier methods is demonstrated on sample T-ray data.
C1 Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
RP Mickan, S (reprint author), Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
EM spm@ieee.org; dabbott@eleceng.adelaide.edu.au
RI Zhang, Xi-Cheng/G-1306-2016; Abbott, Derek/E-8352-2011
OI Zhang, Xi-Cheng/0000-0003-3721-1357; Abbott, Derek/0000-0002-0945-2674
CR ARNONE D, 1999, C TER SPECTR APPL SP
   AUSTON DH, 1984, APPL PHYS LETT, V45, P284, DOI 10.1063/1.95174
   AUSTON DH, 1984, PHYS REV LETT, V53, P1555, DOI 10.1103/PhysRevLett.53.1555
   AUSTON DH, 1988, TOP APPL PHYS, V60, P183
   BASS M, 1962, PHYS REV LETT, V9, P446, DOI 10.1103/PhysRevLett.9.446
   BONVALET A, 1995, APPL PHYS LETT, V67, P2907, DOI 10.1063/1.114838
   Burrus C.S., 1998, INTRO WAVELETS WAVEL
   Cai Y, 1997, APPL PHYS LETT, V71, P2076, DOI 10.1063/1.119346
   Cai Y, 1998, APPL PHYS LETT, V73, P444, DOI 10.1063/1.121894
   Chansungsan C, 1996, J OPT SOC AM B, V13, P2792, DOI 10.1364/JOSAB.13.002792
   Cheville RA, 1998, OPT LETT, V23, P531, DOI 10.1364/OL.23.000531
   Cheville RA, 1997, IEEE T ANTENN PROPAG, V45, P1518, DOI 10.1109/8.633860
   *CYLC, 1997, IEE P-OPTOELECTRON, V144, P44
   DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009
   Duvillaret L, 1996, IEEE J SEL TOP QUANT, V2, P739, DOI 10.1109/2944.571775
   Flanders BN, 1998, IEEE J SEL TOP QUANT, V4, P353, DOI 10.1109/2944.686742
   FROBERG NM, 1992, IEEE J QUANTUM ELECT, V28, P2291, DOI 10.1109/3.159536
   GALLOT G, 1999, C LAS EL OPT 99, P492
   GRAPS A, 1995, IEEE COMPUT SCI ENG, V2, P50, DOI 10.1109/99.388960
   GRISCHKOWSKY D, 1990, J OPT SOC AM B, V7, P2006, DOI 10.1364/JOSAB.7.002006
   Gu P, 1998, JPN J APPL PHYS 2, V37, pL976, DOI 10.1143/JJAP.37.L976
   HU BB, 1995, OPT LETT, V20, P1716, DOI 10.1364/OL.20.001716
   Hunsche S, 1998, OPT COMMUN, V150, P22, DOI 10.1016/S0030-4018(98)00044-3
   Hunsche S, 1998, IEICE T ELECTRON, VE81C, P269
   IZATT JA, 1999, C LAS EL OPT, P336
   Jacobsen RH, 1996, OPT LETT, V21, P2011, DOI 10.1364/OL.21.002011
   Jepsen PU, 1996, J OPT SOC AM B, V13, P2424, DOI 10.1364/JOSAB.13.002424
   Kindt JT, 1996, J PHYS CHEM-US, V100, P10373, DOI 10.1021/jp960141g
   KLAASSEN T, 1999, C TER SPECTR APPL SP
   Knott M, 1999, NEW SCI, V162, P22
   KOCH M, 1999, C TER SKPECTR APPL
   KOROTKOV AN, 1994, APPL PHYS LETT, V65, P1865, DOI 10.1063/1.112865
   Kovarskii VA, 1997, JETP LETT+, V65, P215, DOI 10.1134/1.567312
   LAX B, 1976, SPRINGER SERIES OPTI, V3, P340
   Li M, 1999, APPL PHYS LETT, V74, P2113, DOI 10.1063/1.123773
   LUO MSC, 1994, IEEE J QUANTUM ELECT, V30, P1478, DOI 10.1109/3.299473
   May M, 1997, NEW SCI, V154, P22
   MEADE ML, 1983, NUMERICAL MEASUREMEN, V1
   Mittleman D. M., 1998, Nonlinear Optics '98. Materials, Fundamentals and Applications Topical Meeting (Cat. No.98CH36244), P294, DOI 10.1109/NLO.1998.710288
   Mittleman DM, 1997, OPT LETT, V22, P904, DOI 10.1364/OL.22.000904
   Mittleman DM, 1997, APPL PHYS LETT, V71, P16, DOI 10.1063/1.119456
   Mittleman DM, 1996, IEEE J SEL TOP QUANT, V2, P679, DOI 10.1109/2944.571768
   Mittleman DM, 1999, APPL PHYS B-LASERS O, V68, P1085, DOI 10.1007/s003400050750
   Nuss MC, 1996, IEEE CIRCUIT DEVIC, V12, P25, DOI 10.1109/101.485909
   PLANKEN PCM, 1992, PHYS REV LETT, V69, P3800, DOI 10.1103/PhysRevLett.69.3800
   RICE A, 1994, APPL PHYS LETT, V64, P1324, DOI 10.1063/1.111922
   Sengers AJ, 1997, J OPT SOC AM B, V14, P1057, DOI 10.1364/JOSAB.14.001057
   SMITH PR, 1988, IEEE J QUANTUM ELECT, V24, P255, DOI 10.1109/3.121
   TEOLIS A, 1998, COMPUTATIONAL SIGNAL
   VALDMANIS JA, 1982, APPL PHYS LETT, V41, P211, DOI 10.1063/1.93485
   VANEXTER M, 1989, OPT LETT, V14, P1128, DOI 10.1364/OL.14.001128
   VANEXTER M, 1990, IEEE T MICROW THEORY, V38, P1684, DOI 10.1109/22.60016
   Verghese S, 1998, APPL PHYS LETT, V73, P3824, DOI 10.1063/1.122906
   WASCHKE C, 1993, PHYS REV LETT, V70, P3319, DOI 10.1103/PhysRevLett.70.3319
   Wu Q, 1996, IEEE J SEL TOP QUANT, V2, P693, DOI 10.1109/2944.571769
   Wu Q, 1996, APPL PHYS LETT, V68, P2924, DOI 10.1063/1.116356
   Wu Q, 1997, APPL PHYS LETT, V71, P1285, DOI 10.1063/1.119873
   Wu Q, 1996, APPL PHYS LETT, V69, P1026, DOI 10.1063/1.116920
   WYNNE K, 1999, C LASERS ELECT OPTIC, P397
   YANG KH, 1971, APPL PHYS LETT, V19, P320, DOI 10.1063/1.1653935
   ZHANG XC, 1997, OSA TOPS ULTRAFAST E, V13
NR 61
TC 3
Z9 3
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-3492-2
J9 PROC SPIE
PY 1999
VL 3891
BP 226
EP 237
DI 10.1117/12.364444
PG 12
WC Engineering, Electrical & Electronic; Engineering, Mechanical; Optics
SC Engineering; Optics
GA BP26K
UT WOS:000084509700025
OA Green Published
DA 2018-10-19
ER

PT J
AU Ueng, TH
   Wang, HW
   Chiang, LY
AF Ueng, TH
   Wang, HW
   Chiang, LY
TI Inhibition of drug-metabolizing enzymes in mouse liver by a water
   soluble fullerene C-60
SO FULLERENE SCIENCE AND TECHNOLOGY
LA English
DT Article
ID CYTOCHROME-P450-DEPENDENT MONOOXYGENASES; CHEMISTRY; INDUCTION; TISSUES;
   DNA
AB The microsomal cytochrome P450-dependent monooxygenase system is responsible for the metabolism a variety of xenobiotics including drugs and carcinogens. Fullerenol-1 is a water soluble polyhydroxylated C-60 derivative synthesized by a sequence of reactions involving the electrophilic attack of nitronium tetrafluoroborate on fullerenes in the presence of organocarboxylic acids. The present study has evaluated the acute toxicity of fullerenol-1 and determined the effects of the C-60 compound on the P450-dependent drug-metabolzing activities. Pretreatments with 0.5 and 1.0 g/kg fullerenol-1 decreased P450 and cytochrome b(5) contents, and NADPH-cytochrome P450 reductase, as well as drug metabolizing activities toward test substrates benzo[a]pyrene, 7-ethoxycoumarin, aniline, and erythromycin in liver microsomes. Pretreatments with 0.01 and 0.1 g/kg fullerenol-1 had no effect on these monooxygenases. Immunoblotting anlysis of the microsomal proteins revealed that pretreatments with fullerenol-1 did not alter the protein levels of P450s 1A 2E and 3A. Additions of fullerenol-1 to mouse liver microsomes suppressed monooxygenases activities toward benzo[a]pyrene, 7-ethoxycoumarin, aniline, and erythromycin with IC50 values of 42, 94, 102 and 349 mu M, respectively. These results demonstrate that fullerenol-1 can decrease the activities of microsomal drug-metabolizing enzymes in vivo add in vivo. Proper adjustment of the functionalized fullerene compound may facilitate the biomedical application of the new material.
C1 Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei 10764, Taiwan.
   Natl Taiwan Univ, Ctr Condensed Matter Sci, Taipei 10764, Taiwan.
RP Ueng, TH (reprint author), Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei 10764, Taiwan.
CR An YZ, 1996, TETRAHEDRON, V52, P5179, DOI 10.1016/0040-4020(96)00123-8
   BOUTORINE AS, 1994, ANGEW CHEM INT EDIT, V33, P2462
   CHIANG LY, 1995, J CHEM SOC CHEM COMM, P1283, DOI 10.1039/c39950001283
   CHIANG LY, 1992, J AM CHEM SOC, V114, P10154, DOI 10.1021/ja00052a010
   COON MJ, 1992, FASEB J, V6, P669
   Diederich F, 1996, SCIENCE, V271, P317, DOI 10.1126/science.271.5247.317
   Friedman S H, 1993, J AM CHEM SOC, V115, P6505
   GREENLEE WF, 1978, J PHARMACOL EXP THER, V205, P596
   GUENGERICH FP, 1992, PHARMACOL THERAPEUT, V54, P17
   HALPERT JR, 1995, ANNU REV PHARMACOL, V35, P29, DOI 10.1146/annurev.pa.35.040195.000333
   IMAI Y, 1966, J BIOCHEM, V60, P417, DOI 10.1093/oxfordjournals.jbchem.a128453
   Irie K, 1996, BIOSCI BIOTECH BIOCH, V60, P1359, DOI 10.1271/bbb.60.1359
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Nakamura E, 1996, B CHEM SOC JPN, V69, P2143, DOI 10.1246/bcsj.69.2143
   NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416
   NEBERT DW, 1994, BIOCHEM PHARMACOL, V47, P25, DOI 10.1016/0006-2952(94)90434-0
   NEBERT DW, 1968, J BIOL CHEM, V243, P6242
   NELSON MA, 1993, TOXICOL IND HEALTH, V9, P623, DOI 10.1177/074823379300900405
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652
   RYAN DE, 1990, PHARMACOL THERAPEUT, V45, P153, DOI 10.1016/0163-7258(90)90029-2
   Saunders M, 1996, SCIENCE, V271, P1693, DOI 10.1126/science.271.5256.1693
   SCRIVENS WA, 1994, J AM CHEM SOC, V116, P4517, DOI 10.1021/ja00089a067
   TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064
   Tsai MC, 1997, J PHARM PHARMACOL, V49, P438, DOI 10.1111/j.2042-7158.1997.tb06821.x
   TSUCHIYA T, 1995, BIOCHEM BIOPH RES CO, V206, P885, DOI 10.1006/bbrc.1995.1126
   Ueng TH, 1998, J TOXICOL ENV HEAL A, V54, P509
   UENG TH, 1993, TOXICOL APPL PHARM, V119, P66, DOI 10.1006/taap.1993.1045
   YAMAGO S, 1995, CHEM BIOL, V2, P385, DOI 10.1016/1074-5521(95)90219-8
NR 29
TC 13
Z9 13
U1 0
U2 7
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1064-122X
J9 FULLERENE SCI TECHN
JI Fullerene Sci. Technol.
PY 1999
VL 7
IS 4
BP 681
EP 694
DI 10.1080/10641229909351370
PG 14
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Atomic, Molecular & Chemical
SC Chemistry; Materials Science; Physics
GA 213AJ
UT WOS:000081249600015
DA 2018-10-19
ER

PT S
AU Karlsen, W
AF Karlsen, W
BE Hanninen, H
   Hertzman, S
   Romu, J
TI The effect of nitrogen alloying on stellite 21 cobalt chromium
   molybdenum biomedical implant alloy: processing and microstructure
SO HIGH NITROGEN STEELS '98
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th International Conference on High Nitrogen Steels
CY MAY 27-28, 1998
CL STOCKHOLM, SWEDEN
SP Helsinki Univ, Swedish Inst Mat Res
DE incipient melting; nitrogen-high pressure melting (N-HPM); Stellite 21;
   biomedical
ID PRESSURE; CR; FE
AB There has been an on-going effort to improve the performance of Co-Cr-Mo biomedical implant alloys. However, efforts have been thwarted by the alloy's dependence upon carbon and carbide structures for strengthening, which are also associated with lower incipient melting temperatures, and lower ductilities. In this study, the effect of nitrogen additions to a Stellite 21 has been explored. Borrowing technology from its cousin, austenitic stainless-steels, additions were made to the alloy through nitrogen-high pressure melting (N-HPM) at pressures ranging from 1.4 to 50 atm. The ingots were then rolled into plates from which bars were extracted, and then heat-treated. This paper describes the microstructural development in terms of the second phase structure and grain size of heat treated plate materials. The total nitrogen achieved increased with pressure, and ranged from 0.19 to 1.34 wt%. The findings indicate not only that additions of nitrogen increase the second phase content, but also that as the nitrogen content is increased, a Cr2N second phase is favored over the traditional Cr23C6 carbide. This phase change apparently leads to the subsequent elevation of the incipient melting temperature to above 1260 degrees C (2300 degrees F).
C1 Helsinki Univ Technol, Lab Engn Mat, FIN-02015 HUT, Finland.
RP Karlsen, W (reprint author), Helsinki Univ Technol, Lab Engn Mat, POB 4100, FIN-02015 HUT, Finland.
RI Hanninen, Hannu/G-2260-2013
CR *ASM INT, 1990, ADV MAT P        AUG, P50
   AZIZ AI, ASM METALS HDB, V13, P658
   BLOSSEY RG, 1966, T METALL SOC AIME, V236, P28
   BONFIELD W, 1987, MET MATER, P712
   CROOK P, 1992, ASM HDB, V18, P766
   DEMPSEY AJ, 1987, J MATER SCI, V22, P575, DOI 10.1007/BF01160771
   DIAS MCM, 1992, J MATER SCI, V27, P5154
   Dobbs H S, 1982, Eng Med, V11, P175
   DOWSON D, 1992, ASM HDB, V18, P656
   FARHANGI H, 1989, THESIS U MARYLAND
   KARLSEN W, 1997, THESIS OREGON GRADUA
   KILNER T, 1987, J MATER SCI, V22, P565, DOI 10.1007/BF01160770
   Kilner T., 1984, THESIS U TORONTO
   RAWERS J, 1992, J MATER RES, V7, P1083, DOI 10.1557/JMR.1992.1083
   RAWERS JC, 1992, METALL TRANS A, V23, P2061, DOI 10.1007/BF02647552
NR 15
TC 2
Z9 2
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-843-5
J9 MATER SCI FORUM
PY 1999
VL 318-3
BP 303
EP 308
DI 10.4028/www.scientific.net/MSF.318-320.303
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BQ55N
UT WOS:000088746300040
DA 2018-10-19
ER

PT J
AU Viik, J
   Malmivuo, J
AF Viik, Jari
   Malmivuo, Jaakko
TI Biomedical Engineering as a Career Resource: Survey from Tampere
   University of Technology
SO INTERNATIONAL JOURNAL OF ENGINEERING EDUCATION
LA English
DT Article
AB This paper presents the results of the survey concerning graduates with a Master of Science in Engineering (hereafter engineers), who have studied Biomedical Engineering (BME) in the Ragnar Granit Institute (RGI) at Tampere University of Technology (TUT), Tampere, Finland. The material of the survey consisted of 267 persons who had included BME as a professional subject in their degree program between 1976 and the spring of 1997. The survey was conducted during the summer of 1997 as a postal questionnaire study (respondence rate was 77%). According to the study, 90% of the respondents had found their first job in less than three months. The type of their first employment for 95% of respondents was full-time. The job description of every second respondent was related to BME. Of those who had submitted their Master's thesis to RGI, first job descriptions were clearly related to BME more often than in the cases of other respondents. The first job corresponded very well with the type of education, and this correspondence has even improved in recent years. When comparing the ability provided by their education with the importance of areas of expertise actually required at work, the respondents said deficiencies lay in the areas of project and teamwork, oral communication skills, and negotiation skills. Education in RGI was perceived as a good, interesting, and respected basis for a career.
C1 [Viik, Jari; Malmivuo, Jaakko] Tampere Univ Technol, Ragnar Granit Inst, FIN-33101 Tampere, Finland.
RP Viik, J (reprint author), Tampere Univ Technol, Ragnar Granit Inst, FIN-33101 Tampere, Finland.
EM viik@ee.tut.fi; malmivuo@cc.tut.fi
RI Viik, Jari/A-6303-2009
OI Viik, Jari/0000-0001-6081-6819
FU Ragnar Granit Foundation
FX The authors would like to express their gratitude to Mr. Raimo Lamminen
   for his assistance in various phases of the study. This part of the work
   was supported by the Ragnar Granit Foundation. The report of this survey
   is available as a printed booklet in English or in Finnish by contacting
   the authors.
NR 0
TC 4
Z9 4
U1 0
U2 1
PU TEMPUS PUBLICATIONS
PI DURRUS, BANTRY
PA IJEE , ROSSMORE,, DURRUS, BANTRY, COUNTY CORK 00000, IRELAND
SN 0949-149X
J9 INT J ENG EDUC
JI Int. J. Eng. Educ
PY 1999
VL 15
IS 4
SI SI
BP 308
EP 320
PG 13
WC Education, Scientific Disciplines; Engineering, Multidisciplinary
SC Education & Educational Research; Engineering
GA V11PK
UT WOS:000207543300013
DA 2018-10-19
ER

PT S
AU Sanchez-Huerta, L
   Hernandez, A
   Ayala, G
   Marroquin, J
   Silva, AB
   Khotiaintsev, KS
   Svirid, VA
   Flores, G
   Khotiaintsev, SN
AF Sanchez-Huerta, L
   Hernandez, A
   Ayala, G
   Marroquin, J
   Silva, AB
   Khotiaintsev, KS
   Svirid, VA
   Flores, G
   Khotiaintsev, SN
BE Melker, AI
TI Laser technique for anatomical-functional study of the medial prefrontal
   cortex of the brain
SO INTERNATIONAL WORKSHOP ON NONDESTRUCTIVE TESTING AND COMPUTER
   SIMULATIONS IN SCIENCE AND ENGINEERING
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT International Workshop on Nondestructive Testing and Computer
   Simulations in Science and Engineering
CY JUN 08-12, 1998
CL ST PETERSBURG, RUSSIA
SP St Petersburg Tech Univ, Russia, St Petersburg Acad Sci Strength Problems, Russia, NPO Special Mat, Russia, SPIE Russia Chapter
DE non-destructive testing; brain; prefrontal cortex; neurology;
   neurodevelopment; physiology; behavior studies; laser biomedical
   applications; laser surgery; laser material processing; infrared
   waveguides
ID IBOTENIC ACID LESIONS; HOLLOW WAVE-GUIDES; INDUCED LOCOMOTION;
   DIODE-LASER; NEUROSURGERY; SCHIZOPHRENIA; STRESS; RAT
AB The brain represents one of the most complex systems that we know yet. Ln its study, non-destructive methods - in particular, behavioral studies play an important role. By alteration of brain functioning (e.g. by pharmacological means) and observation of consequent behavior changes an important information on brain organization and functioning is obtained. For inducing local alterations, permanent brain lesions are employed. However, for correct results this technique has to be quasi-non-destructive, i.e, not to affect the normal brain function. Hence, the lesions should be very small, accurate and applied precisely over the structure (e.g. the brain nucleus) of interest. These specifications are difficult to meet with the existing techniques for brain lesions - specifically, neurotoxical, mechanical and electrical means because they result in too extensive damage.
   In this paper, we present new laser technique for quasi-non-destructive anatomical-functional mapping in vivo of the medial prefrontal cortex (MPFC) of the rat. The technique is based on producing of small-size, well-controlled laser-induced lesions over some areas of the MPFC. The anesthetized animals are subjected to stereotactic surgery and certain points of the MPFC are exposed the confined radiation of the 10 W cw CO2 laser. Subsequent behavioral changes observed in neonatal and adult animals as well as histological data prove effectiveness of this technology for anatomical-functional studies of the brain by areas, and as a treatment method for some pathologies.
C1 Univ Autonoma Puebla, Inst Physiol, Puebla 72570, Mexico.
RP Khotiaintsev, SN (reprint author), Univ Autonoma Puebla, Inst Physiol, AP 406, Puebla 72570, Mexico.
EM lsanches@siu.ccn.buap.mx; svirid@cronos.fi-b.unam.mx;
   gflores@siu.cen.buap.mx; sergeikh@hotmail.com
OI Flores, Gonzalo/0000-0002-4100-2104; Hernandez-Cortes,
   Adan/0000-0002-7098-870X
CR ARRINGTON JA, 1990, MILESTONE SERIES
   DEBRABANDER JM, 1991, BEHAV BRAIN RES, V42, P67, DOI 10.1016/S0166-4328(05)80041-5
   Devaux BC, 1996, ACTA NEUROCHIR, V138, P1135, DOI 10.1007/BF01809742
   Devaux BC, 1998, SURG NEUROL, V50, P33, DOI 10.1016/S0090-3019(98)00042-1
   Doherty MD, 1996, BRAIN RES, V715, P86, DOI 10.1016/0006-8993(95)01557-4
   FASANO V A, 1983, Lasers in Surgery and Medicine, V2, P199
   Flores G, 1996, J NEUROSCI, V16, P2020
   Flores G, 1996, J NEUROSCI, V16, P7366
   FLORES G, 1998, P SPIE, V3565
   GOLDSTEIN M, 1992, FASEB J, V6, P2413
   Inberg A, 1996, P SOC PHOTO-OPT INS, V2928, P28, DOI 10.1117/12.259962
   JASKIW GE, 1992, PHARMACOL BIOCHEM BE, V41, P607, DOI 10.1016/0091-3057(92)90380-X
   JASKIW GE, 1990, BRAIN RES, V534, P263, DOI 10.1016/0006-8993(90)90138-2
   Katzir A., 1993, LASERS OPTICAL FIBER
   KOLB B, 1990, CEREBRAL CORTEX RAT, P437
   LOMBARD CF, 1995, P SOC PHOTO-OPT INS, V2623, P302
   Matsuura Y, 1997, OPT LETT, V22, P1308, DOI 10.1364/OL.22.001308
   MOGENSON GJ, 1984, BEHAV NEURAL BIOL, V42, P38, DOI 10.1016/S0163-1047(84)90412-6
   MORRISON JH, 1979, SCIENCE, V205, P313, DOI 10.1126/science.451605
   Nagatani T, 1997, MINIM INVAS NEUROSUR, V40, P98, DOI 10.1055/s-2008-1053425
   Paxinos G, 1986, RAT BRAIN STEREOTACT
   ROSE JE, 1947, RES PUBL ASSOC RES N, V27, P210
   ROUX FX, 1985, NEUROCHIRURGIE, V31, P412
   ROUX FX, 1992, NEUROCHIRURGIE, V38, P229
   Shalem S., 1995, Proceedings of the SPIE - The International Society for Optical Engineering, V2631, P216, DOI 10.1117/12.229185
   SHALIMOV A, 1986, CLIN SURG, V9, P42
   STEICHEN JD, 1990, J NEUROSURG, V73, P611, DOI 10.3171/jns.1990.73.4.0611
   Watanabe T, 1996, P SOC PHOTO-OPT INS, V2928, P19, DOI 10.1117/12.259961
   WEINBERGER DR, 1995, SCHIZOPHR RES, V16, P87, DOI 10.1016/0920-9964(95)00013-C
NR 29
TC 2
Z9 2
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-3161-3
J9 PROC SPIE
PY 1999
VL 3687
BP 34
EP 41
DI 10.1117/12.347469
PG 8
WC Computer Science, Interdisciplinary Applications; Engineering,
   Multidisciplinary; Materials Science, Multidisciplinary; Materials
   Science, Characterization & Testing; Optics; Physics, Applied
SC Computer Science; Engineering; Materials Science; Optics; Physics
GA BN10P
UT WOS:000080723900008
DA 2018-10-19
ER

PT B
AU Muller, RS
AF Muller, RS
BE Wen, T
TI MEMS: the promise for the 3rd millennium
SO ISTM/99: 3RD INTERNATIONAL SYMPOSIUM ON TEST AND MEASUREMENT
LA English
DT Proceedings Paper
CT 3rd International Symposium on Test and Measurement (ISTM 99)
CY JUN 02-04, 1999
CL XIAN, PEOPLES R CHINA
SP Chinese Soc Modern Tech Equipments, Xian Inst Technol, Northwest Inst Mech Elect Engn, North China Inst Technol, Xian Mech Elect Info Res Inst, Chinese Soc Instruments, Chinese Soc Elect Engn
ID POLYCRYSTALLINE SILICON; POLYSILICON; MICROMIRRORS; STRESS
AB "To many of those working in the field of Microeiectromechanical Systems (MEMS), there is a strong sense that a revolution is underway. As MEMS begin to permeate an increasingly wide scope of industrial procedures, not only engineering, but also society as a whole will be strongly affected. MEMS will provide a new design technology having an impact on society that rivals and even surpasses the dizzying effects of integrated circuits." These words, used by the author as a preface to a US National Research Council(*) report, predict a very influential role for MEMS in the 21(st) century. To accept this premise, one has to be convinced that MEMS is more than "miniaturization of engineering systems. " Miniaturization has been an ongoing theme in engineering success over the last century and countless refinements in design and manufacture have contributed to its progress. What is new and revolutionary in MEMS is ifs adaptation to new purpose of the advanced, productive IC technology. Built with countless invested hours and dollars over the past thirty years, silicon IC batch processing today fabricates electrical systems having overwhelming complexity.
   The MEMS revolution arises from harnessing this know-how to the task of building micromechanical and microelectronic elements into engineering microsystems. The scope of MEMS is multidisciplinary, providing challenges and opportunities to electrical mechanical, chemical, and biomedical engineering, and extending beyond engineering to physics, biology, and chemistry.
   Some of the commercial areas in which MEMS has taken root, and in which growth seems clear and healthy are. the automotive industry, where MEMS are in production for sensing applications, particularly for pressure and acceleration, and also for fuel-injection systems printers, where ink-jet technology is revolutionizing a booming field ($3B worldwide market growing at MICROELECTROMECHANICAL SYSTEMS, "Advanced Materials and Fabrication Methods," US National Academy Press, ISBN 0-309-05980-1, December -1997 nearly 20% per year), optical systems where new actuated mirror- and lens- systems are being exploited for display and for fiber-optic communication systems, information storage in which much increased density (expected are 100-fold and greater storage-capacity increases) at increased speed and reduced cost; and bio- and medical applications where MEMS promise truly revolutionary systems.
   The challenges to MEMS progress are many, extending all the way fr om needs for more knowledge of fundamentals to learning a great deal more about materials, processes, and system design as well as about compatibility reliability, and interfacing. To reach a state when MEMS design is as mature as today's IC design, substantial advances in modeling, simulation and computer-aided design must be made. However, with the IC past as prologue, MEMS clearly beckons us towards a fabulous future.
C1 Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.
RP Muller, RS (reprint author), Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.
EM r.muller@ieee.org
CR BEHIN B, 1998, 1998 SOL STAT SENS A, P273
   CHOI MS, 1984, J ELECTROCHEM SOC, V131, P2443, DOI 10.1149/1.2115314
   DANEMAN M, 1995, C LASERS ELECTROOPTI, V15
   Daneman MJ, 1996, IEEE PHOTONIC TECH L, V8, P396, DOI 10.1109/68.481129
   DANEMAN MJ, 1995, MEMS 95 1995 INT C M
   DANEMAN MJ, 1996, 1996 TECHNICAL DIGES, V6
   DANEMAN MJ, 1996, 1996 SENS ACT WORKSH, P109
   FRENCH PJ, 1985, SENSORS ACTUATORS, V8
   GOODENOUGH F, 1991, ELECT DESIGN    0808
   GUCKEL H, 1990, SENSOR ACTUAT A-PHYS, V21, P346, DOI 10.1016/0924-4247(90)85069-G
   Guckel H., 1986, International Electron Devices Meeting 1986. Technical Digest (Cat. No.86CH2381-2), P176
   GUCKEL H, 1987, INT C SOL STAT SENS, P277
   HOWE RT, 1986, IEEE T ELECTRON DEV, V33, P499, DOI 10.1109/T-ED.1986.22519
   HOWE RT, 1985, MICROMACHINING MICRO, P169
   HOWE TT, 1982, 1982 SPRING M EL SOC
   JUDY JW, 1996, SOL STAT SENS ACT WO, P187
   Kamins T., 1998, POLYCRYSTALLINE SILI
   Kiang MH, 1996, IEEE PHOTONIC TECH L, V8, P95, DOI 10.1109/68.475790
   Kiang MH, 1996, IEEE PHOTONIC TECH L, V8, P1707, DOI 10.1109/68.544726
   KIANG MH, 1996, 1996 SENS ACT WORKSH
   KIANG MH, 1996, 1996 TECHNICAL DIGES, V6, P545
   KIANG MH, 1998, J MICROELECTROMECH S, V7, P27
   KIANG MH, 1997, IEEE TRANSDUCERS 97, P323
   KIANG MH, 1995, C LASERS ELECTROOPTI, V15, P248
   KIANG MH, 1996, IEEE MEMS 96 WORKSH
   Lebouitz K. S., 1995, 8th International Conference on Solid-State Sensors and Actuators and Eurosensors IX. Digest of Technical Papers (IEEE Cat. No.95TH8173), P224
   Mastrangelo CH, 1997, TRIBOL LETT, V3, P223, DOI 10.1023/A:1019133222401
   MULHERN G. T., 1993, P 7 INT C SOL STAT S, P296
   Muller RS, 1998, P IEEE, V86, P1705, DOI 10.1109/5.704276
   MURARKA SP, 1983, J APPL PHYS, V54, P2069, DOI 10.1063/1.332255
   NATHANSON HC, 1967, IEEE T ELECTRON DEV, VED14, P117, DOI 10.1109/T-ED.1967.15912
   PETERSEN KE, 1982, P IEEE, V70, P420, DOI 10.1109/PROC.1982.12331
   PISANO AP, 1989, 1989 IEEE MICR EL ME, P44
   PISTER KSJ, 1992, SENSOR ACTUAT A-PHYS, V33, P249, DOI 10.1016/0924-4247(92)80172-Y
   SETO JYW, 1976, J APPL PHYS, V47, P4780, DOI 10.1063/1.322515
   SOLGAARD O, 1995, IEEE PHOTONIC TECH L, V7, P41, DOI 10.1109/68.363382
   SOLGAARD O, 1995, 1995 INT S OPT MICR
   SOLGAARD O, 1994 C LAS EL CLEO 9
   TANG WC, 1989, 1989 IEEE MEMS C SAL, P53
   TIEN NC, 1994, 1994 INT EL DEV M SA, P924
   TIEN NC, 1994, 1994 SENS ACT WORKSH
   TIEN NC, 1996, SPIE P, V2687
   TIEN NC, 1995, 1995 IEEE INT C SOL, P352
   TIEN NC, 1995, P 8 INT C SOL STAT S, P352
NR 44
TC 0
Z9 0
U1 0
U2 4
PU WORLD PUBLISHING CORPORATION
PI BEIJING
PA 137 CHAONEI DAJIE, BEIJING 100010, PEOPLES R CHINA
BN 7-80003-441-0
PY 1999
BP 1
EP 8
PG 8
WC Acoustics; Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Engineering, Electrical & Electronic;
   Engineering, Mechanical; Instruments & Instrumentation; Materials
   Science, Characterization & Testing
SC Acoustics; Computer Science; Engineering; Instruments & Instrumentation;
   Materials Science
GA BN14D
UT WOS:000080858500001
DA 2018-10-19
ER

PT J
AU Ambrosio, L
   Borzacchiello, A
   Netti, PA
   Nicolais, L
AF Ambrosio, L
   Borzacchiello, A
   Netti, PA
   Nicolais, L
TI Rheological study on hyaluronic acid and its derivative solutions
SO JOURNAL OF MACROMOLECULAR SCIENCE-PURE AND APPLIED CHEMISTRY
LA English
DT Article; Proceedings Paper
CT Polymeric Materials - Science and Engineering Symposium at the 216th ACS
   National Meeting on Biomedical Applications of Water-Soluble Polymers
   and Hydrogels
CY AUG 23-27, 1998
CL BOSTON, MASSACHUSETTS
SP Amer Chem Soc, Div Polymer Chem
DE hyaluronic acid; polysaccharides; rheology; viscosity; viscoelasticity;
   molecular weight; concentration
AB Rheological measurements were performed an Hyaluronic acid (HA) and its derivative solutions to evaluate steady flow viscosity and dynamics response with the aim to correlate the materials properties to the concentration, molecular weight and chemical structure. At low molecular weight and concentration, the HA solutions behaved as viscous liquid, whereas a soft-gel response was evident at higher molecular weight and concentration due to chains entanglement. Increasing the molecular weight was more effective than increasing concentration in promoting entanglement of molecular chains of HA. Comparing the behavior of HA solutions with that of Hyaluronic acid derivatives, it is showed that it is possible to modulate the rheological properties of HA based solutions by chemical modification preserving the biocompatibility of the materials. The results of the rheological analysis provide a valuable tool to properly design optimal substitutes for specific biomedical application.
C1 Univ Naples Federico II, Inst Composite Mat Technol, CNR, Interdisciplinary Res Ctr Biomat, Naples, Italy.
RP Ambrosio, L (reprint author), Univ Naples Federico II, Inst Composite Mat Technol, CNR, Interdisciplinary Res Ctr Biomat, Ple Tecchio 80, Naples, Italy.
OI AMBROSIO, LUIGI/0000-0002-8367-2405; NETTI, PAOLO/0000-0002-2435-7181
CR BALAZS EA, 1993, J RHEUMATOL, V20, P3
   BALAZS EA, 1967, ARTHRITIS RHEUM, V10, P357, DOI 10.1002/art.1780100407
   BERRIAUD N, 1994, INT J BIOL MACROMOL, V16, P137, DOI 10.1016/0141-8130(94)90040-X
   CLARK AH, 1987, ADV POLYM SCI, V83, P61
   DE SMEDT SC, 1993, BIORHEOLOGY, V30, P31
   Della V.F., 1987, European Patent, Patent No. 216453
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   KOBAYASHI Y, 1994, BIORHEOLOGY, V31, P235
   LAURENT TC, 1992, FASEB J, V6, P2397
   ROSSMURPHY SB, 1991, POLYMER GELS, P21
   1987, Patent No. 4713488
NR 11
TC 63
Z9 64
U1 1
U2 22
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1060-1325
J9 J MACROMOL SCI PURE
JI J. Macromol. Sci.-Pure Appl. Chem.
PY 1999
VL A36
IS 7-8
BP 991
EP 1000
DI 10.1080/10601329908951195
PG 10
WC Polymer Science
SC Polymer Science
GA 224VQ
UT WOS:000081921000009
DA 2018-10-19
ER

PT J
AU Czarnowska, E
   Wierzchon, T
   Maranda-Niedbala, A
   Karczmarewicz, E
AF Czarnowska, E
   Wierzchon, T
   Maranda-Niedbala, A
   Karczmarewicz, E
TI Improvement of titanium alloy for biomedical applications by nitriding
   and carbonitriding processes under glow discharge conditions
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID GROOVED SUBSTRATA; FIBROBLASTS; BIOCOMPATIBILITY; ORIENTATION; WEAR
AB Although titanium alloys are used in medicine, they present low wear resistance. In this paper we present the results of studies on surface layers produced by nitriding at three different temperatures, and by carbonitriding under glow discharge conditions in order to improve wear resistance, hardness, and to modulate microstructure and chemical composition of surface layers. A cell culture model using human fibroblasts was chosen to study the effect of such treatments on the cytocompatibility of these materials. The results showed that nitrided and carbonitrided surface layers were cytocompatible. Modulation of surface microstructure by temperature in the nitriding process and chemical composition of surface layers by carbonitriding led to differences in cellular behaviour. Cell proliferation appeared to be slightly reduced from the 6th day of culture on nitrided surfaces produced at 730 degrees C and 1000 degrees C, however after 12 days of culture, the best growth was on surface layers produced at 850 degrees C. The best viability was observed on the carbonitrided layer. The orientation and shape of the cells corresponded to surface topography. Nitriding and carbonitriding under glow discharge conditions may constitute interesting techniques allowing the formation of surface layers on parts with sophisticated shapes. They may also permit modulating surface topography in a way improving the features of titanium alloys for various applications in medicine. (C) 2000 Kluwer Academic Publishers.
C1 Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland.
   Warsaw Univ Technol, Fac Mat Sci & Engn, Warsaw, Poland.
   Childrens Mem Hlth Inst, Dept Expt Med, Warsaw, Poland.
RP Czarnowska, E (reprint author), Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland.
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   AMSTUTZ HC, 1991, CLIN ORTHOP RELAT R, V276, P7
   BEHRNDT H, 1991, MAT SCI ENG A-STRUCT, V139, P58, DOI 10.1016/0921-5093(91)90596-F
   Bianco PD, 1996, BIOMATERIALS, V17, P1937, DOI 10.1016/0142-9612(96)00023-3
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   MERRITT K, 1992, J BIOMED MATER RES, V26, P1503, DOI 10.1002/jbm.820261109
   MEYLE J, 1991, J APPL BIOMATER, V2, P273, DOI 10.1002/jab.770020409
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MORTON PH, 1980, MEMOIRES ETUDES SCI, P639
   SCALES JT, 1991, J BONE JOINT SURG BR, V73, P5346
   VANRAAY JJAM, 1995, J MATER SCI-MATER M, V6, P80, DOI 10.1007/BF00120412
   Wierzchon T, 1997, SURF COAT TECH, V96, P205, DOI 10.1016/S0257-8972(97)00113-8
   WIERZCHON T, 1995, P INT C CARB NITR AT, P341
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
   1983, PN83H04302
NR 23
TC 4
Z9 4
U1 0
U2 5
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 1999
VL 11
IS 2
BP 73
EP 81
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 271ND
UT WOS:000084599600002
DA 2018-10-19
ER

PT J
AU Paquis, P
   Pignol, JP
   Lonjon, M
   Brassart, N
   Courdi, A
   Chauvel, P
   Grellier, P
   Chatel, M
AF Paquis, P
   Pignol, JP
   Lonjon, M
   Brassart, N
   Courdi, A
   Chauvel, P
   Grellier, P
   Chatel, M
TI Boron Neutron Capture Enhancement (BNCE) of fast neutron irradiation for
   glioblastoma: increase of thermal neutron flux with heavy material
   collimation, a theoretical evaluation
SO JOURNAL OF NEURO-ONCOLOGY
LA English
DT Article
DE glioblastoma; BNCT; fast neutron; BPA
ID BRAIN-BARRIER DISRUPTION; CONCOMITANT TUMOR BOOST; HIGH-GRADE
   ASTROCYTOMAS; MALIGNANT GLIOMAS; IN-VITRO; INTRACAROTID INJECTION;
   PHOTON IRRADIATION; IV ASTROCYTOMAS; MIXED NEUTRON; CELL LINES
AB Despite the fact that fast neutron irradiation of glioblastoma has shown on autopsies an ability to sterilize tumors, no therapeutic windows have been found for these particles due to their toxicity toward normal brain. Therefore, the Boron Neutron Capture Enhancement (BNCE) of fast neutron beam has been suggested. This paper addresses the problem of fast neutron beam collimation, which induces a dramatic decrease of the thermal neutron flux in the depth of the tissues when smaller irradiation fields are used. Thermoluminescent dosimeter TLD-600 and TLD-700 were used to determine the thermal neutron flux within a Plexiglas phantom irradiated under the Nice Biomedical Cyclotron p(60)+Be(32) fast neutron beam. A BNCE of 4.6% in physical dose was determined for a 10 x 10 cm(2) field, and of 10.4% for a 20 x 20 cm(2) one. A Dose Modification Factor of 1.19 was calculated for CAL 58 glioblastoma cells irradiated thanks to the larger field. In order to increase the thermal flux in depth while shaping the beam, heavy material collimation was studied with Monte Carlo simulations using coupled FLUKA and MCNP-4A codes. The use of 20 cm width lead blocks allowed a 2 fold thermal neutron flux increase in the depth of the phantom, while shielding the fast neutron beam with a fast neutron dose transmission of 23%. Using the DMF of 1.19, a BNCE of 40% was calculated in the beam axis. This enhancement might be sufficient to open, at least theoretically, a therapeutic window.
C1 Hop Louis Pasteur, Serv Neurochirurg, F-06002 Nice, France.
   Hop Hasenrain, Serv Radiotherapie, Mulhouse, France.
   Ctr Antoine Lacassagne, Cyclotron Biomed, F-06054 Nice, France.
   Hop Louis Pasteur, Serv Neurol, F-06002 Nice, France.
RP Paquis, P (reprint author), Hop Louis Pasteur, Serv Neurochirurg, 30 Ave Voie Romaine, F-06002 Nice, France.
CR Barth RF, 1997, CANCER RES, V57, P1129
   BARTH RF, 1992, CANCER-AM CANCER SOC, V70, P2995
   BRETEAU N, 1989, STRAHLENTHER ONKOL, V165, P320
   Briesmeister J.F., 1986, LA7396M
   Buchholz TA, 1997, J NEURO-ONCOL, V33, P171, DOI 10.1023/A:1005798004420
   BUCHHOLZ TA, 1994, RADIOLOGY, V191, P863, DOI 10.1148/radiology.191.3.8184080
   BUCHHOLZ TA, 1994, ACTA ONCOL, V33, P307, DOI 10.3109/02841869409098422
   Capala J, 1996, RADIAT RES, V146, P554, DOI 10.2307/3579556
   CARLSSON J, 1994, ACTA ONCOL, V33, P315, DOI 10.3109/02841869409098423
   CATERALL M, 1980, INT J RADIAT ONCOL, V6, P261
   CODERRE JA, 1993, INT J RADIAT ONCOL, V27, P1121, DOI 10.1016/0360-3016(93)90533-2
   Courdi A, 1996, ACTA ONCOL, V35, P237, DOI 10.3109/02841869609098507
   COURDI A, 1992, RADIOTHER ONCOL, V24, P102, DOI 10.1016/0167-8140(92)90286-4
   DUNCAN W, 1986, BRIT J RADIOL, V59, P379, DOI 10.1259/0007-1285-59-700-379
   DUNCAN W, 1986, BRIT J RADIOL, V59, P373, DOI 10.1259/0007-1285-59-700-373
   DUNCAN W, 1986, BRIT J RADIOL, V59, P441, DOI 10.1259/0007-1285-59-701-441
   FAIRCHILD RG, 1985, INT J RADIAT ONCOL, V11, P831, DOI 10.1016/0360-3016(85)90318-9
   FASSO A, 1994, P SPEC M SHIELD ASP
   FERTIL B, 1984, RADIAT RES, V99, P73, DOI 10.2307/3576448
   HENDRICKS JS, 1994, LA12891
   HERSKOVIC A, 1982, CANCER, V49, P2463, DOI 10.1002/1097-0142(19820615)49:12<2463::AID-CNCR2820491208>3.0.CO;2-3
   HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907
   KOLKER JD, 1990, INT J RADIAT ONCOL, V19, P409, DOI 10.1016/0360-3016(90)90550-4
   LARAMORE GE, 1978, CANCER, V42, P96, DOI 10.1002/1097-0142(197807)42:1<96::AID-CNCR2820420116>3.0.CO;2-W
   LARAMORE GE, 1988, INT J RADIAT ONCOL, V14, P1093, DOI 10.1016/0360-3016(88)90384-7
   LARAMORE GE, 1990, INT J RADIAT ONCOL, V19, P493, DOI 10.1016/0360-3016(90)90564-Z
   LARAMORE GE, 1989, INT J RADIAT ONCOL, V17, P1351, DOI 10.1016/0360-3016(89)90549-X
   LARAMORE GE, 1994, INT J RADIAT ONCOL, V28, P1135, DOI 10.1016/0360-3016(94)90487-1
   LASTER BH, 1991, CANCER RES, V51, P4588
   Mizoe J. E., 1993, Strahlentherapie und Onkologie, V169, P222
   PIGNOL JP, 1996, B CANC RADIOTHER, V83, P201
   POLLER F, 1991, RADIOTHER ONCOL, V21, P179, DOI 10.1016/0167-8140(91)90035-F
   SAROJA KR, 1989, INT J RADIAT ONCOL, V17, P1295, DOI 10.1016/0360-3016(89)90539-7
   SAUERWEIN W, 1990, STRAHLENTHER ONKOL, V166, P26
   SAUERWEIN W, 1989, STRAHLENTHER ONKOL, V165, P208
   STRAGLIOTTO G, 1995, NEUROSURGERY, V36, P285, DOI 10.1227/00006123-199502000-00007
   UTSUMI H, 1991, NUCL SCI APPL, V4, P325
   Yang WL, 1997, J NEURO-ONCOL, V33, P59, DOI 10.1023/A:1005769214899
   YOUNG PG, 1990, LA11753 MS
NR 39
TC 5
Z9 5
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0167-594X
J9 J NEURO-ONCOL
JI J. Neuro-Oncol.
PD JAN
PY 1999
VL 41
IS 1
BP 21
EP 30
DI 10.1023/A:1006115404262
PG 10
WC Oncology; Clinical Neurology
SC Oncology; Neurosciences & Neurology
GA 186HT
UT WOS:000079723400004
PM 10222419
DA 2018-10-19
ER

PT J
AU Verne, E
   Ferraris, M
   Jana, C
AF Verne, E
   Ferraris, M
   Jana, C
TI Pressureless sintering of Bioverit (R) III/Ti particle biocomposites
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE titanium particles; sintering; composites; glass ceramics; biomedical
   applications
ID MEDICAL APPLICATIONS; MATRIX COMPOSITES; GLASS
AB A new bioactive material, based on Bioverit(R) III glass-ceramic (B3), was synthesised, it is a composite material (named B3T) having a glass-ceramic matrix and titanium particles as toughening phase. The aim was to toughen the Bioverit(R) III glass-ceramic, already successfully tested by in vivo experiments. The B3T biocomposite, reinforced by 15 vol% Ti particles, was prepared by pressureless sintering, starting from Bioverit(R) III base glass powders. The sintering conditions were carefully optimised by using differential scanning calorimetry and hot stage microscopy. On the basis of this study a low temperature viscous flow sintering process was chosen, and high density glass-matrix composites were obtained. A further crystallisation, using the temperature and time conditions for bulk Bioverit(R) III glass ceramic, was performed to obtain a glass-ceramic matrix/Ti particle composite. A qualitative mechanical characterisation revealed toughening benefits in the Ti additions. An in vitro test (fibro-blast growth) was performed on the composites in order to demonstrate their biocompatibility. (C) 1999 Elsevier Science Limited. All rights reserved.
C1 Politecn Torino, Dept Mat Sci & Chem Engn, I-10129 Turin, Italy.
   Univ Jena, Otto Schott Inst, D-07743 Jena, Germany.
RP Verne, E (reprint author), Politecn Torino, Dept Mat Sci & Chem Engn, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
OI Verne, Enrica/0000-0002-8649-4739
CR DONALD IW, 1993, J MATER SCI, V28, P2841, DOI 10.1007/BF00354689
   DUCHEYNE P, 1993, INTRO BIOCERAMICS, P281
   Ferraris M, 1996, J EUR CERAM SOC, V16, P421, DOI 10.1016/0955-2219(95)00114-X
   FERRARIS M, 1994, COMPOSITES, V25, P494, DOI 10.1016/0010-4361(94)90175-9
   Holand W., 1993, INTRO BIOCERAMICS, P125
   Rizkalla AS, 1996, BRIT CERAM T, V95, P151
   SWAIN MV, 1983, AM CERAM SOC COM FEB, pC27
   Verne E, 1998, J EUR CERAM SOC, V18, P363, DOI 10.1016/S0955-2219(97)00134-9
   VERNE E, 1997, 99 ACERS ANN M CINC, P11
   Vogel J, 1997, GLASTECH BER-GLASS, V70, P220
   WANG LH, 1995, PHARMACEUT RES, V12, P275, DOI 10.1023/A:1016243313027
   Wang P., 1990, SILICATES IND, V7-8, P231
NR 12
TC 12
Z9 12
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
EI 1873-619X
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PY 1999
VL 19
IS 12
BP 2039
EP 2047
DI 10.1016/S0955-2219(99)00036-9
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA 227UE
UT WOS:000082097700001
DA 2018-10-19
ER

PT S
AU Herman, PR
   Goodno, G
   Gu, XJ
   Kalbfleisch, JB
   Long, J
   Lukacs, M
   Marjoribanks, RS
   Miller, RJD
   Nantel, M
   Ness, S
   Oettl, A
AF Herman, PR
   Goodno, G
   Gu, XJ
   Kalbfleisch, JB
   Long, J
   Lukacs, M
   Marjoribanks, RS
   Miller, RJD
   Nantel, M
   Ness, S
   Oettl, A
BE Dubowski, JJ
   Helvajian, H
   Kreutz, EW
   Sugioka, K
TI Advanced-laser processing of photonic and microelectronic components at
   Photonics Research Ontario
SO LASER APPLICATIONS IN MICROELECTRONIC AND OPTOELECTRONIC MANUFACTURING
   IV
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Laser Applications in Microelectronic and Optoelectronic
   Manufacturing IV
CY JAN 25-27, 1999
CL SAN JOSE, CA
SP USAF Off Sci Res, SPIE
DE laser micromachining; ablation; laser trimming; photonics; Bragg
   gratings; photosensitivity; ultrafast lasers
ID EXCIMER-LASER; FEMTOSECOND LASER; INDUCED BREAKDOWN; OPTICAL FIBERS;
   FUSED-SILICA; WAVE-GUIDES; PULSES; PHOTOSENSITIVITY
AB Photonics Research Ontario (PRO) is an Ontario Provincial Center of Excellence supporting a broad range of laser-processing activities within its photonics program. These activities are centered at the University of Toronto, and split between an industrial-user facility and the individual research programs of principal investigators. The combined effort furnishes forefront laser systems and advanced optical tools to explore novel processing applications in photonic, biomedical, and microelectronic areas. Facilities include laser micromachining stations, excimer-based mask-projection stations, extremely short wavelength lasers such as the molecular fluorine laser (157 nm), and ultrafast laser systems (100 fs - I ps). The latter two advanced lasers offer interesting advantages and contrasts in processing 'difficult' materials through linear and nonlinear absorption processes, respectively. These laser systems provide fine precision and strong interaction with a wide range of materials, including 'transparent' glasses, and also ceramics and metals. Applications fall broadly into several areas: wafer-level circuit trimming (electronics), high-resolution ultrasonic transducers (biomedical devices), and the shaping of optical waveguides and Bragg-gratings for photonic components (telecommunications). This paper summarizes the laser-processing infrastructure and research activities at PRO.
C1 Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.
RP Herman, PR (reprint author), Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.
RI Herman, Peter/A-6464-2008
OI Herman, Peter/0000-0002-9157-8259
CR ALBERT J, 1992, OPT LETT, V17, P1652, DOI 10.1364/OL.17.001652
   ALBERT J, 1995, APPL PHYS LETT, V67, P3529, DOI 10.1063/1.114911
   Allan DC, 1996, OPT LETT, V21, P1960, DOI 10.1364/OL.21.001960
   Ashkenasi D, 1997, APPL SURF SCI, V120, P65, DOI 10.1016/S0169-4332(97)00218-3
   Davis KM, 1996, OPT LETT, V21, P1729, DOI 10.1364/OL.21.001729
   DU D, 1994, APPL PHYS LETT, V64, P3071, DOI 10.1063/1.111350
   FERTEIN E, 1991, ELECTRON LETT, V20, P1838
   Glezer EN, 1996, OPT LETT, V21, P2023, DOI 10.1364/OL.21.002023
   Goodno GD, 1998, J OPT SOC AM B, V15, P1791, DOI 10.1364/JOSAB.15.001791
   Herman PR, 1997, P SOC PHOTO-OPT INS, V2992, P86, DOI 10.1117/12.270086
   Herman PR, 1997, P SOC PHOTO-OPT INS, V2991, P170, DOI 10.1117/12.273724
   HERMAN PR, 1997, OSA TECH DIGEST, P159
   HERMAN PR, 1999, IN PRESS SPIE, V3616
   Jackson BD, 1998, APPL SURF SCI, V127, P595, DOI 10.1016/S0169-4332(97)00712-5
   Kruger J, 1998, APPL SURF SCI, V127, P892, DOI 10.1016/S0169-4332(97)00763-0
   KUPER S, 1987, APPL PHYS B-PHOTO, V44, P199, DOI 10.1007/BF00692122
   Kurosawa K., 1998, Journal of Photopolymer Science and Technology, V11, P367, DOI 10.2494/photopolymer.11.367
   LEMAIRE PJ, 1993, ELECTRON LETT, V29, P1191, DOI 10.1049/el:19930796
   LUKAS M, 1999, THESIS QUEENS U KING
   MORIMOTO Y, 1994, J NON-CRYST SOLIDS, V179, P260, DOI 10.1016/0022-3093(94)90704-8
   PRESS S, 1995, APPL PHYS LETT, V67, P338
   PRONKO PP, 1995, OPT COMMUN, V114, P1036
   Stuart BC, 1996, PHYS REV B, V53, P1749, DOI 10.1103/PhysRevB.53.1749
   Sugioka K, 1996, APPL SURF SCI, V96-8, P347, DOI 10.1016/0169-4332(95)00442-4
   Varel H, 1997, APPL PHYS A-MATER, V65, P367, DOI 10.1007/s003390050593
   Vengsarkar AM, 1996, OPT LETT, V21, P336, DOI 10.1364/OL.21.000336
NR 26
TC 4
Z9 4
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3088-9
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3618
BP 240
EP 250
DI 10.1117/12.352687
PG 11
WC Engineering, Electrical & Electronic; Materials Science, Coatings &
   Films; Optics
SC Engineering; Materials Science; Optics
GA BN65R
UT WOS:000082492400027
DA 2018-10-19
ER

PT S
AU Anikeev, BV
   Khramov, VN
   Podolskii, VL
AF Anikeev, BV
   Khramov, VN
   Podolskii, VL
BE Chikishev, AY
   Zadkov, VN
   Zheltikov, AM
TI Laser-plasma technologies for the biomedical purposes: experiment for
   stomatology
SO LASER SPECTROSCOPY AND OPTICAL DIAGNOSTICS: NOVEL TRENDS AND
   APPLICATIONS IN LASER CHEMISTRY, BIOPHYSICS, AND BIOMEDICINE - ICONO'98
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 16th International Conference on Coherent and Nonlinear Optics (ICONO
   98)
CY JUN 29-JUL 03, 1998
CL MOSCOW, RUSSIA
SP Minist Sci & Technol Russian Federat, Russian Fdn Basic Res, Minist Educ Russian Federat, Basic Opt & Spect Educ & Res Ctr, Opt Soc Amer, SPIE-Int Soc Opt Engn, Int Union Pure & Appl Phys, EPS-European Phys Soc, Lawrence Livermore Natl Lab, European Off Aerosp Res & Dev, SPIE Russia Chapter, US Army European Res Off
DE laser plasma; ultrashort pulses; method of short-term resonance
   modulation of losses; stomatology
AB Results of experiment on dental solid tissues treatment with help the new laser-plasma method used the designed by authors the high energy Nd-glass picosecond laser are informed. Advantages of the method are the dot source of plasma, low transmission of heat deep into treated material etc. According with results proposing arrangement productivity is higher than setup of German company "KAVO" one.
C1 Volgograd State Univ, Volgograd 400062, Russia.
RP Anikeev, BV (reprint author), Volgograd State Univ, 30,2 Ya Prodolnaya St, Volgograd 400062, Russia.
RI Khramov, Vladimir/B-1929-2018
OI Khramov, Vladimir/0000-0002-1876-8216; Khramov,
   Vladimir/0000-0001-8988-0929
CR Anikeev B. V., 1996, Quantum Electronics, V26, P57, DOI 10.1070/QE1996v026n01ABEH000588
   ANIKEEV BV, 1980, Patent No. 716484
   ANIKEEV BV, 1985, KVANTOVAYA ELEKTRON, P3
   PROKHONCHUKOV AA, 1986, LASERS STOMATOLOGY
   YAMAMOTO H, 1980, J DENT RES, V59, P2171
NR 5
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3206-7
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3732
BP 367
EP 370
DI 10.1117/12.340037
PG 4
WC Biophysics; Chemistry, Multidisciplinary; Engineering, Biomedical;
   Optics
SC Biophysics; Chemistry; Engineering; Optics
GA BM55P
UT WOS:000079092500049
DA 2018-10-19
ER

PT J
AU Mecerreyes, D
   Jerome, R
   Dubois, P
AF Mecerreyes, D
   Jerome, R
   Dubois, P
TI Novel macromolecular architectures based on aliphatic polyesters:
   Relevance of the "coordination-insertion" ring-opening polymerization
SO MACROMOLECULAR ARCHITECTURES
SE ADVANCES IN POLYMER SCIENCE
LA English
DT Review
DE lactones; lactides; aliphatic polyesters; ring opening polymerization;
   living polymerization; macromolecular engineering
ID EPSILON-CAPROLACTONE POLYMERIZATION; SELECTIVE END-FUNCTIONALIZATION;
   LIVING RADICAL POLYMERIZATION; ALUMINUM ISOPROPOXIDE; BLOCK-COPOLYMERS;
   BULK-POLYMERIZATION; GRAFT-COPOLYMERS; POLYIMIDE NANOFOAMS;
   BIODEGRADABLE HOMOPOLYMERS; METATHESIS POLYMERIZATION
AB Recent developments in the macromolecular engineering of aliphatic polyesters have been overviewed. First, aluminum alkoxides mediated living ring opening polymerization (ROP) of cyclic (di)esters, i.e., lactones, lactides, glycolide, is introduced. An insight into this so-called "coordination-insertion" mechanism and the ability of this living polymerization process to prepare well-defined homopolymers, telechelic polymers, random and block copolymers is then discussed. In the second part, the combination of the living ROP of (di)lactones with other well-controlled polymerization mechanisms such as anionic, cationic, free radical, and metathesis polyadditions of unsaturated comonomers, as well as polycondensations, is reported with special emphasis on the design of new and well-tailored macromolecular architectures. As a result of the above synthetic breakthrough, a variety of novel materials have been developed with versatile applications in very different fields such as biomedical and microelectronics.
C1 Univ Liege, Ctr Educ & Res Macromol, B-4000 Liege, Belgium.
   Univ Mons, Lab Polymer & Composite Mat, B-7000 Mons, Belgium.
RP Mecerreyes, D (reprint author), Univ Liege, Ctr Educ & Res Macromol, B6, B-4000 Liege, Belgium.
RI Mecerreyes, David/K-7541-2014; DUBOIS, Philippe/B-9983-2008
OI Mecerreyes, David/0000-0002-0788-7156; 
CR ANDINI S, 1988, MAKROMOL CHEM-RAPID, V9, P119
   Balsamo V, 1996, MACROMOL CHEM PHYSIC, V197, P1159, DOI 10.1002/macp.1996.021970332
   BARAKAT I, 1994, J POLYM SCI POL CHEM, V32, P2099, DOI 10.1002/pola.1994.080321112
   BARAKAT I, 1994, MACROMOL SYMP, V88, P227, DOI 10.1002/masy.19940880118
   BARAKAT I, 1993, J POLYM SCI POL CHEM, V31, P505, DOI 10.1002/pola.1993.080310222
   BARAKAT I, 1993, THESIS U LIEGE BELGI
   BARAKAT I, 1999, IN PRESS J POLYM PC
   Baran J, 1997, MACROMOL SYMP, V123, P93, DOI 10.1002/masy.19971230110
   BARR SJ, 1993, J ORTHOP RES, V11, P10, DOI 10.1002/jor.1100110103
   Biela T, 1996, J POLYM SCI POL CHEM, V34, P1807, DOI 10.1002/(SICI)1099-0518(19960715)34:9<1807::AID-POLA19>3.0.CO;2-A
   Bisht KS, 1997, MACROMOLECULES, V30, P7735, DOI 10.1021/ma9708858
   CARTER KR, 1996, ACS POLYM PREPR, V37, P607
   CHARLIER Y, 1995, POLYMER, V36, P987, DOI 10.1016/0032-3861(95)93599-H
   CHUJO Y, 1994, J CHEM SOC CHEM COMM, P635, DOI 10.1039/c39940000635
   COX EF, 1972, Patent No. 3021309
   Degee P, 1997, MACROMOL CHEM PHYSIC, V198, P1985, DOI 10.1002/macp.1997.021980624
   Degee P, 1997, MACROMOL CHEM PHYSIC, V198, P1973, DOI 10.1002/macp.1997.021980623
   DEGEE P, 1993, J POLYM SCI POL CHEM, V31, P275, DOI 10.1002/pola.1993.080310132
   Degee P, 1997, MACROMOL SYMP, V123, P67, DOI 10.1002/masy.19971230108
   DEGEE P, 1991, THESIS U LIEGE BELGI
   Demonceau A, 1997, MACROMOLECULES, V30, P3127, DOI 10.1021/ma961040j
   DUBOIS P, 1991, MACROMOLECULES, V24, P2266, DOI 10.1021/ma00009a022
   Dubois P, 1996, MACROMOLECULES, V29, P1965, DOI 10.1021/ma951738h
   DUBOIS P, 1992, MACROMOLECULES, V25, P2614, DOI 10.1021/ma00036a009
   DUBOIS P, 1991, MACROMOLECULES, V24, P977, DOI 10.1021/ma00005a002
   DUBOIS P, 1989, POLYM BULL, V22, P475, DOI 10.1007/BF00718922
   DUBOIS P, 1994, POLYMER, V35, P4998, DOI 10.1016/0032-3861(94)90655-6
   DUBOIS P, 1995, MACROMOLECULES, V28, P1965
   DUBOIS P, 1991, THESIS U LIEGE BELGI
   DUBOIS P, 1997, MACROMOLECULAR DESIG, P247
   DUDA A, 1995, MACROMOL RAPID COMM, V16, P67, DOI 10.1002/marc.1995.030160112
   DUDA A, 1995, MACROMOLECULES, V28, P5981, DOI 10.1021/ma00122a001
   DUDA A, 1991, MAKROMOL CHEM-M SYMP, V47, P127, DOI 10.1002/masy.19910470111
   Duda A, 1996, MACROMOL CHEM PHYSIC, V197, P1273, DOI 10.1002/macp.1996.021970408
   Duda A, 1996, MACROMOLECULES, V29, P1399, DOI 10.1021/ma951442b
   EGIBURU JL, 1996, POLYMER, V37, P3615
   EGIBURU JL, 1996, THESIS U BASQUE COUN
   ENDO M, 1987, MACROMOLECULES, V20, P2982, DOI 10.1021/ma00178a005
   FRECHET JMJ, 1994, SCIENCE, V263, P1710, DOI 10.1126/science.8134834
   FUJINO T, 1985, POLYM PREPR JPN, V25, P2330
   GELVIN ME, 1992, J AM CHEM SOC, V114, P3962
   GITSOV I, 1994, MACROMOL RAPID COMM, V15, P387, DOI 10.1002/marc.1994.030150501
   GITSOV I, 1992, ANGEW CHEM INT EDIT, V31, P1200, DOI 10.1002/anie.199212001
   Grubbs R. H., 1982, COMPREHENSIVE ORGANO, V8, P499
   HAMAIDE T, 1994, MACROMOL SYMP, V88, P191, DOI 10.1002/masy.19940880115
   HAMITOU A, 1977, J POLYM SCI POL CHEM, V32, P285
   HARRIS JF, 1986, MACROMOLECULES, V19, P2903, DOI 10.1021/ma00166a004
   Hawker CJ, 1997, MACROMOL CHEM PHYSIC, V198, P155, DOI 10.1002/macp.1997.021980112
   HAWKER CJ, 1998, MACROMOLECULES, V31, P214
   Hedrick JL, 1998, CHEM MATER, V10, P39, DOI 10.1021/cm960523z
   Hedrick JL, 1996, REACT FUNCT POLYM, V30, P43, DOI 10.1016/1381-5148(96)00020-X
   Hedrick JL, 1996, MACROMOLECULES, V29, P3642, DOI 10.1021/ma950903q
   HEDRICK JL, 1998, UNPUB J POLYM SCI PC
   Heroguez V, 1997, MACROMOLECULES, V30, P4791, DOI 10.1021/ma970098a
   HEUSCHEN J, 1981, MACROMOLECULES, V14, P242, DOI 10.1021/ma50003a003
   HOFMAN A, 1987, MAKROMOL CHEM-RAPID, V8, P387
   Ihre H, 1996, J AM CHEM SOC, V118, P6388, DOI 10.1021/ja954171t
   INOUE S, 1993, MAKROMOL CHEM-M SYMP, V73, P27, DOI 10.1002/masy.19930730105
   JACOBS C, 1991, MACROMOLECULES, V24, P3027, DOI 10.1021/ma00011a001
   JONTE JM, 1986, J MACROMOL SCI CHEM, VA23, P495
   Kessler B, 1998, MACROMOL SYMP, V130, P245, DOI 10.1002/masy.19981300122
   KIMURA Y, 1988, MACROMOLECULES, V21, P3338, DOI 10.1021/ma00189a037
   KOALCZUK M, 1994, MACROMOLECULES, V24, P572
   KOBAYASHI S, 1995, ADV POLYM SCI, V121, P1
   Kricheldorf HR, 1998, MACROMOL SYMP, V128, P121, DOI 10.1002/masy.19981280113
   KRICHELDORF HR, 1989, EUR POLYM J, V25, P585, DOI 10.1016/0014-3057(89)90010-4
   KRICHELDORF HR, 1990, MAKROMOL CHEM-M SYMP, V32, P285, DOI 10.1002/masy.19900320122
   KUHLING S, 1992, MAKROMOL CHEM, V193, P1207
   Kurcok P, 1997, MACROMOLECULES, V30, P5591, DOI 10.1021/ma970212p
   Kurcok P, 1996, POLYM INT, V41, P479, DOI 10.1002/(SICI)1097-0126(199612)41:4<479::AID-PI652>3.0.CO;2-W
   Kylma J, 1997, MACROMOLECULES, V30, P2876, DOI 10.1021/ma961569g
   LEBORGNE A, 1994, MACROMOL RAPID COMM, V15, P955
   Lecomte P, 1998, POLYM BULL, V40, P631, DOI 10.1007/s002890050301
   LOFGREN A, 1994, MACROMOLECULES, V27, P5556
   LOFGREN A, 1995, J MACROMOL SCI R M C, VC35, P379
   LOFGREN A, 1995, J APPL POLYM SCI, V55, P1589
   LUNDBERG RD, 1969, RING OPENING POLYM, V6, P266
   Matsumura S, 1998, MACROMOL SYMP, V130, P285, DOI 10.1002/masy.19981300125
   MCLAIN SJ, 1992, AM CHEM SOC DIV POLY, V33, P463
   Mecerreyes D, 1998, ANGEW CHEM INT EDIT, V37, P1274, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1274::AID-ANIE1274>3.0.CO;2-J
   MECERREYES D, 1998, IN PRESS
   MECERREYES D, 1999, IN PRESS MACROMOL CH
   MECERREYES D, 1997, ACS POLYM MAT SCI EN, V77, P189
   MECERREYES D, 1999, UNPUB
   MECERREYES D, IN PRESS
   MECERREYES D, 1998, IN PRESS MAKROMOL CH
   MIOLA C, 1997, POLYMER, V38, P22
   Moad G, 1995, MACROMOLECULES, V28, P8722, DOI 10.1021/ma00130a003
   MOGSTAD AL, 1994, MACROMOLECULES, V27, P2313, DOI 10.1021/ma00086a050
   NIJENHUIS AJ, 1992, MACROMOLECULES, V25, P6419, DOI 10.1021/ma00050a006
   Nobes GAR, 1996, MACROMOLECULES, V29, P4829, DOI 10.1021/ma951774g
   NYSSEN C, 1996, THESIS U LIEGE LIEGE
   OUHADI T, 1976, MACROMOLECULES, V9, P927, DOI 10.1021/ma60054a009
   OUHADI T, 1975, MAKROMOL CHEM S, V1, P1991
   PALMGREN R, 1997, J POLYM SCI POL CHEM, V35, P9
   PITT CG, 1987, J POLYM SCI POL CHEM, V25, P955, DOI 10.1002/pola.1987.080250402
   RIQUELURBET L, 1994, POLYMER, V35, P4563
   ROPSON N, 1992, MACROMOLECULES, V25, P3820, DOI 10.1021/ma00040a034
   Ropson N, 1997, J POLYM SCI POL CHEM, V35, P183, DOI 10.1002/(SICI)1099-0518(19970115)35:1<183::AID-POLA18>3.0.CO;2-G
   ROPSON N, 1995, MACROMOLECULES, V28, P758
   Shen YQ, 1996, MACROMOLECULES, V29, P8289, DOI 10.1021/ma9518060
   Simic V, 1997, MACROMOLECULES, V30, P7338, DOI 10.1021/ma970615p
   Slomkowski S, 1997, MACROMOL SYMP, V123, P45, DOI 10.1002/masy.19971230106
   SMITH DM, 1995, MATER RES SOC SYMP P, V371, P261
   SMITH DM, 1995, MATER RES SOC S P, V37, P261
   Sobry R, 1996, J MOL STRUCT, V383, P63, DOI 10.1016/S0022-2860(96)09269-1
   Steinbuchel A, 1997, MACROMOL SYMP, V123, P61, DOI 10.1002/masy.19971230107
   Stevels WM, 1996, MACROMOLECULES, V29, P6132, DOI 10.1021/ma9605311
   Stevels WM, 1996, MACROMOLECULES, V29, P8296, DOI 10.1021/ma960701+
   Stevels WM, 1997, TRENDS POLYM SCI, V5, P300
   STOREY RF, 1994, POLYMER, V35, P830, DOI 10.1016/0032-3861(94)90882-6
   THAMM RC, 1977, ANGEW MAKROMOL CHEM, V58, P345, DOI 10.1002/apmc.1977.050580115
   Tian D, 1997, MACROMOLECULES, V30, P1947, DOI 10.1021/ma961614k
   Tian D, 1997, J POLYM SCI POL CHEM, V35, P2295, DOI 10.1002/(SICI)1099-0518(199708)35:11<2295::AID-POLA21>3.0.CO;2-8
   Tian D, 1996, POLYMER, V37, P3983, DOI 10.1016/0032-3861(96)00199-1
   Tian D, 1997, MACROMOLECULES, V30, P406, DOI 10.1021/ma961631+
   Tian D, 1997, MACROMOLECULES, V30, P2575, DOI 10.1021/ma961567w
   Tian D, 1998, MACROMOL SYMP, V130, P217, DOI 10.1002/masy.19981300120
   Tian D, 1997, CHEM MATER, V9, P1704, DOI 10.1021/cm9709030
   TIAN D, 1994, MACROMOLECULES, V27, P4134, DOI 10.1021/ma00093a015
   TIAN D, 1997, THESIS U LIEGE BELGI
   Tortosa K, 1997, J APPL POLYM SCI, V65, P2357, DOI 10.1002/(SICI)1097-4628(19970919)65:12<2357::AID-APP9>3.0.CO;2-8
   Trollsas M, 1998, J POLYM SCI POL CHEM, V36, P3187, DOI 10.1002/(SICI)1099-0518(199812)36:17<3187::AID-POLA21>3.0.CO;2-A
   Trollsas M, 1998, MACROMOLECULES, V31, P2756, DOI 10.1021/ma971645v
   Trollsas M, 1997, MACROMOLECULES, V30, P8508, DOI 10.1021/ma970798f
   TROLLSAS M, 1997, POLYM MAT SCI ENG, V77, P208
   UYAMA H, 1995, MACROMOLECULES, V28, P7046, DOI 10.1021/ma00125a002
   VANHOORNE P, 1992, MACROMOLECULES, V30, P1947
   Vert M., 1979, ACS POLYM PREPT, V20, P608
   Vert M., 1992, BIODEGRADABLE POLYM
   WANG JS, 1995, J AM CHEM SOC, V117, P5614, DOI 10.1021/ja00125a035
   WEBSTER OW, 1991, SCIENCE, V251, P887, DOI 10.1126/science.251.4996.887
   YAMASHITA Y, 1981, ACS SYM SER, V66, P199
   YASUDA H, 1993, PROG POLYM SCI, V18, P1097, DOI 10.1016/0079-6700(93)90011-Z
   YASUDA H, 1995, MACROMOL CHEM PHYSIC, V196, P2417, DOI 10.1002/macp.1995.021960802
NR 135
TC 238
Z9 241
U1 2
U2 65
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
J9 ADV POLYM SCI
PY 1999
VL 147
BP 1
EP 59
PG 59
WC Polymer Science
SC Polymer Science
GA BN41V
UT WOS:000081879100001
DA 2018-10-19
ER

PT S
AU Kline-Schoder, R
   Kynor, D
   Jaeger, M
   Winder, A
   Desilets, C
AF Kline-Schoder, R
   Kynor, D
   Jaeger, M
   Winder, A
   Desilets, C
BE Shung, KK
TI Physical vapor deposition of multi-layered lead-zirconate-titanate films
   for ultrasonic transducer fabrication
SO MEDICAL IMAGING 1999: ULTRASONIC TRANSDUCER ENGINEERING
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Medical Imaging 1999 Conference
CY FEB 21-25, 1999
CL SAN DIEGO, CA
SP SPIE, Amer Assoc Physicists Med, Amer Physiol Soc, FDA Ctr Devices & Radiol Hlth, Soc Imaging Sci & Technol, Natl Elect Mfg Assoc/Diagnost Imaging & Therapy Syst Div, Radiol Soc N Amer, Soc Comp Applicat Radiol
DE sputtering; multi-layer PZT; multi-dimensional array
AB Creare is developing microfabrication techniques to manufacture low-cost, multi-dimensional ultrasonic transducer arrays with single- and multi-layer piezoelectric elements for low impedance and high sensitivity. The manufacturing approach is scaleable for fabrication of transducer arrays in the frequency range of 10-500 MHz in dense or sparse array configurations. Our approach employs the following processes: (1) Physical Vapor Deposition (PVD or sputtering) of high-quality, piezoelectric films using reactive sputtering of metallic targets and (2) Novel use of state-of-the-art photolithography and masking to provide the interlayer electrodes, element interconnections, and array element fabrication. To date, Creare has successfully demonstrated that piezoelectrically active thick films of PZT material can be deposited by using a reactive sputtering approach. In addition, these thick, multi-layer PZT films have been formed into high aspect ratio elements using dicing to fabricate a 12 MHz transducer. Array designs based on these films show that expected performance should meet the requirements for high resolution biomedical imaging.
C1 Creare Res & Dev Inc, Hanover, NH 03755 USA.
RP Kline-Schoder, R (reprint author), Creare Res & Dev Inc, Hanover, NH 03755 USA.
CR FOSTER FS, 1984, ULTRASONIC IMAGING, V6, P234
   GOLDBERG RL, 1994, IEEE T ULTRASON FERR, V41, P761, DOI 10.1109/58.308512
   SHERAR MD, 1987, NATURE, V330, P493, DOI 10.1038/330493a0
NR 3
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3136-2
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3664
BP 221
EP 228
DI 10.1117/12.350679
PG 8
WC Engineering, Biomedical; Optics; Radiology, Nuclear Medicine & Medical
   Imaging
SC Engineering; Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BN29M
UT WOS:000081443300026
DA 2018-10-19
ER

PT S
AU Mariella, R
AF Mariella, R
BE Ferrari, M
TI Instrumentation for biomedical and environmental applications based on
   microtechnology - Lessons learned
SO MICRO- AND NANOFABRICATED STRUCTURES AND DEVICES FOR BIOMEDICAL
   ENVIRONMENTAL APPLICATIONS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Micro- and Nanofabricated Structures and Devices for
   Biomedical Environmental Applications II
CY JAN 25-26, 1999
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
DE microtechnology; instrumentation
ID STREAM WAVE-GUIDE; COLLECTION
AB Over the last ten years, LLNL has been developing Microtechnology for instrumentation with applications in the biosciences and environment. In order to build and field high-performance instruments, we have often had to alter our original premises and assumptions, significantly. This meant that we were forced to abandon materials and dimensions that were appealing to us when we began the R&D, Examples include our work on silicon-based electrophoresis systems, etched-fluidics for sample/sheath flow nozzles in flow cytometers, and polymerase-chain-reaction thermal-cycling; chambers based an silicon-nitride. This presentation will discuss these and our work on other devices and instruments.
C1 Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
RP Mariella, R (reprint author), Univ Calif Lawrence Livermore Natl Lab, POB 808,Mail Stop L-222, Livermore, CA 94551 USA.
CR Belgrader P, 1998, J FORENSIC SCI, V43, P315
   BELGRADER P, UNPUB PCR ANAL BACTE
   CIARLO D, UNPUBN
   DAVIDSON JD, COMMUNICATION
   HUANG Z, UNPUB HIGH SIDE SCAT
   LANGLOIS RG, 1998, CYTOMETRY S, V9, P55
   Mariella R, 1996, CYTOMETRY, V24, P27, DOI 10.1002/(SICI)1097-0320(19960501)24:1<27::AID-CYTO3>3.0.CO;2-F
   Mariella R, 1997, P SOC PHOTO-OPT INS, V2982, P367, DOI 10.1117/12.273636
   MARIELLA RP, 1995, Patent No. 5475487
   NORTHRUP MA, 1996, Patent No. 5589136
   YAGER P, 1998, U WASH CTR PROC AN C
NR 11
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3076-5
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3606
BP 74
EP 81
PG 8
WC Chemistry, Analytical; Engineering, Biomedical; Medical Laboratory
   Technology; Optics
SC Chemistry; Engineering; Medical Laboratory Technology; Optics
GA BN19W
UT WOS:000081054000009
DA 2018-10-19
ER

PT S
AU Madou, M
   Zhang, YS
   Xu, T
   Kellogg, GJ
   Duffy, DC
AF Madou, M
   Zhang, YS
   Xu, T
   Kellogg, GJ
   Duffy, DC
BE Ahn, CH
   Frazier, AB
TI From batch to continuous manufacturing of micro-biomedical and
   micro-analytical devices
SO MICROFLUIDIC DEVICES AND SYSTEMS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT SPIE Conference on Microfluidic Devices and Systems II
CY SEP 20-21, 1999
CL SANTA CLARA, CA
SP SPIE
DE micromachining; modular approach; continuous process; fluidic platform;
   drug delivery; bio-MEMS
ID SYSTEMS; DNA
AB We demonstrate how manufacturing of miniaturized biosensors, fluidic platforms, drug delivery systems and other micro biomedical devices is relying more and more on non-Si micromanufacturing techniques. The new methodologies are hybrid in nature and merge IC fabrication methods (e.g. lithography) with more traditional manufacturing (e.g, lamination, plastic molding and electroplating). These proposed methods may involve large sheets of materials or may even be continuous, i.e., the number of devices that can be produced per single substrate is larger than that of a Si batch. The techniques are also modular rather than integrated and involve methods such as lamination, drop delivery, pick and place, laser drilling and cutting and other methods borrowed from the IC packaging and PC board industries. These new processes will afford for the first time miniaturized sensors, fluidics and other micro-biomedical devices at a cost that will enable them to become pervasive in our daily lives. The greater modularity in combining different components and the wider choice of materials with the required properties ( e.g. biocompatibility, toughness, and optical transparency) will further accelerate the advent of many more innovative micro biomedical devices. In this paper we first discuss four important technology needs crucial to the realization of inexpensive disposable micro biomedical devices and then show early results obtained in our own laboratories towards the manufacture of three micro-biomedical and micro-analytical devices: disposable biosensors, CD based microfluidic platforms and responsive drug delivery pills.
C1 Ohio State Univ, Dept Mat Sci & Engn, Ctr Ind Sensors & Measurements, Columbus, OH 43210 USA.
RP Madou, M (reprint author), Ohio State Univ, Dept Mat Sci & Engn, Ctr Ind Sensors & Measurements, 2041 Coll Rd, Columbus, OH 43210 USA.
RI Madou, Marc/E-5869-2013
OI Madou, Marc/0000-0003-4847-3117
CR Becker H, 1998, P SOC PHOTO-OPT INS, V3515, P177, DOI 10.1117/12.322081
   BECKER H, 1998, SENSORS UPDATE, V3, P208
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Effenhauser CS, 1997, ANAL CHEM, V69, P3451, DOI 10.1021/ac9703919
   EHRFELD W, 1987, P IEEE MICR TEL WORK, P53
   ERHFELD W, 1995, RADIAT PHYS CHEM, V45, P349
   FRAZIER AB, 1994, SOL STAT SENS ACT WO, P90
   Jackman RJ, 1998, ANAL CHEM, V70, P2280, DOI 10.1021/ac971295a
   JUAN WH, 1994, SOL STAT SENS ACT WO, P82
   KOPP MU, 1997, CURRENT OPINION CHEM, P1410
   Lauks IR, 1998, ACCOUNTS CHEM RES, V31, P317, DOI 10.1021/ar9700670
   LOW LCK, IN PRESS
   Madou M., 1994, <IT>US Patent</IT>, Patent No. [5,304,293, 5304293]
   Madou MJ, 1998, P SOC PHOTO-OPT INS, V3259, P80, DOI 10.1117/12.307314
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   Manz A., 1998, TOP CURR CHEM, p[194, 215]
   McCormick RM, 1997, ANAL CHEM, V69, P2626, DOI 10.1021/ac9701997
   Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545
NR 18
TC 2
Z9 2
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3474-4
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3877
BP 44
EP 53
DI 10.1117/12.359353
PG 10
WC Engineering, Mechanical; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BP26J
UT WOS:000084509600006
DA 2018-10-19
ER

PT S
AU Bachman, M
   Chiang, YM
   Chu, C
   Li, GP
AF Bachman, M
   Chiang, YM
   Chu, C
   Li, GP
BE Ahn, CH
   Frazier, AB
TI Laminated microfluidic structures using a micromolding technique
SO MICROFLUIDIC DEVICES AND SYSTEMS II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT SPIE Conference on Microfluidic Devices and Systems II
CY SEP 20-21, 1999
CL SANTA CLARA, CA
SP SPIE
DE microfluidics; micromolding; microfabrication; BioMEMS; plastic chips;
   laminated microdevices
AB Microfluidic networks suitable for biomedical applications have been fabricated in a variety of polymer materials using micromolding and lamination. By molding several layers of 2D microfluidic patterns in a variety of materials, then laminating together, a wide variety of complex 3D systems with micron sized resolution can be constructed. The process of micromolding and lamination, and the integrated fabrication process for biomedical microfluidic devices is presented. Emphasis is on the practical aspects of fabricating fluidic prototypes in the research laboratory.
C1 Univ Calif Irvine, Dept Elect & Comp Engn, Irvine, CA 92697 USA.
RP Bachman, M (reprint author), Univ Calif Irvine, Dept Elect & Comp Engn, Irvine, CA 92697 USA.
RI Li, Guann-Pyng/B-8466-2009
CR AVIRAM A, 1984, Patent No. 4440801
   Brittain S, 1998, PHYS WORLD, V11, P31
   Chan CM, 1996, SURF SCI REP, V24, P3
   Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Folch A, 1999, J MICROELECTROMECH S, V8, P85, DOI 10.1109/84.749407
   Folch A, 1999, J BIOMECH ENG-T ASME, V121, P28, DOI 10.1115/1.2798038
   FOLCH A, 1999, T ASME, V121
   HECKELE M, 1998, MICROSYSTEM TECHNOLO, V4
   LAPCZYNA M, 1998, APPL PHYSICS A
   Larsson O, 1997, TRANSDUCERS 97, V2, P1415
   LINDSAY J, 1982, Patent No. 4395313
   NAKAMOTO T, 1996, J MICROMECHANICS MIC, V6
   PIOTTER V, 1997, MICROSYSTEM TECHNOLO, V3
   Zhao XM, 1997, APPL PHYS LETT, V71, P1017, DOI 10.1063/1.119713
NR 15
TC 3
Z9 3
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3474-4
J9 PROC SPIE
PY 1999
VL 3877
BP 139
EP 146
DI 10.1117/12.359331
PG 8
WC Engineering, Mechanical; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BP26J
UT WOS:000084509600017
DA 2018-10-19
ER

PT S
AU Brazzle, JD
   Mohanty, S
   Frazier, AB
AF Brazzle, JD
   Mohanty, S
   Frazier, AB
BE Ahn, CH
   Frazier, AB
TI Hollow metallic micromachined needles with multiple output ports
SO MICROFLUIDIC DEVICES AND SYSTEMS II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT SPIE Conference on Microfluidic Devices and Systems II
CY SEP 20-21, 1999
CL SANTA CLARA, CA
SP SPIE
DE microneedles; Navier-Stokes; microchannels; fluid modeling;
   micromachining; drug delivery
AB In this paper, hollow metallic micromachined needles with multiple output ports are designed, fabricated, characterized, and packaged. The hollow metallic needles include design features such as tapered needle tips and multiple output ports on the bottom and top of each needle. The needle tip and shaft are formed by microelectroformed metal. The now characteristics of the needles are currently being experimentally investigated and modeled using a finite element numerical model. The experimental results and theoretical models will be presented as part of this paper. The micromachined needles can be fabricated on a variety of substrates and can use micro-electroformed palladium as the structural material. The use of palladium as a structural material provides high mechanical strength and durability, as well as, biocompatibility for use in biomedical applications. The cross-sectional dimensions of individual needle tips begin at less than 10 mu m in width and 15 mu m in height and then taper to 200 mu m in width and 60 mu m in height. The significance of this work includes the development of hollow metallic micromachined needles for biomedical applications, as well as, a discussion of structural, fluidic, and packaging design considerations.
C1 Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Brazzle, JD (reprint author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
EM brazzle@eng.utah.edu; kumarlvs@xmission.com; frazier@ee.utah.edu
CR Black J., 1992, BIOL PERFORMANCE MAT
   Brazzle J, 1998, P ANN INT IEEE EMBS, V20, P1837, DOI 10.1109/IEMBS.1998.746949
   BRAZZLE JD, 1998, P SPIE MICR FLUID DE, P116
   Constantinescu V, 1995, LAMINAR VISCOUS FLOW
   Dennis J. K., 1993, NICKEL CHROMIUM PLAT
   HENRY S, 1998, IEEE MICR EL MECH SY
   KADIJA I, 1990, P 77 ANN C AM EL SUR
   LIN L, 1999, J MICROELECTROMECH S, V8, P78, DOI DOI 10.1109/84.749406
   LIN L, 1993, P 7 INT C SOL STAT S, P237
   McAllister D. V., 1999, P 10 INT C SOL STAT, P1098
   Papautsky I, 1999, SENSOR ACTUAT A-PHYS, V73, P101, DOI 10.1016/S0924-4247(98)00261-1
   RATNER B, 1996, BIOMATERIALS SCI INT, P346
   Safranek WH, 1974, PROPERTIES ELECTRODE
   TALBOT NH, 1998, IEEE TECH DIG SOLID, P265
NR 14
TC 11
Z9 11
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3474-4
J9 PROC SPIE
PY 1999
VL 3877
BP 257
EP 266
DI 10.1117/12.359344
PG 10
WC Engineering, Mechanical; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BP26J
UT WOS:000084509600030
DA 2018-10-19
ER

PT S
AU Nicolau, DV
   Cross, R
   Carter, N
   Taguchi, T
AF Nicolau, DV
   Cross, R
   Carter, N
   Taguchi, T
BE Conley, W
TI Protein patterning using bilayer lithography and confocal microscopy
SO MICROLITHOGRAPHY 1999: ADVANCES IN RESIST TECHNOLOGY AND PROCESSING XVI,
   PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Microlithography 1999
CY MAR 15-17, 1999
CL SANTA CLARA, CA
SP SPIE, Semiconductor Equipment & Mat Int
DE protein patterning; bilayer resist; confocal microscopy; biosensors;
   biomicrolithography
AB Protein patterns were printed using conventional microlithographic materials in a bilayer arrangement and unconventional exposure tools. The bilayer resist stack consists of a bottom Poly(tertButylMethAcrylate) layer and a top DNQ/novolak layer. The protein features were printed in both "contact printing", and "step & repeat" mode. The latter printing mode can be managed in a single-cell, "real-time" process, as follows: (i) the exposure step is carried out in a cell by focused beam of a confocal microscope tuned to 488nm exposure; (ii) the development step is performed flowing the photoresist developer through the cell; (iii) the selective deposition of the protein (a green fluorescent protein, FITC avidin) is achieved via the flow of the protein solution through the cell until a desired contrast has been reached; (iv) the control; step consists of an online monitoring of the red fluorescence for the control of the development of the top layer, and of the green fluorescence for the control of the protein patterning, respectively. The techniques have of a seamless portability in a biomedical environment, and for "step & repeat" protein patterning the advantage: of a high and controllable resolution. The process dan be applied in the fabrication of medical microanalysis devices.
C1 Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England.
RP Nicolau, DV (reprint author), Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England.
CR ALLEN RD, 1994, ACS SYM SER, V537, pCH11
   DAMMEL R, 1993, DIAZONAPHTOQUINOE BA
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   GALLOP MA, 1994, J MED CHEM, V37, P1233, DOI 10.1021/jm00035a001
   HATZAKIS M, 1969, J ELECTROCHEM SOC, V116, P1033, DOI 10.1149/1.2412145
   McGall G, 1996, P NATL ACAD SCI USA, V93, P13555, DOI 10.1073/pnas.93.24.13555
   Nicolau DV, 1998, LANGMUIR, V14, P1927, DOI 10.1021/la970802g
   NICOLAU DV, IN PRESS COL SURF A
   1986, Patent No. 4007047
NR 9
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3152-4
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3678
BP 602
EP 607
DI 10.1117/12.350244
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Characterization & Testing; Optics; Physics, Applied
SC Engineering; Materials Science; Optics; Physics
GA BN32U
UT WOS:000081634600060
DA 2018-10-19
ER

PT S
AU Hafez, M
   Sidler, TC
AF Hafez, M
   Sidler, TC
BE Nelson, BJ
   Breguet, JM
TI Fast steering two-axis tilt mirror for laser pointing and scanning
SO MICROROBOTICS AND MICROASSEMBLY
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Microrobotics and Microassembly
CY SEP 21-22, 1999
CL BOSTON, MA
SP SPIE
DE compact scanner; two-axis tilt mirror; tracking; aim and shoot; beam
   handling
AB Compact fast-steering two axis-tilt mirrors are key components in astronomy, laser communications, material processing applications, imaging systems, biomedical and ophthalmologic applications. The laser scanner presented in this paper can perform a variety of functions such as tracking, beam stabilization and alignment, pointing and scanning. The small overall volume of 30 x 40 x 50 mm(3) can lead to a very stable and compact system design. The fact that the steered mirror has a single point of rotation for the two tilt axes is a clear advantage for systems with scanning lenses designed for this purpose. The scanner is composed of one single mirror driven by two pairs of push-pull linear electromagnetic actuators. The suspension of the mirror is based on a cone-ball bearing with optimized friction and wear behavior. A Position Sensitive Detector (PSD) integrated in the module is used for the closed loop feedback positioning. The mirror can be tilted by more than +/- 52 mrad (+/-3 degrees) with an accuracy better than 50 mu rad. A differential resolution of the order of 5 mu rad and a settling time for maximum deflection of 9 ms is achieved.
   Due to the large active area of the mirror (30 mm x 40 mm), very small spot diameters can be reached (less than 1 mu m) using high quality laser beams. Therefore, the scanner can be used e.g. in high precision micro-material processing of semiconductor and sensor industry.
C1 Swiss Fed Inst Technol, Microengn Dept, Inst Appl Opt, BM, CH-1015 Lausanne, Switzerland.
RP Hafez, M (reprint author), Swiss Fed Inst Technol, Microengn Dept, Inst Appl Opt, BM, CH-1015 Lausanne, Switzerland.
CR BELLOUARD Y, 1998, IN PRESS ICOMAT 98 7
   Hamdi E.S., 1994, DESIGN SMALL ELECT M
   HATTORI S, 1987, Patent No. 4660941
   Hoving W, 1997, P SOC PHOTO-OPT INS, V3097, P284
   Johnson K. L., 1985, CONTACT MECH
   Jufer M., 1995, TRAITE ELECT ELECTRO
   MASOTTI L, 1997, Patent No. 0790512
   SCHWEIZER J, 1997, Patent No. 5668655
   Smith S. T., 1992, FDN ULTRAPRECISION M
   SMITH ST, 1990, P I MECH ENG C-J MEC, V204, P243, DOI 10.1243/PIME_PROC_1990_204_102_02
   WALTI R, 1998, J BIOMEDICAL OPTICS, V3
   ZAGO L, 1997, SPAC MICR ACC CONTR
NR 12
TC 4
Z9 4
U1 0
U2 10
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3427-2
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3834
BP 172
EP 181
DI 10.1117/12.357822
PG 10
WC Automation & Control Systems; Engineering, Manufacturing; Optics
SC Automation & Control Systems; Engineering; Optics
GA BN92L
UT WOS:000083488400019
DA 2018-10-19
ER

PT S
AU Surbled, P
   Le Pioufle, B
   Yang, EH
   Fujita, H
AF Surbled, P
   Le Pioufle, B
   Yang, EH
   Fujita, H
BE Gorecki, C
TI Shape memory alloys for micromembranes actuation
SO MICROSYSTEMS METROLOGY AND INSPECTION
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Microsystems Metrology and Inspection
CY JUN 15-16, 1999
CL MUNICH, GERMANY
SP European Opt Soc, SPIE, Commiss European Communities, Directorate Gen Sci, Res & Dev, Wissenschaftliche Gesell Lasertech eV
DE microsystems; microactuator; micromembrane; shape memory alloy;
   micromachining
ID THIN-FILM; TINI; MICROACTUATORS; DEPOSITION; SILICON
AB More and more technologies and new materials have been combined with silicon process technologies to enhance the performances of microsystems and extend the application fields. Among these technologies, the Shape Memory Alloys (SMA's) as thin films have been developed recently. They have been shown to induce high displacement and large force/mass ratio under low voltage. They can produce work output higher than can be provided with other kinds of actuators. However, such SMA actuators are not easy to make because specific annealing treatments or mechanical bias springs are needed to realize cyclic device operation. Moreover, adhesion problems of SMA thin films may occur during the annealing treatment. We have developed a simple fabrication process allowing a reliable operation principle of a micromembrane. The cyclic actuation is ensured by membrane thickness residual stresses that avoids the assembling steps. These membranes whose surface varies from 200x200 mu m(2) up to 2x2 mm(2) have been successfully tested. As developed, they are very adapted to integration process of microelectronics and can be applied to many applications such as optical, fluidic devices, and especially for biomedical. applications as SMA's are biocompatible.
C1 Univ Tokyo, CNRS, Inst Ind Sci, LIMMS, Tokyo 1068558, Japan.
RP Surbled, P (reprint author), Univ Tokyo, CNRS, Inst Ind Sci, LIMMS, 7-22-1 Roppongi, Tokyo 1068558, Japan.
RI Le Pioufle, Bruno/B-6951-2013; Yang, Eui-Hyeok/B-5339-2012
OI Le Pioufle, Bruno/0000-0002-0010-2475; Yang,
   Eui-Hyeok/0000-0003-4893-1691
CR BARTH PW, 1995, 8 INT C SOL STAT SEN, V2, P276
   BUCHAILLOT L, 1996, MECATRONICS 96, P627
   BUSCH JD, 1990, J APPL PHYS, V68, P6224, DOI 10.1063/1.346914
   Gorecki C, 1997, OPT LETT, V22, P1784, DOI 10.1364/OL.22.001784
   GRUMMON DS, 1992, MATER RES SOC SYMP P, V268, P167, DOI 10.1557/PROC-268-167
   Ikuta K., 1994, IEEE MICRO ELEC MECH, P355
   IKUTA K, 1990, IEEE MICRO ELECTRON, P38
   ISHIDA A, 1993, THIN SOLID FILMS, V228, P210, DOI 10.1016/0040-6090(93)90600-T
   JARDINE AP, 1994, MATER CHARACT, V32, P169
   Krulevitch P, 1996, J MICROELECTROMECH S, V5, P270, DOI 10.1109/84.546407
   MAKINO E, 1999, S DES TEST MICR MEMS, P1030
   MIYAZAKI S, 1994, IEEE INT MICRO ELECT, P176
   NAKAMURA Y, 1997, IEEE MICR EL MECH SY, P262
   NESHEV I, 1993, VACUUM, V44, P209, DOI 10.1016/0042-207X(93)90155-4
   OLANDER A, 1932, J AM CHEM SOC, V56, P3819
   PEIRS J, 1994, P 4 INT C NEW ACT AC, P381
   Ryhanen J, 1998, J BIOMED MATER RES, V41, P481, DOI 10.1002/(SICI)1097-4636(19980905)41:3<481::AID-JBM19>3.0.CO;2-L
   Tsuchiya K, 1998, NANOTECHNOLOGY, V9, P67, DOI 10.1088/0957-4484/9/2/005
   WALKER JA, 1990, SENSOR ACTUAT A-PHYS, V21, P243, DOI 10.1016/0924-4247(90)85047-8
   WAYMAN CM, 1989, JOM-J MIN MET MAT S, V41, P26, DOI 10.1007/BF03220327
   Wolf RH, 1995, J MICROELECTROMECH S, V4, P206, DOI 10.1109/84.475547
NR 21
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3311-X
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3825
BP 63
EP 70
DI 10.1117/12.364304
PG 8
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Optics; Physics, Applied
SC Engineering; Instruments & Instrumentation; Optics; Physics
GA BN80S
UT WOS:000082991800007
DA 2018-10-19
ER

PT J
AU Dresser, R
AF Dresser, R
TI Public advocacy and allocation of federal funds for biomedical research
SO MILBANK QUARTERLY
LA English
DT Article
ID SCIENCE
AB Members of Congress and officials of the National Institutes of Health face heightened pressure from public advocacy groups seeking more funding for research on specific health conditions. In response, Congress and the Institute of Medicine have urged the NIH to create more opportunities for the public to participate in decision making on allocation of biomedical research resources. The ethical and policy implications of including advocates in the deliberations are explored, leading to the conclusion that public participation could contribute to more defensible decisions under three conditions: public participants are fairly selected and meaningful opinions are solicited; public participants look beyond their narrow constituencies to consider the health needs of the broader public; and NIH officials develop materials to assist participants with their deliberations.
C1 Washington Univ, Sch Law, St Louis, MO 63130 USA.
RP Dresser, R (reprint author), Washington Univ, Sch Law, 1 Brookings Dr,Campus Box 1120, St Louis, MO 63130 USA.
CR *AD HOC GROUP MED, 1997, AD HOC GROUP MED RES
   AGNEW B, 1996, J NIH RES, V8, P19
   Anglin MK, 1997, SOC SCI MED, V44, P1403, DOI 10.1016/S0277-9536(96)00321-8
   Callahan D, 1998, FALSE HOPES WHY AM Q
   CALLAHAN D, 1999, HLTH POLICY ANAL
   DICKSON D, 1988, NEW POLITICS SCI
   Dresser R, 1998, HASTINGS CENT REP, V28, P21, DOI 10.2307/3528647
   DRESSER R, 1992, HASTINGS CENT REP, V22, P24, DOI 10.2307/3562720
   Epstein Steven, 1996, IMPURE SCI AIDS ACTI
   *I MED, 1998, SCI OPP PUBL NEEDS I
   *I MED, 1997, APPR DEATH IMPR CAR
   Johnson J.A., 1998, 97917 C RES SERV
   KAISER J, 1996, SCIENCE, V274, P167
   LAUERMAN JF, 1998, HARVARD MAGAZINE JUL, P26
   Lawler A, 1998, SCIENCE, V281, P635, DOI 10.1126/science.281.5377.635
   Marshall E, 1997, SCIENCE, V276, P344, DOI 10.1126/science.276.5311.344
   MURPHY TF, 1991, HASTINGS CENT REP, V21, P7, DOI 10.2307/3562329
   *NIH, 1998, CALL NOM MEMB NIH DI
   *NIH, 1998, NIH POL INCL CHILDR
   *NIH, 1997, NIH PUB
   Resnik D. B, 1998, ETHICS SCI INTRO
   SAREWITZ D, 1997, ISSUES SCI TECHN SUM, P29
   Sclove Richard, 1995, DEMOCRACY TECHNOLOGY
   STAPLETON S, 1998, AMA NEWS         FEB, P1
   STAPLETON S, 1998, AMA NEWS         FEB, P29
   Stolberg Sheryl Gay, 1997, N Y Times Web, pB10
   Stolberg Sheryl Gay, 1997, N Y Times Web, pA18
   Weijer C, 1996, CAMB Q HEALTHC ETHIC, V5, P334, DOI 10.1017/S0963180100007155
   1998, SCI GOVT REPORT, P2
   1997, J NIH RES, V9, P21
   1998, NY TIMES        0106, pA20
NR 31
TC 21
Z9 21
U1 0
U2 0
PU BLACKWELL PUBLISHERS
PI MALDEN
PA 350 MAIN STREET, STE 6, MALDEN, MA 02148 USA
SN 0887-378X
J9 MILBANK Q
JI Milbank Q.
PY 1999
VL 77
IS 2
BP 257
EP +
DI 10.1111/1468-0009.00133
PG 19
WC Health Care Sciences & Services; Health Policy & Services
SC Health Care Sciences & Services
GA 209NL
UT WOS:000081054600005
PM 10392164
OA Green Published
DA 2018-10-19
ER

PT S
AU Pantelides, ST
   Winkler, R
   Ferconi, M
   Alvarez, JJV
AF Pantelides, ST
   Winkler, R
   Ferconi, M
   Alvarez, JJV
BE Bulatov, VV
   DiazdelaRubia, T
   Phillips, R
   Kaxiras, E
   Ghoniem, N
TI Nonlinear response of solids and molecules in intense infrared radiation
SO MULTISCALE MODELLING OF MATERIALS
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Multiscale Modelling of Materials, at the 1998 MRS Fall
   Meeting
CY NOV 30-DEC 03, 1998
CL BOSTON, MA
SP Mat Res Soc
ID DENSITY-FUNCTIONAL THEORY; MULTIPHOTON DISSOCIATION; LASER-RADIATION;
   HYDROGEN-ATOMS; DYNAMICS; BOND; CHEMISTRY; MODE; SYSTEMS; PULSES
AB Infrared radiation, which couples with vibrations in molecules and solids, has long been considered as a promising way to selectively control chemical reactions, materials processing, and biomedical applications. The expectation is that particular frequencies couple to specific atomic motions, in contrast to heat which imparts energy indiscriminately. The promise has yet to be fulfilled, but recent successes and the development of new lasers have rekindled interest. We report calculations of the dynamics of solids and molecules under intense infrared radiation. In solids, using a model calculation, we find that narrowly-defined "windows of opportunity" exist for resonant enhancement of impurity diffusion at moderate intensities. In molecules, using a generalization of Car-Parrinello dynamics, we find that, for very intense fields, energy absorption at normal modes is not very efficient and that selective bond-breaking may occur at nonresonant frequencies by "concerted kicks". Finally, time-dependent density functional theory is used to show that the effect of very intense infrared radiation on atoms and molecules is to produce very high harmonics as found experimentally.
C1 Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.
RP Pantelides, ST (reprint author), Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.
CR BLOEMBERGEN N, 1984, J PHYS CHEM-US, V88, P5459, DOI 10.1021/j150667a004
   BOTINA J, 1995, J CHEM PHYS, V102, P226, DOI 10.1063/1.469395
   Brewczyk M, 1997, PHYS REV LETT, V78, P191, DOI 10.1103/PhysRevLett.78.191
   BRONIKOWSKI MJ, 1993, J PHYS CHEM-US, V97, P2194, DOI 10.1021/j100112a021
   BRUMER P, 1995, SCI AM, V272, P56, DOI 10.1038/scientificamerican0395-56
   CAR R, 1985, PHYS REV LETT, V55, P2471, DOI 10.1103/PhysRevLett.55.2471
   CHELKOWSKI S, 1990, PHYS REV LETT, V65, P2355, DOI 10.1103/PhysRevLett.65.2355
   CHELKOWSKI S, 1993, J CHEM PHYS, V99, P4279, DOI 10.1063/1.466081
   CHUANG TJ, 1982, PHYS REV LETT, V49, P382, DOI 10.1103/PhysRevLett.49.382
   EDWARDS G, 1994, NATURE, V371, P416, DOI 10.1038/371416a0
   GILLAN MJ, 1986, J PHYS C SOLID STATE, V19, P6169, DOI 10.1088/0022-3719/19/31/012
   GIUSTISUZOR A, 1995, J PHYS B-AT MOL OPT, V28, P309, DOI 10.1088/0953-4075/28/3/006
   HEATHER R, 1988, J CHEM PHYS, V88, P5496, DOI 10.1063/1.454561
   KALUZA M, 1994, J CHEM PHYS, V100, P4211, DOI 10.1063/1.466305
   Kan C, 1997, PHYS REV LETT, V79, P2971, DOI 10.1103/PhysRevLett.79.2971
   KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133
   KULANDER KC, 1991, COMP PHYS COMMUN, V63
   KULANDER KC, 1994, MOL LASER FIELDS
   METZ RB, 1993, J CHEM PHYS, V99, P1744, DOI 10.1063/1.465291
   PAYNE MC, 1992, REV MOD PHYS, V64, P1045, DOI 10.1103/RevModPhys.64.1045
   POTTER ED, 1992, NATURE, V355, P66, DOI 10.1038/355066a0
   RAPPE AK, 1991, J PHYS CHEM-US, V95, P3358, DOI 10.1021/j100161a070
   RICE OK, 1972, UNIMOLECULAR REACTIO
   RUNGE E, 1984, PHYS REV LETT, V52, P997, DOI 10.1103/PhysRevLett.52.997
   SCHATZ GC, 1984, J PHYS CHEM-US, V88, P2971, DOI 10.1021/j150658a011
   SHI S, 1991, COMPUT PHYS COMMUN, V63, P71, DOI 10.1016/0010-4655(91)90239-H
   SINHA A, 1991, J CHEM PHYS, V94, P4928, DOI 10.1063/1.460578
   SINHA A, 1990, J CHEM PHYS, V92, P633
   SINHA A, 1993, J CHEM PHYS, V97, P2204
   TANNOR DJ, 1994, NATURE, V369, P445, DOI 10.1038/369445a0
   TULLY JC, 1987, J ELECTRON SPECTROSC, V45, P381, DOI 10.1016/0368-2048(87)80084-1
   UEDA A, 1994, NUCL INSTRUM METH B, V100, P427
   VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892
   Winkler R, 1997, J CHEM PHYS, V106, P7714, DOI 10.1063/1.473772
   ZARE RN, 1993, NATURE, V365, P105, DOI 10.1038/365105a0
   Zewail A. H., 1994, FEMTOCHEMISTRY ULTRA
   Zhang J, 1996, PHYS REV LETT, V77, P2186, DOI 10.1103/PhysRevLett.77.2186
NR 37
TC 0
Z9 0
U1 0
U2 0
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-444-0
J9 MATER RES SOC SYMP P
PY 1999
VL 538
BP 453
EP 464
PG 12
WC Materials Science, Multidisciplinary; Mechanics
SC Materials Science; Mechanics
GA BN10W
UT WOS:000080728000061
DA 2018-10-19
ER

PT J
AU Bhatt, R
   Scott, B
   Whitney, S
   Bryan, RN
   Cloney, L
   Lebedev, A
AF Bhatt, R
   Scott, B
   Whitney, S
   Bryan, RN
   Cloney, L
   Lebedev, A
TI Detection of nucleic acids by cycling probe technology on magnetic
   particles: High sensitivity and ease of separation
SO NUCLEOSIDES & NUCLEOTIDES
LA English
DT Article; Proceedings Paper
CT XIII International Round Table Conference on Nucleosides, Nucleotides
   and their Biological Applications
CY SEP 06-10, 1998
CL MONTPELLIER, FRANCE
AB Cycling Probe Technology (CPT) is a signal amplification system that allows detection of nucleic acid target sequences without target amplification. CPT employs a sequence specific chimeric probe, typically DNA-RNA-DNA, which hybridizes to a complementary target DNA sequence and becomes a substrate for RNase H. Cleavage occurs at the RNA internucleotide linkages and results in dissociation of the probe from the target, thereby making it available for the next probe molecule. This communication describes the use of oligonucleotides attached to solid supports for target capture and release followed by solution and solid phase cycling. Through the attachment of chimeric probes to Sera-Mag(TM) magnetic particles (SMP) a simple and effective method of separating the cleaved probe from non-cycled probe has been developed. By capturing the target DNA on particles and separating it from the extraneous non-specific DNA we are able to dramatically reduce background and thus discriminate between samples of Methicillin Resistant (MRSA) and Methicillin Sensitive (MSSA) Staphylococcus Aureus. We conjugated oligonucleotide probes to SMPs (similar to 1 um) and Nylon beads (NB) which were coated with ID Biomedical's proprietary coating materials (R, patent pending). The general structure of the constructs is shown below:
   [GRAPHICS]
C1 ID Biomed Inc, San Diego, CA 92121 USA.
   ID Biomed Corp, Burnaby, BC V5J 5J1, Canada.
RP Bhatt, R (reprint author), ID Biomed Inc, 11588 Sorrento Valley Rd 16, San Diego, CA 92121 USA.
NR 0
TC 9
Z9 9
U1 0
U2 4
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0732-8311
J9 NUCLEOS NUCLEOT
JI Nucleosides Nucleotides
PY 1999
VL 18
IS 6-7
BP 1297
EP 1299
DI 10.1080/07328319908044696
PG 3
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 222VK
UT WOS:000081805900046
PM 10474219
DA 2018-10-19
ER

PT S
AU Ulatowska, A
   Andrzejewski, D
   Maruszewski, K
   Podbielska, H
   Strek, W
AF Ulatowska, A
   Andrzejewski, D
   Maruszewski, K
   Podbielska, H
   Strek, W
BE DalFante, M
   Foth, HJ
   Krasner, N
   Marchesini, R
   Podbielska, H
   Katzir, A
TI Advantages of sol-gel technologies for biomedical applications
SO OPTICAL AND IMAGING TECHNIQUES FOR BIOMONITORING IV, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optical and Imaging Techniques for Biomonitoring IV
CY SEP 11-12, 1998
CL STOCKHOLM, SWEDEN
SP European Opt Soc, Soc Photo Opt Instrumentat Engineers, European Laser Assoc, Scandinavian Soc Laser Therapy, Int Biomed Opt Soc, Swedish Opt Soc, Commiss European Communities, Directorate Gen Sci Res & Dev
DE sol-gel technology; sol gel matrices; sensors; medical applications
ID ENZYMES; GLASSES
AB Sol-gel techniques have became very popular recently due to their high chemical homogeneity, low processing temperatures, possibility of controlling of the size and morphology of particles. The sol-gel-derived materials provide excellent matrices for a variety of organic and inorganic compounds. One of the most important features of doped sol-gel materials is their ability for preservation of chemical and physical properties of the dopants. This feature marks those materials as almost unique hosts for a number of biologically important molecules what can be exploited in number of biomedical applications. The advantages of sol-gel technology used for construction of biomedical sensors, laser materials or for retarded drug delivery, will be discussed.
C1 Wroclaw Tech Univ, Inst Phys, Bioopt Grp, PL-50370 Wroclaw, Poland.
RP Ulatowska, A (reprint author), Wroclaw Tech Univ, Inst Phys, Bioopt Grp, PL-50370 Wroclaw, Poland.
RI Podbielska, Halina/A-7311-2012
OI Podbielska, Halina/0000-0001-7162-8530
CR ABRAMOFF B, 1990, SPIE, V1328, P241
   Andrzejewski D, 1997, P SOC PHOTO-OPT INS, V2976, P137, DOI 10.1117/12.275549
   ANDRZEJEWSKI D, 1996, THESIS TU WROCLAW
   AVNIR D, 1992, ACS SYM SER, V499, P384
   Boiko AA, 1996, PROC SPIE, V2772, P263, DOI 10.1117/12.238109
   BRAUN S, 1990, MATER LETT, V10, P1, DOI 10.1016/0167-577X(90)90002-4
   BRAUN S, BIOTECHNOLOGY
   Brinker C. J., 1990, SOL GEL SCI
   EBELMEN M, 1845, CR HEBD ACAD SCI, V21, P502
   Hensh LL, 1990, CHEM REV, V90, P33
   JORGENSEN CK, 1996, STRUCTURE BONDING, V85
   JORGENSEN CK, 1992, STRUCTURE BONDING, V77
   Klein L. C., 1994, SOL GEL OPTICS PROCE
   KURSAWE M, 1997, 6 INT WORKSH GLASS C
   Maruszewski K, 1996, P SOC PHOTO-OPT INS, V2927, P222, DOI 10.1117/12.260647
   POPE EJA, 1997, 9 INT WORKSH GLASS C
   REISFELD R, 1996, STRUCTURE BONDING, V85
   Sermon PA, 1995, P SOC PHOTO-OPT INS, V2633, P464, DOI 10.1117/12.228295
   SHTELZER S, 1992, BIOTECHNOL APPL BIOC, V15, P227
   Sieminska L, 1996, J PHYS CHEM-US, V100, P4591, DOI 10.1021/jp952759g
   WANG R, 1993, ANAL CHEM, V65, P2671, DOI 10.1021/ac00067a020
   WOLFBEIS OS, 1996, SOL GELS CHEM SENSOR, V85
NR 22
TC 4
Z9 4
U1 1
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3029-3
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3567
BP 50
EP 58
DI 10.1117/12.339188
PG 9
WC Engineering, Biomedical; Medical Laboratory Technology; Optics
SC Engineering; Medical Laboratory Technology; Optics
GA BM82D
UT WOS:000079846000007
DA 2018-10-19
ER

PT S
AU Hisaka, M
   Sugiura, T
   Kawata, S
AF Hisaka, M
   Sugiura, T
   Kawata, S
BE Yamaguchi, I
TI Ultrasound-assisted optical measurement for observation inside the
   scattering medium
SO OPTICAL ENGINEERING FOR SENSING AND NANOTECHNOLOGY (ICOSN'99)
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT International Conference on Optical Sensing and Nanotechnology (ICOSN
   99)
CY JUN 16-18, 1999
CL YOKOHAMA, JAPAN
SP Opt Soc Japan, SPIE
DE optical measurement; scattering media; ultrasound; biomedical optics
ID MODULATION; LIGHT
AB We have developed an optical measurement method to investigate the inside of scattering media by using focused ultrasound to specify the measuring point. This method enables us to observe the internal structure of human tissue non-invasively for biomedical applications. This method may give us various kinds of material information such as spectroscopic characteristics. To get the information from only particular region in a tissue sample with light, we use a focused ultrasound. At the focal region of the ultrasound, refractive index of the tissue changes with strong acoustic field. So a part of incident light reflects at the focal region of the ultrasound. The reflected light has information of the sample. According to the scanning of the sample, we can get an image of the sample. In our experiments, we have observed samples that consist of an agarose block which contains a piece of agarose cube stained with dye as absorbing material. The intensity of reflected light from the focal region of the ultrasound decreased when the measuring point was in the stained agarose section, because incident light was absorbed with the dye. Furthermore, we have observed a sample with a weak scattering object made of agarose in strong scattering agarose that contains PMMA particles.
C1 Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan.
RP Hisaka, M (reprint author), Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan.
CR HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   LEUTZ W, 1995, PHYSICA B, V204, P14, DOI 10.1016/0921-4526(94)00238-Q
   Leveque S, 1999, OPT LETT, V24, P181, DOI 10.1364/OL.24.000181
   WANG LH, 1995, OPT LETT, V20, P629, DOI 10.1364/OL.20.000629
NR 4
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3214-8
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3740
BP 146
EP 149
DI 10.1117/12.347786
PG 4
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BN88B
UT WOS:000083313900031
DA 2018-10-19
ER

PT S
AU Griesser, HJ
   McLean, KM
   Beumer, GJ
   Gong, XY
   Kingshott, P
   Johnson, G
   Steele, JG
AF Griesser, HJ
   McLean, KM
   Beumer, GJ
   Gong, XY
   Kingshott, P
   Johnson, G
   Steele, JG
BE Lee, WW
   DAgostino, R
   Wertheimer, MR
TI Surface immobilization of synthetic proteins via plasma polymer
   interlayers
SO PLASMA DEPOSITION AND TREATMENT OF POLYMERS
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Plasma Deposition and Treatment of Polymers, at the 1998
   MRS Fall Meeting
CY NOV 30-DEC 02, 1998
CL BOSTON, MA
SP Mat Res Soc
ID COLLAGEN-BASED STRUCTURES; N-ISOBUTYLGLYCINE NLEU; CELL ATTACHMENT;
   CIRCULAR-DICHROISM; OPTICAL-ROTATION; PEPTIDES; SEQUENCES; OXIDATION;
   ADHESION
AB Coatings of biologically active molecules on synthetic "bulk'' materials are of much interest for biomedical applications since they can in principle elicit specific, predictable, controlled responses of the host environment to an implanted device. However. issues such as shelf life, storage conditions, biological safety, and enzymatic attack in the biological environment must be considered; synthetic proteins may offer advantages. In this study we investigated the covalent immobilization onto polymeric materials of synthetic proteins which possess some properties that mimic those of the natural protein collagen, particularly the ability to form triple helical structures, and thus may provide similar bio-responses while avoiding enzymatic degradation. In order to perform immobilization of these collagen-like molecules (CLMs) under mild reaction conditions, the bulk materials are first equipped with suitable surface groups using rf plasma methods. Plasma polymer interlayers offer advantages as versatile reactive platforms for the immobilization of proteins and other biologically active molecules. Application of a thin plasma polymer coating from an aldehyde monomer is particularly suitable as it enables direct immobilization of CLMs by reaction with their terminal amine groups, using reductive amination chemistry. An alternative route is via plasma polymer layers that contain carboxylic acid groups and using carbodiimide chemistry. A third route makes use of alkylamine plasma polymer interlayers, which are less process sensitive than aldehyde and acid plasma coatings. A layer of poly-carboxylic acid compounds such as carboxylic acid terminated PAMAM-starburst dendrimers or carboxymethylated dextran is then attached by carbodiimide chemistry onto the amine plasma layer. Amine-terminated CLMs can then be immobilized onto the poly-carboxylic acid layer. Surface analytical methods have been used to characterize the immobilization steps and to assess the surface coverage. Initial cell attachment and growth assays indicate that the biological performance of the CLMs depends on their amino acid sequence.
C1 CSIRO, Clayton Lab, Clayton, Vic 3169, Australia.
RP Griesser, HJ (reprint author), CSIRO, Clayton Lab, Private Bag 10, Clayton, Vic 3169, Australia.
EM h.griesser@molsci.csiro.au
RI McLean, Keith/H-1568-2011; Griesser, Hans/E-5628-2011
OI Griesser, Hans/0000-0003-1072-7863; Kingshott, Peter/0000-0001-5882-5804
CR *BECT DICK LABW, 1986, PRIM UN MOD TISS CUL
   BEUMER GJ, 1996, P 5 WORLD BIOM C MAY, P881
   El-Ghannam A, 1998, J BIOMED MATER RES, V41, P30, DOI 10.1002/(SICI)1097-4636(199807)41:1<30::AID-JBM4>3.0.CO;2-R
   Evans MDM, 1997, EXP CELL RES, V233, P88, DOI 10.1006/excr.1997.3523
   Feng YB, 1997, BIOCHEMISTRY-US, V36, P8716, DOI 10.1021/bi962980z
   Feng YB, 1996, BIOPOLYMERS, V39, P859, DOI 10.1002/(SICI)1097-0282(199612)39:6<859::AID-BIP10>3.3.CO;2-Z
   GENGENBACH TR, 1994, J POLYM SCI POL CHEM, V32, P1399, DOI 10.1002/pola.1994.080320801
   Gengenbach TR, 1996, SURF INTERFACE ANAL, V24, P611, DOI 10.1002/(SICI)1096-9918(19960916)24:9<611::AID-SIA169>3.0.CO;2-7
   Gong X, 1997, PLASMAS POLYM, V2, P261
   Goodman M, 1996, J AM CHEM SOC, V118, P10928, DOI 10.1021/ja961717i
   GRIESSER HJ, 1990, J APPL POLYM SCI APP, V46, P361
   Grzesiak JJ, 1997, BIOMATERIALS, V18, P1625, DOI 10.1016/S0142-9612(97)00103-8
   Huber M, 1998, J BIOMED MATER RES, V41, P278, DOI 10.1002/(SICI)1097-4636(199808)41:2<278::AID-JBM13>3.0.CO;2-H
   KINGSHOTT P, 1998, UNPUB J BIOMED MAT R
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MCLEAN KM, 1998, UNPUB COLL SURF B
   Melacini G, 1996, J AM CHEM SOC, V118, P10725, DOI 10.1021/ja9617193
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   NICOLSON P, 1995, Patent No. 5760100
   Olbrich KC, 1996, BIOMATERIALS, V17, P759, DOI 10.1016/0142-9612(96)81412-8
   SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
NR 23
TC 4
Z9 4
U1 0
U2 3
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-450-5
J9 MATER RES SOC SYMP P
PY 1999
VL 544
BP 9
EP 20
PG 12
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA BN69B
UT WOS:000082590500002
DA 2018-10-19
ER

PT J
AU Zaikov, GE
   Gumargalieva, KZ
   Polishchuk, AY
   Adamyan, AA
   Vinokurova, TI
AF Zaikov, GE
   Gumargalieva, KZ
   Polishchuk, AY
   Adamyan, AA
   Vinokurova, TI
TI Biodegradation of polyolefins in biomedical applications
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
AB Although polymer plastics find broad application in different areas of industry, and particularly in the medical industry, the behavior of these materials in biological media still requires better understanding. Biodegradation and biostability of polyolefins are reviewed with reference to the prediction of material durability, which requires permanent study of the stability of material properties.
C1 Russian Acad Sci, Nm Emanuel Inst Biochem Phys, Moscow 117334, Russia.
   Russian Acad Sci, NN Semenov Chem Phys Inst, Moscow 117334, Russia.
   Russian Acad Med Sci, AA Vishnevskii Inst Surg, Moscow 113093, Russia.
RP Zaikov, GE (reprint author), Russian Acad Sci, Nm Emanuel Inst Biochem Phys, 4 Kosygin St, Moscow 117334, Russia.
CR ALBERTSON AC, 1975, P 3 INT S BIOD KINGS, P743
   ALBERTSSON AC, 1987, POLYM DEGRAD STABIL, V18, P73, DOI 10.1016/0141-3910(87)90084-X
   AMRSHALL KC, 1979, MICROBIAL ADHESION A
   BINY J, 1968, ACTA PATHOL MICROB S, V16, P105
   BRUCK, 1977, J BIOMED MAT RES, V11, P1
   CALNAN J, 1963, Br J Plast Surg, V16, P1, DOI 10.1016/S0007-1226(63)80153-8
   DOLEZEL J, 1976, PLASTY KAUT, V13, P257
   FISHER IP, 1980, P 1 BIOM C HUTH VIEN, P20
   GUMARGALIEVA KZ, 1998, BIODEGRADATION POLYM
   Kinley Mc, 1981, VERH INT VER THEOR L, V21, P1348
   LAIFUT E, 1977, TRANSFER PHENOMENA L
   LEBANER D, 1985, MEDIZINTECHNIK, V105, P19
   LEFAUX R, 1964, CHIMIE TOXILOGIE MAT, P57
   LIEBERT TC, 1976, J BIOMED MATER RES, V10, P939, DOI 10.1002/jbm.820100611
   MAZUR FF, 1959, BIOL TESTS WOODPULP
   MEREZHKO TV, 1977, ACTUAL PROBLEMS MODE, P142
   MINAC M, 1978, P 2 INT S DEGR STAB, P8
   MOISEEV YV, 1977, CHEM STABILITY POLYM
   MOISEEV YV, 1984, CHEM RESISTANCE POLY
   Neuman Z., 1957, BRIT J PLAST SURG, V9, P195
   Polishchuk A. Y., 1997, MULTICOMPONENT TRANS
   POSTLETHWAIT RW, 1979, ANN SURG, V190, P10
   SALTHOUSE TN, 1975, J SURG RES, V19, P127, DOI 10.1016/0022-4804(75)90117-1
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   VINOKUROVA TI, 1977, P 3 S SYNTH POL MAT, P32
   WYKRISZ NB, 1974, PLAST POLYM, V42, P195
   ZAIKOV GE, 1998, POLYM MED
NR 27
TC 6
Z9 6
U1 0
U2 1
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0360-2559
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PY 1999
VL 38
IS 4
BP 621
EP 646
DI 10.1080/03602559909351604
PG 26
WC Polymer Science
SC Polymer Science
GA 228CZ
UT WOS:000082120500003
DA 2018-10-19
ER

PT J
AU Kelly, PA
   Hills, DA
   O'Connor, JJ
AF Kelly, PA
   Hills, DA
   O'Connor, JJ
TI Elastic contact on a double-layered substrate
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART C-JOURNAL OF
   MECHANICAL ENGINEERING SCIENCE
LA English
DT Article
DE layer; contact; stress
AB Results are given for the contact law and state of stress induced in the contact resulting from application of a pressure distribution on a double-layered half-plane, or its indentation by a body of prescribed shape. The geometry is representative of that found widely in biomedical applications, particularly the knee prosthesis, and also in more general engineering problems. The solution is given in a numerically efficient form, and the stress states at the surface and within the structure that are associated with a number of different combinations of materials are displayed.
C1 Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England.
RP Kelly, PA (reprint author), Univ Auckland, Dept Engn Sci, Private Bag 92019, Auckland, New Zealand.
OI Kelly, Piaras/0000-0002-7120-9421
CR BARTEL DL, 1982, J BONE JOINT SURG AM, V64, P1026, DOI 10.2106/00004623-198264070-00009
   BENTALL RH, 1968, INT J MECH SCI, V10, P637, DOI 10.1016/0020-7403(68)90070-2
   Chen W. T., 1972, International Journal of Solids and Structures, V8, P1257, DOI 10.1016/0020-7683(72)90079-0
   EBERHARDT AW, 1991, J BIOMECH ENG-T ASME, V113, P410, DOI 10.1115/1.2895420
   FELLOWS LJ, 1995, WEAR, V185, P235, DOI 10.1016/0043-1648(95)06613-6
   Johnson K. L., 1985, CONTACT MECH
   Kelly PA, 1997, P I MECH ENG C-J MEC, V211, P301, DOI 10.1243/0954406971522060
   KELLY PA, 1996, 205995 OUEL U OXF IN
   LI H, 1990, INT J NUMER METH ENG, V29, P57, DOI 10.1002/nme.1620290106
   NOWELL D, 1988, INT J SOLIDS STRUCT, V24, P105, DOI 10.1016/0020-7683(88)90102-3
   Sneddon I. N., 1951, FOURIER TRANSFORMS
   URQUHART EE, 1994, INT J SOLIDS STRUCT, V31, P2445, DOI 10.1016/0020-7683(94)90030-2
NR 12
TC 2
Z9 2
U1 0
U2 0
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI BURY ST EDMUNDS
PA NORTHGATE AVENUE,, BURY ST EDMUNDS IP32 6BW, SUFFOLK, ENGLAND
SN 0954-4062
J9 P I MECH ENG C-J MEC
JI Proc. Inst. Mech. Eng. Part C-J. Eng. Mech. Eng. Sci.
PY 1999
VL 213
IS 4
BP 331
EP 342
DI 10.1243/0954406991522293
PG 12
WC Engineering, Mechanical
SC Engineering
GA 221CA
UT WOS:000081705400003
DA 2018-10-19
ER

PT J
AU Guinovart-Diaz, R
   Bravo-Castillero, J
   Rodriguez-Ramos, R
AF Guinovart-Diaz, R
   Bravo-Castillero, J
   Rodriguez-Ramos, R
TI Application of piezoelectric composite materials to sensors design
SO QUIMICA ANALITICA
LA English
DT Article; Proceedings Paper
CT 1st Ibero-American Congress on Sensors and Biosensors (IBERSENSOR 98)
CY NOV 09-13, 1998
CL UNIV HAVANA, HAVANA, CUBA
SP Inst Mat Reactivos, Fac Phys, Ctr Invest Microelectron, Ctr Estudios Aplicados Desarroll Energ Nucl, Inst Cibernet, Ctr Ultrason, Matemat Fis
HO UNIV HAVANA
DE piezocomposite; effective properties; biomedical applications
AB The purpose of this paper is to present analytical expressions of the effective constants of reinforced piezoelectric composite materials with periodical distributed unidirectional cylindrical fibers for transducer applications. Each periodic cell of the medium is a binary piezoelectric composite wherein both constituents are homogeneous piezoelectric materials with hexagonal symmetry. The general formulae obtained allow the prediction of global properties of an important class of piezocomposites. Numerical calculations show an adequate concordance with other theoretical models. Finally, we apply these results to a piezocomposite material and obtain new piezoelectrics with better global properties for biomedical imaging applications.
C1 Univ La Habana, Fac Matemat & Computac, La Habana 10400 4, Cuba.
RP Guinovart-Diaz, R (reprint author), Univ La Habana, Fac Matemat & Computac, La Habana 10400 4, Cuba.
CR BRAVO J, 1998, THESIS U HAVANA HAVA
   BRAVOCASTILLERO J, 1998, INT J SOLIDS STRUCT, V35, P527
   Pastor J, 1997, MECH RES COMMUN, V24, P145, DOI 10.1016/S0093-6413(97)00006-2
   SCHULGASSER K, 1992, J MECH PHYS SOLIDS, V40, P473, DOI 10.1016/S0022-5096(05)80022-5
   SMITH WA, 1991, IEEE T ULTRASON FERR, V38, P40, DOI 10.1109/58.67833
NR 5
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER INFORMACION PROFESSIONAL, S A
PI BARCELONA
PA C/ENTENCA, 28 ENTL, 08015 BARCELONA, SPAIN
SN 0212-0569
J9 QUIM ANAL
JI Quim. Anal.
PY 1999
VL 18
SU 1
BP 46
EP 47
PG 2
WC Chemistry, Analytical
SC Chemistry
GA 328CZ
UT WOS:000087832400012
DA 2018-10-19
ER

PT J
AU Costello, RG
   Emery, R
   Whitehead, L
AF Costello, RG
   Emery, R
   Whitehead, L
TI A field method for validating estimated P-32 activities in solid
   radioactive waste
SO RADIATION PROTECTION DOSIMETRY
LA English
DT Article
ID LARGE UNIVERSITY; COMPLEX
AB Solid radioactive wastes containing P-32 are commonly generated as a byproduct of biomedical research and academic endeavours. The amount of radioactivity contained in these wastes is usually based on generalised mass balance calculations and intimate knowledge of the experiments performed. But since most solid waste is actually incidental to the protocols conducted, activity estimates can be inaccurate. Hence, a rapid field test method to validate activity levels reported by generators would be useful; similar tests are regularly used for the validation of activities of wastes containing photon-emitting radionuclides. Although this methodology is not typically applied to wastes containing beta-emitting radionuclides, due to the significant potential for radiation attenuation by the solid waste material, the beta emission from P-32 is actually energetic enough readily to penetrate most paper, plastic and glass solid waste constituents. In this study, waste packages with variable predetermined amounts of P-32 were monitored at a set of pre-established points using standard portable survey instrumentation. A series of waste activity correction curves were developed and used as a basis for validating actual waste package activity content. The results of the study revealed that over 90% of the waste packages monitored exhibited significant discrepancies between the measured and reported activity content. Although the technique used in this study accurately indicated radioactive content over a wide range, it can be hampered by a significant probability of exhibiting false negative results. Nonetheless, the method can be used as a valuable tool for waste minimisation programmes when applied judiciously.
C1 Univ Texas, Hlth Sci Ctr, Houston, TX 77064 USA.
   Univ Texas, Hlth Sci Ctr, Houston, TX 77030 USA.
RP Costello, RG (reprint author), Univ Texas, Hlth Sci Ctr, 1851 Crosspoint Ave, Houston, TX 77064 USA.
CR *ANSI, 1983, ANSIN15351983
   Beretta A, 1997, RADIAT PROT DOSIM, V71, P223, DOI 10.1093/oxfordjournals.rpd.a032057
   CHASE GD, 1962, PRINCIPLES RADIOISOT
   EMERY R, 1992, HEALTH PHYS, V62, P183, DOI 10.1097/00004032-199202000-00009
   Evans RD, 1955, ATOMIC NUCL
   *INT AT EN AG, 1996, ST1 IAEA
   *INT AT EN AG, 1996, 383 IAEA
   Rees B, 1996, HEALTH PHYS, V70, P639, DOI 10.1097/00004032-199605000-00003
   RING J, 1993, HEALTH PHYS, V65, P193, DOI 10.1097/00004032-199308000-00011
   *TEX DEP HLTH BUR, 1992, TEX REG CONTR RA P21
   *US NUCL REG COMM, 1992, COD FED REG
NR 11
TC 0
Z9 0
U1 0
U2 1
PU NUCLEAR TECHNOLOGY PUBL
PI ASHFORD
PA PO BOX 7, ASHFORD, KENT, ENGLAND TN23 1YW
SN 0144-8420
J9 RADIAT PROT DOSIM
JI Radiat. Prot. Dosim.
PY 1999
VL 81
IS 1
BP 65
EP 70
DI 10.1093/oxfordjournals.rpd.a032572
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 156VZ
UT WOS:000078024000008
DA 2018-10-19
ER

PT J
AU Lopez-Cozar, ED
   Ruiz-Perez, R
   Jimenez-Contreras, E
AF Lopez-Cozar, ED
   Ruiz-Perez, R
   Jimenez-Contreras, E
TI Editorial quality, diffusion and bibliometric indicators of the Revista
   Espanola de Enfermedades Digestivas
SO REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
LA English
DT Article
DE Revista Espanola de Enfermedades Digestivas; scientific journal
   evaluation; editorial quality; diffusion; visibility; bibliometric
   analysis; standards
ID INFORMATIVE ABSTRACTS; STRUCTURED ABSTRACTS; SCIENTIFIC JOURNALS;
   MEDICINA-CLINICA; ARTICLES; PUBLICATION; STANDARDS; SCIENCES
AB AIM: to evaluate the editorial quality, diffusion, relevance of the scientific content, and the publication practices of the specialised journal Revista Espanola de Enfermedades Digestivas.
   MATERIALS AND METHODS: We checked 136 parameters based on ISO standards, the recommendations of scientific and editorial organisations, and studies of scientific editing and international publishing practices for biomedical journals. Diffusion was calculated using national and international databases, specialised libraries in Spain, and Internet sources. The analysis of the scientific content and publication practices was based on bibliometric indicators for the journal, authorship, and contributions. The sample for this study comprised six alternate issues of volume number 88 (1996), the last issue of this volume, and the first issue of volume 89 (1997). The samples used for the bibtiometric analysis varied depending on the characteristics of specific indicators and the availability of information.
   RESULTS: the overall mean value for compliance with standards was 46.1%, while the real mean was calculated at 72.21%. The editorial procedures at the journal are similar to those of analogous international journals. The Revista Espanola de Enfermedades Digestivas is included in international databases of biomedical journals, and in the interdisciplinary international database SCI. It was found to be present in 70% of the medical libraries of Spanish universities, and in 73% of the hospital libraries studied. Bibliometric indicators showed co-authorship to be 5.5%; the origin of the authors grouped by province and by type of institutional affiliations showed 27.8% of all authors to be from Madrid, and that more were affiliated with general hospitals than with university hospitals. The mean delay between initial receipt of a manuscript and its publication was 300 days. Cocitation analysis gave the journal a central position amongst the 38 Spanish biomedical journals considered representative of the field. The journal's impact factor for 1996 was 0.260.
   CONCLUSIONS: the Revista Espanola de Enfermedades Digestivas is a high-quality vehicle of research results, and has acceptable internal editorial procedures. The journal is widely distributed, though its visibility on the Internet should be improved. Co-authorship is similar to that seen in other medical journals. Steps should be taken to make this journal better known within Spain, and to reduce the delay between the initial receipt and the final publication of manuscripts. Its impact factor is increasing steadily.
C1 Univ Granada, Dept Biblioteconomia & Documentac, E-18071 Granada, Spain.
RP Ruiz-Perez, R (reprint author), Univ Granada, Dept Biblioteconomia & Documentac, Campus Cartuja, E-18071 Granada, Spain.
RI Delgado Lopez-Cozar, Emilio/I-8406-2012; Ruiz-Perez, Rafael/C-6871-2009
OI Delgado Lopez-Cozar, Emilio/0000-0002-8184-551X; Ruiz-Perez,
   Rafael/0000-0002-2656-1645
CR ABT HA, 1992, SCIENTOMETRICS, V24, P441, DOI 10.1007/BF02051040
   ALAEZ LF, 1986, REV ESP DOC CIENT, V9, P9
   *AM MED ASS, 1989, MAN STYL
   *ANSI, 1996, Z39560 ANSI NISO
   BADIA JG, 1994, ATEN PRIM, V14, P1105
   CAMI J, 1993, MED CLIN-BARCELONA, V101, P721
   Clever L, 1997, NEW ENGL J MED, V336, P309
   *COMP SOFTW INT, 1996, CD 17 96 CAT PUBL PE
   *COUNC BIOL ED, 1987, MAN EST CBE
   DELAVIESCA R, 1979, REV ESP DOC CIENT, V2, P357
   Delgado Lopez-Cozar E., 1997, REV ESP DOC CIENT, V20, P39
   FEDERER A, 1996, CBE VIEWS, V19, P124
   FERNANDEZ CO, 1993, REV ESPANOLA DOCUMEN, V16, P221
   GARFIELD E, 1990, CURR CONTENTS, V22, P5
   GRUNEWALD MD, 1982, PGI79WS8
   GUERRERO R, 1994, MICROBIOLOGIA SEM, V10, P215
   GUIU JM, 1996, REV NEUROL, V24, P5
   GUIU JM, 1996, REV NEUROL BARC, V24, P765
   Hartley J, 1996, J INFORM SCI, V22, P27, DOI 10.1177/016555159602200103
   HAYNES RB, 1990, ANN INTERN MED, V113, P69, DOI 10.7326/0003-4819-113-1-69
   HAYNES RB, 1993, J CLIN EPIDEMIOL, V46, P595, DOI 10.1016/0895-4356(93)90030-5
   HAYNES RB, 1987, ANN INTERN MED, V106, P598
   HILLS J, 1971, 5091 OSTI
   HUTH E, 1987, STYLE FORMAT INT MAN
   KOVENDI D, 1975, B UNESCO BIBL, V29, P220
   Lopez-Cozar ED, 1997, REV NEUROLOGIA, V25, P1942
   LopezCozar ED, 1995, LIBRI, V45, P145, DOI 10.1515/libr.1995.45.3-4.145
   LOPEZCOZAR ED, 1997, PROGR OBSTET GINECOL
   LOPEZCOZAR ED, 1998, NORMALIZACION REV CI
   LOPEZCOZAR ED, 1997, REV ESP SALUD PUBLIC, V71, P511
   MCCAIN KW, 1990, J AM SOC INFORM SCI, V16, P217
   Medicina Clinica, 1993, MAN EST PUBL BIOM
   MULROW CD, 1988, ANN INTERN MED, V108, P613, DOI 10.7326/0003-4819-108-4-613
   PEREZ RR, 1997, ANALES MED INTERNA, V14, P384
   PEREZ RR, 1994, EVALUACION NORMATIVA
   PINERO JML, 1992, MED CLIN-BARCELONA, V98, P101
   PULIDO M, 1994, MED CLIN-BARCELONA, V103, P770
   PULIDO M, 1990, MED CLIN-BARCELONA, V95, P257
   Pulido M, 1991, Aten Primaria, V8, P589
   *REV NEUR, 1996, REV NEUROL, V24, P475
   SILVA A, 1991, MED CLIN-BARCELONA, V97, P744
   SPILKER B, 1992, MED CLIN-BARCELONA, V98, P303
   TADDIO A, 1994, CAN MED ASSOC J, V150, P1611
   TERRADA ML, 1992, INDICE CITAS INDICAD
   VILLA JJ, 1994, ATEN PRIM, V14, P1101
   Yus ES, 1996, MED CLIN-BARCELONA, V107, P319
   1996, REV NEUROL BARC, V24, P1014
NR 47
TC 3
Z9 3
U1 0
U2 5
PU EDITORIAL GARSI
PI MADRID
PA JUAN BRAVO, 46, 28006 MADRID, SPAIN
SN 1130-0108
J9 REV ESP ENFERM DIG
JI Rev. Esp. Enferm. Dig.
PD JAN
PY 1999
VL 91
IS 1
BP 17
EP 32
PG 16
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 172HZ
UT WOS:000078918600001
DA 2018-10-19
ER

PT B
AU Varadan, VK
   Varadan, VV
AF Varadan, VK
   Varadan, VV
BE Tomlinson, GR
   Bullough, WA
TI Microsensors, MEMS and their applications in smart structures and
   devices
SO SMART MATERIALS AND STRUCTURES
LA English
DT Proceedings Paper
CT 4th European Conference on Smart Structures and Materials in conjunction
   with the 2nd International Conference on Micromechanics, Intelligent
   Materials and Robotics
CY JUL 06-08, 1998
CL HARROGATE, ENGLAND
ID SILICON
AB This talk will overview the MEMS and Interdigital Transducer (IDT) sensors, introduce the basis of silicon, polymer and composite material technology and characterize the selected aspects of the signal conditioning for sensors with the applications to aerospace, marine and civil structures. This will be followed by an overview of the currently available MEMS sensors and processing technologies including wafer processing lithography, film growth and deposition, ion implantation, and etching. Finally, the integration of the sensors, MEMS, and smart electronics into structures will be discussed. Wireless communication between sensors and display will be outlined. Topics to be covered include:
   silicon, UV curable conducting polymer, composite material sensor
   health monitoring and condition-based maintenance of structures using MEMS sensors
   transient MEMS design and biomedical devices
   MEMS sensors for automobile, aircraft and underwater vehicles including accelerometers and gyroscope, etc.
   microfabricated 'smart tongue' and 'electronic nose' sensors for food, liquor and beverages.
C1 Penn State Univ, Engn Elect & Acoust Mat Res Ctr, University Pk, PA 16802 USA.
RP Varadan, VK (reprint author), Penn State Univ, Engn Elect & Acoust Mat Res Ctr, University Pk, PA 16802 USA.
CR AEIDEL H, 1987, P INT C SOL STAT SEN, P120
   BRYZEK J, 1994, IEEE SPECTRUM    MAY, P20
   FAN LS, P TRANSDUCERS 87, P849
   IKUTA K, 1993, P IEEE MICR EL MECH, V42
   MARKUS K, 1995, SPIE, V2639
   Middelhoek S., 1989, SILICON SENSORS
   PETERSEN KE, 1982, P IEEE, V70, P420, DOI 10.1109/PROC.1982.12331
   SHAW KA, 1994, SENSOR ACTUAT A-PHYS, V40, P63, DOI 10.1016/0924-4247(94)85031-3
   Varadan VK, 1997, P SOC PHOTO-OPT INS, V3046, P209, DOI 10.1117/12.276610
   VARADAN VK, 1998, SMART ELECT MEMS SPI, V3242
   VARADAN VK, 1997, SPIE PUBLICATION
   VARADAN VK, 1995, INT S MICR INT MAT R
   VARADAN VK, 1996, SPIE P, V2722
   1993, P IEEE MEMS
NR 14
TC 0
Z9 0
U1 0
U2 4
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
BN 0-7503-0547-9
PY 1999
BP 683
EP 691
PG 9
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Materials Science, Multidisciplinary; Mechanics
SC Automation & Control Systems; Computer Science; Materials Science;
   Mechanics
GA BQ98C
UT WOS:000165242400087
DA 2018-10-19
ER

PT S
AU Canfield, S
   Edinger, B
   Frecker, M
   Koopmann, G
AF Canfield, S
   Edinger, B
   Frecker, M
   Koopmann, G
BE Wereley, NM
TI Design of piezoelectric inchworm actuator and compliant end-effector for
   Minimally Invasive Surgery
SO SMART STRUCTURES AND MATERIALS 1999: SMART STRUCTURES AND INTEGRATED
   SYSTEMS, PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 1999 Conference
CY MAR 01-04, 1999
CL NEWPORT BEACH, CA
SP SPIE, Soc Exptl Mech, Amer Soc Mech Engineers, BFGoodrich Aerosp, Def Adv Res Projects Agcy, US Army Res Off, USAF Res Lab, Ceram Soc Japan, Intelligent Mat Forum, Japan
DE Minimally Invasive Surgery (MIS); compliant mechanism; piezoelectric
   actuator; inchworm actuator
ID FORCE-FEEDBACK; MECHANISMS; ROBOTICS
AB Recent advances in robotics, tele-robotics, smart material actuators, and mechatronics raise new possibilities for innovative developments in millimeter-scale robotics capable of manipulating objects only fractions of a millimeter in size. These advances can have a wide range of applications in the biomedical community. A potential application of this technology is in minimally invasive surgery (MIS). The focus of this paper is the development of a single degree of freedom prototype to demonstrate the viability of smart materials, force feedback and compliant mechanisms for minimally invasive surgery. The prototype is a compliant gripper that is 7-mm by 17-mm, made from a single piece of titanium that is designed to function as a needle driver for small scale suturing. A custom designed piezoelectric "inchworm" actuator drives the gripper. The integrated system is computer controlled providing a user interface device capable of force feedback. The design methodology described draws from recent advances in three emerging fields in engineering: design of innovative tools for MIS, design of compliant mechanisms, and design of smart materials and actuators. The focus of this paper is on the design of a millimeter-scale inchworm actuator for use with a compliant end effector in MIS.
C1 Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA.
RP Canfield, S (reprint author), Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA.
CR Ananthasuresh G. K., 1994, Technical Digest. Solid-State Sensor and Actuator Workshop, P189
   ANANTHASURESH GK, 1994, P 1994 ASME WINT DSC, V55
   Arai F, 1998, IEEE-ASME T MECH, V3, P17, DOI 10.1109/3516.662864
   BALAZS M, 1998, IEEE ENG MED BIO MAY, P45
   Beebe DJ, 1995, SENSOR ACTUAT A-PHYS, V50, P55, DOI 10.1016/0924-4247(96)80085-9
   BICCHI A, 1996, IEEE INT C ROB AUT M
   Brett PN, 1997, P I MECH ENG H, V211, P309, DOI 10.1243/0954411971534430
   CAO C, 1996, KINESIOLOGY, P224
   Chen E, 1998, P IEEE, V86, P524, DOI 10.1109/5.662877
   COHN MB, 1995, J ROBOTIC SYST, V12, P401, DOI 10.1002/rob.4620120606
   Dario P, 1998, IEEE-ASME T MECH, V3, P9, DOI 10.1109/3516.662863
   Frecker MI, 1997, J MECH DESIGN, V119, P238, DOI 10.1115/1.2826242
   FRECKER MI, 1997, P ASME DES ENG TECHN
   HOWELL LL, 1994, J MECH DESIGN, V116, P280, DOI 10.1115/1.2919359
   KOOPMANN G, 1998, P SPIE 5 ANN INT S S, P3329
   KU S, 1996, IEEE INT C ROB AUT M
   Larsen UD, 1997, J MICROELECTROMECH S, V6, P99, DOI 10.1109/84.585787
   Lazeroms M, 1996, MECHATRONICS, V6, P437, DOI 10.1016/0957-4158(96)00008-6
   Majeed AW, 1996, LANCET, V347, P989, DOI 10.1016/S0140-6736(96)90143-9
   *NAT INSTR CORP, LABVIEW VER 5 1
   SAGGERE L, 1997, P 1997 ASME DES ENG
   Sastry SS, 1997, ROBOT AUTON SYST, V21, P305, DOI 10.1016/S0921-8890(96)00082-6
   STEINER C, 1994, NEW ENGL J MED, V30, P403
   *STRUCT DYN RES CO, I DEAS MAST SER VER
NR 24
TC 7
Z9 7
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3142-7
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3668
BP 835
EP 843
DI 10.1117/12.350759
PG 9
WC Acoustics; Engineering, Aerospace; Engineering, Mechanical; Optics
SC Acoustics; Engineering; Optics
GA BN32S
UT WOS:000081632900074
DA 2018-10-19
ER

PT S
AU Morgenthaler, GW
   Stodieck, L
AF Morgenthaler, GW
   Stodieck, L
BE ElGenk, MS
TI Potential commercial use of the International Space Station by the
   Biotechnology/Pharmaceutical/Biomedical Sector
SO SPACE TECHNOLOGY AND APPLICATIONS INTERNATIONAL FORUM - 1999, PTS ONE
   AND TWO
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 1999 Space Technology and Applications International Forum (STAIF-99) -
   Opportunities and Challenges for the New Millennium
CY JAN 31-FEB 04, 1999
CL ALBUQUERQUE, NM
SP Boeing Co, Lockheed Martin Astronaut, NASA, USAF, Air Force Res Lab, US DOE, IAF 99, Amsterdam, Amer Inst Chem Engineers, AIAA, Amer Astronaut Soc, ASME Int, Amer Inst Aeronaut & Astronaut, Amer Inst Chem Engineers, Heat Transfer & Energ Convers Div, Amer Nucl Soc, Trin Sect, Amer Soc Mech Engineers, Nucl Engn Div & Heat Transfer Div, Inst Elect & Electr Engineers Inc, Nucl & Plasma Sci Soc, NASA Natl Space Grant Coll & Fellowship Program, New Mexico Space Grant Consortium, Profess Aerosp Contractors Assoc
ID GRAVITY
AB The International Space Station (ISS) is the linch-pin of NASA's future space plans. It emphasizes scientific research by providing a world-class scientific laboratory in which to perform long-term basic science experiments in the space environment of microgravity, radiation, vacuum, vantage-point, etc. It will serve as a test-bed for determining human system response to long-term space flight and for developing the life support equipment necessary for NASA's Human Exploration and Development of Space (HEDS) enterprise. The ISS will also provide facilities (up to 30% of the U.S. module) for testing material, agricultural, cellular, human, aquatic, and plant/animal systems to reveal phenomena heretofore shrouded by the veil of I-g. These insights will improve life on Earth and will provide a commercial basis for new products and services. In fact, some products, e.g., rare metal-alloys, semiconductor chips, or protein crystals that cannot now be produced on Earth may be found to be sufficiently valuable to be manufactured on-orbit. Biotechnology, pharmaceutical and biomedical experiments have been regularly flown on 10-16 day Space Shuttle flights and on three-month Mir flights for basic science knowledge and for life support system and commercial product development. Since 1985, NASA has created several Commercial Space Centers (CSCs) for the express purpose of bringing university, government and industrial researchers together to utilize space flight and space technology to develop new industrial products and processes. BioServe Space Technologies at the University of Colorado at Boulder and Kansas State University, Manhattan, Kansas, is such a NASA sponsored CSC that has worked with over 65 companies and institutions in the Biotech Sector in the past 11 years and has successfully discovered and transferred new product and process information to its industry partners. While tests in the space environment have been limited to about two weeks on Shuttle or a few months on Mir, tests on ISS can be performed over many months, or even years. More importantly, a test can be regularly scheduled so that the effects of microgravity and other space environment parameters can be thoroughly researched and quantified. This paper attempts to envision the potential benefits of this soon-to-be-available orbital laboratory and the broad commercial utilization of ISS that will likely occur.
C1 Univ Colorado, Dept Aerosp Engn Sci, Boulder, CO 80309 USA.
RP Morgenthaler, GW (reprint author), Univ Colorado, Dept Aerosp Engn Sci, CB 429, Boulder, CO 80309 USA.
CR ARMSTRONG JW, 1994, KANSAS AGR EXPT STAT, P584
   BATEMAN TA, 1998, BONE, V23, P1
   Campbell J, 1996, J PLANT PHYSIOL, V149, P539, DOI 10.1016/S0176-1617(96)80331-2
   HAMACHER H, 1986, MAT SCI SPACE
   HEYENGA AG, 1998, IN PRESS COSPAR
   HOEHN A, 972366 SAE
   IGNATIEV A, 1998, 49 IAF IAA INT SPAC
   KLAUS D, 1998, AIP C P, V420, P633
   Klaus DM, 1998, TRENDS BIOTECHNOL, V16, P369, DOI 10.1016/S0167-7799(98)01197-4
   Lam KS, 1998, APPL MICROBIOL BIOT, V49, P579, DOI 10.1007/s002530051216
   STODIEK LS, 1998, AIP C P, V420, P578
   STODIEK LS, 1998, AIP C P, V420, P627
   Todd P, 1989, ASGSB Bull, V2, P95
   Todd P, 1998, ADV SPACE RES-SERIES, V21, P1263, DOI 10.1016/S0273-1177(97)00397-9
   TODD P, 31 AER SCI M EXH, P1
   ZIMMERMAN RJ, 1994, 12 ANN S SPAC NUCL P, P1
NR 16
TC 0
Z9 0
U1 2
U2 4
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 1-56396-846-0
J9 AIP CONF PROC
PY 1999
VL 458
BP 239
EP 244
PG 6
WC Engineering, Aerospace; Thermodynamics; Engineering, Multidisciplinary;
   Geosciences, Multidisciplinary; Multidisciplinary Sciences; Nuclear
   Science & Technology; Remote Sensing; Physics, Applied; Physics,
   Multidisciplinary
SC Engineering; Thermodynamics; Geology; Science & Technology - Other
   Topics; Nuclear Science & Technology; Remote Sensing; Physics
GA BM78K
UT WOS:000079755200039
DA 2018-10-19
ER

PT S
AU Afanasyeva, N
   Bruch, R
   Katzir, A
AF Afanasyeva, N
   Bruch, R
   Katzir, A
BE Katzir, A
   Harrington, JA
TI Infrared fiberoptic evanescent wave spectroscopy: applications in
   biology and medicine
SO SPECIALTY FIBER OPTICS FOR MEDICAL APPLICATIONS, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Specialty Fiber Optics for Medical Applications
CY JAN 24-25, 1999
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
ID FEW-FTIR SPECTROSCOPY; CANCER TISSUES; TRANSFORM; DIAGNOSTICS; FIBERS;
   VIVO
AB A new powerful and highly sensitive technique for non-invasive biomedical diagnostics in vivo has been developed using Infrared Fiberoptic Evanescent Wave Fourier Transform Spectroscopy (FEW-FTIR). This compact and portable method allows to detect functional chemical groups and bonds via vibrational spectroscopy directly from surfaces including living tissue. Such differences and similarities in molecular structure of tissue and materials can be evaluated online. Operating in the attenuated total reflection (ATR) regime in the middle-infrared (MIR) range, the FEW-FTIR technique provides direct contact between the fiber probe and tissue for non-destructive, noninvasive, fast and remote (few meters) diagnostics and quality control of materials.
   This method utilizes highly flexible and extremely low loss unclad fibers, for example silver halide fibers. Applications of this method include investigations of normal skin, precancerous and cancerous conditions, monitoring of the process of aging, allergic reactions and radiation damage to the skin. This setup is suitable as well for the detection of the influence of environmental factors (sun, water, pollution, and weather) on skin surfaces. The FEW-FTIR technique is very promising also for fast histological examinations in vitro. In this review, we present recent investigations of skin, breast, lung, stomach, kidney tissues in vivo and ex vivo (during surgery) to define the areas of tumor localization. The main advantages of the FEW-FTIR technique for biomedical, clinical, and environmental applications are discussed.
C1 Univ Nevada, Dept Phys 220, Reno, NV 89557 USA.
RP Afanasyeva, N (reprint author), Univ Nevada, Dept Phys 220, Reno, NV 89557 USA.
CR AFANASYEVA N, 1995, MACROMOL SYMP, V94, P269, DOI 10.1002/masy.19950940124
   AFANASYEVA N, 1998, IN PRESS MACRO MOL S
   AFANASYEVA N, 1995, C OPT BIOPS BIOS EUR, P22
   AFANASYEVA N, 1995, SPECTRAL BIODIAGNOST, V94
   Afanasyeva NI, 1997, P SOC PHOTO-OPT INS, V2979, P478, DOI 10.1117/12.280279
   Afanasyeva NI, 1998, P SOC PHOTO-OPT INS, V3250, P140, DOI 10.1117/12.305383
   Afanasyeva NI, 1998, P SOC PHOTO-OPT INS, V3257, P260, DOI 10.1117/12.306092
   AFANASYEVA NI, 1997, P SOC PHOTO-OPT INS, V3195, P314
   ARTJUSHENKO VG, 1993, P SOC PHOTO-OPT INS, V2085, P142
   BORMASHENKO E, 1999, IN PRESS P SPIE, V3596
   BROOKS A, 1998, IN PRESS JOU SURFACE
   Brooks AL, 1998, P SOC PHOTO-OPT INS, V3195, P323, DOI 10.1117/12.297892
   Bruch R, 1997, P SOC PHOTO-OPT INS, V2970, P408, DOI 10.1117/12.275022
   FRANK CJ, 1995, ANAL CHEM, V67, P777, DOI 10.1021/ac00101a001
   GERMAN A, 1997, BIOS 97, V2977, P106
   GOTSHAL Y, 1998, BIOS 98 C, V3262, P188
   HEISE HM, 1995, J MOL STRUCT, V348, P127, DOI 10.1016/0022-2860(95)08605-U
   HEISE HM, 1989, JOU ANAL CHEM, V61, P2010
   HELM D, 1991, J MICROBIOL METH, V14, P127, DOI 10.1016/0167-7012(91)90042-O
   Hocde S, 1998, P SOC PHOTO-OPT INS, V3262, P144, DOI 10.1117/12.309467
   HUNG J, 1991, LASER SURG MED, V11, P99, DOI 10.1002/lsm.1900110203
   KRIMM S, 1987, VIBRATIONAL SPECTRA
   LAKOWIEZ JR, 1995, P SPIE, V2388
   LeFoulgoc K, 1996, P SOC PHOTO-OPT INS, V2836, P26, DOI 10.1117/12.260610
   Lewis EN, 1996, APPL SPECTROSC, V50, P263, DOI 10.1366/0003702963906618
   Mahadevan-Jansen A, 1996, J Biomed Opt, V1, P31, DOI 10.1117/12.227815
   Mantsch HH, 1996, INFRARED SPECTROSCOP
   MARECHAL Y, 1987, VIBRATIONAL SPECTRA
   Mourant JR, 1995, LASER SURG MED, V17, P350, DOI 10.1002/lsm.1900170403
   MULLER G, 1998, IN PRESS P SPIE
   NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0
   PARKER FS, 1971, INFRARED SPECTROSCOP
   RIGAS B, 1990, P NATL ACAD SCI USA, V87, P8140, DOI 10.1073/pnas.87.20.8140
   SPIELVOGEL J, 1998, BIOS 98 C, V3262, P188
   TSUBOI M, 1969, APPL SPECTROSC REV, V3, P45
   WASCHE W, 1998, IN PRESS P SPIE
   ZHANG XH, 1995, P SOC PHOTO-OPT INS, V2396, P78, DOI 10.1117/12.208388
   1993, NONINVASIVE METHODS
   1998, NANOTECHNOLOGY SCI T, V9
   1989, CUTANEOUS INVESTIGAT
   1998, VIBRATIONAL SPECTROS
   1995, HDB NONINVASIVE METH
NR 42
TC 16
Z9 16
U1 2
U2 7
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3066-8
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3596
BP 152
EP 164
DI 10.1117/12.346712
PG 13
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BN04G
UT WOS:000080481400019
DA 2018-10-19
ER

PT S
AU Rahman, SA
AF Rahman, SA
BE Cohn, GE
   Owicki, JC
TI A spectral unmixing algorithm for distributed endmembers with
   applications to biomedical imaging
SO SYSTEMS AND TECHNOLOGIES FOR CLINICAL DIAGNOSTICS AND DRUG DISCOVERY II,
   PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Systems and Technologies for Clinical Diagnostics and Drug
   Discovery II
CY JAN 24-25, 1999
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
DE multispectral image processing; spectral unmixing; subpixel; anomaly
   detection; edge detection; biomedical imaging
AB Spectral unmixing algorithms tend to make the simplifying assumptions that each type of material (endmember) in a spectral library may be represented by a single reference spectrum and that the mixing process is linear. While these assumptions are convenient in that they allow techniques of linear algebra to be used, they lack realism as each material type in a spectral image will in general emit a distribution of spectra while the mixing itself need not be linear.
   We describe a 'common sense' spectral unmixing algorithm for the general case where endmembers are described by arbitrary D-dimensional probability distributions and the mixing can be non-linear. As an application we outline an unsupervised procedure for deriving the fractional material content of every pixel in an image and identifying anomalies given no a priori knowledge. Accurate endmember distributions are obtained by first masking out impure pixels using locally normalised Sobel and Laplacian filters and then Performing single-link hierarchical clustering on the pure pixels which remain. The most probable endmember decomposition for a given target spectrum is found by selecting an appropriate set of endmembers based on the target's immediate neighbourhood, and performing a constrained maximum likelihood search over the space of fractional abundances. We also explain how the procedure may be applied to subpixel and anomaly detection. To illustrate our ideas the techniques described are applied to biomedical images throughout.
C1 Raytheon Opt Syst Inc, Algorithm Dev & Data Proc, Danbury, CT 06810 USA.
RP Rahman, SA (reprint author), Raytheon Opt Syst Inc, Algorithm Dev & Data Proc, Danbury, CT 06810 USA.
CR BOREL CC, 1994, REMOTE SENS ENVIRON, V47, P403, DOI 10.1016/0034-4257(94)90107-4
   BOSDOGIANNI P, 1995, SIGN IM 5 HELL C INF
   Crist EP, 1998, P SOC PHOTO-OPT INS, V3438, P66, DOI 10.1117/12.328123
   Duda R. O., 1973, PATTERN CLASSIFICATI
   FABER V, 1994, LOS ALAMOS SCI, V22
   Gross HN, 1996, P SOC PHOTO-OPT INS, V2821, P30, DOI 10.1117/12.257182
   Levenson RM, 1998, P SOC PHOTO-OPT INS, V3438, P300, DOI 10.1117/12.328111
   MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020
   Press WH, 1992, NUMERICAL RECIPES C
   Rahman SA, 1998, P SOC PHOTO-OPT INS, V3438, P210, DOI 10.1117/12.328105
   SIBSON R, 1973, COMPUT J, V16, P30, DOI 10.1093/comjnl/16.1.30
NR 11
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3073-0
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3603
BP 143
EP 154
DI 10.1117/12.346735
PG 12
WC Chemistry, Medicinal; Engineering, Biomedical; Medical Laboratory
   Technology; Optics
SC Pharmacology & Pharmacy; Engineering; Medical Laboratory Technology;
   Optics
GA BN04J
UT WOS:000080481600015
DA 2018-10-19
ER

PT S
AU Barnett, SM
   Bormett, RW
   Whitley, A
AF Barnett, SM
   Bormett, RW
   Whitley, A
BE Cabib, D
   Cogswell, CJ
   Conchello, JA
   Lerner, JM
   Wilson, T
TI Multi-dimensional Raman spectroscopy: From the UV to the near-IR
SO THREE-DIMENSIONAL AND MULTIDIMENSIONAL MICROSCOPY: IMAGE ACQUISITION AND
   PROCESSING VI, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on 3-Dimensional and Multidimensional Microscopy - Image
   Acquisition and Processing VI
CY JAN 24-25, 1999
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
AB The structural elucidation of complex systems may be simplified with multi-dimensional spectroscopic techniques with some combination of spatial and spectral resolution. Raman spectroscopy permits the addition of another variable to this scenario -excitation wavelength. Data obtained using excitation wavelengths from the UV (244 nm) to near-IR (785 nm) regions will be presented showing the qualitative and quantitative study of diamond-like carbon (DLC), silicon, and other systems of an industrial or biomedical nature. The choice of appropriate wavelength provides an additional advantage over other spectroscopic techniques for elucidating specific structural information from these systems. The advantages of UV-Raman for materials science and thin film studies will be considered. The design of instruments and probes for the application of Raman spectroscopy to industrial process control and the development of Raman spectroscopic libraries for contaminant analysis will be discussed.
C1 Renishaw Inc, Schaumburg, IL 60173 USA.
RP Barnett, SM (reprint author), Renishaw Inc, 623 Cooper Ct, Schaumburg, IL 60173 USA.
CR BOND JS, 1998, 216 ACS NAT M BOST A
   Freeman TL, 1997, J RAMAN SPECTROSC, V28, P641, DOI 10.1002/(SICI)1097-4555(199708)28:8<641::AID-JRS197>3.0.CO;2-T
   Gilkes KWR, 1997, APPL PHYS LETT, V70, P1980, DOI 10.1063/1.118798
   Magidson V, 1998, APPL PHYS LETT, V73, P1044, DOI 10.1063/1.122079
   Otto C, 1997, J RAMAN SPECTROSC, V28, P143
   Poweleit CD, 1998, APPL PHYS LETT, V73, P2275, DOI 10.1063/1.121700
   Prawer S, 1996, DIAM RELAT MATER, V5, P433, DOI 10.1016/0925-9635(95)00363-0
NR 7
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3075-7
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3605
BP 308
EP 316
DI 10.1117/12.347577
PG 9
WC Microscopy; Optics
SC Microscopy; Optics
GA BN09P
UT WOS:000080657900035
DA 2018-10-19
ER

PT J
AU Sung, HW
   Huang, RN
   Huang, LLH
   Tsai, CC
   Chiu, CT
AF Sung, HW
   Huang, RN
   Huang, LLH
   Tsai, CC
   Chiu, CT
TI Feasibility study of a natural crosslinking reagent for biological
   tissue fixation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biological tissue; crosslinking reagent; genipin; cytotoxicity;
   enzymatic degradation
ID IN-VITRO; COLLAGEN; DEGRADATION; GENIPOSIDE; TEMPERATURE; BIOMATERIAL;
   GENIPIN
AB Bioprostheses derived from biological tissues must be chemically modified and subsequently sterilized before they can be implanted in humans. Various crosslinking reagents, including formaldehyde, glutaraldehyde,dialdehyde starch, and epoxy compound, have been used to chemically modify biological tissues. However, these synthetic crosslinking reagents are all highly (or relatively highly) cytotoxic. It is therefore desirable to provide a crosslinking reagent suitable for use in biomedical applications that is of low cytotoxicity and that forms stable and biocompatible crosslinked products. This study evaluates the feasibility of using a naturally occurring crosslinking reagent-genipin-to chemically modify biological tissues. Genipin and ifs related iridoid compounds, extracted from gardenia fruits, have been used in traditional Chinese medicine for the treatments of jaundice and various inflammatory and hepatic diseases, In this feasibility study, the cytotoxicity of genipin and the crosslinking characteristics of genipin-fixed biological tissues were investigated. Fresh porcine pericardia procured from a slaughterhouse were used as raw materials. Glutaraldehyde and an epoxy compound (ethylene glycol diglycidyl ether), which has been used extensively in developing bioprostheses, were used as controls. It was found that the cytotoxicity of genipin was significantly lower than that of glutaraldehyde and the epoxy compound. The amino acid residues in the porcine pericardium that may react with genipin were lysine, hydroxylysine, and arginine. Additionally, the genipin-fixed tissue had a mechanical strength and resistance against enzymatic degradation comparable to the glutaraldehyde-fixed tissue. This suggests that genipin can form stable crosslinked products. The results of this in vitro study demonstrate that genipin is an effective crosslinking reagent for biological tissue fixation. (C) 1998 John Wiley & Sons, Inc.
C1 Natl Cent Univ, Dept Chem Engn, Chungli 32054, Taiwan.
   Natl Cent Univ, Inst Life Sci, Chungli 32054, Taiwan.
   Natl Taiwan Univ, Coll Med, Ctr Biomed Engn, Taipei, Taiwan.
RP Sung, HW (reprint author), Natl Cent Univ, Dept Chem Engn, Chungli 32054, Taiwan.
RI Huang, Lynn/J-9237-2016
OI Huang, Lynn/0000-0002-6602-7578; Huang, Rong Nan/0000-0002-5117-8672
CR ABURADA M, 1980, PHARMACOMETRICS, V19, P259
   AKAO T, 1994, BIOL PHARM BULL, V17, P1573
   BUCHI G, 1967, J AM CHEM SOC, V89, P2776
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P139, DOI 10.1002/jbm.820290202
   FUJIKAWA S, 1987, TETRAHEDRON LETT, V28, P4699, DOI 10.1016/S0040-4039(00)96601-2
   FUJIKAWA S, 1987, BIOTECHNOL LETT, V9, P697, DOI 10.1007/BF01024600
   HARPER E, 1972, BIOPOLYMERS, V11, P1607, DOI 10.1002/bip.1972.360110807
   LEE JM, 1995, MED ENG PHYS, V17, P115, DOI 10.1016/1350-4533(95)91882-H
   Lohre J M, 1993, ASAIO J, V39, P106, DOI 10.1097/00002480-199304000-00007
   LOHRE JM, 1992, ARTIF ORGANS, V16, P630
   MCCLAIN PE, 1972, J BIOL CHEM, V247, P692
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   NOISHIKI Y, 1993, INT J ARTIF ORGANS, V16, P192
   NOISHIKI Y, 1986, T AM SOC ART INT ORG, V32, P114
   Noishiki Y., 1989, U. S. Patent, Patent No. [4,806,599, 4806599]
   Rosenberg D., 1978, VASCULAR GRAFTS, P261
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Sung H. W., 1993, ASIAN CARDIOVASC THO, V1, P104
   Sung HW, 1996, J BIOMED MATER RES, V31, P511, DOI 10.1002/(SICI)1097-4636(199608)31:4<511::AID-JBM11>3.0.CO;2-J
   Sung HW, 1997, ARTIF ORGANS, V21, P50
   Sung HW, 1997, J BIOMED MATER RES, V35, P147
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P668
   TSAI TH, 1994, J LIQ CHROMATOGR, V17, P2199
   TU R, 1994, J BIOMED MATER RES, V28, P677, DOI 10.1002/jbm.820280604
   YAMANO T, 1990, FOOD CHEM TOXICOL, V28, P515, DOI 10.1016/0278-6915(90)90122-4
   Yamazaki M, 1996, BIOL PHARM BULL, V19, P791
   YANNAS IV, 1975, J BIOMED MATER RES, V9, P623, DOI 10.1002/jbm.820090608
NR 28
TC 207
Z9 220
U1 4
U2 68
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 1998
VL 42
IS 4
BP 560
EP 567
DI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 135HJ
UT WOS:000076795500012
PM 9827680
DA 2018-10-19
ER

PT J
AU Mastroianni, AC
   Kahn, JP
AF Mastroianni, AC
   Kahn, JP
TI The importance of expanding current training in the responsible conduct
   of research
SO ACADEMIC MEDICINE
LA English
DT Article
ID TEACHING SCIENTIFIC INTEGRITY; SCIENCE
AB Despite the growing need to teach principles of the responsible conduct of research (RCR) to those training to be biomedical researchers, no descriptive, easily compared information about the nation's RCR programs exists. To draw some preliminary conclusions about the state of RCR education and training and to gain insight into what kinds of future initiatives are needed, the authors reviewed materials describing U.S. training programs in RCR that had been collected by the Department of Health and Human Services in June-August 1996.
   In direct response to a 1990 federal policy, formal RCR training programs have been established at many institutions that carry out research. This policy requires that recipients of National Research Service Award Institutional Research Training Grants from the National Institutes of Health provide RCR training to the predoctoral and postdoctoral trainees supported by these grants. The authors found that two thirds of the 45 institutions represented in the materials provided RCR training only to those trainees whom they were required to train, although among the rest of the institutions, a few required that all trainees receive such training. The training programs studied were quite diverse regarding who was responsible for the program (the principal investigator, the ethics faculty, etc.), what kinds of instruction were given (lectures, seminars, small-group discussions, etc.), course content, and how discipline-specific the focus was,
   The authors review the obstacles to effective RCR training (e.g., the needs for culture change and for sizable faculty, financial, course time, and administrative resources; the need for proper evaluation of programs) and discuss ways to foster such programs (e.g., sharing of resources; identifying competencies; tailoring teaching to the individual institution's and department's characteristics; public-private partnerships). They conclude that the institutional efforts needed to establish widespread and effective RCR training are more than justified by the result that such training will help foster: the integrity of the research process and a solid future for the research enterprise.
C1 Univ Minnesota, Ctr Bioeth, Minneapolis, MN 55455 USA.
   Univ Washington, Sch Law, Seattle, WA 98195 USA.
   Univ Washington, Publ Hlth Genet Program, Seattle, WA 98195 USA.
   Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.
   Univ Minnesota, Sch Publ Hlth, Div Hlth Serv Res & Policy, Minneapolis, MN 55455 USA.
   Univ Minnesota, Dept Philosophy, Minneapolis, MN 55455 USA.
RP Kahn, JP (reprint author), Univ Minnesota, Ctr Bioeth, Suite N504 Boynton,410 Church St SE, Minneapolis, MN 55455 USA.
CR *ADV COMM HUM RAD, 1996, HUM RAD EXP
   *AM ASS ADV SCI, 1996, INT SCI RES 5 VID VI
   BENDITT J, 1995, SCIENCE, V268, P1705, DOI 10.1126/science.11644751
   BULGER RE, 1993, ACAD MED, V68, pS5, DOI 10.1097/00001888-199309000-00026
   BULGER RE, 1993, ETHICAL DIMENSIONS B
   Bulger Ruth Ellen, 1995, SOC CHOICES SOCIAL E
   COHEN J, 1995, SCIENCE, V268, P1715, DOI 10.1126/science.7792594
   COHEN J, 1995, SCIENCE, V268, P1706, DOI 10.1126/science.7540770
   Coughlin SS, 1996, AM J PREV MED, V12, P242
   *DEP HHS, 1995, INT MISC RES
   FRIEDMAN PJ, 1990, ACAD MED, V65, P32, DOI 10.1097/00001888-199001000-00009
   *I MED COMM RESP C, 1989, RESP COND RES HLTH S
   Korenman S. G., 1994, TEACHING RESPONSIBLE
   LENZ ER, 1995, J PROF NURS, V11, P213, DOI 10.1016/S8755-7223(95)80022-0
   MACRINA FL, 1995, J PROF NURS, V11, P40, DOI 10.1016/S8755-7223(95)80071-9
   MACRINA FL, 1995, SCI INTEGRITY INTRO
   MASTROIANNI AC, IN PRESS ACCOUNTABIL
   *NAT AC SCI, 1997, UNPUB PLANN WORKSH G
   *NAT AC SCI, 1995, BEING SCI
   *NAT AC SCI NAT AC, 1992, RESP SCI ENS INT RES
   *NIH, 1998, MENT SCI DEV AW RES
   *NIH, 1998, REM UPD REQ INSTR RE
   *NIH, 1998, SHORT TERM COURS RES
   PRITCHARD IA, 1993, ACAD MED, V68, pS67, DOI 10.1097/00001888-199309000-00037
   Range LM, 1995, ETHICS BEHAV, V5, P49, DOI 10.1207/s15327019eb0501_4
   SACHS GA, 1993, ACAD MED, V68, P871, DOI 10.1097/00001888-199312000-00001
NR 26
TC 26
Z9 26
U1 0
U2 10
PU HANLEY & BELFUS INC
PI PHILADELPHIA
PA 210 S 13TH ST, PHILADELPHIA, PA 19107 USA
SN 1040-2446
J9 ACAD MED
JI Acad. Med.
PD DEC
PY 1998
VL 73
IS 12
BP 1249
EP 1254
DI 10.1097/00001888-199812000-00013
PG 6
WC Education, Scientific Disciplines; Health Care Sciences & Services
SC Education & Educational Research; Health Care Sciences & Services
GA 150ZT
UT WOS:000077697000017
PM 9883199
OA Bronze
DA 2018-10-19
ER

PT J
AU Suarez, N
   Brocchini, S
   Kohn, J
AF Suarez, N
   Brocchini, S
   Kohn, J
TI The study of water uptake in degradable polymers by thermally stimulated
   depolarization currents
SO BIOMATERIALS
LA English
DT Article
DE thermally stimulated depolarization currents (TDSC); degradable
   polymers; tyrosine; degradable biomaterials; mechanisms of hydration;
   secondary relaxations; polyarylate
ID GLASS-TRANSITION; AQUEOUS-MEDIA; RELAXATION; POLYARYLATES; COPOLYMERS;
   MATRICES; NYLON-12; SYSTEMS; DESIGN; ACID)
AB Poly(DTH succinate) is a new, degradable polymer with potential applications as a medical implant material. This polymer can be classified as an alternating copolymer of succinic acid and desaminotyrosyl-tyrosine hexyl ester (DTH), a diphenolic monomer derived from the natural amino acid L-tyrosine. In this study, the effects of water uptake (hydration) on the secondary relaxations of poly(DTH succinate) were investigated using the technique of thermally stimulated depolarization currents (TDSC). Four relaxation peaks were precisely characterized by means of Gaussian activation energy distributions. Drying and rehydration treatments show that only small amounts of water, at most 0.5% (w/w), are necessary to hydrate two of the four polar moieties in poly(DTH succinate): the pendent chain ester carbonyls and the amide carbonyls in the polymer backbone. Water appeared to be more tightly bound to the amide carbonyl group and more loosely bound to the ester carbonyl group in the pendent chain. Even at a high state of hydration (1.2% w/w), TDSC indicated that no water was associated with the phenyl ester bond in the polymer backbone. This finding may explain the unexpectedly high stability of this polymer toward hydrolysis under physiological conditions. Polymer packing was also affected by hydration. In an intermediate hydration state (water content: 0.5% w/w) polymer packing was less dense than in the wet state (water content: 1.2% w/w). This study represents the first application of the TDSC technique to the study of hydration in a degradable biomedical polymer. The results obtained indicate that the TDSC technique may be useful to assist in the understanding of the mechanisms of hydration and subsequent hydrolytic degradation in degradable biomaterials. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Rutgers State Univ, Dept Chem, New Brunswick, NJ 08903 USA.
   Univ Simon Bolivar, Dept Phys, Caracas, Venezuela.
RP Kohn, J (reprint author), Rutgers State Univ, Dept Chem, 610 Taylor Rd, Piscataway, NJ 08855 USA.
FU NIGMS NIH HHS [GM 49894]
CR ALDANA M, 1994, J POLYM SCI POL PHYS, V32, P2197, DOI 10.1002/polb.1994.090321307
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   CHO CS, 1988, J CONTROL RELEASE, V7, P283
   COLMENERO J, 1988, MAKROMOL CHEM-M SYMP, V20-1, P397, DOI 10.1002/masy.19880200142
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P601, DOI 10.1016/0142-9612(92)90028-M
   DELVAL JJ, 1986, POLYMER, V27, P1771, DOI 10.1016/0032-3861(86)90275-2
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   FIORDELISO J, 1995, POLYM BIOMATERIALS S, P695
   Frank B, 1996, J POLYM SCI POL PHYS, V34, P1853, DOI 10.1002/(SICI)1099-0488(199608)34:11<1853::AID-POLB2>3.0.CO;2-T
   GINDE RM, 1987, J APPL POLYM SCI, V33, P2411, DOI 10.1002/app.1987.070330712
   HOOPER KA, 1998, 24 ANN M SOC BIOM SA, P387
   HOOPER KA, 1998, IN PRESS J BIOMED MA
   KEMNITZER J, 1997, HDB BIODEGRADABLE PO, V7, P251
   LACABANNE C, 1980, J POLYM SCI POL PHYS, V18, P277, DOI 10.1002/pol.1980.180180210
   LEHUY HM, 1994, POLYMER, V35, P136, DOI 10.1016/0032-3861(94)90061-2
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   LIN HL, 1993, J BIOMED MATER RES, V27, P153, DOI 10.1002/jbm.820270204
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   PATHMANATHAN K, 1992, J POLYM SCI POL PHYS, V30, P341, DOI 10.1002/polb.1992.090300404
   PATHMANATHAN K, 1995, J CHEM SOC FARADAY T, V91, P337, DOI 10.1039/ft9959100337
   PEPPAS NA, 1980, J MEMBRANE SCI, V7, P241, DOI 10.1016/S0376-7388(00)80471-8
   PERLMAN MM, 1971, J APPL PHYS, V42, P2645, DOI 10.1063/1.1660602
   PISSIS P, 1991, J NON-CRYST SOLIDS, V131, P1174, DOI 10.1016/0022-3093(91)90749-V
   Pissis P, 1996, J POLYM SCI POL PHYS, V34, P1529, DOI 10.1002/(SICI)1099-0488(19960715)34:9<1529::AID-POLB1>3.0.CO;2-G
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   PUFFR R, 1967, J POLYM SCI C, V16, P79
   SCHACHTER DM, 1996, ADV CONTROLLED DELIV, P49
   SCHARTEL B, 1995, POLYMER, V36, P899, DOI 10.1016/0032-3861(95)93586-B
   Shimizu H, 1996, JPN J APPL PHYS 2, V35, pL231, DOI 10.1143/JJAP.35.L231
   SUAREZ N, 1993, FUEL, V72, P13, DOI 10.1016/0016-2361(93)90369-D
   SUAREZ N, 1997, J APPL POLYM SCI, V63, P1157
   Vanderschueren J., 1979, Thermally stimulated relaxation in solids, P135
   VANTURNHOUT J, 1980, TOP APPL PHYS, V33, P2685
   VERT M, 1991, J CONTROL RELEASE, V16, P15, DOI 10.1016/0168-3659(91)90027-B
NR 35
TC 19
Z9 19
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 1998
VL 19
IS 24
BP 2347
EP 2356
DI 10.1016/S0142-9612(98)00151-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 150BU
UT WOS:000077643200014
PM 9884049
DA 2018-10-19
ER

PT J
AU Mohanty, M
   Kumary, TV
   Lal, AV
   Sivakumar, R
AF Mohanty, M
   Kumary, TV
   Lal, AV
   Sivakumar, R
TI Short term tissue response to carbon fibre: A preliminary in vitro and
   in vivo study
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE carbon fibre; biocompatibility; bone
ID FIBER
AB Carbon in the form of pyrolytic carbon coating is used in a number of implantable medical devices. Carbon-reinforced carbon composite and other forms of diamond-like carbon coatings are being evaluated for their many potential biomedical applications. There is also a possibility of using carbon in fibre form. Though the possibility of using the fibre form of carbon in skeletal and dental implants has been recognized, a detailed study of tissue reaction to carbon fibre has not been reported so far. In this paper, we describe in vitro and irt vivo evaluation of carbon fibre in bone and muscle. Good cell and tissue biocompatibility of the material was observed in bone and muscle. New bone was present in contact with the fibres. Results of this study indicate that carbon fibre has potential in non-load bearing applications, such as skeletal repair and as ligament prosthesis.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Pathophysiol, Trivandrum 695012, Kerala, India.
   Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Vivarium & Mat Grp, Trivandrum 695012, Kerala, India.
RP Mohanty, M (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Pathophysiol, Trivandrum 695012, Kerala, India.
CR BENSON J, 1972, BIOCERAMICS ENG ME 1, P41
   BRAND G, 1992, AM BOOK REV, V13, P9
   DIIRSELEN L, 1989, ADV BIOMATER, V9, P439
   Foster I W, 1978, Clin Orthop Relat Res, P299
   JENKINS DHR, 1977, 13 BIENN C CARB U PA, P178
   KEIFER H, 1987, ADV BIOMATER, V7, P253
   LODR GH, 1986, TECHNIQUES BIOCOMPAT, V1, P18
   LYMAN DJ, 1991, ACS SYM SER, V457, P116
   MINNS RJ, 1989, BIOMATERIALS, V10, P273, DOI 10.1016/0142-9612(89)90105-1
   MINNS RJ, 1982, BIOMATERIALS, V3, P81, DOI 10.1016/0142-9612(82)90038-2
   NEUGEBAUER R, 1981, BIOMATERIALS, V2, P182, DOI 10.1016/0142-9612(81)90049-1
   RUSHTON N, 1983, J BONE JOINT SURG BR, V65, P308
   TAYTON K, 1982, J BONE JT SURG B, V64, P112
   TURNER JE, 1973, J BIOMED MATER RES, V7, P39, DOI 10.1002/jbm.820070104
   WOLTER D, 1977, T 3 ANN M SOC BIOM, P126
   YANAGISAWA S, 1986, MAT SCI MONOGRAPHS, V33, P333
NR 16
TC 3
Z9 3
U1 0
U2 3
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD DEC
PY 1998
VL 21
IS 6
BP 439
EP 444
DI 10.1007/BF02790343
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 146HE
UT WOS:000077422600001
DA 2018-10-19
ER

PT J
AU Antonietti, M
   Breulmann, M
   Goltner, CG
   Colfen, H
   Wong, KKW
   Walsh, D
   Mann, S
AF Antonietti, M
   Breulmann, M
   Goltner, CG
   Colfen, H
   Wong, KKW
   Walsh, D
   Mann, S
TI Inorganic/organic mesostructures with complex architectures:
   Precipitation of calcium phosphate in the presence of double-hydrophilic
   block copolymers
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE biomimetic synthesis; biomineralization; calcium; crystal growth;
   colloids
ID PARTICLES; OXIDE
AB Double-hydrophilic block copolymers consisting of a long poly(ethylene oxide) block and a short poly(methacrylic acid) block, modified by partial alkylation with dodecylamine (PEO-b-PMAA-C-12) were employed as dispersed templates for the controlled precipitation of calcium phosphate from aqueous solution at different pH values. Two new and nontrivial superstructures of an organized inorganic/organic hybrid material were characterized by ultracentrifugation, small- and wide-angle X-ray analysis, and electron microscopy. At pH 3.5 and 4.0, and pH 4.5, 5.0, and 6.3, two different types of discrete nested structures are obtained which consist of hybrid nanofilaments arranged to give an unusual neuronlike morphology. The fibers originate from a core of similar size to the primary polymer aggregates, suggesting that cooperative interactions at a local level between dissolving calcium phosphate clusters and disassembling polymer units could be responsible for the highly anisotropic nature of the secondary growth process. Aging of the nanofilaments grown in acidic solution results in a second hybrid morphology, consisting of compact aggregates with a diameter of about 130nm, which show the interlocked layer structure of an ordered inorganic/organic mesophase with a repeat period of about 3 nm. Such calcium phosphate/polymer nanohybrids with complex morphologies are interesting from the viewpoint of prebiotic structure formation, and might also be useful as novel ceramics precursors, reinforcing fillers, or biomedical implants.
C1 Max Planck Inst Kolloid & Grenzflachenforsch, D-14513 Teltow, Germany.
   Univ Bath, Sch Chem, Bath BA2 7AY, Avon, England.
RP Antonietti, M (reprint author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.
RI Mann, Stephen/D-1332-2012
OI Mann, Stephen/0000-0003-3012-8964
CR Antonietti M, 1997, MACROMOL RAPID COMM, V18, P295, DOI 10.1002/marc.1997.030180405
   BRACE R, 1973, J INORG NUCL CHEM, V35, P3691, DOI 10.1016/0022-1902(73)80058-2
   CHITTOFRATI A, 1990, COLLOID SURFACE, V48, P65, DOI 10.1016/0166-6622(90)80219-T
   Colfen H, 1998, LANGMUIR, V14, P582, DOI 10.1021/la970765t
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   Forster S, 1998, ADV MATER, V10, P195, DOI 10.1002/(SICI)1521-4095(199802)10:3<195::AID-ADMA195>3.0.CO;2-V
   Hopwood JD, 1997, CHEM MATER, V9, P1819, DOI 10.1021/cm970113q
   KNEBELKAMP A, 1996, MACROMOL S, V102, P91
   LYSTER RLJ, 1984, BIOCHIM BIOPHYS ACTA, V801, P315, DOI 10.1016/0304-4165(84)90082-5
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   MANN S, 1995, BIOMINERALIZATION CH
   Mann S, 1995, BIOMIMETIC MAT CHEM
   MANN S, 1989, BIOMINERALIZATION CH
   Nancollas G. H., 1989, BIOMINERALISATION, P157
   SAPIESZKO RS, 1980, J COLLOID INTERF SCI, V74, P405, DOI 10.1016/0021-9797(80)90210-6
   Sedlak M, 1998, MACROMOL CHEM PHYSIC, V199, P247, DOI 10.1002/(SICI)1521-3935(19980201)199:2<247::AID-MACP247>3.0.CO;2-9
   WALSH D, 1993, J CRYST GROWTH, V133, P1, DOI 10.1016/0022-0248(93)90097-G
   WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998
NR 18
TC 203
Z9 210
U1 6
U2 46
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0947-6539
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD DEC
PY 1998
VL 4
IS 12
BP 2493
EP 2500
DI 10.1002/(SICI)1521-3765(19981204)4:12<2493::AID-CHEM2493>3.0.CO;2-V
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 147AN
UT WOS:000077466200013
DA 2018-10-19
ER

PT J
AU Chen, ZH
   Luo, RC
AF Chen, ZH
   Luo, RC
TI Design and implementation of capacitive proximity sensor using
   microelectromechanical systems technology
SO IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS
LA English
DT Article
DE fringe capacitance; microelectromechanical systems; proximity sensor
ID DISPLACEMENT TRANSDUCER
AB This paper presents an innovative proximity sensor using microelectromechanical systems (MEMS) technology. The proximity sensor works on the principle of fringe capacitance. The target object does not need to be part of the measuring system and could be either a conductor or nonconductor. Modeling of the proximity sensor is performed and closed-form analytical solution is obtained for a ring-shaped sensing pattern. The proximity sensors could be batch fabricated using MEMS technology, and the fabrication process is relatively simple. Measurement of the prototype sensors revealed promising results. The size of the proximity sensor could vary from a few hundred micrometers to the size of the substrate. The flexibility on sensor size, sensing patterns, and sensing pattern geometrical parameters makes the sensor very versatile and capable of precision measurement of proximity in the range from micrometers to centimeters. The small size of the sensor makes it possible to surface mount the sensor in many space-constrained places. This advantage is vital in many areas, such as MEMS, microrobotics, precision engineering, machine automation, inspection tools, and many other applications. The ability of the proximity sensor in measuring relative permittivity of materials also finds the sensor useful applications in biomedical and tissue engineering. In addition, this micro proximity sensor is an ideal building block for many other types of sensors, such as force, tactile, and flow sensors.
C1 Rockwell Automat Allen Bradley, Chelmsford, MA 01824 USA.
   Natl Chung Cheng Univ, Dept Elect Engn, Chiayi, Taiwan.
RP Chen, ZH (reprint author), Rockwell Automat Allen Bradley, Chelmsford, MA 01824 USA.
EM luo@cs.ccu.edu.tw
CR BERTONE GA, 1990, IEEE T INSTRUM MEAS, V39, P424, DOI 10.1109/19.52527
   Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   FERTNER A, 1989, IEEE T INSTRUM MEAS, V38, P870, DOI 10.1109/19.31006
   FRANK R, 1991, SENSOR ACTUAT A-PHYS, V28, P93, DOI 10.1016/0924-4247(91)85018-J
   GARRATT JD, 1979, J PHYS E SCI INSTRUM, V12, P563, DOI 10.1088/0022-3735/12/7/002
   HUANG SM, 1992, IEE PROC-G, V139, P83, DOI 10.1049/ip-g-2.1992.0014
   HUISING JH, 1993, SENSOR ACTUAT A-PHYS, V30, P167
   KOBAYASHI T, 1986, SENSOR ACTUATOR, V9, P235, DOI 10.1016/0250-6874(86)80024-5
   Kung J. T., 1992, Journal of Microelectromechanical Systems, V1, P121, DOI 10.1109/84.186391
   LUO RC, 1993, P 1993 IEEE RSJ INT, P1709
   LUO RC, 1993, P 1993 JSME INT C AD, P621
   MICHELSON L, 1979, MACH DES, P117
   Noltingk B.E., 1976, P ACTA IMEKO, P537
   NOLTINGK BE, 1969, J PHYS E SCI INSTRUM, V2, P356, DOI 10.1088/0022-3735/2/4/314
   SYDENHAM PH, 1972, J PHYS E SCI INSTRUM, V5, P721, DOI 10.1088/0022-3735/5/8/001
NR 15
TC 64
Z9 70
U1 1
U2 13
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0278-0046
J9 IEEE T IND ELECTRON
JI IEEE Trans. Ind. Electron.
PD DEC
PY 1998
VL 45
IS 6
BP 886
EP 894
DI 10.1109/41.735332
PG 9
WC Automation & Control Systems; Engineering, Electrical & Electronic;
   Instruments & Instrumentation
SC Automation & Control Systems; Engineering; Instruments & Instrumentation
GA 144EA
UT WOS:000077299800007
DA 2018-10-19
ER

PT J
AU Rowlands, JA
AF Rowlands, JA
TI Current advances and future trends in X-ray digital detectors for
   medical applications
SO IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT
LA English
DT Article
DE biomedical X-ray imaging; thin-film devices; photoconducting materials
ID AMORPHOUS SELENIUM; RADIOGRAPHY; MAMMOGRAPHY; SYSTEMS; ARRAYS
AB Despite the progress made in imaging modalities based on nonionizing radiation such as ultrasound and magnetic resonance imaging, X-ray is still the primary imaging method in most radiology departments. In recent years, digital electronics and manufacturing methods have led to many approaches for the design and construction of X-ray detectors. The ideal medical X-ray system is a digital, Bat-panel able to perform all current radiological modalities at reduced dose. It would, immediately after the patient's X-ray exposure, provide a high quality radiograph on a video monitor. It would also be usable for real-time imaging (e.g., digital cine loops and fluoroscopy), The physical form would be similar to a film/screen cassette (except for the addition of an umbilical cord) which could easily fit into the Bucky tray of existing X-ray rooms, There are two main approaches both based on active matrix technology developed for lap-top displays. The first, called the direct method employs a photoconductive layer of amorphous selenium (a-Se) to detect X-rays, The charge image formed on the surface of the a-Se is digitally read out in situ using a two-dimensional array of thin-film transistors (TFT's), i.e., an active matrix. The second flat panel method is called the indirect method and uses an active matrix to readout a phosphor layer. Phosphors give off light on interaction with X-rays and this is sensed by photo diodes on the active matrix, The relative practicality of the direct and indirect active matrix readout systems is an area of current investigation.
C1 Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada.
RP Rowlands, JA (reprint author), Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada.
CR ANTONUK LE, 1992, MED PHYS, V19, P1455, DOI 10.1118/1.596802
   BRODIE I, 1982, MED PHYS, V9, P79, DOI 10.1118/1.595054
   CHAN HP, 1987, MED PHYS, V14, P538, DOI 10.1118/1.596065
   FUJIEDA I, 1993, JPN J APPL PHYS 1, V32, P198, DOI 10.1143/JJAP.32.198
   KASAP SO, 1997, FUTURE DIRECTIONS TH
   NUDELMAN S, 1982, P IEEE, V70, P700, DOI 10.1109/PROC.1982.12377
   Powell M.J., 1992, MATER RES SOC S P, V258, P1127
   ROUGEOT H, 1993, AAPM MONOGRAPH, V22, P49
   ROWLANDS JA, 1989, MED PHYS, V16, P553, DOI 10.1118/1.596357
   Rowlands JA, 1996, AM J ROENTGENOL, V167, P409, DOI 10.2214/ajr.167.2.8686617
   SANADA S, 1991, MED PHYS, V18, P414, DOI 10.1118/1.596688
   SCHIEBEL U, 1994, P SOC PHOTO-OPT INS, V2163, P129, DOI 10.1117/12.174248
   SPEKOWIUS G, 1995, P SOC PHOTO-OPT INS, V2432, P12, DOI 10.1117/12.208339
   Yaffe MJ, 1997, PHYS MED BIOL, V42, P1, DOI 10.1088/0031-9155/42/1/001
   ZHAO W, 1995, MED PHYS, V22, P1595, DOI 10.1118/1.597628
NR 15
TC 9
Z9 11
U1 0
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9456
J9 IEEE T INSTRUM MEAS
JI IEEE Trans. Instrum. Meas.
PD DEC
PY 1998
VL 47
IS 6
BP 1415
EP 1418
DI 10.1109/19.746705
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 167NU
UT WOS:000078640800003
DA 2018-10-19
ER

PT J
AU Laidlaw, DH
AF Laidlaw, DH
TI Comments on "Partial-Volume Bayesian classification of material mixtures
   in MR volume data using voxel histograms" - Author's reply
SO IEEE TRANSACTIONS ON MEDICAL IMAGING
LA English
DT Letter
DE Bayesian probability theory; biomedical signal processing; discrete
   signal processing; feature extraction; functional analysis; geometric
   modeling; image processing; partial volume; mixed modeling and
   estimation; multiscale analysis; multidimensional signal processing;
   multispectral classification; multivariate segmentation; tissue
   classification; volume measurement
C1 Henry Ford Hlth Syst, Dept Radiol, Image Anal Lab, Detroit, MI 48202 USA.
   Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA.
   Univ Tehran, Dept Elect & Comp Engn, Tehran 14399, Iran.
RP Laidlaw, DH (reprint author), Henry Ford Hlth Syst, Dept Radiol, Image Anal Lab, Detroit, MI 48202 USA.
EM dhl@cs.brown.edu
CR ABDALLAH MA, 1993, IEEE T NUCL SCI, V40, P1204
   WINDHAM JP, 1988, J COMPUT ASSIST TOMO, V12, P1, DOI 10.1097/00004728-198801000-00001
NR 2
TC 2
Z9 2
U1 0
U2 0
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0278-0062
J9 IEEE T MED IMAGING
JI IEEE Trans. Med. Imaging
PD DEC
PY 1998
VL 17
IS 6
BP 1094
EP 1096
DI 10.1109/42.746728
PG 3
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Electrical & Electronic; Imaging Science &
   Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging
SC Computer Science; Engineering; Imaging Science & Photographic
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA 166TH
UT WOS:000078592900027
DA 2018-10-19
ER

PT J
AU Spaans, CJ
   De Groot, JH
   Belgraver, VW
   Pennings, AJ
AF Spaans, CJ
   De Groot, JH
   Belgraver, VW
   Pennings, AJ
TI A new biomedical polyurethane with a high modulus based on
   1,4-butanediisocyanate and epsilon-caprolactone
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIODEGRADABLE POLYMER IMPLANTS; MENISCUS RECONSTRUCTION
AB A new approach to the synthesis of biomedical polyurethanes based on epsilon-caprolactone and 1,4-butanediisocyanate with a high modulus, has been developed. By chain extending an epsilon-caprolactone prepolymer with a long uniform-size diisocyanate block, a segmented polyurethane with uniform-size hard segments was obtained. It shows excellent mechanical properties; an extremely high modulus of 105 MPa and a tensile strength of 35 MPa. The polymer is soluble at high concentrations in various volatile solvents such as chloroform and 1,4-dioxane. By a combination of salt-leaching and freeze-drying, porous materials have been obtained in which macropores ranging in size from 150-300 mu m are highly interconnected by micropores. The material shows a sufficiently high compression modulus of 200 kPa and appears to be suitable for biomedical applications such as meniscal prostheses. (C) 1998 Kluwer Academic Publishers.
C1 Univ Groningen, Dept Polymer Chem, NL-9747 AG Groningen, Netherlands.
RP Pennings, AJ (reprint author), Univ Groningen, Dept Polymer Chem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
CR ALLEN CFH, 1995, ORGANIC SYNTHESES CO, V3, P846
   COENEN JMF, 1993, EUR BURN ASS 5 C
   COENEN JMF, 1990, 8 INT C BURN INJ NEW
   DEGROOT JH, 1990, COLLOID POLYM SCI, V268, P1073, DOI 10.1007/BF01410672
   deGroot JH, 1996, BIOMATERIALS, V17, P163, DOI 10.1016/0142-9612(96)85761-9
   deGroot JH, 1997, BIOMATERIALS, V18, P613, DOI 10.1016/S0142-9612(96)00169-X
   DEGROOT JH, IN PRESS POLYM B
   ELEMA H, 1990, COLLOID POLYM SCI, V268, P1082, DOI 10.1007/BF01410673
   GOGOLEWSKI S, 1988, P SPE INT C MED PLAS
   HESSELS J, 1991, THESIS U GRONINGEN N
   KLOMPMAKER J, 1992, J ORTHOP RES, V10, P359, DOI 10.1002/jor.1100100308
   Lelah M. D., 1986, POLYURETHANES MED
   PENNINGS AJ, 1990, COLLOID POLYM SCI, V268, P2, DOI 10.1007/BF01410416
   Spaans CJ, 1998, POLYM BULL, V41, P131, DOI 10.1007/s002890050343
   SPAANS CJ, IN PRESS
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
NR 17
TC 35
Z9 36
U1 1
U2 11
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1998
VL 9
IS 12
BP 675
EP 678
DI 10.1023/A:1008922128455
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 161CK
UT WOS:000078270600002
PM 15348920
DA 2018-10-19
ER

PT J
AU Pereira, CS
   Cunha, AM
   Reis, RL
   Vazquez, B
   San Roman, J
AF Pereira, CS
   Cunha, AM
   Reis, RL
   Vazquez, B
   San Roman, J
TI New starch-based thermoplastic hydrogels for use as bone cements or
   drug-delivery carriers
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID GRAFT-COPOLYMERIZATION; SWELLING BEHAVIOR; ACRYLIC-MONOMERS; AMINE
   ACTIVATORS; RELEASE; POLYMERS; POLYMERIZATION; METHACRYLATE; COMPOSITES;
   MIXTURES
AB The development of new biodegradable hydrogels, based on corn starch/cellulose acetate blends, produced by free-radical polymerization with methyl methacrylate monomer (MMA) and/or an acrylic acid monomer (AA), is reported. The polymerization was initiated by a redox system consisting of a benzoyl peroxide and 4-dimethlyaminobenzyl alcohol at low temperature. These hydrogels may constitute an alternative to the materials currently used as bone cements or drug-delivery carriers. Swelling studies were carried out, as a function of pH and temperature, in buffered solutions. The xerogels were further characterized by Fourier transform-infrared spectroscopy. Tensile and compression tests, and dynamic mechanical thermal analysis were used to assess the mechanical performance of the developed materials. The fracture surfaces were observed by scanning electron microscopy. The developed materials are sensitive to the pH, showing a clear reversible transition in a relatively narrow interval of pH, which is just in the range of physiological conditions. These properties make the materials developed in this study very promising for biomedical applications. Fickian-type diffusion is the mechanism predominant in these systems, except for the composition with a higher concentration of AA, that corresponds to the most desirable kinetical behavior for controlled release (case II-transport mechanism). Furthermore, the results obtained in the mechanical tests are in the range of those reported for typical PMMA bone cements, showing that it is possible to develop partially degradable cements with an adequate mechanical behavior. (C) 1998 Kluwer Academic Publishers.
C1 Univ Minho, Dept Polymer Engn, P-4800 Guimaraes, Portugal.
   INEB Inst Biomed Engn, Biomat Lab, P-4150 Porto, Portugal.
   CSIC, Inst Sci & Technol Polymers, E-28006 Madrid, Spain.
RP Reis, RL (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4800 Guimaraes, Portugal.
EM rgreis@fe.up.pt
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Cunha
   M., Antonio/0000-0003-3860-7732; Vazquez, Blanca/0000-0001-5539-8026
CR Abusafieh A, 1997, J BIOMED MATER RES, V38, P314
   ANDREOPOULOS AG, 1994, CLIN MAT, V15, P691
   BASTIOLI C, 1994, RECYCLE 94 DAVOS GLO
   Bastiolli C., 1995, DEGRADABLE POLYM PRI, P112
   Blanco MD, 1996, BIOMATERIALS, V17, P1061, DOI 10.1016/0142-9612(96)85906-0
   CASTELLANO I, 1994, J APPL POLYM SCI, V54, P577, DOI 10.1002/app.1994.070540508
   CLARKE RL, 1989, BIOMATERIALS, V10, P494, DOI 10.1016/0142-9612(89)90092-6
   DISILVIO L, 1994, BIOMATERIALS, V15, P931, DOI 10.1016/0142-9612(94)90120-1
   Domb AJ, 1996, BIOMATERIALS, V17, P411, DOI 10.1016/0142-9612(96)89657-8
   Elvira C, 1996, J POLYM SCI POL CHEM, V34, P2783, DOI 10.1002/(SICI)1099-0518(19960930)34:13<2783::AID-POLA24>3.0.CO;2-7
   HELLER J, 1996, APPL MAT MED DENT 2, P346
   JANE J, 1995, J MACROMOL SCI PURE, VA32, P751, DOI 10.1080/10601329508010286
   Karadag E, 1996, BIOMATERIALS, V17, P67, DOI 10.1016/0142-9612(96)80757-5
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   Kost J, 1986, HYDROGELS MED PHARM, V3, P95
   LANGER R, 1995, MRS B            AUG, P18
   LAUTENSCHLAGER EP, 1974, J BIOMED MATER RES 1, P185
   Lewis G, 1997, J BIOMED MATER RES, V38, P221, DOI 10.1002/(SICI)1097-4636(199723)38:3<221::AID-JBM6>3.0.CO;2-R
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Liso PA, 1997, BIOMATERIALS, V18, P15, DOI 10.1016/S0142-9612(96)00082-8
   LOHMANN D, 1995, MACROMOL SYMP, V100, P25, DOI 10.1002/masy.19951000105
   MACK EJ, 1988, HYDROGELS MED PHARM, V2, P65
   MIGIARESI C, 1994, BIOMATERIALS, V15, P875
   NETTI PA, 1993, BIOMATERIALS, V14, P1098, DOI 10.1016/0142-9612(93)90211-J
   NORMAN TL, 1995, J BIOMED MATER RES, V29, P495, DOI 10.1002/jbm.820290409
   Ogawa Y, 1997, J BIOMAT SCI-POLYM E, V8, P391, DOI 10.1163/156856297X00173
   Pascual B, 1996, POLYMER, V37, P1005, DOI 10.1016/0032-3861(96)87284-3
   PEPPAS NA, 1988, HYDROGELS MED PHARM, V1, P1
   PEPPAS NA, 1988, MED PHARM PROPERTIES, V3, P109
   PEPPAS NA, 1996, BIOMATERIALS SCI INT, P60
   PEREIRA CS, 1998, IN PRESS NATO ASI SE
   Reis R. L., 1997, MED PLAST BIOMATER, V4, P46
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.0.CO;2-T
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   REIS RL, 1998, IN PRESS ANTEC 98 PL
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   TOPOLESKI LDT, 1993, BIOMATERIALS, V14, P1165, DOI 10.1016/0142-9612(93)90162-U
   Vazquez B, 1997, J BIOMED MATER RES, V34, P129
   Vazquez B, 1997, POLYMER, V38, P4365, DOI 10.1016/S0032-3861(96)01014-2
   WOERLY S, 1993, BIOMATERIALS, V14, P1056, DOI 10.1016/0142-9612(93)90205-G
   Yang JM, 1997, BIOMATERIALS, V18, P1293, DOI 10.1016/S0142-9612(97)00060-4
NR 43
TC 92
Z9 95
U1 0
U2 29
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1998
VL 9
IS 12
BP 825
EP 833
DI 10.1023/A:1008944127971
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 161CK
UT WOS:000078270600030
PM 15348948
DA 2018-10-19
ER

PT J
AU Shen, L
   Shah, AM
   Dahlback, B
   Nelsestuen, GL
AF Shen, L
   Shah, AM
   Dahlback, B
   Nelsestuen, GL
TI Enhancement of human protein C function by site-directed mutagenesis of
   the gamma-carboxyglutamic acid domain
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID K-DEPENDENT PROTEINS; CLOTTING FACTOR-X; PHOSPHOLIPID-VESICLES;
   MEMBRANE-BINDING; ANTICOAGULANT ACTIVITY; BLOOD-COAGULATION; FACTOR VA;
   RESIDUES; PHOSPHATIDYLETHANOLAMINE; PROTHROMBIN
AB This study reports properties of site-directed mutants of human protein C that display enhanced calcium and/or membrane binding properties. Mutants containing the S11G modification all showed increased affinity for membranes at saturating calcium concentration. Ser-ll is unique to human protein C, whereas all other vitamin R-dependent proteins contain glycine, This site is located in a compact region of the protein, close to a suggested membrane contact site. Additional changes of H10Q or S12N resulted in proteins with lower calcium requirement for membrane contact but without further increase in membrane affinity at saturating calcium. Mutations Q32E and N33D did not, by themselves, alter membrane affinity to a significant degree. These mutations were included in other mutant proteins and may contribute somewhat to higher function in these mutants. This family of mutants helped discriminate events that are necessary for protein-membrane binding. These include calcium binding to the free protein and subsequent protein-membrane contact. Depending on conditions of the assay used, the mutants displayed increased activity of the corresponding activated protein C (APC) derivatives, The degree of enhanced activity (up to 10-fold) was dependent on the concentration of phospholipid and quality of phospholipid (+/- phosphatidylethanolamine) used in the assay. This was expected, because APC is active in its membrane-associated form, which can be regulated by changes in either the protein or phospholipid. As expected, the largest impact of the mutants occurred at low phospholipid concentration and in the absence of phosphatidylethanolamine. The anticoagulant activity of all proteins was stimulated by protein S, with the greatest impact on the enhanced mutants. Whereas plasma containing Factor V:R506Q was partially resistant to all forms of APC, the enhanced variants were more active than normal APC, Protein C variants with enhanced function present new reagents for study of coagulation and may offer improved materials for biomedical applications.
C1 Univ Minnesota, Dept Biochem, St Paul, MN 55108 USA.
   Malmo Gen Hosp, Dept Clin Chem, S-20502 Malmo, Sweden.
   Univ Lund, S-20502 Malmo, Sweden.
RP Nelsestuen, GL (reprint author), Univ Minnesota, Dept Biochem, 1479 Gortner Ave, St Paul, MN 55108 USA.
FU NHLBI NIH HHS [HL60859]
CR BAZZI MD, 1992, BIOCHEMISTRY-US, V31, P1125, DOI 10.1021/bi00119a022
   CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033
   CHRISTIANSEN WT, 1995, BIOCHEMISTRY-US, V34, P8082, DOI 10.1021/bi00025a014
   CHRISTIANSEN WT, 1994, BIOCHEMISTRY-US, V33, P14993, DOI 10.1021/bi00254a007
   CHRISTIANSEN WT, 1995, BIOCHEMISTRY-US, V34, P10376, DOI 10.1021/bi00033a008
   DAHLBACK B, 1995, THROMB RES, V77, P1, DOI 10.1016/0049-3848(94)00138-4
   ESMON CT, 1989, J BIOL CHEM, V264, P4743
   FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4882, DOI 10.1021/bi00776a002
   Gale AJ, 1997, PROTEIN SCI, V6, P132
   GILBERT GE, 1995, J BIOL CHEM, V270, P18500, DOI 10.1074/jbc.270.31.18500
   HASHIMOTO T, 1988, Patent No. 1085096
   HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8
   HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048
   Jalbert LR, 1996, BIOCHEMISTRY-US, V35, P7093, DOI 10.1021/bi960290p
   KIM JY, 1994, J BIOL CHEM, V269, P28214
   Larson PJ, 1996, J BIOL CHEM, V271, P3869
   Larson PJ, 1998, BIOCHEMISTRY-US, V37, P5029, DOI 10.1021/bi972428p
   McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160
   NELSESTUEN GL, 1973, P NATL ACAD SCI USA, V70, P3366, DOI 10.1073/pnas.70.12.3366
   NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4164, DOI 10.1021/bi00638a005
   NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4172, DOI 10.1021/bi00638a006
   NELSESTUEN GL, 1978, FED PROC, V37, P2621
   NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004
   PLAGER DA, 1994, BIOCHEMISTRY-US, V33, P13239, DOI 10.1021/bi00249a010
   PLETCHER CH, 1983, J BIOL CHEM, V258, P1086
   RATCLIFFE JV, 1993, J BIOL CHEM, V268, P24339
   Shah AM, 1998, P NATL ACAD SCI USA, V95, P4229, DOI 10.1073/pnas.95.8.4229
   Shen L, 1997, BIOCHEMISTRY-US, V36, P16025, DOI 10.1021/bi971730v
   SMIRNOV MD, 1994, J BIOL CHEM, V269, P816
   Smirnov MD, 1998, J BIOL CHEM, V273, P9031, DOI 10.1074/jbc.273.15.9031
   Smith OP, 1997, LANCET, V350, P1590, DOI 10.1016/S0140-6736(97)06356-3
   SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016
   Thariath A, 1997, BIOCHEM J, V322, P309, DOI 10.1042/bj3220309
   ZHANG L, 1993, J BIOL CHEM, V268, P12040
   ZHANG L, 1994, J BIOL CHEM, V269, P3590
   ZHANG L, 1992, BLOOD, V80, P942
NR 36
TC 18
Z9 18
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 20
PY 1998
VL 273
IS 47
BP 31086
EP 31091
DI 10.1074/jbc.273.47.31086
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 141HG
UT WOS:000077136900036
PM 9813008
OA Bronze
DA 2018-10-19
ER

PT J
AU Suh, JS
   Jeong, EK
   Shin, KH
   Cho, JH
   Na, JB
   Kim, DH
   Han, CD
AF Suh, JS
   Jeong, EK
   Shin, KH
   Cho, JH
   Na, JB
   Kim, DH
   Han, CD
TI Minimizing artifacts caused by metallic implants at MR imaging:
   Experimental and clinical studies
SO AMERICAN JOURNAL OF ROENTGENOLOGY
LA English
DT Article
ID SPIN-ECHO; SUSCEPTIBILITY ARTIFACTS; MAGNETIC-SUSCEPTIBILITY; BIOMEDICAL
   IMPLANTS; REDUCTION; TITANIUM; IMAGES; 1.5-T; FIELD; 2D
AB OBJECTIVE. The purpose of this study was to investigate the effect of metallic implant positioning on MR imaging artifacts, to determine the optimal imaging conditions for minimizing artifacts, and to show the usefulness of artifact-minimizing methods in imaging of the knee.
   MATERIALS AND METHODS. Using MR images of experimental phantoms (titanium alloy and stainless steel screws), we compared the magnitude of metal-induced artifacts for various pulse sequences, different imaging parameters for the fast spin-echo sequence, and different imaging parameters for several incremental angles between the long axis of the screw and the direction of the main magnetic field. In clinical MR imaging of knees with metallic implants (n = 19), we assessed geometric distortion of anatomic structures to compare the influence of different pulse sequences (n = 19), frequency-encoding directions (n = 7), and knee positions (n = 15).
   RESULTS, Titanium alloy screws consistently produced smaller artifacts than did stainless steel screws. In experimental MR studies, artifacts were reduced with fast spin-echo sequences, with a screw orientation as closely parallel to the main magnetic field as possible, and, particularly, with smaller voxels that correlated positively with artifact size (R-2 = .88, p < .01). In clinical MR studies, fast spin-echo MR imaging obscured articular structures less than did spin-echo imaging (8/19 patients), In particular, the anterior-posterior frequency-encoding direction (3/7 patients) and the flexion position of the knee (5/15 patients) were effective in reducing artifacts.
   CONCLUSION. MR artifacts can be minimized by optimally positioning in the magnet subjects with metallic implants and by choosing fast spin-echo sequences with an anterior-posterior frequency-encoding direction and the smallest voxel size.
C1 Yonsei Univ, Coll Med, Dept Diagnost Radiol, Seoul 120752, South Korea.
   Yonsei Univ, Coll Med, Res Inst Radiol Sci, Seoul, South Korea.
   Yonsei Univ, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
RP Suh, JS (reprint author), Yonsei Univ, Coll Med, Dept Diagnost Radiol, 134 Shinchon Dong Seodaemun Gu, Seoul 120752, South Korea.
OI Na, Jaeboem/0000-0002-6182-2986; Suh, jin-suck/0000-0001-9455-9240
CR AUGUSTINY N, 1987, J COMPUT ASSIST TOMO, V11, P678, DOI 10.1097/00004728-198707000-00024
   BAKKER CJG, 1994, MAGN RESON IMAGING, V12, P767, DOI 10.1016/0730-725X(94)92201-2
   BAKKER CJG, 1993, MAGN RESON IMAGING, V11, P539, DOI 10.1016/0730-725X(93)90473-Q
   BAKKER CJG, 1992, MAGN RESON IMAGING, V10, P597, DOI 10.1016/0730-725X(92)90011-N
   Beuf O, 1996, J MAGN RESON SER B, V112, P111, DOI 10.1006/jmrb.1996.0120
   BHAGWANDIEN R, 1992, MAGN RESON IMAGING, V10, P299, DOI 10.1016/0730-725X(92)90489-M
   CHO ZH, 1992, MAGNET RESON MED, V23, P193, DOI 10.1002/mrm.1910230120
   EBRAHEIM NA, 1992, CLIN ORTHOP RELAT R, P194
   EBRAHEIM NA, 1992, CLIN ORTHOP RELAT R, P133
   KIM JK, 1993, RADIOLOGY, V187, P735, DOI 10.1148/radiology.187.3.8497623
   Ludeke K M, 1985, Magn Reson Imaging, V3, P329, DOI 10.1016/0730-725X(85)90397-2
   LYONS CJ, 1989, SPINE, V14, P670, DOI 10.1097/00007632-198907000-00004
   Petersilge CA, 1996, AM J ROENTGENOL, V166, P1213, DOI 10.2214/ajr.166.5.8615272
   POSSE S, 1990, J MAGN RESON, V88, P473, DOI 10.1016/0022-2364(90)90282-E
   RUPP R, 1993, SPINE, V18, P379
   Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854
   SHELLOCK FG, 1992, JMRI-J MAGN RESON IM, V2, P225, DOI 10.1002/jmri.1880020217
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   SIMMONS A, 1994, MAGNET RESON MED, V32, P121, DOI 10.1002/mrm.1910320117
   TARTAGLINO LM, 1994, RADIOLOGY, V190, P565, DOI 10.1148/radiology.190.2.8284417
   VINITSKI S, 1993, JMRI-J MAGN RESON IM, V3, P501, DOI 10.1002/jmri.1880030312
NR 23
TC 120
Z9 121
U1 0
U2 10
PU AMER ROENTGEN RAY SOC
PI RESTON
PA 1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA
SN 0361-803X
J9 AM J ROENTGENOL
JI Am. J. Roentgenol.
PD NOV
PY 1998
VL 171
IS 5
BP 1207
EP 1213
DI 10.2214/ajr.171.5.9798849
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 131MT
UT WOS:000076580400007
PM 9798849
OA Bronze
DA 2018-10-19
ER

PT J
AU Dewhurst, DG
   Williams, AD
AF Dewhurst, DG
   Williams, AD
TI An investigation of the potential for a computer-based tutorial program
   covering the cardiovascular system to replace traditional lectures
SO COMPUTERS & EDUCATION
LA English
DT Article
DE cardiovascular physiology; computer-based learning; evaluation;
   undergraduate teaching
ID UNDERGRADUATE STUDENTS; MICROCOMPUTER SIMULATIONS; INSTRUCTION;
   PHYSIOLOGY; EDUCATION; TEACH
AB Although the availability of computer-based learning materials in the biomedical sciences is increasing there are relatively few studies which compare the effectiveness of this mode of teaching with traditional methods. Here we present the results of a comparative study to evaluate the effectiveness of two interactive CBL programs, covering the cardiovascular system (one covering the heart, one the circulatory system), as an alternative to lectures for first year undergraduate students at a UK university. The study demonstrated: (a) that the CBL program was as effective as lectures in disseminating factual information (knowledge gain from pre- and post-tests were equivalent for both topics (P = 0.28; heart topic; P = 0.03; circulation topic); (b) that students generally preferred lectures to using CBL as a mode of study (attitude scales constructed from a pre- and post-test questionnaire demonstrated a slightly more positive attitude on Delivery; Knowledge; and Time and Place for lectures) and (c) that they recognised both the advantages and disadvantages of CBL as a mode of teaching. The results are discussed in relation to the design of evaluative studies and the future use of CBL programs of this type in undergraduate teaching. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Leeds Metropolitan Univ, Sch Appl Sci, Leeds LS1 3HE, W Yorkshire, England.
RP Dewhurst, DG (reprint author), Leeds Metropolitan Univ, Sch Appl Sci, Caverley St, Leeds LS1 3HE, W Yorkshire, England.
CR ANDERSONHARPER HM, 1988, AM J PHARM EDUC, V52, P259
   CLARK RE, 1985, ECTJ-EDUC COMMUN TEC, V33, P249
   CLARKE KA, 1987, ATLA-ALTERN LAB ANIM, V14, P134
   Coleman I. P., 1994, American Journal of Physiology, V266, pS2
   DEWHURST DG, 1993, BRIT J PHARMACOL, V108, pP238
   DEWHURST DG, 1988, ATLA-ALTERN LAB ANIM, V15, P280
   Dewhurst DG, 1996, BRIT J PHARMACOL, V117, pP345
   DEWHURST DG, 1995, BRIT J PHARMACOL, V115, pP157
   FELDMAN RD, 1989, J CLIN PHARMACOL, V29, P158, DOI 10.1002/j.1552-4604.1989.tb03306.x
   FINCHER RME, 1988, SOUTHERN MED J, V81, P1291, DOI 10.1097/00007611-198810000-00020
   GARRETT TJ, 1987, J MED EDUC, V62, P918
   GARRUD P, 1993, MED EDUC, V27, P474, DOI 10.1111/j.1365-2923.1993.tb00306.x
   HAGLER P, 1987, J COMPUT-BASE INSTR, V14, P84
   HOLLINGSWORTH M, 1991, BRIT J PHARM P S, V102, pP216
   JONES BT, 1992, INT J NURS STUD, V29, P411, DOI 10.1016/0020-7489(92)90018-C
   KULIK JA, 1980, REV EDUC RES, V50, P525, DOI 10.2307/1170294
   Leathard HL, 1995, ASS LEARNING TECHNOL, V3, P118
   LIKERT R, 1932, ARCH PSYCHOL, V140
   MATTHEWS R, 1992, P UYK TOOLB US C 95
   MCCURRIE J, 1992, P CTI CTR MED C, P23
   Modell H. I., 1992, Computers in Life Science Education, V9, P65
   MODELL HI, 1992, AM J PHYSL ADV PHYSL, V261, pS29
   NAPHOLZ L, 1994, COMPUT NURS, V12, P149
NR 23
TC 12
Z9 12
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-1315
J9 COMPUT EDUC
JI Comput. Educ.
PD NOV
PY 1998
VL 31
IS 3
BP 301
EP 317
DI 10.1016/S0360-1315(98)00043-8
PG 17
WC Computer Science, Interdisciplinary Applications; Education &
   Educational Research
SC Computer Science; Education & Educational Research
GA 137XL
UT WOS:000076942300004
DA 2018-10-19
ER

PT J
AU Phillips, TM
   Dickens, BF
AF Phillips, TM
   Dickens, BF
TI Analysis of recombinant cytokines in human body fluids by immunoaffinity
   capillary electrophoresis
SO ELECTROPHORESIS
LA English
DT Article
DE immunoaffinity; capillary electrophoresis; cytokines; body fluids
ID LASER-INDUCED FLUORESCENCE; ALPHA-INTERFERON; INTERLEUKIN-2;
   MICRODIALYSIS; CYCLOSPORINE; IMMUNOASSAY; COMBINATION; PROTEIN; SERUM;
   CELL
AB An immunoaffinity capillary electrophoresis (ICE) system for rapidly quantifying recombinant cytokines in human body fluids has been developed. Cytokines within biological fluids were labeled with a red light emitting fluorochrome and injected into the capillary. Selected cytokines were captured by immobilized antibodies on the internal surface of the capillary, and held while unbound materials were purged. The cytokines were then eluted electrophoretically in acidic buffer. Individual cytokine peaks were detected by on-line laser-induced fluorescence detection coupled to a computerized fiber-optic spectrometer, and analyzed by integration of the eluted peaks. The comparison of the results of ICE to routine assays used for these cytokines demonstrates that ICE provides a fast and accurate procedure for defining these cytokines in complex biological samples. Immunoaffinity separations can be used for any material to which a specific antibody can be raised, making this procedure applicable to a wide range of molecules of biomedical interest.
C1 George Washington Univ, Immunochem Lab, Med Ctr, Washington, DC 20037 USA.
RP Phillips, TM (reprint author), George Washington Univ, Immunochem Lab, Med Ctr, 413 Ross Hall,GWUMC,2300 Eye St NW, Washington, DC 20037 USA.
EM tmphil@erols.com
CR BARBOLLA L, 1993, VOX SANG, V65, P156, DOI 10.1111/j.1423-0410.1993.tb02135.x
   BORDEN EC, 1986, CLIN APPL INTERFERON, P101
   CHEN FTA, 1994, J CHROMATOGR A, V680, P425, DOI 10.1016/0021-9673(94)85139-5
   CHENG YF, 1988, SCIENCE, V242, P562, DOI 10.1126/science.3140381
   DOVICHI NJ, 1993, CAPILLARY ELECTROPHO, P25
   EINHORN S, 1982, INT J CANCER, V30, P167, DOI 10.1002/ijc.2910300207
   Katzmann JA, 1997, ELECTROPHORESIS, V18, P1775, DOI 10.1002/elps.1150181011
   KIRKWOOD JM, 1994, IMMUNOL SER, V61, P239
   Krull IS, 1997, LC GC-MAG SEP SCI, V15, P620
   Legha SS, 1997, SEMIN ONCOL, V24, pS39
   MacTaylor CE, 1997, ELECTROPHORESIS, V18, P2279, DOI 10.1002/elps.1150181218
   MURRAY JL, 1988, J BIOL RESP MODIF, V7, P152
   Oda RP, 1997, ELECTROPHORESIS, V18, P1715, DOI 10.1002/elps.1150181004
   Phillips T M, 1996, Curr Opin Nephrol Hypertens, V5, P380, DOI 10.1097/00041552-199607000-00016
   Phillips TM, 1997, J CHROMATOGR B, V697, P101, DOI 10.1016/S0378-4347(97)00132-1
   PHILLIPS TM, 1994, J CHROMATOGR B, V656, P259, DOI 10.1016/0378-4347(94)00036-0
   PHILLIPS TM, 1994, BIOMED CHROMATOGR, V8, P242, DOI 10.1002/bmc.1130080509
   PINTO DM, 1997, ANAL CHEM, V69, P3016
   Piscitelli SC, 1997, CLIN PHARMACOKINET, V32, P368, DOI 10.2165/00003088-199732050-00003
   QUESADA JR, 1984, NEW ENGL J MED, V310, P15, DOI 10.1056/NEJM198401053100104
   Reali UM, 1998, MELANOMA RES, V8, P77
   SAMUEL CE, 1986, CLIN APPLICATION INT, P1
   SCHULTZ NM, 1993, ANAL CHEM, V65, P3161, DOI 10.1021/ac00069a035
   Staller TD, 1997, ELECTROPHORESIS, V18, P2291, DOI 10.1002/elps.1150181219
   Valaskovic GA, 1996, SCIENCE, V273, P1199, DOI 10.1126/science.273.5279.1199
   WANG TS, 1991, ANAL CHEM, V63, P1372, DOI 10.1021/ac00014a007
   WEIDMANN E, 1991, CANCER IMMUNOL IMMUN, V33, P398, DOI 10.1007/BF01741601
   WHICHER JT, 1990, CLIN CHEM, V36, P1269
   Yang H, 1996, PHARM RES-DORDR, V13, P622, DOI 10.1023/A:1016066609489
NR 29
TC 47
Z9 47
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0173-0835
J9 ELECTROPHORESIS
JI Electrophoresis
PD NOV
PY 1998
VL 19
IS 16-17
BP 2991
EP 2996
DI 10.1002/elps.1150191632
PG 6
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 147MG
UT WOS:000077570900031
PM 9870401
DA 2018-10-19
ER

PT J
AU Jokinen, M
   Patsi, M
   Rahiala, H
   Peltola, T
   Ritala, M
   Rosenholm, JB
AF Jokinen, M
   Patsi, M
   Rahiala, H
   Peltola, T
   Ritala, M
   Rosenholm, JB
TI Influence of sol and surface properties on in vitro bioactivity of
   sol-gel-derived TiO2 and TiO2-SiO2 films deposited by dip-coating method
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE sol-gel films; titania; silica; dip coating; bioactivity
ID GLASS-CRYSTALLINE MATERIALS; THIN-FILMS; STAINLESS-STEEL; BIOMEDICAL
   APPLICATIONS; OPTICAL-PROPERTIES; ACETIC-ACID; IN-VITRO; TITANIUM;
   HYDROLYSIS; SPECTROSCOPY
AB Different sol-gel-derived titania and titania-silica films were prepared and their properties related to in vitro bioactivity. The films were prepared by depositing the sols on the substrate surface using a dip-coating method. The sols were monitored carefully as a function of time, using theological techniques and dynamic light scattering. The topography of the films was characterized using atomic force microscopy, and thicknesses and refractive indexes of the films were evaluated by fitting: transmittance spectra measured in a wave length region of 370-1100 nm with a spectrophotometer. The in vitro bioactivity tests were performed in simulated body fluid. Surface topography was found to be of great importance with respect to the bioactivity of the studied films. (C) 1998 John Wiley & Sons, Inc.
C1 Abo Akad Univ, Dept Chem Phys, FIN-20500 Turku, Finland.
   Turku Univ, Dept Appl Phys, Mat Sci Lab, FIN-200014 Turku, Finland.
   Univ Turku, Inst Dent, FIN-20520 Turku, Finland.
   Univ Helsinki, Dept Chem, Inorgan Chem Lab, FIN-00014 Helsinki, Finland.
RP Jokinen, M (reprint author), Abo Akad Univ, Dept Chem Phys, Porthaninkatu 3-5, FIN-20500 Turku, Finland.
RI Ritala, Mikko/N-7268-2013
OI Ritala, Mikko/0000-0002-6210-2980
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Almeida RM, 1997, J SOL-GEL SCI TECHN, V8, P409
   ANAST M, 1994, THIN SOLID FILMS, V253, P303, DOI 10.1016/0040-6090(94)90338-7
   Andersson OH, 1994, BIOCERAMICS, VOL 7, P67
   ARMELAO L, 1992, J NON-CRYST SOLIDS, V139, P198, DOI 10.1016/S0022-3093(05)80826-9
   Arnal P, 1997, CHEM MATER, V9, P694, DOI 10.1021/cm960337t
   ATIK M, 1995, J APPL ELECTROCHEM, V25, P142, DOI 10.1007/BF00248171
   ATIK M, 1994, J MATER SCI LETT, V13, P1301, DOI 10.1007/BF00270967
   BLUM J, 1996, BIOCERAMICS, V9, P89
   BRINKER CJ, 1981, SOL ENERG MATER, V5, P159, DOI 10.1016/0165-1633(81)90027-7
   BRINKER CJ, 1992, CHEMICAL PROCESSING OF ADVANCED MATERIALS, P395
   BRINKER CJ, 1994, J PHYS III, V4, P1231, DOI 10.1051/jp3:1994198
   BRINKER CJ, 1990, SOL GEL SCI PHYSICS
   CHO SB, 1997, THESIS KYOTO U KYOTO
   DOEUFF S, 1987, J NON-CRYST SOLIDS, V89, P206, DOI 10.1016/S0022-3093(87)80333-2
   Du XM, 1997, J SOL-GEL SCI TECHN, V8, P377, DOI 10.1023/A:1026420009842
   DUNUWILA DD, 1994, CHEM MATER, V6, P1556, DOI 10.1021/cm00045a013
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   ECKERT KL, 1995, BIOCERAMICS, V8, P447
   FLOOD RU, 1995, J PHYS CHEM-US, V99, P8954, DOI 10.1021/j100022a004
   Greenspan DC, 1994, BIOCERAMICS, VOL 7, P55
   GREENSPAN DC, 1995, BIOCERAMICS, V8, P477
   Haddow DB, 1996, J MATER SCI-MATER M, V7, P255, DOI 10.1007/BF00058562
   Haddow DB, 1996, BIOMATERIALS, V17, P501, DOI 10.1016/0142-9612(96)82724-4
   HADDOW DB, 1995, BR CERAM P, V54, P155
   HASHIMOTO T, 1994, B CHEM SOC JPN, V67, P653, DOI 10.1246/bcsj.67.653
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   HENCH LL, 1993, INTRO BIOCERAMICS
   HU LL, 1992, THIN SOLID FILMS, V219, P18, DOI 10.1016/0040-6090(92)90718-Q
   Imai H, 1997, J SOL-GEL SCI TECHN, V8, P365, DOI 10.1007/BF02436866
   KALLALA M, 1993, PHYS REV E, V48, P3692, DOI 10.1103/PhysRevE.48.3692
   KARLSSON KH, 1989, J NON-CRYST SOLIDS, V112, P69, DOI 10.1016/0022-3093(89)90495-X
   Kasgoz A, 1994, J SOL-GEL SCI TECHN, V1, P185, DOI 10.1007/BF00490248
   KATO K, 1994, J MATER SCI, V29, P5911, DOI 10.1007/BF00366875
   KEDDIE JL, 1994, J AM CERAM SOC, V77, P1592, DOI 10.1111/j.1151-2916.1994.tb09761.x
   KIM HM, 1996, BIOCERAMICS, V9, P301
   KIM HM, 1997, THESIS KYOTO U KYOTO
   KIM YJ, 1993, J AM CERAM SOC, V76, P737, DOI 10.1111/j.1151-2916.1993.tb03668.x
   Klein L. C., 1991, THIN FILM PROCESSES, VII, P501
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   Kokubo T, 1994, BIOCERAMICS, VOL 7, P49
   Kokubo T, 1991, BIOCERAMICS, V4, P113
   KOTHARI S, 1995, BRIT CERAM P, V54, P173
   KOZHUKHAROV V, 1992, J MATER SCI LETT, V11, P1206, DOI 10.1007/BF00730286
   KUMAR KNP, 1992, J NON-CRYST SOLIDS, V147, P375, DOI 10.1016/S0022-3093(05)80646-5
   LACZKA M, 1995, J MATER SCI LETT, V14, P1417, DOI 10.1007/BF00462202
   LANGLET M, 1992, THIN SOLID FILMS, V221, P44, DOI 10.1016/0040-6090(92)90794-C
   Li P, 1996, J SOL-GEL SCI TECHN, V7, P27, DOI 10.1007/BF00401880
   LI P, 1993, THESIS LEIDEN U NETH
   Lobel KD, 1996, J SOL-GEL SCI TECHN, V7, P69, DOI 10.1007/BF00401885
   MATSUDA A, 1993, J AM CERAM SOC, V76, P2899, DOI 10.1111/j.1151-2916.1993.tb04034.x
   MELPOLDER SM, 1991, J MATER SCI, V26, P3585, DOI 10.1007/BF00557148
   Miyaji F, 1994, BIOCERAMICS, VOL 7, P119
   MUELLERMAI C, 1994, BIOCERAMICS, V7, P159
   NAGPAL VJ, 1995, J MATER RES, V10, P3068, DOI 10.1557/JMR.1995.3068
   NAKAO A, 1996, BIOCERAMICS, V9, P131
   Nishide T, 1997, THIN SOLID FILMS, V298, P89, DOI 10.1016/S0040-6090(96)09140-7
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHTSUKI C, 1994, BIOCERAMICS, V7, P73
   Ohya Y, 1996, J AM CERAM SOC, V79, P825, DOI 10.1111/j.1151-2916.1996.tb08512.x
   Orignac X, 1997, J SOL-GEL SCI TECHN, V8, P243, DOI 10.1007/BF02436847
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   PAPOUTSI D, 1995, LANGMUIR, V11, P1, DOI 10.1021/la00001a001
   PAPOUTSI D, 1994, LANGMUIR, V10, P1684, DOI 10.1021/la00018a014
   Pena J, 1997, J BIOMED MATER RES, V35, P129, DOI 10.1002/(SICI)1097-4636(199704)35:1<129::AID-JBM13>3.0.CO;2-E
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   PEREIRA MM, 1994, J MATER SYNTH PROCES, V2, P189
   PERESDURAND S, 1995, COLLOID SURFACE A, V98, P251, DOI 10.1016/0927-7757(94)03123-H
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Sakka S, 1994, J SOL-GEL SCI TECHN, V2, P451, DOI 10.1007/BF00486289
   Stathatos E, 1997, J SOL-GEL SCI TECHN, V10, P83, DOI 10.1023/A:1018340423513
   STEPANEK P, 1993, MONOGRAPHS PHYSICS C, V49, P177
   SYMS RRA, 1994, J NON-CRYST SOLIDS, V170, P223, DOI 10.1016/0022-3093(94)90051-5
   TAKAHASHI Y, 1988, J MATER SCI, V23, P2259, DOI 10.1007/BF01115798
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TORRUELLAS WE, 1991, APPL PHYS LETT, V58, P1128, DOI 10.1063/1.104392
   Turyna B, 1996, BIOMATERIALS, V17, P1379, DOI 10.1016/0142-9612(96)87278-4
   XU QY, 1994, J AM CERAM SOC, V77, P1939, DOI 10.1111/j.1151-2916.1994.tb07074.x
   YAN WQ, 1996, BIOCERAMICS, V9, P305
   YAN YG, 1995, CHEM MATER, V7, P2007, DOI 10.1021/cm00059a006
   Yan YG, 1996, J AM CERAM SOC, V79, P1061, DOI 10.1111/j.1151-2916.1996.tb08548.x
   YLILAMMI M, 1993, THIN SOLID FILMS, V232, P56, DOI 10.1016/0040-6090(93)90762-E
   YOLDAS BE, 1986, J MATER SCI, V21, P1087, DOI 10.1007/BF01117399
   ZAHARESCU M, 1993, J NON-CRYST SOLIDS, V160, P162, DOI 10.1016/0022-3093(93)90296-A
   ZANONI R, 1994, SURF INTERFACE ANAL, V22, P376, DOI 10.1002/sia.740220182
NR 86
TC 118
Z9 124
U1 1
U2 33
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 1998
VL 42
IS 2
BP 295
EP 302
DI 10.1002/(SICI)1097-4636(199811)42:2<295::AID-JBM15>3.0.CO;2-I
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122FC
UT WOS:000076060400015
PM 9773826
DA 2018-10-19
ER

PT J
AU Tredget, EE
   Shankowsky, HA
   Groeneveld, A
   Burrell, R
AF Tredget, EE
   Shankowsky, HA
   Groeneveld, A
   Burrell, R
TI A matched-pair, randomized study evaluating the efficacy and safety of
   Acticoat silver-coated dressing for the treatment of burn wounds
SO JOURNAL OF BURN CARE & REHABILITATION
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA; QUANTITATIVE MICROBIOLOGY; EPIDEMIOLOGY;
   INFECTIONS; OUTBREAK; INJURY; AGENTS
AB A new silver-coating technology was developed to prevent wound adhesion, limit nosocomial infection, control bacterial growth, and facilitate burn wound care through a silver-coated dressing material. For the purposes of this article, Acticoat (Westaim Biomedical Inc, Fort Saskatchawan, Alberta, Canada) silver-coated dressing was used. After in vitro and in vivo studies, a randomized, prospective clinical study was performed to assess the efficacy and ease of use of Acticoat dressing as compared with the efficacy and ease of our institution's standard burn wound care. Thirty burn patients with symmetric wounds were randomized to be treated with either 0.5% silver nitrate solution or Acticoat silver-coated dressing. The dressing was evaluated on the basis of overall patient comfort, ease of use for the wound care provider, and level of antimicrobial effectiveness. Wound pain was rated by the patient using a visual analog scale during dressing removal, application, and 2 hours after application. Ease of use was rated by the nurse providing wound care. Antimicrobial effectiveness was evaluated by quantitative burn wound biopsies performed before and at the end of treatment. Patients found dressing removal less painful with Acticoat than with silver nitrate, but they found the pain to be comparable during application and 2 hours after application. According to the nurses, there was no statistically significant difference in the ease of use. The frequency of burn wound sepsis (> 10(5) organisms per gram of tissue) was less in Acticoat-treated wounds than in those treated with silver nitrate (5 vs 16). Secondary bacteremias arising from infected burn wounds were also less frequent with Acticoat than with silver nitrate-treated wounds (1 vs 5). Acticoat dressing offers a new form of dressing for the burn wound, but it requires further investigation with greater numbers of patients in a larger number of centers and in different phases of burn wound care.
C1 Univ Alberta Hosp, Dept Surg, Edmonton, AB T6G 2B7, Canada.
   Westaim Biomed Inc, Ft Saskatchewan, AB, Canada.
RP Tredget, EE (reprint author), Univ Alberta Hosp, Dept Surg, 2D3-81 WMHSC,8440-112 St, Edmonton, AB T6G 2B7, Canada.
OI Burrell, Robert/0000-0003-0210-8536
CR BALLIN JC, 1984, JAMA-J AM MED ASSOC, V230, P1184
   BOOSALIS MG, 1987, SURGERY, V101, P40
   BRIDGES K, 1979, BRIT MED J, V1, P446, DOI 10.1136/bmj.1.6161.446
   BUCHANAN K, 1986, J CLIN MICROBIOL, V23, P258
   BURRELL RE, 1997, IN VITRO IN VIVO ANT
   DEITCH EA, 1983, ANTIMICROB AGENTS CH, V23, P356, DOI 10.1128/AAC.23.3.356
   DEVIA A, 1996, P AM BURN ASS, V28, pA141
   FARMER JJ, 1982, J CLIN MICROBIOL, V16, P266
   FOX CL, 1968, ARCH SURG-CHICAGO, V96, P184
   GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3
   GREENHALGH D, 1997, P AM BURN ASS, V18, pA67
   Heggers John, 1996, P98
   Iwasaki S, 1997, AM J KIDNEY DIS, V30, P287, DOI 10.1016/S0272-6386(97)90067-6
   KAYE ET, 1995, INFECT DIS CLIN N AM, V9, P547
   Li XZ, 1997, J BACTERIOL, V179, P6127, DOI 10.1128/jb.179.19.6127-6132.1997
   LOEBL EC, 1974, AM J CLIN PATHOL, V61, P20
   Marvin Janet A., 1996, P529
   MAYHALL CG, 1979, J INFECT DIS, V139, P166, DOI 10.1093/infdis/139.2.166
   MCMANUS AT, 1987, ARCH SURG-CHICAGO, V122, P74
   MCMANUS AT, 1985, EUR J CLIN MICROBIOL, V4, P219, DOI 10.1007/BF02013601
   MONAFO WW, 1978, SURG CLIN N AM, V58, P1157
   MOYER CA, 1965, ARCH SURG-CHICAGO, V90, P812
   PRECHT RJ, 1997, J BURN CARE REHABIL, V18, pS178
   PRUITT BA, 1984, AM J MED, V76, P146, DOI 10.1016/0002-9343(84)90334-6
   PRUITT BA, 1992, WORLD J SURG, V16, P57, DOI 10.1007/BF02067116
   RICHARD P, 1994, J INFECT DIS, V170, P377, DOI 10.1093/infdis/170.2.377
   ROSENQUIST MD, 1992, P AM BURN ASS, V24, pA177
   Russell AD, 1994, PROGR MED CHEM, V31, P351, DOI DOI 10.1016/S0079-6468(08)70024-9
   Shankowsky Heather A., 1994, Journal of Burn Care and Rehabilitation, V15, P143, DOI 10.1097/00004630-199403000-00007
   Sheridan R. L., 1997, Journal of Burn Care and Rehabilitation, V18, P139, DOI 10.1097/00004630-199703000-00008
   SLAWSON RM, 1992, PLASMID, V27, P72, DOI 10.1016/0147-619X(92)90008-X
   Steer JA, 1996, BURNS, V22, P173, DOI 10.1016/0305-4179(95)00116-6
   Thomson Philip D., 1990, Journal of Burn Care and Rehabilitation, V11, P151, DOI 10.1097/00004630-199003000-00012
   TREDGET EE, 1992, CLIN INFECT DIS, V15, P941, DOI 10.1093/clind/15.6.941
   TREDGET EE, 1990, ANN SURG, V212, P720, DOI 10.1097/00000658-199012000-00011
   WALKER HL, 1968, J TRAUM, V8, P1049, DOI 10.1097/00005373-196811000-00006
   WAN AT, 1991, CLIN CHEM, V37, P1683
   WARD RS, 1995, PHYS THER, V75, P526, DOI 10.1093/ptj/75.6.526
   WINTER GD, 1963, NATURE, V197, P91, DOI 10.1038/197091b0
NR 39
TC 125
Z9 132
U1 0
U2 11
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0273-8481
J9 J BURN CARE REHABIL
JI J. Burn Care Rehabil.
PD NOV-DEC
PY 1998
VL 19
IS 6
BP 531
EP 537
DI 10.1097/00004630-199811000-00013
PG 7
WC Emergency Medicine; Rehabilitation; Surgery
SC Emergency Medicine; Rehabilitation; Surgery
GA 144HP
UT WOS:000077308700011
PM 9848045
DA 2018-10-19
ER

PT J
AU Kobayashi, E
   Doi, H
   Yoneyama, T
   Hamanaka, H
   Gibson, IR
   Best, SM
   Shelton, JC
   Bonfield, W
AF Kobayashi, E
   Doi, H
   Yoneyama, T
   Hamanaka, H
   Gibson, IR
   Best, SM
   Shelton, JC
   Bonfield, W
TI Influence of aging heat treatment on mechanical properties of biomedical
   Ti-Zr based ternary alloys containing niobium
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB Titanium-zirconium based alloys containing a small amount of niobium were investigated in order to evaluate their possible use as biomedical materials. Zirconium, which belongs to the IVa group, is known to have good corrosion resistance and biocompatibility similar to titanium. As the titanium-zirconium system shows a complete solid solution, a wide variation of alloy design is available and large quantities of solid-solution hardening must be possible. Niobium, having a beta-phase stabilizing effect, was chosen as a ternary element in order to control desirably the microstructure. There have been no reports which suggest its harm to a living body. The alloys containing 2% or 3% niobium showed the highest hardness value after aging heat treatment at 773 K. In contrast to this, no alteration of hardness was seen in specimens aged at 1073 K. Through conventional X-ray diffractometry and in situ X-ray analysis using a hot stage, beta-phase precipitation in the a matrix was identified. From the above results, it is concluded that alloys containing 2%-3% niobium are hopeful candidates for new kinds of biomedical alloys, when they are heat treated under suitable conditions. (C) 1998 Kluwer Academic Publishers.
C1 Tokyo Med & Dent Univ, Inst Med & Dent Engn, Chiyoda Ku, Tokyo 101, Japan.
   Univ London Queen Mary & Westfield Coll, Interdisciplinary Res Ctr Biomed Mat, London E1 4NS, England.
RP Kobayashi, E (reprint author), Tokyo Med & Dent Univ, Inst Med & Dent Engn, Chiyoda Ku, Kanda Surugadai, Tokyo 101, Japan.
RI Gibson, Iain/B-1753-2010
OI Gibson, Iain/0000-0002-3393-1464
CR *ASTM, 1992, 129592 ASTM F
   COLLINGS EW, 1984, PHYSICAL METALLURGY, P69
   DUWEZ P, 1952, J I MET, V80, P525
   ETCHU Y, 1992, J JPN SOC DENT MAT D, V11, P270
   HANSEN M, 1951, T AM I MIN MET ENG, V191, P881
   INGRAM AG, 1962, J LESS-COMMON MET, V4, P217
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   KOBAYASHI E, 1995, J J DENT MAT, V14, P321
   Kobayashi E., 1995, J JPN SOC DENT MAT D, V14, P406
   KOBAYASHI E, 1996, 5 WORLD BIOM C PROGR, V2, P481
   Murray J. L., 1987, PHASE DIAGRAMS BINAR, P340
   OGAWA A, 1994, CURRENT ADV MAT PROC, V7, P654
   OKAZAKI Y, 1993, J JPN SOC BIOMATER, V11, P160
   OKUNO O, 1985, J JPN SOC DENT MAT D, V4, P408
   RUDMAN PS, 1964, ACTA METALL MATER, V12, P1381, DOI 10.1016/0001-6160(64)90126-9
   TSUCHIYA T, 1998, J TISS ENG, V4, P197
   YAMAMOTO A, 1996, J JAPANESE SOC BIOMA, V14, P167
   Yamamoto Y., 1989, Shimadzu Review, V46, P63
   YONEYAMA T, 1994, J JPN DENT MAT DEVIC, V13, P213
NR 19
TC 45
Z9 46
U1 1
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 1998
VL 9
IS 11
BP 625
EP 630
DI 10.1023/A:1008927407556
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 170YR
UT WOS:000078835300003
PM 15348680
DA 2018-10-19
ER

PT J
AU Bergveld, P
   Hendrikse, J
   Olthuis, W
AF Bergveld, P
   Hendrikse, J
   Olthuis, W
TI Theory and application of the material work function for chemical
   sensors based on the field effect principle
SO MEASUREMENT SCIENCE AND TECHNOLOGY
LA English
DT Article
DE redox potential; work function; field effect transistor (FET);
   environmental monitoring; process control; biomedical measurements
ID GATE
AB This paper gives first of all the definition of the work function of an electronic as well as an ionic conductor. PET-type gas sensors known from the literature are considered in view of this basic theory and the parameter of the work function which is responsible for the sensing properties is noticed. This appears not always to be possible for the various types of gas sensors, in this case the gas FET, the SGFET and the IGFET. In contrast to this ambiguity, the sensing parameters of the recently developed (MOSFET)-M-E, meant for application in an electrolyte, can clearly be identified. As an example an oxygen sensor based on the developed (MOSFET)-M-E is described.
C1 Univ Twente, MESA Res Inst, NL-7500 AE Enschede, Netherlands.
RP Bergveld, P (reprint author), Univ Twente, MESA Res Inst, Box 217, NL-7500 AE Enschede, Netherlands.
CR BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688
   BLACKBURN GF, 1983, APPL PHYS LETT, V43, P700, DOI 10.1063/1.94536
   Hendrikse J, 1998, SENSOR ACTUAT B-CHEM, V47, P1, DOI 10.1016/S0925-4005(98)00047-1
   HENDRIKSE J, 1998, IN PRESS SENSORS A B
   JANATA J, 1991, ANAL CHEM, V63, P2546, DOI 10.1021/ac00022a003
   JOSOWICZ M, 1986, ANAL CHEM, V58, P514, DOI 10.1021/ac00294a003
   KREY D, 1982, SENSOR ACTUATOR, V3, P169
   Liess M, 1996, THIN SOLID FILMS, V286, P252, DOI 10.1016/S0040-6090(95)08233-6
   LUNDSTROEM I, 1975, APPL PHYS LETT, V26, P55, DOI 10.1063/1.88053
   Papez V, 1997, SENSOR ACTUAT B-CHEM, V40, P143, DOI 10.1016/S0925-4005(97)80253-5
NR 10
TC 38
Z9 38
U1 2
U2 12
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-0233
EI 1361-6501
J9 MEAS SCI TECHNOL
JI Meas. Sci. Technol.
PD NOV
PY 1998
VL 9
IS 11
BP 1801
EP 1808
DI 10.1088/0957-0233/9/11/003
PG 8
WC Engineering, Multidisciplinary; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 138MH
UT WOS:000076975300003
DA 2018-10-19
ER

PT J
AU Birungi, H
AF Birungi, H
TI Injections and self-help: Risk and trust in Ugandan health care
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE injection practices; health systems; Uganda; domestication;
   personalization; therapeutic relations; risk perceptions and trust
AB The paper draws upon research material collected during a one year long ethnographic study on injection use and a WHO funded Injection Practices Research Project, which were both carried out during 1992/1993. The paper examines the changing trends in injection use and practices in the context of the Ugandan health system and in relation to popular views about risk and trust. Generally, people mistrust injections provided at government health institutions and prefer to gain access to injections as symbolic tokens of healing through personal contacts and private ownership of injecting equipment. It now appears that the use of this Western biomedical technology is widespread at all levels of the health care system; needles, syringes and injectables are readily available in homes for use by Families and untrained providers. In other words, the injection technology has been domesticated and personalized. The Giddens (1990) framework [Giddens, A. (1990) Consequences of Modernity. Stanford University Press, California.] concerning modernity, trust and risk is applied to understand the motivations behind these processes. The basic argument is that the weakening of state institutions of health care has been accompanied by a loss of trust in the treatment offered there. In addition, the massive anti-AIDS education campaigns which have warned people against the dangers of sharing unsterilized needles, have reinforced existing mistrust in public health facilities and induced families to seek care from people they know and using injecting equipment over which they have personal control. The paper concludes that changing the current injection practices in Uganda will necessitate a change in the organization of public health institutions. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Makerere Univ, Makarere Inst Social Res, Kampala, Uganda.
RP Birungi, H (reprint author), Makerere Univ, Makarere Inst Social Res, POB 16022, Kampala, Uganda.
CR *ACP, 1985, AV AIDS STD AIDS CON
   ADOME OR, 1996, POPULAR PILLS COMMUN
   BANUGIRE FR, 1987, CRISIS DEV ISSUES UG
   BANUGIRE FR, 1989, IMF WORLD BANK AFRIC, V2
   Birungi H, 1994, Essent Drugs Monit, P11
   BIRUNGI H, 1993, IMPACT INJECTIONS DA, P93
   BIRUNGI H, 1994, MED MEANINGS CONTEXT, P125
   BIRUNGI H, 1994, WHODAP9418
   BLUHM LH, 1989, INT J CONT SOCIOLOGY, V26, P133
   Dodge Cole P., 1985, CRISIS UGANDA BREAKD
   Giddens A, 1990, CONSEQUENCES MODERNI
   GLENTHOJ J, 1991, SURVEY PPF PRESCRIPT
   *HLTH POL REV COMM, 1987, REP REC HLTH POL REV
   Kafuko Jessica M., 1996, RATIONAL DRUG USE RU
   KLEINMANN A., 1980, PATIENTS HEALERS CON
   LEWIS JD, 1985, SOC FORCES, V63, P967, DOI 10.2307/2578601
   MBURU FM, 1984, MANAGING ESSENTIAL D
   *MIH HLTH, 1992, HLTH BUDG
   *MIN HLTH MOH, 1991, LIV AIDS COMM
   OBBO C, 1991, CHANGING UGANDA, P98
   *UEDMP, 1990, STAT IMPR PRESCR DRU
   *UEDMP, 1992, PRIM HLTH CAR SUPP U
   *UNICEF, 1989, CHILDR WOM UG SIT AN
   *USAID, 1980, AIDSODPDCC0198
   van der Geest S., 1989, MED ANTHROPOL Q, V3, P345, DOI DOI 10.1525/MAQ.1989.3A.02A00030
   *WHO, 1991, WHODAP918
   *WHO, 1992, WHODAP922
   WHYTE SR, 1992, CULT MED PSYCHIAT, V16, P163, DOI 10.1007/BF00117017
   WHYTE SR, 1994, MED MEANINGS CONTEXT, P137
   Whyte SR, 1991, CHANGING UGANDA DILE, P130
   World Health Organization (WHO), 1989, WHO AIDS SER
   1993, UGANDA GAZETTE  1203, V86
NR 32
TC 60
Z9 61
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD NOV
PY 1998
VL 47
IS 10
BP 1455
EP 1462
DI 10.1016/S0277-9536(98)00194-4
PG 8
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 130ZA
UT WOS:000076549500006
PM 9823041
DA 2018-10-19
ER

PT J
AU Nenoff, TM
   Thoma, SG
   Provencio, P
   Maxwell, RS
AF Nenoff, TM
   Thoma, SG
   Provencio, P
   Maxwell, RS
TI Novel zinc phosphate phases formed with chiral d-glucosamine molecules
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID ZEOLITE; ZINCOPHOSPHATE; SIEVES; FRAMEWORKS
AB Chiral syntheses and separations of both intermediate and final compounds are currently extremely important areas of research, especially for the chemical, pharmaceutical, agrochemical, and biomedical industries. We are investigating the synthesis of new inorganic porous materials for enantiomeric selectivity. We present a study of inorganic zinc phosphate crystalline phases templated with the chiral molecule d-glucosamine hydrochloride. The crystallization of these phases is highly dependent on reaction time, temperature, and stoichiometry. Resultant new phases include a mesoporous phase and a layered phase. Data indicates that the walls of the new 32 Angstrom sized mesoporous phase are crystalline and ordered. Characterization techniques applied include powder X-ray diffraction, TEM, and P-31 MAS NMR.
C1 Sandia Natl Labs, Albuquerque, NM 87185 USA.
   Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
RP Nenoff, TM (reprint author), Sandia Natl Labs, POB 5800,MS-0710, Albuquerque, NM 87185 USA.
CR Anderson MT, 1998, CHEM MATER, V10, P311, DOI 10.1021/cm9704600
   Bruce DA, 1996, J SOLID STATE CHEM, V125, P228, DOI 10.1006/jssc.1996.0290
   CORMA A, 1991, J CHEM SOC CHEM COMM, P1253, DOI 10.1039/c39910001253
   DAVIS ME, 1992, CHEM MATER, V4, P756, DOI 10.1021/cm00022a005
   DAVIS ME, 1993, ACCOUNTS CHEM RES, V26, P111, DOI 10.1021/ar00027a006
   DAVIS ME, 1995, SYNTHESIS MICROPOROU
   Feng PY, 1997, J AM CHEM SOC, V119, P2497, DOI 10.1021/ja9634841
   FIROUZI A, 1995, SCIENCE, V267, P1138, DOI 10.1126/science.7855591
   GIBSON HW, 1979, LIQ CRYST, P99
   GIER TE, 1992, SYNTHESIS OF MICROPOROUS MATERIALS, VOL 1, P407
   HARRISON WTA, 1991, CHEM MATER, V3, P27, DOI 10.1021/cm00013a012
   Harrison WTA, 1996, CHEM MATER, V8, P145, DOI 10.1021/cm950300t
   HARRISON WTA, 1992, J MATER CHEM, V2, P1127, DOI 10.1039/jm9920201127
   Harrison WTA, 1997, CHEM MATER, V9, P1837, DOI 10.1021/cm9701264
   HARRISON WTA, 1996, J CHEM SOC CHEM COMM, P2771
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Kubota Y, 1996, MICROPOROUS MATER, V6, P213, DOI 10.1016/0927-6513(96)00002-8
   MONNIER A, 1993, SCIENCE, V261, P1299, DOI 10.1126/science.261.5126.1299
   NENOFF TM, 1991, J AM CHEM SOC, V113, P378, DOI 10.1021/ja00001a065
   Nenoff TM, 1996, ENVIRON SCI TECHNOL, V30, P3630, DOI 10.1021/es9605331
   NEWSAM JM, 1988, P ROY SOC LOND A MAT, V420, P375, DOI 10.1098/rspa.1988.0131
   OGUNWUMI SB, 1997, J CHEM SOC CHEM COMM, P901
   Ryoo R, 1996, J PHYS CHEM-US, V100, P17718, DOI 10.1021/jp9620835
   Stucky GD, 1997, STUD SURF SCI CATAL, V105, P3
   TOMBO GMR, 1991, ANGEW CHEM INT EDIT, V30, P1193, DOI 10.1002/anie.199111933
   VARTULI JC, 1994, CHEM MATER, V6, P2070, DOI 10.1021/cm00047a029
   1993, CHEM ENG NEWS, V71, P38
   1994, CHEM ENG NEWS, V72, P38
NR 28
TC 25
Z9 26
U1 0
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD OCT
PY 1998
VL 10
IS 10
BP 3077
EP 3080
DI 10.1021/cm980191t
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 132YF
UT WOS:000076658700050
DA 2018-10-19
ER

PT J
AU Bacon, JR
   Crain, JS
   Van Vaeck, L
   Williams, JG
AF Bacon, JR
   Crain, JS
   Van Vaeck, L
   Williams, JG
TI Atomic spectrometry update - Atomic mass spectrometry
SO JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY
LA English
DT Review
ID INDUCTIVELY-COUPLED PLASMA; TRACE-ELEMENT ANALYSIS; PERFORMANCE
   LIQUID-CHROMATOGRAPHY; CURRENT GLOW-DISCHARGE; RARE-EARTH-ELEMENTS;
   NITROGEN ISOTOPE ANALYSIS; 3-DIMENSIONAL DENSITY PROFILES; RAY
   PHOTOELECTRON-SPECTROSCOPY; ION-EXCHANGE CHROMATOGRAPHY; SOLID-PHASE
   MICROEXTRACTION
AB The format of this year's Update follows that used last year(1) with some minor changes in the section headings, Although an attempt is made to consider all relevant refereed papers, conference abstracts, reports, book chapters and patents for inclusion, this review does not attempt to be comprehensive in its coverage, Critical selection is based an criteria which have been applied more strictly this year than in previous years in order to focus more sharply on the mast significant developments reported during the period (approximately corresponding to 1997) covered by this Update, The prime consideration is that the reports should present advances in instrumentation and methodology or improved understanding of the fundamental professes involved in the MS process. As a general rule, conference abstracts are not included because they rarely provide sufficient information to judge whether or not they meet the criteria, We consider it better to wait for full details to appear in a refereed journal. A similar policy applies to those papers in a language other than English and unlikely to reach a wide readership,
   Routine applications of atomic MS are not covered in this Update and readers are referred to the Updates on Industrial Analysis: Metals, Chemicals and Advanced Materials,(2) Environmental Analysis(3) and Clinical and Biological: Materials, Food and Beverages.(4) An additional review that can be recommended is that of Moens(5) on applications of MS in the analysis of biological materials. Comprehensive evaluations of MS techniques for the analysis of solid samples have been reported by Gijbels and Bogaerts(6) and Becker et al.(7)
   Papers included in this Update must be on atomic spectrometry but some areas of study introduce problems in defining atomic and molecular studies, One of the major drives in recent years has been to develop methods for speciation studies, in particular using ESMS, GC-MS or ICP-MS, The study, for example, of organic arsenic species by ICP-MS involves MS of the atomic ions but in ESMS and GC-MS the molecular species are usually detected. In general, studies of 'exotic' nuclei far from stability are excluded but the determination of radioactive elements in 'real' samples can be included. Very few measurements in SIRMS are of atomic species, yet the object of measuring natural isotopic composition is to study or use a fundamental atomic property, Such studies are included but the use of enriched spikes in tracer studies are excluded because the focus of the study is not on the atomic properties of the tracer element.
   The strong progress being made in most areas of atomic MS is evident from the different sections of this Update. The various trends have been identified in each section and range from the continued improvements in sample preparation for TIMS analysis of remarkable sensitivity and precision to the demand for simpler and cheaper AMS instrumentation so that applications to biomedical research can be fully exploited. Much attention continues to be given to sample preparation and introduction for ICP-MS, in particular for speciation analysis, yet relatively little effort is being given to instrumental development. Although SIMS and SNMS are widely used techniques, fundamental problems remain for quantification and work continues on developing methodologies to optimize analyses.
C1 Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland.
   Union Carbide Corp, Ctr Tech, S Charleston, WV 25303 USA.
   Univ Instelling Antwerp, Dept Chem, Micro & Trace Anal Ctr, B-2610 Antwerp, Belgium.
   Univ London Imperial Coll Sci Technol & Med, TH Huxley Sch Environm Earth Sci & Engn, NERC ICP MS Facil, Ascot SL5 7TE, Berks, England.
RP Bacon, JR (reprint author), Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland.
EM j.bacon@mluri.sari.ac.uk
CR Adriaens A, 1997, INT J MASS SPECTROM, V164, P107, DOI 10.1016/S0168-1176(97)00053-0
   Aguilera R, 1996, J CHROMATOGR B, V687, P43, DOI 10.1016/S0378-4347(96)00016-3
   Akatsuka K, 1998, J ANAL ATOM SPECTROM, V13, P271, DOI 10.1039/a708837j
   Allen LA, 1997, ANAL CHEM, V69, P2384, DOI 10.1021/ac9610624
   Alvarez DE, 1997, NUCL INSTRUM METH B, V123, P39, DOI 10.1016/S0168-583X(96)00412-0
   Amakawa H, 1996, CHEM GEOL, V131, P183, DOI 10.1016/0009-2541(96)00066-6
   Anbar AD, 1997, ANAL CHEM, V69, P2444, DOI 10.1021/ac961129n
   Baba T, 1997, NUCL INSTRUM METH B, V123, P183, DOI 10.1016/S0168-583X(96)00784-7
   Bacon JR, 1997, J ANAL ATOM SPECTROM, V12, pR407
   BACON JR, 1996, MASS SPECTROM SOILS, P31
   Barker J, 1997, NUCL INSTRUM METH B, V123, P275, DOI 10.1016/S0168-583X(96)00704-5
   Barnett DA, 1997, J ANAL ATOM SPECTROM, V12, P497, DOI 10.1039/a603643k
   Barnowski C, 1997, J ANAL ATOM SPECTROM, V12, P1155, DOI 10.1039/a702120h
   Barrie A., 1996, MASS SPECTROMETRY SO, P1
   Barth S, 1997, CHEM GEOL, V143, P255, DOI 10.1016/S0009-2541(97)00107-1
   Barth S, 1997, FRESEN J ANAL CHEM, V358, P854, DOI 10.1007/s002160050522
   Bayon MM, 1998, J ANAL ATOM SPECTROM, V13, P277, DOI 10.1039/a707496d
   Beary ES, 1997, ANAL CHEM, V69, P758, DOI 10.1021/ac9606923
   Beauchemin D, 1998, J ANAL ATOM SPECTROM, V13, P1, DOI 10.1039/a703781c
   Beauchemin D, 1997, ANAL CHEM, V69, P3183, DOI 10.1021/ac970273l
   Becker JS, 1997, MIKROCHIM ACTA, V125, P153, DOI 10.1007/BF01246179
   Becker JS, 1997, INT J MASS SPECTROM, V164, P81, DOI 10.1016/S0168-1176(97)00021-9
   Bedard LP, 1997, CHEM GEOL, V138, P1, DOI 10.1016/S0009-2541(96)00169-6
   Begley IS, 1997, J ANAL ATOM SPECTROM, V12, P395, DOI 10.1039/a605078f
   Begley IS, 1997, ANAL CHEM, V69, P1530, DOI 10.1021/ac960935r
   Belkin MA, 1997, J ANAL ATOM SPECTROM, V12, P1255, DOI 10.1039/a700266a
   Belyaev BN, 1997, RADIOCHEMISTRY+, V39, P59
   Bennett J, 1997, SURF INTERFACE ANAL, V25, P454
   BENNINGHOVEN A, 1997, Patent No. 0471958
   BETTINELLI M, 1997, SPEC PUBL R SOC CHEM, V202, P152
   Bhattacharjee S, 1997, NUCL INSTRUM METH B, V129, P123, DOI 10.1016/S0168-583X(97)00145-6
   Birck JL, 1997, GEOSTANDARD NEWSLETT, V21, P19, DOI 10.1111/j.1751-908X.1997.tb00528.x
   BlichertToft J, 1997, CONTRIB MINERAL PETR, V127, P248, DOI 10.1007/s004100050278
   Bock W, 1997, FRESEN J ANAL CHEM, V358, P300, DOI 10.1007/s002160050412
   Bogaerts A, 1997, J ANAL ATOM SPECTROM, V12, P751, DOI 10.1039/a608262i
   Bogaerts A, 1997, J AM SOC MASS SPECTR, V8, P1021, DOI 10.1016/S1044-0305(97)00120-7
   Bogaerts A, 1997, SPECTROCHIM ACTA B, V52, P765, DOI 10.1016/S0584-8547(97)82786-3
   Bogaerts A, 1997, SPECTROCHIM ACTA B, V52, P205, DOI 10.1016/S0584-8547(96)01577-7
   Bogaerts A, 1997, SPECTROCHIM ACTA B, V52, P219, DOI 10.1016/S0584-8547(96)01578-9
   Bogaerts A, 1997, ANAL CHEM, V69, pA719, DOI 10.1021/ac971868j
   Boulyga SF, 1997, RADIAT MEAS, V28, P349, DOI 10.1016/S1350-4487(97)00098-X
   Breuer U, 1997, FRESEN J ANAL CHEM, V358, P47, DOI 10.1007/s002160050342
   Briche CSJ, 1997, ANAL CHEM, V69, P791, DOI 10.1021/ac9607368
   Brown TA, 1997, NUCL INSTRUM METH B, V123, P208, DOI 10.1016/S0168-583X(96)00676-3
   Brunner C, 1997, FRESEN J ANAL CHEM, V358, P233, DOI 10.1007/s002160050392
   Brunner C, 1997, MIKROCHIM ACTA, V125, P69, DOI 10.1007/BF01246164
   Burgoyne TW, 1997, ANAL CHEM, V69, P485, DOI 10.1021/ac960673t
   Burgoyne TW, 1997, J AM SOC MASS SPECTR, V8, P307, DOI 10.1016/S1044-0305(96)00290-5
   Burgoyne TW, 1997, J ANAL ATOM SPECTROM, V12, P1149, DOI 10.1039/a607861c
   Bushaw BA, 1997, SPECTROCHIM ACTA B, V52, P1839, DOI 10.1016/S0584-8547(97)00066-9
   Byrne JP, 1997, SPECTROCHIM ACTA B, V52, P1575, DOI 10.1016/S0584-8547(97)00064-5
   Byrne JP, 1997, CAN J ANAL SCI SPECT, V42, P95
   Caimi RJ, 1997, J CHROMATOGR A, V757, P307, DOI 10.1016/S0021-9673(96)00694-2
   Challa VR, 1998, J NEUROPATH EXP NEUR, V57, P140, DOI 10.1097/00005072-199802000-00005
   Chang CC, 1997, ANAL CHIM ACTA, V353, P173, DOI 10.1016/S0003-2670(97)87775-6
   Chen M, 1997, SPECTROCHIM ACTA B, V52, P1161
   Chen MB, 1997, NUCL INSTRUM METH B, V123, P102, DOI 10.1016/S0168-583X(96)00739-2
   Chen YB, 1997, SPECTROCHIM ACTA B, V52, P231, DOI 10.1016/S0584-8547(96)01576-5
   Chen YW, 1997, CHEM GEOL, V137, P195, DOI 10.1016/S0009-2541(96)00163-5
   Chew A, 1997, J ANAL ATOM SPECTROM, V12, P1101, DOI 10.1039/a700086c
   Chi PH, 1997, J VAC SCI TECHNOL A, V15, P2565, DOI 10.1116/1.580772
   Chisholm W, 1997, ANAL CHIM ACTA, V347, P351, DOI 10.1016/S0003-2670(97)00176-1
   Chu DP, 1997, PHYS REV B, V56, P15167, DOI 10.1103/PhysRevB.56.15167
   Chu PK, 1998, MATER CHEM PHYS, V52, P60, DOI 10.1016/S0254-0584(98)80007-2
   Clemens D, 1997, FRESEN J ANAL CHEM, V358, P122, DOI 10.1007/s002160050361
   Coedo AG, 1997, ISIJ INT, V37, P878, DOI 10.2355/isijinternational.37.878
   Collon P, 1997, NUCL INSTRUM METH B, V123, P122, DOI 10.1016/S0168-583X(96)00674-X
   CORDT HH, 1994, ISOTOPENPRAXIS, V30, P259, DOI 10.1080/00211919408046742
   Cornett RJ, 1997, NUCL INSTRUM METH B, V123, P249, DOI 10.1016/S0168-583X(96)00731-8
   Corso TN, 1997, P NATL ACAD SCI USA, V94, P1049, DOI 10.1073/pnas.94.4.1049
   CREWS HM, 1997, 30 C SPECTR INT CSI
   Crighton JS, 1997, J ANAL ATOM SPECTROM, V12, p509R
   Currie LA, 1997, NUCL INSTRUM METH B, V123, P475, DOI 10.1016/S0168-583X(96)00783-5
   Datar SA, 1997, NUCL INSTRUM METH B, V123, P571, DOI 10.1016/S0168-583X(96)00703-3
   Datta BP, 1997, SPECTROCHIM ACTA B, V52, P471, DOI 10.1016/S0584-8547(96)01603-5
   Dautraix S, 1996, J CHROMATOGR A, V756, P203, DOI 10.1016/S0021-9673(96)00640-1
   Day DA, 1997, MICROCHEM J, V55, P208, DOI 10.1006/mchj.1996.1415
   De Bievre P, 1997, FRESEN J ANAL CHEM, V359, P523, DOI 10.1007/s002160050625
   Dean JR, 1998, J ANAL ATOM SPECTROM, V13, p1R, DOI 10.1039/a704305h
   deBoer JLM, 1997, SPECTROCHIM ACTA B, V52, P389, DOI 10.1016/S0584-8547(96)01604-7
   DelaCalleGuntinas MB, 1997, J ANAL ATOM SPECTROM, V12, P1041
   DeLaeter JR, 1996, MASS SPECTROM REV, V15, P261, DOI 10.1002/(SICI)1098-2787(1996)15:4<261::AID-MAS3>3.0.CO;2-G
   DeNeve K, 1997, J RADIOANAL NUCL CH, V221, P79, DOI 10.1007/BF02035246
   Denniston RF, 1997, GEOCHIM COSMOCHIM AC, V61, P1803, DOI 10.1016/S0016-7037(97)00049-5
   DeNollin S, 1997, PATHOL RES PRACT, V193, P313
   Dias RF, 1997, ANAL CHEM, V69, P944, DOI 10.1021/ac960635+
   Diemer J, 1997, FRESEN J ANAL CHEM, V357, P74, DOI 10.1007/s002160050114
   Ding GJ, 1997, NUCL INSTRUM METH B, V123, P424, DOI 10.1016/S0168-583X(96)00609-X
   Ding GJ, 1997, NUCL INSTRUM METH B, V123, P414, DOI 10.1016/S0168-583X(96)00746-X
   Dixon P, 1997, ANAL CHEM, V69, P1692, DOI 10.1021/ac961159q
   DONAHUE DJ, 1990, RADIOCARBON, V32, P135
   Donahue DJ, 1997, NUCL INSTRUM METH B, V123, P51, DOI 10.1016/S0168-583X(96)00729-X
   Du ZH, 1997, J AM SOC MASS SPECTR, V8, P1230, DOI 10.1016/S1044-0305(97)00220-1
   Duan YX, 1997, INT J MASS SPECTROM, V161, P27, DOI 10.1016/S0168-1176(96)04434-5
   Dummler W, 1997, INT J MASS SPECTROM, V164, P155, DOI 10.1016/S0168-1176(97)00054-2
   Eiden GC, 1997, RAPID COMMUN MASS SP, V11, P37, DOI 10.1002/(SICI)1097-0231(19970115)11:1<37::AID-RCM815>3.0.CO;2-C
   Eiler JM, 1997, CHEM GEOL, V138, P221, DOI 10.1016/S0009-2541(97)00015-6
   Elmore D, 1997, NUCL INSTRUM METH B, V123, P69, DOI 10.1016/S0168-583X(96)00621-0
   Elokhin VA, 1997, J ANAL CHEM+, V52, P1030
   Ender RM, 1997, NUCL INSTRUM METH B, V123, P575, DOI 10.1016/S0168-583X(96)00416-8
   Erdmann N, 1997, FRESEN J ANAL CHEM, V359, P378, DOI 10.1007/s002160050591
   Farquhar GD, 1997, RAPID COMMUN MASS SP, V11, P1554, DOI 10.1002/(SICI)1097-0231(199709)11:14<1554::AID-RCM980>3.0.CO;2-I
   Faude F, 1997, FRESEN J ANAL CHEM, V358, P67, DOI 10.1007/s002160050347
   Faulhaber S, 1997, J AGR FOOD CHEM, V45, P4719, DOI 10.1021/jf970534s
   Faulhaber S, 1997, J AGR FOOD CHEM, V45, P2579, DOI 10.1021/jf9607728
   Feldmann J, 1997, J ANAL ATOM SPECTROM, V12, P1069, DOI 10.1039/a701264k
   Fiala A, 1997, SPECTROCHIM ACTA B, V52, P531, DOI 10.1016/S0584-8547(96)01617-5
   Fifield LK, 1997, NUCL INSTRUM METH B, V123, P400, DOI 10.1016/S0168-583X(96)00428-4
   Fifield LK, 1996, NUCL INSTRUM METH A, V382, P292, DOI 10.1016/S0168-9002(96)00394-4
   Figg D, 1997, APPL SPECTROSC, V51, P1185, DOI 10.1366/0003702971941728
   Fitzgerald N, 1998, J ANAL ATOM SPECTROM, V13, P13, DOI 10.1039/a703491a
   Fletcher IR, 1997, INT J MASS SPECTROM, V163, P1, DOI 10.1016/S0168-1176(96)04540-5
   Fonseca RW, 1997, APPL SPECTROSC, V51, P1800, DOI 10.1366/0003702971939866
   Fourre C, 1997, J ANAL ATOM SPECTROM, V12, P1105, DOI 10.1039/a700777i
   Fragu P, 1997, MICROSC RES TECHNIQ, V36, P296, DOI 10.1002/(SICI)1097-0029(19970215)36:4<296::AID-JEMT7>3.0.CO;2-K
   Frei R, 1997, GEOCHIM COSMOCHIM AC, V61, P393, DOI 10.1016/S0016-7037(96)00343-2
   Friedrich M, 1997, NUCL INSTRUM METH B, V123, P410, DOI 10.1016/S0168-583X(96)00404-1
   Funaya N, 1997, NUCL INSTRUM METH B, V123, P174, DOI 10.1016/S0168-583X(96)00740-9
   Gale NH, 1996, ANAL CHIM ACTA, V332, P15, DOI 10.1016/0003-2670(96)00207-3
   Gard E, 1997, ANAL CHEM, V69, P4083, DOI 10.1021/ac970540n
   Gartenmann P, 1997, NUCL INSTRUM METH B, V123, P132, DOI 10.1016/S0168-583X(96)00403-X
   Gastel M, 1997, FRESEN J ANAL CHEM, V358, P207, DOI 10.1007/s002160050385
   Gautier B, 1996, SURF INTERFACE ANAL, V24, P733, DOI 10.1002/(SICI)1096-9918(199610)24:11<733::AID-SIA173>3.3.CO;2-N
   Gehre M, 1996, ANAL CHEM, V68, P4414, DOI 10.1021/ac9606766
   Gehre M, 1996, ISOT ENVIRON HEALT S, V32, P335, DOI 10.1080/10256019608234026
   Gelbart WZ, 1997, NUCL INSTRUM METH B, V123, P550, DOI 10.1016/S0168-583X(96)00616-7
   Gelinas Y, 1998, ANAL CHEM, V70, P1021, DOI 10.1021/ac970974i
   Gerardi C, 1997, SURF INTERFACE ANAL, V25, P397, DOI 10.1002/(SICI)1096-9918(199706)25:6<397::AID-SIA248>3.3.CO;2-0
   Gerstenberger H, 1997, CHEM GEOL, V136, P309, DOI 10.1016/S0009-2541(96)00033-2
   Gibson JK, 1997, ANAL CHEM, V69, P111, DOI 10.1021/ac960805i
   Gijbels R, 1997, FRESEN J ANAL CHEM, V359, P326, DOI 10.1007/s002160050581
   GIUSSANI A, 1997, ISOT ENVIRON HEALT S, V33, P207
   Gnaser H, 1997, J VAC SCI TECHNOL A, V15, P445, DOI 10.1116/1.580872
   Gnaser H, 1997, FRESEN J ANAL CHEM, V358, P171, DOI 10.1007/s002160050375
   Gnaser H, 1997, APPL SURF SCI, V120, P220, DOI 10.1016/S0169-4332(97)00250-X
   Gnaser H, 1997, SURF INTERFACE ANAL, V25, P737, DOI 10.1002/(SICI)1096-9918(199709)25:10<737::AID-SIA294>3.0.CO;2-M
   Gobel M, 1997, FRESEN J ANAL CHEM, V358, P131, DOI 10.1007/s002160050363
   Goessler W, 1997, J CHROMATOGR A, V789, P233, DOI 10.1016/S0021-9673(97)00874-1
   Golser R, 1997, NUCL INSTRUM METH B, V123, P170, DOI 10.1016/S0168-583X(96)00781-1
   Goltz DM, 1997, J ANAL ATOM SPECTROM, V12, P1175, DOI 10.1039/a703588h
   Gong B, 1997, INT J COAL GEOL, V34, P53, DOI 10.1016/S0166-5162(97)00006-2
   Gong B, 1997, FUEL PROCESS TECHNOL, V50, P69, DOI 10.1016/S0378-3820(96)01057-0
   Gorecki T, 1997, ANAL COMMUN, V34, P275, DOI 10.1039/a704264g
   Goschnick J, 1997, FRESEN J ANAL CHEM, V358, P159, DOI 10.1007/s002160050371
   Gottdang A, 1997, NUCL INSTRUM METH B, V123, P163, DOI 10.1016/S0168-583X(96)00410-7
   Grabowski KS, 1997, NUCL INSTRUM METH B, V123, P566, DOI 10.1016/S0168-583X(96)00627-1
   Graham IJ, 1997, NUCL INSTRUM METH B, V123, P307, DOI 10.1016/S0168-583X(96)00737-9
   Griesser M, 1997, FRESEN J ANAL CHEM, V358, P293, DOI 10.1007/s002160050410
   Grignon N, 1997, J MICROSC-OXFORD, V186, P51, DOI 10.1046/j.1365-2818.1997.1850747.x
   Groenewold GS, 1998, ANAL CHEM, V70, P534, DOI 10.1021/ac9705172
   Grunke K, 1997, SPECTROCHIM ACTA B, V52, P1545, DOI 10.1016/S0584-8547(97)00051-7
   Grunke K, 1997, FRESEN J ANAL CHEM, V359, P465, DOI 10.1007/s002160050613
   GudmandHoyer L, 1996, SURF INTERFACE ANAL, V24, P856, DOI 10.1002/(SICI)1096-9918(199612)24:13<856::AID-SIA194>3.0.CO;2-1
   Gunther D, 1997, FRESEN J ANAL CHEM, V359, P390, DOI 10.1007/s002160050594
   Gunther D, 1997, J ANAL ATOM SPECTROM, V12, P939, DOI 10.1039/a701423f
   Gwizdala AB, 1997, J ANAL ATOM SPECTROM, V12, P503, DOI 10.1039/a606413b
   Hang W, 1997, ANAL CHEM, V69, P4957, DOI 10.1021/ac9710386
   Harris D, 1997, COMMUN SOIL SCI PLAN, V28, P747, DOI 10.1080/00103629709369827
   Harrison WW, 1997, J ANAL ATOM SPECTROM, V12, P891, DOI 10.1039/a701641g
   Heinemeier J, 1997, NUCL INSTRUM METH B, V123, P487, DOI 10.1016/S0168-583X(96)00705-7
   Henry BM, 1997, APPL SURF SCI, V108, P485, DOI 10.1016/S0169-4332(96)00581-8
   Herner SB, 1996, J VAC SCI TECHNOL B, V14, P3593, DOI 10.1116/1.588731
   Hintelmann H, 1997, FRESEN J ANAL CHEM, V358, P378, DOI 10.1007/s002160050433
   Hintelmann H, 1997, FRESEN J ANAL CHEM, V358, P363, DOI 10.1007/s002160050431
   Hirata T, 1997, J ANAL ATOM SPECTROM, V12, P1337, DOI 10.1039/a704169a
   Hobson KA, 1997, CAN J ZOOL, V75, P1720, DOI 10.1139/z97-799
   Holmden C, 1997, GEOCHIM COSMOCHIM AC, V61, P2253, DOI 10.1016/S0016-7037(97)00057-4
   Holt BD, 1997, ANAL CHEM, V69, P2727, DOI 10.1021/ac961096b
   Hoshi T, 1997, APPL SURF SCI, V121, P146, DOI 10.1016/S0169-4332(97)00275-4
   HOTCHKIS MAC, 1995, P AUST C NUCL TECH A, P29
   Houk RS, 1997, J ANAL ATOM SPECTROM, V12, P1139, DOI 10.1039/a607579g
   Huang CC, 1997, ANAL CHEM, V69, P3930, DOI 10.1021/ac970284e
   Huang LJ, 1997, J VAC SCI TECHNOL A, V15, P2196, DOI 10.1116/1.580533
   Hughes DM, 1997, SPECTROCHIM ACTA B, V52, P517, DOI 10.1016/S0584-8547(96)01595-9
   Hughey BJ, 1997, NUCL INSTRUM METH B, V123, P153, DOI 10.1016/S0168-583X(96)00420-X
   Hughey BJ, 1997, NUCL INSTRUM METH B, V123, P186, DOI 10.1016/S0168-583X(96)00408-9
   Hwang TJ, 1997, J ANAL ATOM SPECTROM, V12, P579, DOI 10.1039/a607469c
   Hwang TJ, 1997, ANALYST, V122, P233, DOI 10.1039/a606577e
   Iltgen K, 1997, J VAC SCI TECHNOL A, V15, P460, DOI 10.1116/1.580874
   Im HS, 1997, APPL SURF SCI, V108, P197, DOI 10.1016/S0169-4332(96)00602-2
   Ingelbrecht C, 1997, NUCL INSTRUM METH A, V397, P30, DOI 10.1016/S0168-9002(97)00582-2
   Jager R, 1997, INT J MASS SPECTROM, V171, P183, DOI 10.1016/S0168-1176(97)00119-5
   Jager R, 1997, MIKROCHIM ACTA, V125, P41, DOI 10.1007/BF01246160
   Jager R, 1997, FRESEN J ANAL CHEM, V358, P214, DOI 10.1007/s002160050387
   Jamin E, 1997, PLANT CELL ENVIRON, V20, P589, DOI 10.1111/j.1365-3040.1997.00099.x
   Jiang SS, 1997, NUCL INSTRUM METH B, V123, P405, DOI 10.1016/S0168-583X(96)00747-1
   Jiang ZX, 1997, SURF INTERFACE ANAL, V25, P285, DOI 10.1002/(SICI)1096-9918(199704)25:4<285::AID-SIA235>3.0.CO;2-0
   Jiang ZX, 1997, SURF INTERFACE ANAL, V25, P817, DOI 10.1002/(SICI)1096-9918(199709)25:10<817::AID-SIA305>3.0.CO;2-O
   Joannon S, 1997, SPECTROCHIM ACTA B, V52, P1783, DOI 10.1016/S0584-8547(97)00072-4
   Jochum KP, 1997, FRESEN J ANAL CHEM, V359, P385, DOI 10.1007/s002160050593
   JOCHUM KP, 1997, SPECTROSCOPY EUROPE, V9, P22
   Johnson RR, 1997, NUCL INSTRUM METH B, V123, P283, DOI 10.1016/S0168-583X(96)00617-9
   Jones OR, 1997, RAPID COMMUN MASS SP, V11, P179, DOI 10.1002/(SICI)1097-0231(19970131)11:2<179::AID-RCM757>3.0.CO;2-#
   Karhu JA, 1997, ANAL CHEM, V69, P4728, DOI 10.1021/ac9704467
   Kaviladze MS, 1997, INT J MASS SPECTROM, V161, P87, DOI 10.1016/S0168-1176(96)04432-1
   Kilius LR, 1997, NUCL INSTRUM METH B, V123, P5, DOI 10.1016/S0168-583X(96)00715-X
   Kilius LR, 1997, NUCL INSTRUM METH B, V123, P10, DOI 10.1016/S0168-583X(96)00421-1
   King SJ, 1997, ANALYST, V122, P1049, DOI 10.1039/a702002c
   Kirner DL, 1997, NUCL INSTRUM METH B, V123, P214, DOI 10.1016/S0168-583X(96)00752-5
   Kitagawa H, 1997, NUCL INSTRUM METH B, V123, P218, DOI 10.1016/S0168-583X(96)00622-2
   Klotzli US, 1997, ANALYST, V122, P1239, DOI 10.1039/a704114d
   Knie K, 1997, NUCL INSTRUM METH B, V123, P128, DOI 10.1016/S0168-583X(96)00753-7
   Knies DL, 1997, NUCL INSTRUM METH B, V123, P589, DOI 10.1016/S0168-583X(96)00626-X
   Konarski P., 1996, Electron Technology, V29, P277
   Koslowsky VT, 1997, NUCL INSTRUM METH B, V123, P226, DOI 10.1016/S0168-583X(96)00604-0
   Koslowsky VT, 1997, NUCL INSTRUM METH B, V123, P203, DOI 10.1016/S0168-583X(96)00628-3
   Koslowsky VT, 1997, NUCL INSTRUM METH B, V123, P144, DOI 10.1016/S0168-583X(96)00741-0
   Koziet J, 1997, J MASS SPECTROM, V32, P103, DOI 10.1002/(SICI)1096-9888(199701)32:1<103::AID-JMS463>3.0.CO;2-9
   Kretschmer W, 1997, NUCL INSTRUM METH B, V123, P455, DOI 10.1016/S0168-583X(96)00603-9
   Kretschmer W, 1997, NUCL INSTRUM METH B, V123, P93, DOI 10.1016/S0168-583X(96)00610-6
   Krimke R, 1997, J PHYS D APPL PHYS, V30, P1676, DOI 10.1088/0022-3727/30/11/017
   Kume H, 1997, NUCL INSTRUM METH B, V123, P31, DOI 10.1016/S0168-583X(96)00632-5
   Kutschera W, 1997, NUCL INSTRUM METH B, V123, P47, DOI 10.1016/S0168-583X(96)00782-3
   Kutschera W, 1997, NUCL INSTRUM METH B, V123, P594, DOI 10.1016/S0168-583X(96)00738-0
   LaBelle RD, 1996, PHYS REV A, V54, P4461, DOI 10.1103/PhysRevA.54.4461
   Lancin M, 1997, INT J MASS SPECTROM, V163, P69, DOI 10.1016/S0168-1176(97)00002-5
   LAWSON EM, 1995, P AUST C NUCL TECH A, P130
   Leadley SR, 1997, BIOMATERIALS, V18, P311, DOI 10.1016/S0142-9612(96)00134-2
   LeClercq M, 1997, NUCL INSTRUM METH B, V123, P443, DOI 10.1016/S0168-583X(96)00721-5
   Ledingham KWD, 1997, INT J MASS SPECTROM, V163, P149, DOI 10.1016/S0168-1176(97)00015-3
   Lefevre O, 1996, MIKROCHIM ACTA, P399
   Leloup C, 1997, J ANAL ATOM SPECTROM, V12, P945, DOI 10.1039/a701450c
   Lhuissier F, 1997, BOT ACTA, V110, P378, DOI 10.1111/j.1438-8677.1997.tb00653.x
   LI GQ, 1995, Patent No. 434931
   Litherland AE, 1997, NUCL INSTRUM METH B, V123, P18, DOI 10.1016/S0168-583X(96)00736-7
   Liu BH, 1996, CHINESE SCI BULL, V41, P790
   Liu DY, 1997, ANAL CHEM, V69, P1808, DOI 10.1021/ac9612988
   Liu YZ, 1997, INT J MASS SPECTROM, V171, P73, DOI 10.1016/S0168-1176(97)00114-6
   Liu YZ, 1997, ANAL COMMUN, V34, P171, DOI 10.1039/a701957b
   Lodding AR, 1997, MIKROCHIM ACTA, V125, P317, DOI 10.1007/BF01246205
   Lofthouse SD, 1997, J ANAL ATOM SPECTROM, V12, P1373, DOI 10.1039/a705047j
   Luo XZ, 1997, INT J MASS SPECTROM, V171, P105, DOI 10.1016/S0168-1176(97)00136-5
   Lyon IC, 1998, INT J MASS SPECTROM, V172, P115, DOI 10.1016/S0168-1176(97)00143-2
   Macko SA, 1997, ANAL CHEM, V69, P926, DOI 10.1021/ac960956l
   Mahoney PP, 1997, APPL SPECTROSC, V51, P1464, DOI 10.1366/0003702971939235
   Mahoney PP, 1997, APPL SPECTROSC, V51, pA16, DOI 10.1366/0003702971938759
   MARCHANTEGAYON JM, 1997, SPEC PUBL R SOC CHEM, V202, P85
   Marchetti AA, 1997, NUCL INSTRUM METH B, V123, P230, DOI 10.1016/S0168-583X(96)00611-8
   Marchetti AA, 1997, NUCL INSTRUM METH B, V123, P352, DOI 10.1016/S0168-583X(96)00633-7
   Markey R, 1998, TALANTA, V45, P935, DOI 10.1016/S0039-9140(97)00198-7
   Martin CJ, 1997, ENVIRON GEOL, V32, P107, DOI 10.1007/s002540050199
   Mason RS, 1997, PHYS REV E, V55, P7462, DOI 10.1103/PhysRevE.55.7462
   MASSONET S, 1997, AIP C P 2, V392, P795
   Masters BJ, 1997, ANAL COMMUN, V34, P237, DOI 10.1039/a704726f
   McAninch JE, 1997, NUCL INSTRUM METH B, V123, P137, DOI 10.1016/S0168-583X(96)00411-9
   McIntyre RS, 1997, J ANAL ATOM SPECTROM, V12, P547, DOI 10.1039/a607270d
   McLean JA, 1998, ANAL CHEM, V70, P1012, DOI 10.1021/ac9708553
   MeierAugenstein W, 1997, LC GC-MAG SEP SCI, V15, P244
   Metges CC, 1997, ANAL BIOCHEM, V247, P158, DOI 10.1006/abio.1997.2037
   Milgram KE, 1997, ANAL CHEM, V69, P3714, DOI 10.1021/ac970126n
   MIN H, 1997, ANAL CHEM, V69, P1135
   Minnich MG, 1998, J ANAL ATOM SPECTROM, V13, P167, DOI 10.1039/a704274d
   Moens L, 1997, FRESEN J ANAL CHEM, V359, P309, DOI 10.1007/s002160050579
   Moini M, 1997, J MASS SPECTROM, V32, P420, DOI 10.1002/(SICI)1096-9888(199704)32:4<420::AID-JMS495>3.0.CO;2-N
   Montero P, 1998, ANAL CHIM ACTA, V358, P227, DOI 10.1016/S0003-2670(97)00599-0
   Montgomery NJ, 1997, J ALLOY COMPD, V251, P355, DOI 10.1016/S0925-8388(96)02810-1
   Mootz T, 1997, INT J MASS SPECTROM, V163, P197, DOI 10.1016/S0168-1176(97)00012-8
   Mootz T, 1996, INT J MASS SPECTROM, V156, P1, DOI 10.1016/S0168-1176(96)04410-2
   Mora J, 1998, J ANAL ATOM SPECTROM, V13, P175, DOI 10.1039/a706833f
   Mosandl A, 1997, ANALUSIS, V25, pM31
   Mous DJW, 1997, NUCL INSTRUM METH B, V123, P159, DOI 10.1016/S0168-583X(96)00423-5
   Mulvaney RL, 1997, J AUTOM CHEM, V19, P165, DOI 10.1155/S1463924697000175
   Murphy DM, 1997, J GEOPHYS RES-ATMOS, V102, P6341, DOI 10.1029/96JD00858
   Nadeau MJ, 1997, NUCL INSTRUM METH B, V123, P22, DOI 10.1016/S0168-583X(96)00730-6
   Nagashima Y, 1996, NUCL INSTRUM METH A, V382, P321, DOI 10.1016/S0168-9002(96)00628-6
   Nam SH, 1998, APPL SPECTROSC, V52, P161, DOI 10.1366/0003702981942500
   NAULET N, 1996, HERBA POL, V42, P221
   Nicolussi GK, 1997, ANAL CHEM, V69, P1140, DOI 10.1021/ac960871k
   Nihei Y, 1997, J TRACE MICROPROBE T, V15, P593
   NIHEI Y, 1997, J SURF ANAL, V3, P178
   Nonose N, 1996, SPECTROCHIM ACTA B, V51, P1551, DOI 10.1016/0584-8547(96)01517-0
   Novak SW, 1997, J VAC SCI TECHNOL A, V15, P1724, DOI 10.1116/1.580927
   Nusko R, 1997, FRESEN J ANAL CHEM, V357, P1050, DOI 10.1007/s002160050303
   Ochs M, 1997, NUCL INSTRUM METH B, V123, P235, DOI 10.1016/S0168-583X(96)00680-5
   OConnor G, 1997, J ANAL ATOM SPECTROM, V12, P1263, DOI 10.1039/a703733c
   Ohata M, 1998, J ANAL ATOM SPECTROM, V13, P447, DOI 10.1039/a707117e
   Oi T, 1997, ANAL CHIM ACTA, V340, P221, DOI 10.1016/S0003-2670(96)00519-3
   Okuno M, 1997, NUCL INSTRUM METH B, V123, P470, DOI 10.1016/S0168-583X(96)00614-3
   Olesik JW, 1997, APPL SPECTROSC, V51, pA158, DOI 10.1366/0003702971940792
   Olesik JW, 1997, J ANAL ATOM SPECTROM, V12, P507, DOI 10.1039/a606420e
   OLESIK JW, 1997, SPEC PUBL R SOC CHEM, V202, P1
   Olivas RM, 1998, TALANTA, V45, P1023, DOI 10.1016/S0039-9140(97)00172-0
   Parent M, 1997, TALANTA, V44, P221, DOI 10.1016/S0039-9140(96)02037-1
   Parks CC, 1997, J VAC SCI TECHNOL A, V15, P1328, DOI 10.1116/1.580584
   Passler G, 1997, KERNTECHNIK, V62, P85
   PATTERSON K, 1997, 24 FACSS PROV RI US
   Paul M, 1997, NUCL INSTRUM METH B, V123, P394, DOI 10.1016/S0168-583X(96)00708-2
   Perry M, 1997, NUCL INSTRUM METH B, V123, P178, DOI 10.1016/S0168-583X(96)00719-7
   Persson P, 1998, REV SCI INSTRUM, V69, P1188, DOI 10.1063/1.1148751
   Pin C, 1997, ANAL CHIM ACTA, V339, P79, DOI 10.1016/S0003-2670(96)00499-0
   Potts PJ, 1997, ANALYST, V122, P1179, DOI 10.1039/a704856d
   Pozebon D, 1998, J ANAL ATOM SPECTROM, V13, P363, DOI 10.1039/a707849h
   Pozebon D, 1998, J ANAL ATOM SPECTROM, V13, P7, DOI 10.1039/a706837i
   Pretty JR, 1997, ANAL CHEM, V69, P3544, DOI 10.1021/ac970360d
   Priller A, 1997, NUCL INSTRUM METH B, V123, P193, DOI 10.1016/S0168-583X(96)00780-X
   Prudon G, 1997, THIN SOLID FILMS, V294, P54, DOI 10.1016/S0040-6090(96)09330-3
   Purser KH, 1997, NUCL INSTRUM METH B, V123, P167, DOI 10.1016/S0168-583X(96)00673-8
   Qi HP, 1997, INT J MASS SPECTROM, V171, P263, DOI 10.1016/S0168-1176(97)00125-0
   Quetel CR, 1997, SPECTROCHIM ACTA B, V52, P177, DOI 10.1016/S0584-8547(96)01587-X
   Ramsey CB, 1997, NUCL INSTRUM METH B, V123, P539, DOI 10.1016/S0168-583X(96)00612-X
   Raynor MW, 1997, J ANAL ATOM SPECTROM, V12, P1057
   Rebane JA, 1997, J MATER CHEM, V7, P2085, DOI 10.1039/a702798b
   Rebane JA, 1996, FRESEN J ANAL CHEM, V356, P484
   Rebane JA, 1997, THIN SOLID FILMS, V302, P140, DOI 10.1016/S0040-6090(96)09585-5
   Reger N, 1997, FRESEN J ANAL CHEM, V358, P143, DOI 10.1007/s002160050366
   Riedel M, 1997, RAPID COMMUN MASS SP, V11, P667
   Roberts ML, 1997, NUCL INSTRUM METH B, V123, P57, DOI 10.1016/S0168-583X(96)00426-0
   Roberts ML, 1997, NUCL INSTRUM METH B, V123, P367, DOI 10.1016/S0168-583X(96)00407-7
   Rocholl ABE, 1997, GEOSTANDARD NEWSLETT, V21, P101, DOI 10.1111/j.1751-908X.1997.tb00537.x
   RUSSO R, 1997, 24 FACSS PROV RI US
   Sah RN, 1997, MICROCHEM J, V56, P285, DOI 10.1006/mchj.1997.1428
   Sah RN, 1997, PLANT SOIL, V193, P15, DOI 10.1023/A:1004251606504
   Sahoo SK, 1997, CHEM GEOL, V141, P117, DOI 10.1016/S0009-2541(97)00024-7
   Saito M, 1997, ANAL CHIM ACTA, V355, P129, DOI 10.1016/S0003-2670(97)00506-0
   Saito M, 1997, FRESEN J ANAL CHEM, V357, P18, DOI 10.1007/s002160050103
   Salem AA, 1996, J MATER SCI-MATER EL, V7, P373
   Sands DG, 1997, GEOSTANDARD NEWSLETT, V21, P77, DOI 10.1111/j.1751-908X.1997.tb00533.x
   Sansone FJ, 1997, ANAL CHEM, V69, P40, DOI 10.1021/ac960241i
   Santos GM, 1997, NUCL INSTRUM METH B, V123, P34, DOI 10.1016/S0168-583X(96)00425-9
   Santosa SJ, 1997, ENVIRON MONIT ASSESS, V44, P515, DOI 10.1023/A:1005782500773
   Santosa SJ, 1997, FRESEN J ANAL CHEM, V357, P1122, DOI 10.1007/s002160050317
   Santucci S, 1997, J VAC SCI TECHNOL A, V15, P905, DOI 10.1116/1.580730
   Saprykin AI, 1997, FRESEN J ANAL CHEM, V359, P449, DOI 10.1007/s002160050609
   Saprykin AI, 1997, FRESEN J ANAL CHEM, V358, P145, DOI 10.1007/s002160050367
   Saverwyns S, 1997, J ANAL ATOM SPECTROM, V12, P1047, DOI 10.1039/a701554b
   Scerbo R, 1997, QUIM ANAL, V16, P87
   SCHMIDT G, 1997, ISOT ENVIRON HEALT S, V33, P235
   Schmitz R, 1997, FRESEN J ANAL CHEM, V358, P42, DOI 10.1007/s002160050341
   Schneider RJ, 1997, NUCL INSTRUM METH B, V123, P546, DOI 10.1016/S0168-583X(96)00607-6
   Schoeller DA, 1997, J MASS SPECTROM, V32, P1332, DOI 10.1002/(SICI)1096-9888(199712)32:12<1332::AID-JMS598>3.0.CO;2-E
   Scholz J, 1997, J ALLOY COMPD, V253, P459, DOI 10.1016/S0925-8388(96)03000-9
   Seah MP, 1997, J VAC SCI TECHNOL A, V15, P485, DOI 10.1116/1.580878
   Seki S, 1997, SURF INTERFACE ANAL, V25, P155
   Serrano JJ, 1997, VACUUM, V48, P643, DOI 10.1016/S0042-207X(97)00077-8
   Seufert HM, 1997, FRESEN J ANAL CHEM, V359, P454, DOI 10.1007/s002160050610
   Shackleton CHL, 1997, STEROIDS, V62, P379, DOI 10.1016/S0039-128X(96)00253-X
   Sharma P, 1997, NUCL INSTRUM METH B, V123, P347, DOI 10.1016/S0168-583X(96)00675-1
   Sharp BL, 1997, J ANAL ATOM SPECTROM, V12, P603, DOI 10.1039/a701420a
   Sheng J, 1997, J ELECTRON MATER, V26, P588, DOI 10.1007/s11664-997-0199-0
   Shi BR, 1997, J VAC SCI TECHNOL B, V15, P273, DOI 10.1116/1.589277
   Shibata Y, 1997, NUCL INSTRUM METH B, V123, P554, DOI 10.1016/S0168-583X(96)00424-7
   Shichi H, 1997, RAPID COMMUN MASS SP, V11, P175, DOI 10.1002/(SICI)1097-0231(19970131)11:2<175::AID-RCM725>3.0.CO;2-K
   Sie SH, 1997, MATER SCI FORUM, V248-2, P313, DOI 10.4028/www.scientific.net/MSF.248-249.313
   Sie SH, 1997, NUCL INSTRUM METH B, V123, P558, DOI 10.1016/S0168-583X(96)00422-3
   Sie SH, 1997, NUCL INSTRUM METH B, V123, P112, DOI 10.1016/S0168-583X(96)00417-X
   SIE SH, 1997, AIP C P 2, V392, P799
   Sisterson JM, 1997, NUCL INSTRUM METH B, V123, P324, DOI 10.1016/S0168-583X(96)00409-0
   Sommer D, 1997, FRESEN J ANAL CHEM, V358, P236, DOI 10.1007/s002160050393
   Song KS, 1997, MICROCHEM J, V57, P265, DOI 10.1006/mchj.1996.1472
   Specht AA, 1998, ANAL CHEM, V70, P1036, DOI 10.1021/ac9710691
   Stefanova V, 1997, J ANAL ATOM SPECTROM, V12, P1271, DOI 10.1039/a704472k
   Steiner RE, 1997, ANAL CHEM, V69, P1715, DOI 10.1021/ac961171i
   Stott AW, 1996, ANAL CHEM, V68, P4402, DOI 10.1021/ac960199r
   Sturgeon RE, 1997, ANAL CHEM, V69, P2129, DOI 10.1021/ac9611982
   Sturup S, 1997, J ANAL ATOM SPECTROM, V12, P919, DOI 10.1039/a704079b
   Su YX, 1997, SPECTROCHIM ACTA B, V52, P633, DOI 10.1016/S0584-8547(96)01621-7
   Sun GY, 1997, J NUCL MATER, V246, P9, DOI 10.1016/S0022-3115(97)00080-9
   Suter M, 1997, NUCL INSTRUM METH B, V123, P148, DOI 10.1016/S0168-583X(96)00613-1
   Sylvester PJ, 1997, CHEM GEOL, V141, P49, DOI 10.1016/S0009-2541(97)00057-0
   Synal HA, 1997, NUCL INSTRUM METH B, V123, P62, DOI 10.1016/S0168-583X(96)00608-8
   Takahata N, 1997, APPL GEOCHEM, V12, P377, DOI 10.1016/S0883-2927(97)00007-3
   Takakuwa C, 1996, APPL SURF SCI, V103, P255, DOI 10.1016/0169-4332(96)00529-6
   Takase M, 1997, NUCL INSTRUM METH B, V121, P288, DOI 10.1016/S0168-583X(96)00648-9
   Tangen A, 1997, J ANAL ATOM SPECTROM, V12, P667, DOI 10.1039/a607623h
   Taylor A, 1998, J ANAL ATOM SPECTROM, V13, p57R, DOI 10.1039/a800371h
   Thielecke F, 1997, J MASS SPECTROM, V32, P323, DOI 10.1002/(SICI)1096-9888(199703)32:3<323::AID-JMS491>3.0.CO;2-X
   Thomas P, 1997, ANALUSIS, V25, P19
   Thomas S, 1997, J ANAL ATOM SPECTROM, V12, P553, DOI 10.1039/a606446i
   Tobias HJ, 1997, ANAL CHEM, V69, P3148, DOI 10.1021/ac970332v
   TRAINA AJ, 1995, NUCL MAT MANAGE, V24, P1125
   Trumbore S. E., 1996, Mass spectrometry of soils., P311
   Tucek JC, 1997, SURF SCI, V382, P137, DOI 10.1016/S0039-6028(97)00117-9
   Tuniz C, 1997, NUCL INSTRUM METH B, V123, P73, DOI 10.1016/S0168-583X(96)00732-X
   Uchida H, 1997, ANAL SCI, V13, P391, DOI 10.2116/analsci.13.391
   Uchida H, 1997, J ANAL ATOM SPECTROM, V12, P913, DOI 10.1039/a701269a
   Uggerud HT, 1997, J ANAL ATOM SPECTROM, V12, P1169, DOI 10.1039/a701805c
   vanderBorg K, 1997, NUCL INSTRUM METH B, V123, P97, DOI 10.1016/S0168-583X(96)00713-6
   VANVEEN EH, 1997, SPEC PUBL R SOC CHEM, V202, P77
   Vela NP, 1997, APPL SPECTROSC, V51, P1500, DOI 10.1366/0003702971938993
   Wagter ML, 1997, SURF INTERFACE ANAL, V25, P788, DOI 10.1002/(SICI)1096-9918(199709)25:10<788::AID-SIA300>3.0.CO;2-W
   Walczyk T, 1997, INT J MASS SPECTROM, V161, P217, DOI 10.1016/S0168-1176(96)04532-6
   Wan CC, 1997, J ANAL ATOM SPECTROM, V12, P683, DOI 10.1039/a605765i
   Wayne DM, 1997, J ANAL ATOM SPECTROM, V12, P1195, DOI 10.1039/a701959i
   Wendt K, 1997, RADIOCHIM ACTA, V79, P183
   Wendt K, 1997, KERNTECHNIK, V62, P81
   Wendt K, 1997, FRESEN J ANAL CHEM, V359, P361, DOI 10.1007/s002160050587
   WHITE J, 1994, PHYSICIAN SPORTSMED, V22, P23
   Wijma S, 1997, NUCL INSTRUM METH B, V123, P87, DOI 10.1016/S0168-583X(96)00720-3
   Wilke T, 1997, J ANAL ATOM SPECTROM, V12, P1083, DOI 10.1039/a701654i
   Willie SN, 1997, ANALYST, V122, P751, DOI 10.1039/a701169e
   Wilson GC, 1997, NUCL INSTRUM METH B, V123, P498, DOI 10.1016/S0168-583X(96)00414-4
   Wilson GC, 1997, NUCL INSTRUM METH B, V123, P579, DOI 10.1016/S0168-583X(96)00413-2
   Wilson GC, 1997, NUCL INSTRUM METH B, V123, P583, DOI 10.1016/S0168-583X(96)00415-6
   Wittmaack K, 1997, PHYS REV B, V56, pR5701, DOI 10.1103/PhysRevB.56.R5701
   Wolff JC, 1996, INT J MASS SPECTROM, V156, P67, DOI 10.1016/S0168-1176(96)04419-9
   Wolff JC, 1997, ANAL CHIM ACTA, V346, P3, DOI 10.1016/S0003-2670(96)00544-2
   Wolkenstein M, 1997, ANAL CHEM, V69, P777, DOI 10.1021/ac9605105
   Wolkenstein M, 1997, FRESEN J ANAL CHEM, V358, P165, DOI 10.1007/s002160050373
   Wolkenstein M, 1997, FRESEN J ANAL CHEM, V357, P783, DOI 10.1007/s002160050249
   Woller A, 1998, J ANAL ATOM SPECTROM, V13, P141, DOI 10.1039/a704772j
   Xiao YK, 1997, ANAL CHEM, V69, P5203, DOI 10.1021/ac970621j
   Yamazaki H, 1997, SURF INTERFACE ANAL, V25, P937, DOI 10.1002/(SICI)1096-9918(199711)25:12<937::AID-SIA327>3.0.CO;2-S
   Yamazaki H, 1998, NUCL INSTRUM METH B, V134, P121, DOI 10.1016/S0168-583X(98)80041-4
   Yamazaki H, 1997, NUCL INSTRUM METH B, V124, P91, DOI 10.1016/S0168-583X(97)00075-X
   Yamazaki H, 1997, J VAC SCI TECHNOL A, V15, P2542, DOI 10.1116/1.580767
   Yan XM, 1997, J ANAL ATOM SPECTROM, V12, P697, DOI 10.1039/a606934g
   Yang PY, 1997, ANAL SCI, V13, P3, DOI 10.2116/analsci.13.Supplement_3
   Yoshimura E, 1997, ANAL LETT, V30, P135
   Zhang J, 1997, J VAC SCI TECHNOL A, V15, P243, DOI 10.1116/1.580519
   ZHAO R, 1996, DIZHI KEXUE, V31, P308
   Zhao XL, 1997, NUCL INSTRUM METH B, V126, P297, DOI 10.1016/S0168-583X(96)01034-8
   Zheng R, 1997, SPECTROCHIM ACTA B, V52, P339, DOI 10.1016/S0584-8547(96)01584-4
   Zhu W, 1997, J ANAL ATOM SPECTROM, V12, P661, DOI 10.1039/a607621a
   Zondervan A, 1997, NUCL INSTRUM METH B, V123, P79, DOI 10.1016/S0168-583X(96)00406-5
   Zoorob G, 1997, J ANAL ATOM SPECTROM, V12, P517, DOI 10.1039/a602682f
   Zoppi U, 1997, NUCL INSTRUM METH B, V123, P319, DOI 10.1016/S0168-583X(96)00742-2
NR 416
TC 4
Z9 4
U1 0
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0267-9477
EI 1364-5544
J9 J ANAL ATOM SPECTROM
JI J. Anal. At. Spectrom.
PD OCT
PY 1998
VL 13
IS 10
BP 171R
EP 208R
PG 38
WC Chemistry, Analytical; Spectroscopy
SC Chemistry; Spectroscopy
GA 131KT
UT WOS:000076575800025
DA 2018-10-19
ER

PT J
AU Kishida, A
   Murakami, K
   Goto, H
   Akashi, M
   Kubota, H
   Endo, T
AF Kishida, A
   Murakami, K
   Goto, H
   Akashi, M
   Kubota, H
   Endo, T
TI Polymer drugs and polymeric drugs X: Slow release of 5-fluorouracil from
   biodegradable poly(gamma-glutamic acid) and its benzyl ester matrices
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
AB We prepared poly(gamma-glutamic acid)(gamma-PGA) benzyl ester(gamma-PBG) by the esterification of gamma-PGA and benzyl bromide and evaluated the degradation behavior and its usefulness as a drug delivery system (DDS) matrix using B-fluorouracil (5-FU) as a model drug. gamma-PBG degraded in an acidic solution gradually for up to 130 days, and degraded very slowly in a phosphate buffer solution (pH 7.4). After 150 days, the weight loss of the gamma-PBG film was only 10% in a phosphate buffer solution. A slow release of 5-FU from gamma-PBG films was achieved. The release rate was affected by the pH of the outer solution and the loading drug. We observed an initial burst-release on the first day, after that, the release of 5-FU was diffusion-controlled gamma-PBG may be a novel biodegradable material that may be useful in the pharmaceutical, biomedical, and agricultural fields.
C1 Kagoshima Univ, Fac Engn, Dept Chem Engn & Appl Chem, Kagoshima 8900065, Japan.
   Meiji Seika Kaisha Ltd, Pharmaceut Technol Lab, Odawara 2500000, Japan.
   Tokyo Inst Technol, Resources Utilizat Res Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan.
RP Akashi, M (reprint author), Kagoshima Univ, Fac Engn, Dept Chem Engn & Appl Chem, 1-21-40 Korimoto, Kagoshima 8900065, Japan.
CR AKASHI M, 1993, BIOMEDICAL APPL POLY, P371
   BECK LR, 1979, FERTIL STERIL, V31, P545
   Bovarnick M, 1942, J BIOL CHEM, V145, P415
   CHANDY T, 1991, BIOMATERIALS, V12, P667
   DABROWSKA W, 1949, SCIENCE, V110, P95, DOI 10.1126/science.110.2847.95
   HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   Ikada Y, 1989, HIGH TECHNOLOGY FIBE, P253
   Kishida A, 1998, J BIOACT COMPAT POL, V13, P222, DOI 10.1177/088391159801300305
   KUBOTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1212, DOI 10.1271/bbb.57.1212
   KUBOTA H, 1993, J POLYM SCI POL CHEM, V31, P2877, DOI 10.1002/pola.1993.080311127
   KUBOTA H, 1993, NIPPON KAGAKU KAISHI, V8, P973
   KUROYANAGI Y, 1992, J APPL BIOMATER, V3, P153, DOI 10.1002/jab.770030211
   Li S, 1995, DEGRADABLE POLYM PRI, P43
   THORNE CB, 1954, J BACTERIOL, V68, P307
   VOLCANI BE, 1957, J BACTERIOL, V74, P646
   Wise D L, 1979, DRUG CARRIERS BIOL M, P237
NR 17
TC 38
Z9 39
U1 1
U2 4
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD OCT
PY 1998
VL 13
IS 4
BP 270
EP 278
DI 10.1177/088391159801300403
PG 9
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 121HW
UT WOS:000076008600003
DA 2018-10-19
ER

PT J
AU Chandy, T
   Sharma, CP
AF Chandy, T
   Sharma, CP
TI Activated charcoal microcapsules and their applications
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE activated charcoal; microencapsulation; hemoperfusion; chitosan
   encapsulated charcoal; adsorbent for toxins; blood compatibility
ID IMMOBILIZED CHITOSAN BEADS; PERMEABILITY PROPERTIES; ARTIFICIAL KIDNEY;
   HEMOPERFUSION; ADSORBENTS; PLASMA; ADSORPTION; MOLECULES; REMOVAL;
   INVITRO
AB Activated charcoal, long known to the ancients as a substance of therapeutic value in a variety of maladies, has recently been "rediscovered" to be of great value in medical applications. Activated charcoal hemoperfusion is effective in blood purification for removal of various circulating toxic materials and waste metabolites, directly. However, particulate release and platelet adhesion prevent its continued clinical use. Polymeric coatings or microencapsulation of charcoal within polymers have improved their blood compatibility. Chitosan encapsulated activated charcoal (ACCB) beads have been extensively investigated in our group for the removal of various toxins such as urea, creatinine, uric acid, bilirubin, etc. This article highlights various methods of microencapsulation procedures of activated charcoal and the importance of this novel material for a variety of biomedical applications. Further, this review provides an insight to the future perspectives for using them in clinical practice.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Biosurface Technol, Trivandrum 695012, Kerala, India.
RI Sharma, Chandra/A-4140-2009
OI Sharma, Chandra/0000-0002-6982-0926
CR ANDRADE JD, 1972, T AM SOC ART INT ORG, V18, P473
   ASH SR, 1992, INT J ARTIF ORGANS, V15, P151
   Beena M S, 1994, J Biomater Appl, V8, P385, DOI 10.1177/088532829400800405
   BEHM E, 1987, BIOMATER ARTIF CELL, V15, P101, DOI 10.3109/10731198709118511
   BOEHM J J, 1977, Australian Journal of Pharmaceutical Sciences, V6, P107
   Boquet A, 1928, CR HEBD ACAD SCI, V187, P959
   Brockstedt M, 1993, Kinderarztl Prax, V61, P378
   BYSANI GK, 1990, CRIT CARE MED, V18, P67, DOI 10.1097/00003246-199001000-00015
   CHANDY T, 1987, POLYM-PLAST TECHNOL, V26, P143, DOI 10.1080/03602558708071937
   CHANDY T, 1991, BIOMAT ARTIF CELL IM, V19, P745, DOI 10.3109/10731199109117852
   CHANDY T, 1992, ARTIF ORGANS, V16, P568
   CHANDY T, 1989, J COLLOID INTERF SCI, V130, P331, DOI 10.1016/0021-9797(89)90112-4
   CHANDY T, 1993, J MICROENCAPSUL, V10, P475, DOI 10.3109/02652049309015324
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   CHANDY T, 1992, J APPL POLYM SCI, V44, P2145, DOI 10.1002/app.1992.070441210
   CHANDY T, 1987, T SOC BIOMAT, V10, P31
   CHANDY T, 1984, J BIOMED MATER RES, P1115
   CHANDY T, 1993, P 6 NATL C BIOM ART, P54
   CHANG TM, 1978, ARTIFICIAL KIDNEY AR
   CHANG TMS, 1973, T AM SOC ART INT ORG, V19, P87
   CHANG TMS, 1983, LANCET, V2, P1051
   CHANG TMS, 1966, T AM SOC ART INT ORG, V12, P13
   CHANG TMS, 1970, T AM SOC ART INT ORG, V16, P141
   CHANG TMS, 1973, CAN MED ASSOC J, V108, P429
   CHEN GX, 1991, BIOMAT ARTIF CELLS I, V19, P227
   CHEN YM, 1991, J MICROENCAPSUL, V8, P327
   CHIRITO E, 1977, ARTIF ORGANS, V1, P76
   COONEY DO, 1980, ACTIVATED CHARCOAL A, P16
   DALY JS, 1978, J PHARM SCI, V67, P1181, DOI 10.1002/jps.2600670846
   DAVIS TA, 1975, KIDNEY INT, V7, pS406
   DECKER WJ, 1968, TOXICOL APPL PHARM, V13, P454, DOI 10.1016/0041-008X(68)90122-1
   DENT E, 1975, P EUR SOC ARTIF ORGA, V2, P215
   DIRKS E, 1990, Z KARDIOL, V79, P54
   DUNEA G, T AM SOC ARTIF INT O, V11, P179
   EBATA T, 1980, PROGR MED, V113, P173
   ERSTAD BL, 1992, CLIN PHARMACY, V11, P800
   GRIMES DJ, 1990, DRUG SAFETY, V5, P447, DOI 10.2165/00002018-199005060-00005
   HASIRCI N, 1986, J BIOMED MATER RES, V20, P963, DOI 10.1002/jbm.820200711
   HERREN T, 1993, SCHWEIZ MED WOCHENSC, V123, P1175
   ITO M, 1991, BIOMATERIALS, V12, P41, DOI 10.1016/0142-9612(91)90130-3
   KASSNER JT, 1993, ANN EMERG MED, V22, P1392, DOI 10.1016/S0196-0644(05)81984-5
   Kim KY, 1988, T SOC BIOMATER, V11, P558
   KLINKMANN H, 1987, BIOMATER ARTIF CELL, V15, P41, DOI 10.3109/10731198709118507
   Kolff WJ, 1944, ACTA MED SCAND, V117, P121
   LIN JL, 1993, J TOXICOL-CLIN TOXIC, V31, P645, DOI 10.3109/15563659309025768
   LIPSCOMB DJ, 1975, ARCH TOXICOL, V34, P37, DOI 10.1007/BF00353337
   LYMAN DJ, 1971, FED PROC, V30, P1658
   MALCHESKY PS, 1976, P EDTA, P242
   MARANGONI R, 1990, BIOMATER ARTIF CELL, V18, P541, DOI 10.3109/10731199009119631
   MARTINEZCHUECOS J, 1992, CRIT CARE MED, V20, P1538, DOI 10.1097/00003246-199211000-00010
   MORLEY DB, 1991, INT J ARTIF ORGANS, V14, P371
   MURUGAVEL S, 1992, J TOXICOL-CLIN TOXIC, V30, P69, DOI 10.3109/15563659208994447
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   NAGAKI M, 1993, J MED MICROBIOL, V38, P354, DOI 10.1099/00222615-38-5-354
   NOLAN JP, 1981, HEPATOLOGY, V1, P458, DOI 10.1002/hep.1840010516
   PERIAGO JF, 1992, J APPL TOXICOL, V12, P91, DOI 10.1002/jat.2550120205
   Plank G, 1990, Tierarztl Prax, V18, P483
   POND SM, 1991, MED J AUSTRALIA, V154, P617
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P4213
   SPLENDIANI G, 1987, BIOMATER ARTIF CELL, V15, P175, DOI 10.3109/10731198709118517
   STAFONI S, 1993, B SOC ITAL BIOL SPER, V69, P675
   SULDIN AV, 1976, NAUCH T PERMSK GOS F, V10, P35
   TERMAN DS, 1977, SCAND J IMMUNOL, V6, P195, DOI 10.1111/j.1365-3083.1977.tb00384.x
   TERMAN DS, 1976, J IMMUNOL, V117, P1971
   TIJSSEN J, 1979, ARTIF ORGANS, V3, P11, DOI 10.1111/j.1525-1594.1979.tb03797.x
   TURK J, 1993, VET HUM TOXICOL, V35, P489
   VALE JA, 1975, BRIT MED J, V1, P5, DOI 10.1136/bmj.1.5948.5
   VAUGHAN JH, 1971, IMMUNOLOGICAL DIS, V2, P987
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P65, DOI 10.1111/j.1749-6632.1977.tb41753.x
   WAKABAYASHI Y, 1994, J TOXICOL-CLIN TOXIC, V32, P419, DOI 10.3109/15563659409011043
   WICKS SR, 1980, J BIOMED MATER RES, V14, P743, DOI 10.1002/jbm.820140606
   WILKINSON SP, 1977, SCAND J GASTROENTERO, V12, P385, DOI 10.3109/00365527709181676
   Xiang-Nan D, 1987, BIOMAT ART CELLS ART, V15, P229
   XU CX, 1981, INT J ARTIF ORGANS, V4, P200
   XU CX, 1983, ARTIF ORG ISAO 83, V7, P78
   YATZIDIS H, 1976, KIDNEY INT, V10, P215
   Yatzidis H., 1964, P EUROP DIALYSIS TRA, V1, P83
   YU YT, 1990, BIOMATER ARTIF CELL, V18, P499
   ZHU XX, 1990, BIOMATER ARTIF CELL, V18, P75, DOI 10.3109/10731199009117290
NR 79
TC 19
Z9 21
U1 1
U2 13
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD OCT
PY 1998
VL 13
IS 2
BP 128
EP 157
DI 10.1177/088532829801300204
PG 30
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122FN
UT WOS:000076061400002
PM 9777464
DA 2018-10-19
ER

PT J
AU Knepper, M
   Milthorpe, BK
   Moricca, S
AF Knepper, M
   Milthorpe, BK
   Moricca, S
TI Interdiffusion in short-fibre reinforced hydroxyapatite ceramics
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PLASMA-SPRAYED COATINGS
AB Sintering in air and hot isostatic pressing are production methods regarded as being capable of producing fibre-reinforced hydroxyapatite ceramics for biomedical applications. These composites may have the advantage of improved mechanical properties and be suitable for applications in areas where there are significant levels of load on the material. The use of pure hydroxyapatite is restricted to those free of dynamical load. Obtaining improved mechanical strength is a question of the bond between the matrix phase and the fibre-reinforcement phase. However, a chemical bond between both phases, indicated by large diffusion zones, might lead to the dehydration of the hydroxyapatite leading to undesired tricalcium phosphate in the matrix resulting in a weakening of the mechanical and biological stability of the composites. Composites with three fibre types, alumina, 316L-stainless steel and titanium were prepared and sintered in air or hot isostatically pressed. A reaction zone was noted around the titanium and stainless steel fibres, but not around the alumina fibres. The reaction zone was larger for stainless steel than titanium. Hot isostatic pressing also reduced the reaction zone markedly compared to sintering in air.
C1 Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   Australian Nucl Sci & Technol Org, Adv Mat Div, Menai, NSW 2234, Australia.
RP Knepper, M (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
RI Milthorpe, Bruce/A-7014-2008
CR BARDOS DI, 1990, CONCISE ENCY MED DEN, P28
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   HEIMKE G, 1990, CONCISE ENCY MED DEN, P360
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   Knepper M, 1997, BIOMATERIALS, V18, P1523, DOI 10.1016/S0142-9612(97)00066-5
   KNEPPER M, 1996, ASB S MOL ENG BIOM C, P9
   KNEPPER M, 1996, P PAC RIM 2 C
   Li J, 1990, INTERCERAM, V39, P13
   LUGSCHEIDER E, 1992, ADV BIOMATERIALS, V10
   ONOSHI H, 1991, BIOMATERIALS, V12, P1375
   PFAFF HG, 1993, 10 EUR C BIOM DAV, P78
   RUYS AJ, 1992, CERAMICS ADDING VALU, V1, P591
   SUTOW EJ, 1990, CONCISE ENCY MED DEN, P232
NR 14
TC 19
Z9 20
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 1998
VL 9
IS 10
BP 589
EP 596
DI 10.1023/A:1008965626695
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 133JL
UT WOS:000076683400007
PM 15348692
DA 2018-10-19
ER

PT J
AU Amass, W
   Amass, A
   Tighe, B
AF Amass, W
   Amass, A
   Tighe, B
TI A review of biodegradable polymers: Uses, current developments in the
   synthesis and characterization of biodegradable polyesters, blends of
   biodegradable polymers and recent advances in biodegradation studies
SO POLYMER INTERNATIONAL
LA English
DT Review
DE biodegradation; biodegradable polyesters; packaging; synthesis;
   characterization; blends
ID BOVINE SERUM-ALBUMIN; IN-VITRO BIODEGRADATION; LIQUID PHASE-SEPARATION;
   ATOMIC-FORCE MICROSCOPY; LOW-MOLECULAR-WEIGHT; NEWBORN CALF SERUM;
   CELL-CULTURE TEST; DRUG-DELIVERY; BACTERIAL POLY(3-HYDROXYBUTYRATE);
   ENZYMATIC DEGRADABILITY
AB This review considers the uses of biodegradable polymers in terms of their relevance within current plastic waste management of packaging materials, biomedical applications and other uses; research papers and patents are catalogued. The chemical synthesis of polyesters and the microbial production of poly(hydroxyalkanoate)s, including recent publications in these areas, are covered and methods of characterization and structural analysis are outlined. Current research into two- and three-component blends is reviewed as a method of reducing overall costs and modifying both properties and biodegradation rates of materials. Finally, there is a summary of degradation processes. Both abiotic and biotic reactions are discussed, together with the development of biodegradation test methods, particularly with respect to composting. (C) 1998 Society of Chemical Industry.
C1 Aston Univ, CEAC, Specialty Polymer Res Grp, Birmingham B4 7ET, W Midlands, England.
RP Amass, W (reprint author), Aston Univ, CEAC, Specialty Polymer Res Grp, Birmingham B4 7ET, W Midlands, England.
CR Abe H, 1996, MACROMOLECULES, V29, P8683, DOI 10.1021/ma960907a
   ABE H, 1995, MACROMOLECULES, V28, P844, DOI 10.1021/ma00108a007
   ABE H, 1994, MACROMOLECULES, V27, P6012, DOI 10.1021/ma00099a012
   Akamatsu K, 1997, INT J PHARM, V155, P65, DOI 10.1016/S0378-5173(97)00159-2
   ALBERTSSON AC, 1994, J APPL POLYM SCI, V51, P1097, DOI 10.1002/app.1994.070510616
   ALBERTSSON AC, 1987, POLYM DEGRAD STABIL, V18, P73, DOI 10.1016/0141-3910(87)90084-X
   Albertsson AC, 1996, J MACROMOL SCI PURE, VA33, P1565, DOI 10.1080/10601329608014926
   ALBERTSSON AC, 1994, CHEM TECHNOLOGY BIOD, P48
   ALI SAM, 1994, J APPL POLYM SCI, V51, P1389, DOI 10.1002/app.1994.070510805
   ALONSO MJ, 1994, VACCINE, V12, P299, DOI 10.1016/0264-410X(94)90092-2
   *APME, 1997, PLAST REC PERS
   Arvanitoyannis I, 1997, STARCH-STARKE, V49, P306, DOI 10.1002/star.19970490712
   Atkins TW, 1997, J BIOMAT SCI-POLYM E, V8, P833, DOI 10.1163/156856297X00038
   Atkins TW, 1996, J BIOMAT SCI-POLYM E, V7, P1065, DOI 10.1163/156856296X00552
   Atkins TW, 1996, J BIOMAT SCI-POLYM E, V7, P1075, DOI 10.1163/156856296X00561
   Atkins TW, 1997, BIOMATERIALS, V18, P173, DOI 10.1016/S0142-9612(96)00111-1
   Atkins TW, 1997, J MICROENCAPSUL, V14, P35, DOI 10.3109/02652049709056466
   Atkins TW, 1996, J MICROENCAPSUL, V13, P709, DOI 10.3109/02652049609026054
   Avella M, 1996, POLYM INT, V39, P191
   BASA N, 1984, HIGH TECHNOL     FEB, P67
   BASTIOLI C, 1995, J ENVIRON POLYM DEGR, V3, P81, DOI 10.1007/BF02067484
   Beach ED, 1996, APPL MATH MODEL, V20, P388, DOI 10.1016/0307-904X(95)00158-G
   BEAUMER GJ, 1994, J BIOMED MATER RES, V28, P545
   BERO M, 1993, POLYM BULL, V31, P9, DOI 10.1007/BF00298757
   BLOEMBERGEN S, 1989, MACROMOLECULES, V22, P1656, DOI 10.1021/ma00194a027
   BLOEMBERGEN S, 1986, MACROMOLECULES, V19, P2865, DOI 10.1021/ma00165a034
   BLUMM E, 1995, POLYMER, V36, P4077, DOI 10.1016/0032-3861(95)90987-D
   BUCHANAN CM, 1995, J MACROMOL SCI PURE, VA32, P683, DOI 10.1080/10601329508010281
   CABALLERO KP, 1995, INT J BIOL MACROMOL, V17, P86, DOI 10.1016/0141-8130(95)93522-Y
   CAM D, 1995, BIOMATERIALS, V16, P833, DOI 10.1016/0142-9612(95)94144-A
   CECCORULLI G, 1993, MACROMOLECULES, V26, P6722, DOI 10.1021/ma00077a005
   CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   CHABOT F, 1983, POLYMER, V24, P53, DOI 10.1016/0032-3861(83)90080-0
   CHAPUT C, 1995, BIOMATER LIVING SYST, V3, P19
   CHAPUT C, 1995, BIOMATER LIVING SYST, V3, P29
   CHIELLINI E, 1995, J BIOMAT SCI-POLYM E, V7, P307
   Chiellini E, 1997, MACROMOL SYMP, V123, P25, DOI 10.1002/masy.19971230105
   Chiu LK, 1995, INT J PHARM, V126, P169, DOI 10.1016/0378-5173(95)04119-2
   Choe S, 1995, POLYMER, V36, P4977, DOI 10.1016/0032-3861(96)81624-7
   CHU CC, 1981, J APPL POLYM SCI, V26, P1727, DOI 10.1002/app.1981.070260527
   Chung YJ, 1997, J FERMENT BIOENG, V83, P492, DOI 10.1016/S0922-338X(97)83009-7
   Cleek RL, 1997, J CONTROL RELEASE, V48, P259, DOI 10.1016/S0168-3659(97)00052-7
   Collett J., 1989, POLYM PREPR, V30, P468
   CONTI B, 1997, EUROPEAN J PHARM SCI, V85, P287
   Conway BR, 1997, J CONTROL RELEASE, V49, P1, DOI 10.1016/S0168-3659(97)01641-6
   Coombes AGA, 1997, BIOMATERIALS, V18, P1153, DOI 10.1016/S0142-9612(97)00051-3
   Dang MH, 1997, J ENVIRON POLYM DEGR, V5, P49
   Dang MH, 1996, J ENVIRON POLYM DEGR, V4, P197, DOI 10.1007/BF02067453
   DAVE P, 1990, POLYM MATER SCI ENG, V63, P726
   DAVID C, 1994, ANGEW MAKROMOL CHEM, V216, P21, DOI 10.1002/apmc.1994.052160102
   Dawes E A, 1973, Adv Microb Physiol, V10, P135, DOI 10.1016/S0065-2911(08)60088-0
   Day M, 1997, J ENVIRON POLYM DEGR, V5, P137
   DeGroot JH, 1997, J MATER SCI-MATER M, V8, P707, DOI 10.1023/A:1018544124990
   DEKONING G, 1995, CAN J MICROBIOL, V41, P303, DOI 10.1139/m95-201
   DOHSE DM, 1994, ENVIRON SCI TECHNOL, V28, P541, DOI 10.1021/es00053a003
   DOI Y, 1990, MACROMOLECULES, V23, P26, DOI 10.1021/ma00203a006
   DOI Y, 1987, J APPL MICROBIOL BIO, V28, P330
   Doi Y., 1990, MICROBIAL POLYESTERS
   EGGLESTON D, 1998, EMAP BUSINESS PUBLIC, V1726
   Eldsater C, 1997, ACTA POLYM, V48, P478, DOI 10.1002/actp.1997.010481103
   Engelhardt J, 1996, PAPIER, V50, P701
   Erlandsson B, 1997, POLYM DEGRAD STABIL, V57, P15, DOI 10.1016/S0141-3910(96)00221-2
   Eschenlauer AC, 1996, INT J BIOL MACROMOL, V19, P121, DOI 10.1016/0141-8130(96)01114-2
   Finelli L, 1997, J MACROMOL SCI PURE, VA34, P13, DOI 10.1080/10601329708014931
   FOSTER LJR, 1995, BIOMATERIALS, V16, P341, DOI 10.1016/0142-9612(95)93263-D
   Freeman MB, 1996, ACS SYM SER, V627, P118
   FREEMAN MB, 1994, ABSTR PAP AM CHEM S, V207, P185
   FUKADA E, 1983, Q REV BIOPHYS, V16, P59, DOI 10.1017/S0033583500004923
   GARDNER RM, 1994, J APPL POLYM SCI, V52, P1477, DOI 10.1002/app.1994.070521012
   Gassner F, 1996, POLYM INT, V39, P215, DOI 10.1002/(SICI)1097-0126(199603)39:3<215::AID-PI497>3.0.CO;2-0
   Gazzano M, 1997, MACROMOL CHEM PHYSIC, V198, P71, DOI 10.1002/macp.1997.021980106
   Ghiya VP, 1996, J MACROMOL SCI PURE, VA33, P627, DOI 10.1080/10601329608010883
   Gilmore D. F., 1993, J ENVIRON POLYM DEGR, V1, P269
   GIORDANO GG, 1995, INVEST OPHTH VIS SCI, V36, pS251
   GLASSER WG, 1994, BIOTECHNOL PROGR, V10, P214, DOI 10.1021/bp00026a011
   GOLDBERG D, 1995, J ENVIRON POLYM DEGR, V3, P61, DOI 10.1007/BF02067481
   Grandfils C, 1996, J CONTROL RELEASE, V38, P109, DOI 10.1016/0168-3659(95)00102-6
   GRECO P, 1989, POLYMER, V30, P1475, DOI 10.1016/0032-3861(89)90219-X
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   GROSS RA, 1989, MACROMOLECULES, V22, P1106, DOI 10.1021/ma00193a018
   GROSS RA, 1995, J MACROMOL SCI PURE, VA32, P613, DOI 10.1080/10601329508010275
   GURSEL I, 1995, J MICROENCAPSUL, V12, P185, DOI 10.3109/02652049509015289
   HAMILTON JD, 1995, J AIR WASTE MANAGE, V45, P247, DOI 10.1080/10473289.1995.10467364
   Hampl J, 1997, INT J PHARM, V155, P19, DOI 10.1016/S0378-5173(97)00144-0
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hashizoe M, 1997, CURR EYE RES, V16, P633, DOI 10.1076/ceyr.16.7.633.5063
   HiljanenVainio M, 1996, J APPL POLYM SCI, V59, P1281, DOI 10.1002/(SICI)1097-4628(19960222)59:8<1281::AID-APP11>3.0.CO;2-9
   Hirt TD, 1996, MACROMOL CHEM PHYSIC, V197, P1609, DOI 10.1002/macp.1996.021970503
   Hirt TD, 1996, MACROMOL CHEM PHYS, V197, P4253, DOI 10.1002/macp.1996.021971221
   Hocking P. J., 1994, CHEM TECHNOLOGY BIOD, P48
   HOCKING PJ, 1995, MACROMOLECULES, V28, P6401, DOI 10.1021/ma00123a003
   Hocking PJ, 1996, MACROMOLECULES, V29, P2472, DOI 10.1021/ma951361f
   HOCKING PJ, 1993, POLYM BULL, V30, P163, DOI 10.1007/BF00296845
   Hocking PJ, 1996, MACROMOLECULES, V29, P2467, DOI 10.1021/ma951360n
   HOFMANN GO, 1995, ARCH ORTHOP TRAUM SU, V114, P123, DOI 10.1007/BF00443385
   HOLLAND SJ, 1986, THESIS ASTON U BIRMI
   HOLLAND SJ, 1992, ADV PHARM SCI, V6, P101
   HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305
   Hori Y, 1996, MACROMOLECULES, V29, P804, DOI 10.1021/ma951345i
   HORI Y, 1995, CAN J MICROBIOL, V41, P282, DOI 10.1139/m95-198
   HU DSG, 1994, J APPL POLYM SCI, V51, P473, DOI 10.1002/app.1994.070510310
   Huang YY, 1997, INT J PHARM, V156, P9, DOI 10.1016/S0378-5173(97)00154-3
   HUATAN H, 1995, J MICROENCAPSUL, V12, P557, DOI 10.3109/02652049509006786
   IIDA M, 1977, MACROMOLECULES, V10, P275, DOI 10.1021/ma60056a012
   Inoue Y, 1996, POLYM INT, V39, P183
   ITAVAARA M, 1995, CHEMOSPHERE, V31, P4359
   Itavaara M, 1996, J ENVIRON POLYM DEGR, V4, P29, DOI 10.1007/BF02083880
   Itavaara M, 1997, COMPOST SCI UTIL, V5, P84
   IWAMOTO Y, 1994, POLYM PREPR-JAPAN, V43, P4022
   Jacobsen S, 1996, POLYM ENG SCI, V36, P2799, DOI 10.1002/pen.10680
   Jameela SR, 1996, CURR SCI INDIA, V70, P669
   JANE J, 1995, J MACROMOL SCI PURE, VA32, P751, DOI 10.1080/10601329508010286
   JANNACE S, 1995, J MACROMOL SCI CHEM, V32, P881
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   JURGENS C, 1995, UNFALLCHIRURG, V98, P233
   Kamijo A, 1996, J CONTROL RELEASE, V40, P269, DOI 10.1016/0168-3659(95)00194-8
   KARLSSON S, 1995, J MACROMOL SCI PURE, VA32, P599, DOI 10.1080/10601329508010273
   KARLSSON S, 1988, POLYM DEGRAD STABIL, V21, P237, DOI 10.1016/0141-3910(88)90030-4
   Kawai F, 1997, MACROMOL SYMP, V123, P177, DOI 10.1002/masy.19971230118
   KEMNITZER JE, 1995, J ENVIRON POLYM DEGR, V3, P37, DOI 10.1007/BF02067792
   Kim IB, 1995, POLYM-KOREA, V19, P727
   KIM YJ, 1995, POLYM ENG SCI, V35, P1652, DOI 10.1002/pen.760352012
   KIM YJ, 1994, KOREAN J CHEM ENG, V11, P172, DOI 10.1007/BF02697462
   KNOWLES JC, 1991, BIOMATERIALS, V12, P210, DOI 10.1016/0142-9612(91)90202-L
   KOBAYASHI T, 1995, POLYMER, V36, P4707, DOI 10.1016/0032-3861(95)96839-Z
   KOENIG MF, 1994, POLYM DEGRAD STABIL, V45, P139, DOI 10.1016/0141-3910(94)90189-9
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Koyama N, 1996, MACROMOLECULES, V29, P5843, DOI 10.1021/ma960119l
   KOYAMA N, 1995, CAN J MICROBIOL, V41, P316, DOI 10.1139/m95-203
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P1653
   Kricheldorf HR, 1997, MACROMOLECULES, V30, P5693, DOI 10.1021/ma970244c
   KRICHELDORF HR, 1992, POLYMER, V33, P2817, DOI 10.1016/0032-3861(92)90459-A
   KRICHELDORF HR, 1990, MAKROMOL CHEM, V191, P1057
   KUBOTA M, 1988, CHEM PHARM BULL, V36, P333
   KUMAGAI Y, 1992, POLYM DEGRAD STABIL, V35, P87, DOI 10.1016/0141-3910(92)90139-V
   KUMAGAI Y, 1992, POLYM DEGRAD STABIL, V36, P241, DOI 10.1016/0141-3910(92)90062-A
   KWAN L, 1991, Patent No. 406015
   Lacasse FX, 1997, PHARMACEUT RES, V14, P887, DOI 10.1023/A:1012147700014
   LAUZIER C, 1992, POLYMER, V33, P823, DOI 10.1016/0032-3861(92)90343-U
   Leadley SR, 1997, MACROMOLECULES, V30, P6920, DOI 10.1021/ma9702612
   LEFEBVRE F, 1995, J MACROMOL SCI PURE, VA32, P867, DOI 10.1080/10601329508010299
   Li XW, 1997, J APPL POLYM SCI, V66, P583, DOI 10.1002/(SICI)1097-4628(19971017)66:3<583::AID-APP20>3.0.CO;2-V
   LOTTI N, 1993, POLYMER, V34, P4935, DOI 10.1016/0032-3861(93)90022-3
   Mader K, 1997, J PHARM SCI-US, V86, P126, DOI 10.1021/js9505105
   MANESS PC, 1994, APPL BIOCHEM BIOTECH, V45-6, P395, DOI 10.1007/BF02941814
   Marcato B, 1996, J CHROMATOGR B, V682, P147, DOI 10.1016/0378-4347(96)00061-8
   MARGAERT J, 1995, CAN J MICROBIOL, V41, P154
   MARGAERT J, 1993, J APPL ENV MICROBIOL, V50, P3233
   Maruyama A, 1997, BIOCONJUGATE CHEM, V8, P735, DOI 10.1021/bc9701048
   Masson V, 1996, INT J PHARMACEUT, V139, P113, DOI 10.1016/0378-5173(96)04611-X
   Matsumoto A, 1997, J CONTROL RELEASE, V48, P19, DOI 10.1016/S0168-3659(97)00031-X
   MATT T, 1988, Patent No. 293172
   Mayer JM, 1996, ACS SYM SER, V627, P159
   MCCARTHYBATES L, 1993, PLASTICS WORLD   MAR, P22
   Mehta RC, 1996, J CONTROL RELEASE, V41, P249, DOI 10.1016/0168-3659(96)01332-6
   MERLOZ P, 1995, REV CHIR ORTHOP, V81, P433
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MINO T, 1995, WATER SCI TECHNOL, V31, P95, DOI 10.1016/0273-1223(95)00183-N
   MITOMO H, 1995, RADIAT PHYS CHEM, V46, P233, DOI 10.1016/0969-806X(95)00018-S
   Miyata T, 1997, POLYMER, V38, P4003, DOI 10.1016/S0032-3861(96)00987-1
   Molpeceres J, 1997, J MICROENCAPSUL, V14, P777, DOI 10.3109/02652049709006828
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209
   Mulhaupt R, 1996, CHIMIA, V50, P191
   Nakashima T, 1996, J MACROMOL SCI PHYS, VB35, P659, DOI 10.1080/00222349608220401
   NAKAYAMA K, 1985, BIOCHIM BIOPHYS ACTA, V827, P63, DOI 10.1016/0167-4838(85)90101-3
   NEDEA ME, 1991, POLYM BULL, V26, P549, DOI 10.1007/BF01032681
   Nishio Y, 1997, CELLULOSE, V4, P131, DOI 10.1023/A:1018475520600
   Nobes GAR, 1996, MACROMOLECULES, V29, P8330, DOI 10.1021/ma961219u
   ODonnell PB, 1996, J MICROENCAPSUL, V13, P667, DOI 10.3109/02652049609026050
   Ogawa Y, 1997, J BIOMAT SCI-POLYM E, V8, P391, DOI 10.1163/156856297X00173
   OHAGAN DT, 1994, INT J PHARM, V103, P37, DOI 10.1016/0378-5173(94)90201-1
   Ohtake Y, 1996, NIPPON KAGAKU KAISHI, P853, DOI 10.1246/nikkashi.1996.853
   OHTAKE Y, 1995, J APPL POLYM SCI, V56, P1789, DOI DOI 10.1002/APP.1995.070561309
   OHURA Y, 1995, SURV OPHTHALMOL, V39, pS17
   OKADA H, 1994, J CONTROL RELEASE, V28, P121
   OKADA H, 1995, CRIT REV THER DRUG, V12, P1
   Orts WJ, 1995, CAN J CHEM, V73, P2094, DOI 10.1139/v95-258
   ORTS WJ, 1991, MACROMOLECULES, V24, P6435, DOI 10.1021/ma00024a010
   Otal E, 1997, J CHEM TECHNOL BIOT, V70, P147
   PAGGA U, 1995, CHEMOSPHERE, V31, P4475, DOI 10.1016/0045-6535(95)00326-4
   Paik YH, 1996, ADV CHEM SER, V248, P79
   Panagiotopoulos E, 1997, ACTA ORTHOP SCAND, V68, P119, DOI 10.1080/17453674.1997.11744763
   Park ES, 1997, J CONTROL RELEASE, V48, P67, DOI 10.1016/S0168-3659(97)00034-5
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   PEARCE R, 1994, POLYMER, V35, P3990, DOI 10.1016/0032-3861(94)90285-2
   PEARCE R, 1992, POLYMER, V33, P4647, DOI 10.1016/0032-3861(92)90428-Y
   PEARCE R, 1994, POLYMER, V35, P3984, DOI 10.1016/0032-3861(94)90284-4
   PEARCE RP, 1994, MACROMOLECULES, V27, P3869, DOI 10.1021/ma00092a029
   Penco M, 1996, BIOMATERIALS, V17, P1583, DOI 10.1016/0142-9612(95)00323-1
   PERES R, 1994, POLYMER, V35, P1059, DOI 10.1016/0032-3861(94)90952-0
   PETTIGREW CA, 1995, J MACROMOL SCI PURE, VA32, P811, DOI 10.1080/10601329508010291
   Pettit DK, 1997, PHARMACEUT RES, V14, P1422, DOI 10.1023/A:1012176823155
   POIRIER Y, 1995, INT J BIOL MACROMOL, V17, P7, DOI 10.1016/0141-8130(95)93511-U
   POOL R, 1989, SCIENCE, V245, P1187, DOI 10.1126/science.245.4923.1187
   Poulton C.W., 1996, ADV DRUG DELIVERY RE, V18, P133
   Poutanen K, 1996, TRENDS POLYM SCI, V4, P128
   Pranamuda H, 1996, J ENVIRON POLYM DEGR, V4, P1, DOI 10.1007/BF02083877
   PRASAD MP, 1993, J CONTROL RELEASE, V27, P219, DOI 10.1016/0168-3659(93)90153-V
   PUECHNER P, 1995, J ENVIRON POLYM DEGR, V3, P133, DOI 10.1007/BF02068464
   QuintanarGuerrero D, 1997, COLLOID POLYM SCI, V275, P640, DOI 10.1007/s003960050130
   Rafler G, 1997, PHARM IND, V59, P620
   Ramchandani M, 1997, J CONTROL RELEASE, V43, P161, DOI 10.1016/S0168-3659(96)01481-2
   RAMSAY BA, 1993, APPL ENVIRON MICROB, V59, P1242
   RAMSAY JA, 1990, APPL PHYCOL FORUM, V7
   REEVE MS, 1993, MACROMOLECULES, V26, P888, DOI 10.1021/ma00057a002
   REEVE MS, 1994, MACROMOLECULES, V27, P825, DOI 10.1021/ma00081a030
   Rodgers ES, 1997, FOOD AGR IMMUNOL, V9, P159, DOI 10.1080/09540109709354946
   Saad B, 1996, J MATER SCI-MATER M, V7, P56, DOI 10.1007/BF00121191
   Saad B, 1997, J MATER SCI-MATER M, V8, P497, DOI 10.1023/A:1018582311361
   SAH H, 1995, J APPL POLYM SCI, V58, P197, DOI 10.1002/app.1995.070580123
   SAH H, 1995, J CONTROL RELEASE, V35, P137, DOI 10.1016/0168-3659(95)00029-8
   Saito Y, 1996, POLYM INT, V39, P169
   SATOH H, 1994, POLYMER, V35, P286, DOI 10.1016/0032-3861(94)90692-0
   SATOH H, 1992, WATER SCI TECHNOL, V26, P933
   Scandola M, 1997, MACROMOLECULES, V30, P2568, DOI 10.1021/ma961431y
   SCANDOLA M, 1992, MACROMOLECULES, V25, P6441, DOI 10.1021/ma00050a009
   SCANDOLA M, 1995, CAN J MICROBIOL, V41, P310, DOI 10.1139/m95-202
   SCANDOLA M, 1992, MACROMOLECULES, V25, P1405, DOI 10.1021/ma00031a008
   SCANDOLA M, 1998, P 5 INT SCI WORKSH B
   Scherzer T, 1997, NUCL INSTRUM METH B, V131, P382, DOI 10.1016/S0168-583X(97)00195-X
   Schugens C, 1996, J BIOMED MATER RES, V30, P449, DOI 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P
   Schugens C, 1996, POLYMER, V37, P1027, DOI 10.1016/0032-3861(96)87287-9
   SCHWACH G, 1994, POLYM BULL, V32, P617, DOI 10.1007/BF00973910
   Seal K. J., 1994, Chemistry and technology of biodegradable polymers., P116
   Semler EJ, 1997, BIOTECHNOL PROGR, V13, P630, DOI 10.1021/bp9700871
   Seneker SD, 1996, ADV CHEM SER, V248, P125
   Shakesheff KM, 1997, J COLLOID INTERF SCI, V185, P538, DOI 10.1006/jcis.1996.4637
   SHAKESHEFF KM, 1995, LANGMUIR, V11, P3921, DOI 10.1021/la00010a049
   Shakesheff KM, 1996, CRIT REV THER DRUG, V13, P225, DOI 10.1615/CritRevTherDrugCarrierSyst.v13.i3-4.20
   SHAKESHEFF KM, 1994, LANGMUIR, V10, P4417, DOI 10.1021/la00024a005
   Shih C, 1996, J CONTROL RELEASE, V38, P69, DOI 10.1016/0168-3659(95)00104-2
   Shih C, 1995, PHARMACEUT RES, V12, P2036, DOI 10.1023/A:1016276830464
   SHIRAKURA Y, 1986, BIOCHIM BIOPHYS ACTA, V880, P46, DOI 10.1016/0304-4165(86)90118-2
   Sobry R, 1996, J MOL STRUCT, V383, P63, DOI 10.1016/S0022-2860(96)09269-1
   *SOLV INT LTD, 1997, PROD INF
   Song CX, 1997, J CONTROL RELEASE, V43, P197, DOI 10.1016/S0168-3659(96)01484-8
   Spitzer B, 1996, J ENVIRON POLYM DEGR, V4, P157, DOI 10.1007/BF02067450
   Spyros A, 1997, MACROMOLECULES, V30, P327, DOI 10.1021/ma9601979
   STAINMESSE S, 1995, COLLOID POLYM SCI, V273, P505, DOI 10.1007/BF00656896
   STEINBUCHEL A, 1993, APPL MICROBIOL BIOT, V39, P443, DOI 10.1007/BF00205030
   STEINBUCHEL A, 1995, J ENVIRON POLYM DEGR, V3, P243, DOI 10.1007/BF02068679
   STOLNIK S, 1995, COLLOID SURFACE A, V97, P235, DOI 10.1016/0927-7757(95)03081-N
   Suominen I, 1997, J IND MICROBIOL BIOT, V19, P104, DOI 10.1038/sj.jim.2900424
   SWIFT G, 1995, J MACROMOL SCI PURE, VA32, P641, DOI 10.1080/10601329508010277
   TAJIMA K, 1995, MOKUZAI GAKKAISHI, V41, P749
   Talaba P, 1997, J CARBOHYD CHEM, V16, P573, DOI 10.1080/07328309708007336
   Thomas PA, 1997, J CONTROL RELEASE, V43, P273, DOI 10.1016/S0168-3659(96)01497-6
   Tighe BJ, 1997, MACROMOL SYMP, V123, P133, DOI 10.1002/masy.19971230114
   Timmins MR, 1996, MACROMOL CHEM PHYSIC, V197, P1193, DOI 10.1002/macp.1996.021970403
   Torres A, 1996, J ENVIRON POLYM DEGR, V4, P213, DOI 10.1007/BF02070690
   TSAI HB, 1991, POLYM BULL, V27, P141, DOI 10.1007/BF00296023
   Tsuji H, 1997, J APPL POLYM SCI, V63, P855
   TUNC DC, 1988, POLYM MAT SCI ENG, V59, P383
   TUNC DC, 1989, Patent No. 321176
   URSTADT S, 1995, J ENVIRON POLYM DEGR, V3, P121, DOI 10.1007/BF02068463
   VACANTI CA, 1994, ACS SYM SER, V540, P16
   VALLINI G, 1994, J GEN APPL MICROBIOL, V40, P445, DOI 10.2323/jgam.40.445
   VANDERHART DL, 1995, MACROMOLECULES, V28, P6394, DOI 10.1021/ma00123a002
   vanGinkel CG, 1996, ENVIRON TOXICOL CHEM, V15, P270, DOI 10.1897/1551-5028(1996)015<0270:TBANOC>2.3.CO;2
   VERHOOGT H, 1995, CAN J MICROBIOL, V41, P323, DOI 10.1139/m95-204
   VERHOOGT H, 1994, POLYMER, V35, P5155, DOI 10.1016/0032-3861(94)90465-0
   VERT M, 1992, BRE2CT920205
   VIKMAN M, 1995, J ENVIRON POLYM DEGR, V3, P23, DOI 10.1007/BF02067790
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Wang GB, 1997, J CHROMATOGR B, V698, P69, DOI 10.1016/S0378-4347(97)00282-X
   WASSERBAUER R, 1990, BIOMATERIALS, V11, P36, DOI 10.1016/0142-9612(90)90049-V
   WEILAND M, 1995, POLYM DEGRAD STABIL, V48, P275, DOI 10.1016/0141-3910(95)00040-S
   Westesen K, 1997, J CONTROL RELEASE, V48, P223, DOI 10.1016/S0168-3659(97)00046-1
   Winternitz CI, 1996, PHARMACEUT RES, V13, P368, DOI 10.1023/A:1016032207246
   WOOD LA, 1958, J POLYM SCI, V28, P319, DOI 10.1002/pol.1958.1202811707
   YASIN M, 1989, BIOMATERIALS, V10, P400, DOI 10.1016/0142-9612(89)90132-4
   Yasin M, 1995, POLYMER AND OTHER ADVANCED MATERIALS, P597
   Yoon BS, 1996, J APPL POLYM SCI, V60, P1677, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1677::AID-APP20>3.0.CO;2-0
   Yue CL, 1996, POLYM DEGRAD STABIL, V51, P205, DOI 10.1016/0141-3910(95)00201-4
   Zhang LL, 1997, POLYMER, V38, P5379, DOI 10.1016/S0032-3861(97)84642-3
   Zhang XC, 1996, INT J PHARM, V137, P199, DOI 10.1016/0378-5173(96)04521-8
   1997, SUNDAY TIMES    0323, P5
   1992, GESELLCHAFT VERPACKU
   1997, LEGISLATIVE REQUIREM
NR 283
TC 610
Z9 639
U1 16
U2 258
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD OCT
PY 1998
VL 47
IS 2
BP 89
EP 144
DI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
PG 56
WC Polymer Science
SC Polymer Science
GA 131RL
UT WOS:000076589000001
DA 2018-10-19
ER

PT J
AU Scholz, C
   Iijima, M
   Nagasaki, Y
   Kataoka, K
AF Scholz, C
   Iijima, M
   Nagasaki, Y
   Kataoka, K
TI Polymeric micelles as drug delivery systems: a reactive polymeric
   micelle carrying aldehyde groups
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE polymeric micelle; block copolymer; light scattering; site-specific drug
   delivery
ID HETEROBIFUNCTIONAL POLY(ETHYLENE OXIDE); POLYETHYLENE OXIDE;
   BLOCK-COPOLYMERS; ETHYLENE-OXIDE; HYDROXYL GROUP; ONE END; SURFACES
AB Nanospheric particles as drug delivery systems are gaining increasing interest in the biomedical field. Nanospheres have been proven as efficient drug delivery systems for intravenous administration because of their comparatively long bloodstream circulation. A novel approach in the field of polymeric drug delivery systems was introduced by the formation of polymeric micelles and subsequently by functionalized polymeric micelles. Functionalized polymeric micelles are expected to find a wide application in the fields of drug delivery and diagnosis since the possibility of coupling to bioactive substances is provided. A large number of densely packed functional groups on the outer shell of the micelle allows an immobilization of biologically active substances at a high density. This is a great advantage for utilizing this particular type of nanosphere in the biomedical field. The possibilities synthesizing heterobifunctional block copolymers be demonstrated and the influence of the individual block length on the micelle properties will be discussed. Functionalized polymeric micelles were synthesized from poly(ethylene glycol) (PEG) and poly(lactide) (PLA), and combine the advantages given by the hydrophobic PLA core and the hydrophilic PEG corona. An established quantitative synthetic method for the formation of heterobifunctional PEG was advanced and applied to the block copolymerization. A heterobifunctional block copolymer was synthesized, terminated by an acetal group a the PEG end and a vinyl group was introduced at the PLA end ii a one-pot synthesis. After the micellization the acetal groups on the micelle surface were converted into aldehyde groups by an acidic treatment. Aldehyde groups call react rapidly with primary amines forming Schiff bases, a potential future pathway for the conjugation of functionalized polymeric micelles with proteins. PLA was chosen as core-forming segment since it is a biodegradable, non-toxic polymer that is well established as implant material. Dynamic and static light scattering was applied to determine the micelle size and shape and to study the dependence of the micelle geometry on the block length of the copolymer. (C) 1998 John Wiley & Sons, Ltd.
C1 Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA.
   Sci Univ Tokyo, Int Ctr Biomat Sci, Noda, Chiba 278, Japan.
RP Scholz, C (reprint author), Univ Massachusetts, Dept Chem, 1 Univ Ave, Lowell, MA 01854 USA.
RI Kataoka, Kazunori/K-7108-2012
OI Kataoka, Kazunori/0000-0002-8591-413X
CR Akizawa T., 1989, T AM SOC ART INT ORG, V35, P333
   ANTONIETTI M, 1994, MACROMOLECULES, V27, P3276, DOI 10.1021/ma00090a021
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P122
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   HARADA A, 1995, MACROMOLECULES, V28, P5294, DOI 10.1021/ma00119a019
   JEDLINSKI Z, 1991, MAKROMOL CHEM, V192, P2051
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   KATAOKA K, 1994, J MACROMOL SCI PURE, VA31, P1759, DOI 10.1080/10601329408545880
   KATAOKA K, 1996, CONTROLLED DRUG DELI, pCH4
   KIM YJ, 1994, POLYM BULL, V33, P1, DOI 10.1007/BF00313466
   KJELLANDER R, 1981, J CHEM SOC FARAD T 1, V77, P2053, DOI 10.1039/f19817702053
   KOPECEK J, 1991, ANN NY ACAD SCI, V618, P335, DOI 10.1111/j.1749-6632.1991.tb27253.x
   KOPECKOVA P, 1990, NEW POLYM MATER, V1, P289
   KWON GS, 1995, ADV DRUG DELIVER REV, V16, P295, DOI 10.1016/0169-409X(95)00031-2
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   NAGASAKI Y, 1995, BIOCONJUGATE CHEM, V6, P231, DOI 10.1021/bc00032a012
   PERRIN DD, 1980, PURIFICATION LAB CHE
   SCHOLZ C, 1995, MACROMOLECULES, V28, P7295, DOI 10.1021/ma00125a040
   Scott ND, 1936, J AM CHEM SOC, V58, P2442, DOI 10.1021/ja01303a022
   TUZAR Z, 1976, ADV COLLOID INTERFAC, V6, P201, DOI 10.1016/0001-8686(76)80009-7
   VERT M, 1986, Critical Reviews in Therapeutic Drug Carrier Systems, V2, P291
   VILLACAMPA M, 1995, MACROMOLECULES, V28, P1025, DOI 10.1021/ma00108a033
   XU RL, 1991, MACROMOLECULES, V24, P87, DOI 10.1021/ma00001a014
   YOKOYAMA M, 1994, J CONTROL RELEASE, V32, P269, DOI 10.1016/0168-3659(94)90237-2
NR 28
TC 18
Z9 18
U1 4
U2 20
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD OCT-NOV
PY 1998
VL 9
IS 10-11
BP 768
EP 776
DI 10.1002/(SICI)1099-1581(1998100)9:10/11<768::AID-PAT828>3.0.CO;2-O
PG 9
WC Polymer Science
SC Polymer Science
GA 134GD
UT WOS:000076733900026
DA 2018-10-19
ER

PT J
AU Sturtevant, B
AF Sturtevant, B
TI Shock wave effects in biomechanics
SO SADHANA-ACADEMY PROCEEDINGS IN ENGINEERING SCIENCES
LA English
DT Article
DE focused shock waves; kidney stone disease; blunt impact trauma;
   extracorporeal shock wave lithotripsy
ID LITHOTRIPSY
AB Focused shock waves convey energy from a source and deposit it in a localized region remote from the source. This mechanism is used to deliver crushing impulses to kidney stones in patients, but it may also be an undesirable source of tissue injury. Tissue injury occurs in extracorporeal shock wave lithotripsy (ESWL), a popular procedure used around the world to treat kidney stone disease. Shock waves can also be responsible for unexpected symptoms appearing remote from the site of blunt impact trauma. This paper describes two examples of the effects of focused shock waves on tissue, A victim of gunshot wound suffered specific neurological symptoms indicating highly localized injury to the spinal cord remote from the impact point and penetration of the missile. We suggest that wave focusing by thoracic vertebrae can concentrate energy into the spinal canal, with consequent injury to the spinal cord. Impulsive stress in repeated shock waves of order 20 MPa strength administered in ESWL is the mechanical stimulus of injury to the kidney. Research to increase the understanding of the causal relationship between the shock-induced mechanical stimulus and the consequent biomedical symptoms in the shock-wave treatment of kidney stone disease is described. The interaction of focusing shock waves with simple, planar polymeric membranes immersed in tissue-mimicking fluids has been studied. We have explored the nature of membrane failure in both cavitating and non-cavitating fluids. In water, thin nitrocellulose membranes are easily damaged during the passage of a lithotriptor shock wave by the collapse of proximal bubbles generated by cavitation. In uniform non-cavitating liquids, focusing shock waves do not by themselves cause damage, but after passing through tissue or simulated tissue, they do. Shocks with large amplitude and short-rise time (for example, in uniform media) cause no damage in non-cavitating fluids, while long-rise time, dispersed shock waves, though only moderately attenuated, do. A simple model of shearing at small scale provides a framework for accounting for the properties of the scattering medium and the membrane material in dynamic fatigue. The fact that the membranes exhibit fatigue-like behaviour suggests that a definition of dose can be formulated based on Miner's Law. This definition gives the dose at failure in terms of the stress applied to the membrane by each shock wave and the failure stress. This analysis suggests that ESWL shock waves induce strain rates in tissue of order 10000 s(-1) and that behind a tissue, phantom membranes fail after a dose of about 1400 effective shock waves, of the same order as the number of shock waves typically used in lithotripsy therapy and research. Above strain rates of about 40000 s(-1), ESWL shocks cause virtually no damage.
C1 CALTECH, Grad Aeronaut Labs, Pasadena, CA 91001 USA.
RP Sturtevant, B (reprint author), CALTECH, Grad Aeronaut Labs, Pasadena, CA 91001 USA.
CR Brown-Sequard C.E., 1860, COURSE LECT PHYSL PA
   Evan A. P., 1996, J ACOUST SOC AM, V99, P2510
   EVAN AP, 1996, NEW DEV MANAGEMENT U, P3
   EVAN AP, 1996, J ACOUST SOC AM, V98, P2943
   GOSS SA, 1978, J ACOUST SOC AM, V64, P423, DOI 10.1121/1.382016
   HOGE KG, 1967, APPL POLYM S, V5, P19
   Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1
   JANZON B, 1988, J TRAUMA, V28, P29
   KAUDE JV, 1985, AM J ROENTGENOL, V145, P305, DOI 10.2214/ajr.145.2.305
   MINER MA, 1945, J APPL MECH-T ASME, V12, pA159
   MING L, 1988, J TRAUMA S1, V28, P104
   SAXON M, 1982, J ORAL MAXIL SURG, V40, P299, DOI 10.1016/0278-2391(82)90223-3
   SUNESON A, 1990, J TRAUMA, V30, P281, DOI 10.1097/00005373-199003000-00006
   SUNESON A, 1988, J TRAUMA, V28, P197
   TAYLOR RG, 1957, J BONE JOINT SURG BR, V39, P438
   WILLIAMS PL, 1989, GRAYS ANAT
NR 16
TC 4
Z9 4
U1 1
U2 8
PU INDIAN ACADEMY SCIENCES
PI BANGALORE
PA P B 8005 C V RAMAN AVENUE, BANGALORE 560 080, INDIA
SN 0256-2499
J9 SADHANA-ACAD P ENG S
JI Sadhana-Acad. Proc. Eng. Sci.
PD OCT-DEC
PY 1998
VL 23
BP 579
EP 596
DI 10.1007/BF02744581
PN 5-6
PG 18
WC Engineering, Multidisciplinary
SC Engineering
GA 179WT
UT WOS:000079353500010
DA 2018-10-19
ER

PT J
AU Jakubiec, B
   Marois, Y
   Zhang, Z
   Roy, R
   Sigot-Luizard, MF
   Dugre, FJ
   King, MW
   Dao, L
   Laroche, G
   Guidoin, R
AF Jakubiec, B
   Marois, Y
   Zhang, Z
   Roy, R
   Sigot-Luizard, MF
   Dugre, FJ
   King, MW
   Dao, L
   Laroche, G
   Guidoin, R
TI In vitro cellular response to polypyrrole-coated woven polyester
   fabrics: Potential benefits of electrical conductivity
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE polypyrrole; polyester; conductivity; in vitro; cell culture; cell
   activation; interleukin expression
ID SYNTHETIC VASCULAR PROSTHESES; BIOMEDICAL POLYMERS; MONOCYTES
   MACROPHAGES; CYTOKINE PRODUCTION; IN-VITRO; ELECTRODES;
   POLYDIMETHYLSILOXANE; ADHESION; GLUCOSE; CELLS
AB Electrically conducting polypyrrole-treated films have recently been shown to influence the morphology and function of mammalian cells in vitro. This type of polymer represents a possible alternative biomaterial for use in vascular implantation. The present study compared the in vitro biocompatibility of five different polyester woven fabrics having increasing levels of electrical conductivity ranging from 4.5 x 10(4) to 123 Ohm/square with that of low density polyethylene and polydimethylsiloxane primary reference materials. Biocompatibility was measured in terms of four different types of in vitro cellular response, including (a) an indirect and (b) a direct control organotypic culture assay using endothelial cells, (c) a polymorphonuclear (PMN) cell activation study using flow-cytometric measurements of CD11/CD18 integrin molecule expression and (d) a semiquantification of interleukin (IL)-6 mRNA expression on monotytes/macrophages using reverse-transcriptase polymerase chain reaction. The organotypic culture study revealed that the fabrics with high levels of conductivity exhibited lower cell migration, proliferation, and viability. The PMN activation study of blood from 10 healthy adult donors demonstrated that the two most conductive fabrics were able to identify the more reactive donors. The levels of IL-6 mRNA expression by monocytes/macrophages decreased as the conductivity level of the fabrics increased. The results of the present study therefore indicate that high levels of conductivity (<200 Ohm/square) on polyester fabrics are detrimental to the growth, migration, and viability of endothelial cells; induce elevated PMN activation; and affect the intracellular metabolism of monocytes. They also point to a specific range of conductivity (10(3) < 10(4) Ohm n/square) which is associated with an optimum in vitro cellular response. (C) 1998 John Wiley & Sons, Inc. J Biomed Mater Res, 41, 519-526, 1998.
C1 CHU Quebec, Ctr Rech Rhumatol & Immunol, Quebec City, PQ, Canada.
   CHU Quebec, Inst Biomat Quebec Inc, Quebec City, PQ, Canada.
   Univ Laval, Fac Med, Dept Chirurg, Quebec City, PQ G1K 7P4, Canada.
   Univ Technol Compiegne, Dept Genie Biol, Compiegne, France.
   Univ Manitoba, Dept Clothing & Text, Winnipeg, MB, Canada.
   INRS Energie & Mat, Varennes, PQ, Canada.
RP Guidoin, R (reprint author), Univ Laval, Expt Surg Lab, Room 1701,Serv Bldg, St Foy, PQ G1K 7P4, Canada.
RI Zhang, Ze/A-7902-2008
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BORDENAVE L, 1992, J BIOMAT SCI-POLYM E, V3, P509, DOI 10.1163/156856292X00475
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DUVAL JL, 1988, BIOMATERIALS, V9, P155, DOI 10.1016/0142-9612(88)90115-9
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   FORTIER G, 1990, BIOSENS BIOELECTRON, V5, P473, DOI 10.1016/0956-5663(90)80036-D
   GAO ZQ, 1994, ANALYST, V119, P459, DOI 10.1039/an9941900459
   GREGORY RL, 1991, PERCEPTION, V20, P1
   HORII Y, 1988, J IMMUNOL, V141, P1529
   Jakubiec B, 1994, ASAIO J, V40, pM616, DOI 10.1097/00002480-199407000-00072
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   KUHN HH, 1991, TECH PAP SOC PLAST E, V37, P760
   LAGOODEENADAYALAN S, 1993, LYMPHOKINE CYTOK RES, V12, P59
   LIAN A, IN PRESS CONDUCTING
   Marois Y, 1996, BIOMATERIALS, V17, P1835, DOI 10.1016/0142-9612(95)00245-6
   MCFAUL SJ, 1990, J IMMUNOL METHODS, V130, P15, DOI 10.1016/0022-1759(90)90293-5
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   PETILLO O, 1994, J BIOMED MATER RES, V28, P635, DOI 10.1002/jbm.820280514
   ROITT Y, 1991, ESSENTIAL IMMUNOLOGY
   ROTH S, 1993, SYNTHETIC MET, V57, P3623, DOI 10.1016/0379-6779(93)90487-H
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   Selampinar F, 1997, BIOMATERIALS, V18, P1163, DOI 10.1016/S0142-9612(97)00056-2
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   SUN ZS, 1992, ANAL CHEM, V64, P1112, DOI 10.1021/ac00034a008
   TROJANOWICZ M, 1990, BIOSENS BIOELECTRON, V5, P149, DOI 10.1016/0956-5663(90)80005-X
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   WITKOWSKI A, 1992, ANAL CHEM, V64, P635, DOI 10.1021/ac00030a012
   WITKOWSKI A, 1991, ANAL CHEM, V63, P622, DOI 10.1021/ac00006a013
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   WONG JY, 1993, MATER RES SOC SYMP P, V293, P179
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   ZHANG WB, 1990, J INORG BIOCHEM, V40, P189, DOI 10.1016/0162-0134(90)80052-Y
NR 35
TC 48
Z9 50
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 1998
VL 41
IS 4
BP 519
EP 526
DI 10.1002/(SICI)1097-4636(19980915)41:4<519::AID-JBM2>3.0.CO;2-F
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 104KM
UT WOS:000075013600002
PM 9697023
DA 2018-10-19
ER

PT J
AU Chen, JH
   Wei, J
   Chang, CY
   Laiw, RF
   Lee, YD
AF Chen, JH
   Wei, J
   Chang, CY
   Laiw, RF
   Lee, YD
TI Studies on segmented polyetherurethane for biomedical application:
   Effects of composition and hard-segment content on biocompatibility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE segmented polyetherurethane (SPEU); hemolysis; cytotoxicity; cell
   culture; blood compatibility
ID PLATELET-ADHESION; BLOOD COMPATIBILITY; BLOCK COPOLYMER; POLYURETHANE;
   SURFACES; CYTOTOXICITY; BIOMATERIALS; BIOSTABILITY; ELASTOMER; CRACKING
AB Segmented polyetherurethane (SPEU) materials based on polytetramethylene oxide (PTMO, Mw 1000 and 2000) with various hard-segment contents were synthesized and their biocompatibilities studied via different tests. The static contact angle data reveal that the higher hard-segment-content SPEU material possesses a lower contact angle, implying that the surface of the higher hard-segment-content SPEU is more hydrophilic than its low hard-segment-content SPEU counterpart. The catalyst- and additive-free PTMO-based SPEU materials in this study possess neither a hemolytic nor a cytotoxic response that could be considered non toxic for biomedical applications. By using L-929 cell lines, a cell-seeding test indicated that the higher hard-segment-content SPEU material possesses quicker cell attachment and proliferation behaviors. In vitro platelet adhesion tests indicated that the lower hard-segment-content SPEU possesses less platelet adhesion than the high hard-segment-content SPEU material. Both ex vivo canine artery-artery (A-A) and arterio-venous (A-V) shunting tests revealed that the extent of platelet adhesion reaction is less for lower hard-segment-content SPEU. Ln addition, the blood compatibility of SPEU material synthesized from PTMO 1000 excels over PTMO 2000 SPEU material by nearly the same levels as the hard-segment-content SPEU. (C) 1998 John Wiley & Sons, Inc. J Biomed Mater Res, 41, 633-648, 1998.
C1 Ind Technol Res Inst, Union Chem Labs, Hsinchu, Taiwan.
   Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan.
   Cheng Hsin Gen Hosp, Dept Cardiovasc Surg, Taipei, Taiwan.
RP Lee, YD (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, 101 Kuang Fu Rd,Sec 2, Hsinchu, Taiwan.
CR ASHAR B, 1981, T AM SOC ART INT ORG, V27, P372
   BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   BUMGARDNER JD, 1989, J BIOMED MATER RES, V23, P1103, DOI 10.1002/jbm.820231002
   CHO CS, 1990, J BIOMED MATER RES, V24, P1369, DOI 10.1002/jbm.820241008
   COOPER SL, 1986, POLYM MED, V2, P199
   DONG A, 1989, J BIOMED MAT RES APP, V23, P211
   FRAYSSINET P, 1994, J MATER SCI-MATER M, V5, P11, DOI 10.1007/BF00121147
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P335, DOI 10.1002/jbm.820270307
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   GREISLER HP, 1993, J BIOMED MATER RES, V27, P955, DOI 10.1002/jbm.820270715
   HASTINGS GW, 1986, POLYM MED, V2, P1
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1385, DOI 10.1002/jbm.820241010
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   HELLER J, 1983, POLYM BIOMATERIALS, P167
   ITO Y, 1989, J BIOMED MATER RES, V23, P191, DOI 10.1002/jbm.820230205
   JOHNSON SD, 1992, J BIOMED MATER RES, V26, P915, DOI 10.1002/jbm.820260707
   KIREMITCI M, 1993, J BIOMATER APPL, V7, P251
   KLINKMANN H, 1985, BIOMATERIALS ARTIFIC, P1
   LELAH MD, 1986, POLYURETHANES MED, P1
   LYMAN DJ, 1989, POLYM BIOMATERIALS M, P52
   LYMAN DJ, 1975, POLYM MED SURG, P29
   MARCHANT RE, 1988, SURFACE CHARACTERIZA, P297
   MESTRES CA, 1987, POLYURETHANE BIOMEDI, V2, P4
   MESTRES CA, 1987, POLYURETHANE BIOMEDI, V2, P39
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   NYILAS E, 1977, J BIOMED MATER RES, V8, P69
   OLSON, 1986, ARTIF ORG, V11, P63
   PIZZOFERRATO A, 1986, BIOMATERIALS CLIN AP, P1
   RATHBUN MA, 1991, J BIOMED MATER RES, V25, P443
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Reed A M, 1994, J Biomater Appl, V8, P210, DOI 10.1177/088532829400800303
   SCHMALZ G, 1994, J MATER SCI-MATER M, V5, P43, DOI 10.1007/BF00121153
   SILVER JH, 1993, J BIOMED MATER RES, V27, P1443, DOI 10.1002/jbm.820271111
   STOKES K, 1984, POLYURETHANES BIOMED, P243
   STOKES KB, 1986, PACE, V9, P1160, DOI 10.1111/j.1540-8159.1986.tb06687.x
   STOKES KB, 1985, POLYM MATER SCI ENG, V53, P6
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P1095, DOI 10.1002/jbm.820250905
   TSENG YC, 1990, J BIOMED MATER RES, V24, P1335
   TSUCHIYA T, 1993, J BIOMED MATER RES, V27, P885, DOI 10.1002/jbm.820270707
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 43
TC 24
Z9 25
U1 1
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 1998
VL 41
IS 4
BP 633
EP 648
DI 10.1002/(SICI)1097-4636(19980915)41:4<633::AID-JBM16>3.0.CO;2-F
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 104KM
UT WOS:000075013600016
PM 9697037
DA 2018-10-19
ER

PT J
AU Abraham, GA
   Frontini, PM
   Cuadrado, TR
AF Abraham, GA
   Frontini, PM
   Cuadrado, TR
TI Molding of biomedical segmented polyurethane delamination events and
   stretching behavior
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE segmented polyurethane devices; solution-casting technique;
   delamination; demolding technique; tensile properties
ID DEGRADATION; ELASTOMER
AB Segmented polyurethane devices for medical applications are generally processed by the solution-casting technique. The processing parameters in the molding and demolding stages strongly affect the physicochemical properties of the finished articles. Thus, the solution concentration, immersion cycle and drying temperature, type of mold (material and geometry), additives, and the drying time between the casting of successive layers define the surface and bulk properties of the manufactured articles. In this work, new commercially available medical-grade segmented polyurethanes were processed by two techniques to obtain multilayer films. Processing parameters were chosen to ensure the generation of a coating with the desired structural and surface characteristics. In the solution-casting technique, multiple dipping of the preshaped former into the polymer solution were used to obtain proper film thickness. Thin and uniform plaques were produced by the spin-casting technique. The two materials selected have different chemical compositions: one is an aromatic poly(ether urethane urea) (Biospan(TM)) and the other an aromatic ether-free polyurethane (Chronoflex(TM)). An analysis of the possibility of delamination events, considering the influence of surface-modifying additives and drying times, is presented. The freeze-fracture surface appearance is qualitatively described by SEM. In addition, tensile properties are determined and their influence on demolding and assembling procedures are also discussed. (C) 1998 John Wiley & Sons, Inc.
C1 Univ Mar del Plata, Inst Mat Sci & Technol, INTEMA, Natl Res Council,CONICET, RA-7600 Mar Del Plata, Argentina.
RP Abraham, GA (reprint author), Univ Mar del Plata, Inst Mat Sci & Technol, INTEMA, Natl Res Council,CONICET, JB Justo 4302, RA-7600 Mar Del Plata, Argentina.
RI Abraham, Gustavo/E-2820-2014
OI Abraham, Gustavo/0000-0001-7094-1031
CR Abraham GA, 1997, J APPL POLYM SCI, V65, P1193, DOI 10.1002/(SICI)1097-4628(19970808)65:6<1193::AID-APP15>3.0.CO;2-V
   AHN TO, 1994, J APPL POLYM SCI, V51, P43, DOI 10.1002/app.1994.070510105
   CABLE M, 1996, 5 WORLD BIOM C TOR C
   *CARD TECH INT, PROD INF
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V49, P815, DOI 10.1002/app.1993.070490507
   Galletti PM, 1996, J BIOMED MATER RES, V32, P289
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LELAH MD, 1989, POLYURETHANES MED, P73
   LIOTTA D, 1994, ASSISTED CIRCULATION, V4
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MARCUS GE, 1988, ANTHROPOL QUART, V61, P3, DOI 10.2307/3317867
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   Orang F, 1996, BIOMATERIALS, V17, P485, DOI 10.1016/0142-9612(96)82722-0
   PHILLIPS WM, 1985, SYNTHETIC BIOMEDICAL
   PIERCE WS, 1967, T AM SOC ART INT ORG, V13, P299
   *POLYM TECHN GROUP, PROD INF
   Szycher Michael, 1994, P233
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   WANG TLD, 1993, J POLYM SCI POL CHEM, V31, P1983, DOI 10.1002/pola.1993.080310806
   WARD RS, 1995, MED PLASTICS BIOMATE
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
NR 22
TC 4
Z9 4
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 12
PY 1998
VL 69
IS 11
BP 2159
EP 2167
DI 10.1002/(SICI)1097-4628(19980912)69:11<2159::AID-APP7>3.0.CO;2-F
PG 9
WC Polymer Science
SC Polymer Science
GA 106CP
UT WOS:000075112400007
DA 2018-10-19
ER

PT J
AU Hooper, KA
   Macon, ND
   Kohn, J
AF Hooper, KA
   Macon, ND
   Kohn, J
TI Comparative histological evaluation of new tyrosine-derived polymers and
   poly (L-lactic acid) as a function of polymer degradation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE poly(lactic acid); subcutaneous implantation; tyrosine-derived polymers;
   poly(DTE carbonate); poly(DTE adipate); biocompatibility
ID IN-VIVO DEGRADATION; MEDICAL APPLICATIONS; BIOCOMPATIBILITY;
   POLY(L-LACTIDE); POLYCARBONATES; BIOMATERIALS; TISSUE; IMPLANTATION;
   TOXICITY; FIXATION
AB Previous studies demonstrated that poly(DTE carbonate) and poly (DTE adipate), two tyrosine-derived polymers, have suitable properties for use in biomedical applications. This study reports the evaluation of the in vivo tissue response to these polymers in comparison to poly(L-lactic acid) (PLLA). Typically, the biocompatibility of a material is determined through histological evaluations as a function of implantation time in a suitable animal model. However, due to changes that can occur in the tissue response at different stages of the degradation process, a fixed set of time points is not ideal for comparative evaluations of materials having different rates of degradation. Therefore the tissue response elicited by poly(DTE carbonate), poly(DTE adipate), and PLLA was evaluated as a function of molecular weight. This allowed the tissue response to be compared at corresponding stages of degradation. Poly(DTE adipate) consistently elicited the mildest tissue response, as judged by the width and lack of cellularity of the fibrous capsule formed around the implant. The tissue response to poly(DTE carbonate) was mild throughout the 570 day study. However, the response to PLLA fluctuated as a function of the degree of degradation, exhibiting an increase in the intensity of inflammation as the implant began to lose mass. At the completion of the study, tissue ingrowth into the degrading and disintegrating poly(DTE adipate) implant was evident while no comparative ingrowth of tissue was seen far PLLA. The similarity of the in vivo and in vitro degradation rates of each polymer confirmed the absence of enzymatic involvement in the degradation process. A comparison of molecular weight retention, water uptake, and mass loss in vivo with two commonly used in vitro systems [phosphate-buffered saline (PBS) and simulated body fluid (SBF)] demonstrated that for the two tyrosine-derived polymers the in vivo results were equally well simulated in vitro with PBS and SBF;. However, for PLLA the in vivo results were better simulated in vitro using PBS. (C) 1998 John Wiley & Sons, Inc.
C1 Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA.
RP Kohn, J (reprint author), Rutgers State Univ, Dept Chem, 610 Taylor Rd, Piscataway, NJ 08854 USA.
FU NIGMS NIH HHS [GM49894, GM39455]
CR ALTMAN NH, 1979, LAB RAT, V1, P348
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BERGSMA JE, 1995, J BIOMED MATER RES, V29, P173, DOI 10.1002/jbm.820290206
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   ERTEL SI, 1995, J BIOMED MATER RES, V29, P1337, DOI 10.1002/jbm.820291105
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   FIORDELISO J, 1995, POLYM BIOMATERIALS S, P695
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   GOURLAY SJ, 1978, J BIOMED MATER RES, V12, P219, DOI 10.1002/jbm.820120207
   HOLLANDER CF, 1976, LAB ANIM SCI, V26, P320
   Hooper KA, 1995, J BIOACT COMPAT POL, V10, P327, DOI 10.1177/088391159501000404
   Hooper KA, 1997, J APPL POLYM SCI, V63, P1499, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1499::AID-APP12>3.0.CO;2-Y
   JAMES KS, 1997, 23 ANN M SOC BIOM NE, P120
   Jansen J A, 1994, J Invest Surg, V7, P123, DOI 10.3109/08941939409015356
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   Lewis D. H., 1990, BIODEGRADABLE POLYM, P1
   LORD GF, 1986, TECHNIQUES BIOCOMPAT, V1, P5
   PISTNER H, 1993, BIOMATERIALS, V14, P671, DOI 10.1016/0142-9612(93)90066-B
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Pulapura S, 1992, J Biomater Appl, V6, P216, DOI 10.1177/088532829200600303
   SUGANUMA J, 1993, J APPL BIOMATER, V4, P13, DOI 10.1002/jab.770040103
   TURNER JE, 1973, J BIOMED MATER RES, V7, P39, DOI 10.1002/jbm.820070104
   VANSLIEDREGT A, 1994, BIOMATERIALS, V15, P251, DOI 10.1016/0142-9612(94)90047-7
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P1115, DOI 10.1002/jbm.820270817
   ZHOU J, 1994, 20 ANN M SOC BIOM BO, P371
NR 30
TC 73
Z9 76
U1 1
U2 13
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 1998
VL 41
IS 3
BP 443
EP 454
DI 10.1002/(SICI)1097-4636(19980905)41:3<443::AID-JBM14>3.0.CO;2-J
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ZX504
UT WOS:000074523300014
PM 9659614
DA 2018-10-19
ER

PT J
AU Sosabowski, MH
   Herson, K
   Lloyd, AW
AF Sosabowski, MH
   Herson, K
   Lloyd, AW
TI Implementation and student assessment of Intranet-based learning
   resources
SO AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION
LA English
DT Article
ID PHARMACY STUDENTS; COMPUTER
AB The recent development of Web browsers and tools has enabled the wider use of the Internet for learning and teaching. Such developments have also provided effective methods of information management within institutions through the establishments of Intranets. Within the School of Pharmacy and Biomedical Sciences, University of Brighten, UK, the use of the Intranet has been extended to provide an integrated learning resource to enhance the quality of pharmacy education. The Pharmacy Intranet was developed as a learning support management system for module courses across the Department providing course information, directed access to Internet-based learning support material, academic lecture notes, links to relevant computer aided learning (CAL) packages and worksheets within a structured framework. Electronic monitoring of Intranet usage and subsequent questionnaire-based evaluation demonstrated that the Intranet was deemed to be a useful learning resource, empowering students to take greater responsibility for their own learning.
C1 Brighton Univ, Sch Pharm & Biomed Sci, Brighton BN2 4GJ, E Sussex, England.
RP Sosabowski, MH (reprint author), Brighton Univ, Sch Pharm & Biomed Sci, Cockcroft Bldg, Brighton BN2 4GJ, E Sussex, England.
EM M.H.Sosabowski@Brighton.ac.uk
RI Lloyd, Andrew/D-1369-2011
OI Lloyd, Andrew/0000-0003-2778-8195
CR Blackmore P, 1997, ASLIB PROC, V49, P67, DOI 10.1108/eb051451
   Chandra A, 1996, AM J PHARM EDUC, V60, P297
   DEARING R, 1997, NATL COMMITTEE INQUI, V8, P118
   Kaplan IP, 1996, AM J PHARM EDUC, V60, P422
   MORRELL P, 1997, ASLIB P, V49, P7
   MURALI R, 1997, AM J PHARM EDUC, V61, P141
   Sylvester RK, 1997, AM J PHARM EDUC, V61, P50
   TYSINGER JW, 1995, AM J PHARM EDUC, V59, P43
NR 8
TC 5
Z9 5
U1 0
U2 6
PU AMER ASSOC COLL PHARMACY
PI ALEXANDRIA
PA 1426 PRINCE STREET, ALEXANDRIA, VA 22314-2815 USA
SN 0002-9459
J9 AM J PHARM EDUC
JI Am. J. Pharm. Educ.
PD FAL
PY 1998
VL 62
IS 3
BP 302
EP 306
PG 5
WC Education, Scientific Disciplines; Pharmacology & Pharmacy
SC Education & Educational Research; Pharmacology & Pharmacy
GA 139EM
UT WOS:000077015000011
DA 2018-10-19
ER

PT J
AU Sharp, MK
   Mohammad, SF
AF Sharp, MK
   Mohammad, SF
TI Scaling of hemolysis in needles and catheters
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE blood; blood damage; shear stress; cannula
ID FLOW; CELL
AB Hemolysis in clinical blood samples leads to inaccurate assay results and often to the need for repeated blood draws. In vitro experiments were conducted to determine the influence on hemolysis in phlebotomy needles and catheters of pressure difference, cannula diameter, and cannula material. Fresh blood from five human volunteers was forced from a syringe inside a pressurized chamber through 14, 18, and 27 gauge 304 stainless steel needles and polyurethane and Teflon(R) catheters, all 40 mm long. Hemolysis was measured in the samples by a spectrophotometer. It was found that hemolysis increased with increases in pressure difference and cannula diameter and no consistent trend could be identified with regard to cannula material. The pressure differences required for significant hemolysis were above those typical of clinical venipuncture blood draws. While there was substantial variability among individuals, the hemolysis values scaled with exponent S=(t/t(0))[(tau/tau(0)) - 1](2), where t is the characteristic duration of shear, t(0) is a time constant, tau is the wall shear stress, and tau(0) is the wall shear stress threshold below which no hemolysis occurs. A hemolysis threshold including both time and shear stress was also defined for S= constant. The threshold implies that a threshold shear stress exists below which erythrocytes are not damaged for any length of exposure time, but that red cells may be damaged by an arbitrarily short period of exposure to sufficiently large shear stress. (C) 1998 Biomedical Engineering Society. [S0090-6964(98)02805-7].
C1 Univ Utah, Dept Civil & Environm Engn, Biofluid Mech Lab, Salt Lake City, UT 84112 USA.
   Univ Utah, Artificial Heart Res Lab, Salt Lake City, UT USA.
RP Sharp, MK (reprint author), Univ Utah, Dept Civil & Environm Engn, Biofluid Mech Lab, 160 S Cent Campus Dr,Rm 104, Salt Lake City, UT 84112 USA.
EM m.k.sharp@m.cc.utah.edu
CR BACHER RP, 1970, J LAB CLIN MED, V76, P485
   BEISSINGER RL, 1987, AICHE J, V33, P99, DOI 10.1002/aic.690330112
   BESSIS M, 1975, BLOOD CELLS, V1, P229
   BESSIS M, 1977, BLOOD CELLS, V3, P307
   Blackshear PL, 1987, HDB BIOENGINEERING, P151
   CHANDRAN KB, 1983, J BIOMECH, V16, P865, DOI 10.1016/0021-9290(83)90011-8
   CHANDRAN KB, 1984, J BIOMECH, V17, P9
   COAKLEY WT, 1977, BIORHEOLOGY, V14, P91
   COKELET GR, 1980, ANNU REV PHYSIOL, V42, P311, DOI 10.1146/annurev.ph.42.030180.001523
   FISCHER TM, 1980, BIOPHYS J, V32, P863, DOI 10.1016/S0006-3495(80)85022-3
   Forstrom R. J., 1969, THESIS U MINNESOTA M
   Goldsmith H L, 1972, Prog Hemost Thromb, V1, P97
   GOLDSMITH HL, 1971, FED PROC, V30, P1578
   GOLDSMITH HL, 1974, T AM SOC ART INT ORG, VA 20, P21
   GOLDSMITH HL, 1972, 13 IUTAM C
   Hellums JD, 1977, CARDIOVASCULAR FLOW, P799
   HELLUMS JD, 1981, RHEOLOGY BLOOD BLOOD, P160
   JONES SA, 1995, UNPUB P 1995 BIOENG, P557
   KESHAVIAH PR, 1974, THESIS U MINNESOTA S
   Lee CS, 1996, J BIOMECH ENG-T ASME, V118, P97, DOI 10.1115/1.2795951
   LEUER L, 1986, UNPUB ANN M CAN COUN
   *NIH, 1985, NIH PUBL, P78
   NIIMI H, 1985, J BIOMECH ENG-T ASME, V107, P91, DOI 10.1115/1.3138541
   RAISKY F, 1994, ANN BIOL CLIN-PARIS, V52, P523
   RAND RP, 1964, BIOPHYS J, V4, P303, DOI 10.1016/S0006-3495(64)86784-9
   ROONEY JA, 1970, SCIENCE, V169, P869, DOI 10.1126/science.169.3948.869
   SUTERA SP, 1977, CIRC RES, V41, P2, DOI 10.1161/01.RES.41.1.2
   THURSTON GB, 1989, BIORHEOLOGY, V26, P199
   WILLIAMS A R, 1973, Biorheology, V10, P313
   WILLIAMS AR, 1970, SCIENCE, V169, P871, DOI 10.1126/science.169.3948.871
NR 30
TC 58
Z9 58
U1 0
U2 11
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP-OCT
PY 1998
VL 26
IS 5
BP 788
EP 797
DI 10.1114/1.65
PG 10
WC Engineering, Biomedical
SC Engineering
GA 124ZV
UT WOS:000076213500008
PM 9779951
DA 2018-10-19
ER

PT J
AU Sacks, MS
   Chuong, CJ
AF Sacks, MS
   Chuong, CJ
TI Orthotropic mechanical properties of chemically treated bovine
   pericardium
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE chemical fixation; constitutive modeling; bioprostheses; heart valves;
   small angle light scattering
ID TENSILE VISCOELASTIC PROPERTIES; BIOPROSTHETIC HEART-VALVE; COLLAGEN
   FIBER ARCHITECTURE; CANINE PERICARDIUM; BIAXIAL STRESS; TISSUE;
   QUANTIFICATION; XENOGRAFT; STIFFNESS; FIXATION
AB To facilitate bioprosthetic heart valve design, especially in the use of novel antimineralization chemical technologies, a thorough understanding of the multiaxial mechanical properties of chemically treated bovine pericardium (BP) is needed. In this study. we utilized a small angle light scattering based tissue pre-sorting procedure to select BP specimens with a high degree of structural uniformity. Both conventional glutaraldehyde (GL) and photo-oxidation (PO) chemical treatment groups were studied, with untreated tissue used as the control group. A second set of GL and PO groups was prepared by prestretching them along the preferred fiber direction during the chemical treatment. An extensive biaxial test protocol was used and the resulting stress-strain data fitted to an exponential strain energy Function. The high structural uniformity resulted in both a consistent mechanical response and low variability in the material constants. For free fixed tissues, the strain energy per unit volume for GL treated BP was similar to 2.8 times that of PO treated BP at an equibiaxial Green's strain level of 0.16. Prestretched tissues exhibited a profound increase in both stiffness and the degree of anisotropy, with the GL treatment demonstrating a greater effect. Thus, structural control leads to an improved understanding of chemically treated BP mechanical propel-ties. Judicious use of this knowledge can facilitate the design and enhanced long-term performance of bioprosthetic heart valves. (C) 1998 Biomedical Engineering Society.
C1 Univ Miami, Dept Biomed Engn, Coral Gables, FL USA.
   Univ Texas, Biomed Engn Program, Arlington, TX 76019 USA.
RP Sacks, MS (reprint author), Univ Pittsburgh, Dept Bioengn, 742 Benedum Engn Hall, Pittsburgh, PA 15261 USA.
EM msacks@engrng.pitt.edu
CR Billiar KL, 1997, J BIOMECH, V30, P753, DOI 10.1016/S0021-9290(97)00019-5
   BLACK MM, 1991, J BIOMECH, V24, P793, DOI 10.1016/0021-9290(91)90304-6
   CHEW PH, 1986, J MOL CELL CARDIOL, V18, P567, DOI 10.1016/S0022-2828(86)80965-8
   CHOI HS, 1990, J BIOMECH ENG-T ASME, V112, P153, DOI 10.1115/1.2891166
   CHRISTIE CW, 1982, FINITE ELEMENT BIOME, P153
   DEMIRAY H, 1972, J BIOMECH, V5, P308
   DOWNS J, 1990, IEEE T BIO-MED ENG, V37, P903, DOI 10.1109/10.58600
   FUNG Y, 1965, INT SERIES DYNAMICS, P525
   Fung Y.-C., 1993, BIOMECHANICS MECH PR, P568, DOI [10.1007/978-1-4757-2257-4, DOI 10.1007/978-1-4757-2257-4]
   HAMID MS, 1986, J BIOMECH, V19, P759, DOI 10.1016/0021-9290(86)90199-5
   Haziza F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   HUMPHREY JD, 1987, J BIOMECH, V20, P59, DOI 10.1016/0021-9290(87)90267-3
   HWANG NHC, 1982, CRIT REV BIOMED ENG, V9, P99
   KRUCINSKI S, 1993, J BIOMECH, V26, P929, DOI 10.1016/0021-9290(93)90055-J
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   LEE JM, 1984, J BIOMED MATER RES, V18, P61, DOI 10.1002/jbm.820180108
   LEE JM, 1989, J BIOMED MATER RES, V23, P491, DOI 10.1002/jbm.820230504
   MAYNEWMAN K, 1995, AM J PHYSIOL-HEART C, V269, pH1319
   MOORE MA, 1994, J BIOMED MATER RES, V28, P611, DOI 10.1002/jbm.820280511
   MOORE MW, 1996, J BIOMED MATER RES, V32, P20
   Press W. H., 1988, NUMERICAL RECIPES C, P735
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845
   SACKS MS, 1992, J BIOMECH ENG-T ASME, V114, P183, DOI 10.1115/1.2891370
   SACKS MS, 1993, J BIOMECH ENG-T ASME, V115, P202, DOI 10.1115/1.2894122
   Schoen F J, 1992, Cardiovasc Pathol, V1, P29, DOI 10.1016/1054-8807(92)90006-A
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   THUBRIKAR MJ, 1986, AM J CARDIOL, V58, P304, DOI 10.1016/0002-9149(86)90067-6
   Vesely I, 1996, ASAIO J, V42, P993, DOI 10.1097/00002480-199642060-00012
   YIN FCP, 1986, J BIOMECH, V19, P27, DOI 10.1016/0021-9290(86)90106-5
   YIN FCP, 1987, J BIOMECH, V20, P577, DOI 10.1016/0021-9290(87)90279-X
   ZIOUPOS P, 1994, BIOMATERIALS, V15, P366, DOI 10.1016/0142-9612(94)90249-6
   ZIOUPOS P, 1994, J BIOMED MATER RES, V28, P49, DOI 10.1002/jbm.820280107
NR 35
TC 108
Z9 108
U1 2
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP-OCT
PY 1998
VL 26
IS 5
BP 892
EP 902
DI 10.1114/1.135
PG 11
WC Engineering, Biomedical
SC Engineering
GA 124ZV
UT WOS:000076213500019
PM 9779962
DA 2018-10-19
ER

PT J
AU Long, M
   Rack, HJ
AF Long, M
   Rack, HJ
TI Titanium alloys in total joint replacement - a materials science
   perspective
SO BIOMATERIALS
LA English
DT Review
DE titanium; titanium alloys; total joint replacement; orthopaedics;
   fatigue; wear; biocompatibility
ID ION-IMPLANTED TI-6AL-4V; POLYETHYLENE WEAR; FRETTING-WEAR; SURFACE
   CHARACTERIZATION; MECHANICAL-PROPERTIES; KNEE REPLACEMENT; ACETABULAR
   CUPS; SLIDING WEAR; BEHAVIOR; FRICTION
AB Increased use of titanium alloys as biomaterials is occurring due to their lower modulus, superior biocompatibility and enhanced corrosion resistance when compared to more conventional stainless steels and cobalt-based alloys. These attractive properties were a driving force for the early introduction of alpha (cpTi) and alpha + beta (Ti-6A1-4V) alloys as well as for the more recent development of new Ti-alloy compositions and orthopaedic metastable beta titanium alloys. The later possess enhanced biocompatibility, reduced elastic modulus, and superior strain-controlled and notch fatigue resistance. However, the poor shear strength and wear resistance of titanium alloys have nevertheless limited their biomedical use. Although the wear resistance of beta-Ti alloys has shown some improvement when compared to alpha + beta alloys, the ultimate utility of orthopaedic titanium alloys as wear components will require a more complete fundamental understanding of the wear mechanisms involved. This review examines current information on the physical and mechanical characteristics of titanium alloys used in artifical joint replacement prostheses, with a special focus on those issues associated with the long-term prosthetic requirements, e.g., fatigue and wear. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
C1 Clemson Univ, Sch Chem & Mat Engn, Clemson, SC 29634 USA.
RP Rack, HJ (reprint author), Clemson Univ, Sch Chem & Mat Engn, Clemson, SC 29634 USA.
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   AHMED T, 1995, 8 WORLD TIT C BIRM U
   *AM AC ORTH SURG, 1995, OTH RES SOC ANN M OR
   ARDILL J, 1995, THESIS QUEENS U BELF
   ARGENSON JN, 1992, J BONE JOINT SURG BR, V74, P228
   BANIA PJ, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P3
   BERRY DJ, 1993, CLIN ORTHOP RELAT R, V293, P204
   BERTHIER Y, 1989, TRIBOL INT, V22, P235, DOI 10.1016/0301-679X(89)90081-9
   BERTHIER Y, 1992, EUR C BRAK LILL FRAN, P1
   BILL RC, 1985, WEAR, V106, P283, DOI 10.1016/0043-1648(85)90113-9
   BLACK J, 1990, J BONE JOINT SURG AM, V72A, P126, DOI 10.2106/00004623-199072010-00021
   Black J., 1992, BIOL PERFORMANCE MAT
   BLANCHARD P, 1991, METALL TRANS A, V22, P1535, DOI 10.1007/BF02667367
   BOROWY KH, 1995, TITANIUM 84 SCI TECH, V2, P1381
   BOYER RR, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P77
   Boyer RR, 1987, MICROSTRUCTURE FRACT, P149
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P367, DOI 10.1002/jbm.820210309
   BUDINSKI KG, 1991, WEAR, V151, P203, DOI 10.1016/0043-1648(91)90249-T
   CATES HE, 1993, J BONE JOINT SURG BR, V75, P249
   CHARNLEY J, 1970, CLIN ORTHOP RELAT R, P7
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   CHENGWEI C, 1995, TRIBOL T, V38, P875
   CHESNUTT JC, 1978, AFMLTR7868 AIR FORC
   CLARKE IC, 1983, ASTM STP, V796, P136
   COLLINGS EW, 1984, CLEVELAND METALS PAR
   COLOMBIE C, 1987, FATIGUE 87 CHARLOTTE, P567
   COOK SD, 1984, J BIOMED MATER RES, V18, P497, DOI 10.1002/jbm.820180504
   CRAPPER DR, 1993, BIOL ASPECTS METALS, P209
   CRONIN J, 1988, TRIBOL INT, V21, P309, DOI 10.1016/0301-679X(88)90107-7
   DEGATICA NLH, 1993, APPL SURF SCI, V68, P107, DOI 10.1016/0169-4332(93)90220-6
   DOBBS HS, 1983, ASTM STP, V796, P173
   DOWSON D, 1985, POLYM WEAR ITS CONTR, P171
   Dowson D., 1992, BIOMECHANICS DIARTHR, V2, P305
   DOWSON D, 1992, ASM HDB, V18, P656
   Dujovne A R, 1993, J Arthroplasty, V8, P7, DOI 10.1016/S0883-5403(06)80102-6
   Dumbleton J H, 1988, J Biomater Appl, V3, P3, DOI 10.1177/088532828800300101
   Dumbleton J.H., 1991, JOINT REPLACEMENT AR, P47
   Dumbleton JH, 1981, TRIBOLOGY SERIES
   EASTER TL, 1994, P 20 ANN M SOC BIOM, P185
   EBERHARDT AW, 1995, J APPL BIOMATER, V6, P171, DOI 10.1002/jab.770060305
   ENGH CA, 1988, CLIN ORTHOP RELAT R, V231, P7
   ENGH GA, 1992, J BONE JOINT SURG BR, V74, P9
   FANNING JC, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P411
   FANNING JC, 1995, TIMET TECHNICAL LAB
   FAYEULLE S, 1993, TRIBOL T, V36, P267, DOI 10.1080/10402009308983158
   Fisher J, 1991, Proc Inst Mech Eng H, V205, P73, DOI 10.1243/PIME_PROC_1991_205_271_02
   FISHER J, 1994, WEAR, V175, P219, DOI 10.1016/0043-1648(94)90185-6
   FLOWER HM, 1985, TITANIUM 84 SCI TECH, V4, P1651
   FREESE H, 1995, COMMUNICATION
   FRICKER DC, 1990, BIOMATERIALS, V11, P495, DOI 10.1016/0142-9612(90)90064-W
   GALANTE JO, 1973, ACTA ORTHOP SCAND, P1
   GIBBESCH B, 1992, BIOMATERIALS, V13, P455, DOI 10.1016/0142-9612(92)90166-L
   GREGORY JK, 1991, 7 INT M TIT 15 NOV 1
   HEILMANN P, 1983, ACTA METALL MATER, V31, P1293, DOI 10.1016/0001-6160(83)90191-8
   HIRTH JP, 1980, STRENGTH METALS ALLO, V3, P1483
   HOEPPNER DW, 1994, WEAR, V173, P189, DOI 10.1016/0043-1648(94)90272-0
   HONG H, 1989, J TRIBOL-T ASME, V111, P504, DOI 10.1115/1.3261958
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Hutchings I. M., 1992, TRIBOLOGY FRICTION W
   Jacobs JJ, 1994, J AM ACAD ORTHOP SUR, V2, P212
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   JONES SMG, 1992, J BONE JOINT SURG BR, V74, P18
   KABO JM, 1993, J BONE JOINT SURG BR, V75, P254
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   KOVACS P, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2705
   KUHLMAN GW, 1991, MICROSTRUCTURE / PROPERTY RELATIONSHIPS IN TITANIUM ALUMINIDES AND ALLOYS, P465
   KULHMANNWILSDOR.D, 1980, FUNDAMENTALS FRICTIO, P119
   KUO SM, 1992, MAT SCI ENG A-STRUCT, V157, P131, DOI 10.1016/0921-5093(92)90020-2
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LING FW, 1974, METALL TRANS, V5, P179
   Lorenz M., 1978, Engineering in Medicine, V7, P241
   LOWMAN EW, 1955, JAMA-J AM MED ASSOC, V157, P487, DOI 10.1001/jama.1955.02950230001001
   LUTJERING G, 1985, TITANIUM SCI TECHNOL, V4, P2065
   MAUSLI PA, 1988, 6TH P WORLD C TIT, P1759
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   MCKELLOP H, 1981, J BIOMED MATER RES, V15, P619, DOI 10.1002/jbm.820150503
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   MEDLEY JB, 1995, T 21 ANN M SOC BIOM, P47
   MERGET M, 1985, TITANIUM 84 SCI TECH, V4, P1393
   Miller P. D, 1958, WEAR, V2, P133, DOI DOI 10.1016/0043-1648(58)90428-9
   MISHRA AK, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P61
   MOORE MA, 1976, METALL TRANS A, V7, P1833, DOI 10.1007/BF02654978
   MORTON PH, 1989, MEM ETUD SCI REV MET, V86, P639
   MOW VC, 1991, FRICTION LUBRICATION, P245
   NOLAN JF, 1992, J BONE JOINT SURG BR, V74, P23
   NUTT SR, 1983, WEAR MAT, P426
   OKAZAKI Y, 1993, J JPN I MET, V57, P332, DOI 10.2320/jinstmet1952.57.3_332
   OONISHI H, 1992, BIOCERAMICS, V3, P147
   OONISHI T, 1992, BIOCERAMICS, V3, P137
   Park JB, 1992, BIOMATERIALS INTRO
   PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858
   Peters M, 1981, TITANIUM 80 SCI TECH, P1777
   PETERSON CD, 1988, J BIOMED MATER RES, P22
   POGGIE RA, 1992, AM SOC TEST MATER, V1145, P65, DOI 10.1520/STP15333S
   POLMEAR JJ, 1981, LIGHT ALLOYS, pCH6
   Pourbaix M, 1966, ATLAS ELECTROCHEMICA
   PRENDERGAST PJ, 1990, J BIOMED ENG, V12, P379, DOI 10.1016/0141-5425(90)90020-N
   PROTEK AG, 1994, METASUL METAL ON MET
   RAIKAR GN, 1995, J VAC SCI TECHNOL A, V13, P2633, DOI 10.1116/1.579462
   Rice S., 1989, KEY ENG MATER, P77
   RIES MD, 1995, 62 ANN M AM AC ORTH
   RIEU J, 1991, BIOMATERIALS, V12, P139, DOI 10.1016/0142-9612(91)90192-D
   ROSTOKER W, 1981, BIOMATERIALS, V2, P221, DOI 10.1016/0142-9612(81)90061-2
   Rudinger K., 1985, TITANIUM 84 SCI TECH, V4, P2123
   SAIKKO V, 1994, WEAR, V176, P207, DOI 10.1016/0043-1648(94)90148-1
   SAIKKO V, 1993, WEAR, V166, P169, DOI 10.1016/0043-1648(93)90259-O
   SANDSTROM PW, 1993, WEAR, V166, P163, DOI 10.1016/0043-1648(93)90258-N
   SANNINO AP, 1995, WEAR, V189, P1, DOI 10.1016/0043-1648(95)06657-8
   SANTAVIRTA S, 1993, CLIN ORTHOP RELAT R, P100
   SCHUMACHER HR, 1988, PRIMER RHEUMATIC DIS
   SCHUTZ RW, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P75
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   STEIJN RP, 1969, ASLE TRANS, V12, P21
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   STEINEMANN SG, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2689
   STEINEMANN SG, 1985, TITANIUM SCI TECHNOL, V2, P1373
   STREICHER RM, 1991, BIOMATERIALS, V12, P125, DOI 10.1016/0142-9612(91)90190-L
   STREICHER RM, 1990, BIOMED TECH, V35, P78, DOI 10.1515/bmte.1990.35.4.78
   STREICHER RM, 1994, T 20 ANN M SOC BIOM, P323
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, V274, P202
   SUTULA LC, 1995, 62 ANN M AM AC ORTH
   TATEISHI T, 1992, BIOCERAMICS, V2, P145
   TUMMLER HP, 1985, TITANIUM 84 SCI TECH, V2, P1335
   Unsworth A, 1991, Proc Inst Mech Eng H, V205, P163, DOI 10.1243/PIME_PROC_1991_205_287_02
   *US DEP DEF, 1976, MIL HDB MET MAT EL A, V5
   VASSEL A, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P173
   VINCENT L, 1987, TRAITEMENTS SURFACE
   WAGNER L, 1991, MICROSTRUCTURE / PROPERTY RELATIONSHIPS IN TITANIUM ALUMINIDES AND ALLOYS, P521
   WAGNER L, 1991, FATIGUE 90, P323
   WAGNER L, 1985, TITANIUM 84 SCI TECH, V4, P2147
   WALKER PS, 1971, WEAR, V17, P285, DOI 10.1016/0043-1648(71)90032-9
   WANG K, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2697
   WANG K, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P49
   WATERHOUSE RB, 1973, WEAR, V25, P171, DOI 10.1016/0043-1648(73)90069-0
   WATERHOUSE RB, 1974, WEAR, V29, P337, DOI 10.1016/0043-1648(74)90019-2
   WATERHOUSE RB, 1980, WEAR, V60, P357, DOI 10.1016/0043-1648(80)90234-3
   WERT JJ, 1989, KEY ENG MATER, V33, P101
   WHITE SE, 1995, 62 ANN M AM AC ORTH
   WILLIAMS DN, 1971, MCIC7101 BATT COL LA
   WINTER M, 1990, BIOCERAMICS, V2, P436
   WOLFARTH D, 1990, J APPL BIOMATER, V1, P3, DOI 10.1002/jab.770010103
   *WRIGHT MED TECHN, 1995, 62 ANN M AM AC ORTH
   ZWICKER J, 1985, TITANIUM 84 SCI TECH, V2, P1343
   ZWICKER R, 1980, TITANIUM 80 SCI TECH, P505
NR 145
TC 1870
Z9 1972
U1 43
U2 721
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 1998
VL 19
IS 18
BP 1621
EP 1639
DI 10.1016/S0142-9612(97)00146-4
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 137VZ
UT WOS:000076938600001
PM 9839998
DA 2018-10-19
ER

PT J
AU Peterson, NC
   Peavey, JE
AF Peterson, NC
   Peavey, JE
TI Comparison of in vitro monoclonal antibody production methods with an in
   vivo ascites production technique
SO CONTEMPORARY TOPICS IN LABORATORY ANIMAL SCIENCE
LA English
DT Article
AB Economic, technical, legislative, and ethical issues influence decisions concerning alternatives to the use of animals in biomedical research. Since the development of cell hybridoma technology, production of ascites in mice has been a popular technique for generating high concentrations of monoclonal antibodies. However, the availability of several in vitro methods that can be performed in most laboratories make these alternative methods of monoclonal antibody production an attractive option. To evaluate the practicality of the use of in vitro techniques, three tissue culture methods and a technique for production of ascites were compared on the basis of yield, material costs, and time requirements. Analysis of results revealed that the time and material costs to produce 100 mg of monoclonal antibody 7.16.4 by inducing ascites in irradiated mice was similar or slightly more than that for tissue culture in standard plastic flasks and hollow fiber cartridge bioreactors; however, tissue culture in gas permeable bags was slightly less expensive than these methods in terms of cost and time. When ascites production in irradiated mice was compared with tissue culture in plastic flasks or gas permeable bags for monoclonal antibody 225, the in vitro methods were approximately five times more expensive than the ascites production technique. Information reported here outlines factors that should be considered and evaluated when choosing a monoclonal antibody production method. Furthermore, these results documented that in vitro technology for the production of monoclonal antibodies can be adapted by most conventional laboratories to provide sufficient resources for the most commonly performed experimental protocols.
C1 Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
RP Peterson, NC (reprint author), Univ Penn, Dept Pathol & Lab Med, 36 & Hamilton Walk, Philadelphia, PA 19104 USA.
CR *AM ANT SOC, 1997, PET REQ NAT I HLTH P
   AMYX HL, 1987, J AM VET MED ASSOC, V191, P1287
   BRODEUR BR, 1984, J IMMUNOL METHODS, V71, P265, DOI 10.1016/0022-1759(84)90073-5
   BRODEUR BR, 1986, J IMMUNOL METHODS, V86, P239, DOI 10.1016/0022-1759(86)90459-X
   DARBY CR, 1993, J IMMUNOL METHODS, V159, P125, DOI 10.1016/0022-1759(93)90149-2
   DREBIN JA, 1984, NATURE, V312, P545, DOI 10.1038/312545a0
   EVANS TL, 1988, BIOTECHNIQUES, V6, P762
   FALKENBERG FW, 1993, J IMMUNOL METHODS, V165, P193, DOI 10.1016/0022-1759(93)90345-8
   FALKENBERG FW, 1995, J IMMUNOL METHODS, V179, P13, DOI 10.1016/0022-1759(94)00266-Y
   FEDERSPIEL G, 1991, J IMMUNOL METHODS, V145, P213, DOI 10.1016/0022-1759(91)90329-E
   GILL GN, 1984, J BIOL CHEM, V259, P7755
   GORTER A, 1993, J IMMUNOL METHODS, V161, P145, DOI 10.1016/0022-1759(93)90289-J
   Guide for the Care and the Use of Laboratory Animals, 1996, GUID CAR US LAB AN
   HOOVER CS, 1990, BIOTECHNIQUES, V8, P76
   Jackson LR, 1996, J IMMUNOL METHODS, V189, P217, DOI 10.1016/0022-1759(95)00251-0
   KNAZEK RA, 1972, SCIENCE, V178, P65, DOI 10.1126/science.178.4056.65
   Marx U, 1997, ATLA-ALTERN LAB ANIM, V25, P121
   MCGILL MW, 1989, ILAR NEWS, V31, P7
   MUELLER UW, 1986, J IMMUNOL METHODS, V87, P193, DOI 10.1016/0022-1759(86)90530-2
   *NIH, 1997, WORKSH J HOPK CTR AL
   NOEMAN SA, 1982, J IMMUNOL METHODS, V55, P319, DOI 10.1016/0022-1759(82)90091-6
   POTTER M, 1972, J NATL CANCER I, V49, P305
   SJOGRENJANSSON E, 1991, HYBRIDOMA, V10, P411, DOI 10.1089/hyb.1991.10.411
   TARLETON RL, 1991, BIOTECHNIQUES, V11, P590
   VELEZ D, 1986, J IMMUNOL METHODS, V86, P45, DOI 10.1016/0022-1759(86)90263-2
NR 25
TC 9
Z9 10
U1 0
U2 2
PU AMER ASSOC LABORATORY ANIMAL SCIENCE
PI MEMPHIS
PA 9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA
SN 1060-0558
J9 CONTEMP TOP LAB ANIM
JI Contemp. Top. Lab. Anim. Sci.
PD SEP
PY 1998
VL 37
IS 5
BP 61
EP 66
PG 6
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA V2596
UT WOS:000165287500003
PM 12456135
DA 2018-10-19
ER

PT J
AU Becker, JS
   Dietze, HJ
AF Becker, JS
   Dietze, HJ
TI Ultratrace and precise isotope analysis by double-focusing sector field
   inductively coupled plasma mass spectrometry
SO JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY
LA English
DT Article; Proceedings Paper
CT Winter Conference on Plasma Spectrochemistry
CY JAN 05-10, 1998
CL SCOTTSDALE, AZ
DE calcium, magnesium and potassium; isotope analysis; double-focusing
   sector field mass spectrometry; high-purity samples; inductively coupled
   plasma; long-lived radionuclides; ultratrace analysis; zirconium oxide
ID LIQUID-LIQUID-EXTRACTION; BIOMEDICAL-RESEARCH; RATIO MEASUREMENT;
   INVITED LECTURE; ICP-MS; TRACE; MULTIELEMENT; ELEMENTS; INTERFERENCES;
   IONIZATION
AB Double-focusing sector field inductively coupled plasma source mass spectrometry with its capability of providing a very sensitive multi-element analysis has been established for the determination of trace and ultratrace elements in high-purity materials, environmental samples and radioactive waste materials. Some applications of double-focusing sector field ICP-MS for the multi-element analysis of trace and ultratrace impurities in high-purity inorganic materials are described. A, matrix separation procedure for ZrO(2) by liquid-liquid extraction after microwave-induced dissolution in an acid mixture is proposed in order to determine ultratrace impurities. The detection limits of ICP-MS reached after matrix separation in solid samples are in the low ng g(-1) concentration range, The detection limits in ICP-MS (determined by the blank values of the chemicals used) are comparable to those of solid-state mass spectrometry, which allows the direct determination of trace impurities in high-purity solids. Isotope ratio measurements of Mg, K and Ca were performed to investigate the transport phenomena of nutrient solutions in plants by tracer experiments using highly enriched (25)Mg, (26)Mg, (41)K, (42)Ca and (44)Ca isotopes. In order to separate the (38)ArH(+) and (40)ArH(+) ions from the (39)K(+) and (41)K(+) analyte ions for potassium isotope ratio measurements, double-focusing sector field ICP-MS with an ultrasonic nebulizer was used at a mass resolution of 9000, The precision of potassium isotope ratio measurements was 0.7% (at a potassium concentration of 100 pg l(-1)). Isotope ratios of Mg and Ca teach at a concentration of 50 mu g l(-1) were determined at a mass resolution of 3000 with a precision of 0.4 and 0.5% on real biological samples. The accuracy of isotope ratio measurements of K and Mg was determined using isotopic standard reference materials with natural isotope composition (NBS SRM 985 and 980), The results of isotope ratio measurements of K, Mg and Ca on real biological samples doped with enriched stable isotopes are discussed.
C1 Forschungszentrum Julich, Zent Abt Chem Anal, D-52425 Julich, Germany.
RP Becker, JS (reprint author), Forschungszentrum Julich, Zent Abt Chem Anal, Postfach 1913, D-52425 Julich, Germany.
CR Alvarado JS, 1996, J ANAL ATOM SPECTROM, V11, P923, DOI 10.1039/ja9961100923
   BARANOV VI, 1998, 1998 WINT C PLASM SP, P301
   Barinaga CJ, 1996, FRESEN J ANAL CHEM, V355, P487
   Barnes RM, 1996, FRESEN J ANAL CHEM, V355, P433
   Becker JS, 1996, J ANAL ATOM SPECTROM, V11, P643, DOI 10.1039/ja9961100643
   Becker JS, 1997, FRESEN J ANAL CHEM, V359, P338, DOI 10.1007/s002160050583
   Becker JS, 1997, J ANAL ATOM SPECTROM, V12, P881, DOI 10.1039/a702178j
   BECKER JS, 1996, BERICHTE FORSCHUNGSZ, V3272, P143
   BECKER JS, 1998, IN PRESS SPECTROCH B, V53
   BECKER JS, 1997, ADV MASS SPECTROM, V14, P681
   BECKER JS, IN PRESS J ANAL AT S
   BECKER JS, 1994, AD MASS SPECTROM, V14
   BECKER JS, 1997, BER FORSCHUNGSZENTRU, V3468, P1
   Bowman J, 1997, J ANAL ATOM SPECTROM, V12, P313, DOI 10.1039/a605704g
   Brenner IB, 1997, J ANAL ATOM SPECTROM, V12, P273, DOI 10.1039/a605533h
   DAHMEN J, 1996, FRESEN J ANAL CHEM, V359, P410
   DELAETER JR, 1991, PURE APPL CHEM, V63, P991
   Doring T, 1997, FRESEN J ANAL CHEM, V359, P382, DOI 10.1007/s002160050592
   Eiden GC, 1997, RAPID COMMUN MASS SP, V11, P37, DOI 10.1002/(SICI)1097-0231(19970115)11:1<37::AID-RCM815>3.0.CO;2-C
   EIDEN GC, 1998, 1998 WINT C PLASM SP, P299
   Feldmann J, 1996, ANAL COMMUN, V33, P11, DOI 10.1039/ac9963300011
   Fletcher IR, 1997, INT J MASS SPECTROM, V163, P1, DOI 10.1016/S0168-1176(96)04540-5
   Gastel M, 1997, SPECTROCHIM ACTA B, V52, P2051, DOI 10.1016/S0584-8547(97)00111-0
   HALLIDAY AN, 1995, INT J MASS SPECTROM, V146, P21, DOI 10.1016/0168-1176(95)04200-5
   HEUMANN KG, 1992, INT J MASS SPECTROM, V118, P575, DOI 10.1016/0168-1176(92)85076-C
   HEUMANN KG, IN PRESS J ANAL AT S
   HEUMANN KG, 1998, 1998 WINT C PLASM SP, P302
   Hieftje GM, 1996, J ANAL ATOM SPECTROM, V11, P613, DOI 10.1039/ja9961100613
   Hoppstock K, 1997, ATOM SPECTROSC, V18, P180
   HOUK RS, 1994, ACCOUNTS CHEM RES, V27, P33
   HOUK RS, 1998, 1998 WINT C PLASM SP, P295
   JIANG SJ, 1988, ANAL CHEM, V60, P1217, DOI 10.1021/ac00162a023
   KERKL W, 1997, AD MASS SPECTROM, V14
   Kerl W, 1996, J ANAL ATOM SPECTROM, V11, P723, DOI 10.1039/ja9961100723
   Kerl W, 1997, FRESEN J ANAL CHEM, V359, P407, DOI 10.1007/s002160050598
   KERL W, IN PRESS FRESENIUS J
   KERL W, 1998, 1998 WINT C PLASM SP, P401
   KIM CK, 1992, J RADIOAN NUCL CH AR, V156, P201, DOI 10.1007/BF02037434
   KIM S, 1998, 1998 WINT C PLASM SP, P368
   KOBOTA M, 1989, ANAL SCI, V5, P701
   KOHL N, 1996, FRESEN J ANAL CHEM, V359, P317
   KOPPENAAL DW, 1998, WINT C PLASM SPECTR, P294
   KUHN AJ, 1997, HOLZFORSCHUNG, V51, P1
   MARRIOTT P, 1998, WINT C PLASM SPECTR, P360
   McLafferty FW, 1995, ADV MASS SPECTROM, V13, P115
   Moens L, 1997, FRESEN J ANAL CHEM, V359, P309, DOI 10.1007/s002160050579
   Montaser A., 1998, INDUCTIVELY COUPLED
   NONOSE NS, 1994, SPECTROCHIM ACTA B, V49, P955, DOI 10.1016/0584-8547(94)80084-7
   NUI H, 1996, SPECTROCHIM ACTA B, V51, P779
   Panday VK, 1996, ATOM SPECTROSC, V17, P98
   Panday VK, 1996, ANAL CHIM ACTA, V329, P153, DOI 10.1016/0003-2670(96)00138-9
   PAUCOT H, 1998, 1998 WINT C PLASM SP, P350
   REED NM, 1994, J ANAL ATOM SPECTROM, V9, P881, DOI 10.1039/ja9940900881
   Riondato J, 1997, J ANAL ATOM SPECTROM, V12, P933, DOI 10.1039/a701652b
   SCHRODER W, UNPUB
   SPEAKMAN J, 1998, 1998 WINT C PLASM SP, P357
   Sturup S, 1997, J ANAL ATOM SPECTROM, V12, P919, DOI 10.1039/a704079b
   TANNER SD, 1995, ATOM SPECTROSC, V16, P16
   TANNER SD, 1988, 1998 WINT C PLASM SP, P296
   Taylor DB, 1996, J ANAL ATOM SPECTROM, V11, P187, DOI 10.1039/ja9961100187
   Vanhaecke F, 1996, ANAL CHEM, V68, P567, DOI 10.1021/ac9507247
   Vanhaecke F, 1997, ANAL CHEM, V69, P268, DOI 10.1021/ac960740j
   Vanhaecke F, 1996, J ANAL ATOM SPECTROM, V11, P543, DOI 10.1039/ja9961100543
   WALDER AJ, 1993, ANAL SCI, V9, P675, DOI 10.2116/analsci.9.675
   WALDER AJ, 1993, J ANAL ATOM SPECTROM, V8, P19, DOI 10.1039/ja9930800019
   WIEDERIN D, 1998, 1998 WINT C PLASM SP, P349
   Yamasaki SI, 1991, ANAL SCI, V7, P1135, DOI 10.2116/analsci.7.Supple_1135
NR 67
TC 47
Z9 48
U1 0
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0267-9477
J9 J ANAL ATOM SPECTROM
JI J. Anal. At. Spectrom.
PD SEP
PY 1998
VL 13
IS 9
BP 1057
EP 1063
DI 10.1039/a801528g
PG 7
WC Chemistry, Analytical; Spectroscopy
SC Chemistry; Spectroscopy
GA 121FP
UT WOS:000076002900035
DA 2018-10-19
ER

PT J
AU Whitson, BA
   Cheng, BC
   Kokini, K
   Badylak, SF
   Patel, U
   Morff, R
   O'Keefe, CR
AF Whitson, BA
   Cheng, BC
   Kokini, K
   Badylak, SF
   Patel, U
   Morff, R
   O'Keefe, CR
TI Multilaminate resorbable biomedical device under biaxial loading
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE multilaminate sheet; biaxial testing; ball burst test; rehydration
   effects; small intestinal submucosa
ID SMALL-INTESTINAL SUBMUCOSA; PRESSURE; GRAFT; DOG
AB The design and test of a multilaminate sheet developed for a hernia repair application is presented. As biomaterial applications become more complex, characterization of uniaxial properties becomes insufficient and biaxial testing becomes necessary. A measure of the in-plane biaxial strength of the device is inferred from a ball burst test. The results of this test for different thicknesses of the device are correlated with the uniaxial strength of the material, A biaxial test such as the ball burst test is more indicative of the properties of a planar material than would be a uniaxial test. The interactions in the biaxial mode of failure are of value and can be related hack to a classical uniaxial tensile test from the ball burst test, The material used in this study to fabricate the device was a resorbable biomaterial called small intestinal submucosa (SIS), The effects of rehydration on the stiffness and associated hall burst properties of the SIS device were also measured, It is shown that at a rehydration time of 5 min from a reference dry state, steady-state mechanical properties are reached. (C) 1998 John Wiley & Sons, Inc.
C1 Purdue Univ, W Lafayette, IN 47907 USA.
   Univ Wisconsin, Madison, WI 53706 USA.
RP Kokini, K (reprint author), Purdue Univ, W Lafayette, IN 47907 USA.
OI Badylak, Stephen/0000-0003-3555-0689
CR ASPDEN RM, 1987, CLIN BIOMECH, V2, P168, DOI 10.1016/0268-0033(87)90010-6
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1993, IN PRESS J BIOMED MA, P179
   BADYLAK SF, INPRESS J BIOMED MAT
   CLARKE KM, IN PRESS J SURG RES
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   MCGILL SM, 1990, ERGONOMICS, V33, P147, DOI 10.1080/00140139008927106
   PHEASANT S, 1986, ANTHROPOMETRY ERGONO
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SHIGLEY JE, 1989, MECH ENG DESIGN, P60
NR 13
TC 30
Z9 33
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FAL
PY 1998
VL 43
IS 3
BP 277
EP 281
DI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 112JN
UT WOS:000075490900008
PM 9730065
DA 2018-10-19
ER

PT J
AU Duffee, N
   Fallon, MT
AF Duffee, N
   Fallon, MT
TI Researcher training: A new frontier
SO LAB ANIMAL
LA English
DT Article
AB Few training materials exist to specifically teach biomedical research staff the animal care and use procedures that are relevant to their work. A project is currently in progress to produce computer-based and videotape training materials that address the training needs of this segment of the laboratory animal community. Plans are also underway to construct a self-assessment web server to administer content examinations covering these modules.
C1 Washington Univ, Sch Med, Div Comparat Med, St Louis, MO 63110 USA.
   Dept Vet Affairs, Atlanta VA Med Ctr, Vet Med Unit, Atlanta, GA 30033 USA.
   Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30033 USA.
RP Duffee, N (reprint author), Washington Univ, Sch Med, Div Comparat Med, St Louis, MO 63110 USA.
CR AZARMSA R, 1998, SYLLABUS, V11, P18
   BRENNAN M, 1998, DETROIT FREE PR 0315
   CARMAN J, 1997, CBT SOLUTIONS    NOV
   *CBT, 1997, CBT SOLUTIONS    MAR
   COTTON C, 1997, SYLLABUS, V11, P50
   DANIEL J, 1998, SYLLABUS, V11, P20
   DIAMOND D, 1998, WIRED            MAY
   *I LAB AN RES, 1996, GUID CAR US LAB AN
   JOHNS JF, 1998, P AM SOC TRAIN DEV S, P18
   JULIAN E, 1998, PR NEWSWIRE     0526
   KOPF D, 1998, AM NETWORKS     0701
   LELAND J, 1998, VIDEOGRAPHY      MAY, P126
   LHOTKA PH, 1994, J INTERACTIVE INSTRU, P23
   LIVINGSTON S, 1982, PASSING SCORES
   MCLAREN T, 1997, CBT SOLUTIONS   0707
   *RAYM KARS ASS, 1998, ADV SOLUTIONS TRAINI, V2, P8
   *RAYM KARS ASS, 1998, ADV SOLUTIONS TRAINI, V2, P6
   *RAYM KARS ASS, 1998, ADV SOLUTIONS TRAINI, V2, P1
   Russell WMS, 1992, PRINCIPLES HUMANE EX
   SCHWARZ K, 1996, ENTERPRISE REENG JUL
NR 20
TC 0
Z9 0
U1 0
U2 0
PU NATURE AMERICA INC
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 0093-7355
J9 LAB ANIMAL
JI Lab Anim.
PD SEP
PY 1998
VL 27
IS 8
BP 32
EP 36
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA 116FM
UT WOS:000075713700010
DA 2018-10-19
ER

PT J
AU Maillet, A
   Pavy-Le Traon, A
AF Maillet, A
   Pavy-Le Traon, A
TI MEDES clinical research facility as a tool to prepare ISSA space
   flights.
SO ACTA ASTRONAUTICA
LA English
DT Article
ID BODY NEGATIVE-PRESSURE
AB This new multi-disciplinary medical experimentation center provides the ideal scientific, medical and technical environment required for research programs and to prepare international space station Alpha (ISSA) missions, where space and healthcare industries can share their expertise. Different models are available to simulate space flight effects (bed-rest, confinement,...). This is of particular interest for research in Human psychology, physiology, physiopathology and ergonomics, validation of biomedical materials and procedures, testing of drugs, and other healthcare related products.
   This clinical research facility (CRF) provides valuable services in various fields of Human research requiring healthy volunteers. CRF is widely accessible to national and international, scientific, medical and industrial organisations. Furthermore, users have at their disposal the multi-disciplinary skills of MEDES staff and all MEDES partners on a single site. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 CHU Rangueil, Clin Spatiale Medes, F-31403 Toulouse 4, France.
RP Maillet, A (reprint author), CHU Rangueil, Clin Spatiale Medes, 1 Ave Jean Poulhes, F-31403 Toulouse 4, France.
EM Alain.Maillet@medes.cnes.fr
CR GUELL A, 1992, ACTA ASTRONAUT, V27, P103, DOI 10.1016/0094-5765(92)90185-L
   GUELL A, 1991, AVIAT SPACE ENVIR MD, V62, P331
   MAILLET A, 1995, 951513 SAE, P1
   Pavy-Le Traon A., 1995, Aviation Space and Environmental Medicine, V66, P982
   Pavy-Le Traon A, 1998, EUR J APPL PHYSIOL, V77, P50
   PavyLeTraon A, 1997, AVIAT SPACE ENVIR MD, V68, P829
   PAVYLETRAON A, 1994, ACTA ASTRONAUT, V32, P319
   PavyLeTraon A, 1997, CLIN PHYSIOL, V17, P41, DOI 10.1046/j.1365-2281.1997.01111.x
NR 8
TC 1
Z9 1
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0094-5765
J9 ACTA ASTRONAUT
JI Acta Astronaut.
PD AUG-SEP
PY 1998
VL 43
IS 3-6
BP 321
EP 328
DI 10.1016/S0094-5765(98)00164-7
PG 8
WC Engineering, Aerospace
SC Engineering
GA 121CE
UT WOS:000075993900021
PM 11541934
DA 2018-10-19
ER

PT J
AU Brown, D
   Fleurov, VB
   Carroll, P
   Lawson, CM
AF Brown, D
   Fleurov, VB
   Carroll, P
   Lawson, CM
TI Coherence-based imaging through turbid media by use of degenerate
   four-wave mixing in thin liquid-crystal films and photorefractives
SO APPLIED OPTICS
LA English
DT Article
ID TIME-RESOLVED HOLOGRAPHY; SCATTERING MEDIA; TRANSILLUMINATION;
   AMPLIFICATION
AB We describe a coherence-based imaging technique based on degenerate four-wave mixing in two materials. First, a 45 degrees-cut BaTiO3 crystal was used as a self-pumped phase conjugator to obtain depth-resolved images through a 4 mean-free-path (mfp) scattering media. In addition, an HITC dye-doped K15 liquid-crystal layer was used to provide single-shot image acquisition through a 2 mfp scattering media. This technique can be used to provide instantaneous (single-pulse), depth-resolved, two-dimensional images of the internal structure of scattering materials. Potential applications of this technique include subsurface imaging of biomedical tissue and nondestructive evaluation of composite materials. (C) 1998 Optical Society of America.
C1 Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA.
RP Brown, D (reprint author), Univ Alabama Birmingham, Dept Phys, 310 Campbell Hall,1300 Univ Blvd, Birmingham, AL 35294 USA.
EM lawson@uab.edu
CR ABRAMSON N, 1996, LIGHT FLIGHT, pCH4
   ANDERSSONENGELS S, 1990, OPT LETT, V15, P1179, DOI 10.1364/OL.15.001179
   BARRY N, 1997, OSA P SERIES, V11, P42
   BOHREN CF, 1983, ABSORPTION SCATTERIN, pCH8
   CRONINGOLOMB M, 1985, APPL PHYS LETT, V47, P1131, DOI 10.1063/1.96352
   DANIELSON BL, 1991, APPL OPTICS, V30, P2975, DOI 10.1364/AO.30.002975
   DEVAUX F, 1995, OPT COMMUN, V118, P25, DOI 10.1016/0030-4018(95)00212-Q
   DUNCAN MD, 1991, OPT LETT, V16, P1868, DOI 10.1364/OL.16.001868
   Fleurov V, 1997, J NONLINEAR OPT PHYS, V6, P95, DOI 10.1142/S0218863597000083
   Fleurov VB, 1996, P SOC PHOTO-OPT INS, V2853, P126, DOI 10.1117/12.253467
   FORD JE, 1989, APPL OPTICS, V28, P4808, DOI 10.1364/AO.28.004808
   FUJIMOTO JG, 1986, OPT LETT, V11, P150, DOI 10.1364/OL.11.000150
   GAYEN SK, 1996, OPT PHOTONICS NEWS, V7, P17
   HEE MR, 1993, OPT LETT, V18, P1107, DOI 10.1364/OL.18.001107
   HYDE SCW, 1995, OPT LETT, V20, P1331, DOI 10.1364/OL.20.001331
   Hyde SCW, 1996, OPT COMMUN, V122, P111, DOI 10.1016/0030-4018(95)00520-X
   Jones R, 1998, OPT LETT, V23, P103, DOI 10.1364/OL.23.000103
   Jones R, 1996, APPL PHYS LETT, V69, P1837, DOI 10.1063/1.117450
   Khoo IC, 1998, OPT LETT, V23, P253, DOI 10.1364/OL.23.000253
   KHOO IC, 1995, OPT LETT, V20, P2137, DOI 10.1364/OL.20.002137
   Khoo IC, 1996, IEEE J QUANTUM ELECT, V32, P525, DOI 10.1109/3.485406
   KHOO IC, 1995, LIQUID CRYSTALS PHYS, pCH10
   LEITH E, 1992, J OPT SOC AM A, V9, P1148, DOI 10.1364/JOSAA.9.001148
   LI L, 1994, LIQ CRYST, V16, P703, DOI 10.1080/02678299408036542
   REBANE A, 1991, NATURE, V351, P378, DOI 10.1038/351378a0
   Simoni F, 1997, OPT LETT, V22, P549, DOI 10.1364/OL.22.000549
   Steele DD, 1998, OPT LETT, V23, P153, DOI 10.1364/OL.23.000153
   WANG L, 1991, SCIENCE, V253, P769, DOI 10.1126/science.253.5021.769
   WECHSLER BA, 1994, OPT LETT, V19, P536, DOI 10.1364/OL.19.000536
   YAN C, 1995, APPL OPTICS, V34, P2993, DOI 10.1364/AO.34.002993
   YARIV A, 1978, IEEE J QUANTUM ELECT, V14, P650, DOI 10.1109/JQE.1978.1069870
   Zhang JW, 1996, OPT COMMUN, V132, P574, DOI 10.1016/0030-4018(96)00087-9
NR 32
TC 2
Z9 2
U1 1
U2 4
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1559-128X
EI 2155-3165
J9 APPL OPTICS
JI Appl. Optics
PD AUG 1
PY 1998
VL 37
IS 22
BP 5306
EP 5312
DI 10.1364/AO.37.005306
PG 7
WC Optics
SC Optics
GA 106AJ
UT WOS:000075107300038
PM 18286011
DA 2018-10-19
ER

PT J
AU Riess, JG
   Krafft, MP
AF Riess, JG
   Krafft, MP
TI Fluorinated materials for in vivo oxygen transport (blood substitutes),
   diagnosis and drug delivery
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT European-Materials-Research-Society 1997 Meeting, Symposium G -
   Biomaterials - Perspectives for Research and Industry at the Century
   Change
CY JUN 16-20, 1997
CL STRASBOURG, FRANCE
SP Council Europe, Commiss European Communities, Banque Populair (France), Elsevier Science (Netherlands), Off Tourisme, Strasbourg
DE fluorocarbons; perfluorochemicals; fluorinated amphiphiles; fluorocarbon
   emulsions; gels; vesicles; liposomes; tubules; bilayers; oxygen
   delivery; drug delivery
ID CHAIN PERFLUOROALKYLATED AMPHIPHILES; PARTIAL LIQUID VENTILATION;
   FLUOROCARBON EMULSIONS; SURFACTANTS; LIPOSOMES; SYSTEMS;
   PERFLUOROCARBON; VESICLES; ASSEMBLIES; PERFLUBRON
AB Fluorocarbons are characterized by exceptional chemical and biological inertness, extreme hydrophobicity, lipophobicity, high gas-dissolving capacities, low surface tensions, high fluidity and spreading coefficients, high density, absence of protons, and magnetic susceptibilities comparable to that of water. These unique properties are the foundation for a range of biomedical applications. An injectable fluorocarbon-in-water emulsion is in advanced clinical trials as a temporary oxygen carrier (blood substitute) to prevent tissue hypoxia or ischemia in the surgical and critical care patient. A liquid fluorocarbon is in Phase II/III clinical trials for treatment of acute respiratory failure through liquid ventilation. Several fluorocarbon-based contrast agents for ultra-sound imaging are in various stages of clinical investigation. Multiple families of well-defined pure fluorinated surfactants have recently been synthesized. These surfactants have a modular structure which allows stepwise adjustment of their physicochemical characteristics. Their polar head group derives from polyols, sugars, aminoacids, amides, amine oxides, phosphocholine, phosphatidylcholine, etc. Fluorinated surfactants are significantly more surface-active than their hydrocarbon analogs and they display a greater tendency to self-assemble, thus forming well-ordered, stable supramolecular assemblies such as vesicles, tubules, fibers, ribbons, etc. Fluorinated amphiphiles also allowed the obtaining of a variety of stable reverse and multiple emulsions and gels. These systems are being investigated as drug delivery devices. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Inst Charles Sadron, CNRS, F-67083 Strasbourg, France.
   Univ Calif San Diego, Med Ctr, MRI Inst, San Diego, CA 92103 USA.
RP Riess, JG (reprint author), Inst Charles Sadron, CNRS, 6 Rue Boussingault, F-67083 Strasbourg, France.
EM jg.reiss@hol.fr; kraft@europe.4-strasbg.fr
OI KRAFFT, Marie Pierre/0000-0002-3379-2783
CR [Anonymous], 1995, Tobramycin inhalation powder (TIP) administered once daily continuously versus TIP administered BID in 28 day on/28 day off cycles, Patent No. [5,437,272, 5437272]
   BLINDER KJ, 1991, BRIT J OPHTHALMOL, V75, P240, DOI 10.1136/bjo.75.4.240
   BRUNETON JN, 1989, RADIOLOGY, V170, P179, DOI 10.1148/radiology.170.1.2909093
   CARNEY MJ, 1995, Patent No. 5399634
   CEVE G, 1993, PHOSPHOLIPIDS HDB
   CHANG S, 1989, OPHTHALMOLOGY, V96, P785
   CHANG TMS, 1994, ART CELLS BLOOD SUBS, V22
   CHARPIOT B, 1991, Patent No. 4985550
   CHARPIOT B, 1992, Patent No. 0255443
   ELBERT R, 1984, J AM CHEM SOC, V106, P7687, DOI 10.1021/ja00337a005
   FAITHFULL NS, 1994, YB INTENSIVE CARE EM, P237
   FAITHFULL NS, 1992, Patent No. 9219232
   FREZARD F, 1994, BBA-BIOMEMBRANES, V1194, P61, DOI 10.1016/0005-2736(94)90203-8
   FUHRHOP JH, 1993, CHEM REV, V93, P1565, DOI 10.1021/cr00020a008
   GARELLI N, 1993, EUR J MED CHEM, V28, P235, DOI 10.1016/0223-5234(93)90139-6
   GIULIERI F, 1994, ANGEW CHEM INT EDIT, V33, P1514, DOI 10.1002/anie.199415141
   Gregoriadis G, 1993, LIPOSOME TECHNOLOGY
   GREINER J, 1993, ORGANOFLUORINE COMPO, P339
   IMAE T, 1992, J AM CHEM SOC, V114, P3414, DOI 10.1021/ja00035a038
   JAFFE CC, 1988, AM HEART J, V115, P1156, DOI 10.1016/0002-8703(88)90002-6
   Johnson K. A, 1992, Aerosol drug formulations, Patent No. [US Patent 5126123, 5126123, US Patent 5 126, 123]
   JONES MN, 1994, ADV DRUG DELIVER REV, V13, P215, DOI 10.1016/0169-409X(94)90013-2
   KEIPERT PE, 1996, OXYGEN TRANSPORT TIS, V17, P603
   Kissa E., 1993, FLUORINATED SURFACTA
   KRAFFT MP, 1994, ANGEW CHEM INT EDIT, V33, P1100, DOI 10.1002/anie.199411001
   KRAFFT MP, 1993, ANGEW CHEM INT EDIT, V32, P741, DOI 10.1002/anie.199307411
   KRAFFT MP, 1994, COLLOID SURFACE A, V84, P113, DOI 10.1016/0927-7757(93)02681-4
   KRAFFT MP, 1988, NOVEL COSMETIC DELIV
   KRAFFT MP, 1998, SUBMICRON EMULSION D, pR30
   KRAFFT MP, 1997, 15 INTL S FLUOR CHEM
   KRAFFT MP, 1995, Patent No. 2737135
   KRAFT M, 1998, IN PRESS BIOCHIMIE, V80
   KUNITAKE T, 1992, ANGEW CHEM INT EDIT, V31, P709, DOI 10.1002/anie.199207091
   Leach CL, 1996, NEW ENGL J MED, V335, P761, DOI 10.1056/NEJM199609123351101
   LEHN JM, 1993, MAKROMOL CHEM-M SYMP, V69, P1, DOI 10.1002/masy.19930690103
   LONG DC, 1989, BLOOD SUBSTITUTES, P441
   LONG DM, 1991, Patent No. 4987154
   MATHIS G, 1984, J AM CHEM SOC, V106, P6162, DOI 10.1021/ja00333a007
   MATTREY RF, 1994, INVEST RADIOL, V29, pS139, DOI 10.1097/00004424-199406001-00046
   MAURIZIS JC, 1994, XENOBIOTICA, V24, P535, DOI 10.3109/00498259409043256
   NIVET JB, 1992, EUR J MED CHEM, V27, P891, DOI 10.1016/0223-5234(92)90020-2
   Overbeck MC, 1996, CRIT CARE MED, V24, P1208, DOI 10.1097/00003246-199607000-00024
   PAVIA AA, 1996, Patent No. 5527962
   PAVIA AA, 1997, Patent No. 5650393
   PAVIA AA, 1993, Patent No. 2665705
   PAVIA AA, 1997, Patent No. 5637564
   PAVIA AA, 1994, P INT S CONTROL REL, V21, P87
   PAVIA AA, 1994, Patent No. 2694559
   PAVIA AA, 1995, Patent No. 5446023
   POLIDORI A, 1994, NEW J CHEM, V18, P839
   PRICE AK, 1974, Patent No. 3828085
   PRIVITERA N, 1995, BBA-LIPID LIPID MET, V1254, P1, DOI 10.1016/0005-2760(94)00153-P
   QUAY S, Patent No. 9305819
   RAVEY JC, 1990, PROG COLL POL SCI S, V82, P218
   REISS JG, 1994, ART CELLS BLOOD SUBS, V22
   Riess J. G., 1994, U.S. Patent, Patent No. [US5344930A, 5344930]
   RIESS JG, 1995, CHEM PHYS LIPIDS, V75, P1, DOI 10.1016/0009-3084(94)02402-Q
   RIESS JG, 1994, J DRUG TARGET, V2, P455, DOI 10.3109/10611869408996822
   RIESS JG, 1978, ANGEW CHEM INT EDIT, V17, P621, DOI 10.1002/anie.197806213
   RIESS JG, 1991, VOX SANG, V61, P225, DOI 10.1111/j.1423-0410.1991.tb00952.x
   RIESS JG, 1992, BIOMAT ARTIF CELL IM, V20, P839, DOI 10.3109/10731199209119726
   RIESS JG, 1991, ADV MATER, V3, P249, DOI 10.1002/adma.19910030507
   RIESS JG, 1994, ADV EXP MED BIOL, V345, P227
   RIESS JG, 1994, COLLOID SURFACE A, V84, P33, DOI 10.1016/0927-7757(93)02696-C
   Riess JG, 1995, J LIPOS RES, V5, P413, DOI 10.3109/08982109509010232
   Riess JG, 1997, ARTIF CELL BLOOD SUB, V25, P43, DOI 10.3109/10731199709118896
   RIESS JG, 1992, J DISPER SCI TECHNOL, V13, P349, DOI 10.1080/01932699208943319
   RIESS JG, 1995, NEW J CHEM, V19, P891
   RIESS JG, 1989, BLOOD SUBSTITUTES, P421
   RIESS JG, 1995, Patent No. 2677360
   RIESS JG, 1995, Patent No. 2710840
   RIESS JG, 1998, BLOOD SUBSTITUTES ME, P101
   RIESS JG, 1990, Patent No. 2620445
   RIESS JG, 1994, Patent No. 2679150
   RIESS JG, 1994, Patent No. 9407068
   RIESS JG, 1997, Patent No. 5679459
   RIESS JG, 1994, Patent No. 08214411
   RIESS JG, 1996, HDB NONMEDICAL APPL, V3, P98
   RIESS JG, 1992, Patent No. 07916216
   RIESS JG, 1996, P INT S BLOOD SUBST
   RIESS JG, 1993, Patent No. 478686
   RIESS JG, 1993, CARBOHYDRATES ORGANI, V2, P209
   ROSANO HL, 1973, Patent No. 3778381
   Sadtler VM, 1996, ANGEW CHEM INT EDIT, V35, P1976, DOI 10.1002/anie.199619761
   SANTAELLA C, 1993, FEBS LETT, V336, P481, DOI 10.1016/0014-5793(93)80860-W
   SCHNUR JM, 1993, SCIENCE, V262, P1669, DOI 10.1126/science.262.5140.1669
   SCHUBERT KV, 1994, COLLOID SURFACE A, V84, P97, DOI 10.1016/0927-7757(93)02704-I
   SCHUTT EA, 1997, Patent No. 5639443
   SCHUTT EG, 1996, ACAD RADIOL, V35, P188
   TREVINO L, 1994, COLLOID SURFACE A, V88, P223, DOI 10.1016/0927-7757(94)02789-7
   Wahr JA, 1996, ANESTH ANALG, V82, P103, DOI 10.1097/00000539-199601000-00018
   WEERS JG, 1994, ARTIF CELL BLOOD SUB, V22, P1175, DOI 10.3109/10731199409138813
   WEERS JG, 1993, J FLUORINE CHEM, V64, P73, DOI 10.1016/S0022-1139(00)80064-0
   WINSLOW RM, 1994, ART CELLS BLOOD SUBS, V22
   YOKOYAMA K, 1983, LIFE CHEM REPORTS, V2, P35
   ZUCK TF, 1994, CRIT REV CL LAB SCI, V31, P295, DOI 10.3109/10408369409084678
   1993, P 5 INT S BLOOD SUBS
NR 97
TC 140
Z9 140
U1 0
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1998
VL 19
IS 16
BP 1529
EP 1539
DI 10.1016/S0142-9612(98)00071-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 128LU
UT WOS:000076408900021
PM 9794531
DA 2018-10-19
ER

PT J
AU Donachie, M
AF Donachie, M
TI Biomedical alloys
SO ADVANCED MATERIALS & PROCESSES
LA English
DT Article
AB The most widely selected structural materials for implants in the body include stainless steel, cobalt-chromium, and titanium alloys.
C1 Biomed Engn Alliance Connecticut & Rensselaer, Hartford, CT USA.
RP Donachie, M (reprint author), POB 11, Winchester, NH 03470 USA.
NR 0
TC 18
Z9 20
U1 0
U2 3
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 0026-0665
J9 ADV MATER PROCESS
JI Adv. Mater. Process.
PD JUL
PY 1998
VL 154
IS 1
BP 63
EP 65
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA ZY058
UT WOS:000074582400009
DA 2018-10-19
ER

PT J
AU Grande, KJ
   Cochran, RP
   Reinhall, PG
   Kunzelman, KS
AF Grande, KJ
   Cochran, RP
   Reinhall, PG
   Kunzelman, KS
TI Stress variations in the human aortic root and valve: The role of
   anatomic asymmetry
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE aortic valve; aortic root; anatomy; stress; strain; finite-element
   modeling; asymmetry
ID AGE-RELATED-CHANGES; NORMAL HUMAN HEARTS; MECHANICAL-PROPERTIES;
   LEAFLETS; MICROMECHANICS; CALCIFICATION; STRAIN; CANINE
AB The asymmetry of the aortic valve and aortic root may influence their biomechanics, yet was not considered in previous valve models. This study developed an anatomically representative model to evaluate the regional stresses of the valve within the root environment. A finite-element model was created from magnetic-resonance images of nine human valve-root specimens, carefully preserving their asymmetry. Regional thicknesses and anisotropic material properties were assigned to higher-order elastic shell elements representing the valve and root. After diastolic pressurization, peak principal stresses were evaluated for the right, left, and noncoronary leaflets and root walls. Valve stresses were highest in the noncoronary leaflet (538 kPa vs right 473 kPa vs left 410 kPa); peak stresses were located at the free margin and belly near the coaptation surfaces (averages 537 and 482 kPa for all leaflets, respectively). Right and noncoronary sinus stresses were 21% and 10% greater than the left sinus. In all sinuses, stresses near the annulus were higher than near the sinotubular junction. Stresses vary across the valve and root, likely due to their inherent morphologic asymmetry and stress sharing. These factors may influence bioprosthetic valve durability and the incidence of isolated sinus dilatation. (C) 1998 Biomedical Engineering Society.
C1 Univ Washington, Div Cardiothorac Surg, Seattle, WA 98195 USA.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.
RP Kunzelman, KS (reprint author), Univ Washington, Div Cardiothorac Surg, Box 356310, Seattle, WA 98195 USA.
RI Grande-Allen, Kathryn/P-4042-2014
OI Grande-Allen, Kathryn/0000-0003-1533-3767
CR HAMID MS, 1987, CIRC RES, V61, P687, DOI 10.1161/01.RES.61.5.687
   HAN HC, 1995, J BIOMECH, V28, P637, DOI 10.1016/0021-9290(94)00091-H
   HANSEN B, 1995, ANN THORAC SURG, V60, pS384, DOI 10.1016/0003-4975(95)00262-J
   KALATH S, 1986, ANN BIOMED ENG, V14, P513, DOI 10.1007/BF02484469
   KITZMAN DW, 1988, MAYO CLIN PROC, V63, P137, DOI 10.1016/S0025-6196(12)64946-5
   Kunzelman K S, 1993, J Heart Valve Dis, V2, P326
   KUNZELMAN KS, 1994, J THORAC CARDIOV SUR, V107, P162
   LO D, 1995, ANN THORAC SURG, V60, pS374, DOI 10.1016/0003-4975(95)00249-K
   Peskin Charles S., 1995, Symposia of the Society for Experimental Biology, V49, P265
   REID K, 1970, THORAX, V25, P79, DOI 10.1136/thx.25.1.79
   SABBAH HN, 1986, ANN THORAC SURG, V42, P93, DOI 10.1016/S0003-4975(10)61845-0
   SAHASAKUL Y, 1988, AM J CARDIOL, V62, P424, DOI 10.1016/0002-9149(88)90971-X
   THUBRIKAR MJ, 1986, ANN THORAC SURG, V42, P434, DOI 10.1016/S0003-4975(10)60554-1
   THUBRIKAR MJ, 1986, J THORAC CARDIOV SUR, V92, P29
   VESELY I, 1992, J CARDIAC SURG, V7, P85, DOI 10.1111/j.1540-8191.1992.tb00779.x
   VESELY I, 1992, J BIOMECH, V25, P101, DOI 10.1016/0021-9290(92)90249-Z
   VESELY I, 1989, J BIOMECH, V22, P655, DOI 10.1016/0021-9290(89)90016-X
NR 17
TC 147
Z9 148
U1 0
U2 11
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL-AUG
PY 1998
VL 26
IS 4
BP 534
EP 545
DI 10.1114/1.122
PG 12
WC Engineering, Biomedical
SC Engineering
GA ZV306
UT WOS:000074291400003
PM 9662146
DA 2018-10-19
ER

PT J
AU Takahashi, K
   Sato, E
   Sagae, M
   Tsukahara, Y
AF Takahashi, K
   Sato, E
   Sagae, M
   Tsukahara, Y
TI Semi-monochromatic plasma flash radiography and its application to
   biomedical imaging simulation
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES &
   REVIEW PAPERS
LA English
DT Article
DE plasma flash X-ray generator; biomedical imaging simulation;
   semi-monochromatic radiography; filter of half value layer; Computed
   Radiography; molybdenum target; characteristic X-rays
ID X-RAY GENERATOR; TRIODE
AB A high-intensity plasma flash X-ray generator having a radiation tube with a rod-shaped target and its application to biomedical imaging simulations are described. Plasma flash radiography was performed with charged voltages of 40, 50, and 60 kV, and with filter of the same material as the target. In the present work, molybdenum target was employed. With filter of the half value layer in thickness for each target, nearly monochromatic radiography with only K-characteristic X-ray spectra could be achieved, Next, with real X-ray spectra data acquired from the present generator. we performed a computer aided biomedical imaging simulation using the program SPECTRA. It was developed as an assisting tool for our fundamental research on optimum control of Bash X-ray spectra. Qualitatively, the simulated biomedical phantom images agreed with those from the Computed Radiography.
C1 Iwate Med Univ, Sch Med, Med Comp Res Ctr, Morioka, Iwate 0200015, Japan.
   Iwate Med Univ, Sch Liberal Arts, Dept Phys, Morioka, Iwate 0200015, Japan.
   Tohoku Univ, Grad Sch Informat Sci, Dept Informat Biol, Aoba Ku, Sendai, Miyagi 9800812, Japan.
RP Takahashi, K (reprint author), Iwate Med Univ, Sch Med, Med Comp Res Ctr, 3-16-1 Honcho Dori, Morioka, Iwate 0200015, Japan.
CR DAVANLOO F, 1987, REV SCI INSTRUM, V59, P2103
   GERMER R, 1979, J PHYS E SCI INSTRUM, V12, P336, DOI 10.1088/0022-3735/12/5/001
   GERMER R, 1992, IONIZ RAD, V18, P3
   MATTSSON A, 1972, PHYS SCRIPTA, V5, P99, DOI 10.1088/0031-8949/5/1-2/017
   SATO E, 1991, REV SCI INSTRUM, V62, P2115, DOI 10.1063/1.1142376
   SATO E, 1986, REV SCI INSTRUM, V57, P1399, DOI 10.1063/1.1138609
   SATO E, 1990, REV SCI INSTRUM, V61, P2343, DOI 10.1063/1.1141958
   SATO E, 1992, IONIZ RAD, V18, P17
   SATO E, 1992, P SOC PHOTO-OPT INS, V1801, P628
   SATO E, 1990, P SOC PHOTO-OPT INS, V1358, P193
   TAKAHASHI K, 1994, JPN J APPL PHYS 1, V33, P4146, DOI 10.1143/JJAP.33.4146
   TAKAHASHI K, 1993, P SOC PHOTO-OPT INS, V2002, P141, DOI 10.1117/12.161360
   TAKAHASHI K, 1994, P SOC PHOTO-OPT INS, V2513, P736
   TAKAHASHI K, 1992, P SOC PHOTO-OPT INS, V1801, P658
NR 14
TC 20
Z9 20
U1 0
U2 0
PU JAPAN J APPLIED PHYSICS
PI MINATO-KU TOKYO
PA DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 1
JI Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.
PD JUL
PY 1998
VL 37
IS 7
BP 4222
EP 4227
DI 10.1143/JJAP.37.4222
PG 6
WC Physics, Applied
SC Physics
GA 110CV
UT WOS:000075363300070
DA 2018-10-19
ER

PT J
AU Jiang, T
   Ozin, GA
   Verma, A
   Bedard, RL
AF Jiang, T
   Ozin, GA
   Verma, A
   Bedard, RL
TI Adsorption and sensing properties of microporous layered tin sulfide
   materials
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID ARRAY
AB The adsorption and sensing behavior of three structurally well defined microporous layered tin sulfides R2Sn3S7, denoted DABCOH-SnS-1, ATEA-SnS-1 and TEA-SnS-1, have been explored. In the case of small non-polar guests a micropore-filling process is observed, whereas for certain larger guests an integration of micropore-filling and intercalation is found to occur. The former is controlled by the size while the latter depends on the adsorption properties of the guest molecules. It seems that guests with a propensity for hydrogen bonding are favored for intercalation. Electrical and optical responses with respect to adsorption of specific guests, such as NH3, H2S and alcohols, show high sensitivity, reversibility and fast reaction times that are comparable to some commercial semiconductor sensors. This makes microporous layered tin sulfides potentially interesting in environmental, industrial and biomedical monitoring.
C1 Univ Toronto, Dept Chem, Mat Chem Res Grp, Toronto, ON M5S 3H6, Canada.
   Universal Oil Prod, Des Plaines, IL 60017 USA.
RP Ozin, GA (reprint author), Univ Toronto, Dept Chem, Mat Chem Res Grp, Toronto, ON M5S 3H6, Canada.
CR ANDO M, 1994, J MATER CHEM, V4, P631, DOI 10.1039/jm9940400631
   AZAD HM, 1992, J ELECT SOC, P3690
   Balkus KJ, 1997, CHEM MATER, V9, P380, DOI 10.1021/cm960041n
   Bedard R. L., 1989, U.S. Patent, Patent No. 4880761
   BEDARD RL, 1997, Patent No. 5594263
   BEDARD RL, 1990, Patent No. 4933068
   BEIN T, 1989, J AM CHEM SOC, V111, P7640, DOI 10.1021/ja00201a069
   Bein T, 1996, CHEM MATER, V8, P1636, DOI 10.1021/cm960148a
   Bowes CL, 1998, J MATER CHEM, V8, P711, DOI 10.1039/a706278h
   BOWES CL, 1996, THESIS U TORONTO
   BRAKER W, 1980, MATHESON GAS DATA BO, P476
   Breck D. W., 1974, ZEOLITE MOL SIEVES S
   COLES GSV, 1994, CHEM ENG NEWS   1003, P40
   Dickinson TA, 1996, NATURE, V382, P697, DOI 10.1038/382697a0
   Gaskell DR, 1981, INTRO METALLURGICAL
   GREGG SJ, 1982, ADSORPTION SURFACE A
   HAMNETT A, 1987, SOLID STATE CHEM, pCH8
   Jiang T, 1998, ADV MATER, V10, P42, DOI 10.1002/(SICI)1521-4095(199801)10:1<42::AID-ADMA42>3.0.CO;2-W
   Jiang T, 1998, J MATER CHEM, V8, P733, DOI 10.1039/a706042d
   Jiang T, 1998, J MATER CHEM, V8, P721, DOI 10.1039/a706279f
   Jiang T, J MAT CHEM
   LIFSHITZ E, 1993, J PHYS CHEM-US, V97, P238, DOI 10.1021/j100103a041
   Lonergan MC, 1996, CHEM MATER, V8, P2298, DOI 10.1021/cm960036j
   Moy L, 1996, AM LAB, V28, P22
   NEWSAM JM, 1986, SCIENCE, V231, P1093, DOI 10.1126/science.231.4742.1093
   OHARE D, 1992, INORG MATER, pCH4
   OZIN GA, 1992, ADV MATER, V4, P612, DOI 10.1002/adma.19920041003
   PARISE JB, 1994, J CHEM SOC CHEM COMM, P527, DOI 10.1039/c39940000527
   ROBERTSON J, 1979, J PHYS C SOLID STATE, V12, P4735
   Shriver D. F., 1994, INORGANIC CHEM
   THOMAS JM, 1988, ANGEW CHEM INT EDIT, V27, P1673, DOI 10.1002/anie.198816731
   WEST AR, 1989, SOLID STATE CHEM ITS, pCH15
   Whittingham M. S., 1982, INTERCALATION CHEM
   YAN YG, 1992, J PHYS CHEM-US, V96, P9387, DOI 10.1021/j100202a060
   YAN YG, 1992, CHEM MATER, V4, P975, DOI 10.1021/cm00023a007
   YAN YG, 1991, MATER RES SOC SYMP P, V233, P175, DOI 10.1557/PROC-233-175
NR 36
TC 65
Z9 66
U1 0
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON ROAD, CAMBRIDGE CB4 4WF,
   CAMBS, ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD JUL
PY 1998
VL 8
IS 7
BP 1649
EP 1656
DI 10.1039/a801501e
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 100JB
UT WOS:000074812100025
DA 2018-10-19
ER

PT J
AU Chebotareva, G
AF Chebotareva, G
TI Achievement and prospects of pulsed photothermal radiometry techniques
   in diagnostics of laser-tissue interaction
SO LASER PHYSICS
LA English
DT Article
ID HYDRATION MEASUREMENT; ABSORPTION
AB This paper considers the achievements of Pulsed Photothermal Radiometry (PPTR) in the investigation of physical properties of biological materials and the diagnostics of the interaction of laser radiation with biological materials. We separate the main directions of modern studies and present the results of experimental and theoretical investigations. A detailed chronological list of references on the development of biomedical PPTR technologies is presented for the first time.
C1 PN Lebedev Phys Inst, Moscow Phys Soc, Moscow 117924, Russia.
RP Chebotareva, G (reprint author), PN Lebedev Phys Inst, Moscow Phys Soc, Leninsky Prospect 53, Moscow 117924, Russia.
EM chebotar@sci.lpi.ac.ru
CR Bindra R. M. S., 1995, International Journal of Cosmetic Science, V17, P105, DOI 10.1111/j.1467-2494.1995.tb00114.x
   BINDRA RMS, 1994, J PHYS IV, V4, P465, DOI 10.1051/jp4:19947108
   BINDRA RMS, 1995, P SOC PHOTO-OPT INS, V2395, P566, DOI 10.1117/12.209144
   BINDRA RMS, 1994, J PHYS IV, V4, P445, DOI 10.1051/jp4:19947103
   Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   CHEBOTAREVA GP, 1995, P SOC PHOTO-OPT INS, V2394, P243, DOI 10.1117/12.207449
   CHEBOTAREVA GP, 1993, P SOC PHOTO-OPT INS, V2080, P117
   CHEBOTAREVA GP, 1987, 146 GEN PHYS I RUSS
   CHEBOTAREVA GP, 1996, OPT TECHN MED 2 M, P23
   CHEBOTAREVA GP, 1994, P SOC PHOTO-OPT INS, V2327, P188
   CHEBOTAREVA GP, 1994, ADV LASER DENTISTRY
   CHEBOTAREVA GP, 1996, INT C LAS PHYS 96 MO
   CHEBOTAREVA GP, 1996, P 10 NORD BALT C BIO
   CHEBOTAREVA GP, 1996, PW 96 P SPIE, V2681
   GAL D, 1987, IEEE J QUANTUM ELECT, V23, P1827, DOI 10.1109/JQE.1987.1073240
   Imhof R.E, 1994, PROGR PHOTOTHERMAL P, V2, P185
   IMHOF RE, 1984, J PHYS E SCI INSTRUM, V17, P521, DOI 10.1088/0022-3735/17/6/020
   JACQUES SL, 1993, APPL OPTICS, V32, P2439, DOI 10.1364/AO.32.002439
   KANSTAD S, 1979, PHYSICA SCRIPTA, V20, P659
   Kanstad S.O., 1978, POWDER TECHNOL, V22, P133
   LEUNG WP, 1984, OPT LETT, V9, P93, DOI 10.1364/OL.9.000093
   LEUNG WP, 1984, J APPL PHYS, V56, P153, DOI 10.1063/1.333739
   LONG FH, 1987, APPL PHYS LETT, V51, P2076, DOI 10.1063/1.98985
   LONG FH, 1987, IEEE J QUANTUM ELECT, V23, P1821, DOI 10.1109/JQE.1987.1073232
   Milner T E, 1996, J Biomed Opt, V1, P92, DOI 10.1117/12.227537
   MILNER TE, 1993, P SOC PHOTO-OPT INS, V2077, P228
   MILNER TE, 1992, P SOC PHOTO-OPT INS, V1876, P122
   NELSON JS, 1995, P SOC PHOTO-OPT INS, V2623, P20
   NIKITIN AP, 1994, P SOC PHOTO-OPT INS, V2323, P156
   SMITHIES J, 1996, P SPIE, V2975
   TAM AC, 1983, APPL PHYS LETT, V43, P333, DOI 10.1063/1.94346
   XIAO P, 1996, P SPIE, V2681
   ZHAROV VP, 1989, KVANTOVAYA ELEKTRON+, V16, P1941
   ZHAROV VP, 1988, P 13 INT C COH NONL, P412
NR 34
TC 3
Z9 3
U1 0
U2 1
PU INTERPERIODICA
PI BIRMINGHAM
PA PO BOX 1831, BIRMINGHAM, AL 35201-1831 USA
SN 1054-660X
J9 LASER PHYS
JI Laser Phys.
PD JUL-AUG
PY 1998
VL 8
IS 4
BP 941
EP 948
PG 8
WC Optics; Physics, Applied
SC Optics; Physics
GA 120PA
UT WOS:000075963700019
DA 2018-10-19
ER

PT J
AU Magnani, A
   Lamponi, S
   Rappuoli, R
   Barbucci, RB
AF Magnani, A
   Lamponi, S
   Rappuoli, R
   Barbucci, RB
TI Sulphated hyaluronic acids: a chemical and biological characterisation
SO POLYMER INTERNATIONAL
LA English
DT Article
DE hyaluronic acid; sulphated hyaluronic acid; physicochemical
   characterization; enzymatic digestion; anticoagulant activity;
   biocompatibility; platelet aggregation and activation; MW influence;
   copper(II) complexes; endothelial cell migration; angiogenesis; new
   blood-compatible materials
ID HEPARIN-LIKE MOLECULE; VONWILLEBRAND-FACTOR; AQUEOUS-SOLUTION; BEHAVIOR;
   POLYURETHANE; ANGIOGENESIS; CONFORMATION; PERFORMANCE; INHIBITION;
   POLYMERS
AB This review focuses on the possibility of modifying hyaluronic acid by the insertion of sulphate groups in order to obtain heparin-like compounds with controllable properties. In particular, the physicochemical and biological behaviour of sulphated hyaluronic acid (HyalS(x)) with various degrees of sulphation and different molecular weights has been particularly investigated.
   The mobilization of endothelial cells was investigated by the use of copper(II) complexes with HyalS(x) and the results were compared with those from the corresponding complex with heparin.
   New materials containing HyalS(x) are proposed for biomedical applications. (C) 1998 SCI.
C1 Univ Siena, CRISMA, I-53100 Siena, Italy.
   Univ Siena, Dept Chem & Biosyst Sci & Technol, I-53100 Siena, Italy.
RP Barbucci, RB (reprint author), Univ Siena, CRISMA, Via E Bastianini 12, I-53100 Siena, Italy.
RI Magnani, Agnese/E-7999-2017
OI Magnani, Agnese/0000-0002-6960-9418
CR Abatangelo G, 1997, BIOMATERIALS, V18, P1411, DOI 10.1016/S0142-9612(97)00089-6
   ALBANESE A, 1994, BIOMATERIALS, V15, P129, DOI 10.1016/0142-9612(94)90262-3
   ALESSANDRI G, 1983, CANCER RES, V43, P1790
   ANDRESSON LO, 1979, THROMB RES, V15, P531
   ARNOTT S, 1983, J MOL BIOL, V169, P861, DOI 10.1016/S0022-2836(83)80140-5
   ATKINS EDT, 1980, INT J BIOL MACROMOL, V2, P318, DOI 10.1016/0141-8130(80)90053-7
   ATKINS EDT, 1973, SCIENCE, V179, P562, DOI 10.1126/science.179.4073.562
   Balazs E. A., 1970, CHEM MOL BIOL INTERC
   BARBUCCI R, 1983, MACROMOLECULES, V16, P456, DOI 10.1021/ma00237a023
   BARBUCCI R, 1994, J MATER SCI-MATER M, V5, P830, DOI 10.1007/BF00213143
   BARBUCCI R, 1991, POLYMER, V32, P897, DOI 10.1016/0032-3861(91)90517-M
   BARBUCCI R, 1992, COORDIN CHEM REV, V120, P29, DOI 10.1016/0010-8545(92)80046-T
   BARBUCCI R, 1995, GAZZ CHIM ITAL, V125, P169
   Barbucci R, 1996, POLYM ADVAN TECHNOL, V7, P675, DOI 10.1002/(SICI)1099-1581(199608)7:8<675::AID-PAT609>3.3.CO;2-L
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   Barbucci R, 1996, MACROMOL SYMP, V105, P1, DOI 10.1002/masy.19961050103
   BARBUCCI R, IN PRESS BIOMATERIAL
   BARBUCCI R, IN PRESS J THROMB TH
   Bellamy L.J., 1975, INFRARED SPECTRA COM, V1-2
   BOCIEK SM, 1980, EUR J BIOCHEM, V109, P447, DOI 10.1111/j.1432-1033.1980.tb04814.x
   BRAY B, 1989, BIOCHEM J, V262, P225, DOI 10.1042/bj2620225
   CALLEGARIO L, 1998, Patent No. 000037
   CASOLARO M, 1990, P 2 INT S POL EL AMS, P311
   CASU B, 1985, ADV CARBOHYD CHEM BI, V43, P51, DOI 10.1016/S0065-2318(08)60067-0
   Casu B., 1985, NUCL MAGNETIC RESONA, P1
   CATTERAL JB, 1996, CANCER J, V8, P221
   Chen GP, 1997, BIOCONJUGATE CHEM, V8, P730, DOI 10.1021/bc9700493
   CIMMINO S, 1993, J APPL POLYM SCI, V47, P631, DOI 10.1002/app.1993.070470407
   COMPER WD, 1978, PHYSIOL REV, V58, P255
   CUMMING AM, 1986, THROMB RES, V41, P593
   DHAON MK, 1982, J ORG CHEM, V47, P1962, DOI 10.1021/jo00349a028
   FAVIA P, IN PRESS PLASMA POLY
   FERRUTI P, 1984, ADV POLYM SCI, V58, P55
   GANS P, 1977, INORG CHIM ACTA, V25, P41
   GULLINO PM, 1978, JNCI-J NATL CANCER I, V61, P639
   ITO Y, 1986, J BIOMED MATER RES, V20, P1017, DOI 10.1002/jbm.820200715
   KENT KC, 1989, J VASC SURG, V9, P271, DOI 10.1067/mva.1989.vs0090271
   KNUDSON CB, 1993, FASEB J, V7, P1233
   LAURENT TC, 1992, FASEB J, V6, P2397
   Maaroufi RM, 1997, BIOMATERIALS, V18, P203, DOI 10.1016/S0142-9612(96)00125-1
   Magnani A, 1996, THROMB RES, V81, P383, DOI 10.1016/0049-3848(96)00009-6
   MAGNANI A, 1998, FRONTIERS BIOMEDICAL, P171
   MULVIHILL JN, 1993, ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS, P69
   OBRIEN JR, 1990, LANCET, V335, P711, DOI 10.1016/0140-6736(90)90815-M
   ORDINAS A, 1993, ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS, P3
   PETITT LD, 1993, STABILITY CONSTANTS
   SHEEHAN JK, 1977, J MOL BIOL, V117, P113, DOI 10.1016/0022-2836(77)90027-4
   SHEEHAN JK, 1975, J MOL BIOL, V91, P153, DOI 10.1016/0022-2836(75)90156-4
   SOBEL M, 1991, J CLIN INVEST, V87, P1787, DOI 10.1172/JCI115198
   SOBEL M, 1992, J BIOL CHEM, V267, P8857
   TUGGERI ZM, 1993, THROMB HEMOSTASIS, V70, P119
   WINTER WT, 1975, J MOL BIOL, V99, P219, DOI 10.1016/S0022-2836(75)80142-2
   WINTER WT, 1977, J MOL BIOL, V117, P761, DOI 10.1016/0022-2836(77)90068-7
NR 53
TC 28
Z9 28
U1 0
U2 6
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JUL
PY 1998
VL 46
IS 3
BP 225
EP 240
DI 10.1002/(SICI)1097-0126(199807)46:3<225::AID-PI45>3.0.CO;2-I
PG 16
WC Polymer Science
SC Polymer Science
GA ZZ917
UT WOS:000074782400009
DA 2018-10-19
ER

PT J
AU Corneillie, S
   Lan, PN
   Schacht, E
   Davies, M
   Shard, A
   Green, R
   Denyer, S
   Wassall, M
   Whitfield, H
   Choong, S
AF Corneillie, S
   Lan, PN
   Schacht, E
   Davies, M
   Shard, A
   Green, R
   Denyer, S
   Wassall, M
   Whitfield, H
   Choong, S
TI Polyethylene glycol-containing polyurethanes for biomedical applications
SO POLYMER INTERNATIONAL
LA English
DT Article
DE polyurethane; polyethylene oxide; synthesis; characterization;
   biocompatibility
ID PROTEIN ADSORPTION; POLY(ETHER URETHANE); SURFACES; INFECTION; ADHESION
AB The synthesis and characterization of some new polyethylene glycol (PEG)-containing polyurethane elastomers are described. These materials were evaluated with respect to their potential use as biomaterials, more specifically for their use as blood- or urine-contacting materials. The stability of the materials towards heat, hydrolysis and gamma-irradiation was examined. Before biological testing, material purity was investigated using X-ray photoelectron spectroscopy (XPS). Atomic force microscopy (AFM) revealed smooth, continuous films with a stability towards imaging depending on the chain extender used. Surface plasmon resonance (SPR) experiments indicated a strongly reduced adsorption of human serum albumin (HSA) on these PEG-containing polymers. Atomic absorption spectroscopy (AAS) was used to quantify in vitro calcium deposition after incubation in urine. Bacterial adhesion was strongly reduced and cytocompatibility experiments using fibroblast cultures showed the importance of catalyst residues in the materials. (C) 1998 SCI.
C1 Univ Ghent, Inst Biomed Technol, IBITECH, Polymer Mat Res Grp, B-9000 Ghent, Belgium.
   Univ Nottingham, Dept Pharmaceut Sci, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
   Univ Brighton, Dept Pharm, Brighton BN2 4AT, E Sussex, England.
   UCL Hosp, Dept Chem Pathol, London, England.
RP Schacht, E (reprint author), Univ Ghent, Inst Biomed Technol, IBITECH, Polymer Mat Res Grp, Krijgslaan 281,S-4 Bis, B-9000 Ghent, Belgium.
RI Shard, Alexander/B-4530-2010
OI Green, Rebecca/0000-0001-6783-549X; Davies, Martyn/0000-0001-7695-0596;
   Shard, Alexander/0000-0002-8931-5740
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   BAILEY J, 1976, POLYETHYLENEOXIDE
   Brash JL, 1996, CURR OPIN COLLOID IN, V1, P682, DOI 10.1016/S1359-0294(96)80109-9
   DAVIES J, 1994, NANOBIOLOGY, V3, P5
   Dewez JL, 1996, J BIOMED MATER RES, V30, P373
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GREEN RJ, UNPUB
   GRIFFITH DP, 1976, INVEST UROL, V13, P346
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HOFFMAN AS, 1987, ANN NY ACAD SCI, V516, P96, DOI 10.1111/j.1749-6632.1987.tb33033.x
   HOGT AH, 1987, ZENTRALBL BAKTERIO S, V16, P113
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Joshi RR, 1996, J BIOMED MATER RES, V31, P201
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   LELAH MD, 1986, POLYURETHANES MED, P1
   LELAH MD, 1986, POLYURETHANES MED, P159
   LELAH MD, 1986, POLYURETHANES MED, P21
   MERRILL EA, 1984, ASAIO J, V6, P60
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   PIGLOWSKI J, 1994, BIOMATERIALS, V15, P909, DOI 10.1016/0142-9612(94)90116-3
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   VANWACHEM PB, 1994, J MATER SCI-MATER M, V5, P628, DOI 10.1007/BF00120344
   WESSLEN B, 1994, BIOMATERIALS, V15, P278, DOI 10.1016/0142-9612(94)90052-3
   WILLIAMS D, 1991, MED DEVICE TECHNOL, P44
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
NR 27
TC 19
Z9 20
U1 1
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
EI 1097-0126
J9 POLYM INT
JI Polym. Int.
PD JUL
PY 1998
VL 46
IS 3
BP 251
EP 259
DI 10.1002/(SICI)1097-0126(199807)46:3<251::AID-PI6>3.0.CO;2-Z
PG 9
WC Polymer Science
SC Polymer Science
GA ZZ917
UT WOS:000074782400011
DA 2018-10-19
ER

PT J
AU Zylinski, J
   Allan, GL
   Jamieson, P
   Maher, KP
   Green, R
   Hislop, J
AF Zylinski, J
   Allan, GL
   Jamieson, P
   Maher, KP
   Green, R
   Hislop, J
TI The implementation of an integrated on-line health education system at
   RMIT
SO INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Health and Medical Informatics Education
CY AUG 14-16, 1997
CL NEWCASTLE, AUSTRALIA
SP Int Med Informat Assoc (IMIA), Asia Pacific Assoc Med Informat (APAMI), Health Informat Soc Australia (HISA)
DE Learning Centre; WWW; collaborative learning; on-line education; systems
   thinking
AB The Faculty of Biomedical and Health Sciences at RMIT has been developing an on-line health education system using a systems thinking approach, to create a learning environment whose basis is supported by Information Technology (IT). The centre-piece of this system is the Faculty Learning Centre, which has been created: both in space and layout, to promote collaborative learning between the students, so that the educator is physically assimilated with the student body. This facility is supplemented by the Faculty WWW server, which has been the main vehicle for course material dissemination to students. To ensure an effective on-line teaching environment, the position of an on-line facilitator has been created, whose responsibilities include both the continual evaluation of the system and the implementation of appropriate system changes. Aspects have included the production of a staff development training program and extensive user documentation. This paper discusses the systems thinking approach used to implement this integrated on-line system, and the establishment of explicit educational rationales in the use of IT to support learning strategies. Some examples of the on-line educational programs are also presented. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
C1 Royal Melbourne Inst Technol, Fac Biomed & Hlth Sci, Melbourne, Vic 3001, Australia.
   Royal Melbourne Inst Technol, Educ Program Improvement Grp, Melbourne, Vic 3001, Australia.
RP Zylinski, J (reprint author), Royal Melbourne Inst Technol, Fac Biomed & Hlth Sci, GPO Box 2476V, Melbourne, Vic 3001, Australia.
CR BERGE ZL, ROLE ONLINE INSTRUCT
   CLARKE RE, REV ED RES, V53, P445
   Harasim LM., 1989, MINDWEAVE COMMUNICAT, P50
   MARJANOVIC O, 1995, ELECT COLLABORATIVE, P306
   REEVES T, EVALUATING WHAT REAL
   SENGE PM, 1997, 5 DISC FIELDB STRAT, P59
   SENGE PM, 1994, 5 DISCIPLINE, P373
NR 7
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 1386-5056
J9 INT J MED INFORM
JI Int. J. Med. Inform.
PD JUN
PY 1998
VL 50
IS 1-3
BP 261
EP 265
DI 10.1016/S1386-5056(98)00078-1
PG 5
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 104HN
UT WOS:000075008800035
PM 9726521
DA 2018-10-19
ER

PT J
AU Soucek, B
   Abbattista, F
   Bellifemine, F
   Dalbis, D
AF Soucek, B
   Abbattista, F
   Bellifemine, F
   Dalbis, D
TI Quantum mind breeder
SO PERIODICUM BIOLOGORUM
LA English
DT Article
DE mind; quantum mind; brain; mind-brain link; evoked potential;
   neurodiagnoses; quantum mind theory; mind-computer interface; mind
   reading machines; primary oscillator; primary code; primary symbol;
   intelligent agent
AB Background and purpose: The Quantum Mind Breeder QM, is a fine grain computing structure that directly emulates some of the functions of animal and human mind. This work presents the creation of the QM structure that emulates the generation of Evoked Potentials, EP.
   Materials and methods: QM system combines 4 groups of techniques: Analytical. Machine Learning; Personal judgement; Graphic interaction. The response of QM, has been compared with the experimentally observed evoked potential: in human, after short auditory stimulation; in human, after the stimulation with the verbal stimuli; in mice and wistar rats after short electrical pulse stimulation.
   Results: QM structure is based on the Quantum Mind Theory with the focus on the Primary Oscillators PO. Each PO defines the basic timing and behavior of an agent, or oscillator; Flocks of agents operate in parallel and sequentially. The EP record represents the filtered self organized activity of a large set of these individual agents or oscillators.
   Conclusion: Using the Evolution and Association breeder EVA, the highly lit individual QM structure is found. QM responds to the received stimulus in the same way as a natural brain. QM generated Eps are presented, related to healthy and diabetic rodents. normal and sclerotic patients verbal stimulation and perception.
   Applications: Biomedical research; clinical diagnoses; drug testing; QM computing systems; man-machine interfaces; self-organized media; data compression in Internet browsing.
C1 IRIS, I-70125 Bari, Italy.
RP Soucek, B (reprint author), IRIS, Via Michele Troisi 18, I-70125 Bari, Italy.
CR ABBATTISTA F, 1998, PERIOD BIOL, V100, P2
   Bjegovic Milica, 1995, Periodicum Biologorum, V97, P295
   HO R, 1994, FRONTIER DECISION SU
   KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0
   PLANTAMURA VL, 1994, FRONTIER DECISION SU
   Soucek B., 1995, Informatica, V19, P591
   Soucek B., 1994, Informatica, V18, P109
   SOUCEK B, 1998, PERIOD BIOL, V100, P2
   SOUCEK B, 1997, QUANTUM MIND NETWORK
   Soucek Branko, 1996, Periodicum Biologorum, V98, P67
   Soucek Branko, 1997, Periodicum Biologorum, V99, P3
NR 11
TC 0
Z9 0
U1 0
U2 0
PU PERIODICUM BIOLOGORUM
PI ZAGREB
PA HRVATSKO PRIRODOSLOVNO DRUSTVO ILICA 16/111, 41000 ZAGREB, CROATIA
SN 0031-5362
J9 PERIOD BIOL
JI Period. Biol.
PD JUN
PY 1998
VL 100
IS 2
BP 211
EP 215
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 159BV
UT WOS:000078152700012
DA 2018-10-19
ER

PT J
AU Martinez-Pardo, E
   Vera-Graziano, R
   Ramos-Duron, LE
AF Martinez-Pardo, E
   Vera-Graziano, R
   Ramos-Duron, LE
TI Biomedical applications of radiation technology in Mexico.
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 10th International Meeting on Radiation Processing (IMRP-10)
CY MAY 11-16, 1997
CL ANAHEIM, CALIFORNIA
DE polydimethylsiloxanes; radiation induced polymerization; amniotic
   membrane; radiosterilization
AB Mexican Health Institutions continuously require suitable medical grade prosthetic materials for reconstructive and plastic surgery. In particular, the requirements of polydimethylsiloxane? PDMS, for soft tissue replacements are rapidly growing. In addition to molecular weight, the properties of PDMS in biomedicine strongly depend on its purity, formulation and processing. High energy radiation has been used for both the synthesis of highly pure PDMS. free of catalyst and chemicals, and for sterilization of biomedical products. Here. are discussed the gamma radiation polymerization of different siloxane precursors to obtain PDMS with specific functionality and molecular structure as well as the radiation sterilization of amniotic membranes used as wound dressing.
C1 Inst Nacl Invest Nucl, Mexico City 11801, DF, Mexico.
   Natl Autonomous Univ Mexico, Inst Invest Mat, Mexico City 04510, DF, Mexico.
   HCSAE, Mexico City 14140, DF, Mexico.
RP Martinez-Pardo, E (reprint author), Inst Nacl Invest Nucl, Apdo Postal 18-1027,Col Escandon, Mexico City 11801, DF, Mexico.
OI Vera-Graziano, Ricardo/0000-0003-2870-9831
CR GARCIA MFD, 1995, THESIS FACULTAD MED
   GUTIERREZ PG, 1995, THESIS U AUTONOMA ED
   Kendrick T. C., 1989, CHEM ORGANIC SILICON, P1289
   LIZARRAGA RRL, 1996, EL USO MEMBRANAS AMN
   PARDO MEM, 1995, FQ9512 ININ
   PHILLIPS GO, 1994, RAD STERILISATION TI
   RIVERA F, 1997, IIM0197 IIMUNAM INF
   SPERLING LH, 1992, INTRO PHYSICAL POLYM
   VERAGRAZIANO R, 1995, J APPL POLYM SCI, V55, P1317, DOI 10.1002/app.1995.070550905
NR 9
TC 0
Z9 0
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1998
VL 52
IS 1-6
BP 301
EP 306
PG 6
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA ZX723
UT WOS:000074548000060
DA 2018-10-19
ER

PT J
AU Shellock, FG
   Kanal, E
AF Shellock, FG
   Kanal, E
TI Yasargil aneurysm clips: Evaluation of interactions with a 1.5-T MR
   system
SO RADIOLOGY
LA English
DT Article
DE aneurysm, cerebral; aneurysm, surgery; magnetic resonance (MR), safety;
   radiology and radiologists, iatrogenic injury
ID BIOMEDICAL IMPLANTS; METALLIC IMPLANTS; IMAGE ARTIFACTS; MAGNETIC-FIELD;
   DEVICES; MOTION; FORCES
AB PURPOSE: To evaluate the magnetic field interactions with Yasargil aneurysm clips exposed to a 1.5-T MR system.
   MATERIALS AND METHODS: Sixteen Yasargil aneurysm clips made with Phynox (10 clips returned to the manufacturer due to suspected magnetic field interactions and six clips obtained from the manufacturer in sterile packages) were tested for magnetic field interaction at 1.5 T by using techniques to assess magnetic field-induced translational (deflection angle test) and torque (changes in alignment or rotation) forces.
   RESULTS: None of the aneurysm clips demonstrated magnetic field interactions; that is, deflection angles were zero and there were no changes in alignment or evidence of rotational forces present.
   CONCLUSION: It is safe to perform MR procedures at 1.5 T or less in patients with Yasargil aneurysm clips made with nonferromagnetic material.
C1 Univ So Calif, Sch Med, Dept Radiol, Los Angeles, CA 90033 USA.
   Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA USA.
RP Shellock, FG (reprint author), 7511 McConnell Ave, Los Angeles, CA 90045 USA.
CR [Anonymous], 1994, ANN BOOK ASTM STAND
   APPLEBAUM EL, 1990, ANN OTO RHINOL LARYN, V99, P801, DOI 10.1177/000348949009901009
   APPLEBAUM EL, 1985, ARCH OTOLARYNGOL, V111, P820
   BARRAFATO D, 1984, CAN J SURG, V27, P509
   BECKER RL, 1988, AM J NEURORADIOL, V9, P885
   BROWN MA, 1987, MAGN RESON IMAGING, V5, P443, DOI 10.1016/0730-725X(87)90378-X
   Dujovny M, 1997, CRIT REV NEUROSURG, V7, P169, DOI 10.1007/s003290050021
   Dujovny M, 1997, RADIOLOGY, V202, P637, DOI 10.1148/radiology.202.3.9051008
   Dujovny M, 1996, NEUROL RES, V18, P483
   Dujovny M, 1997, SURG NEUROL, V47, P547, DOI 10.1016/S0090-3019(97)00030-X
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   DUJOVNY M, 1985, CEREBRAL VASCULAR SU, P997
   Fleckenstein JL, 1997, RADIOLOGY, V202, P640, DOI 10.1148/radiology.202.3.9051009
   HOLTAS S, 1988, AM J NEURORADIOL, V9, P891
   JOHNSON GC, 1993, RADIOLOGY, V188, P287, DOI 10.1148/radiology.188.1.8511314
   KAGETSU NJ, 1991, RADIOLOGY, V179, P505, DOI 10.1148/radiology.179.2.2014301
   Kanal E, 1996, RADIOLOGY, V200, P576, DOI 10.1148/radiology.200.2.8685361
   Kanal E, 1997, RADIOLOGY, V202, P641, DOI 10.1148/radiology.202.3.641
   KANAL E, 1994, AM J NEURORADIOL, V15, P1394
   Kanal E, 1997, RADIOLOGY, V202, P638, DOI 10.1148/radiology.202.3.638
   KANAL E, 1993, RADIOLOGY, V187, P612, DOI 10.1148/radiology.187.3.8497603
   Kato Y, 1996, MINIM INVAS NEUROSUR, V39, P82, DOI 10.1055/s-2008-1052223
   KEAN DM, 1985, J NEUROL NEUROSUR PS, V48, P286, DOI 10.1136/jnnp.48.3.286
   KLUCZNIK RP, 1993, RADIOLOGY, V187, P855, DOI 10.1148/radiology.187.3.8497645
   Lawton MT, 1996, NEUROSURGERY, V38, P1170, DOI 10.1097/00006123-199606000-00026
   Lawton MT, 1996, NEUROSURGERY, V38, P1158, DOI 10.1097/00006123-199606000-00022
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   NOGUEIRA M, 1995, AJR, V163, P1472
   Ooka K, 1996, ACTA NEUROCHIR, V138, P1241, DOI 10.1007/BF01809754
   PIEPGRAS A, 1995, RADIOLOGE, V35, P830
   Planert J, 1996, MED PHYS, V23, P851, DOI 10.1118/1.597853
   ROMNER B, 1989, J NEUROSURG, V70, P426, DOI 10.3171/jns.1989.70.3.0426
   Shellock F. G., 1996, MAGNETIC RESONANCE B
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   Shellock FG, 1998, RADIOLOGY, V206, P838, DOI 10.1148/radiology.206.3.9494511
   Shellock FG, 1997, RADIOLOGY, V203, P568, DOI 10.1148/radiology.203.2.9114123
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   SHELLOCK FG, 1991, AM J NEURORADIOL, V12, P279
   SHELLOCK FG, 1990, RADIOLOGY P, V177, P271
   Shellock FG, 1997, POCKET GUIDE MR PROC
   *US FOOD DRUG ADM, 1993, MED DEVICES B, V11, P1
   Wichmann W, 1997, AM J NEURORADIOL, V18, P939
NR 42
TC 29
Z9 29
U1 0
U2 1
PU RADIOLOGICAL SOC NORTH AMER
PI EASTON
PA 20TH AND NORTHAMPTON STS, EASTON, PA 18042 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD JUN
PY 1998
VL 207
IS 3
BP 587
EP 591
DI 10.1148/radiology.207.3.9609877
PG 5
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA ZN534
UT WOS:000073655500006
PM 9609877
DA 2018-10-19
ER

PT J
AU Trigwell, S
   Hayden, RD
   Nelson, KF
   Selvaduray, G
AF Trigwell, S
   Hayden, RD
   Nelson, KF
   Selvaduray, G
TI Effects of surface treatment on the surface chemistry of NiTi alloy for
   biomedical applications
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE Ni; Ti; XPS; AES; AFM
AB Alloys of NiTi have gained popularity in biomedical applications; however, Ni is known to cause toxic and allergic reactions in the body, and concerns have been expressed regarding the material's biocompatibility. In this study, coupons of equiatomic NiTi were prepared by four methods, namely, mechanically polishing to a mirror finish, electropolishing, chemical etching and argon plasma etching, to produce various levels of roughness, and then examined by atomic force microscopy (AFM), XPS and AES. The resulting surface chemistry depended upon the method of preparation and was found not to be a function of surface roughness. The mechanically polished samples, although having the smoothest surface, showed the highest level of Ni in the near-surface region. The other preparation methods produced surfaces that were predominantly TiO2, with the electropolished surfaces showing the next smoothest surface and the least Ni in the near-surface region. The correlation between method of preparation, surface roughness and surface chemistry may be important in the preparation of NiTi for biomedical applications. (C) 1998 John Wiley & Sons, Ltd.
C1 VG Sci, Beverly, MA 01915 USA.
   Surface Sci Labs, Mt View, CA 94043 USA.
   San Jose State Univ, Dept Mat Engn, San Jose, CA 95192 USA.
RP Trigwell, S (reprint author), VG Sci, 100 Cummings Ctr,Suite 4075, Beverly, MA 01915 USA.
CR BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603
   Castleman L. S., 1981, BIOCOMPATIBILITY CLI, P129
   CHAN CM, 1990, SURF INTERFACE ANAL, V15, P349, DOI 10.1002/sia.740150602
   GYUNTER VE, 1992, SHAPE MEMORY EFFECTS
   KUBASCHEWSKI O, 1958, METALLURGICAL THERMO, P341
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   *PERK, 1979, HDB XRAY PHOT SPECTR
   RONDELLI G, 1990, CORROS SCI, V30, P805, DOI 10.1016/0010-938X(90)90004-O
   SHABALOVSKAYA SA, 1995, J VAC SCI TECHNOL A, V13, P2624, DOI 10.1116/1.579461
   SUNDERMANN FW, 1977, ANN CLIN LAB SCI, V7, P337
   WAYMAN CM, 1993, MRS B, V49
   WICKS CE, 1963, B BUR MINES, V605, P120
NR 12
TC 72
Z9 80
U1 1
U2 10
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JUN
PY 1998
VL 26
IS 7
BP 483
EP 489
DI 10.1002/(SICI)1096-9918(199806)26:7<483::AID-SIA388>3.0.CO;2-5
PG 7
WC Chemistry, Physical
SC Chemistry
GA 100TU
UT WOS:000074832100001
DA 2018-10-19
ER

PT J
AU Dai, LM
   Lu, JP
   Matthews, B
   Mau, AWH
AF Dai, LM
   Lu, JP
   Matthews, B
   Mau, AWH
TI Doping of conducting polymers by sulfonated fullerene derivatives and
   dendrimers
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Letter
ID STARBURST CASCADE DENDRIMERS; NONLINEAR-OPTICAL-RESPONSE;
   CHARGE-TRANSFER; DOPED POLYANILINES; C-60; BUCKMINSTERFULLERENE;
   CHEMISTRY; MOLECULES; STATE; C-70
AB We report here the use of sulfonated fullerene derivatives and dendrimers with multiple -(O)SO3H groups as protonic acid dopants for polyaniline emeraldine base (PANI-EB). While doping of PANI-EB films with the sulfonated dendrimers gives conductivities up to ca. 10 S/cm, the hydrogensulfated fullerenol-doped materials show metallic characteristics with room-temperature conductivities as high as 100 S/cm-about 6 orders of magnitude higher than the typical value for fullerene-doped conducting polymers. This, coupled with the anticipated photoinduced charge-transfer effects characteristic of fullerene C-60 and potential biomedical applications of dendrimers, could make these highly conducting materials useful in many advanced optoelectronic and/or biomedical devices.
C1 CSIRO, S Clayton MDC, Vic 3169, Australia.
RP Dai, LM (reprint author), CSIRO, Private Bag 10, S Clayton MDC, Vic 3169, Australia.
CR Ahlskog M, 1997, SYNTHETIC MET, V84, P619, DOI 10.1016/S0379-6779(96)04077-5
   ANDERSON MR, 1991, SCIENCE, V252, P1412, DOI 10.1126/science.252.5011.1412
   BARTUS J, 1991, J MACROMOL SCI CHEM, VA28, P917, DOI 10.1080/00222339108054069
   BAUM R, 1997, C E NEWS        0106, P29
   BAUM RM, 1994, CHEM ENG NEWS   0613, P7
   BAUM RM, 1993, C E NEWS        1022, P8
   CAO Y, 1992, APPL PHYS LETT, V60, P2711, DOI 10.1063/1.106852
   CAO Y, 1992, SYNTHETIC MET, V48, P91, DOI 10.1016/0379-6779(92)90053-L
   CHEN SA, 1995, MACROMOLECULES, V28, P1239, DOI 10.1021/ma00108a062
   CHIANG LY, 1993, J AM CHEM SOC, V115, P5453, DOI 10.1021/ja00066a014
   CHIANG LY, 1992, J CHEM SOC CHEM COMM, P1791, DOI 10.1039/c39920001791
   CHIANG LY, 1994, J ORG CHEM, V59, P3960, DOI 10.1021/jo00093a030
   Dai LM, 1997, POLYMER, V38, P775, DOI 10.1016/S0032-3861(96)00573-3
   Dai LM, 1997, SYNTHETIC MET, V86, P2277, DOI 10.1016/S0379-6779(97)81124-1
   DAI LM, 1992, J PHYS CHEM-US, V96, P6469, DOI 10.1021/j100194a067
   Dai LM, 1998, J MATER CHEM, V8, P325, DOI 10.1039/a703764c
   DAI LM, 1995, J PHYS CHEM-US, V99, P17302, DOI 10.1021/j100048a002
   DIEDERICH F, 1994, CHEM SOC REV, V23, P243, DOI 10.1039/cs9942300243
   Diederich F, 1996, SCIENCE, V271, P317, DOI 10.1126/science.271.5247.317
   FLOM SR, 1992, PHYS REV B, V46, P15598, DOI 10.1103/PhysRevB.46.15598
   GILMOUR S, 1994, ADV MATER, V6, P494, DOI 10.1002/adma.19940060613
   GONG X, IN PRESS J POLYM S A
   Gong XY, 1998, J POLYM SCI POL CHEM, V36, P633, DOI 10.1002/(SICI)1099-0518(199803)36:4<633::AID-POLA12>3.0.CO;2-N
   GrunnetJepsen A, 1997, SCIENCE, V277, P549, DOI 10.1126/science.277.5325.549
   HADDON RC, 1992, ACCOUNTS CHEM RES, V25, P127, DOI 10.1021/ar00015a005
   Hammond G. S., 1992, ACS S SERIES, V481
   HEBARD AF, 1991, NATURE, V350, P600, DOI 10.1038/350600a0
   HEBARD AF, 1993, ANNU REV MATER SCI, V23, P159, DOI 10.1146/annurev.ms.23.080193.001111
   HENARI FZ, 1993, ADV MATER, V5, P930, DOI 10.1002/adma.19930051212
   Hirsch A, 1994, CHEM FULLERENES
   Holland ER, 1997, SYNTHETIC MET, V84, P777, DOI 10.1016/S0379-6779(96)04141-0
   Hopkins AR, 1996, MACROMOLECULES, V29, P7838, DOI 10.1021/ma9606519
   Imahori H, 1997, ADV MATER, V9, P537, DOI 10.1002/adma.19970090704
   ISSBERNER J, 1994, ANGEW CHEM INT EDIT, V33, P2413
   KAJZAR F, 1994, CHEM PHYS LETT, V217, P418, DOI 10.1016/0009-2614(93)E1396-X
   Kohlman RS, 1997, SYNTHETIC MET, V84, P709, DOI 10.1016/S0379-6779(96)04115-X
   KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0
   KROTO HW, 1991, CHEM REV, V91, P1213, DOI 10.1021/cr00006a005
   KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0
   KROTO HW, 1993, CHEM ENG NEWS   0104, P29
   KROTO HW, 1996, CHEM ENG NEWS   1014, P7
   LEE JY, 1995, SYNTHETIC MET, V74, P103, DOI 10.1016/0379-6779(95)03359-9
   Lee SB, 1996, SYNTHETIC MET, V77, P155, DOI 10.1016/0379-6779(96)80078-6
   LINDLE JR, 1993, PHYS REV B, V48, P9447, DOI 10.1103/PhysRevB.48.9447
   MACDIAMID AG, 1986, CONDUCTING POLYM SPE
   MACDIARMID AG, 1994, SYNTHETIC MET, V65, P103, DOI 10.1016/0379-6779(94)90171-6
   MacDiarmid AG, 1997, SYNTHETIC MET, V84, P27, DOI 10.1016/S0379-6779(97)80658-3
   MATTHEWS BR, 1995, Patent No. 34595
   MEKELBURGER HB, 1992, ANGEW CHEM INT EDIT, V31, P1571, DOI 10.1002/anie.199215711
   MORITA S, 1992, SOLID STATE COMMUN, V82, P249, DOI 10.1016/0038-1098(92)90636-N
   MORITA S, 1993, J PHYS-CONDENS MAT, V5, P2103
   NEWLOME GR, 1992, ALDRICHIM ACTA, V25, P31
   OHNISHI T, 1991, SYNTHETIC MET, V41, P309, DOI 10.1016/0379-6779(91)91069-M
   Prato M, 1997, J MATER CHEM, V7, P1097, DOI 10.1039/a700080d
   SARICIFTCI NS, 1995, PROG QUANT ELECTRON, V19, P131, DOI 10.1016/0079-6727(94)00012-N
   Schlebusch C, 1996, SYNTHETIC MET, V77, P151, DOI 10.1016/0379-6779(96)80077-4
   SERVICE RF, 1995, SCIENCE, V267, P458, DOI 10.1126/science.267.5197.458
   Sixou B, 1996, PHYS REV B, V53, P4509, DOI 10.1103/PhysRevB.53.4509
   SIXOU B, 1995, EUROPHYS LETT, V30, P157, DOI 10.1209/0295-5075/30/3/006
   Taylor R., 1995, CHEM FULLERENES
   TOMALIA DA, 1993, TOP CURR CHEM, V165, P193
   TOMALIA DA, 1994, ADV MATER, V6, P529, DOI 10.1002/adma.19940060703
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   TUTT LW, 1992, NATURE, V356, P225, DOI 10.1038/356225a0
   vanderSanden MCM, 1997, SYNTHETIC MET, V87, P137, DOI 10.1016/S0379-6779(96)04918-1
   vanderSanden MCM, 1997, SYNTHETIC MET, V87, P141, DOI 10.1016/S0379-6779(96)04919-3
   WANG Y, 1993, J AM CHEM SOC, V115, P3844, DOI 10.1021/ja00062a088
   WANG Y, 1992, NATURE, V356, P585, DOI 10.1038/356585a0
   WEI Y, 1993, J CHEM SOC CHEM COMM, P603, DOI 10.1039/c39930000603
   WUDL F, 1992, ACCOUNTS CHEM RES, V25, P157, DOI 10.1021/ar00015a009
   XIA YN, 1995, CHEM MATER, V7, P443, DOI 10.1021/cm00051a002
   YANG Y, 1994, APPL PHYS LETT, V64, P1245, DOI 10.1063/1.110853
   Yoshino K, 1996, SYNTHETIC MET, V78, P301, DOI 10.1016/0379-6779(96)80154-8
   YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789
   Zakhidov AA, 1996, SYNTHETIC MET, V77, P127, DOI 10.1016/0379-6779(96)80074-9
NR 75
TC 61
Z9 63
U1 0
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1089-5647
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD MAY 21
PY 1998
VL 102
IS 21
BP 4049
EP 4053
DI 10.1021/jp980410y
PG 5
WC Chemistry, Physical
SC Chemistry
GA ZR647
UT WOS:000073999700002
DA 2018-10-19
ER

PT J
AU Hu, ZB
   Chen, YY
   Wang, CJ
   Zheng, YD
   Li, Y
AF Hu, ZB
   Chen, YY
   Wang, CJ
   Zheng, YD
   Li, Y
TI Polymer gels with engineered environmentally responsive surface patterns
SO NATURE
LA English
DT Article
ID SPINODAL DECOMPOSITION; ISOPROPYLACRYLAMIDE
AB The polymer gels called hydrogels may be induced to swell or shrink (taking up or expelling water between the crosslinked polymer chains) in response to a variety of environmental stimuli, such as changes in pH or temperature, or the presence of a specific chemical substrate(1). These gels are being explored for several technological applications, particularly as biomedical materials(2). When hydrogels swell or shrink, complex patterns may be generated on their surfaces(3-7). Here we report the synthesis and controlled modulation of engineered surface patterns on environmentally responsive hydrogels. We modify the character of a gel surface by selectively depositing another material using a mask. For example, we use sputter deposition to imprint the surface of an N-isopropylacrylamide (NIPA) gel with a square array of gold thin films. The periodicity of the array can be continuously varied as a function of temperature or electric field (which alter the gel's volume), and so such an array might serve as an optical grating for sensor applications. We also deposit small areas of an NIPA gel on the surface of an acrylamide gel; the patterned area can be rendered invisible reversibly by switching the temperature above or below the lower critical solution temperature of the NIPA gel. We anticipate that these surface patterning techniques may find applications in display and sensor technology.
C1 Univ N Texas, Dept Phys, Denton, TX 76203 USA.
   Kimberly Clark Corp, Neenal, WI 54956 USA.
RP Hu, ZB (reprint author), Univ N Texas, Dept Phys, Denton, TX 76203 USA.
CR Bansil R, 1996, PHYSICA A, V231, P346, DOI 10.1016/0378-4371(96)00081-7
   GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008
   Hirotsu S., 1985, Japanese Journal of Applied Physics, Supplement, P396
   HU ZB, 1995, SCIENCE, V269, P525, DOI 10.1126/science.269.5223.525
   Imisides MD, 1996, CHEMTECH, V26, P19
   LI CF, 1994, J CHEM PHYS, V100, P4645, DOI 10.1063/1.466247
   LI Y, 1995, MACROMOLECULES, V28, P4194, DOI 10.1021/ma00116a021
   LI Y, 1994, J CHEM PHYS, V100, P4637, DOI 10.1063/1.466296
   MISCH W, 1994, BIOSENS BIOELECTRON, V9, P737
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   SATOMATSUO E, 1992, NATURE, V358, P482
   Suzuki A, 1996, J CHEM PHYS, V104, P1751, DOI 10.1063/1.470760
   TANAKA T, 1987, NATURE, V325, P796, DOI 10.1038/325796a0
   TANAKA T, 1981, SCI AM, V244, P124, DOI 10.1038/scientificamerican0181-124
   WANG J, 1994, ANAL CHEM, V66, P1007, DOI 10.1021/ac00079a013
   Weissman JM, 1996, SCIENCE, V274, P959, DOI 10.1126/science.274.5289.959
NR 16
TC 239
Z9 247
U1 6
U2 95
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW
SN 0028-0836
J9 NATURE
JI Nature
PD MAY 14
PY 1998
VL 393
IS 6681
BP 149
EP 152
DI 10.1038/30205
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ZN200
UT WOS:000073619900042
DA 2018-10-19
ER

PT J
AU Kay, MW
   Roe, SC
   Stikeleather, LF
   Mahmoud, A
   Abrams, CF
AF Kay, MW
   Roe, SC
   Stikeleather, LF
   Mahmoud, A
   Abrams, CF
TI Axial vibration of threaded external fixation pins: Detection of pin
   loosening
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE vibration; external fixation pin; interface; loosening; nondestructive
ID IMPLANTS
AB The hypothesis of this study was that a nondestructive vibrational method could detect bone lysis at the external fixation pin-bone interface prior to current clinical and radiographic methods. In vitro models were used to simulate changes observed during pin loosening in vivo. Fixation pin axial natural frequency decreased with decreasing tensile modulus of the material into which it was implanted. In a live animal study the right tibia of 12 dogs was fractured and stabilized with a four-pin unilateral external fixation frame. The axial natural frequency of each pin was measured and radiographs were taken at 0, 2, 4, 6, 8, and 10 weeks after surgery. The natural frequency did not change when the first radiographic changes around the interface were observed. Pins were palpably stable at this point. As loosening progressed, the natural frequency did decrease. Frequency and quasistatic tests of dissected pin-bone structures revealed a good correlation between natural frequency and pin-bone interface stiffness. In addition, the measurement of natural frequency was more sensitive to bone structure changes at the pin-bone interface than low-load quasi-static stiffness. Therefore, a nondestructive vibration technique could be used instead of low-load quasistatic tests for assessing the pin-bone interface ex vivo. (C) 1998 Biomedical Engineering Society.
C1 N Carolina State Univ, Dept Biol & Agr Engn, Raleigh, NC 27695 USA.
   N Carolina State Univ, Coll Vet Med, Dept Compan Anim & Special Species Med, Raleigh, NC 27695 USA.
RP Kay, MW (reprint author), Washington Univ, Dept Mech Engn, Campus Box 1185,1 Brookings Dr, St Louis, MO 63130 USA.
EM mwkay@spud.me.wustl.edu
CR ANDERSON MA, 1993, VET SURG, V22, P482, DOI 10.1111/j.1532-950X.1993.tb00425.x
   ARO HT, 1993, HAND CLIN, V9, P531
   BEHRENS F, 1989, CLIN ORTHOP RELAT R, P15
   Clary E. M., 1995, Veterinary and Comparative Orthopaedics and Traumatology, V8, P1
   CORNELISSEN M, 1984, ORTHOPEDICS, V7, P623, DOI 10.3928/0147-7447-19840401-12
   DICKENS JR, 1994, ULTRASONICS, V32, P65, DOI 10.1016/0041-624X(94)90082-5
   Fung Y. C., 1993, BIOMECHANICS MECH PR, P251
   GEORGE TF, 1992, J APPL BIOMATER, V3, P29, DOI 10.1002/jab.770030106
   HARDY N, 1984, ORTHOPEDICS, V7, P616, DOI 10.3928/0147-7447-19840401-11
   HORN TS, 1993, BONE, V14, P259, DOI 10.1016/8756-3282(93)90149-5
   KANEKO T, 1987, J MATER SCI, V22, P3495, DOI 10.1007/BF01161448
   LI PLS, 1995, J BONE JOINT SURG BR, V77B, P640
   PETTINE KA, 1993, CLIN ORTHOP RELAT R, P18
   ROEDLICH CB, 1994, THESIS N CAROLINA ST
   RUBIN CT, 1987, J BIOMECH, V20, P723, DOI 10.1016/0021-9290(87)90038-8
   WEINHOLD PS, 1995, ORTHOP T, V20, P534
NR 16
TC 12
Z9 12
U1 0
U2 2
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY-JUN
PY 1998
VL 26
IS 3
BP 361
EP 368
DI 10.1114/1.92
PG 8
WC Engineering, Biomedical
SC Engineering
GA ZH211
UT WOS:000073084100003
PM 9570219
DA 2018-10-19
ER

PT J
AU Morrison, B
   Meaney, DF
   McIntosh, TK
AF Morrison, B
   Meaney, DF
   McIntosh, TK
TI Mechanical characterization of an in vitro device designed to
   quantitatively injure living brain tissue
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE cell culture; mechanical stimulus; stretch injury; dynamic loading
ID STRETCH-INDUCED INJURY; DIFFUSE AXONAL INJURY; ENDOTHELIAL-CELLS;
   INVITRO; MODEL; TRAUMA; CULTURE; PRIMATE; NEURONS
AB Due to the nonlinear, viscoelastic material properties of brain, its mechanical response is dependent upon its total strain history. Therefore, a low strain rate, large strain will likely produce a tissue injury unique from that due to a high strain rate, moderate strain. Due to a lack of current understanding of specific in vivo physiological injury mechanisms, a priori assumptions cannot be made that a low strain rate injury induced by currently employed in vitro injury devices is representative of clinical, nonimpact, inertial head injuries. in the present study, an in vitro system capable of mechanically injuring cultured tissue at high strain rates was designed and characterized. The design of the device was based upon existing systems in which a clamped membrane, on which cells have been cultured, is deformed. However, the present system incorporates three substantial improvements: (1) noncontact measurement of the membrane deflection during injury; (2) precise and independent control over several characteristics of the deflection; and (3) generation of mechanical insults over a wide range of strains (up to 0.65) and strain rates (up to 15 s(-1)). Such a system will be valuable in the elucidation of the mechanisms of mechanical trauma and determination of injury tolerance criteria on a cellular level utilizing appropriate mechanical injury parameters. (C) 1998 Biomedical Engineering Society.
C1 Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.
RP McIntosh, TK (reprint author), 3320 Smith Walk,Hayden Hall,Room 120, Philadelphia, PA 19104 USA.
EM mcintosh@eniac.seas.upenn.edu
RI Morrison, Barclay/B-7132-2008
OI Morrison, Barclay/0000-0001-7676-0864
FU NINDS NIH HHS [NINDS-P01-NS08803, NINDS-R01-NS26818]
CR ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610
   ADKINS JE, 1952, PHILOS TR R SOC S-A, V244, P505, DOI 10.1098/rsta.1952.0013
   BALENTINE JD, 1988, LAB INVEST, V58, P93
   BRODLAND GW, 1988, INT J SOLIDS STRUCT, V24, P351
   Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395
   CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173
   ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325
   GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464
   GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357
   GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611
   GORFIEN SF, 1989, J CELL PHYSIOL, V139, P492, DOI 10.1002/jcp.1041390307
   HARTSMIT.LJ, 1967, INT J ENG SCI, V5, P1, DOI 10.1016/0020-7225(67)90051-1
   HARTSMITH LJ, 1966, Z ANGEW MATH PHYS, V17, P608, DOI 10.1007/BF01597242
   KIRKPATRICK JB, 1985, J NEUROPATH EXP NEUR, V44, P268, DOI 10.1097/00005072-198505000-00005
   KLINGBEIL WW, 1964, Z ANGEW MATH PHYS, V15, P608, DOI 10.1007/BF01595147
   KOENEMAN JR, 1966, THESIS CASE I TECHNO
   LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844
   LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355
   LUCAS JH, 1991, BRAIN RES, V543, P181, DOI 10.1016/0006-8993(91)90027-S
   LUCAS JH, 1992, J NEUROTRAUM, V9, P117, DOI 10.1089/neu.1992.9.117
   MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3
   MARGULIES SS, 1990, THESIS U PENNSYLVANI
   McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934
   Meaney D., 1991, THESIS U PENNSYLVANI
   Meaney D.F., 1990, INT C BIOM IMP LYON, P215
   MURPHY EJ, 1993, J NEUROTRAUM, V10, P431, DOI 10.1089/neu.1993.10.431
   OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299
   PAMIDI MR, 1978, J BIOMECH ENG-T ASME, V100, P44, DOI 10.1115/1.3426188
   Press WH, 1992, NUMERICAL RECIPES C, P609
   Rand CW, 1934, ARCH NEURO PSYCHIATR, V31, P527, DOI 10.1001/archneurpsyc.1934.02250030067004
   REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X
   REISSNER E, 1949, P S APPL MATH AM MAT, P213
   SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B
   SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588
   Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767
   THIBAULT LE, 1983, J BIOMECH ENG-T ASME, V105, P31, DOI 10.1115/1.3138381
   WANG HC, 1972, J BIOMECH, V5, P431, DOI 10.1016/0021-9290(72)90002-4
   WILLIAMS JL, 1992, J BIOMECH ENG-T ASME, V114, P377, DOI 10.1115/1.2891398
   WINSTON FK, 1989, J APPL PHYSIOL, V67, P397
NR 39
TC 49
Z9 50
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY-JUN
PY 1998
VL 26
IS 3
BP 381
EP 390
DI 10.1114/1.61
PG 10
WC Engineering, Biomedical
SC Engineering
GA ZH211
UT WOS:000073084100005
PM 9570221
DA 2018-10-19
ER

PT J
AU Markou, CP
   Lutostansky, EM
   Ku, DN
   Hanson, SR
AF Markou, CP
   Lutostansky, EM
   Ku, DN
   Hanson, SR
TI A novel method for efficient drug delivery
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE local drug delivery; mass transfer; blood-materials interactions
ID INTIMAL HYPERPLASIA; THROMBOSIS; HEPARIN; INFUSION; ANGIOPLASTY;
   CATHETER; GRAFTS
AB Local delivery of anti-thrombotic and anti-restenotic drugs is desired to achieve high concentrations of agents which may be rapidly degraded systemically or which exhibit very short half-lives in vivo. In this article, the operating characteristics of a novel local drug delivery method are described and its effectiveness demonstrated computationally and experimentally. Computational models used a finite volume method to determine the concentration field. Optical dye density measurements of Evans blue in saline were performed in an in vitro steady flow system. Modeling parameters were kept in the physiologic range. Experimental how visualization studies demonstrated high concentrations of infusate near the vessel wall. Computational studies predicted high, clinically significant drug concentrations along the wall downstream of the infusion device. When the radial infusion velocity is large (infusion flow rate, Q(inf)>0.5% of the main flow rate, Q), the wall concentration of the infused drug remains high, e.g., levels are greater than 80% of the infusate concentration 5 cm downstream of the infusion device. At lower infusion rates (Q(inf)<0.001Q), the drug concentration at the wall decreases exponentially with axial distance to less than 25% of the infusate concentration 5 cm downstream of the infusion device, although therapeutic drug levels are still readily maintained. The near wall drug concentration is a function of flow conditions, infusion rate, and the drug diffusivity. Good agreement was obtained between computational and experimental concentration measurements. Flow simulation and experimental results indicate that the technique can effectively sustain high local drug concentrations for inhibition of thrombosis and vascular lesion formation. (C) 1998 Biomedical Engineering Society.
C1 Emory Univ, Sch Med, Dept Med, Div Hematol Oncol, Atlanta, GA 30322 USA.
   Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Hanson, SR (reprint author), Emory Univ, Sch Med, Dept Med, Div Hematol Oncol, 1639 Pierce Dr,Room 1129, Atlanta, GA 30322 USA.
FU NHLBI NIH HHS [HL 48667, HL 31469, HL 39437-07]
CR BIRD RB, 1960, TRANSPORT PHENOMENA, P42
   Chen CY, 1997, J SURG RES, V69, P300, DOI 10.1006/jsre.1997.5052
   Chen CY, 1996, CIRCULATION, V94, P1989, DOI 10.1161/01.CIR.94.8.1989
   CHEN CY, 1995, J VASC SURG, V22, P237, DOI 10.1016/S0741-5214(95)70136-2
   Chen CY, 1996, ANN VASC SURG, V10, P147, DOI 10.1007/BF02000759
   Chen CY, 1997, J SURG RES, V67, P26, DOI 10.1006/jsre.1996.4915
   CUMBERLAND DC, 1994, J AM COLL CARDIOL, V23, pA186
   CUSSLER EL, 1984, DIFFUSION
   Hanson S R, 1995, Adv Pharmacol, V34, P383
   HONG MK, 1993, CORONARY ARTERY DIS, V4, P1023, DOI 10.1097/00019501-199311000-00011
   LAMBERT CR, 1993, CORONARY ARTERY DIS, V4, P469, DOI 10.1097/00019501-199305000-00011
   LINCOFF AM, 1994, CIRCULATION, V90, P2070, DOI 10.1161/01.CIR.90.4.2070
   LOVICH MA, 1995, CIRC RES, V77, P1143, DOI 10.1161/01.RES.77.6.1143
   MA PP, 1994, INT J HEAT MASS TRAN, V37, P2723, DOI 10.1016/0017-9310(94)90389-1
   Markou CP, 1996, CIRCULATION, V94, P1563
   Mattar SG, 1996, J SURG RES, V60, P339, DOI 10.1006/jsre.1996.0054
   MULLER DWM, 1990, CORONARY ARTERY DIS, V1, P438, DOI 10.1097/00019501-199007000-00005
   NATHAN A, 1995, MOL INTERVENTIONS LO, P29
   PINCHAK AC, 1975, J APPL PHYSIOL, V41, P646
   ROGERS C, 1995, MOL INTERVENTIONS LO, P131
   Saavedra JE, 1996, J MED CHEM, V39, P4361, DOI 10.1021/jm960616s
   SCOTT NA, 1994, CIRCULATION, V90, P1951, DOI 10.1161/01.CIR.90.4.1951
   WOLINSKY H, 1990, J AM COLL CARDIOL, V15, P475, DOI 10.1016/S0735-1097(10)80079-8
NR 23
TC 20
Z9 20
U1 0
U2 3
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY-JUN
PY 1998
VL 26
IS 3
BP 502
EP 511
DI 10.1114/1.97
PG 10
WC Engineering, Biomedical
SC Engineering
GA ZH211
UT WOS:000073084100016
PM 9570232
DA 2018-10-19
ER

PT J
AU Feit, MD
   Rubenchik, AM
   Kim, BM
   da Silva, LB
   Perry, MD
AF Feit, MD
   Rubenchik, AM
   Kim, BM
   da Silva, LB
   Perry, MD
TI Physical characterization of ultrashort laser pulse drilling of
   biological tissue
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Laser Ablation (COLA 97)
CY JUL 21-25, 1997
CL MONTEREY BAY, CA
DE ultrashort laser pulse ablation; biological tissue; physical
   characterization
ID DIELECTRICS; NANOSECOND; ABLATION
AB Ultrashort laser pulse ablation removes material with low-energy fluence required and minimal collateral damage. The ultimate usefulness of this technology for biomedical application depends, in part, on characterization of the physical conditions attained, and determination of the zone of shockwave and heat-affected material in particular tissues. Detailed numerical modeling of the relevant physics (deposition, plasma formation, shockwave generation and propagation, thermal conduction) are providing this information. A wide range of time scales is involved, ranging from picosecond for energy deposition and peak pressure and temperature, to nanosecond for development of shockwave, to microsecond for macroscopic thermophysical response. (C) 1998 Elsevier Science B.V.
C1 Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RP Feit, MD (reprint author), Univ Calif Lawrence Livermore Natl Lab, POB 808,Mail Stop L-439, Livermore, CA 94550 USA.
EM feit1@llnl.gov; rubenchik1@llnl.gov; kim12@llnl.gov; dasilva1@llnl.gov;
   perry10@llnl.gov
RI Feit, Michael/A-4480-2009
CR Anisimov V. N., 1987, Soviet Journal of Quantum Electronics, V17, P101, DOI 10.1070/QE1987v017n01ABEH006449
   DASILVA LB, 1996, SPIE
   FEIT MD, 1996, SPIE
   Juhasz T, 1996, LASER SURG MED, V19, P23, DOI 10.1002/(SICI)1096-9101(1996)19:1<23::AID-LSM4>3.0.CO;2-S
   Kim BM, 1998, APPL SURF SCI, V127, P857, DOI 10.1016/S0169-4332(97)00756-3
   KRUGER RR, 1995, SPIE, V2393, P94
   London RA, 1996, P SOC PHOTO-OPT INS, V2672, P231, DOI 10.1117/12.238772
   LONDON RA, 1996, SPIE
   Neev J, 1996, IEEE J SEL TOP QUANT, V2, P790, DOI 10.1109/2944.577301
   Oraevsky AA, 1996, IEEE J SEL TOP QUANT, V2, P801, DOI 10.1109/2944.577302
   PERRY MD, 1997, UNPUB PHYS PLASMA
   Rubenchik AM, 1998, APPL SURF SCI, V127, P193, DOI 10.1016/S0169-4332(97)00631-4
   RUBENCHIK AM, 1996, SPIE
   STUART BC, 1995, PHYS REV LETT, V74, P2248, DOI 10.1103/PhysRevLett.74.2248
   Stuart BC, 1996, PHYS REV B, V53, P1749, DOI 10.1103/PhysRevB.53.1749
   Stuart BC, 1996, J OPT SOC AM B, V13, P459, DOI 10.1364/JOSAB.13.000459
NR 16
TC 38
Z9 39
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY
PY 1998
VL 127
BP 869
EP 874
DI 10.1016/S0169-4332(97)00758-7
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA ZP584
UT WOS:000073768100146
DA 2018-10-19
ER

PT J
AU Krafft, MP
   Riess, JG
AF Krafft, MP
   Riess, JG
TI Highly fluorinated amphiphiles and colloidal systems, and their
   applications in the biomedical field. A contribution
SO BIOCHIMIE
LA English
DT Review
DE fluorocarbons; fluorinated amphiphiles; fluorocarbon emulsions; gels;
   vesicles; liposomes; tubules; bilayers; Langmuir monolayers; oxygen
   delivery; drug delivery; diagnosis
ID SEMIFLUORINATED NORMAL-ALKANES; MOUSE PERITONEAL-MACROPHAGES;
   FLUOROCARBON EMULSIONS; SUPRAMOLECULAR ASSEMBLIES; PERFLUOROCARBON
   EMULSIONS; SYNTHETIC GLYCOLIPIDS; CONTRAST AGENT; PERFLUOROALKYLATED
   AMPHIPHILES; TELOMERIC SURFACTANTS; NONIONIC SURFACTANTS
AB Fluorocarbons and fluorocarbon moieties are uniquely characterized by very strong intramolecular bonds and very weak intermolecular interactions. This results in a combination of exceptional thermal, chemical and biological inertness, low surface tension, high fluidity, excellent spreading characteristics, low solubility in water, and high gas dissolving capacities, which are the basis for innovative applications in the biomedical field. Perfluoroalkyl chains are larger and more rigid than their hydrogenated counterparts. They are considerably more hydrophobic, and are lipophobic as well. A large variety of well-defined, modular fluorinated surfactants whose polar head groups consist of polyols, sugars, sugar phosphates, amino acids, amine oxides, phosphocholine, phosphatidylcholine, etc, has recently been synthesized. Fluorinated surfactants are significantly more surface active than their hydrocarbon counterparts, both in terms of effectiveness and of efficiency. Despite this, they are less hemolytic and less detergent. Fluorosurfactants appear unable to extract membrane proteins. Fluorinated chains confer to surfactants a powerful driving force for collecting and organizing at interfaces. As compared to non-fluorinated analogs, fluorosurfactants have also a much stronger capacity to self-aggregate into discrete molecular assemblies when dispersed in water and other solvents. Even very short, single-chain fluorinated amphiphiles can form highly stable, heat-sterilizable vesicles, without the need for supplementary associative interactions. Sturdy microtubules were obtained from nonchiral, non-hydrogen bonding single-chain fluorosurfactants. Fluorinated amphiphiles can be used to engineer a variety of colloidal systems and manipulate their morphology, structure and properties. Stable fluorinated films, membranes and vesicles can also be prepared from combinations of standard surfactants with fluorocarbon/hydrocarbon diblock molecules. In bilayer membranes made from fluorinated amphiphiles the fluorinated tails segregate to form an internal teflon-like hydrophobic and lipophobic Nm that increases the stability of the membrane and reduces its permeability. This fluorinated film can also influence the behavior of fluorinated vesicles in a biological milieu. For example, it can affect the in vivo recognition and fate of particles, or the enzymatic hydrolysis of phospholipid components. Major applications of fluorocarbons currently in advanced clinical trials include injectable emulsions for delivering oxygen to tissues at risk of hypoxia; a neat fluorocarbon for treatment of acute respiratory failure by liquid ventilation; and gaseous fluorocarbon-stabilized microbubbles for use as contrast agents for ultrasound imaging. Fluorosurfactants also allow the preparation of a range of stable direct and reverse emulsions, microemulsions, multiple emulsions, and gels, some of which may include fluorocarbon and hydrocarbon and aqueous phases simultaneously. Highly fluorinated systems have potential for the delivery of drugs, prodrugs, vaccines, genes, markers, contrast agents and other materials ((C) Societe francaise de biochimie et biologie moleculaire / Elsevier, Paris).
C1 Inst Charles Sadron, UPR, CNRS 22, F-67083 Strasbourg, France.
   Univ Calif San Diego, Ctr Med, MRI Inst, San Diego, CA 92103 USA.
RP Krafft, MP (reprint author), Inst Charles Sadron, UPR, CNRS 22, 6 Rue Boussingault, F-67083 Strasbourg, France.
OI KRAFFT, Marie Pierre/0000-0002-3379-2783
CR Allouch M, 1996, J AM OIL CHEM SOC, V73, P87, DOI 10.1007/BF02523453
   ANTHONY P, 1995, BIOTECHNOL TECH, V9, P777, DOI 10.1007/BF00159400
   BARTON SW, 1992, J CHEM PHYS, V96, P1343, DOI 10.1063/1.462170
   BOULEY L, 1997, 8 INT S BLOOD SUBST
   BRACE NO, 1973, J ORG CHEM, V38, P3167, DOI 10.1021/jo00958a020
   CHANG S, 1994, FLUORINE MED 21 CENT, pCH24
   Chang T.M.S., 1994, ARTIF CELL BLOOD SUB, V22, P123, DOI [10.3109/10731199409117408, DOI 10.3109/10731199409117408]
   CONWAY MD, 1993, INT OPHTHALMOL, V17, P259, DOI 10.1007/BF01007793
   CORNELUS C, 1994, J COLLOID INTERF SCI, V163, P391, DOI 10.1006/jcis.1994.1118
   Der Mardirossian C, 1998, BIOCHIMIE, V80, P531, DOI 10.1016/S0300-9084(00)80018-8
   DERMARDIROSSIAN C, 1995, EUR J CLIN INVEST S2, V25, P141
   DITTRICH HC, 1998, P ULTR CONTR RES S S
   EILENBERG SS, 1994, ARTIF CELL BLOOD SUB, V22, P1477, DOI 10.3109/10731199409138853
   ELBERT R, 1984, J AM CHEM SOC, V106, P7687, DOI 10.1021/ja00337a005
   ELGHOUL M, 1992, J FLUORINE CHEM, V59, P107, DOI 10.1016/S0022-1139(00)80208-0
   ESCOULA B, 1985, SYNTHETIC COMMUN, V15, P35, DOI 10.1080/00397918508063775
   FAITHFULL NS, 1994, YB INTENSIVE CARE EM, P237
   FLAIM SF, 1994, ARTIF CELL BLOOD SUB, V22, P1043, DOI 10.3109/10731199409138801
   FREZARD F, 1994, BBA-BIOMEMBRANES, V1194, P61, DOI 10.1016/0005-2736(94)90203-8
   FREZARD F, 1994, BBA-BIOMEMBRANES, V1192, P61, DOI 10.1016/0005-2736(94)90143-0
   Fritz TA, 1997, INVEST RADIOL, V32, P735, DOI 10.1097/00004424-199712000-00003
   FUHRHOP JH, 1993, CHEM REV, V93, P1565, DOI 10.1021/cr00020a008
   GAINES GL, 1991, LANGMUIR, V7, P3054, DOI 10.1021/la00060a025
   GAO JM, 1995, J MED CHEM, V38, P2292, DOI 10.1021/jm00013a005
   GEYER RP, 1979, P 4 INT S PERFL BLOO, P3
   Giulieri F, 1996, THIN SOLID FILMS, V284, P195, DOI 10.1016/S0040-6090(95)08304-9
   Giulieri F, 1996, CHEM-EUR J, V2, P1335, DOI 10.1002/chem.19960021022
   GIULIERI F, 1996, ANGEW CHEM INT EDIT, V34, P1514
   GOLDMANN M, 1993, PHYSICA A, V200, P688, DOI 10.1016/0378-4371(93)90576-P
   GREC JJ, 1982, C NAT GEN BIOL MED T
   GREINER J, 1993, ORGANOFLUORINE COMPO, P339
   GUEDJ C, 1994, ART CELLS BLOOD SUBS, V22, P1485
   GUILLOD F, 1996, CHEM PHYS LIPIDS, V72, P153
   HAIDT S J, 1982, Investigative Ophthalmology and Visual Science, V22, P233
   Held P, 1997, TETRAHEDRON LETT, V38, P1937, DOI 10.1016/S0040-4039(97)00258-X
   HILDEBRANDT JH, 1970, REGULAR RELATED SOLU
   HIRSCHL RB, 1995, LANCET, V346, P1201, DOI 10.1016/S0140-6736(95)92903-7
   HOEFLING TA, 1991, J PHYS CHEM-US, V95, P7127, DOI 10.1021/j100172a006
   HOLMAN WL, 1995, J THORAC CARDIOV SUR, V110, P774, DOI 10.1016/S0022-5223(95)70111-7
   HOPKEN J, 1988, MAKROMOL CHEM, V189, P911
   Imae T, 1997, PROG COLL POL SCI S, V106, P52, DOI 10.1007/BF01189490
   IMAE T, 1992, J AM CHEM SOC, V114, P3414, DOI 10.1021/ja00035a038
   ISHIKAWA Y, 1994, J AM CHEM SOC, V116, P5579, DOI 10.1021/ja00092a008
   IVANITSKY GR, 1989, PERFTORAN BLOOD SUBS
   JACQUEMAIN D, 1990, J AM CHEM SOC, V112, P7724, DOI 10.1021/ja00177a037
   Johnson K. A, 1992, Aerosol drug formulations, Patent No. [US Patent 5126123, 5126123, US Patent 5 126, 123]
   Johnston KP, 1996, SCIENCE, V271, P624, DOI 10.1126/science.271.5249.624
   KAUFMAN RJ, 1995, BLOOD SUBSTITUTES, P53
   KEIPERT PE, 1996, OXYGEN TRANSPORT TIS, V17, P603
   KHALFOUN S, 1995, TRANSPL P, V27, P2210
   Kissa E., 1994, FLUORINATED SURFACTA
   Krafft M.P., 1996, CELL MOL BIOL LETT, V1, P459
   KRAFFT MP, 1994, ANGEW CHEM INT EDIT, V33, P1100, DOI 10.1002/anie.199411001
   Krafft MP, 1996, PHOSPHORUS SULFUR, V109, P281
   KRAFFT MP, 1993, ANGEW CHEM INT EDIT, V32, P741, DOI 10.1002/anie.199307411
   KRAFFT MP, 1994, COLLOID SURFACE A, V84, P113, DOI 10.1016/0927-7757(93)02681-4
   KRAFFT MP, 1997, 15 INT S FLUOR CHEM
   KRAFFT MP, IN PRESS NOVEL COSME
   KRAFFT MP, 1998, SUBMICRONIC EMULSION, V10, P235
   KRAFFT MP, 1997, Patent No. 9721425
   KRAFFT MP, 1998, AM CHEM SOC S FLUOR
   KRAFFT MP, 1995, Patent No. 2737135
   KRAFFT MP, 1997, INT S FLUOR CHEM VAN
   LASCHEWSKY A, 1985, THIN SOLID FILMS, V134, P153, DOI 10.1016/0040-6090(85)90127-0
   LATGE P, 1991, J DISPER SCI TECHNOL, V12, P227, DOI 10.1080/01932699108913127
   Leach CL, 1996, NEW ENGL J MED, V335, P761, DOI 10.1056/NEJM199609123351101
   LEBLANC M, 1985, PHARMACEUT RES, P245
   LI MY, 1994, NATURE, V367, P151, DOI 10.1038/367151a0
   LI R, S RESP DRUG DEL 5 PH, V5
   Lisby DA, 1997, HUM GENE THER, V8, P919, DOI 10.1089/hum.1997.8.8-919
   MathyHartert M, 1997, ARTIF CELL BLOOD SUB, V25, P563, DOI 10.3109/10731199709117453
   MATHYHARTERT M, 1997, 12 INT S ART CELLS B
   MATTREY RF, 1994, ARTIF CELL BLOOD SUB, V22, P295, DOI 10.3109/10731199409117422
   MATTREY RF, 1994, RADIOLOGY, V191, P841, DOI 10.1148/radiology.191.3.8184076
   MAURIZIS JC, 1994, XENOBIOTICA, V24, P535, DOI 10.3109/00498259409043256
   MAURIZIS JC, 1993, BIOORG MED CHEM LETT, V3, P161, DOI 10.1016/S0960-894X(01)80868-4
   MCCREATH GE, 1994, J CHROMATOGR A, V659, P275, DOI 10.1016/0021-9673(94)85069-0
   MEINERT H, 1993, BIOMAT ARTIF CELL IM, V21, P583, DOI 10.3109/10731199309117383
   Menchen S, 1996, ELECTROPHORESIS, V17, P1451, DOI 10.1002/elps.1150170909
   MUKERJEE P, 1976, J PHYS CHEM-US, V80, P1388, DOI 10.1021/j100553a028
   Mulvagh SL, 1996, J AM COLL CARDIOL, V27, P1519, DOI 10.1016/0735-1097(95)00619-2
   NAITO R, 1981, PERFLUOROCHEMICAL BL
   NAKASHIMA N, 1985, J AM CHEM SOC, V107, P509, DOI 10.1021/ja00288a043
   OLSON CT, 1983, TOXICOL APPL PHARM, V70, P362, DOI 10.1016/0041-008X(83)90154-0
   PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V394, P483, DOI 10.1016/0005-2736(75)90299-0
   PAVIA AA, 1994, P INT S CONTROL REL, V21, P87
   PERMADI H, 1992, BIOCHEM PHARMACOL, V44, P1183, DOI 10.1016/0006-2952(92)90383-T
   PFANNEMULLER B, 1985, CHEM PHYS LIPIDS, V37, P227, DOI 10.1016/0009-3084(85)90011-8
   Polidori A, 1996, MACROMOL RAPID COMM, V17, P229, DOI 10.1002/marc.1996.030170405
   POLIDORI A, 1995, CHEM PHYS LIPIDS, V77, P225, DOI 10.1016/0009-3084(95)02475-X
   PRIVITERA N, 1995, INT J PHARM, V120, P73, DOI 10.1016/0378-5173(94)00411-W
   PRIVITERA N, 1994, INT J PHARM, V104, P41, DOI 10.1016/0378-5173(94)90335-2
   PRIVITERA N, 1994, BIOCHIM BIOPHYS ACTA, V1254, P1
   RABOLT JF, 1984, MACROMOLECULES, V17, P2786, DOI 10.1021/ma00142a060
   RAVEY JC, 1990, PROG COLL POL SCI S, V82, P218
   RAVEY JC, 1994, COLLOID SURFACE A, V91, P237, DOI 10.1016/0927-7757(94)02942-3
   Ravily V, 1997, BBA-BIOMEMBRANES, V1324, P1, DOI 10.1016/S0005-2736(96)00203-9
   Reed T. M., 1964, FLUORINE CHEM, V5, P133
   REMY JS, 1994, BIOCONJUGATE CHEM, V5, P647, DOI 10.1021/bc00030a021
   RicoLattes I, 1997, COLLOID SURFACE A, V123, P37, DOI 10.1016/S0927-7757(96)03778-8
   RICOLATTES I, 1995, SCI CHIM         FEV, P15
   Riess J.G., 1996, HDB NONMEDICAL APPL, P97
   RIESS JG, 1994, J DRUG TARGET, V2, P455, DOI 10.3109/10611869408996822
   RIESS JG, 1991, VOX SANG, V61, P225, DOI 10.1111/j.1423-0410.1991.tb00952.x
   RIESS JG, 1991, ADV MATER, V3, P249, DOI 10.1002/adma.19910030507
   Riess JG, 1996, CURR OPIN COLLOID IN, V1, P652, DOI 10.1016/S1359-0294(96)80104-X
   RIESS JG, 1994, ADV EXP MED BIOL, V345, P227
   RIESS JG, 1994, COLLOID SURFACE A, V84, P33, DOI 10.1016/0927-7757(93)02696-C
   Riess JG, 1995, J LIPOS RES, V5, P413, DOI 10.3109/08982109509010232
   Riess JG, 1997, ARTIF CELL BLOOD SUB, V25, P43, DOI 10.3109/10731199709118896
   RIESS JG, 1992, J DISPER SCI TECHNOL, V13, P349, DOI 10.1080/01932699208943319
   RIESS JG, 1995, NEW J CHEM, V19, P891
   RIESS JG, 1989, BLOOD SUBSTITUTES, P421
   RIESS JG, 1994, ARTIF CELL BLOOD SUB, V22, P945
   RIESS JG, 1998, BLOOD SUBSTITUTES ME, P101
   RIESS JG, 1994, Patent No. 9407068
   RIESS JG, 1998, BLOOD SUBSTITUTES
   RIESS JG, 1998, IN PRESS BIOMATERIAL, V31
   RIESS JG, 1993, CARBOHYDRATES ORGANI, V2, P209
   Ringler P, 1997, CHEM-EUR J, V3, P620, DOI 10.1002/chem.19970030419
   RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131
   Ristori S, 1997, J PHYS CHEM B, V101, P4155, DOI 10.1021/jp963745t
   RUSSELL TP, 1986, MACROMOLECULES, V19, P1135, DOI 10.1021/ma00158a035
   Sadtler VM, 1996, ANGEW CHEM INT EDIT, V35, P1976, DOI 10.1002/anie.199619761
   Sadtler VM, 1998, NEW J CHEM, V22, P609, DOI 10.1039/a708757h
   SADTLER VM, 1997, P S CONTR REL SOC ST
   SANCHEZ V, 1994, ARTIF CELL BLOOD SUB, V22, P1421, DOI 10.3109/10731199409138846
   SANTAELLA C, 1991, ANGEW CHEM INT EDIT, V30, P567, DOI 10.1002/anie.199105671
   SANTAELLA C, 1994, BBA-BIOMEMBRANES, V1190, P25, DOI 10.1016/0005-2736(94)90031-0
   SANTAELLA C, 1993, FEBS LETT, V336, P481, DOI 10.1016/0014-5793(93)80860-W
   SCHNUR JM, 1993, SCIENCE, V262, P1669, DOI 10.1126/science.262.5140.1669
   SCHUTT EG, 1996, ACAD RADIOL, V35, P188
   SCIALLI AR, 1990, IN VITRO CELL DEV B, V26, P507, DOI 10.1007/BF02624093
   SELVE C, 1983, TETRAHEDRON, V39, P1313, DOI 10.1016/S0040-4020(01)91897-6
   Smart B. E., 1994, ORGANOFLUORINE CHEM, P57
   Szlavik Z, 1997, TETRAHEDRON LETT, V38, P8757, DOI 10.1016/S0040-4039(97)10344-6
   SZONYI S, 1993, NEW J CHEM, V17, P425
   TANFORD C, 1973, HYDROPHOBIC EFFECT F, P19
   TREMPER KK, 1995, CRITICAL CARE STATE, P143
   TREVINO L, 1994, COLLOID SURFACE A, V88, P223, DOI 10.1016/0927-7757(94)02789-7
   TREVINO L, 1994, P INT S CONTROL REL, V21, P606
   Trevino Leo, 1994, Journal of Liposome Research, V4, P1017, DOI 10.3109/08982109409018619
   TURBERG MP, 1988, J AM CHEM SOC, V110, P7797, DOI 10.1021/ja00231a034
   TWIEG RJ, 1985, MACROMOLECULES, V18, P1361, DOI 10.1021/ma00148a060
   UBEL FA, 1980, AM IND HYG ASSOC J, V41, P584, DOI 10.1080/15298668091425310
   VANDENHEUVEL JP, 1991, J BIOCHEM TOXICOL, V6, P83
   Voiglio EJ, 1996, J SURG RES, V63, P439, DOI 10.1006/jsre.1996.0289
   WEERS JG, 1994, ARTIF CELL BLOOD SUB, V22, P1175, DOI 10.3109/10731199409138813
   Worah Dilip M., 1997, Drugs of the Future, V22, P378
   YAGANAWA H, 1989, J AM CHEM SOC, V111, P4567
   YONETANI M, 1984, FLUORINE COMPOUNDS M, P58
   ZARIF L, 1994, COLLOID SURFACE A, V84, P107, DOI 10.1016/0927-7757(93)02680-D
   ZARIF L, 1994, PHARMACEUT RES, V11, P122, DOI 10.1023/A:1018914215345
   ZUCK TF, 1994, CRIT REV CL LAB SCI, V31, P295, DOI 10.3109/10408369409084678
NR 154
TC 246
Z9 247
U1 4
U2 94
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0300-9084
J9 BIOCHIMIE
JI Biochimie
PD MAY-JUN
PY 1998
VL 80
IS 5-6
BP 489
EP 514
DI 10.1016/S0300-9084(00)80016-4
PG 26
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 120PH
UT WOS:000075964400015
PM 9782389
DA 2018-10-19
ER

PT J
AU Folch, A
   Toner, M
AF Folch, A
   Toner, M
TI Cellular micropatterns on biocompatible materials
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; MATERIALS SCIENCE; ADHESION; SURFACES; CELLS;
   GROWTH; HEPATOCYTES; FIBRONECTIN; CULTURE; CAPILLARIES
AB We present a method to produce micropatterns of cells on tissue culture substrates. A network of deep elastomeric microchannels defining the desired pattern is sealed onto the surface of interest, and a protein template is created by injecting sub-milliliter quantities of protein solution into the microchannels. Protein adsorbs only on the areas that were exposed to the microflow. After the channels are flushed and the elastomer is removed, cells attach only on the protein template. Micropatterns of collagen or fibronectin were used to selectively adhere cells on various biomedical polymers and on heterogeneous or microtextured substrates. Since the bare substrate areas remain apt for seeding other, more adhesive cell types such as fibroblasts, we were able to create micropatterned co-cultures. Our method allows for inexpensive patterning of a rich assortment of biomolecules, cells, and surfaces under physiological conditions.
C1 Harvard Univ, Sch Med, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, Surg Serv, Boston, MA 02114 USA.
   Shriners Burns Hosp, Boston, MA 02114 USA.
RP Toner, M (reprint author), Shriners Res Ctr Bldg,1400 W,1 Kendall Sq, Cambridge, MA 02139 USA.
CR ALLARA DL, 1995, BIOSENS BIOELECTRON, V10, P771, DOI 10.1016/0956-5663(95)99215-7
   Bhatia SN, 1998, BIOTECHNOL PROGR, V14, P378, DOI 10.1021/bp980036j
   Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   CARTER SB, 1967, EXP CELL RES, V48, P189, DOI 10.1016/0014-4827(67)90298-4
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CLARK P, 1992, J CELL SCI, V103, P287
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779
   DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007
   Garcia AJ, 1997, TISSUE ENG, V3, P197, DOI 10.1089/ten.1997.3.197
   Harrison RG, 1914, J EXP ZOOL, V17, P521, DOI 10.1002/jez.1400170403
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Ito Y, 1997, LANGMUIR, V13, P2756, DOI 10.1021/la961087y
   Kim E, 1996, J AM CHEM SOC, V118, P5722, DOI 10.1021/ja960151v
   KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0
   KLEBE RJ, 1988, EXP CELL RES, V179, P362, DOI 10.1016/0014-4827(88)90275-3
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   LAIBINIS PE, 1991, J AM CHEM SOC, V113, P7152, DOI 10.1021/ja00019a011
   LEE JS, 1993, BIOMATERIALS, V14, P958, DOI 10.1016/0142-9612(93)90139-S
   LEE JS, 1994, APPL PHYS LETT, V65, P400, DOI 10.1063/1.112314
   LEE SH, 1988, J COLLOID INTERF SCI, V125, P365, DOI 10.1016/0021-9797(88)90001-X
   LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6
   MATSUSHIMA N, 1990, MOKUZAI GAKKAISHI, V36, P559
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   ODENTHAL M, 1992, EXP CELL RES, V203, P289, DOI 10.1016/0014-4827(92)90001-O
   Potter M. C., 1982, FLUID MECH
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   RISTIC L, 1994, SENSOR TECHNOLOGY DE
   ROHR S, 1991, CIRC RES, V68, P114, DOI 10.1161/01.RES.68.1.114
   ROVASIO RA, 1983, J CELL BIOL, V96, P462, DOI 10.1083/jcb.96.2.462
   ROVENSKY YA, 1971, EXP CELL RES, V65, P193, DOI 10.1016/S0014-4827(71)80066-6
   Schaffner AE, 1995, J NEUROSCI METH, V62, P111, DOI 10.1016/0165-0270(95)00063-1
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   STENGER DA, 1992, J AM CHEM SOC, V114, P8435, DOI 10.1021/ja00048a013
   TAKEZAWA T, 1990, BIO-TECHNOL, V8, P854, DOI 10.1038/nbt0990-854
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   Ulman A., 1991, INTRO ULTRATHIN ORGA
   WEISS P, 1959, REV MOD PHYS, V31, P11, DOI 10.1103/RevModPhys.31.11
NR 43
TC 202
Z9 207
U1 3
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD MAY-JUN
PY 1998
VL 14
IS 3
BP 388
EP 392
DI 10.1021/bp980037b
PG 5
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA ZT713
UT WOS:000074117200006
PM 9622519
DA 2018-10-19
ER

PT J
AU Weir, L
AF Weir, L
TI Cultural intertexts and scientific rationality: the case of pregnancy
   ultrasound
SO ECONOMY AND SOCIETY
LA English
DT Article
DE Canguilhem; intertextuality; domain; ultrasound; foetus
AB The text begins a line of dialogue between feminist and epistemological work in the life sciences using a case study of the concepts 'foetus' and 'baby' in diagnostic ultrasound and parental discourse. The case material illustrates the multiple, coexisting registers of clinical discourse and the significance of cultural intertexts, the insertion within biomedical discourse of concepts from other cultural domains. It follows that biomedical rationality lacks the autonomy that Canguilhem argued it has; rather than giving itself its own laws, biomedical rationality is heteronomous, receiving and using cultural intertexts from many and varied domains.
C1 Univ York, York, ON, Canada.
RP Weir, L (reprint author), Univ York, York, ON, Canada.
CR BACHELARD G, 1977, MAT RATIONNEL, P207
   BLUME SS, 1992, INSIGHT IND
   Canguilhem G., 1988, IDEOLOGY RATIONALITY
   DUDEN B, 1991, WOMAN BENEATH SKIN
   Duden B., 1993, DISEMBODYING WOMEN P
   Dunstan G. R., 1990, HUMAN EMBRYO ARISTOT
   FRANKLIN S, 1995, ANNU REV ANTHROPOL, V24, P163, DOI 10.1146/annurev.an.24.100195.001115
   Haraway D, 1989, PRIMATE VISIONS
   Haraway D, 1997, MODEST WITNESS 2 MIL
   JORDANOVA LJ, 1989, SEXUAL VISIONS IMAGE
   Kristeva Julia, 1986, KRISTEVA READER, P34
   Martin E, 1987, WOMAN BODY CULTURAL
   Merchant C., 1980, DEATH NATURE WOMEN E
   Morgan Lynn, 1989, ABORTION RIGHTS FETA, P89
   NEWMAN K, 1996, FOETAL POSITIONS
   Noble David F, 1992, WORLD WOMEN CHRISTIA
   Rabinow Paul, 1994, VITAL RATIONALIST SE, P11
   Ross A, 1996, SCI WARS
   Russett Cynthia Eagle, 1989, SEXUAL SCI
   SCHIEBINGER L., 1989, MIND HAS NO SEX WOME
   STRATHERN M, 1993, TECHNOLOGIES PROCREA, P132
   WEIR L, 1998, IN PRESS VITAL SIGNS
   WEIR L., 1996, ECON SOC, V25, P372
NR 23
TC 6
Z9 6
U1 0
U2 4
PU ROUTLEDGE
PI LONDON
PA 11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND
SN 0308-5147
J9 ECON SOC
JI Econ. Soc.
PD MAY
PY 1998
VL 27
IS 2-3
BP 249
EP 258
DI 10.1080/03085149800000018
PG 10
WC Economics; Sociology
SC Business & Economics; Sociology
GA ZN788
UT WOS:000073682700011
DA 2018-10-19
ER

PT J
AU Prigent-Richard, S
   Cansell, M
   Vassy, J
   Viron, A
   Puvion, E
   Jozefonvicz, J
   Letourneur, D
AF Prigent-Richard, S
   Cansell, M
   Vassy, J
   Viron, A
   Puvion, E
   Jozefonvicz, J
   Letourneur, D
TI Fluorescent and radiolabeling of polysaccharides: Binding and
   internalization experiments on vascular cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE polysaccharides; DTAF labeling; radiolabeling; smooth-muscle cells;
   confocal analysis
ID SMOOTH-MUSCLE CELLS; DEXTRAN DERIVATIVES; ANTICOAGULANT ACTIVITY;
   HEPARIN-BINDING; FUCOIDAN; GLYCOSAMINOGLYCANS; PROLIFERATION;
   INHIBITION; METABOLISM; PROTEINS
AB Glycosaminoglycans (GAGs) such as heparan sulfates are complex carbohydrate polymers. These structural components of the extracellular matrix are essential for the adhesion, migration, and regulation of cellular growth. To understand the physiological role of GAGs and GAG analogues, a practical approach consists of labeling and detecting them in cell extracts, or analyzing binding domains and their distributions into the cells. We propose a convenient and reliable method for preparing and labeling amino-enriched polysaccharides with the fluorescent derivative 5-[(4,6-dichlorotriazine-2-yl)amino]-fluorescein (DTAF). Radioiodination is then performed on the DTAF moiety. This method was applied to polysaccharides known to inhibit vascular smooth-muscle cell (SMC) proliferation such as functionalized dextrans derived from poly(alpha 1-6 glucose) and fucan, poly(l-fucose 4-sulfate) extracted from brown seaweed. Using autoradiography and confocal microscopy, we observed the fixation and internalization of labeled antiproliferative products in SMCs from rat aorta. These probes can be useful for the understanding of polysaccharide-cell interactions. In addition, the method presented here can be applied to various synthetic or natural biomedical materials. (C) 1998 John Wiley & Sons, Inc.
C1 Univ Paris 13, IFREMER URM2, LRM, CNRS,URA 502, F-93430 Villetaneuse, France.
   Univ Paris 07, Hop St Louis, AIPC, F-75475 Paris 10, France.
   IRC, CNRS, UPR 9044, F-94801 Villejuif, France.
RP Letourneur, D (reprint author), Univ Paris 13, IFREMER URM2, LRM, CNRS,URA 502, Av JB Clement, F-93430 Villetaneuse, France.
RI Didier, letourneur/H-5268-2012
OI Didier, letourneur/0000-0003-2197-9468
CR AVRAMOGLOU T, 1991, J BIOMAT SCI-POLYM E, V3, P149, DOI 10.1163/156856291X00241
   Barzu T, 1996, J CELL PHYSIOL, V167, P8, DOI 10.1002/(SICI)1097-4652(199604)167:1<8::AID-JCP2>3.0.CO;2-T
   BIWAS C, 1988, J CELL PHYSL, V136, P147
   BLAKESLEE D, 1976, J IMMUNOL METHODS, V13, P305, DOI 10.1016/0022-1759(76)90078-8
   BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529
   BOURDILLON MC, 1976, BIOMED EXPRESS, V25, P263
   BUSCH SJ, 1992, J CELL BIOL, V116, P31, DOI 10.1083/jcb.116.1.31
   CASTELLOT JJ, 1985, J CELL PHYSIOL, V124, P13, DOI 10.1002/jcp.1041240104
   COLLIEC S, 1991, THROMB RES, V64, P143, DOI 10.1016/0049-3848(91)90114-C
   DAWES J, 1979, THROMB RES, V14, P845, DOI 10.1016/0049-3848(79)90004-5
   FAGER G, 1992, IN VITRO CELL DEV-AN, V28A, P176
   FISCHER AM, 1985, BIOMATERIALS, V6, P198, DOI 10.1016/0142-9612(85)90010-9
   GAUFFEL V, 1989, BIOMATERIALS, V10, P363
   GLABE CG, 1983, ANAL BIOCHEM, V130, P287, DOI 10.1016/0003-2697(83)90590-0
   HATTON MWC, 1980, ANAL BIOCHEM, V106, P417, DOI 10.1016/0003-2697(80)90542-4
   HIGSHIYAMA S, 1993, J CELL BIOL, V122, P933
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   LARSEN AK, 1986, P NATL ACAD SCI USA, V83, P2964, DOI 10.1073/pnas.83.9.2964
   LETOURNEUR D, 1993, J BIOMAT SCI-POLYM E, V4, P431, DOI 10.1163/156856293X00681
   LETOURNEUR D, 1995, J CELL PHYSIOL, V165, P676, DOI 10.1002/jcp.1041650327
   Logeart D, 1996, J BIOMED MATER RES, V30, P501, DOI 10.1002/(SICI)1097-4636(199604)30:4<501::AID-JBM8>3.3.CO;2-F
   Logeart D, 1997, EUR J CELL BIOL, V74, P376
   LOGEART D, 1995, THESIS PARIS N U FRA
   MALSCH R, 1994, ANAL BIOCHEM, V217, P255, DOI 10.1006/abio.1994.1117
   MAUZAC M, 1984, BIOMATERIALS, V5, P301, DOI 10.1016/0142-9612(84)90078-4
   MAUZAC M, 1985, BIOMATERIALS, V6, P61, DOI 10.1016/0142-9612(85)90040-7
   MCCAFFREY TA, 1992, BIOCHEM BIOPH RES CO, V184, P773, DOI 10.1016/0006-291X(92)90657-7
   MEHLMAN T, 1990, ANAL BIOCHEM, V188, P159, DOI 10.1016/0003-2697(90)90545-K
   NEYTS J, 1995, BIOCHEM PHARMACOL, V50, P743, DOI 10.1016/0006-2952(95)00193-4
   ROGERS A, 1979, TECHNIQUES ATORADIOG
   SANANTONIO JD, 1994, ANAL BIOCHEM, V217, P255
   SMITH JW, 1987, ANAL BIOCHEM, V160, P105, DOI 10.1016/0003-2697(87)90619-1
   Stearns NA, 1997, ANAL BIOCHEM, V247, P348, DOI 10.1006/abio.1997.2096
   THOMAS H, 1995, BIOMATERIALS, V16, P1163, DOI 10.1016/0142-9612(95)93581-W
   VANDOORNE F, 1991, MAKROMOL CHEM, V192, P673
   VAUDAUX P, 1992, J BIOMAT SCI-POLYM E, V4, P89
   VISCHER P, 1991, EUR J CELL BIOL, V56, P407
NR 37
TC 25
Z9 25
U1 1
U2 19
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 1998
VL 40
IS 2
BP 275
EP 281
DI 10.1002/(SICI)1097-4636(199805)40:2<275::AID-JBM12>3.0.CO;2-P
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ZD360
UT WOS:000072677400012
PM 9549622
DA 2018-10-19
ER

PT J
AU Culbertson, BM
   Xie, D
   Thakur, A
AF Culbertson, BM
   Xie, D
   Thakur, A
TI Amino acid functionalized ionomeric materials in biomedical applications
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Macromolecule-Metal Complexes
CY OCT 06-10, 1997
CL NOORDWIJKERHOUT, NETHERLANDS
SP Int Union Pure & Appl Chem, Macromolec Div, Royal Netherlands Chem Soc
AB Several N-acryloyl and N-methacryloyl substituted amino acids have been prepared and copolymerized with acrylic acid and itaconic acid to prepare new polyelectrolytes. Due to an acid-base reaction, mixing of the water soluble copolymers with glass powders, having leachable Ca2+, Al3+, etc., type cations, produces inorganic-organic composites hardened by salt -bridge formation. These heretofore unexplored polyelectrolytes are shown to be very useful for preparing improved dental biomaterials.
C1 Ohio State Univ, Columbus, OH 43210 USA.
RP Culbertson, BM (reprint author), Ohio State Univ, 305 W 12th Ave, Columbus, OH 43210 USA.
CR CRISP S, 1980, J DENT RES, V59, P1055, DOI 10.1177/00220345800590060801
   CULBERTSON BM, 1994, Patent No. 5369142
   CULBERTSON BM, 1996, J DENT MAT, V12, P44
   KOVARIK RE, 1993, DENT MATER, V9, P222, DOI 10.1016/0109-5641(93)90065-X
   MITRA SB, 1992, Patent No. 5130347
NR 5
TC 6
Z9 6
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD MAY
PY 1998
VL 131
BP 11
EP 18
DI 10.1002/masy.19981310104
PG 8
WC Polymer Science
SC Polymer Science
GA ZY874
UT WOS:000074670700003
DA 2018-10-19
ER

PT J
AU Meinert, K
   Uerpmann, C
   Matschullat, J
   Wolf, GK
AF Meinert, K
   Uerpmann, C
   Matschullat, J
   Wolf, GK
TI Corrosion and leaching of silver doped ceramic IBAD coatings on SS 316L
   under simulated physiological conditions
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Surface Modification of Metals by Ion
   Beams (SMMIB 97)
CY SEP 21-26, 1997
CL GATLINBURG, TENNESSEE
SP Oak Ridge Natl Lab, Danfysik, Implant Sci Corp, Spire Corp
DE bactericidal properties; biocompatibility; corrosion protection;
   stainless steel
ID CATHETERS; IMPLANTS
AB In order to improve the biomedical applications of stainless steel AISI 316L, commonly used for medical implants, ceramic coatings in combination with a thin (50 nm) silver layer on the outermost part of the ceramic coating were deposited by IBAD lion beam assisted deposition). The interference of the bactericidal silver layer with the insulating properties of the ceramic coating was of special interest. As corrosion protection coatings for SS 316L, different ceramic materials, Al2O3, TiO2, SiO2 and ZrO2, were deposited by IBAD. They were chosen because of their already known bioinert or bioactive properties. In addition, investigations were performed to determine the most effective minimal thickness of the ceramic coatings. To achieve bactericidal properties, the top layer (50-150 nm) of the ceramic coatings was doped with silver simultaneously with the deposition of the outermost part of the coating. Interesting differences occurred during the corrosion evaluations of the pure ceramic coating in comparison with the silver doped ceramic coatings. The electrochemical corrosion tests were done by potentiodynamic current density and by chronoamperometric measurements under simulated physiological conditions. Leaching tests of the silver doped ceramic coatings were performed in human plasma to determine the amount of dissolved silver. The quantification of the dissolved silver in human plasma was done by using solid sample graphite furnace atomic absorption spectroscopy. The amount of doped silver was determined by Auger depth profiles. During the evaluations, the pure and silver doped ZrO2 coating had the best performance of the investigated coatings, followed by the pure and silver doped TiO2 coatings. (C) 1998 Elsevier Science S.A.
C1 Univ Heidelberg, Phys Chem Inst Radiochem, D-69120 Heidelberg, Germany.
   Univ Heidelberg, Inst Umwelt Geochem, D-69120 Heidelberg, Germany.
RP Meinert, K (reprint author), Univ Heidelberg, Phys Chem Inst Radiochem, Neuenheimer Feld 500, D-69120 Heidelberg, Germany.
CR BAMBAUER R, 1994, ARTIF ORGANS, V18, P272, DOI 10.1111/j.1525-1594.1994.tb02194.x
   GURLAND HJ, 1994, NEPHROLOGY DIALYS S2, V9
   LINDBERG H, 1990, BR J UROL, V65, P379
   MEINERT K, 1998, IN PRESS SURF COAT T
   MUCK D, 1997, THESIS U HEIDELBERG
   ONDRACEK G, 1988, VERBUNDWERKSTOFFE ST, V2, P3
   SELLA C, 1991, SURF COAT TECH, V45, P129, DOI 10.1016/0257-8972(91)90215-I
   SIOSHANSI P, 1994, ARTIF ORGANS, V18, P266, DOI 10.1111/j.1525-1594.1994.tb02193.x
   STREIT B, 1991, LEXIKON OKOTOXIKOLOG, P585
   VIEGAS MF, 1990, J MATER SCI-MATER M, V1, P105, DOI 10.1007/BF00839076
   WILLIAMS M, 1992, INT J NUMER METH FL, V14, P1, DOI 10.1002/fld.1650140102
   WINTERMANTEL E, 1996, BIOKOMPATIBLE WERKST, P139
   Wituschek H, 1995, SURF COAT TECH, V74-75, P729, DOI 10.1016/0257-8972(95)08354-5
   WITUSCHEK H, 1992, REV SCI INSTRUM, V63, P2411, DOI 10.1063/1.1142946
   ZITTER H, 1991, WERKST KORROS, V42, P455
NR 15
TC 31
Z9 36
U1 1
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAY
PY 1998
VL 104
BP 58
EP 65
DI 10.1016/S0257-8972(98)00375-2
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA ZZ476
UT WOS:000074733200012
DA 2018-10-19
ER

PT J
AU Loinaz, A
   Rinner, M
   Alonso, F
   Onate, JI
   Ensinger, W
AF Loinaz, A
   Rinner, M
   Alonso, F
   Onate, JI
   Ensinger, W
TI Effects of plasma immersion ion implantation of oxygen on mechanical
   properties and microstructure of Ti6Al4V
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Surface Modification of Metals by Ion
   Beams (SMMIB 97)
CY SEP 21-26, 1997
CL GATLINBURG, TENNESSEE
SP Oak Ridge Natl Lab, Danfysik, Implant Sci Corp, Spire Corp
DE plasma immersion ion implantation; Ti6Al4V alloy; oxygen; tribological
   properties
ID TI-6AL-4V ALLOY; NITROGEN; TITANIUM; CARBON
AB Plasma immersion ion implantation (PIII) is a surface treatment with increasing interest, as it offers the possibility of performing three-dimensional ion beam treatments, reducing the need for manipulation under vacuum to obtain a uniform treatment in geometrically complex parts. In this work the PIII process has been used to perform surface treatment on Ti6Al4V alloy. This Ti alloy is commonly used in aerospace and biomedical applications, due to its good combination of mechanical and chemical properties, such as strength to weight ratio, corrosion resistance or bioinertness. However, due to its poor tribological properties, the use of surface treatments to improve wear resistance or decrease friction coefficient is often recommended. PIII has been used to implant the surface of Ti6Al4V alloy with oxygen ions. The oxygen plasma was generated by electron cyclotron resonance microwave excitation, working at two different pressures. At the lower pressure plasma density was increased by means of an external ring magnet. High voltage pulses of -40 kV, at of 400 and 600 Hz pulse repetition rates, were applied. Elastic recoil detection (ERD) analysis showed retained doses in the range of 3 x 10(17) to 1 x 10(18) O atoms cm(-2), with oxygen concentration values ca 65% in the near surface region. Surface mechanical properties such as hardness, wear and friction have been evaluated. Microindentation tests showed an increase of up to 100% in the surface hardness of the ion implanted samples compared to the non implanted material. Dry pin-on-disk tests with spherical ended UHMWPE pins showed a very significant increase in wear resistance in oxygen implanted Ti6Al4V samples. Scanning electron microscopy and optical profilometry showed an important roughening of the Ti alloy surface after PIII treatment under selected conditions. (C) 1998 Elsevier Science S.A.
C1 INASMET, San Sebastian 20009, Spain.
   Univ Augsburg, Inst Phys, D-86159 Augsburg, Germany.
RP Alonso, F (reprint author), INASMET, San Sebastian 20009, Spain.
RI Onate, J. Ignacio/I-1555-2015; Ensinger, Wolfgang/N-7074-2017
OI Ensinger, Wolfgang/0000-0003-3858-6230; Onate de la Presa, Jose
   Ignacio/0000-0002-9078-4480
CR Alonso F, 1995, SURF COAT TECH, V74-75, P986, DOI 10.1016/0257-8972(95)08291-3
   Alonso F, 1997, SURF COAT TECH, V93, P305, DOI 10.1016/S0257-8972(97)00065-0
   Alonso F, 1996, SURF COAT TECH, V83, P301, DOI 10.1016/0257-8972(96)02767-3
   BOLSTER RN, 1987, SURF COAT TECH, V33, P469, DOI 10.1016/0257-8972(87)90211-8
   CHEN A, 1991, WEAR MATERIALS, P667
   Elder J. E., 1989, Surface Engineering, V5, P55
   Ensinger W, 1996, MATER RES SOC SYMP P, V396, P521
   GUNZEL R, 1994, J VAC SCI TECHNOL B, V12, P927, DOI 10.1116/1.587329
   Han SH, 1996, SURF COAT TECH, V82, P270, DOI 10.1016/0257-8972(95)02722-X
   HOHMUTH K, 1985, MATER SCI ENG, V69, P489, DOI 10.1016/0025-5416(85)90351-9
   HUTCHINGS R, 1992, SURF COAT TECH, V51, P489, DOI 10.1016/0257-8972(92)90287-K
   ONATE JI, 1994, SURF COAT TECH, V65, P165, DOI 10.1016/S0257-8972(94)80025-1
   PIVIN JC, 1987, J MATER SCI, V22, P1087, DOI 10.1007/BF01103555
   QIU X, 1990, METALL TRANS A, V21, P1663, DOI 10.1007/BF02672581
   RIEU J, 1992, SURFACE MODIFICATION, V5, P155
   SARITAS S, 1987, MATER SCI ENG, V90, P297, DOI 10.1016/0025-5416(87)90225-4
NR 16
TC 31
Z9 39
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAY
PY 1998
VL 104
BP 262
EP 267
DI 10.1016/S0257-8972(98)00411-3
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA ZZ476
UT WOS:000074733200050
DA 2018-10-19
ER

PT J
AU Guzman, L
   Celva, R
   Miotello, A
   Voltolini, E
   Ferrari, F
   Adami, M
AF Guzman, L
   Celva, R
   Miotello, A
   Voltolini, E
   Ferrari, F
   Adami, M
TI Polymer surface modification by ion implantation and reactive deposition
   of transparent films
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Surface Modification of Metals by Ion
   Beams (SMMIB 97)
CY SEP 21-26, 1997
CL GATLINBURG, TENNESSEE
SP Oak Ridge Natl Lab, Danfysik, Implant Sci Corp, Spire Corp
DE ion implantation; polycarbonate; cross-linking; hardening
AB The use of polymeric materials is often limited by low hardness, poor wear resistance and wettability considerations. The area of mechanical changes caused by ion beam treatments has been explored only to a limited extent for polymers despite their growing usage in automotive, biomedical and aerospace applications, in which traditionally metals have been used.
   Polycarbonate (PC) specimens were subjected to medium-high energy (160 keV) nitrogen ion implantation at different dosage. Ion irradiation, even at low fluence, can improve surface properties in a well controlled way. A colour change from amber to dark brown with increasing fluence is associated with the ion implantation process. Hardness and elastic modulus, as measured by a nanoindenter, increase dramatically with increasing N dose.
   The surface property improvement can be explained by cross-linking phenomena, responsible for the formation of a three-dimensionally connected rigid network. Such hypothesis is confirmed by TOF-SIMS analyses of untreated and ion bombarded specimens.
   Too high implanted fluence may induce progressive degradation of the PC surface. Should the thickness of the ion-modified layer be too low for a specific application, it is possible to extend the ion irradiation treatment by plasma or ion beam assisted deposition of hard semi-transparent top layers. Using such a method the advantages of both the techniques can be retained to obtain PC surfaces with optimum wear resistance properties. (C) 1998 Elsevier Science S.A.
C1 CMBM, I-38050 Trent, Italy.
   Univ Trent, INFM, I-38050 Trent, Italy.
   Univ Trent, Dept Phys, I-38050 Trent, Italy.
   Univ Trent, Dept Struct Mech, I-38050 Trent, Italy.
RP Guzman, L (reprint author), CMBM, I-38050 Trent, Italy.
CR AWAZU K, 1992, SURF COAT TECH, V51, P509, DOI 10.1016/0257-8972(92)90290-Q
   BRIGGS D, 1986, SURF INTERFACE ANAL, V9, P391
   DICKIE RA, 1988, ACS S SER, V367
   GISSLER W, 1994, SURFACE MODIFICATION, V7, P571
   LEE EH, 1994, J MATER RES, V9, P1043, DOI 10.1557/JMR.1994.1043
   LEE EH, 1993, NUCL INSTRUM METH B, V74, P326, DOI 10.1016/0168-583X(93)95070-L
   ROST A, 1969, METAUX USUELS, P123
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
NR 8
TC 30
Z9 31
U1 0
U2 1
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAY
PY 1998
VL 104
BP 375
EP 379
DI 10.1016/S0257-8972(98)00430-7
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA ZZ476
UT WOS:000074733200070
DA 2018-10-19
ER

PT J
AU Rintoul, L
   Panayiotou, H
   Kokot, S
   George, G
   Cash, G
   Frost, R
   Bui, T
   Fredericks, P
AF Rintoul, L
   Panayiotou, H
   Kokot, S
   George, G
   Cash, G
   Frost, R
   Bui, T
   Fredericks, P
TI Fourier transform infrared spectrometry: a versatile technique for real
   world samples
SO ANALYST
LA English
DT Article; Proceedings Paper
CT XXX Colloquium Spectroscopy International
CY SEP 21-26, 1997
CL MELBOURNE, AUSTRALIA
SP GBC Sci Equipment, Hewlett Packard, Perkin Elmer, Spectro Anal Instruments, Varian
DE Fourier transform infrared spectrometry; infrared microscopy; emission;
   attenuated total reflectance; photoacoustic; chemometrics; hair; skin;
   bauxite; clay; polymer
ID PHOTOACOUSTIC-SPECTROSCOPY; EMISSION SPECTROSCOPY; PHASE-ANALYSIS;
   MINERALS; INSITU
AB The versatility of FTIR spectrometry was explored by considering a variety of samples drawn from industrial applications, materials science and biomedical research. These samples included polymeric insulators, bauxite ore, clay, human hair and human skin. A range of sampling techniques suitable for these samples is discussed, in particular FTIR microscopy, FTIR emission spectroscopy, attenuated total reflectance and photoacoustic FTIR spectrometry, The power of modern data processing techniques, particularly multivariate analysis, to extract useful information from spectral data is also illustrated.
C1 Queensland Univ Technol, Ctr Instrumental & Dev Chem, Brisbane, Qld 4000, Australia.
RP Fredericks, P (reprint author), Queensland Univ Technol, Ctr Instrumental & Dev Chem, 2 George St, Brisbane, Qld 4000, Australia.
CR BAIER RE, 1978, J SOC COSMET CHEM, V29, P283
   BERTRAND L, 1988, APPL SPECTROSC, V42, P134, DOI 10.1366/0003702884428644
   Carter EA, 1996, TEXT RES J, V66, P787, DOI 10.1177/004051759606601207
   COMPTON DAC, 1988, APPL SPECTROSC, V42, P972, DOI 10.1366/0003702884430317
   DITTMAR RM, 1991, APPL SPECTROSC, V45, P1104, DOI 10.1366/0003702914336138
   Farmer V. C., 1974, INFRARED SPECTRA MIN
   Ferraro J. R., 1990, PRACTICAL FOURIER TR
   Frost RL, 1996, CLAY CLAY MINER, V44, P635, DOI 10.1346/CCMN.1996.0440506
   GEORGE GA, 1995, POLYM DEGRAD STABIL, V48, P199, DOI 10.1016/0141-3910(95)00035-K
   Graham J. A., 1985, FOURIER TRANSFORM IN, V4, P345
   GRIFFITHS PR, 1986, FOURIER TRANSFORM IN
   Harrick N. J, 1967, INTERNAL REFLECTION
   JOHNSTON SF, 1991, FOURIER TRANSFORM IN
   JONAS K, 1970, ACTA CHIM HUNG, V66, P1
   Kidder LH, 1997, OPT LETT, V22, P742, DOI 10.1364/OL.22.000742
   KOZLOWSKI TR, 1968, APPL OPTICS, V7, P795, DOI 10.1364/AO.7.000795
   MARCOTT C, 1996, MIKROCHIM ACTA S, V14, P157
   Massart DL, 1988, CHEMOMETRICS TXB
   MEGLEN RR, 1988, CHEMOMETR INTELL LAB, V3, P17, DOI 10.1016/0169-7439(88)80062-5
   Messerschmidt R. G., 1988, INFRARED MICROSPECTR
   Nishikida K., 1996, SELECTED APPL MODERN
   OTTO M, 1988, CHEMOMETR INTELL LAB, V4, P101, DOI 10.1016/0169-7439(88)80083-2
   PUTTNAM NA, 1972, J SOC COSMET CHEM, V23, P209
   RINTOUL L, 1995, APPL SPECTROSC, V49, P1608, DOI 10.1366/0003702953965696
   Smith B.C., 1996, FUNDAMENTALS FOURIER
   SOWA MG, 1994, APPL SPECTROSC, V48, P316, DOI 10.1366/0003702944028182
   VASSALLO AM, 1992, APPL SPECTROSC, V46, P73, DOI 10.1366/0003702924444407
   VIDRINE DW, 1982, FOURIER TRANSFORM IN, V3, P125
   WENTRUPBYRNE E, 1995, APPL SPECTROSC, V49, P1028, DOI 10.1366/0003702953964813
   WILMSHURST JK, 1963, J CHEM PHYS, V39, P2545, DOI 10.1063/1.1734059
   YANG CQ, 1987, APPL SPECTROSC, V41, P889, DOI 10.1366/0003702874448319
NR 31
TC 34
Z9 35
U1 0
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON ROAD, CAMBRIDGE CB4 4WF,
   CAMBS, ENGLAND
SN 0003-2654
J9 ANALYST
JI Analyst
PD APR
PY 1998
VL 123
IS 4
BP 571
EP 577
DI 10.1039/a707111f
PG 7
WC Chemistry, Analytical
SC Chemistry
GA ZK143
UT WOS:000073289700008
PM 9684399
DA 2018-10-19
ER

PT J
AU De Aza, PN
   Guitian, F
   De Aza, S
   Valle, FJ
AF De Aza, PN
   Guitian, F
   De Aza, S
   Valle, FJ
TI Analytical control of wollastonite for biomedical applications by use of
   atomic absorption spectrometry and inductively coupled plasma atomic
   emission spectrometry
SO ANALYST
LA English
DT Article
DE wollastonite; pseudowollastonite; biomaterials; impurities analysis;
   cold vapour atomic absorption spectrometry; hydride generation atomic
   absorption spectrometry; inductively coupled plasma atomic emission
   spectrometry
ID SIMULATED BODY-FLUID; GLASSES; BIOACTIVITY; CERAMICS
AB Preliminary in vitro experiments revealed that wollastonite (CaSiO3) is a potentially highly bioactive material that forms a hyroxyapatite (HA) surface layer on exposure to simulated body fluid with an ion concentration, pH and temperature virtually identical with those of human blood plasma. The formation of the HA layer is an essential requirement for an artificial material to be used as bioactive bone substitute, This finding opens up a wide field for biomedical applications of wollastonite, Biomaterials used as implants in the human body require strict control of trace elements and of the toxic species specified in American Society for Testing and Materials F-1185-88 (As, Cd, Hg and Pb) in ceramic hydroxyapatite for surgical implantation. In this work, two types of pseudowollastonite, the high temperature form of wollastonite, mere analysed by using cold vapour atomic absorption spectrometry and hydride generation atomic absorption spectrometry, in order to determine the elements stated in the above-mentioned norm, and inductively coupled plasma atomic emission spectrometry to establish the SiO2/CaO ratio of the two materials and analyse for all other impurities introduced by the raw materials and by the processes of synthesis, sintering and grinding, Barium and Mg were especially prominent in raw materials, and Zr, Y, Mg, W, Co and Ni come mainly from the processing.
C1 CSIC, Inst Ceram & Vidrio, E-28500 Madrid, Spain.
RP De Aza, PN (reprint author), Univ Santiago de Compostela, Inst Ceram, Santiago De Compostela, Spain.
RI De Aza, Piedad/A-7621-2015
OI De Aza, Piedad/0000-0001-9316-4407
CR *ASTM, 1988, 118588 F ASTM
   BOUMANS PWJ, 1987, INDUCTIVELY COUPLED, P102
   DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   DeAza PN, 1996, J MICROSC-OXFORD, V182, P24, DOI 10.1111/j.1365-2818.1996.tb04794.x
   DeAza PN, 1996, J MATER SCI-MATER M, V7, P399, DOI 10.1007/BF00122007
   DEAZA PN, 1995, ADV SCI TECHNOLOGY, V12, P9
   DEVESA L, COMMUNICATION
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS U, 1988, CRC CRITICAL REV BIO, V4, P2
   Hench L. L., 1993, ADV SERIES CERAMICS, V1, P1
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOROWITZ E, INTRO BIOCERAMICS, V335, P93
   KOBUBO T, 1982, B I CHEM RES KYOTO U, V60, P260
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1991, CERAMICS 21 CENTURY, P500
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHURA K, 1992, J MATER SCI-MATER M, V3, P95, DOI 10.1007/BF00705275
   Potts P., 1987, HDB SILICATE ROCK AN, P47
NR 19
TC 26
Z9 27
U1 1
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON ROAD, CAMBRIDGE CB4 4WF,
   CAMBS, ENGLAND
SN 0003-2654
J9 ANALYST
JI Analyst
PD APR
PY 1998
VL 123
IS 4
BP 681
EP 685
DI 10.1039/a708445e
PG 5
WC Chemistry, Analytical
SC Chemistry
GA ZK143
UT WOS:000073289700027
PM 9684401
DA 2018-10-19
ER

PT J
AU Niu, M
   Su, Y
   Yan, JK
   Fu, CP
   Xu, DM
AF Niu, M
   Su, Y
   Yan, JK
   Fu, CP
   Xu, DM
TI An improved open-ended waveguide measurement technique on parameters
   epsilon(r) and mu(r) of high-loss materials
SO IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT
LA English
DT Article
DE electromagnetic parameters; high-loss material; open-ended waveguide;
   simultaneous measurement
AB An improved technique of using rectangular waveguide aperture for simultaneous measurement of the electromagnetic parameters epsilon(r), mu(r) of materials is developed in this paper, Both multilayer and single-layer medium sheet samples can be tested, Samples are sandwiched between a flange of an open-ended waveguide and a shorting plate, The parameters are obtain by using an optimization technique by fitting the theoretical values of the reflection coefficients Gamma(epsilon(r), mu(r)) to the measured values with epsilon(r), mu(r) as the argument. The related details, such as test theories, waveguide design, sample preparation, and error analysis are also discussed in this paper. The experimental results are validated by the measurements performed using the reflection-transmission method using an automatic network analyzer and the published data from manufactures. By virtue of its open-ended waveguide configuration, this technique is well suited for sheet or coating materials, and it might be applied for industrial on-the-worksite testing or biomedical analysis.
C1 Shanghai Univ, Shanghai 201800, Peoples R China.
   Chinese Univ Hong Kong, Hong Kong, Peoples R China.
RP Niu, M (reprint author), Shanghai Univ, Shanghai 201800, Peoples R China.
CR ARJALINGAM, 1990, IEEE T MICROWAVE THE, V38
   BAKHTIARI S, 1994, IEEE T MICROWAVE THE, V24
   CULLEN AL, 1971, PROC R SOC LON SER-A, V325, P493, DOI 10.1098/rspa.1971.0181
   DEMING X, 1987, IEEE T MICROW THEORY, V35, P1424
   GARDIOL FE, 1985, ADV ELECTRON EL PHYS, V63, P139
   Hakki B.W., 1960, Institute of Radio Engineers Transactions on Microwave Theory and Techniques, VMTT-8, P402, DOI 10.1109/TMTT.1960.1124749
   KHAN SA, 1992, P INT C MICR COMM NA, P702
   LI CL, 1995, IEEE T INSTRUM MEAS, V44, P19, DOI 10.1109/19.368108
   MISRA D, 1990, IEEE T MICROWAVE THE, V38
   STUCHLY MA, 1980, IEEE T INSTRUM MEAS, V29, P176, DOI 10.1109/TIM.1980.4314902
   TANABE E, 1976, IEEE T INSTRUM MEAS, V25, P222, DOI 10.1109/TIM.1976.6312350
   WEI YZ, 1991, IEEE T MICROW THEORY, V39, P526, DOI 10.1109/22.75296
   Weir W., 1974, P IEEE, V62
   1975, IEE C PUB
NR 14
TC 3
Z9 3
U1 1
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9456
J9 IEEE T INSTRUM MEAS
JI IEEE Trans. Instrum. Meas.
PD APR
PY 1998
VL 47
IS 2
BP 476
EP 481
DI 10.1109/19.744194
PG 6
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 166CC
UT WOS:000078557800023
DA 2018-10-19
ER

PT J
AU Tolfree, DWL
AF Tolfree, DWL
TI Microfabrication using synchrotron radiation
SO REPORTS ON PROGRESS IN PHYSICS
LA English
DT Review
ID X-RAY-LITHOGRAPHY; LIGA PROCESS; FABRICATION; GENERATION; PROFILES
AB The realization of precision deep microstructures requires high-energy, intense parallel beams of x-rays from synchrotron radiation sources and novel process technology. Deep x-ray lithography with synchrotron radiation is basically a shadow printing process in which a two-dimensional pattern is accurately transferred from a mask into a resist material by chemical changes induced by the radiation. Subsequent electroforming and moulding processes are used to manufacture microstructures from metals, plastics and ceramics. This process, known as LIGA (Lithographie, Galvanoformung, and Abformung), first developed in Germany, is based on a combination of lithography, electroforming and replication processes. The development of the LIGA process for the fabrication of a wide range of precision microstructures has been stimulated by the increasing use of synchrotron radiation sources for lithography.
   Applications for microstructures exist in many sectors of industry. These include chemical and process engineering, biomedical instrumentation, automotive and aerospace technology, environmental monitoring and information technology. Emphasis is placed on three main areas, micromechanics, micro-optics and microfluidics, which are emerging with the widest range of industrial applications.
   This paper reviews the progress being made in microfabrication technology using x-ray beam lithography and the LIGA process. It includes a description of synchrotron radiation, storage ring sources, the fabrication processes, applications and potential markets. Reference is also made to European networks and R&D activity worldwide.
C1 SERC, Daresbury Lab, CCLRC, Warrington WA4 4AD, Cheshire, England.
RP Tolfree, DWL (reprint author), SERC, Daresbury Lab, CCLRC, Warrington WA4 4AD, Cheshire, England.
CR AIKEN T, 1995, COMMUNICATION
   AITKEN T, 1995, COMMUNICATION
   BACHER W, 1995, IEE T IND ELECT, V42
   BACHER W, 1994, P ACTUATOR 94, P86
   BALLANDRAS S, 1995, J MICROMECH MICROENG, V5, P203, DOI 10.1088/0960-1317/5/3/001
   BARNES P, 1992, NUCL INSTRUM METH A, V314, P345, DOI 10.1016/0168-9002(92)90978-D
   BAUER H, 1994, MST NEWS, V10, P18
   BAUER HD, 1994, ENCY ADV MAT, V3, P1613
   BECKER EW, 1982, NATURWISSENSCHAFTEN, V69, P520
   Becker H, 1993, Endosc Surg Allied Technol, V1, P40
   BECKER H, 1988, P WORKSH MMI TECHN N
   BECKER HM, 1993, INTERDISCIPL SCI REV, V18, P289
   BEERNAERT D, 1995, MST NEWS, V14
   BERG A, 1994, MICRO TOTAL ANAL WOR
   BLEWETT JP, 1946, PHYS REV, V69, P87, DOI 10.1103/PhysRev.69.87
   BLEY P, 1993, INTERDISCIPL SCI REV, V18, P267
   BLEY P, 1991, MICRO SYSTEM TECHNOL, P302
   BLEY P, 1991, MICROELECTRON ENG, V14, P323
   BOURBON C, FABRICATION CAPACITA, P559
   BOURBON C, 1991, SENSOR ACTUAT A-PHYS, V27, P1
   Burbaum C, 1991, SENSOR MATER, V3, P75
   CERRINA F, 1992, MICROELECTRON ENG, V17, P135, DOI 10.1016/0167-9317(92)90027-O
   CERRINA F, 1996, HDB MICROLITHOGRAPHY
   CHAN CT, 1991, EUROPHYS LETT, V16, P563, DOI 10.1209/0295-5075/16/6/009
   CHOWANIETZ E, 1995, P MICROSIM 95
   Cuschieri A, 1992, OPERATIVE MANUAL END
   DARIO P, 1994, IROS '94 - INTELLIGENT ROBOTS AND SYSTEMS: ADVANCED ROBOTIC SYSTEMS AND THE REAL WORLD, VOLS 1-3, P739, DOI 10.1109/IROS.1994.407554
   DEFREEZ RK, 1989, SPIE, V1043, P343
   EHRFELD H, 1992, 3 EUR PART ACC C, P1687
   Ehrfeld W, 1996, DECH MONOG, V132, P1
   Ehrfeld W., 1986, Microelectronic Engineering, V5, P463, DOI 10.1016/0167-9317(86)90078-X
   EHRFELD W, 1995, RADIAT PHYS CHEM, V45, P349, DOI 10.1016/0969-806X(93)E0007-R
   EHRFELD W, 1988, J VAC SCI TECHNOL B, V6, P178, DOI 10.1116/1.584039
   EHRFELD W, 1987, 666 VDI, P85
   EHRFELD W, 1991, NUCL INSTRUM METHODS, V303, P65
   EHRFELD W, 1990, MICROSYST TECHNOL, V2, P521
   EHRFELD W, 1986, MICROELECTRON ENG, V4, P35
   EHRFELD W, 1988, P IEEE
   EHRFELD W, 1988, J VAC SCI B, V6
   EHRFELD W, 1994, J PHYSIQUE, V4, P229
   EHRFELD W, 1987, P IEEE MICR ROB TEL, V87, P1
   ELDER FR, 1947, PHYS REV, V71, P829, DOI 10.1103/PhysRev.71.829.5
   ELKHOLI A, 1993, MICROELECTRON ENG, V21, P271, DOI 10.1016/0167-9317(93)90071-C
   ELKHOLI A, 1993, 5238 KFK, P114
   ELLEAUME P, 1990, PHYS SCRIPTA, VT31, P67, DOI 10.1088/0031-8949/1990/T31/009
   Feiertag G, 1996, NATO ADV SCI INST SE, V315, P63
   FEIERTAG G, 1996, IN PRESS MICROELECTR
   FOULGER M, 1996, XRAY LITHOGRAPHY SEL
   GODWIN RP, 1969, SPRINGER TRACTS MODE, V51
   GOU ZY, 1993, IBM J RES DEV
   GROBMAN W, 1985, SYNCHROTRON RAD RES
   GUCKEL H, 1993, NUCL INSTRUM METH B, V79, P247, DOI 10.1016/0168-583X(93)95336-4
   GUCKEL H, 1995, SPIE M AUST TX
   GUCKEL H, 1994, SPIES S MICR, P2194
   GUCKEL H, 1991, P TRANSDUCERS
   HARMENING M, 1992, 075030497792 IEEE, P202
   *HARMST C, 1997, MICR TECHN, V26
   HECTOR SD, 1993, VAC SCI TECHNOL, V13, P2981
   HEINRICH K, 1981, J VAC SCI TECHNOL, V19, P1254, DOI 10.1116/1.571255
   HESCH K, 1996, MICROFABRICATION SYN
   HEUBERGER A, 1984, MICROENGINEERING 84, V9, P283
   HILL JW, 1994, IEEE INT CONF ROBOT, P2302, DOI 10.1109/ROBOT.1994.350942
   HOH K, 1984, PUBL BUSINESS CTR AC
   HURTEAU R, 1994, IEEE INT CONF ROBOT, P2286, DOI 10.1109/ROBOT.1994.350945
   Ishihara S., 1994, NTT R & D, V43, P585
   ITO H, 1983, POLYM ENG SCI, V23, P1002
   IWANENKO D, 1944, PHYS REV, V65
   KRINSKY S, 1993, HDB SYNCHROTRON RAD, P65
   LAWES RA, 1994, ENG SCI ED J
   LEHMANN O, 1991, APPL PHYS A-MATER, V53, P343, DOI 10.1007/BF00357199
   LINGNAU R, 1989, SOLID STATE TECHNOL, V107
   MAID B, 1989, 4579 KFK
   MANER A, 1989, MAT MANUF PROCESS, V4, P537
   MARKS N, 1995, RADIAT PHYS CHEM, V45, P315, DOI 10.1016/0969-806X(95)92798-4
   MATHIESON D, 1994, MST 94 INT C MICR EL, P889
   McCormick M., 1994, Engineering Science and Education Journal, V3, P255, DOI 10.1049/esej:19940604
   MENCHMEYER D, 1987, SPIE P SERIES, V803, P72
   MENZ W, 1993, INTERDISCIPL SCI REV, V18, P253
   MESINGER H, 1995, MICROMASS ANAL SYSTE, P227
   MOHR J, 1988, J VAC SCI TECHNOL B, V6, P2264, DOI 10.1116/1.584067
   MOHR J, 1993, J MICROMECH MICROENG
   Moreau W. M., 1988, SEMICONDUCTOR LITHOG
   MORISHA H, 1993, RSJ IEEE INT C INT R, P1717
   MULLER RS, 1990, SENSOR ACTUAT A-PHYS, V21, P1, DOI 10.1016/0924-4247(90)85001-K
   MUNRO I, 1991, EUROPEAN SYNCH RAD S
   MURATA K, 1985, J APPL PHYS, V57, P575, DOI 10.1063/1.334740
   PATERSON KE, 1982, P IEEE, V70, P420
   PROSSER S, 1993, IEE C, V183
   RAPP P, 1993, P MEMS 93, P123
   REUBEN R, 1995, IEE C LOND
   RIVKIN, 1996, EPAC
   Rogner A., 1991, Journal of Micromechanics and Microengineering, V1, P167, DOI 10.1088/0960-1317/1/3/007
   ROWE EM, 1979, TOP CURR PHYS, V10, P25
   RUSSEL R, 1993, RSJ IEEE INT C INT R, P471
   SAMOTO N, 1983, J APPL PHYS, V54, P3855, DOI 10.1063/1.332610
   SATEESH S, 1997, IN PRESS HARMST P
   SCHELB W, 1987, 666 VDI, P85
   SCHIFF LI, 1946, REV SCI INSTRUM, V17, P798
   Schmidt A, 1996, MICROELECTRON ENG, V30, P215, DOI 10.1016/0167-9317(95)00230-8
   SCHULZ C, 1994, MEMS COURSE BOOKLET
   SCHULZ C, 1994, UETP MEMS FRSM NEUCH, P119
   SCHWINGER J, 1946, PHYS REV, V70, P798
   SILVERMAN JP, 1994, NUCL INSTRUM METH A, V347, P31, DOI 10.1016/0168-9002(94)91849-X
   Sokolov A. A., 1968, SYNCHROTRON RAD
   SOKOLOV AA, 1957, ZH EKSP TEOR FIZ, V4, P396
   SOUKOULIS CM, 1993, J OPT SOC AM B, V10, P208
   SULLER V, 1992, P 3 EUR PART ACC C E
   TERNOV I.M., 1985, SYNCHROTRON RAD ITS
   TIMOTHY JG, 1983, HDB SYNCHROTRON RA A, V1, P325
   TISCHER P, 1978, P 8 C EL ION BEAM SC, P444
   TOLFREE D, 1994, P TECH T C TCD
   TOLFREE DWL, 1997, MST NEWS, V21
   TOMBOULIAN DH, 1956, PHYS REV, V102, P1423, DOI 10.1103/PhysRev.102.1423
   TURNER S, 1989, 9030 CERN ACC SCH
   WANG T, 1994, IROS '94 - INTELLIGENT ROBOTS AND SYSTEMS: ADVANCED ROBOTIC SYSTEMS AND THE REAL WORLD, VOLS 1-3, P862, DOI 10.1109/IROS.1994.407491
   WEBER, 1997, MICRO MACH DEVICES, V2, P1
   WEBER L, 1994, EUR C EUPAC 94 EUR K
   WECHSUNG R, 1995, MST NEWS, V14, P13
   WILSON MN, 1992, REV SCI INSTRUM, V63, P707, DOI 10.1063/1.1142643
   WILSON MN, 1988, P M EL GROUP IOP, P13
   Winick H., 1980, Synchrotron radiation research, P11
   WOLLERSHEIM O, 1994, J MICROMECH MICROENG, V4, P84, DOI 10.1088/0960-1317/4/2/006
   YAMAMOTO S, 1989, REV SCI INSTRUM, V60, P1834, DOI 10.1063/1.1140916
   ZINNER H, 1994, MST NEWS, P9
   ZURNIQUE H, 1997, SIMULATION STUDIES M
   1992, MICROMECHANICS INT
   1997, SRI CONSULTING REPOR
   1996, MST NEWS, V7
   1996, P C COMM MICR KON HI
   1995, IEE C MICR MIS LOND
   1995, LIGA NEWSLETTER
   1996, MST NEWS, V17
NR 132
TC 50
Z9 51
U1 1
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0034-4885
J9 REP PROG PHYS
JI Rep. Prog. Phys.
PD APR
PY 1998
VL 61
IS 4
BP 313
EP 351
DI 10.1088/0034-4885/61/4/001
PG 39
WC Physics, Multidisciplinary
SC Physics
GA ZL100
UT WOS:000073398800001
DA 2018-10-19
ER

PT J
AU Lotters, JC
   Bomer, JG
   Verloop, AJ
   Droog, EA
   Olthuis, W
   Veltink, PH
   Bergveld, P
AF Lotters, JC
   Bomer, JG
   Verloop, AJ
   Droog, EA
   Olthuis, W
   Veltink, PH
   Bergveld, P
TI Design, fabrication and characterization of a highly symmetrical
   capacitive triaxial accelerometer
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article; Proceedings Paper
CT 9th International Conference on Solid-State Sensors and Actuators
CY JUN 16-19, 1997
CL CHICAGO, ILLINOIS
SP IEEE Electron Devices Soc
DE triaxial accelerometers; capacitive sensors; three-dimensional
   structures; biomedical applications
ID FILM
AB A highly symmetrical cubic capacitive triaxial accelerometer for biomedical applications has been designed, fabricated and characterized. The outer dimensions of the sensors are 5 mm x 5 mm x 5 mm. The devices are mounted on a standard IC package for easy testing. Features of the triaxial accelerometer are a highly symmetrical cubic structure, capacitive coupling of the high-frequency input voltage to the seismic mass, and the use of the polymer polydimethylsiloxane (PDMS) as spring material between the capacitor plates and the mass and polyimide (PI) as the flexible interconnection layer between the capacitor plates. The sensor structure and its basic operating principle, its mathematical mass-spring-damper model and the cleanroom technology necessary for the fabrication of the devices are described. The measurement results show a sensitivity of similar to 0.2 V (m s(-2))(-1) with a corresponding resolution of 0.01 m s(-2). an off-axis sensitivity of < 5%, a good linearity in the output voltage for accelerations up to at least 50 m s(-2) and a bandwidth of d.c. to similar to 1 kHz. (C) 1998 Elsevier Science S.A. All rights reserved.
C1 Univ Twente, Dept Elect Engn, MESA Res Inst, NL-7500 AE Enschede, Netherlands.
   Bronkhorst High Tech, NL-7261 AK Ruurlo, Netherlands.
   Univ Twente, BMTI, NL-7500 AE Enschede, Netherlands.
RP Olthuis, W (reprint author), Univ Twente, Dept Elect Engn, MESA Res Inst, POB 217, NL-7500 AE Enschede, Netherlands.
RI Veltink, Peter/L-3738-2016
OI Veltink, Peter/0000-0002-1796-9999
CR Andersson G. I., 1995, 8th International Conference on Solid-State Sensors and Actuators and Eurosensors IX. Digest of Technical Papers (IEEE Cat. No.95TH8173), P558
   ANDREWS MK, 1993, SENSOR ACTUAT A-PHYS, V36, P219, DOI 10.1016/0924-4247(93)80196-N
   BATEN CTM, 1996, P 11 ANN INT OCC ERG, V1, P315
   BLOM C, 1985, THESIS U TWENTE, P35
   Bouten CVC, 1997, IEEE T BIO-MED ENG, V44, P136, DOI 10.1109/10.554760
   CHO YH, 1994, SENSOR ACTUAT A-PHYS, V40, P31, DOI 10.1016/0924-4247(94)85027-5
   FRANKEN HM, 1994, IEEE ENG MED BIOL, V13, P564
   JANSEN H, 1995, J MICROMECH MICROENG, V5, P115, DOI 10.1088/0960-1317/5/2/015
   Jono K., 1994, Proceedings IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robotic Systems (Cat. No.94CH3404-1), P251, DOI 10.1109/MEMSYS.1994.555762
   KWON K, 1997, 9 INT C SOL STAT SEN, P1221
   LEMKIN MA, 1997, 9 INT C SOL STAT SEN, P1185
   LOTTERS JC, UNPUB IEEE T INSTRUM
   LOTTERS JC, 1997, THESIS U TWENTE NETH, P98
   LOTTERS JC, 1997, J MICROSYSTEM TECHNO, V3, P64
   LOTTERS JC, 1997, IN PRESS J MICROMECH, V7
   Mineta T., 1995, 8th International Conference on Solid-State Sensors and Actuators and Eurosensors IX. Digest of Technical Papers (IEEE Cat. No.95TH8173), P554
   Okada K., 1992, 11 SENS S, P245
   SKVOR Z, 1991, STUDIES ELECT ELECT, V40, P176
   SUZUKI K, 1994, J MICROELECTROMECH S, V3, P4, DOI 10.1109/84.285718
   Takao H., 1995, 8th International Conference on Solid-State Sensors and Actuators and Eurosensors IX. Digest of Technical Papers (IEEE Cat. No.95TH8173), P683
   TAKAO H, 1998, IN PRESS SENSORS ACT, V66
   VANHILTEN JJ, 1993, THESIS U LEIDEN NETH
   VANSOMEREN EJW, 1993, J NEUROL SCI, V117, P16, DOI 10.1016/0022-510X(93)90148-R
   WHORLOW RW, 1980, RHEOLOGICAL TECHNIQU, P229
NR 24
TC 18
Z9 20
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD APR 1
PY 1998
VL 66
IS 1-3
BP 205
EP 212
DI 10.1016/S0924-4247(98)00036-3
PG 8
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA ZJ338
UT WOS:000073204000033
DA 2018-10-19
ER

PT J
AU Niinomi, M
AF Niinomi, M
TI Mechanical properties of biomedical titanium alloys
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT Conference on Thermomechanical Processing and Metallurgy of Titanium
   Alloys
CY JUL 07-11, 1997
CL UNIV WOLLONGONG, WOLLONGONG, AUSTRALIA
SP Asian Off Aerosp Res & Dev, USAF, Off Sci Res
HO UNIV WOLLONGONG
DE biomedical titanium alloys; mechanical properties; fracture
   characteristics; fatigue characteristics
AB Titanium alloys are expected to be much more widely used for implant materials in the medical and dental fields because of their superior biocompatibility, corrosion resistance and specific strength compared with other metallic implant materials. Pure titanium and Ti-6Al-4V, in particular, Ti-6Al-4V ELI have been, however, mainly used for implant materials among various titanium alloys to date. V free alloys like Ti-6Al-7Nb and Ti-5A1-2.5Fe have been recently developed for biomedical use. More recently V and Al free alloys have been developed. Titanium alloys composed of non-toxic elements like Nb, Ta, Zr and so on with lower modulus have been started to be developed mainly in the USA. The beta type alloys are now the main target for medical materials. The mechanical properties of the titanium alloys developed for implant materials to date are described in this paper. (C) 1998 Elsevier Science S.A. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 441, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 441, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   [Anonymous], 1994, ANN BOOK ASTM STAND
   BOROWY KH, 1985, PROPERTIES NEW TITAN, P1381
   Brown S A, 1996, ASTM STP
   DAVIDSON JA, 1986, P IMPLANT MANUFACTUR, V122, P122
   HIGO Y, 1994, AM SOC TEST MATER, V1173, P148, DOI 10.1520/STP18101S
   *IR STEE I JAP, 1990, DAT BOOK FRACT TOUGH, P37
   KURODA D, 1996, IRON STEEL I JPN, V9, P421
   Niinomi M, 1996, METALL MATER TRANS A, V27, P3925, DOI 10.1007/BF02595641
   OKAZAKI Y, 1995, J JPN I MET, V59, P1078, DOI 10.2320/jinstmet1952.59.10_1078
   OKUNO O, 1996, J JPN SOC BIOMATER, V14, P267
   Semlitsch M., 1986, TITAN, V2, P721
   SEN DYM, 1986, TITAN, V2, P712
   Tokaji K., 1994, Journal of the Society of Materials Science, Japan, V43, P710
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wang K., 1993, CHARACTERIZATION TI, P49
   ZWICKER U, 1986, Z METALLKD, V77, P714
NR 17
TC 754
Z9 799
U1 14
U2 224
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAR 15
PY 1998
VL 243
IS 1-2
BP 231
EP 236
DI 10.1016/S0921-5093(97)00806-X
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA ZH762
UT WOS:000073145100031
DA 2018-10-19
ER

PT J
AU Kuroda, D
   Niinomi, M
   Morinaga, M
   Kato, Y
   Yashiro, T
AF Kuroda, D
   Niinomi, M
   Morinaga, M
   Kato, Y
   Yashiro, T
TI Design and mechanical properties of new beta type titanium alloys for
   implant materials
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT Conference on Thermomechanical Processing and Metallurgy of Titanium
   Alloys
CY JUL 07-11, 1997
CL UNIV WOLLONGONG, WOLLONGONG, AUSTRALIA
SP Asian Off Aerosp Res & Dev, USAF, Off Sci Res
HO UNIV WOLLONGONG
DE biomedical titanium alloys; d-electron alloy design method; mechanical
   properties; Young's modulus; biocompatibility
ID STRENGTH
AB Pure titanium and Ti-6Al-4V alloy have been mainly used as implant materials. V-free titanium alloys like Ti-6Al-7Nb and Ti-5Al-2.5Fe have been then developed because toxicity of V has been pointed out. Al-and V-free titanium alloys as implant materials have been developed. Most of them are, however, alpha + beta type alloys. beta type titanium alloys with lower moduli of elasticity and greater strength have been developed recently. Design of new beta type titanium alloys composed of non-toxic elements like Nb, Ta, Zr, Mo or Sn with lower moduli of elasticity and greater strength were, therefore, studied based on the d-electron alloy design method, and the basic mechanical properties of designed alloys of button ingots melted by tri-are furnace in the laboratory were investigated in this study. beta type alloys, Ti-Nb-Ta-Zr, Ti-Nb-Ta-Mo and Ti-Nb-Ta-Sn system alloys designed in this study are expected to have greater performance for implant materials. The Young's moduli of these alloys are lower compared with that of Ti-6Al-4V ELI which has been used as an implant material. The alloys on which some heat treatments have been conducted offer suitable tensile properties as implant materials. The tensile strength and elongation of designed alloys in this study are equivalent or greater than required values already reported. (C) 1998 Elsevier Science S.A. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 441, Japan.
   Nagoya Univ, Dept Mat Sci & Engn, Chikusa Ku, Nagoya, Aichi 46401, Japan.
   Daido Steel, Market Dev Dept, Minato Ku, Nagoya, Aichi, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 441, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR Morinaga M., 1992, P 7 INT C TIT SAN DI, P276
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   Zwicker R, 1980, P 4 INT C TIT KYOT J, P505
NR 4
TC 673
Z9 708
U1 8
U2 167
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAR 15
PY 1998
VL 243
IS 1-2
BP 244
EP 249
DI 10.1016/S0921-5093(97)00808-3
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA ZH762
UT WOS:000073145100033
DA 2018-10-19
ER

PT J
AU De Angelis, AA
   Capitani, D
   Crescenzi, V
AF De Angelis, AA
   Capitani, D
   Crescenzi, V
TI Synthesis and C-13 CP-MAS NMR characterization of a new chitosan-based
   polymeric network
SO MACROMOLECULES
LA English
DT Article
ID SOLID-STATE NMR; CROSS POLARIZATION; CPMAS NMR; RESINS; COATINGS
AB New chemical hydrogels, potentially suitable for biomedical applications, have been synthesized and characterized by C-13 CP-MAS NMR spectroscopy. The polysaccharidic component of these hydrogels is chitosan, while the novel cross-linking agent is diethyl squarate (DES). H-1 and C-13 NMR spectra of chitosan allow a good characterization of the starting materials. In dried chitosan/DES networks, the structure of the chemical bridges (i.e., of the cross-links), has been investigated by C-13 CP-MAS NMR. The spectrum of the cross-linked material appears rather broad and poorly resolved. A large number of weak signals in the 160-190 ppm region is observed, all due to the squarate moiety, but none due to the original diethyl squarate. Squarate may be thought to act both as a bidentate cross-linking agent and as a monodentate substituent. A partial spectral assignment of the CP-MAS spectrum was obtained through a spectral "editing" sequence.
C1 Univ Rome La Sapienza, Dipartimento Chim, I-00185 Rome, Italy.
   CNR, NMR Serv, Area Ric Roma, I-00016 Rome, Italy.
   CNR, Ist Strutturist Chim, Area Ric Roma, I-00016 Rome, Italy.
RP De Angelis, AA (reprint author), Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.
EM adeangel@ea.oac.uci.edu; nmr@mlib.cnr.it; crescenzi@axrma.uniromal.it
OI Capitani, Donatella/0000-0003-2392-0187
CR AUJLA RS, 1982, POLYM B, V8, P2353
   BAIN AD, 1989, GLINFIT
   BAUER DR, 1984, J POLYM SCI POL PHYS, V22, P2009, DOI 10.1002/pol.1984.180221202
   BAUER DR, 1986, PROG ORG COAT, V14, P45, DOI 10.1016/0033-0655(86)80015-2
   BELFIORE LA, 1984, MACROMOLECULES, V17, P2561, DOI 10.1021/ma00142a017
   BURUM DP, 1991, J MAGN RESON, V95, P184, DOI 10.1016/0022-2364(91)90336-R
   COTTON FA, 1988, ADV INORGANIC CHEM, pCH8
   Crescenzi V, 1997, POLYM GELS NETW, V5, P225, DOI 10.1016/S0966-7822(96)00051-2
   CRESCENZI V, 1995, MACROMOL CHEM PHYSIC, V196, P2873, DOI 10.1002/macp.1995.021960912
   DEANGELIS AA, 1996, THESIS LA SAPIENZA U
   DEMARGERANDRE S, 1994, CARBOHYD POLYM, V23, P211, DOI 10.1016/0144-8617(94)90104-X
   DOMARD A, 1987, INT J BIOL MACROMOL, V9, P98, DOI 10.1016/0141-8130(87)90033-X
   ENGLISH AD, 1983, MACROMOLECULES, V16, P1422, DOI 10.1021/ma00243a004
   GARROWAY AN, 1982, MACROMOLECULES, V15, P1051, DOI 10.1021/ma00232a019
   GORY DG, 1988, CHEM PHYS LETT, V152, P431
   HATFIELD GR, 1987, MACROMOLECULES, V20, P608, DOI 10.1021/ma00169a024
   Hayes E., 1978, P 1 INT C CHIT CHIT, P406
   IJIMA H, BIOCH INT, V19, P353
   Kamath VP, 1996, GLYCOCONJUGATE J, V13, P315, DOI 10.1007/BF00731506
   Law RV, 1996, MACROMOLECULES, V29, P6284, DOI 10.1021/ma951606o
   Law RV, 1997, MACROMOLECULES, V30, P2868, DOI 10.1021/ma9616470
   LINDBERG JJ, 1985, ADV POLYM SCI, V66, P1
   MACIEL GE, 1983, MACROMOLECULES, V16, P598, DOI 10.1021/ma00238a022
   MARK HF, 1990, ENCY POLYM SCI ENG, V13, P441
   MCBRIERTY VJ, 1993, NMR SOLID POLYM
   Muzzarelli R. A. A., 1996, CHITIN ENZYMOLOGY, V2
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   MUZZARELLI RAA, 1993, CHITIN ENZYMOLOGY, V1
   OPELLA SJ, 1979, J AM CHEM SOC, V101, P5854, DOI 10.1021/ja00513a079
   OTTENBRITE RM, 1996, ACS S SERIES, V627
   PEGG DT, 1982, J CHEM PHYS, V77, P2745, DOI 10.1063/1.444188
   RINAUDO M, 1993, INT J BIOL MACROMOL, V15, P281, DOI 10.1016/0141-8130(93)90027-J
   SORENSEN OW, 1982, J MAGN RESON, V46, P180, DOI 10.1016/0022-2364(82)90181-0
   SORENSEN UB, 1985, J MAGN RESON, V65, P222, DOI 10.1016/0022-2364(85)90004-6
   Takai S.M., 1989, NMR XRAY STUDIES CHI
   TIETZE LF, 1991, CHEM BER, V124, P1215, DOI 10.1002/cber.19911240539
   TONELLI AE, 1989, NMR SPECTROSCOPY POL, pCH4
   WANG W, 1994, INT J BIOL MACROMOL, V16, P149, DOI 10.1016/0141-8130(94)90042-6
   WU XL, 1993, J MAGN RESON SER A, V102, P205, DOI 10.1006/jmra.1993.1092
   WU XL, 1993, J MAGN RESON SER A, V104, P119, DOI 10.1006/jmra.1993.1199
   WU XL, 1988, J MAGN RESON, V77, P343
NR 41
TC 40
Z9 40
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD MAR 10
PY 1998
VL 31
IS 5
BP 1595
EP 1601
DI 10.1021/ma971619x
PG 7
WC Polymer Science
SC Polymer Science
GA ZB605
UT WOS:000072489300022
DA 2018-10-19
ER

PT J
AU Merritt, K
   Gaind, A
   Anderson, JM
AF Merritt, K
   Gaind, A
   Anderson, JM
TI Detection of bacterial adherence on biomedical polymers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bacterial adherence; Staphylococcus epidermidis; dye elution
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CAPSULAR POLYSACCHARIDE ADHESIN; SLIME
   PRODUCTION; INTRAVASCULAR CATHETERS; EPIDERMIDIS; IDENTIFICATION;
   INFECTION; DEVICES; INVITRO; MARKER
AB The ability to adhere to materials and promote formation of a biofilm is an important feature of the pathogenicity of some organisms, most notably the coagulase negative staphylococci. Various methods to detect bacterial adherence are available, but detection of adherence to nontransparent materials can be difficult. It was the purpose of this study to establish the suitability of a dye elution technique to detect adherence. The technique involves fixing the bacterial film with formalin, staining with crystal violet, eluting the dye with ethanol, and determining the optical density of the solution using 96-well plates and an enzyme immunosorbent assay reader with a 540-nm filter. This technique distinguished a known adherent from a known nonadherent organism and demonstrated that the presence of protein can inhibit adherence, and that adherence of different organisms to different biomedically important polymers can be measured. The dye elution technique was used to evaluate the adherence of known slime-producing polysaccharide antigen-positive (PSA+) and known nonslime-producing polysaccharide antigen-negative (PSA-) Staphylococcus epidermidis organisms to implant grade materials (polyethylene, expanded polytetrafluoroethylene, Dacron, silicone, and collagen) as well as to polystyrene. (C) 1998 John Wiley & Sons, Inc.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
RP Merritt, K (reprint author), 17704 Stoneridge Dr, Gaithersburg, MD 20878 USA.
FU NHLBI NIH HHS [HL 47300]
CR ARDEHALI R, 1993, J BIOMED MATER RES, V27, P269, DOI 10.1002/jbm.820270217
   BADDOUR LM, 1987, J CLIN MICROBIOL, V25, P207
   BISNO AL, 1989, INFECT ASS INDWELLIN
   Bisno AL, 1994, INFECT ASS INDWELLIN
   CHANG CC, 1994, J ORTHOPAED RES, V12, P526, DOI 10.1002/jor.1100120409
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870
   CHRISTENSEN GD, 1990, INFECT IMMUN, V58, P2906
   COLLIGNON PJ, 1989, EUR J CLIN MICROBIOL, V8, P807, DOI 10.1007/BF02185853
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DEIGHTON MA, 1990, J CLIN MICROBIOL, V28, P2442
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   FRANSON TR, 1986, J CLIN MICROBIOL, V24, P559
   FRANSON TR, 1984, J CLIN MICROBIOL, V20, P500
   GRISTINA AG, 1987, SCIENCE, V237, P1583
   HAAGEN IA, 1990, J INFECT DIS, V161, P266, DOI 10.1093/infdis/161.2.266
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   KOTILAINEN P, 1990, J CLIN MICROBIOL, V28, P2779
   LADD TI, 1985, J CLIN MICROBIOL, V21, P1004
   Merritt K, 1991, J Biomater Appl, V5, P185, DOI 10.1177/088532829100500304
   MULLER E, 1993, INFECT IMMUN, V61, P551
   MULLER E, 1993, J INFECT DIS, V168, P1211, DOI 10.1093/infdis/168.5.1211
   MULLER E, 1991, INFECT IMMUN, V59, P3323
   QUIE PG, 1987, J INFECT DIS, V156, P543, DOI 10.1093/infdis/156.4.543
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   TSAI CL, 1988, J ORTHOPAED RES, V6, P666, DOI 10.1002/jor.1100060507
   VANPETT K, 1990, J ORTHOPAED RES, V8, P321, DOI 10.1002/jor.1100080303
   WANG I, 1993, J BIOMED MATER RES, V27, P1119, DOI 10.1002/jbm.820270902
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
NR 30
TC 49
Z9 50
U1 0
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 1998
VL 39
IS 3
BP 415
EP 422
DI 10.1002/(SICI)1097-4636(19980305)39:3<415::AID-JBM10>3.0.CO;2-9
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA YR639
UT WOS:000071515400010
PM 9468050
DA 2018-10-19
ER

PT J
AU Engebretson, J
AF Engebretson, J
TI A heterodox model of healing
SO ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE
LA English
DT Article
ID UNITED-STATES
AB A heterodox model of healing incorporating the basic dualism of Western philosophy-the world of concrete material substance versus that of thought, ideals, and spirit-is proposed. Such dualism is reflected in Western constructions of healing. An explanatory paradigm model with a horizontal axis representing paradigms of healing from positivism to metaphysics and a vertical axis representing activities of healing from the material to the spiritual was derive from ethnographic work with healers. A health practice model following the same philosophical patterns illustrates reflected American cultural values in the relative positioning of healing modalities from the orthodox biomedical to the most metaphysical or alternative. Examples of specific modalities of healing, many of which are resurfacing with increasing public interest in alternative therapies, are illustrated. This model places biomedicine in the same context as other philosophical approaches to healing as a standard for comparison. Implications for practice and research are discussed.
C1 InnoVis Commun, Aliso Viejo, CA 92656 USA.
   Univ Texas, Houston Hlth Sci Ctr, Sch Nursing, Houston, TX USA.
RP Engebretson, J (reprint author), InnoVis Commun, 101 Columbia, Aliso Viejo, CA 92656 USA.
CR ANDREWS M, 1995, TRANSCULTURAL CONCEP
   BACH E, 1977, HEAL THYSELF BACH FL
   BROWN PS, 1988, MED HIST, V32, P174, DOI 10.1017/S0025727300047980
   Cassidy C M, 1995, J Altern Complement Med, V1, P19, DOI 10.1089/acm.1995.1.19
   Cox Harvey, 1995, FIRE FROM HEAVEN
   Dossey L, 1995, Altern Ther Health Med, V1, P6
   DOSSEY L, 1995, ALTERN THER HEALTH M, V1, P79
   DOSSEY L, 1993, HEALING WORDS POWER
   DOUGLAS M, 1989, PURITY DANGER ANAL C
   EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406
   Engebretson J, 1996, QUAL HEALTH RES, V6, P526, DOI 10.1177/104973239600600405
   Engebretson J, 1993, Nurse Pract, V18, P51
   ENGEBRETSON J, 1992, THESIS U TEXAS HOUST
   English-Lueck J. A., 1990, HLTH NEW AGE STUDY C
   EVANS RG, 1994, WHY SOME PEOPLE HLTH
   Foster George, 1978, MED ANTHR
   Freund PES, 1991, HLTH ILLNESS SOCIAL
   Fuller Robert C, 1989, ALTERNATIVE MED AM R
   GOOD B, 1994, MED RATIONALITY EXPE
   GROSSINGER R, 1990, PLANET MED
   Guba EB, 1989, 4 GENERATION EVALUAT
   HORGAN J, 1955, END SCI FACING LIMIT
   KALWEIT H, 1987, SHAMANS HEALERS MED
   KAPTCHUK TJ, 1983, WEB THAT HAS NO WEAV
   Kiev Ari, 1964, MAGIC FAITH HEALING
   KONNER M, 1987, BECOMING DOCTOR JOUR
   Lavine T. Z., 1984, SOCRATES SARTRE PHIL
   LEVIN JS, 1986, SOC SCI MED, V23, P889, DOI 10.1016/0277-9536(86)90217-0
   Lloyd J, 1996, J MANAGE ENG, V12, P5, DOI 10.1061/(ASCE)0742-597X(1996)12:6(5.3)
   LOCK M, MED ANTHR CONT THEOR, P90
   Lock M, 1988, BIOMEDICINE EXAMINED
   McGuire M., 1988, RITUAL HEALING SUBUR
   Morris B., 1987, ANTHR STUDIES RELIG
   NEEDLEMAN J, 1982, INDESTRUCTIBLE QUEST
   ORTHGOMER K, 1996, BEHAV MED APPROACHES
   Russell B., 1959, WISDOM W
   SCHNEIDERMAN N, 1992, PERSPECTIVES BEHAV M
   Snow CP, 1959, 2 CULTURES
   STARR P, 1949, SOCIAL TRANSFORMATIO
   STEIN HF, 1990, AM MED CULTURE
   TARNAS R, 1991, PASSION W WORLD UNDE
   Whorton J., 1982, CRUSADERS FITNESS HI
NR 42
TC 4
Z9 4
U1 0
U2 0
PU INNOVISION COMMUNICATIONS
PI ALISO VIEJO
PA 101 COLUMBIA, ALISO VIEJO, CA 92656 USA
SN 1078-6791
J9 ALTERN THER HEALTH M
JI Altern. Ther. Health Med.
PD MAR
PY 1998
VL 4
IS 2
BP 37
EP 43
PG 7
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 141ZL
UT WOS:000077175400014
PM 9682510
DA 2018-10-19
ER

PT J
AU Burns, NL
   Emoto, K
   Holmberg, K
   Van Alstine, JM
   Harris, JM
AF Burns, NL
   Emoto, K
   Holmberg, K
   Van Alstine, JM
   Harris, JM
TI Surface characterization of biomedical materials by measurement of
   electroosmosis
SO BIOMATERIALS
LA English
DT Article
DE biocompatible; coatings; electrophoresis; electroosmosis; polymer;
   poly(ethylene glycol); surface analysis
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; PLASMA POLYMER SURFACES;
   POLY(ETHYLENE GLYCOL); PROTEIN ADSORPTION; POLYSTYRENE SURFACES;
   PELLICLE FORMATION; SILICA; COATINGS; DEXTRAN; QUARTZ
AB This paper reviews recent studies by the authors on the surface characterization of biomedically significant materials through electroosmosis determination. The surfaces studied include transparent and nontransparent materials such as quartz, ceramics, paper, and cast polymer capillaries, slides, and particles, in both native and surface modified form. The method is nondestructive, relatively fast, mechanistically simple, automatable to varying degrees, and can be used to analyze samples under physiologically compatible conditions. New experimental and mathematical modeling approaches allow estimates to be obtained with regard to the surface density and pK of various chemical groups, as well as the thickness of polymer or other surface coatings. Surface modifications which may be characterized include, covalent alteration via radiofrequency plasma discharge or organosilane grafting, noncovalent alteration via polymer adsorption, and covalent grafting of neutral polymers, such as poly(ethylene glycol) or dextran. Results complement those from other surface analysis techniques, and correlate with physiologically significant phenomena such as protein adsorption. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
C1 Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
   Inst Surface Chem, S-11486 Stockholm, Sweden.
   Univ Alabama, Mat Sci Program, Huntsville, AL 35899 USA.
   Royal Inst Technol, Dept Chem Engn, S-10044 Stockholm, Sweden.
   Royal Inst Technol, Dept Biotechnol, S-10044 Stockholm, Sweden.
RP Van Alstine, JM (reprint author), Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
CR ANDERSON DJ, 1995, ANAL CHEM, V67, pR475, DOI 10.1021/ac00108a032
   ANDRADE JD, 1988, DYNAMIC ASPECTS POLY
   BALE MD, 1988, J COLLOID INTERF SCI, V125, P516, DOI 10.1016/0021-9797(88)90017-3
   BastosGonzalez D, 1996, J COLLOID INTERF SCI, V177, P372, DOI 10.1006/jcis.1996.0046
   BATTJES KP, SILANES OTHER COUPLI, V199, P92
   BAUER J, 1987, J CHROMATOGR-BIOMED, V418, P359, DOI 10.1016/0378-4347(87)80015-4
   Bergstrom L., 1992, THESIS ROYAL I TECHN
   BOYCE JF, 1992, J COLLOID INTERF SCI, V149, P153, DOI 10.1016/0021-9797(92)90400-G
   BRINK C, 1992, COLLOID SURFACE, V66, P149, DOI 10.1016/0166-6622(92)80131-K
   BROOKS DE, 1973, J COLLOID INTERF SCI, V43, P714, DOI 10.1016/0021-9797(73)90416-5
   Burns NL, 1996, J COLLOID INTERF SCI, V183, P249, DOI 10.1006/jcis.1996.0540
   BURNS NL, 1995, LANGMUIR, V11, P2768, DOI 10.1021/la00007a070
   Burns NL, 1996, J COLLOID INTERF SCI, V178, P116, DOI 10.1006/jcis.1996.0099
   CHURAEV NV, 1995, J COLLOID INTERF SCI, V169, P300, DOI 10.1006/jcis.1995.1037
   CLAESSON PM, 1997, IN PRESS COLLOIDS A
   DEBACHER N, 1992, COLLOID SURFACE, V65, P51, DOI 10.1016/0166-6622(92)80174-Z
   DOREN A, 1989, J COLLOID INTERF SCI, V130, P146, DOI 10.1016/0021-9797(89)90085-4
   DUNSTAN DE, 1994, J CHEM SOC FARADAY T, V90, P1261, DOI 10.1039/ft9949001261
   EKDAHL KN, 1993, J COLLOID INTERF SCI, V158, P121, DOI 10.1006/jcis.1993.1236
   Emoto K, 1996, ANAL CHEM, V68, P3751, DOI 10.1021/ac960114m
   EMOTO K, 1997, IN PRESS LANGMUIR
   EMOTO K, 1996, IN PRESS ANAL CHEM
   EREMENKO BV, 1974, COLLOID J USSR+, V36, P240
   GILGES M, 1994, ANAL CHEM, V66, P2038, DOI 10.1021/ac00085a019
   GROSSMAN PD, 1992, CAPILLARY ELECTROPHO, P3
   HARRIS JM, 1984, J POLYM SCI POL CHEM, V22, P341, DOI 10.1002/pol.1984.170220207
   HARRIS JM, 1987, DYNAMIC ASPECTS POLY, P111
   HARRIS JM, 1992, POLYETHYLENE GYLCOL
   HEALY TW, 1978, ADV COLLOID INTERFAC, V9, P303, DOI 10.1016/0001-8686(78)85002-7
   HERREN BJ, 1987, J COLLOID INTERF SCI, V115, P46, DOI 10.1016/0021-9797(87)90007-5
   HLADY V, 1985, SURFACE INTERFACIAL, V2, P109
   Hommel H, 1996, COLLOID SURFACE A, V111, P67, DOI 10.1016/0927-7757(96)03516-9
   Hunter R. J, 1981, ZETA POTENTIAL COLLO
   James R.O., 1982, SURFACE COLLOID SCI, V12
   KNOX RJ, 1996, IN PRESS ANAL CHEM
   KOHLER J, 1987, J CHROMATOGR, V385, P125, DOI 10.1016/S0021-9673(01)94628-X
   KOOPAL LK, 1988, J COLLOID INTERF SCI, V121, P49, DOI 10.1016/0021-9797(88)90407-9
   LASSEN B, 1994, J MATER SCI-MATER M, V5, P662, DOI 10.1007/BF00120352
   Lin Y S, 1994, Colloids Surf B Biointerfaces, V3, P49, DOI 10.1016/0927-7765(93)01114-7
   LYKLEMA J, 1985, SURFACE INTERFACIAL, V1, P293
   MAKINO K, 1995, J COLLOID INTERF SCI, V174, P400, DOI 10.1006/jcis.1995.1407
   Malmsten M, 1996, COLLOID SURFACE B, V6, P191, DOI 10.1016/0927-7765(95)01255-9
   Malmsten M, 1996, J COLLOID INTERF SCI, V178, P123, DOI 10.1006/jcis.1996.0100
   Malmsten M, 1996, J COLLOID INTERF SCI, V177, P502, DOI 10.1006/jcis.1996.0064
   MATSON RS, 1994, ANAL BIOCHEM, V217, P306, DOI 10.1006/abio.1994.1123
   NORDE W, 1985, SURFACE INTERFACIAL, V2, P293
   NORDT FJ, 1976, ACS SYM SER, V31, P225
   OLSSON J, 1995, COLLOID SURFACE B, V5, P161, DOI 10.1016/0927-7765(95)01212-2
   ONEILL K, 1994, ANAL BIOCHEM, V222, P185, DOI 10.1006/abio.1994.1471
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   PRATTTERPSTRA IH, 1989, J DENT RES, V68, P463, DOI 10.1177/00220345890680030501
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   RUSSEL WB, 1989, COLLOIDAL DISPERSION, P211
   SCALES PJ, 1992, LANGMUIR, V8, P965, DOI 10.1021/la00039a037
   SEAMAN GVF, 1975, RED BLOOD CELL, V1, P1135
   SHARP KA, 1985, BIOPHYS J, V47, P563, DOI 10.1016/S0006-3495(85)83951-5
   THOMAS V, 1993, COLLOID SURFACE A, V77, P125, DOI 10.1016/0927-7757(93)80109-R
   TOWNS JK, 1990, J CHROMATOGR, V516, P69, DOI 10.1016/S0021-9673(01)90205-5
   VANALSTINE JM, 1993, COLLOID SURFACE A, V77, P149, DOI 10.1016/0927-7757(93)80111-Q
   VANALSTINE JM, Patent No. 5108568
   VANALSTINE JM, 1993, ACS SYM SER, P293
   VANALSTINE JM, Patent No. 4690749
   VANDENBERG ET, 1991, J COLLOID INTERF SCI, V147, P103, DOI 10.1016/0021-9797(91)90139-Y
   XU B, 1988, J CHROMATOGR, V445, P1, DOI 10.1016/S0021-9673(01)84504-0
   ZALIPSKY S, 1992, BIOTECHNOL APPL BIOC, V15, P100, DOI 10.1111/j.1470-8744.1992.tb00198.x
NR 66
TC 15
Z9 15
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1998
VL 19
IS 4-5
BP 423
EP 440
DI 10.1016/S0142-9612(97)00225-1
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ZP913
UT WOS:000073794900010
PM 9677155
DA 2018-10-19
ER

PT J
AU Brook, IM
   Hatton, PV
AF Brook, IM
   Hatton, PV
TI Glass-ionomers: bioactive implant materials
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT 1st European Union Conference on Glass-Ionomers
CY MAY 14-16, 1997
CL UNIV WARWICK, WARWICK, ENGLAND
HO UNIV WARWICK
DE glass-ionomer cement; bone cements; biocompatibility
ID PERIPHERAL-NERVE FUNCTION; ACRYLIC BONE CEMENTS; OTOLOGIC SURGERY;
   DIFFERENTIATION INVIVO; TRICALCIUM PHOSPHATE; FLUORIDE; INVITRO;
   ALUMINUM; PROLIFERATION; INTERFACE
AB Glass-ionomer cements (GICs) originally designed for use as dental materials have a number of advantages over acrylic bone cements. These include lack of exotherm during setting, absence of monomer and improved release of incorporated therapeutic agents; this has resulted in the development of GICs for biomedical applications. Major landmarks in this history are the formulation of defined-composition ionomer glasses and an improved understanding of the biological and material properties of GICs. Following implantation, GICs can form a stable integration with bone, and affect the growth and development of bone, both adjacent to their surface and systemically, through an ion release mechanism. The 'non-inert' nature of this group of materials is also demonstrated by their adverse effects on neural tissue. Successful clinical use of GICs, both as bone cements and as preformed implants for hard tissue replacement, have been reported in the fields of otologic surgery (Cochlear implant fixation, repair of the tympanic chain, eustation tube obliteration and as ear ossicles), and oral and reconstructive surgery. The use of GICs in situations where they will come into contact with nerves or neural tissue is contraindicated. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
C1 Univ Sheffield, Sch Clin Dent, Biomat Res Grp, Sheffield S10 2TA, S Yorkshire, England.
RP Brook, IM (reprint author), Univ Sheffield, Sch Clin Dent, Biomat Res Grp, Claremont Crescent, Sheffield S10 2TA, S Yorkshire, England.
EM i.brook@sheffield.ac.uk
OI Hatton, Paul/0000-0001-5234-1104
CR Babighian G, 1994, Acta Otorhinolaryngol Ital, V14, P107
   BABIGHIAN G, 1992, J LARYNGOL OTOL, V106, P954, DOI 10.1017/S0022215100121450
   BAGAMBISA FB, 1993, J BIOMED MATER RES, V27, P1047, DOI 10.1002/jbm.820270810
   BAGAMBISA FB, 1994, J CRANIO MAXILL SURG, V22, P12, DOI 10.1016/S1010-5182(05)80290-2
   BAKER AS, 1988, J BONE JOINT SURG AM, V70A, P1551, DOI 10.2106/00004623-198870100-00015
   BLUMENTHAL NC, 1984, CALCIFIED TISSUE INT, V36, P438
   BODELL SM, 1993, J DENT RES, V73, P740
   BRADEN M, 1988, Patent No. 47916150
   BROOK I M, 1991, Clinical Materials, V7, P295, DOI 10.1016/0267-6605(91)90073-O
   BROOK IM, 1992, BIOMATERIALS, V13, P721, DOI 10.1016/0142-9612(92)90134-A
   BROOK IM, 1991, BIOMATERIALS, V12, P179, DOI 10.1016/0142-9612(91)90197-I
   BROOK IM, 1994, P 11 EUR C BIOM 13 1, P466
   CARTER DH, 1991, J HISTOCHEM CYTOCHEM, V39, P599, DOI 10.1177/39.5.1707904
   CHARNLEY J, 1970, ACRYLIC CEMENT ORTHO, V33
   CHARNLEY J, 1961, LANCET, V1, P129
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   DEVLIN AJ, 1994, PUB TIPOGRAFIA VIGO, P459
   DOHERTY P J, 1991, Clinical Materials, V7, P335, DOI 10.1016/0267-6605(91)90078-T
   FARLEY JR, 1983, SCIENCE, V222, P330
   FISCHER AA, 1986, CUTIS, V37, P425
   FORSTEN L, 1991, SCAND J DENT RES, V99, P241
   GEYER G, 1993, EUR ARCH OTO-RHINO-L, V250, P253
   Geyer G, 1992, Eur Arch Otorhinolaryngol Suppl, V1, P185
   GEYER G, 1990, ADV BIOMATER, V10, P529
   GOODMAN WG, 1991, KIDNEY INT, V39, P602, DOI 10.1038/ki.1991.71
   GOODMAN WG, 1985, AM J KIDNEY DIS, V6, P330, DOI 10.1016/S0272-6386(85)80089-5
   Gross U, 1987, BIOMATERIALS CLIN AP, P547
   HATTON PV, 1992, BRIT DENT J, V173, P275, DOI 10.1038/sj.bdj.4808026
   HATTON PV, 1992, MICRON MICROSC ACTA, V23, P363
   HELMS J, 1994, J LARYNGOL OTOL, V108, P202
   HILL RG, 1995, P CERMAICS CELLS TIS
   JARCHO M, 1977, J BIOENG, V1, P79
   JOHAL K, 1995, J MAT SCI MED, V7, P690
   JOHAL K, 1996, J DENT RES, V75, P325
   JONCK L M, 1990, Clinical Materials, V6, P323, DOI 10.1016/0267-6605(90)90052-W
   JONCK LM, 1989, CLIN MAT, V4, P201, DOI DOI 10.1016/0267-6605(89)90030-9
   JONCK LM, 1989, CLIN MATER, V4, P85
   KAVANAGH BF, 1987, J BONE JOINT SURG AM, V69A, P1144, DOI 10.2106/00004623-198769080-00006
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   LAU KHW, 1991, MOL CELL BIOCHEM, V105, P93
   LOESCHER AR, 1994, J MATER SCI-MATER M, V5, P551, DOI 10.1007/BF00124888
   LOESCHER AR, 1994, J MATER SCI-MATER M, V5, P108, DOI 10.1007/BF00121699
   LUNDY MW, 1986, BONE, V7, P289, DOI 10.1016/8756-3282(86)90210-3
   MACKIE EJ, 1987, J CELL BIOL, V105, P2569, DOI 10.1083/jcb.105.6.2569
   MALLAKH BF, 1990, DENT MATER, V6, P118
   MCCLEAN JW, 1988, BR DENT J, V164, P293
   MCELVEEN JT, 1994, OTOLARYNG CLIN N AM, V27, P777
   MEHTA S, 1995, BIOMATERIALS, V16, P97, DOI 10.1016/0142-9612(95)98269-K
   MEYER U, 1993, BIOMATERIALS, V14, P917, DOI 10.1016/0142-9612(93)90133-M
   MULLER J, 1993, LARYNGO RHINO OTOL, V72, P36, DOI 10.1055/s-2007-997850
   MULLER J, 1994, LARYNGO RHINO OTOL, V73, P160, DOI 10.1055/s-2007-997102
   NICHOLSON J W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P277, DOI 10.1163/156856291X00179
   NORDENVALL KJ, 1992, SWED DENT J, V6, P87
   PAK CYC, 1989, J CLIN ENDOCR METAB, V68, P150, DOI 10.1210/jcem-68-1-150
   PATEL MP, 1991, BIOMATERIALS, V12, P653, DOI 10.1016/0142-9612(91)90112-N
   QUARLES LD, 1991, MINER ELECTROL METAB, V17, P233
   QUARLES LD, 1990, J BONE MINER RES, V5, P625
   RAMSDEN RT, 1995, ADV OTO-RHINO-LARYNG, V50, P51
   RAMSDEN RT, 1992, J LARYNGOL OTOL, V106, P949, DOI 10.1017/S0022215100121449
   RENARD JL, 1994, LANCET, V344, P63, DOI 10.1016/S0140-6736(94)91089-8
   REUSCHE E, 1994, LANCET, V345, P1633
   SASANALUCKIT P, 1993, BIOMATERIALS, V14, P906, DOI 10.1016/0142-9612(93)90132-L
   SOGAARD CH, 1995, BONE, V16, P163, DOI 10.1016/S8756-3282(94)00025-5
   SZULCZEWSKI DH, 1993, CELL MATER, V3, P83
   TALLROTH K, 1989, J BONE JOINT SURG BR, V71, P571
   TURNER RT, 1989, J BONE MINER RES, V4, P477
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   WEISS RE, 1981, EXP CELL RES, V133, P247, DOI 10.1016/0014-4827(81)90316-5
   WILSON AD, 1973, Patent No. 1316129
   WILSON AD, 1988, GLASS IONOMER CEMENT
   WITTWER C, 1994, J MATER SCI-MATER M, V5, P711, DOI 10.1007/BF00120362
   WOOD D, 1991, Clinical Materials, V7, P301, DOI 10.1016/0267-6605(91)90074-P
NR 72
TC 83
Z9 86
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1998
VL 19
IS 6
BP 565
EP 571
DI 10.1016/S0142-9612(98)00138-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ZR149
UT WOS:000073942300013
PM 9645564
DA 2018-10-19
ER

PT J
AU Jones, R
   Barry, NP
   Hyde, SCW
   Tziraki, M
   Dainty, JC
   French, PMW
   Nolte, DD
   Kwolek, KM
   Melloch, MR
AF Jones, R
   Barry, NP
   Hyde, SCW
   Tziraki, M
   Dainty, JC
   French, PMW
   Nolte, DD
   Kwolek, KM
   Melloch, MR
TI Real-time 3-D holographic imaging using photorefractive media including
   multiple-quantum-well devices
SO IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS
LA English
DT Article; Proceedings Paper
CT Meeting on Ultrafast Optics
CY 1997
CL MONTEREY, CALIFORNIA
DE biomedical infrared imaging; holography; photorefractive materials
ID OPTICAL COHERENCE TOMOGRAPHY; HIGHLY SCATTERING MEDIA; DIFFUSING MEDIA;
   THICK TISSUES; AMPLIFICATION
AB We discuss a real-time coherence gated three-dimensional (3-D) imaging system, based on photorefractive holography with ultrashort pulses, which has been applied to imaging through turbid media with a view to developing biomedical instrumentation. Sub-100-mu m depth-resolved images of 3-D objects embedded in a scattering medium have been obtained. Using a long integration time in rhodium-doped barium titanate (Rh:BaTiO3), an image of a test chart has been obtained through 16 mean-free paths of scattering medium. Real-time depth-resolved imaging through 13 mean free paths of scattering medium has been demonstrated using a fast response time (< 0.4 ms) photorefractive multiple quantum well device. This latter system can acquire depth-resolved images direct to video with no requirement for frame grabbing or signal processing. We discuss the tradeoffs and limitations of these photorefractive media for this application.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Phys, Femtosecond Opt Grp, London SW7 2BZ, England.
   Univ Illinois, Fluorescence Dynam Lab, Urbana, IL 61801 USA.
   Purdue Univ, W Lafayette, IN 47907 USA.
RP Jones, R (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Phys, Femtosecond Opt Grp, London SW7 2BZ, England.
CR ABRAMSON N, 1978, OPT LETT, V3, P121, DOI 10.1364/OL.3.000121
   ANDERSON GE, 1994, OPT LETT, V19, P981, DOI 10.1364/OL.19.000981
   CHEN H, 1991, OPT LETT, V16, P487, DOI 10.1364/OL.16.000487
   CHERNIKOV SV, 1997, P CLEO 97, P83
   DAS BB, 1993, OPT LETT, V18, P1092, DOI 10.1364/OL.18.001092
   DILWORTH DS, 1991, APPL OPTICS, V30, P1796, DOI 10.1364/AO.30.001796
   HEE MR, 1993, OPT LETT, V18, P1107, DOI 10.1364/OL.18.001107
   HEE MR, 1993, OPT LETT, V18, P950, DOI 10.1364/OL.18.000950
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   HYDE SCW, 1995, OPT LETT, V20, P2330, DOI 10.1364/OL.20.002330
   Hyde SCW, 1996, IEEE J SEL TOP QUANT, V2, P965, DOI 10.1109/2944.577323
   HYDE SCW, 1995, OPT LETT, V20, P1331, DOI 10.1364/OL.20.001331
   Jones R, 1996, APPL PHYS LETT, V69, P1837, DOI 10.1063/1.117450
   KNUTTEL A, 1994, OPT LETT, V19, P302, DOI 10.1364/OL.19.000302
   LEITH EN, 1991, OPT LETT, V16, P1820, DOI 10.1364/OL.16.001820
   MAMAEV AV, 1993, P C LAS EL, P632
   MELLISH R, 1995, OPT LETT, V20, P2312, DOI 10.1364/OL.20.002312
   MILLER DAB, 1984, PHYS REV LETT, V53, P2173, DOI 10.1103/PhysRevLett.53.2173
   MOON JA, 1994, OPT LETT, V19, P1234, DOI 10.1364/OL.19.001234
   NOLTE DD, 1990, J OPT SOC AM B, V7, P2217, DOI 10.1364/JOSAB.7.002217
   NOLTE DD, 1995, PHOTOREFRACTIVE EFFE, pCH7
   PARTOVI A, 1993, OPT LETT, V18, P906, DOI 10.1364/OL.18.000906
   REBANE A, 1991, NATURE, V351, P378, DOI 10.1038/351378a0
   ROWE MP, 1995, OPT LETT, V20, P608, DOI 10.1364/OL.20.000608
   SPEARS KG, 1989, IEEE T BIO-MED ENG, V36, P1210, DOI 10.1109/10.42116
   WANG Q, 1992, J OPT SOC AM B, V9, P1626, DOI 10.1364/JOSAB.9.001626
   WATSON J, 1995, OPT LETT, V20, P231, DOI 10.1364/OL.20.000231
   YOO KM, 1991, OPT LETT, V16, P1019, DOI 10.1364/OL.16.001019
NR 28
TC 13
Z9 13
U1 0
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1077-260X
J9 IEEE J SEL TOP QUANT
JI IEEE J. Sel. Top. Quantum Electron.
PD MAR-APR
PY 1998
VL 4
IS 2
BP 360
EP 369
DI 10.1109/2944.686743
PG 10
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA ZV019
UT WOS:000074260200026
DA 2018-10-19
ER

PT J
AU Udelson, D
   Nehra, A
   Hatzichristou, DG
   Azadzoi, K
   Moreland, RB
   Krane, J
   de Tejada, IS
   Goldstein, I
AF Udelson, D
   Nehra, A
   Hatzichristou, DG
   Azadzoi, K
   Moreland, RB
   Krane, J
   de Tejada, IS
   Goldstein, I
TI Engineering analysis of penile hemodynamic and structural-dynamic
   relationships: Part I - Clinical implications of penile tissue
   mechanical properties
SO INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
LA English
DT Article
DE penile rigidity; erectile physiology; impotence; biomedical engineering;
   tissue mechanical properties
ID CLINICOPATHOLOGICAL CORRELATION; IMPOTENCE; ERECTION
AB Purpose: The least investigated physical determinant of penile rigidity has been penile tissue material properties. The goals in this study (Part I) were to define two penile mechanical parameters, cavernosal expandability X and tunical distensibility V-E/V-F, determine their magnitudes in humans and develop an analytical expression for penile volume as a function of these two tissue characteristics and intracavernosal pressure.
   Methods: Dynamic infusion pharmacocavernosometry was performed in 21 impotent patients (age 43+/-19y) to provide human geometric, hemodynamic and structural data. A mathematically derived model of hemodynamic and structural-dynamic characteristics of penile erection was developed (Parts I, II, III) incorporating penile tissue mechanical qualities.
   Results: Cavernosal expandability X provided a measure of the ability to approach maximum volume at relatively low intracavernosal pressures. Tunical distensibility V-E/V-F denoted the maximal erect to flaccid penile volume ratio. The magnitudes of X and V-E/V-F in the study population were 0.04-0.17 mmHg(-1) and 1.7-5.0 respectively.
   Conclusions: Enabling penile volume to be derived as a function of tissue mechanical characteristics and pressure, allows for penile rigidity to be expressed (in Part II) as a function of pressure, geometry and tissue qualities.
C1 Boston Univ, Sch Med, Dept Urol, Boston, MA 02118 USA.
   Boston Univ, Coll Engn, Dept Aerosp & Mech Engn, Boston, MA 02215 USA.
RP Goldstein, I (reprint author), Boston Univ, Sch Med, Dept Urol, 720 Harrison Ave,P606, Boston, MA 02118 USA.
FU NIDDK NIH HHS [DK-39080, DK-40025, DK-40487]
CR BEER FP, 1992, MECH MATER, P77
   Bondil P, 1990, INT J IMPOT RES, V2, P193
   CHAUDHOKE PS, 1989, INT J IMPOT RES, V1, P137
   DETEJADA IS, 1991, AM J PHYSIOL, V260, pH1590
   DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83
   FREIDENBERG DH, 1987, J UROLOGY, V138, P533, DOI 10.1016/S0022-5347(17)43251-4
   FROHRIB DA, 1987, J BIOMECH ENG-T ASME, V109, P110, DOI 10.1115/1.3138651
   HALL SJ, 1995, J UROLOGY, V153, P372, DOI 10.1097/00005392-199502000-00023
   HATZICHRISTOU DG, 1995, J UROLOGY, V153, P1126, DOI 10.1016/S0022-5347(01)67530-X
   KRANE RJ, 1989, NEW ENGL J MED, V321, P1648, DOI 10.1056/NEJM198912143212406
   LUE TF, 1984, UROLOGY, V24, P347, DOI 10.1016/0090-4295(84)90208-5
   NEHRA A, 1995, J UROLOGY, V153, P1140, DOI 10.1016/S0022-5347(01)67533-5
   Nehra A, 1996, J UROLOGY, V156, P1320, DOI 10.1016/S0022-5347(01)65578-2
   NELSON RP, 1989, J UROLOGY, V141, P1123, DOI 10.1016/S0022-5347(17)41188-8
   OLSON, 1990, ESS ENG FLUID MECH, P314
   PUECHLEAO P, 1992, INT J IMPOT RES S2, V4, P43
   Udelson Daniel, 1995, Journal of Urology, V153, p332A
   WESPES E, 1984, BRIT J UROL, V56, P416, DOI 10.1111/j.1464-410X.1984.tb05834.x
   WESPES E, 1990, INT J IMPOT RES, V2, P228
NR 19
TC 50
Z9 52
U1 0
U2 0
PU STOCKTON PRESS
PI BASINGSTOKE
PA HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND
SN 0955-9930
J9 INT J IMPOT RES
JI Int. J. Impot. Res.
PD MAR
PY 1998
VL 10
IS 1
BP 15
EP 24
DI 10.1038/sj.ijir.3900310
PG 10
WC Urology & Nephrology
SC Urology & Nephrology
GA ZB678
UT WOS:000072496600004
PM 9542686
OA Bronze
DA 2018-10-19
ER

PT J
AU Hughes, PSH
   Hughes, AP
AF Hughes, PSH
   Hughes, AP
TI Absence of human papillomavirus DNA in the plume of erbium : YAG
   laser-treated warts
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Article
ID CARBON-DIOXIDE LASER; ABLATION; VAPOR
AB Bnckground: The erbium:YAG laser (Continuum Biomedical, Dublin, Calif.) is a new resurfacing and ablating laser that produces minimal residual thermal damage. Laser safety requires careful attention to the hazards of the laser plume. It is important to know whether viable organisms survive in the vapors. Human papillomavirus (HPV) DNA has been detected in the vapor of carbon dioxide laser-treated and electrodesiccated human warts. The presence or absence of HPV DNA in the laser plume of erbium:YAG laser-treated warts has not been previously studied to out knowledge,
   Objective: Our purpose was to determine the presence or absence of HPV DNA in the laser plume of erbium:YAG laser-treated human warts.
   Methods: One half of clinically typical and histopathologically confirmed verrucae vulgares from five patients were submitted for HPV DNA detection with in situ hybridization. After erbium:YAG laser ablation of the remainder of the warts, the laser plume was deposited on the handpiece as an abundant fluffy material and was submitted for evaluation of HPV DNA by polymerase chain reaction with consensus primers for the HPV type detected in the wart specimens.
   Results: HPV2 DNA was found in all warts. HPV DNA was not detected in the erbium:YAG laser plume after ablation of these same warts.
   Conclusion: The absence of HPV DNA in the plume of erbium:YAG laser-treated warts is a significant safety feature of this laser.
C1 Vanderbilt Univ, Nashville, TN USA.
CR Fitzpatrick RE, 1996, ARCH DERMATOL, V132, P469, DOI 10.1001/archderm.132.4.469
   GAGLIANO FP, 1974, APPL OPTICS, V13, P274, DOI 10.1364/AO.13.000274
   GARDEN JM, 1988, JAMA-J AM MED ASSOC, V259, P1199, DOI 10.1001/jama.259.8.1199
   Hohenleutner U, 1997, LASER SURG MED, V20, P242, DOI 10.1002/(SICI)1096-9101(1997)20:3<242::AID-LSM2>3.0.CO;2-Q
   HRUZA GJ, 1993, ARCH DERMATOL, V129, P1026, DOI 10.1001/archderm.129.8.1026
   KAUFMANN R, 1990, CLIN EXP DERMATOL, V15, P389, DOI 10.1111/j.1365-2230.1990.tb02125.x
   Majewski S, 1997, J AM ACAD DERMATOL, V36, P659, DOI 10.1016/S0190-9622(97)80315-5
   SAWCHUK WS, 1989, J AM ACAD DERMATOL, V21, P41, DOI 10.1016/S0190-9622(89)70146-8
   Teikemeier G, 1997, DERMATOL SURG, V23, P685, DOI 10.1111/j.1524-4725.1997.tb00389.x
   TREVOR M, 1987, HOSP INFECT CONTROL, P166
   WALSH JT, 1989, LASER SURG MED, V9, P314, DOI 10.1002/lsm.1900090403
   WALSH JT, 1988, THESIS MIT ARCH CAMB
   YANG CC, 1995, ANN PLAS SURG, V35, P154, DOI 10.1097/00000637-199508000-00007
NR 13
TC 28
Z9 29
U1 0
U2 3
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD MAR
PY 1998
VL 38
IS 3
BP 426
EP 428
DI 10.1016/S0190-9622(98)70500-6
PG 3
WC Dermatology
SC Dermatology
GA ZB160
UT WOS:000072442400006
PM 9520024
DA 2018-10-19
ER

PT J
AU Wang, Y
   Khor, KA
   Cheang, P
AF Wang, Y
   Khor, KA
   Cheang, P
TI Thermal spraying of functionally graded calcium phosphate coatings for
   biomedical implants
SO JOURNAL OF THERMAL SPRAY TECHNOLOGY
LA English
DT Article
DE alpha-tricalcium phosphate; calcium phosphates; functionally graded
   materials (FGM); hydroxyapatite; plasma spraying
ID HYDROXYAPATITE COATINGS; COATED IMPLANTS; TITANIUM; FABRICATION; BONE
AB Biomedical requirements in a prosthesis are often complex and diverse in nature. Biomaterials for implants have to display a wide range adaptability to suit the various stages of the bio-integration process of any foreign material into the human body, Often, a combination of materials is needed. The preparation of a functionally graded bioceramic coating composed of essentially calcium phosphate compounds is explored. The coating is graded in accordance to adhesive strength, bioactivity, and bioresorbability. The bond coat on the Ti-6Al-4V stub is deposited with a particle range of the hydroxyapatite (HA) that will provide a high adhesive strength and bioactivity but have poor bioresorption properties. The top coat, however, is composed of predominantly alpha-tricalcium phosphate (alpha-TCP) that is highly bioresorbable. This arrangement has the propensity of allowing accelerated bio-integration of the coating by the body tissues as the top layer is rapidly resorbed, leaving the more bioactive intermediate layer to facilitate the much needed bioactive properties for proper osteoconduction. The processing steps and problems are highlighted, as well as the results of post-spray heat treatment.
C1 Nanyang Technol Univ, Singapore 639798, Singapore.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR BERNDT CC, 1992, THERMAL SPRAY : INTERNATIONAL ADVANCES IN COATINGS TECHNOLOGY, P465
   BROWN PW, 1992, J AM CERAM SOC, V75, P17, DOI 10.1111/j.1151-2916.1992.tb05435.x
   Cheang P, 1996, BIOMATERIALS, V17, P537, DOI 10.1016/0142-9612(96)82729-3
   CLAES L, 1990, HDB BIOACTIVE CERAMI, V2, P77
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   EVANS SL, 1994, J MATER SCI-MATER M, V5, P495, DOI 10.1007/BF00058990
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   GROSS KA, 1995, P 8 INT S CER MED, P361
   HARADA Y, 1989, J TOKYO DENT COLL SO, V89, P263
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HUELSMAN SW, 1994, T MRS JAP, V16, P1259
   JI HX, 1992, J MATER SCI-MATER M, V3, P283, DOI 10.1007/BF00705294
   KAWAMURA M, 1994, T MRS JAP, V16, P1251
   Khor KA, 1997, J MATER PROCESS TECH, V63, P271, DOI 10.1016/S0924-0136(96)02634-9
   KHOR KA, 1997, IN PRESS J THERM SPR
   KHOR KA, 1994, INFLUENCE POWDER CHA, P147
   KIJIMA T, 1979, J AM CERAM SOC, V62, P455, DOI 10.1111/j.1151-2916.1979.tb19104.x
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P909, DOI 10.1002/jbm.820280810
   KOIZUMI M, 1995, MRS BULL, V20, P19
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   *MILL THERM INC, 1993, OP MAN
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   PARK JB, 1984, BIOMATERIALS SCI ENG, P212
   RAVAGLIOLI A, 1992, BIOCERAMICS, P176
   REY C, 1991, BIOCERAMICS, V4, P57
   TISDEL CL, 1994, J BONE JOINT SURG AM, V76A, P159, DOI 10.2106/00004623-199402000-00001
   WANG BC, 1993, J MATER SCI-MATER M, V4, P394, DOI 10.1007/BF00122198
   YAMASHITA K, 1994, J AM CERAM SOC, V77, P2401, DOI 10.1111/j.1151-2916.1994.tb04611.x
   ZYMAN Z, 1993, BIOMATERIALS, V14, P1140, DOI 10.1016/0142-9612(93)90158-X
NR 33
TC 22
Z9 23
U1 0
U2 4
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 1059-9630
J9 J THERM SPRAY TECHN
JI J. Therm. Spray Technol.
PD MAR
PY 1998
VL 7
IS 1
BP 50
EP 57
DI 10.1007/s11666-006-5003-9
PG 8
WC Materials Science, Coatings & Films
SC Materials Science
GA ZB684
UT WOS:000072497200033
DA 2018-10-19
ER

PT J
AU Fischer, P
   Hausmann, J
   Overdick, M
   Raith, B
   Wermes, N
   Blanquart, L
   Bonzom, V
   Delpierre, P
AF Fischer, P
   Hausmann, J
   Overdick, M
   Raith, B
   Wermes, N
   Blanquart, L
   Bonzom, V
   Delpierre, P
TI A counting pixel readout chip for imaging applications
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article
DE pixels; imaging; readout chip
AB A pixel readout chip for imaging applications has been designed and tested. It consists of an array of 12 x 63 pixels with an active pixel cell area of 50 mu m x 350 mu m Every pixel contains a low-noise charge sensitive amplifier, a CMOS comparator including individually adjustable thresholds, and a 15 bit counter realized using a linear feedback shift register, During data accumulation, every pixel independently counts the number of signal hits above threshold. After accumulation all counters in a column are sequentially read out, all columns in parallel. Thresholds can be set globally with the possibility of an individual threshold adjust in every cell. The chip can be operated with threshold settings in every cell well below equivalent noise charges (ENC) of 1000 electrons. The dead time of a pixel after being hit is similar to 500 ns. The chip is alive for data accumulation in > 99.9% of the total data acquisition time. For photon counting in biomedical or material science applications, a suitable sensor with high Z material can be bump bonded to the counting chip. (C) 1998 Elsevier Science B.V. All rights reserved.
C1 Univ Bonn, Inst Phys, D-53115 Bonn, Germany.
   CNRS, IN2P3, Ctr Phys Particules, F-13288 Marseille 9, France.
RP Wermes, N (reprint author), Univ Bonn, Inst Phys, Nussallee 12, D-53115 Bonn, Germany.
EM wermes@physik.uni-bonn.de
CR ATLAS Collaboration The ATLAS Collaboration, 1994, CERNLHCC9443 ATLAS C
   *ATLAS INNER DETEC, 1997, CERNLHCC9717 ATLAS I
   Blanquart L, 1997, NUCL INSTRUM METH A, V395, P313, DOI 10.1016/S0168-9002(96)01238-7
   BLANQUART L, UNPUB NUCL INSTR A
   *BLUE BOARD, SIL SOL
   CAMPBELL M, 1994, NUCL INSTRUM METH A, V342, P52, DOI 10.1016/0168-9002(94)91410-9
   Fischer P, 1996, NUCL INSTRUM METH A, V378, P297, DOI 10.1016/0168-9002(96)00200-8
   FISCHER P, 1997, P 7 PIS M ADV DET
   FISCHER P, 1997, BONNHE9703
   Heijne EHM, 1996, NUCL INSTRUM METH A, V383, P55, DOI 10.1016/S0168-9002(96)00658-4
   HEIJNE EHM, 1994, NUCL INSTRUM METH A, V349, P138, DOI 10.1016/0168-9002(94)90617-3
   HEIJNE EHM, 1994, NUCL INSTRUM METH A, V348, P399, DOI 10.1016/0168-9002(94)90769-2
   HORISBERGER R, 1997, P 7 PIS M ADV DET EL
   HOROWITZ P, 1994, IEEE T COMPUT, V43, P560
   Watson J, 1962, MATH COMPUT, V16, P368
   WRIGHT M, 1992, P I8NT C HIGH EN PHY
NR 16
TC 27
Z9 27
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD MAR 1
PY 1998
VL 405
IS 1
BP 53
EP 59
DI 10.1016/S0168-9002(97)01146-7
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA ZD608
UT WOS:000072703600007
DA 2018-10-19
ER

PT J
AU Baglin, JEE
   Davis, JC
   Gabella, P
   Prozesky, VM
   Sie, S
AF Baglin, JEE
   Davis, JC
   Gabella, P
   Prozesky, VM
   Sie, S
TI Future analytical needs for industry and technology
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 13th International Conference on Ion Beam Analysis (IBA-13)
CY JUL 27-AUG 01, 1997
CL LISBON, PORTUGAL
DE future analytical needs; semiconductors; biomedicine; minerals;
   geoscience; PIXE; AMS; ion microbeams
AB This paper summarizes reports and opinions presented during a Roundtable Session of the same title at the 13th International Conference on Ion Beam Analysis, Lisbon, 1997, The evolution of new technologies and new fields of research is creating new demands for advanced materials analysis, often at a level not attainable with current techniques. We therefore explore some opportunities for creative development of new or enhanced ion beam techniques to satisfy major predictable needs of the future. In particular, new analytical applications are discussed for the semiconductor industry. for biomedical research, and for advanced research in minerals and geoscience. (C) 1998 Elsevier Science B.V.
C1 IBM Corp, Almaden Res Ctr, San Jose, CA 95120 USA.
   Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
   SEMATECH, SEMI, Austin, TX 78741 USA.
   Natl Accelerator Ctr, Van de Graaff Grp, ZA-7131 Faure, South Africa.
   CSIRO Explorat & Min, N Ryde, NSW 2113, Australia.
RP Baglin, JEE (reprint author), IBM Corp, Almaden Res Ctr, 650 Harry Rd,K191D1, San Jose, CA 95120 USA.
EM baglin@almaden.ibm.com
NR 0
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD MAR
PY 1998
VL 136
BP 35
EP 41
DI 10.1016/S0168-583X(97)00832-X
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA ZW154
UT WOS:000074380400005
DA 2018-10-19
ER

PT J
AU El Khoby, T
   Galal, N
   Fenwick, A
AF El Khoby, T
   Galal, N
   Fenwick, A
TI The USAID Government of Egypt's Schistosomiasis Research Project (SRP)
SO PARASITOLOGY TODAY
LA English
DT Review
ID NILE DELTA; MANSONI; ANTIGEN
AB Schistosomiasis is the major public health problem in rural Egypt, with almost six million Egyptians infected as at min 1996. lit 1983, the prevalence of schistosomiasis in rural Egypt was greater than 50%(1), but a ten-year campaign of diagnosis and treatment has reduced the prevalence and intensity of infection. Parallel to this campaign, the government of the USA has funded a research project to examine all aspects of schistosomiasis with a view to improving the control strategy. As outlined here by Taha EI Khoby, Nabil Galal and Alan Fenwick, after almost ten years, the project's achievements include: assisting WHO in its attempts to develop a vaccine against schistosomiasis, developing a suspension formulation of praziquantel suitable for young children, and establishing a unit to monitor reports of resistance to praziquantel(2,3). In addition, a large epidemiological study has established the extent of the problem in Egypt(4). Slow-release formulation of niclosamide(5), health education material for use on TV, dipstick diagnostic tests(6), and evaluation of ultrasound as a diagnostic tool have also been achieved(7-9). As the project closes, Egypt is left with an effective strategy for the control of schistosomiasis and several back-tip tools for use in the event of development of resistance to praziquantel. The Ministry of Health and Population has the basis of a Geographical Information System (GIS) unit and the country has a trained and equipped scientific community capable of biomedical research, and almost 100 scientific papers published on their work.
C1 SRP, Cairo, Egypt.
RP Fenwick, A (reprint author), SRP, 51 Wezarat El Zeraa St Agouza, Cairo, Egypt.
EM SRP@FRCU.EUN.EG
CR Al-Sherbiny M., 1996, Journal of the Egyptian German Society of Zoology, V20, P81
   Barakat R, 1995, TROP GEOGR MED, V47, P259
   Bennett JL, 1997, EXP PARASITOL, V87, P260, DOI 10.1006/expr.1997.4229
   CLINE BL, 1989, AM J TROP MED HYG, V41, P56, DOI 10.4269/ajtmh.1989.41.56
   DEJONGE N, 1988, T ROY SOC TROP MED H, V82, P591, DOI 10.1016/0035-9203(88)90523-8
   EMARA LH, 1995, P INT S CONTR REL BI, V22, P220
   Fallon PG, 1996, PARASITOL TODAY, V12, P316, DOI 10.1016/0169-4758(96)10029-6
   HASSAN MM, 1992, AM J TROP MED HYG, V46, P737, DOI 10.4269/ajtmh.1992.46.737
   Ismail M, 1996, AM J TROP MED HYG, V55, P214, DOI 10.4269/ajtmh.1996.55.214
   Katsha S, 1997, TROP MED INT HEALTH, V2, P846
   LEIPER R. T., 1915, Journal of the Royal Army Medical Corps, V25, P1
   Malone JB, 1997, PARASITOL TODAY, V13, P112, DOI 10.1016/S0169-4758(97)01009-0
   Scott JA, 1937, AM J HYG, V25, P566, DOI 10.1093/oxfordjournals.aje.a118323
   STRICKLAND GT, 1993, T ROY SOC TROP MED H, V87, P132, DOI 10.1016/0035-9203(93)90458-3
   WAHAB MFA, 1993, T R SOC TROP MED HYG, V87, P135
   WAHAB MFA, 1993, AM J GASTROENTEROL, V88, P560
   WEBBE G, 1990, T ROY SOC TROP MED H, V84, P394, DOI 10.1016/0035-9203(90)90334-B
   Yousif Fouad, 1995, Journal of Medical and Applied Malacology, V5, P69
   1987, T R SOC TROP MED HYG, V81, P1
NR 19
TC 38
Z9 39
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0169-4758
J9 PARASITOL TODAY
JI Parasitol. Today
PD MAR
PY 1998
VL 14
IS 3
BP 92
EP 96
DI 10.1016/S0169-4758(97)01206-4
PG 5
WC Parasitology
SC Parasitology
GA ZA134
UT WOS:000072332300004
PM 17040713
DA 2018-10-19
ER

PT J
AU Palmaz, JC
AF Palmaz, JC
TI Biopolymers for endovascular use
SO SEMINARS IN INTERVENTIONAL RADIOLOGY
LA English
DT Review
DE vascular polymers, properties; stent grafts; endovascular implants
ID ABDOMINAL AORTIC-ANEURYSMS; BIOMEDICAL POLYMERS; GRAFTS; STENTS;
   POLYTETRAFLUOROETHYLENE; BIOSTABILITY; POLYURETHANE; STIMULATION;
   GENERATION; ARTERIES
AB This article reviews the current status of polymeric graft materials used in stent grafts. The chemical structure, physical properties, and biological properties of polyethylene terephthalate (PET), polytetrafluoroethylene (PET), and polyurethane (PU) are described. Each polymer has specific advantages and disadvantages. Polymer thrombogenicity, porosity, tensile strength, and durability impact on endovascular applications. PTFE appears most suitable to small diameter grafts, while PET materials are used for large (>10 mm diameter) grafts. Endovascular grafts composed of PU are not currently available. The use of currently available polymeric graft materials for endovascular procedures requires careful matching of polymer properties with clinical applications.
C1 Univ Texas, Hlth Sci Ctr, San Antonio, TX 78284 USA.
RP Palmaz, JC (reprint author), Univ Texas, Hlth Sci Ctr, 7703 Floyd Curl Dr, San Antonio, TX 78284 USA.
CR Abbott W M, 1997, Semin Vasc Surg, V10, P3
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   Blum U, 1997, NEW ENGL J MED, V336, P13, DOI 10.1056/NEJM199701023360103
   BURGER K, 1972, ANN SURG, V175, P118
   CLOUSE AW, 1986, AM J PATHOL, V123, P220
   DEREUME JPE, 1997, ENDOVASCULAR SURG AO
   HAMLIN GW, 1978, BRIT J SURG, V65, P272, DOI 10.1002/bjs.1800650416
   HASTINGS GW, 1984, MACROMOLECULAR BIOMA
   *ICI ADV MAT, F1213 ICI
   KALMAN PG, 1993, J VASC SURG, V17, P531, DOI 10.1016/0741-5214(93)90154-E
   KATO N, IN PRESS JVIR
   LEIDNER J, 1983, J BIOMED MATER RES, V17, P229, DOI 10.1002/jbm.820170203
   MARIN ML, 1995, J VASC SURG, V21, P595, DOI 10.1016/S0741-5214(95)70191-5
   Marin ML, 1996, J VASC INTERV RADIOL, V7, P651, DOI 10.1016/S1051-0443(96)70823-0
   MCCLURKEN ME, 1984, J COLLOID INTERF SCI, V101, P436
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   MURPHY JG, 1992, CIRCULATION, V86, P1596, DOI 10.1161/01.CIR.86.5.1596
   Norgren L, 1997, J ENDOVASC SURG, V4, P169, DOI 10.1583/1074-6218(1997)004<0169:BRTETO>2.0.CO;2
   Palmaz F, 1996, J VASC INTERV RADIOL, V7, P657, DOI 10.1016/S1051-0443(96)70824-2
   Palmaz JC, 1995, J VASC INTERV RADIOL, V6, P879, DOI 10.1016/S1051-0443(95)71207-6
   PALMAZ JC, 1993, AM J ROENTGENOL, V160, P613, DOI 10.2214/ajr.160.3.8430566
   PALMAZ JC, 1997, LIF FDN RES IN VASC
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   SAPOVAL MR, 1995, AM J ROENTGENOL, V164, P1271, DOI 10.2214/ajr.164.5.7717245
   SNYDER WR, 1983, CLIN APPL TECHNIQUES
   SPEERSCHNEIDER CJ, 1962, J APPL PHYS, V33, P1871, DOI 10.1063/1.1728849
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Szycher M, 1991, J Biomater Appl, V6, P110, DOI 10.1177/088532829100600202
   WHITE RA, 1983, CLIN APPL TECHNIQUES
   Wilson G J, 1993, ASAIO J, V39, pM526
NR 32
TC 0
Z9 0
U1 0
U2 9
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0739-9529
J9 SEMIN INTERVENT RAD
JI Semin. Interv. Radiol.
PD MAR
PY 1998
VL 15
IS 1
BP 13
EP 19
DI 10.1055/s-2008-1057053
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 172RT
UT WOS:000078938600004
DA 2018-10-19
ER

PT J
AU Sanz-Medel, A
AF Sanz-Medel, A
TI Trace element analytical speciation in biological systems: importance,
   challenges and trends
SO SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY
LA English
DT Article
DE biological materials; speciation; state of the art; trace analysis
ID PLASMA-MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; ATOMIC
   EMISSION-SPECTROMETRY; DIRECTLY COUPLED CHROMATOGRAPHY;
   GAS-CHROMATOGRAPHY; ALUMINUM; SPECTROSCOPY; GENERATION; CHEMISTRY;
   MEDICINE
AB Speciation of trace elements is a relatively new field and it was in toxicology that the relationship between the chemical form of a metal and its harmful effects was first recognized. The present need for chemical speciation information in biochemistry bioinorganic and clinical chemistry is documented in an attempt to justify the present demand for innovative chemical speciation strategies and analytical technologies.
   The challenge and complexity of speciation is stressed and three different categories of analytical speciation of increasing analytical difficulty are proposed. Analytical strategies developed so far to try to tackle speciation problems (computational approaches, direct species-specific and hybrid techniques) are reviewed and critically assessed for biological materials. It is indisputable these days that in most cases of real-life analytical speciation we have to resort to the development and use of hybrid techniques combining an adequate separation technique for the species physical separation and an element specific detector such as those based in atomic spectrometry. Examples of such strategies, as developed mainly in the author's laboratory and including chromatographic and non-chromatographic type hybrid strategies coupled to flame, plasma and electrothermal vaporization atomic detectors, are discussed in more detail.
   Finally, in light of the latest trends observed in this new held, the author attempts to cast a forward look into the foreseeable future of analytical speciation research in biological and biomedical sciences. The urgent plea for quality assurance in nonroutine analysis and the concept of using complementary analytical techniques and definitive methods to attack the complexity of chemical speciation in biological systems are particularly highlighted. (C) 1998 Elsevier Science B.V.
C1 Univ Oviedo, Fac Chem, Dept Phys & Analyt Chem, E-33006 Oviedo, Spain.
RP Sanz-Medel, A (reprint author), Univ Oviedo, Fac Chem, Dept Phys & Analyt Chem, C Julian Claveria 8, E-33006 Oviedo, Spain.
OI /0000-0003-2899-1347
CR *ATOM SPECTR UPD, 1996, J ANAL AT SPECTR APR
   BARNES RM, 1993, ANAL CHIM ACTA, V283, P115, DOI 10.1016/0003-2670(93)85214-5
   BEHNE D, 1995, ANALYST, V120, P823, DOI 10.1039/an9952000823
   BERG JM, 1990, J BIOL CHEM, V265, P6513
   CAMARA C, 1995, QUALITY ASSURANCE EN, pCH7
   CARUSO JA, 1996 WINT C PLASM SP, P60
   CORNELIS R, 1994, J ANAL ATOM SPECTROM, V9, P945, DOI 10.1039/ja9940900945
   CORNELIS R, 1993, ANAL CHIM ACTA, V283, P183, DOI 10.1016/0003-2670(93)85221-5
   COSTAFERNANDEZ JM, 1995, J ANAL ATOM SPECTROM, V10, P1019, DOI 10.1039/ja9951001019
   DAWSON JB, 1986, FRESEN Z ANAL CHEM, V324, P463, DOI 10.1007/BF00474118
   DEBIEVRE P, 1993, ANAL PROC, V30, P328
   DEDINA J, 1996, HYDRODE GENERATION A
   DIAZGARCIA ME, 1994, MIKROCHIM ACTA, V113, P211, DOI 10.1007/BF01243612
   DOLPHIN D, 1982, VITAMIN B 12, V1
   DONARD OFX, 1993, ENV ANAL TECHNIQUES, pCH16
   DUNEMANN L, 1993, ANAL CHIM ACTA, V283, P199, DOI 10.1016/0003-2670(93)85223-7
   EBDON L, 1987, ANALYST, V112, P1, DOI 10.1039/an9871200001
   EBDON L, 1986, ANALYST, V111, P1113, DOI 10.1039/an9861101113
   EVANS EH, 1994, ANAL CHEM, V66, P3400, DOI 10.1021/ac00092a017
   FAIRMAN BE, 1995, QUALITY ASSURANCE EN, pCH9
   FANG Z, 1993, FLOW INJECTION SEPAR
   FERNANDEZ MD, 1994, TRACE ELEM MED, V11, P198
   FLORENCE TM, 1983, ANAL CHIM ACTA, V151, P281, DOI 10.1016/S0003-2670(00)80091-4
   GALLORINI M, 1992, J RADIOAN NUCL CH AR, V160, P549, DOI 10.1007/BF02037130
   GARCIAMUNOZ M, 1990, 21ST P INT COSM RAY, V6, P69
   GIDDINGS JC, 1991, UNIFIED SEPARATION S, P189
   Harmer A., 1996, CHEM BIOCH SENSING O
   HARRIS WR, 1992, CLIN CHEM, V38, P1809
   HARRISON RM, 1989, ENV ANAL CHROMATOGRA
   HEUMANN KG, 1996, PLEN LECT 8 JAI EXP
   HILL SJ, 1993, J ANAL ATOM SPECTROM, V8, P499, DOI 10.1039/ja9930800499
   HOLCOMBE D, 1996, QUALITY ASSURANCE BE
   JAKUBOWSKY N, 1996 WINT C PLASM SP, P48
   KARLIN KD, 1993, SCIENCE, V261, P701, DOI 10.1126/science.7688141
   KRULL IS, 1992, TRACE METAL ANAL SPE
   LARSEN EH, 1993, J ANAL ATOM SPECTROM, V8, P557, DOI 10.1039/ja9930800557
   LARSEN EH, 1993, THESIS NATL FOOD AGE
   Lippard S. J., 1994, PRINCIPLES BIOINORGA
   LIU Y, 1995, ANAL CHEM, V67, P2020, DOI 10.1021/ac00109a019
   LIU YM, 1993, J ANAL ATOM SPECTROM, V8, P815, DOI 10.1039/ja9930800815
   LU QH, 1995, ANAL CHEM, V67, P2949, DOI 10.1021/ac00113a033
   MACLEOD CW, 1990, SPECTROSC WORLD, V2, P32
   MARTIN RB, 1986, CLIN CHEM, V32, P1797
   MENENDEZ A, 1990, ANAL CHIM ACTA, V234, P133
   MENENDEZGARCIA A, 1995, FRESEN J ANAL CHEM, V353, P128
   MENENDEZGARCIA A, 1996, MIKROCHIM ACTA, V122, P157
   MERTZ W, 1987, TRACE ELEMENTS HUMAN, V2
   Mertz W., 1987, TRACE ELEMENTS HUMAN, V1
   MOODY JR, 1991, SPECTROCHIM ACTA B, V46, P1571, DOI 10.1016/0584-8547(91)80160-5
   MOTA AM, 1996, ELEMENT SPECIATION B, pCH2
   Okamoto K, 1996, MIKROCHIM ACTA, V123, P15, DOI 10.1007/BF01244373
   OLESIK JW, 1995, ANAL CHEM, V67, P1, DOI 10.1021/ac00097a003
   OSTER O, 1986, FORTSCHR ATOMSPEKTRO, V2, P185
   Quevauviller P, 1996, MIKROCHIM ACTA, V123, P3, DOI 10.1007/BF01244372
   QUEVAUVILLER P, 1994, 1600 EN EUR EUR COMM, P53
   Quijano MA, 1996, J ANAL ATOM SPECTROM, V11, P407, DOI 10.1039/ja9961100407
   RAYMOND KN, 1984, TOP CURR CHEM, V123, P49
   SANZMEDEL A, 1995, ANALYST, V120, P799, DOI 10.1039/an9952000799
   SANZMEDEL A, 1992, MIKROCHIM ACTA, V109, P157, DOI 10.1007/BF01243230
   SANZMEDEL A, 1996, ELEMENT SPECIATION B, pCH7
   SANZMEDEL A, 1996 WINT C PLASM SP, P58
   SEGOVIA E, 1996, 15 REUN NAC ESP OV S
   SHUM SCK, 1992, ANAL CHEM, V64, P2444, DOI 10.1021/ac00044a025
   SPAREN A, 1994, THESIS ROYAL I TECHN
   SULLIVAN JJ, 1991, TRENDS ANAL CHEM, V10, P24
   SULLIVAN JJ, 1992, ACS SERIES, V479, pCH4
   SUZUKI KT, 1995, J CHROMATOGR B, V666, P13, DOI 10.1016/0378-4347(94)00561-I
   TAYLOR HE, 1992, ANAL CHEM, V64, P2036, DOI 10.1021/ac00042a005
   TAYLOR JK, 1987, QUALITY ASSURANCE CH
   TESSIER A, 1979, ANAL CHEM, V51, P884
   Thayer J.S., 1984, ORGANOMETALLIC COMPO
   THOMAS RP, 1994, ANAL CHIM ACTA, V286, P423, DOI 10.1016/0003-2670(94)85088-7
   UDEN PC, 1992, ACS S SERIES, V479
   Valcarcel M., 1991, NONCHROMATOGRAPHIC C
   VANHAECKE F, 1996 WINT C PLASM SP, P310
   VANLANDEGHEM GF, 1994, ANAL CHEM, V66, P216, DOI 10.1021/ac00074a007
   VELA NP, 1993, J ANAL ATOM SPECTROM, V8, P787, DOI 10.1039/ja9930800787
   Wang J., 1988, ELECTROANALYTICAL TE
   WILLIAMS RJP, 1996, CHEM BRIT, P42
   WROBEL K, 1994, J ANAL ATOM SPECTROM, V9, P281, DOI 10.1039/ja9940900281
   YANG MJ, 1996, LC GC, V5, P283
   1996, 1996 WINT C PLASM SP, P319
NR 82
TC 125
Z9 128
U1 0
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0584-8547
J9 SPECTROCHIM ACTA B
JI Spectroc. Acta Pt. B-Atom. Spectr.
PD FEB 27
PY 1998
VL 53
IS 2
BP 197
EP 211
DI 10.1016/S0584-8547(97)00135-3
PG 15
WC Spectroscopy
SC Spectroscopy
GA ZW243
UT WOS:000074389900007
DA 2018-10-19
ER

PT J
AU Lands, WEM
AF Lands, WEM
TI A review of alcohol clearance in humans
SO ALCOHOL
LA English
DT Review
DE acetate; adenosine; alcohol clearance; alcohol dehydrogenase; alcohol
   dependence; binding site; blood alcohol level; catalytic site; enzyme
   kinetics; millimolar alcohol; orphan genes; withdrawal
ID ALDEHYDE DEHYDROGENASE GENOTYPES; CENTRAL-NERVOUS-SYSTEM; FIRST-PASS
   METABOLISM; HUMAN-LIVER; ENZYMATIC-PROPERTIES; ETHANOL ELIMINATION;
   KINETIC CHARACTERIZATION; OXIDOREDUCTION INVIVO; POSTMENOPAUSAL WOMEN;
   HYDROGEN TRANSFER
AB The level of blood or brain alcohol is considered to influence alcohol ingestion by causing subjective perceptions or neural activations that are reinforcing or rewarding. Alcohol-dependent people may try to maintain some desired tissue level, drinking to replace the millimolar levels that were cleared from the blood by metabolism. The biomedical literature describes many approaches to understanding the role of blood alcohol levels in human physiology and behavior, and this review examines some of the published results. They include the general kinetics of intake and removal of beverage alcohol as well as the characteristics of many different catalysts that can interact with alcohol. Because ingested alcohol creates blood levels that are a 1000-fold greater than those normally experienced during abstinence, ethanol may impose itself as an alternate substrate for the many oxidoreductases that act physiologically on other endogenous alcohols. Many enzymes that can act on millimolar ethanol have been isolated, and their structural genes are sequenced. Unfortunately, the genetic sequence does not indicate the physiological material upon which the translated gene product may act. In a sense, the set of enzymes with catalytic sites occupied by millimolar ethanol during alcohol drinking might constructively be regarded as "orphan gene products" whose physiological role remains to be clarified. This review is designed to indicate some of what is known, what is not known, and what needs to be known to improve the interpretations regarding adaptations to beverage alcohol and the ability of millimolar levels of alcohol to diminish dysphoria. The dysphoria may be influenced by ethanol, by ethanol metabolites, or by altered metabolism of currently unspecified endogenous substrates. A major challenge is to evaluate the multiple alternative variables within a context that stimulates curiosity and encourages quantitative tests of the relative contribution of each variable to the overall physiology of an individual. Published by Elsevier Science Inc.
C1 NIAAA, NIH, Bethesda, MD 20892 USA.
RP Lands, WEM (reprint author), NIAAA, NIH, Willco Bldg,Suite 400,6000 Execut Blvd,MSC 7003, Bethesda, MD 20892 USA.
EM wlands@willco.niaaa.nih.gov
CR Ammon E, 1996, CLIN PHARMACOL THER, V59, P503, DOI 10.1016/S0009-9236(96)90178-2
   ANDERSSON S, 1986, ALCOHOL CLIN EXP RES, V10, pS55, DOI 10.1111/j.1530-0277.1986.tb05181.x
   Asai H, 1996, J PHARMACOL EXP THER, V277, P1004
   Atwater WO, 1902, MEM NAT ACAD SCI, VVIII, P231
   BEISSWENGER TB, 1985, P NATL ACAD SCI USA, V82, P8369, DOI 10.1073/pnas.82.24.8369
   BOLEDA MD, 1993, ARCH BIOCHEM BIOPHYS, V307, P85, DOI 10.1006/abbi.1993.1564
   BOSRON WF, 1983, PHARMACOL BIOCHEM BE, V18, P223, DOI 10.1016/0091-3057(83)90175-2
   BOSRON WF, 1983, BIOCHEMISTRY-US, V22, P1852, DOI 10.1021/bi00277a017
   BOSRON WF, 1993, SEMIN LIVER DIS, V13, P126, DOI 10.1055/s-2007-1007344
   BOSRON WF, 1987, ENZYME, V37, P19, DOI 10.1159/000469238
   BURNELL JC, 1987, BIOCHEM BIOPH RES CO, V146, P1227, DOI 10.1016/0006-291X(87)90779-0
   BURNELL JC, 1989, BIOCHEMISTRY-US, V28, P6810, DOI 10.1021/bi00443a005
   CARMICHAEL FJ, 1991, J PHARMACOL EXP THER, V259, P403
   CHAO HM, 1995, ALCOHOL CLIN EXP RES, V19, P104, DOI 10.1111/j.1530-0277.1995.tb01477.x
   CONSALVI V, 1986, BIOCHEM BIOPH RES CO, V139, P1009, DOI 10.1016/S0006-291X(86)80278-9
   CORNELL NW, 1979, ALCOHOL NUTR
   CRABB DW, 1983, ARCH BIOCHEM BIOPHYS, V224, P299, DOI 10.1016/0003-9861(83)90213-8
   CRABB DW, 1993, J LAB CLIN MED, V122, P234
   CRAFT PP, 1994, SOUTHERN MED J, V87, P47, DOI 10.1097/00007611-199401000-00011
   Cronholm T, 1987, Alcohol Alcohol Suppl, V1, P265
   CRONHOLM T, 1985, BIOCHEM J, V229, P315, DOI 10.1042/bj2290315
   CRONHOLM T, 1988, ALCOHOL CLIN EXP RES, V12, P683, DOI 10.1111/j.1530-0277.1988.tb00265.x
   CRONHOLM T, 1985, BIOCHEM J, V229, P323, DOI 10.1042/bj2290323
   Davis GJ, 1996, J BIOL CHEM, V271, P17057, DOI 10.1074/jbc.271.29.17057
   DEETZ JS, 1984, BIOCHEMISTRY-US, V23, P6822, DOI 10.1021/bi00321a084
   DEITRICH RA, 1976, PSYCHONEUROENDOCRINO, V1, P325, DOI 10.1016/0306-4530(76)90002-0
   DERR RF, 1993, J PHARM SCI, V82, P677, DOI 10.1002/jps.2600820702
   DEUSTER G, 1991, DRUGS ALCOHOL ABUSE, V2
   DONG Y, 1988, P NATL ACAD SCI USA, V85, P767, DOI 10.1073/pnas.85.3.767
   EKLUND H, 1990, EUR J BIOCHEM, V193, P303, DOI 10.1111/j.1432-1033.1990.tb19337.x
   EKLUND H, 1987, EUR J BIOCHEM, V167, P185, DOI 10.1111/j.1432-1033.1987.tb13322.x
   EKSTROM G, 1993, BIOCHEM PHARMACOL, V45, P1989, DOI 10.1016/0006-2952(93)90008-K
   Eriksson C J, 1993, Alcohol Alcohol Suppl, V2, P9
   FARRES J, 1995, ADV EXP MED BIOL, V372, P331
   FARRES J, 1994, EUR J BIOCHEM, V193, P303
   FELDER MR, 1988, J BIOL CHEM, V263, P14531
   Ginsburg ES, 1996, JAMA-J AM MED ASSOC, V276, P1747, DOI 10.1001/jama.276.21.1747
   GINSBURG ES, 1995, FERTIL STERIL, V63, P1227, DOI 10.1016/S0015-0282(16)57602-X
   Goldberg L., 1943, ACTA PHYSIOL SCAND, V5, P1
   Haber PS, 1996, GASTROENTEROLOGY, V111, P863, DOI 10.1016/S0016-5085(96)70054-9
   HAHN RG, 1994, ALCOHOL ALCOHOLISM, V29, P673
   HANNAK D, 1985, BIOL CHEM H-S, V366, P749, DOI 10.1515/bchm3.1985.366.2.749
   HENEHAN GTM, 1993, BIOCHEMISTRY-US, V32, P736
   Higuchi S, 1996, ALCOHOL CLIN EXP RES, V20, P493, DOI 10.1111/j.1530-0277.1996.tb01080.x
   Higuchi S, 1996, HUM GENET, V97, P431
   HOOG JO, 1987, BIOCHEMISTRY-US, V26, P1926, DOI 10.1021/bi00381a021
   HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x
   Hunt WA, 1996, ALCOHOL, V13, P147, DOI 10.1016/0741-8329(95)02026-8
   HURLEY TD, 1991, P NATL ACAD SCI USA, V88, P8149, DOI 10.1073/pnas.88.18.8149
   HURLEY TD, 1994, J MOL BIOL, V239, P415, DOI 10.1006/jmbi.1994.1382
   HURLEY TD, 1990, J BIOL CHEM, V265, P16366
   ISRAEL Y, 1994, ALCOHOL CLIN EXP RES, V18, P144, DOI 10.1111/j.1530-0277.1994.tb00894.x
   JONES AW, 1994, J FORENSIC SCI, V39, P1084
   JONES AW, 1983, PHARMACOL BIOCHEM BE, V18, P267, DOI 10.1016/0091-3057(83)90184-3
   JORNVALL H, 1987, P NATL ACAD SCI USA, V84, P2580, DOI 10.1073/pnas.84.9.2580
   JORNVALL H, 1995, ALCOHOL ALCOHOLISM, V30, P153
   JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x
   JORNVALL H, 1987, ENZYME, V37, P5
   Julia P, 1987, Alcohol Alcohol Suppl, V1, P169
   KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502
   KEUNG WM, 1995, BIOCHEM BIOPH RES CO, V215, P1137, DOI 10.1006/bbrc.1995.2581
   Keung WM, 1997, P NATL ACAD SCI USA, V94, P1675, DOI 10.1073/pnas.94.5.1675
   KEUNG WM, 1993, ALCOHOL CLIN EXP RES, V17, P1254, DOI 10.1111/j.1530-0277.1993.tb05238.x
   KREBS HA, 1969, ENERGY LEVEL METABOL
   LANDS WEM, 1991, AM J CLIN NUTR, V54, P47
   LANDS WEM, 1995, AM J CLIN NUTR, V62, P1101
   LARSEN JA, 1959, NATURE, V184, P1236, DOI 10.1038/1841236a0
   Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063
   LEVITT MD, 1994, J PHARMACOL EXP THER, V269, P297
   Levy A, 1996, LANCET, V347, P73, DOI 10.1016/S0140-6736(96)90206-8
   LI TK, 1969, SURG CLIN N AM, V49, P577
   LI TK, 1975, BIOCHEM BIOPH RES CO, V63, P202, DOI 10.1016/S0006-291X(75)80030-1
   LIANG CS, 1978, J CLIN INVEST, V62, P1029, DOI 10.1172/JCI109207
   LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382
   LUNDQUIST F, 1962, J CLIN INVEST, V41, P955, DOI 10.1172/JCI104574
   LUNDQUIST F, 1962, NATURE, V193, P579, DOI 10.1038/193579b0
   LUNDQUIST F, 1970, INT ENCYCLOPAEDIA 20, V1, P95
   MARDH G, 1985, P NATL ACAD SCI USA, V82, P4979, DOI 10.1073/pnas.82.15.4979
   MARDH G, 1986, P NATL ACAD SCI USA, V83, P8908, DOI 10.1073/pnas.83.23.8908
   MARDH G, 1986, P NATL ACAD SCI USA, V83, P2836
   MARDH G, 1986, BIOCHEMISTRY-US, V25, P7279, DOI 10.1021/bi00371a005
   MCEVILY AJ, 1988, BIOCHEMISTRY-US, V27, P4284, DOI 10.1021/bi00412a013
   MCMILLEN BA, 1995, ALCOHOL, V12, P79
   Miyamae M, 1997, P NATL ACAD SCI USA, V94, P3235, DOI 10.1073/pnas.94.7.3235
   MIZOI Y, 1994, ALCOHOL ALCOHOLISM, V29, P707
   MOULIS JM, 1991, BIOCHEMISTRY-US, V30, P5743, DOI 10.1021/bi00237a016
   MUNDT JC, 1995, J STUD ALCOHOL, V56, P491, DOI 10.15288/jsa.1995.56.491
   NOMURA F, 1983, J PHARMACOL EXP THER, V227, P78
   NUUTINEN H, 1985, ALCOHOL, V2, P623, DOI 10.1016/0741-8329(85)90090-4
   OKUDA A, 1983, J BIOL CHEM, V258, P2899
   ORREGO H, 1988, CAN J PHYSIOL PHARM, V66, P1, DOI 10.1139/y88-001
   PAGE RA, 1991, BIOCHEM J, V278, P659, DOI 10.1042/bj2780659
   PARES X, 1993, ADV EXP MED BIOL, V328, P475
   PEOPLES RW, 1995, P NATL ACAD SCI USA, V92, P2825, DOI 10.1073/pnas.92.7.2825
   PIETRUSZKO R, 1972, ARCH BIOCHEM BIOPHYS, V153, P279, DOI 10.1016/0003-9861(72)90446-8
   PIETRUSZKO R, BIOCH PHARM ETHANOL, P87
   POTTER JJ, 1991, ARCH BIOCHEM BIOPHYS, V285, P246, DOI 10.1016/0003-9861(91)90356-N
   REINUS JF, 1989, METABOLISM, V38, P125, DOI 10.1016/0026-0495(89)90251-5
   SATO K, 1995, FASEB J, V9, P651
   SEARLES JS, 1995, J STUD ALCOHOL, V56, P375, DOI 10.15288/jsa.1995.56.375
   SMITH GD, 1993, ALCOHOL ALCOHOLISM, V28, P25
   SMITH M, 1973, ANN HUM GENET, V37, P49, DOI 10.1111/j.1469-1809.1973.tb01814.x
   SMITH M, 1986, ADV HUM GENET, V15, P249
   SMITH M, 1973, ANN HUM GENET, V36, P401, DOI 10.1111/j.1469-1809.1973.tb00604.x
   Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4
   SWIFT RM, 1993, ADDICTION, V88, P1037, DOI 10.1111/j.1360-0443.1993.tb02122.x
   SWIFT RM, 1992, ALCOHOL CLIN EXP RES, V16, P721, DOI 10.1111/j.1530-0277.1992.tb00668.x
   TANK AW, 1986, BIOCHEM PHARMACOL, V35, P4563, DOI 10.1016/0006-2952(86)90779-3
   TEKKANAT KK, 1988, J LAB CLIN MED, V112, P686
   THOMASSON HR, 1993, BEHAV GENET, V23, P131, DOI 10.1007/BF01067417
   Thomasson HR, 1995, ALCOHOL CLIN EXP RES, V19, P1494, DOI 10.1111/j.1530-0277.1995.tb01013.x
   THOMASSON HR, 1991, AM J HUM GENET, V48, P677
   TSUTSUMI M, 1989, HEPATOLOGY, V10, P437, DOI 10.1002/hep.1840100407
   Ueno Y, 1996, ALCOHOL CLIN EXP RES, V20, pA17, DOI 10.1111/j.1530-0277.1996.tb01720.x
   VALLEE BL, 1983, ISOZYMES CURRENT TOP, P219
   VANOOIJ C, 1992, MOL CELL BIOL, V12, P3023, DOI 10.1128/MCB.12.7.3023
   VOLTAIRE A, 1992, ALCOHOL CLIN EXP RES, V16, P281, DOI 10.1111/j.1530-0277.1992.tb01377.x
   VONBAHRLINDSTROM H, 1986, BIOCHEMISTRY-US, V25, P2465
   VONWARTBURG JP, 1964, BIOCHEMISTRY-US, V3, P1775, DOI 10.1021/bi00899a033
   WAGNER FW, 1984, BIOCHEMISTRY-US, V23, P2193, DOI 10.1021/bi00305a014
   WAGNER FW, 1983, BIOCHEMISTRY-US, V22, P1857, DOI 10.1021/bi00277a018
   WALLGREN H, 1970, ACTIONS ALCOHOL, V1, P95
   WALLGREN H, 1970, ACTIONS ALCOHOL, V1, P47
   WALLGREN H, 1970, ACTIONS ALCOHOL, V1, P89
   WANG YL, 1989, MOL MECH ALCOHOL, P97
   WATSON PE, 1981, J STUD ALCOHOL, V42, P547, DOI 10.15288/jsa.1981.42.547
   Widmark EMP, 1932, THEORETISCHEN GRUNDL
   WILKINSON PK, 1977, J PHARMACOKINET BIOP, V5, P207, DOI 10.1007/BF01065396
   WINTER LA, 1990, GENE, V91, P233, DOI 10.1016/0378-1119(90)90093-7
   WRATTEN CC, 1963, BIOCHEMISTRY-US, V2, P935, DOI 10.1021/bi00905a007
   Yamamoto Kenji, 1993, Japanese Journal of Alcohol Studies and Drug Dependence, V28, P13
   YANG ZN, 1994, ALCOHOL CLIN EXP RES, V17, P496
   YIN SJ, 1989, MOL MECHANISMS ALCOH, P227
   ZIMATKIN SM, 1992, ALCOHOL CLIN EXP RES, V16, P1162, DOI 10.1111/j.1530-0277.1992.tb00713.x
NR 134
TC 58
Z9 60
U1 1
U2 24
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0741-8329
EI 1873-6823
J9 ALCOHOL
JI Alcohol
PD FEB
PY 1998
VL 15
IS 2
BP 147
EP 160
DI 10.1016/S0741-8329(97)00110-9
PG 14
WC Substance Abuse; Pharmacology & Pharmacy; Toxicology
SC Substance Abuse; Pharmacology & Pharmacy; Toxicology
GA YT983
UT WOS:000071667700007
PM 9476961
DA 2018-10-19
ER

PT J
AU Del Bigio, MR
AF Del Bigio, MR
TI Biological reactions to cerebrospinal fluid shunt devices: A review of
   the cellular pathology
SO NEUROSURGERY
LA English
DT Review
DE cerebrospinal fluid; foreign body; hydrocephalus; inflammation; silicone
ID LATERAL PERIVENTRICULAR TISSUE; SILICONE BREAST IMPLANTS; CENTRAL
   NERVOUS-SYSTEM; VENTRICULOPERITONEAL SHUNTS; LONG-TERM; BIOMEDICAL
   POLYMERS; TUBING IMPLANTS; NEURAL TISSUE; BRAIN-TISSUE; INTRAVENTRICULAR
   HEMORRHAGE
AB OBJECTIVE: To understand the interaction between cerebrospinal fluid shunt components and the brain and other tissues.
   METHODS: A systematic review of the medical literature directly pertaining to shunt complications, and that dealing with tissues' reactions to implants in general, was conducted.
   RESULTS: Vascularized pedicles of glial tissue or choroid plexus grow into ventricular catheters, primarily as a mechanical phenomenon. Cellular debris or blood can cause dysfunction of valve components. Chronic inflammation, which is nonspecific, might contribute to degradation of the components.
   CONCLUSION: Care must be taken to prevent early entry of debris or blood into the shunt system. Ventricular collapse onto the shunt must be avoided. Refinement of manufacturing methods or modification of shunt materials could reduce the susceptibility of shunts to infection and improve longevity of the apparatus.
C1 Hlth Sci Ctr, Dept Pathol, Winnipeg, MB R3E 0W3, Canada.
   Univ Manitoba, Winnipeg, MB R3E 0W3, Canada.
RP Del Bigio, MR (reprint author), Hlth Sci Ctr, Dept Pathol, D212-770 Bannatyne Ave, Winnipeg, MB R3E 0W3, Canada.
OI Del Bigio, Marc/0000-0001-8366-0394
CR ABBAS AK, 1994, CELLULAR MOL IMMUNOL, P286
   AGNEW WILLIAM F., 1962, JOUR SURG RES, V2, P357, DOI 10.1016/S0022-4804(62)80047-X
   ALLEYNE CH, 1994, J NEUROSURG, V81, P610, DOI 10.3171/jns.1994.81.4.0610
   ALTKANOV G, 1996, J BIOMED MATER RES, V30, P385
   AMMAR A, 1990, NEUROSURG REV, V13, P299, DOI 10.1007/BF00346368
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   ANDERSSON H, 1966, NEUROCHIRURGIA, V9, P61
   AOKI N, 1990, SURG NEUROL, V33, P256, DOI 10.1016/0090-3019(90)90045-Q
   BABB TL, 1984, EXP NEUROL, V86, P171, DOI 10.1016/0014-4886(84)90179-1
   BARRETT SP, 1985, J MED MICROBIOL, V20, P249, DOI 10.1099/00222615-20-2-249
   BAYSTON R, 1981, J CLIN PATHOL, V34, P1057, DOI 10.1136/jcp.34.9.1057
   BECKER DP, 1968, J NEUROSURG, V28, P215, DOI 10.3171/jns.1968.28.3.0215
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   Bhatnagar V, 1983, Indian J Pediatr, V50, P133, DOI 10.1007/BF02821431
   BIGNER SH, 1985, ACTA CYTOL, V29, P391
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BORGES LF, 1982, NEUROSURGERY, V10, P55, DOI 10.1227/00006123-198201000-00010
   BREM H, 1989, SELECT CANCER THER, V5, P55, DOI 10.1089/sct.1989.5.55
   BREM H, 1990, BIOMATERIALS, V11, P699, DOI 10.1016/0142-9612(90)90030-T
   BREM H, 1994, J NEUROSURG, V80, P283, DOI 10.3171/jns.1994.80.2.0283
   BROSNAN CF, 1982, J NEUROPATH EXP NEUR, V41, P221, DOI 10.1097/00005072-198203000-00009
   BROWNLEE RD, 1995, PEDIATR NEUROSURG, V22, P315, DOI 10.1159/000120922
   BRUNI JE, 1986, NEUROSURGERY, V19, P337, DOI 10.1227/00006123-198609000-00001
   Brydon HL, 1996, BRIT J NEUROSURG, V10, P267, DOI 10.1080/02688699650040124
   Brydon HL, 1996, BRIT J NEUROSURG, V10, P245, DOI 10.1080/02688699650040098
   Brydon HL, 1996, NEUROSURGERY, V38, P498, DOI 10.1097/00006123-199603000-00016
   Brydon HL, 1996, J NEUROL NEUROSUR PS, V60, P671, DOI 10.1136/jnnp.60.6.671
   COLLIAS JC, 1957, J NEUROSURG, V14, P302, DOI 10.3171/jns.1957.14.3.0302
   COLLINS P, 1978, J NEUROSURG, V48, P609, DOI 10.3171/jns.1978.48.4.0609
   Craver RD, 1996, PEDIATR PATHOL LAB M, V16, P713, DOI 10.1080/107710496175336
   DABERNAT H, 1985, NOUV REV MED TOULOUS, V3, P15
   DASILVA MC, 1992, PEDIATR NEUROSURG, V17, P304
   DELBIGIO MR, 1995, GLIA, V14, P1, DOI 10.1002/glia.440140102
   DELBIGIO MR, 1986, J NEUROSURG, V64, P932, DOI 10.3171/jns.1986.64.6.0932
   DELBIGIO MR, 1992, J BIOMED MATER RES, V26, P979, DOI 10.1002/jbm.820260802
   DEWAN PA, 1995, BRIT J UROL, V75, P666, DOI 10.1111/j.1464-410X.1995.tb07429.x
   ECHIZENYA K, 1987, J NEUROSURG, V67, P584, DOI 10.3171/jns.1987.67.4.0584
   EDVINSSON L, 1971, ACTA PHYSIOL SCAND, V82, P527, DOI 10.1111/j.1748-1716.1971.tb04998.x
   ELISEVICH K, 1994, PEDIATR NEUROSURG, V21, P71, DOI 10.1159/000120818
   Ferguson JH, 1997, NEUROLOGY, V48, P1504, DOI 10.1212/WNL.48.6.1504
   FERRARO FT, 1989, NEUROSURGERY, V25, P209, DOI 10.1227/00006123-198908000-00009
   GEDIKOGLU Y, 1993, ACTA NEUROCHIR, V122, P266, DOI 10.1007/BF01405540
   GERMANO IM, 1992, J NEUROSURG, V76, P607, DOI 10.3171/jns.1992.76.4.0607
   GIUFFRE R, 1976, J NEUROSURG SCI, V20, P123
   GO KG, 1981, CLIN NEUROL NEUROSUR, V83, P47, DOI 10.1016/0303-8467(81)90001-9
   GOLDBLUM RM, 1992, LANCET, V340, P510, DOI 10.1016/0140-6736(92)91710-P
   GOWER DJ, 1986, PEDIATR NEUROSCI, V12, P127
   GOWER DJ, 1984, J NEUROSURG, V61, P1079, DOI 10.3171/jns.1984.61.6.1079
   GOWER DJ, 1992, NEUROSURGERY, V31, P1132, DOI 10.1227/00006123-199212000-00024
   GRABB PA, 1992, NEUROSURGERY, V30, P630
   GRIEBEL RW, 1987, CHILD NERV SYST, V3, P180, DOI 10.1007/BF00717898
   GUEVARA JA, 1987, J NEUROSURG, V67, P438, DOI 10.3171/jns.1987.67.3.0438
   GUEVARA JA, 1981, CHILD BRAIN, V8, P284
   HAASE J, 1976, ACTA NEUROCHIR, V33, P213, DOI 10.1007/BF01886670
   HABAL MB, 1984, ARCH SURG-CHICAGO, V119, P843
   HAKIM S, 1969, DEV MED CHILD NEUROL, VS, P42
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   IMBER G, 1974, PLAST RECONSTR SURG, V54, P183, DOI 10.1097/00006534-197408000-00010
   IRVING IM, 1971, J PEDIATR SURG, V6, P724, DOI 10.1016/0022-3468(71)90852-9
   JAEGER CB, 1991, BRAIN RES, V551, P163, DOI 10.1016/0006-8993(91)90929-P
   JIMENEZ DF, 1994, CHILD NERV SYST, V10, P59, DOI 10.1007/BF00313586
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KENNEDY CR, 1988, DEV MED CHILD NEUROL, V30, P386
   KOLMEL HW, 1990, FORTSCHR NEUROL PSYC, V58, P191, DOI 10.1055/s-2007-1001183
   KOSSOVSKY N, 1983, SURG FORUM, V34, P527
   KOSSOVSKY N, 1989, J BIOMED MATER RES-A, V23, P73, DOI 10.1002/jbm.820231308
   Leininger R I, 1972, CRC Crit Rev Bioeng, V1, P333
   LILLA JA, 1976, PLAST RECONSTR SURG, V57, P637, DOI 10.1097/00006534-197605000-00012
   LLOYD DA, 1993, J PEDIATR SURG, V28, P345, DOI 10.1016/0022-3468(93)90229-E
   MENEI P, 1993, BIOMATERIALS, V14, P470, DOI 10.1016/0142-9612(93)90151-Q
   MENEI P, 1994, J BIOMED MATER RES, V28, P1079, DOI 10.1002/jbm.820280913
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   Nakamura S, 1982, MONOGR NEURAL SCI, V8, P191
   NAKAOKA T, 1983, Neurologia Medico-Chirurgica, V23, P818, DOI 10.2176/nmc.23.818
   Nicolai U, 1992, Ger J Ophthalmol, V1, P180
   PAGE LK, 1985, CONCEPTS PAEDIATRIC, V5, P75
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PHELPS CP, 1995, J SUBMICR CYTOL PATH, V27, P83
   PIATT JH, 1995, PEDIATR NEUROSURG, V23, P133, DOI 10.1159/000120950
   PITTMAN T, 1994, BRIT J NEUROSURG, V8, P41, DOI 10.3109/02688699409002391
   PUDENZ RH, 1981, SURG NEUROL, V15, P15, DOI 10.1016/S0090-3019(81)80084-5
   RAFTOPOULOS C, 1994, ACTA NEUROCHIR, V129, P177, DOI 10.1007/BF01406499
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   RAUCH HC, 1986, J BIOMED MATER RES, V20, P1277, DOI 10.1002/jbm.820200905
   REINBERG Y, 1993, J UROLOGY, V150, P594
   REINHARDT V, 1980, ADV NEUROSURG, V8, P267
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   ROSSITCH E, 1985, NEUROSURGERY, V17, P838, DOI 10.1227/00006123-198511000-00021
   SAINTEROSE C, 1993, PEDIATR NEUROSURG, V19, P156, DOI 10.1159/000120722
   SANCHEZGUERRERO J, 1995, NEW ENGL J MED, V332, P1666, DOI 10.1056/NEJM199506223322502
   SANGER JR, 1992, PLAST RECONSTR SURG, V89, P931, DOI 10.1097/00006534-199205000-00025
   SCARFF TB, 1983, CONCEPTS PEDIAT NEUR, V4, P81
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P1059, DOI 10.1016/0142-9612(92)90138-E
   SCHMIDT S, 1993, J BIOMED MATER RES, V27, P1393, DOI 10.1002/jbm.820271106
   Schoener W, 1991, HYDROCEPHALUS PATHOG, P452
   SEIFERT LM, 1985, J BIOMED MATER RES, V19, P1043, DOI 10.1002/jbm.820190916
   SEKHAR LN, 1982, J NEUROSURG, V56, P411, DOI 10.3171/jns.1982.56.3.0411
   SERGOTT TJ, 1986, PLAST RECONSTR SURG, V78, P104, DOI 10.1097/00006534-198607000-00018
   SEVASTIANOV VI, 1984, J BIOMED MATER RES, V18, P969, DOI 10.1002/jbm.820180902
   SHERERTZ RJ, 1995, J BIOMED MATER RES, V29, P635, DOI 10.1002/jbm.820290511
   SHIMOTAKE K, 1988, SURG NEUROL, V30, P156, DOI 10.1016/0090-3019(88)90104-8
   SMETANA K, 1990, J BIOMED MATER RES, V24, P463, DOI 10.1002/jbm.820240405
   STEINBERG J, 1989, J BIOMED MATER RES, V23, P591, DOI 10.1002/jbm.820230605
   STENSAAS SS, 1976, ACTA NEUROPATHOL, V35, P187
   SUGAR O, 1974, J NEUROSURG, V41, P367, DOI 10.3171/jns.1974.41.3.0367
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   TAYLOR DE, 1986, BIOMATERIALS, V7, P277, DOI 10.1016/0142-9612(86)90050-5
   TRAVIS WD, 1985, HUM PATHOL, V16, P19, DOI 10.1016/S0046-8177(85)80209-4
   TRAYNELIS VC, 1988, NEUROSURGERY, V23, P645, DOI 10.1227/00006123-198811000-00019
   TUCKER OP, 1983, Z KINDERCHIR, V38, P71
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   TURNER MS, 1995, SURG NEUROL, V43, P314, DOI 10.1016/0090-3019(95)80056-M
   TZVETANOVA EM, 1986, ACTA CYTOL, V30, P277
   VALE BH, 1982, J BIOMED MATER RES, V16, P471, DOI 10.1002/jbm.820160414
   VARIEND S, 1982, LANCET, V2, P1162
   VONDRACEK P, 1984, BIOMATERIALS, V5, P209, DOI 10.1016/0142-9612(84)90017-6
   VONHOLST H, 1981, ACTA NEUROCHIR, V56, P239, DOI 10.1007/BF01407234
   WINN SR, 1989, J BIOMED MATER RES, V23, P31, DOI 10.1002/jbm.820230104
   WOERLY S, 1993, BIOMATERIALS, V14, P1056, DOI 10.1016/0142-9612(93)90205-G
   WOERLY S, 1991, BIOMATERIALS, V12, P197, DOI 10.1016/0142-9612(91)90200-T
   WOERLY S, 1990, BIOMATERIALS, V11, P97, DOI 10.1016/0142-9612(90)90123-8
   Wong TT, 1991, HYDROCEPHALUS PATHOG, P438
   WOODRUFF WW, 1986, RADIOLOGY, V158, P171, DOI 10.1148/radiology.158.1.3940376
   WU MP, 1994, J BIOMED MATER RES, V28, P387, DOI 10.1002/jbm.820280314
   YUEN TGH, 1990, NEURAL PROSTHESES FU, P197
   ZUMSTEIN B, 1974, ACTA NEUROCHIR, V30, P287, DOI 10.1007/BF01405585
NR 128
TC 64
Z9 65
U1 1
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0148-396X
EI 1524-4040
J9 NEUROSURGERY
JI Neurosurgery
PD FEB
PY 1998
VL 42
IS 2
BP 319
EP 325
DI 10.1097/00006123-199802000-00064
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA YV348
UT WOS:000071814200023
PM 9482182
DA 2018-10-19
ER

PT J
AU Yamamoto, S
   Miyamoto, T
   Kokubo, T
   Nakamura, T
AF Yamamoto, S
   Miyamoto, T
   Kokubo, T
   Nakamura, T
TI Preparation of polymer-silicate hybrid materials bearing silanol groups
   and the apatite formation on/in the hybrid materials
SO POLYMER BULLETIN
LA English
DT Article
ID GLASS; WOLLASTONITE; GEL
AB The aim of this work is to develop a basic approach to the preparation of biologically active polymer-apatite composites with various mechanical properties. To this end, a type of hybrid materials bearing silanol groups were prepared from triethoxysilyl-terminated poly(oxyethylene) (PEG) and tetraethoxysilane (TEOS) by using the in-situ sol-gel process. The hybrid materials having different PEG contents were subjected to the biomimetic process for forming the bone-like apatite layer on/in the hybrid materials. It was found that a dense bone-like apatite layer can be prepared in an arbitrary thickness on/in the hybrid materials, indicating that the silanol groups introduced provide the effective sites for the apatite nucleation and formation. The polymer-apatite composites thus obtained are expected to have a great potential in the biomedical applications.
C1 Kyoto Univ, Inst Chem Res, Kyoto 611, Japan.
   Kyoto Univ, Grad Sch Engn, Div Mat Chem, Sakyo Ku, Kyoto 60601, Japan.
   Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 606, Japan.
RP Miyamoto, T (reprint author), Kyoto Univ, Inst Chem Res, Kyoto 611, Japan.
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR HUANG ZH, 1995, POLYM BULL, V35, P607, DOI 10.1007/BF00324115
   KOHJIYA S, 1991, POLYMER GELS, P77
   KOHJIYA S, 1991, POLYM-PLAST TECHNOL, V30, P351, DOI 10.1080/03602559108021001
   KOKUBO T, 1991, NIPPON SERAM KYO GAK, V99, P965
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   ONO K, 1990, BIOMATERIALS, V11, P265
   SUZUKI K, 1993, BIOCERAMICS, V6, P245
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   YAMAMOTO S, IN PRESS
   YAMAMURO T, 1990, J BONE JOINT SURG BR, V72, P889
NR 12
TC 17
Z9 19
U1 0
U2 2
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0170-0839
J9 POLYM BULL
JI Polym. Bull.
PD FEB-MAR
PY 1998
VL 40
IS 2-3
BP 243
EP 250
DI 10.1007/s002890050248
PG 8
WC Polymer Science
SC Polymer Science
GA ZA846
UT WOS:000072407900017
DA 2018-10-19
ER

PT J
AU Min, S
   Nakamura, T
   Teramoto, A
   Abe, K
AF Min, S
   Nakamura, T
   Teramoto, A
   Abe, K
TI Preparation and characterization of crosslinked porous silk fibroin gel
SO SEN-I GAKKAISHI
LA English
DT Article
ID MEMBRANE
AB In order to develop new biomedical materials, the preparation and characterization of crosslinked porous silk fibroin gel (CPFG) were investigated by using ethylene glycol diglycidyl ether (EGDE) as a crosslinking agent. The CPFG was prepared by freezing (-50 degrees C similar to -5 degrees C) and thawing a homogeneous fibroin solution containing EGDE. The average pore size of CPFG was varied from 100 similar to 300 mu m by adjusting the concentrations of silk fibroin, EGDE and the freezing temperature. The tenacity and elongation ratio of CPFG were improved by increasing the concentration of silk fibroin and EGDE within a certain range. From these results, it was found that CPFG with excellent properties can be prepared at low temperatures by using EGDE as a crosslinking agent.
C1 Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 386, Japan.
OI Nakamura, Toshinobu/0000-0003-3881-3368
CR Asakura T, 1987, BIOINDUSTRY, V4, P878
   CHEN K, 1992, J SERICUET SCI JPN, V62, P56
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   HANAWA T, 1995, CHEM PHARM BULL, V43, P284
   KAMIISHI Y, 1995, J SERICUET SCI JPN, V64, P323
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   SHIOZAKI H, 1980, STRUCTURES SILK, P625
   TSUKADA M, 1994, J APPL POLYM SCI, V54, P507, DOI 10.1002/app.1994.070540411
NR 8
TC 6
Z9 7
U1 0
U2 3
PU SOC FIBER SCIENCE TECHNOLOGY
PI TOKYO
PA KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN
SN 0037-9875
J9 SEN-I GAKKAISHI
JI Sen-I Gakkaishi
PD FEB
PY 1998
VL 54
IS 2
BP 85
EP 92
DI 10.2115/fiber.54.2_85
PG 8
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA ZF709
UT WOS:000072924200010
OA Bronze
DA 2018-10-19
ER

PT B
AU Richardson, MC
   Rajyaguru, JM
   Kado, M
   Yamamoto, Y
   Friedman, H
   Muszynski, MJ
AF Richardson, MC
   Rajyaguru, JM
   Kado, M
   Yamamoto, Y
   Friedman, H
   Muszynski, MJ
BE Talwar, GP
   Nath, I
   Ganguly, NK
   Rao, KVS
TI High resolution (nanometer scale) X-ray imaging of live macrophage
   surface and pseudopodia
SO 10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 10th International Congress of Immunology
CY NOV 01-06, 1998
CL NEW DELHI, INDIA
AB Macrophage motility and migration are critical in phagocytosis but the mechanisms are not well defined, High resolution X-ray microscopy of live cells is relatively new in biomedical application, We used laser plasma to X-ray images of live hydrated macrophages. A sealed 5 mu l cell suspension was placed on photoresist, and exposed to X-rays tuned for carbon-rich material. Atomic force microscope scans for differential absorption showed the first X-ray images of live thioglycollate-elicited murine peritoneal macrophages, No fixatives or stains were used, Macrophages expressing circular and oval globuiar pseudopodia were seen, Higher resolution scans of cell surface showed fine long hair-like extensions protruding out and extending away from the cell, These latter processes may be involved in determination of chemotaxis which is very important in phagocytosis.
C1 Univ Cent Florida, Orlando, FL 32816 USA.
RP Richardson, MC (reprint author), Univ Cent Florida, Orlando, FL 32816 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
BN 88-323-1101-1
PY 1998
BP 595
EP 598
PG 4
WC Immunology
SC Immunology
GA BM18S
UT WOS:000077938500099
DA 2018-10-19
ER

PT S
AU Powell, DJ
   Mould, J
   Wojcik, GL
AF Powell, DJ
   Mould, J
   Wojcik, GL
BE Schneider, SC
   Levy, M
   McAvoy, BR
TI Dielectric and mechanical absorption mechanisms for time and frequency
   domain transducer modeling
SO 1998 IEEE ULTRASONICS SYMPOSIUM - PROCEEDINGS, VOLS 1 AND 2
SE ULTRASONICS SYMPOSIUM
LA English
DT Proceedings Paper
CT 1998 IEEE Ultrasonics Symposium
CY OCT 05-08, 1998
CL SENDAI, JAPAN
SP IEEE, Ultrason Ferroelect & Frequency Control Soc
AB In all practical transduction systems-such as biomedical imaging arrays, underwater sonar systems or piezoelectric actuators and transformers, electromechanical losses impact overall system performance. Adverse effects of these losses include heat generation, sub-optimal electrical matching, and reduced operational efficiency. Consequently, it is imperative to fully understand the implications of loss mechanisms and incorporate them properly in numerical and analytical models. In this paper, time-domain electromechanical absorption mechanisms are studied in terms of their physical mechanisms and frequency-domain counterparts. We examine the mechanical and dielectric losses of some common piezoelectric materials and discuss some of the issues that arise in attempting to measure and model them.
C1 Weidlinger Assoc Inc, Los Altos, CA 94022 USA.
RP Powell, DJ (reprint author), Weidlinger Assoc Inc, Los Altos, CA 94022 USA.
CR GERHARDT R, 1998, ADV DIELECTRIC CERAM, V88, P41
   HAYWARD G, 1984, ULTRASONICS      JUL, P153
   IEEE An American National Standard, 1988, IEEE STAND PIEZ
   Kino G. S., 1987, ACOUSTIC WAVES DEVIC
   *PENNW CORP, 1987, KYN PIEZ FILM TECHN
   *TASI, TASI TECHN SOFTW
   WOJCIK G, P 1995 IEEE ULTR S, P1617
NR 7
TC 3
Z9 3
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1051-0117
BN 0-7803-4096-5
J9 ULTRASON
PY 1998
BP 1019
EP 1024
PG 6
WC Acoustics; Engineering, Electrical & Electronic
SC Acoustics; Engineering
GA BM87A
UT WOS:000079968900223
DA 2018-10-19
ER

PT S
AU LeClair, T
   Harper, A
   Graham, S
   Ackley, D
AF LeClair, T
   Harper, A
   Graham, S
   Ackley, D
GP SOC PHOTO OPT INSTRUMENTAT ENGINEERS
   SOC PHOTO OPT INSTRUMENTAT ENGINEERS
TI Flip chin interconnection of DNA chip devices
SO 1998 INTERNATIONAL SYMPOSIUM ON MICROELECTRONICS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 1998 International Symposium on Microelectronics
CY NOV 01-04, 1998
CL SAN DIEGO, CA
SP Int Microelectron & Pkg Soc
DE gene chips; flip chip interconnects; Ag adhesive bumps; Sn/Pb solder
   bumps; fine line polyimide flex circuits; fluidic interfaces to Si chips
AB Nanogen has developed a novel instrument system that utilizes silicon microelectronic technologies to execute rapid DNA hybridization analyses optimized for diagnostic and research applications. This system incorporates an active DNA away-formatted Si microchip, that is flip-chip mounted to a polyimide flex circuit microfluidic cartridge assembly. This disposable cartridge assembly is inserted for analysis into Nanogen's desktop instrument much like a music CD enters the CD player drawer. Multiplex DNA hybridization, electronic control of hybridization stringency, sample detection, and computer analysis functions can be automatically performed within a 10 to 15 minute timeframe. Present applications are directed at infectious disease detection, genetic testing, drug discovery, and biomedical research. The microelectronic materials and processes selected for the DNA chip, the interconnection circuits, the cartridge fluidics, and the optical detection system will be presented.
C1 Nanogen Inc, San Diego, CA 92121 USA.
RP LeClair, T (reprint author), Nanogen Inc, 10398 Pacific Ctr Court, San Diego, CA 92121 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-930815-52-1
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3582
BP 732
EP 736
PG 3
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BM46L
UT WOS:000078815800124
DA 2018-10-19
ER

PT J
AU Callesen, H
   Greve, T
   Avery, B
AF Callesen, H
   Greve, T
   Avery, B
TI Embryo technology in cattle: Brief review
SO ACTA AGRICULTURAE SCANDINAVICA SECTION A-ANIMAL SCIENCE
LA English
DT Article; Proceedings Paper
CT Bertebos Prize Symposium on Impact of Reproductive Technology on Animal
   Breeding and Genetic Conservation
CY SEP 18-19, 1997
CL FALKENBERG, SWEDEN
DE embryo cloning; embryo technology; in vitro embryo production; in vivo
   embryo production; sexing of semen; vitrification of embryos
ID PREIMPLANTATION MOUSE EMBRYOS; LOW-TEMPERATURE PRESERVATION;
   INVITRO-FERTILIZED EMBRYOS; CHROMOSOME-BEARING SPERM; VITRIFIED BOVINE
   EMBRYOS; VITRO PRODUCED EMBRYOS; DEVELOPMENT PED GENE; IN-VITRO; NUCLEAR
   TRANSFER; SEX DETERMINATION
AB Aspects of embryo technology are discussed with the main emphasis on cattle. In vivo embryo production with recovery of embryos from superovulated animals followed by freezing and transfer of embryos is performed routinely. The average yield of transferable embryos obtained in the Danish MOET project is six originating from approximately 80% of the superovulated donors. The pregnancy rate following non-surgical transfer of fresh or frozen embryos is around 50% and the fetal loss 5%. In vitro production of embryos based on oocytes recovered from slaughterhouse material or from live animals following ultrasound guided transvaginal oocyte recovery (OPU or TVOR) is used in many laboratories for experimentation and also in practice as an alternative or supplement to in vivo embryo production. The expected rate of blastocyst formation on day 8 after insemination reaches 40-50% in several laboratories. The main problem encountered with in vitro production is the reduced viability of embryos compared with their in vivo counterparts. This is particularly apparent following freezing and thawing. Vitrification of embryos seems to be a valuable alternative to conventional freezing of embryos which have a more fragile constitution, e.g. early in vitro produced or cloned embryos. Sexing of embryos through PCR analysis of embryo biopsies is used in embryo transfer practice in several countries. Sexing of semen is still at the experimental level and is used in conjunction with in vitro production of calves. Cloning of embryos is in progress in many laboratories, but with limited success. Current blastocyst and pregnancy rates are 30% and 20%, respectively, but the rate of fetal loss is high. Factors such as cell cycle synchrony, remodelling and reprogramming of the introduced nucleus still need further elucidation before a more widespread practical use of this technology. Genetically modified animals are used for production of certain valuable pharmaceuticals in their milk and to improve certain growth charateristics. The actual success is still limited, but transgenic pigs will be used in biomedical research in the future. Production of embryonic stem cell-like cell lines has been successful in certain laboratories.
C1 Danish Inst Agr, Embryo Technol Ctr, DK-8830 Tjele, Denmark.
   Royal Vet & Agr Univ, Dept Clin Studies, DK-1870 Frederiksberg C, Denmark.
RP Callesen, H (reprint author), Danish Inst Agr, Embryo Technol Ctr, DK-8830 Tjele, Denmark.
OI Callesen, Henrik/0000-0002-0185-7300
CR ARMSTRONG DT, 1993, THERIOGENOLOGY, V39, P7, DOI 10.1016/0093-691X(93)90021-V
   Avery B., 1993, Ars Veterinaria, V9, P35
   AVERY B, 1992, MOL REPROD DEV, V32, P265, DOI 10.1002/mrd.1080320312
   AVERY B, 1991, THERIOGENOLOGY, V35, P953, DOI 10.1016/0093-691X(91)90306-X
   AVERY B, 1989, J REPROD FERTIL, V87, P627
   AVERY B, 1989, ACTA VET SCAND, V30, P147
   AVERY B, 1995, P 30 INT S SIPZ, P171
   BAK A, 1989, Theriogenology, V31, P170, DOI 10.1016/0093-691X(89)90578-5
   BAK A, 1989, Theriogenology, V31, P169, DOI 10.1016/0093-691X(89)90577-3
   BARNES F, 1993, J REPROD FERTIL, V97, P317
   BARNES FL, 1993, MOL REPROD DEV, V36, P33, DOI 10.1002/mrd.1080360106
   BOLAND MP, 1993, MOL REPROD DEV, V36, P266, DOI 10.1002/mrd.1080360227
   BOLAND MP, 1978, THERIOGENOLOGY, V10, P175, DOI 10.1016/0093-691X(78)90018-3
   BOLAND MP, 1994, P 1 EUR C PROGR EMBR, P103
   BONDIOLI KR, 1990, THERIOGENOLOGY, V33, P165, DOI 10.1016/0093-691X(90)90607-U
   BRAND A, 1978, ANIM PROD, V26, P55, DOI 10.1017/S0003356100012009
   BRAND A, 1977, EMBRYO TRANSFER FARM, V16, P31
   BRANDENHOFF HR, 1994, P 10 SCI M AETE LYON, P156
   BREDBACKA P, 1994, THERIOGENOLOGY, V41, P1023, DOI 10.1016/S0093-691X(05)80025-1
   BREM G, 1992, PORTL PR P, P147
   BUEHR M, 1994, GENETICALLY MODIFIED
   CALLESEN H, 1992, PORTL PR P, P207
   CALLESEN H, 1995, J ANIM SCI, V73, P1539
   CALLESEN H, 1986, THERIOGENOLOGY, V25, P71, DOI 10.1016/0093-691X(86)90184-6
   Callesen H, 1996, ANIM REPROD SCI, V42, P215, DOI 10.1016/0378-4320(96)01513-8
   CALLESEN H, 1997, EMBRYO TRANSFER PHYS, P23
   Callesen H, 1994, P 10 SCI M AETE LYON, P125
   Callesen H, 1994, P 1 INT EUR C PROGR, P97
   Campbell K. H. S., 1993, Theriogenology, V39, P199, DOI 10.1016/0093-691X(93)90054-9
   CAMPBELL KHS, 1994, BIOL REPROD, V50, P1385, DOI 10.1095/biolreprod50.6.1385
   CAMPBELL KHS, 1993, BIOL REPROD, V49, P933, DOI 10.1095/biolreprod49.5.933
   CASSAR G, 1994, J REPROD FERTIL, V101, P317
   CHESNE P, 1992, P 8 SCI M AETE LYON, P138
   CHRISTENSEN LG, 1991, THERIOGENOLOGY, V35, P141, DOI 10.1016/0093-691X(91)90153-5
   CHUPIN D, 1979, ANN BIOL ANIM BIOCH, V19, P1489, DOI 10.1051/rnd:19790911
   CLARK AJ, 1989, BIO-TECHNOL, V7, P487, DOI 10.1038/nbt0589-487
   CLEMENTSENGEWALD A, 1993, REPROD DOMEST ANIM, V28, P399, DOI 10.1111/j.1439-0531.1993.tb01015.x
   CRAN DG, 1993, VET REC, V132, P40, DOI 10.1136/vr.132.2.40
   CRAN DG, 1992, PORTL PR P, P125
   CRITSER JK, 1980, THERIOGENOLOGY, V13, P397, DOI 10.1016/0093-691X(80)90066-7
   DENDAAS N, 1994, P 10 REUN AETE LY SE, P117
   DIELEMAN SJ, 1993, MOL REPROD DEV, V36, P271, DOI 10.1002/mrd.1080360228
   Ding Jianchi, 1995, Theriogenology, V43, P196, DOI 10.1016/0093-691X(95)92350-I
   DUFOUR E, 1994, P 10 SCI M AETE LYON, P166
   Fair T., 1995, Theriogenology, V43, P209, DOI 10.1016/0093-691X(95)92363-E
   FAIR T, 1994, P 10 SCI M AETE LYON, P168
   FIGUEIREDO JR, 1994, THERIOGENOLOGY, V42, P1303, DOI 10.1016/0093-691X(94)90250-M
   Gall L., 1995, Theriogenology, V43, P215, DOI 10.1016/0093-691X(95)92369-K
   GALLI C, 1994, P 1 EUR C PROGR EMBR, P111
   GOLDBARD SB, 1985, BIOL REPROD, V33, P30, DOI 10.1095/biolreprod33.1.30
   GORDON I, 1994, LAB PRODUCTION CATTL
   GREVE T, 1991, REPROD NUTR DEV, V31, P147, DOI 10.1051/rnd:19910205
   GREVE T, 1992, REPROD DOMEST ANIM, V27, P22, DOI 10.1111/j.1439-0531.1992.tb00372.x
   GREVE T, 1993, REPROD DOMEST ANIM, V28, P164, DOI 10.1111/j.1439-0531.1993.tb00113.x
   GREVE T, 1977, THERIOGENOLOGY, V7, P239, DOI 10.1016/0093-691X(77)90220-5
   GREVE T, 1979, ACTA VET SCAND, V20, P135
   GREVE T, 1981, THESIS COPENHAGEN
   HAHN J, 1978, DEUT TIERARZTL WOCH, V85, P140
   HAHN J, 1992, THERIOGENOLOGY, V38, P269, DOI 10.1016/0093-691X(92)90235-J
   HASLER JF, 1995, THERIOGENOLOGY, V43, P141, DOI 10.1016/0093-691X(94)00020-U
   HASLER JF, 1987, THERIOGENOLOGY, V27, P139, DOI 10.1016/0093-691X(87)90075-6
   HEYMAN Y, 1994, THERIOGENOLOGY, V42, P695, DOI 10.1016/0093-691X(94)90386-W
   Heyman Y., 1995, Theriogenology, V43, P234, DOI 10.1016/0093-691X(95)92388-P
   HEYMAN Y, 1993, P 9 SCI M AETE LYON, P210
   HYTTEL P, 1988, J REPROD FERTIL, V82, P1
   JENSEN AM, 1982, THERIOGENOLOGY, V18, P33, DOI 10.1016/0093-691X(82)90046-2
   Johnson LA, 1995, REPROD FERT DEVELOP, V7, P893, DOI 10.1071/RD9950893
   KRIMPENFORT P, 1991, BIO-TECHNOL, V9, P844, DOI 10.1038/nbt0991-844
   KRUIP TAM, 1994, P 1 EUR C PROGR EMBR, P117
   LAVITRANO M, 1992, PORTL PR P, P165
   LEHNJENSEN H, 1978, THERIOGENOLOGY, V9, P313, DOI 10.1016/0093-691X(78)90124-3
   LEHNJENSEN H, 1986, THESIS COPENHAGEN
   LOHUIS MM, 1993, ANIM PROD, V57, P369, DOI 10.1017/S1357729800042697
   Loskutoff N. M., 1993, Theriogenology, V39, P263, DOI 10.1016/0093-691X(93)90118-O
   LU KH, 1987, VET REC, V121, P259, DOI 10.1136/vr.121.11.259
   MAHMOUDZADEH AR, 1994, THERIOGENOLOGY, V42, P1389, DOI 10.1016/0093-691X(94)90259-L
   MAHMOUDZADEH AR, 1993, THERIOGENOLOGY, V39, P1291, DOI 10.1016/0093-691X(93)90231-S
   Marquant-Le-Guienne B, 1992, THERIOGENOLOGY, V37, P253, DOI DOI 10.1016/0093-691X(92)90322-I
   MARQUANTLEGUIENNE B, 1990, REPROD NUTR DEV, V30, P259, DOI 10.1051/rnd:19900212
   MASSIP A, 1993, J REPROD FERTIL, V97, P65
   MASSIP A, 1979, THERIOGENOLOGY, V12, P79, DOI 10.1016/0093-691X(79)90012-8
   MASSIP A, 1993, P 9 SCI M AETE LYON, P240
   MERMILLOD P, 1992, P 8 SCI M AETE LYON, P194
   MILLER JR, 1991, REPROD DOMEST ANIM, V26, P58, DOI 10.1111/j.1439-0531.1991.tb01515.x
   MOOR R, 1992, ANIM REPROD SCI, V28, P423, DOI 10.1016/0378-4320(92)90129-2
   MULLER M, 1992, J INTERFERON RES, V12, P119, DOI 10.1089/jir.1992.12.119
   NEWCOMB R, 1980, VET REC, V106, P48, DOI 10.1136/vr.106.3.48
   Newcomb R., 1976, Egg transfer in cattle. Seminar on egg transfer in cattle in the EEC programme of co-ordination of research on beef production, Cambridge, 1975., P1
   Newcomb R., 1978, CURRENT TOPICS VET M, VI, P292
   NIBART M, 1992, PORTL PR P, P215
   Nicholas FW, 1996, ANIM REPROD SCI, V42, P205, DOI 10.1016/0378-4320(96)01511-4
   NIEMANN H, 1993, LIVEST PROD SCI, V36, P17, DOI 10.1016/0301-6226(93)90132-2
   NIEMANN H, 1982, THERIOGENOLOGY, V18, P445, DOI 10.1016/0093-691X(82)90166-2
   NIEMANN H, 1991, THERIOGENOLOGY, V35, P109, DOI 10.1016/0093-691X(91)90151-3
   NIEMANN H, 1992, Theriogenology, V37, P265, DOI 10.1016/0093-691X(92)90334-N
   NIEMANN H, 1994, P 1 EUR C PROGR EMBR, P157
   NOTARIANNI E, 1992, PORTL PR P, P175
   OTTESEN J, 1997, THESIS ROYAL VET AGR
   PAVLOK A, 1992, MOL REPROD DEV, V31, P63, DOI 10.1002/mrd.1080310111
   PEURA T, 1991, THERIOGENOLOGY, V35, P547, DOI 10.1016/0093-691X(91)90451-I
   PIETERSE MC, 1991, THERIOGENOLOGY, V35, P857, DOI 10.1016/0093-691X(91)90426-E
   PIETERSE MC, 1988, THERIOGENOLOGY, V30, P751, DOI 10.1016/0093-691X(88)90310-X
   POLGE C, 1991, P 7 SCI M AETE CAMBR, P103
   PROCHAZKA R, 1990, Theriogenology, V33, P301, DOI 10.1016/0093-691X(90)90725-9
   PURSEL VG, 1993, J ANIM SCI, V71, P10, DOI 10.2527/1993.71suppl_310x
   Rao V. H., 1993, Theriogenology, V39, P292, DOI 10.1016/0093-691X(93)90147-W
   RATH D, 1996, P 12 SCI M AETE LYON, P103
   REICHENBACH HD, 1992, J REPROD FERTIL, V95, P363
   Reinders J. M. C., 1995, Theriogenology, V43, P306, DOI 10.1016/0093-691X(95)92460-Q
   RENARD JP, 1981, THERIOGENOLOGY, V15, P311, DOI 10.1016/0093-691X(81)90052-2
   Roschlau K, 1989, J Reprod Fertil Suppl, V38, P153
   ROWSON LEA, 1972, J REPROD FERTIL, V28, P427
   ROWSON LEA, 1971, NATURE, V233, P379, DOI 10.1038/233379a0
   SAUMANDE J, 1978, CURRENT TOPICS VET M, V1, P195
   SAUMANDE J, 1978, CURRENT TOPICS VET M, V1, P169
   SCHAMS D, 1979, ZUCHTHYGIENE, V14, P11
   SCHIEWE MC, 1983, THERIOGENOLOGY, V19, P147, DOI 10.1016/0093-691X(83)90165-6
   Schmidt M, 1996, THERIOGENOLOGY, V46, P527, DOI 10.1016/0093-691X(96)00174-4
   SCHROEDER A, 1990, Animal Biotechnology, V1, P121
   SCHWERIN M, 1994, THERIOGENOLOGY, V41, P553, DOI 10.1016/0093-691X(94)90090-6
   SHAMSUDDIN M, 1993, THERIOGENOLOGY, V39, P1067, DOI 10.1016/0093-691X(93)90007-R
   Sims M. M., 1993, Theriogenology, V39, P313, DOI 10.1016/0093-691X(93)90168-5
   Smith S, 1994, P 10 SCI M AETE LYON, P248
   Techakumphu M., 1993, Theriogenology, V39, P328, DOI 10.1016/0093-691X(93)90183-6
   TECHAKUMPHU M, 1992, P 8 SCI M AETE LYON, P218
   THIBIER M, 1995, THERIOGENOLOGY, V43, P71, DOI 10.1016/0093-691X(94)00008-I
   THIBIER M, 1996, EMBRYO TRANSFER NEWS, V14, P27
   THOMSEN PD, 1991, REPROD DOMEST ANIM, V26, P66, DOI 10.1111/j.1439-0531.1991.tb01516.x
   TROUNSON AO, 1978, THERIOGENOLOGY, V10, P111, DOI 10.1016/0093-691X(78)90085-7
   Vajta G, 1997, J REPROD FERTIL, V111, P65
   Vajta G, 1997, THERIOGENOLOGY, V47, P501, DOI 10.1016/S0093-691X(97)00008-3
   Vajta G, 1996, THERIOGENOLOGY, V45, P683, DOI 10.1016/0093-691X(95)00414-4
   Vajta G, 1997, CRYO-LETT, V18, P191
   Vajta G, 1996, ANIM REPROD SCI, V45, P191, DOI 10.1016/S0378-4320(96)01583-7
   VALDIVIA RPA, 1993, MOL REPROD DEV, V35, P121, DOI 10.1002/mrd.1080350204
   Van Wagtendonk-De Leeuw A. M., 1994, Theriogenology, V41, P326, DOI 10.1016/S0093-691X(05)80236-5
   VANDERSCHANS A, 1992, 12TH P INT C AN REPR, V3, P1366
   VANSOOM A, 1994, THERIOGENOLOGY, V41, P855, DOI 10.1016/0093-691X(94)90501-9
   Wall RJ, 1996, THERIOGENOLOGY, V45, P57, DOI 10.1016/0093-691X(95)00355-C
   WARNER CM, 1987, BIOL REPROD, V36, P611, DOI 10.1095/biolreprod36.3.611
   WARNER CM, 1987, BIOL REPROD, V36, P606, DOI 10.1095/biolreprod36.3.606
   WESTHUSIN ME, 1992, J REPROD FERTIL, V95, P475
   WILLADSEN S, 1978, J REPROD FERTIL, V52, P391
   WILLADSEN SM, 1986, NATURE, V320, P63, DOI 10.1038/320063a0
   WILLADSEN SM, 1991, THERIOGENOLOGY, V35, P161, DOI 10.1016/0093-691X(91)90155-7
   WILLADSEN SM, 1979, NATURE, V277, P298, DOI 10.1038/277298a0
   WILLADSEN SM, 1981, VET REC, V108, P211, DOI 10.1136/vr.108.10.211
   WILMUT, 1992, EMBRYONIC DEV MANIPU, P135
   WILMUT I, 1973, VET REC, V92, P686, DOI 10.1136/vr.92.26.686
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   WILMUT I, 1992, ANIM REPROD SCI, V28, P149, DOI 10.1016/0378-4320(92)90101-I
   WILMUT I, 1972, J REPROD FERTIL, V31, P513
   WURTH YA, 1994, THERIOGENOLOGY, V42, P1275, DOI 10.1016/0093-691X(94)90247-G
   XU KP, 1992, MOL REPROD DEV, V31, P249, DOI 10.1002/mrd.1080310404
   XU KP, 1987, J REPROD FERTIL, V81, P501
   YADAV BR, 1993, MOL REPROD DEV, V36, P434, DOI 10.1002/mrd.1080360405
NR 156
TC 0
Z9 0
U1 1
U2 7
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0906-4702
J9 ACTA AGR SCAND A-AN
JI Acta Agric. Scand. Sect. A-Anim. Sci.
PY 1998
SU 29
BP 19
EP 29
PG 11
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA 146WU
UT WOS:000077456200004
DA 2018-10-19
ER

PT J
AU Burtscher, IM
   Owman, T
   Romner, B
   Stahlberg, F
   Holtas, S
AF Burtscher, IM
   Owman, T
   Romner, B
   Stahlberg, F
   Holtas, S
TI Aneurysm clip MR artifacts - Titanium versus stainless steel and
   influence of imaging parameters
SO ACTA RADIOLOGICA
LA English
DT Article
DE brain, aneurysm clip; implants; MR imaging, artifacts
ID FAST SPIN-ECHO; METALLIC IMPLANTS; BIOMEDICAL IMPLANTS; POTENTIAL
   HAZARDS; MAGNETIC-FIELDS; DEVICES; FERROMAGNETISM; STRENGTH; IMAGES;
   SAFETY
AB Purpose. The aim of this study was to evaluate the extent to which titanium aneurysm clips could improve the quality of MR imaging compared with stainless steel clips, and to determine whether the clip artifacts could be reduced by controlling certain MR imaging parameters in frequently used pulse sequences.
   Material and Methods. The metal artifacts induced by 3 aneurysm clips were compared in 3 pulse sequences. The clips were: a Yasargil titanium aneurysm clip FT 752 T; a Yasargil standard aneurysm clip FE 752 K; and, for comparison. a ferromagnetic Scoville aneurysm clip En-58J. The pulse sequences were: spin echo (SE); gradient echo (GE); and fast SE. An evaluation was made of 3 imaging parameters with regard to their influence on the size of the metal artifacts. The parameters were: bandwidth; echo time (TE); and echo-train length.
   Results: The titanium clip showed artifacts that were about 60% smaller than those from the stainless steel clip. The only parameter that influenced artifact size to any major degree was bandwidth in the SE sequences but not in the GE sequences. GE sequences induced larger artifacts than SE sequences and showed larger artifacts with longer TE.
   Conclusion: Titanium aneurysm clips reduced MR artifacts by approximately 60% compared to stainless steel clips. Artifacts were further reduced by using SE-based sequences with a high bandwidth or, if necessary, GE sequences with a low TE.
C1 Univ Lund Hosp, Dept Diagnost Radiol, S-22185 Lund, Sweden.
   Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden.
   Univ Lund Hosp, Dept Radiat Phys, S-22185 Lund, Sweden.
RP Burtscher, IM (reprint author), Univ Lund Hosp, Dept Diagnost Radiol, S-22185 Lund, Sweden.
CR BECKER RL, 1988, AM J NEURORADIOL, V9, P885
   BELLON EM, 1986, AM J ROENTGENOL, V147, P1271, DOI 10.2214/ajr.147.6.1271
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   DISEGI JA, 1992, INJURY, V23, P1
   GOMORI JM, 1987, J COMPUT ASSIST TOMO, V11, P684, DOI 10.1097/00004728-198707000-00025
   HOLTAS S, 1988, AM J NEURORADIOL, V9, P891
   JOHNSON GC, 1993, RADIOLOGY, V188, P287, DOI 10.1148/radiology.188.1.8511314
   JONES KM, 1992, AM J ROENTGENOL, V158, P1313, DOI 10.2214/ajr.158.6.1590133
   JONES KM, 1992, RADIOLOGY, V182, P53, DOI 10.1148/radiology.182.1.1727309
   KAGETSU NJ, 1991, RADIOLOGY, V179, P505, DOI 10.1148/radiology.179.2.2014301
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   KANAL E, 1994, AM J NEURORADIOL, V15, P1394
   KANAL E, 1993, RADIOLOGY, V187, P612, DOI 10.1148/radiology.187.3.8497603
   KANAL E, 1993, RADIOLOGY, V186, P914
   KANAL E, 1992, TODAY VIDEO, P6
   KLUCZNIK RP, 1993, RADIOLOGY, V187, P855, DOI 10.1148/radiology.187.3.8497645
   LAAKMAN RW, 1985, RADIOLOGY, V157, P711, DOI 10.1148/radiology.157.3.4059558
   Ludeke K M, 1985, Magn Reson Imaging, V3, P329, DOI 10.1016/0730-725X(85)90397-2
   MESGARZADEH M, 1985, SKELETAL RADIOL, V14, P205, DOI 10.1007/BF00355565
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   OEHLER MC, 1995, AM J NEURORADIOL, V16, P1135
   PHILLIPS DS, 1978, BASIC STAT HLTH SCI
   PIEPGRAS A, 1995, RADIOLOGE, V35, P1
   ROMNER B, 1989, J NEUROSURG, V70, P426, DOI 10.3171/jns.1989.70.3.0426
   RUPP R, 1993, SPINE, V18, P379
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1994, J MAGN RESON IMAGING, V4, P756, DOI 10.1002/jmri.1880040521
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   SHELLOCK FG, 1994, RADIOLOGY P, V193, P266
   SZE G, 1993, AM J NEURORADIOL, V14, P1203
   TARTAGLINO LM, 1994, RADIOLOGY, V190, P565, DOI 10.1148/radiology.190.2.8284417
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
   VACCARO AR, 1994, SPINE, V19, P1237, DOI 10.1097/00007632-199405310-00008
   VINITSKI S, 1993, JMRI-J MAGN RESON IM, V3, P501, DOI 10.1002/jmri.1880030312
NR 35
TC 22
Z9 28
U1 0
U2 1
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0284-1851
J9 ACTA RADIOL
JI Acta Radiol.
PD JAN
PY 1998
VL 39
IS 1
BP 70
EP 76
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA YU555
UT WOS:000071729600013
PM 9498874
DA 2018-10-19
ER

PT S
AU Narayan, RJ
   Wei, Q
   Sharma, AK
   Cuomo, JJ
   Narayan, J
AF Narayan, RJ
   Wei, Q
   Sharma, AK
   Cuomo, JJ
   Narayan, J
BE Singh, RK
   Lowndes, DH
   Chrisey, DB
   Fogarassy, E
   Narayan, J
TI Diamondlike carbon, carbon nitride, and titanium nitride coatings on
   metal and polymer substrates
SO ADVANCES IN LASER ABLATION OF MATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Advances in Laser Ablation of Materials at the 1998 MRS
   Spring Meeting
CY APR 13-16, 1998
CL SAN FRANCISCO, CA
SP Mat Res Soc (MRS)
AB We have deposited diamondlike carbon, carbon nitride, and titanium nitride biocompatible coatings using pulsed laser deposition and magnetron sputtering on metallic (cobalt-chromium and titanium- 6% aluminum- 4% vanadium) and polymeric (high-density polyethylene) substrates commonly used in human prosthetic devices. A major advantage of the magnetron sputtering deposition technique is that it provides conformal coverage of large-area films. The coatings were characterized by electron diffraction and imaging, Raman spectroscopy, X- ray photoelectron spectroscopy, and electron- energy loss spectroscopy, and nanoindenter hardness measurements. The physical properties (especially hardness) of the diamondlike carbon films were controlled using carbide and noncarbide forming elements. By varying the doping concentration as a function of thickness, functionally gradient materials with superior tribological and mechanical properties can be created. The implications of these results are discussed in the context of biomedical applications.
C1 N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
RP Narayan, RJ (reprint author), N Carolina State Univ, Dept Mat Sci & Engn, Box 7907, Raleigh, NC 27695 USA.
RI Narayan, Roger/J-2789-2013; Wei, Qiuming/B-7579-2008; Narayan,
   Jagdish/D-1874-2009
OI Narayan, Roger/0000-0002-4876-9869; 
NR 0
TC 2
Z9 2
U1 0
U2 6
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-432-7
J9 MATER RES SOC SYMP P
PY 1998
VL 526
BP 355
EP 360
DI 10.1557/PROC-526-355
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Optics
SC Materials Science; Optics
GA BM12Q
UT WOS:000077696000054
DA 2018-10-19
ER

PT S
AU Cales, B
   Chevalier, J
AF Cales, B
   Chevalier, J
BE Jacobs, JJ
   Craig, TL
TI Wear behavior of ceramic pairs compared on different testing
   configurations
SO ALTERNATIVE BEARING SURFACES IN TOTAL JOINT REPLACEMENT
SE American Society for Testing and Materials Selected Technical Papers
LA English
DT Proceedings Paper
CT Symposium on Alternative Bearing Surfaces in Total Joint Replacement
CY NOV 11-12, 1997
CL SAN DIEGO, CA
SP ASTM Comm F04
DE zirconia ceramic; ceramic-on-ceramic; wear test; hip joint simulator;
   finite element analysis; total hip prosthesis
ID ZIRCONIA
AB The wear properties of ceramic pairs including a biomedical grade zirconia ceramic (PROZYR(R)) were studied. In a simple disk-on-disk wear test in synthetic serum, the best wear behavior was observed with alumina-zirconia pairing. These tests also showed that the zirconia-zirconia combination can be considered for hip joint applications because it demonstrates wear behavior close to the classic alumina-alumina pairing. Hip simulator tests up to 10 million cycles for zirconia-alumina combinations confirm the previous experiments. It is clearly shown, if zirconia ceramic material and convenient wear test procedures are used, that the wear behavior of zirconia ceramic in ceramic-ceramic pairing is outstanding. The wear performance of zirconia was similar to, if not better than, that of alumina. Furthermore, tensile stresses in heads and cups, determined using finite element analysis, were found to be significantly higher in ceramic-on-ceramic bearings than in conventional ceramic-on-polyethylene couplings. This may influence the incidence of ceramic component fractures in ceramic-on ceramic bearings and may have implications concerning ceramic material selection for this application.
C1 Norton Desmarquest, Biomed Act, F-27025 Evreux, France.
RP Cales, B (reprint author), Norton Desmarquest, Biomed Act, ZI N1,Rue de Ind, F-27025 Evreux, France.
CR Birkby I., 1989, Journal of the European Ceramic Society, V5, P37, DOI 10.1016/0955-2219(89)90007-1
   Black J, 1996, CLIN ORTHOP RELAT R, pS244
   BOUTIN P, 1988, J BIOMED MATER RES, V22, P1203, DOI 10.1002/jbm.820221210
   CALES B, 1995, 4 EUROCERAMICS, V8, P45
   Chan FW, 1996, CLIN ORTHOP RELAT R, P96
   CHEVALIER J, 1997, BIOCERAMICS, V8, P271
   CHRISTEL PS, 1989, B HOSP JOINT DIS ORT, V49, P170
   Fritsch EW, 1996, CLIN ORTHOP RELAT R, P129
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Jacobs JJ, 1996, CLIN ORTHOP RELAT R, pS256
   KABO JM, 1993, J BONE JOINT SURG BR, V75, P254
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   LEE SW, 1993, J AM CERAM SOC, V76, P1937, DOI 10.1111/j.1151-2916.1993.tb08315.x
   MANLEY MT, 1994, CLIN ORTHOP RELAT R, V298, P37
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   MCKELLOP H, 1996, 5 WORLD BIOM C TOR M
   MCKELLOP H, 1992, P ORTH RES SOC M WAS
   Michaud RJ, 1995, J ARTHROPLASTY, V10, P863, DOI 10.1016/S0883-5403(05)80089-0
   MULLER ME, 1970, CLIN ORTHOP RELAT R, P46
   Paul J. P, 1967, P I MECH ENG, V181, P8
   POLINELI VK, 1992, 23 ANN M SOC BIOM NE
   Ring P A, 1968, J Bone Joint Surg Br, V50, P720
   RISKA EB, 1993, CLIN ORTHOP RELAT R, V297, P87
   Schmalzried TP, 1996, J ARTHROPLASTY, V11, P322, DOI 10.1016/S0883-5403(96)80085-4
   SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60
   SCHMALZRIED TP, 1994, J BONE JOINT SURG AM, V76A, P677, DOI 10.2106/00004623-199405000-00008
   SEDEL L, 1994, CLIN ORTHOP RELAT R, V298, P175
   SYCHTERZ CJ, 1995, J BONE JOINT SURG AM, V78, P1311
   Willmann G, 1996, BIOMATERIALS, V17, P2157, DOI 10.1016/0142-9612(96)00042-7
   Wright T., 1996, IMPLANT WEAR FUTURE
NR 30
TC 3
Z9 3
U1 0
U2 0
PU AMER SOCIETY TESTING AND MATERIALS
PI W CONSHOHOCKEN
PA 100 BARR HARBOR DRIVE, W CONSHOHOCKEN, PA 19428-2959 USA
SN 0066-0558
BN 0-8031-2490-2
J9 AM SOC TEST MATER
PY 1998
VL 1346
BP 186
EP 196
DI 10.1520/STP12839S
PG 11
WC Engineering, Biomedical; Orthopedics
SC Engineering; Orthopedics
GA BM49Q
UT WOS:000078897100013
DA 2018-10-19
ER

PT J
AU Chang, CY
   Glassman, AB
   Bueso-Ramos, CE
AF Chang, CY
   Glassman, AB
   Bueso-Ramos, CE
TI Applicability of direct in situ reverse transcription-polymerase chain
   reaction on bone marrow smears
SO ANNALS OF CLINICAL AND LABORATORY SCIENCE
LA English
DT Article
ID LEUKEMIA PATIENTS; REACTION PCR; EXPRESSION; ABL; BCR; AMPLIFICATION;
   LOCALIZATION; CELLS
AB In situ reverse transcription (RT)-polymerase chain reaction (PCR) is a promising laboratory tool for biomedical investigation at the molecular level in tissues. Direct in-cell amplification of the breakpoint cluster region (BCR)-Abelson (ABL) fusion transcript of chronic myeloid leukemia (CML) has recently been accomplished in Italy using bone marrow mononuclear cell suspensions. The goals of this study are to determine if in situ RT-PCR amplification is possible on bone marrow spirate smears and to demonstrate any unique factors in this procedure. A commercially available method was used because of the existence of published protocols for adaptation. Bone marrow (BM) aspirate smears (n = 17) from patients with CML in blast crisis (positive case material) or other hematological malignancies (negative case material) were evaluated. Satisfactory amplification of the BCR-ABL fusion transcript occurred, and distinct blue cytoplasmic granules that varied in intensity were found in most CML blasts. The negative case materials lacked the specifically amplified granular signals. Overall signal strength and backgrounds were readily affected by the quality of the specimen as well as by changes in assay parameters. In conclusion, the direct in situ RT-PCR technique is applicable for bone marrow aspirate smear evaluation. However, it remains an investigative tool until optimization for sensitivity, specificity, and accuracy can be achieved.
C1 Univ Texas, Md Anderson Canc Ctr, Div Lab Med, Hematopathol Sect, Houston, TX 77030 USA.
RP Bueso-Ramos, CE (reprint author), Univ Texas, Md Anderson Canc Ctr, Div Lab Med, Hematopathol Sect, Box 72,1515 Holcombe Blvd, Houston, TX 77030 USA.
CR BIERNAUX C, 1995, BLOOD, V86, P3118
   CROSS NCP, 1994, LEUKEMIA, V8, P186
   Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01
   HENIFORD BW, 1993, NUCLEIC ACIDS RES, V21, P3159, DOI 10.1093/nar/21.14.3159
   KOMMINOTH P, 1993, VIRCHOWS ARCH B, V64, P67, DOI 10.1007/BF02915097
   KONOPKA JB, 1986, P NATL ACAD SCI USA, V83, P4049, DOI 10.1073/pnas.83.11.4049
   MAKOWSKI GS, 1995, CLIN CHEM, V41, P477
   MARTINEZ A, 1995, J HISTOCHEM CYTOCHEM, V43, P739, DOI 10.1177/43.8.7542678
   Nuovo GJ, 1995, J HISTOTECHNOL, V18, P295
   NUOVO GJ, 1997, IN SITU HYBRIDIZATIO, P74
   OLeary JJ, 1996, J PATHOL, V178, P11
   PESTANER JP, 1994, ACTA CYTOL, V38, P676
   Roberts WM, 1997, NEW ENGL J MED, V336, P317, DOI 10.1056/NEJM199701303360501
   SALLSTROM JF, 1993, ANTICANCER RES, V13, P1153
   TAOKA T, 1993, LEUKEMIA RES, V17, P695, DOI 10.1016/0145-2126(93)90076-W
   Testoni N, 1996, BLOOD, V87, P3822
   TSONGALIS GJ, 1994, ANN CLIN LAB SCI, V24, P436
   WETZLER M, 1993, J CLIN INVEST, V92, P1925, DOI 10.1172/JCI116786
NR 18
TC 4
Z9 5
U1 0
U2 2
PU INST CLINICAL SCIENCE INC
PI PHILADELPHIA
PA 1833 DELANCEY PLACE, PHILADELPHIA, PA 19103 USA
SN 0091-7370
J9 ANN CLIN LAB SCI
JI Ann. Clin. Lab. Sci.
PD JAN-FEB
PY 1998
VL 28
IS 1
BP 34
EP 42
PG 9
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA YY337
UT WOS:000072137000006
PM 9512783
DA 2018-10-19
ER

PT J
AU Weiss, KM
AF Weiss, KM
TI Coming to terms with human variation
SO ANNUAL REVIEW OF ANTHROPOLOGY
LA English
DT Article
DE human genetics
ID HUMAN GENOME PROJECT; POPULATION-GENETICS; NATIVE-AMERICANS;
   HUMAN-EVOLUTION; HUMAN-DISEASES; HUMAN ORIGINS; DIVERSITY; DNA;
   MICROSATELLITES; MITOCHONDRIAL
AB Genetics has become the major tool of the life sciences. This is driven partly by technology, and partly by the belief that genes are the ultimate units of biomedical or evolutionary information. The search for variation associated with disease has motivated the Human Genome Project to construct a detailed road map of the entire set of human genetic material, and some additional form of globally representative human genome diversity resource has been proposed for the anthropological purposes of reconstructing human population history. Any such resource raises complex societal and ethical issues as well as scientific ones. However, the amount and complexity of genetic variation has frustrated hopes for simple genetic answers to important biomedical or anthropological questions, and a consequent converging of these differing interests suggests that developing a genetic variation resource will be important in many disciplines.
C1 Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.
RP Weiss, KM (reprint author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.
EM kmw4@psu.edu
CR Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516
   BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0
   Boyd W. C., 1950, GENETICS RACES MAN
   CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0
   Cavalli-Sforza L. L., 1971, GENETICS HUMAN POPUL
   Cavalli-Sforza LL, 1994, HSIT GEOGRAPHY HUMAN
   CAVALLISFORZA LL, 1990, AM J HUM GENET, V46, P649
   CAVALLISFORZA LL, 1991, GENOMICS, V11, P490, DOI 10.1016/0888-7543(91)90169-F
   CHADWICK D, 1996, CIBA FDN S, V197
   COLLINS F, 1993, SCIENCE, V262, P43, DOI 10.1126/science.8211127
   COLLINS FS, 1991, FASEB J, V5, P77
   Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580
   Cook-Deegan R., 1994, GENE WARS SCI POLITI
   DEKA R, 1995, AM J HUM GENET, V56, P461
   Deka R, 1996, GENOME RES, V6, P1177, DOI 10.1101/gr.6.12.1177
   Durham W. H., 1991, COEVOLUTION GENES CU
   EVANS E, 1995, GENOME DIG, V2, P12
   Friedlaender J. S., 1996, CULTURAL SURVIVAL Q, V20, P22
   Friedlaender J. S., 1975, PATTERNS HUMAN VARIA
   GREELY HT, 1996, CULTURAL SURVIVAL Q, V20, P54
   HAMMER M, 1997, EVOL ANTHROPOL, P116
   Harding RM, 1998, NAT GENET, V18, P307
   Harding RM, 1997, AM J HUM GENET, V60, P772
   HARPENDING H, 1974, ANNU REV ANTHROPOL, V3, P229, DOI 10.1146/annurev.an.03.100174.001305
   HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195
   Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961
   Hartl D. L., 1997, PRINCIPLES POPULATIO
   Hey J, 1997, MOL BIOL EVOL, V14, P166, DOI 10.1093/oxfordjournals.molbev.a025749
   *HGDP COMM, 1994, HUM GEN DIV HGD PROJ
   Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100
   KIDD JR, 1993, HUM BIOL, V65, P1
   Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4
   Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21
   LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226
   Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536
   LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110
   Merriwether DA, 1996, MOL PHYLOGENET EVOL, V5, P241, DOI 10.1006/mpev.1996.0017
   Moore J. H., 1996, RACE OTHER MISADVENT, P217
   MOORE JH, 1994, AM ANTHROPOL, V96, P925, DOI 10.1525/aa.1994.96.4.02a00110
   MOORE JH, 1994, RES EXPLOR, V10, P10
   MOORE JH, 1996, CULT SURVIVAL, V20, P60
   MOURANT A, 1978, DISTRIBUTION HUMAN B
   Mourant A, 1978, BLOOD GROUPS DIS
   National Research Council, 1997, EV HUM GEN DIV
   NEEL JV, 1978, ANNU REV GENET, V12, P365, DOI 10.1146/annurev.ge.12.120178.002053
   Nei M, 1987, MOL EVOLUTIONARY GEN
   OLSON MV, 1993, P NATL ACAD SCI USA, V90, P4338, DOI 10.1073/pnas.90.10.4338
   OROURKE DH, 1985, AM J PHYS ANTHROPOL, V67, P241, DOI 10.1002/ajpa.1330670309
   OROURKE DH, 1986, ANN HUM BIOL, V13, P13, DOI 10.1080/03014468600008171
   OTT J, 1991, ANAL HUMAN GENETIC L
   Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516
   ROYCHOUDHURY AK, 1988, HUMAN POLYMORPHIC GE
   SARICH VM, 1967, SCIENCE, V158, P1200, DOI 10.1126/science.158.3805.1200
   Sherry ST, 1997, GENOME RES, V7, P947, DOI 10.1101/gr.7.10.947
   Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838
   STONEKING M, 1996, HUMAN GENOME EVOLUTI
   SUAREZ B, 1985, AM J PHYS ANTHROPOL, V67, P271
   Templeton AR, 1997, CURR OPIN GENET DEV, V7, P841, DOI 10.1016/S0959-437X(97)80049-4
   TERWILLIGER J, 1998, IN PRESS HUM HERED
   Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380
   TORRONI A, 1995, AM J HUM GENET, V56, P1234
   TORRONI A, 1993, AM J HUM GENET, V53, P591
   Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996
   Vogel F, 1997, HUMAN GENETICS PROBL
   vonHaeseler A, 1996, NAT GENET, V14, P135, DOI 10.1038/ng1096-135
   WATSON JD, 1990, SCIENCE, V248, P44, DOI 10.1126/science.2181665
   WEISS K, 1995, BIOTECHNOLOGY GENOME
   WEISS K, 1982, PHYSICAL ANTHR 50 YE, P371
   WEISS K, 1998, IN PRESS GENOME RES
   Weiss K. M., 1992, EVOLUTIONARY ANTHR, V1, P80
   Weiss KM, 1996, MOL PHYLOGENET EVOL, V5, P259, DOI 10.1006/mpev.1996.0019
   WEISS KM, 1976, AM J PHYS ANTHROPOL, V44, P31, DOI 10.1002/ajpa.1330440106
   WEISS KM, 1995, GENETIC VARIATION HU
   WEISS KM, 1996, CULT SURVIVAL Q, V20, P26
   WEISS KM, 1989, J QUANT ANTHR, V1, P79
NR 75
TC 15
Z9 15
U1 0
U2 1
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0084-6570
EI 1545-4290
J9 ANNU REV ANTHROPOL
JI Annu. Rev. Anthropol.
PY 1998
VL 27
BP 273
EP 300
DI 10.1146/annurev.anthro.27.1.273
PG 28
WC Anthropology
SC Anthropology
GA 134RZ
UT WOS:000076758100014
DA 2018-10-19
ER

PT S
AU Datskos, PG
   Demos, SG
   Rajic, S
AF Datskos, PG
   Demos, SG
   Rajic, S
BE Lieberman, RA
   VoDinh, T
   Katzir, A
TI Miniature uncooled infrared sensitive detectors for in vivo biomedical
   applications
SO BIOMEDICAL SENSING AND IMAGING TECHNOLOGIES, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Sensing and Imaging Technologies
CY JAN 26-27, 1998
CL SAN JOSE, CA
SP Soc Photo Opt Instrumentat Engineers, Int Biomed Opt Soc
DE infrared detection; photon detector; thermal detector; in vivo;
   temperature mapping
AB Broadband infrared (IR) radiation detectors have been developed using miniature, inexpensive, mass produced microcantilevers capable of detecting temperature differences as small as 10(-6) K. Microcantilevers made out of semiconductor materials with dimensions of 50 to 200 mu m long, 10 to 30 mu m wide and 0.4 to 4 mu m thick, undergo bending when exposed to IR radiation and can be used either as uncooled photon or thermal detectors. Mounted on a probe 1 mm in diameter a number of microcantilevers can be accommodated in the working channel of existing endoscopes for in vivo proximity focus measurements inside the human body.
C1 Univ Tennessee, Knoxville, TN 37996 USA.
RP Datskos, PG (reprint author), Univ Tennessee, 401 Nielsen Phys Bldg, Knoxville, TN 37996 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2692-X
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3253
BP 94
EP 100
DI 10.1117/12.308020
PG 7
WC Engineering, Biomedical; Medical Laboratory Technology; Optics
SC Engineering; Medical Laboratory Technology; Optics
GA BL08J
UT WOS:000074223000013
DA 2018-10-19
ER

PT S
AU Golub, M
   Grossinger, I
AF Golub, M
   Grossinger, I
BE Baldini, F
   Croitoru, NI
   Dickinson, MR
   Frenz, M
   Miyagi, M
   Pratesi, R
   Seeger, S
   Katzir, A
TI Diffractive optical elements for biomedical applications
SO BIOMEDICAL SYSTEMS AND TECHNOLOGIES II, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Systems and Technologies II
CY SEP 04-06, 1997
CL SAN REMO, ITALY
SP Soc Italiana Laser Chirurg & Med, European Laser Assoc, Int Biomed Opt Soc, European Opt Soc, Soc Photo Opt Instrumentat Engineers, Commiss European Communities, Directorate Gen Sci Res & Dev
DE diffractive optics; DOE; laser focusing; multifocal lens; contact lens;
   beam shaping; computer modeling
AB The set of diffractive optical elements for CO2 and Nd-Yag lasers was theoretically calculated, fabricated by microlithographic technology and experimentally tested. It is shown that the laser systems for therapy, surgery and welding gain from advanced capabilities of the DOEs: uniform focal-spot intensity, simultaneous formation of focal line contours, sharp and multiple-spot focusing, dual-wavelength achromatization, miniaturization. Novel multifocal diffractive contact lenses are elaborated based on diffractive microrelief considerations, nonparaxial variant of diffraction integral on curved surface and computer simulations of intensity distribution on eye retina. Tri-focal diffractive contact lenses that were diamond-turned on rigid and soft materials successfully passed tests.
C1 Holo Or Ltd, IL-76114 Rehovot, Israel.
RP Golub, M (reprint author), Holo Or Ltd, Kiryat Weizmann,POB 1051, IL-76114 Rehovot, Israel.
NR 0
TC 4
Z9 4
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2631-8
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3199
BP 220
EP 231
DI 10.1117/12.301110
PG 12
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BK45Y
UT WOS:000072273800028
DA 2018-10-19
ER

PT J
AU Tsafrir, J
   Grinberg, M
AF Tsafrir, J
   Grinberg, M
TI Who needs evidence-based health care?
SO BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION
LA English
DT Article; Proceedings Paper
CT 5th Conference of the
   European-Association-of-Health-Information-and-Libraries
CY SEP 18-21, 1996
CL COIMBRA, PORTUGAL
SP European Assoc Hlth Info & Lib
ID EVIDENCE-BASED MEDICINE; SYSTEMATIC REVIEWS; CLINICAL-PRACTICE;
   METAANALYSIS; BIAS
AB The vast amount of published material in clinical and biomedical sciences, and conflicting results on diagnostic and therapeutic procedures may introduce doubts in decision-making for patient care. Information retrieving skills and the critical appraisal of published literature, together with elaboration of practice guidelines based on epidemiological methodology, form the basis of the trend towards evidence-based health care, which aims to overcome these problems. A survey conducted by questionnaire at the Chaim Sheba Medical Center analyzed which types of information sources are considered most relevant and useful for patient care by a cross-section of physicians with varying degrees of experience. They considered review articles and meta-analyses extremely reliable for information purposes, while for practical patient-care purposes they tended to rely more on the opinions of peers and experts. As the requirements of evidence-based health care may influence the attitudes of clinicians to the published literature and its evaluation, they have implications for medical libraries and information centers. Specifically information specialists will be called upon more and more to impart information-retrieval and critical appraisal skills to clinicians. The involvement of information specialists in information gathering and selection will provide added value to the expertise and knowledge of in-house experts for decision-making.
C1 Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Miriam Gutwirth Med Lib,Reference Serv, IL-52621 Tel Hashomer, Israel.
   Tel Aviv Univ, Gitter Smolarz Lib Life Sci & Med, Reference Serv, IL-69978 Tel Aviv, Israel.
RP Tsafrir, J (reprint author), Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Miriam Gutwirth Med Lib,Reference Serv, IL-52621 Tel Hashomer, Israel.
EM jtsafrir@post.tau.ac.il; miriamg@taulib.tau.ac.il
RI Grinberg, Miriam/D-2259-2009
CR Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637
   Buckley NA, 1996, LANCET, V347, P1167, DOI 10.1016/S0140-6736(96)90615-7
   CARRHILL R, 1995, SOC SCI MED, V41, P1467, DOI 10.1016/0277-9536(95)00351-7
   DAVIDOFF F, 1995, ANN INTERN MED, V122, P727, DOI 10.7326/0003-4819-122-9-199505010-00012
   Dep. Clin. Epidemiol. Biostat. McMaster Univ., 1981, CAN MED ASSOC J, V124, P985
   DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x
   DICKERSIN K, 1994, BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286
   Dickersin K, 1993, ANN NY ACAD SCI, V703, P146
   EYSENCK HJ, 1994, BRIT MED J, V309, P789, DOI 10.1136/bmj.309.6957.789
   FOWLER PBS, 1995, LANCET, V346, P838
   Freemantle N, 1997, ANN INTERN MED, V126, P81, DOI 10.7326/0003-4819-126-1-199701010-00011
   FULLERTONSMITH I, 1995, EVIDENCE BASED MED, V1, P7
   GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B
   GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032
   HAYNES RB, 1981, CAN MED ASSOC J, V124, P703
   IVES DG, 1994, EPIDEMIOLOGY, V5, P456
   *JOINT COMM ACCR H, 1994, MED REF SERV Q, V13, P85
   LEWIS S, 1995, CAN MED ASSOC J, V153, P1073
   McCarthy Laine H., 1996, Medical Reference Services Quarterly, V15, P63
   MEAD TL, 1995, B MED LIBR ASSOC, V83, P461
   NAYLOR CD, 1995, LANCET, V345, P840, DOI 10.1016/S0140-6736(95)92969-X
   RAFUSE J, 1994, CAN MED ASSOC J, V150, P1479
   REES J, 1995, BRIT MED J, V310, P850, DOI 10.1136/bmj.310.6983.850
   ROSENBERG W, 1995, BRIT MED J, V310, P1122, DOI 10.1136/bmj.310.6987.1122
   Sackett D. L., 1995, EVIDENCE BASED MED, V1, P5
   SACKETT DL, 1981, CAN MED ASSOC J, V124, P555
   Sackett DL, 1996, BRIT MED J, V312, P71
   SACKETT DL, 1981, CAN MED ASSOC J, V124, P1156
   Smith Jack T. Jr., 1994, Medical Reference Services Quarterly, V13, P57
   Sorensen TIA, 1996, LANCET, V348, P351, DOI 10.1016/S0140-6736(05)64988-4
   TANENBAUM SJ, 1993, NEW ENGL J MED, V329, P1268, DOI 10.1056/NEJM199310213291713
   TUGWELL PX, 1981, CAN MED ASSOC J, V124, P869
   Urquhart CJ, 1996, B MED LIBR ASSOC, V84, P482
NR 33
TC 7
Z9 8
U1 0
U2 0
PU MEDICAL LIBRARY ASSOC
PI CHICAGO
PA 65 EAST WACKER PLACE, STE 1900, CHICAGO, IL 60601-7298 USA
SN 0025-7338
J9 B MED LIBR ASSOC
JI Bull. Med. Libr. Assoc.
PD JAN
PY 1998
VL 86
IS 1
BP 40
EP 45
PG 6
WC Information Science & Library Science
SC Information Science & Library Science
GA ZC511
UT WOS:000072587500006
PM 9549011
DA 2018-10-19
ER

PT J
AU Dilworth, JR
   Parrott, SJ
AF Dilworth, JR
   Parrott, SJ
TI The biomedical chemistry of technetium and rhenium
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID MYOCARDIAL IMAGING AGENT; TC-99M; COMPLEXES; RADIOPHARMACEUTICALS; SPECT
AB This review describes recent developments in the chemistry of both first and second generation 99m-technetium-based imaging agents. The material is presented according to the biological target for the agent, and where possible actual images are presented to indicate the type of information available to the clinician, Beta emitting isotopes of rhenium offer a possible method for the in situ treatment of cancerous tissue using analogous targeting strategies to those for technetium. Recent developments in the relevant coordination chemistry of rhenium and their extension to in vitro and in vivo studies are presented.
C1 Univ Oxford, Inorgan Chem Lab, Oxford OX1 3QR, England.
   Univ Essex, Dept Chem & Biol Sci, Colchester CO4 3SQ, Essex, England.
RP Dilworth, JR (reprint author), Univ Oxford, Inorgan Chem Lab, S Parks Rd, Oxford OX1 3QR, England.
CR ARCHER CM, 1996, CURRENT DIRECTIONS R, P81
   BLOWER P J, 1990, Journal of Nuclear Medicine, V31, P768
   CHEESEMAN EH, 1986, J NUCL MED, V29, P288
   CHI DY, 1994, J MED CHEM, V37, P928, DOI 10.1021/jm00033a010
   CLARKE MJ, 1987, COORDIN CHEM REV, V78, P253, DOI 10.1016/0010-8545(87)85029-4
   COSTELLO CE, 1983, J NUCL MED, V24, P353
   DEROSCH MA, 1992, J NUCL MED, V33, P850
   DEUTSCH E, 1983, PROG INORG CHEM, V30, P75, DOI 10.1002/9780470166314.ch2
   DEVOUS MD, 1988, BRAIN IMAGING APPLIC, P147
   DILWORTH JR, 1996, DIRECTIONS RADIOPHAR
   FRITZBERG AR, 1986, J NUCL MED, V27, P111
   FRITZBERG AR, 1994, CHEM STRUCTURAL APPR, P125
   FRITZBERG AR, 1995, HANDB PHARM TOX, P83
   GEORGE AJT, 1995, P NATL ACAD SCI USA, V92, P8538
   GERSON MC, 1983, EUR J NUCL MED, V8, P371
   HNATOWICH DJ, 1993, J NUCL MED CHEM, V34, P172
   HOLMAN BL, 1992, J NUCL MED, V33, P1888
   HOLMAN BL, 1984, J NUCL MED, V25, P1350
   KELLY JD, 1992, J NUCL MED, V24, P353
   KRAMER EL, 1995, CLIN SPECT IMAGING
   Kung HF, 1996, EUR J NUCL MED, V23, P1527, DOI 10.1007/BF01254479
   LEONARD JP, 1986, J NUCL MED, V27, P1819
   LIBSON K, 1980, J AM CHEM SOC, V102, P2476, DOI 10.1021/ja00527a066
   LINDER KE, 1990, INORG CHEM, V29, P2428, DOI 10.1021/ic00338a009
   LISTERJAMES J, 1994, TECHNETIUM RHENIUM C, V3, P269
   LIU S, 1996, BIOCONJ CHEM, V7, P203
   LIU S, 1996, BIOCONJ CHEM, V7, P83
   Nicolini M., 1995, TECHNETIUM RHENIUM N, V4
   PASQUALINI R, 1992, J CHEM SOC CHEM COMM, P1354, DOI 10.1039/c39920001354
   PONTO JA, 1990, PHARM MED IMAGING, P501
   SINGH J, 1991, J CHEM SOC CHEM COMM, P15
   Spies H., 1995, TECHNETIUM RHENIUM C, V4, P243
   TISATO F, 1994, COORDIN CHEM REV, V135, P235
   TOP S, 1995, J AM CHEM SOC, V117, P8372, DOI 10.1021/ja00137a010
   VOLKERT WA, 1993, ADV METALS MED, V1, P115
   Welch M. J., 1996, CURRENT DIRECTIONS R, P137
   Yoshihava K., 1996, TOP CURR CHEM, V176, P2
NR 37
TC 485
Z9 489
U1 2
U2 55
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON ROAD, CAMBRIDGE CB4 4WF,
   CAMBS, ENGLAND
SN 0306-0012
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PD JAN
PY 1998
VL 27
IS 1
BP 43
EP 55
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA YV681
UT WOS:000071852100005
DA 2018-10-19
ER

PT B
AU Simon, BR
   Kaufmann, MV
   Liu, J
   Baldwin, AL
AF Simon, BR
   Kaufmann, MV
   Liu, J
   Baldwin, AL
BE Middleton, J
   Jones, ML
   Pande, GN
TI Porohyperelastic-transport-swelling finite element models: Applications
   and material properties for large arteries
SO COMPUTER METHODS IN BIOMECHANICS & BIOMEDICAL ENGINEERING - 2
LA English
DT Proceedings Paper
CT 3rd International Symposium on Computer Methods in Biomechanics and
   Biomedical Engineering
CY MAY, 1997
CL BARCELONA, SPAIN
SP 3M Unitek (Div 3M Hlth Care Ltd), Gordon & Breach Publishers, Welsh Dev Agcy, Wilde & Partners (FE Div)
DE finite element models; porohyperelastic; transport; arteries
AB This communication summarizes a presentation at the Third International Symposium on Computer Methods in Biomechanics and Biomedical Engineering,(1) and describes the development and applications of porohyperelastic-transport-swelling (PHETS) formulations and finite element models (FEMs) for the analysis of soft, hydrated rabbit aortic tissues. These PHETS models include both material and geometric nonlinearity and coupled transport of mobile tissue fluid and species dissolved in the fluid. Corresponding Eulerian and Lagrangian field theories allow identification of material property functions and form the basis for the FEMs. Data-reduction procedures provided intimal and medial elasticity, permeability, and diffusion-convection transport properties. PHETS FEM results compare well with data from our laboratory and data presented in the literature for pressure-radius response, free tissue fluid flux, and diffusive-convective flux of labeled mobile albumin in the walls of rabbit aortas.
C1 Univ Arizona, Tucson, AZ 85721 USA.
RP Simon, BR (reprint author), Univ Arizona, Tucson, AZ 85721 USA.
CR Kaufmann M. V., 1996, THESIS U ARIZONA TUC
   SIMON BR, 1997, 3 INT S COMP METH BI
   SIMON BR, 1997, IN PRESS J BIOMECH E
   TEDGUI A, 1985, CIRC RES, V57, P856, DOI 10.1161/01.RES.57.6.856
NR 4
TC 0
Z9 0
U1 0
U2 1
PU GORDON AND BREACH SCIENCE PUBL
PI 1062 EV AMSTERDAM
PA RIJSWIJKSTRAAT 175, 1062 EV AMSTERDAM, NETHERLANDS
BN 90-5699-206-6
PY 1998
BP 505
EP 510
PG 6
WC Computer Science, Interdisciplinary Applications; Dentistry, Oral
   Surgery & Medicine; Engineering, Biomedical; Orthopedics; Surgery
SC Computer Science; Dentistry, Oral Surgery & Medicine; Engineering;
   Orthopedics; Surgery
GA BM39Z
UT WOS:000078630800062
DA 2018-10-19
ER

PT S
AU Roberts, RS
   Aimonetti, WD
   Bixler, JV
AF Roberts, RS
   Aimonetti, WD
   Bixler, JV
BE Matthews, MB
TI Material characterization using a hyperspectral infrared imaging
   spectrometer
SO CONFERENCE RECORD OF THE THIRTY-SECOND ASILOMAR CONFERENCE ON SIGNALS,
   SYSTEMS & COMPUTERS, VOLS 1 AND 2
SE CONFERENCE RECORD OF THE ASILOMAR CONFERENCE ON SIGNALS, SYSTEMS AND
   COMPUTERS
LA English
DT Proceedings Paper
CT 32nd Asilomar Conference on Signals, Systems and Computers
CY NOV 01-04, 1998
CL PACIFIC GROVE, CA
SP Naval Postgrad Sch, Monterey, San Jose State Univ, San Jose, Monterey Bay Aquarium Res Inst, IEEE Signal Proc Soc
AB Fourier transform spectroscopy has found application ill many areas including chemometrics, biomedical and biochemical studies, and atmospheric chemistry. This paper describes an investigation into the application of the LLNL Hyperspectral Infrared Imaging Spectrometer (HIRIS) to the non-destructive evaluation of man-made and natural materials. We begin by describing the HIRIS system and the objects studied In the investigation. Next, we describe the technique used to collect the hyperspectral imagery, and discuss the processing required to transform the data into usable form. We then describe a technique to analyze the data, and provide some preliminary results.
C1 Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RP Roberts, RS (reprint author), Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
CR *ASTM, ASTM MET REF BOOK
   Beer R., 1992, REMOTE SENSING FOURI
   BENNETT CL, 1998, FOUR TRANSF SPECTR 1
   BYLER D, 1998, FOUR TRANSF SPECTR 1
   DING Q, 1998, FOUR TRANSF SPECTR 1
   Fukunaga K., 1990, INTRO STAT PATTERN R
   Jain A. K, 1989, FUNDAMENTALS DIGITAL
   MALINOWSKI ER, 1991, FACTOR ANAL CHEM
   TAUB W, 1998, FOUR TRANSF SPECTR 1
   TILLEY CE, 1959, ENCY BRITANNICA
NR 10
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1058-6393
BN 0-7803-5149-5
J9 CONF REC ASILOMAR C
PY 1998
BP 1273
EP 1277
PG 5
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Computer Science, Theory & Methods;
   Engineering, Electrical & Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA BM43X
UT WOS:000078743600240
DA 2018-10-19
ER

PT B
AU Gaiseanu, F
   Postolache, C
   Dascalu, D
   Esteve, J
   Tsoukalas, D
   Badoiu, A
   Vasile, E
AF Gaiseanu, F
   Postolache, C
   Dascalu, D
   Esteve, J
   Tsoukalas, D
   Badoiu, A
   Vasile, E
BE White, NM
TI Material characterization of the capacitive pressure sensors for
   biomedical applications fabricated by surface micromachining technology
SO EUROSENSORS XII, VOLS 1 AND 2
SE SENSORS SERIES
LA English
DT Proceedings Paper
CT 12th European Conference on Solid-State Transducers - 9th UK Conference
   on Sensors and Their Applications
CY SEP 13-16, 1998
CL SOUTHAMPTON, ENGLAND
AB An integrated structure of capacitive pressure sensor for biomedical applications achieved by surface micromachining technology, consisting in the pressure sensor and a testing component is presented.. The test structure permitted to apply the pull-in voltage method for the evaluation of the residual stress in the polysilicon layer on the basis of a new form of the set of two equations describing the beam pull-in voltage effect. The integrated structure allowed the optimization of the phosphorus diffusion process to obtain low stress polysilicon membranes of the capacitive pressure sensors for biomedical applications.
C1 Natl Inst Res Dev Microtechnol, IMT, R-72996 Bucharest, Romania.
RP Gaiseanu, F (reprint author), Natl Inst Res Dev Microtechnol, IMT, Erou Lancu Nicolae 32B,POB 38-160, R-72996 Bucharest, Romania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
BN 0-7503-0536-3
J9 SENSORS SER
PY 1998
BP 43
EP 46
PG 4
WC Engineering, Multidisciplinary; Instruments & Instrumentation; Materials
   Science, Multidisciplinary
SC Engineering; Instruments & Instrumentation; Materials Science
GA BL96Z
UT WOS:000077311200011
DA 2018-10-19
ER

PT B
AU Williams, WS
   Kaloyeros, AE
AF Williams, WS
   Kaloyeros, AE
BE Kumar, A
   Chung, YW
   Chia, RWJ
TI Synthesis, characterization and potential applications of amorphous
   coatings of titanium carbide and titanium diboride
SO HARD COATINGS: BASED ON BORIDES, CARBIDES & NITRIDES: SYNTHESIS,
   CHARACTERIZATION & APPLICATIONS
LA English
DT Proceedings Paper
CT International Symposium on Hard Coatings Based on Borides, Carbides and
   Nitrides - Synthesis, Characterization and Applications at the 1998 TMS
   Annual Meeting
CY FEB 16-19, 1998
CL SAN ANTONIO, TX
SP Minerals Met & Mat Soc, Mat Design & Mfg Div, Surface Modificat & Coatings Technol Comm
AB Amorphous materials have an advantage over crystalline versions: the absence of grain boundaries reduces the probability of fracture and corrosion. However, many amorphous metal alloys crystallize at moderate temperatures, thus limiting their applications. One amorphous titanium carbide (TiC) film to be described did not crystallize until 1000 degrees C. The TiC film was synthesized by metal-organic chemical vapor deposition (MOCVD). The organometallic precursor molecule dissociated and left hydrogen and organic fragments which help stabilize the carbide with respect to crystallization and corrosion. The reason for its amorphous state-determined by X-ray diffraction (XRD) and transmission electron microscopy selected area diffraction (TEM/SAD)-was the low substrate temperature required, between 150 degrees C and 300 degrees C. Pure amorphous TiC and titanium diboride (TiB2) films were prepared by electron-beam vaporization (EBV) of single crystal chips onto liquuid-nitrogen cooled substrates; they crystallized at lower temperatures. All the films analyzed by extended X-ray absorption fine structure (EXAFS) and extended electron energy loss fine structure (EXELFS) exhibited short-range order but no long-range order, so they could still be described as "amorphous." Potential applications of these high hardness, high melting-point, corrosion-resistant, low-friction and diffusion-resistant coatings could include bearings, cylinder linings, microcircuits and biomedical implants.
C1 Univ Illinois, Dept Phys, Urbana, IL 61801 USA.
RP Williams, WS (reprint author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.
NR 0
TC 1
Z9 1
U1 1
U2 2
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-389-9
PY 1998
BP 269
EP 280
PG 12
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Coatings & Films
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BK53L
UT WOS:000072465900024
DA 2018-10-19
ER

PT B
AU Drukier, AK
   Volkovitsky, P
   Coursey, BM
   Karam, LR
   Stodolsky, L
AF Drukier, AK
   Volkovitsky, P
   Coursey, BM
   Karam, LR
   Stodolsky, L
BE Kumar, A
   Chung, YW
   Chia, RWJ
TI MPD technology for tribology applications
SO HARD COATINGS: BASED ON BORIDES, CARBIDES & NITRIDES: SYNTHESIS,
   CHARACTERIZATION & APPLICATIONS
LA English
DT Proceedings Paper
CT International Symposium on Hard Coatings Based on Borides, Carbides and
   Nitrides - Synthesis, Characterization and Applications at the 1998 TMS
   Annual Meeting
CY FEB 16-19, 1998
CL SAN ANTONIO, TX
SP Minerals Met & Mat Soc, Mat Design & Mfg Div, Surface Modificat & Coatings Technol Comm
AB The new ultra-sensitive MPD technology, already employed successfully in biomedical applications, has such a high sensitivity that it is possible to use extremely low level radioactive materials, below licensing requirements and presenting no health hazard. It can now be employed in tribology, both as a research tool and in industrial and consumer applications. We discuss a few straightforward tribological applications of the MPD technique.
C1 Biotraces Inc, Fairfax, VA 22030 USA.
RP Drukier, AK (reprint author), Biotraces Inc, 10517-A W Dr, Fairfax, VA 22030 USA.
OI stodolsky, leo/0000-0002-4842-1889
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-389-9
PY 1998
BP 321
EP 327
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Coatings & Films
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BK53L
UT WOS:000072465900028
DA 2018-10-19
ER

PT B
AU Mitra, K
   Kumar, S
AF Mitra, K
   Kumar, S
BE Lee, JS
TI Interaction of short pulse radiation with scattering media: Issues and
   transient radiative transfer formulation
SO HEAT TRANSFER 1998, VOL 7: GENERAL PAPERS
LA English
DT Proceedings Paper
CT 11th International Heat Transfer Conference
CY AUG 23-28, 1998
CL KYONGJU, SOUTH KOREA
SP Korean Soc Mech Engineers
ID OPTICAL-PROPERTIES; TISSUE; LIGHT; DIFFUSION; ABLATION; LASERS
AB This paper discusses the various applications of short pulse radiation and the research issues related to the understanding of the fundamentals of the physics of interaction of such radiation with material and the associated modeling. The focus is on the interaction of pulsed radiation with absorbing and scattering media, with an emphasis on biomedical applications.
C1 Florida Inst Technol, Mech Engn Program, Melbourne, FL 32901 USA.
RP Mitra, K (reprint author), Florida Inst Technol, Mech Engn Program, 150 W Univ Blvd, Melbourne, FL 32901 USA.
CR AKHMANOV SA, 1992, OPTICS FEMTOSECONDS
   BIRNGRUBER R, 1987, IEEE J QUANTUM ELECT, V23, P1836, DOI 10.1109/JQE.1987.1073235
   BREWSTER MQ, 1995, INT J HEAT MASS TRAN, V38, P2569, DOI 10.1016/0017-9310(95)00013-Y
   CAIN SR, 1992, J APPL PHYS, V72, P5172, DOI 10.1063/1.351997
   Churnside JH, 1997, APPL OPTICS, V36, P6011, DOI 10.1364/AO.36.006011
   FORK RL, 1987, OPT LETT, V12, P483, DOI 10.1364/OL.12.000483
   GANDJBAKHCHE AH, 1993, APPL OPTICS, V32, P504, DOI 10.1364/AO.32.000504
   GEMERT MJC, 1989, IEEE ENG MED BIOL, P10
   GORDON CL, 1995, OPT LETT, V20, P1056, DOI 10.1364/OL.20.001056
   GRANT KJ, 1991, APPL OPTICS, V31, P4515
   HALLER JD, 1992, P IEEE, V80, P861, DOI 10.1109/5.149449
   HONG JS, 1994, ASME HTD, V288, P17
   ISHIMARU A, 1989, APPL OPTICS, V28, P2210, DOI 10.1364/AO.28.002210
   ISHIMARU A, 1978, WAVE PROPAGATION SCA, V1, P175
   KOSHAK WJ, 1994, J GEOPHYS RES-ATMOS, V99, P14361, DOI 10.1029/94JD00022
   Kumar S, 1996, APPL OPTICS, V35, P3372, DOI 10.1364/AO.35.003372
   KUMAR S, 1995, P 1 INT S RAD HEAT T, P488
   KUMAR S, 1995, INT MECH ENG C EXP, V322, P43
   PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331
   RACKMIL CI, 1983, NUMERICAL HEAT TRANS, V6, P135
   Siegel R., 1981, THERMAL RAD HEAT TRA
   SKOCYPEC RD, 1982, J QUANT SPECTROSC RA, V28, P425, DOI 10.1016/0022-4073(82)90008-5
   SRINIVASAN R, 1986, SCIENCE, V234, P559, DOI 10.1126/science.3764428
   THOMPSON KP, 1992, P IEEE, V80, P838, DOI 10.1109/5.149448
   Tien C.L., 1994, THERMAL SCI ENG, V2, P1
   VISKANTA R, 1987, PROG ENERG COMBUST, V13, P97, DOI 10.1016/0360-1285(87)90008-6
   WEINMAN JA, 1972, J GEOPHYS RES, V77, P7123, DOI 10.1029/JC077i036p07123
   White SM, 1990, J THERMOPHYS HEAT TR, V4, P305, DOI 10.2514/3.181
   Yamada Y, 1995, ANN REV FLUID MECH H, V6, P1
   YODH A, 1995, PHYS TODAY, V48, P34, DOI 10.1063/1.881445
   YOO KM, 1990, PHYS REV LETT, V64, P2647, DOI 10.1103/PhysRevLett.64.2647
NR 31
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI LONDON
PA 11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND
PY 1998
BP 313
EP 318
PG 6
WC Thermodynamics; Engineering, Mechanical; Mechanics
SC Thermodynamics; Engineering; Mechanics
GA BQ70Y
UT WOS:000089221200051
DA 2018-10-19
ER

PT S
AU Saidane, A
   Amri, A
AF Saidane, A
   Amri, A
GP INST ELECT ENGINEERS, LONDON
   INST ELECT ENGINEERS, LONDON
   INST ELECT ENGINEERS, LONDON
TI A Transmission-Line-Matrix model for microwave heating problems
SO INTERNATIONAL CONFERENCE ON SIMULATION '98
SE IEE CONFERENCE PUBLICATIONS
LA English
DT Proceedings Paper
CT International Conference on Simulation
CY SEP 30-OCT 02, 1998
CL UNIV YORK, YORK, ENGLAND
SP Inst Elect Engineers, Control Div, AES, CEA, IFAC, BCS, EPSRC, EUREL, IEEE, UKRI Sect, InstMC, ISCS, UKSS
HO UNIV YORK
AB The use of microwaves to melt, dry, sinter or join materials is gaining acceptance in many industrial applications extending to the field of biomedical engineering. Such technology, however, is characterized by thermal runaway and the formation of localized areas of high temperature or hot-spots that develop as the material is being irradiated Hot-spots can be utilized in smelting or joining since they enhance the process but avoided in sintering or drying since they can lead to damage. In any case, it is important to predict the conditions of their occurrence and how to control them.
   Microwave heating is a highly coupled nonlinear problem and the purpose of this paper is to show how the Transmission-Line-Matrix (TLM) technique can be used to model this complex physical process. The numericals solutions are compared with some analytical and other numerical results. Our preliminary results show that the TLM method is well suited to wicrowave heat modelling and that the conditions under which hot spots develop can be predicted.
C1 ORAN, ENSET, Oran, Algeria.
RP Saidane, A (reprint author), ORAN, ENSET, Oran, Algeria.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU INST ELECTRICAL ENGINEERS INSPEC INC
PI EDISON
PA 379 THORNALL ST, EDISON, NJ 08837 USA
SN 0537-9989
BN 0-85296-709-8
J9 IEE CONF PUBL
PY 1998
IS 457
BP 317
EP 324
PG 8
WC Engineering, Aerospace; Engineering, Biomedical; Engineering,
   Industrial; Engineering, Electrical & Electronic; Transportation
SC Engineering; Transportation
GA BM06G
UT WOS:000077496200050
DA 2018-10-19
ER

PT J
AU Simmons-Potter, K
   Potter, B
   Sinclair, M
AF Simmons-Potter, K
   Potter, B
   Sinclair, M
TI Photosensitive thin films: Manipulation of defects through synthesis
   control
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS BRIEF
   COMMUNICATIONS & REVIEW PAPERS
LA English
DT Article; Proceedings Paper
CT International Workshop on Structure and Functional Optical Properties of
   Silica and Silica-Related Glasses
CY JUL 10-11, 1997
CL TOYOTA MOTOR CORP, MIKKABI CREAT CTR, SHIZUOKA, JAPAN
SP US Govt
HO TOYOTA MOTOR CORP, MIKKABI CREAT CTR
DE photosensitivity; defects; germanosilicate; rf-sputtering; thin film
ID GLASS-FILMS; SIO2-GEO2 GLASSES; WAVE-GUIDES; FIBERS; BAND; CENTERS
AB Multi-functional, integrated optical devices are the foundation for technologies commanding a significant high-tech market share. Areas such as telecommunications, remote sensing, biomedical applications, information processing and data storage benefit from devices based on the patterning of refractive index modulations. Current synthesis techniques used to achieve the desired device structures typically involve multi-step processing, relying on complex chemical and/or mechanical procedures. We have demonstrated the ability to produce highly photosensitive germanosilicate thin films using a novel sputtering approach which enables us to obtain the largest reported Delta n in as-synthesized materials. In addition, control of processing environment has allowed us to engineer not only the magnitude of the optical response of the films but also the sign of the induced index change. We have developed a defect model to describe the effects observed and have demonstrated proof-of-principle devices in our waveguides.
C1 Sandia Natl Labs, Albuquerque, NM 87185 USA.
RP Simmons-Potter, K (reprint author), Sandia Natl Labs, POB 5800,MS 1423, Albuquerque, NM 87185 USA.
CR AWAZU K, 1990, J APPL PHYS, V68, P2713, DOI 10.1063/1.346445
   FRIEBELE EJ, 1986, MATER RES SOC S P, V61, P319
   HAND DP, 1990, OPT LETT, V15, P102, DOI 10.1364/OL.15.000102
   HOSONO H, 1992, PHYS REV B, V46, P11445, DOI 10.1103/PhysRevB.46.11445
   LEMAIRE PJ, 1993, ELECTRON LETT, V29, P1191, DOI 10.1049/el:19930796
   MIZRAHI V, 1993, APPL PHYS LETT, V63, P1727, DOI 10.1063/1.110696
   NAKAHARA M, 1986, J LIGHTWAVE TECHNOL, V4, P127, DOI 10.1109/JLT.1986.1074693
   NEUSTRUEV VB, 1989, FIBER INTEGRATED OPT, V8, P143, DOI 10.1080/01468038908202872
   Nishii J, 1995, RADIAT EFF DEFECT S, V136, P133, DOI 10.1080/10420159508218808
   NISHII J, 1994, APPL PHYS LETT, V64, P282, DOI 10.1063/1.111181
   POTTER BG, 1997, SPIE P, V2998, P146
   SIMMONS KD, 1991, OPT LETT, V16, P141, DOI 10.1364/OL.16.000141
   SIMMONS KD, 1993, OPT LETT, V18, P25, DOI 10.1364/OL.18.000025
   SimmonsPotter K, 1996, APPL PHYS LETT, V68, P2011, DOI 10.1063/1.115621
   SIMMONSPOTTER K, 1995, APPL PHYS LETT, V66, P2104, DOI 10.1063/1.113917
   Warren WL, 1996, APPL PHYS LETT, V69, P1453, DOI 10.1063/1.117612
NR 16
TC 8
Z9 8
U1 1
U2 1
PU JAPAN SOC APPLIED PHYSICS
PI TOKYO
PA KUDAN-KITA BUILDING 5TH FLOOR, 1-12-3 KUDAN-KITA, CHIYODA-KU, TOKYO,
   102-0073, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 1
JI Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Brief Commun. Rev. Pap.
PY 1998
VL 37
SU 1
BP 8
EP 11
DI 10.7567/JJAPS.37S1.8
PG 4
WC Physics, Applied
SC Physics
GA ZP235
UT WOS:000073731500004
OA Bronze
DA 2018-10-19
ER

PT J
AU Lemmouchi, Y
   Schacht, E
   Dejardin, S
AF Lemmouchi, Y
   Schacht, E
   Dejardin, S
TI Biodegradable poly[(amino acid ester)phosphazenes] for biomedical
   applications
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
ID DEGRADABLE POLYPHOSPHAZENES; POLY(ORGANOPHOSPHAZENES)
AB Polyphosphazene derivatives with amino acid ester side groups were prepared by reacting poly(dichlorophosphazene) with ethyl esters of amino acids and were characterizedby H-1, P-31-NMR and DSC analyses. The in vitro rate of degradation of these polymers depended on the nature of the amino acids while introducing small amounts of depsipeptide ester co-substituents increased degradation rates. The rate of hydrolytic degradation of the poly[(organo)phosphazene] materials could be controlled by the amino acid ester by the depsipeptide ester side group content and by blending poly[(amino acid ester)phosphazenes] with poly[(amino acid ester)-co-(depsipeptide ester)phosphazenes]. Poly[(glycine ethyl ester)phosphazenes] prepared from poly[(dichloro)phosphazenes] degradation rates were independent of molecular weight. Degradations of polymer blends indicate that an intramolecular catalysis of the polymer by the pendent carboxylic acid.
C1 State Univ Ghent, IBITECH, Inst Biomed Technol, Polymer Mat Res Grp, B-9000 Ghent, Belgium.
RP Schacht, E (reprint author), State Univ Ghent, IBITECH, Inst Biomed Technol, Polymer Mat Res Grp, Krijgslaan 281, B-9000 Ghent, Belgium.
CR Allcock H.R., 1979, CONT TOPICS POLYM SC, V3, P55
   ALLCOCK HR, 1986, MAKROMOL CHEM-M SYMP, V6, P101, DOI 10.1002/masy.19860060112
   ALLCOCK HR, 1972, CHEM REV, V72, P315, DOI 10.1021/cr60278a002
   ALLCOCK HR, 1983, MACROMOLECULES, V16, P715, DOI 10.1021/ma00239a001
   ALLCOCK HR, 1994, BIOMATERIALS, V15, P563, DOI 10.1016/0142-9612(94)90205-4
   ALLCOCK HR, 1982, INORG CHEM, V21, P515, DOI 10.1021/ic00132a009
   ALLCOCK HR, 1983, MACROMOLECULES, V16, P1401, DOI 10.1021/ma00243a001
   ALLCOCK HR, 1990, BIODEGRADABLE POLYM, P163
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P24
   BOISSONNAS RA, 1953, HELV CHIM ACTA, V36, P875, DOI 10.1002/hlca.19530360418
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   CROMMEN J, 1993, J CONTROL RELEASE, V24, P167, DOI 10.1016/0168-3659(93)90176-6
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P511, DOI 10.1016/0142-9612(92)90102-T
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P601, DOI 10.1016/0142-9612(92)90028-M
   CROMMEN JHL, 1991, B SOC CHIM BELG, V10, P747
   DHALLUIN G, 1992, MACROMOLECULES, V25, P1254, DOI 10.1021/ma00030a008
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GOEDEMOED JH, 1991, J CONTROL RELEASE, V170, P245
   GOEDEMOED JH, 1990, POLYPHOSPHAZENE DRUG, pCH7
   GROLLEMAN C W J, 1986, Journal of Controlled Release, V4, P119, DOI 10.1016/0168-3659(86)90047-7
   HELLER J, 1984, MED APPL CONTROLLED, V2, P70
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   Lewis D. H., 1990, BIODEGRADABLE POLYM, P1
   Schacht E, 1996, BIOTECHNOL BIOENG, V52, P102, DOI 10.1002/(SICI)1097-0290(19961005)52:1<102::AID-BIT10>3.3.CO;2-B
   SCHLINDLER A, 1977, POLYM SCI, V2, P251
NR 26
TC 19
Z9 19
U1 0
U2 3
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 1998
VL 13
IS 1
BP 4
EP 18
DI 10.1177/088391159801300102
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA ZA151
UT WOS:000072334000002
DA 2018-10-19
ER

PT J
AU Andreopoulos, AG
   Plytaria, M
AF Andreopoulos, AG
   Plytaria, M
TI Biomedical silicone elastomers as carriers for controlled release
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE biomedical elastomers; silicones; controlled release of drugs;
   propranolol; membranes
ID BIODEGRADABLE SYSTEMS; QUINOLONES; NETWORKS
AB Biomedical silicone elastomers have been studied for their potential application as carriers for controlled release of drugs, since these materials display a unique combination of properties, which might be favorable to the above use. A two component silicone gel system was used and various cross-linker ratio was applied, in order to produce networks with varying crosslink density. Swelling experiments in toluene were run in order to evaluate the network characteristics. The silicone elastomer was loaded with salicylic acid and propranolol hydrochloride and their delivery in distilled water was followed. The results showed that release is almost of zero order for high loading of salicylic acid, while delivery seems to be diffusion controlled up to a certain limit. The administered drug concentrations are relatively low if silicone discs are used, due to the hydrophobic nature of this material. On the other hand, when membranes are used with a thickness of 0.1-0.2 mm, then the delivery rate is much higher depending of course on the hydrophilic character of the drug.
C1 Natl Tech Univ Athens, Dept Chem Engn, Athens 15780, Greece.
CR Andreopoulos A G, 1994, J Biomater Appl, V8, P344, DOI 10.1177/088532829400800403
   Andreopoulos A. G., 1994, Clinical Materials, V15, P89, DOI 10.1016/0267-6605(94)90074-4
   ANDREOPOULOS AG, 1989, J APPL POLYM SCI, V37, P2121, DOI 10.1002/app.1989.070370804
   ANDREOPOULOS AG, 1989, BIOMATERIALS, V10, P101, DOI 10.1016/0142-9612(89)90040-9
   Andreopoulos AG, 1995, J BIOMATER APPL, V10, P163, DOI 10.1177/088532829501000206
   Andreopoulos AG, 1996, J BIOMATER APPL, V10, P338, DOI 10.1177/088532829601000404
   ANDREOPOULOS AG, 1993, J APPL POLYM SCI, V50, P729, DOI 10.1002/app.1993.070500419
   ANDREOPOULOS AG, 1992, J APPL POLYM SCI, V45, P1005, DOI 10.1002/app.1992.070450609
   ANDREOPOULOS AG, 1988, J MATER SCI LETT, V7, P235, DOI 10.1007/BF01730181
   BRAND C, 1983, POLYM PREPRINTS, V24, P71
   DEMETRIOU PP, 1988, J MATER SCI LETT, V7, P233, DOI 10.1007/BF01730180
   LEE P I, 1985, Journal of Controlled Release, V2, P277, DOI 10.1016/0168-3659(85)90051-3
   LEE PI, 1987, ACS SYM SER, V348, P1
   LINHARDT RJ, 1983, POLYM PREPR-ACS, V24, P47
   LONTZ JF, 1976, 1 INT S FACIAL PROTH
   MIGLIARESI C, 1984, POLYMER, V25, P686, DOI 10.1016/0032-3861(84)90037-5
   PINCHUK L, 1984, J APPL POLYM SCI, V29, P1749, DOI 10.1002/app.1984.070290528
   Vlachou M, 1996, J BIOMATER APPL, V10, P217, DOI 10.1177/088532829601000303
NR 18
TC 21
Z9 22
U1 0
U2 4
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 1998
VL 12
IS 3
BP 258
EP 271
DI 10.1177/088532829801200306
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA YW018
UT WOS:000071887400005
PM 9493072
DA 2018-10-19
ER

PT J
AU Han, DK
   Park, KD
   Kim, YH
AF Han, DK
   Park, KD
   Kim, YH
TI Sulfonated poly(ethylene oxide)-grafted polyurethane copolymer for
   biomedical applications
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biomaterial; polyurethane; sulfonated PEO; copolymer; bulk modification;
   biocompatibility
ID BLOOD COMPATIBILITY; ANTICOAGULANT ACTIVITY; SURFACE; PEO; ADHESION;
   ADSORPTION; POLYMERS
AB Sulfonated poly(ethylene oxide) (PEO-SO3)-grafted polyurethane (PU) copolymer (PU-PEO-SO3) was developed for utilization as a material for biomedical applications. Its bulk properties and biocompatibility were investigated and the results were compared to those of PU and PU-PEO (not sulfonated). PU-PEO-SO3 copolymer showed higher water uptake than PU and PU-PEO, indicative of increased hydrophilicity due to the grafting of PEO-SO3. Compared with PU, PU-PEO-SO3 displayed lower glass transition temperature (T-g) and melting endotherm from DSC analysis, suggesting the increase of microphase separation and the suppression of hard-segment packing. PU-PEO-SO3 had practically similar mechanical properties to PU, indicating that the chemical modification of PU was accomplished without reducing its bulk properties. From the results of biocompatibility tests, PU-PEO-SO3 copolymer showed significantly lower adhesion of platelets and S. epidermidis than PU control and PU-PEO. In addition, the platelet factor 4 (PF4) released from platelets was the lowest in PU-PEO-SO3 among the test materials. PU-PEO-SO3 copolymer, which has excellent mechanical properties and biocompatibility, is expected to be useful as coating, molding, and blending materials for artificial organs and medical devices.
C1 Korea Inst Sci & Technol, Biomat Res Ctr, Seoul 130650, South Korea.
RP Kim, YH (reprint author), Korea Inst Sci & Technol, Biomat Res Ctr, POB 131, Seoul 130650, South Korea.
EM yhakim@kistmail.kist.re.kr
OI Han, Dong Keun/0000-0003-4641-7883
CR Andrade J. D., 1987, ASAIO J, V33, P75
   BRUNSTEDT MR, 1995, J BIOMED MATER RES, V29, P455, DOI 10.1002/jbm.820290405
   CHEN WY, 1982, J POLYM SCI POL CHEM, V20, P547, DOI 10.1002/pol.1982.170200228
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   HAN DK, 1995, BIOMATERIALS, V16, P467, DOI 10.1016/0142-9612(95)98819-Z
   HAN DK, 1993, J BIOMED MATER RES, V27, P1063, DOI 10.1002/jbm.820270812
   HAN DK, 1991, J BIOMED MATER RES, V25, P561, DOI 10.1002/jbm.820250502
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   Han DK, 1996, J BIOMED MATER RES, V30, P23, DOI 10.1002/(SICI)1097-4636(199601)30:1<23::AID-JBM4>3.0.CO;2-T
   HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P579
   HAN DK, 1993, ASAIO J, V39, P537
   HAN DK, 1993, THESIS SEOUL NATL U
   IKADA Y, 1984, ADV POLYM SCI, V57, P103
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ITO Y, 1989, CRIT REV BIOCOMPAT, V5, P45
   ITO Y, 1988, ARTIFICIAL HEART, V2, P35
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   KIM S W, 1985, Critical Reviews in Biocompatibility, V1, P229
   KIM YH, 1995, ENCY HDB BIOMATERI B, V2, P1071
   KIM YH, 1996, POLYM MAT ENCY, V1, P825
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1986, J BIOMED MATER RES, V20, P433, DOI 10.1002/jbm.820200403
   MILLER GW, 1970, J POLYM SCI A, V18, P1923
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   *NIH, 1985, NIH PUBL
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   PARK KD, 1992, J BIOMED MATER RES, V26, P739, DOI 10.1002/jbm.820260605
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI DOI 10.1021/SYMPOSIUM
   SALZMAN EW, 1977, ANN NY ACAD SCI, V283, P114, DOI 10.1111/j.1749-6632.1977.tb41760.x
   SEMOUR RW, 1973, MACROMOLECULES, V6, P48
   Szycher M., 1991, HIGH PERFORMANCE BIO
   Tsuruta T, 1996, ADV POLYM SCI, V126, P1
   YU J, 1994, BIOMATERIALS, V15, P805, DOI 10.1016/0142-9612(94)90035-3
NR 33
TC 43
Z9 46
U1 1
U2 16
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1998
VL 9
IS 2
BP 163
EP 174
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA YX386
UT WOS:000072034800005
PM 9493843
DA 2018-10-19
ER

PT J
AU Bhaduri, A
   Das, KP
AF Bhaduri, A
   Das, KP
TI Covalent grafting of tryptophan to solid surfaces inhibit protein
   adsorption
SO JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY
LA English
DT Article
ID BETA-LACTOGLOBULIN; ALBUMIN; BIOCOMPATIBILITY
AB In recent years, increasing attention has been paid to improve biocompatibility of polymer surfaces because of their potential application hs drug release(1), drug carrier systems(2) and most important of all as high tensile material for artificial organs(3). Development of suitable synthetic materials for artificial organs has long been a major objective of biomedical research. When a foreign synthetic material is implanted as a replacement of damaged or deseased organ the human body, it elicits hundreds of immune responses(4) and interactions that mainly involve several phenomena like platelet adhesion(5), intrinsic coagulation(6), activation of erythrocyte(7) and morphological changes inmonocyte/macrophage(8) and most importantly activation of the complement cascade of immune system(9). So any implant must be biocompatible which is able to generate nonthrombotic foreign-body response and call evade undesired immune responses.
C1 Bose Inst, Dept Chem, Prot Chem Lab, Calcutta 700009, W Bengal, India.
RP Das, KP (reprint author), Bose Inst, Dept Chem, Prot Chem Lab, 93-1 APC Rd, Calcutta 700009, W Bengal, India.
CR ALMAKHLAFI H, 1995, APPL ENVIRON MICROB, V61, P2013
   ANDERHEIDEN D, 1992, J MATER SCI-MATER M, V3, P1, DOI 10.1007/BF00702936
   ARMSTRONG JM, 1967, BIOCHIM BIOPHYS ACTA, V147, P60, DOI 10.1016/0005-2795(67)90090-6
   Beena M S, 1994, J Biomater Appl, V8, P385, DOI 10.1177/088532829400800405
   BHADURI A, 1994, J DISPER SCI TECHNOL, V15, P165, DOI 10.1080/01932699408943551
   BHADURI A, 1997, THESIS JADAVPUR U
   BIRDI KS, 1977, P MEMBRANE TRANSPORT
   BIZZI B, 1993, INT J ARTIF ORGANS, V16, P209
   BODMEIER R, 1993, J PHARM SCI, V82, P191, DOI 10.1002/jps.2600820215
   Cazenave J.-P., 1986, BLOOD SURFACE INTERA
   CHATTORAJ DK, 1984, ADSORPTION GIBBS SUR, P612
   CHATTORAJ DK, 1984, ADSORPTION GIBBS SUR, P204
   Dawson R. M. C, 1986, DATA BIOCH RES
   Di Massimo C, 1993, Riv Eur Sci Med Farmacol, V15, P199
   FAVEL A, 1989, INT J PEPT PROT RES, V33, P202
   GIUDELLI R, 1992, NATO ASI SER, V335, P337
   HORBETT TA, 1982, ADV CHEM SER, V199, P233
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KOHLCHUTTER HW, 1969, THIN LAYER CHROMATOG
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   NAGAOKA S, 1983, POLYM PREPR-ACS, V24, P67
   NOZAKI Y, 1971, J BIOL CHEM, V246, P2211
   PERI JB, 1965, J PHYS CHEM-US, V69, P211, DOI 10.1021/j100885a032
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   SADHUKHAN BK, 1984, SURFACTANTS SOLUTION
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   WIRZING G, 1963, NATURWISSENSCHAFTEN, V50, P466, DOI 10.1007/BF00632911
NR 28
TC 1
Z9 1
U1 0
U2 1
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0193-2691
J9 J DISPER SCI TECHNOL
JI J. Dispersion Sci. Technol.
PY 1998
VL 19
IS 4
BP 451
EP 464
DI 10.1080/01932699808913188
PG 14
WC Chemistry, Physical
SC Chemistry
GA ZT885
UT WOS:000074127800003
DA 2018-10-19
ER

PT S
AU Chapyak, EJ
   Godwin, RP
AF Chapyak, EJ
   Godwin, RP
BE Anderson, RR
   Bartels, KE
   Bass, LS
   Garrett, CG
   Gregory, KW
   Lui, H
   Malek, RS
   Perlmutter, AP
   Reinisch, L
   Smalley, PJ
   Tate, LP
   Thomsen, SL
   Watson, GM
   Katzir, A
TI Physical mechanisms of importance to Laser Thrombolysis
SO LASERS IN SURGERY: ADVANCED CHARACTERIZATION, THERAPEUTICS, AND SYSTEMS
   VIII, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Lasers in Surgery - Advanced Characterization,
   Therapeutics, and Systems VIII
CY JAN 24-25, 1998
CL SAN JOSE, CA
SP Int Biomed Opt Soc, Soc Photo Opt Instrumentat Engineers
DE Laser Thrombolysis; bubble dynamics; numerical methods; hydrodynamics;
   material properties; tissue properties
AB Bubble dynamics plays a key role in many medical procedures including Laser Thrombolysis (L-T), acoustic and laser lithotripsy, interocular laser surgery, photoacoustic drug delivery, and perhaps ultrasonic imaging. We are investigating the effect that interfaces of different materials, especially biological and biomedical materials, have on the dynamics of nearby bubbles. Collapsing bubbles often become nonspherical, resulting in spectacular directed motion with potentially both beneficial and undesirable consequences. This directed motion may explain L-T mass removal and some types of laser-induced tissue damage.
C1 Univ Calif Los Alamos Natl Lab, Appl Theoret & Computat Phys Div, Los Alamos, NM 87545 USA.
RP Chapyak, EJ (reprint author), Univ Calif Los Alamos Natl Lab, Appl Theoret & Computat Phys Div, POB 1663, Los Alamos, NM 87545 USA.
NR 0
TC 11
Z9 11
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2684-9
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3245
BP 12
EP 18
DI 10.1117/12.312270
PG 7
WC Dermatology; Optics; Otorhinolaryngology; Surgery; Veterinary Sciences
SC Dermatology; Optics; Otorhinolaryngology; Surgery; Veterinary Sciences
GA BL37M
UT WOS:000075318900002
DA 2018-10-19
ER

PT J
AU Goldman, L
AF Goldman, L
TI Future of laser dermatology
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE laser diagnostics; microscopies; multiwavelength lasers; melanocyte
   cells; langerhans cells
AB Background and Objective: Laser dermatology, a long-time model for laser tissue interactions, will play an important part in the future of research, diagnostics, and therapeutics. Study
   Design/Materials and Methods: Laser research continues in photobiology, especially in molecular reactions, and it continues at the cellular level in melanocyte and Langerhans cells.
   Results: Laser diagnostics in the development of opto-electronics concern new developments in imagery. Some studies include new types of microscopes for living skin and vary from the portable illuminated skin microscopes, the current dermatoscopes, to the coaxial polarizing microscope and the new scanning confocal microscope of Gmitro for living tissues. The regular confocal microscope for fixed tissue slides will revolutionize dermatopathology. The other research microscopes include the ultrasonic biomedical microscope and the IR microscope and the holographic microscope of optical phase conjugation used for living tissues.
   Conclusion: New lasers for therapy include micromedical lasers, economical junction diode lasers alone and for pumping solid-state lasers, FEL of the future, and multiwavelength laser units. These later units include seven-wavelength units of barium, copper vapor and ruby, and are available for other heavy metal laser heads, ds gold-628 nm and lead-722 nm. Copper vapor can pump also Ti sapphire. The MOPO series (200 nm in the UV to >4,500 in the IR) is the most extensive modern multiwavelength laser box type. (C) 1998 Wiley-Liss, Inc.(dagger)
C1 USN, Med Ctr, Dept Clin Invest, San Diego, CA 92134 USA.
   USN, Med Ctr, Dept Dermatol, San Diego, CA 92134 USA.
RP Goldman, L (reprint author), USN, Med Ctr, Dept Clin Invest, San Diego, CA 92134 USA.
CR BERGFELT L, 1993, ACTA DERM-VENER    S, P180
   DECKELBAUM LI, 1990, LASERS CARDIOVASCULA
   GOLDMAN L, 1985, LASER SURG MED, V5, P453, DOI 10.1002/lsm.1900050503
   GOLDMAN L, 1958, ARCH DERMATOL, V78, P246, DOI 10.1001/archderm.1958.01560080106017
   GOLDMAN L, 1951, J INVEST DERMATOL, V16, P407, DOI 10.1038/jid.1951.48
   GOLDMAN L, 1967, BIOMEDICAL ASPECTS L
   GOLDMAN L, 1973, APPL LASER
   GOLDMAN L, 1993, SPIE, P17
   GOLDMAN L, 1980, J DERMATOL SURG ONC, V6, P9
   Goldman L., 1971, LASERS MED
   GOLDMAN L, 1981, BIOMEDICAL LASER TEC
   GOLDMAN L, 1990, LASERS CARDIOVASCULA
   GOLDMAN L, 1991, LASER NONSURGICAL ME
   GOLDMAN L, 1966, LASER CANC RES
   GOLDMAN L, 1990, LASERS SYSTEMS PHOTO
   GOLDMAN L, 1947, J INVEST DERMATOL, V9, P1116
   GOLDMAN L, 1975, ARCH DERMAOL, V75, P345
   KENET RO, 1993, ARCH DERMATOL, V129, P157, DOI 10.1001/archderm.129.2.157
   STEFANATO CM, 1993, J AM ACAD DERMATOL, V29, P486, DOI 10.1016/S0190-9622(08)82002-6
NR 19
TC 5
Z9 5
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PY 1998
VL 22
IS 1
BP 3
EP 8
DI 10.1002/(SICI)1096-9101(1998)22:1<3::AID-LSM3>3.0.CO;2-T
PG 6
WC Dermatology; Surgery
SC Dermatology; Surgery
GA YP485
UT WOS:000071281500003
PM 9443142
DA 2018-10-19
ER

PT S
AU Centeno, JA
   Ramos, MS
   Mullick, FG
   Offiah, OO
   Rastogi, T
   Panos, RG
AF Centeno, JA
   Ramos, MS
   Mullick, FG
   Offiah, OO
   Rastogi, T
   Panos, RG
BE Collery, P
   Bratter, P
   deBratter, VN
   Khassanova, L
   Etienne, JC
TI Biophysical findings associated with silicone-gel breast implants:
   determination of silicon, calcium, and magnesium levels in capsular
   tissues
SO METAL IONS IN BIOLOGY AND MEDICINE, VOL 5
SE METAL IONS IN BIOLOGY AND MEDICINE
LA English
DT Proceedings Paper
CT 5th International Symposium on Metal Ions in Biology and Medicine
CY MAY 08-10, 1998
CL NEUHERBERG, GERMANY
SP Hahn Meitner Inst Berlin, Dept Trace Elements Hlth & Nutr, GSF Forschungszent Umwelt & Gesundheit, Inst Int Rech Ions Metall, G N PHARM Umwelt & Med, Hewlett Packard GmbH, F Kolher Chem, Ursapharm Arzneimittel GmbH, PROTINA GmbH
ID ASSAYS
AB Background: Recent concerns about medical problems associated with the use of silicone-gel breast implants (SBI) including immune problems sand local tissue reactions have continue to appear in the clinical and medical literature. In order to study the possible role of trace elements as markers of exposure and patient morbidity, reproducible basic scientific data on the analysis of biological materials is needed. The present study was designed to measure silicon (originating from silicone), calcium and magnesium levels in capsular implant tissues of patients with SBI and saline breast implants.
   Design: Breast implant capsular tissues (BICT) were studied by histological, biophysical, and chemical methods. Fifty-three capsules from patients with silicone-gel breast implants (N=32), patients with saline implants (N=5), cases with observable "bleed" materials (N=5), and normal non-silicone exposed controls (N=10) were investigated. Breast capsules were obtained from patients with well established clinical records and with local problems such as capsular contractures whom requested to have their implants removed. Normal tissues were obtained from patients without any history of exposure to biomedical implants, and from patients undergoing reduction mammoplasty. Prior to the chemical analyses, all tissues were prepared by employing acid-induced microwave digestion, and analysed by inductively coupled plasma optical emission spectrometry (ICP-OES).
   Results: High levels of calcium and magnesium in BICT were strongly associated with the use of implant fixation patches and double-lumen textured surfaces. Similarly, elevated levels of silicon in breast capsular tissues were associated with the use of gel-filled implants and the "bleed" effect of the gel material migrating to the adjacent connective fibrous tissues.
   Conclusions Breast implant capsular tissues demonstrated significantly higher levels of silicon (similar to 1000 - 4000x) than the control group (p<0.05). Capsular silicon levels from saline breast implants approached those of the control non-exposed patients. High levels of calcium and magnesium correlated with the use of fixation materials and with the formation of foreign body response reactions. The significance of these results in determining the role of silicone on the development of immune problems remains to be established.
C1 Armed Forces Inst Pathol, Dept Environm & Toxicol Pathol, Washington, DC 20306 USA.
RP Centeno, JA (reprint author), Armed Forces Inst Pathol, Dept Environm & Toxicol Pathol, Washington, DC 20306 USA.
CR BARKER DE, 1978, PLAST RECONSTR SURG, V61, P836, DOI 10.1097/00006534-197861060-00002
   BRAUTBAR N, 1992, TOXICOL IND HEALTH, V8, P231
   CENTENO JA, UNPUB AM J CLIN PATH
   EVANS GRD, 1994, PLAST RECONSTR SURG, V93, P1117, DOI 10.1097/00006534-199405000-00001
   Evans GRD, 1996, PLAST RECONSTR SURG, V97, P1207, DOI 10.1097/00006534-199605000-00016
   Luke JL, 1997, PLAST RECONSTR SURG, V100, P1558, DOI 10.1097/00006534-199711000-00029
   McConnell JP, 1997, AM J CLIN PATHOL, V107, P236, DOI 10.1093/ajcp/107.2.236
   PETERS W, 1995, ANN PLAS SURG, V34, P578, DOI 10.1097/00000637-199506000-00003
   TEUBER SS, 1995, BIOL TRACE ELEM RES, V48, P121, DOI 10.1007/BF02789186
NR 9
TC 1
Z9 1
U1 0
U2 1
PU JOHN LIBBEY EUROTEXT
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1257-2535
BN 2-7420-0214-6
J9 METAL IONS BIOL MED
PY 1998
VL 5
BP 362
EP 366
PG 5
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism; Nutrition
   & Dietetics; Physiology; Toxicology
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism; Nutrition
   & Dietetics; Physiology; Toxicology
GA BM31W
UT WOS:000078374100067
DA 2018-10-19
ER

PT S
AU Hansford, D
   Desai, T
   Tu, J
   Ferrari, M
AF Hansford, D
   Desai, T
   Tu, J
   Ferrari, M
BE Gourley, PL
   Katzir, A
TI Biocompatible silicon wafer bonding for biomedical microdevices
SO MICRO- AND NANOFABRICATED STRUCTURES AND DEVICES FOR BIOMEDICAL
   ENVIRONMENTAL APPLICATIONS
SE PROGRESS IN BIOMEDICAL OPTICS
LA English
DT Proceedings Paper
CT Conference on Microfabricated and Nanofabricated Structures and Devices
   for Biomedical Environmental Applications
CY JAN 26-27, 1998
CL SAN JOSE, CA
SP SPIE, Int Soc Opt Engn, Int Biomed Opt Soc
DE biocompatible; wafer bonding; adhesive; methacrylates
AB In this paper, several candidate bonding materials are reviewed for use in biomedical microdevices. These include poly propylmethacrylate (PPMA), poly methylmethacrylate (PMMA), a copolymer of poly (ethyl, butyl) methacrylate (PBEMA) and two types of silicone gels. They were evaluated based on their cytotoxicity and bond strength, as well as several other qualitative assessments. The cytotoxicity was determined through a cell growth assay protocol in which cells were grown on the various substrata and their growth was compared to cells sown on control substrata. The adhesive strength was assessed by using a pressurized plate test in which the adhesive interface was pressurized to failure, Ab of the substrata were found (once cured) to be non-cytotoxic in an inert manner except for the industrial silicone adhesive gel (Dow Coming 736). The adhesive strengths of the various materials are compared to each other and to previously published adhesive strengths. All of the materials were found to have a sufficient bonding strength for biomedical applications, but several other factors were determined that limit the use of each material (including defect density, patternability, and ease of application).
C1 Univ Calif Berkeley, Biomed Microdevices Ctr, Berkeley, CA 94720 USA.
RP Hansford, D (reprint author), Univ Calif Berkeley, Biomed Microdevices Ctr, 721 Davis Hall, Berkeley, CA 94720 USA.
NR 0
TC 6
Z9 6
U1 2
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 1017-2661
BN 0-8194-2697-0
J9 PROG BIOM O
PY 1998
VL 3258
BP 164
EP 168
DI 10.1117/12.304376
PG 5
WC Engineering, Multidisciplinary; Engineering, Biomedical; Optics
SC Engineering; Optics
GA BK80K
UT WOS:000073452100020
DA 2018-10-19
ER

PT S
AU Ingal, VN
   Beliaevskaya, EA
AF Ingal, VN
   Beliaevskaya, EA
BE Melker, AI
TI Phase image testing of an internal structure of x-ray transparent
   materials.
SO NEW APPROACHES TO HIGH-TECH MATERIALS: NONDESTRUCTIVE TESTING AND
   COMPUTER SIMULATIONS IN MATERIALS SCIENCE AND ENGINEERING
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT International Workshop on New Approaches to High-Tech Materials -
   Nondestructive Testing and Computer Simulations in Materials Science and
   Engineering
CY JUN 09-13, 1997
CL ST PETERSBURG, RUSSIA
SP St Petersburg State Tech Univ, Russia, St Petersburg Acad Sci Strength Problems, Russia, NPO Special Mat, Russia, Soc Photo Opt Instrumentat Engineers, Russia Chapter, Polytest Co Ltd, Russia
DE phase imaging; Bragg diffraction; plane wave; internal structure; x-ray
   transparent materials; biological objects; soft tissues; treated
   diamonds
AB A new technique for imaging an inner structure of x-ray transparent materials and biomedical objects characterized by small density changes of their structure components is presented. The phase imaging is based on two principal phenomena; radiation refraction in a tested object and diffraction in highly perfect crystals used both for creation of an incident beam and for imaging. It is shown that a phase, radiography providing possibilities of an opacification free investigation of biomedical objects soft tissues can be developed upon the technique reported here.
C1 Xray Lab, St Petersburg 195252, Russia.
RP Ingal, VN (reprint author), Xray Lab, 68 Maloochtinskiy Pr, St Petersburg 195252, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2792-6
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3345
BP 61
EP 75
DI 10.1117/12.299573
PG 15
WC Computer Science, Interdisciplinary Applications; Engineering,
   Multidisciplinary; Materials Science, Multidisciplinary; Materials
   Science, Characterization & Testing; Optics
SC Computer Science; Engineering; Materials Science; Optics
GA BK57X
UT WOS:000072612100014
DA 2018-10-19
ER

PT S
AU Kunz, R
   Anders, C
   Gersonde, K
AF Kunz, R
   Anders, C
   Gersonde, K
BE Haris, PI
   Chapman, D
TI Principles for the reduction of bacterial adhesion to surface-modified
   polymers
SO NEW BIOMEDICAL MATERIALS: BASIC AND APPLIED STUDIES
SE BIOMEDICAL AND HEALTH RESEARCH
LA English
DT Proceedings Paper
CT 1st International Conference on Biomedical Materials
CY MAY, 1997
CL ANCONA, ITALY
SP Biocompatibles Int, Dideco SPA, Johnson & Johnson Corp Biomat Ctr, Smith & Nephew Res Ltd, Univ London, Interdisciplinary Res Ctr Biomed Appl Sci
AB Bacterial infection is a frequent complication associated with the use of biomedical materials. Our strategy is to reduce bacterial adhesion by surface modification of biomaterials to such an extent that biofilm formation and thus infections are inhibited.
C1 Huls AG, DNE Med Technol, D-45764 Marl, Germany.
RP Kunz, R (reprint author), Huls AG, DNE Med Technol, Paul Baumann Str 1, D-45764 Marl, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU I O S PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0929-6743
BN 90-5199-365-X
J9 BIOM HLTH R
PY 1998
VL 16
BP 115
EP 121
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BL79T
UT WOS:000076774700015
DA 2018-10-19
ER

PT B
AU Okabe, T
   Watanabe, I
   Okuno, O
   Takada, Y
AF Okabe, T
   Watanabe, I
   Okuno, O
   Takada, Y
BE Froes, FHS
   Allen, PG
   Niinomi, M
TI Dental casting of titanium and titanium alloys
SO NON-AEROSPACE APPLICATIONS OF TITANIUM
LA English
DT Proceedings Paper
CT 1998 TMS Annual Meeting on Non-Aerospace Applications of Titanium
CY FEB 16-19, 1998
CL SAN ANTONIO, TX
SP Minerals Met & Mat Soc, Div Struct Mat
AB The dental profession has become increasingly concerned with problems related to biocompatibility and the corrosion behavior of intraoral materials. Because of the well-documented safety of titanium for biomedical uses, interest in applying titanium and its alloys to dental applications has recently grown. A tremendous amount of international effort has been directed toward the development of a titanium casting system that would successfully produce dental prostheses using the lost-wax technique (used for many years in dentistry). By adapting applicable technologies from the titanium casting industry, the evolution of casting machines and investment materials specifically made for dental casting has greatly advanced during the last 20 years. It appears that dental titanium casting has now almost reached the stage where its practical applications should seriously be assessed, although some problems have not been completely solved. In this article, a brief review is given of the present status of dental titanium casting, including some recently acquired experimental results obtained in the authors' laboratories.
C1 Texas A&M Univ, Baylor Coll Dent, Dept Biomat Sci, Dallas, TX USA.
RP Okabe, T (reprint author), Texas A&M Univ, Baylor Coll Dent, Dept Biomat Sci, Dallas, TX USA.
NR 0
TC 6
Z9 6
U1 0
U2 2
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-394-5
PY 1998
BP 207
EP 215
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BL56E
UT WOS:000075891500021
DA 2018-10-19
ER

PT B
AU Niinomi, M
   Daisuke, K
   Morinaga, M
   Kato, Y
   Yashiro, T
AF Niinomi, M
   Daisuke, K
   Morinaga, M
   Kato, Y
   Yashiro, T
BE Froes, FHS
   Allen, PG
   Niinomi, M
TI New beta-type titanium alloys with high biocompatibility
SO NON-AEROSPACE APPLICATIONS OF TITANIUM
LA English
DT Proceedings Paper
CT 1998 TMS Annual Meeting on Non-Aerospace Applications of Titanium
CY FEB 16-19, 1998
CL SAN ANTONIO, TX
SP Minerals Met & Mat Soc, Div Struct Mat
AB Pure titanium and Ti - 6Al - 4V alloy have been mainly used as implant materials. V free titanium alloys like Ti - 6Al - 7Nb and Ti - 5Al - 2.5Fe have been then del eloped because toxicity of V has een pointed out. Al and V free titanium alloys as implant materials have been then developed. Most of them are, however, alpha + beta type alloys. beta type titanium alloys with lower moduli of elasticity and greater strength have been started to be developed recently. Design of new beta type titanium alloys composed of non - toxic elements like Nb, Ta, Zr, Mo or Sn with lower moduli of elasticity and eater strength were, therefore,done based on the d - electron alloy design method, and the basic mechanical properties of designed alloys of button ingots melted by tri - are furnace in the laboratory ere investigated in this study. beta type alloys, Ti - Nb - Ta - Zr, Ti - Nb - Ta - Mo and Ti - Nb - Ta - system alloys designed in this study are expected to have greater performance for implant materials. The Young's moduli of these alloys are lower comparing with that of Ti - 6Al - 4V ELI which has been used as an implant material. The alloys conducted with some heat treatments offer suitable tensile properties as implant materials. The tensile strength, elongation and wear resistance of designed alloys in this study are equivalent or greater comparing with those of conventional biomedical titanium alloys for implant materials.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 441, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 441, Japan.
NR 0
TC 13
Z9 13
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-394-5
PY 1998
BP 217
EP 223
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BL56E
UT WOS:000075891500022
DA 2018-10-19
ER

PT S
AU Ramakrishna, S
   Tang, ZG
   Teoh, SH
   Tsai, KT
AF Ramakrishna, S
   Tang, ZG
   Teoh, SH
   Tsai, KT
BE Ye, L
   Mai, YW
TI Knitted fabric reinforced flexible composite material
SO POLYMER BLENDS AND POLYMER COMPOSITES
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT International Workshop on Polymer Blends and Polymer Composites
CY JUL 08-11, 1997
CL UNIV SYDNEY, CTR ADV MAT TECHNOL, SYDNEY, AUSTRALIA
HO UNIV SYDNEY, CTR ADV MAT TECHNOL
DE biomaterials; textile composites; knitted fabrics; polyurethane;
   biomedical applications
AB Primary objective of this research work is to develop a flexible and biocompatible composite material by reinforcing polyurethane elastomer with knitted fabric of polyester fibers. A new composite fabrication method has been developed, as the conventional thermoplastic composite fabrication methods are not suitable for reinforcing a polymer of high melting temperature with fibers of low melting temperature, The flexible composite material displayed an elastic modulus of 22.3 MPa, tensile strength of 19.5 MPa and a failure strain of 141%.
C1 Natl Univ Singapore, Ctr Biomed Mat Applicat & Technol, Singapore 119260, SINGAPORE.
   Natl Univ Singapore, Dept Mech & Prod Engn, Singapore 119260, SINGAPORE.
   Natl Univ Singapore, Inst Mat Res & Engn, Singapore 119260, SINGAPORE.
   INSTRON Singapore Pte Ltd, Singapore 0511, SINGAPORE.
RP Ramakrishna, S (reprint author), Natl Univ Singapore, Ctr Biomed Mat Applicat & Technol, 10 Kent Ridge Crescent, Singapore 119260, SINGAPORE.
CR BJORCK CG, 1994, EUR J SURG, V160, P9
   JONES AJ, 1988, POLYM BIOMATERIALS B
   Marois Y, 1996, BIOMATERIALS, V17, P1289, DOI 10.1016/0142-9612(96)88674-1
   ROMAN JS, 1996, J BIOMED MATER RES, V32, P19
   Sharma C. P., 1991, BLOOD COMPATIBLE MAT
   Zhang Z, 1997, BIOMATERIALS, V18, P113, DOI 10.1016/S0142-9612(96)00054-3
NR 6
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-766-8
J9 KEY ENG MATER
PY 1998
VL 137
BP 16
EP 23
DI 10.4028/www.scientific.net/KEM.137.16
PG 8
WC Materials Science, Multidisciplinary; Materials Science, Composites;
   Polymer Science
SC Materials Science; Polymer Science
GA BJ19C
UT WOS:A1998BJ19C00003
DA 2018-10-19
ER

PT J
AU Schmitt-Thomas, KG
   Yang, ZG
   Hiermer, T
AF Schmitt-Thomas, KG
   Yang, ZG
   Hiermer, T
TI Development of torsion loading facility used for evaluating shear
   performance of polymeric composite implant rods
SO POLYMER TESTING
LA English
DT Article
ID BONE
AB A torsion loading facility, which integrates a specially-devised torsion tester with an Instron universal testing machine, was developed to evaluate shear performance and failure behavior of implant rods comprised of a variety of materials. The experimental technique and some key instruments employed during the torsion test are described in detail. With this newly-developed facility, torsion fracture test for seven kinds of implant rods made up of polymeric composites and metallic materials were conducted to assess their comprehensive shear properties and characterize their failure behavior. it was concluded that the novel testing facility was able to provide satisfactory measurement for shear performance of the rods consisting of various materials, and polymeric composite rod with braiden-fabrics is an ideal replacement metal material for biomedical implant. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Tech Univ Munich, Inst Appl Mat Engn, D-80333 Munich, Germany.
RP Hiermer, T (reprint author), Tech Univ Munich, Inst Appl Mat Engn, Arcisstr 21, D-80333 Munich, Germany.
CR Akay M, 1996, J BIOMED MATER RES, V31, P167
   [Anonymous], 1991, 5835 ISO
   *ASTM, 1979, ASTM DES F117 STAND
   Dupraz A, 1996, J MATER SCI-MATER M, V7, P52, DOI 10.1007/BF00121190
   HASTINGS GW, 1976, BIOCOMPATIBILITY IMP, P128
   *INA, 1992, TECHN POCK, P148
   *ISO, 1987, 5382 ISO
   *ISO, 1989, 6475 ISO
   LIAO K, 1993, AM SOC TEST MATER, V1178, P72, DOI 10.1520/STP15544S
   MARTENS M, 1985, THESIS U LEIDEN NETH
   MATTHEW RM, 1994, J BIOMED MATER RES, V28, P1221
   REILLY DT, 1974, J BIOMECH, V7, P271, DOI 10.1016/0021-9290(74)90018-9
NR 12
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9418
J9 POLYM TEST
JI Polym. Test
PY 1998
VL 17
IS 2
BP 117
EP 130
DI 10.1016/S0142-9418(97)00037-8
PG 14
WC Materials Science, Characterization & Testing; Polymer Science
SC Materials Science; Polymer Science
GA 100AX
UT WOS:000074792700005
DA 2018-10-19
ER

PT B
AU Nelson, RC
   Goldman, M
   Anspaugh, LR
   Hoover, MD
   James, AC
   McCraw, TF
   Napier, B
   Templeton, WL
AF Nelson, RC
   Goldman, M
   Anspaugh, LR
   Hoover, MD
   James, AC
   McCraw, TF
   Napier, B
   Templeton, WL
BE Mosleh, A
   Bari, RA
TI Assessing consequences of plutonium releases from potential spacecraft
   accidents
SO PROBABILISTIC SAFETY ASSESSMENT AND MANAGEMENT (PSAM 4), VOLS 1-4
LA English
DT Proceedings Paper
CT 4th International Conference on Probabilistic Safety Assessment and
   Management
CY SEP 13-18, 1998
CL NEW YORK, NY
SP Int Assoc Probabilist Safety Assessment & Management, Amer Inst Chem Engineers, Amer Nucl Soc, Amer Soc Civil Engineers, Amer Soc Mech Engineers, Atom Energy Soc Japan, European Nucl Soc, European Safety & Reliabil Assoc, Fed Aviat Adm, Human Factors Soc, Inst Elect & Electr Engineers, Int Atom Energy Agcy, European Union, Joint Res Ctr, NASA, Org Econ Cooperat & Dev, Soc Risk Analy, Syst Safety Soc, UK Safety & Reliabil Soc, US Coast Guard, US DOE, US Nucl Regulatory Commiss, Associated Univ Inc, Beta Corp Int, BOOZ ALLEN & HAMILTON Inc, Brookhaven Sci Associates, ERIN Engn & Res Inc, PLG Inc, Sci Applicat Int Corp, SCIENTECH INC, Univ Maryland, Ctr Technol Risk Stud
AB All United States space missions involving launch vehicles carrying significant amounts of nuclear material are required by U.S. law to obtain approval from the Office of the President. Pursuant to that approval, the mission and all its systems must undergo evaluations of the associated nuclear environmental, health and safety risks. These evaluations are documented in a Safety Analysis Report prepared by the organization proposing the mission, and by an overall Safety Evaluation Report prepared for the President by an independent Nuclear Safety Review Panel (INSRP).
   Recent deep space missions have had their onboard electrical power derived from Radioisotopic Thermoelectric Generators (RTGs) whose thermal energy is provided by using the decay heat from encapsulated plutonium-238 General Purpose Heat Sources (GPHS). Smaller Light Weight Radioisotope Heater Units (LWRHU) are also used to maintain the temperatures of critical components. This paper will summarize the central part of the overall evaluation with a risk assessment of potential "source terms" of plutonium which might be released following postulated accidents. The amount of plutonium released, the fraction in particle sizes which could be inhaled, the subsequent dispersion, deposition, resuspension and absorption all must be evaluated for each accident scenario. In addition the population densities, integrated air concentrations and physiological and sociological aspects mustbe included Special consideration is given to the chemical form of particles and to their size distributions and inhalability.
   The assessment integrates the newest information on local and global environmental and biomedical factors, and provides new means to derive radiation doses and consequences as well as approaches to understanding associated uncertainties. Finally, individual and collective population radiation doses are estimated and are coupled with appropriate risk coefficients to yield estimates for potential early and late lifetime radiation effects.
C1 ATL Int Inc, Richland, WA USA.
RP Nelson, RC (reprint author), ATL Int Inc, Richland, WA USA.
RI Hoover, Mark/I-4201-2012
OI Hoover, Mark/0000-0002-8726-8127
CR *INSRP, 1990, 9006 INSRP
   *INSRP, 1997, BIOM ENV EFF SUBP BE
   International Commission on Radiological Protection, 1994, ICRP PUBL, V66
   MAXWELL R, IN PRESS RAD RES
   WHICKER FW, 1982, RADIOECOLOGY NUCL EN, V1, P161
   *WHO, 1983, 25 WHO
NR 6
TC 0
Z9 0
U1 0
U2 5
PU SPRINGER-VERLAG LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL RD FARNCOMBE, GODALMING GU7 1NH, SURREY,
   ENGLAND
BN 3-540-76262-0
PY 1998
BP 939
EP 944
PG 6
WC Engineering, Multidisciplinary; Multidisciplinary Sciences
SC Engineering; Science & Technology - Other Topics
GA BP34L
UT WOS:000084758100142
DA 2018-10-19
ER

PT B
AU Sendemir, A
   Altintas, S
AF Sendemir, A
   Altintas, S
GP IEEE
TI Production of hydroxylapatite reinforced polymer composites for
   biomedical applications
SO PROCEEDINGS OF THE 1998 2ND INTERNATIONAL CONFERENCE BIOMEDICAL
   ENGINEERING DAYS
LA English
DT Proceedings Paper
CT 2nd International Biomedical Engineering Days Conference
CY MAY 20-22, 1998
CL ISTANBUL, TURKEY
SP Bogazici Univ, Inst Biomed Engn, IEEE, Engn Med & Biol Soc
AB In this study, hydroxylapatite (HAp) reinforced polymer composites were produced and evaluated to be used in bone implants. The aim was to produce a material that has similar modulus of elasticity (E) and other mechanical properties to those of bone in order to achieve mechanical compatibility in the body. Hydroxylapatite was mixed with high density polyethylene (HDPE) and polypropylene (PP) in different amounts. The resulting composite materials were injection molded into standard tensile and impact test specimens and their mechanical properties were examined, Stiffness and hardness of the composites were increased toughness, percent elongation and impact energy were decreased with increasing HAp content. No significant change was observed in ultimate tensile strength while an increase was significant in the yield strength related to HAp content. PP composites were found to have better impact properties in spite of more ductile behavior of HDPE composites under tension. Although the problem of mechanical compatibility in bone implants has not totally been solved, hydroxylapatite reinforced polymer composites are suggested as promising alternatives to traditional implant materials.
C1 Bogazici Univ, Dept Engn Mech, Istanbul, Turkey.
RP Sendemir, A (reprint author), Bogazici Univ, Dept Engn Mech, PK 2, Istanbul, Turkey.
RI Sendemir Urkmez, Aylin/A-6347-2014
OI Sendemir Urkmez, Aylin/0000-0003-1818-6651
NR 0
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-4242-9
PY 1998
BP 114
EP 117
DI 10.1109/IBED.1998.710601
PG 4
WC Engineering, Biomedical
SC Engineering
GA BL61J
UT WOS:000076010900033
DA 2018-10-19
ER

PT S
AU Lal, A
AF Lal, A
BE Chang, HK
   Zhang, YT
TI Silicon-based ultrasonic surgical actuators
SO PROCEEDINGS OF THE 20TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 20, PTS 1-6: BIOMEDICAL
   ENGINEERING TOWARDS THE YEAR 2000 AND BEYOND
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 10th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 29-NOV 01, 1998
CL HONG KONG, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc
AB A novel ultrasonic biomedical actuator technology fabricated using micromachining and piezoelectric ceramics is presented. Advantages and limitations of micromachining technology in the context of biomedical actuators are outlined. Micromachining allows the fabrication of extremely small devices with integrated electronics. Silicon's material properties make it ideal for high-intensity ultrasonic applications. Cutting tip velocity and sharpness were shown to be superior to that of conventional ultrasonic surgical tool technology.
C1 Univ Wisconsin, Dept Elect & Comp Engn, Madison, WI 53706 USA.
RP Lal, A (reprint author), Univ Wisconsin, Dept Elect & Comp Engn, 1415 Johnson Dr, Madison, WI 53706 USA.
CR Ashby M. F., 1992, MAT SELECTION MECH D
   CHARLES S, 1981, VITREOUS MICROSURGER
   Lal A, 1996, SENSOR ACTUAT A-PHYS, V54, P542, DOI 10.1016/S0924-4247(97)80011-8
   LAL A, 1997, ASME WORLD C DALL
   LAL A, 1994, IEEE ULTR S CANN FRA
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   NEZHAT CR, 1998, FUNDAMENTALS SURG
   Rosen A., 1995, WILEY SERIES MICROWA
   SUSLICK KS, 1988, ULTRASOUND ITS CHEM
NR 9
TC 9
Z9 9
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-5164-9
J9 P ANN INT IEEE EMBS
PY 1998
VL 20
BP 2785
EP 2790
PN 1-6
PG 6
WC Cardiac & Cardiovascular Systems; Engineering, Biomedical; Medical
   Informatics; Medical Laboratory Technology; Clinical Neurology;
   Radiology, Nuclear Medicine & Medical Imaging
SC Cardiovascular System & Cardiology; Engineering; Medical Informatics;
   Medical Laboratory Technology; Neurosciences & Neurology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BM59Y
UT WOS:000079210400762
DA 2018-10-19
ER

PT S
AU Wang, CX
   Chen, ZQ
   Zhang, HL
AF Wang, CX
   Chen, ZQ
   Zhang, HL
BE Chang, HK
   Zhang, YT
TI Design of Ti/HA biomedical implants using ion-beam-assisted deposition
SO PROCEEDINGS OF THE 20TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 20, PTS 1-6: BIOMEDICAL
   ENGINEERING TOWARDS THE YEAR 2000 AND BEYOND
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 10th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 29-NOV 01, 1998
CL HONG KONG, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc
ID CALCIUM-PHOSPHATE COATINGS; SURFACE MODIFICATION; THIN-FILMS
AB Hydroxy-apatite (Ca(10)(PO(4))(6)(OH)(2), HA), owing to its bioaffinity and osteo-integration to body, is potential materials for coating on metal implants. At present, in addition to bulk HA directly used in restoration and reconstruction surgery, hydroxy-apatite is also coated on metal implants by plasma-spraying method, adhesion and sintering. However, these kinds of biomaterials are restricted in application due to their insufficient strength and weak bonding between substrate and coating. It is of great advantage to modify the surface of titanium and its alloy by ion-beam-assisted deposition (IBAD) combining ion implantation with physical vapor deposition (PVD). This paper is focused on the design of Ti/HA implants by ion-beam-assisted deposition technique and the computation of fabricating parameter using Trim 96 program The present investigation lays a foundation of the further research and application.
C1 W China Univ Med Sci, Coll Stomatol, Chengdu 610041, Peoples R China.
RP Wang, CX (reprint author), W China Univ Med Sci, Coll Stomatol, Chengdu 610041, Peoples R China.
EM wcumsdds@public.sc.cninfo.net
CR CHEN A, 1991, SURF COAT TECH, V50, P1, DOI 10.1016/0257-8972(91)90184-X
   Ektessabi AM, 1995, THIN SOLID FILMS, V270, P335, DOI 10.1016/0040-6090(95)06714-0
   EKTESSABI AM, 1995, NUCL INSTRUM METH B, V99, P610, DOI 10.1016/0168-583X(94)00568-0
   HOWLETT CR, 1994, J MATER SCI-MATER M, V5, P715, DOI 10.1007/BF00120363
   KORBER FJ, 1993, SURF COAT TECH, V59, P226, DOI 10.1016/0257-8972(93)90088-6
   Leitao E, 1997, J MATER SCI-MATER M, V8, P365, DOI 10.1023/A:1018532900458
   MATTOX DM, 1989, J VAC SCI TECHNOL A, V7, P1105, DOI 10.1116/1.576238
   Murayama Y, 1997, NUCL INSTRUM METH B, V127, P1015, DOI 10.1016/S0168-583X(97)00080-3
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   SUZUKI, 1994, NUCL INSTRUMENTS MET, V91, P580
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
NR 14
TC 3
Z9 4
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-5164-9
J9 P ANN INT IEEE EMBS
PY 1998
VL 20
BP 2890
EP 2892
PN 1-6
PG 3
WC Cardiac & Cardiovascular Systems; Engineering, Biomedical; Medical
   Informatics; Medical Laboratory Technology; Clinical Neurology;
   Radiology, Nuclear Medicine & Medical Imaging
SC Cardiovascular System & Cardiology; Engineering; Medical Informatics;
   Medical Laboratory Technology; Neurosciences & Neurology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BM59Y
UT WOS:000079210400790
DA 2018-10-19
ER

PT B
AU Stockton, E
   Fisher, RJ
AF Stockton, E
   Fisher, RJ
BE Wolpert, S
   Weiss, WJ
   Gaumond, RP
TI Designing biomimetic membranes for ion transport
SO PROCEEDINGS OF THE IEEE 24TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT IEEE 24th Annual Northeast Bioengineering Conference
CY APR 09-10, 1998
CL HERSHEY, PA
SP IEEE
AB Supported Liquid Membrane Systems (SLMS) have previously been shown to be effective mimics of active transport of ions. This can be controlled through use of thin film, fixed site carrier membranes on the external surfaces of an SLMS, to encapsulate it. This film must exhibit selective facilitated transport characteristics. We demonstrate this entrapping concept here by incorporating our previously successful SLMS with a thin film coating of a cation exchange membrane, Nafion (R) 124. Successful experiments for nickel transport were conducted in a recirculating dialysis unit. We also attempted to use fixed site carrier membranes; an ethylene-acrylic acid ionomer. Preliminary data indicates the approach is be sound for some cations, however the data for nickel was not conclusive. The most probable design for biomedical applications appears to be combination (laminate) system that incorporates supported liquid membranes and highly selective molecularly engineered thin film entrapping membranes utilizing advanced materials technologies.
C1 Univ Connecticut, SABRE Lab Engn Biosci, Dept Chem Engn, Storrs, CT 06269 USA.
RP Stockton, E (reprint author), Univ Connecticut, SABRE Lab Engn Biosci, Dept Chem Engn, Storrs, CT 06269 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-4544-4
PY 1998
BP 49
EP 51
DI 10.1109/NEBC.1998.664873
PG 3
WC Engineering, Biomedical
SC Engineering
GA BK95J
UT WOS:000073938800018
DA 2018-10-19
ER

PT J
AU Gil, FJ
   Planell, JA
AF Gil, FJ
   Planell, JA
TI Shape memory alloys for medical applications
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE shape memory; pseudoelasticity; NiTi alloys
ID ZN-AL ALLOYS; MARTENSITIC TRANSFORMATIONS; WIRE; PSEUDOELASTICITY;
   BEHAVIOR; DSC
AB The shape memory alloys exhibit a number of remarkable properties, which open new possibilities in engineering and more specifically in biomedical engineering. The most important alloy used in biomedical applications is NiTi. This alloy combines the characeristics of the shape memory effect and superelasticity with excellent corrosion resistance, wear characteristics, mechanical properties and a good biocompatibility. These properties make it an ideal biological engineering material, especially in orthopaedic surgery and orthodontics. In this work the basis of the memory effect lies in the fact that the materials exhibiting such a property undergo a thermoelastic martensitic transformation. In order to understand even the most elementary engineering aspects of the shape memory effect it is necessary to review some basic principles of the formation and the characteristics of the martensitic phase. The different properties of shape memory, superelasticity, two-way shape memory, rubber-like behaviour and a high damping capacity are reviewed. Some applications proposed in recent years are described and classified according to different medical fields.
C1 Univ Politecn Cataluna, Escola Tecn Super Engn Barcelona, Dept Ciencia Mat & Engn Met, Barcelona, Spain.
RP Gil, FJ (reprint author), Univ Politecn Cataluna, Escola Tecn Super Engn Barcelona, Dept Ciencia Mat & Engn Met, Barcelona, Spain.
CR AHLERS M, 1978, SCRIPTA METALL MATER, V12, P1075, DOI 10.1016/0036-9748(78)90077-7
   AMENGUAL A, 1989, THERMOCHIM ACTA, V145, P101, DOI 10.1016/0040-6031(89)85130-5
   AMENGUAL A, 1991, THERMOCHIM ACTA, V188, P63, DOI 10.1016/0040-6031(91)80205-W
   ANDREASEN G, 1980, AM J ORTHOD DENTOFAC, V78, P528, DOI 10.1016/0002-9416(80)90303-6
   ANDREASEN GF, 1978, AM J ORTHOD DENTOFAC, V73, P141
   BARCELO G, 1978, SCRIPTA METALL MATER, V12, P1069, DOI 10.1016/0036-9748(78)90076-5
   BAUMGART F, 1977, TECH MITT KRUPP FORS, V35, P157
   BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603
   BURSTONE CJ, 1985, AM J ORTHOD DENTOFAC, V87, P445, DOI 10.1016/0002-9416(85)90083-1
   BUSH RE, 1966, 65021 AMRA CR
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CASTLEMAN LS, 1981, BIOCOMPATIBILITY CLI, P567
   CUTRIGHT DE, 1973, ORAL SURG ORAL MED O, V35, P578, DOI 10.1016/0030-4220(73)90017-0
   DEHAVEN K, 1993, 3 C INT SOC KNEE GLE, P256
   DELAEY L, 1974, J MATER SCI, V9, P1521, DOI 10.1007/BF00552939
   DELAEY L, 1987, MAT SCI TECHNOLOGY, V5, P339
   DELAEY L, 1975, SHAPE MEMORY EFFECTS, P124
   DELAEY L, 1978, 78R1 KATH U LEUV DEP, P24
   FUKUYO S, 1990, SHAPE MEMORY ENG ASP, P470
   GIL FJ, 1993, J MATER SCI-MATER M, V4, P281, DOI 10.1007/BF00122281
   GIL FJ, 1991, THERMOCHIM ACTA, V191, P179, DOI 10.1016/0040-6031(91)87248-U
   GIL FJ, 1989, THESIS U BARCELONA, P250
   GIL FJ, 1996, BIOMED MAT ENG, V6, P153
   Gil FX, 1996, J MATER SCI-MATER M, V7, P403, DOI 10.1007/BF00122008
   GOLESTANEH AA, 1980, ACTA METALL MATER, V28, P1427, DOI 10.1016/0001-6160(80)90011-5
   Greninger AB, 1938, T AM I MIN MET ENG, V128, P337
   GUILEMANY JM, 1990, MATER RES BULL, V25, P1325, DOI 10.1016/0025-5408(90)90092-G
   GYUNTER VE, 1992, SHAPE MEMORY EFFECTS, P600
   GYUNTER VE, 1993, SUPERELASTIC IMPLANT, P213
   HAARSTERS J, 1990, SHAPE MEMORY ENG ASP, P426
   HAASTERS J, 1980, CURRENT CONCEPTS INT, P128
   HAMADA H, P 4 C JAP SOC BIOM, P191
   HAMANAKA H, 1982, P 8 ANN M SOC BIOM, P91
   HORNBOGEN E, 1990, SHAPE MEMORY ENG ASP, P267
   HUGHES JL, 1977, 1774C4041 DAMD US AR, P72
   JAMES DW, 1969, MATER SCI ENG, V4, P322
   JARDINE AP, 1989, J MATER SCI, V24, P2587, DOI 10.1007/BF01174530
   KAUFMAN L, 1958, PROG MET PHYS, V7, P165, DOI 10.1016/0502-8205(58)90005-4
   KROUSBROCK R, 1984, SHAPE MEMORY ALLOYS, V2, P82
   KROUSBROECK R, 1982, ADV BIOMATER, V3, P767
   KURDYUMOV GV, 1949, DOKL AKAD NAUK SSSR+, V66, P211
   LI L, 1988, SCRIPTA METALL, V22, P1435
   LIBENSON C, 1996, ORTHOD KIEFERORTHOP, V28, P135
   LIBENSON C, 1996, REV ORTHOP DENTO FAC, V30, P129
   LIN HC, 1993, METALL TRANS A, V24, P2189, DOI 10.1007/BF02648593
   LU S, 1990, SHAPE MEMORY ENG ASP, P445
   MELLOR BG, 1980, SCI TECHNOLOGY SHAPE, P125
   MELTON KN, 1990, SHAPE MEMORY ENG ASP, P21
   MIURA F, 1988, AM J ORTHOD DENTOFAC, V94, P89, DOI 10.1016/0889-5406(88)90356-3
   MonteroOcampo C, 1996, J BIOMED MATER RES, V32, P583, DOI 10.1002/(SICI)1097-4636(199612)32:4<583::AID-JBM11>3.0.CO;2-F
   NETSU N, 1978, B RES I MINERAL DRES, V34, P67
   Olander A, 1932, J AM CHEM SOC, V54, P3819, DOI 10.1021/ja01349a004
   OLEARY J, 1990, SHAPE MEMORY ENG ASP, P477
   ORTIN J, 1988, ACTA METALL MATER, V36, P1873, DOI 10.1016/0001-6160(88)90291-X
   OTSUKA K, 1981, P INT C SOLID SOLID, P1267
   OTSUKA K, 1976, INT METALS REV, V31, P93
   OTSUKA K, 1977, INT Q SCI REV J REV, V2
   PERKINS J, 1990, SHAPE MEMORY ENG ASP, P195
   PICORNELL C, 1989, SCRIPTA METALL MATER, V23, P371, DOI 10.1016/0036-9748(89)90385-2
   PONS J, 1993, MATER T JIM, V34, P888, DOI 10.2320/matertrans1989.34.888
   SABRIA J, 1995, BIOMED MAT ENG, V5, P161
   SADE M, 1988, Z METALLKD, V79, P487
   SADE M, 1988, Z METALLKD, V79, P678
   SAWYER PN, 1971, T AM SOC ART INT ORG, V17, P470
   SCHMERLING MA, 1976, J BIOMED MATER RES, V10, P879, DOI 10.1002/jbm.820100607
   SCHROEDER TA, 1976, METALL TRANS A, V7, P535, DOI 10.1007/BF02643969
   SEKIGUCI Y, 1984, MED APPL SHAPE MEMOR, P10
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   SHIMIZU K, 1984, SHAPE MEMORY EFFECT, P10
   SIMON M, 1977, RADIOLOGY, V125, P89, DOI 10.1148/125.1.89
   STALMANS R, 1992, ACTA METALL MATER, V40, P501, DOI 10.1016/0956-7151(92)90399-Y
   STICE J, 1990, SHAPE MEMORY ENG ASP, P483
   SUZUKI Y, 1990, SHAPE MEMORY ENG ASP, P256
   WARLIMONT H, 1974, PROG MATER SCI, V18, P93
   WASILEWSKI RJ, 1975, METALL TRANS A, V6, P1405, DOI 10.1007/BF02641933
   WAYMAN CM, 1990, INTRO MARTENSITE SHA, P5
   ZHANG XF, 1986, SHAPE MEMORY ALLOY 8, P24
   ZHONGGUO W, 1988, SCRIPTA METALL, V22, P1245
NR 78
TC 49
Z9 49
U1 0
U2 19
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-4119
EI 2041-3033
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PY 1998
VL 212
IS H6
BP 473
EP 488
DI 10.1243/0954411981534231
PG 16
WC Engineering, Biomedical
SC Engineering
GA 140LJ
UT WOS:000077088500008
PM 9852742
DA 2018-10-19
ER

PT B
AU German, RM
AF German, RM
BE Khor, KA
   Srivatsan, TS
   Moore, JJ
TI Powder injection molding applications to new materials
SO PROCESSING AND FABRICATION OF ADVANCED MATERIALS VI, VOLS 1 & 2
LA English
DT Proceedings Paper
CT International Symposium on Processing and Fabrication of Advanced
   Materials
CY NOV 24-26, 1997
CL SINGAPORE, SINGAPORE
SP Nanyang Technol Univ, Sch Mech & Prod Engn, Inst Mat, Minerals Met & Mat Soc, Adv Mat Res Ctr
DE powder injection molding; applications; new materials
ID COMPONENTS
AB A new technology known as powder injection molding (PIM) has grown from a curiosity to a viable production process over the past 15 years. It is now the manufacturing route of choice for many biomedical, computer, automotive, firearm, and turbine components. The process uses the shaping advantage of plastic injection molding, while delivering competitive mechanical, physical, and thermal properties. Original materials were alumina, steel, and stainless steel, but most all ceramics and metals can now be formed by the technique. Some exciting developments are occurring in the forming of complex components with high production volumes. A few of the challenges are associated with the production of titanium golf clubs, superelastic eyewear, zirconia toughened spraying nozzles, gold and silver jewelry, tool steel drilling components, cobalt-chromium biomedical implants, and novel cemented carbide tools. These developments continue to expand the applications and materials as more difficult systems are mastered.
C1 Penn State Univ, PM Lab, University Pk, PA 16802 USA.
RP German, RM (reprint author), Penn State Univ, PM Lab, 118 Res W, University Pk, PA 16802 USA.
CR BOSE A, 1992, POWDER INJECTION MOLDING SYMPOSIUM - 1992, P261
   BOSE A, 1990, ADV POWDER METALLURG, V3, P401
   EBENHOCH J, 1994, ADV PARTICULATE MAT, V4, P261
   German R.M., 1997, INJECTION MOLDING ME
   German R. M., 1989, ADV POWDER METALLURG, V3, P51
   GERMAN RM, 1993, REV PARTICUL MATER, V1, P109
   GERMAN RM, 1993, ADV POWDER MET PART, V6, P180
   HECKER R, 1990, HIGH TEMP HIGH PRESS, V22, P79
   Hens K F, 1994, ADV POWDER METALLURG, V4, P217
   HENS KF, 1994, ADV POWDER MET PART, V4, P249
   Kaneko Y., 1990, Journal of the Japan Society of Powder and Powder Metallurgy, V37, P191
   KANEKO Y, 1990, J JAPAN SOC POWDER P, V37, P13
   Kusaka K., 1996, ADV POWDER MET PART, V19, P127
   Kusaka K., 1995, J JPN SOC POWDER POW, V42, P383
   Kyogoku H., 1995, J JPN SOC POWDER POW, V42, P1052
   LIN ST, 1989, POWDER METALL INT, V21, P19
   MARTYN MT, 1994, INT J REFRACT MET H, V12, P61
   MOON IH, 1996, ADV POWDER MET PART
   MOON IH, 1989, INT J REFRACT MET H, V8, P244
   WEI TS, 1988, INT J POWDER METALL, V24, P327
   WIECH RE, 1980, MODERN DEV POWDER ME, V12, P317
   YANG B, 1995, TUNGSTEN REFRACTORY, P237
   YANG B, 1993, ADV POWDER METALLURG, V5, P105
   YANG MJ, 1995, ADV POWDER MET PART
   Zu YS, 1996, J MATER ENG PERFORM, V5, P609, DOI 10.1007/BF02646090
NR 25
TC 0
Z9 0
U1 0
U2 6
PU IOM COMMUNICATIONS LTD
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON SW1Y 5DB, ENGLAND
BN 1-86125-039-8
PY 1998
BP 1363
EP 1375
PG 13
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering; Materials Science, Composites
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BP03C
UT WOS:000083931500125
DA 2018-10-19
ER

PT B
AU Racz, LM
   Abedian, B
AF Racz, LM
   Abedian, B
BE Li, BQ
TI Dynamic interfacial phenomena in polymer-matrix composites
SO PROCESSING OF METALS AND ADVANCED MATERIALS: MODELING, DESIGN AND
   PROPERTIES
LA English
DT Proceedings Paper
CT International Symposium on Processing of Metals and Advanced Materials -
   Modeling, Design and Properties at the 1998 TMS Annual Meeting
CY FEB 16-19, 1998
CL SAN ANTONIO, TX
SP Minerals Met & Mat Soc, Mat Design & Mfg Div, Synthesis Control & Anal Mat Proc Comm, Minerals Met & Mat Soc, Extract & Proc Div, Synthesis Control & Analy Mat Proc Comm
AB We address dynamic interactions between high-energy, reactive surfaces of polymer-matrix composites and solid surfaces. A common characteristic of these interfaces is that bonding occurs readily upon contact. In many industrial and biomedical applications, it is desirable to suppress this bonding phenomenon. This interfacial effect is discussed in light of the development of our new method of handling polymer-matrix composites in dental applications. This method involves vibration of the solid-polymer interface at different frequencies. For each material, there is a critical frequency at which the sum of the viscoelastic and inertial energies of the fluid at the surface exceeds the energy available for bonding. When the polymer is vibrated at or beyond this frequency, it does not adhere to solid surfaces. An important aspect of the developed process is that it can be used to characterize surface and interfacial properties of polymers under dynamic conditions, whereas existing techniques are restricted to the study of bulk dynamic properties.
C1 Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA.
RP Racz, LM (reprint author), Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-395-3
PY 1998
BP 41
EP 51
PG 11
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BK53P
UT WOS:000072467400004
DA 2018-10-19
ER

PT B
AU Armstrong, BL
   Song, L
   Smith, PA
   Coffey, GW
AF Armstrong, BL
   Song, L
   Smith, PA
   Coffey, GW
BE Alman, DE
   Hawk, JA
   Simmons, JW
TI Processing and characterization of biomaterials
SO ROLL OF CHARACTERIZATION IN UNDERSTANDING ENVIRONMENTAL DEGRADATION OF
   MATERIALS
SE MICROSTRUCTURAL SCIENCE
LA English
DT Proceedings Paper
CT 30th Annual Technical Meeting of the
   International-Metallographic-Society
CY JUL 20-23, 1997
CL SEATTLE, WA
SP Int Met Soc
AB A variety of materials are currently being used in biomedical applications. With these materials, there are also a variety of processing methods which have characteristic advantages and disadvantages. An overview of these traditional materials and processes will be presented. Promising advances in processes and materials will also be discussed.
C1 Pacific NW Natl Lab, Richland, WA 99352 USA.
RP Armstrong, BL (reprint author), Pacific NW Natl Lab, Richland, WA 99352 USA.
RI Armstrong, Beth/E-6752-2017
OI Armstrong, Beth/0000-0001-7149-3576
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 0-87170-658-X
J9 MICROSTR SC
PY 1998
VL 25
BP 217
EP 220
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BL08V
UT WOS:000074227900026
DA 2018-10-19
ER

PT B
AU Karlsen, W
   Atteridge, D
AF Karlsen, W
   Atteridge, D
BE Alman, DE
   Hawk, JA
   Simmons, JW
TI Microstructure and mechanical properties of high-nitrogen Stellite 21
   Co-Cr-Mo biomedical implant alloy
SO ROLL OF CHARACTERIZATION IN UNDERSTANDING ENVIRONMENTAL DEGRADATION OF
   MATERIALS
SE MICROSTRUCTURAL SCIENCE
LA English
DT Proceedings Paper
CT 30th Annual Technical Meeting of the
   International-Metallographic-Society
CY JUL 20-23, 1997
CL SEATTLE, WA
SP Int Met Soc
AB Stellite 21 Co-Cr-Mo alloy was melted under a nitrogen atmosphere at pressures ranging from 1.4 to 50 atm. The total nitrogen achieved increased with pressure, and ranged from 0.19 to 1.34 wt%. Nitrogen was present interstitially, and as chrome nitride precipitates, Cr2N and CrN, A finer grain size achieved by hot-rolling, and the presence of second phase material were observed to increase the yield strength. Increased interstitial nitrogen was observed to increase the ductility, but with increasing nitride formation, the ductility decreased. With increasing nitrogen contents, there was a shift from the traditional Cr23C6 to a Cr2N, with an apparent elevation in the incipient melting temperature to above 1260 degrees C (2300 degrees F).
C1 Oregon Grad Inst, Portland, OR 97208 USA.
RP Karlsen, W (reprint author), Oregon Grad Inst, Portland, OR 97208 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 0-87170-658-X
J9 MICROSTR SC
PY 1998
VL 25
BP 221
EP 230
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BL08V
UT WOS:000074227900027
DA 2018-10-19
ER

PT S
AU Beutel, H
   Stieglitz, T
   Meyer, JU
AF Beutel, H
   Stieglitz, T
   Meyer, JU
BE Varadan, VK
   McWhorter, PJ
   Singer, RA
   Vellekoop, MJ
TI Versatile 'microflex'-based interconnection technique
SO SMART STRUCTURES AND MATERIALS 1998: SMART ELECTRONICS AND MEMS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT SPIE Conference on Smart Electronics and MEMS
CY MAR 02-04, 1998
CL SAN DIEGO, CA
SP SPIE, Soc Exptl Mech Inc, Amer Soc Mech Engineers, BFGoodrich Aerosp
DE interconnects; flexible microcable; biocompatibility; micromachining;
   small pitch; flip chip; stud bonding
AB A new interconnection technique has been developed that allows versatile multiple strand connections between microsensors, sensor arrays, and chips designed for wire bonding. The new technique has been termed 'microflex interconnects' (MFI).
   Conventional wire bonding technique is commonly restricted to planar interconnects with a limited degree of freedom for placing microsystem components. The MFI technique has overcome this limitation by interconnecting microsystem components through custom designed flexible foils with embedded metallized conductors. The MFI foils may also serve as circuit substrates. This basic foil material is polyimide (Du Pont PI 2611)(1) or BCB2 which are patterned photolithographically. Platinum, gold or either conductive metals are sputtered or evaporated on the foil and patterned using lift-off technique. Several metallization layers can be embedded in the material. Pitch and shape of the MFI contact pads correspond to the one of the chips to be interconnected. A via hole is placed in the center of the MFI contact pads. MFI pads and chip pads are adjusted. Metal balls or wedges generate the electrical and mechanical contact through the vias between the chips and the MFI substrate. An commercial wire bonder is the only equipment needed to perform, the MFI method.
   The MFI technique was applied to bond standard CMOS integrated circuit (IC) bond pads with a width of 30 mu m and a pitch of 70 mu m to a 10 mu m thick MFI foil. The integration density of the MFI technique correspond to one of the flip-chip technology(3). Special advantages of the MFI technique are three-dimensional interconnects, the flexibility in design and shape, and easy visual inspection of alignment qualities. The MFI method is also suited for biomedical applications because all materials used are biocompatible.
C1 Fraunhofer Inst Biomed Engn, Dept Sensor Syst Microsyst, D-66386 Sankt Ingbert, Germany.
RP Beutel, H (reprint author), Fraunhofer Inst Biomed Engn, Dept Sensor Syst Microsyst, Ensheimer Str 48, D-66386 Sankt Ingbert, Germany.
RI Stieglitz, Thomas/C-7916-2013
OI Stieglitz, Thomas/0000-0002-7349-4254
NR 0
TC 4
Z9 4
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2772-1
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3328
BP 174
EP 182
DI 10.1117/12.320167
PG 9
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BL49P
UT WOS:000075701400019
DA 2018-10-19
ER

PT S
AU Giurgiutiu, V
   Rogers, CA
AF Giurgiutiu, V
   Rogers, CA
BE Regelbrugge, ME
TI Recent advancements in the electro-mechanical (E/M) impedance method for
   structural health monitoring and NDE
SO SMART STRUCTURES AND MATERIALS 1998: SMART STRUCTURES AND INTEGRATED
   SYSTEMS, PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT SPIE Conference on Smart Structures and Integrated Systems
CY MAR 02-05, 1998
CL SAN DIEGO, CA
SP SPIE, Soc Exptl Mech, Amer Soc Mech Engineers, BFGoodrich Aerosp
DE damage detection; health monitoring; failure prevention;
   electro-mechanical impedance; NDE; non-destructive evaluation; incipient
   damage; piezo-electric transducer; crack propagation; crack detection
AB The emerging electro-mechanical impedance technology has high potential for in-situ health monitoring and NDE of structural systems and complex machinery. At first, the fundamental principles of the electro-mechanical impedance method are briefly reviewed and ways for practical implementation are highlighted. The equations of piezo-electric material response are given, and the coupled electro-mechanical impedance of a piezo-electric wafer transducer as affixed to the monitored structure is discussed. Due to the high frequency operation of this NDE method, wave propagation phenomena are identified as the primary coupling method between the structural substrate and the piezo-electric wafer transducer. Attention is then focused on several recent advancements that have extended the electro-mechanical impedance method into new areas of applications and/or have developed its underlying principles. US Army Construction Engineering Research Laboratory used the electro-mechanical impedance method to monitor damage development in composite overlaid civil infrastructure specimens under full-scale static testing. A simplified E/M impedance measuring technique was employed at the Polytechnic University of Madrid, Spain, to detect damage in GFRP composite specimens. The development of miniaturized "barebones" impedance analyzer equipment that could be easily packaged into transponder-size dimensions is being studied at the University of South Carolina. US Army Research Laboratory developed novel piezo-composite film transducers for embedment into composite structures. Disbond gauges for monitoring the structural joints of adhesively bonded rotor blades have been studies in the Mechanical Engineering Department at the University of South Carolina.
   These recent developments accentuate the importance and benefits of using the electro-mechanical impedance method for online health monitoring and damage detection in a variety of applications. Further investigation of the electro-mechanical impedance method is warranted. A further examination of the complex interaction between wave propagation, drive-point impedance, structural damage and electro-mechanical impedance of the piezo-electric wafer transducer is needed. Once these aspects are better understood, the E/M impedance method has the potential to become a widely used NDE technique with large applicability in diverse engineering fields (aerospace, automotive, infrastructure and biomedical implants).
C1 Univ S Carolina, Dept Mech Engn, Columbia, SC 29212 USA.
RP Giurgiutiu, V (reprint author), Univ S Carolina, Dept Mech Engn, Columbia, SC 29212 USA.
RI GIURGIUTIU, VICTOR/B-3137-2012; Giurgiutiu, Victor/F-1394-2011
OI GIURGIUTIU, VICTOR/0000-0001-8948-677X; 
NR 0
TC 79
Z9 85
U1 1
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2773-X
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3329
BP 536
EP 547
DI 10.1117/12.316923
PN 1-2
PG 12
WC Acoustics; Engineering, Aerospace; Engineering, Mechanical; Optics
SC Acoustics; Engineering; Optics
GA BL52W
UT WOS:000075786600046
DA 2018-10-19
ER

PT B
AU Hahn, KL
AF Hahn, KL
BE Nielsen, CS
   Herkert, JR
TI Developing a picture of electronic publishing: A qualitative study of
   the ecology community
SO SOCIOECONOMIC DIMENSIONS OF ELECTRONIC PUBLISHING WORKSHOP -
   PROCEEDINGS: MEETING THE NEEDS OF THE ENGINEERING AND SCIENTIFIC
   COMMUNITIES
LA English
DT Proceedings Paper
CT Socioeconomic Dimensions of Electronic Publishing Workshop - Meeting the
   Needs of the Engineering and Scientific Communities
CY APR 23-25, 1998
CL SANTA BARBARA, CA
SP Natl Sci Fdn, IEEE Fdn
AB There is widespread recognition that scientists acting as the producers of the raw material of electronic publications will, to a large extent, drive the ultimate adoption process of electronic publishing. However, there has been little research focusing on the interests and perceptions of scientists acting as authors and editors. At the same time, it should be recognized that various scientific communities are pursuing different paths in the development and adoption of electronic publication and dissemination of research results. This variation in developmental approaches may well reflect different needs and interests of the communities involved. To date the physics community and some biomedical communities have received greatest attention for their early work in developing new modes of publishing. However, these communities may well have unique practices and history that are shaping developments in ways that may not be indicative of subsequent electronic publishing in other disciplines. This work reports preliminary results of a qualitative study of authors and editors of two new journals serving the environmental science community, a community that is relatively new to the arena of scientific publishing. One journal is entirely electronic, while the other provides both paper and electronic formats. Some of the questions investigated include how the participants in these ventures perceive electronic publishing and its impact and how their individual encounters with electronic publishing shape those perceptions.
C1 Univ Maryland Lib, College Pk, MD 20742 USA.
RI Strieb, Karla/B-1835-2008
OI Strieb, Karla/0000-0002-9160-1834
NR 0
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-5101-0
PY 1998
BP 23
EP 29
DI 10.1109/SEDEP.1998.730704
PG 7
WC Communication; Information Science & Library Science
SC Communication; Information Science & Library Science
GA BM14T
UT WOS:000077803600004
DA 2018-10-19
ER

PT S
AU Vail, NK
   Swain, LD
   Fox, WC
   Aufdemorte, TB
   Lee, G
   Barlow, JW
AF Vail, NK
   Swain, LD
   Fox, WC
   Aufdemorte, TB
   Lee, G
   Barlow, JW
BE Marcus, HL
   Beaman, JJ
   Bourell, DL
   Barlow, JW
   Crawford, RH
TI Materials for biomedical applications
SO SOLID FREEFORM FABRICATION PROCEEDINGS, AUGUST, 1998
SE SOLID FREEFORM FABRICATION PROCEEDINGS (SERIES)
LA English
DT Proceedings Paper
CT 9th Solid Freeform Fabrication (SFF) Symposium
CY AUG 10-12, 1998
CL UNIV TEXAS, AUSTIN, TX
SP DARPA, Rapid Prototyping Assoc, Soc Mfg Engineers, Minerals Met & Mat Soc, Univ Connecticut Storrs, Univ Texas Austin, Mech Engn Dept, Lab Freeform Fabricat, Univ Texas Austin, Texas Mat Inst
HO UNIV TEXAS
DE selective laser sintering; porous; ceramic implant; biocompatible
ID CONTOUR AUGMENTATION; GRAFT
AB This paper discusses two ceramic material systems for selective laser sintering (SLS) that are being developed for biomedical applications for use in repair of bone defects. SLS is the preferred method of fabricating ceramic implants that exhibit well defined porous microstructures. Implants fabricated in this manner have proven effective in-vivo showing excellent biocompatibility as well as considerable osseous integration and remodeling of the implant material.
C1 BioMed Enterprises Inc, San Antonio, TX 78245 USA.
RP Vail, NK (reprint author), BioMed Enterprises Inc, Texas Res Pk,14785 Omicron Dr,Suite 205, San Antonio, TX 78245 USA.
CR BALASUBRAMANIAN.B, 1995, THESIS U TEXAS AUSTI
   ERICKSON D, 1997, COMMUNICATION
   FAUST GT, 1944, AM J SCI, V242, P447
   Holle J, 1996, PLAST RECONSTR SURG, V98, P542, DOI 10.1097/00006534-199609000-00031
   HOLMES RE, 1987, J ORAL MAXIL SURG, V45, P421, DOI 10.1016/0278-2391(87)90010-3
   James WJ, 1998, J ORAL MAXIL SURG, V56, P512, DOI 10.1016/S0278-2391(98)90726-1
   LEE G, 1996, SOLID FREEFORM FAABR, V7, P15
   NELSON JC, 1992, THESIS U TEXAS AUSTI
   PAPACHARALAMBOUS SK, 1993, INT J ORAL MAX SURG, V22, P260, DOI 10.1016/S0901-5027(05)80511-9
   VAIL NK, 1994, J APPL POLYM SCI, V52, P789, DOI 10.1002/app.1994.070520610
   VAIL NK, 1996, SOLID FREEFORM FABRI, V7, P481
   VAIL NK, 1994, THESIS U TAXAS AUSTI
   WHITE E, 1986, DENT CLIN N AM, V30, P49
NR 13
TC 3
Z9 3
U1 0
U2 1
PU UNIV TEXAS AUSTIN
PI AUSTIN
PA MECHANICAL ENGINEERING DEPT, AUSTIN, TX 00000 USA
SN 1053-2153
J9 SOL FREEFORM FABRIC
PY 1998
BP 621
EP 628
PG 8
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BN63N
UT WOS:000082420400071
DA 2018-10-19
ER

PT B
AU Khor, KA
   Wang, Y
   Cheang, P
AF Khor, KA
   Wang, Y
   Cheang, P
BE Sudarshan, TS
   Jeandin, M
   Khor, KA
TI Thermal spraying of functionally graded coatings for biomedical
   applications
SO SURFACE MODIFICATION TECHNOLOGIES XI
LA English
DT Proceedings Paper
CT 11th International Conference on Surface Modification Technologies
CY SEP 08-10, 1997
CL PARIS, FRANCE
SP Soc Francaise Met & Materiaux, Federat European Mat Soc, Inst Mat, London, Minerals, Met & Mat Soc, ASM Int
ID HYDROXYAPATITE COATINGS; COATED IMPLANTS; PLASMA; FABRICATION; TITANIUM;
   BONE
AB Biomedical requirements in a prosthesis are often complex and diverse in nature. These multifaceted requirements can be met by functionally graded materials (FGM). Biomaterials for implants have to display a wide range of adaptability to suit the various stages of the biointegration of a foreign material into the human body. This paper reports the preparation of functionally graded bioceramic coatings that are composed of essentially calcium phosphate compounds. Two FGM systems were investigated. System 1 utilised the thermal response of different size ranges of hydroxyapatite (HA) powders in the plasma name to form the gradient in biological/physical properties while System 2 synergized two types of calcium phosphates, namely, cr-tricalcium phosphate and HA, to form the FGM. The coating is graded in accordance to adhesive strength and bioresorbability. The bond coat on the metal stub is deposited with a particle range of HA that will provide high adhesive strength but have poor biocompatibility. The top coat of System 1 is composed of a particle size range of HA that elicit a layer that is highly biocompatible while in System 2, the top coat is mainly a-tricalcium phosphate that is highly bioresorbable. This arrangement has the propensity of allowing accelerated biointegration of the coating by the body tissues. The processing steps and problems will be highlighted in this paper as well as the results of post-spray treatment by conventional heat treatment and hot isostatic pressing (HIP).
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Khor, KA (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Nanyang Ave, Singapore 639798, Singapore.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
CR BROWN SR, 1994, J MATER SCI-MATER M, V5, P756, DOI 10.1007/BF00120371
   Cheang P, 1996, BIOMATERIALS, V17, P537, DOI 10.1016/0142-9612(96)82729-3
   CHEANG P, 1995, J MATER PROCESS TECH, V48, P429, DOI 10.1016/0924-0136(94)01679-U
   Cheang P, 1996, J THERM SPRAY TECHN, V5, P310, DOI 10.1007/BF02645883
   CLAES L, 1990, HDB BIOACTIVE CERAMI, V2, P77
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   DANTONIO JA, 1992, J BONE JOINT SURG AM, V74A, P995, DOI 10.2106/00004623-199274070-00006
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DOUGLAS HH, 1990, P 3 NTSC LONG BEACH, P419
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   HARADA Y, 1989, J TOKYO DENT COLL SO, V89, P263
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HUELSMAN SW, 1994, T MRS JAP, V16, P1259
   KAWAMURA M, 1994, T MRS JAP, V16, P1251
   KAY J F, 1992, Dental Clinics of North America, V36, P1
   Khor KA, 1997, J MATER PROCESS TECH, V63, P271, DOI 10.1016/S0924-0136(96)02634-9
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   KOIZUMI M, 1995, MRS BULL, V20, P19
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   WANG BC, 1993, J MATER SCI-MATER M, V4, P394, DOI 10.1007/BF00122198
   WANG PE, 1993, J MATER SCI-MATER M, V4, P150, DOI 10.1007/BF00120384
   WEINLAENDER M, 1992, J MATER SCI-MATER M, V3, P397, DOI 10.1007/BF00701234
   WENG J, 1995, BIOMATERIALS, V16, P39, DOI 10.1016/0142-9612(95)91094-F
NR 25
TC 0
Z9 0
U1 0
U2 2
PU INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON SW1Y 5DB, ENGLAND
BN 1-86125-055-X
PY 1998
BP 1038
EP 1050
PG 13
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BN40T
UT WOS:000081833400113
DA 2018-10-19
ER

PT J
AU Burg, KJL
   Shalaby, SW
AF Burg, KJL
   Shalaby, SW
TI Water fugacity in absorbing polymers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE water fugacity; absorbing polymers; differential scanning calorimetry
ID HYDROLYTIC DEGRADATION; ACID)
AB Absorbable biomaterials, as dynamic systems, require special handling, processing, and characterization techniques beyond those of the traditional nonabsorbable materials. As the material degrades or absorbs, in vitro or in vivo, it undergoes structural, physical, and chemical changes. These changes in the base material may significantly impact the performance of a particular biomedical device; hence, it is important that the investigator consider the full range of properties that constitute the lifetime of a given absorbable material. The long term degradation study presented here sought to identify. one such property, the change in water retention of a degrading oriented polylactide film. The investigation found through differential scanning calorimetry that later stages of degradation are often characterized by a stronger retention of water, potentially due to a higher number of polar carboxyl groups within the relatively hydrophobic polymer matrix. (C) 1997 John Wiley & Sons, Inc.
C1 CLEMSON UNIV,DEPT BIOENGN,RHODES ENGN RES CTR,CLEMSON,SC.
   POLY MED INC,CTR APPL TECHNOL,PENDLETON,SC.
CR BURG KJL, IN PRESS J BIOMATER
   CAM D, 1995, BIOMATERIALS, V16, P833, DOI 10.1016/0142-9612(95)94144-A
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   HAUSBERGER AG, 1995, J PHARMACEUT BIOMED, V13, P747, DOI 10.1016/0731-7085(95)01276-Q
   LIN HL, 1993, J BIOMED MATER RES, V27, P153, DOI 10.1002/jbm.820270204
   Perrin D., 1974, BUFFERS PH METAL ION
   SHALABY SW, 1996, Patent No. 5529736
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
NR 8
TC 5
Z9 6
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD WIN
PY 1997
VL 38
IS 4
BP 337
EP 341
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA YJ612
UT WOS:A1997YJ61200006
PM 9421754
DA 2018-10-19
ER

PT J
AU Filmon, R
   Chappard, D
   Basle, MF
AF Filmon, R
   Chappard, D
   Basle, MF
TI Scanning and transmission electron microscopy of poly 2-hydroxyethyl
   methacrylate-based biomaterials
SO JOURNAL OF HISTOTECHNOLOGY
LA English
DT Article
DE biomaterial; bone mineralization; HEMA; pHEMA; poly 2-hydroxyethyl
   methacrylate; scanning electron microscopy; transmission electron
   microscopy; 2-hydroxyethyl methacrylate
ID BONE; SPECIMENS
AB Hydrogels, especially poly 2-hydroxyethyl methacrylate, or pHEMA, have received increased attention for numerous biomedical applications. We have prepared several pHEMA-based biomaterials suitable as bone substitutes; alkaline phosphatase, for example, when immobilized in pHEMA in a copolymerization technique at 4 degrees C retains its biological activity. When pellets of the biomaterial were placed in synthetic body fluids or tissue culture medium containing organic phosphates, numerous calcified nodules formed spontaneously. Osteoblast-like cells harvested on pHEMA or pHEMA/alkaline phosphatase materials can spread and establish direct contacts. However, the hydrophilicity of pHEMA is a real handicap for preparing scanning and transmission electron microscopic analyses. We have found that 2-propanol was an excellent dehydrating preparing for scanning electron microscopy before critical point drying. HEMA itself was found to dehydrate the transmission electron microscopy blocks because it can copolymerize with the methacrylate-based embedding resin Lowicryl K4M. These 2 preparation techniques have allowed us to study calcium-phosphate crystal growth and cellular responses in vitro on these hydrogel biomaterials.
C1 FAC MED,LHEA,F-49045 ANGERS,FRANCE.
   SERV COMMUN MICROSCOPIE ELECTON,ANGERS,FRANCE.
   CGU,LAB HISTOL EMBRYOL,ANGERS,FRANCE.
CR ACETARIN JD, 1986, J MICROSC-OXFORD, V143, P81, DOI 10.1111/j.1365-2818.1986.tb02766.x
   ARMBRUSTER BL, 1982, J MICROSC-OXFORD, V126, P77, DOI 10.1111/j.1365-2818.1982.tb00358.x
   BECKSTEAD JH, 1981, BLOOD, V57, P1088
   BENNETT HS, 1976, STAIN TECHNOL, V51, P71, DOI 10.3109/10520297609116677
   BRADBEER JN, 1992, J BONE MINER RES, V7, P905
   CASWELL AM, 1991, CRIT REV CL LAB SCI, V28, P175, DOI 10.3109/10408369109106862
   CHAPPARD D, 1983, STAIN TECHNOL, V58, P299, DOI 10.3109/10520298309066802
   FILMON R, IN PRESS CELLS MAT
   GLAUERT AM, 1965, TECHNICS ELECT MICRO
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   MONTHEARD JP, 1997, DESK REFERENCE FUNCT, P669
   PINCHUK L, 1984, J BIOMED MATER RES, V18, P671, DOI 10.1002/jbm.820180608
   SMETANA K, 1992, BIOMATERIALS, V13, P639, DOI 10.1016/0142-9612(92)90033-K
   WUTHIER RE, 1982, CLIN ORTHOP RELAT R, V169, P219
   YAMADA S, 1994, J BIOMED MATER RES, V28, P1357, DOI 10.1002/jbm.820281114
NR 15
TC 6
Z9 6
U1 0
U2 3
PU NATL SOC HISTOTECHNOLOGY
PI BOWIE
PA 4201 NORTHVIEW DR, STE 502, BOWIE, MD 20716-1073
SN 0147-8885
J9 J HISTOTECHNOL
JI J. Histotechnol.
PD DEC
PY 1997
VL 20
IS 4
BP 343
EP 346
PG 4
WC Cell Biology
SC Cell Biology
GA YJ241
UT WOS:A1997YJ24100008
DA 2018-10-19
ER

PT J
AU Schober, A
   Schlingloff, G
   Thamm, A
   Kiel, HJ
   Tomandl, D
   Gebinoga, M
   Doring, M
   Kohler, JM
   Mayer, G
AF Schober, A
   Schlingloff, G
   Thamm, A
   Kiel, HJ
   Tomandl, D
   Gebinoga, M
   Doring, M
   Kohler, JM
   Mayer, G
TI System integration of microsystems chip elements in miniaturized
   automata for high-throughput synthesis and screening in biology,
   biochemistry and chemistry
SO MICROSYSTEM TECHNOLOGIES
LA English
DT Article
AB Microsystems recently have been introduced as tools for screening in modern chemistry, biochemistry and biology. It has been shown that new microsystems can be implemented in the biomedical laboratory by using the microsystemic approach for the sample carrier-the miniaturized microtiter plate ("the nanotiter plate")-or the production of nanodroplets with ink jetters and to integrate those systems in macrodevices like xyz tables and detection devices like CCD-cameras. We show in this paper that decisive problems of the approach-the evaporation problem and the problem of chemical/biochemical/biological compatibility of the assays and the used materials can be solved successfully. It is possible to realize chemical synthesis in miniaturized flow systems and to perform isothermal amplification of RNA in silicon wafers. Furthermore real high throughput screening with in vivo systems can be performed and all relevant parameters as evaporation, pipetting and detection can be controlled on reasonable time scales.
C1 Inst Mol Biotechnol eV, D-07745 Jena, Germany.
   EVOTEC Biosyst GmbH, D-22529 Hamburg, Germany.
   Fa Microdrop, D-22844 Norderstedt, Germany.
   Inst Phys High Technol eV, D-07745 Jena, Germany.
RP Schober, A (reprint author), Inst Mol Biotechnol eV, Beutenbergstr 11, D-07745 Jena, Germany.
CR BOREGO B, 1995, NUCL ACIDS RES, V23
   EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740
   Gebinoga M, 1996, EUR J BIOCHEM, V235, P256, DOI 10.1111/j.1432-1033.1996.00256.x
   GEBINOGA M, 1995, UNPUB ENDOCYTOBI SEP
   KOHLER JM, 1996, MICROSYSTEMS TECHNOL
   KOHLER JM, 1995, MICROSYST TECHNOL, V1, P202
   KOPPEL DE, 1994, BIOPHYS J, V66, P502
   Schena M., 1995, SCIENCE, V270
   SCHOBER A, 1993, BIOL CYBERN, V69, P493, DOI 10.1007/BF01185421
   SCHOBER A, 1995, MICROSYST TECHNOL, V1, P168
   SCHOBER A, 1993, Patent No. 02173
   Tomandl D, 1997, J COMPUT AID MOL DES, V11, P29, DOI 10.1023/A:1008071310472
NR 12
TC 48
Z9 48
U1 1
U2 3
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0946-7076
J9 MICROSYST TECHNOL
JI Microsyst. Technol.
PD DEC
PY 1997
VL 4
IS 1
BP 35
EP 39
DI 10.1007/s005420050089
PG 5
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Materials Science;
   Physics
GA YN076
UT WOS:000071130700010
DA 2018-10-19
ER

PT J
AU McMillen, BA
AF McMillen, BA
TI Going forward or in reverse with GABA neurotransmission: Reviews and
   comments on alcohol research
SO ALCOHOL
LA English
DT Article
ID ETHANOL; INTOXICATION; DEPENDENCE; RO15-4513
AB This section of the journal is designed to provide readers with reviews of recent literature, and to stimulate research on ques tions that are important in the treatment and prevention of alcohol addiction. Research can provide insight into the causes of alcohol abuse and addiction, as well as answers to questions concerning the biomedical and psychological consequences of alcohol consumption. The ideas and critique expressed ir. this department are those of the author and do not necessarily represent the views of the editor, editorial board, or publisher of Alcohol. Reference to the original articles is recommended before quoting any of this material in scientific publications.
C1 E CAROLINA UNIV,DEPT PHARMACOL,SCH MED,GREENVILLE,NC 27858.
RP McMillen, BA (reprint author), E CAROLINA UNIV,CTR ALCOHOL & DRUG ABUSE STUDIES,SCH MED,GREENVILLE,NC 27858, USA.
CR DURCAN MJ, 1989, PHARMACOL BIOCHEM BE, V32, P667, DOI 10.1016/0091-3057(89)90015-4
   GALLIMBERTI L, 1992, ALCOHOL CLIN EXP RES, V16, P673, DOI 10.1111/j.1530-0277.1992.tb00658.x
   JUNE HL, 1991, ALCOHOL CLIN EXP RES, V15, P406, DOI 10.1111/j.1530-0277.1991.tb00538.x
   LISTER RG, 1989, LIFE SCI, V44, P111, DOI 10.1016/0024-3205(89)90528-6
   LISTER RG, 1989, BRAIN RES, V482, P141, DOI 10.1016/0006-8993(89)90551-9
   MICZEK KA, 1987, SCIENCE, V235, P1127
   SUZDAK PD, 1988, J PHARMACOL EXP THER, V245, P880
   Whitworth AB, 1996, LANCET, V347, P1438, DOI 10.1016/S0140-6736(96)91682-7
NR 8
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0741-8329
J9 ALCOHOL
JI Alcohol
PD NOV-DEC
PY 1997
VL 14
IS 6
BP 623
EP 625
DI 10.1016/S0741-8329(97)00081-5
PG 3
WC Substance Abuse; Pharmacology & Pharmacy; Toxicology
SC Substance Abuse; Pharmacology & Pharmacy; Toxicology
GA YG467
UT WOS:A1997YG46700016
DA 2018-10-19
ER

PT J
AU Pollnau, M
AF Pollnau, M
TI The route toward a diode-pumped 1-W erbium 3-mu m fiber laser
SO IEEE JOURNAL OF QUANTUM ELECTRONICS
LA English
DT Article
DE diode-pumped lasers; infrared lasers; laser biomedical applications;
   optical fiber lasers; rare earth lasers
ID EXCITED-STATE ABSORPTION; 3 MU-M; CASCADE LASER; UP-CONVERSION; OUTPUT
   POWER; OPERATION; ER-LIYF4; CRYSTAL
AB A rate-equation analysis of the erbium 3-mu m ZBLAN fiber laser is performed, The computer calculation includes the longitudinal spatial resolution of the host material, It considers ground-state bleaching, excited-state absorption (ESA), interionic processes, lifetime quenching by co-doping, and stimulated emission at 2.7 mu m and 850 nm, State-of-the-art technology including double-clad diode pumping is assumed in the calculation, Pump ESA is identified as the major problem of this laser, With high Er3+ concentration, suitable Pr3+ co-doping, and low pump density, ESA is avoided and a diode-pumped erbium 3-mu m ZBLAN laser is predicted which is capable of emitting a transversely single-mode output power of 1.0 W when pumped with 7-W incident power at 800 nm, The corresponding output intensity which is relevant for surgical applications will be in the range of 1.8 MW/cm(2), Compared to Ti:sapphire-pumped cascade-lasing regimes, the proposed approach represents a strong decrease of the requirements on mirror coatings, cavity alignment, and especially pump intensity, Of the possible drawbacks investigated in the simulation, only insufficient lifetime quenching is found to have a significant influence on laser performance.
C1 UNIV BERN,INST APPL PHYS,CH-3012 BERN,SWITZERLAND.
CR BEDO S, 1995, ELECTRON LETT, V31, P199, DOI 10.1049/el:19950151
   BEDO S, 1995, OPT COMMUN, V116, P81, DOI 10.1016/0030-4018(95)00040-F
   CHOU H, 1989, OSA P SERIES, V5, P167
   Clarkson WA, 1996, OPT LETT, V21, P375, DOI 10.1364/OL.21.000375
   ESTEROWITZ L, 1991 TECH DIG SER, P160
   ESTEROWITZ L, 1989, SPIE INFRARED FIBER, V1048, P129
   FRIEL GJ, 1996 OSA TECH DIG SE, V9, P144
   GHISLER C, 1995, ELECTRON LETT, V31, P373, DOI 10.1049/el:19950276
   ITH M, 1994, APPL PHYS B-LASERS O, V59, P621, DOI 10.1007/BF01081183
   JACQUES SL, 1991, SPIE LASER TISSUE IN, V1427, P63
   Jensen T, 1996, OPT LETT, V21, P585, DOI 10.1364/OL.21.000585
   JENSEN T, 1996, ADV SOLID STATE LASE, P265
   KNOWLES DS, 1992, IEEE J QUANTUM ELECT, V28, P1197, DOI 10.1109/3.135247
   MUENDEL MH, 1996 OSA TECH DIG SE, V9, P209
   POLLNAU M, 1994, PHYS REV A, V49, P3990, DOI 10.1103/PhysRevA.49.3990
   Pollnau M, 1996, APPL PHYS B-LASERS O, V62, P339, DOI 10.1007/BF01081195
   POLLNAU M, 1992, APPL PHYS A-MATER, V54, P404, DOI 10.1007/BF00324164
   POLLNAU M, 1995, APPL PHYS LETT, V66, P3564, DOI 10.1063/1.113788
   Pollnau M, 1997, J OPT SOC AM B, V14, P974, DOI 10.1364/JOSAB.14.000974
   Pollnau M, 1997, OPT LETT, V22, P612, DOI 10.1364/OL.22.000612
   Pollnau M, 1996, IEEE J QUANTUM ELECT, V32, P657, DOI 10.1109/3.488840
   POLLNAU M, C LAS EL OPT EUR 199, P132
   Prokhorov AM, 1993, LASER PHYS, V3, P79
   QUIMBY RS, 1989, APPL OPTICS, V28, P14, DOI 10.1364/AO.28.000014
   QUIMBY RS, 1991, SPIE FIBER LASER SOU, V1581, P72
   SCHNEIDER J, 1994, INT J INFRARED MILLI, V15, P1907, DOI 10.1007/BF02096058
   WETENKAMP L, 1992, J NON-CRYST SOLIDS, V140, P25, DOI 10.1016/S0022-3093(05)80735-5
   WETENKAMP L, 1991, THESIS TU BRAUNSCHWE
   Wyss C, 1997, OPT COMMUN, V139, P215, DOI 10.1016/S0030-4018(97)00130-2
   ZELLMER H, 1995, OPT LETT, V20, P578, DOI 10.1364/OL.20.000578
   ZEMON S, 1990, SPIE P, V1373, P21
NR 31
TC 41
Z9 43
U1 0
U2 8
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9197
J9 IEEE J QUANTUM ELECT
JI IEEE J. Quantum Electron.
PD NOV
PY 1997
VL 33
IS 11
BP 1982
EP 1990
DI 10.1109/3.641313
PG 9
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA YC838
UT WOS:A1997YC83800010
DA 2018-10-19
ER

PT J
AU Bendel, LP
   Shellock, FG
   Steckel, M
AF Bendel, LP
   Shellock, FG
   Steckel, M
TI The effect of mechanical deformation on magnetic properties and MRI
   artifacts of type 304 and type 316L stainless steel
SO JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING
LA English
DT Article
DE stainless steel; MRI; deformation
ID EX-VIVO EVALUATION; METALLIC IMPLANTS; FERROMAGNETISM; SYSTEM; DEVICES;
   STENTS
AB The purpose of this study was to evaluate the influence of composition and deformation of biomedical stainless steels on mechanical properties, magnetic properties, and MRI artifacts. Type 304 and Type 316L samples were prepared using standard wire-drawing techniques. Mechanical properties were determined using standard test methods. The amount of ferromagnetic phase present was estimated using a Severn Gage and x-ray diffraction. Magnetic field attraction and artifacts were determined using previously described techniques. The strength of both steels increased significantly with increasing deformation. None of the type 316L wires transformed to the magnetic phase. The amount of magnetic phase in the type 304 wires increased with increasing deformation. There was no magnetic field attraction, and artifacts were minimal for all of type 316L wires and the undeformed type 304 wire. Deflection and artifacts were significant for the deformed type 304 stainless steel. These results provide guidance regarding the use of type 304 and type 316L stainless steels for bioimplants. In this regard, type 316L stainless steel seems to be a more acceptable material with respect to MR compatibility.
C1 Mat Technol Associates, Lebanon, NJ 08833 USA.
RP Bendel, LP (reprint author), Mat Technol Associates, 2 Country Hill Rd, Lebanon, NJ 08833 USA.
CR [Anonymous], 1995, ANN BOOK ASTM STAND
   BARDOS DI, 1977, HDB STAINLESS STEEL
   BELLON EM, 1986, AM J ROENTGENOL, V147, P1271, DOI 10.2214/ajr.147.6.1271
   DAVIS JR, 1994, ASM SPECIALTY HDB ST, P498
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   FAGAN LL, 1995, JMRI-J MAGN RESON IM, V5, P614
   HOKE JH, 1977, HDB STAINLESS STEEL
   LAAKMAN RW, 1985, RADIOLOGY, V157, P711, DOI 10.1148/radiology.157.3.4059558
   MATSUMOTO AH, 1989, RADIOLOGY, V170, P753, DOI 10.1148/radiology.170.3.2916029
   MECHLIN M, 1984, AM J ROENTGENOL, V143, P1281, DOI 10.2214/ajr.143.6.1281
   MOSCATEL MA, 1995, JMRI-J MAGN RESON IM, V5, P369, DOI 10.1002/jmri.1880050324
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1994, J MAGN RESON IMAGING, V4, P756, DOI 10.1002/jmri.1880040521
   SHELLOCK FG, 1994, MAGNETIC RESONANCE B
   SHELLOCK FG, 1996, POCKET GUIDE MR PROC
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
   TEITELBAUM GP, 1990, AM J NEURORADIOL, V11, P267
NR 18
TC 13
Z9 13
U1 0
U2 2
PU SOC MAGNETIC RESONANCE IMAGING
PI EASTON
PA 1991 NORTHAMPTON ST, EASTON, PA 18042-3189 USA
SN 1053-1807
J9 JMRI-J MAGN RESON IM
JI JMRI-J. Magn. Reson. Imaging
PD NOV-DEC
PY 1997
VL 7
IS 6
BP 1170
EP 1173
DI 10.1002/jmri.1880070635
PG 4
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 102UU
UT WOS:000074944300032
PM 9400866
DA 2018-10-19
ER

PT J
AU Doillon, CJ
   Drouin, R
   Cote, MF
   Dallaire, N
   Pageau, JF
   Laroche, G
AF Doillon, CJ
   Drouin, R
   Cote, MF
   Dallaire, N
   Pageau, JF
   Laroche, G
TI Chemical inactivators as sterilization agents for bovine collagen
   materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE collagen materials; chemical inactivators; sterilization; prion; nucleic
   acids
ID SCRAPIE; SKIN; CONTRACTION; INFECTIVITY; INVITRO; PROTEIN; TISSUE
AB The use of collagen as a biomedical implant raises safety issues with regard to viruses and prions. Specific chemical agents that inactivate prion infectivity could be applied to collagen implants. The physicochemical changes and the in vitro and in vivo biocompatibility of collagen treated by formic acid (FA), trifluoroacetic acid (TFA), tetrafluoroethanol (TFE), and hexafluoroisopropanol (HFIP) were investigated. In addition, the effects of these treatments on nucleic acids incorporated in collagen were analyzed. The molecules of FA and, more important, of TFA remained within collagen. FA, TFA and HFIP treatments modify the secondary structure of collagen, as shown by Fourier transform infrared spectroscopy, while TFE does not. Differential scanning calorimetry measurements showed a decrease in the denaturation temperature compared to untreated collagen. However, resistance to collagenase was modified only after HFIP treatment. In vitro, cell growth was not impaired; in vivo, implants induced a temporary inflammatory reaction that was prolonged with TFA and HFIP treatments. TFE and FA-treated collagen were thoroughly infiltrated by fibroblasts. On the other hand, FA and TFA resulted in extensive depurination of nucleic acids while HFIP and TFE did so to a lesser degree. Among the investigated chemical scrapie inactivators, FA treatment could offer a safe and biocompatible collagen-derived material for biomedical use. (C) 1997 John Wiley & Sons, Inc.
C1 UNIV LAVAL,DEPT SURG,LAVAL,PQ,CANADA.
   HOSP ST FRANCOIS ASSISE,RES UNIT HUMAN GENET,QUEBEC CITY,PQ G1L 3L5,CANADA.
   UNIV LAVAL,DEPT PATHOL,LAVAL,PQ,CANADA.
RP Doillon, CJ (reprint author), HOSP ST FRANCOIS ASSISE,INST BIOMAT E0 178,10 ESPINAY,QUEBEC CITY,PQ G1L 3L5,CANADA.
CR BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BERG RA, 1982, METHOD ENZYMOL, V82, P372
   BROWN DM, 1974, BASIC PRINCIPLES NUC, V2, P1
   BROWN P, 1990, J INFECT DIS, V161, P467, DOI 10.1093/infdis/161.3.467
   COTE MF, 1992, J BIOMAT SCI-POLYM E, V3, P301, DOI 10.1163/156856292X00394
   DEBLOIS C, 1994, BIOMATERIALS, V15, P665, DOI 10.1016/0142-9612(94)90164-3
   DOILLON CJ, 1985, SCANNING ELECT MICRO, V2, P897
   Drouin Regen, 1996, P37
   ELLENDER G, 1994, CLIN MAT, V9, P201
   ELLWART JW, 1990, CYTOMETRY, V11, P239, DOI 10.1002/cyto.990110204
   GRIFFITHS PR, 1986, TRAC-TREND ANAL CHEM, V5, P209, DOI 10.1016/0165-9936(86)80015-2
   KAJAVA AV, 1991, J MOL BIOL, V218, P815, DOI 10.1016/0022-2836(91)90269-C
   KEEFE J, 1994, CLIN MAT, V9, P155
   KLUNK WE, 1994, J NEUROCHEM, V62, P349
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   LAZAREV YA, 1985, BIOPOLYMERS, V24, P1449, DOI 10.1002/bip.360240804
   LEE JM, 1995, MED ENG PHYS, V17, P115, DOI 10.1016/1350-4533(95)91882-H
   LILLIE JH, 1977, J ULTRA MOL STRUCT R, V58, P134, DOI 10.1016/S0022-5320(77)90025-9
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   MIYATAT, 1994, CLIN MAT, V9, P139
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   PRUSINER SB, 1994, P NATL ACAD SCI USA, V91, P4611, DOI 10.1073/pnas.91.11.4611
   PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762
   Ramachandran G.N., 1967, TREATISE COLLAGEN, P103
   ROSENBERG RN, 1986, ANN NEUROL, V19, P75, DOI 10.1002/ana.410190113
   SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220
   Sambrook J, 1989, MOL CLONING LAB MANU
   TATEISHI J, 1988, ANN NEUROL, V24, P466, DOI 10.1002/ana.410240325
   VEIS A, 1964, MACROMOLECULAR CHEM, V5
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YOSHIZATO K, 1994, MAT SCI ENG C-BIOMIM, V1, P95, DOI 10.1016/0928-4931(94)90061-2
NR 31
TC 21
Z9 21
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 1997
VL 37
IS 2
BP 212
EP 221
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA YD952
UT WOS:A1997YD95200010
PM 9358314
DA 2018-10-19
ER

PT J
AU Meurman, JH
   Pyrhonen, S
   Teerenhovi, L
   Lindqvist, C
AF Meurman, JH
   Pyrhonen, S
   Teerenhovi, L
   Lindqvist, C
TI Oral sources of septicaemia in patients with malignancies
SO ORAL ONCOLOGY
LA English
DT Article
DE bacterial infections; septicaemia; mouth diseases; immunosuppression;
   antineoplastic agents; cancer; xerostomia; oral health care
ID ACUTE MYELOID-LEUKEMIA; REMISSION-INDUCTION THERAPY; BONE-MARROW
   TRANSPLANTATION; RECEIVING CYTOSTATIC DRUGS; IMMUNOCOMPROMISED PATIENTS;
   HEMATOLOGIC MALIGNANCIES; PATHOGENIC MICROORGANISMS; MICROBIOLOGICAL
   FINDINGS; PERIODONTAL INFECTION; FEBRILE EPISODES
AB This article reviews papers dealing with oral infections of adult septicaemia patients, searched from MEDLINE, Current Contents and Core Biomedical Collection databases from January 1966 to November 1996. Case reports were excluded. The systematic review of literature revealed that our knowledge of the topic is mostly based on very small patient material. There are no multicentre studies on the effects of various oral health treatment modes on the prevention of septicaemia of oral origin. The number of controlled and comparative studies on the efficacy of the different treatment protocols of oral infections is also small. Current recommendations in this respect are mainly empirical and not evidence based. Clinical practice guidelines are therefore urgently needed. Nevertheless, close co-operation between oncological and oral health units is emphasised because many studies have shown that the oral cavity is indeed an important source of bacteraemia. Life-threatening infections may follow if maintenance of oral health is neglected during anticancer therapy and if potential oral infection foci are left untreated before immunosuppressive therapy. (C) 1997 Elsevier Science Ltd. All rights reserved.
C1 Univ Helsinki, Inst Dent, Helsinki, Finland.
   Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland.
   Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Surg, Helsinki, Finland.
RP Meurman, JH (reprint author), Univ Helsinki, Inst Dent, Helsinki, Finland.
OI Meurman, Jukka/0000-0001-6702-6836
CR BARRETT AP, 1987, ORAL SURG ORAL MED O, V63, P424, DOI 10.1016/0030-4220(87)90253-2
   BERGMANN OJ, 1988, J CLIN MICROBIOL, V26, P2105
   BERGMANN OJ, 1990, SCAND J INFECT DIS, V22, P353, DOI 10.3109/00365549009027059
   BERGMANN OJ, 1991, SCAND J INFECT DIS, V23, P355, DOI 10.3109/00365549109024323
   BERGMANN OJ, 1989, SCAND J INFECT DIS, V21, P43, DOI 10.3109/00365548909035679
   BERGMANN OJ, 1992, DAN MED BULL, V39, P15
   BERGMANN OJ, 1990, EUR J HAEMATOL, V44, P296
   BERGMANN OJ, 1989, EUR J CLIN MICROBIOL, V8, P207, DOI 10.1007/BF01965262
   BERGMANN OJ, 1992, J CLIN PERIODONTOL, V19, P169, DOI 10.1111/j.1600-051X.1992.tb00634.x
   BROWN LR, 1978, J DENT RES, V57, P882, DOI 10.1177/00220345780570090901
   CARL W, 1986, Seminars in Surgical Oncology, V2, P187, DOI 10.1002/ssu.2980020402
   Dawes C., 1996, SALIVA ORAL HLTH, V2, P27
   DEPAOLA L G, 1986, Journal of the American Dental Association, V112, P198
   Dreizen S, 1990, NCI Monogr, P11
   DREIZEN S, 1992, POSTGRAD MED, V91, P349
   DREIZEN S, 1986, ORAL SURG ORAL MED O, V62, P650, DOI 10.1016/0030-4220(86)90258-6
   DREIZEN S, 1983, ORAL SURG ORAL MED O, V55, P1113
   DREIZEN S, 1992, POSTGRAD MED, V91, P353
   DREIZEN S, 1992, POSTGRAD MED, V91, P357
   DUGGAN JM, 1985, J HOSP INFECT, V6, P406, DOI 10.1016/0195-6701(85)90057-X
   Edgar WM, 1990, SALIVA DENT HLTH
   ELLEGAARD B, 1989, J ORAL PATHOL MED, V18, P54, DOI 10.1111/j.1600-0714.1989.tb00734.x
   EPSTEIN JB, 1992, ORAL SURG ORAL MED O, V73, P682, DOI 10.1016/0030-4220(92)90009-F
   Fine DH, 1996, J AM DENT ASSOC, V127, P641, DOI 10.14219/jada.archive.1996.0276
   HEIMDAHL A, 1985, J CLIN MICROBIOL, V22, P299
   HEIMDAHL A, 1990, ACTA ODONTOL SCAND, V48, P77, DOI 10.3109/00016359009012737
   HEIMDAHL A, 1985, CHEMIOTERAPIA, V4, P186
   HEIMDAHL A, 1990, J CLIN PERIODONTOL, V17, P501
   HEIMDAHL A, 1990, J CLIN MICROBIOL, V28, P12
   KEENE HJ, 1987, ORAL SURG ORAL MED O, V64, P421, DOI 10.1016/0030-4220(87)90146-0
   KOSTIALA I, 1982, CURR THER RES CLIN E, V31, P752
   LAINE P, 1993, J CLIN PERIODONTOL, V20, P628, DOI 10.1111/j.1600-051X.1993.tb00707.x
   LAINE P, 1992, ORAL ONCOL, V28B, P125
   LAINE P, 1993, ORAL FINDINGS LYMPHO
   LAINE PO, 1992, ORAL ONCOL, V28B, P103
   LAWSON RD, 1980, CURR THER RES CLIN E, V27, P774
   MAKKONEN TA, 1986, ORAL SURG ORAL MED O, V62, P270, DOI 10.1016/0030-4220(86)90007-1
   MAKKONEN TA, 1989, BRIT J ORAL MAX SURG, V27, P334, DOI 10.1016/0266-4356(89)90048-X
   MANDEL ID, 1980, CRC CR REV CL LAB SC, V12, P321, DOI 10.3109/10408368009108733
   Maxymiw W G, 1989, J Can Dent Assoc, V55, P193
   MCELROY TH, 1984, J AM DENT ASSOC, V109, P454, DOI 10.14219/jada.archive.1984.0406
   MEURMAN JH, 1991, ORAL MICROBIOL IMMUN, V6, P177, DOI 10.1111/j.1399-302X.1991.tb00473.x
   MEURMAN JH, 1991, J CLIN PERIODONTOL, V18, P587, DOI 10.1111/j.1600-051X.1991.tb00094.x
   MEURMAN JH, 1994, ORAL ONCOL, V30B, P204
   MEURMAN JH, 1995, EUR J ORAL SCI, V103, P253, DOI 10.1111/j.1600-0722.1995.tb00169.x
   NAUM BJ, 1985, J SPECIAL CARE DENT, V5, P274
   NEWMAN HN, 1992, J DENT RES, V71, P1854, DOI 10.1177/00220345920710111801
   NIKOSKELAINEN J, 1990, J CLIN PERIODONTOL, V17, P504
   OLMOS RAV, 1994, CANCER, V73, P2886
   OTIS LL, 1985, ORAL SURG ORAL MED O, V60, P125, DOI 10.1016/0030-4220(85)90228-2
   OVERHOLSER CD, 1982, ARCH INTERN MED, V142, P551, DOI 10.1001/archinte.142.3.551
   PETERSON DE, 1987, J CLIN ONCOL, V5, P1461, DOI 10.1200/JCO.1987.5.9.1461
   PETERSON DE, 1990, ORAL SURG ORAL MED O, V70, P720, DOI 10.1016/0030-4220(90)90007-F
   RONALD D, 1980, CURRENT THERAPEUTIC, V27, P774
   Sackett DL, 1996, EVIDENCE BASED MED, V1, P37
   Scully C, 1996, ORAL ONCOL, V32B, P281
   Semba SE, 1994, COMPEND, V15, P1380
   Semba SE, 1994, COMPEND, V15, P1388
   SEMBS SE, 1994, COMPENDIUM, V14, P1378
   SPIJKERVET FKL, 1991, IRRADIATION MUCOSITI
   Sweeney MP, 1996, NT RES, V1, P389
   TOTH B B, 1983, Current Problems in Cancer, V7, P7, DOI 10.1016/S0147-0272(83)80011-7
   TOTH BB, 1990, J CLIN PERIODONTOL, V17, P508
   Uhari M, 1996, BRIT MED J, V313, P1180, DOI 10.1136/bmj.313.7066.1180
   VALDEZ IH, 1993, INT J RADIAT ONCOL, V25, P41, DOI 10.1016/0360-3016(93)90143-J
   WADE JC, 1982, ANN INTERN MED, V97, P503, DOI 10.7326/0003-4819-97-4-503
   WAHLIN YB, 1988, ORAL SURG ORAL MED O, V65, P411, DOI 10.1016/0030-4220(88)90354-4
   WEISDORF DJ, 1989, BONE MARROW TRANSPL, V4, P89
   WRIGHT WE, 1985, J AM DENT ASSOC, V110, P43, DOI 10.14219/jada.archive.1985.0292
   YEO E, 1985, J CLIN ONCOL, V3, P1668, DOI 10.1200/JCO.1985.3.12.1668
NR 70
TC 33
Z9 33
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0964-1955
J9 ORAL ONCOL
JI Oral Oncol.
PD NOV
PY 1997
VL 33
IS 6
BP 389
EP 397
DI 10.1016/S0964-1955(97)00032-8
PG 9
WC Oncology; Dentistry, Oral Surgery & Medicine
SC Oncology; Dentistry, Oral Surgery & Medicine
GA YR472
UT WOS:000071498700002
PM 9509121
DA 2018-10-19
ER

PT J
AU Schmitt, JM
   Lee, SL
   Yung, KM
AF Schmitt, JM
   Lee, SL
   Yung, KM
TI An optical coherence microscope with enhanced resolving power in thick
   tissue
SO OPTICS COMMUNICATIONS
LA English
DT Article
DE microscopy; tomography; interferometry; biomedical optics
ID TOMOGRAPHY; LIGHT
AB A new configuration of an optical coherence microscope for high-resolution imaging of biological tissues and other scattering materials is described. The microscope employs multiple sources and detectors combined with high-numerical-aperture optics to suppress speckle fluctuations and enhance resolution. Results of experiments on living tissue and tissue phantoms are presented to demonstrate the design principles of the microscope and to compare its performance to that of a conventional optical coherence microscope. (C) 1997 Elsevier Science B.V.
RP Schmitt, JM (reprint author), HONG KONG UNIV SCI & TECHNOL,DEPT ELECT & ELECT ENGN,CLEAR WATER BAY,KOWLOON,HONG KONG.
CR BOUMA B, 1995, OPT LETT, V20, P1486, DOI 10.1364/OL.20.001486
   BURCKHARDT CB, 1978, IEEE T SON ULTRASON, V25, P1
   CHAN KP, 1992, APPL OPTICS, V31, P1505, DOI 10.1364/AO.31.001505
   CLIVAZ X, 1995, P SOC PHOTO-OPT INS, V2083, P338
   FERCHER AF, 1988, OPT LETT, V13, P186, DOI 10.1364/OL.13.000186
   FUJIMOTO JG, 1995, NAT MED, V1, P970, DOI 10.1038/nm0995-970
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217
   RAO YJ, 1993, OPT LETT, V18, P462, DOI 10.1364/OL.18.000462
   SCHMITT JM, 1994, PHYS MED BIOL, V39, P1705, DOI 10.1088/0031-9155/39/10/013
   SCHMITT JM, 1995, DERMATOLOGY, V191, P93, DOI 10.1159/000246523
   SCHMITT JM, IN PRESS J OPT SOC A
   SWANSON EA, 1992, OPT LETT, V17, P151, DOI 10.1364/OL.17.000151
   Tearney GJ, 1996, OPT LETT, V21, P543, DOI 10.1364/OL.21.000543
NR 14
TC 127
Z9 128
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0030-4018
J9 OPT COMMUN
JI Opt. Commun.
PD OCT 15
PY 1997
VL 142
IS 4-6
BP 203
EP 207
DI 10.1016/S0030-4018(97)00280-0
PG 5
WC Optics
SC Optics
GA YB814
UT WOS:A1997YB81400009
DA 2018-10-19
ER

PT J
AU Grady, RE
   Wass, CT
   Maus, TP
   Felmlee, JP
AF Grady, RE
   Wass, CT
   Maus, TP
   Felmlee, JP
TI Fiberoptic intracranial pressure monitoring during magnetic resonance
   imaging
SO ANESTHESIOLOGY
LA English
DT Article
DE biocompatible material, chemistry, metals; magnetic resonance imaging,
   adverse effects, contraindications; material testing; radiofrequency
ID BIOMEDICAL IMPLANTS; DEVICES
C1 MAYO CLIN & MAYO GRAD SCH MED,DEPT ANESTHESIOL,ROCHESTER,MN 55905.
   MAYO CLIN & MAYO GRAD SCH MED,DEPT RADIOL,ROCHESTER,MN 55905.
CR BARNETT GH, 1988, J NEUROSURG, V68, P246, DOI 10.3171/jns.1988.68.2.0246
   ELSTER AD, 1994, AM J ROENTGENOL, V162, P195, DOI 10.2214/ajr.162.1.8273665
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   TOBIAS M, 1994, ANESTHESIA NEUROSURG, P435
NR 7
TC 2
Z9 2
U1 0
U2 0
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0003-3022
J9 ANESTHESIOLOGY
JI Anesthesiology
PD OCT
PY 1997
VL 87
IS 4
BP 1001
EP 1003
DI 10.1097/00000542-199710000-00042
PG 3
WC Anesthesiology
SC Anesthesiology
GA YD117
UT WOS:A1997YD11700042
PM 9357910
DA 2018-10-19
ER

PT J
AU Bernatchez, SF
   Atkinson, MR
   Parks, PJ
AF Bernatchez, SF
   Atkinson, MR
   Parks, PJ
TI Expression of intercellular adhesion molecule-1 on macrophages in vitro
   as a marker of activation
SO BIOMATERIALS
LA English
DT Article
DE macrophages; cytokines; cell surface markers; activation; polylactic
   acid
ID TUMOR-NECROSIS-FACTOR; BIOMEDICAL POLYMERS; HUMAN-MONOCYTES; IN-VITRO;
   IMMUNOMODULATORS IMIQUIMOD; INTERLEUKIN-1 GENERATION; CYTOKINE
   PRODUCTION; TISSUE DISTRIBUTION; INTERFERON-GAMMA; FACTOR-ALPHA
AB Macrophage activation is a major component of wound healing. It also determines the extent of inflammatory reactions and the response of the body to implanted materials. We have previously shown, using an in vitro model, that the extent of spreading of macrophages on different materials is a marker of activation, and that a soluble inducer has a dose-response effect on the secretion of cytokines in the culture medium. This work investigates the expression of three different cell surface markers [macrophages MAC-1, MAC-3 and intercellular adhesion molecule-1 (ICAM-1)] on macrophages in vitro using confocal microscopy and shows that ICAM-1 is also a marker of macrophage activation in this model. We observed increased amounts of ICAM-1 on activated macrophages compared to unactivated macrophages, whereas MAC-1 and MAC-3 were either expressed constitutively or demonstrated no quantitative change in expression after activation under the same experimental conditions. We also tested the expression of ICAM-1 with various concentrations of soluble inducers (lipopolysaccharide, 0.001, 0.01, 0.1, 1 and 10 mu g ml(-1); S-27609, 0.1, 0.25, 0.5, 1, 2 and 3 mu g ml(-1)) and on a sheet of polylactic acid alone or in combination with soluble inducers. All doses of soluble inducers induced the expression of ICAM-1 on cells grown in glass chamber slides. The induction was not dose related but seemed to work rather in an on-off manner. There was no effect of material on ICAM-1 expression on the cell surface when no soluble inducer was added. This was similar to cytokine secretion, which was not induced by our material alone. When either lipopolysaccharide or S-27609 was used in combination with the material, there was an increase in the average measured intensity of ICAM-1. In this in vitro model, ICAM-1 staining as measured by confocal microscopy is a marker for macrophage activation. Our results suggest that the extent of macrophage activation as measured by ICAM-1 and by cytokine secretion is more sensitive to soluble inducers than to the action of the flat sheet of polylactic acid. (C) 1997 Elsevier Science Limited. All rights reserved.
C1 LIFE SCI SECTOR LAB, ST PAUL, MN 55144 USA.
   ANALYT & PROPERTIES RES LABS, ST PAUL, MN 55144 USA.
RP Bernatchez, SF (reprint author), UNIV MINNESOTA, CTR INTERFACIAL ENGN, SHEPHERD LABS 187, 100 UNION ST SE, MINNEAPOLIS, MN 55455 USA.
CR ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   Bernatchez SF, 1996, BIOMATERIALS, V17, P2077, DOI 10.1016/0142-9612(96)00014-2
   BOCK E, 1991, BIOCHEM SOC T, V19, P1076, DOI 10.1042/bst0191076
   BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BRANDWOOD A, 1992, BIOMATERIALS, V13, P646, DOI 10.1016/0142-9612(92)90035-M
   BROWDER W, 1988, SURGERY, V104, P224
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Chapekar MS, 1996, J BIOMED MATER RES, V31, P251, DOI 10.1002/(SICI)1097-4636(199606)31:2<251::AID-JBM12>3.0.CO;2-O
   DARVILLE T, 1992, IMMUNOL INVEST, V21, P539, DOI 10.3109/08820139209069389
   DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D
   DUBOIS CM, 1989, AM REV RESPIR DIS, V139, P1257, DOI 10.1164/ajrccm/139.5.1257
   DUSTIN ML, 1986, J IMMUNOL, V137, P245
   FRASER I, 1994, J IMMUNOL METHODS, V174, P95, DOI 10.1016/0022-1759(94)90013-2
   FRASER I, 1993, BLOOD CELL BIOCH, V5, P1
   GASPAR R, 1992, PHARM RES-DORDR, V9, P782, DOI 10.1023/A:1015807706530
   GIBSON SJ, 1995, J INTERF CYTOK RES, V15, P537, DOI 10.1089/jir.1995.15.537
   GORDON S, 1992, CURR OPIN IMMUNOL, V4, P25, DOI 10.1016/0952-7915(92)90119-Y
   HO MK, 1983, J BIOL CHEM, V258, P636
   HUNT TK, 1984, SURGERY, V96, P48
   JOHANSSON A, 1995, CELL IMMUNOL, V161, P61, DOI 10.1006/cimm.1995.1009
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   Kapur R, 1996, J BIOMED MATER RES, V32, P133
   KRIEGSMANN J, 1993, CELL MOL BIOL, V39, P791
   LAMBERT LE, 1989, CELL IMMUNOL, V120, P401, DOI 10.1016/0008-8749(89)90208-6
   LEAKE ES, 1975, J RETICULOENDOTH SOC, V17, P370
   LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1
   LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71
   LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0
   LEIBOVICH SJ, 1988, GROWTH FACTORS OTHER, P131
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MCANALLEY BH, 1994, Patent No. 5308838
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   POLVERINI PJ, 1977, NATURE, V269, P804, DOI 10.1038/269804a0
   PRIETO J, 1989, EUR J IMMUNOL, V19, P1551, DOI 10.1002/eji.1830190906
   PUEYO ME, 1993, J BIOMAT SCI-POLYM E, V5, P197
   REITER MJ, 1994, J LEUKOCYTE BIOL, V55, P234
   RICH A, 1981, J CELL SCI, V50, P1
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   SUZUKI Y, 1993, AGENTS ACTIONS, V38, P32, DOI 10.1007/BF02027210
   TABATA Y, 1988, J BIOMED MATER RES, V22, P837, DOI 10.1002/jbm.820221002
   TESTERMAN TL, 1995, J LEUKOCYTE BIOL, V58, P365
   THORENS B, 1987, CELL, V48, P671, DOI 10.1016/0092-8674(87)90245-5
   TIZARD I R, 1989, Molecular Biotherapy, V1, P290
   TREZZINI C, 1988, BIOCHEM BIOPH RES CO, V156, P477, DOI 10.1016/S0006-291X(88)80866-0
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   WYNN TA, 1992, CELL IMMUNOL, V140, P184, DOI 10.1016/0008-8749(92)90186-S
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   Zenni G C, 1994, J Invest Surg, V7, P135, DOI 10.3109/08941939409015357
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 59
TC 17
Z9 17
U1 2
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1997
VL 18
IS 20
BP 1371
EP 1378
DI 10.1016/S0142-9612(97)00072-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA YB250
UT WOS:A1997YB25000007
PM 9363337
DA 2018-10-19
ER

PT J
AU Moens, L
AF Moens, L
TI Applications of mass spectrometry in the trace element analysis of
   biological materials
SO FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 3rd Symposium on Mass Spectrometric Method of Elemental Trace Analysis
   and 12th ICP-MS Users Meeting
CY SEP 23-26, 1996
CL RES CTR, JULICH, GERMANY
HO RES CTR
ID INDUCTIVELY-COUPLED PLASMA; PERFORMANCE LIQUID-CHROMATOGRAPHY; CAPILLARY
   ELECTROPHORESIS; SPECTRAL INTERFERENCES; THERMAL IONIZATION; ISOTOPE
   RATIOS; HUMAN-SERUM; ION-SOURCE; ICP-MS; URINE
AB The importance of mass spectrometry for the analysis of biological material is illustrated by reviewing the different mass spectrometric methods applied and describing some typical applications published recently. Though atomic absorption spectrometry is used in the majority of analyses of biological material, most mass spectrometric methods have been used to some extent for trace element determination in biomedical research. The relative importance of the different methods is estimated by reviewing recent research papers. It is striking that especially inductively coupled plasma mass spectrometry is increasingly being applied, partly because the method can be used on-line after chromatographic separation, in speciation studies. Mass spectrometric methods prove to offer unique possibilities in stable isotope tracer studies and for this purpose also experimentally demanding methods such as thermal ionization mass spectrometry and accelerator mass spectrometry are frequently used.
RP Moens, L (reprint author), STATE UNIV GHENT,ANALYT CHEM LAB,PROEFTUINSTR 86,B-9000 GHENT,BELGIUM.
CR AGGARWAL SK, 1994, CRIT REV CL LAB SCI, V31, P35, DOI 10.3109/10408369409084673
   AGGARWAL SK, 1994, ANAL CHEM, V66, P1316, DOI 10.1021/ac00080a017
   AGGARWAL SK, 1992, ANAL BIOCHEM, V202, P367, DOI 10.1016/0003-2697(92)90120-V
   Begerow J, 1996, J ANAL ATOM SPECTROM, V11, P303, DOI 10.1039/ja9961100303
   BRADSHAW N, 1989, J ANAL ATOM SPECTROM, V4, P801, DOI 10.1039/ja9890400801
   CAREY JM, 1992, J ANAL ATOM SPECTROM, V7, P1173, DOI 10.1039/ja9920701173
   CREWS HM, 1994, ANALYST, V119, P2491, DOI 10.1039/an9941902491
   DeSmaele T, 1996, FRESEN J ANAL CHEM, V355, P778, DOI 10.1007/s0021663550778
   GIESSMANN U, 1994, FRESEN J ANAL CHEM, V350, P186, DOI 10.1007/BF00322469
   HEITKEMPER D, 1989, J ANAL ATOM SPECTROM, V4, P279, DOI 10.1039/ja9890400279
   HEUMANN KG, 1985, FRESEN Z ANAL CHEM, V320, P457, DOI 10.1007/BF00479812
   HOHL C, 1994, NUCL INSTRUM METH B, V92, P478, DOI 10.1016/0168-583X(94)96058-5
   JOHNSON RR, 1994, NUCL INSTRUM METH B, V92, P483, DOI 10.1016/0168-583X(94)96059-3
   Kinzer JA, 1996, ANAL CHEM, V68, P3250, DOI 10.1021/ac951143k
   LARSEN EH, 1993, J ANAL ATOM SPECTROM, V8, P557, DOI 10.1039/ja9930800557
   Lu QH, 1996, MICROCHEM J, V54, P129, DOI 10.1006/mchj.1996.0086
   MOENS L, 1995, J ANAL ATOM SPECTROM, V10, P569, DOI 10.1039/ja9951000569
   TAYLOR A, 1994, J ANAL ATOM SPECTROM, V9, pR87, DOI 10.1039/ja994090087r
   Taylor A, 1996, J ANAL ATOM SPECTROM, V11, pR103, DOI 10.1039/ja996110103r
   TAYLOR A, 1995, J ANAL ATOM SPECTROM, V10, pR61
   TURNLUND JR, 1993, ANAL CHEM, V65, P1717, DOI 10.1021/ac00061a014
   Vanhaecke F, 1996, ANAL CHEM, V68, P567, DOI 10.1021/ac9507247
   Vanhaecke F, 1997, ANAL CHEM, V69, P268, DOI 10.1021/ac960740j
   VANHOE H, 1994, J ANAL ATOM SPECTROM, V9, P177, DOI 10.1039/ja9940900177
   VANHOE H, 1995, TRACE ELEM ELECTROLY, V12, P81
   VANLOON JC, 1986, SPECTROSC LETT, V19, P1125, DOI 10.1080/00387018608069314
   VELA NP, 1993, ANAL CHEM, V65, pA585, DOI 10.1021/ac00061a002
   VERSIECK J, 1988, ANAL CHIM ACTA, V204, P63, DOI 10.1016/S0003-2670(00)86346-1
   VOGEL JS, 1994, NUCL INSTRUM METH B, V92, P445, DOI 10.1016/0168-583X(94)96052-6
   VOLLKOPF U, 1995, ATOM SPECTROSC, V16, P19
   WAIDMANN E, 1994, FRESEN J ANAL CHEM, V350, P293, DOI 10.1007/BF00322485
   WALDER AJ, 1992, J ANAL ATOM SPECTROM, V7, P571, DOI 10.1039/ja9920700571
NR 32
TC 26
Z9 27
U1 0
U2 6
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0937-0633
J9 FRESEN J ANAL CHEM
JI Fresenius J. Anal. Chem.
PD OCT-NOV
PY 1997
VL 359
IS 4-5
BP 309
EP 316
DI 10.1007/s002160050579
PG 8
WC Chemistry, Analytical
SC Chemistry
GA YC028
UT WOS:A1997YC02800002
DA 2018-10-19
ER

PT J
AU Schmit, BD
   Mortimer, JT
AF Schmit, BD
   Mortimer, JT
TI The tissue response to epimysial electrodes for diaphragm pacing in dogs
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE biological tissues; biomedical materials; implantable electrodes;
   nervous system; neuromuscular stimulation; prostheses/orthoses;
   respiratory system
ID INTRAMUSCULAR ELECTRICAL ACTIVATION; PHRENIC-NERVE; VENTILATORY SUPPORT;
   RIB CAGE; STIMULATION; QUADRIPLEGIA; SILICONE; IMPLANTS
AB Epimysial electrodes stapled to the abdominal surface of the diaphragm produced a chronic inflammatory response that appeared to be mediated by mechanical stresses placed on the encapsulation tissue by periodic diaphragm contraction, The tissue response surrounding 34 epimysial electrodes implanted in 11 dogs was studied three months post implant, The tissue response was characterized by a capsule having a mean thickness of 1.24 mm between the electrode and the muscle, while having only a very thin capsule on the back, or abdominal side of the electrode, The tissue response between the electrode and the muscle was comprised of two tissue layers: a layer of granulation tissue and a layer of collagen, The granulation tissue layer contained evidence of acute inflammatory processes including the presence of polymorphonuclear leukocytes in 68% of the samples, Granulation layer thickness was inversely correlated with back encapsulation indicating a reduction in granulation tissue for mechanically stabilized electrodes, In addition, encapsulation tissue surrounding the granulation layer was comprised of collagen fibers with an oblique orientation and an extraperitoneal locale suggesting mechanical load transfers between the electrode and the surrounding tissue, As a result, the histological response to epimysial electrodes implanted on the diaphragm suggests that mechanical loading, induced by movement associated with the contraction of adjacent muscle, must be a consideration for devices that employ epimysial electrodes.
C1 CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,APPL NEURAL CONTROL LAB,CLEVELAND,OH 44106.
   VET ADM MED CTR,CLEVELAND,OH 44106.
CR AKERS JM, 1994, THESIS CASE W RESERV
   CIESIELSKI TE, 1983, J NEUROSURG, V58, P92, DOI 10.3171/jns.1983.58.1.0092
   COREY JM, 1990, THESIS CASE W RESERV
   DANIELSEN CC, 1981, EUR SURG RES, V13, P194, DOI 10.1159/000128185
   DETROYER A, 1982, J APPL PHYSIOL, V53, P30
   ESKELAND G, 1977, J BONE JOINT SURG BR, V59, P206
   FRISCH EE, 1983, BIOMATERIALS RECONST, P73
   Fung Y-C, 1993, BIOMECHANICS
   GALLIN JI, 1984, CLIN RES, V67, P329
   GLENN WWL, 1984, NEW ENGL J MED, V310, P1150, DOI 10.1056/NEJM198405033101804
   GLENN WWL, 1988, PACE, V11, P2121, DOI 10.1111/j.1540-8159.1988.tb06360.x
   GLENN WWL, 1976, ANN SURG, V183, P566, DOI 10.1097/00000658-197605000-00014
   GOLDMAN MD, 1973, J APPL PHYSIOL, V35, P197
   GRANDJEAN PA, 1986, ANN BIOMED ENG, V14, P53, DOI 10.1007/BF02364648
   HABAL MB, 1984, ARCH SURG-CHICAGO, V119, P843
   KEITH MW, 1989, J HAND SURG-AM, V14A, P524, DOI 10.1016/S0363-5023(89)80017-6
   KEITH MW, 1988, CLIN ORTHOPAEDICS, V233, P25
   KIM JH, 1976, J THORAC CARDIOV SUR, V72, P602
   KULONEN E, 1980, EXP PATHOL-JENA, V18, P456, DOI 10.1016/S0014-4908(80)80047-0
   LASSER A, 1983, HUM PATHOL, V14, P108, DOI 10.1016/S0046-8177(83)80239-1
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   MORTIMER JT, 1994, UNPUB
   NOCHOMOVITZ ML, 1983, AM REV RESPIR DIS, V127, P325
   PETERSON DK, 1994, IEEE T BIO-MED ENG, V41, P1115, DOI 10.1109/10.335860
   PETERSON DK, 1989, PACE, V12, P854, DOI 10.1111/j.1540-8159.1989.tb01910.x
   PETERSON DK, 1986, IEEE T BIO-MED ENG, V33, P342, DOI 10.1109/TBME.1986.325720
   PETERSON DK, 1994, IEEE T BIO-MED ENG, V41, P1127, DOI 10.1109/10.335861
   PILLIAR RM, 1981, CLIN ORTHOP RELAT R, V156, P249
   SCHMIT BD, 1995, THESIS CASE W RESERV
   STELLATO TA, 1985, SURG FORUM, V36, P297
   TAYLOR DE, 1986, BIOMATERIALS, V7, P277, DOI 10.1016/0142-9612(86)90050-5
   WALTERS RL, 1988, CLIN ORTHOPED RELATE, V233, P44
   WHALEN RL, 1988, T SOC ARTIFICIAL INT, V24, P887
NR 33
TC 8
Z9 8
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD OCT
PY 1997
VL 44
IS 10
BP 921
EP 930
DI 10.1109/10.634644
PG 10
WC Engineering, Biomedical
SC Engineering
GA XW750
UT WOS:A1997XW75000002
PM 9311161
DA 2018-10-19
ER

PT J
AU Dmitriev, SN
   Zaitseva, NG
   Starodub, GY
   Maslov, OD
   Shishkin, SV
   Shishkina, TV
   Buklanov, GV
   Sabelnikov, AV
AF Dmitriev, SN
   Zaitseva, NG
   Starodub, GY
   Maslov, OD
   Shishkin, SV
   Shishkina, TV
   Buklanov, GV
   Sabelnikov, AV
TI High-purity radionuclide production: material, construction, target
   chemistry for Al-26, Ru-97, W-178, Np-235, Pu-235,Pu-237
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 18th World Conference of the
   International-Nuclear-Target-Development-Society
CY OCT 07-11, 1996
CL STRASBOURG, FRANCE
SP Int Nucl Target Dev Soc
ID PROTON ENERGY-RANGE; EXCITATION-FUNCTION; METABOLISM; PU-237
AB The work on isotopically pure Al-26, Ru-97, W-178/Ta-178, Np-235, Pu-236 and Pu-237 production was initiated because of intensive research on their applications in the biomedical held and environmental chemistry. The conditions for isotopically pure production have been investigated. This paper describes the data for the nuclear reactions of the radionuclide production, the different target designs and target chemistry procedures.
C1 JOINT INST NUCL RES,FLEROV LAB NUCL REACT,DUBNA 141980,MOSCOW REGION,RUSSIA.
CR DMITRIEV SN, 1995, APPL RADIAT ISOTOPES, V46, P307, DOI 10.1016/0969-8043(94)00134-L
   DMITRIEV SN, 1993, APPL RADIAT ISOTOPES, V44, P1097, DOI 10.1016/0969-8043(93)90112-N
   DMITRIEV SN, 1995, INT C IS BEIJ CHIN, P71
   LACY JL, 1984, J NUCL MED, V25, P1003
   MEIRAV O, 1990, NUCL INSTRUM METH B, V52, P536, DOI 10.1016/0168-583X(90)90472-7
   NEIRINCKX RD, 1981, INT J APPL RADIAT IS, V32, P85, DOI 10.1016/0020-708X(81)90138-1
   PERELYGIN VP, 1993, HEAVY ION PHYSICS, P375
   TALBOT RJ, 1993, HEALTH PHYS, V65, P41, DOI 10.1097/00004032-199307000-00006
   TANAKA S, 1975, J INORG NUCL CHEM, V37, P2002, DOI 10.1016/0022-1902(75)80937-7
   Zaitseva NG, 1996, APPL RADIAT ISOTOPES, V47, P145, DOI 10.1016/0969-8043(95)00272-3
   ZAITSEVA NG, 1992, RADIOCHIM ACTA, V56, P59, DOI 10.1524/ract.1992.56.2.59
   ZAITSEVA NG, 1994, RADIOCHIM ACTA, V64, P1
NR 12
TC 7
Z9 7
U1 2
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD SEP 21
PY 1997
VL 397
IS 1
BP 125
EP 130
DI 10.1016/S0168-9002(97)00735-3
PG 6
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA XZ065
UT WOS:A1997XZ06500027
DA 2018-10-19
ER

PT J
AU LaIuppa, JA
   McAdams, TA
   Papoutsakis, ET
   Miller, WM
AF LaIuppa, JA
   McAdams, TA
   Papoutsakis, ET
   Miller, WM
TI Culture materials affect ex vivo expansion of hematopoietic progenitor
   cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hematopoietic cultures; biocompatibility; culture materials; serum-free
   medium; CD34(+) cells
ID HUMAN-BONE-MARROW; EXVIVO EXPANSION; RECOMBINANT CYTOKINES;
   MONONUCLEAR-CELLS; CD34(+) CELLS; PERFUSION; STEM; BIOCOMPATIBILITY;
   TRANSPLANTATION; BIOREACTORS
AB Ex vivo expansion of hematopoietic cells is important for applications such as cancer treatment, gene therapy, and transfusion medicine. While cell culture systems are widely used to evaluate the biocompatibility of materials for implantation, the ability of materials to support proliferation of primary human cells in cultures for reinfusion into patients has not been addressed. We screened a variety of commercially available polymer (15 types), metal (four types), and glass substrates for their ability to support expansion of hematopoietic cells when cultured under conditions that would be encountered in a clinical setting. Cultures of peripheral blood (PB) CD34(+) cells and mononuclear cells (MNC) were evaluated for expansion of total cells and colony-forming unit-granulocyte monocyte (CFU-GM; progenitors committed to the granulocyte and/or monocyte lineage). Human hematopoietic cultures in serum-free medium were found to be extremely sensitive to the substrate material. The only materials tested that supported expansion at or near the levels of polystyrene were tissue culture polystyrene, Teflon perfluoroalkoxy, Tenon fluorinated ethylene propylene, cellulose acetate, titanium, new polycarbonate, and new polymethylpentene. MNC were less sensitive to the substrate materials than the primitive CD34(+) progenitors, although similar trends were seen for expansion of the two cell populations on the substrates tested. CFU-GM expansion was more sensitive to substrate materials than was total cell expansion. The detrimental effects of a number of the materials on hematopoietic cultures appear to be caused by protein adsorption and/or leaching of toxins. Factors such as cleaning, sterilization, and reuse significantly affected the performance of some materials as culture substrates. We also used PB CD34(+) cell cultures to examine the biocompatibility of gas-permeable cell culture and blood storage bags and several types of tubing commonly used with biomedical equipment. While many of the culture bag materials gave satisfactory results, all of the tubing materials severely inhibited total cell and CFU-GM expansion. Taken together, our results show that many materials approved for blood contact or considered biocompatible are not suitable for use with hematopoietic cells cultured in serum-free medium. As hematopoietic cultures are scaled up for a variety of clinical applications, it will be essential to carefully examine the biocompatibility of all materials involved. (C) 1997 John Wiley & Sons, Inc.
C1 NORTHWESTERN UNIV,DEPT CHEM ENGN,EVANSTON,IL 60208.
RI Papoutsakis, Eleftherios/A-5254-2010; Papoutsakis,
   Eleftherios/B-7612-2009; Miller, William/B-7650-2009
OI Miller, William/0000-0003-0750-6314
FU NIGMS NIH HHS [GM08449]
CR ANDREESEN R, 1983, J IMMUNOL METHODS, V56, P295, DOI 10.1016/S0022-1759(83)80019-2
   BARNES D, 1980, ANAL BIOCHEM, V102, P255, DOI 10.1016/0003-2697(80)90151-7
   Bender J G, 1992, J Hematother, V1, P329, DOI 10.1089/scd.1.1992.1.329
   BENTLEY KL, 1985, J BIOMED MATER RES, V19, P757, DOI 10.1002/jbm.820190704
   BRUGGER W, 1993, BLOOD, V81, P2579
   CHANDY T, 1991, BLOOD COMPATIBILITY, P131
   COHEN PA, 1994, CIBA F SYMP, V187, P179
   COURTNEY JM, 1993, INT J ARTIF ORGANS, V16, P164
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   HAAS R, 1995, BLOOD, V85, P3754
   HAYLOCK DN, 1992, BLOOD, V80, P1405
   HENSCHLER R, 1994, BLOOD, V84, P2898
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P403, DOI 10.1002/jbm.820150311
   JOHNSON HJ, 1983, J BIOMED MATER RES, V17, P571, DOI 10.1002/jbm.820170403
   KOLLER M, 1995, AM I CHEM ENG ANN M
   KOLLER MR, 1993, BIO-TECHNOL, V11, P358, DOI 10.1038/nbt0393-358
   KOLLER MR, 1993, BLOOD, V82, P378
   LEMOLI RM, 1992, EXP HEMATOL, V20, P569
   MARTINSON J, 1993, BLOOD, V82, pA393
   MCALISTER IB, 1992, EXP HEMATOL, V20, P626
   MELBERG SG, 1988, DIABETIC MED, V5, P243, DOI 10.1111/j.1464-5491.1988.tb00977.x
   Northup S. J, 1986, HDB BIOMATERIALS EVA, P209
   PALSSON BO, 1993, BIO-TECHNOL, V11, P368, DOI 10.1038/nbt0393-368
   SANDSTROM CE, 1994, BIOTECHNOL BIOENG, V43, P706, DOI 10.1002/bit.260430806
   SANDSTROM CE, 1995, BLOOD, V86, P958
   SARDONINI CA, 1993, BIOTECHNOL PROGR, V9, P131, DOI 10.1021/bp00020a600
   SHAPIRO F, 1994, BLOOD, V84, P3567
   SMITH SL, 1993, EXP HEMATOL, V21, P870
   TAKAUE Y, 1992, ANN HEMATOL, V64, P217, DOI 10.1007/BF01738299
   Tzannis ST, 1996, P NATL ACAD SCI USA, V93, P5460, DOI 10.1073/pnas.93.11.5460
   *US FDA, 1996, DRAFT DOC REG PER BL
   *US FDA, 1991, 91N0428 FDA
   VANDERMEER JWM, 1982, J RETICULOENDOTH SOC, V32, P355
   VANDERMEER JWM, 1978, J EXP MED, V147, P271, DOI 10.1084/jem.147.1.271
   VISOR GC, 1990, J PARENT SCI TECHN, V44, P130
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
   WIESLANDER A, 1990, BIOMATER ARTIF CELL, V18, P367, DOI 10.3109/10731199009117314
   Williams SF, 1996, BLOOD, V87, P1687
   YANG MB, 1994, CELL TRANSPLANT, V3, P373, DOI 10.1177/096368979400300504
   ZANDSTRA PW, 1994, BIO-TECHNOL, V12, P909, DOI 10.1038/nbt0994-909
NR 41
TC 40
Z9 40
U1 2
U2 13
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 1997
VL 36
IS 3
BP 347
EP 359
DI 10.1002/(SICI)1097-4636(19970905)36:3<347::AID-JBM10>3.0.CO;2-B
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XP501
UT WOS:A1997XP50100010
PM 9260106
DA 2018-10-19
ER

PT J
AU SanchezGuerrero, J
AF SanchezGuerrero, J
TI Autoantibody testing in patients with silicone implants
SO CLINICS IN LABORATORY MEDICINE
LA English
DT Article
ID GEL BREAST IMPLANTS; CONNECTIVE-TISSUE DISEASES; SJOGRENS-LIKE SYNDROME;
   AUGMENTATION MAMMAPLASTY; RHEUMATIC DISEASE; SYMPTOMATIC WOMEN;
   ANTIBODIES; RISK; MANIFESTATIONS; SCLERODERMA
AB Since 1938, when silicone was first synthesized, it has been in widespread use, including as a base material for many biomedical implants and devices. Silicone breast implants (SBI), the most popular silicone implants, have been in use for more than 30 years(35); however, during this decade a controversy over the safety of SBI has developed, a controversy that is still not resolved and has extended to other medical implants.
   At first, the controversy was about the potential association of SBI and connective tissue diseases (CTD); later, other rheumatic diseases such as fibromyalgia (FM), myofascial syndromes, and chronic fatigue syndrome (CFS) were involved. Lately, an increasing number of diseases, including neurologic diseases, nonspecific symptoms, and even the possibility of a novel disease caused by silicone have been mentioned.
   It will take many years before firm conclusions can be drawn; meanwhile, between 1 and 2 million women with SBI ask whether they are at an increased risk of developing any of the many diseases in question, and what can be done to identify and prevent such risk.
   In this review, the published evidence about the utility of autoantibody testing in women with SBI and other silicone devices will be discussed. Because it is impossible to generalize published results to all women with SBI, discussion will be separated into symptomatic and asymptomatic women. Also, many immunologic abnormalities, clinical and investigational, have been reported in these women. This review will focus on clinical immunologic tests, mostly antinuclear antibodies (ANA), rheumatoid factor (RF), and ANA profile, according to the following classification of symptoms: (1) local reactions; (2) nonimmunologic rheumatic diseases;and (3) definite/possible connective tissue diseases. Autoantibody screening in women with SBI, antisilicone antibodies, and other silicone devices also will be reviewed.
   This article presents the information available about autoantibody testing in women with silicone breast implants. Definite connective tissue diseases, non-autoimmune rheumatic diseases and a possible novel disease are covered. Autoantibody testing in asymptomatic women with breast implants, anti-silicone antibodies and other silicone implants are also discussed.
C1 UNIV NACL AUTONOMA MEXICO,MEXICO CITY 04510,DF,MEXICO.
CR BARMEIR E, 1995, J AUTOIMMUN, V8, P267, DOI 10.1006/jaut.1995.0020
   Basbug Eray, 1995, Arthritis and Rheumatism, V38, pS265
   BATES DW, 1995, ARCH INTERN MED, V155, P97, DOI 10.1001/archinte.155.1.97
   BLACKBURN WD, 1992, ARTHRITIS RHEUM, V35, pS212
   BOENSTEIN D, 1993, ARTHRITIS RHEUM, V36, pS117
   BRIDGES AJ, 1993, ARTHRITIS RHEUM, V36, pS70
   BRIDGES AJ, 1993, ANN INTERN MED, V118, P929, DOI 10.7326/0003-4819-118-12-199306150-00003
   BULPITT KJ, 1992, ARTHRITIS RHEUM, V35, pS161
   Burns CJ, 1996, J RHEUMATOL, V23, P1904
   Chow Henry Y., 1995, Arthritis and Rheumatism, V38, pS264
   Cuellar M. L., 1994, Arthritis and Rheumatism, V37, pS270
   CUELLAR ML, 1995, J RHEUMATOL, V22, P236
   DECAMARA DL, 1993, PLAST RECONSTR SURG, V91, P828, DOI 10.1097/00006534-199304001-00012
   DUGOWSON CE, 1992, ARTHRITIS RHEUM, V35, pS66
   Edworthy S. M., 1995, Arthritis and Rheumatism, V38, pS325
   FREUNDLICH B, 1994, SEMIN ARTHRITIS RHEU, V24, P44, DOI 10.1016/0049-0172(94)90109-0
   FREUNDLICH B, 1992, ARTHRITIS RHEUM, V35, pS67
   FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009
   GABRIEL SE, 1994, NEW ENGL J MED, V330, P1697, DOI 10.1056/NEJM199406163302401
   GOIN JM, 1981, CHANGING BODY PSYCHO, P191
   GOLDBLUM RM, 1995, FASEB J, V9, pA1029
   GOLDBLUM RM, 1992, LANCET, V340, P510, DOI 10.1016/0140-6736(92)91710-P
   HENNEKENS CH, 1987, EPIDEMIOLOGY MED, P327
   Hochberg MC, 1996, ARTHRITIS RHEUM, V39, P1125, DOI 10.1002/art.1780390708
   KEYSTONE E, 1993, ARTHRITIS RHEUM, V36, pS71
   Marcus DM, 1996, ARTHRITIS RHEUM, V39, P1619, DOI 10.1002/art.1780391003
   Martin L., 1995, Arthritis and Rheumatism, V38, pS264
   MARTIN L, 1993, ARTHRITIS RHEUM, V36, pS117
   Mease Philip J., 1995, Arthritis and Rheumatism, V38, pS324
   Nardella Francis A., 1995, Arthritis and Rheumatism, V38, pS264
   OSBORN TG, 1993, ARTHRITIS RHEUM, V36, pS118
   PRESS RI, 1992, LANCET, V340, P1304, DOI 10.1016/0140-6736(92)92491-W
   RANDALL T, 1992, JAMA-J AM MED ASSOC, V268, P1821
   Rosenau B, 1996, CURR TOP MICROBIOL, V210, P69
   SANCHEZGUERRERO J, 1994, ARTHRITIS RHEUM-US, V37, P158
   SANCHEZGUERRERO J, 1995, NEW ENGL J MED, V332, P1666, DOI 10.1056/NEJM199506223322502
   Silverman BG, 1996, ANN INTERN MED, V124, P744, DOI 10.7326/0003-4819-124-8-199604150-00008
   SOLOMON G, 1994, SEMIN ARTHRITIS RHEU, V24, P29, DOI 10.1016/0049-0172(94)90107-4
   STROM BL, 1994, J CLIN EPIDEMIOL, V47, P1211, DOI 10.1016/0895-4356(94)90109-0
   TEUBER SS, 1993, J AUTOIMMUN, V6, P367, DOI 10.1006/jaut.1993.1031
   VASEY FB, 1994, SEMIN ARTHRITIS RHEU, V24, P22, DOI 10.1016/0049-0172(94)90106-6
   VASEY FB, 1992, ARTHRITIS RHEUM, V35, pS212
   WEINER SR, 1992, ARTHRITIS RHEUM, V35, pS212
   WOLF LE, 1993, FASEB J, V7, P1265
   WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203
   Wolfe F., 1995, Arthritis and Rheumatism, V38, pS265
   WRONA N, 1993, ARTHRITIS RHEUM, V36, pS144
   ZANDMANGODDAR G, IN PRESS J RHEUMATOL
NR 48
TC 5
Z9 5
U1 0
U2 3
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0272-2712
J9 CLIN LAB MED
JI Clin. Lab. Med.
PD SEP
PY 1997
VL 17
IS 3
BP 341
EP &
PG 14
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA XX955
UT WOS:A1997XX95500003
PM 9316762
DA 2018-10-19
ER

PT J
AU Sievert, MC
   Johnson, DT
   Hartman, T
   Patrick, TB
AF Sievert, MC
   Johnson, DT
   Hartman, T
   Patrick, TB
TI New educational strategies for training information professionals:
   Building awareness, concepts, and skills through learning technologies
SO JOURNAL OF EDUCATION FOR LIBRARY AND INFORMATION SCIENCE
LA English
DT Article
AB Libraries, Medical Informatics, and Health Care was an experimental distance-education course aimed at both health sciences and other librarians and graduate students. The course included three modalities for delivering instruction: a satellite broadcast, materials on the Internet, and an intensive seminar. The teleconference focused, on two topics, consumer health care information and telemedicine and the relation of each to librarianship. The Internet-based materials covered the U.S. health care delivery system, the language of medicine, MeSH (Medical Subject Headings), and MEDLINE. The intensive seminar covered other health sciences resources, the biomedical community, trends in health sciences librarianship, and medical informatics. Each modality presented opportunities and challenges to the instructional team and the students. Evaluations revealed that participants were generally favorable about the experience but that there were more problems with the Internet section of the course than with the other sections.
C1 Univ Missouri, Coll Educ, Sch Informat Sci & Learning Technol, Columbia, MO 65211 USA.
   Univ Missouri, Sch Med, Integrated Technol Serv, Columbia, MO 65211 USA.
RP Sievert, MC (reprint author), Univ Missouri, Coll Educ, Sch Informat Sci & Learning Technol, Columbia, MO 65211 USA.
OI Hartman, Teresa/0000-0003-1621-6167
CR BARRON D, 1991, WILSON LIBR BULL, V66, P41
   DELAPENAMCCOOK K, 1993, PROJECT CENTURY 21 R, P1
   JOHNSON DT, 1997, IN PRESS 3 INT C CON
   *MED LIB ASS, 1991, PLATF CHANG ED POL S
   *NIH, 1996, REP PLANN PAN ED TRA
   SMITH B, 1992, BYTE, V17, P37
   TODD RD, 1990, TECHNOLOGY TEACH DEC, P3
NR 7
TC 1
Z9 1
U1 0
U2 4
PU ASSOC LIBRARY INFORMATION SCIENCE EDUCATION
PI ARLINGTON
PA PO BOX 7640, ARLINGTON, VA 22207 USA
SN 0748-5786
J9 J EDUC LIBR INF SCI
JI J. Educ. Libr. Inf. Sci.
PD FAL
PY 1997
VL 38
IS 4
BP 303
EP 313
DI 10.2307/40324191
PG 11
WC Education & Educational Research; Information Science & Library Science
SC Education & Educational Research; Information Science & Library Science
GA 192JJ
UT WOS:000080075000005
DA 2018-10-19
ER

PT J
AU Sim, CP
   Cheang, P
   Liang, MH
   Khor, KA
AF Sim, CP
   Cheang, P
   Liang, MH
   Khor, KA
TI Injection moulding of hydroxyapatite composites
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE injection moulding; rheology; hydroxyapatite; composites; microwave;
   mechanical properties
ID IMPLANTS; HYDROXYLAPATITE; COATINGS
AB Hydroxyapatite (HA) is an important bioceramic with tremendous potential for biomedical applications. Its unique bioactivity promotes rapid bone growth and strong interfacial fixation that has particular benefit to orthopaedic and dental applications. Although it possesses good biocompatibility, its mechanical properties in terms of toughness and modulus values are still not comparable to those of cortical bone, which has severely limited its usage to mainly low-stress applications. Composite blending with a low modulus polymeric material introduces new improvement possibilities, but often requires high HA loading to attain useful properties. This high loading creates poor flow characteristics which hinders processing. In this study the critical powder loading and the rheological behaviour of hydroxyapatite-high density polyethylene (HA-HDPE) composites are studied using a capillary rheometer to ascertain the injection mouldability of the composite system. The mechanical properties of the injection moulded composites are evaluated by tensile testing. The effects of coupling agents and lubricant on the flow and mechanical property of HA-HDPE composite are examined in addition to the post heat-treatment of the composites. (C) 1997 Elsevier Science S.A.
C1 NANYANG TECHNOL UNIV,SCH MECH & PROD ENGN,SINGAPORE 639798,SINGAPORE.
   NANYANG TECHNOL UNIV,SCH APPL SCI,SINGAPORE 639798,SINGAPORE.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR CHEANG P, 1995, J MATER PROCESS TECH, V48, P429, DOI 10.1016/0924-0136(94)01679-U
   DELANGE GL, 1989, J DENT RES, V68, P509, DOI 10.1177/00220345890680031601
   Frame, 1989, INT J ORAL MAXILLOF, V16, P142
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   Hirota Kazushi, 1993, Bio-Medical Materials and Engineering, V3, P147
   KHOR KA, 1994, J THERM SPRAY TECHN, V3, P45, DOI 10.1007/BF02648998
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   LIANG MH, 1993, J I MAT, V2, P53
   PILLIAR RM, 1991, MRS BULL, V16, P55
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   SOBELLE ES, 1990, ACTA ORTHOP SCAND, V61, P299
   TANNER KE, 1991, 7 INT C BIOM ENG SIN, P400
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   VOLFON SA, 1985, NEGNATOR PRINCIPLES
NR 15
TC 13
Z9 13
U1 0
U2 4
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD SEP
PY 1997
VL 69
IS 1-3
BP 75
EP 78
DI 10.1016/S0924-0136(96)00044-1
PG 4
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA XW219
UT WOS:A1997XW21900010
DA 2018-10-19
ER

PT J
AU Lee, YM
   Kim, SS
   Kim, SH
AF Lee, YM
   Kim, SS
   Kim, SH
TI Synthesis and properties of poly(ethylene glycol) macromer/beta-chitosan
   hydrogels
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID INTERPENETRATING POLYMER NETWORKS; BETA-CHITIN; SQUID CHITIN;
   MORPHOLOGY; OXIDE); WATER; EPOXY
AB Semi-interpenetrating polymer network (semi-IPN) hydrogels composed of beta-chitosan a nd poly(ethylene glycol) diacrylate macromer (PEGM) were synthesized and characterized for the application as potential biomedical materials. The mixture of PEGM and beta-chitosan, dissolved in water including a small amount of acetic acid, was cast to prepare hydrogel films, followed by a subsequent crosslinking with 2,2-dimethoxy-2-phenylacetophenone as a non-toxic photoinitiator by ultraviolet irradiation. Photocrosslinked hydrogels exhibited relatively high equilibrium water content in the range 77-83% which is mainly attributed to the free water content rather than to the bound water, hydrogen bonded with components in semi-IPN hydrogels. The crystallinity, thermal properties and mechanical properties of semi-IPN hydrogels were studied. All the photocrosslinked hydrogels revealed a remarkable decrease in crystallinity. The glass transition temperatures, T-g, of crosslinked PEGM segment in semi-IPNs increased compared with poly(ethylene glycol) itself. However, with increasing beta-chitosan content their T-g decreased owing to the higher degree of crosslinking. The tensile strengths of semi-IPNs in dry state were rather high, but those of hydrogels in wet state decreased drastically.
RP Lee, YM (reprint author), HANYANG UNIV,COLL ENGN,DEPT IND CHEM,SEOUL 133791,SOUTH KOREA.
RI Lee, Young Moo/G-5920-2015
OI Lee, Young Moo/0000-0002-5047-3143
CR DAS B, 1994, J APPL POLYM SCI, V53, P1491, DOI 10.1002/app.1994.070531111
   DAVIS TP, 1990, POLYMER, V31, P513, DOI 10.1016/0032-3861(90)90395-F
   DESAI NP, 1992, MACROMOLECULES, V25, P226, DOI 10.1021/ma00027a038
   DOMSZY JG, 1985, MAKROMOL CHEM, V186, P1671
   GRAHAM NB, 1990, POLYMER, V31, P909, DOI 10.1016/0032-3861(90)90055-4
   GUPTA N, 1994, POLYMER, V35, P3769, DOI 10.1016/0032-3861(94)90560-6
   HACKMAN RH, 1954, AUST J BIOL SCI, V7, P168, DOI 10.1071/BI9540168
   KHARE AR, 1993, POLYMER, V34, P4736, DOI 10.1016/0032-3861(93)90710-R
   KIM SS, 1995, POLYMER, V36, P4497, DOI 10.1016/0032-3861(95)96859-7
   KIM SS, 1995, J POLYM SCI POL CHEM, V33, P2285, DOI 10.1002/pola.1995.080331324
   Kim SS, 1996, J POLYM SCI POL PHYS, V34, P2367
   KURITA K, 1993, J POLYM SCI POL CHEM, V31, P485, DOI 10.1002/pola.1993.080310220
   KURITA K, 1994, J POLYM SCI POL CHEM, V32, P1027, DOI 10.1002/pola.1994.080320603
   LEE YM, 1997, IN PRESS POLYMER
   LIN MS, 1993, J POLYM SCI POL CHEM, V31, P3317, DOI 10.1002/pola.1993.080311320
   MAGHAMI GG, 1988, MAKROMOL CHEM, V189, P195
   MIMA S, 1983, J APPL POLYM SCI, V28, P1909, DOI 10.1002/app.1983.070280607
   PENG T, 1994, J POLYM SCI POL CHEM, V32, P591, DOI 10.1002/pola.1994.080320322
   PRIOLA A, 1993, POLYMER, V34, P3653, DOI 10.1016/0032-3861(93)90050-K
   RAMARAJ B, 1994, J APPL POLYM SCI, V52, P837, DOI 10.1002/app.1994.070520701
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Yao KD, 1994, J POLYM SCI A, V32, P1213
NR 22
TC 42
Z9 44
U1 1
U2 22
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 1997
VL 8
IS 9
BP 537
EP 541
DI 10.1023/A:1018594614087
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XV771
UT WOS:A1997XV77100003
PM 15348705
DA 2018-10-19
ER

PT J
AU Bistue, G
   Elizalde, JG
   GarciaAlonso, I
   Olaizola, S
   Castano, E
   Gracia, FJ
   GarciaAlonso, A
AF Bistue, G
   Elizalde, JG
   GarciaAlonso, I
   Olaizola, S
   Castano, E
   Gracia, FJ
   GarciaAlonso, A
TI A micromachined pressure sensor for biomedical applications
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article; Proceedings Paper
CT 7th Workshop on Micromachining, Micromechanics and Microsystems in
   Europe (MME 96)
CY OCT 21-22, 1996
CL BARCELONA, SPAIN
ID SILICON
AB A silicon pressure microsensor fabrication process is reported. The microsensor has been designed as a low-cost disposable device for invasive blood pressure measurements. Results obtained from static, dynamic and leakage pressure tests are presented. A sensitivity of 20 (mu V/V)/mmHg has been measured. The combined linearity and hysteresis is less than 1.5% FSO. The dynamic response is fast enough to reproduce the blood pressure waveform of the human heart, Results based on a material biocompatibility study are also included.
C1 UNIV BASQUE COUNTRY, LAB CIRUGIA EXPT, E-48940 LEJONA, SPAIN.
RP Bistue, G (reprint author), CTR ESTUDIOS & INVEST TECN GUIPUZCOA, POB 1555, E-20009 SAN SEBASTIAN, SPAIN.
RI Elizalde, Jorge/A-5508-2013
OI Elizalde, Jorge/0000-0002-5785-0618; Garcia-Alonso,
   Ignacio/0000-0002-3701-1761
CR Berne RM, 1993, PHYSL MOSBY YB
   BRYSEK J, 1991, SILICON SENSORS MICR
   DZIUBAN J, 1994, SENSOR ACTUAT A-PHYS, V41, P368
   GHANDHI SK, 1994, VLSI FABRICATION PRI
   GOTZ A, 1993, SENSOR ACTUAT A-PHYS, V37-8, P744, DOI 10.1016/0924-4247(93)80126-2
   KLOECK B, 1989, IEEE T ELECTRON DEV, V36, P663, DOI 10.1109/16.22472
   KO WH, 1979, IEEE T ELECTRON DEV, V26, P1896
   Ning XJ, 1996, J ELECTROCHEM SOC, V143, P3389, DOI 10.1149/1.1837217
   Samaun K. D. Wise, 1973, IEEE T BIOMED ENG, V20, P101
   Terry S., 1990, SENSOR ACTUAT A-PHYS, VA21-A23, P1070
NR 10
TC 13
Z9 13
U1 1
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD SEP
PY 1997
VL 7
IS 3
BP 244
EP 246
DI 10.1088/0960-1317/7/3/044
PG 3
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA YA662
UT WOS:A1997YA66200044
DA 2018-10-19
ER

PT J
AU Ciardelli, G
   Kojima, K
   Lendlein, A
   Neuenschwander, P
   Suter, UW
AF Ciardelli, G
   Kojima, K
   Lendlein, A
   Neuenschwander, P
   Suter, UW
TI Synthesis of biomedical, fluorescence-labelled polyesterurethanes for
   the investigation of their degradation
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID POLY<(R)-3-HYDROXYBUTYRIC ACID>; PHOTORESPONSIVE POLYMERS; PEPTIDE;
   POLY(EPSILON-CAPROLACTONE); DICYCLOHEXYLCARBODIIMIDE; DIISOCYANATE;
   ACTIVATION
AB The synthesis and characterization of fluorescence-labelled, phase segregating block polyesterurethanes based on the known biocompatible and degradable materials poly[(R)-3-hydroxybutyric acid] (PHB), poly(epsilon-caprolactone) (PCL), and poly[(epsilon-caprolactone)-co-glycolide] (PCL/PGA) is described. To introduce fluorescence labels in the amorphous domains of the polymers, phenacyl 10,11-dihydroxyundecanoate (PDUA) was synthesized and copolymerized with a PHB diol, a PCL diol, and aliphatic diisocyanates. After cleavage of the protecting group (without degradation of the polymer backbone), the carboxyl group was reacted with a fluorescent amine (dansylcadaverine) in the presence of 4,6-diphenylthieno[3,4-d]-1,3-dioxol-2-one 5,5-dioxide (Steglich reagent). Also a polymer containing C-13-labelled carboxy groups was synthesized and the labelling reaction monitored by C-13 NMR spectroscopy. To introduce fluorescence labels in the hard segment of the polymers, a new low-molecular-weight diol based on poly[(R)-hydroxybutyric acid] and containing protected carboxy groups was synthesized. After the deprotection, the carboxy groups were reacted with a fluorescent amine (dansylcadaverine) in the presence of an activating system based on dicyclohexylcarbodiimide. The labelled PHB diol was then copolymerized with a poly[(epsilon-caprolactone)-co-glycolide] diol and an aliphatic diisocyanate. The so obtained fluorescence-labelled block polyesterurethanes are promising materials for the investigation of the biocompatibility and degradation of the corresponding, non-labelled materials (DegraPol(R)) by means of fluorescence-aided microscopic and spectroscopic techniques.
C1 ETH ZURICH,INST POLYMERS,DEPT MAT,CH-8092 ZURICH,SWITZERLAND.
RI Lendlein, Andreas/K-9553-2013; Suter, Ulrich/H-8900-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Suter,
   Ulrich/0000-0001-7467-7346; Ciardelli, Gianluca/0000-0003-0199-1427
CR ALDINGER W, 1908, THESIS U STUTTGART
   BAKER JW, 1947, J CHEM SOC, P713, DOI 10.1039/jr9470000713
   BAKER JW, 1949, J CHEM SOC, P19, DOI 10.1039/jr9490000019
   BERGBREITER DE, 1975, J ORG CHEM, V40, P779, DOI 10.1021/jo00894a605
   BOCHNITSCHEK SF, 1989, J ORG CHEM, V54, P751
   BRUIN P, 1990, BIOMATERIALS, V11, P291, DOI 10.1016/0142-9612(90)90013-G
   CHEN RF, 1967, ARCH BIOCHEM BIOPHYS, V120, P609, DOI 10.1016/0003-9861(67)90526-7
   Ciardelli G, 1997, MACROMOL CHEM PHYSIC, V198, P1481, DOI 10.1002/macp.1997.021980514
   CLARK JH, 1977, TETRAHEDRON LETT, V7, P599
   COGNETGEORJON E, 1995, MACROMOL CHEM PHYSIC, V196, P3733, DOI 10.1002/macp.1995.021961125
   FISSI A, 1987, BIOPOLYMERS, V26, P1993, DOI 10.1002/bip.360261203
   FISSI A, 1989, MACROMOLECULES, V22, P1115, DOI 10.1021/ma00193a019
   GEFFKEN D, 1987, CHEM ZTG, V111, P245
   Hassner A., 1978, TETRAHEDRON LETT, V19, P4475
   HAUGLAND RP, 1992, HDB FLUORESCENT PROB
   HENDRICKSON JB, 1970, TETRAHEDRON LETT, V5, P343
   Hirt TD, 1996, MACROMOL CHEM PHYSIC, V197, P1609, DOI 10.1002/macp.1996.021970503
   Hirt TD, 1996, MACROMOL CHEM PHYS, V197, P4253, DOI 10.1002/macp.1996.021971221
   HOLLITZER O, 1976, ANGEW CHEM INT EDIT, V15, P444, DOI 10.1002/anie.197604441
   HOLLITZER O, 1976, ANGEW CHEM, V88, P480
   HUYNHBA G, 1981, ACS SYM SER, V172, P205
   ITO Y, 1991, J BIOMED MATER RES, V25, P1325, DOI 10.1002/jbm.820251102
   KABALKA GW, 1980, J ORG CHEM, V45, P3578, DOI 10.1021/jo01306a007
   KIRSTGEN R, 1987, J CHEM SOC CHEM COMM, P1870, DOI 10.1039/c39870001870
   KLAUSNER YS, 1972, SYNTH-INT J METHODS, P453
   KONIG W, 1970, CHEM BER-RECL, V103, P2034, DOI 10.1002/cber.19701030705
   KONIG W, 1970, CHEM BER-RECL, V103, P788, DOI 10.1002/cber.19701030319
   KOVACS J, 1967, J AM CHEM SOC, V89, P183, DOI 10.1021/ja00977a059
   KOVACS L, 1969, TETRAHEDRON, V25, P2555
   KURTH MJ, 1988, INT J PEPT PROT RES, V31, P388
   Larock R. C., 1989, COMPREHENSIVE ORGANI
   LEE KN, 1985, J BIOL CHEM, V260, P4689
   LENDLEIN A, UNPUB
   MIRVISS SB, 1989, J ORG CHEM, V54, P1948, DOI 10.1021/jo00269a038
   NEISES B, 1978, ANGEW CHEM INT EDIT, V17, P522, DOI 10.1002/anie.197805221
   Neises B., 1978, ANGEW CHEM, V90, P556, DOI DOI 10.1002/ANGE.19780900718
   PIERONI O, COMMUNICATION
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   ROBINS MJ, 1974, BIOCHEMISTRY-US, V13, P553, DOI 10.1021/bi00700a023
   Saad B, 1996, J BIOMED MATER RES, V30, P429, DOI 10.1002/(SICI)1097-4636(199604)30:4<429::AID-JBM1>3.3.CO;2-D
   SAAD B, IN PRESS J MAT SCI M
   SAAD B, IN PRESS J BIOMED MA
   SHEEHAN JC, 1955, J AM CHEM SOC, V77, P1067, DOI 10.1021/ja01609a099
   STOLL R, COMMUNICATION
   Stryer L., 1988, BIOCHEMISTRY
   VINCZER P, 1988, ACTA CHIM HUNG, V125, P797
   WEYGAND F, 1966, Z NATURFORSCH PT B, VB 21, P426
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   WUNSCH E, 1966, CHEM BER-RECL, V99, P110, DOI 10.1002/cber.19660990119
NR 49
TC 5
Z9 6
U1 1
U2 13
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4, CH-4052 BASEL, SWITZERLAND
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD SEP
PY 1997
VL 198
IS 9
BP 2667
EP 2688
DI 10.1002/macp.1997.021980903
PG 22
WC Polymer Science
SC Polymer Science
GA XW915
UT WOS:A1997XW91500003
DA 2018-10-19
ER

PT J
AU Alonso, F
   Rinner, M
   Loinaz, A
   Onate, JI
   Ensinger, W
   Rauschenbach, B
AF Alonso, F
   Rinner, M
   Loinaz, A
   Onate, JI
   Ensinger, W
   Rauschenbach, B
TI Characterization of Ti-6Al-4V modified by nitrogen plasma immersion ion
   implantation
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 3rd International Workshop on Plasma-Based Ion Implantation
CY SEP 15-18, 1996
CL DRESDEN, GERMANY
SP Res Ctr Rossendorf, Dresden, State Saxony, Saxonian Minist Sci & Arts, Dresden, AP & T Adv Prod & Technol GmbH, Nurtingen, Germany, DANFYSIK, Jyllinge, Denmark, Hiden Anal, Ried, Germany, Leybold Serv GmbH, Dresden, N Star Res Corp, Albuquerque, NM, Roth & Rau Oberfiachentech GmbH, Wustenbrand, Germany, SASKIA Hochvakuum GmbH, Ilmenau, Germany, SENTECH, Berlin
DE friction; load bearing capacity; plasma immersion ion implantation;
   Ti-6Al-4V; wear
ID SURFACE MODIFICATION; PROFILES; OXYGEN; CARBON; ALLOY
AB Ti-6Al-4V alloy is commonly used in biomedical or aerospace applications, due to its excellent combination of chemical and mechanical properties, such as bioinertness, corrosion resistance or high strength to weight ratio. The use of surface treatments or coatings has widened the application possibilities of this alloy. The often observed poor tribological performance can be overcome by the correct choice of surface: engineering methods. Ion implantation is a candidate among the different available processes and excellent results have been obtained in biomedical applications. However, when complex geometries are involved, it can be a difficult and less economically effective treatment. Plasma immersion ion implantation (PIII) offers the possibility of performing three-dimensional ion beam treatments, reducing the need for manipulation under vacuum to obtain a uniform treatment of geometrically complex parts.
   In this work, PIII was used to implant nitrogen in the Ti-6Al-4V alloy. The nitrogen plasma was generated with a 2.45 GHz microwave excitation, and a pulsed bias voltage of 45 kV with pulse repetition rates of 50 and 400 Hz were applied. Nitrogen retained doses were evaluated by means crf Rutherford backscattering spectroscopy (RES). Pin-on-disc wear and friction tests were performed on the implanted samples. An ultra high molecular weight polyethylene pin was used as the counterface material to partially simulate the conditions encountered in biomedical applications. A reasonable improvement in load bearing capacity with respect to the unimplanted alloy was observed after these tribological tests. However, no hardening could be measured after ion implantation. The worn surfaces were observed by scanning electron microscopy and optical profilometry after the tests and the type of wear mechanism was studied. The effect of the implantation was to increase the load at which breakthrough occurred on the protective surface layer. (C) 1997 Elsevier Science S.A.
C1 UNIV AUGSBURG,INST PHYS,D-86135 AUGSBURG,GERMANY.
RP Alonso, F (reprint author), INASMET,CAMINO PORTUETXE 12,SAN SEBASTIAN 20009,SPAIN.
RI Ensinger, Wolfgang/N-7074-2017; Onate, J. Ignacio/I-1555-2015
OI Ensinger, Wolfgang/0000-0003-3858-6230; Onate de la Presa, Jose
   Ignacio/0000-0002-9078-4480
CR Alonso F, 1995, SURF COAT TECH, V74-75, P986, DOI 10.1016/0257-8972(95)08291-3
   Alonso F, 1996, SURF COAT TECH, V83, P301, DOI 10.1016/0257-8972(96)02767-3
   CHEN A, 1991, SURF COAT TECH, V50, P1, DOI 10.1016/0257-8972(91)90184-X
   CHEN A, 1991, WEAR MATERIALS, P667
   Collins GA, 1996, SURF COAT TECH, V84, P537, DOI 10.1016/S0257-8972(95)02792-0
   CONRAD JR, 1990, J VAC SCI TECHNOL A, V8, P3146, DOI 10.1116/1.576598
   CONRAD JR, 1989, J APPL PHYS, V65, P1707, DOI 10.1063/1.342942
   CONRAD JR, 1987, J APPL PHYS, V62, P777, DOI 10.1063/1.339858
   DOOLITTLE LR, 1985, NUCL INSTRUM METH B, V9, P344, DOI 10.1016/0168-583X(85)90762-1
   Ensinger W, 1996, MATER RES SOC SYMP P, V396, P521
   GUNZEL R, 1994, J VAC SCI TECHNOL B, V12, P927, DOI 10.1116/1.587329
   Han SH, 1996, SURF COAT TECH, V82, P270, DOI 10.1016/0257-8972(95)02722-X
   Hartmann J, 1996, J VAC SCI TECHNOL A, V14, P3144, DOI 10.1116/1.580183
   Hartmann J, 1996, NUCL INSTRUM METH B, V112, P255, DOI 10.1016/0168-583X(95)01248-6
   HUTCHINGS R, 1994, MAT SCI ENG A-STRUCT, V184, P87, DOI 10.1016/0921-5093(94)91023-5
   Munson CP, 1996, SURF COAT TECH, V84, P528, DOI 10.1016/S0257-8972(95)02836-6
   ONATE JI, 1994, SURF COAT TECH, V65, P165, DOI 10.1016/S0257-8972(94)80025-1
   QIU X, 1990, METALL TRANS A, V21, P1663, DOI 10.1007/BF02672581
   TENDYS J, 1988, APPL PHYS LETT, V53, P2143, DOI 10.1063/1.100299
   VAJO JJ, 1994, J APPL PHYS, V76, P5666, DOI 10.1063/1.357072
   XIE L, 1991, MAT SCI ENG A-STRUCT, V139, P179, DOI 10.1016/0921-5093(91)90614-S
NR 21
TC 24
Z9 26
U1 1
U2 4
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP
PY 1997
VL 93
IS 2-3
BP 305
EP 308
DI 10.1016/S0257-8972(97)00065-0
PG 4
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA YH798
UT WOS:A1997YH79800029
DA 2018-10-19
ER

PT J
AU Kobayashi, K
   Tawada, E
   Akaike, T
   Usui, T
AF Kobayashi, K
   Tawada, E
   Akaike, T
   Usui, T
TI Artificial glycopolypeptide conjugates: Simple synthesis of lactose- and
   N,N'-diacetylchitobiose-substituted poly(L-glutamic acid)s through
   N-beta-glycoside linkages and their interaction with lectins
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE glycopolypeptide; lectin; biomedical material; glycotechnology
ID DERIVATIVES
AB Poly(glutamic acid)s carrying lactose-and N,N'-diacetylchitobiose residues were synthesized via a simple two-step procedure. The oligosaccharides were treated with ammonium hydrogen carbonate and the resulting N-beta-glycosylamine was coupled with pendant carboxyl groups of poly(L-glutamic acid) in the presence of a mixture of benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and 1-hydroxybenzotriazole (HOBt) in dimethyl sulfoxide. The oligosaccharide incorporated as pendant N-glycosides was estimated by H-1-NMR spectroscopy to be 30 mol% (or 45 wt%) for lactose and 27 mol% (46 wt%) for chitobiose. The glycopolypeptide carrying N,N'-diacetyl-chitobiose inhibited hemagglutination activity of wheat germ agglutinin (WGA) much more strongly (about 10(6) times) than N,N'-diacetylchitobiose itself, The high activity is due to the cluster or high density effect of the glycopolypeptides.
C1 NAGOYA UNIV, SCH AGR SCI, CHIKUSA KU, NAGOYA, AICHI 46401, JAPAN.
   TOKYO INST TECHNOL, FAC BIOSCI & TECHNOL, YOKOHAMA, KANAGAWA 226, JAPAN.
   SHIZUOKA UNIV, FAC AGR, OYA, SHIZUOKA 422, JAPAN.
RP Kobayashi, K (reprint author), NAGOYA UNIV, GRAD SCH ENGN, CHIKUSA KU, NAGOYA, AICHI 46401, JAPAN.
CR ANISFELD ST, 1990, J ORG CHEM, V55, P5566
   BODANSZKY M, 1975, J ORG CHEM, V40, P2495, DOI 10.1021/jo00905a016
   COHENANISFELD ST, 1993, J AM CHEM SOC, V115, P10531, DOI 10.1021/ja00076a010
   KAWAGISHI H, 1994, J BIOL CHEM, V269, P1375
   Kiessling LL, 1996, CHEM BIOL, V3, P71, DOI 10.1016/S1074-5521(96)90280-X
   KOBAYASHI K, IN PRESS MACROMOLECU
   LEE YC, 1994, NEOGLYCOCONJUGATES P
   LEE YC, 1994, METHODS ENZYMOLOGY, V247
   LEE YC, 1994, METHODS ENZYMOLOGY, V242
   LIKHOSHERSTOV LM, 1986, CARBOHYD RES, V146, pC1, DOI 10.1016/0008-6215(86)85037-6
   Montreuil J, 1995, GLYCOPROTEINS A, V29a
   NISHIMURA SI, 1994, MACROMOLECULES, V27, P4876, DOI 10.1021/ma00096a004
   UEDA M, 1992, B CHEM SOC JPN, V65, P1636, DOI 10.1246/bcsj.65.1636
NR 13
TC 28
Z9 28
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD AUG 29
PY 1997
VL 1336
IS 2
BP 117
EP 122
DI 10.1016/S0304-4165(97)00018-4
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA XU954
UT WOS:A1997XU95400001
PM 9305781
DA 2018-10-19
ER

PT J
AU Abraham, GA
   Frontini, PM
   Cuadrado, TR
AF Abraham, GA
   Frontini, PM
   Cuadrado, TR
TI Physical and mechanical behavior of sterilized biomedical segmented
   polyurethanes
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE mechanical properties; segmented polyurethanes; biomedical
   polyurethanes; sterilization; irradiation-
ID POLY(ETHER URETHANE UREAS); PROTEIN ADSORPTION; DEGRADATION; ELASTOMERS;
   ADDITIVES; POLYMER; FTIR
AB Changes in the physical and mechanical behavior induced by two sterilization methods, gamma irradiation and ethylene oxide, were determined on two commercial medical-grade segmented polyurethanes. The two materials have different chemical composition: one is an aromatic poly(ether urethane urea), Biospan(TM), and the other an aliphatic ether-free polyurethane, Chronoflex(TM). Properties before and after sterilization procedures were compared resulting in specific structural changes for each formulation. The thermal and mechanical properties were examined using differential scanning calorimetry (DSC), dynamic mechanical analysis (DMA), stress-strain measurements, and its hysteresis cycle. Molecular weight measurements were performed by gel permeation chromatography (GPC). Sterilized Biospan samples showed a decrease in the soft-segment glass transition temperature (T-g,T-s) and an increase in the soft. segment crystallization heat along the quenching process. Sterilized Chronoflex materials showed the opposite behavior. The hysteresis percent and residual strain percent increased after sterilization. The same effect was observed when irradiation dose and strain level increased. Surface analysis performed by scanning electron microscopy showed magnification of original surface defects after sterilization. (C) 1997 John Wiley & Sons, Inc.
RP Abraham, GA (reprint author), UNIV MAR DEL PLATA,INST MAT SCI & TECHNOL,CONICET,JB JUSTO 4302,RA-7600 MAR DEL PLATA,ARGENTINA.
RI Abraham, Gustavo/E-2820-2014
OI Abraham, Gustavo/0000-0001-7094-1031
CR ABOUZAHR S, 1982, POLYMER, V23, P1077, DOI 10.1016/0032-3861(82)90411-6
   AHN TO, 1994, J APPL POLYM SCI, V51, P43, DOI 10.1002/app.1994.070510105
   BIAGINI E, 1983, MAKROMOL CHEM, V184, P1213
   BORETOS JW, 1975, J BIOMED MATER RES, V9, P327, DOI 10.1002/jbm.820090308
   BORETOS JW, 1980, PURE APPL CHEM, V52, P1851, DOI 10.1351/pac198052071851
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P255, DOI 10.1002/jbm.820270216
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   COLEMAN MM, 1988, MACROMOLECULES, V21, P59, DOI 10.1021/ma00179a014
   DENG M, 1995, J APPL POLYM SCI, V58, P2111, DOI 10.1002/app.1995.070581123
   DUMITRIU S, 1994, POLYM BIOMATERIALS, pCH1
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V49, P815, DOI 10.1002/app.1993.070490507
   Kolff T, 1973, Biomater Med Devices Artif Organs, V1, P669
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LELAH MD, 1989, POLYURETHANES MED, pCH7
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MARCHANT RE, 1988, SURFACE CHARACTERIZA
   MARTAKIS N, 1994, J APPL POLYM SCI, V51, P313, DOI 10.1002/app.1994.070510214
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   MERRILL EW, 1985, POLYM COMMUN, V26, P105
   MORBITZER L, 1972, J APPL POLYM SCI, V16, P2697, DOI 10.1002/app.1972.070161022
   PIERCE WS, 1967, T AM SOC ART INT ORG, V13, P299
   *POL IND INC, PROD INF
   *POL TECHN GROUP I, PROD INF
   SEYMOUR RW, 1970, MACROMOLECULES, V3, P579, DOI 10.1021/ma60017a021
   SEYMOUR RW, 1973, MACROMOLECULES, V6, P896, DOI 10.1021/ma60036a021
   Sung C.S., 1980, MACROMOLECULES, V13, P117
   Szycher M., 1991, BLOOD COMPATIBLE MAT
   SZYCHER M, 1994, POLYM BIOMATERIALS, pCH6
   Takigawa T, 1996, J APPL POLYM SCI, V59, P1563, DOI 10.1002/(SICI)1097-4628(19960307)59:10<1563::AID-APP9>3.0.CO;2-K
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
NR 32
TC 40
Z9 40
U1 0
U2 14
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 8
PY 1997
VL 65
IS 6
BP 1193
EP 1203
DI 10.1002/(SICI)1097-4628(19970808)65:6<1193::AID-APP15>3.0.CO;2-V
PG 11
WC Polymer Science
SC Polymer Science
GA XH702
UT WOS:A1997XH70200015
DA 2018-10-19
ER

PT J
AU DiMartino, E
   Pietrabissa, R
   Mantero, S
AF DiMartino, E
   Pietrabissa, R
   Mantero, S
TI The computational approach applied to the design and structural
   verification of a trileaflet polymeric heart valve
SO ADVANCES IN ENGINEERING SOFTWARE
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Computer Simulations in Biomedicine
   (BIOMED 97)
CY JUN 09-11, 1997
CL ACQUASPARTA, ITALY
SP Wessex Inst Technol, Southampton, UK, Univ Perugia, Mat Engn Ctr, Italy, Ctr Ric WIT Ingegneria Computaz, Terni, Italy
DE computational methods; structural FEM analysis; polymeric trileaflet
   heart valves
AB This study represents an application of the computational methods to the design and structural verification of a cardiac trileaflet polymeric valve. Numerical methods are commonly used for mechanic, fluid dynamic and thermal preliminary testing of engineering devices. In this paper commercial codes have been used to design and analyse a device which operates in contact with a biologic environment. Several simplifications are necessary to fulfill this aim due to the actual characteristics of the material, loads and boundary conditions. Six 3-D valve models have been developed and their mechanic behavior compared. The results allow an evaluation of the method that has been adopted and of the simplifications imposed. The method can be used to solve biomedical engineering problems though it requires an accurate description of the geometric and operating characteristics of both the device and its environment together with a critical evaluation of the results. (C) 1997 Elsevier Science Ltd.
RP DiMartino, E (reprint author), POLITECN MILAN,DIPARTIMENTO BIOINGN,I-20133 MILAN,ITALY.
RI Mantero, Sara/F-6587-2013
OI MANTERO, SARA/0000-0002-1264-0465
CR BERNACCA GM, 1995, BIOMATERIALS, V16, P279, DOI 10.1016/0142-9612(95)93255-C
   GHISTA DN, 1977, J BIOMECH, V10, P313, DOI 10.1016/0021-9290(77)90004-5
   KNIERBEIN B, 1990, INT J ARTIF ORGANS, V13, P307
   KNIERBEIN B, 1992, J BIOMED ENG, V14, P275, DOI 10.1016/0141-5425(92)90001-2
   KRUCINSKY S, 1992, J BIOMECH, V26, P929
   LOCKIE KJ, 1993, ANN THORAC SURG, V56, P125, DOI 10.1016/0003-4975(93)90415-E
   Pinchuk L., 1992, US Patent, Patent No. [5,133,742, 5133742]
   POWELL G, 1981, INT J NUMER METH ENG, V17, P1455, DOI 10.1002/nme.1620171003
   Ramm E., 1981, NONLINEAR FINITE ELE
   SWANSON WM, 1974, CIRC RES, V35, P871, DOI 10.1161/01.RES.35.6.871
   TANZI MC, 1994, J MATER SCI-MATER M, V5, P705, DOI 10.1007/BF00120361
   Thubrikar MJ, 1990, AORTIC VALVE
NR 12
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0965-9978
J9 ADV ENG SOFTW
JI Adv. Eng. Softw.
PD AUG
PY 1997
VL 28
IS 6
BP 341
EP 346
DI 10.1016/S0965-9978(97)00026-4
PG 6
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Engineering, Multidisciplinary
SC Computer Science; Engineering
GA XT703
UT WOS:A1997XT70300002
DA 2018-10-19
ER

PT J
AU Streicher, J
   Weninger, TJ
   Muller, GB
AF Streicher, J
   Weninger, TJ
   Muller, GB
TI External marker-based automatic congruencing: A new method of 3D
   reconstruction from serial sections
SO ANATOMICAL RECORD
LA English
DT Article
DE histology; serial sections; 3D reconstruction; section alignment;
   molecular morphology
ID AIDED 3-DIMENSIONAL RECONSTRUCTION; DISSIMILAR IMAGES; FIDUCIAL MARKERS;
   ALIGNMENT; SYSTEM; HEART; SEGMENTATION; RESOLUTION; MICROSCOPY
AB Background: Computer-based three-dimensional (3D) visualizations reconstructed from sectional images represent a valuable tool in biomedical research and medical diagnosis. Particularly with those imaging techniques that provide virtual sections, such as CT, MRI, and CLSM, 3D reconstructions have become routine. Reconstructions from physical sections, such as those used in histological preparations, have not experienced an equivalent breakthrough, due to inherent shortcomings in sectional preparation that impede automated image-processing and reconstruction. The increased use of molecular techniques in morphological research, however, generates an overwhelming amount of 3D molecular information, stored within series of physical sections. This valuable information can be fully appreciated and interpreted only through an adequate method of 3D visualization.
   Methods and results: In this paper we present a new method for a reliable and largely automated 3D reconstruction from physically sectioned material. The 'EMAC' concept (External Marker-based Automatic Congruencing) successfully approaches the three major obstacles Lo automated 3D reconstruction from serial physical sections: misalignment, distortion, and staining variation. It utilizes the objectivity of external markers for realignment of the sectional images and or geometric correction of distortion. A self-adapting dynamic thresholding technique compensates for artifactual staining variation and automatically selects the desired object contours.
   Conclusions: Implemented on a low-cost hardware platform, EMAC provides a fast and efficient tool that largely facilitates the use of computer-based 3D visualization for the analysis of complex structural, molecular, and genetic information in morphological research. Due to its conceptual versatility, EMAC can be easily adapted for a broad range of tasks, including all modern molecular-staining techniques, such as immunohistochemistry and in situ hybridization. (C) 1997 Wiley-Liss, Inc.
RP Streicher, J (reprint author), UNIV VIENNA,DEPT ANAT,WAHRINGERSTR 13,A-1090 VIENNA,AUSTRIA.
CR ANDREASEN A, 1991, J NEUROSCI METH, V37, P151, DOI 10.1016/0165-0270(91)90125-J
   ARNOLDS WJA, 1978, STAIN TECHNOL, V53, P287
   Born G, 1883, ARCH MIKROSK ANAT, V22, P584
   BRANDLE K, 1989, COMPUT BIOMED RES, V22, P52, DOI 10.1016/0010-4809(89)90015-3
   BRAVERMAN MS, 1986, J INVEST DERMATOL, V86, P290, DOI 10.1111/1523-1747.ep12285445
   BRON C, 1992, VISUALIZATION BIOMED, P75
   BURSTON WR, 1957, J ANAT, V91, P409
   CHATEL D, 1993, SURG RADIOL ANAT, V15, P341, DOI 10.1007/BF01627890
   CHAWLA SD, 1981, CANCER BIOCHEM BIOPH, V5, P153
   DAVIS RE, 1991, LARYNGOSCOPE, V101, P573
   DORUP J, 1983, J ULTRA MOL STRUCT R, V85, P82, DOI 10.1016/S0022-5320(83)90118-1
   DRUSHEL RF, 1993, SURVEY METHODS 3 DIM
   GEIGER B, 1993, 2105 N NATL RECH INF
   HARALICK RM, 1991, PATTERN RECOGN, V24, P69, DOI 10.1016/0031-3203(91)90117-N
   HERBIN M, 1989, COMPUT VISION GRAPH, V47, P77, DOI 10.1016/0734-189X(89)90055-8
   HIBBARD LS, 1988, J NEUROSCI METH, V26, P55, DOI 10.1016/0165-0270(88)90129-X
   HIBBARD LS, 1992, J NEUROSCI METH, V41, P133, DOI 10.1016/0165-0270(92)90056-J
   HIBBARD LS, 1987, SCIENCE, V236, P1641, DOI 10.1126/science.3603004
   HIS W, 1885, UEBER METHODEN PLAST, V3
   His W, 1887, ANAT ANZEIGER, VII, P382
   HUIJSMANS DP, 1986, ANAT RECORD, V216, P449, DOI 10.1002/ar.1092160402
   JAEGERS SMHJ, 1992, SURG RADIOL ANAT, V14, P241, DOI 10.1007/BF01794948
   JOHNSON CL, 1989, ANAT REC, V223, P104, DOI 10.1002/ar.1092230115
   KANG YK, 1993, J BIOMED ENG, V15, P497, DOI 10.1016/0141-5425(93)90065-7
   KNOX CK, 1990, P E MULT SOC COMP SI, P12
   LAAN AC, 1989, ANAT REC, V224, P443, DOI 10.1002/ar.1092240313
   LIU HC, 1990, IEEE T PATTERN ANAL, V12, P1072, DOI 10.1109/34.61706
   MCLEAN MR, 1987, ANAT REC, V219, P434, DOI 10.1002/ar.1092190415
   MITCHIE A, 1983, COMPUTER GRAPHICS IM, V22, P296
   MOSS VA, 1990, J MICROSC-OXFORD, V158, P187, DOI 10.1111/j.1365-2818.1990.tb02992.x
   ONGARO I, 1991, ANAT REC, V229, P285, DOI 10.1002/ar.1092290217
   POELMANN RE, 1987, ACTA ANAT, V130, P132
   PROTHERO JS, 1986, COMPUT BIOMED RES, V19, P361, DOI 10.1016/0010-4809(86)90048-0
   RINGWALD M, 1994, SCIENCE, V265, P2033, DOI 10.1126/science.8091224
   Rittenhouse DR, 1996, ACTA ANAT, V155, P282
   RYDMARK M, 1992, J MICROSC-OXFORD, V165, P29, DOI 10.1111/j.1365-2818.1992.tb04303.x
   SCHOOK P, 1978, ACTA MORPHOL NEER SC, V16, P157
   SJOSTRAND FS, 1958, J ULTRA MOL STRUCT R, V2, P122, DOI 10.1016/S0022-5320(58)90050-9
   Stevens J. K., 1994, 3 DIMENSIONAL CONFOC
   STOCKLEY EW, 1993, J NEUROSCI METH, V47, P39, DOI 10.1016/0165-0270(93)90020-R
   SUNDSTEN JW, 1983, ANAT REC, V207, P665, DOI 10.1002/ar.1092070415
   TAKAGI A, 1989, ANN OTO RHINOL LARYN, V98, P515, DOI 10.1177/000348948909800705
   THEILER K, 1972, HOUSE MOUSE
   VERBEEK F, 1995, THESIS TU DELFT
   VERWEY A, 1992, THESIS TU DELFT
   VUILLEMIN M, 1992, EUR J MORPHOL, V30, P181
   WONG V, 1983, AM J ANAT, V167, P143, DOI 10.1002/aja.1001670202
   WRIGHT SJ, 1991, J ELECTRON MICR TECH, V18, P2, DOI 10.1002/jemt.1060180103
   YASUMURA S, 1993, LARYNGOSCOPE, V103, P1043
   ZHANG YJ, 1991, CYTOMETRY, V12, P308, DOI 10.1002/cyto.990120404
   ZINREICH SJ, 1992, AM J NEURORADIOL, V13, P893
NR 51
TC 72
Z9 77
U1 0
U2 3
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0003-276X
J9 ANAT REC
JI Anat. Rec.
PD AUG
PY 1997
VL 248
IS 4
BP 583
EP 602
PG 20
WC Anatomy & Morphology
SC Anatomy & Morphology
GA XP478
UT WOS:A1997XP47800010
PM 9268147
DA 2018-10-19
ER

PT J
AU Lindblad, M
   Lestelius, M
   Johansson, A
   Tengvall, P
   Thomsen, P
AF Lindblad, M
   Lestelius, M
   Johansson, A
   Tengvall, P
   Thomsen, P
TI Cell and soft tissue interactions with methyl- and hydroxyl-terminated
   alkane thiols on gold surfaces
SO BIOMATERIALS
LA English
DT Article
DE cell-material interactions; methyl; hydroxyl; protein adsorption
ID HUMAN-ENDOTHELIAL-CELLS; PROTEIN ADSORPTION; POLYMER SURFACES;
   PLASMA-PROTEIN; STRUCTURAL CHARACTERIZATION; BIOMEDICAL POLYMERS;
   HUMAN-MONOCYTES; ABDOMINAL-WALL; METAL-SURFACES; L-CYSTEINE
AB In order to evaluate the biological response induced by true methyl and hydroxyl surfaces, alkane thiols were immobilized onto gold. Initial protein adsorption from human plasma was measured in vitro by ellipsometry-antibody techniques and in vivo surface-cell interactions were evaluated in rat subcutaneous tissues for time periods ranging between 1 and 28 days. Rat mononuclear cells were studied after culturing (24 h) on the surfaces. Plasma protein experiments revealed deposition of fibrinogen onto the pure gold and the methylated surface. The hydroxylated surface tended to release the surface-associated proteins tested for by antibodies. None of the in vivolin vitro models used showed differences between the hydroxyl and methyl surfaces for spontaneous or augmented cell hydrogen peroxide and interleukin-1 alpha secretions. However, the different surface chemistries markedly affected the distribution of the cells that were recruited to the interfaces (cells in the fluid space and surface-associated DNA content on the retrieved implants) at late and early time periods. The results indicate that different implant surface properties, such as chemical functionality and hydrophobicity, influence specific events in the inflammatory cell response, and ultimately the wound healing around implantable materials. (C) 1997 published by Elsevier Science Limited. All rights reserved.
C1 LINKOPING UNIV,DEPT PHYS & MEASUREMENT TECHNOL,S-58183 LINKOPING,SWEDEN.
RP Lindblad, M (reprint author), GOTHENBURG UNIV,INST ANAT & CELL BIOL,MED AREGATAN 3,S-41390 GOTHENBURG,SWEDEN.
OI Thomsen, Peter/0000-0003-3910-6665
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDERSON JM, 1981, FUNDAMENTAL ASPECTS, V11, P205
   ANKER M, 1995, UNPUB CELL INTERACTI
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   BERTILSSON L, 1993, LANGMUIR, V9, P141, DOI 10.1021/la00025a032
   BJURSTEN LM, 1990, BIOMATERIALS, V11, P596, DOI 10.1016/0142-9612(90)90085-5
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BRADLEY JV, 1968, DISTRIBUTION FREE ST, P68
   BRAIDE M, 1986, J IMMUNOL METHODS, V93, P183, DOI 10.1016/0022-1759(86)90187-0
   CAMARERO VCPC, 1990, J CELL PHYSIOL, V145, P481, DOI 10.1002/jcp.1041450313
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   DEKKER A, 1991, J MATER SCI-MATER M, V2, P227, DOI 10.1007/BF00703376
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   ENGQUIST I, 1995, J PHYS CHEM-US, V99, P12257, DOI 10.1021/j100032a031
   ERIKSSON AS, 1994, J MATER SCI-MATER M, V5, P269, DOI 10.1007/BF00122396
   Gretzer C, 1996, BIOMATERIALS, V17, P851, DOI 10.1016/0142-9612(96)83279-0
   GUILBAULT GG, 1968, ANAL CHEM, V40, P190, DOI 10.1021/ac60257a002
   JANSEN JA, 1992, BIOMATERIALS, V13, P959, DOI 10.1016/0142-9612(92)90121-4
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LESTELIUS M, 1994, J BIOMED MATER RES, V28, P871, DOI 10.1002/jbm.820280806
   MARTENSSON J, 1995, LANGMUIR, V11, P963
   McCrackin F. L., 1969, 479 NBS
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   NAKAGAWARA A, 1981, J CLIN INVEST, V68, P1243, DOI 10.1172/JCI110370
   NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   ROSENGREN A, 1994, BIOMATERIALS, V15, P17, DOI 10.1016/0142-9612(94)90190-2
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SHERMAN LA, 1977, J EXP MED, V145, P76, DOI 10.1084/jem.145.1.76
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TENGVALL P, 1992, LANGMUIR, V8, P1236, DOI 10.1021/la00041a001
   THOMSEN P, 1996, UNPUB H2O2 PRODUCTIO
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P701, DOI 10.1002/jbm.820210603
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   WILLIAMS DF, 1985, J BIOMED MATER RES, V19, P313, DOI 10.1002/jbm.820190312
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P206, DOI 10.1016/0142-9612(88)90085-3
NR 47
TC 65
Z9 67
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1997
VL 18
IS 15
BP 1059
EP 1068
DI 10.1016/S0142-9612(97)00029-X
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XJ968
UT WOS:A1997XJ96800006
PM 9239468
DA 2018-10-19
ER

PT J
AU Wever, DJ
   Veldhuizen, AG
   Sanders, MM
   Schakenraad, JM
   vanHorn, JR
AF Wever, DJ
   Veldhuizen, AG
   Sanders, MM
   Schakenraad, JM
   vanHorn, JR
TI Cytotoxic, allergic and genotoxic activity of a nickel-titanium alloy
SO BIOMATERIALS
LA English
DT Article
DE NiTi; memory metal; biocompatibility; biological safety
ID NITINOL
AB The nearly equiatomic nickel-titanium (NiTi) alloy is known for its shape memory properties. These properties can be put to excellent use in various biomedical applications, such as wires for orthodontic tooth alignment and osteosynthesis staples. The aim of this study was to evaluate the short-term biological safety of the NiTi alloy. We carried out an end-point dilution minimal essential medium (MEM) extract cytotoxicity test, a guinea-pig sensitization test and two genotoxicity tests: the Salmonella reverse mutation test and the chromosomal aberration test. The NiTi alloy showed no cytotoxic, allergic or genotoxic activity, similar to the clinical reference control material AISI 316 LVM stainless steel. This promising biological behaviour was most likely due to a minimal release of ions and in that way a reflection of the good corrosion resistance of the NiTi alloy. Given these very good results, together with the good tissue compatibility as shown in several implantation studies in the literature, the NiTi alloy can be regarded as a biologically safe implant material with many promising clinical applications. (C) 1997 Elsevier Science Limited. All rights reserved.
C1 BIOSCAN,LAB MED DEVICE EVALUAT,BILTHOVEN,NETHERLANDS.
   ACROMED BV,ROTTERDAM,NETHERLANDS.
RP Wever, DJ (reprint author), UNIV GRONINGEN HOSP,DEPT ORTHOPAED,POB 30001,NL-9700 RB GRONINGEN,NETHERLANDS.
CR ANDREASEN G, 1980, AM J ORTHOD DENTOFAC, V78, P528, DOI 10.1016/0002-9416(80)90303-6
   ASSAD M, 1994, P 40 ANN M ORTH RES, P591
   BENSMANN G, 1982, TECH MITT KRUPP FORS, V40, P123
   Buehler WJ, 1968, OCEAN ENGNG, V1, P105
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CASTLEMAN LS, 1981, BIOCOMPATIBILITY CLI, P129
   CRAGG AH, 1993, RADIOLOGY, V189, P775, DOI 10.1148/radiology.189.3.8234703
   CUTWRIGHT DE, 1973, ORAL SURG, V35, P578
   EVANS EJ, 1994, BIOMATERIALS, V15, P713, DOI 10.1016/0142-9612(94)90170-8
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   GORBET M, 1996, P 5 WORLD BIOM C TOR, P599
   *ISO, 1992, 10993EN30993 ISO 3
   KAMBIC H, 1988, INT J ARTIF ORGANS, V11, P487
   LATAL D, 1994, UROL RES, V22, P295, DOI 10.1007/BF00297198
   McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   PRINCE MR, 1988, INVEST RADIOL, V23, P249
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   SANDERS JO, 1993, SPINE, V18, P1640, DOI 10.1097/00007632-199309000-00012
   SANDERS MM, 1992, P INT S 3D SCOL DEF, P343
   SIMON M, 1989, RADIOLOGY, V172, P99, DOI 10.1148/radiology.172.1.2662259
   VICENTINI B, 1986, P INT S SHAP MEM ALL, P447
   WILLIAMS DF, 1982, BIOCOMPATIBILITY ORT, P197
   1993, ANN BOOK ASTM STANDA, P22
NR 24
TC 217
Z9 226
U1 1
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1997
VL 18
IS 16
BP 1115
EP 1120
DI 10.1016/S0142-9612(97)00041-0
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XK250
UT WOS:A1997XK25000006
PM 9247349
DA 2018-10-19
ER

PT J
AU Draget, KI
   SkjakBraek, G
   Smidsrod, O
AF Draget, KI
   SkjakBraek, G
   Smidsrod, O
TI Alginate based new materials
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article; Proceedings Paper
CT Plant Polysaccharide Symposium
CY JUL 17-19, 1996
CL NANTES, FRANCE
DE alginates; gels; polysaccharides
ID AZOTOBACTER-VINELANDII; CHEMICAL-COMPOSITION; URONATE RESIDUES; GELS;
   ACID; SEQUENCE; ISLETS
AB Present and future applications of alginates are mainly linked to the most striking feature of the alginate molecule; i.e. a sol/gel transition in the presence of multivalent cations, e.g. Ca2+, almost independent on temperature. These very mild conditions, combined with the fact that alginates are highly characterised and understood both in the liquid and in the gel phase, makes this biopolymer unique compared to other gelling polysaccharides. Only pectins resemble alginate in the sol/gel transition behaviour, but this system can hardly be said to be as well characterised and understood as the alginates. The properties of alginate solutions and gels suggest biomedical and pharmaceutical uses. In this paper, the question of the specifications required by a polymer for applications in some biomedical areas will be discussed. (C) 1997 Elsevier Science B.V.
RP Draget, KI (reprint author), NORWEGIAN UNIV SCI & TECHNOL, DEPT BIOTECHNOL, NORWEGIAN BIOPOLYMER LAB, NBOIPOL, N-7034 TRONDHEIM, NORWAY.
CR DELLAVALLE F, Patent No. 874014640
   Draget KI, 1996, CARBOHYD POLYM, V29, P209, DOI 10.1016/0144-8617(96)00029-X
   DRAGET KI, 1994, CARBOHYD POLYM, V25, P31, DOI 10.1016/0144-8617(94)90159-7
   DRAGET KI, 1989, APPL MICROBIOL BIOT, V31, P79
   DRAGET KI, 1988, J PLANT PHYSIOL, V132, P552, DOI 10.1016/S0176-1617(88)80252-9
   ERTESVAG H, 1995, MOL MICROBIOL, V16, P719, DOI 10.1111/j.1365-2958.1995.tb02433.x
   ERTESVAG H, 1994, J BACTERIOL, V176, P2846
   Espevik T., 1996, CARBOHYDR EUR, V14, P19
   GRASDALEN H, 1979, CARBOHYD RES, V68, P23, DOI 10.1016/S0008-6215(00)84051-3
   GRASDALEN H, 1983, CARBOHYD RES, V118, P255, DOI 10.1016/0008-6215(83)88053-7
   GRASDALEN H, 1977, CARBOHYD RES, V56, pC11, DOI 10.1016/S0008-6215(00)83369-8
   HAUG A, 1967, ACTA CHEM SCAND, V21, P2859, DOI 10.3891/acta.chem.scand.21-2859
   HAUG A, 1963, ACTA CHEM SCAND, V17, P1466, DOI 10.3891/acta.chem.scand.17-1466
   HAUG A, 1963, ACTA CHEM SCAND, V17, P1653, DOI 10.3891/acta.chem.scand.17-1653
   KOHN R, 1972, ACTA CHEM SCAND, V26, P2455, DOI 10.3891/acta.chem.scand.26-2455
   LARSEN B, 1970, ACTA CHEM SCAND, V24, P726, DOI 10.3891/acta.chem.scand.24-0726
   LEO WJ, 1990, BIOTECHNOL PROGR, V6, P51, DOI 10.1021/bp00001a008
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   MARTINSEN A, 1992, BIOTECHNOL BIOENG, V39, P186, DOI 10.1002/bit.260390210
   MIKKELSEN A, 1995, BIOPOLYMERS, V36, P1741
   Moe S., 1992, US Patent, Patent No. [5,144,016, 5144016]
   MOE ST, 1993, MACROMOLECULES, V26, P3589, DOI 10.1021/ma00066a017
   PENMAN A, 1972, CARBOHYD RES, V25, P273, DOI 10.1016/S0008-6215(00)81637-7
   SIME WJ, 1990, FOOD GELS, P53
   SKJAKBRAEK G, 1986, INT J BIOL MACROMOL, V8, P330, DOI 10.1016/0141-8130(86)90051-6
   SKJAKBRAEK G, 1989, CARBOHYD POLYM, V10, P31, DOI 10.1016/0144-8617(89)90030-1
   SMIDSROD O, 1972, ACTA CHEM SCAND, V26, P79, DOI 10.3891/acta.chem.scand.26-0079
   SMIDSROD O, 1963, ACTA CHEM SCAND, V17, P1473, DOI 10.3891/acta.chem.scand.17-1473
   SMIDSROD O, 1963, ACTA CHEM SCAND, V17, P2628, DOI 10.3891/acta.chem.scand.17-2628
   SMIDSROD O, 1969, MACROMOLECULES, V2, P42, DOI 10.1021/ma60007a008
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   SMIDSROD O, 1974, FARADAY DISCUSS, V57, P263
   SMIDSROD O, FOOD COLLOIDS PROTEI, P279
   SMIDSROD O, 1967, CARBOHYD RES, V5, P482
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   SOONSHIONG P, 1991, TRANSPLANT P, V23, P758
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   SOONSHOING P, Patent No. 92709364
   STOKKE BT, 1993, CARBOHYD POLYM, V21, P39, DOI 10.1016/0144-8617(93)90115-K
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Thu B, 1996, BIOMATERIALS, V17, P1069, DOI 10.1016/0142-9612(96)85907-2
   Thu B, 1996, PROGR BIOTECHNOL, V11, P19
NR 42
TC 297
Z9 305
U1 1
U2 89
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD AUG
PY 1997
VL 21
IS 1-2
BP 47
EP 55
DI 10.1016/S0141-8130(97)00040-8
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA XQ942
UT WOS:A1997XQ94200008
PM 9283015
DA 2018-10-19
ER

PT J
AU Ozin, GA
   Varaksa, N
   Coombs, N
   Davies, JE
   Perovic, DD
   Ziliox, M
AF Ozin, GA
   Varaksa, N
   Coombs, N
   Davies, JE
   Perovic, DD
   Ziliox, M
TI Bone mimetics: A composite of hydroxyapatite and calcium
   dodecylphosphate lamellar phase
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID TRANSFORM INFRARED-SPECTROSCOPY; PHOSPHATE ESTER; EARLY DEPOSITS;
   SOLID-PHASE; PO4 DOMAIN; ENVIRONMENT; EVOLUTION; ENAMEL; AGE; NMR
AB The synthesis of composites based upon mineral and organic constituents is of importance for the development of materials for biomedical applications, such as bone replacement, augmentation and repair. Herein we describe a biologically inspired inorganic materials chemistry approach to bone mimetics. The synthetic strategy is based upon the surfactant-templated cooperative assembly of a composite that is composed of a calcium dodecylphosphate lamellar phase (CaDDP) and a calcium hydroxyphosphate (CaP) mineral phase. The measured properties of the chemically formed composite suggest that it is distinct from simple physical mixtures of the CaDDP and CaP components. A key difference is the generation of biologically important hydrogenphosphate located at the interface between the CaDDP and CaP phases only in the chemically formed composite. The synthesis of the composite is considered to involve the synergistic interaction of CaDDP and CaP, possibly aided by interfacial complementarity of charge and geometry. CaDDP is chemically stable and non-toxic, rendering the composite potentially useful for biomedical applications.
C1 IMAGETEK ANALYT IMAGING,TORONTO,ON M6J 2K4,CANADA.
   UNIV TORONTO,CTR BIOMAT,TORONTO,ON M5S 1A1,CANADA.
   UNIV TORONTO,DEPT MET & MAT SCI,TORONTO,ON M5S 3E4,CANADA.
   BRUKER INSTRUMENTS INC,BILLERICA,MA 01821.
RP Ozin, GA (reprint author), UNIV TORONTO,LASH MILLER CHEM LABS,MAT CHEM RES GRP,80 ST GEORGE ST,TORONTO,ON M5S 3H6,CANADA.
CR AUE WP, 1984, BIOCHEMISTRY-US, V23, P6110, DOI 10.1021/bi00320a032
   BUNTON CA, 1958, J CHEM SOC, V3, P3574
   BUTCHER WW, 1955, J AM CHEM SOC, V77, P2420, DOI 10.1021/ja01614a018
   DALLEMAGNE MJ, 1973, BIOL MINERALIZATION
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Emsley J., 1976, CHEM PHOSPHORUS
   FOWLER BO, 1993, CHEM MATER, V5, P1417, DOI 10.1021/cm00034a009
   GORENSTEIN DG, 1975, J AM CHEM SOC, V97, P898, DOI 10.1021/ja00837a039
   HULL D, 1981, INTRO COMPOSITE MATE
   MIQUEL J L, 1990, Clinical Materials, V5, P115, DOI 10.1016/0267-6605(90)90011-J
   *MRS, 1996, MRS BULL, V21, P18
   *NAT MAT ADV BOARD, 1994, HIER STRUCT BIOL AS
   OKAZAKI M, 1989, BIOMATERIALS, V10, P126, DOI 10.1016/0142-9612(89)90045-8
   OKAZAKI M, 1991, BIOMATERIALS, V12, P46, DOI 10.1016/0142-9612(91)90131-S
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   ROTHWELL WP, 1980, J AM CHEM SOC, V102, P2637, DOI 10.1021/ja00528a020
   SUBIRADE M, 1961, ANN CHIM FR, V16, P41
   Vincent JFV., 1990, STRUCTURAL BIOMATERI
   YESINOWSKI JP, 1987, J AM CHEM SOC, V109, P6274, DOI 10.1021/ja00255a009
NR 20
TC 50
Z9 52
U1 0
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CAMBS,
   ENGLAND CB4 4WF
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD AUG
PY 1997
VL 7
IS 8
BP 1601
EP 1607
DI 10.1039/a702416i
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA XQ209
UT WOS:A1997XQ20900050
DA 2018-10-19
ER

PT J
AU HernandezBorges, AA
   Pareras, LG
   Jimenez, A
AF HernandezBorges, AA
   Pareras, LG
   Jimenez, A
TI Comparative analysis of pediatric mailing lists on the Internet
SO PEDIATRICS
LA English
DT Article
DE Internet; mailing lists; pediatric information sources
AB Objective. To analyze quantitative aspects and the relative quality of various pediatric discussion groups on the Internet and to contrast them with qualitative aspects of a selected number of pediatric journals.
   Material and Methods. An extensive number of mailing lists an the Internet of interest to pediatricians was compiled. Twelve of them concerned with pediatric specialties were selected. Six representative journals of pediatric specialties were also analyzed and compared with the corresponding mailing lists. From the list of subscribers we studied the potential quality of each mailing list. The postings sent by each member to the on-line discussions were also analyzed. As an estimate of the standing as author of each list member as well as of each first author of the selected journals, we calculated several indexes of quality using the 1995 Medline database and the impact factors of the biomedical journals reported by the 1994 Science Citation Index. Results. The most popular lists were NICU-NET and PICU, both having more than 1100 subscribers. PEDPATH and PEDIHEART had the highest percentage of subscribers who were published authors, and their papers also yielded the highest impact factors. The most active lists were NICU-NET and PICU. The most participative ones were CHILD-NEURO and FED-LUNG. CHILD-NEURO had the highest percentage of authors among the participants. PEDPATH and CHILD-NEURO had the authors with the highest impact factors among the people who participated in the discussions. These latter two lists also showed the highest impact factor per posting. Those which had the highest yield (highest activity with highest quality per posting) were CHILD-NEURO and PEDIHEART. The average impact factor per first author of the analyzed journals was always higher than the average impact factor per participant of the lists.
   Conclusions. The electronic-mad discussion groups on the Internet are new nonacademic forums in which knowledge and experience in pediatrics can be shared. They cannot replace but they complement other more academic sources such as medical journals.
C1 UNIV HOSP CANARY ISL, DEPT PEDIAT, TENERIFE, CANARY ISLANDS, SPAIN.
   UNIV HOSP CANARY ISL, DEPT NEUROSURG, TENERIFE, CANARY ISLANDS, SPAIN.
   UNIV HOSP CANARY ISL, RES UNIT, TENERIFE, CANARY ISLANDS, SPAIN.
CR Baldwin F D, 1995, Pa Med, V98, P22
   Cochran W. G., 1977, SAMPLING TECHNIQUES
   Elliott SJ, 1996, PEDIATRICS, V97, P399
   Gilas T, 1995, J Am Coll Surg, V181, P277
   GILAS T, 1995, DIS COLON RECTUM, V38, P780, DOI 10.1007/BF02048043
   LAPORTE RE, 1995, BRIT MED J, V310, P1387, DOI 10.1136/bmj.310.6991.1387
   MONTGOMERY CH, 1995, B MED LIBR ASSOC, V83, P234
   Pallen M, 1995, BRIT MED J, V311, P1626, DOI 10.1136/bmj.311.7020.1626
   PALLEN M, 1995, BRIT MED J, V311, P1487, DOI 10.1136/bmj.311.7018.1487
   PARERAS LG, 1996, INTERNET MED, P1
   PARKIN D, 1993, PUBLIC HLTH PHYSICIA, V4, P10
   TarczyHornoch P, 1996, PEDIATRICS, V97, P398
NR 12
TC 11
Z9 11
U1 0
U2 0
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD, ELK GROVE VILLAGE, IL 60007-1098
SN 0031-4005
J9 PEDIATRICS
JI Pediatrics
PD AUG
PY 1997
VL 100
IS 2
BP art. no.
EP e8
DI 10.1542/peds.100.2.e8
PG 7
WC Pediatrics
SC Pediatrics
GA XP050
UT WOS:A1997XP05000023
PM 9233979
OA Bronze
DA 2018-10-19
ER

PT J
AU Chen, XH
   McCarthy, SP
   Gross, RA
AF Chen, XH
   McCarthy, SP
   Gross, RA
TI Synthesis and characterization of [L]-lactide - Ethylene oxide
   multiblock copolymers
SO MACROMOLECULES
LA English
DT Article
ID RING-OPENING POLYMERIZATION; CONTROLLED MOLECULAR-WEIGHT; ALUMINUM
   PORPHYRIN; BLOCK-COPOLYMERS; POLY(ETHYLENE GLYCOL); LIVING
   POLYMERIZATION; EPSILON-CAPROLACTONE; PROPYLENE-OXIDE; L-LACTIDE;
   DEGRADATION
AB [L]-Lactide ([L]-LA)/ethylene oxide (EO) ring-opening copolymerizations were successfully carried out by using various catalysts including isobutylaluminoxane (IBAO), in situ AlR3 . 0.5H(2)O systems (R = ethyl, isobutyl) and Sn-Al bimetallic catalysts. Analysis of products by H-1 NMR showed that methanol insoluble copolymer fractions had multiblock structures. The multiblock segment length and molecular weight of the copolymers were regulated by a variation in the reaction temperature, reaction time, reaction medium, and the catalyst structure. An increase in the reaction temperature was used to obtain shorter segment block lengths. Bulk reactions at elevated temperatures gave shorter block lengths than those of corresponding polymerizations conducted in solution (xylene). Differential scanning calorimetry (DSC) results showed two melting transitions corresponding to poly(ethylene oxide) (PEG) and [L]-polylactide ([L]-PLA) crystalline phases. The melting temperature and enthalpy of fusion for the phase-separated [L]-PLA crystalline phase was ''tailored'' by modulating the copolymer composition and the [L]-PLA block length. Blends with PW were prepared by substituting poly(ethylene glycol) (PEG) with a high EO content [L]-PLA/EO multiblock copolymer. The idea explored was that the multiblock copolymers would be expected to leach into aqueous environments at a slower rate than PEGs. Substitution of the [L]-PLA/EO copolymer in place of PEG resulted in important increases in the film modulus and yield strength without loss in elongation at yield, break stress, and elongation at break. Thus, we demonstrated a versatile route to important new multiblock [L]-PLA/EO copolymers which have excellent potential to be useful for a wide range of biomedical applications including bioresorbable implant materials and tissue engineering. Furthermore, the synthetic methods developed herein provide routes which will be useful in ''fine-tuning'' product physicomechanical properties and degradation rates.
C1 UNIV MASSACHUSETTS,NSF,BIODEGRADABLE POLYMER RES CTR,LOWELL,MA 01854.
CR AIDA T, 1980, MAKROMOL CHEM-RAPID, V1, P677
   AIDA T, 1981, MACROMOLECULES, V14, P1162, DOI 10.1021/ma50006a004
   Alexander H, 1981, ORTHOP REV, V10, P41
   ANDREOPOULOS AG, 1994, J ELASTOM PLAST, V26, P308, DOI 10.1177/009524439402600401
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   BRANDRUP J, 1975, POLYM HDB, P250
   CAKMAK I, 1995, MACROMOL REP A, V32, P1113
   CERRAI P, 1994, J MATER SCI-MATER M, V5, P308, DOI 10.1007/BF00058953
   Chen X., UNPUB
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   DENG XM, 1995, J APPL POLYM SCI, V55, P1193, DOI 10.1002/app.1995.070550806
   ECHEVERR.E, 1970, SURG GYNECOL OBSTETR, V131, P1
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   ENDO M, 1987, MACROMOLECULES, V20, P2982, DOI 10.1021/ma00178a005
   FREDERICKS RJ, 1984, J POLYM SCI POL PHYS, V22, P57, DOI 10.1002/pol.1984.180220106
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GRIJPMA DW, 1994, MACROMOL CHEM PHYSIC, V195, P1633, DOI 10.1002/macp.1994.021950515
   GROSS RA, 1988, MACROMOLECULES, V21, P2657, DOI 10.1021/ma00187a002
   Inoue S, 1992, NEW METHOD POLYM SYN, P33
   KIM SH, 1992, MAKROMOL CHEM, V193, P1623
   KIMURA Y, 1989, POLYMER, V30, P1342, DOI 10.1016/0032-3861(89)90058-X
   Li S., UNPUB
   ODIAN G, 1991, PRINCIPLES POLYM, P554
   OKTEM Z, 1993, EUR POLYM J, V29, P637, DOI 10.1016/0014-3057(93)90121-U
   OUCHI T, 1987, J MACROMOL SCI CHEM, VA24, P1011, DOI 10.1080/00222338708078140
   SHEN ZQ, 1994, J POLYM SCI POL CHEM, V32, P597, DOI 10.1002/pola.1994.080320401
   SHETH M, IN PRESS J APPL POLY
   SHIMASAKI K, 1987, MACROMOLECULES, V20, P3076, DOI 10.1021/ma00178a023
   STEVELS WM, 1995, MACROMOL CHEM PHYSIC, V196, P3687, DOI 10.1002/macp.1995.021961121
   TIJSMA EJ, 1994, J MACROMOL SCI R M C, VC34, P515, DOI 10.1080/15321799408014166
   TROFIMOFF L, 1987, CHEM LETT, P991, DOI 10.1246/cl.1987.991
   WANG Y, 1995, J FUNCT MAT, V26, P567
   YASHUDA T, 1983, MACROMOLECULES, V16, P1792
   ZHANG Y, 1990, MACROMOLECULES, V23, P3206, DOI 10.1021/ma00215a002
   ZHANG YF, 1989, INORG CHIM ACTA, V155, P263
NR 35
TC 90
Z9 94
U1 4
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUL 28
PY 1997
VL 30
IS 15
BP 4295
EP 4301
DI 10.1021/ma970385e
PG 7
WC Polymer Science
SC Polymer Science
GA XP202
UT WOS:A1997XP20200008
DA 2018-10-19
ER

PT J
AU Thompson, JY
   Bayne, SC
   Swift, EJ
   Stamatiades, F
AF Thompson, JY
   Bayne, SC
   Swift, EJ
   Stamatiades, F
TI Dental materials citations: Part A, January to June 1997
SO DENTAL MATERIALS
LA English
DT Bibliography
AB Objective. A search was conducted in biomedical journals published from January 1997 to June 1997 to identify all dental materials publications and sort them into major categories.
   Methods. Tables of contents for 79 journals for the period of January to June, 1997 were inspected and divided into 17 categories. Citations were analyzed by both frequency in journals and in categories, as well as compared to frequencies for previous years.
   Results. A total of 445 citations were detected in 79 journals for the period January 1997 to June 1997. Certain journals (n = 19) demonstrated a higher citation frequency (greater than or equal to 10 citations for 6 months) and represented 77.8% of all citations. The greatest number of citations continued to involve bonding (n = 97), resin-based restorative materials (composites; glass ionomers) (n = 95), prosthodontic materials (n = 51), and pulp protection I luting materials (n = 48). Frequencies by category were very similar to those for the last four years.
   Significance. The compiled literature citations provide a supplement for researchers and academicians seeking information in existing electronic databases.
C1 Univ N Carolina, Sch Dent, Dept Operat Dent, Chapel Hill, NC 27599 USA.
RP Thompson, JY (reprint author), Univ N Carolina, Sch Dent, Dept Operat Dent, Chapel Hill, NC 27599 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD JUL
PY 1997
VL 13
IS 4
BP 270
EP 285
DI 10.1016/S0109-5641(97)80039-5
PG 16
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 110DJ
UT WOS:000075364600008
PM 11696907
DA 2018-10-19
ER

PT J
AU Arazi, ZS
   Harel, H
   Marom, G
   Yavin, B
AF Arazi, ZS
   Harel, H
   Marom, G
   Yavin, B
TI Polyethylene/polyethylene composite materials for ballistic protection
SO SAMPE JOURNAL
LA English
DT Article
ID POLYETHYLENE
AB The ability to manufacture polyethylene fiber reinforced polyethylene (PE/PE) composites (classified as ''single polymer composites'') without causing fiber relaxation and loss of mechanical properties is currently utilized in a number of engineering and biomedical applications. This paper describes the manufacture and characterization of PE/LDPE and PE/HDPE composites for ballistic protection. Preliminary ballistic impact testing and fracture analysis show that both, and in particular the PE/HDPE, system exhibit impressive ballistic resistance.
C1 ISRAEL MIL IND,ROCKET SYST DIV,RAMAT HASHARON,ISRAEL.
RP Arazi, ZS (reprint author), HEBREW UNIV JERUSALEM,GRAD SCH APPL SCI,CASALI INST APPL CHEM,IL-91905 JERUSALEM,ISRAEL.
CR ARAZI ZS, 1996, THESIS HEBREW U JERU
   CHARNIS CC, 1972, ASTM STP, V497
   FRISSEN R, 1995, P ICCM 10, V5, P759
   JANG BZ, 1990, POLYM COMPOSITE, V11, P144, DOI 10.1002/pc.750110303
   LEE BL, 1994, J COMPOS MATER, V28, P1202, DOI 10.1177/002199839402801302
   PENNINGS AJ, 1979, J POLYM SCI POL PHYS, V17, P1011, DOI 10.1002/pol.1979.180170610
   STERN T, UNPUB
   STERN T, 1995, ADV COMPOS LETT, V5, P103
   STERN T, 1997, IN PRESS COMPOSITE A, V6
   TEISHEV A, 1993, J APPL POLYM SCI, V50, P503, DOI 10.1002/app.1993.070500314
   TEISHEV A, 1995, J APPL POLYM SCI, V56, P503
   VANMELE B, 1995, COMPOS INTERFACE, V3, P83
   YOUNG RJ, 1992, INTRO POLYM, P341
NR 13
TC 9
Z9 10
U1 0
U2 9
PU SAMPE PUBLISHERS
PI COVINA
PA 1161 PARKVIEW DRIVE, COVINA, CA 91722
SN 0091-1062
J9 SAMPE J
JI Sampe J.
PD JUL-AUG
PY 1997
VL 33
IS 4
BP 72
EP 75
PG 4
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA XK810
UT WOS:A1997XK81000012
DA 2018-10-19
ER

PT J
AU Bistue, G
   Elizalde, JG
   GarciaAlonso, S
   Castano, E
   Gracia, FJ
   GarciaAlonso, A
AF Bistue, G
   Elizalde, JG
   GarciaAlonso, S
   Castano, E
   Gracia, FJ
   GarciaAlonso, A
TI A design tool for pressure microsensors based on FEM simulations
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article; Proceedings Paper
CT EUROSENSORS X Meeting
CY SEP 08-11, 1996
CL LOUVAIN, BELGIUM
DE silicon; microsensors; pressure; simulation
ID SENSOR
AB The main features involved in the design of a pressure sensor are :he maximum non-destructive pressure and the sensitivity. In this work, these two characteristics are related to the following design variables: dimensions of the membrane and mechanical properties of the selected material. Von Misses stress and strain distributions have been calculated by the finite-element method (FEM). The knowledge of these distributions is a good design guideline for an accurate location of the piezoresistors. The results obtained have been applied to the design of silicon microsensors for biomedical and domestic applications. (C) 1997 Elsevier Science S.A.
C1 UNIV NAVARRA,ESCUELA SUPER INGN IND,E-20009 SAN SEBASTIAN,SPAIN.
RP Bistue, G (reprint author), CEIT,CTR ESTUD & INVEST TECN GUIPUZCOA,POB 1555,E-20009 SAN SEBASTIAN,SPAIN.
RI Elizalde, Jorge/A-5508-2013
OI Elizalde, Jorge/0000-0002-5785-0618
CR FOLKMER B, 1992, SENSOR ACTUAT A-PHYS, V32, P521, DOI 10.1016/0924-4247(92)80037-4
   Hoffmann K., 1989, INTRO MEASUREMENTS U, P145
   KOVACS A, 1994, SENSOR ACTUAT A-PHYS, V42, P672, DOI 10.1016/0924-4247(94)80073-1
   MARCO S, 1991, REAL SOC ESPANOLA P, V19, P912
   SEIDE P, 1992, THEORETICAL MANUAL C, P141
   SUZUKI K, 1987, IEEE T ELECTRON DEV, V34, P1360, DOI 10.1109/T-ED.1987.23092
   TANIGAWA H, 1985, IEEE T ELECTRON DEV, V32, P1191, DOI 10.1109/T-ED.1985.22099
   TIMOSHENKO S, 1959, THEORY PLATES SHELLS, P5
   ZIENKIEWICZ OC, 1982, METODO ELEMENTOS FIN, P6
NR 9
TC 20
Z9 20
U1 1
U2 3
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD JUL
PY 1997
VL 62
IS 1-3
BP 591
EP 594
DI 10.1016/S0924-4247(97)01598-7
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA YD906
UT WOS:A1997YD90600023
DA 2018-10-19
ER

PT J
AU DeWitte, JI
   Welie, JVM
AF DeWitte, JI
   Welie, JVM
TI The status of genetic material and genetic information in the
   Netherlands
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE ownership; body material; genetic material; genetic information
AB The moral status of genetic material and information and the ethics of controlling and manipulating them, is a topic of hot debate in many European countries, including The Netherlands. That heat is due partly to the complexity of the topic, and partly to researchers' fear that their investigations will be hampered by restrictions on the use of personal data or body material. But there is little doubt that manifold diverging interpretations about the status of the human body, body materials, and personal information in Dutch law, written and unwritten, contribute to the intensity of the debates. This article intends to structure the debate by creating more clarity at the conceptual level. By carefully examining relevant articles of the Constitution and Civil Codes, as well as policy documents and authoritative publications, notably in reference to prominent legal concepts such as property, ownership and privacy, an answer should be provided to the following crucial question: is the status of genetic material and information in any sense special in comparison with other body parts and other kinds of information about a person? This paper first discusses the status of human body materials and personal information in general, and then continues with a more specific discussion about the status of genetic material and information. It concludes that the Dutch legislature had carefully avoided (or not felt the need to employ) the concept of ownership in regulating biomedical research; rather, privacy is found to be the prime regulatory concept. (C) 1997 Elsevier Science Ltd.
C1 UNIV NIJMEGEN,DEPT ETH PHILOSOPHY & HIST MED,NL-6500 HB NIJMEGEN,NETHERLANDS.
RP DeWitte, JI (reprint author), UNIV NIJMEGEN,CTR ETH,POB 9103,NL-6500 HD NIJMEGEN,NETHERLANDS.
CR ABBING HDC, 1989, TIJDSCHRIFT GEZONDHE, V13, P362
   De Wert G, 1990, MAG IK UW GENENPASPO
   DOPPEGIETER RMS, 1991, MEDISCH CONTACT, V46, P1081
   *ERF GENTH, 1990, BRIEF STAATSS WELZ V
   FRANKENA HC, 1990, TIJDSCHRIFT GEZONDHE, V14, P185
   Gevers J K, 1989, Ned Tijdschr Geneeskd, V133, P173
   GEVERS JKM, 1988, METAMEDICA, V67, P56
   GEVERS JKM, 1987, JURIDISCHE ASPECTEN
   GEVERS JKM, 1990, BESCHIKKEN OVER CELL
   *GEZ, 1989, ERF MAATSCH WET
   KUITERT HM, 1989, MAG ALLES WAT KAN, P177
   LEENEN HJJ, 1978, TIJDSCHRIFT GEZONDHE, V2, P1
   LEENEN HJJ, 1988, HDB GEZONDHEIDSRECHT
   *NAT RAAD VOLKSG, 1991, ADV NORM OND LICH
   *RICHTL VER GEZ, 1991, MEDISCH CONTACT, V46, P1086
   TENKATE LP, 1976, METAMEDICA, V55, P49
   VANGALENHERMAN RE, 1992, NEDERLANDS JURISTENB, V67, P1263
   *VERW IMM DEF, 1989, BRIEF MIN JUST AANH
NR 18
TC 1
Z9 1
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD JUL
PY 1997
VL 45
IS 1
BP 45
EP 49
DI 10.1016/S0277-9536(96)00308-5
PG 5
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA XE824
UT WOS:A1997XE82400007
PM 9203270
OA Green Published
DA 2018-10-19
ER

PT J
AU McVea, KLSP
AF McVea, KLSP
TI Lay injection practices among migrant farmworkers in the age of AIDS:
   Evolution of a biomedical folk practice
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE injections; HIV-infection; migrant farmworkers; self medication
ID POLIOMYELITIS; KINSHASA; WORKERS; ZAIRE
AB The practice of injecting vitamins and antibiotics by lay people is common among Hispanic migrant farmworkers in the U.S.A. This practice has recent roots in the Latin American cultures from which these farmworkers originate, but it presents a public health concern in its new context because of the high prevalence of HIV infection among this disenfranchised population. Reasons for use of lay injections include cultural beliefs about the superiority of injections over oral forms of medications, perceived irrelevance of a professional diagnostician in prescribing empirical treatment, and a multitude of barriers to access to Western medicine. Although HIV educational materials directed at migrant farmworkers do not address the issue of sharing needles for these types of injections, some farmworkers indicated they had already modified their injection techniques in response to simple directives from physicians in their home country. In contrast to other folk treatment practices that have been resistant to change mediated solely through the provision of information, lay injection is such a new development that considerable experimentation and incorporation of new knowledge are still actively shaping its use. In this process; physicians are seen as legitimate sources of information about the use of Western pharmaceuticals; they should use this role to discourage unsafe injection practices. Efforts to extinguish the practice of lay injection entirely are less likely to meet with success so long as other means of accessing Western medicine are limited. (C) 1997 Elsevier Science Ltd.
RP McVea, KLSP (reprint author), UNIV NEBRASKA,MED CTR,DEPT FAMILY PRACTICE,600 S 42ND ST,OMAHA,NE 68198, USA.
CR Angeles-Chimal P, 1992, Salud Publica Mex, V34, P554
   BLOEM M, 1993, IMPACT INJECTIONS DA
   *CDC, 1988, MMWR-MORBID MORTAL W, V37, P517
   COSMINSKY S, 1980, SOC SCI MED-MED ANTH, V14, P267, DOI 10.1016/0160-7987(80)90052-6
   CUNNINGH.CE, 1970, SOC SCI MED, V4, P1, DOI 10.1016/0037-7856(70)90056-9
   Ferguson Anne, 1988, CONTEXT MED DEV COUN, P19
   Finkler K., 1985, SPIRITUALIST HEALERS
   FITZSIMMONS CI, 1974, THESIS U TEXAS AUSTI
   JONES JL, 1991, SOUTHERN MED J, V84, P1088, DOI 10.1097/00007611-199109000-00007
   LAFFERTY J, 1991, AM J PUBLIC HEALTH, V81, P221, DOI 10.2105/AJPH.81.2.221
   Lewis Oscar, 1961, CHILDREN SANCHEZ
   Lewis Oscar, 1959, 5 FAMILIES MEXICAN C
   LILLESAND D, 1977, ESTIMATE NUMBER MIGR
   LOGAN K, 1988, CONTEXT MED DEV COUN, P107
   LOUE S, 1994, AIDS EDUC PREV, V6, P74
   MANN JM, 1986, LANCET, V2, P654
   MANN JM, 1986, JAMA-J AM MED ASSOC, V256, P3099, DOI 10.1001/jama.256.22.3099
   MARIN G, 1989, PUBLIC HEALTH REP, V104, P411
   MESSER E, 1975, THESIS U MICHIGAN AN
   MURDOCK GP, 1985, OUTLINE WORLD CULTUR
   NASH J, 1967, AM ANTHROPOL, V69, P455, DOI 10.1525/aa.1967.69.5.02a00020
   QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379
   REELER AV, 1990, SOC SCI MED, V31, P1119, DOI 10.1016/0277-9536(90)90233-I
   RODRIGUEZ BU, 1994, ATENCION PRIMARIA, V13, P57
   RUBEL AJ, 1966, TRACKS MEXICAN AM TE
   SAUNDERS L, 1954, CULTURAL DIFFERENCE
   TAYLOR RB, 1960, THESIS U OREGON EUGE
   VAN DER GEEST S., 1988, CONTEXT MED DEV COUN
   VANDERGEEST S, 1982, MED ANTHR        FAL, P197
   WOLFF MJ, 1993, CLIN INFECT DIS, V17, pS346, DOI 10.1093/clinids/17.Supplement_2.S346
   WOODS CM, 1977, MED ANTHROPOL, V1, P25
   WYATT HV, 1992, SOC SCI MED, V35, P795, DOI 10.1016/0277-9536(92)90079-6
   WYATT HV, 1984, SOC SCI MED, V19, P911, DOI 10.1016/0277-9536(84)90320-4
NR 33
TC 26
Z9 27
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD JUL
PY 1997
VL 45
IS 1
BP 91
EP 98
DI 10.1016/S0277-9536(96)00318-8
PG 8
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA XE824
UT WOS:A1997XE82400011
PM 9203274
DA 2018-10-19
ER

PT J
AU Chate, DM
   Kamra, AK
AF Chate, DM
   Kamra, AK
TI Collection efficiencies of large water drops collecting aerosol
   particles of various densities
SO ATMOSPHERIC ENVIRONMENT
LA English
DT Article
DE scavenging; washout; aerosol removal; deposition
ID CLOUD DROPS; RAINDROPS; COLLIDE
AB A laboratory experiment to study the effect of the density of aerosol material on collection efficiency of water drops, is conducted with MgSO4 and MnCl2 particles. When compared with the earlier results for NaCl and other particles, our observations show that the collection efficiency of water drops increases with increase in impaction parameter, irrespective of whether the change in impaction parameter is caused by the change in the density of particles or the size of particles/water drop. Our results are correlated through the aerodynamical diameter parameter and with earlier experimental results of other investigators for particles of different densities. The agreement between our experimental results and the theory of Slinn (1983, Precipitation Scavenging in Atmospheric Sciences and Power Production, Chap. 11. Division of Biomedical Environmental Research, U.S. Department of Energy) increases with the increase in the density or size of the particles. Moreover, our experimental results confirm the prediction of Slinn's theory that inertial impaction mechanism is dominant for smaller particles if their density is higher. (C) 1997 Elsevier Science Ltd.
RP Chate, DM (reprint author), INDIAN INST TROP METEOROL,PUNE 411008,MAHARASHTRA,INDIA.
CR ADAM JR, 1970, PRECIPITATION SCAVEN
   BEARD KV, 1976, J ATMOS SCI, V33, P851, DOI 10.1175/1520-0469(1976)033<0851:TVASOC>2.0.CO;2
   BERGLUND RN, 1973, ENVIRON SCI TECHNOL, V7, P147, DOI 10.1021/es60074a001
   GROVER SN, 1975, J ATMOS SCI, V32, P2156, DOI 10.1175/1520-0469(1975)032<2156:ANDOTE>2.0.CO;2
   HORN HG, 1988, J AEROSOL SCI, V19, P855, DOI 10.1016/0021-8502(88)90051-1
   KERKER M, 1974, J ATMOS SCI, V31, P1368, DOI 10.1175/1520-0469(1974)031<1368:SOAPBA>2.0.CO;2
   LAI KY, 1978, J ATMOS SCI, V35, P674, DOI 10.1175/1520-0469(1978)035<0674:SOAPBA>2.0.CO;2
   LEONG KH, 1982, J ATMOS SCI, V39, P1130
   MCGANN BT, 1991, ATMOS ENVIRON A-GEN, V25, P791, DOI 10.1016/0960-1686(91)90077-K
   NETO PJG, 1994, ATMOS ENVIRON, V28, P2335
   Pranesha TS, 1996, J GEOPHYS RES-ATMOS, V101, P23373, DOI 10.1029/96JD01311
   SEINFELD JH, 1986, ATMOSPHERIC CHEM PHY, P620
   Slinn W., 1983, PRECIPITATION SCAVEN
   SOOD SK, 1969, IIRT1C61059 IL RES I
   STARR JR, 1966, Q J ROY METEOR SOC, V92, P490, DOI 10.1002/qj.49709239405
   Walton W. H., 1960, AERODYNAMIC CAPTURE, P129
   WHITBY KT, 1968, ATMOS ENVIRON, V2, P103, DOI 10.1016/0004-6981(68)90026-7
NR 17
TC 20
Z9 20
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 1352-2310
J9 ATMOS ENVIRON
JI Atmos. Environ.
PD JUN
PY 1997
VL 31
IS 11
BP 1631
EP 1635
DI 10.1016/S1352-2310(96)00338-X
PG 5
WC Environmental Sciences; Meteorology & Atmospheric Sciences
SC Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences
GA WR161
UT WOS:A1997WR16100004
DA 2018-10-19
ER

PT J
AU Nicolas, FL
   Gagnieu, CH
AF Nicolas, FL
   Gagnieu, CH
TI Denatured thiolated collagen .2. Cross-linking by oxidation
SO BIOMATERIALS
LA English
DT Article
DE collagen; gelatin; thiol; cross-linking; disulphide bridge
ID GLUTARALDEHYDE; SUSCEPTIBILITY; IRRADIATION; PROTEOLYSIS
AB We have recently described a new method for the thiolation of denatured collagen, which allows precise amounts of SH groups to be attached onto the protein backbone. The oxidation of denatured thiolated collagen produces disulphide cross-linking. The cross-linking of these products has been studied, optimized and compared to the cross-linking of native and denatured collagen with 0.5% aqueous glutaraldehyde. Films have been prepared and their tensile mechanical properties and biodegradation rates with trypsin and collagenase have been evaluated. Our results indicate that the cross-linking in oxidized thiolated collagen depends on the number of the disulphide bridges formed and on their intermolecular versus intramolecular repartition. Since the number of disulphide bridges can be controlled by the level of thiol in the denatured collagen and by the oxidation procedure, it is possible to control the mechanical properties and the biodegradation rates of these new materials. Under optimized conditions, oxidized denatured thiolated collagen films are more resistant and rigid than glutaraldehyde-cross-linked collagen films. Cross-linked thiolated collagen materials are also more resistant to collagenase degradation. However, because of the loss of the triple-helical structure, they are more susceptible to trypsin degradation relative to glutaraldehyde-cross-linked triple-helical collagen. Denatured collagen cross-linked by physiological bridges such as disulphide bridges, with controllable mechanical properties and biodegradation rates, is of considerable interesting biomedical applications. (C) 1997 Elsevier Science Limited.
C1 INST NATL SCI APPL,EQUIPE BIOMAT,CHIM BIOL LAB,F-69621 VILLEURBANNE,FRANCE.
CR ACHET D, 1995, POLYMER, V36, P787, DOI 10.1016/0032-3861(95)93109-Y
   BOEDTKER H, 1954, J PHYS CHEM-US, V58, P968, DOI 10.1021/j150521a010
   CAPOZZI G, 1974, CHEM THIOL GROUP 2, P785
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   DELUSTRO F, 1986, J BIOMED MATER RES, V20, P109, DOI 10.1002/jbm.820200110
   DIAMOND AM, 1991, MATRIX, V11, P321, DOI 10.1016/S0934-8832(11)80203-9
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   HUC A, 1985, J AM LEATHER CHEM AS, V80, P195
   JOCELYN PC, 1987, METHOD ENZYMOL, V143, P44
   KATO YP, 1990, BIOMATERIALS, V11, P169, DOI 10.1016/0142-9612(90)90150-O
   KAWAMOTO Y, 1990, BIOCHIM BIOPHYS ACTA, V1035, P361, DOI 10.1016/0304-4165(90)90101-2
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   LIU BC, 1989, J BIOMED MATER RES, V23, P833, DOI 10.1002/jbm.820230803
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   MIYATA T, 1971, BIOCHIM BIOPHYS ACTA, V229, P672, DOI 10.1016/0005-2795(71)90283-2
   Nicolas FL, 1997, BIOMATERIALS, V18, P807, DOI 10.1016/S0142-9612(97)00002-1
   PETERKOFSKY B, 1982, METHOD ENZYMOL, V82, P453
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   PIEZ KA, 1989, ENCY POLYM SCI ENG, V3, P699
   ROE SC, 1990, ARTIF ORGANS, V14, P443, DOI 10.1111/j.1525-1594.1990.tb03001.x
   Rose PJ, 1989, ENCY POLYM SCI ENG, V7, P488
   SIEGEL RC, 1985, Patent No. 4544638
   STEGEMANN H, 1958, H-S Z PHYSIOL CHEM, V311, P41, DOI 10.1515/bchm2.1958.311.1.41
   TARDY M, 1990, Patent No. 4931546
   WALLACE TJ, 1963, J ORG CHEM, V28, P1311, DOI 10.1021/jo01040a038
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
NR 28
TC 33
Z9 33
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1997
VL 18
IS 11
BP 815
EP 821
DI 10.1016/S0142-9612(97)00003-3
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XA275
UT WOS:A1997XA27500008
PM 9177861
DA 2018-10-19
ER

PT J
AU Baumgartner, JN
   Yang, CZ
   Cooper, SL
AF Baumgartner, JN
   Yang, CZ
   Cooper, SL
TI Physical property analysis and bacterial adhesion on a series of
   phosphonated polyurethanes
SO BIOMATERIALS
LA English
DT Article
DE glycerophosphorylcholine; polyurethane; physical properties; bacterial
   adhesion
ID SURFACES; CHAIN; FLOW
AB Grycerophosphorylcholine (GPC) was incorporated as the chain extender in a series of poly(tetramethylene oxide)-based polyurethane block copolymers. in order to determine the feasibility of use of these polyurethanes in biomedical devices, the effects of GPC incorporation on physical properties were studied. The effect of soft-segment molecular weight was also investigated. Biocompatibility of these materials was studied with regard to bacterial adhesion and protein deposition. Tensile testing showed that as GPC content increased, elongation at break decreased, while Young's modulus increased. Differential scanning calorimetry (DSC) results showed slightly decreased glass transition temperatures (T(g)s) with increasing GPC content, indicating increased phase separation. Dynamic mechanical analysis (DMA) confirmed the decrease in T-g and the increase in rubbery plateau modulus with increasing GPC content. Water absorption was also increased with GPC content. Decreased bacterial adhesion was found on the GPC-containing materials compared to other functionalized polyurethanes. These experiments were carried out in a radial flow chamber utilizing automated video microscopy. Bacterial attachment was found to be lower on the GPC-containing polyurethanes both in the absence of and after pre-adsorption with plasma proteins. (C) 1997 Elsevier Science Limited.
C1 UNIV DELAWARE,DEPT CHEM ENGN,NEWARK,DE 19716.
   NANJING UNIV,DEPT CHEM,NANJING 210093,JIANGSU,PEOPLES R CHINA.
CR ANDERSON JM, 1993, CARDIOVASCULAR PATHO, V2
   ARICOLA CR, 1993, BIOMATERIALS, V14, P1161
   CHAPMAN D, 1993, BIOCHEM SOC T, V21, P258, DOI 10.1042/bst0210258
   CHAPMAN D, 1995, CHEM BRIT, V28, P253
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   GODDARD RJ, 1994, J POLYM SCI POL PHYS, V32, P1557, DOI 10.1002/polb.1994.090320827
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   HERGENROTHER RW, 1992, J MATER SCI-MATER M, V3, P313, DOI 10.1007/BF00705361
   ISHIHARA K, 1995, J BIOMED MATER RES, V29, P181, DOI 10.1002/jbm.820290207
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   MAKI DG, 1992, INF CONT S INFL MED, P27
   MOLLER PS, 1963, AERONAUT QUART, V14, P163, DOI 10.1017/S0001925900002742
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   OKKEMA AZ, 1991, J BIOMED MATER RES, V25, P1371, DOI 10.1002/jbm.820251106
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   SILVER JH, 1993, J BIOMED MATER RES, V27, P1443, DOI 10.1002/jbm.820271111
NR 19
TC 52
Z9 54
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1997
VL 18
IS 12
BP 831
EP 837
DI 10.1016/S0142-9612(96)00197-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XB095
UT WOS:A1997XB09500001
PM 9184746
DA 2018-10-19
ER

PT J
AU Schierholz, JM
   Steinhauser, H
   Rump, AFE
   Berkels, R
   Pulverer, G
AF Schierholz, JM
   Steinhauser, H
   Rump, AFE
   Berkels, R
   Pulverer, G
TI Controlled release of antibiotics from biomedical polyurethanes:
   Morphological and structural features
SO BIOMATERIALS
LA English
DT Article
DE controlled release; antibiotics; polyurethanes; drug-polymer
   compatibility
ID CONTROLLED DRUG RELEASE; IN-VITRO; PREVENTION; COLONIZATION;
   IMPREGNATION; CATHETERS; INFECTION; DEVICES; GRAFT
AB Polymer-associated infections are of increasing importance. Antistaphylococcal antimicrobial substances (ciprofloxacin, gentamycin, fosfomycin, flucloxacillin) were incorporated into polyurethanes by the solvent casting technique. Drug release rates, bacterial colonization and morphological features were evaluated to predict and understand the antimicrobial activity of these delivery systems. Drug release characteristics were investigated by standard bioassay and high-performance liquid chromatography (HPLC), and the physico-chemical mechanisms of the delivery were discussed. Ciprofloxacin hydrochloride showed a fast initial release rate, whereas gentamicin-base was characterized by a more continuous release type of behaviour. Bacterial colonization to the antibiotic-loaded polyurethanes was inhibited effectively by preparations showing a slower but more sustained antimicrobial delivery. Polyurethane-antibiotic combinations were most homogeneous for gentamicin-base and flucloxacillin as shown by scanning electron microscopy (SEM). In polymers loaded with fosfomycin and ciprofloxacin a granular structure of the crystallized drug embedded in the polyurethane matrix could be demonstrated. Physico-chemical similarity of the polymeric material and the antibiotics is important for the homogeneity of polymer-antibiotic combinations. High homogeneity is required for a sustained and prolonged release over time and effective inhibition of bacterial colonization. (C) 1997 Elsevier Science Limited.
C1 UNIV COLOGNE,INST MED MICROBIOL & HYG,COLOGNE,GERMANY.
   UNIV COLOGNE,INST CHEM PHYS,COLOGNE,GERMANY.
   UNIV COLOGNE,INST PHARMACOL,COLOGNE,GERMANY.
CR BACH A, 1994, J ANTIMICROB CHEMOTH, V33, P969
   BAYSTON R, 1989, J NEUROL NEUROSUR PS, V52, P605, DOI 10.1136/jnnp.52.5.605
   BENVENISTY AI, 1988, J SURG RES, V44, P1, DOI 10.1016/0022-4804(88)90116-3
   BROWN MRW, 1985, J ANTIMICROB CHEMOTH, V15, P7, DOI 10.1093/jac/15.suppl_A.7
   CHIEN YW, 1974, J PHARM SCI, V63, P365, DOI 10.1002/jps.2600630311
   CHIEN YW, 1974, J PHARM SCI, V63, P515, DOI 10.1002/jps.2600630405
   CHIEN YW, 1985, J PHARM SCI, V68, P689
   CHIEN YW, 1976, J PHARM SCI, V65, P481
   DESAI J, 1965, J PHARM SCI, V54, P1469
   DESAI SJ, 1966, J PHARM SCI-US, V55, P1224, DOI 10.1002/jps.2600551112
   HAMPL J, 1995, ACTA NEUROCHIR, V133, P147, DOI 10.1007/BF01420065
   Maki DG, 1989, INFECT ASS INDWELLIN, P161
   Maki DG, 1992, HOSP INFECT, P849
   McDougal E G, 1986, J Vasc Surg, V4, P5
   PEPPAS NA, 1984, ANN NY ACAD SCI, V5, P26
   Raad I, 1996, J INFECT DIS, V173, P418, DOI 10.1093/infdis/173.2.418
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   SAMPATH LA, 1995, J HOSP INFECT, V30, P201, DOI 10.1016/S0195-6701(95)90315-1
   SCHIERHOLZ J, 1994, BIOMATERIALS, V15, P996, DOI 10.1016/0142-9612(94)90080-9
   SCHIERHOLZ J, 1991, NEW POLYM MAT, V3, P61
   SCHIERHOLZ J, 1996, HYG MED S1, V21
   SCHIERHOLZ J, 1995, HOSPITALIS, V65, P1
   Schierholz JM, 1996, ZBL BAKT-INT J MED M, V284, P390
   SOLOMON DD, 1987, CONTR REL, P343
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
NR 25
TC 95
Z9 100
U1 4
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1997
VL 18
IS 12
BP 839
EP 844
DI 10.1016/S0142-9612(96)00199-8
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XB095
UT WOS:A1997XB09500002
PM 9184747
DA 2018-10-19
ER

PT J
AU Zasadzinski, JA
AF Zasadzinski, JA
TI Novel approaches to lipid based drug delivery
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
ID LIPOSOMES; VESICLES; EQUILIBRIUM; PHASE
AB Lipid based drug delivery is hardly new; however, it is experiencing a renaissance due to new applications, such as gene therapy, new methods of enhancing vesicle circulation in the bloodstream by steric stabilization, and novel self-assembly approaches to more complex structures. Interfacing electronic materials with lipids and proteins is also showing promise with possible applications toward combinatorial chemistry, biosensors, and protein separations. What appears necessary in all of these endeavors is a better appreciation of lipid phase behavior and its modifications due to the proteins, polymers and ions, and how these interactions can be best controlled to provide an optimal microstructure, combined with a careful understanding of the biomedical application to determine just what that optimal microstructure might be.
C1 UNIV CALIF SANTA BARBARA,DEPT MAT,SANTA BARBARA,CA 93106.
RP Zasadzinski, JA (reprint author), UNIV CALIF SANTA BARBARA,DEPT CHEM ENGN,SANTA BARBARA,CA 93106, USA.
CR ALLEN TM, 1995, ADV DRUG DELIVER REV, V16, P267, DOI 10.1016/0169-409X(95)00029-7
   ALLEN TM, 1993, BIOCHIM BIOPHYS ACTA, V1150, P9, DOI 10.1016/0005-2736(93)90115-G
   BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6
   BAYER EA, 1979, BIOCHIM BIOPHYS ACTA, V550, P464, DOI 10.1016/0005-2736(79)90149-4
   Boman NL, 1996, CANCER CHEMOTH PHARM, V37, P351, DOI 10.1007/s002800050396
   CANTU L, 1994, J PHYS II, V4, P1585, DOI 10.1051/jp2:1994219
   Chen HM, 1996, PHARMACEUT RES, V13, P1378, DOI 10.1023/A:1016030202104
   CHIRUVOLU S, 1994, SCIENCE, V264, P1753, DOI 10.1126/science.8209255
   CHIRUVOLU S, 1994, SCIENCE, V266, P1222, DOI 10.1126/science.7973704
   CHONN A, 1995, J BIOL CHEM, V270, P25845, DOI 10.1074/jbc.270.43.25845
   Corti M, 1996, TENSIDE SURFACT DET, V33, P214
   Gelbart WM, 1996, J PHYS CHEM-US, V100, P13169, DOI 10.1021/jp9606570
   GRAYSON LS, 1995, CRIT CARE MED, V23, P84, DOI 10.1097/00003246-199501000-00016
   Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651
   GulikKrzywicki T, 1996, LANGMUIR, V12, P4668, DOI 10.1021/la960069d
   HERVE P, 1993, J PHYS II, V3, P1255, DOI 10.1051/jp2:1993196
   Holland JW, 1996, BIOCHEMISTRY-US, V35, P2610, DOI 10.1021/bi951999j
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   KALER EW, 1989, SCIENCE, V245, P1371, DOI 10.1126/science.2781283
   KELLER SL, 1997, IN PRESS PHYS REV LE
   Kim T, 1996, ANESTHESIOLOGY, V85, P331, DOI 10.1097/00000542-199608000-00015
   Kirpotin D, 1996, FEBS LETT, V388, P115, DOI 10.1016/0014-5793(96)00521-2
   Lasic DD, 1996, CURR OPIN SOLID ST M, V1, P392, DOI 10.1016/S1359-0286(96)80031-3
   LASIC DD, 1996, LIPOSOMES GENE DELIV
   LASIC DD, 1993, LIPOSOMES PHYSICS AP
   Longman SA, 1995, CANCER CHEMOTH PHARM, V36, P91
   PAPAHADJOPOULOS D, 1977, BIOCHIM BIOPHYS ACTA, V465, P579, DOI 10.1016/0005-2736(77)90275-9
   Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Service RF, 1997, SCIENCE, V275, P31, DOI 10.1126/science.275.5296.31
   Spector MS, 1996, LANGMUIR, V12, P4704, DOI 10.1021/la960218s
   STOLOWITZ M, 1997, Patent No. 5594151
   Stolowitz M.L., 1997, US Patent, Patent No. [5594111 A, 5594111, 5, 594, 111]
   SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343
   Uster PS, 1996, FEBS LETT, V386, P243, DOI 10.1016/0014-5793(96)00452-8
   Walker SA, 1997, NATURE, V387, P61, DOI 10.1038/387061a0
   WALKER SA, 1996, THESIS U CALIFORNIA
   Warriner HE, 1996, SCIENCE, V271, P969, DOI 10.1126/science.271.5251.969
   Wong JY, 1997, SCIENCE, V275, P820, DOI 10.1126/science.275.5301.820
   Zalipsky S, 1996, J CONTROL RELEASE, V39, P153, DOI 10.1016/0168-3659(95)00149-2
   ZALIPSKY S, 1994, FEBS LETT, V353, P71, DOI 10.1016/0014-5793(94)01013-7
NR 42
TC 18
Z9 18
U1 0
U2 6
PU CURRENT SCIENCE LTD
PI LONDON
PA 34-42 CLEVELAND STREET, LONDON, ENGLAND W1P 6LB
SN 1359-0286
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD JUN
PY 1997
VL 2
IS 3
BP 345
EP 349
DI 10.1016/S1359-0286(97)80126-X
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA XL161
UT WOS:A1997XL16100013
DA 2018-10-19
ER

PT J
AU Solaro, R
   Chiellini, EE
   Giannasi, D
   Morganti, F
   Chiellini, E
AF Solaro, R
   Chiellini, EE
   Giannasi, D
   Morganti, F
   Chiellini, E
TI Multifunctional polymeric materials for biomedical applications
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 36th International Symposium on Macromolecules (IUPAC MACRO SEOUL 96)
CY AUG 04-09, 1996
CL SEOUL, SOUTH KOREA
SP Int Union Pure & Appl Chem, Polym Soc Korea, Minist Sci & Technol Republic Korea, Korea Petrochem Ind Assoc, Korea Sci & Engn Fdn, Korea Res Fdn
ID BETA-CYCLODEXTRIN; INCLUSION-COMPOUNDS; PHARMACEUTICAL INTERACTIONS;
   AQUEOUS-SOLUTION; DOSAGE FORMS; WATER; COMPLEXATION; STATES; ETHERS;
   DRUGS
AB The work performed by our research group during the last few years in the area of bioerodible-biodegradable polymers as designed to the formulation of systems for the controlled delivery of drugs and as specific sorbents of uraemic toxins is broadly reviewed. In particular, attention has been focused on the strategies adopted in the preparation of functional polymers containing hydroxyl or carboxyl groups, suitable to establish specific bonding and non-bonding interactions with conventional and proteic drugs.
RP Solaro, R (reprint author), UNIV PISA,DIPARTIMENTO CHIM & CHIM IND,VIA RISORGIMENTO 35,I-56126 PISA,ITALY.
CR AHMAD MB, 1994, POLYM INT, V33, P273, DOI 10.1002/pi.1994.210330306
   BALESTRI LP, 1972, CLIN SCI, V42, P395
   BARSOTTI G, 1989, NUTR TREATMENT CHRON, P33
   CHIELLINI A, 1989, POLYM MED SURG
   CHIELLINI E, 1995, MACROMOL SYMP, V98, P803, DOI 10.1002/masy.19950980168
   CHIELLINI E, 1992, MAKROMOL CHEM-M SYMP, V54-5, P483, DOI 10.1002/masy.19920540136
   CHIELLINI E, 1992, J CONTROL RELEASE, V22, P273, DOI 10.1016/0168-3659(92)90102-W
   Chiellini E, 1996, ADV MATER, V8, P305, DOI 10.1002/adma.19960080406
   CHIELLINI E, 1992, J BIOACT COMPAT POL, V7, P161, DOI 10.1177/088391159200700204
   CHIELLINI E, 1994, J BIOACT COMPAT POL, V9, P152, DOI 10.1177/088391159400900203
   CHIELLINI E, 1993, CHEMTECH, P29
   CHIELLINI E, 1994, P 1994 WORKSH PROD S, P235
   CHIELLINI E, 1994, DEV SCI IMPROVEMENT, P133
   CHIELLINI E, 1995, ADV BIOMATERIALS BIO, P28
   CHIELLINI E, 1978, INF CHEM, V176, P221
   GARDNER DL, 1971, T AM SOC ART INT ORG, V17, P239
   GIORDANO C, 1975, KIDNEY INT, V7, pS380
   Giordano C, 1973, Proc Eur Dial Transplant Assoc, V10, P136
   GIORDANO C, 1979, CLIN NEPHROL, V11, P142
   HIGUCHI A, 1984, POLYM BULL, V11, P203
   HOFFMAN AS, 1995, ARTIF ORGANS, V19, P458, DOI 10.1111/j.1525-1594.1995.tb02359.x
   IKEDA K, 1974, J PHARM SCI, V63, P1186
   JOHN MS, 1973, J BIOMED MATER RES, V7, P509
   KIZUMI K, 1974, YAKUGAKU ZASSHI, V94, P1515
   KNOCHEL JP, 1976, KIDNEY, P1448
   KUROZUMI M, 1975, CHEM PHARM BULL, V23, P3062
   LACH JL, 1963, J PHARM SCI-US, V52, P137, DOI 10.1002/jps.2600520207
   LEE CJ, 1990, J BIOMED MATER RES, V24, P243, DOI 10.1002/jbm.820240210
   MIYAJI T, 1976, CHEM PHARM BULL, V24, P1155
   NAKAMURA K, 1983, POLYMER, V24, P871, DOI 10.1016/0032-3861(83)90206-9
   NAMBU N, 1978, CHEM PHARM BULL, V26, P2952
   OTAGIRI M, 1978, PHARM ACTA HELV, V53, P241
   Peppas N. A., 1987, HYDROGELS MED PHARM, V1-3
   PITHA J, 1981, LIFE SCI, V29, P30
   SAENGER W, 1980, ANGEW CHEM INT EDIT, V19, P344, DOI 10.1002/anie.198003441
   SOLARO R, 1994, ACS SYM SER, V575, P112
   SPARKS RE, 1969, T AM SOC ART INT ORG, V15, P353
   SPARKS RE, 1972, T AM SOC ART INT ORG, V18, P458
   SZEJTLI J, 1981, PHARMAZIE, V36, P283
   Szejtli J., 1988, CYCLODEXTRIN TECHNOL
   UEKAMA K, 1978, CHEM PHARM BULL, V26, P1162
   WOJCIK JF, 1975, J PHYS CHEM-US, V79, P225
   YOSHIDA A, 1988, INT J PHARM, V46, P217, DOI 10.1016/0378-5173(88)90081-6
NR 43
TC 1
Z9 1
U1 0
U2 1
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUN
PY 1997
VL 118
BP 603
EP 617
DI 10.1002/masy.19971180179
PG 15
WC Polymer Science
SC Polymer Science
GA XP301
UT WOS:A1997XP30100078
DA 2018-10-19
ER

PT J
AU Vecchiato, NL
AF Vecchiato, NL
TI Sociocultural aspects of tuberculosis control in Ethiopia
SO MEDICAL ANTHROPOLOGY QUARTERLY
LA English
DT Article
DE tuberculosis; ethnomedical knowledge; primary health care; Ethiopia
ID PULMONARY TUBERCULOSIS; DEVELOPING-COUNTRIES; KNOWLEDGE; ILLNESS;
   CHILDREN; DISEASE; HEALTH; SURVEILLANCE; PERCEPTIONS; EXPERIENCE
AB This article examines ethnomedical knowledge and practices related to tuberculosis conceptualization and management in a rural southern Ethiopian community. An adult health-status survey, administered to 217 adults selected through quota sampling procedures, investigated prevailing nosological structures. Additionally, disease-enhancing behaviors were identified through qualitative-research methods. The findings show that while symptomatological concepts coincide with biomedicine, the local etiological model postulates empirically based causational factors unrelated to tubercle bacilli. Therapeutic preference hinges on the utilization of ethnobotanical remedies and their expected emetic effects. The relevance of tuberculosis-related ethnomedical knowledge and management practices is discussed in relation to primary health care and disease-control programs in Ethiopia. It is recommended that health-education interventions, illustrating the nature and transmission avenues of tuberculosis and the effects of biomedical therapies, precede and/or accompany vaccination campaigns or chemotherapy. Teaching materials should valorize existing ethnomedical notions that emphasize contagion as an avenue of disease transmission, and the importance of nutritional adequacy in fighting the disease.
C1 UNIV WASHINGTON,DEPT ANTHROPOL,SEATTLE,WA 98195.
CR ARATA K, 1991, TUBERCLE, V72, P1
   AZBITE M, 1992, ETHIOPIAN MED J, V30, P215
   BARNESDEAN VL, 1986, AFRICA, V56, P334, DOI 10.2307/1160688
   BARNHOORN F, 1992, SOC SCI MED, V34, P291, DOI 10.1016/0277-9536(92)90271-Q
   BISHAW M, 1991, SOC SCI MED, V33, P193, DOI 10.1016/0277-9536(91)90180-K
   BONNLANDER H, 1993, AM J PUBLIC HEALTH, V83, P583, DOI 10.2105/AJPH.83.4.583
   BRIEGER WR, 1992, HEALTH EDUC RES, V7, P471, DOI 10.1093/her/7.4.471
   Brieger WR, 1996, SOC SCI MED, V42, P233, DOI 10.1016/0277-9536(95)00098-4
   BROEKMANS JF, 1991, TROP GEOGR MED, V43, pS13
   BROWN PJ, 1990, MED ANTHR CONT THEOR, P187
   COLLINGS DA, 1990, TROP DOCT, V20, P151, DOI 10.1177/004947559002000403
   DEMISSIE M, 1994, ETHIOPIAN MED J, V32, P97
   Dunn Frederick L., 1986, ANTHR EPIDEMIOLOGY, P3
   ETKIN NL, 1986, PLANTS INDIGENOUS ME
   FINERMAN R, 1989, Medical Anthropology Quarterly, V3, P162, DOI 10.1525/maq.1989.3.2.02a00040
   Finkler K, 1984, Med Anthropol, V8, P195
   GARRO LC, 1988, AM ETHNOL, V15, P98, DOI 10.1525/ae.1988.15.1.02a00070
   GARRO LC, 1986, AM ANTHROPOL, V88, P351, DOI 10.1525/aa.1986.88.2.02a00040
   GEBRE N, 1995, T ROY SOC TROP MED H, V89, P191, DOI 10.1016/0035-9203(95)90491-3
   GHIDEY Y, 1983, ETHIOPIAN MED J, V21, P161
   Good C., 1987, ETHNOMEDICAL SYSTEMS
   *GOV ETH, 1986, ETH STAT ABSTR, P23
   GRANGE JM, 1993, TUBERCLE LUNG DIS, V74, P219, DOI 10.1016/0962-8479(93)90046-Z
   Hamer J. H., 1987, HUMANE DEV PARTICIPA
   HODES RM, 1988, NEW ENGL J MED, V31, P918
   HODES RM, 1993, ECOLOGY HLTH DIS ETH, P265
   Iyun BF, 1996, SOC SCI MED, V42, P437, DOI 10.1016/0277-9536(95)00103-4
   JONES K, 1987, HLTH DIS SOC INTRO M
   Kokwaro J. O., 1976, MED PLANTS E AFRICA
   KOPANOFF DE, 1988, AM J PUBLIC HEALTH, V78, P30, DOI 10.2105/AJPH.78.1.30
   LEMMA E, 1989, ETHIOPIAN MED J, V27, P147
   Liefooghe R, 1995, SOC SCI MED, V41, P1685, DOI 10.1016/0277-9536(95)00129-U
   MAMMO A, 1992, ETHIOPIAN REV, V3, P38
   MENZIES R, 1993, TUBERCLE LUNG DIS, V74, P32, DOI 10.1016/0962-8479(93)90066-7
   MESSING SD, 1972, TARGET HLTH ETHIOPIA
   *MOH, 1991, COMPR HLTH SERV DIR
   Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6
   NGOKWEY N, 1988, SOC SCI MED, V26, P793, DOI 10.1016/0277-9536(88)90173-6
   NICHTER M, 1994, SOC SCI MED, V38, P649, DOI 10.1016/0277-9536(94)90456-1
   NKHOMA WA, 1987, E AFR MED J, V64, P643
   Pankhurst R., 1990, MED HIST ETHIOPIA
   Pankhurst R, 1965, ETHIOPIA OBSERVER, V9, P114
   REYNARD JM, 1989, TROPICAL MED PARASIT, P133
   RIEDER HL, 1992, TUBERCLE LUNG DIS, V73, P181, DOI 10.1016/0962-8479(92)90082-U
   RUBEL AJ, 1992, PUBLIC HEALTH REP, V107, P626
   RUBEL AJ, 1990, MED ANTHR CONT THEOR, P115
   SAUNDERSON P, 1994, ETHIOPIAN MED J, V32, P269
   SAUNDERSON PR, 1995, SOC SCI MED, V40, P1203, DOI 10.1016/0277-9536(94)00240-T
   Schaller K.F., 1972, ETHIOPIA GEOMEDICAL
   Sofowora A., 1982, MED PLANTS TRADITION
   STONE L, 1992, SOC SCI MED, V35, P409, DOI 10.1016/0277-9536(92)90333-L
   STYBLO K, 1991, HEALTH POLICY PLANN, V6, P391, DOI 10.1093/heapol/6.4.391
   TEKLU B, 1984, TUBERCLE, V65, P17, DOI 10.1016/0041-3879(84)90026-6
   TRUE WR, 1990, MED ANTHR CONT THEOR, P115
   VANDERWERF TS, 1990, TUBERCLE, V71, P247, DOI 10.1016/0041-3879(90)90036-8
   Vecchiato N, 1993, ECOLOGY HLTH DIS ETH, P157
   Vecchiato N. L., 1993, AFRICA, V63, P176
   VECCHIATO NL, IN PRESS ANTHR INFEC
   VECCHIATO NL, 1985, THESIS U CALIFORNIA
   VECCHIATO NL, 1994, NEW TRENDS ETHIOPIAN, P1033
   VECCHIATO NL, 1991, INT Q COMMUNITY HLTH, V11, P285
   WESTAWAY MS, 1994, TUBERCLE LUNG DIS, V75, P70, DOI 10.1016/0962-8479(94)90107-4
   WESTAWAY MS, 1990, TUBERCLE, V71, P55, DOI 10.1016/0041-3879(90)90062-D
   Yoder Stanley P., 1981, SOCIAL SCI MED B, V15B, P237
   ZERIHUN G, 1984, ETHIOPIAN MED J, V22, P49
NR 65
TC 25
Z9 26
U1 0
U2 5
PU AMER ANTHROPOLOGICAL ASSOC
PI ARLINGTON
PA 4350 NORTH FAIRFAX DRIVE SUITE 640, ARLINGTON, VA 22203
SN 0745-5194
J9 MED ANTHROPOL Q
JI Med. Anthropol. Q.
PD JUN
PY 1997
VL 11
IS 2
BP 183
EP 201
DI 10.1525/maq.1997.11.2.183
PG 19
WC Anthropology; Public, Environmental & Occupational Health; Social
   Sciences, Biomedical
SC Anthropology; Public, Environmental & Occupational Health; Biomedical
   Social Sciences
GA XR865
UT WOS:A1997XR86500004
PM 9186960
DA 2018-10-19
ER

PT J
AU Davy, KWM
   Anseau, MR
   Odlyha, M
   Foster, GM
AF Davy, KWM
   Anseau, MR
   Odlyha, M
   Foster, GM
TI X-ray opaque methacrylate polymers for biomedical applications
SO POLYMER INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT Cambridge Polymer Conference: Partnership in Polymers
CY SEP 30-OCT 02, 1996
CL CAMBRIDGE, ENGLAND
DE iodinated methacrylate monomers; methacrylates; polymers; X-ray opaque
   polymers
ID RADIOPAQUE
AB The synthesis of a number of halogenated aromatic methacrylate monomers was achieved by (1) the esterification of hydroxyl-containing methacrylate esters with 2,3,5-tri-iodobenzoic acid and (2) by the nucleophilic addition of 2,3,5-tri-iodobenzoic acid, or polyhalogenated phenols, to 2,3-epoxypropyl methacrylate, yielding white crystalline products which were fully characterized. These monomers could be homopolymerized in the melt to produce clear, intensely X-ray opaque glasses possessing high refractive indices. The monomers themselves were soluble in a variety of methacrylate monomers with which they could be copolymerized to produce clear radiopaque materials. The stability of the homopolymers in an aqueous environment was excellent as was thermal stability, exhibiting little decomposition below 300 degrees C.
C1 UNIV LONDON BIRKBECK COLL,DEPT CHEM,ULIRS,THERMAL METHODS LAB,LONDON WC1H 0AJ,ENGLAND.
RP Davy, KWM (reprint author), UNIV LONDON,ST BARTHOLOMEWS & ROYAL LONDON HOSP,SCH MED & DENT,IRC BIOMED MAT,LONDON E1 2AD,ENGLAND.
CR CHANDLER H H, 1971, Journal of Biomedical Materials Research, V5, P253, DOI 10.1002/jbm.820050312
   COOMBE E, 1971, DENTAL PRACTIT, V22, P51
   DAVY KWM, 1995, Patent No. 953035086
   DAVY KWM, IN PRESS J DENT
   DAVY KWM, 1995, Patent No. 953075058
   HOLDEN G, 1968, DENTAL PRACTIT, V18, P209
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   Kruft MAB, 1996, BIOMATERIALS, V17, P1803, DOI 10.1016/0142-9612(95)00339-8
   LEADER SA, 1948, Patent No. 2439374
   PARKER RE, 1959, CHEM REV, V59, P737, DOI 10.1021/cr50028a006
   RAWLS HR, 1990, DENT MATER, V6, P250, DOI 10.1016/S0109-5641(05)80006-5
   RAWLS HR, 1992, DENT MATER, V8, P54, DOI 10.1016/0109-5641(92)90054-G
   SAUNSBURY P, 1964, DENT PRACT, V14, P243
   SIMMONS GC, 1975, THESIS U ASTON BIRMI
   SODERHOLM KJM, 1990, SCAND J DENT RES, V98, P82
   WILLEMS G, 1991, J DENT, V19, P362, DOI 10.1016/0300-5712(91)90056-5
NR 16
TC 62
Z9 63
U1 0
U2 4
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JUN
PY 1997
VL 43
IS 2
BP 143
EP 154
DI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
PG 12
WC Polymer Science
SC Polymer Science
GA XF717
UT WOS:A1997XF71700008
DA 2018-10-19
ER

PT J
AU Evans, C
   Lambert, H
AF Evans, C
   Lambert, H
TI Health-seeking strategies and sexual health among female sex workers in
   urban India: Implications for research and service provision
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE health-seeking behaviour; India; HIV; sex work; sexual health; sexually
   transmitted diseases; compliance
ID BEHAVIOR; THERAPY; ANTHROPOLOGY; DISTANCE; CARE
AB This paper presents and discusses selected findings from a study of health-seeking strategies in relation to sexual health among a group of female sex workers in Calcutta, India. Background information on sex work and sexually transmitted disease in Calcutta is followed by the presentation of findings pertaining to women's understandings of(sexual) health, treatment-seeking and service utilisation. In the urban context where health services are readily available, patterns of initial treatment-seeking are shown to be generally (biomedically) appropriate, but subsequent ''non-compliant'' therapeutic practices give cause for concern. Conventional approaches to the study of ''health-seeking behaviour'' are reviewed in the light of these findings and questions raised about the appropriateness of approaches that focus on initial choice of treatment type and/or assume processes of health-seeking to be determined primarily by cultural ''beliefs'' about illness. Inherent biomedical and culturalist biases in the orientation of such research are shown to produce an analytic neglect of the dual influences of material life conditions and people's perceptions of health, rather than illness, upon health-related strategies. Recommendations are made for operational research and policy formulation on the provision of effective sexual health services, and implications are drawn for the scope of interventions and applied research directed at improving sexual health. (C) 1997 Elsevier Science Ltd.
C1 UNIV LONDON LONDON SCH HYG & TROP MED, DEPT PUBL HLTH & POLICY, LONDON WC1E 7HT, ENGLAND.
OI Evans, Catrin/0000-0002-5338-2191
CR *ABVA, 1990, WOM AIDS DEN BLAM CI
   *AIIHPH, 1992, REP COMM BAS SURV SE
   *ALLHPH, 1994, EV STD HIV INT SEX W
   *ALLHPH, 1993, ASS SEX TRAD CALC HO
   *ALLHPH, 1994, SEX WORK NEED CAR CH
   *BCC, 1991, REP IND INT COND 30
   BECKER MH, 1974, HEALTH EDUC QUART, V2, P409, DOI 10.1177/109019817400200407
   BENTLEY M, 1990, P INT C RAP ASS METH
   BOTTERO A, 1991, CULT MED PSYCHIAT, V15, P303, DOI 10.1007/BF00046541
   BRUNHAM RC, 1991, RES ISSUES HUMAN BEH, P61
   Calnan M., 1987, HLTH ILLNESS LAY PER
   CARSTAIRS M, 1957, TWICE BORN STUDY COM
   CATANIA JA, 1990, HEALTH EDUC QUART, V17, P53, DOI 10.1177/109019819001700107
   *CENTR SOC WELF BO, 1992, REP SOC EC STUD FEM
   Chand A D, 1994, Med Anthropol, V15, P395
   Chaudhuri S., 1990, CALCUTTA LIVING CITY, Vii
   *CINI, 1994, GYN MORB WOM W BENG
   CORNWELL J, 1984, HARD EARNED LIVES AC
   DASGUPTA A, 1990, W BENGAL J SOCIAL WE, P9
   DCUNHA J, 1990, LEGALISATION PROSTIT
   DUA V, 1994, SOC SCI MED, V38, P717, DOI 10.1016/0277-9536(94)90462-6
   EARLY EA, 1982, SOC SCI MED, V16, P1491, DOI 10.1016/0277-9536(82)90064-8
   ELIAS CJ, 1991, 5 POP COUNC PROGR DI
   EVANS C, 1993, THESIS SCH ORIENT AF
   EVANS C, 1994, PILOT STUDY EXPLORE
   GOOD B, 1994, MED RATIONALITY EXPE
   *GOV W BENG, 1994, FACTS AIDS W BENG FA
   GRAHAM H, 1984, WOMEN HLTH FAMILY
   GREENHALGH T, 1987, SOC SCI MED, V25, P307, DOI 10.1016/0277-9536(87)90233-4
   GROSSKURTH H, 1995, LANCET, V346, P519
   HO S, 1984, SOC SCI MED, V25, P745
   JOARDAR B, 1984, PROSTITUTION HIST MO
   KAMAT VR, 1995, SOC SCI MED, V41, P87, DOI 10.1016/0277-9536(94)00309-H
   KANANI S, 1991, C WOM HLTH ACT AG 90
   KENDALL C, 1984, SOC SCI MED, V19, P253, DOI 10.1016/0277-9536(84)90216-8
   KLOOS H, 1987, SOC SCI MED, V25, P1003, DOI 10.1016/0277-9536(87)90005-0
   LAGA M, 1995, LANCET, V346, P518, DOI 10.1016/S0140-6736(95)91374-2
   LAGA M, 1992, REPROD BIOL, P131
   LUTHRA UK, 1992, REPROD BIOL, P317
   MAHILA S, BARBONITA BOLCHI PRO
   MANDERSON L, 1992, SOC SCI MED, V35, P839, DOI 10.1016/0277-9536(92)90098-B
   McGilvray D., 1982, ETHNOGRAPHY FERTILIT, P25
   Mull D S, 1994, Med Anthropol, V15, P335
   *NACO, 1994, NAT AIDS CONTR PROGR
   NATARAJ S, 1994, PRIVATE DECISIONS PU, P7
   NICHTER M, 1994, SOC SCI MED, V39, P1509, DOI 10.1016/0277-9536(94)90003-5
   NICHTER M, 1980, SOC SCI MED-MED ANTH, V14, P225, DOI 10.1016/0160-7987(80)90048-4
   Nichter M, 1994, Med Anthropol, V15, P353
   NICHTER M, 1994, MED ANTHROPOL, V14, P319
   NICHTER M, 1978, MED ANTHROPOL, V2, P29
   NICHTER M, 1988, CULT MED PSYCHIAT, V13, P367
   Nichter Mark, 1989, ANTHR INT HLTH S ASI
   PARKER RL, 1986, SOC SCI MED, V22, P23, DOI 10.1016/0277-9536(86)90304-7
   PELTO PJ, 1990, ANTHR PRIMARY HLTH C, P253
   RAHAMAN MM, 1982, AM J PUBLIC HEALTH, V72, P1124, DOI 10.2105/AJPH.72.10.1124
   SACHS L, 1989, CULT MED PSYCHIAT, V13, P335, DOI 10.1007/BF00054342
   *SANL, 1994, SOC EC SURV COMM SEX
   Scrimshaw S.C.M, 1987, RAPID ASSESSMENT PRO
   SHEPPERDSON M, 1988, IND NAT C POL EC IND
   SINGER M, 1990, SOC SCI MED, V30, P179, DOI 10.1016/0277-9536(90)90078-7
   SINGER M, 1988, Medical Anthropology Quarterly, V2, P370, DOI 10.1525/maq.1988.2.4.02a00060
   STANDING H, 1990, DEPENDENCE AUTONOMY
   Stewart KM, 1994, MED ANTHROPOL, V15, P377
   STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8
   VAN DER GEEST S., 1988, CONTEXT MED DEV COUN
   WASSERHEIT JN, 1992, REPROD BIOL, P7
   *WHO, 1995, MAN SEX TRANS DIS
   YESUDIAN C, 1989, HLTH SERVICES UTILIS
   YESUDIAN C, 1988, UTILISATION HLTH SER
   YESUDIAN CAK, 1994, HEALTH POLICY PLANN, V9, P72, DOI 10.1093/heapol/9.1.72
   Young JC, 1981, MED CHOICE MEXICAN V
   Zimmerman Francis, 1987, JUNGLE AROMA MEATS E
NR 72
TC 41
Z9 41
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD JUN
PY 1997
VL 44
IS 12
BP 1791
EP 1803
DI 10.1016/S0277-9536(96)00288-2
PG 13
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA XD563
UT WOS:A1997XD56300003
PM 9194241
DA 2018-10-19
ER

PT J
AU Miyata, T
   Nakamae, K
AF Miyata, T
   Nakamae, K
TI Polymers with pendent saccharides - 'Glycopolymers'
SO TRENDS IN POLYMER SCIENCE
LA English
DT Article
ID SURFACE FREE-ENERGY; CHEMOENZYMATIC SYNTHESIS; PENDANT MONOSACCHARIDES;
   GLYCOPROTEIN MODELS; COPOLYMER FILMS; DRUG-DELIVERY; GLYCOSIDES; SUGAR;
   HYDROGELS; BEARING
AB Synthetic polysaccharides have been found to be useful for basic biomedical research and practice medical applications. Those polysaccharides having a backbone consisting of a synthetic polymer are called 'glycopolymers'. Most glycopolymers are linear synthetic polymers with pendent mono-, oligo- and polysaccharides. Saccharide units in glycopolymers are recognized by a variety of carbohydrate receptors in a similar manner to natural polysaccharides. Investigation of glycopolymers has significantly contributed to our understanding of biochemical phenomena in relation to cell-cell interactions through molecular recognition. Furthermore, the properties of glycopolymers suggest that they have much potential as suitable materials for biochemical and biomedical applications, such as protein separation, cell culture and drug-delivery systems. This article provides a short overview of current research in the synthesis of glycopolymers and their applications to be biochemical and biomedical fields.
C1 KANSAI UNIV,FAC ENGN,SUITA,OSAKA 564,JAPAN.
CR BLINKOVSKY AM, 1993, TETRAHEDRON-ASYMMETR, V4, P1221, DOI 10.1016/S0957-4166(00)80231-1
   CHEN XM, 1994, MACROMOL CHEM PHYSIC, V195, P3567, DOI 10.1002/macp.1994.021951105
   CHEN XM, 1995, MACROMOLECULES, V28, P6014, DOI 10.1021/ma00122a005
   DORDICK JS, 1994, CHEMTECH, V24, P33
   Dusek K., 1993, ADV POLYM SCI, V109
   DUSEK K, 1993, ADV POLYM SCI, V110
   FUKUDOME N, 1994, J APPL POLYM SCI, V52, P1759, DOI 10.1002/app.1994.070521210
   FURUIKE T, 1995, CHEM LETT, P823, DOI 10.1246/cl.1995.823
   GOTO M, 1994, J CONTROL RELEASE, V28, P223
   HOREJSI V, 1978, BIOCHIM BIOPHYS ACTA, V538, P293, DOI 10.1016/0304-4165(78)90357-4
   KIM S W, 1990, Journal of Controlled Release, V11, P193
   KITAZAWA S, 1990, CHEM LETT, P1733, DOI 10.1246/cl.1990.1733
   KOBAYASHI K, 1994, J CARBOHYD CHEM, V13, P753, DOI 10.1080/07328309408011678
   KOBAYASHI K, 1993, MAKROMOL CHEM-RAPID, V14, P293
   KOBAYASHI K, 1994, NEOGLYCOCONJUGATES P, P262
   KOBAYASHI K, 1994, METHOD ENZYMOL, V247, P47
   KOPECEK J, 1992, J CONTROL RELEASE, V19, P121, DOI 10.1016/0168-3659(92)90070-8
   KOPECKOVA P, 1994, J CONTROL RELEASE, V28, P211, DOI 10.1016/0168-3659(94)90168-6
   Lee Y. C., 1994, P3
   LEE YC, 1978, CARBOHYD RES, V67, P509
   LEE YC, 1994, NEOGLYCOCONJUGATES
   MAKINO K, 1990, J CONTROL RELEASE, V12, P235, DOI 10.1016/0168-3659(90)90104-2
   MARTIN BD, 1992, MACROMOLECULES, V25, P7081, DOI 10.1021/ma00052a001
   MATSUOKA K, 1995, MACROMOLECULES, V28, P2961, DOI 10.1021/ma00112a049
   MIYATA T, 1994, MACROMOL CHEM PHYSIC, V195, P3597, DOI 10.1002/macp.1994.021951107
   MIYATA T, 1995, J APPL POLYM SCI, V56, P1615, DOI 10.1002/app.1995.070561212
   Miyata T, 1996, MACROMOL CHEM PHYSIC, V197, P1135, DOI 10.1002/macp.1996.021970330
   NAKAMAE K, 1994, MACROMOL CHEM PHYSIC, V195, P2663, DOI 10.1002/macp.1994.021950733
   NAKAMAE K, 1993, MAKROMOL CHEM-RAPID, V14, P413
   NAKAMAE K, 1994, J BIOMAT SCI-POLYM E, V6, P79, DOI 10.1163/156856295X00779
   NAKAMAE K, 1994, MACROMOL CHEM PHYSIC, V195, P1953, DOI 10.1002/macp.1994.021950606
   NISHIMURA SI, 1994, MACROMOLECULES, V27, P157, DOI 10.1021/ma00079a023
   NISHIMURA SI, 1994, MACROMOLECULES, V27, P4876, DOI 10.1021/ma00096a004
   NISHIMURA SI, 1990, MACROMOLECULES, V23, P4182, DOI 10.1021/ma00220a024
   NISHIMURA SI, 1991, MACROMOLECULES, V24, P4236, DOI 10.1021/ma00015a002
   Ouchi Tatsuro, 1994, P465
   PATIL DR, 1991, MACROMOLECULES, V24, P3462, DOI 10.1021/ma00011a068
   SPALTENSTEIN A, 1991, J AM CHEM SOC, V113, P686, DOI 10.1021/ja00002a053
   USUI T, 1993, CARBOHYD RES, V244, P315, DOI 10.1016/0008-6215(83)85010-1
   WULFF G, 1994, MACROMOL CHEM PHYSIC, V195, P2603, DOI 10.1002/macp.1994.021950728
NR 40
TC 69
Z9 70
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0966-4793
J9 TRENDS POLYM SCI
JI Trends Polym. Sci.
PD JUN
PY 1997
VL 5
IS 6
BP 198
EP 206
PG 9
WC Polymer Science
SC Polymer Science
GA XG735
UT WOS:A1997XG73500006
DA 2018-10-19
ER

PT J
AU Bradbury, SR
   Lewis, DB
   Archer, PM
   Ahmed, W
AF Bradbury, SR
   Lewis, DB
   Archer, PM
   Ahmed, W
TI Impact of surface engineering technologies on the performance and life
   of multi-point cutting tools
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE surface engineering technologies; multi-point cutting tools
ID NITROGEN; STEEL
AB Advanced surface engineering technologies such as chemical vapour deposition, sputtering and ion-implantation have shown considerable potential for use in a variety of industrial applications, These include a wide range of decorative, optical, electronic, biomedical and engineering products. Much of the success of surface engineering treatments have been in the laboratories and in products that use flat substrates such as nar panel displays and microelectronic devices. However, for applications requiring samples that have complex geometrical features such as cutting tools and biomedical prosthesis the results of surface engineering treatments have been rather variable and less spectacular,
   In this paper pre focus on the application of surface engineering on multi-point cutting tools, in particular band saws and circular saws. The effects of substrate surface preparation, coating materials and-processes, and surface modifications through ion implantation are considered on the performance and life of multi-point cutting tools. The results presented utilise a key performance parameter that has been applied to all the types of tools considered to compare the effects of each surface engineering treatment. For the product under consideration we show that careful substrate preparation, ion-implantation of Ar+ and N+ ions, coatings of TiN, TiAlN, WC, TiAlVN and the coating process have led to significant improvements in performance and life compared to untreated cutting edges, The trends observed may also be applied to other multi-point and single point cutting tools. (C) 1997 Elsevier Science S.A.
C1 MANCHESTER POLYTECH,DEPT CHEM,MANCHESTER M1 5GD,LANCS,ENGLAND.
   UNIV SHEFFIELD,DEPT MECH ENGN,SHEFFIELD S1 3JD,S YORKSHIRE,ENGLAND.
   SHEFFIELD HALLAM UNIV,INST MAT RES,SHEFFIELD S1 1WB,S YORKSHIRE,ENGLAND.
OI Ahmed, Waqar/0000-0003-4152-5172
CR AHMED NAG, 1987, ION PLATING TECHNOLO
   AHMED W, 1992, FLAGSHIP, P55
   AHMED W, 1989, J CRYST GROWTH, V79, P394
   ALONSO F, 1994, SURF COAT TECH, V66, P291, DOI 10.1016/0257-8972(94)90015-9
   ARCHER PM, 1991, THESIS SHEFFIELD HAL, P26
   BIERSACK JP, 1980, NUCL INSTRUM METHODS, V174, P257, DOI 10.1016/0029-554X(80)90440-1
   BOOTHROYD G, 1965, FUNDAMENTALS METAL M, P18
   BUNSHAH RF, 1982, DEPOSITION TECHNOLOG, P83
   FAYEULLE S, 1985, NUCL INSTRUM METH B, V7-8, P171, DOI 10.1016/0168-583X(85)90550-6
   KELLY PJ, 1993, MAT WORLD, V3, P161
   Lewis DB, 1996, WEAR, V197, P82, DOI 10.1016/0043-1648(95)06835-X
   LEWIS DB, 1995, INT C ADV MATS P TEC, P310
   MCNALLY JI, 1989, HDB PLASMA PROCESSES, P466
   MESSIER R, 1987, THIN SOLID FILMS, V153, P1, DOI 10.1016/0040-6090(87)90164-7
   MONAGHAN D, 1992, FINISHING        OCT, P37
   PETHICA JB, 1983, NUCL INSTRUM METHODS, V209, P995, DOI 10.1016/0167-5087(83)90911-0
   SARWAR M, 1984, P 1 IR MAN COMM DUBL, P84
   SARWAR M, 1993, P 3 INT S ADV MATS, P499
   SARWAR M, 1993, P INT C ADV MAT PROC, P1939
   SARWAR M, 1995, P 4 INT S ADV MATS, P197
   SARWAR M, 1995, P 1 INT C QUAL REL, V2, P23
   SARWAR M, 1988, P 4 NATL C PROD RES, P494
   SINGER IL, 1980, J VAC SCI TECHNOL, V17, P327, DOI 10.1116/1.570379
   TRENT EM, 1977, METAL CUTTING, P93
NR 24
TC 9
Z9 9
U1 0
U2 3
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAY 20
PY 1997
VL 91
IS 3
BP 192
EP 199
DI 10.1016/S0257-8972(96)03183-0
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA XF657
UT WOS:A1997XF65700006
DA 2018-10-19
ER

PT J
AU Geckeler, KE
   Rupp, F
   GeisGerstorfer, J
AF Geckeler, KE
   Rupp, F
   GeisGerstorfer, J
TI Interfaces and interphases of (Bio)materials: Definitions, structures,
   and dynamics
SO ADVANCED MATERIALS
LA English
DT Article
ID COMMERCIALLY PURE TITANIUM; PROTEIN ADSORPTION; IN-VITRO; ADHESION;
   SURFACES; IMPLANTS; HYDROXYAPATITE; DEPOSITION; POLYMERS; SUPPORTS
AB What exactly is an interface, and when is an interphase the more correct concept? The nature of interfaces and the phenomena occurring there are described before the role of interphases is illustrated with a series of examples taken from purely artificial systems (e.g., polymer and polymer-metal ''interfaces'') and natural and mixed artificial-natural systems (e.g., the multilayer interphase of a biomedical system such as a dental implant). The approach presented demonstrates that ''interphase'' or ''interface'' depends to some extent on the point of view.
C1 UNIV TUBINGEN, DEPT PROSTHODONT, D-72076 TUBINGEN, GERMANY.
RP Geckeler, KE (reprint author), UNIV TUBINGEN, FAC CHEM & PHARM, DEPT ORGAN CHEM, MORGENSTELLE 18, D-72076 TUBINGEN, GERMANY.
RI Rupp, Frank/G-4725-2012
CR ADAM G, 1995, PHYSIKALISCHE CHEM B, P293
   BALL P, 1991, NATURE, V349, P101, DOI 10.1038/349101a0
   BERGETHON PR, 1990, BIOPHYSICAL CHEM MOL, P217
   BHUSHAN B, 1995, NATURE, V374, P607, DOI 10.1038/374607a0
   BREME J, 1995, BIOMATERIALS, V16, P239, DOI 10.1016/0142-9612(95)92123-N
   BRUCE A, 1995, MOLEKULARBIOLOGIE ZE, P563
   CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102
   CAIAZZA S, 1991, BIOMATERIALS, V12, P474, DOI 10.1016/0142-9612(91)90145-Z
   CHAKRABORTY AK, 1990, J POLYM SCI POL CHEM, V28, P3185, DOI 10.1002/pola.1990.080281201
   CLAROTTI G, 1992, BIOMATERIALS, V13, P832, DOI 10.1016/0142-9612(92)90176-O
   CLAROTTI G, 1991, MAKROMOL CHEM, V192, P2581
   COLLIS JJ, 1992, BIOMATERIALS, V13, P548, DOI 10.1016/0142-9612(92)90107-Y
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   DORFLER HD, 1994, GRENZFLACHEN KOLLOID, P88
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   ELIAS HG, 1993, INTRO PLASTICS, P220
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   FEAST WJ, 1985, POLYM SURFACES INTER, V1
   GECKELER K, 1981, ADV POLYM SCI, V39, P65
   GECKELER KE, 1992, NATURWISSENSCHAFTEN, V79, P325, DOI 10.1007/BF01138713
   GECKELER KE, 1995, ADV POLYM SCI, V121, P31
   GECKELER KE, 1993, NATURWISSENSCHAFTEN, V80, P487, DOI 10.1007/BF01140804
   GECKELER KE, 1989, TELECHELIC POLYM SYN, P229
   HOFFMAN AS, 1982, BIOMATERIALS INTERFA
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   JOHANSSON CB, 1990, BIOMATERIALS, V11, P277, DOI 10.1016/0142-9612(90)90010-N
   Junqueira L.C., 1996, HISTOLOGIE
   KAPS C, 1993, KERAM Z, V45, P147
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   KRAMER A, 1989, Z ZAHNARZTLICHE IMPL, V5, P283
   Krekeler G, 1984, Schweiz Monatsschr Zahnmed (1984), V94, P647
   LASSEN B, 1994, COLLOID POLYM SCI, V272, P1143, DOI 10.1007/BF00652384
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LECKBAND D, 1995, NATURE, V376, P617, DOI 10.1038/376617a0
   LEE LH, 1994, J ADHESION, V46, P15, DOI 10.1080/00218469408026646
   Lelah M. D., 1986, POLYURETHANES MED
   McAlarney M E, 1993, N Y State Dent J, V59, P45
   MILLER JD, 1991, FUNDAMENTALS ADHESIO, pCH10
   MIYAZAKI T, 1994, B KANAGAWA DENT COL, V22, P113
   MYERS D, 1991, SURFACES INTERFACES, P7
   NYVAD B, 1989, CARIES RES, V23, P151, DOI 10.1159/000261169
   PETTY MC, 1985, POLYM SURFACES INTER, V1, P163
   Ponec V, 1995, CATALYSIS METALS ALL
   RATNER BD, 1985, POLYM SURFACES INTER, V1, P231
   Richards R. W., 1993, POLYM SURFACES INTER
   ROALD HE, 1994, BLOOD COAGUL FIBRIN, V5, P355
   Rupp F, 1996, ADV MATER, V8, P254, DOI 10.1002/adma.19960080316
   SCHAMBERGER PC, 1994, COLLOID SURFACE B, V2, P209, DOI 10.1016/0927-7765(94)80036-7
   SCHROEDER HE, 1970, DENTAL PLAQUE, P49
   SHI GQ, 1995, SCIENCE, V267, P994, DOI 10.1126/science.267.5200.994
   SONJU T, 1973, CARIES RES, V7, P30
   SUTHERLAND DS, 1993, BIOMATERIALS, V14, P893, DOI 10.1016/0142-9612(93)90130-T
   THULL R, 1994, NATURWISSENSCHAFTEN, V81, P481, DOI 10.1007/s001140050113
   VANOSS CJ, 1993, POLYM SURFACES INTER, V2, P267
   VANSANTEN RA, 1991, THEORETICAL HETEROGE
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   WANG J, 1991, NATURE, V354, P377, DOI 10.1038/354377a0
   WILLIAMS DF, 1992, MAT SCI TECHNOLOGY, V14
   Wool R. P., 1991, FUNDAMENTALS ADHESIO, P207
NR 60
TC 21
Z9 21
U1 0
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD MAY
PY 1997
VL 9
IS 6
BP 513
EP +
DI 10.1002/adma.19970090614
PG 1
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA WZ682
UT WOS:A1997WZ68200013
DA 2018-10-19
ER

PT J
AU Litvin, AL
   Kaplan, DL
   Sung, CM
AF Litvin, AL
   Kaplan, DL
   Sung, CM
TI Microstructure of aragonite grown at an air-liquid interface
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID TEMPERATURE
AB Aragonite particles dispersed in a bioresorbable polymer matrix a re considered to be a good candidate for bone prosthesis materials. It is important to characterize the microstructure of synthetic aragonite used for biomedical applications, since the microstructure may influence its integration, resorption and replacement by bone. We studied late stages of aragonite growth, at an air-liquid interface, from a solution not doped with additives. Comparison was made between the types of synthetic aragonite microstructure and that of aragonite which is found in nature (mollusc shells, gallstones, Earth's crust). The microstructure of natural aragonite is unique to certain classes of living organisms and the understanding of its structure/function relationships may help to select the types of synthetic aragonite for specific biomedical applications. Three types of synthetic aragonite were observed based on grain size and grain morphology.
C1 GEOCENTERS INC,NATICK,MA 01760.
   TUFTS UNIV,CTR BIOTECHNOL,MEDFORD,MA 02155.
   UNIV LOWELL,CTR ADV MAT,LOWELL,MA 01854.
RP Litvin, AL (reprint author), USA,NATICK RES DEV & ENGN CTR,DIV BIOTECHNOL,NATICK,MA 01760, USA.
CR ADAMS AE, 1983, J SEDIMENT PETROL, V2, P417
   BASSI N, 1994, CURR THER RES CLIN E, V55, P1169, DOI 10.1016/S0011-393X(05)80257-7
   Bathurst R. C. G., 1975, CARBONATE SEDIMENTS
   BUEHRER TF, 1940, J PHYS CHEM-US, V44, P551
   CHIROFF RT, 1977, J BIOMED MATER RES, V11, P165, DOI 10.1002/jbm.820110203
   CHRISTEL P, 1995, Patent No. 5433751
   FRANKE WA, 1992, CRYST RES TECHNOL, V27, P295, DOI 10.1002/crat.2170270302
   GIRAUDGUILLE MM, 1994, MICROSC RES TECHNIQ, V5, P420
   GUO L, 1992, SEDIMENTOLOGY, V39, P1067, DOI 10.1111/j.1365-3091.1992.tb01997.x
   HENCH LL, 1993, INTRO BIOCERAMICS
   HONDA E, 1994, B I OCEANOGR MONACO, V14, P115
   LITVIN AL, 1995, J PHYS CHEM-US, V99, P492, DOI 10.1021/j100002a006
   LITVIN AL, 1995, J PHYS CHEM-US, V99, P12065, DOI 10.1021/j100032a001
   LITVIN AL, 1995, P SMART STRUCT MAT S, P54
   LITVIN AL, 1997, UNPUB ADV MAT
   LITVIN JL, 1996, BIOCERAMICS, V9, P363
   Lowenstam HA, 1989, BIOMINERALIZATION
   MANN H, 1987, J PHYCOL, V23, P506, DOI 10.1111/j.1529-8817.1987.tb02539.x
   Mann S., 1996, BIOMIMETIC MAT CHEM
   OKUMURA M, 1986, GEOCHIM COSMOCHIM AC, V50, P49, DOI 10.1016/0016-7037(86)90047-5
   PUTNIS A, 1993, INTRO MINERAL SCI
   Reeder R. J., 1990, CARBONATES MINERALOG
   SARIKAYA M, 1994, MICROS RES TECH, V5, P360
   Zum Gahr K.-H., 1987, TRIBOLOGY SERIES, V10
NR 24
TC 5
Z9 5
U1 0
U2 2
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD MAY 1
PY 1997
VL 32
IS 9
BP 2233
EP 2236
DI 10.1023/A:1018511930559
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA WY350
UT WOS:A1997WY35000001
DA 2018-10-19
ER

PT J
AU Dahmen, KG
   Maurin, N
   Richter, HA
   Mittermayer, CH
AF Dahmen, KG
   Maurin, N
   Richter, HA
   Mittermayer, CH
TI Screening of biomedical polymer biocompatibility in NMRI-mice peritoneal
   cavity - A comparison between ultra-high-molecular-weight polyethylene
   (UHMW-PE) and polyethyleneterephthalate (PET)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID INVITRO; CELLS
AB The peritoneal resident cell population is influenced by various inflammatory and immunogenic stimuli. The influence of intraperitoneal application of polyethyleneterephthalate (PET) (group A) and ultra-high-molecular-weight polyethylene (UHMW-PE) (group B) powders on peritoneal cell count and macrophage activity was investigated. Powders were tested to mimic wear particles from solid implant devices as these particles often cause chronic granulomatous inflammation. The results were compared with the inflammatory response following an abdominal midline incision (group C) and untreated animals (group D). On days 1,7,14 and 30 peritoneal cells were quantified and the number of active macrophages was assessed. Groups A and C mice showed a significant loss of macrophages in the peritoneal ravage at day 1 but this returned to normal values (group D) on day 7. In contrast, group B animals remained at low peritoneal cell counts but showed the highest number of active macrophages. Only in this latter group was adhesion formation and granulomatous clustering of polymer powder observed. Applying the parameters macrophage count and the number of active macrophages it can be concluded that PET elicits a weaker inflammatory reaction than UHMW-PE in mice peritoneal cavity. Thus this animal model may be used as a screening test for biomedical materials, especially their wear products.
C1 UNIV PARIS,FAC MED ST ANTOINE,HISTOL LAB,F-75571 PARIS 12,FRANCE.
   RHEIN WESTFAL TH AACHEN,INST PATHOL,D-52074 AACHEN,GERMANY.
RP Dahmen, KG (reprint author), TECH UNIV DRESDEN,INST ANESTHESIOL & INTENS CARE,INST BIOL,FETSCHERSTASSE 74,D-01307 DRESDEN,GERMANY.
CR BACHELET CM, 1987, EXP LUNG RES, V13, P241, DOI 10.3109/01902148709069592
   CANNISTRA SA, 1994, EXP HEMATOL, V22, P996
   CHARNLEY J, 1970, CLIN ORTHOPAEDICS, V72, P7
   COHEN J, 1959, J BONE JOINT SURG AM, V41, P152, DOI 10.2106/00004623-195941010-00018
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   Matturri L, 1990, Minerva Cardioangiol, V38, P279
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NELSON DS, 1963, IMMUNOLOGY, V6, P264
   NELSON DS, 1965, LAB INVEST, V14, P89
   RENDELLBAKER L, 1970, ANESTH ANAL CURR RES, V49, P919
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   SULTAN AM, 1978, J PATHOL, V126, P221, DOI 10.1002/path.1711260406
   Tardito E, 1993, Minerva Cardioangiol, V41, P59
   TETIK RD, 1974, J BIOMED MATER RES, V8, P231, DOI 10.1002/jbm.820080506
   VANSLIEDREGT A, 1992, BIOMATERIALS, V13, P819, DOI 10.1016/0142-9612(92)90174-M
   Willert HG, 1990, CLIN ORTHOPAEDICS, V258, P95
   Woodward SC, 1986, HDB BIOMATERIALS EVA, P364
   WORTMAN RS, 1983, BIOMATER ARTIF CELL, V11, P103, DOI 10.3109/10731198309118799
NR 21
TC 5
Z9 5
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 1997
VL 8
IS 5
BP 239
EP 245
DI 10.1023/A:1018595825048
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WX994
UT WOS:A1997WX99400001
PM 15348744
DA 2018-10-19
ER

PT J
AU Zhang, QQ
   Ren, L
   Liu, LR
   Wang, C
AF Zhang, QQ
   Ren, L
   Liu, LR
   Wang, C
TI Structure investigation of poly(vinyl alcohol)-collagen composite
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
ID COLLAGEN; HYDROGELS
AB Naturally derived collagen protein was mixed thoroughly with medical grade poly (vinyl alcohol) (PVA) at the ratio of 90:10 (w/w) and was crosslinked by formaldehyde to form a homogeneous composite membrane. The bulk structure of the membrane was characterized by means of X-ray diffraction (XRD) and transmission electron microscopy (TEM). The membrane surface structure was investigated using Fourier transform-infrared spectroscopy (attenuated total refraction) (FTIR-ATR), electron spectroscopy for chemical analysis (ESCA) and contact angle measurement. It was found that collagen and PVA can remain stable. This was supported by the fact that no sign of phase separation had been observed. The use of crosslinking agent can substantially influence the structure of the composite. It is suggested that this new composite deserves further investigation and is potentially usable as a biomedical material.
C1 UNIV UTAH,CCCD,SALT LAKE CITY,UT 84112.
RP Zhang, QQ (reprint author), CHINESE ACAD MED SCI,INST BIOMED ENGN,TIANJIN 300192,PEOPLES R CHINA.
RI ren, lei/G-3459-2010; Zhang, QQ/G-3361-2010
OI ren, lei/0000-0003-2131-1601; 
CR CHIELLINI E, 1983, POLYM MED BIOMEDICAL, P23
   CIFKOVA I, 1987, BIOMATERIALS, V8, P30, DOI 10.1016/0142-9612(87)90024-X
   EVANGELISTA RA, 1986, BIOMATERIALS, V7, P206, DOI 10.1016/0142-9612(86)90104-3
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   RAO JK, 1994, BIOMATERIALS, V15, P383, DOI 10.1016/0142-9612(94)90251-8
   SAWHNEY AS, 1993, BIOMATERIALS, V14, P1008, DOI 10.1016/0142-9612(93)90194-7
   WATLER PK, 1988, BIOMATERIALS, V9, P150, DOI 10.1016/0142-9612(88)90114-7
   ZHANG QQ, 1991, POLYM BIOMATERIALS, V3, P289
   ZHANG QQ, 1990, P FAR E C MED BIOL E, P264
NR 9
TC 13
Z9 16
U1 0
U2 1
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD MAY
PY 1997
VL 13
IS 3
BP 179
EP 183
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA WX547
UT WOS:A1997WX54700003
DA 2018-10-19
ER

PT J
AU Ektessabi, AM
AF Ektessabi, AM
TI Surface modification of biomedical implants using ion-beam-assisted
   sputter deposition
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Ion Beam Modification of Materials
   (IBMM-96)
CY SEP 01-06, 1996
CL ALBUQUERQUE, NM
ID CALCIUM-PHOSPHATE; TRICALCIUM PHOSPHATE; CERAMIC COATINGS; THIN-FILMS;
   IN-VIVO; HYDROXYAPATITE; TITANIUM; ALLOYS
AB Hydroxy-apatite (Ca-10(PO4)(6)(OH)(2)), owing to its good bioaffinity and enhancement of osseo-integration, is a potential material for costing on dental and orthopedic implants. At present, hydroxy-apatite is coated on metal implants by a plasma spraying method or is used in its bulk form in reconstruction surgery. In this paper, experimental results are given for preparation of hydroxy-apatite thin films on various biomedical implant materials using ion-beam sputter deposition and ion-beam-assisted sputter deposition methods. By using the ion-beam-assisted sputter deposition method, the adhesion of hydroxy-apatite thin films to substrate has improved significantly and increased to a level comparable to Ti and Al oxide thin films. Relative atomic densities of Ca, P, O and H in hydroxy-apatite thin films were obtained using ion-beam analysis methods such as RES, RE-RES, ERDA, and PIXE. The relative concentrations of Ca, and P were affected by assisting-beam density, and stoichiometric films were obtained for certain assisting-beam current densities.
RP Ektessabi, AM (reprint author), KYOTO UNIV,GRAD SCH ENGN,SAKYO KU,KYOTO 60601,JAPAN.
CR BABA S, 1986, J VAC SCI TECHNOL A, V4, P3015, DOI 10.1116/1.573617
   BARHELL BL, 1988, MATER RES SOC S P, P709
   BENGHUZZI HA, 1995, IEEE P 14 S BIOM ENG, P289
   BENJAMIN P, 1960, PROC R SOC LON SER-A, V254, P163, DOI 10.1098/rspa.1960.0012
   BUMA P, 1995, J ARTHROPLASTY, V10, P389, DOI 10.1016/S0883-5403(05)80190-1
   DALTON JE, 1995, J BIOMED MATER RES, V29, P239, DOI 10.1002/jbm.820290215
   DEAZA PN, 1995, J AM CERAM SOC, V78, P1653
   DING XF, 1995, J CERAM SOC JPN, V103, P867, DOI 10.2109/jcersj.103.867
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   EKTESSABI AM, 1994, SURF COAT TECH, V68, P208, DOI 10.1016/0257-8972(94)90162-7
   Ektessabi AM, 1995, THIN SOLID FILMS, V270, P335, DOI 10.1016/0040-6090(95)06714-0
   EKTESSABI AM, 1995, NUCL INSTRUM METH B, V99, P610, DOI 10.1016/0168-583X(94)00568-0
   EKTESSABI AM, 1995, 3 INT S SPUTT PLASM, P341
   Feldman LE, 1986, FUNDAMENTALS SURFACE
   Geesink R G, 1993, Acta Orthop Belg, V59 Suppl 1, P160
   GOTTLANDER M, 1991, International Journal of Oral and Maxillofacial Implants, V6, P399
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   JANSEN JA, 1993, J BIOMED MATER RES, V27, P603, DOI 10.1002/jbm.820270507
   KAY JF, 1993, COMPENDIUM S, V15, pS520
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   Kramer EJ, 1996, MRS BULL, V21, P37
   Lacefield W R, 1988, Ann N Y Acad Sci, V523, P72, DOI 10.1111/j.1749-6632.1988.tb38501.x
   MUDRA DR, 1995, IEEE P 14 S BIOM ENG, P111
   Nimb L, 1993, Acta Orthop Belg, V59, P333
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   PAN J, 1995, UNPUB
   PAN J, IN PRESS BIOMATERIAL
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   STEVENSON JR, 1988, MATER RES SOC S P, P715
   THOMAS KA, 1994, ORTHOPEDICS, V17, P267
   Umegaki T., 1988, Memoirs of Faculty of Technology, Tokyo Metropolitan University, V38, P133
   VANDIJK K, 1995, SURFACE COATINGS TEC
   VANDIJK K, 1995, BIOMATERIALS
   VAUGHN B K, 1992, Dental Clinics of North America, V36, P263
   YAMASHITA K, 1994, J AM CERAM SOC, V77, P2401, DOI 10.1111/j.1151-2916.1994.tb04611.x
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
NR 36
TC 23
Z9 24
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD MAY
PY 1997
VL 127
BP 1008
EP 1014
DI 10.1016/S0168-583X(97)00049-9
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA XG605
UT WOS:A1997XG60500222
DA 2018-10-19
ER

PT J
AU Anglin, MK
AF Anglin, MK
TI Working from the inside out: Implications of breast cancer activism for
   biomedical policies and practices
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Review
DE breast cancer; activism; treatment; policy; research
ID AFRICAN-AMERICAN WOMEN; LATE-STAGE DIAGNOSIS; SOCIAL-CLASS;
   RISK-FACTORS; MEDICAL PROGRESS; CERVICAL-CANCER; FAMILIAL BREAST;
   OVARIAN-CANCER; AIDS TRIALS; AGE
AB Much has been written about women with breast cancer: about women's lifestyles and reproductive strategies as possible risk Factors for the disease, factors which impede or Facilitate women's participation in mammography screening, ways to involve women in treatment decision-making, and women's ability to cope with breast cancer diagnoses. Seldom do these accounts examine breast cancer from the perspective of women with the disease. This essay presents material from an ethnographic study in the United Stales to explore the ways that women have come forward as informed consumers and activists working to make biomedical practices more responsive to the needs of women with breast cancer. Insofar as breast cancer activists reflect the concerns of a predominantly white, middle class constituency, however, additional questions are raised concerning their constructions of breast cancer and the problematics of treatment. (C) 1997 Elsevier Science Ltd.
RP Anglin, MK (reprint author), UNIV KENTUCKY, DEPT ANTHROPOL, 211 LAFFERTY HALL, LEXINGTON, KY 40506 USA.
FU NIA NIH HHS [T32 AG00045]
CR *AM CANC SOC, 1996, CANC FACTS FIG 1996
   ANGELL M, 1994, NEW ENGL J MED, V330, P1448, DOI 10.1056/NEJM199405193302010
   ANGLIN MK, 1992, UNPUB
   ANGLIN MK, 1994, SOWING SEEDS MOUNTAI, P179
   [Anonymous], 1992, NY TIMES        1029
   ASTROW AB, 1994, LANCET, V343, P494, DOI 10.1016/S0140-6736(94)91454-0
   BAIR B, 1993, WINGS GAUZE WOMEN CO
   Baker R, 1995, BETA, P6
   BALSHEM M, 1991, AM ETHNOL, V18, P152, DOI 10.1525/ae.1991.18.1.02a00070
   BASSETT MT, 1986, AM J PUBLIC HEALTH, V76, P1400, DOI 10.2105/AJPH.76.12.1400
   BATT S, 1994, PATIENT NO MORE POLI
   BIESELE M, 1996, PERFORMANCE HEALING
   BLACK WC, 1995, J NATL CANCER I, V87, P720, DOI 10.1093/jnci/87.10.720
   BLOOM JR, 1994, CANCER, V74, P1464, DOI 10.1002/1097-0142(19940815)74:4+<1464::AID-CNCR2820741611>3.0.CO;2-K
   BRADY J, 1991, ONE 3 WOMEN CANC CON
   BURTNESS BA, 1995, JAMA-J AM MED ASSOC, V273, P1702, DOI 10.1001/jama.273.21.1702
   Butler Sandra, 1991, CANC 2 VOICES
   BYAR DP, 1990, NEW ENGL J MED, V323, P1343, DOI 10.1056/NEJM199011083231912
   CHAVEZ LR, 1995, MED ANTHROPOL Q, V9, P40, DOI 10.1525/maq.1995.9.1.02a00030
   COLDITZ GA, 1993, JAMA-J AM MED ASSOC, V270, P338, DOI 10.1001/jama.270.3.338
   COOPER CL, 1992, PSYCHOL MED, V22, P447, DOI 10.1017/S0033291700030397
   COPE O, 1965, AM J SURG, V110, P119, DOI 10.1016/0002-9610(65)90165-0
   COPE O, 1977, BREAST ITS TROUBLES
   COTTON P, 1990, JAMA-J AM MED ASSOC, V264, P666
   CRILE G, 1961, ANN SURG, V153, P745
   CRILE G, 1973, WHAT WOMEN SHOULD KN
   DAYAL HH, 1970, J CHRON DIS, V23, P105
   EASTON DF, 1993, AM J HUM GENET, V52, P678
   ELEY JW, 1994, JAMA-J AM MED ASSOC, V272, P947, DOI 10.1001/jama.272.12.947
   ERIKSON J, 1995, SCIENCE, V269, P1508, DOI 10.1126/science.7667631
   FARLEY TA, 1989, AM J PUBLIC HEALTH, V79, P1508, DOI 10.2105/AJPH.79.11.1508
   FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302
   FRIEDMAN LS, 1994, CANCER RES, V54, P6374
   FUGHBERMAN A, 1992, LANCET, V340, P1143, DOI 10.1016/0140-6736(92)93161-F
   FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630
   GANZ PA, 1995, CA-CANCER J CLIN, V45, P114, DOI 10.3322/canjclin.45.2.114
   GANZ PA, 1992, J CLIN EPIDEMIOL, V45, P473, DOI 10.1016/0895-4356(92)90096-6
   GANZ PA, 1992, NEW ENGL J MED, V326, P1147, DOI 10.1056/NEJM199204233261708
   Gifford S., 1986, ANTHR EPIDEMIOLOGY, P213
   GLANZ K, 1992, Annals of Behavioral Medicine, V14, P204
   GOOD MJD, 1995, AM MED QUEST COMPETE
   GREGG J, 1994, SOC SCI MED, V39, P519, DOI 10.1016/0277-9536(94)90094-9
   HACK TF, 1994, SOC SCI MED, V39, P279, DOI 10.1016/0277-9536(94)90336-0
   HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482
   HARRIS JR, 1992, NEW ENGL J MED, V327, P473, DOI 10.1056/NEJM199208133270706
   HARRIS JR, 1992, NEW ENGL J MED, V327, P390, DOI 10.1056/NEJM199208063270606
   HARRIS JR, 1992, NEW ENGL J MED, V327, P319, DOI 10.1056/NEJM199207303270505
   HELLMAN S, 1993, CANCER-AM CANCER SOC, V71, P2430, DOI 10.1002/1097-0142(19930401)71:7<2430::AID-CNCR2820710743>3.0.CO;2-Z
   HENDERSON BE, 1991, BREAST CANCER RES TR, V18, pS11, DOI 10.1007/BF02633520
   HENDERSON IC, 1990, CURR PROB CANCER, V14, P163
   HENDERSON IC, 1993, CANCER-AM CANCER SOC, V71, P2127, DOI 10.1002/1097-0142(19930315)71:6+<2127::AID-CNCR2820711602>3.0.CO;2-2
   HENDERSON IC, 1992, NEW ENGL J MED, V326, P1774, DOI 10.1056/NEJM199206253262611
   HENDERSON IC, 1991, BREAST DISEASES, P547
   HENDERSON IC, 1991, BREAST DIS, P427
   HILTS PJ, 1996, NY TIMES        0330, P1
   HILTS PJ, 1996, NY TIMES        0330, P8
   HOLMES FF, 1981, J AM GERIATR SOC, V29, P55, DOI 10.1111/j.1532-5415.1981.tb01227.x
   *I MED, 1993, STRAT MAN BREAST CAN
   JENG MH, 1992, CANCER RES, V52, P6539
   JONES JH, 1981, BAD BLOOD TUSKEGEE S
   KANG SH, 1993, J NATL CANCER I, V85, P737, DOI 10.1093/jnci/85.9.737
   KELSEY JL, 1991, CA-CANCER J CLIN, V41, P146, DOI 10.3322/canjclin.41.3.146
   KELSEY JL, 1993, EPIDEMIOL REV, V15, P7, DOI 10.1093/oxfordjournals.epirev.a036118
   KLIJN JGM, 1994, HUM REPROD, V9, P181, DOI 10.1093/humrep/9.suppl_1.181
   KOHLMEIER L, 1990, ANN NY ACAD SCI, V609, P259, DOI 10.1111/j.1749-6632.1990.tb32073.x
   KRIEGER N, 1990, AM J EPIDEMIOL, V131, P804, DOI 10.1093/oxfordjournals.aje.a115571
   Kushner R., 1975, BREAST CANC PERSONAL
   KUSHNER R, 1984, ALTERNATIVES
   KUSKA B, 1995, J NATL CANCER I, V87, P1578, DOI 10.1093/jnci/87.21.1578
   KUSKA B, 1995, J NATL CANCER I, V87, P1505, DOI 10.1093/jnci/87.20.1505
   Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301
   LAUVER D, 1994, RES NURS HEALTH, V17, P421, DOI 10.1002/nur.4770170605
   LORDE A, 1988, BURST LIGHT
   Lorde Audre, 1980, CANC J
   LOVE SM, 1993, JAMA-J AM MED ASSOC, V269, P2417, DOI 10.1001/jama.269.18.2417
   Mahon S M, 1990, Oncol Nurs Forum, V17, P47
   MANDELBLATT J, 1991, AM J PUBLIC HEALTH, V81, P646, DOI 10.2105/AJPH.81.5.646
   MARSHALL E, 1992, SCIENCE, V258, P732, DOI 10.1126/science.1439774
   MATHEWS HF, 1994, SOC SCI MED, V38, P789, DOI 10.1016/0277-9536(94)90151-1
   MATHEWS J, 1992, WASHINGTON POST 1102
   McCoy H V, 1992, J Community Health, V17, P27
   MCPHERSON K, 1994, BRIT MED J, V309, P1003, DOI 10.1136/bmj.309.6960.1003
   MERIGAN TC, 1990, NEW ENGL J MED, V323, P1341, DOI 10.1056/NEJM199011083231911
   Metzger D., 1981, WOMAN WHO SLEPT MEN
   MILLER AB, 1992, CAN MED ASSOC J, V147, P1459
   MILLONUNDERWOOD S, 1993, CANCER NURS, V16, P25
   MONTINI T, 1989, RES SOCIOLOGY HLTH C, V8, P3
   MONTINI TM, 1991, THESIS
   *NAT CTR HLTH STAT, 1990, DHHS PUBL
   NAYFIELD SG, 1994, J NATL CANCER I, V86, P1202, DOI 10.1093/jnci/86.16.1202
   *NIH, 1994, NIH GUID, V2310
   *NIH, 1993, P SECR C EST NAT ACT
   *NO CA CTR, 1994, 5 NO CAL CTR GREAT B
   *NORCAL, UNPUB BRIEF HIST
   *NORCAL CBCC, UNPUB CANC IN RESP
   *PRES CANC PAN, 1992, M SUMM PAT ADV VOL O
   QUINN SC, 1993, HEALTH EDUC QUART, V20, P305, DOI 10.1177/109019819302000303
   Raloff Janet, 1992, Sci News, V142, P378, DOI 10.2307/4017895
   RAPP R, 1993, KNOWLEDGE POWER PRAC, P55
   RIES LAG, 1994, NIH PUB
   RIMER BK, 1995, J NATL CANCER I, V87, P703, DOI 10.1093/jnci/87.10.703
   Rollin Betty, 1976, 1 YOU CRY
   ROWELL S, 1994, AM J HUM GENET, V55, P861
   ROWLAND JH, 1991, BREAST DISEASES, P849
   ROY B, 1995, J NATL MED ASSOC, V87, P56
   Ruzek Sheryl Burt, 1978, WOMENS HLTH MOVEMENT
   SALISBURY DA, 1990, CAN MED ASSOC J, V142, P1057
   SCHAG CAC, 1993, J CLIN ONCOL, V11, P783, DOI 10.1200/JCO.1993.11.4.783
   SEACHRIST L, 1994, SCIENCE, V264, P499, DOI 10.1126/science.8160006
   SOLOMON A, 1992, CAMERA OBSCURA, P157
   SPIEGEL D, 1990, PSYCHOSOMATICS, V31, P361, DOI 10.1016/S0033-3182(90)72130-5
   SPIEGEL D, 1989, LANCET, V2, P888
   STOCKER M, 1991, CANC WOMENS ISSUE SC
   Stocker Midge, 1993, CONFRONTING CANC CON
   THOMAS SB, 1991, AM J PUBLIC HEALTH, V81, P1498, DOI 10.2105/AJPH.81.11.1498
   THOMPSON D, 1992, TIME            1012, P66
   THOMPSON WD, 1994, CANCER, V74, P279
   VITETTA ES, 1994, CANCER RES, V54, P5301
   WACHTER RM, 1992, NEW ENGL J MED, V326, P128, DOI 10.1056/NEJM199201093260209
   WADLER J, 1992, MY BREAST ONE WOMANS
   WEBER BL, 1994, NEW ENGL J MED, V331, P1523, DOI 10.1056/NEJM199412013312214
   WEBER BL, 1996, JNCI-J NATL CANCER I, V88, P70
   White E., 1990, BLACK WOMENS HLTH BO
   Williams T.T., 1991, REFUGE UNNATURAL HIS
   ZUCKER A, 1994, DEATH STUD, V18, P555, DOI 10.1080/07481189408252699
   1992, NY TIMES        1019
   1996, LANCET, V347, P133
NR 127
TC 37
Z9 37
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD MAY
PY 1997
VL 44
IS 9
BP 1403
EP 1415
DI 10.1016/S0277-9536(96)00321-8
PG 13
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA WV612
UT WOS:A1997WV61200014
PM 9141172
DA 2018-10-19
ER

PT J
AU Kobayashi, K
   Tsuchida, A
   Usui, T
   Akaike, T
AF Kobayashi, K
   Tsuchida, A
   Usui, T
   Akaike, T
TI A new type of artificial glycoconjugate polymer: A convenient synthesis
   and its interaction with lectins
SO MACROMOLECULES
LA English
DT Article
ID WHEAT-GERM-AGGLUTININ; SPECIFICITY; BINDING; OLIGOSACCHARIDES;
   GLYCOSYLAMINES; PURIFICATION
AB A convenient synthetic route to a new type of artificial glycoconjugate polymer has been designed to develop biomedical materials using oligosaccharide moieties as recognition signals. An amino function was introduced to the reducing end of lactose and N,N'-diacetylchitobiose with ammonium hydrogen carbonate and then was allowed to react with p-vinylbenzoyl chloride. The N-glycosidation proceeded stereospecifically in one flask to give only the beta-glycoside without any protection and deprotection steps; The resulting p-vinylbenzamide glycoside derivatives were homo- and copolymerized with acrylamide using 2,2'-azobisisobutyronitrile as initiator in dimethyl sulfoxide at 60 degrees C. The interaction of the glycopolymers with lectins was investigated by means of a two-dimensional immunodiffusion test in agar and inhibition of the hemagglutinating activity. The specificity of lectins with these glycopolymers was similar to that reported for naturally-occurring glycoconjugates. Binding between wheat germ agglutinin lectin (WGA) and poly((p-vinylbenzamido)-beta-diacetylchitobiose) was increased by 10(3) times compared with that of the oligosaccharide itself. The enhancement was attributed to the presence of the hydrophobic phenyl aglycon as well as the high density, multiantennary disaccharide ligands along the polymer chain. The present synthetic method is useful to introduce biologically important, complex oligosaccharides into glycopolymers.
C1 NAGOYA UNIV, GRAD SCH ENGN, DEPT BIOTECHNOL, NAGOYA, AICHI 46401, JAPAN.
   SHIZUOKA UNIV, FAC AGR, SHIZUOKA 422, JAPAN.
   TOKYO INST TECHNOL, FAC BIOSCI & TECHNOL, YOKOHAMA, KANAGAWA 226, JAPAN.
RP Kobayashi, K (reprint author), NAGOYA UNIV, GRAD SCH ENGN, DEPT MOL DESIGN, NAGOYA, AICHI 46401, JAPAN.
CR Bock K., 1974, J CHEM SOC        P2, V2, P293
   BYSTROV VF, 1973, TETRAHEDRON, V29, P873, DOI 10.1016/0040-4020(73)80031-6
   COHENANISFELD ST, 1993, J AM CHEM SOC, V115, P10531, DOI 10.1021/ja00076a010
   CROWLEY JF, 1984, ARCH BIOCHEM BIOPHYS, V231, P524, DOI 10.1016/0003-9861(84)90417-X
   GOLDSTEIN IJ, 1972, METHODS CARBOHYD CHE, V6, P106
   IGLESIAS JL, 1982, EUR J BIOCHEM, V123, P247, DOI 10.1111/j.1432-1033.1982.tb19760.x
   KALLIN E, 1989, J CARBOHYD CHEM, V8, P597, DOI 10.1080/07328308908048020
   KAWAGISHI H, 1994, J BIOL CHEM, V269, P1375
   KOBAYASHI A, 1994, J BIOMAT SCI-POLYM E, V6, P325, DOI 10.1163/156856295X00030
   KOBAYASHI K, 1988, J MACROMOL SCI CHEM, VA25, P655, DOI 10.1080/00222338808053391
   KOBAYASHI K, 1985, POLYM J, V17, P567, DOI 10.1295/polymj.17.567
   KOBAYASHI K, 1994, J CARBOHYD CHEM, V13, P753, DOI 10.1080/07328309408011678
   KOBAYASHI K, 1994, NEOGLYCOCONJUGATES B, P409
   KOBAYASHI K, 1990, TRENDS GLYCOSCI GLYC, V2, P26
   Kobayashi Kazukiyo, 1994, P261
   LANDSCHOOT AV, 1977, EUR J BIOCHEM, V79, P275
   LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001
   LEE YC, 1994, NEOGLYCOCONJUGATES P
   LEE YC, 1994, METHODS ENZYMOLOGY, V247
   LEE YC, 1994, METHODS ENZYMOLOGY, V242
   LIKHOSHERSTOV LM, 1986, CARBOHYD RES, V146, pC1, DOI 10.1016/0008-6215(86)85037-6
   LOTAN R, 1975, J BIOL CHEM, V250, P8518
   MATSUOKA K, 1995, MACROMOLECULES, V28, P2961, DOI 10.1021/ma00112a049
   NAGATA Y, 1974, J BIOL CHEM, V249, P3116
   NICOLSON GL, 1972, BIOCHIM BIOPHYS ACTA, V266, P543, DOI 10.1016/0005-2736(72)90109-5
   NISHIMURA SI, 1994, MACROMOLECULES, V27, P4876, DOI 10.1021/ma00096a004
   WRIGHT CS, 1990, J MOL BIOL, V215, P635, DOI 10.1016/S0022-2836(05)80174-3
NR 27
TC 129
Z9 130
U1 1
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
EI 1520-5835
J9 MACROMOLECULES
JI Macromolecules
PD APR 7
PY 1997
VL 30
IS 7
BP 2016
EP 2020
DI 10.1021/ma961681e
PG 5
WC Polymer Science
SC Polymer Science
GA WT213
UT WOS:A1997WT21300021
DA 2018-10-19
ER

PT J
AU Yang, ZH
   Yu, H
AF Yang, ZH
   Yu, H
TI Preserving a globular protein shape on glass slides: A self-assembled
   monolayer approach
SO ADVANCED MATERIALS
LA English
DT Article
ID LATERAL DIFFUSION; SURFACE INTERACTIONS; POLYETHYLENE OXIDE; ADSORPTION;
   MEMBRANE
AB The manufacture of low-cost, protein-friendly, biocompatible materials is important for biomedical applications. A method is presented for making glass surfaces-on which the globular protein shape is often lost-benign to proteins by covalently grafting relatively short poly(ethylene glycol) chains (functionalized with trimethylsilane, see Figure), which form a brush-like self-assembled monolayer.
C1 UNIV WISCONSIN,DEPT CHEM,MADISON,WI 53706.
CR ALLARA DL, 1992, POLYM SURFACES INTER, V2
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   ANDRADE JD, 1996, HYDROPHILIC POLYM
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   Fadley C. S., 1976, Progress in Solid State Chemistry, P265, DOI 10.1016/0079-6786(76)90013-3
   FRITZ M, 1995, LANGMUIR, V11, P3529, DOI 10.1021/la00009a040
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   HENIS YI, 1988, BIOPOLYMERS, V27, P123, DOI 10.1002/bip.360270110
   Hoffman AS, 1996, MACROMOL SYMP, V101, P443, DOI 10.1002/masy.19961010150
   JENNISSEN HP, 1989, BER BUNSEN PHYS CHEM, V93, P948, DOI 10.1002/bbpc.19890930905
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   KIM S, 1992, PROG COLL POL SCI S, V89, P202
   KIM SH, 1992, J PHYS CHEM-US, V96, P4034, DOI 10.1021/j100189a023
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SMITH BA, 1978, P NATL ACAD SCI USA, V75, P2759, DOI 10.1073/pnas.75.6.2759
   TAKEZOE H, 1981, BIOCHEMISTRY-US, V20, P5275, DOI 10.1021/bi00521a028
   VROMAN L, 1966, BLOOD
   ZHDANOV SP, 1987, LANGMUIR, V3, P960, DOI 10.1021/la00078a014
NR 24
TC 11
Z9 11
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD APR
PY 1997
VL 9
IS 5
BP 426
EP &
DI 10.1002/adma.19970090515
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA WT969
UT WOS:A1997WT96900014
DA 2018-10-19
ER

PT J
AU Wink, T
   vanZuilen, SJ
   Bult, A
   vanBennekom, WP
AF Wink, T
   vanZuilen, SJ
   Bult, A
   vanBennekom, WP
TI Self-assembled monolayers for biosensors
SO ANALYST
LA English
DT Review
DE self-assembled monolayer; immunoassay; electrochemistry; surface plasmon
   resonance; (electrochemical) quartz crystal microbalance; biosensor
ID SURFACE-PLASMON RESONANCE; ORGANIZED MOLECULAR ASSEMBLIES;
   SCANNING-TUNNELING-MICROSCOPY; QUARTZ-CRYSTAL MICROBALANCE; GOLD
   SURFACES; ENZYME ELECTRODES; METAL-SURFACES; STRUCTURAL
   CHARACTERIZATION; COVALENT IMMOBILIZATION; ALKANETHIOL MONOLAYERS
AB The use of self-assembled monolayers (SAMs) in various fields of research is rapidly growing, In particular, many biomedical fields apply SAMs as an interface-layer between a metal surface and a solution or vapour, This review summarises methods for the formation of SAMs upon the most commonly used materials and techniques used for monolayer characterisation, Emphasis will lie on uniform, mixed and functionalised monolayers applied for immobilisation of biological components including (oligo-)nucleotides, proteins, antibodies and receptors as well as polymers, The application of SAMs in today's research, together with some applications will be discussed.
RP Wink, T (reprint author), UNIV UTRECHT, FAC PHARM, DEPT PHARMACEUT ANAL, POB 80082, NL-3508 TB UTRECHT, NETHERLANDS.
CR ACHTNICH UR, 1992, BIOSENS BIOELECTRON, V7, P279, DOI 10.1016/0956-5663(92)87006-B
   ALLARA DL, 1995, BIOSENS BIOELECTRON, V10, P771, DOI 10.1016/0956-5663(95)99215-7
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   BAIN CD, 1989, J AM CHEM SOC, V111, P7164, DOI 10.1021/ja00200a040
   BERTILSSON L, 1993, LANGMUIR, V9, P141, DOI 10.1021/la00025a032
   BHARATHI S, 1993, LANGMUIR, V9, P1614, DOI 10.1021/la00031a002
   BYFIELD MP, 1994, BIOSENS BIOELECTRON, V9, P373, DOI 10.1016/0956-5663(94)80038-3
   Carraway K L, 1972, Methods Enzymol, V25, P616, DOI 10.1016/S0076-6879(72)25060-1
   CHENG CA, 1995, ANAL CHEM, V67, P2767
   CHENG Q, 1992, ANAL CHEM, V64, P1998, DOI 10.1021/ac00041a041
   CHIDSEY CED, 1990, LANGMUIR, V6, P682, DOI 10.1021/la00093a026
   COLLINSON M, 1992, LANGMUIR, V8, P1247, DOI 10.1021/la00041a004
   CREAGER SE, 1995, ANAL CHIM ACTA, V307, P277, DOI 10.1016/0003-2670(94)00506-H
   DELAMARCHE E, 1994, LANGMUIR, V10, P4103, DOI 10.1021/la00023a033
   DEWELDIGE K, 1995, FRESEN J ANAL CHEM, V353, P329, DOI 10.1007/BF00322062
   DOWNS MEA, 1987, ANAL LETT, V20, P1897
   DUAN CM, 1994, ANAL CHEM, V66, P1369, DOI 10.1021/ac00081a003
   DUBOIS LH, 1992, ANNU REV PHYS CHEM, V43, P437, DOI 10.1146/annurev.pc.43.100192.002253
   Duschl C, 1996, BIOPHYS J, V70, P1985, DOI 10.1016/S0006-3495(96)79763-1
   EBERSOLE RC, 1990, J AM CHEM SOC, V112, P3239, DOI 10.1021/ja00164a070
   EDINGER K, 1993, LANGMUIR, V9, P4, DOI 10.1021/la00025a002
   FAGERSTAM LG, 1992, J CHROMATOGR, V597, P397, DOI 10.1016/0021-9673(92)80137-J
   Finklea H. O., 1996, ELECTROANALYTICAL CH, V19, P110
   FINKLEA HO, 1987, LANGMUIR, V3, P409, DOI 10.1021/la00075a024
   Ford JF, 1996, LANGMUIR, V12, P1944, DOI 10.1021/la950913k
   GODDARD NJ, 1994, ANALYST, V119, P583, DOI 10.1039/an9941900583
   GOPEL W, 1995, BIOSENS BIOELECTRON, V10, P853, DOI 10.1016/0956-5663(95)99225-A
   Grate JW, 1996, ANAL CHEM, V68, P913, DOI 10.1021/ac950518z
   GRUNZE M, 1993, PHYS SCRIPTA, VT49B, P711, DOI 10.1088/0031-8949/1993/T49B/056
   Harsanyi G, 1996, MATER CHEM PHYS, V43, P199, DOI 10.1016/0254-0584(95)01629-9
   HAUSSLING L, 1991, LANGMUIR, V7, P1837
   HEINEMAN WR, 1985, ANAL CHEM, V57, P1321, DOI 10.1021/ac00289a804
   HOSHI T, 1994, ANAL CHIM ACTA, V289, P321, DOI 10.1016/0003-2670(94)90008-X
   IVARSSON B A, 1985, Colloids and Surfaces, V13, P169, DOI 10.1016/0166-6622(85)80015-9
   JIANG L, 1995, J CHEM SOC CHEM COMM, P1293, DOI 10.1039/c39950001293
   JONSSON U, 1988, METHOD ENZYMOL, V137, P381
   KARPOVICH DS, 1994, LANGMUIR, V10, P3315, DOI 10.1021/la00021a066
   KELLER H, 1992, THIN SOLID FILMS, V210, P799, DOI 10.1016/0040-6090(92)90408-4
   KEPLEY LJ, 1992, ANAL CHEM, V64, P3191, DOI 10.1021/ac00048a018
   KIM YT, 1993, LANGMUIR, V9, P1941, DOI 10.1021/la00032a001
   KOOYMAN RPH, 1994, THIN SOLID FILMS, V244, P913, DOI 10.1016/0040-6090(94)90599-1
   KRETSCHM.E, 1968, Z NATURFORSCH PT A, VA 23, P2135
   LIEDBERG B, 1985, PROG COLL POL SCI S, V70, P67
   LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526
   LOFAS S, 1995, BIOSENS BIOELECTRON, V10, P813
   Lu B, 1996, ANALYST, V121, pR29, DOI 10.1039/an996210029r
   LUNDSTROM I, 1985, PROG COLL POL SCI S, V70, P76
   LUNDSTROM I, 1985, J COLLOID INTERF SCI, V108, P288, DOI 10.1016/0021-9797(85)90264-4
   MALEM F, 1993, ANAL CHEM, V65, P37, DOI 10.1021/ac00049a009
   Mandler D, 1996, ELECTROANAL, V8, P207, DOI 10.1002/elan.1140080302
   MATSUDA T, 1995, LANGMUIR, V11, P2267
   MILLAN KM, 1993, ANAL CHEM, V65, P2317, DOI 10.1021/ac00065a025
   MINUNNI M, 1995, ANAL LETT, V28, P749, DOI 10.1080/00032719508001422
   MITTLERNEHER S, 1995, BIOSENS BIOELECTRON, V10, P903, DOI 10.1016/0956-5663(95)99228-D
   MORGAN H, 1992, THIN SOLID FILMS, V210, P773, DOI 10.1016/0040-6090(92)90400-6
   MORGEN H, 1995, BIOSENS BIOELECTRON, V10, P841, DOI 10.1016/0956-5663(95)99223-8
   MRKSICH M, 1995, LANGMUIR, V11, P4383, DOI 10.1021/la00011a034
   NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012
   NUZZO RG, 1987, J AM CHEM SOC, V109, P2358, DOI 10.1021/ja00242a020
   NUZZO RG, 1987, J AM CHEM SOC, V109, P733, DOI 10.1021/ja00237a017
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   PAN J, 1993, LANGMUIR, V9, P1556, DOI 10.1021/la00030a022
   Pang DW, 1996, J ELECTROANAL CHEM, V403, P183, DOI 10.1016/0022-0728(95)04383-7
   PISCEVIC D, 1995, APPL SURF SCI, V90, P425, DOI 10.1016/0169-4332(95)00171-9
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   POSTLETHWAITE TA, 1995, LANGMUIR, V11, P4109, DOI 10.1021/la00010a076
   Rickert J, 1996, BIOSENS BIOELECTRON, V11, P591, DOI 10.1016/0956-5663(96)83294-5
   RIKLIN A, 1995, ANAL CHEM, V67, P4118, DOI 10.1021/ac00118a014
   ROBERTS GG, 1983, LANGMUIR BLODGETT FI
   Rubin S, 1996, LANGMUIR, V12, P363, DOI 10.1021/la950071p
   SADIK OA, 1993, ANAL CHIM ACTA, V279, P209, DOI 10.1016/0003-2670(93)80319-G
   SAGIV J, 1980, J AM CHEM SOC, V102, P2
   SAYRE CN, 1995, LANGMUIR, V11, P302, DOI 10.1021/la00001a051
   SCHIERBAUM KD, 1994, SCIENCE, V265, P1413, DOI 10.1126/science.265.5177.1413
   Schmidt A., 1992, Biophysical Journal, V63, P1185
   SCHMITT FJ, 1992, THIN SOLID FILMS, V210, P815, DOI 10.1016/0040-6090(92)90412-5
   SCHNEIDER TW, 1993, J AM CHEM SOC, V115, P12391, DOI 10.1021/ja00079a021
   SCHRAMM W, 1993, IMMUNOMETHODS, V3, P93
   SCOUTEN WH, 1987, METHOD ENZYMOL, V135, P30
   Sellergren B, 1996, ANAL CHEM, V68, P402, DOI 10.1021/ac9508356
   Sigal GB, 1996, ANAL CHEM, V68, P490, DOI 10.1021/ac9504023
   SPINKE J, 1993, J CHEM PHYS, V99, P7012, DOI 10.1063/1.465447
   STRONG L, 1988, LANGMUIR, V4, P546, DOI 10.1021/la00081a009
   SUN L, 1993, LANGMUIR, V9, P1951, DOI 10.1021/la00032a004
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V113, P530, DOI 10.1016/S0021-9797(86)90446-7
   TERRETTAZ S, 1993, LANGMUIR, V9, P1361, DOI 10.1021/la00029a033
   TROUGHTON EB, 1988, LANGMUIR, V4, P365, DOI 10.1021/la00080a021
   Truong KD, 1995, PROG SURF SCI, V50, P207, DOI 10.1016/0079-6816(95)00055-0
   Turner A., 1987, BIOSENSORS FUNDAMENT
   ULMAN A, 1995, CHARACTERIZATION ORG
   VANDENHEUVEL DJ, 1993, ANAL BIOCHEM, V215, P223, DOI 10.1006/abio.1993.1579
   VANOS PJHJ, 1995, ANAL CHIM ACTA, V305, P18, DOI 10.1016/0003-2670(94)00374-U
   Wagner P, 1996, BIOPHYS J, V70, P2052, DOI 10.1016/S0006-3495(96)79810-7
   WALCZAK MM, 1991, LANGMUIR, V7, P2687, DOI 10.1021/la00059a048
   WEISSHAAR DE, 1992, J AM CHEM SOC, V114, P5860, DOI 10.1021/ja00040a058
   WIDRIG CA, 1991, J ELECTROANAL CHEM, V310, P335, DOI 10.1016/0022-0728(91)85271-P
   WILLICUT RJ, 1995, ADV MATER, V7, P759, DOI 10.1002/adma.19950070819
   WILLNER I, 1994, ANAL CHEM, V66, P1535, DOI 10.1021/ac00081a028
   WOLFE CAC, 1995, ANAL BIOCHEM, V231, P123, DOI 10.1006/abio.1995.1511
   XU J, 1995, J COLLOID INTERF SCI, V176, P138, DOI 10.1006/jcis.1995.0017
   ZHAO S, 1992, LANGMUIR, V8, P2785, DOI 10.1021/la00047a034
NR 102
TC 320
Z9 330
U1 6
U2 109
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
EI 1364-5528
J9 ANALYST
JI Analyst
PD APR
PY 1997
VL 122
IS 4
BP R43
EP R50
DI 10.1039/a606964i
PG 8
WC Chemistry, Analytical
SC Chemistry
GA WU814
UT WOS:A1997WU81400001
PM 9177074
DA 2018-10-19
ER

PT J
AU Jha, LJ
   Best, SM
   Knowles, JC
   Rehman, I
   Santos, JD
   Bonfield, W
AF Jha, LJ
   Best, SM
   Knowles, JC
   Rehman, I
   Santos, JD
   Bonfield, W
TI Preparation and characterization of fluoride-substituted apatites
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CRYSTAL-GROWTH; HYDROXYAPATITE; TEMPERATURE
AB Apatites were prepared with three different fluoride concentrations: 0.0 mM (pure hydroxyapatite) 2.5 mM and 5 mM. Reactions were performed in aqueous medium using a reaction between diammonium orthophosphate and calcium nitrate 4-hydrate and ammonium fluoride at temperatures of 3 degrees, 25 degrees, 60 degrees and 90 degrees C. The effects of reaction temperature and fluoride concentration on the crystal morphology, phase purity and crystallinity of the precipitates were observed, using transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier transform infrared (FTIR) spectroscopy and ion chromatography. Transmission electron micrographs revealed that the crystallites precipitated at 3 degrees C were spheroidal, but became increasingly acicular with increasing precipitation temperature. X-ray diffraction results indicated that all the materials produced were phase pure and that the crystallinity of apatites prepared at higher precipitation temperatures was higher than those prepared at lower precipitation temperatures. A significant difference in the a-axis dimension of fluoride-substituted apatites was observed, as compared to hydroxyapatite. FTIR spectroscopy revealed a hydroxyl band at 3568 cm(-1), along with a broad peak of adsorbed water in the region of 3568 cm(-1) to 2670 cm(-1) in the hydroxyapatite and fluoride-substituted apatite powders. Hence by careful selection of the precipitation conditions and fluoride contents, the composition and morphology of fluoride-substituted apatite may be controlled and this has interesting implications for the development of these materials for biomedical implantation.
C1 UNIV PORTO, FAC ENGN, DEPT MET, P-4099 OPORTO, PORTUGAL.
   UNIV LONDON QUEEN MARY & WESTFIELD COLL, INTERDISCIPLINARY RES CTR BIOMED MAT, LONDON E1 4NS, ENGLAND.
RP Jha, LJ (reprint author), UNIV PORTO, FAC ENGN, NATL INST BIOMED ENGN, RUA BRAGAS, P-4099 OPORTO, PORTUGAL.
RI Knowles, Jonathan Campbell/B-9019-2008
OI Knowles, Jonathan Campbell/0000-0003-3917-3446; Santos, Jose
   Domingos/0000-0002-6871-9850
CR ABRAHAMS I, 1994, J MATER CHEM, V4, P185, DOI 10.1039/jm9940400185
   ARENDS J, 1981, J CRYST GROWTH, V53, P135, DOI 10.1016/0022-0248(81)90060-9
   BARONE JP, 1978, J DENT RES, V57, P735, DOI 10.1177/00220345780570051601
   BETTS F, 1981, J CRYST GROWTH, V53, P63, DOI 10.1016/0022-0248(81)90056-7
   BOIVIN G, 1990, METABOLLIC MOL BASIS
   CHRISTOFFERSEN J, 1980, J CRYST GROWTH, V49, P29, DOI 10.1016/0022-0248(80)90057-3
   CHRISTOFFERSEN J, 1995, 12 EUR C BIOM PORT P
   CHRISTOFFERSEN MR, 1990, J CRYST GROWTH, V106, P349, DOI 10.1016/0022-0248(90)90079-Z
   Dorozhkin S. V., 1994, Russian Journal of Inorganic Chemistry, V39, P217
   DRIESSENS FCM, 1988, BIOCERAMICS CALCIUM, P1
   DUFF EJ, 1971, J CHEM SOC A, P33, DOI 10.1039/j19710000033
   ISHIKAWA K, 1994, J DENT RES, V73, P1462, DOI 10.1177/00220345940730081101
   KANDORI K, 1995, CHEM MATER, V7, P26, DOI 10.1021/cm00049a007
   LARSON AC, 1990, GSAS GEN CRYSTAL STR
   LEGEROS RZ, 1988, J FLUORINE CHEM, V41, P53, DOI 10.1016/S0022-1139(00)83016-X
   MEYER JL, 1972, J DENT RES, V51, P1443, DOI 10.1177/00220345720510053201
   MORENO EC, 1981, J CRYST GROWTH, V53, P20, DOI 10.1016/0022-0248(81)90052-X
   MORENO EC, 1974, NATURE, V247, P64, DOI 10.1038/247064a0
   NANCOLLAS GH, 1979, ACS SYM SER, V93, P475
   PANTUMVANIT P, 1977, CARIES RES, V11, P52
   TENHUISEN KS, 1994, J DENT RES, V73, P598, DOI 10.1177/00220345940730030501
   VANDENHOEK WGM, 1980, J PHYS CHEM-US, V84, P3312, DOI 10.1021/j100461a035
NR 22
TC 103
Z9 110
U1 1
U2 22
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 1997
VL 8
IS 4
BP 185
EP 191
DI 10.1023/A:1018531505484
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WU945
UT WOS:A1997WU94500002
PM 15348758
DA 2018-10-19
ER

PT J
AU Baselt, DR
   Lee, GU
   Hansen, KM
   Chrisey, LA
   Colton, RJ
AF Baselt, DR
   Lee, GU
   Hansen, KM
   Chrisey, LA
   Colton, RJ
TI A high-sensitivity micromachined biosensor
SO PROCEEDINGS OF THE IEEE
LA English
DT Article
DE biomedical transducers; magnetic forces; magnetic materials, devices;
   magnetic transducers; microelectromechanical devices; piezoresistive
   materials, devices
ID ATOMIC-FORCE MICROSCOPE; DNA
AB The Force Amplified Biological Sensor (FABS) is a desktop or portable instrument currently under development at the Naval Research Laboratory. FABS will use a rapid automated immunoassay to detect analytes such as proteins, viruses, and bacteria. The assay uses forces produced by micron-sized magnetic particles to pull on antibody-antigen bonds. Microfabricated piezoresistive cantilevers measure the resulting piconewton-level forces with sufficient sensitivity to detect single antibody-antigen bonds. These forces also serve to characterize the bonds, allowing FABs to distinguish specific antibody-antigen bonds from nonspecific interactions.
C1 GEOCENTERS INC, FT WASHINGTON, MD 20375 USA.
RP Baselt, DR (reprint author), USN, RES LAB, WASHINGTON, DC 20375 USA.
RI Lee, Gil/P-8696-2016
OI Lee, Gil/0000-0002-7949-5848
CR ALBRECHT TR, 1990, J VAC SCI TECHNOL A, V8, P3386, DOI 10.1116/1.576520
   Baselt DR, 1996, J VAC SCI TECHNOL B, V14, P789, DOI 10.1116/1.588714
   BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3
   BHATIA SK, 1992, J AM CHEM SOC, V114, P4432, DOI 10.1021/ja00037a077
   BHATIA SK, 1993, ANAL BIOCHEM, V208, P197, DOI 10.1006/abio.1993.1027
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BOLAND T, 1995, P NATL ACAD SCI USA, V92, P5297, DOI 10.1073/pnas.92.12.5297
   CALVERT JM, 1995, THIN FILMS ORGANIC T, V20, P109
   Chilkoti A, 1995, BIOPHYS J, V69, P2125, DOI 10.1016/S0006-3495(95)80083-4
   CHRISEY LA, IN PRESS NUCL ACIDS
   CHRISEY LA, 1994, MATER RES SOC S P, V300, P179
   Chui BW, 1996, APPL PHYS LETT, V69, P2767, DOI 10.1063/1.117669
   CUSSLER EL, 1994, MASS TRANSFER FLUID, P230
   DAMMER U, 1995, SCIENCE, V267, P1173, DOI 10.1126/science.7855599
   Dammer U, 1995, NATO ADV SCI INST SE, V286, P625
   Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4
   DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C
   GIMZEWSKI JK, 1994, CHEM PHYS LETT, V217, P589, DOI 10.1016/0009-2614(93)E1419-H
   Harley John, COMMUNICATION
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   HOH JH, 1992, J AM CHEM SOC, V114, P4917, DOI 10.1021/ja00038a075
   KRICKA LJ, 1994, CLIN CHEM, V40, P347
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628
   LEE GU, IN PRESS ISRAELI J C
   MANNING B, 1996, BIOSENS BIOELECTRON, V7, P391
   MEYER G, 1988, APPL PHYS LETT, V53, P1045, DOI 10.1063/1.100061
   Morgan CL, 1996, CLIN CHEM, V42, P193
   MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660
   NATISHAN PM, 1992, SURF COAT TECH, V51, P30, DOI 10.1016/0257-8972(92)90210-2
   OShea SJ, 1996, J VAC SCI TECHNOL B, V14, P1383, DOI 10.1116/1.589103
   RICHTER HJ, 1988, REV SCI INSTRUM, V59, P1388, DOI 10.1063/1.1139674
   SAKAGUCHI Y, 1994, MAT SCI ENG A-STRUCT, V181, P1232, DOI 10.1016/0921-5093(94)90837-0
   STENBERG M, 1988, J IMMUNOL METHODS, V113, P5
   STUART JK, 1995, LANGMUIR, V11, P1368, DOI 10.1021/la00004a051
   Sugawara Y, 1996, J VAC SCI TECHNOL B, V14, P953, DOI 10.1116/1.589182
   THUNDAT T, 1995, ANAL CHEM, V67, P519, DOI 10.1021/ac00099a006
   TORTONESE M, 1993, APPL PHYS LETT, V62, P834, DOI 10.1063/1.108593
NR 40
TC 102
Z9 102
U1 0
U2 17
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9219
J9 P IEEE
JI Proc. IEEE
PD APR
PY 1997
VL 85
IS 4
BP 672
EP 680
DI 10.1109/5.573755
PG 9
WC Engineering, Electrical & Electronic
SC Engineering
GA WX055
UT WOS:A1997WX05500014
DA 2018-10-19
ER

PT J
AU Meydan, T
   Oduncu, H
AF Meydan, T
   Oduncu, H
TI Enhancement of magnetostrictive properties of amorphous ribbons for a
   biomedical application
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article; Proceedings Paper
CT 1st European Magnetic Sensors and Actuators Conference
CY JUL 22-24, 1996
CL AL I CUZA UNIV, IASI, ROMANIA
SP Inst Tech Phys
HO AL I CUZA UNIV
DE inverse magnetostriction; amorphous ribbon; bone fracture healing;
   biomedical sensor; prestressing
ID FRACTURE
AB A novel method of monitoring bone fracture healing has been developed. The sensor is based on the stress dependence of permeability of the highly magnetostrictive amorphous ribbons. The magnetoelastic sensor is bonded to a stainless steel plate. The detection is provided by an outside coil surrounding the limb. Stresses introduced by the adhesives degrade the sensor's performance. These are overcome by prestressing and annealing the material bonded with ii high temperature adhesive. Using these techniques, it is possible to design a tensile stress or compressive stress sensor to be used in strain measurement of the plates. Such a sensor has considerably higher sensitivity, lower power consumption and is less invasive than a traditional strain gauge, The characteristics of these enhanced sensors are studied and optimum conditions on sensors' performance are reported. (C) 1997 Elsevier Science S.A.
RP Meydan, T (reprint author), UNIV WALES COLL CARDIFF,CARDIFF SCH ENGN,WOLFSON CTR MAGNET TECHNOL,POB 917,CARDIFF CF2 1XH,S GLAM,WALES.
OI Meydan, Turgut/0000-0002-4608-0507
CR BOURGOIS R, 1972, J BIOMECH, V5, P85, DOI 10.1016/0021-9290(72)90021-8
   BURNY F, 1984, ORTHOPEDICS, V7, P1823, DOI 10.3928/0147-7447-19841201-08
   HINZ G, 1989, MAGNETIC SENSORS, V5, P98
   MEYDAN T, 1994, J MAGN MAGN MATER, V133, P525, DOI 10.1016/0304-8853(94)90613-0
   Oduncu H, 1996, J MAGN MAGN MATER, V160, P233, DOI 10.1016/0304-8853(96)00214-4
   SAVAGE HT, 1982, J APPL PHYS, V53, P8092, DOI 10.1063/1.330269
   VANSCHUYLENBERG.K, 1992, P 14 ANN INT C IEEE, P2672
   WUNFOGLE M, 1989, J MAT ENG, V11, P1023
NR 8
TC 8
Z9 8
U1 0
U2 2
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD APR
PY 1997
VL 59
IS 1-3
BP 192
EP 196
DI 10.1016/S0924-4247(97)80172-0
PG 5
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA XN008
UT WOS:A1997XN00800036
DA 2018-10-19
ER

PT J
AU Lebrun, JP
   Corre, Y
   Douet, M
AF Lebrun, JP
   Corre, Y
   Douet, M
TI Cold plasma for surface treatment of titanium alloys
SO VIDE-SCIENCE TECHNIQUE ET APPLICATIONS
LA English
DT Article
ID WEAR
AB Because of their poor tribological properties, titanium alloys have a restricted field of applications.
   Modifying their surface properties is thus a real concern. The introduction of nitrogen on the surface improves significantly the tribological behaviour of these materials.
   Nitrogen ion implantation is a technique largely used in titanium alloy surface treatment. Industrial applications of this process are numerous (biomedical, aeronautics,...) but the limitations of this technique (essentially treatment depth) prevent its use in certain cases. The increase in treatment temperature can overcome these limitations. Thus, the analysis of the properties obtained after treatment at various temperatures (20 degrees C to 1000 degrees C) enables us to find the best compromise between metallurgic, geometrical properties (surface condition, deformation) and friction properties. This compromise enables us to solve a majority of tribological problems of titanium alloys.
   TITANIUM AND ITS ALLOYS are materials which are more and more frequently used in mechanical applications. Their low density combined with their very advantageous mechanical characteristics (such as resistance to fatigue), make them the first choice of material in many areas (aeronautics, automobile precision mechanics, biomedical applications, for example), especially in chlorinated environments. However, their mediocre tribological properties often lead to their rejection as friction surfaces.
   Treating the surface of these materials with nitrogen can give them excellent tribological properties.
   It is necessary, though, to choose the most suitable surface treatment in accordance with the stresses and frictional pairs encountered, in order to avoid deterioration of the mass properties of the pieces.
   We present here an industrial technique for adding nitrogen to the surface of titanium alloys, ion implantation together with a development of this process towards a surface heat treatment effect.
C1 NITRUVID, F-42490 FRAISSE, FRANCE.
   ECOLE MINES, F-42100 ST ETIENNE, FRANCE.
RP Lebrun, JP (reprint author), NITRUVID, F-95100 ARGENTEUIL, FRANCE.
CR AURELLE JL, 1992, AMELIORATION MATRIAU
   FLECHE D, 1985, EUROTRIB 85
   HUTCHINGS R, 1983, WEAR, V92, P143, DOI 10.1016/0043-1648(83)90014-5
   MARTINELLA R, 1984, MATER RES SOC S P, V27, P711
   PICHAT A, 1990, 44TD EC MIN SAINT ET
   RABBE LM, 1993, 99TD EC MIN SAINT ET
   SIOSHANSI P, 1985, J VAC SCI TECHNOL A, V3, P2670, DOI 10.1116/1.572811
NR 7
TC 0
Z9 0
U1 0
U2 1
PU SOC FRANCAISE DU VID
PI PARIS
PA 19 RUE DU RENARD, 75004 PARIS, FRANCE
SN 1266-0167
J9 VIDE
JI Vide-Sci. Techn. Appl.
PD APR-JUN
PY 1997
VL 53
IS 284
BP 219
EP +
PG 1
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA XB068
UT WOS:A1997XB06800003
DA 2018-10-19
ER

PT J
AU Tangpasuthadol, V
   Shefer, A
   Yu, C
   Zhou, J
   Kohn, J
AF Tangpasuthadol, V
   Shefer, A
   Yu, C
   Zhou, J
   Kohn, J
TI Thermal properties and enthalpy relaxation of tyrosine-derived
   polyarylates
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE physical aging; enthalpy relaxation; glass transition temperature;
   differential scanning calorimetry; tyrosine; biomaterial; biopolymer;
   structure-property correlation
ID GLASS-TRANSITION TEMPERATURE; POLYVINYL METHYL-ETHER); AGING
   TEMPERATURE; DESIGN
AB Sixteen degradable, tyrosine-derived polyarylates with well-defined chemical structures were used to study the effect of polymer structure on the glass transition temperature and enthalpy relaxation kinetics (physical aging). These polyarylates compose a model system where the number of methylene groups present in either the pendent chain or the polymer backbone can be altered independently and in a systematic fashion. Quantitative differential scanning calorimetry was employed to measure the glass transition temperature and the enthalpy relaxation kinetics. Correlations between these material properties and the polymer structure were established. The glass transition temperature of this family of polymers ranged from 13 to 78 degrees C. The addition of methylene groups to either the pendent chain or the polymer backbone made a fairly constant contribution to lowering the glass transition temperature. The rate of enthalpy relaxation increased with an increasing number of methylene groups in the polymer backbone, but was independent of the number of methylene groups in the pendent chain. This observation indicated that the rate of enthalpy relaxation in these polymers was limited by the mobility of the polymer backbone. The enthalpy relaxation data was fitted to the Cowie-Ferguson model and the relaxation times obtained ranged from 44 min to about 100 min. Although these structure-property correlations facilitate the design of new materials with predictable thermal properties, they are rarely investigated for biomedical polymers. (C) 1997 John Wiley & Sons, Inc.
C1 RUTGERS STATE UNIV,DEPT CHEM,NEW BRUNSWICK,NJ 08903.
RI Tangpasuthadol, Varawut/F-9260-2010
CR BAUWENSCROWET C, 1986, POLYMER, V27, P709, DOI 10.1016/0032-3861(86)90128-X
   BROCCHINI S, 1996, POLYM MAT ENCY
   BRON S, 1993, POLYM MAT SCI ENG, V69, P37
   CAI H, 1995, POLYM PREPR, V36, P422
   CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   CHENG SZD, 1991, POLYMER, V32, P2053, DOI 10.1016/0032-3861(91)90172-F
   CLARSON SJ, 1985, POLYMER, V26, P930, DOI 10.1016/0032-3861(85)90140-5
   COWIE JMG, 1986, POLYM COMMUN, V27, P258
   COWIE JMG, 1989, MACROMOLECULES, V22, P2312, DOI 10.1021/ma00195a054
   COWIE JMG, 1989, MACROMOLECULES, V22, P2307, DOI 10.1021/ma00195a053
   DIX LR, 1993, TRENDS POLYM SCI, V1, P25
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   FIORDELISO J, 1993, THESIS RUTGERS U
   JAMES K, 1996, CONTROLLED DRUG DELI
   KOHN J, 1994, 20 ANN M SOC BIOM BO, P67
   KOHN J, 1993, TRENDS POLYM SCI, V1, P206
   KOHN JB, 1993, Patent No. 5216115
   MONTSERRAT S, 1994, J POLYM SCI POL PHYS, V32, P509, DOI 10.1002/polb.1994.090320312
   PETHRICK RA, 1993, TRENDS POLYM SCI, V1, P226
   SCHERER GW, 1986, RELAXATION GLASS COM, P51
   SHEFER A, 1992, MACROMOLECULES, V25, P4036, DOI 10.1021/ma00041a028
   STRUIK LCE, 1978, PHYSICAL AGING AMORP
   TANGPASUTHADOL V, 1996, BIOMATERIALS, V17, P465
   YOSHIDA H, 1982, J MACROMOL SCI PHYS, VB21, P565, DOI 10.1080/00222348208215191
   ZHOU J, 1994, 20 ANN M SOC BIOM BO, P371
NR 25
TC 11
Z9 11
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 14
PY 1997
VL 63
IS 11
BP 1441
EP 1448
PG 8
WC Polymer Science
SC Polymer Science
GA WH586
UT WOS:A1997WH58600007
DA 2018-10-19
ER

PT J
AU Peluso, G
   Petillo, O
   Anderson, JM
   Ambrosio, L
   Nicolais, L
   Melone, MAB
   Eschbach, FO
   Huang, SJ
AF Peluso, G
   Petillo, O
   Anderson, JM
   Ambrosio, L
   Nicolais, L
   Melone, MAB
   Eschbach, FO
   Huang, SJ
TI The differential effects of poly(2-hydroxyethyl methacrylate) and
   poly(2-hydroxyethyl methacrylate)/poly(caprolactone) polymers on cell
   proliferation and collagen synthesis by human lung fibroblasts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ANCHORAGE-DEPENDENT FIBROBLASTS; EXTRACELLULAR-MATRIX; MESSENGER-RNA;
   GROWTH; SHAPE; SURFACE; ANGIOGENESIS; INITIATION; INVITRO; BETA
AB Because of its chemical versatility and demonstrated biocompatibility, poly(2-hydroxyethyl methacrylate) (pHEMA) has been widely used as a polymer for biomedical applications. Since this hydrophilic material shows a poor interface with cells, blendings with other polymers were done to improve cytocompatibility. In our polymer, the presence of hydrophobic dominions on the material surface, due to the interpenetrating polymerization of pHEMA with poly(caprolactone) (PCL), seems to ameliorate the cytocompatibility in terms of cell adhesion and metabolism. For our experiments, we used IMR-90 human fibroblasts, as these cells strongly regulate DNA, RNA, and protein synthesis as anchorage-dependent variables. Cell attachment on a pHEMA/PCL interpenetrating polymer network was optimal, suggesting a strong adhesion between the cells and the polymer surface. Cell adhesion was weaker on pHEMA, as a significant fraction of the fibroblasts revealed a lack of spreading, with most cells remaining spherical. Moreover, only fibroblasts seeded on pHEMA significantly decreased mRNA synthesis; collagen production and cell shapes ranged from fully flat and proliferating, to minimally spread and nonproliferating. Finally, DNA synthesis, as a measure of cell proliferation, was markedly inhibited in cells cultured on pHEMA but not on pHEMA/PCL. Ln conclusion, our results suggest that control of cell growth and metabolism by biomedical polymers is based on physicochemical mechanism(s) in which the hydrophilicity/hydrophobicity ratio of the material surfaces may play an important role. (C) 1997 John Wiley & Sons, Inc.
C1 CASE WESTERN RESERVE UNIV, INST PATHOL, CLEVELAND, OH 44106 USA.
   UNIV NAPLES 2, DIV NEUROL 2, NAPLES, ITALY.
   UNIV NAPLES, DEPT MAT & PROD ENGN, I-80125 NAPLES, ITALY.
   CNR, INST COMPOSITE MAT TECHNOL, I-80125 NAPLES, ITALY.
   UNIV CONNECTICUT, INST MAT SCI, STORRS, CT 06269 USA.
RP Peluso, G (reprint author), INST PROT BIOCHEM & ENZYMOL, VIA TOIANO 6, I-80072 ARCO, NAPLES, ITALY.
RI TERRACCIANO, CHIARA/C-2955-2018; Melone, Mariarosa/N-6788-2015
OI TERRACCIANO, CHIARA/0000-0002-1853-5578; Melone,
   Mariarosa/0000-0002-7213-9277; AMBROSIO, LUIGI/0000-0002-8367-2405
CR BENECKE BJ, 1978, CELL, V14, P931, DOI 10.1016/0092-8674(78)90347-1
   BENECKE BJ, 1980, J CELL PHYSIOL, V103, P247, DOI 10.1002/jcp.1041030209
   BENZEEV A, 1980, CELL, V21, P365, DOI 10.1016/0092-8674(80)90473-0
   BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   CHU ML, 1985, J BIOL CHEM, V260, P2315
   DEPHILIP RM, 1980, BIOCHEMISTRY-US, V19, P1662, DOI 10.1021/bi00549a022
   ESCHBACH FO, 1994, ADV CHEM SER, V239, P205
   FARMER SR, 1978, CELL, V15, P627, DOI 10.1016/0092-8674(78)90031-4
   FARRELL RE, 1992, J CELL PHYSIOL, V153, P429, DOI 10.1002/jcp.1041530223
   FINE A, 1987, J BIOL CHEM, V262, P3897
   FOLKMAN J, 1982, ANN NY ACAD SCI, V401, P212, DOI 10.1111/j.1749-6632.1982.tb25720.x
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   GALL WE, 1981, SCIENCE, V213, P903, DOI 10.1126/science.7196087
   GOSPODAROWICZ D, 1978, CANCER RES, V38, P4155
   HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0
   INGBER DE, 1987, IN VITRO CELL DEV B, V23, P387
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   LASMAN JB, 1987, NATURE, V325, P811
   MANIATIS T, 1982, MOL CLONING LABORATO, P196
   NICOLINI C, 1986, CELL BIOPHYS, V8, P103, DOI 10.1007/BF02788475
   SACHS F, 1989, CELL SHAPE DETERMINA
   SALTZMAN WM, 1991, J BIOMED MATER RES, V25, P741, DOI 10.1002/jbm.820250605
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 26
TC 35
Z9 36
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 1997
VL 34
IS 3
BP 327
EP 336
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WL071
UT WOS:A1997WL07100007
PM 9086402
DA 2018-10-19
ER

PT J
AU Li, SH
   Liu, Q
   deWijn, JR
   Zhou, BL
   deGroot, K
AF Li, SH
   Liu, Q
   deWijn, JR
   Zhou, BL
   deGroot, K
TI In vitro calcium phosphate formation on a natural composite material,
   bamboo
SO BIOMATERIALS
LA English
DT Article
DE bamboo; grafts; calcium phosphate
ID CORROSION FILMS
AB A natural self-reinforced composite material, bamboo, is studied for the first time as a biomedical material. Its anatomical structure was investigated and its mechanical properties were measured and compared with those of some common bone-bonding or bone-repairing biomaterials. It is found that, among all kinds of biomaterials, bamboo has the closest modulus of elasticity to human long bone. The cytotoxicity of bamboo was tested using the agar overlay method before and after heat or chemical treatments. The results reveal that ethanol, methanol and toluene can remove toxic leachable components from bamboo to some extent through extraction. After grafting a polymer whose molecule includes poly(ethylene glycol), alpha,omega-di(aminopropyl)poly(ethylene glycol) 800 on bamboo, bamboo has the ability to form a calcium phosphate coating after being immersed in calcification solution (simulated body fluid and accelerated calcification solution). The characteristics and the morphology of the mineral formed on bamboo were studied by infrared spectroscopy and scanning electron microscopy. (C) 1997 Elsevier Science Limited. All rights reserved.
C1 ACAD SINICA,INST MET RES,SHENYANG 110015,PEOPLES R CHINA.
RP Li, SH (reprint author), LEIDEN UNIV,BIOMAT RES GRP,PROF BRONKHORSTLAAN 10,NL-3723 MB BILTHOVEN,NETHERLANDS.
CR AOKI H, 1991, SCI MED APPL HYDROXY, P104
   BEDNAR H, 1982, BIOMATERIALS 1980, P97
   CHARNOT Y, 1978, P269
   CLARK AE, 1976, J AM CERAM SOC, V59, P37, DOI 10.1111/j.1151-2916.1976.tb09382.x
   FENGEL D, 1984, WOOD SCI TECHNOL, V18, P103
   FRENSDORFF HK, 1971, J AM CHEM SOC, V93, P4684, DOI 10.1021/ja00748a006
   GRENOBLE DE, 1972, J BIOMED MATER RES, V6, P221, DOI 10.1002/jbm.820060311
   HAMON RF, 1982, TALANTA, V29, P313, DOI 10.1016/0039-9140(82)80118-5
   Hench L., 1992, BONE GRAFTS BONE SUB, P263
   HENCH LL, 1991, BONE-BIOMATERIAL INTERFACE, P33
   HOSSAINY SFA, 1994, BIOMATERIALS, V15, P921, DOI 10.1016/0142-9612(94)90118-X
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   KOKUBO T, 1992, BONE BONDING BIOMATE, P31
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   Li SH, 1995, MAT SCI ENG C-BIOMIM, V3, P125, DOI 10.1016/0928-4931(95)00115-8
   Li Shihong, 1994, Biomimetics, V2, P15
   LIU Q, 1996, 5 WORLD BIOM C TOR C
   PANTANO CG, 1974, J AM CERAM SOC, V57, P412, DOI 10.1111/j.1151-2916.1974.tb11429.x
   PARK JB, 1992, BIOMATERIALS INTRO, P197
   RADDER AM, 1995, CELL MATER, V5, P55
   TORRISI L, 1993, THIN SOLID FILMS, V227, P32, DOI 10.1016/0040-6090(93)90183-P
   VANBLITTERSWIJK CA, 1992, BONE BONDING BIOMATE, P31
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
NR 23
TC 33
Z9 34
U1 2
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1997
VL 18
IS 5
BP 389
EP 395
DI 10.1016/S0142-9612(96)00122-6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WK062
UT WOS:A1997WK06200003
PM 9061179
DA 2018-10-19
ER

PT J
AU Green, RJ
   Davies, J
   Davies, MC
   Roberts, CJ
   Tendler, SJB
AF Green, RJ
   Davies, J
   Davies, MC
   Roberts, CJ
   Tendler, SJB
TI Surface plasmon resonance for real time in situ analysis of protein
   adsorption to polymer surfaces
SO BIOMATERIALS
LA English
DT Article
DE surface plasmon resonance; AFM; protein adsorption; polystyrene
ID SCANNING-TUNNELING-MICROSCOPY; ATOMIC-FORCE MICROSCOPY; HUMAN
   SERUM-ALBUMIN; MICROTITER WELLS; KINETIC-ANALYSIS; FIBRINOGEN;
   MICROSPHERES; MORPHOLOGY; BIOSENSOR; BLOOD
AB The adsorption of a range of plasma proteins to metal and polymer surfaces has been examined using surface plasmon resonance (SPR). The adsorption of proteins was initially studied on the SPR silver sensor surface, and then on a model polystyrene film spun coated directly onto this substrate. In both cases, reproducible adsorption profiles for albumin were attained which compared well with corresponding atomic force microscopy (AFM) and ellipsometry data on protein monolayer packing and thickness respectively. The SPR data revealed the influence of concentration on both protein adsorption kinetics and the time for formation of a monolayer coating. SPR data also highlighted different adsorption kinetics and final monolayer SPR angle shift values for three plasma proteins which have been interpreted in terms of their molecular dimensions and orientation at the polymer interface. AFM data confirmed the presence of a closely packed protein layer for all three protein systems. These studies are discussed in terms of employing SPR in the study of protein interactions at surfaces which are important in the design and evaluation of novel biomedical polymeric materials. (C) 1997 Elsevier Science Limited. All rights reserved.
C1 UNIV NOTTINGHAM,DEPT PHARMACEUT SCI,LAB BIOPHYS & SURFACE ANAL,NOTTINGHAM NG7 2RD,ENGLAND.
   JOHNSON & JOHNSON CLIN DIAG LTD,POLLARDS WOOD LABS,CHALFONT ST GILES HP8 4SP,BUCKS,ENGLAND.
RI Roberts, Clive/C-6970-2009
OI Roberts, Clive/0000-0001-9443-3445; Green, Rebecca/0000-0001-6783-549X;
   Davies, Martyn/0000-0001-7695-0596
CR ANDRADE JD, 1985, PRINCIPLES PROTEIN A, V2, pCH1
   BONDESON K, 1993, ANAL BIOCHEM, V214, P245, DOI 10.1006/abio.1993.1484
   BRASH JL, 1977, ANN NY ACAD SCI, V283, P356, DOI 10.1111/j.1749-6632.1977.tb41781.x
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   Chen XY, 1996, ANAL CHEM, V68, P1451, DOI 10.1021/ac950844e
   CHENG YL, 1987, J COLLOID INTERF SCI, V118, P212, DOI 10.1016/0021-9797(87)90450-4
   DAVIES J, 1994, LANGMUIR, V10, P2654, DOI 10.1021/la00020a026
   DAVIES J, 1994, J IMMUNOL METHODS, V167, P263, DOI 10.1016/0022-1759(94)90095-7
   DAVIES J, 1994, NANOBIOLOGY, V3, P5
   DAVIES J, 1994, P INT C SURF PROP BI, P117
   DAVIS SS, 1995, DRUGS EXPT CLIN RES, V11, P633
   DEBRUIJN HE, 1992, APPL OPTICS, V31, P440
   DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211
   GREEN NM, 1969, ADV IMMUNOL, P1
   GREEN RJ, 1995, 42 NAT S AM VAC SOC, P278
   HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0
   IKADA Y, 1994, ACS SYM SER, V540, P35
   KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9
   KOOYMAN RPH, 1990, J MOL STRUCT, V218, P345, DOI 10.1016/0022-2860(90)80291-Q
   LAWRENCE CR, 1992, THIN SOLID FILMS, V208, P269, DOI 10.1016/0040-6090(92)90655-U
   LEATHERBARROW RJ, 1991, J MOL BIOL, V221, P361, DOI 10.1016/0022-2836(91)80056-Z
   LIEDBERG B, 1993, SENSOR ACTUAT B-CHEM, V11, P63, DOI 10.1016/0925-4005(93)85239-7
   LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7
   LOK BK, 1983, J COLLOID INTERF SCI, V91, P104, DOI 10.1016/0021-9797(83)90317-X
   LYMAN DJ, 1975, T AM SOC ART INT ORG, V21, P49
   MARQUART M, 1980, J MOL BIOL, V141, P369, DOI 10.1016/0022-2836(80)90252-1
   NORMAN ME, 1992, BIOMATERIALS, V13, P841, DOI 10.1016/0142-9612(92)90177-P
   NORMAN ME, 1993, BIOMATERIALS, V14, P193, DOI 10.1016/0142-9612(93)90023-U
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   POOT AA, 1991, MODERN ASPECTS OF PROTEIN ADSORPTION ON BIOMATERIALS, P29
   ROBERTS CJ, 1995, LANGMUIR, V11, P1822, DOI 10.1021/la00005a063
   ROBERTS CJ, 1996, IN PRESS ULTRAMICROS
   SHAKESHEFF KM, 1995, LANGMUIR, V11, P3921, DOI 10.1021/la00010a049
   SHAKESHEFF KM, 1995, MACROMOLECULES, V28, P1108, DOI 10.1021/ma00108a044
   SILIN VI, 1993, OPT COMMUN, V97, P19, DOI 10.1016/0030-4018(93)90610-H
   VROMAN L, 1980, BLOOD, V55, P156
   WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H
   WILLIAMS M, 1992, INT J NUMER METH FL, V14, P1, DOI 10.1002/fld.1650140102
   Williams PM, 1996, J VAC SCI TECHNOL B, V14, P1557, DOI 10.1116/1.589138
NR 39
TC 178
Z9 182
U1 2
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1997
VL 18
IS 5
BP 405
EP 413
DI 10.1016/S0142-9612(96)00141-X
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WK062
UT WOS:A1997WK06200005
PM 9061181
DA 2018-10-19
ER

PT J
AU Bayne, SC
   Swift, EJ
   Thompson, JY
AF Bayne, SC
   Swift, EJ
   Thompson, JY
TI Dental materials citations .B. July to December 1996
SO DENTAL MATERIALS
LA English
DT Article
ID RESTORATIVE-DENTISTRY; AMERICAN-ACADEMY; COMMITTEE
AB Objective. A search was conducted in biomedical journals from July 1996 to December 1996 to identify dental materials publications and sort them into major categories. They were compared by frequency in different journals and in different categories during recent years.
   Methods. Tables of contents for 16 primary and 51 secondary journals were inspected from July to December of 1996 and were divided into 17 categories. The frequencies of citations for primary journals and for different citation categories were examined over a four-year period from 1993 to 1996.
   Results. There were 334 total citations from July to December 1996. The greatest number of citations continued to involve bonding (n = 159) and resin-based (composites; glass ionomers) restorative materials (n = 158). The numbers of articles by journal and by category were very similar over the last four years. The average number of articles per year was 531 +/- 15.
   Significance. The literature citations compiled in this list provide a supplement for researchers and academicians to the current electronic databases.
RP Bayne, SC (reprint author), UNIV N CAROLINA,SCH DENT,DEPT OPERAT DENT,CHAPEL HILL,NC 27599, USA.
CR Allen EP, 1996, J PROSTHET DENT, V76, P56, DOI 10.1016/S0022-3913(96)90347-9
   BAYNE SC, 1995, DENT MATER, V11, P281, DOI 10.1016/0109-5641(95)80064-6
   BAYNE SC, 1994, DENT MATER, V10, P59, DOI 10.1016/0109-5641(94)90023-X
   JENDRESEN MD, 1993, J PROSTHET DENT, V70, P44, DOI 10.1016/0022-3913(93)90036-N
   JENDRESEN MD, 1995, J PROSTHET DENT, V74, P60, DOI 10.1016/S0022-3913(05)80231-8
   JENDRESEN MD, 1994, J PROSTHET DENT, V72, P39, DOI 10.1016/0022-3913(94)90214-3
   LLOYD CH, 1995, J DENT, V23, P67, DOI 10.1016/0300-5712(95)98973-7
   Swift EJ, 1996, DENT MATER, V12, P127
   SWIFT EJ, 1995, DENT MATER, V11, P52, DOI 10.1016/0109-5641(95)80009-3
   Thompson JY, 1996, DENT MATER, V12, P272, DOI 10.1016/S0109-5641(96)80034-0
   VANNOORT R, 1993, J DENT, V21, P5, DOI 10.1016/0300-5712(93)90046-S
   VANNOORT R, 1994, J DENT, V22, P5, DOI 10.1016/0300-5712(94)90139-2
NR 12
TC 2
Z9 2
U1 0
U2 1
PU ACAD DENTAL MATERIALS
PI DALLAS
PA BAYLOR COLLEGE DENTISTRY, 3302 GASTON AVE, DALLAS, TX 75266-0677
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD MAR
PY 1997
VL 13
IS 2
BP 128
EP 142
DI 10.1016/S0109-5641(97)80022-X
PG 15
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA XM605
UT WOS:A1997XM60500008
PM 9467315
DA 2018-10-19
ER

PT J
AU Rutherford, KL
   Hutchings, IM
AF Rutherford, KL
   Hutchings, IM
TI Theory and application of a micro-scale abrasive wear test
SO JOURNAL OF TESTING AND EVALUATION
LA English
DT Article; Proceedings Paper
CT Symposium on Needs and Applications in Precision Measurement and
   Monitoring of Wear
CY MAY   22, 1996
CL ORLANDO, FL
SP ASTM, Comm G2
DE abrasion; wear test; coatings; surface engineering
ID METALLIC GLASSES; RESISTANCE; COATINGS; WIRES
AB A micro-scale abrasion test has recently been developed that allows measurement of the wear resistance of the surface regions of a material. The typical penetration depth is less than 30 mu m The test uses a simple mechanical and optical system and involves rotating a hard steel sphere against a specimen in the presence of small abrasive particles. The method has been used to investigate the wear resistance of thin PVD coatings (1 to 5 mu m), metallic glass ribbons, and paint films in addition to bulk samples of metals, ceramics, and glasses. The associated theory has been extended so that results may be obtained from any curved surface. This furthers its applicability to practical surface-engineered components such as twist drills, bearings, turbine blades, and biomedical prostheses. A detailed characterization of the experimental procedure has been undertaken to provide an understanding of the repeatability and sensitivity of the test. In a study of cutting-tool coatings, the wear resistance measured by this method has been shown to correlate with scratch test response and with the performance of coated end-mills in cutting tests.
RP Rutherford, KL (reprint author), UNIV CAMBRIDGE,DEPT MAT SCI & MET,PEMBROKE ST,CAMBRIDGE CB2 3QZ,ENGLAND.
CR BRINELL JA, 1921, JERNKONTORETS ANN, V76, P347
   DONOVAN PE, 1983, PHILOS MAG A, V47, P537, DOI 10.1080/13642818308246456
   GAHLIN R, 1996, UNPUB SURFACE COATIN
   GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947
   GRODZINSKI P, 1949, NATURE, V164, P193, DOI 10.1038/164193a0
   HAPP W, 1956, B AM PHYS SOC, V1, P382
   HAWORTH RD, 1949, T AM SOC METAL, V41, P819
   HEDENQVIST P, 1994, SURF COAT TECH, V63, P115, DOI 10.1016/S0257-8972(05)80015-5
   HUTCHINGS IM, 1995, ADV CERAMICS STRUCTU, P127
   KASSMAN A, 1991, SURF COAT TECH, V50, P75, DOI 10.1016/0257-8972(91)90196-4
   KIM YH, 1994, MATER T JIM, V35, P293, DOI 10.2320/matertrans1989.35.293
   LANCASTE.JK, 1969, WEAR, V14, P223, DOI 10.1016/0043-1648(69)90047-7
   MCDONALD B, 1962, J ELECTROCHEM SOC, V109, P141, DOI 10.1149/1.2425346
   MCNSHUTKIN BN, 1952, RUSSIAS LOMONOSOV
   Mott B. W, 1956, MICRO INDENTATION HA
   NOTHNAGEL G, 1993, SURF COAT TECH, V57, P151, DOI 10.1016/0257-8972(93)90032-J
   PENSAERT S, 1994, WEAR, V171, P99, DOI 10.1016/0043-1648(94)90352-2
   PENSAERT S, 1994, WEAR, V171, P109, DOI 10.1016/0043-1648(94)90353-0
   Rutherford KL, 1996, TRIBOL LETT, V2, P1
   Rutherford KL, 1996, SURF COAT TECH, V79, P231, DOI 10.1016/0257-8972(95)02461-1
   Rutherford KL, 1996, SURF COAT TECH, V86-7, P472, DOI 10.1016/S0257-8972(96)02956-8
   Rutherford KL, 1996, SURF COAT TECH, V80, P176, DOI 10.1016/0257-8972(95)02706-8
   SANTNER E, 1995, WEAR, V181, P350
   SCHOFF CK, 1995, STANDARDIZATION NEWS, P24
   SILVA SRP, 1995, SURF COAT TECH, V73, P132, DOI 10.1016/0257-8972(94)02377-8
   THOMPSON V, 1979, SURF TECHNOL, V8, P421, DOI 10.1016/0376-4583(79)90005-0
   TOLANSKY S, 1949, NATURE, V164, P194, DOI 10.1038/164194a0
   VALLI J, 1985, 435 TECHN RES CTR FI
   WILKS EM, 1952, PHILOS MAG, V43, P1140
   ZHONG ZC, IN PRESS PHILOS MA B
NR 30
TC 151
Z9 154
U1 3
U2 31
PU AMER SOC TESTING MATERIALS
PI W CONSHOHOCKEN
PA 100 BARR HARBOR DR, W CONSHOHOCKEN, PA 19428-2959
SN 0090-3973
J9 J TEST EVAL
JI J. Test. Eval.
PD MAR
PY 1997
VL 25
IS 2
BP 250
EP 260
PG 11
WC Materials Science, Characterization & Testing
SC Materials Science
GA WU021
UT WOS:A1997WU02100016
DA 2018-10-19
ER

PT J
AU Klein, RC
   Party, E
   Gershey, EL
AF Klein, RC
   Party, E
   Gershey, EL
TI Removable surface contamination at a biomedical research institution
SO HEALTH PHYSICS
LA English
DT Article
DE wipe tests; contamination; sampling; surface contamination
AB rigorous, unannounced, campus-wide survey for removable surface contamination was performed at our institution. Wipe samples (n = 1,090) were collected from a variety of standardized locations in 45 large biomedical research laboratories that routinely use kBq-MBq (mu Ci-mCi) amounts of H-3, C-14, P-32, S-35, Cr-51, and I-125. The results showed a log-normal distribution for contamination, with about 90% of all samples below ten times background. Although working surfaces and equipment used in these laboratories can become contaminated with radioactive materials, especially by transfer from soiled gloves, the magnitude of the contamination is very small and typically restricted to surfaces, instruments, and equipment that are directly handled in the course of experimental work and which can be reasonably anticipated to be contaminated. These data suggest that contamination is not a significant problem in biomedical research laboratories at this institution and that the best protection from workplace contamination appears to continue to be the use of well-reviewed standard operating procedures and good work practices.
C1 ROCKEFELLER UNIV, OFF LAB SAFETY, NEW YORK, NY 10021 USA.
CR CAMPBELL JL, 1993, HEALTH PHYS, V64, P540, DOI 10.1097/00004032-199305000-00014
   KLEIN RC, 1992, HEALTH PHYS, V62, P186, DOI 10.1097/00004032-199202000-00010
   *NAT COMM RAD PROT, 1964, 30 NCRP
   *NAT COMM RAD PROT, 1951, NAT BUR STAND HDB, V48
   National Council on Radiation Protection and Measurements, 1978, 57 NCRP
   *US NUCL REG COMM, 1981, US NRC REG GUID 8 23
NR 6
TC 3
Z9 3
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD FEB
PY 1997
VL 72
IS 2
BP 296
EP 299
DI 10.1097/00004032-199702000-00014
PG 4
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA WE857
UT WOS:A1997WE85700015
PM 9003716
DA 2018-10-19
ER

PT J
AU Eichler, HJ
   Findeisen, J
   Liu, B
   Kaminskii, AA
   Butachin, AV
   Peuser, P
AF Eichler, HJ
   Findeisen, J
   Liu, B
   Kaminskii, AA
   Butachin, AV
   Peuser, P
TI Highly efficient diode-pumped 3-mu m Er3+:BaY2F8 laser
SO IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS
LA English
DT Article
DE crystals; diodes; erbium materials; infrared radiation effects; laser
   biomedical applications; solid lasers
ID MU-M
AB A systematic investigation on a series of monoclinic Er3+:BaY2F8 crystals with different dopant concentrations (C-Er = 5%-30%) and crystal orientations was conducted to optimize the laser performance in this new 3-mu m laser medium by laser diode pumping, The highest slope efficiency of 32% near the quantum defect (35%) was obtained with a 10% doped Er3+:BaY2F8 crystal with the orientation (010) and a length of 3.5 mm, A maximum output power of 160 mW was achieved at an absorbed pump power of 550 mW at a wavelength of 970 nm.
C1 RUSSIAN ACAD SCI,INST CRYSTALLOG,MOSCOW 117333,RUSSIA.
   DAIMLER BENZ AG,FORSCH & TECH,D-81663 MUNICH,GERMANY.
RP Eichler, HJ (reprint author), TECH UNIV BERLIN,INST OPT,D-10623 BERLIN,GERMANY.
CR AUZEL F, 1992, PHYS STATUS SOLIDI A, V131, pK63, DOI 10.1002/pssa.2211310146
   Jensen T, 1996, OPT LETT, V21, P585, DOI 10.1364/OL.21.000585
   KAMINSKII AA, 1988, IAN SSSR NEORG MATER, V24, P2080
   KAMINSKII AA, 1990, OPT QUANT ELECTRON, V22, P95
   KNOWLES DS, 1992, IEEE J QUANTUM ELECT, V28, P1197, DOI 10.1109/3.135247
   Pollnau M, 1996, OPT LETT, V21, P48, DOI 10.1364/OL.21.000048
   POLLNAU M, 1994, PHYS REV A, V49, P3390
   STONEMAN RC, 1992, IEEE J QUANTUM ELECT, V28, P1041, DOI 10.1109/3.135226
NR 8
TC 21
Z9 22
U1 0
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 1077-260X
J9 IEEE J SEL TOP QUANT
JI IEEE J. Sel. Top. Quantum Electron.
PD FEB
PY 1997
VL 3
IS 1
BP 90
EP 94
DI 10.1109/2944.585819
PG 5
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA XE895
UT WOS:A1997XE89500015
DA 2018-10-19
ER

PT J
AU Burger, W
   Richter, HG
   Piconi, C
   Vatteroni, R
   Cittadini, A
   Boccalari, M
AF Burger, W
   Richter, HG
   Piconi, C
   Vatteroni, R
   Cittadini, A
   Boccalari, M
TI New Y-TZP powders for medical grade zirconia
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PARTIALLY-STABILIZED ZIRCONIA
AB There is interest in using zirconia for biomedical applications as ball heads for total hip prostheses. Two potential types are under discussion: partially stabilized zirconia (PSZ) and tetragonal zirconia polycrystals (TZP) materials. Because of its enhanced material properties, TZP stabilized with yttria is favourable. To eliminate high amounts of natural radioactive impurities, the precursors are purified. The kind of precursor and purification method determine the powder impurity level. The disadvantage of Y-TZP is that the hydrothermal decomposition reaction method is that it depends very strongly on the grain size and the distribution of the stabilizing yttria within the zirconia grains. Thermodynamical and kinetic investigations on high purity coprecipitated and yttria-coated zirconia powders show different behaviours. Y-TZP materials based on yttria-coated zirconia powders show excellent mechanical strength of more than 1000 MPa, a Weibull modulus of up to 20 and a fracture toughness of 9 MPa root m. The material properties of Y-TZP ceramics based on coprecipitated powders and prepared under the same conditions are less attractive. It is expected that materials based on yttria-coated zirconia will show enhanced properties compared to materials derived from coprecipitated powders. Therefore Y-TZP materials derived from yttria-coated powders are very attractive as medical grade zirconia.
C1 ENEA,DIPARTIMENTO INNOVAZ,ROME,ITALY.
   UNIV CATTOLICA SACRO CUORE,ROME,ITALY.
   FABBRICAZ NUCL,BOSCO MARENGO,AL,ITALY.
RP Burger, W (reprint author), CERASIV GMBH,POB 1149,PLOCHINGEN,GERMANY.
CR BURGER W, 1993, BIOCERAMICS, V6, P299
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   DRANSFIELD GP, 1989, EUROCERAMICS, V1, P275
   Dworak U., 1978, Berichte der Deutschen Keramischen Gesellschaft, V55, P98
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   Haberko K, 1975, CERAMURGIA INT, V1, P111
   HARMSWORTH P, UNPUB
   RICHTER HG, 1994, BIOCERAMICS, V7, P401
   RUHLE M, 1984, ADV CERAM, V12, P352
NR 10
TC 69
Z9 70
U1 0
U2 9
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 1997
VL 8
IS 2
BP 113
EP 118
DI 10.1023/A:1018562917779
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WG209
UT WOS:A1997WG20900008
PM 15348779
DA 2018-10-19
ER

PT J
AU Otto, C
   deGrauw, CJ
   Duindam, JJ
   Sijtsema, NM
   Greve, J
AF Otto, C
   deGrauw, CJ
   Duindam, JJ
   Sijtsema, NM
   Greve, J
TI Applications of micro-Raman imaging in biomedical research
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
ID SINGLE LIVING CELLS; CHROMOSOMES; SPECTROSCOPY; MICROSPECTROSCOPY;
   CHOLESTEROL; EXCITATION; DETECTOR; FILIPIN; DNA
AB Recent results are presented of the application of imaging micro-Raman spectrometers in cellular biophysics and biomedical research. Various micro-Raman spectrometers have been developed that are now routinely applied in these fields. Results are presented that were obtained with a linescan Raman microspectrometer and with a Raman imaging microscope. Applications of Raman linescan spectrometry concern the investigation of polytene chromosomes obtained from the salivary gland of Chironomus thummi thummi. The distribution of DNA and proteins was investigated in bands and interbands. In a second example of Raman linescan spectrometry, bone implants were investigated. These bone implants were coated with thin layers of materials that improve biocompatibility. The density, crystallinity and protein distribution can be investigated. Information from Raman imaging may help in selecting the proper materials for maximum biocompatibility, Raman imaging microscopy is used whenever two-dimensional spatial information is required on the distribution of molecules or molecular components. Raman images are presented of filipine and phenylalanine in human eye-lenses in and around radial shades. Raman imaging is a particularly important toot for the study of the distribution of non-fluorescent drugs inside living cells. This is illustrated for the non-fluorescent drug cobalt octacarboxyphthalocyanine. (C) 1997 by John Wiley & Sons, Ltd.
C1 UNIV TWENTE,BIOMED TECHNOL INST,NL-7500 AE ENSCHEDE,NETHERLANDS.
RP Otto, C (reprint author), UNIV TWENTE,APPL OPT GRP,POB 217,NL-7500 AE ENSCHEDE,NETHERLANDS.
CR BARBILLAT J, 1994, J RAMAN SPECTROSC, V25, P3, DOI 10.1002/jrs.1250250103
   BATCHELDER DN, 1991, MAKROMOL CHEM-M SYMP, V46, P171, DOI 10.1002/masy.19910460121
   BITTMAN R, 1978, LIPIDS, V13, P686, DOI 10.1007/BF02533746
   BOWDEN M, 1990, J RAMAN SPECTROSC, V21, P37, DOI 10.1002/jrs.1250210108
   DELHAYE M, 1975, J RAMAN SPECTROSC, V3, P33, DOI 10.1002/jrs.1250030105
   DEMUL FFM, 1986, J DENT RES, V65, P437, DOI 10.1177/00220345860650031301
   DEMUL FFM, 1984, J RAMAN SPECTROSC, V15, P268, DOI 10.1002/jrs.1250150412
   DUINDAM HJ, 1995, J LIPID RES, V36, P1139
   Duindam JJ, 1996, OPHTHALMIC RES, V28, P86, DOI 10.1159/000267978
   DUINDAM JJ, UNPUB
   GREVE J, 1993, ADV SPECTROSC, V20, P231
   KUBASEK WL, 1986, BIOCHEMISTRY-US, V25, P7440, DOI 10.1021/bi00371a028
   PUPPELS GJ, 1991, EXP CELL RES, V195, P361, DOI 10.1016/0014-4827(91)90385-8
   PUPPELS GJ, 1993, APPL SPECTROSC, V47, P1256, DOI 10.1366/0003702934068017
   PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0
   PUPPELS GJ, 1991, J RAMAN SPECTROSC, V22, P217, DOI 10.1002/jrs.1250220405
   PUPPELS GJ, 1994, BIOCHEMISTRY-US, V33, P3386, DOI 10.1021/bi00177a032
   PUPPELS GJ, 1991, THESIS U TWENTE
   ROBERT M, 1971, CHROMOSOMA, V36, P1, DOI 10.1007/BF00326419
   ROBINSON JM, 1980, J HISTOCHEM CYTOCHEM, V28, P161, DOI 10.1177/28.2.6766487
   SHARONOV S, 1994, J RAMAN SPECTROSC, V25, P699, DOI 10.1002/jrs.1250250733
   TREADO PJ, 1994, APPL SPECTROSC REV, V29, P1, DOI 10.1080/05704929408000896
   WILSON T, 1987, OPT LETT, V12, P227, DOI 10.1364/OL.12.000227
NR 23
TC 49
Z9 50
U1 0
U2 12
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 0377-0486
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD FEB-MAR
PY 1997
VL 28
IS 2-3
BP 143
EP 150
PG 8
WC Spectroscopy
SC Spectroscopy
GA WV161
UT WOS:A1997WV16100012
DA 2018-10-19
ER

PT J
AU Friedrich, CR
   Coane, PJ
   Vasile, MJ
AF Friedrich, CR
   Coane, PJ
   Vasile, MJ
TI Micromilling development and applications for microfabrication
SO MICROELECTRONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT Micro and Nano Engineering Conference 1996 (MNE 96)
CY SEP 22-25, 1996
CL UNIV GLASGOW, GLASGOW, SCOTLAND
SP Univ Glasgow, Glasgow Dev Agcy, Oxford Instruments, Leica Cambridge Ltd, Elsevier, Greater Glasgow & Clyde Valley Tourist Board, City Glasgow, Motorola, IEEE LEOS Scott Chapter
HO UNIV GLASGOW
ID ION
AB In conventional machining, milling is the most versatile of the cuffing processes. Micromechanical milling has also been shown to be a very versatile and rapid method for the removal of material and the creation of microstructures. These microstructures range form direct fabrication of molds in polymethyl methacrylate (PMMA) to direct fabrication of x-ray lithography masks using a machinable carrier and one of several metallic absorbers, or various combinations of absorbers to better suit the machining environment. The micromilling tools are commercially available in diameters larger than 50 micrometers and custom-fabricated tools 22 micrometers in diameter are made at the Institute for Micromanufacturing (IfM). The custom-fabricated tools are made using the focused ion beam process and the resulting microstructures are machined on a very high precision, custom-built milling machine. The focused ion beam process has also been used to fabricate very small probe tips for biomedical use and microscalpels with extremely sharp cutting edges. These devices are currently under study and development for research applications.
RP Friedrich, CR (reprint author), LOUISIANA TECH UNIV,INST MICROMANUFACTURING,RUSTON,LA 71272, USA.
CR Friedrich CR, 1996, J MICROELECTROMECH S, V5, P33, DOI 10.1109/84.485213
   Lucca D.A., 1991, ANN CIRP, V40, P69
   ORLOFF J, 1993, REV SCI INSTRUM, V64, P1105, DOI 10.1063/1.1144104
   VASILE M, 1996, J PRECISION ENG  OCT
   VASILE MJ, 1994, J VAC SCI TECHNOL B, V12, P2388, DOI 10.1116/1.587769
NR 5
TC 32
Z9 33
U1 2
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9317
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD FEB
PY 1997
VL 35
IS 1-4
BP 367
EP 372
DI 10.1016/S0167-9317(96)00198-0
PG 6
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA WM329
UT WOS:A1997WM32900085
DA 2018-10-19
ER

PT B
AU Powell, DJ
   Wojcik, GL
   Desilets, CS
   Gururaja, TR
   Guggenberger, K
   Sherrit, S
   Mukherjee, BK
AF Powell, DJ
   Wojcik, GL
   Desilets, CS
   Gururaja, TR
   Guggenberger, K
   Sherrit, S
   Mukherjee, BK
BE Schneider, SC
   Levy, M
   McAvoy, BR
TI Incremental "model-build-test" validation exercise for a 1-D biomedical
   ultrasonic imaging array
SO 1997 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1 & 2
LA English
DT Proceedings Paper
CT 1997 IEEE Ultrasonics Symposium
CY OCT 05-08, 1997
CL TORONTO MARRIOTT EATON CTR, TORONTO, CANADA
SP IEEE, Ultrason Ferroelect & Frequency Control Soc
HO TORONTO MARRIOTT EATON CTR
AB Quantitative validation is critical to the effective utilization of large-scale modeling in advanced biomedical ultrasonic imaging applications. This work describes an incremental "model-build-test" validation exercise centered around a nonproprietary, 5MHz, 1D linear array design. The step-by-step sequence reported here includes piezoceramic slivers, slivers with matching and slivers with both backing and matching. Furthermore, prior to the fabrication process, all the active and passive material components are accurately characterized. PZFlex, an explicit time-domain finite element modeling package, is used to predict the performance of the incremental array components at each stage of the validation exercise. Deviations between experimental results and finite element predictions are identified and subsequently analyzed. Although the manufacturing techniques used do not push the current operational envelope, observed process effects should be relevant to today's devices.
C1 Weidlinger Associates, Los Altos, CA 94022 USA.
RP Powell, DJ (reprint author), Weidlinger Associates, Los Altos, CA 94022 USA.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-4153-8
PY 1997
BP 1669
EP 1674
PG 6
WC Acoustics; Engineering, Biomedical; Engineering, Electrical &
   Electronic; Radiology, Nuclear Medicine & Medical Imaging
SC Acoustics; Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA BK64T
UT WOS:000072927100356
DA 2018-10-19
ER

PT B
AU Chen, YH
   Erber, EA
   Faris, G
AF Chen, YH
   Erber, EA
   Faris, G
BE Thompson, RB
TI Spectroscopic characterization of upconverting phosphor reporters
SO ADVANCES IN FLUORESCENCE SENSING TECHNOLOGY III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Advances in Fluorescence Sensing Technology III
CY FEB 09-11, 1997
CL SAN JOSE, CA
SP Soc Photo Opt Instrumentat Engineers, Chiron Diag Corp, Ciencia Inc, Coherent Inc Laser Grp, ISS Inc, Jobin Yvon SPEX Instruments SA Inc, LiCONiX, Opt Sensors Inc, Perkin Elmer Corp, PicoQuant, Adv Photon Int, Programmed Test Sources Inc, Spectronics Inc, SpectRx Inc
DE upconverting phosphors; immunoassay; nucleic acid assay; in vivo
   diagnostics
AB We examined the spectroscopic properties of a novel class of reporters for biomedical diagnostics called upconverting phosphors. These materials exhibit high emission efficiencies, extremely low background levels, no photobleaching, minimal phototoxicity and a variety of emission bands suitable for multi-analyte assays. In addition, they are buffer insensitive and can be excited with inexpensive and compact diode lasers. These properties are very useful for immunoassays, nucleic acid assays, in vivo diagnostics, and other applications. We synthesized submicron monodisperse phosphors and measured the emission spectra, excitation spectra, and power dependencies for a variety of phosphor materials containing different active rare earth ions and host materials. In this paper, we discuss the relation between spectral properties and diagnostic applications.
RP Chen, YH (reprint author), SRI INT,333 RAVENSWOOD AVE,MENLO PK,CA 94025, USA.
NR 0
TC 5
Z9 5
U1 1
U2 1
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2391-2
J9 P SOC PHOTO-OPT INS
PY 1997
VL 2980
BP 338
EP 342
PG 5
WC Medicine, Research & Experimental; Optics; Spectroscopy
SC Research & Experimental Medicine; Optics; Spectroscopy
GA BH84B
UT WOS:A1997BH84B00038
DA 2018-10-19
ER

PT B
AU Teoh, SH
   Thampuran, R
   Seah, WKH
   Goh, JCH
AF Teoh, SH
   Thampuran, R
   Seah, WKH
   Goh, JCH
BE Karihaloo, BL
   Mai, YW
   Ripley, MI
   Ritchie, RO
TI Fracture evaluation of a new wear resistant titanium-graphite composite
   for biomedical applications
SO ADVANCES IN FRACTURE RESEARCH, VOLS 1-6
LA English
DT Proceedings Paper
CT 9th International Conference in Fracture (ICF9)
CY APR 01-05, 1997
CL SYDNEY, AUSTRALIA
SP Int Congress Fracture
DE titanium-graphite composites; fracture toughness tests; radial crush
   strength tests; porous materials; pore morphology
AB Fracture studies on a powder metallurgically processed (P/M) titanium-graphite composite has been investigated. The composite was developed to address some of the major concerns with poor wear resistance in many pure titanium prosthetic devices. Wear resistance of the triphasic composition of pure titanium, titanium carbide and free graphite comes from the smearing of graphite on both articulating wear surfaces. Fracture of porous structures is a result of ligamental failure arising from shear localisation introduced by elongating pores. In the composite, fracture of the titanium-graphite bimaterial ligaments occurs along the brittle titanium carbide interdiffusion zone and ligaments of pure titanium. In addition to the influence of graphite composition on the fracture properties of titanium, the experiments also demonstrated the detrimental role of pores and pore morphology.
RP Teoh, SH (reprint author), NATL UNIV SINGAPORE, CTR BIOMED MAT APPLICAT & TECHNOL, INST MAT RES & ENGN, DEPT MECH & PROD ENGN, SINGAPORE 117548, SINGAPORE.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU PERGAMON PRESS LTD
PI OXFORD
PA THE BOULEVARD LANGFORD LANE KIDLINGTON, OXFORD OX5 1GB, ENGLAND
BN 0-08-042820-7
PY 1997
BP 689
EP 699
PG 11
WC Engineering, Mechanical; Materials Science, Multidisciplinary;
   Mechanics; Metallurgy & Metallurgical Engineering
SC Engineering; Materials Science; Mechanics; Metallurgy & Metallurgical
   Engineering
GA BJ89P
UT WOS:A1997BJ89P00075
DA 2018-10-19
ER

PT S
AU Kastner, AJ
   Narayan, C
   OConnor, M
   Kegel, G
   Mittler, A
AF Kastner, AJ
   Narayan, C
   OConnor, M
   Kegel, G
   Mittler, A
BE Duggan, JL
   Morgan, IL
TI Trace elemental analysis of coral and bone samples
SO APPLICATION OF ACCELERATORS IN RESEARCH AND INDUSTRY - PROCEEDINGS OF
   THE FOURTEENTH INTERNATIONAL CONFERENCE, PTS 1 AND 2
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 14th International Conference on Application of Accelerators in Research
   and Industry
CY NOV 06-09, 1996
CL UNIV N TEXAS, PHYS DEPT, DENTON, TX
SP US DOE, Natl Sci Fdn, UNT, Amer Phys Soc, Div Nucl Phys
HO UNIV N TEXAS, PHYS DEPT
AB Biomaterials have been developed for various medical applications. Strength factors as well as the deterioration rate of the biomaterials in the human body must be considered. Extensive research covers the use of hydroxyapatite, a coralline substance for biomedical applications. Coral, bone and hydroxyapatite were examined using external beam Proton Induced X-ray Emission (PIXE), Neutron Activation Analysis (NAA) and X-ray Diffraction (XRD) to determine the similarities among these materials.
RP Kastner, AJ (reprint author), SUSQUEHANNA UNIV,DEPT PHYS,BOX 756,SELINSGROVE,PA 17870, USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AIP PRESS
PI WOODBURY
PA AMERICAN INSTITUTE OF PHYSICS 500 SUNNYSIDE BOULEVARD, WOODBURY, NY
   11797-2999
SN 0094-243X
BN 1-56396-652-2
J9 AIP CONF PROC
PY 1997
IS 392
BP 543
EP 545
PG 3
WC Nuclear Science & Technology; Physics, Applied; Physics, Atomic,
   Molecular & Chemical; Physics, Nuclear
SC Nuclear Science & Technology; Physics
GA BJ23A
UT WOS:A1997BJ23A00132
DA 2018-10-19
ER

PT B
AU Shakesheff, KM
   Davies, MC
   Domb, A
   Roberts, CJ
   Shard, AJ
   Tendler, SJB
   Williams, PM
AF Shakesheff, KM
   Davies, MC
   Domb, A
   Roberts, CJ
   Shard, AJ
   Tendler, SJB
   Williams, PM
BE Cohen, SH
   Lightbody, ML
TI Visualization of the surface degradation of biomedical polymers in situ
   with an atomic force microscope
SO ATOMIC FORCE MICROSCOPY/SCANNING TUNNELING MICROSCOPY 2
LA English
DT Proceedings Paper
CT 2nd Natick-Research-Development-and-Engineering-Center of
   US-Army-Soldier-System-Command Atomic Force Microscopy/Scanning
   Tunneling Microscopy (AFM/STM) Symposium
CY JUN 07-09, 1994
CL NATICK, MA
SP USA Soldier Syst Command, Natick Res Dev & Engn Ctr
AB The ability of the atomic force microscope (AFM) to observe dynamic polymer/liquid interfaces has been utilized to visualize in situ morphological changes occurring during the biodegradation of polymer surfaces. Using this technique we demonstrate the differential rate of degradation of amorphous and crystalline material and study the kinetics of erosion of an immiscible polymer blend. The use of atomic force microscopy in this applied area of research is furthering our knowledge of the importance of the relationship between surface morphology and degradation kinetics and promises to become an invaluable tool in the evaluation of novel biodegradable materials.
RP Shakesheff, KM (reprint author), UNIV NOTTINGHAM,DEPT PHARMACEUT SCI,LAB BIOPHYS & SURFACE ANAL,UNIV PK,NOTTINGHAM NG7 2RD,ENGLAND.
RI Williams, Philip/C-6947-2009; Roberts, Clive/C-6970-2009
OI Williams, Philip/0000-0002-1822-2133; Roberts, Clive/0000-0001-9443-3445
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PLENUM PRESS DIV PLENUM PUBLISHING CORP
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013
BN 0-306-45596-X
PY 1997
BP 93
EP 98
PG 4
WC Microscopy
SC Microscopy
GA BH52R
UT WOS:A1997BH52R00011
DA 2018-10-19
ER

PT B
AU Mucalo, MR
   Johnson, GS
   Lorier, MA
AF Mucalo, MR
   Johnson, GS
   Lorier, MA
BE Sedel, L
   Rey, C
TI Processing and characterisation of biological hydroxyapatite derived
   from cattle, sheep and deer bone
SO BIOCERAMICS, VOL 10
LA English
DT Proceedings Paper
CT 10th International Symposium on Ceramics in Medicine
CY OCT 05-09, 1997
CL PARIS, FRANCE
SP European Soc Biomat, Soc Biomat (USA), European Soc Orthopaed Res, Japanese Soc Biomat, Ceram Soc Japan, Japanese Soc Orthopaed Ceram Implants, Natl Inst Sci & Med Res (INSERM France), Natl Ctr Sci Res (CNRS France)
DE bone; hydroxyapatite; implants; defatting; deproteination; FTIR/NMR
ID RAMAN
AB In New Zealand, the routine slaughter of cattle, sheep and deer produces a large amount of waste bone which is normally converted to low-cost blood-and-bone fertiliser. The porous architecture of bone makes it a valuable material for use in biomedical implants and thus this poster will describe a study into the processing and characterisation of waste bone from animal species for conversion to materials for clinical purposes. Bone samples from these species were defatted using novel methods such as microwaving which was found to be a highly rapid fat removal method. Defatted bone cubes were then bleached using hypochlorite reagents. Infrared spectroscopy monitored bulk fat removal and have demonstrated that the hypochlorite treatment decollagenated bone cubes while leaving carbonate intact. Solid state NMR showed there was still some tenaciously held organic matter in the samples even after hypochlorite treatment. The work demonstrates that waste animal bone can be efficiently processed to produce modifiable materials for clinical use.
C1 Univ Waikato, Dept Chem, Hamilton, New Zealand.
RP Mucalo, MR (reprint author), Univ Waikato, Dept Chem, Private Bag 3105, Hamilton, New Zealand.
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR AKAZAWA T, 1991, PHOSPHORUS RES B, V1, P215
   FRAYSSINET P, 1995, J MATER SCI-MATER M, V6, P473, DOI 10.1007/BF00123372
   REHMAN I, 1995, J BIOMED MATER RES, V29, P1287, DOI 10.1002/jbm.820291016
   WALSH WR, 1994, J MATER SCI-MATER M, V5, P72, DOI 10.1007/BF00121694
   WALTERS MA, 1990, J INORG BIOCHEM, V39, P193, DOI 10.1016/0162-0134(90)84002-7
NR 5
TC 0
Z9 0
U1 0
U2 5
PU PERGAMON PRESS LTD
PI OXFORD
PA THE BOULEVARD LANGFORD LANE KIDLINGTON, OXFORD OX5 1GB, ENGLAND
BN 0-08-042692-1
PY 1997
BP 321
EP 324
DI 10.1016/B978-008042692-1/50076-5
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials; Orthopedics
SC Engineering; Materials Science; Orthopedics
GA BM24P
UT WOS:000078165600076
DA 2018-10-19
ER

PT B
AU Martinetti, R
   Dolcini, L
   Ravaglioli, A
   Krajewski, A
   Mangano, C
AF Martinetti, R
   Dolcini, L
   Ravaglioli, A
   Krajewski, A
   Mangano, C
BE Sedel, L
   Rey, C
TI Experimental study on hydroxyapatite N-Carboxymethyl chitosan fillers
SO BIOCERAMICS, VOL 10
LA English
DT Proceedings Paper
CT 10th International Symposium on Ceramics in Medicine
CY OCT 05-09, 1997
CL PARIS, FRANCE
SP European Soc Biomat, Soc Biomat (USA), European Soc Orthopaed Res, Japanese Soc Biomat, Ceram Soc Japan, Japanese Soc Orthopaed Ceram Implants, Natl Inst Sci & Med Res (INSERM France), Natl Ctr Sci Res (CNRS France)
DE N-Carboxymethyl chitosan coating; porous hydroxyapatite; bioactive
   fillers
AB Hydroxyapatite / N-Carboxymethyl chitosan (HA / N-CMC) fillers were prepared and studied as a new biomaterial for medical use.
   N-CMC could either be a suitable structure where calcium and phosphate ions could arrange to begin mineralisation process or to influence the metabolism of the cells, inducing the synthesis of specific protein able to control the natural mechanism of hydroxyapatite crystals growth and consequently the mineralisation of new osteoid tissue.
   Starting materials and final samples were characterised: morphology and microstructure were evaluated by SEM and IR spectroscopy was used to detect the typical bands.
   N-CMC solution used for the preparation of the fillers coating was also characterised from the reological point of view.
   This experimental work underlines the important role of N-CMC for biomedical application, when in association with hydroxyapatite.
C1 FAENZA Srl, CERAMICA, FIN, I-48018 Faenza, Italy.
RP Martinetti, R (reprint author), FAENZA Srl, CERAMICA, FIN, Via Ravegnana 186, I-48018 Faenza, Italy.
CR LOBIANCO F, 1993, DENT CADMOS, V10, P40
   MATTIOLIBELMONTE M, 1995, J BIOACT COMPAT POL, V10, P249, DOI 10.1177/088391159501000304
   RAVAGLIOLI A, 1996, BIOCERAMICS, V9, P185
   Takechi M, 1996, J MATER SCI-MATER M, V7, P317, DOI 10.1007/BF00154542
NR 4
TC 0
Z9 0
U1 0
U2 3
PU PERGAMON PRESS LTD
PI OXFORD
PA THE BOULEVARD LANGFORD LANE KIDLINGTON, OXFORD OX5 1GB, ENGLAND
BN 0-08-042692-1
PY 1997
BP 503
EP 506
DI 10.1016/B978-008042692-1/50119-9
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials; Orthopedics
SC Engineering; Materials Science; Orthopedics
GA BM24P
UT WOS:000078165600119
DA 2018-10-19
ER

PT J
AU Taylor, GT
   Zheng, D
   Lee, M
   Troy, PJ
   Gyananath, G
   Sharma, SK
AF Taylor, GT
   Zheng, D
   Lee, M
   Troy, PJ
   Gyananath, G
   Sharma, SK
TI Influence of surface properties on accumulation of conditioning films
   and marine bacteria on substrata exposed to oligotrophic waters
SO BIOFOULING
LA English
DT Article
DE bacterial attachment; adhesion; critical surface tension; wettability;
   thermodynamics
ID PROTEIN ADSORPTION; SOLID SUBSTRATA; ADHESION; SEAWATER; ATTACHMENT;
   HYDROPHOBICITY; SORPTION
AB The influence of interfacial wettabilities on initial conditioning and bacterial colonization of polished surfaces was examined in the oligotrophic, subtropical waters off O'ahu's south shore and in the laboratory. After exposures to seawater for 3 d, accumulations of attached bacteria on 11 types of substrata during two deployments varied as a second order function of substratum wettability. As observed in previous biomedical and mesotrophic field studies, surfaces with intermediate critical surface tensions (gamma(crit) = 20-30 mN m(-1)) and extremes in the polar and dispersive components of the composite surface free energy were least colonized by bacteria. Conditioning film thicknesses, varied by a factor of 100 among materials and also appeared to be a second order function of gamma(crit). Sorbed films produced interfaces with a range of wettabilities, dependent upon substratum and sorbate properties. Bacteria isolated from surfaces exhibited four basic partitioning patterns into non-aqueous solvents which demonstrates that cell surface wettabilities vary widely among isolates and are characterized as (i) broadly hydrophobic, (ii) broadly hydrophilic, (iii) only compatible in phases with surface tensions < 20 mN m(-1), or (iv) only compatible in phases with surface tension > 27 mN m(-1). Partitioning patterns of cultured isolates are consistent with held observations of denser colonization of low and high gamma(crit) surfaces. The results support the hypothesis that substratum surface properties influence conditioning film attributes and continue to exert control over bacterial adsorption and attachment even after conditioning films are established.
C1 SUNY STONY BROOK, MARINE SCI RES CTR, STONY BROOK, NY 11794 USA.
   UNIV HAWAII, DEPT OCEANOG, HONOLULU, HI 96822 USA.
   PG CTR, DEPT BIOTECHNOL, NANDED, INDIA.
   UNIV HAWAII, HAWAII INST GEOPHYS, HONOLULU, HI 96822 USA.
RI Taylor, Gordon/A-6735-2009
OI Taylor, Gordon/0000-0002-6925-7571
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Baier R. E., 1970, ADHESION BIOL SYSTEM, P15
   Baier R.E., 1972, 3RD P INT C MAR CORR, P633
   BAIER RE, 1980, ADSORPTION MICROORGA, P59
   BAIER RE, 1981, FOULING HEAT TRANSFE, P293
   Characklis W. G., 1990, BIOFILMS, P195
   DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73
   DEXTER SC, 1979, J COLLOID INTERF SCI, V70, P346, DOI 10.1016/0021-9797(79)90038-9
   DEXTER SC, 1975, APPL MICROBIOL, V30, P298
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   FLETCHER RL, 1984, MAR BIOL LETT, V5, P251
   HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225
   KIRCHMAN DL, 1989, MAR CHEM, V27, P201, DOI 10.1016/0304-4203(89)90048-0
   KJELLEBERG S, 1982, APPL ENVIRON MICROB, V43, P1166
   KJELLEBERG S, 1980, FEMS MICROBIOL LETT, V7, P41, DOI 10.1111/j.1574-6941.1980.tb01572.x
   Little B.J., 1990, BIOFILMS, P635
   Loeb G.I., 1975, ADV CHEM SER, V145, DOI 10.1021/ba-1975-0145.ch016
   Marshall K.C., 1985, BACTERIAL ADHESION M, P133
   MARSHALL KC, 1971, J GEN MICROBIOL, V68, P337, DOI 10.1099/00221287-68-3-337
   MARSHALL KC, 1971, CAN J MICROBIOL, V17, P1413, DOI 10.1139/m71-225
   MARSZALEK DS, 1979, APPL ENVIRON MICROB, V38, P987
   NYILAS E, 1977, J BIOMED MATER RES S, V8, P51
   PRINGLE JH, 1986, APPL ENVIRON MICROB, V51, P1321
   Rittle K. H., 1990, Biofouling, V2, P121
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x
   RUTTER P, 1980, J GEN MICROBIOL, V102, P301
   TAYLOR GT, 1993, APPL SPECTROSC, V47, P1140, DOI 10.1366/0003702934068053
   TAYLOR GT, 1994, MAR CHEM, V47, P21, DOI 10.1016/0304-4203(94)90011-6
   TAYLOR GT, 1994, MAR CHEM, V45, P15, DOI 10.1016/0304-4203(94)90088-4
   VANDEVIVERE P, 1993, APPL ENVIRON MICROB, V59, P3280
   VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   VANLOOSDRECHT MCM, 1990, AQUAT SCI, V52, P103, DOI 10.1007/BF00878244
   WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175
   ZAIDI BR, 1984, APPL ENVIRON MICROB, V48, P519
   ZHENG DQ, 1994, BIOFOULING, V8, P107, DOI 10.1080/08927019409378266
   Zimmermann R, 1977, MICROBIAL ECOLOGY BR, V25, P103, DOI 10.1007/978-3-642-66791-6_10
   Zisman W. A., 1964, ADV CHEM SER, V43, P1
NR 39
TC 40
Z9 43
U1 1
U2 18
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0892-7014
EI 1029-2454
J9 BIOFOULING
JI Biofouling
PY 1997
VL 11
IS 1
BP 31
EP 57
DI 10.1080/08927019709378319
PG 27
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA WM451
UT WOS:A1997WM45100003
DA 2018-10-19
ER

PT J
AU Tang, YW
   Santerre, JP
   Labow, RS
   Taylor, DG
AF Tang, YW
   Santerre, JP
   Labow, RS
   Taylor, DG
TI Application of macromolecular additives to reduce the hydrolytic
   degradation of polyurethanes by lysosomal enzymes
SO BIOMATERIALS
LA English
DT Article
DE polyurethanes; polymeric additives; biodegradation; cholesterol
   esterase; biostability; surface chemistry
ID SURFACE; URETHANES; ADHESION
AB Of the various polymers used in medical devices, polyurethanes have been relatively successful because of their acceptable mechanical and biological properties. However, over the past decade, increasing concerns have arisen in relation to the long-term biostability of polyurethanes when exposed to the harsh environment of the human body. Lysosomal enzymes released from inflammatory cells have been proposed to be important mediators in the degradation of biomedical polyurethanes. In order to increase the biostability of polyurethanes to lysosomal enzymes, a series of surface-modifying macromolecules (SMMs) were synthesized in this work and then combined into a base polyurethane to reduce the material's susceptibility to hydrolysis. X-ray photoelectron spectroscopy (XPS) studies showed that the SMMs were enriched within the upper 10 nm of the surface. In vitro biodegradation test results indicated that the degradation of a polyester-urea-urethane could be inhibited by the new SMM surface. It was also found that different SMM formulations provided varying degrees of inhibition against the biodegradation of the polyester-urea-urethane. Certain formulations of the SMMs were shown to be physically incompatible with the polyurethane and distorted surface morphology to the extent that biodegradation was enhanced. (C) 1996 Elsevier Science Limited
C1 UNIV TORONTO,FAC DENT,DEPT BIOMAT,TORONTO,ON M5G 1G6,CANADA.
   UNIV OTTAWA,INST HEART,CARDIOVASC DEVICES DIV,OTTAWA,ON,CANADA.
   UNIV OTTAWA,DEPT CHEM ENGN,OTTAWA,ON,CANADA.
CR AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   BRUNSTEDT MR, 1990, BIOMATERIALS, V11, P370, DOI 10.1016/0142-9612(90)90089-9
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P255, DOI 10.1002/jbm.820270216
   DERMANN K, 1982, J DENT RES, V61, P1250, DOI 10.1177/00220345820610110901
   HAN DK, 1993, J APPL POLYM SCI, V47, P761, DOI 10.1002/app.1993.070470502
   HUBBELL JA, 1993, CARDIOVASC PATHOL, V2, pS121
   HUNTER SK, 1983, T AM SOC ART INT ORG, V29, P250
   KAMBIC HE, 1986, CHEM ENG NEWS   0414, P31
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   LABOW RS, 1995, BIOMATERIALS, V16, P51, DOI 10.1016/0142-9612(95)91096-H
   LALAH MD, 1986, POLYURETHANES MED
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P309, DOI 10.1002/jbm.820180307
   NOJIRI C, 1988, T ASAIO, V34, P386
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   RATNER BD, 1987, POLYURETHANES BIOMED, V2, P213
   RAUZEL DG, 1994, FUNDAM APPL TOXICOL, V22, P195
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   SUBRAMONIAM A, 1991, TOXICOL LETT, V57, P245, DOI 10.1016/0378-4274(91)90198-F
   TANG YW, 1996, IN PRESS J APPL POLY
   TANG YW, IN PRESS J BIOMED MA
   WANG FGB, IN PRESS J BIOMED MA
   WANG TL, 1992, POLYM BULL, V27, P549, DOI 10.1007/BF00300603
   Ward RS, 1984, POLYURETHANES BIOMED, P181
   WILLIAMS DF, 1986, FUNDAMENTAL ASPECTS, V1
NR 28
TC 37
Z9 37
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 1997
VL 18
IS 1
BP 37
EP 45
DI 10.1016/S0142-9612(96)00101-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WA345
UT WOS:A1997WA34500008
PM 9003895
DA 2018-10-19
ER

PT B
AU Hielscher, AH
   Eick, AA
   Mourant, JR
   Freyer, JP
   Bigio, IJ
AF Hielscher, AH
   Eick, AA
   Mourant, JR
   Freyer, JP
   Bigio, IJ
BE VoDinh, T
   Lieberman, RA
   Vurek, GG
   Katzir, A
TI Biomedical diagnostic with diffusely backscattered linearly and
   circularly polarized light
SO BIOMEDICAL SENSING, IMAGING, AND TRACKING TECHNOLOGIES II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Sensing, Imaging, and Tracking Technologies II
CY FEB 11-13, 1997
CL SAN JOSE, CA
SP Int Biomed Opt Soc, Soc Photo Opt Instrumentat Engineers, Amer Soc Laser Med & Surg Inc
DE mueller matrix; Stokes vector polarization; backscattering; polystyrene
   spheres; biological-cell suspensions; fibroblasts; cancer
AB We report on the development of a method that records spatially dependent intensity patterns of polarized Light that is diffusely backscattered from turbid materials. It is demonstrated that these intensity patterns can be used to differentiate between suspensions of cancerous and noncancerous cells and to observe different metabolic cell processes. Our technique employs polarized light from a He-Ne laser (lambda = 513 nm), which is focused onto the surface of the scattering medium. A surface area of approximately 4 x 4 cm around the light input point is imaged through polarization-analysis optics onto a CCD camera One can observe a manifold of intensity patterns by varying the polarization state of the incident laser light and changing the analyzer configuration to detect different polarization components of the backscattered light Introducing the Mueller-matrix concept for diffusely backscattered light, a framework is provided to select a subset of measurements which comprehensively describe the optical properties of backscattering media.
RP Hielscher, AH (reprint author), LOS ALAMOS NATL LAB,CST-4,MS E535,LOS ALAMOS,NM 87545, USA.
NR 0
TC 24
Z9 24
U1 0
U2 2
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2387-4
J9 P SOC PHOTO-OPT INS
PY 1997
VL 2976
BP 298
EP 305
DI 10.1117/12.275538
PG 8
WC Engineering, Biomedical; Optics; Radiology, Nuclear Medicine & Medical
   Imaging
SC Engineering; Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BJ12R
UT WOS:A1997BJ12R00033
DA 2018-10-19
ER

PT B
AU Ottova, AL
   Hianik, T
   Ziegler, W
   Tvarozek, V
   Sabo, J
   Passechnik, VI
   Ivanov, SA
   Tien, HT
AF Ottova, AL
   Hianik, T
   Ziegler, W
   Tvarozek, V
   Sabo, J
   Passechnik, VI
   Ivanov, SA
   Tien, HT
BE VoDinh, T
   Lieberman, RA
   Vurek, GG
   Katzir, A
TI Self-assembled and supported BLMs as a smart system for biosensors
SO BIOMEDICAL SENSING, IMAGING, AND TRACKING TECHNOLOGIES II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Sensing, Imaging, and Tracking Technologies II
CY FEB 11-13, 1997
CL SAN JOSE, CA
SP Int Biomed Opt Soc, Soc Photo Opt Instrumentat Engineers, Amer Soc Laser Med & Surg Inc
DE bilayer lipid membranes; BLMs; planar lipid bilayers; biosensors; metal
   substrate; hydrogels; agar; interface
AB In the last few years there have been a number of research papers on self-assemblies of molecules as 'advanced materials' or 'smart sensors'. The inspiration for this exciting research, without question, comes from the biological world where, for example, the lipid bilayer of the cell membrane is the most important self-assembling system. Although the first report on self-assembled bilayer lipid membranes (BLMs) in vivo was published in 1962, interface science including surface and colloid science has been dealing with these interfacial self-assemblies of amphiphilic molecules since Robert Hooke's time (1672). In this communication, we present results of extensive study of physical chemical properties of two new membrane systems: metal and hydrogel supported bilayer lipid membranes (BLMs for short, also known as planar lipid bilayers). Several methods have been used to investigate the properties of these metal supported s-BLMs and hydrogel supported salt-bridge sb-BLMs. With the electrostriction method we observed different behavior of the planar lipid bilayer on metal substrate. The obtained results gave possibility to choose optimal properties of the support for constructing s-BLM-based biosensors. The capacitance relaxation method was used to determine the changes of dielectric relaxation times (reorientation of dipole moments of polar groups of individual lipid molecules or lipid clusters) and showed different dynamic properties of Lipids on the metal substrate and in free standing BLMs. Analysis of membrane current noise allowed the examination of the dynamic properties of supported BLMs. Examples of a number of practical applications of s-BLMs for the construction of a glucose sensor for biomedical use as well as applications of agar supported BLMs for determining several toxins will be presented.
RP Ottova, AL (reprint author), MICHIGAN STATE UNIV,DEPT PHYSIOL,E LANSING,MI 48824, USA.
NR 0
TC 1
Z9 1
U1 0
U2 2
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2387-4
J9 P SOC PHOTO-OPT INS
PY 1997
VL 2976
BP 342
EP 349
DI 10.1117/12.275542
PG 8
WC Engineering, Biomedical; Optics; Radiology, Nuclear Medicine & Medical
   Imaging
SC Engineering; Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BJ12R
UT WOS:A1997BJ12R00037
DA 2018-10-19
ER

PT B
AU Tvarozek, V
AF Tvarozek, V
BE Nikolelis, DP
   Krull, UJ
   Wang, J
   Mascini, M
TI Microsystem technology in biosensors
SO BIOSENSORS FOR DIRECT MONITORING OF ENVIRONMENTAL POLLUTANTS IN FIELD
SE NATO ADVANCED SCIENCE INSTITUTES SERIES, SUB-SER 2, ENVIRONMENTAL
   SECURITY
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Biosensors for Direct Monitoring of
   Environmental Pollutants in Field
CY MAY 04-08, 1997
CL SMOLENICE, SLOVAKIA
SP NATO, Sci Comm
AB Miniaturization of biosensors has increased the importance of microsystem technology particulary of microelectronics, micromachining and thin film technology. Thin-film technology microelectrodes and microsystems serve as well-defined and reproducible interfaces between sensing, recognition and transduction sites. Solving the compatibility of bilayer lipid membranes with planar thin-film microsystems is esential for future applications of that very "adaptive" material in the field of microbiosensors. Microsystem technology gives comprehensive and synergetic effect on the innovation and mass-production of microinstruments for biomedical analysis and enviromental monitoring.
C1 Slovak Univ Technol Bratislava, Dept Microelect, Bratislava 81219, Slovakia.
RP Tvarozek, V (reprint author), Slovak Univ Technol Bratislava, Dept Microelect, Ilkovicova 3, Bratislava 81219, Slovakia.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 0-7923-4867-2
J9 NATO ASI 2
PY 1997
VL 38
BP 351
EP 371
PG 21
WC Biology; Chemistry, Multidisciplinary; Chemistry, Analytical;
   Environmental Sciences
SC Life Sciences & Biomedicine - Other Topics; Chemistry; Environmental
   Sciences & Ecology
GA BK63J
UT WOS:000072818700031
DA 2018-10-19
ER

PT S
AU Leclaire, P
   Kelders, L
   Lauriks, W
   Glorieux, C
   Thoen, J
AF Leclaire, P
   Kelders, L
   Lauriks, W
   Glorieux, C
   Thoen, J
BE Lowet, G
   Ruegsegger, P
   Weinans, H
   Meunier, A
TI Ultrasonic wave propagation in porous media: Determination of acoustic
   parameters and high frequency limit of the classical models
SO BONE RESEARCH IN BIOMECHANICS
SE STUDIES IN HEALTH TECHNOLOGY AND INFORMATICS
LA English
DT Proceedings Paper
CT 10th Conference of the European-Society-of-Biomechanics
CY AUG 28-31, 1996
CL LOUVAIN, BELGIUM
SP European Soc Biomech
AB Results on the ultrasonic wave propagation in porous materials are presented with emphasis on the measurement of acoustic parameters and on the discrepancy between experimental results and theoretical predictions for the attenuation at high frequencies. This discrepancy can be observed in Biomedical Engineering where the propagation in different sorts of bones is studied as well as in the fields of Geophysics and Material Science. In the present study, the slow wave propagation in polyurethane foams saturated by different gases is investigated in a frequency range of [70-800 kHz]. Methods are presented to determine the tortuosity and the viscous and thermal characteristic lengths. The experimental results, obtained using standard ultrasonic and vacuum equipments, show that an excess attenuation occurs when the wavelength is not sufficiently large compared to the lateral dimensions of the fibers. This effect constitutes a limit of the classical models of equivalent phases. It is evaluated with the help of a model of ultrasonic scattering. A numerical simulation of osteoporosis using Blot's model is also presented.
RP Leclaire, P (reprint author), KATHOLIEKE UNIV LEUVEN,DEPT NATUURKUNDE,LAB AKOESTIEK & THERM FYS,CELESTIJNENLAAN 200D,B-3001 LOUVAIN,BELGIUM.
NR 0
TC 3
Z9 3
U1 0
U2 5
PU I O S PRESS
PI AMSTERDAM
PA VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS
SN 0926-9630
BN 90-5199-327-7
J9 ST HEAL T
PY 1997
VL 40
BP 139
EP 155
PG 17
WC Engineering, Biomedical; Medical Informatics; Orthopedics
SC Engineering; Medical Informatics; Orthopedics
GA BH94B
UT WOS:A1997BH94B00011
PM 10168875
DA 2018-10-19
ER

PT J
AU Rizkalla, AS
   Jones, DW
   Hall, GC
AF Rizkalla, AS
   Jones, DW
   Hall, GC
TI Synthesis of experimental biomedical glass cement forming systems
SO BRITISH CERAMIC TRANSACTIONS
LA English
DT Article
ID IONOMER CEMENTS
AB Five experimental glass formulations, (SiO2-Al2O3CaF2-AlPO4-AlF3-NaF), were designed to undergo crystallisation during slow cooling or heat treatment. Precursor materials for the five compositions were synthesised by a wet chemical method with various amounts of fluoride and sodium incorporated to act as pur or nucleating agents. Colloidal suspensions of Al2O3, SiO2, and H3PO4 were spray dried, calcined at 1000 degrees C, and mixed with calcium, aluminium and sodium fluorides to produce the precursor powders. Following calcination, the glasses were melted at 1600 degrees C and quenched to produce a clear transparent glass. The bulk chemical compositions were determined by atomic absorption spectrophotometry, and ultraviolet spectroscopy and an ion specific electrode were used to determine the P and F contents respectively. The calcium content of the final glasses varied from 10.64 to 20.03% and the aluminium content from 15.64 to 20.53%. The compositions of all Jive glasses were statistically, significantly different. Setting characteristics were determined by means of an oscillating rheometer. Cements of various reactivities were produced by all five ion leachable glasses when mixed with different ratios of poly(acrylic acid) to tartaric acid. The shear moduli for three experimental cements were comparable with two commercial materials.
C1 DALHOUSIE UNIV,FAC MED,HALIFAX,NS B3H 3J5,CANADA.
RP Rizkalla, AS (reprint author), DALHOUSIE UNIV,FAC DENT,DIV BIOMAT,HALIFAX,NS B3H 3J5,CANADA.
RI Rizkalla, Amin/D-8845-2015
OI Rizkalla, Amin/0000-0003-0548-3817
CR BARRY TI, 1979, J DENT RES, V58, P1072, DOI 10.1177/00220345790580030801
   BERNAS B, 1968, ANAL CHEM, V40, P1682, DOI 10.1021/ac60267a017
   CRISP S, 1974, J DENT RES, V53, P1414, DOI 10.1177/00220345740530062001
   ELLIS J, 1992, DENT MATER, V8, P79, DOI 10.1016/0109-5641(92)90060-P
   HALL GC, 1989, J DENT RES, V68, P978
   HALMANN M, 1972, ANAL CHEM PHOSPHORUS, P51
   JONES DW, 1988, MAT SCI ENG A-STRUCT, V105, P207, DOI 10.1016/0025-5416(88)90498-3
   JONES DW, 1991, J MATER SCI, V26, P6501, DOI 10.1007/BF00551904
   JONES DW, 1991, 17 ANN M SOC BIOM SC
   KNIBBS PJ, 1988, J ORAL REHABIL, V15, P103, DOI 10.1111/j.1365-2842.1988.tb00150.x
   MOUNT JG, 1990, AM J DENT, V3, P79
   MOUNT JG, 1984, CLIN DENT
   RIZKALLA AS, 1991, BRIT CERAM TRANS J, V90, P81
   RIZKALLA AS, 1991, BRIT CERAM TRANS J, V90, P1
   RIZKALLA AS, 1988, J DENT RES, V67, P119
   Smith D.C., 1983, DENT CLIN N AM, V6, P763
   TAY WM, 1989, IR DENT ASS, V35, P53
   TAY WM, 1989, IR DENT ASS, V35, P59
   WALLS AWG, 1986, J DENT, V14, P231, DOI 10.1016/0300-5712(86)90030-8
   Wilson A D, 1989, Int J Prosthodont, V2, P438
   WILSON AD, 1989, J DENT RES, V68, P89, DOI 10.1177/00220345890680021401
   WILSON AD, 1973, Patent No. 1316129
   WILSON AD, 1988, GLASS IONOMER CEMENT
   WILSON AD, 1978, CEMENT RES PROGR, pCH4
   WILSON AD, 1978, CHEM SOC REV, V77, P265
   WOOD D, 1991, BIOMATERIALS, V12, P164, DOI 10.1016/0142-9612(91)90195-G
NR 26
TC 2
Z9 2
U1 0
U2 1
PU INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON, ENGLAND SW1Y 5DB
SN 0967-9782
J9 BRIT CERAM T
JI Br. Ceram. Trans.
PY 1997
VL 96
IS 1
BP 16
EP 20
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA XJ646
UT WOS:A1997XJ64600003
DA 2018-10-19
ER

PT J
AU Rizkalla, AS
   Jones, DW
AF Rizkalla, AS
   Jones, DW
TI Differential thermal analysis of experimental ion leachable glasses
SO BRITISH CERAMIC TRANSACTIONS
LA English
DT Article
ID CRYSTALLIZATION KINETICS; FLUORIDE GLASSES; DEVITRIFICATION; PARAMETERS;
   DTA
AB Five, six component experimental glass formulations were developed as ion leachable biomedical cement forming systems. The precursor powders were synthesised by wet chemistry. Following calcination, the glasses were melted at 1600 degrees C and rapidly cooled to produce clear transparent glass. All five glasses crystallised during heat treatment producing glass ceramics with various degrees of opacity. Crystallisation kinetics were studied by means of differential thermal analysis. Three samples of each glass were heated from 23 to 1200 degrees C in N-2 at heating rates ranging from 5 to 50 K min(-1). The activation energy of crystallisation for each composition wets calculated from an expression relating log hearing late and the reciprocal of the exothermic peak temperature. The compositions of the five glasses were significantly different at the 0.95 level of confidence. The activation energy values ranged from 335 to 678 kJ mol(-1). The results indicate that four of the five glasses underwent bulk crystallisation. The crystalline phases, present in each of the five formulations following heat treatment, were gehlenite, anorthite, and fluoroapatite. Different ratios of the first two phases were present in each of the five materials. (C) 1997 The Institute of Materials.
RP Rizkalla, AS (reprint author), DALHOUSIE UNIV,FAC MED,DIV BIOMAT,HALIFAX,NS B3H 3J5,CANADA.
RI Rizkalla, Amin/D-8845-2015
OI Rizkalla, Amin/0000-0003-0548-3817
CR AUGIS JA, 1978, J THERM ANAL, V13, P283, DOI 10.1007/BF01912301
   Avrami M, 1941, J CHEM PHYS, V9, P177, DOI 10.1063/1.1750872
   Avrami M., 1940, Journal of Chemical Physics, V8, P212, DOI 10.1063/1.1750631
   Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380
   BANSAL NP, 1984, J THERM ANAL, V29, P115, DOI 10.1007/BF02069946
   BANSAL NP, 1985, J NON-CRYST SOLIDS, V70, P379, DOI 10.1016/0022-3093(85)90108-5
   BARO MD, 1977, J THERM ANAL, V11, P271
   BRANDA F, 1984, THERMOCHIM ACTA, V80, P269, DOI 10.1016/0040-6031(84)87204-4
   CHEN HS, 1978, J NON-CRYST SOLIDS, V27, P257, DOI 10.1016/0022-3093(78)90128-X
   GAO YQ, 1986, J NON-CRYST SOLIDS, V81, P135, DOI 10.1016/0022-3093(86)90263-2
   HENDERSON DW, 1984, J NON-CRYST SOLIDS, V64, P43, DOI 10.1016/0022-3093(84)90205-9
   Johnson WA, 1939, T AM I MIN MET ENG, V135, P416
   KING HW, 1993, CAN CERAM QUART, V62, P248
   KISSINGER HE, 1956, J RES NAT BUR STAND, V57, P217, DOI 10.6028/jres.057.026
   KISSINGER HE, 1957, ANAL CHEM, V29, P1702, DOI DOI 10.1021/AC60131A045
   MACFARLANE DR, 1984, J NON-CRYST SOLIDS, V64, P351, DOI 10.1016/0022-3093(84)90188-1
   MACKENZIE RC, 1957, DIFFERENTIAL THERMAL, P51
   Matusita K, 1981, B I CHEM RES KYOTO U, V59, P159
   RAY CS, 1991, J AM CERAM SOC, V74, P60, DOI 10.1111/j.1151-2916.1991.tb07297.x
   Rizkalla AS, 1997, BRIT CERAM T, V96, P16
   SUSIC MV, 1986, J MATER SCI, V21, P1297, DOI 10.1007/BF00553266
   YINNON H, 1983, J NON-CRYST SOLIDS, V54, P253, DOI 10.1016/0022-3093(83)90069-8
NR 22
TC 0
Z9 0
U1 0
U2 1
PU INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON, ENGLAND SW1Y 5DB
SN 0967-9782
J9 BRIT CERAM T
JI Br. Ceram. Trans.
PY 1997
VL 96
IS 2
BP 57
EP 60
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA YC394
UT WOS:A1997YC39400003
DA 2018-10-19
ER

PT J
AU Rondelli, G
   Vicentini, B
   Cigada, A
AF Rondelli, G
   Vicentini, B
   Cigada, A
TI Localised corrosion tests on austenitic stainless steels for biomedical
   applications
SO BRITISH CORROSION JOURNAL
LA English
DT Article
AB Electrochemical localised corrosion tests (cyclic potentiodynamic, potentiostatic with scratch, modified ASTM F746) were conducted in artificial physiological solutions on two traditional austenitic stainless steels, types AISI 316L and ASTM F138, and a new high nitrogen austenitic stainless steel, type 20Cr9Ni2Mo0.39N. The results pointed to the superiority of the 20Cr9Ni2Mo0.39N steel with respect to the traditional ones. No effects on localised corrosion resistance owing to addition of 10% serum to physiological solutions were detected. The possibility that the modified ASTM F746 test could give I ise, for the new 20Cr9Ni2Mo0.39N steel. to a controversial classification of the material's performance, depending on different interpretations of localised corrosion stimulation criteria, is discussed. (C) 1997 The Institute of Materials.
C1 Ist Tecnol Mat, I-20133 Milan, Italy.
   Univ Aquila, Dipartimento Chim Ingn Chim & Mat, I-67040 Laquila, Italy.
OI Cigada, Alberto/0000-0002-0925-5558
CR ANDERSON DB, 1976, ASTM STP, V576, P231
   [Anonymous], 1993, ANN BOOK ASTM STAND
   CHAVA SK, 1990, CORROSION, V46, P147
   CIGADA A, 1938, P 12 INT CORR C HO B, V3
   GURD FRN, 1956, ADV PROTEIN CHEM, V9, P312
   HOAR TP, 1966, PROC R SOC LON SER-A, V294, P486, DOI 10.1098/rspa.1966.0220
   HSU HM, 1984, P 10 ANN M SOC BIOM, P124
   KRUGER J, 1979, STP, V684, P109
   KUHN AT, 1988, STP, V970, P79
   Menzel J., 1990, P 2 INT C HIGH NITR, P365
   PAYER JH, 1990, ADV LOCALIZED CORROS, P235
   PESSAI N, 1971, ELECTROCHIM ACTA, V16, P1997
   SINIGAGLIA D, 1980, WERKST KORROS, V31, P851
   Speidel M.O., 1990, P 2 INT C HIGH NITR
   SPEIDEL MG, 1992, P C CORR 92 NASHV TN
   SPRUIT D, 1980, DERMATOLOGIC EFFECT, P601
   SUTOW EJ, 1981, BIOCOMPATIBILITY CLI, V1, P45
   Williamson D H, 1985, Yeast, V1, P1, DOI 10.1002/yea.320010102
NR 18
TC 17
Z9 18
U1 1
U2 7
PU INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON SW1Y 5DB, ENGLAND
SN 0007-0599
J9 BRIT CORROS J
JI Br. Corros. J.
PY 1997
VL 32
IS 3
BP 193
EP 196
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA ZU596
UT WOS:000074213900005
DA 2018-10-19
ER

PT S
AU Boyer, CN
   Holland, GE
   Seely, JF
AF Boyer, CN
   Holland, GE
   Seely, JF
BE Freund, AK
   Freund, HP
   Howells, MR
TI A pulsed hard x-ray source for nondestructive testing and medical
   imaging
SO COHERENT ELECTRON-BEAM X-RAY SOURCES: TECHNIQUES AND APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Coherent Electron-Beam X-Ray Sources - Techniques and
   Applications
CY JUL 31-AUG 01, 1997
CL SAN DIEGO, CA
SP Soc Photo Opt Instrumentat Engineers
DE Marx generator; field emission; high voltage; ultraviolet; x-ray;
   trigatron
AB The ability to nondestructively image living organisms, examine biological materials, and inspect packages without the necessity of removing the contents are applications well suited to x-ray radiography. We have developed a portable flash x-ray (FX) source having adjustable peak x-ray photon energy, which delivers a 34 milliroentgen rr-ray dose at 30 cm in a 60-ns full-width at half-maximum (FWHM) pulse using less than 5 joules of stored energy. This technology has generated considerable interest in the biomedical imaging community and promises to replace older x-ray systems that were not readily portable.
C1 Univ Space Res Assoc, Washington, DC 20024 USA.
RP Boyer, CN (reprint author), Univ Space Res Assoc, 300 D St SW, Washington, DC 20024 USA.
NR 0
TC 1
Z9 2
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2576-1
J9 P SOC PHOTO-OPT INS
PY 1997
VL 3154
BP 16
EP 26
DI 10.1117/12.279390
PG 11
WC Optics; Physics, Multidisciplinary
SC Optics; Physics
GA BK08U
UT WOS:000071156600002
DA 2018-10-19
ER

PT J
AU Festing, MFW
AF Festing, MFW
TI Variation and its implications for the design of experiments in
   toxicological research
SO COMPARATIVE HAEMATOLOGY INTERNATIONAL
LA English
DT Article
DE experimental design; inbred strains; outbred stocks; statistics
AB The controlled experiment is one of the most powerful tools available in biomedical research, and thousands of such experiments are conducted annually. However, the basic principles of designing such experiments do not seem to be widely understood. If the experimental material is heterogeneous, then the treated and control groups may not be identical at the start of the experiment, even if large sample sizes are used. Yet genetically heterogeneous 'outbred' stocks of laboratory mice and rats are widely used in the pharmaceutical industry in spite of the availability of more homogeneous inbred strains. The use of such stocks is justified on two grounds: that humans are also heterogeneous, and that such stocks offer a wide range of phenotypes for toxicological screening. Both arguments are spurious. It is not necessary for a toxicological model of humans to be a good genetic model. Models do not have to resemble their target in every respect. Were they to do so they would no longer be models. The genetic heterogeneity within an outbred stock simply creates 'noise' when comparing treated and control groups, and prevents more exact matching of groups before the experiment starts. Phenotypic heterogeneity can be achieved without this disadvantage using a factorial experimental design involving more than one strain, with groups exactly matched genetically, but without increasing total numbers.
   The lack of understanding of good experimental design seems to extend to other areas, with few research workers using techniques such as blocking and factorial experimental designs which have been known for over 60 years, and which are widely used in other disciplines. Experiments are often unnecessarily large and surveys suggest that more than half have obvious statistical errors. Better training in experimental design would be cost effective in making better use of scarce resources, and would help to reduce the use of laboratory animals, which is an ethically desirable goal.
C1 Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England.
RP Festing, MFW (reprint author), Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg,POB 138,Lancaster Rd, Leicester LE1 9HN, Leics, England.
CR Altman D G, 1982, Stat Med, V1, P59, DOI 10.1002/sim.4780010109
   ALTMAN DG, 1982, STAT PRACTICE, P1
   ARCOS JC, 1968, CHEM INDUCTION CANC
   Balls M, 1995, ATLA-ALTERN LAB ANIM, V23, P838
   Cox DR, 1958, PLANNING EXPT
   ELASHOFF JD, 1995, NQUERY ADVISOR USERS
   FELTON RP, 1989, J TOXICOL ENV HEALTH, V26, P399, DOI 10.1080/15287398909531264
   FESTING MFW, 1993, J EXP ANIM SCI, V35, P210
   FESTING MFW, 1987, CRIT REV TOXICOL, V18, P1, DOI 10.3109/10408448709089855
   FESTING MFW, 1995, ENVIRON HEALTH PERSP, V103, P44, DOI 10.2307/3432255
   FESTING MFW, 1995, MUTAT RES-FUND MOL M, V329, P221, DOI 10.1016/0027-5107(95)00050-S
   FESTING MFW, 1994, LAB ANIM, V28, P212, DOI 10.1258/002367794780681697
   Festing MFW, 1982, ILAR NEWS, V25, P6
   FESTING MFW, 1996, STAT TOXICOLOGY, P3
   FESTING MFW, 1979, INBRED STRAINS BIOME
   Festing Michael F. W., 1992, Laboratory Animals (London), V26, P256, DOI 10.1258/002367792780745788
   FISHER RA, 1960, DESIGN EXPT
   GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347
   GORE SM, 1977, BRIT MED J, V1, P85, DOI 10.1136/bmj.1.6053.85
   HESTON WE, 1968, JPN CANC ASS GANN MO, V5, P3
   Mead R, 1988, DESIGN EXPT, V620
   NOHYNEK GJ, 1993, HUM EXP TOXICOL, V12, P87, DOI 10.1177/096032719301200201
   PAPAIOANNOU VE, 1980, LAB ANIM, V14, P11, DOI 10.1258/002367780780943015
   SONTAG JM, 1976, NCI CARCINOGENESIS T, V1
NR 24
TC 4
Z9 4
U1 2
U2 9
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0938-7714
J9 COMP HAEMATOL INT
JI Comp. Haematol. Int.
PY 1997
VL 7
IS 4
BP 202
EP 207
DI 10.1007/BF02658690
PG 6
WC Hematology
SC Hematology
GA YN148
UT WOS:000071137900003
DA 2018-10-19
ER

PT B
AU GonzalezCarrasco, JL
   Escudero, ML
   Chao, J
   Rubio, JC
   GarciaAlonso, MC
   Lopez, MF
   Ruiz, J
   Cebollada, F
   Adeva, P
   Canahua, H
AF GonzalezCarrasco, JL
   Escudero, ML
   Chao, J
   Rubio, JC
   GarciaAlonso, MC
   Lopez, MF
   Ruiz, J
   Cebollada, F
   Adeva, P
   Canahua, H
BE Sarton, LAJ
   Zeedijk, HB
TI The MA 956 superalloy: a potential biomaterial for surgical implants.
SO EUROMAT 97 - PROCEEDINGS OF THE 5TH EUROPEAN CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSES AND APPLICATIONS: MATERIALS, FUNCTIONALITY &
   DESIGN, VOL 3: SURFACE ENGINEERING AND FUNCTIONAL MATERIALS
LA English
DT Proceedings Paper
CT 5th European Conference on Advanced Materials and Processes and
   Applications (EUROMAT 97)
CY APR 21-23, 1997
CL MAASTRICHT, NETHERLANDS
SP Federat European Mat Soc, Netherlands Soc Mat Sci
AB Thermal oxidation treatment (1100 degrees C/100 h) of MA 956 produces on the surface a tightly adherent alpha-alumina scale, about 5 mu m thick. The scale/metal system resembles an alumina coated material with the advantage that the coating is easier to perform than by other conventional processes. In vitro experiments have proved that MA 956 with and without scale exhibits an excellent corrosion behaviour being the corrosion intensities lower than those of metallic biomaterials in use. It is worth to remark that scale decreases the corrosion intensity at least up to two orders of magnitude with respect to the uncoated material, which corrosion behaviour is also excellent. The elevated compressive residual stresses in the scale guarantee its integrity during tensile deformation and account for the good fatigue and wear behaviour. SEM examination of implanted samples reveals a bone response similar to that for other biomaterials. These promising results provides with a window of opportunity for preoxidized Ma 956 in biomedical applications.
RP GonzalezCarrasco, JL (reprint author), CSIC,CTR NACL INVEST MET,AVDA GREGORIO DEL AMO 8,E-28040 MADRID,SPAIN.
RI Escudero, Maria Lorenza/L-7113-2014
OI Escudero, Maria Lorenza/0000-0002-2181-448X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NETHERLANDS SOC MATERIALS SCIENCE
PI ZWIJNDRECHT
PA PO BOX 390, N-3330 ZWIJNDRECHT, NETHERLANDS
BN 90-803513-3-4
PY 1997
BP 597
EP 600
PG 4
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BJ43N
UT WOS:A1997BJ43N00138
DA 2018-10-19
ER

PT J
AU Salako, Q
   DeNardo, SJ
AF Salako, Q
   DeNardo, SJ
TI Analysis of long-lived radionuclidic impurities in short-lived
   radiopharmaceutical waste using gamma spectrometry
SO HEALTH PHYSICS
LA English
DT Article
DE nuclear medicine; radioactive materials; waste management; spectrometry,
   gamma
ID LEVEL RADIOACTIVE-WASTE; DISPOSAL
AB Large hospitals and biomedical research centers utilize decay-in-storage programs to minimize the volume of their low level radioactive waste. However, some medically useful radionuclides often contain small amounts of long-lived radionuclidic impurities which may complicate simple waste management procedures. We have evaluated the extent of this problem in low level radioactive waste involving Cu-67 and In-111 over a 6-mo cycle of decay-in-storage by identifying the residual radionuclides in our dry waste using a multichannel analyzer. The multichannel analyzer was also used to quantify the radionuclide constituents of our liquid waste at the beginning of a decay-in-storage cycle. Radionuclides were identified by the presence of characteristic photopeaks of each isotope in the gamma spectrum and quantified by region of interest analysis. After a decay-in-storage cycle, long-lived Co-58, Co-57, and Co-56 isotopes were observed in dry Cu-67 waste and In-114 m identified in dry In-111 waste. The In-114 m was detected in dry In-111 waste containing initial In-114 m activity of 740 kBq (20 mu Ci), while the cobalt radionuclides were detected in dry Cu-67 waste containing initial Co-58, Co-57, and Co-56 activities of 444, 148, and 148 kBq (12, 4, and 4 mu Ci), respectively. Such dry low level radioactive waste was thus disqualified from short-term radioactive waste storage programs. The radionuclide constituents in the liquid waste were quantified in mu Ci mL(-1) and confirmed to be within the Nuclear Regulatory Commission set limits of 2 x 10(-4), 6 x 10(-4) and 6 x 10(-5) mu Ci mL(-1) for Co-58, Co-57, and Co-56, respectively, before disposal. The highest levels of long-lived isotopes that have been found in our liquid low level radioactive waste at the beginning of decay-in-storage were 5.5 x 10(-4), 4.8 x 10(-4), and 1.4 x 10(-4) mu Ci mL(-1) for Co-58, Co-57, and Co-56, respectively. Gamma spectrometry can be used to aid waste segregation and final management decisions on low level radioactive waste.
C1 UNIV CALIF DAVIS, MOL CANC INST, SACRAMENTO, CA 95816 USA.
FU NCI NIH HHS [PHS CA47829]
CR BRILL DR, 1991, INVEST RADIOL, V26, P94, DOI 10.1097/00004424-199101000-00022
   BROWNE E, 1978, TABLE ISOTOPES, P185
   Earley D L, 1993, Med Waste Anal, V2, P5
   EMERY R, 1992, HEALTH PHYS, V62, P183, DOI 10.1097/00004032-199202000-00009
   HAMANO DM, 1993, HEALTH PHYS, V64, P192, DOI 10.1097/00004032-199302000-00011
   HENDEE WR, 1993, JAMA-J AM MED ASSOC, V269, P2403, DOI 10.1001/jama.269.18.2403
   *INT COMM RAD PROT, 1983, ICRP PUBL, V38
   TRIPODES JG, 1993, MED WASTE ANAL, V2, P3
   VETTER RJ, 1992, HEALTH PHYS, V62, P121
   1991, FED REGISTER, V56, P23404
NR 10
TC 0
Z9 0
U1 1
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD JAN
PY 1997
VL 72
IS 1
BP 56
EP 59
DI 10.1097/00004032-199701000-00008
PG 4
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA VY758
UT WOS:A1997VY75800010
PM 8972828
DA 2018-10-19
ER

PT B
AU White, MJ
   Iskander, MF
AF White, MJ
   Iskander, MF
GP IEEE
TI A new 3D FDTD multi-grid techniques with dielectric traverse
   capabilities
SO IEEE ANTENNAS AND PROPAGATION SOCIETY INTERNATIONAL SYMPOSIUM 1997, VOLS
   1-4
LA English
DT Proceedings Paper
CT IEEE Antennas-and-Propagation-Society International Symposium / North
   American Radio Science Meeting
CY JUL 13-18, 1997
CL MONTREAL, CANADA
SP IEEE Antennas & Propagat Soc, Natl Res Council Canada, Canadian Natl Comm URSI, US Natl Comm URSI
AB The finite-difference time-domain technique(FDTD) has become increasingly popular and is being used to model extremely complex and electrically large structures. These simulations are computationally demanding and often exceed available limits of computer resources. In this paper we present a FDTD sub-gridding technique that allows for increased resolution in regions of interest without increasing the overall computational requirements beyond the available resources. Furthermore, the formulation presented here is the first to allow for traversing dielectric boundaries using any integer refinement factor and the maximum Courant number. The technique presented here uses a weighted current value from the coarse region at the boundary between the fine-and coarse-grid regions to update the fine-region tangential fields on that boundary. The weighting function depends on the material properties and the relative position of the line-region electric field within the current contour at the boundary. The complete formulation of this new technique is described and some results of simulation cases are presented to validate the accuracy and stability of the developed FDTD code. In some simulation examples, computer memory savings as high as 70 times what would have been necessary with a uniform-grid code were achieved. It is shown that errors less than 2 percent are achievable with coarse-to-fine-grid ratios exceeding 10. The new technique is expected to be used in simulating many electrically large and complex structures in the biomedical, microwave precessing of materials, and cellular-communications areas.
RP White, MJ (reprint author), UNIV UTAH,SALT LAKE CITY,UT 84112, USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
BN 0-7803-4178-3
PY 1997
BP 2160
EP 2163
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BJ61W
UT WOS:A1997BJ61W00515
DA 2018-10-19
ER

PT B
AU Chen, F
   Suter, D
AF Chen, F
   Suter, D
GP IEEE COMP SOC
TI Elastic spline models for human cardiac motion estimation
SO IEEE NONRIGID AND ARTICULATED MOTION WORKSHOP, PROCEEDINGS
LA English
DT Proceedings Paper
CT IEEE Nonrigid and Articulated Motion Workshop
CY JUN   16, 1997
CL SAN JUAN, PR
SP IEEE Comp Soc, Tech Comm Pattern Anal & Machine Intelligence
AB Elastic splines (including dynamic ''snakes'' and elastic contours), minimising an energy norm of the membrane and/or thin-plate types, have been used to model many surfaces in visual reconstruction and related biomedical applications. In this paper, we model the displacement of the material between successive cardiac images using vector splines. We define a family of elastic splines. These splines can be tuned to enforce different type and different degrees of smoothness. We assess how well these splines can be used to reconstruct human cardiac motion.
RP Chen, F (reprint author), MONASH UNIV,DEPT ELECT & COMP SYST ENGN,CLAYTON,VIC 3168,AUSTRALIA.
OI Suter, David/0000-0001-6306-3023
NR 0
TC 10
Z9 10
U1 0
U2 0
PU I E E E, COMPUTER SOC PRESS
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, LOS ALAMITOS, CA 90720
BN 0-8186-8040-7
PY 1997
BP 120
EP 127
DI 10.1109/NAMW.1997.609862
PG 2
WC Computer Science, Artificial Intelligence
SC Computer Science
GA BJ14K
UT WOS:A1997BJ14K00014
DA 2018-10-19
ER

PT B
AU He, BL
   Ma, JB
AF He, BL
   Ma, JB
GP INST POLYM CHEM
TI Novel polymeric adsorbents as biomedical materials for blood
   purification
SO INTERNATIONAL CONFERENCE ON BIORELATED POLYMERS CONTROLLED RELEASE DRUGS
   AND REACTIVE POLYMERS
LA English
DT Proceedings Paper
CT International Conference on Biorelated Polymers Controlled Release Drugs
   and Reactive Polymers
CY MAY 08-11, 1997
CL XIAN, PEOPLES R CHINA
SP Chinese Chem Soc, Beijing, China, Nankai Univ, Tianjin, China, Wuhan Univ, Wuhan, China, Beijing Univ, Beijing, China, Funct Polym Mat Adsorpt & Separat, State Key Lab, Tianjin, China, Natl Nat Sci Fdn China, State Educ Commiss China
AB In this brief review it is summarized the recent development of polymeric adsorbents for blood purification in our laboratory. The researches on the polymeric adsorbents for adsorption of small organic molecules, middle molecular substance, and biological macromolecules from the blood have been carried out for nearly two decades. Some adsorbents with perfect adsorption properties and good biocompatibility have been prepared and begun to apply in clinical hemoperfusion.
   Blood carries the nutrients to the tissues of human body and brings the wastes over to the liver and kidney for metabolism and excrement while it is circulated all over the body. Once the liver or kidney or the immune system is in disorder or in failure, some excessive chemical components, including small molecules, middle molecular substances, and biological macromolecules; would be accumulated in blood and cause many kinds of diseases. In addition, an excess or wrong intrusion of toxic chemicals such as soporifics, anesthetics, pesticides, and so on would cause a patient poisoned. All excessive substances, whether they are endogenous or exogenous: can be eliminated via extracorporeal circulation of blood either by hemodialysis, hemofiltration, hemoperfusion or by plasma exchange. In hemoperfusion, adsorbents play a key role for removing toxic chemicals from blood. Their structures can be designed and synthesized to fit every actual case of diseases. Since the end of 1970s, polymeric adsorbents for blood purification have been studied in our laboratory for adsorption of small molecules, middle molecular substances. and even biological macromolecules. Some perfect results are briefly reviewed as follows.
RP He, BL (reprint author), NANKAI UNIV,INST POLYMER CHEM,STATE KEY LAB FUNCT POLYMER MAT ADSORPT & SEPARAT,TIANJIN 300071,PEOPLES R CHINA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU INSTITUTE POLYMER CHEMISTRY
PI TIANJIN
PA NANKAI UNIVERSITY, TIANJIN 300071, PEOPLES R CHINA
PY 1997
BP 7
EP 14
PG 8
WC Biotechnology & Applied Microbiology; Chemistry, Applied; Chemistry,
   Medicinal; Engineering, Chemical; Pharmacology & Pharmacy; Polymer
   Science
SC Biotechnology & Applied Microbiology; Chemistry; Pharmacology &
   Pharmacy; Engineering; Polymer Science
GA BJ47W
UT WOS:A1997BJ47W00004
DA 2018-10-19
ER

PT J
AU Kawashima, K
   Sato, H
AF Kawashima, K
   Sato, H
TI Calcium effect on the membrane preparation of segmented
   poly(ether/urethane/amide) (PEUN) as a biomedical material
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polyether urethane amide (PEUN); calcium chloride; solution and
   mechanical properties; permeability; biocompatibility
ID BIOMIMETIC PROCESS; ORGANIC POLYMERS; POLYURETHANE; ADSORPTION;
   PROTEINS; SURFACES
AB Poly(ether/urethane/amide) (PEUN), a segmented polyurethane, was characterized concerning phase relationship, viscosity in solution, hydraulic permeability, mechanical properties, and in vivo biocompatibility with tissue and blood. PEUN was dissolved at the highest concentration of 0.5% in N,N-dimethylformamide (DMF). Addition of calcium chloride at concentrations up to 3.1% progressively increased the solubility of PEUN in DME PEUN2 membrane was prepared by casting from mixtures of PEUN, 3% calcium chloride, and DMF, from which calcium chloride was sufficiently removed. The PEUN2 membrane thus obtained was compared with PEUN membrane which was prepared by casting from DMF solution without the addition of calcium chloride. The water permeability across PEUN2 membrane was higher than that across PEUN membrane. PEUN2 membrane in the swollen state exhibited a lower tensile modulus and much greater elastic property than PEUN membrane. Tissue compatibility of PEUN2 membrane was better than that of PEUN membrane. Thromboresistance of PEUN membrane was good, while PEUN2-coated surface was thrombogenic to some extent in vivo. Our characterization suggested that PEUN2 membrane is more hydrophilic than PEUN membrane, possibly because of the assembly of polar groups on the segments of PEUN molecules which show affinity to calcium chloride in membrane processing.
C1 KYOTO UNIV,DEPT POLYMER CHEM,KYOTO 60601,JAPAN.
CR BALASUBRAMANIAN D, 1975, BIOPOLYMERS, V14, P1019, DOI 10.1002/bip.1975.360140510
   Boretos J W, 1971, J Biomed Mater Res, V5, P373, DOI 10.1002/jbm.820050408
   BORETOS JW, 1972, J BIOMED MATER RES, V6, P473, DOI 10.1002/jbm.820060513
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   Colman RW, 1987, HEMOSTASIS THROMBOSI
   Fung YC, 1984, BIOMECHANICS
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   HASEGAWA M, 1981, J SOC RHEOL JAP, V9, P9
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   KAWABATA S, 1988, P 4 JAP US C COMP MA, V4, P253
   KIMURA I, 1974, MACROMOLECULES, V7, P355, DOI 10.1021/ma60039a018
   NAGAOKA S, 1982, THESIS KYOTO U
   NOISHIKI Y, 1980, JPN J ARTIF ORGANS, V9, P678
   SAKAI Y, 1978, J APPL POLYM SCI, V22, P1085
   SATO H, 1985, J BIOMED MATER RES, V19, P1135, DOI 10.1002/jbm.820190921
   SATO H, 1984, POLYM J, V16, P1, DOI 10.1295/polymj.16.1
   SATO H, 1993, J DISPER SCI TECHNOL, V14, P117, DOI 10.1080/01932699308943390
   SATO H, 1987, ACS SYM SER, V343, P76
   TAKAHARA A, 1982, KOBUNSHI RONBUNSHU, V39, P203, DOI 10.1295/koron.39.203
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   TANAHASHI M, 1995, J BIOMED MATER RES, V29, P349, DOI 10.1002/jbm.820290310
   WALSER M, 1961, J CLIN INVEST, V40, P723, DOI 10.1172/JCI104306
   WHALEM RL, 1980, T AM SOC ART INT ORG, V24, P487
   WILKES GL, 1979, J BIOMED MATER RES, V13, P189, DOI 10.1002/jbm.820130204
   YASUDA H, 1971, J POLYM SCI A2, V9, P1537, DOI 10.1002/pol.1971.160090901
   YASUDA H, 1971, J POLYM SCI A2, V9, P1117, DOI 10.1002/pol.1971.160090608
NR 26
TC 0
Z9 0
U1 0
U2 2
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1997
VL 8
IS 6
BP 467
EP 480
DI 10.1163/156856297X00399
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA WY732
UT WOS:A1997WY73200005
PM 9151194
DA 2018-10-19
ER

PT J
AU Bruck, SD
AF Bruck, SD
TI Current and future directions of biomedical materials research
SO JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS
LA English
DT Editorial Material
DE biomaterials; polymers; implants; medical devices; directions;
   biomedical materials research
AB Biomedical materials and implants are not synonymous. Materials pw se are not implanted-after configuring, processing, and finishing operations, they constitute parts of implants and other devices. The U.S. Food and Drug Administration currently does not ''approve'' biomaterials; rather, it approves medical devices, biologicals, and drugs. There have been important advances during the past 40 years in the clinical uses of medical implants and other devices, especially in ophthalmology, cardiology, orthopaedics, surgery, and dialysis. In the 21st Century, there will be increased emphasis on curing and preventing major genetic diseases. There will be many nontraditional clinical applications of biomaterials, such as viral-and nonviral-mediated delivery agents in gene therapy, synthetic biomaterials with pharmacologic effects, and biomaterials that can integrate with the biological system to form a long-term, living, renewable interface with prosthetic implants. Therefore, those working in the field of biomaterials must become familiar with new molecular biological techniques and be able to collaborate effectively with molecular biologists.
RP Bruck, SD (reprint author), STEPHEN D BRUCK ASSOCIATES INC,BIOMAT & MED DEVICES CONSULTING GRP,9 FENTON PL,CHAPEL HILL,NC 27514, USA.
CR BRUCK SD, 1990, INT J ARTIF ORGANS, V13, P39
   BRUCK SD, 1990, S BIOC POL POL SCI M
   *NIH, 1982, BIOM CONS C
   Williams D. F., 1987, DEFINITIONS BIOMATER
NR 4
TC 0
Z9 0
U1 0
U2 2
PU BEGELL HOUSE INC
PI NEW YORK
PA 79 MADISON AVE, SUITE 1205, NEW YORK, NY 10016-7892
SN 1050-6934
J9 J LONG-TERM EFF MED
JI J. Long-Term Eff. Med. Implants
PY 1997
VL 7
IS 2
BP 115
EP 117
PG 3
WC Engineering, Biomedical; Medicine, Research & Experimental; Orthopedics;
   Pathology
SC Engineering; Research & Experimental Medicine; Orthopedics; Pathology
GA YA462
UT WOS:A1997YA46200001
PM 10174267
DA 2018-10-19
ER

PT J
AU Kontou, E
   Spathis, G
   Kavadias, C
AF Kontou, E
   Spathis, G
   Kavadias, C
TI Viscoplastic behaviour of PMMA blends - The effect of moisture
   absorption
SO JOURNAL OF REINFORCED PLASTICS AND COMPOSITES
LA English
DT Article
ID MECHANICAL-PROPERTIES; THERMAL-EXPANSION; GLASSY-POLYMERS
AB The mechanical properties of a polymeric blend based on PMMA and Poly(butyl methacrylate, methylmethacrylate) were studied. This mixture is the main component of the so-called bone cement used for various biomedical applications. Different types of samples have been prepared with varying the antibiotic content. The compressive stress-strain behaviour has been studied at various strain rates, before and after immersion in water at 37 degrees C, simulating in this way the physiological environment of these materials. Moreover, thermal expansion coefficient tests were carried out in order to check the dimensional stability of the materials examined.
RP Kontou, E (reprint author), NATL TECH UNIV ATHENS,DEPT THEORET & APPL MECH,GR-15773 ATHENS,GREECE.
CR ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442
   ADAMSON MJ, 1980, J MATER SCI, V15, P1736, DOI 10.1007/BF00550593
   ARGON AS, 1977, PHILOS MAG, V35, P917, DOI 10.1080/14786437708232634
   BECKENBAUGH RD, 1978, J BONE JOINT SURG AM, V60, P306, DOI 10.2106/00004623-197860030-00005
   BOYCE MC, 1988, MECH MATER, V7, P15, DOI 10.1016/0167-6636(88)90003-8
   BRAND J, 1977, IPCTTP152
   DROTNING WD, 1989, J MATER SCI, V24, P3137, DOI 10.1007/BF01139031
   HAWARD RN, 1968, PROC R SOC LON SER-A, V302, P453, DOI 10.1098/rspa.1968.0029
   HAWARD RN, 1973, PHYSICS GLASSY POLYM
   HOPE PS, 1980, J APPL POLYM SCI, V25, P1373, DOI 10.1002/app.1980.070250711
   HOPE PS, 1980, J MATER SCI, V15, P2207, DOI 10.1007/BF00552308
   JOHNSON JA, 1994, J MATER SCI, V29, P870, DOI 10.1007/BF00351404
   KRAUSE W, 1988, J BIOMED MATER RES-A, V22, P37
   Matsuoka S., 1992, RELAXATION PHENOMENA
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   SMITH LSA, 1988, POLYMER, V29, P1871, DOI 10.1016/0032-3861(88)90405-3
   STAFFORD GD, 1983, J DENT, V11, P294, DOI 10.1016/0300-5712(83)90113-6
   STRUIK LCE, 1991, J NON-CRYST SOLIDS, V131, P395, DOI 10.1016/0022-3093(91)90333-2
   YOSHIOKA S, 1994, J NONCRYSTALLINE SOL, V171, P765
NR 19
TC 1
Z9 1
U1 0
U2 2
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604
SN 0731-6844
J9 J REINF PLAST COMP
JI J. Reinf. Plast. Compos.
PY 1997
VL 16
IS 4
BP 306
EP 320
DI 10.1177/073168449701600402
PG 15
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA WR684
UT WOS:A1997WR68400002
DA 2018-10-19
ER

PT S
AU Hussain, I
   Kumar, A
   Mangiaracina, A
   Perlaky, SC
   McCombs, CC
   Zhong, F
   Weimer, JJ
   Sanderson, L
AF Hussain, I
   Kumar, A
   Mangiaracina, A
   Perlaky, SC
   McCombs, CC
   Zhong, F
   Weimer, JJ
   Sanderson, L
BE George, EP
   Gotthardt, R
   Otsuka, K
   TrolierMcKinstry, S
   WunFogle, M
TI Fabrication of piezoelectric sensors for biomedical applications
SO MATERIALS FOR SMART SYSTEMS II
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Materials for Smart Systems II, at the 1996 MRS Fall
   Meeting
CY DEC 02-05, 1996
CL BOSTON, MA
SP Mat Res Soc, USA Res Off, Furukawa Elect Co Ltd, Oak Ridge Natl Lab, PIOLAX Inc
AB Biosensors are a special class of chemical sensors that take advantage of the high selectivity and sensitivity of biologically active material. We are currently investigating the characteristics of various deposited electrode coatings (Au and Pt) on 10 MHz quartz crystals using the sputtering method. We are also investigating the effect of magnetic behavior (by intermixing Fe and Ni with electrodes) on the binding nature of antigen with the substrate. A change in mass occurs due to the binding of antigens and antibodies on the surface of the thin film coating. The frequency change as a result of a change in mass makes it possible to use these crystals as biological sensor devices. This paper describes the construction of antibody-based piezoelectric crystals capable of detecting mycobacterial antigens in diluted cultures of attenuated PA. tuberculosis. The microstructural features of these crystals have been studied using scanning electron microscopy (SEM) and atomic force microscopy (AFM) techniques. The crystallographic properties have been characterized using the X-ray diffraction (XRD) method. The long term objective of this research is to develop a rapid quantitative method of analysis for the diagnosis of tuberculosis (TB) and other infections caused by mycobacteria, using biosensor technology.
RP Hussain, I (reprint author), UNIV S ALABAMA,DEPT ELECT ENGN,MOBILE,AL 36688, USA.
OI Weimer, Jeffrey/0000-0002-3460-4000
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563
SN 0272-9172
BN 1-55899-363-0
J9 MATER RES SOC SYMP P
PY 1997
VL 459
BP 501
EP 506
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Materials Science, Composites
SC Materials Science
GA BH71E
UT WOS:A1997BH71E00071
DA 2018-10-19
ER

PT S
AU Lotters, JC
   Olthuis, W
   Veltink, PH
   Bergveld, P
AF Lotters, JC
   Olthuis, W
   Veltink, PH
   Bergveld, P
GP IEEE
TI Theory, technology and assembly of a highly symmetrical capacitive
   triaxial accelerometer
SO MEMS 97, PROCEEDINGS - IEEE THE TENTH ANNUAL INTERNATIONAL WORKSHOP ON
   MICRO ELECTRO MECHANICAL SYSTEMS: AN INVESTIGATION OF MICRO STRUCTURES,
   SENSORS, ACTUATORS, MACHINES AND ROBOTS
SE PROCEEDINGS: IEEE MICRO ELECTRO MECHANICAL SYSTEMS WORKSHOP
LA English
DT Proceedings Paper
CT IEEE 10th Annual International Workshop on Micro Electro Mechanical
   Systems
CY JAN 26-30, 1997
CL NAGOYA, JAPAN
SP IEEE Robot & Automat Soc, ASME Dynam Syst & Control Div, ASME Micromachine Ctr
AB A highly symmetrical cubic easy-to-assemble capacitive triaxial accelerometer for biomedical applications has been designed, realized and tested. The outer dimensions of the sensor are 5 x 5 x 5 mm(3) and the device is mounted on a standard IC package. New aspects of the sensor are an easy assembly procedure, the use of the polymers polydimethylsiloxane (PDMS) as spring material between the capacitor plates and the mass and polyimide (PI) as flexible interconnection layer between the capacitor plates, and the highly symmetrical cubic structure. The mathematical model, technology and assembly procedure of the sensor are described. The measurement results show a good linearity in the output voltage for accelerations up to at least 5 g and a bandwidth of DC - > 50 Hz. In the x-axis the sensitivity was found to be 175 mV/g which is in good correspondence with the theory. The sensitivity can be increased when the PDMS layer is patterned, which was shown in previous versions of the highly symmetrical triaxial accelerometer.
RP Lotters, JC (reprint author), UNIV TWENTE,MESA RES INST,POB 217,NL-7500 AE ENSCHEDE,NETHERLANDS.
RI Veltink, Peter/L-3738-2016
OI Veltink, Peter/0000-0002-1796-9999
NR 0
TC 5
Z9 5
U1 0
U2 1
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
SN 1084-6999
BN 0-7803-3745-X
J9 PROC IEEE MICR ELECT
PY 1997
BP 31
EP 36
DI 10.1109/MEMSYS.1997.581760
PG 6
WC Automation & Control Systems; Engineering, Multidisciplinary;
   Engineering, Electrical & Electronic; Engineering, Mechanical
SC Automation & Control Systems; Engineering
GA BH55X
UT WOS:A1997BH55X00006
DA 2018-10-19
ER

PT B
AU Gourley, PL
   McDonald, AE
AF Gourley, PL
   McDonald, AE
BE Gourley, PL
   Katzir, A
TI Semiconductor microlasers with intracavity microfluidics for biomedical
   applications
SO MICRO- AND NANOFABRICATED ELECTRO-OPTICAL MECHANICAL SYSTEMS FOR
   BIOMEDICAL AND ENVIRONMENTAL APPLICATIONS, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 1st SPIE Conference on Microfabricated and Nanofabricated
   Electro-Optical Mechanical Systems for Biomedical and Environmental
   Applications
CY FEB 10-11, 1997
CL SAN JOSE, CA
SP Soc Photo Opt Instrumentat Engineers
DE microfabrication; microfluidics; semiconductors; glass; microcavities;
   lasers; spectroscopy; biomedical; cells; surface tension; capillarity;
   micro-optical-electrical-mechanical systems
AB Microfrabricated electro-optical-mechanical systems are expected to play an important role in future biomedical, biochemical and environmental technologies. Semiconductor photonic materials and devices are attractive components of such systems because of their ability to generate, transmit, modulate, and detect light. In this paper we report investigations of light-emitting semiconductor/glass microcavities filled with simple fluids. We examine surface tension for transporting liquids into the intracavity space and study the influence of the liquid on the spectral emission of the microcavity.
RP Gourley, PL (reprint author), SANDIA NATL LABS,POB 5800,ALBUQUERQUE,NM 87185, USA.
NR 0
TC 3
Z9 3
U1 0
U2 2
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2389-0
J9 P SOC PHOTO-OPT INS
PY 1997
VL 2978
BP 186
EP 196
DI 10.1117/12.269968
PG 3
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BH52D
UT WOS:A1997BH52D00023
DA 2018-10-19
ER

PT B
AU Gourley, MF
   Gourley, PL
AF Gourley, MF
   Gourley, PL
BE Gourley, PL
   Katzir, A
TI Integration of electro-optical mechanical systems and medicine: Where
   are we and where can we go?
SO MICRO- AND NANOFABRICATED ELECTRO-OPTICAL MECHANICAL SYSTEMS FOR
   BIOMEDICAL AND ENVIRONMENTAL APPLICATIONS, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 1st SPIE Conference on Microfabricated and Nanofabricated
   Electro-Optical Mechanical Systems for Biomedical and Environmental
   Applications
CY FEB 10-11, 1997
CL SAN JOSE, CA
SP Soc Photo Opt Instrumentat Engineers
DE biomedical; analysis; DNA; flow cytometry; microelectromechanical
   systems; Microchip; DNA amplification; fluorescent activated cell
   sorting; diagnosis; medicine
AB The marriage of microfabricated materials with microbiological systems will allow advances in medicine to proceed at an unprecedented pace. Biomedical research is placing new demands on speed and limits of detection to assay body tissues and fluids. Emerging microfabricated chip technologies from the engineering community offer researchers novel types of analysis of human samples. In guiding these developments, the ability to swiftly and accurately gain useful information for identification and establish a diagnosis, is of utmost importance. Current examples of such technology include DNA amplification and analysis, and fluorescent cell analysis by flow cytometry. Potential applications include the development of rapid techniques for examining large number of cells in tissue or in blood. These could serve as screening tools for the detection and quantification of abnormal cell types; for example malignant or HIV infected cells. Micro/Nanofabrication methods will make these devices compact, providing access of this technology to point of care providers; in a clinic, ambulance, or on a battlefield. Currently, these tools are in the construction phase. Upon delivery to researchers, validation of these instruments will lead to clinical demand that requires approval from the Food and Drug Administration. This paper will outline criteria that successful devices must satisfy.
RP Gourley, MF (reprint author), WASHINGTON HOSP CTR,WASHINGTON,DC 20010, USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2389-0
J9 P SOC PHOTO-OPT INS
PY 1997
VL 2978
BP 197
EP 204
DI 10.1117/12.269969
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BH52D
UT WOS:A1997BH52D00024
DA 2018-10-19
ER

PT J
AU McCarthy, DW
   Shefer, RE
   Klinkowstein, RE
   Bass, LA
   Margeneau, WH
   Cutler, CS
   Anderson, CJ
   Welch, MJ
AF McCarthy, DW
   Shefer, RE
   Klinkowstein, RE
   Bass, LA
   Margeneau, WH
   Cutler, CS
   Anderson, CJ
   Welch, MJ
TI Efficient production of high specific activity Cu-64 using a biomedical
   cyclotron
SO NUCLEAR MEDICINE AND BIOLOGY
LA English
DT Article
DE PET; Cu-64; production; cyclotron; targetry; Ni-64
ID POSITRON EMISSION TOMOGRAPHY; EXCITATION-FUNCTIONS; MONOCLONAL-ANTIBODY;
   COLORECTAL-CARCINOMA; COPPER-PTSM; PET TRACER; BLOOD-FLOW; MAB 1A3;
   RADIOIMMUNOTHERAPY; PERFUSION
AB Copper-64 (T-1/2 = 12.7 h) is an intermediate lived positron emitting radionuclide that is a useful radiotracer for positron emission tomography (PET) as well as a promising radiotherapy agent for the treatment for cancer. Currently, copper-64 suitable for biomedical studies is produced in the fast neutron flux trap (irradiation of zinc with fast neutrons) at the Missouri University Research Reactor. Access to the fast neutron flux trap is only possible on a weekly basis, making the availability of this tracer very limited. In order to significantly increase the availability of this intermediate-lived radiotracer, we have investigated and developed a method for the efficient production of high specific activity Cu-64 using a small biomedical cyclotron.
   It has been suggested that it may be possible to produce Cu-64 on a small biomedical cyclotron utilizing the Ni-64(p,n)(CU)-C-64 nuclear reaction. We have irradiated both natural nickel and enriched (95% and 98%) Ni-64 plated on gold disks. Nickel has been electroplated successfully at thicknesses of similar to 20-300 mm and bombarded with proton currents of 15-45 mu A A Special water-cooled target had been designed to facilitate the irradiations on a biomedical cyclotron up to 60 mu A.
   We have shown that it is possible to separate Cu-64 from Ni-64 and other reaction byproducts rapidly and efficiently by using ion exchange chromatography. Production runs using 19-55 mg of 95% enriched Ni-64 have yielded 150-600 mCi of Cu-64 (2.3-5.0 mCi/mu Ah) with specific activities of 94-310 mCi/mu g Cu. The cyclotron produced Cu-64 had been used to radiolabel PTSM [pyruvaldehyde bis-(N-4- methylthiosemicarbazone), used to quantify myocardial, cerebral, renal, and tumor blood flow], MAb 1A3 [monoclonal antibody MAb to colon cancer], and octreotide. A recycling technique for the costly Ni-64 target material has been developed. This technique allows the nickel eluted off the column to be recovered and reused in the electroplating of new targets with an overall efficiency of greater than 90%. Copyright (C) 1997 Elsevire Science Inc.
C1 WASHINGTON UNIV,SCH MED,EDWARD MALLINCKRODT INST RADIOL,ST LOUIS,MO 63110.
   NEWTON SCI INC,WINCHESTER,MA 01890.
OI Anderson, Carolyn/0000-0002-5663-282X
FU NCI NIH HHS [R43-CA66411-01]
CR Anderson C. J., 1996, Journal of Nuclear Medicine, V37, p128P
   ANDERSON CJ, 1995, J NUCL MED, V36, P2315
   ANDERSON CJ, 1995, J NUCL MED, V36, P850
   ANDERSON CJ, 1994, J NUCL MED, V35, pP161
   ANDERSON CJ, 1992, J NUCL MED, V33, P1685
   ANDERSON CJ, 1993, J NUCL MED, V34, pP134
   CLARKE ET, 1991, INORG CHIM ACTA, V190, P36
   Connett J. M., 1995, Journal of Nuclear Medicine, V36, p92P
   CONNETT JM, 1993, J NUCL MED, V34, pP216
   HERR W, 1950, Z NATURFORSCH A, V5, P629
   HERRERO P, 1993, CIRCULATION, V87, P173, DOI 10.1161/01.CIR.87.1.173
   *INT AT EN AG, 1971, 128 IAEA, P164
   KIRBY LJ, 1961, RADIOCHEMISTRY NICKE
   Lynn KG, 1987, NATO ASI SER B, VB169, P161
   MATHIAS CJ, 1991, NUCL MED BIOL, V18, P807
   MATHIAS CJ, 1990, J NUCL MED, V31, P351
   MAZIERE B, 1983, INT J APPL RADIAT IS, V34, P595, DOI 10.1016/0020-708X(83)90061-3
   NICKLES R J, 1991, Journal of Labelled Compounds and Radiopharmaceuticals, V30, P120
   Philpott G. W., 1995, Journal of Nuclear Medicine, V36, p9P
   PHILPOTT GW, 1995, J NUCL MED, V36, P1818
   PIEL H, 1992, RADIOCHIM ACTA, V57, P1
   SEVIOR ME, 1983, AUST J PHYS, V36, P463, DOI 10.1071/PH830463
   SHEFER RE, 1992, P 4 INT WORKSH TARG
   SHELTON ME, 1989, J NUCL MED, V30, P1843
   SZELECSENYI F, 1993, APPL RADIAT ISOTOPES, V44, P575, DOI 10.1016/0969-8043(93)90172-7
   WEBER DA, 1989, MIRD RADIONUCLIDE DA
   WELCH MJ, 1988, RADIOLABELED MONOCLO, P261
   ZINN KR, 1993, J NUCL MED, V34, pP238
   ZWEIT J, 1991, APPL RADIAT ISOTOPES, V42, P193
NR 29
TC 378
Z9 381
U1 0
U2 39
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0883-2897
J9 NUCL MED BIOL
JI Nucl. Med. Biol.
PD JAN
PY 1997
VL 24
IS 1
BP 35
EP 43
DI 10.1016/S0969-8051(96)00157-6
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA WK820
UT WOS:A1997WK82000006
PM 9080473
DA 2018-10-19
ER

PT B
AU DellaVecchia, MA
   Beard, RB
   Dai, X
   Priezzhev, AV
AF DellaVecchia, MA
   Beard, RB
   Dai, X
   Priezzhev, AV
BE Priezzhev, AV
   Asakura, T
   Leif, RC
   Katzir, A
TI Method for the measurements of photonic effects on blood
SO OPTICAL DIAGNOSTICS OF BIOLOGICAL FLUIDS AND ADVANCED TECHNIQUES IN
   ANALYTICAL CYTOLOGY, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optical Diagnostics of Biological Fluids and Advanced
   Techniques in Analytical Cytology
CY FEB 11-14, 1997
CL SAN JOSE, CA
SP Int Biomed Opt Soc, Soc Photo Opt Instrumentat Engineers, Amer Soc Laser Med & Surg Inc
DE terminology; leukocyte; polymorphonuclear; mononuclear; erythrocyte;
   cytotaxis; chemotaxis
AB At the Department of Biomedical Engineering of Drexel University, the study of the reactivity of human white blood cells (leukocytes) had been undertaken originally for biocompatibility measurements. Acute (polymorphonuclear) and chronic (mononuclear) inflammatory white blood cells (leukocytes) have been studied for their response to chemoattractant and chemorepellant implantable materials. Further experiments have lead to the enhancement and retardation of this cytotaxis via electromagnetic fields. These techniques are now being adapted to study the photonic effects of leukocytes.
   Human whole blood is attained through sterile peripheral vacuum venipuncture technique. The whole blood is separated to isolated the white blood cell series using a Sigma Procedure No. 1119. The erythrocytes are lysed and through a series of steps the leukocytes are further isolated to produce a sample of polymorphonuclear (PMN) or mononuclear (MN) leukocytes.
   The leukocytic samples are then placed within a Boyden chamber or an agarose plate. The experiments were conducted in an enclosed incubator to maintain temperature and to isolated light exposure. A control experiment is conducted with a standard chemattractant such as Formyl-L-Methionyl-L-Leucyl-L Phenylalanine. A similar experiment may then be conducted analogous to this control, with the introduction of light of varying intensity or frequency as an experimental variable. The effect of light as a variable in the experiment is then measured as a function of the leukocyte cell migration. This can be measured by direct microscopy or by computer analysis. Results are expressed as a ratio of the variable migration distance divided by the controlled migration distance.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2393-9
J9 P SOC PHOTO-OPT INS
PY 1997
VL 2982
BP 271
EP 283
DI 10.1117/12.273624
PG 13
WC Engineering, Biomedical; Medical Laboratory Technology; Optics
SC Engineering; Medical Laboratory Technology; Optics
GA BH79V
UT WOS:A1997BH79V00032
DA 2018-10-19
ER

PT S
AU Tsuruta, T
AF Tsuruta, T
TI Contemporary topics in polymeric materials for biomedical applications
   (vol 126, pg 1, 1996)
SO POLYMER SYNTHESIS / POLYMER CATALYSIS
SE Advances in Polymer Science
LA English
DT Correction
CR Tsuruta T, 1996, ADV POLYM SCI, V126, P1
NR 1
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-61288-2
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 1997
VL 127
BP U7
EP U7
PG 1
WC Polymer Science
SC Polymer Science
GA BG42C
UT WOS:A1997BG42C00001
DA 2018-10-19
ER

PT J
AU Ravaglioli, A
   Krajewski, A
AF Ravaglioli, A
   Krajewski, A
TI Implantable porous bioceramics
SO POROUS MATERIALS FOR TISSUE ENGINEERING
SE MATERIALS SCIENCE FORUM
LA English
DT Article
DE bioceramic(s); ceramic(s); porous ceramic; porosity
AB Ceramic materials are more and more object of interest in biomedical field for their peculiar biological performances. Their mechanical behaviour (e.g. hardness, compressive resistance, tribology) and their chemical properties are the main parameters considered for production of devices to adopt in many surgical applications, in particular concerning skeletal implants. These materials exhibit two different types of biological behaviour: inert or bioactive. Inert ceramics have good tolerability but no influence on surrounding tissue(s); on the contrary bioactive ones are even able to influence bone growth. They include also resorbable materials which find application in both soft and hard tissues.
   The introduction of porosity in a ceramic body allow the enlargement of the number of possible applications in the biomedical field. With some renounces on the side of mechanical performances, porous ceramic can find application when trapping of biological products is the main target, thanks the general good performances of their surface physical properties. In the following a topic on their production and possibility of application and limits is matter of discussion.
C1 CNR, IRTEC, I-48018 Faenza, Italy.
RP Ravaglioli, A (reprint author), CNR, IRTEC, Via Granarola 64, I-48018 Faenza, Italy.
CR Braunauer S, 1938, J AM CHEM SOC, V60, P309
   GIBBS JW, COLLECTED WORKS
   JOYNER LG, 1948, J AM CHEM SOC, V73, P2359
   JUHOLA AJ, 1952, J AM CHEM SOC, V74, P61, DOI 10.1021/ja01121a015
   RITTER HL, 1945, IND ENG CHEM, V17, P782, DOI 10.1021/i560148a013
   Washburn EW, 1921, P NATL ACAD SCI USA, V7, P115, DOI 10.1073/pnas.7.4.115
   WASHBURN EW, 1922, J AM CERAM SOC, V4, P983
NR 7
TC 14
Z9 14
U1 0
U2 5
PU TRANSTEC PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 1997
VL 250
BP 221
EP 230
DI 10.4028/www.scientific.net/MSF.250.221
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA BK32D
UT WOS:000071779800014
DA 2018-10-19
ER

PT B
AU Hong, HD
   Sheffer, DB
   Loughry, CW
AF Hong, HD
   Sheffer, DB
   Loughry, CW
BE Benton, SA
   Trout, TJ
TI Holographic interferometry for detection of breast lesions
SO PRACTICAL HOLOGRAPHY XI AND HOLOGRAPHIC MATERIALS III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Practical Holography XI and Holographic Materials III
CY FEB 10-11, 1997
CL SAN JOSE, CA
SP Soc Imaging Sci & Technol, Soc Photo Opt Instrumentat Engineers
DE holographic interferometry; breast lesions; ruby laser; holocamera;
   pressure stressing
AB Holographic Interferometry (HI) has been utilized in industry to inspect material for defects or the dynamic characteristics of a laminated structure(1). Application of the HI technique for biomedical diagnostic instrumentation was also reported(2-3). For detection of breast lesions, which could lead to breast cancer, we have utilized the HT technique to create a superficial fringe contour distortion over the underlying lesion. In the HI technique, an appropriate stressing mechanism is crucial to obtain proper density and contrast of fringe patterns. To apply pressure as the stressing mechanism, we have designed the Lucite pressure chamber to enclose both of the subject's breasts. Preliminary results have demonstrated the feasibility of fringe distortions occurring around breast lesions. The location of the possible lesions have been compared with an X-ray mammography.
RP Hong, HD (reprint author), AKRON CITY HOSP,BIOSTEREOMETR LAB,AKRON,OH 44304, USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2422-6
J9 P SOC PHOTO-OPT INS
PY 1997
VL 3011
BP 121
EP 130
DI 10.1117/12.271345
PG 10
WC Optics; Imaging Science & Photographic Technology
SC Optics; Imaging Science & Photographic Technology
GA BH70H
UT WOS:A1997BH70H00015
DA 2018-10-19
ER

PT B
AU Meenan, BJ
   Parker, M
   McAdams, ET
   Zhou, M
   McLaughlin, JA
   Anderson, JM
AF Meenan, BJ
   Parker, M
   McAdams, ET
   Zhou, M
   McLaughlin, JA
   Anderson, JM
BE Boom, H
   Robinson, C
   Rutten, W
   Neuman, M
   Wijkstra, H
TI Ultra-violet (UV) curable hydrogels for biomedical electrode
   applications
SO PROCEEDINGS OF THE 18TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 18, PTS 1-5
SE PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 18th Annual International Conference of IEEE
   Engineering-in-Medicine-amd-Biology-Society
CY OCT 31-NOV 03, 1996
CL AMSTERDAM, NETHERLANDS
SP IEEE Engn Med & Biol Soc
AB UV curable hydrogel formulations based on a photoinitiated polymerization cross-linking process have been prepared and cured, The chosen system is found to result in a high degree of polymerization with significant attendant adhesive characteristics. A degree of control of the effective UV-curing of the photo-reactive hydrogel system is found to result from adjustments to the curing exposure duration and the distance from the source to the sample. Variation of the amount of the photoinitator is show to cause changes in the properties of the cured material. The effectiveness of deliberate changes in the viscosity of the solutions, prior to UV curing, caused by the addition of polyvinylpyrrolidone (PVP) have also been studied, Electrical resistivity values for the various solutions, before and after UV curing, have been calculated and found to be commensurate with good quality commercially available hydrogel adhesives.
C1 Univ Ulster, Sch Elect & Mech Engn, No Ireland Bioengn Ctr, Newtownabbey BT37 0QB, Co Antrim, North Ireland.
RP Meenan, BJ (reprint author), Univ Ulster, Sch Elect & Mech Engn, No Ireland Bioengn Ctr, Newtownabbey BT37 0QB, Co Antrim, North Ireland.
NR 0
TC 0
Z9 0
U1 1
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-3812-X
J9 P IEEE EMBS
PY 1997
VL 18
BP 104
EP 105
PG 2
WC Engineering, Biomedical
SC Engineering
GA BK41A
UT WOS:000072079000052
DA 2018-10-19
ER

PT B
AU Mabuchi, K
   Chinzei, T
   Fujimasa, I
AF Mabuchi, K
   Chinzei, T
   Fujimasa, I
BE Boom, H
   Robinson, C
   Rutten, W
   Neuman, M
   Wijkstra, H
TI Thermal endoscopic systems and their applications in the biomedical
   field
SO PROCEEDINGS OF THE 18TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 18, PTS 1-5
SE PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 18th Annual International Conference of IEEE
   Engineering-in-Medicine-amd-Biology-Society
CY OCT 31-NOV 03, 1996
CL AMSTERDAM, NETHERLANDS
SP IEEE Engn Med & Biol Soc
AB Thermal endoscopic systems could provide not only useful information concerning abnormalities In spaces within tubular tissues or inside the body, but could also have other applications such as in emergency rescue situations. This project examined the possibility of developing endoscopic systems to produce thermal images using fibers and their bundles which can transmit infrared (IR) light, and investigated the feasibility of such systems. Athough it was possible to identify and observe the organs inside a subject's oral cavity and the viscella of experimental animals through the fiber bundle, the transmitted quality of the thermal images is still not good enough for diagnostic purposes. However, recent advances in infrared light detectors, the development of new materials for IR fibers, and improvements in the IR electronic endoscopic system should lead to the development of endoscopic systems for thermal images with the required temperature resolution in the near future.
C1 Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 153, Japan.
RP Mabuchi, K (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 153, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-3812-X
J9 P IEEE EMBS
PY 1997
VL 18
BP 2103
EP 2104
PG 2
WC Engineering, Biomedical
SC Engineering
GA BK41A
UT WOS:000072079001017
DA 2018-10-19
ER

PT B
AU Petraitis, D
AF Petraitis, D
BE Boom, H
   Robinson, C
   Rutten, W
   Neuman, M
   Wijkstra, H
TI Silicone biomaterials
SO PROCEEDINGS OF THE 18TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 18, PTS 1-5
SE PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 18th Annual International Conference of IEEE
   Engineering-in-Medicine-amd-Biology-Society
CY OCT 31-NOV 03, 1996
CL AMSTERDAM, NETHERLANDS
SP IEEE Engn Med & Biol Soc
AB Silicone polymers are of relatively recent invention and commercial production was started in the 1940's. Shortly thereafter it was found that glass surfaces treated with silicone fluid delayed the clotting of blood. By the mid-1950s medical applications of silicones had greatly increased and many studies of the biological properties of these materials were undertaken. Silicones are one of the most widely used and one of the most studied of all artificial materials for medical applications and no discussion of biomaterials is complete without their inclusion.
   This paper will give an overview of silicone chemistry including synthesis, types and curing mechanisms, followed by a review of some of the more important biomedical applications of these materials.
C1 NuSil Technol, Carpinteria, CA 93013 USA.
RP Petraitis, D (reprint author), NuSil Technol, 1050 Cindy Lane, Carpinteria, CA 93013 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-3812-X
J9 P IEEE EMBS
PY 1997
VL 18
BP 2177
EP 2179
PG 3
WC Engineering, Biomedical
SC Engineering
GA BK41A
UT WOS:000072079001048
DA 2018-10-19
ER

PT S
AU Kramer, CD
   Kalla, EM
AF Kramer, CD
   Kalla, EM
BE Bumgardner, JD
   Puckett, AD
TI The challenge of designing biomedical equipment during human research
   for long duration low-gravity NASA missions
SO PROCEEDINGS OF THE 1997 16TH SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE
SE SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE. PROCEEDINGS
LA English
DT Proceedings Paper
CT 16th Southern Biomedical Engineering Conference
CY APR 04-06, 1997
CL BILOXI, MS
SP Mississippi State Univ, Dept Agr & Biol Engn, Univ Mississippi Med Ctr, Dept Restorat Dent Biomat Orthopaed Surg, Whitaker Fdn, Natl Sci Fdn, IEEE Engn Med & Biol Soc, Biomed Engn Soc, Inst Biol Engn, Soc Biomat
AB NASA has been studying human adaptation to low-gravity (zero-g) environments for several years, beginning with the first manned space flight in 1961. As both flight and scientific opportunities have steadily increased, NASA has advanced in the development of sophisticated human experiments. Difficulties encountered include the ability to preserve samples for extended duration flights and the development of flight certifiable biomedical hardware.
   A major challenge to the development of flight biomedical hardware is that it requires minimal power, must accommodate multi-usages, must meet material concern for small enclosed environments, be functional in space radiation environments, and possess minimal volume.
   Discussion will include the types of equipment development for use during previous NASA Space Shuttle missions, including the recent joint NASA/Russian mission flown of the Russian Space Station Mir. Also addressed will be the focus on future needs as NASA prepares for the International Space Station, Lunar Mars Exploration, and a dedicated Neuroscience Spacelab mission.
   All NASA Human Life Sciences experiments are managed at the Lyndon B. Johnson Space Center in Houston, Texas. Principal Investigators (PI's) from around the world have teamed up to perform experiments in a range of disciplines requiring international cooperation.
   Spacelab 1 (SLS-1) opened the door as the first Space Shuttle Spacelab Mission that was totally dedicated to Human Life Sciences research. Over 400 proposals were submitted in response to the 1978 Announcement of Opportunity, of which 20 experiments were selected. These 20 experiments were grouped into four disciplines: 1) Cardiopulmonary; 2) Musculoskeletal, 3) Neuroscience, and 4) Regulatory Physiology. The disciplines allowed sharing of common hardware and scientific data. Equipment required for Human Life Sciences experiments included: echocardiograph, venous occlusion cuff, bicycle ergometer, baroreflex cuff, cardiopulmonary rebreathing unit, gas analyzer, mass spectrometer, Bag in Box (mixing bag, oxygen bag, and exhaust bag), electronic control assemblies, pneumotachograph, blood sampling equipment, body mass measurement devices, urine sampling and measuring devices, rotating chair, accelerometer recording unit, electro-oculograph, rotating dome assembly, otolith-spinal reflex apparatus, centrifuge, incubators, physiological monitoring systems, systems for venous occlusion plethysmography (SVOP), strip chart recorder, video and data tape recorder, and a system for measurement of the central venous pressure (SMCVP).
   The above listed hardware outlines the enormous amount of equipment developed for space flight. Since SLS-1 other Human Life Sciences missions have been successfully accomplished including D-2, IML-1, IML-2, SLS-2, and the NASA/Mir missions.
   Future funded missions include the Neurolab mission (STS-90, March 1998), which is dedicated to the science of Neurology, the International Space Station, and NASA/Mir missions. Studies are currently in progress to meet the needs of the Lunar and Mars exploration. Known requirements for these missions will be addressed, emphasizing the need for biomedical engineers to focus not only on earth-bound medical treatment environments, but also, applications for research in the zero-g environment of space.
RP Kramer, CD (reprint author), NASA,JOHNSON SPACE CTR,BIOMED HARDWARE DEV & ENGN OFF,MAIL CODE EA5,HOUSTON,TX 77058, USA.
NR 0
TC 4
Z9 4
U1 0
U2 2
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
SN 1086-4105
BN 0-7803-3869-3
J9 SO BIOMM ENGN CONF P
PY 1997
BP 30
EP 37
DI 10.1109/SBEC.1997.583208
PG 8
WC Engineering, Biomedical
SC Engineering
GA BH56F
UT WOS:A1997BH56F00008
DA 2018-10-19
ER

PT S
AU Love, BJ
   Sabourin, E
   Shires, PK
   Freer, RJ
AF Love, BJ
   Sabourin, E
   Shires, PK
   Freer, RJ
BE Bumgardner, JD
   Puckett, AD
TI Compact disk educational supplements for biomaterials and biomedical
   education
SO PROCEEDINGS OF THE 1997 16TH SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE
SE SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE. PROCEEDINGS
LA English
DT Proceedings Paper
CT 16th Southern Biomedical Engineering Conference
CY APR 04-06, 1997
CL BILOXI, MS
SP Mississippi State Univ, Dept Agr & Biol Engn, Univ Mississippi Med Ctr, Dept Restorat Dent Biomat Orthopaed Surg, Whitaker Fdn, Natl Sci Fdn, IEEE Engn Med & Biol Soc, Biomed Engn Soc, Inst Biol Engn, Soc Biomat
AB One new way to cost-effectively distribute educational materials is through the use of CD-ROM supplements. We proposed that the creation of a CD-ROM in biomaterials would be useful to two target audiences. One audience includes clinicians who can benefit from a second, more scientific approach to clinical uses of biomaterials. The second group includes scientists and engineers who are involved in device development yet may not have a strong understanding of the clinical environment. This manuscript outlines our approach in creating the CD-ROM. The metrics to analyse the effectiveness of the CD-ROM are not complete.
RP Love, BJ (reprint author), VIRGINIA POLYTECH INST & STATE UNIV,DEPT MAT SCI & ENGN,BLACKSBURG,VA 24061, USA.
OI Love, Brian/0000-0002-7319-5481
NR 0
TC 0
Z9 0
U1 0
U2 0
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
SN 1086-4105
BN 0-7803-3869-3
J9 SO BIOMM ENGN CONF P
PY 1997
BP 171
EP 173
DI 10.1109/SBEC.1997.583242
PG 3
WC Engineering, Biomedical
SC Engineering
GA BH56F
UT WOS:A1997BH56F00039
DA 2018-10-19
ER

PT S
AU Nall, B
   Benghuzzi, H
   Puckett, A
   Parsell, D
   Robert, B
   Tucci, M
AF Nall, B
   Benghuzzi, H
   Puckett, A
   Parsell, D
   Robert, B
   Tucci, M
BE Bumgardner, JD
   Puckett, AD
TI Interrelationship between bioceramics and mice osteoclast in culture
SO PROCEEDINGS OF THE 1997 16TH SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE
SE SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE. PROCEEDINGS
LA English
DT Proceedings Paper
CT 16th Southern Biomedical Engineering Conference
CY APR 04-06, 1997
CL BILOXI, MS
SP Mississippi State Univ, Dept Agr & Biol Engn, Univ Mississippi Med Ctr, Dept Restorat Dent Biomat Orthopaed Surg, Whitaker Fdn, Natl Sci Fdn, IEEE Engn Med & Biol Soc, Biomed Engn Soc, Inst Biol Engn, Soc Biomat
AB The relationship between various bioceramics (similar to bone) used in surgical implantation and osteoclastic response has not been fully elucidated. The objective of this study was to investigate the effect of various biomedical ceramics such as tricalcium phosphate (TCP), hydroxyapatite (HA), and aluminum-calcium-phosphorous oxide (ALCAP) on the adherence and viability of mice osteoclast (OT) in vitro The OT cells were isolated from adult male mice and seeded at a density of 5 x 10(5) cells/well according to standard laboratory procedures. Cells were plated in each micrometer-well pretreated with ceramic capsules (HA, TCP and ALCAP) and buffered control. At the end of 1, 2, 3 and 5 days the viability and cell number of OT were determined using an established assay. Cell number was determined in control wells with known number of cells, and a standard curve was generated by plotting absorbency units versus cell number. Biochemical analysis was performed on the aliquots obtained from the experimental and control wells at the end of each phase of the investigation. The data from this experiment suggest that : (I) OT are capable of adhering to the surface of HA, TCP and ALCAP in an in vitro environment for over a 5 day period. (II) Long term incubation of ceramic capsules with OT revealed that the cells experienced gradual disassociation phenomenon with a greater numbers of cell detachment seen in the ALCAP contained wells. (III) SEM analysis of representative capsules demonstrated that there is an increase in the number of micropores and macropores on the surface of the materials after contacting a cellular environment. This observation suggest that the material surface has been modified (TCP > HA= ALCAP). Information obtained from this study provided new insights on the interrelationship between bioceramics and the possible OT response during chronic inflammation at the site of implantation.
RP Nall, B (reprint author), UNIV MISSISSIPPI,MED CTR,2500 N STATE ST,JACKSON,MS 39216, USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
SN 1086-4105
BN 0-7803-3869-3
J9 SO BIOMM ENGN CONF P
PY 1997
BP 279
EP 282
DI 10.1109/SBEC.1997.583285
PG 4
WC Engineering, Biomedical
SC Engineering
GA BH56F
UT WOS:A1997BH56F00063
DA 2018-10-19
ER

PT S
AU Blanchard, SM
   Dewolf, DK
   Dillon, AE
AF Blanchard, SM
   Dewolf, DK
   Dillon, AE
GP IEEE
   IEEE
TI Biomedical engineering applications - A prototype World Wide Web
   textbook
SO PROCEEDINGS OF THE 19TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 19, PTS 1-6:
   MAGNIFICENT MILESTONES AND EMERGING OPPORTUNITIES IN MEDICAL ENGINEERING
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society
CY OCT 30-NOV 02, 1997
CL CHICAGO, IL
SP IEEE Engn Med & Biol Soc, Natl Inst Hlth
AB A prototype electronic textbook, Biomedical Engineering Applications, is now available on the World Wide Web. It contains 11 chapters - Introduction, Electrodes and Transducers, Cardiovascular System, Respiratory System, Nervous System, Muscular System, Skeletal System, Computers in Medicine, Radiology and Nuclear Medicine, Medical Imaging, and Lasers in Medicine - suitable for an overview course in biomedical engineering. Each chapter includes links to selected topics, instructional objectives, sample tests, and related information. At this time, the textbook is considered to be a prototype since only student-generated projects are associated with each chapter and supplementary reading material, in the form of traditional textbooks, is required. The long-term goal is to have instructor-written material as well as student-generated projects for each topic and to include interactive simulations to illustrate appropriate concepts.
C1 N Carolina State Univ, Dept Biol & Agr Engn, Raleigh, NC 27695 USA.
RP Blanchard, SM (reprint author), N Carolina State Univ, Dept Biol & Agr Engn, Box 7625, Raleigh, NC 27695 USA.
CR Blanchard S M, 1997, Biomed Sci Instrum, V33, P400
   DIXON JW, 1996, BARORECEPTOR MODELIN
   Washington N, 1997, Biomed Sci Instrum, V33, P41
NR 3
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-4262-3
J9 P ANN INT IEEE EMBS
PY 1997
VL 19
BP 922
EP 923
PN 1-6
PG 2
WC Engineering, Biomedical
SC Engineering
GA BM91F
UT WOS:000080103400264
DA 2018-10-19
ER

PT S
AU Singh, VR
AF Singh, VR
GP IEEE
   IEEE
TI Novel bone micro-sensors
SO PROCEEDINGS OF THE 19TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 19, PTS 1-6:
   MAGNIFICENT MILESTONES AND EMERGING OPPORTUNITIES IN MEDICAL ENGINEERING
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society
CY OCT 30-NOV 02, 1997
CL CHICAGO, IL
SP IEEE Engn Med & Biol Soc, Natl Inst Hlth
DE bone; micro-sensor; piezo-ceramics; vibration sensors; diagnostic sensor
AB Bone is now a well estblished pizoelectric material. A systematic and detailed study has been carried out to investigate this property in the bone by using invitro and invivo samples in the laboratory. Conventional ceramic processing technique is utilized to develop transducer elements from the bone material. Different types of micro-sensors developed for various biomedical applicatios, are described.
C1 Natl Phys Lab, Instrumentat & Sensors Grp, New Delhi 110012, India.
RP Singh, VR (reprint author), Natl Phys Lab, Instrumentat & Sensors Grp, Dr Ks Krishnan Rd, New Delhi 110012, India.
CR Fukuda E., 1957, J PHYS SOC JPN, V12, P1158
   FUKUDA E, 1964, JPN J APPL PHYS, V3, P117
   LEWIN PA, 1981, ULTRASONICS, V19, P213, DOI 10.1016/0041-624X(81)90005-6
   SINGH VR, 1988, PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, PTS 1-4, P755, DOI 10.1109/IEMBS.1988.95003
   YADAV S, 1990, INNOV TECH BIOL MED, V11, P89
NR 5
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-4262-3
J9 P ANN INT IEEE EMBS
PY 1997
VL 19
BP 2260
EP 2263
PN 1-6
PG 4
WC Engineering, Biomedical
SC Engineering
GA BM91F
UT WOS:000080103400648
DA 2018-10-19
ER

PT S
AU Katz, DF
   Dunmire, EN
   Henderson, MH
   Owen, DH
   Plenys, AM
AF Katz, DF
   Dunmire, EN
   Henderson, MH
   Owen, DH
   Plenys, AM
GP IEEE
   IEEE
TI Applications of biomedical engineering in reproductive biomedicine:
   Sensing and drug delivery to the lower female reproductive tract
SO PROCEEDINGS OF THE 19TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 19, PTS 1-6:
   MAGNIFICENT MILESTONES AND EMERGING OPPORTUNITIES IN MEDICAL ENGINEERING
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society
CY OCT 30-NOV 02, 1997
CL CHICAGO, IL
SP IEEE Engn Med & Biol Soc, Natl Inst Hlth
DE contraception; prophylaxis; sexually transmitted diseases; drug
   delivery; optical sensing
ID CERVICAL-MUCUS; MUCOADHESION; POLYMERS
AB Current intravaginal products for contraception and prophylaxis against sexually transmitted diseases lack the efficacy that is both needed and technically possible. A multidisciplinary effort - that integrates gynecology, pathology, microbiology, and reproductive biology with engineering and materials science - can provide critical and missing information to the process of design and development of better products. Several engineering sub-disciplines can contribute to this effort, including electrical, mechanical and chemical engineering. Specific contributions will pertain to the polymeric delivery vehicles for drug delivery, the active ingredients of those vehicles, and to methods of testing, both in vitro and in vivo.
C1 Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
RP Katz, DF (reprint author), Duke Univ, Dept Biomed Engn, Box 90281, Durham, NC 27708 USA.
CR DONCEL GF, 1994, BARRIER CONTRACEPTIV, P145
   Dunmire EN, 1997, CONTRACEPTION, V55, P115, DOI 10.1016/S0010-7824(96)00281-8
   DUNMIRE EN, 1997, IN PRESS CONTRACEPTI
   ESPOSITO P, 1994, BIOMATERIALS, V15, P177, DOI 10.1016/0142-9612(94)90064-7
   HENDERSON MH, 1997, IN PRESS AM SOC REPR
   KATZ DF, 1993, ADV DRUG DELIVER REV, V11, P385, DOI 10.1016/0169-409X(93)90017-X
   Leung S. H., 1988, J CONTROL RELEASE, V5, P223
   OWEN DH, AM SOC REPR MED ANN, pS57
   OWEN DH, 1997, IN PRESS AM SOC REPR
   PARK HHS, 1984, J PHARM SCI, V74, P399
   RILLOSI M, 1995, PHARMACEUT RES, V12, P669, DOI 10.1023/A:1016299223369
   SangiHaghpeykar H, 1996, CONTRACEPTION, V53, P353, DOI 10.1016/0010-7824(96)00084-4
NR 12
TC 3
Z9 3
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-4262-3
J9 P ANN INT IEEE EMBS
PY 1997
VL 19
BP 2656
EP 2658
PN 1-6
PG 3
WC Engineering, Biomedical
SC Engineering
GA BM91F
UT WOS:000080103400761
DA 2018-10-19
ER

PT B
AU Devender
   Ramasamy, SR
AF Devender
   Ramasamy, SR
GP SOC EMC ENGINEERS INDIA
TI A review of EMI shielding and suppression materials
SO PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON ELECTROMAGNETIC
   INTERFERENCE AND COMPATIBILITY '97
LA English
DT Proceedings Paper
CT International Conference on Electromagnetic Interference and
   Compatibility 97 (INCEMIC 97)
CY DEC 03-05, 1997
CL HYDERABAD, INDIA
SP Soc Electromagnet Compatibil Engineers India, Hyderabad
AB The effect of growth of electronic industry and its widespread use of electronic equipment in communications, computations, automations, biomedical, space and other purposes has led to many Electromagnetic Interference (EMI) problems to the designers as their systems/subsystems operate in close proximity. It is likely to become more severe in future, unless designers follow EMI control methodology/techniques to meet the EMC requirements during the design stage itself. The elimination or suppression of EMI should be a prime objective of the designer. In this paper the authors have made an attempt to present technical data/details fo various EMI suppression materials/devices available in the market and simplified the job of designer to verify different catalogues and which may be directly applied to problem and harden the system/subsystem in compliance to EMC Standards. As the design and development proceeds, the number of available noise reduction techniques also decreases and at the same time cost of mitigating noise goes up. Hence selecting a right component in right time is very essential. This paper gives a quick reference to the designer to reduce the noise at source level in the system during design and development stages by choosing appropriate component/device and fixing it correctly into the problem.
C1 Res Ctr Imarat, Hyderabad 500069, Andhra Pradesh, India.
RP Devender (reprint author), Res Ctr Imarat, Hyderabad 500069, Andhra Pradesh, India.
NR 0
TC 3
Z9 3
U1 0
U2 3
PU SOCIETY ELECTROMAGNETIC COMPATIBILITY ENGINEERS INDIA
PI HYDERABAD
PA 306, AVIONICS RESEARCH CTR IMARAT, HYDERABAD 500 069, INDIA
BN 81-900652-0-3
PY 1997
BP 459
EP 466
DI 10.1109/ICEMIC.1997.669850
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BK95U
UT WOS:000073941000090
DA 2018-10-19
ER

PT B
AU Morais, S
   Sousa, JP
   Carvalho, GS
AF Morais, S
   Sousa, JP
   Carvalho, GS
BE Ricco, AJ
   Vanyek, P
   Horvai, G
   Silva, AF
TI Quantification of AISI 316L stainless steel corrosion products in cell
   culture using a mercury microelectrode
SO PROCEEDINGS OF THE SYMPOSIUM ON CHEMICAL AND BIOLOGICAL SENSORS AND
   ANALYTICAL ELECTROCHEMICAL METHODS
SE ELECTROCHEMICAL SOCIETY SERIES
LA English
DT Proceedings Paper
CT Symposium on Chemical and Biological Sensors and Analytical
   Electrochemical Methods
CY 1997
CL PARIS, FRANCE
SP Int Soc Electrochem, Electrochem Soc
AB The main goal of this study was to investigate the effects of stainless steel AISI 316L (a commonly used material in orthopedics) corrosion products on in vitro biomineralization process. Adsorptive stripping voltammetric (AdSV) procedures for the determination of the major alloying elements, i.e. Fe, Cr and Ni, were optimized and used to quantify these elements in cell culture medium using a mercury film microelectrode (MFM). The organic ligand and optimized analytical conditions for each metal ion were: a) catechol 5.00x10(-4) mol/L, PIPES buffer 0.01 mol/L (pH=8.0) and deposition potential -1.80 V for Fe; b) diethylenetriaminepentaacetic acid (DTPA) 7.50x10(-3) mol/L, sodium nitrate 0.70 mol/L, sodium acetate 0.05 mol/L (pH=5.9) and deposition potential -1.00 V for Cr; c) dimethylglioxime (DMG) 5.00x10(-4) mol/L, ammonium chloride buffer 0.10 mol/L (pH=9.2) and deposition potential -0.70 V for Ni. The limits of detection achieved (1.93x10(-8) mol/L Fe, 2.80x10(-10) mol/L Cr and 7.70x10(-9) mol/L Ni for a collection time of 30 s, 40 s and 10 s, respectively) are adequate for future applications in the biomaterials/biomedical field.
RP Morais, S (reprint author), UNIV OPORTO,INST BIOMED ENGN,DEPT ENGN QUIM,FAC ENGN,PRACA CORONEL PACHECO 1,P-4050 OPORTO,PORTUGAL.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELECTROCHEMICAL SOCIETY INC
PI PENNINGTON
PA 10 S MAIN ST, PENNINGTON, NJ 08534-2896
BN 1-56677-147-1
J9 ELEC SOC S
PY 1997
VL 97
IS 19
BP 587
EP 596
PG 10
WC Electrochemistry
SC Electrochemistry
GA BJ30V
UT WOS:A1997BJ30V00073
DA 2018-10-19
ER

PT S
AU Cibuzar, G
   Polla, D
   McGlennen, R
AF Cibuzar, G
   Polla, D
   McGlennen, R
GP IEEE
TI Biomedical MEMS research at the University of Minnesota
SO PROCEEDINGS OF THE TWELFTH BIENNIAL UNIVERSITY/GOVERNMENT/INDUSTRY
   MICROELECTRONICS SYMPOSIUM
SE PROCEEDINGS - UNIVERSITY/GOVERNMENT/INDUSTRY MICROELECTRONICS SYMPOSIUM
LA English
DT Proceedings Paper
CT 12th Biennial University/Government/Industry Microelectronics Symposium
CY JUL 20-23, 1997
CL ROCHESTER INST TECHNOL, ROCHESTER, NY
SP IEEE, Electron Devices Soc, IEEE, Rochester Sect, Rochester Inst Technol, Microelectr Engn Dept
HO ROCHESTER INST TECHNOL
AB Microelectromechanical systems (MEMS) technology has often been characterized as an enabling technology. As MEMS technology expands with improved designs, refined processes, and extension to materials beyond standard silicon substrates, opportunities for applications in new research areas are growing rapidly. Beyond the more traditional MEMS areas of accelerometers and pressure sensors, there are many possibilities in research fields such as biology, agriculture, and veterinary and human medicine.
   Over the past two years, the Microtechnology Laboratory at the University of Minnesota has been cultivating a research program based on applying MEMS to biomedical and medical situations. The program was motivated by a fruitful series of discussions between MEMS researchers from the engineering disciplines and faculty from medical Laboratory Medicine and Pathology. These applications of traditional MEMS technology to specialized small surgical tools. The process of applications to reality has been a difficult and rewarding one. In this talk we will give a historical view of development of the program. Some of the topics that will be discussed include: disparate disciplines working collaboratively, funding, organization and management, and interaction with industry.
RP Cibuzar, G (reprint author), UNIV MINNESOTA,MICROTECHNOL LAB,200 UNION ST SE,MINNEAPOLIS,MN 55455, USA.
NR 0
TC 4
Z9 4
U1 0
U2 1
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
SN 0749-6877
BN 0-7803-3791-3
J9 P UNIV GOVT IND MICR
PY 1997
BP 145
EP 149
DI 10.1109/UGIM.1997.616710
PG 5
WC Engineering, Electrical & Electronic
SC Engineering
GA BJ65E
UT WOS:A1997BJ65E00033
DA 2018-10-19
ER

PT J
AU Lambrecht, RM
   Tomiyoshi, K
   Sekine, T
AF Lambrecht, RM
   Tomiyoshi, K
   Sekine, T
TI Radionuclide generators
SO RADIOCHIMICA ACTA
LA English
DT Review
DE radiochemical separations; radiopharmaceutical chemistry; isotope
   production; double neutron capture; generator automation
ID INDUCED NUCLEAR-REACTIONS; POSITRON EMISSION TOMOGRAPHY; RB-81 KR-81M
   GENERATOR; HIGHLY ENRICHED XE-124; CARRIER-FREE HO-166; HIGH-PURITY
   I-123; EXCITATION-FUNCTIONS; RB-81/KR-81M GENERATOR; ZN-62/CU-62
   GENERATOR; MONOCLONAL-ANTIBODIES
AB The present status and future directions of research and development on radionuclide generator technology are reported. The recent interest to develop double-neutron capture reactions for production of in vivo generators; neutron rich nuclides for radioimmunotherapeutic pharmaceuticals; and advances with ultrashort lived generators is highlighted. Emphasis is focused on: production of the parent radionuclide; the selection and the evaluation of support materials and eluents with respect to the resultant radiochemical yield of the daughter, and the breakthrough of the radionuclide parent; and, the uses of radionuclide generators in radiopharmaceutical chemistry, biomedical and industrial applications. The Zn-62 --> Cu-62, Ni-66 --> Cu-66, Rh-103m --> Rh-103, W-188 --> Re-188 and the Ac-225 --> Fr-221 --> Bi-213 generators are predicted to be emphasized for future development. Coverage of the Mo-99 --> Tc-99m generator was excluded, as it the subject of another review. The literature search ended June, 1996.
C1 UNIV WOLLONGONG,DEPT CHEM,WOLLONGONG,NSW 2522,AUSTRALIA.
   GUNMA UNIV,DEPT NUCL MED,MARBASHI 317,JAPAN.
   JAPAN ATOM ENERGY RES INST,DEPT RADIOISOTOPES,TAKASAKI,GUMMA 37012,JAPAN.
RP Lambrecht, RM (reprint author), UNIV TUBINGEN,POSTFACH 35,D-72076 TUBINGEN,GERMANY.
CR AGEEV VA, 1992, RADIOKHIMYA, V34, P122
   AMBE S, 1988, APPL RADIAT ISOTOPES, V39, P49
   ANSARI AN, 1976, Patent No. 3959455
   Arif M, 1996, RADIOCHIM ACTA, V73, P45
   ASANO T, 1978, J INORG NUCL CHEM, V40, P957, DOI 10.1016/0022-1902(78)80487-4
   ASANO T, 1974, J INORG NUCL CHEM, V36, P1433, DOI 10.1016/0022-1902(74)80601-9
   ATCHER RW, 1989, J RADIOAN NUCL CH LE, V135, P215, DOI 10.1007/BF02164974
   ATCHER RW, 1988, APPL RADIAT ISOTOPES, V39, P238
   BABICH JW, 1989, RADIOPHARMACEUTICALS, P3
   Bao B, 1996, J RADIOAN NUCL CH LE, V213, P233, DOI 10.1007/BF02163569
   BARTOS B, 1995, J RADIOAN NUCL CH LE, V201, P89, DOI 10.1007/BF02163720
   BELKOVA MN, 1993, J RADIOAN NUCL CH AR, V173, P3, DOI 10.1007/BF02102692
   BEYER GJ, 1991, APPL RADIAT ISOTOPES, V42, P141
   BIALY J, KFK NACHR JAHRG, V21, pS17
   BILEWICZ A, 1995, RADICHIM ACTA, V69, P127
   BLACHOT J, 1969, INT J APPL RADIAT IS, V20, P467, DOI 10.1016/0020-708X(69)90138-0
   BLAUENSTEIN P, 1996, J RADIOANAL NUCL CHE, V204, P94
   BORMANS G, 1992, APPL RADIAT ISOTOPES, V43, P1437
   BOTROS N, 1986, ISOTOPENPRAXIS, V22, P386
   BREMMER KH, 1989, Patent No. 304780
   BRIHAYE C, 1986, J RADIOAN NUCL CH AR, V102, P399, DOI 10.1007/BF02047914
   BRIHAYE C, 1986, J NUCL MED, V27, P380
   BRIHAYE C, 1989, APPL RADIAT ISOTOPES, V40, P183
   BRIHAYE C, 1988, RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE AND RESEARCH /, P397
   BRITS RJN, 1989, APPL RADIAT ISOTOPES, V40, P103
   BRUCER M, 1965, ISOT RAD TECH, V3, P1
   CACKETTE MR, 1993, APPL RADIAT ISOTOPES, V44, P917, DOI 10.1016/0969-8043(93)90045-C
   CALLAHAN A P, 1987, Journal of Nuclear Medicine, V28, P657
   CALLAHAN AP, 1992, APPL RADIAT ISOTOPES, V43, P801
   CALLAHAN AP, 1989, NUC COMPACT, V20, P3
   CAMPS JAJ, 1990, NUCL MED BIOL, V17, P269
   CHENG C, 1980, J NUCL MED, V21, P1169
   CHINOL M, 1996, J NUCL MED, V37
   Chuang JT, 1996, J RADIOAN NUCL CH AR, V204, P83, DOI 10.1007/BF02060869
   COENEN HH, 1979, THESIS U KOLN KOLN
   COENEN HH, 1979, BER KERNFORSCHUN JUL, V1590
   COURSEY BM, 1992, RADIOACT RADIOCHEM, V3, P42
   DADACHOV M, 1994, J RADIOAN NUCL CH LE, V188, P267, DOI 10.1007/BF02164887
   DADACHOV M, IN PRESS J MAT CHEM
   DADACHOV MS, 1995, J RADIOAN NUCL CH LE, V200, P211, DOI 10.1007/BF02164083
   DADACHOVA E, 1995, J PHYS CHEM-US, V99, P10976, DOI 10.1021/j100027a044
   DADACHOVA E, 1994, ANAL CHEM, V66, P4272, DOI 10.1021/ac00095a024
   DADACHOVA E, 1995, J RADIOAN NUCL CH LE, V199, P115, DOI 10.1007/BF02162474
   DANIELS RJ, 1987, J NUCL MED BIOL, V36, P326
   DAS NR, 1993, RADIOCHIM ACTA, V62, P213
   Das SK, 1996, APPL RADIAT ISOTOPES, V47, P643, DOI 10.1016/0969-8043(96)00025-5
   DEJONG D, 1982, INT J APPL RADIAT IS, V33, P69, DOI 10.1016/0020-708X(82)90208-3
   DEPTULA C, 1989, 689354 JINRR
   DEUTSCH EA, 1989, Patent No. 4839467
   EAKINS MN, 1992, RADIOACT RADIOCHEM, V3, P61
   EHRHARDT G J, 1987, Journal of Nuclear Medicine, V28, P656
   EHRHARDT GJ, 1992, RADIOACT RADIOCHEM, V38, P40
   EHRHARDT GJ, 1990, TECHNETIUM RHENIUM C, V3, P631
   FAILLA G, 1925, Patent No. 1553794
   FAILLA G, 1926, Patent No. 1609614
   FIROUZBAKHT ML, 1987, RADIOCHIM ACTA, V41, P1
   FRANKEN K, 1990, RADIOCHIM ACTA, V50, P97
   FRANKEN PR, 1984, NUKLEARMED-NUCL MED, V30, P1025
   FRITZBERG AR, 1988, PHARMACEUT RES, V5, P325, DOI 10.1023/A:1015995208444
   FRITZBERG AR, 1988, Patent No. 284871
   FUJIBAYASHI Y, 1990, CHEM PHARM BULL, V38, P1946
   FUJIBAYASHI Y, 1989, J NUCL MED, V30, P1838
   GALLORINI M, 1995, J RADIOAN NUCL CH AR, V193, P39, DOI 10.1007/BF02041915
   GLENWORTH P, 1961, J INORG NUCL CHEM, V39, P1049
   GRAHAM D, 1985, J NUCL MED, V26, P105
   GRANT PM, 1985, J RADIOAN NUCL CH LE, V96, P629, DOI 10.1007/BF02165043
   GREEN MA, 1988, J NUCL MED, V29, P1549
   GREEN MA, 1987, NUCL MED BIOL, V14, P59
   GREEN MA, 1990, J NUCL MED, V31, P1989
   GRIFFITHS GL, 1992, BIOCONJUGATE CHEM, V3, P91, DOI 10.1021/bc00014a001
   GRIFFITHS GL, 1991, CANCER RES, V51, P4594
   GUILLAUME M, 1987, RADIOCHIM ACTA, V41, P119
   HAFELI U, 1991, NUCL MED BIOL, V18, P449
   HANSER A, 1989, APPL RADIAT ISOTOPES, V40, P309
   HAYES RL, 1965, J NUCL MED, V7, P797
   HAYES RL, 1965, 1017477 ORAN
   HELLMAN C, 1989, J NUCL MED, V30, P450
   HELUS F, 1990, J RADIOAN NUCL CH AR, V140, P111, DOI 10.1007/BF02037368
   HELUS F, 1996, COMMUNICATION
   Herrero P, 1996, J NUCL MED, V37, P1294
   HETHERINGTON ELR, 1984, INT J APPL RADIAT IS, V35, P68, DOI 10.1016/0020-708X(84)90135-2
   HNATOWICH DJ, 1977, RADIOLOGY, V123, P189, DOI 10.1148/123.1.189
   HSIEH BT, 1991, NUCL SCI, V28, P413
   HUFFMAN EH, 1956, J INORG NUCL CHEM, V3, P49, DOI 10.1016/0022-1902(56)80113-9
   *IAEA, 1995, 852 IAEA TECHDOC
   ILJIN LA, 1987, CURRENT QUESTIONS ME, P97
   ISSACHAR D, 1989, J NUCL MED, V30, P538
   IWATA R, 1992, J RADIOANAL NUCL CHE, V159, P23
   Jackson TW, 1996, AUST J CHEM, V49, P239
   JACKSON TW, 1993, AUST J CHEM, V46, P1093, DOI 10.1071/CH9931093
   JACKSON TW, 1993, Patent No. 93112038
   JACKSON TW, 1993, Patent No. 8099179
   JANNSEN AGM, 1992, J LABELLED COMPD RAD, V30, P478
   JANSSEN AGM, 1990, APPL RADIAT ISOTOPES, V41, P847
   JONES CJ, 1977, J HAZARD MATER, V2, P219
   KAMIOKI H, 1995, SYNTHESIS AND APPLICATIONS OF ISOTOPICALLY LABELLED COMPOUNDS 1994, P237
   KAMIOKI H, 1994, RADIOCHIM ACTA, V65, P39
   KLOCKOW D, 1968, J RADIOANAL CHEM, V1, P325, DOI 10.1007/BF02513687
   KLOFUTAR C, 1970, J RADIOANAL CHEM, V5, P3, DOI 10.1007/BF02513694
   Knapp F.F., 1993, U.S. Patent, Patent No. [5,186,913, 5186913]
   Knapp F. F., 1994, U. S. Patent, Patent No. [5, 275, 802, 5275802]
   KNAPP FF, 1994, EUR J NUCL MED, V21, P1151
   KNAPP FF, 1994, APPL RADIAT ISOTOPES, V45, P1123, DOI 10.1016/0969-8043(94)90026-4
   KNAPP FF, 1992, ORNL12159
   KNAPP FF, 1992, NUCL MED RES PRACTIC, P183
   KNAPP FF, 1988, J NUCL MED, V29, P927
   KNAPP FF, 1993, ORNLTM12485
   KODINA G, 1990, TECHNETIUM RHENIUM C, V3, P635
   KOJIMA M, UNPUB J RADIOANAL NU
   KONYAHIN NA, 1989, ATOM ENERG, V67, P129
   KOVACS Z, 1991, APPL RADIAT ISOTOPES, V42, P329
   KOZAK RW, 1986, P NATL ACAD SCI USA, V83, P474, DOI 10.1073/pnas.83.2.474
   KURENKOV NV, 1989, J RADIOAN NUCL CH LE, V135, P39, DOI 10.1007/BF02165458
   LACY JL, 1991, J NUCL MED, V32, P2158
   LACY JL, 1988, J NUCL MED, V29, P1526
   LAGUNASSOLAR MC, 1990, APPL RADIAT ISOTOPES, V41, P521
   LAMBRECHT RM, 1988, APPL RADIAT ISOTOPES, V39, P1081
   LAMBRECHT RM, 1983, RADIOCHIM ACTA, V34, P9
   LAMBRECHT RM, 1988, RADIOCHIM ACTA, V43, P171
   LAMBRECHT RM, 1972, J NUCL MED, V13, P266
   LAMBRECHT RM, 1976, P 4 INT C POS SOURC
   LAMBRECHT RM, 1976, BORDEAUX MED, V9, P1294
   LAMBRECHT RM, 1975, RADIOPHARMACEUTICALS, P111
   LEDERER CM, 1978, TABLE ISOTOPES
   LEE TW, 1991, ISOTOPENPRAXIS, V27, P269, DOI 10.1080/10256019108622539
   Lenz J. W., 1995, P 6 WORKSH TARG TARG, P149
   LERF A, 1987, HYPERFINE INTERACT, V36, P326
   LEWIS RA, 1965, J NUCL MED, V7, P804
   LUNDQVIST H, 1991, APPL RADIAT ISOTOPES, V42, P447
   MA D, 1993, J NUCL MED, V34
   MACHULLA HJ, 1977, RADIOCHIM ACTA, V24, P42
   MALININ AB, 1991, MED RADIOL, V35, P34
   Malyshev K.V., 1975, RADIOKHIMIYA, V17, P249
   MANI RS, 1987, RADIOCHIM ACTA, V41, P103
   MANSUR MS, 1995, J RADIOAN NUCL CH LE, V201, P205, DOI 10.1007/BF02164828
   MATHIAS CJ, 1991, J NUCL MED, V32, P475
   MATHIAS CJ, 1991, APPL RADIAT ISOTOPES, V42, P317
   MATSUURA T, 1992, P INT SEM CHEM HIGH
   MAUSNER L F, 1989, Journal of Labelled Compounds and Radiopharmaceuticals, V26, P177
   MAUSNER LF, 1987, APPL RADIAT ISOTOPES, V38, P181
   MERRIGAN JA, 1966, J PHYS CHEM-US, V70, P2417, DOI 10.1021/j100879a507
   Mikheev N.S., 1972, ISOTOPENPRAXIS, V8, P248
   Mirzadeh S, 1996, J RADIOAN NUCL CH AR, V203, P471, DOI 10.1007/BF02041524
   Mirzadeh S, 1996, J RADIOAN NUCL CH AR, V202, P7, DOI 10.1007/BF02037941
   MIRZADEH S, 1991, Journal of Nuclear Medicine, V32, P1089
   MIRZADEH S, 1993, RADIOCHIM ACTA, V60, P1
   Mirzadeh S., 1992, P INT C NUCL DAT SCI, P595
   MIRZADEH S, 1992, RADIOACT RADIOCHEM, V3, P31
   MIRZADEH S, 1996, 212 AM ACS M ORL FL
   MIRZADEH SM, 1995, P 6 WORKSH TARG TARG, P129
   MOERLEIN SM, 1983, J AM CHEM SOC, V105, P5418, DOI 10.1021/ja00354a039
   Mushtaq A, 1996, APPL RADIAT ISOTOPES, V47, P727, DOI 10.1016/0969-8043(96)00032-2
   NEIRINCKX RD, 1977, INT J APPL RADIAT IS, V28, P808, DOI 10.1016/0020-708X(77)90121-1
   NORMAN JH, 1991, Patent No. 5038046
   Nozaki T, 1996, J RADIOAN NUCL CH AR, V203, P151, DOI 10.1007/BF02060390
   OKAZAWA H, 1994, J NUCL MED, V35, P1910
   ORVANESSIANT YT, 1982, J PHYS G, V18, P393
   PACKARD AB, 1987, J NUCL MED, V28, P1571
   PACKARD AB, 1985, INT J APPL RADIAT IS, V36, P164, DOI 10.1016/0020-708X(85)90238-8
   PACKARD AB, 1986, INT J APPL RADIAT IS, V36, P519
   PACKARD AB, 1992, RADIOACT RADIOCHEM, V3, P49
   PHILLIPS DR, 1989, CONF891206, P608
   PLOTNOKOV V, 1966, ZH ANAL KHIM, V21, P1260
   PROBST HJ, 1976, INT J APPL RADIAT IS, V27, P431, DOI 10.1016/0020-708X(76)90062-4
   QAIM SM, 1987, RADIOCHIM ACTA, V41, P111
   RACK EP, 1961, J CHEM PHYS, V34, P1855, DOI 10.1063/1.1731784
   RACK EP, 1992, P INT SEM CHEM HIGH, P55
   RAMAMOORTHY N, 1981, RADIOCHEM RADIOA LET, V46, P371
   RAYUDU GVS, 1990, SEMIN NUCL MED, V20, P100, DOI 10.1016/S0001-2998(05)80163-1
   RICHARDS P, 1989, TECHNETIUM RHENIUM C, V3, P5
   Rosch F, 1997, APPL RADIAT ISOTOPES, V48, P19, DOI 10.1016/S0969-8043(96)00041-3
   ROSENSTEIN LM, 1989, J NUCL MED, V30, P1574
   RUBINSON W, 1949, J CHEM PHYS, V17, P542, DOI 10.1063/1.1747317
   RUEGG CL, 1990, CANCER RES, V50, P4221
   SAHA GB, 1990, ADV RADIOPHARMACOLOG, P45
   SAJJAD M, 1986, ANAL CHEM, V53, P667
   SCHINDLER J, 1996, Patent No. 3621189
   SEKINE T, 1981, J INORG NUCL CHEM, V43, P1107, DOI 10.1016/0022-1902(81)80001-2
   SEKINE T, 1978, J INORG NUCL CHEM, V40, P1977, DOI 10.1016/0022-1902(78)80184-5
   SEKINE T, 1978, J INORG NUCL CHEM, V40, P1457, DOI 10.1016/0022-1902(78)80451-5
   SEKINE T, 1980, 1266 JAERI
   Shigeta N, 1996, APPL RADIAT ISOTOPES, V47, P171, DOI 10.1016/0969-8043(95)00254-5
   SHIOKAWA T, 1965, B CHEM SOC JPN, V38, P1340, DOI 10.1246/bcsj.38.1340
   SHIOKAWA T, 1965, CHEM EFFECTS ASSOCIA, V38, P1892
   SHIOKAWA T, 1970, CHEM EFFECTS ASS BET, V43, P2076
   SHIOKAWA T, 1969, CHEM EFFECTS ASSOCIA, V42, P696
   SHOCHAT D, 1989, Patent No. 8909405
   SHOOP D, 1996, J RADIOANAL NUCL CHE, V211
   SIMPSON BRS, 1994, APPL RADIAT ISOTOPES, V45, P669, DOI 10.1016/0969-8043(94)90245-3
   SINGH J, 1991, CHEM SOC CHEM COMMUN, V1115
   SLEWYN AP, 1978, CIRC RES, V42, P771
   SMITH SV, 1995, APPL RADIAT ISOTOPES, V46, P759, DOI 10.1016/0969-8043(94)00149-T
   SPITSIN VI, 1971, ATOM ENERGY REV, V9, P797
   SQOURUS G, 1996, J NUCL MED, V37
   SRIVISTAVA SC, 1988, RADIOLABELLED MONOCL
   STEYN GF, 1991, APPL RADIAT ISOTOPES, V42, P361
   SZELECSENYI F, 1995, P 6 WORKSH TARG TARG
   TARKANYI F, 1990, APPL RADIAT ISOTOPES, V41, P91
   TARKANYI F, 1991, APPL RADIAT ISOTOPES, V42, P221
   TARKANYI F, 1991, APPL RADIAT ISOTOPES, V42, P229
   THOMAS KE, 1987, APPL RADIAT ISOTOPES, V38, P175
   TOBIN MJ, 1991, APPL RADIAT ISOTOPES, V42, P412
   TREVES S, 1980, J NUCL MED, V21, P1151
   TREVES S, 1979, RADIOLOGY, V130, P741
   TSANG BW, 1993, INORG CHEM, V32, P988, DOI 10.1021/ic00058a039
   TsoupkoSitnikov V, 1996, J RADIOAN NUCL CH AR, V205, P75, DOI 10.1007/BF02040552
   Uhlir V, 1996, J RADIOAN NUCL CH AR, V204, P423, DOI 10.1007/BF02060330
   *USDOE, 1996, USDOE WORKSH ALPH EM
   VANDERHEYDEN JL, 1992, Patent No. 51456368
   WEBER DA, 1989, MIRD RADIONUCLIDE DA
   WENZEL W, 1989, Patent No. 8909342
   WIKE JS, 1990, APPL RADIAT ISOTOPES, V41, P861
   WITSENBOER AJ, 1986, J LABELLED COMPD RAD, V23, P1284
   WU C, 1996, 212 ACS SOC M ORL FL
   Yamashita M., 1989, U.S. patent, Patent No. [4,859,931, 4859931]
   YANO Y, 1989, Journal of Nuclear Medicine, V30, P849
   YANO Y, 1989, NUCL INSTRUM METH B, V40-1, P1105, DOI 10.1016/0168-583X(89)90549-1
   YANO Y, 1968, J NUCL MED, V9, P1
   YOKOYAMA A, 1986, Radioisotopes, V35, P249
   YOONG M, 1973, RADIOCHIM ACTA, V19, P124
   ZAITSEVA NG, 1991, J RADIOAN NUCL CH AR, V149, P235, DOI 10.1007/BF02062049
   ZAITSEVA NG, 1994, RADIOCHIM ACTA, V64, P1
   ZAITSEVA NG, 1994, RADIOCHIM ACTA, V65, P157
   ZAITSEVA NG, 1994, RADIOCHIM ACTA, V65, P151
   Zhuikov B.L., 1996, P 6 WORKSH TARG TARG, P112
   ZUCCHINI GL, 1982, INT J NUCL MED BIOL, V9, P83, DOI 10.1016/0047-0740(82)90082-1
   ZURAVLEV BV, 1986, ATOM ENERG, V60, P337
   ZWEIT J, 1992, EUR J NUCL MED, V19, P418
   1990, OAK RIDGE NATL LAB R, P63
NR 229
TC 24
Z9 24
U1 3
U2 11
PU R OLDENBOURG VERLAG
PI MUNCHEN
PA LEKTORAT M/N, K BERBER-NERLINGER, POSTFACH 80 13 60, D-81613 MUNCHEN,
   GERMANY
SN 0033-8230
J9 RADIOCHIM ACTA
JI Radiochim. Acta
PY 1997
VL 77
IS 1-2
BP 103
EP 123
PG 21
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology
SC Chemistry; Nuclear Science & Technology
GA XQ718
UT WOS:A1997XQ71800015
DA 2018-10-19
ER

PT B
AU Schuppel, W
   Muller, R
   Ulbrich, C
   Steinmetz, H
AF Schuppel, W
   Muller, R
   Ulbrich, C
   Steinmetz, H
BE Hafeli, U
   Schutt, W
   Teller, J
   Zborowski, M
TI Magnetic oxide particles prepared by glass crystallization - Properties
   and applications
SO SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS
LA English
DT Proceedings Paper
CT International Conference on Scientific and Clinical Applications of
   Magnetic Carriers
CY SEP 05-07, 1996
CL ROSTOCK, GERMANY
AB Glass crystallization was used and further developed for preparation of micro- and nano-crystalline particulate oxide media of different compositions and with different properties. These media may find applications in high-density magnetic recording devices, in novel ferrofluids, in microwave devices, in glass-ceramic materials, as initial materials for composites and for biomedical purposes. The properties of these media and the performance of this method are discussed as well as its limitations.
RP Schuppel, W (reprint author), INST PHYS HOCHTECHNOL,HELMHOLTZWEG 4,D-07743 JENA,GERMANY.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PLENUM PRESS DIV PLENUM PUBLISHING CORP
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013
BN 0-306-45687-7
PY 1997
BP 109
EP 115
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Pharmacology & Pharmacy
GA BJ32T
UT WOS:A1997BJ32T00008
DA 2018-10-19
ER

PT B
AU Tabrizian, M
   Lerouge, S
   Debrie, A
   Yahia, L
AF Tabrizian, M
   Lerouge, S
   Debrie, A
   Yahia, L
BE Claus, RO
TI New sterilization technologies alternative to ethylene oxide
SO SMART SENSING, PROCESSING, AND INSTRUMENTATION - SMART STRUCTURES AND
   MATERIALS 1997
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Smart Sensing, Processing, and Instrumentation - Smart
   Structures and Materials 1997
CY MAR 03-05, 1997
CL SAN DIEGO, CA
SP Soc Photo Opt Instrumentat Engineers, Soc Exptl Mech Inc, Amer Soc Mech Engineers, USAF Wright Lab, Def Adv Res Projects Agcy, Amer Inst Chem Engineers, Amer Phys Soc, Div Mat Phys, Ceram Soc Japan, USA Res Lab, Intelligent Mat Forum, Japan
DE sterilization; biomedical devices; polymer; surface modification; gas
   plasma; ethylene oxide; photoelectron spectroscopy; oxidation
AB Sterilization of biomedical devices may induce bulk and surface modification, responsible for the decrease or loss of their biofunctionality. Pure ethylene oxide (EO) at low temperature and new alternative techniques such as cold gas plasma sterilization have been developed for heat-sensitive polymers. There is a lack of the knowledge concerning their safety in terms of materials damage and consequences on the biofunctionality of sterilized devices. The objective of our work consists in studying bulk and surface changes in biomedical devices induced by these two sterilization techniques. Samples from PVC, Polyurethane, Polyacrylate and Polyethylene-based medical devices are subjected to 1, 5, and 10 sterilization cycles try Steri-Vac-3M (pure EO), Sterrad-100(R), J & J (gas plasma+H2O2), and studied by X-rays photoelectron spectroscopy (XPS). Preliminary results show an increasing in Oxygen/Carbon ratio by a factor of 1.3 to 4.4 between the first and tenth cycle indicating the surface oxidation by gas plasma sterilization processes. Some changes in C-C chemical bounding are associated with EO sterilization.
RP Tabrizian, M (reprint author), ECOLE POLYTECH,BIOMECH & BIOMAT RES GRP,STN DOWNTOWN,POB 6079,MONTREAL,PQ H3C 3A7,CANADA.
NR 0
TC 1
Z9 1
U1 0
U2 2
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2455-2
J9 P SOC PHOTO-OPT INS
PY 1997
VL 3042
BP 45
EP 51
DI 10.1117/12.275767
PG 7
WC Engineering, Mechanical; Instruments & Instrumentation; Materials
   Science, Characterization & Testing; Optics
SC Engineering; Instruments & Instrumentation; Materials Science; Optics
GA BJ06W
UT WOS:A1997BJ06W00006
DA 2018-10-19
ER

PT S
AU Deuser, MS
   Vellinger, JC
   Weber, JT
AF Deuser, MS
   Vellinger, JC
   Weber, JT
BE ElGenk, MS
TI Advanced flight hardware for organic separations
SO SPACE TECHNOLOGY AND APPLICATIONS INTERNATIONAL FORUM, PTS 1-3: 1ST
   CONFERENCE ON FUTURE SCIENCE & EARTH SCIENCE MISSIONS; 1ST CONFERENCE ON
   SYNERGISTIC POWER & PROPULSION SYSTEMS TECHNOLOGY; 1ST CONFERENCE ON
   APPLICATIONS OF THERMOPHYSICS IN MICROGRAVITY; 2ND CONFERENCE ON
   COMMERCIAL DEVELOPMENT OF SPACE; - 2ND CONFERENCE ON NEXT GENERATION
   LAUNCH SYSTEMS; 14TH SYMPOSIUM ON SPACE NUCLEAR POWER AND PROPULSION
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT Space Technology and Applications International Forum (STAIF-97)
CY JAN 26-30, 1997
CL ALBUQUERQUE, NM
SP Def Special Weapons Agcy, NASA, UN DOE, USAF
AB Aqueous Two-Phase Partitioning (ATPP) is a unique separation technique which allows purification and classification of biological materials. SHOT has employed the ATPP process in separation equipment developed for both space and ground applications. Initial equipment development and research focused on the ORganic SEParation (ORSEP) space flight experiments that were performed on suborbital rockets and the shuffle. ADvanced SEParations (ADSEP) technology was developed as the next generation of ORSEP equipment through a NASA Small Business Innovation Research (SBIR) contract. Under the SBIR contract, a marketing study was conducted, indicating a growing commercial market exists among biotechnology firms for ADSEP equipment and associated flight research and development services. SHOT is preparing to begin manufacturing and marketing laboratory versions of the ADSEP hardware for the ground-based market. In addition, through a self-financed SBIR Phase III effort, SHOT fabricated and integrated the ADSEP flight hardware for a commercially-driven flight experiment as the initial step in marketing space processing services. The ADSEP ground-based and microgravity research is expected to play a vital role in developing important new biomedical and pharmaceutical products.
RP Deuser, MS (reprint author), SHOT INC,5605 FEATHERENGILL RD,FLOYDS KNOBS,IN 47119, USA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AIP PRESS
PI WOODBURY
PA AMERICAN INSTITUTE OF PHYSICS 500 SUNNYSIDE BOULEVARD, WOODBURY, NY
   11797-2999
SN 0094-243X
BN 1-56396-679-4
J9 AIP CONF PROC
PY 1997
IS 387
BP 785
EP 790
DI 10.1063/1.52081
PG 6
WC Engineering, Aerospace; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA BH56D
UT WOS:A1997BH56D00121
DA 2018-10-19
ER

PT S
AU Samson, J
   Peterson, L
   Harmon, L
   Conrad, D
   Clark, K
AF Samson, J
   Peterson, L
   Harmon, L
   Conrad, D
   Clark, K
BE ElGenk, MS
TI The Remote Scientist
SO SPACE TECHNOLOGY AND APPLICATIONS INTERNATIONAL FORUM, PTS 1-3: 1ST
   CONFERENCE ON FUTURE SCIENCE & EARTH SCIENCE MISSIONS; 1ST CONFERENCE ON
   SYNERGISTIC POWER & PROPULSION SYSTEMS TECHNOLOGY; 1ST CONFERENCE ON
   APPLICATIONS OF THERMOPHYSICS IN MICROGRAVITY; 2ND CONFERENCE ON
   COMMERCIAL DEVELOPMENT OF SPACE; - 2ND CONFERENCE ON NEXT GENERATION
   LAUNCH SYSTEMS; 14TH SYMPOSIUM ON SPACE NUCLEAR POWER AND PROPULSION
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT Space Technology and Applications International Forum (STAIF-97)
CY JAN 26-30, 1997
CL ALBUQUERQUE, NM
SP Def Special Weapons Agcy, NASA, UN DOE, USAF
AB Observation and interaction are fundamental aspects of empirical scientific research. While individual requirements for observation and interaction vary across disciplines, there are important common elements. These ''common elements'' are the basis of the $15 billion dollar laboratory automation industry. The United States presently leads the world in this industry, providing products for sample manipulation, sensing (e.g. microscopic and macroscopic imaging devices), data analysis (e.g. image processing, 3D modeling, exploratory data analysis), and human-computer interfaces (e.g. computer graphics, visualization).
   This paper outlines the preliminary design of a unique and innovative system for conducting experiments at a distance, the ''Remote Scientist''. The Remote Scientist extends laboratory automation capability to the microgravity environment. While the Remote Scientist conceptually encompasses a broad spectrum of elements and functionalities, the development approach taken is to:
   establish a baseline capability that is both flexible and versatile incrementally augment the baseline with additional functionalities over time.
   The baseline capability that we have identified as having the most significant impact across multiple research disciplines is the ability to observe on-going experiments during exposure to the microgravity environment. This capability is achievable with technology available today and, additionally, will be able to take advantage of the rapid advances in the underlying technologies that are taking place in the commercial sector.
   The Remote Scientist will support a wide range of experiments through customizable components for: data collection (observation and measurement) manipulation (automated and semi-automated experiment control) investigator interaction (communication between experiment and researcher independent of location)
   By designing for multiple levels of automation, from fully automatic action through remote control and telemanipulation, investigator interaction can be incorporated into experiments at any desired level. The Remote Scientist is designed to offer a full range of digital imaging on both microscopic and macroscopic scales. The system will support spatial and spectral analysis for on-board extraction of important features, thus reducing bandwidth requirements for communications to ground-based investigators. Confocal imaging (optical sectioning), hyperspectral imaging, interferometry, laser scattering, and fluorescence can also be considered as value-added instrumentation within the proposed framework without significant redesign.
   The system is designed to operate within the constraints of a microgravity environment while offering innovative functionality to enhance ground-based experiments as well. The Remote Scientist is initially focused on applications currently being pursued in microgravity such as tissue culture, protein crystal growth and zeolite crystal growth. The real-world requirements of these biomedical and materials applications provide important insight in establishing design-criteria for the system. However, the longer-term applications are envisioned to be much broader.
RP Samson, J (reprint author), NASA,SPACE APPLICAT TECHNOL CTR,ERIM,POB 134001,ANN ARBOR,MI 48113, USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AIP PRESS
PI WOODBURY
PA AMERICAN INSTITUTE OF PHYSICS 500 SUNNYSIDE BOULEVARD, WOODBURY, NY
   11797-2999
SN 0094-243X
BN 1-56396-679-4
J9 AIP CONF PROC
PY 1997
IS 387
BP 877
EP 879
DI 10.1063/1.52094
PG 3
WC Engineering, Aerospace; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA BH56D
UT WOS:A1997BH56D00134
DA 2018-10-19
ER

PT B
AU Cheang, P
   Khor, KA
AF Cheang, P
   Khor, KA
BE Sudarshan, TS
   Khor, KA
   Jeandin, M
TI Properties and microstructure of plasma sprayed hydroxyapatite coatings
   produced with different powder feedstocks
SO SURFACE MODIFICATION TECHNOLOGIES X
LA English
DT Proceedings Paper
CT 10th International Conference on Surface Modification Technologies
CY SEP 02-04, 1996
CL SINGAPORE, SINGAPORE
SP Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore, Inst Mat, Mat Minerals & Meta Soc, US, ASM Int, Natl Sci Fdn, US
AB Hydroxyapatite (HA) is a bioactive material with Ca to P ratio that is comparable to that of natural bone. This similarity encourages rapid bone growth and bonding between bone tissue and the implant surface. Plasma spraying is an efficient coating method of depositing HA onto biomedical implants. However, the biocompatibility of HA changes after plasma spraying. This paper reports the preparation and characterisation of HA coatings using different feedstocks such as agglomerated calcined HA (CHA) and dense flame spheroidised HA (SHA). The results indicate that the state of the starting powder in terms of geometry, shape and structure can produce efficacious effects on the coating characteristics. Both calcined HA and flame spheroidised HA powders were plasma sprayed onto metallic substrates and stubs. Coatings generated from spheroidised HA (SHA) powders have unique surface and microstructure characteristics while the coatings produced with CHA are porous and contain unmelted particles, SEM observation of the coating surface reveals well-formed splats that spread and flatten to a disc configuration without disintegration. This reflects adequate melting of the HA in the plasma with good deposition consistency. The surface topography is generally flat with considerable overlapping of subsequent spreading droplets. Porosity in the form of macropores is substantially reduced compared to CHA coatings. The cross-section microstructure reveals a highly dense coating comprising of randomly stacked lamellae. The tensile adhesion test (TAT) recorded the highest cohesive strength in the flame spheroidised HA coating. This suggests that having a structurally stable powder that is both dense and spherical promotes mechanically strong and coherent coatings.
RP Cheang, P (reprint author), NANYANG TECHNOL UNIV,SCH APPL SCI,NANYANG AVE,SINGAPORE 639798,SINGAPORE.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASHGATE PUBLISHING LTD
PI ALDERSHOT
PA GOWER HOUSE, CROFT ROAD, ALDERSHOT, ENGLAND
BN 1-86125-022-3
PY 1997
BP 747
EP 758
PG 12
WC Engineering, Mechanical; Materials Science, Coatings & Films
SC Engineering; Materials Science
GA BJ63U
UT WOS:A1997BJ63U00062
DA 2018-10-19
ER

PT B
AU Wang, Y
   Khor, KA
   Cheang, P
AF Wang, Y
   Khor, KA
   Cheang, P
BE Sudarshan, TS
   Khor, KA
   Jeandin, M
TI Thermal spraying of functionally graded bioceramic coatings
SO SURFACE MODIFICATION TECHNOLOGIES X
LA English
DT Proceedings Paper
CT 10th International Conference on Surface Modification Technologies
CY SEP 02-04, 1996
CL SINGAPORE, SINGAPORE
SP Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore, Inst Mat, Mat Minerals & Meta Soc, US, ASM Int, Natl Sci Fdn, US
AB Biomedical requirements in a prosthesis are often complex and diverse in nature. Biomaterials for implants have to display a wide range of adaptability to suit the various stages of the bio-integration of the foreign material into the human body. Often a combination of materials is needed. This paper reports the preparation of a functionally graded bioceramic coating composed of essentially calcium phosphate compounds. The coating is graded in accordance to adhesive strength and bioresorbability. The bond coat On the metal stub is deposited with a particle range of the hydroxyapatite materials that will provide a high adhesive strength and bioactivity but have poor bioresorption properties. The top coat however is composed of mainly alpha-tricalcium phosphate that is highly bioresorbable. This arrangement has the propensity of allowing accelerated bio-integration of the coating by the body tissues as the top layer is rapidly resorbed, leaving the more bioactive intermediate layer to facilitate the much needed bioactive properties for proper osteoconduction. The processing steps and problems will be highlighted in this paper as well as the results of post-spray treatment with hot isostatic pressing.
RP Wang, Y (reprint author), NANYANG TECHNOL UNIV,SCH MECH & PROD ENGN,SINGAPORE 639798,SINGAPORE.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ASHGATE PUBLISHING LTD
PI ALDERSHOT
PA GOWER HOUSE, CROFT ROAD, ALDERSHOT, ENGLAND
BN 1-86125-022-3
PY 1997
BP 925
EP 933
PG 9
WC Engineering, Mechanical; Materials Science, Coatings & Films
SC Engineering; Materials Science
GA BJ63U
UT WOS:A1997BJ63U00079
DA 2018-10-19
ER

PT B
AU Lotters, JC
   Olthuis, W
   Veltink, PH
   Bergveld, P
AF Lotters, JC
   Olthuis, W
   Veltink, PH
   Bergveld, P
GP IEEE
TI Characterisation of a highly symmetrical miniature capacitive triaxial
   accelerometer
SO TRANSDUCERS 97 - 1997 INTERNATIONAL CONFERENCE ON SOLID-STATE SENSORS
   AND ACTUATORS, DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 1997 International Conference on Solid-State Sensors and Actuators
CY JUN 16-19, 1997
CL CHICAGO, IL
SP IEEE Electron Devices Soc
DE triaxial accelerometer; capacitive sensor; three-dimensional structure
AB A highly symmetrical cubic capacitive triaxial accelerometer for biomedical applications has been designed, realised and tested. The sensors are available in two outer dimensions, namely 2x2x2 and 5x5x5 mm(3). The devices are mounted on a standard IC package for easy testing. Features of the sensor are a highly symmetrical cubic structure, capacitive coupling of the high frequency input voltage to the seismic mass and the use of the polymers polydimethylsiloxane (PDMS:) as spring material between the capacitor plates and the mass and polyimide (PI) as flexible interconnection layer between the capacitor plates. The sensor structure and its basic operating principle, its mathematical mass-spring-damper model and the necessary cleanroom technology are described. The measurement results show a sensitivity of similar to 0.15 V/(m/s(2)) with a corresponding resolution of 0.01 m/s(2), an off-axis sensitivity of < 5 %, a good linearity in the output voltage for accelerations up to at least 50 m/s(2) and a bandwidth of DC - 500 Hz.
RP Lotters, JC (reprint author), UNIV TWENTE,MESA RES INST,POB 217,NL-7500 AE ENSCHEDE,NETHERLANDS.
RI Veltink, Peter/L-3738-2016
OI Veltink, Peter/0000-0002-1796-9999
NR 0
TC 3
Z9 3
U1 0
U2 0
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
BN 0-7803-3829-4
PY 1997
BP 1177
EP 1180
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BJ35B
UT WOS:A1997BJ35B00288
DA 2018-10-19
ER

PT S
AU Moscato, U
   De Belvis, AG
   Romano-Spica, V
AF Moscato, U
   De Belvis, AG
   Romano-Spica, V
BE Manzo, L
   Descotes, J
   Hoskins, J
TI Indoor pollution by aromatic hydrocarbons: Results of a survey in the
   histopathology laboratories of an Italian hospital
SO VOLATILE ORGANIC COMPOUNDS IN THE ENVIRONMENT - RISK ASSESSMET AND
   NEUROTOXICITY
SE ADVANCES IN OCCUPATIONAL MEDICINE & REHABILITATION
LA English
DT Proceedings Paper
CT International Conference on Volatile Organic Compounds
CY OCT 05-07, 1997
CL SALVATORE MAUGERI FDN MED CTR, PAVIA, ITALY
SP Univ Pavia, Salvatore Maugeri Fdn, Int Soc Built Environm, Natl Res Council, Rome, AgipPetroli, BASF, CON TEC Engn, DANI, Draeger Italiana, FIAT Auto, FKV, Instrumentat Lab, IPSOA Editore Indicitalia, Perkin Elmer, Pollut Srl Clean Air Syst, San Air Ambiente, Tecnol Ind & Ambientali, Unione Petrolifera, Zambelli
HO SALVATORE MAUGERI FDN MED CTR
DE hospital; histopathology laboratories; aromatic hydrocarbons; gas
   chromatography; geostatistics
AB The purpose of this study was to evaluate indoor pollution by benzene, toluene and the xylene isomers (BTX) in the histopathology laboratories of a hospital using spatial data modelling techniques to identify. sources and distribution of air pollutants. Indoor-outdoor and personal sampling were performed in several laboratory environments using diffusive charcoal samplers (radial type). Analysis was carried out using capillary gas-chromatography and mass-spectrometry. All values of BTX were higher in indoor environments than outdoors. These results suggest indoor hospital sources of BTX, such as building materials, office equipment, radiography developers or, in particular, histological slide fixing procedures. We believe that geostatistical methods could he very helpful in the assessment and management of indoor pollution risk. The importance of such risk should not be overlooked as exposure to BTX, deriving from hospital biomedical activities, could involve people other than hospital staff (patients, relatives and hospital visitors).
C1 Catholic Univ, Inst Hyg, I-00168 Rome, Italy.
RP Moscato, U (reprint author), Catholic Univ, Inst Hyg, Largo F Vito 1, I-00168 Rome, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU FONDAZIONE SALVATORE MAUGERI EDIZIONI, PI-ME PRESS
PI PAVIA 27100
PA VIALE SARDEGNA 64, PAVIA 27100, ITALY
SN 1123-8364
BN 88-7963-085-7
J9 ADV OCCUP MED REHAB
PY 1997
VL 3
IS 3
BP 55
EP 68
PG 14
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Rehabilitation; Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Rehabilitation; Toxicology
GA BM07W
UT WOS:000077556200006
DA 2018-10-19
ER

PT J
AU Kobayashi, K
   Kamiya, S
   Enomoto, N
AF Kobayashi, K
   Kamiya, S
   Enomoto, N
TI Amylose-carrying styrene macromonomer and its homo- and copolymers:
   Synthesis via enzyme-catalyzed polymerization and complex formation with
   iodine
SO MACROMOLECULES
LA English
DT Article
ID DIMETHYL-SULFOXIDE; BEHAVIOR; MODEL
AB The objective of our research was to prepare novel conjugates between polysaccharides and vinyl polymers by applying enzymes as polymerization catalyst for polysaccharide synthesis. An approach was attained using amylose-substituted styrene macromonomers (vinylbenzyl amylose amide, VAA; the number-average degree of polymerization of amylose = 24 and 150) which were synthesized from maltopentaose-substituted styrene (VM5A) by phosphorylase-catalyzed polymerization of glucose 1-phosphate. Radical homo- and copolymerization of VAA gave an uncommon type of graft copolymers consisting of polystyrene and polyacrylamide backbones and amylose side chains of uniform length. Water-insoluble amylose was solubilized into water by incorporating VAA units into polyacrylamide main chains and also by hydroxypropylation of the amylose moieties of water-insoluble copolymers. Structural features of these graft copolymers were discussed on the basis of amylose-iodine complexation investigated by UV spectroscopy. Schematic structures of two different types of polystyrene-graft-amylose prepared via homopolymerization of VAA and via enzymatic elongation from poly(VM5A) were proposed. These amylose-carrying polyacrylamide and polystyrene prepared by applying enzyme-catalyzed polymerization are of interest as a new type of biomedical material and a well-defined model for conformational analysis.
C1 NAGOYA UNIV,SCH AGR SCI,NAGOYA,AICHI 46401,JAPAN.
   NAKANO VINEGAR CO LTD,HANDA,AICHI 475,JAPAN.
CR ANDRESZ H, 1978, MAKROMOL CHEM, V179, P301
   BANKS W, 1971, CARBOHYD RES, V17, P25, DOI 10.1016/S0008-6215(00)81539-6
   CESARO A, 1986, J PHYS CHEM-US, V90, P2787, DOI 10.1021/j100403a047
   DAVIS H, 1994, J POLYM SCI POL CHEM, V32, P2267, DOI 10.1002/pola.1994.080321208
   DORDICK JS, 1994, CHEMTECH, P33
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   Guilbot A., 1985, POLYSACCHARIDES, V3, P209
   HANDA T, 1981, BIOPOLYMERS, V20, P2051, DOI 10.1002/bip.1981.360201003
   ITO K, 1991, MACROMOLECULES, V24, P2348, DOI 10.1021/ma00009a035
   KAMOGAWA A, 1963, J BIOCH, V63, P361
   KOBAYASHI K, 1987, MACROMOLECULES, V20, P906, DOI 10.1021/ma00170a035
   KOBAYASHI K, 1994, J CARBOHYD CHEM, V13, P753, DOI 10.1080/07328309408011678
   Kobayashi Kazukiyo, 1994, P261
   LEE DS, 1982, CARBOHYD RES, V106, P1, DOI 10.1016/S0008-6215(00)80728-4
   MISCHNICK P, 1989, CARBOHYD RES, V192, P233, DOI 10.1016/0008-6215(89)85182-1
   NAKANISHI Y, 1993, MACROMOLECULES, V26, P4220, DOI 10.1021/ma00068a023
   PARFONDRY A, 1977, CARBOHYD RES, V57, P39, DOI 10.1016/S0008-6215(00)81918-7
   PATIL DR, 1991, BIOTECHNOL BIOENG, V37, P639, DOI 10.1002/bit.260370706
   PFANNEMULLER B, 1975, NATURWISSENSCHAFTEN, V62, P231, DOI 10.1007/BF00603168
   STJACQUES M, 1976, J AM CHEM SOC, V98, P4386, DOI 10.1021/ja00431a007
   TSUKAHARA Y, 1990, MACROMOLECULES, V23, P5201, DOI 10.1021/ma00227a006
   TSUKAHARA Y, 1989, MACROMOLECULES, V22, P1546, DOI 10.1021/ma00194a007
   VONBRAUNMUHL V, 1995, MACROMOLECULES, V28, P17
   WULFF G, 1992, MAKROMOL CHEM, V193, P1071
   YAJIMA H, 1987, CARBOHYD RES, V163, P155, DOI 10.1016/0008-6215(87)80179-9
   ZIEGAST G, 1987, CARBOHYD RES, V160, P185, DOI 10.1016/0008-6215(87)80311-7
NR 26
TC 65
Z9 65
U1 1
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD DEC 30
PY 1996
VL 29
IS 27
BP 8670
EP 8676
DI 10.1021/ma9603443
PG 7
WC Polymer Science
SC Polymer Science
GA WB741
UT WOS:A1996WB74100015
DA 2018-10-19
ER

PT J
AU Schiager, KJ
   McDougall, MM
   Christman, EA
   Party, E
   Ring, J
   Carlson, DE
   Warfield, CA
   Barkley, WE
AF Schiager, KJ
   McDougall, MM
   Christman, EA
   Party, E
   Ring, J
   Carlson, DE
   Warfield, CA
   Barkley, WE
TI Consensus radiation protection practices for academic research
   institutions
SO HEALTH PHYSICS
LA English
DT Article
DE radiation protection; monitoring, personnel; bioassay; safety standards
AB Under the auspices of the Howard Hughes Medical Institute, a set of consensus guidelines for Radiation Protection Practices has been developed for biomedical research using radioactive materials. The purposes of the guidelines are (1) to promote good radiation protection practices consistent with the needs of biomedical research, the ALARA principle, and regulatory requirements; (2) to establish common goals and consistent practices within radiation safety programs; and (3) to build a meaningful partnership between radiation safety professionals and the biomedical research community, These practices are intended to enhance radiation protection and the efficiency of the research staff, The consensus guidelines will lessen the variability in radiation safety practices that is evident among many academic research institutions and nib encourage better acceptance and regulatory compliance by users of radioactive materials in biomedical research.
C1 UNIV UTAH, SALT LAKE CITY, UT 84112 USA.
   UNIV CALIF SAN DIEGO, SAN DIEGO, CA 92093 USA.
   COLUMBIA UNIV HLTH SCI, NEW YORK, NY 10032 USA.
   ROCKEFELLER UNIV, NEW YORK, NY 10021 USA.
   HARVARD UNIV, CAMBRIDGE, MA 02138 USA.
   UNIV TEXAS, SW MED CTR, DALLAS, TX 75235 USA.
   HOWARD HUGHES MED INST, CHEVY CHASE, MD 20815 USA.
CR *INT COMM RAD PROT, 1979, ANN ICRP, V2, P1
NR 1
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD DEC
PY 1996
VL 71
IS 6
BP 960
EP 965
DI 10.1097/00004032-199612000-00015
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA VW160
UT WOS:A1996VW16000020
PM 8919082
DA 2018-10-19
ER

PT J
AU Zaichik, VE
   Zaichik, SV
AF Zaichik, VE
   Zaichik, SV
TI Instrumental effect on the contamination of biomedical samples in the
   course of sampling
SO JOURNAL OF ANALYTICAL CHEMISTRY
LA English
DT Article
ID NEUTRON-ACTIVATION ANALYSIS; BIOLOGICAL-MATERIALS; TISSUES; ELEMENTS
AB The effect of surgical instruments on the contamination of human soft tissues with trace elements in the course of sampling was examined. Samples were taken with the use of a common scalpel and a knife of titanium from a thyroid gland of a male patient who died in an automobile accident. In these samples, Ag, Co, Cr, Fe, Hg, Rb, Sb, Se, and Zn were determined by instrumental neutron activation analysis. The average concentrations of elements in the samples taken with the scalpel were higher than those in the samples taken with the knife by a factor of 1.4-2.5, and this factor was 48 for chromium. Statistically reliable differences were found only for Cr and Co because of high variances of concentrations caused by nonuniformly distributed trace elements in the bulk of the thyroid gland. Recommendations on the choice of sampling instruments in biomedical examinations were given.
C1 RUSSIAN STATE MED UNIV,MOSCOW 117437,RUSSIA.
RP Zaichik, VE (reprint author), RUSSIAN ACAD MED SCI,MED RADIOL RES INST,UL KOROLEVA 4,OBNINSK 249020,KALUZHSKAYA OBL,RUSSIA.
CR BYRNE AR, 1978, SCI TOTAL ENVIRON, V10, P17, DOI 10.1016/0048-9697(78)90046-3
   CORNELIS R, 1986, MODERN TRENDS ACTIVA, V7, P93
   GILLS TE, 1977, J RADIOANAL CHEM, V39, P285, DOI 10.1007/BF02517234
   HAMILTON EI, 1994, SCI TOTAL ENVIRON, V158, P165, DOI 10.1016/0048-9697(94)04317-G
   Hamilton EI, 1973, SCIENCE TOTAL ENVIRO, V1, P341, DOI DOI 10.1016/0048-9697(73)90024-7
   HEYDORN K, 1984, ELEMENTS HLTH DIS, P42
   HEYDORN K, 1984, NEUTRON ACTIVATION A, V2
   HISLOP JS, 1973, ANALYST, V98, P694, DOI 10.1039/an9739800694
   IYENGAR GV, 1978, ELEMENTAL COMPOSITIO
   IYENGAR GV, 1988, QUANTITATIVE TRACE A, P401
   IYENGAR GV, 1984, DOC323 IAEA TEC, P83
   KABATOV YF, 1977, MEDITSINSKII INSTRUM
   KORELO AM, 1993, D1493325 OIYAI, P326
   MALETSKOS CJ, 1970, TRACE SUBSTANCES ENV, V4, P367
   MOSULISHVILI LM, 1975, J RADIOANAL CHEM, V26, P175, DOI 10.1007/BF02516523
   Parr R., 1980, 2 IAEA
   PARR RM, 1977, J RADIOANAL CHEM, V39, P421, DOI 10.1007/BF02517247
   PIETRA R, 1985, J RADIOAN NUCL CH AR, V92, P247, DOI 10.1007/BF02219754
   PIETRA R, 1990, ANALYST, V115, P1025, DOI 10.1039/an9901501025
   PLANTIN LO, 1972, NUCLEAR ACTIVATION T, P73
   SATEL EF, 1964, SPRAVOCHNIK MASHINOS, V6
   SPEECKE A, 1975, NBS SPECIAL PUBL, V422
   VERSIECK J, 1973, CLIN CHEM, V19, P472
   VERSIECK J, 1982, TALANTA, V29, P973, DOI 10.1016/0039-9140(82)80238-5
   VERSIECK J, 1972, NUCLEAR ACTIVATION T, P39
   Ward N. I., 1993, Trace elements in man and animals - TEMA 8: Proceedings of the Eighth International Symposium on Trace Elements in Man and Animals., P108
   Zaichick V, 1978, LAB DELO, V2, P109
NR 27
TC 6
Z9 8
U1 0
U2 0
PU MAIK NAUKA/INTERPERIODICA
PI NEW YORK
PA C/O PLENUM/CONSULTANTS BUREAU 233 SPRING ST, NEW YORK, NY 10013
SN 1061-9348
J9 J ANAL CHEM+
JI J. Anal. Chem.
PD DEC
PY 1996
VL 51
IS 12
BP 1200
EP 1205
PG 6
WC Chemistry, Analytical
SC Chemistry
GA VX862
UT WOS:A1996VX86200015
DA 2018-10-19
ER

PT J
AU Schubert, MA
   Wiggins, MJ
   DeFife, KM
   Hiltner, A
   Anderson, JM
AF Schubert, MA
   Wiggins, MJ
   DeFife, KM
   Hiltner, A
   Anderson, JM
TI Vitamin E as an antioxidant for poly(etherurethane urea): In vivo
   studies
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID POLYURETHANE ELASTOMERS; GIANT-CELLS; INVIVO; BIOCOMPATIBILITY;
   DEGRADATION; INVITRO; FORM
AB Poly(etherurethane) elastomers are useful materials in medical devices because of their mechanical properties and biocompatibility. However, it is necessary to stabilize these elastomers against the oxidation of their ether soft segments. Synthetic antioxidants such as Santowhite(R) and Irganox(R) are often satisfactory; however, particularly for biomedical applications, it was of interest to test the natural antioxidant vitamin E in poly(etherurethane urea) (PEUU) elastomers in vivo. The alpha-tocopherol form of vitamin E was added to PEUU at 5% by weight. Biaxially strained PEUU specimens with and without vitamin E were tested in vivo in the cage implant system. The influence of vitamin E on PEUU biostability was analyzed by attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy and scanning electron microscopic (SEM) characterization of the PEUU surface. ATR-FTIR results showed that vitamin E prevented chemical degradation of the PEUU surface up to 5 weeks implantation, and at 10 weeks 82% of the ether remained. In contrast, without an antioxidant, only 18% of the ether remained after 10 weeks. No surface pitting or cracking was observed by SEM on PEUU with vitamin E; PEUU without antioxidant ruptured owing to extensive pitting and cracking. It was concluded that the antioxidant properties of vitamin E prevented oxidation of strained PEUU elastomers in vivo. The influence of vitamin E on PEUU biocompatibility was characterized by exudate leukocyte counts, density of leukocytes adherent to the PEUU, and morphology of adherent leukocytes. These results indicated decreased leukocyte counts in the exudate and less active adherent cells on the PEUU with vitamin E compared to PEUU without antioxidant. A proposed cell-polymer feedback system demonstrates how vitamin E improves both biostability and biocompatibility of PEUU elastomers in vivo. (C) 1996 John Wiley & Sons, Inc.
C1 CASE WESTERN RESERVE UNIV,DEPT MACROMOL SCI,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106.
FU NHLBI NIH HHS [HL-25239, HL-33849]
CR ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Andrade JD, 1985, SURFACE INTERFACIAL, V2, P1
   BURTON GW, 1985, J AM CHEM SOC, V107, P7053, DOI 10.1021/ja00310a049
   GREEN J, 1965, BIOCH QUINONES, P261
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   HEIPLE JM, 1990, CELL MOTIL CYTOSKEL, V15, P260, DOI 10.1002/cm.970150408
   *INF INC, 1973, GRAS FOOD INGR TOC, P237
   KAMBIC HE, 1986, CHEM ENG NEWS   0414, P31
   Lelah M. D., 1986, POLYURETHANES MED
   LIEBLER DC, 1994, METHOD ENZYMOL, V234, P310
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   MEYDANI M, 1995, LANCET, V345, P170, DOI 10.1016/S0140-6736(95)90172-8
   MOUDJOU M, 1989, J CELL SCI, V94, P237
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Packer Lester, 1993, P179
   PARINS DJ, 1981, IN VIVO DEGRADATION
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
   ZHAO QH, 1992, J BIOMED MATER RES, V26, P1019, DOI 10.1002/jbm.820260805
NR 23
TC 38
Z9 38
U1 1
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC
PY 1996
VL 32
IS 4
BP 493
EP 504
DI 10.1002/(SICI)1097-4636(199612)32:4<493::AID-JBM1>3.3.CO;2-H
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA VV829
UT WOS:A1996VV82900001
PM 8953138
DA 2018-10-19
ER

PT J
AU Nickell, D
   Herzog, HA
AF Nickell, D
   Herzog, HA
TI Ethical ideology and moral persuasion: Personal moral philosophy,
   gender, and judgments of pro- and anti-animal research propaganda
SO SOCIETY & ANIMALS
LA English
DT Article
ID ATTITUDES; KNOWLEDGE
AB We examined the relationship between personal moral philosophy, gender, and judgments of the effectiveness of materials designed by advocacy groups to sway public opinion about biomedical research using nonhuman animals. Twenty-six male and 74 female undergraduates evaluated 16 advertisements or brochures developed by groups which either supported or opposed animal research. The subjects also completed the Ethics Position Questionnaire (EPQ) and were offered the opportunity to sign postcards urging their congressperson to either support or eliminate federal funding of animal research. Females perceived the anti-animal research materials to be more effective than did the males, a difference that was not found in the case of the pro-animal research materials. The idealism dimension of the EPQ and gender accounted for a significant portion of the variation in judgments of the effectiveness of the anti-animal research materials but not the pro-animal research materials. The pattern of postcard signing was predicted by the subjects' evaluations of the stimulus materials but not gender or the EPQ variables.
C1 WESTERN CAROLINA UNIV, DEPT PSYCHOL, CULLOWHEE, NC 28723 USA.
CR BALZAR J, 1993, LOS ANGELES TIM 1225, P30
   BALZAR J, 1993, LOS ANGELES TIM 1225, P1
   BALZAR J, 1993, LOS ANGELES TIM 1225, P31
   Bowd A. D., 1989, ANTHROZOOS, V3, P20
   Broida John, 1993, SOC ANIM, V1, P129, DOI DOI 10.1163/156853093X00037
   DRISCOLL JW, 1992, ANTHROZOOS, V5, P32, DOI 10.2752/089279392787011575
   EAGLY AH, 1993, PSYCHOL ATTITUDES
   FORSYTH DR, 1984, J PERS SOC PSYCHOL, V46, P1365, DOI 10.1037/0022-3514.46.6.1365
   FORSYTH DR, 1980, J PERS SOC PSYCHOL, V39, P175, DOI 10.1037//0022-3514.39.1.175
   FORSYTH DR, 1982, J SOC PSYCHOL, V117, P53, DOI 10.1080/00224545.1982.9713406
   FORSYTH DR, 1988, J PSYCHOL, V122, P243, DOI 10.1080/00223980.1988.9915511
   GALLUP GG, 1988, AM PSYCHOL, V43, P474, DOI 10.1037/0003-066X.43.6.474
   Galvin Shelley L, 1992, Ethics Behav, V2, P263
   Galvin Shelley L, 1992, Ethics Behav, V2, P141, DOI 10.1207/s15327019eb0203_1
   GALVIN SL, 1994, M SE PSYCH ASS NEW O
   HERZOG HA, 1993, J SOC ISSUES, V49, P103, DOI 10.1111/j.1540-4560.1993.tb00911.x
   HERZOG HA, IN PRESS RESPONSIBLE
   HERZOG HA, IN PRESS ANTHROPOMOR
   Herzog Jr H. A., 1990, ANTHROZOOS, V4, P184, DOI DOI 10.2752/089279391787057170
   JASEPR JM, 1992, ANIMAL RIGHTS CRUSAD
   KELLERT SR, 1987, WILDLIFE SOC B, V15, P363
   KELLERT SR, 1980, INT J STUD ANIM PROB, V1, P87
   PAUL ES, 1993, ANIM WELFARE, V2, P321
   PETERSON C, 1984, PSYCHOL REV, V91, P347, DOI 10.1037//0033-295X.91.3.347
   PETERSON C, 1982, COGNITIVE THER RES, V6, P287, DOI 10.1007/BF01173577
   PLOUS S, 1991, PSYCHOL SCI, V2, P194, DOI 10.1111/j.1467-9280.1991.tb00131.x
   SCHLENKER BR, 1977, J EXP SOC PSYCHOL, V13, P369, DOI 10.1016/0022-1031(77)90006-3
   SHAPIRO K, 1994, SOC ANIM, V2, P145, DOI 10.1163/156853094X00153
   Singer P., 1975, ANIMAL LIBERATION
   SINGH B, 1989, B PSYCHONOMIC SOC, V27, P160, DOI 10.3758/BF03329928
   SPERLING S, 1988, ANIMAL LIBERATORS RE
   WUENSCH KL, 1992, M AN BEH SOC KINGST
NR 32
TC 10
Z9 11
U1 0
U2 10
PU BRILL ACADEMIC PUBLISHERS
PI LEIDEN
PA PLANTIJNSTRAAT 2, P O BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 1063-1119
EI 1568-5306
J9 SOC ANIM
JI Soc. Anim.
PD WIN
PY 1996
VL 4
IS 1
BP 53
EP 64
DI 10.1163/156853096X00043
PG 12
WC Sociology; Veterinary Sciences
SC Sociology; Veterinary Sciences
GA UC991
UT WOS:A1996UC99100004
PM 11654529
DA 2018-10-19
ER

PT J
AU Bernatchez, SF
   Parks, PJ
   Gibbons, DF
AF Bernatchez, SF
   Parks, PJ
   Gibbons, DF
TI Interaction of macrophages with fibrous materials in vitro
SO BIOMATERIALS
LA English
DT Article
DE fibres; macrophages; adhesion; cytokines
ID RAT ALVEOLAR MACROPHAGES; BIOMEDICAL POLYMERS; INTERLEUKIN-1 GENERATION;
   CYTOKINE PRODUCTION; SYNTHETIC-FIBERS; COLLAGEN SPONGE; TISSUE-RESPONSE;
   ASBESTOS FIBERS; HUMAN-MONOCYTES; POROUS POLYMER
AB Fibrous materials have the potential of being used for tissue scaffolding. The interaction of macrophages with fibres of various compositions and sizes was observed in vitro. The following materials were tested: individual gold fibres; woven fibres of polyester and nylon; non-woven fibres of polybutylene/polypropylene 80:20 and polyester. All fibres had diameters between 2 and 40 mu m. At the end of the 24 h incubation time, culture media were retrieved for the assay of tumour necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6), two cytokines secreted by activated macrophages. Fibre samples were processed for scanning electron microscopy (SEM), or for immunofluorescence labelling of the MAC-1 and ICAM-1 cell surface markers. Confocal microscopy was used for the latter, which was performed with the woven and non-woven samples. None of the fibre samples induced significant amounts of TNF-alpha or IL-6 secretion in the culture medium, suggesting that the cells did not activate this pathway. SEM on individual gold fibres showed that the fibre diameter had an effect on the morphology of the cells, namely on their extent of spreading. Larger fibres had a higher number of cells, which tended to cluster together without spreading extensively. When comparing woven and non-woven fibres, SEM showed that cells spread extensively on the woven fibres, whereas they tended to maintain their spherical shape on the non-woven fibres. Confocal microscopy demonstrated a difference between materials in the number of MAC-1 and ICAM-1 positive cells. These results demonstrate that a combination of morphological, immune and biochemical markers can be used to distinguish the response of elicited macrophages to various materials. The cells appeared to be only moderately activated on all materials tested, with changes in their morphology but without increased secretion of cytokines. The measured responses imply interactions between nominal fibre composition and fibre diameter. (C) 1996 Elsevier Science Limited
C1 UNIV MINNESOTA, CTR INTERFACIAL ENGN, SHEPHERD LABS 187, MINNEAPOLIS, MN 55455 USA.
   3M CO, LIFE SCI SECTOR LAB, ST PAUL, MN 55144 USA.
CR ADAMSON IYR, 1991, LAB INVEST, V64, P339
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1988, ASAIO, V11, P101
   ANDESON JM, 1993, CARDIOVASC PATHOL, V4, pS33
   BARBUL A, 1990, CLIN PLAST SURG, V17, P433
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   BERTHOD F, 1993, BIOMATERIALS, V14, P749, DOI 10.1016/0142-9612(93)90039-5
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BRANDWOOD A, 1992, BIOMATERIALS, V13, P646, DOI 10.1016/0142-9612(92)90035-M
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   CLARK RAF, 1988, MOL CELLULAR BIOL WO, P1
   CLARKE IC, 1992, AM SOC TEST MATER, V1144, P7, DOI 10.1520/STP14848S
   DARVILLE T, 1992, IMMUNOL INVEST, V21, P539, DOI 10.3109/08820139209069389
   Doillon C J, 1988, J Biomater Appl, V2, P562
   DOILLON CJ, 1987, BIOMATERIALS, V8, P195, DOI 10.1016/0142-9612(87)90063-9
   DUBOIS CM, 1989, AM REV RESPIR DIS, V139, P1257, DOI 10.1164/ajrccm/139.5.1257
   EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4
   FORNASIER V, 1994, SCI REG INT S MONTR, P53
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Gibbons D. F., 1994, Clinical Materials, V15, P37, DOI 10.1016/0267-6605(94)90007-8
   GIBBONS DF, 1994, STUD POLYM SCI, V12, P470
   GIBSON SJ, 1995, J INTERF CYTOK RES, V15, P537, DOI 10.1089/jir.1995.15.537
   GOODGLICK LA, 1990, CANCER RES, V50, P5153
   JANSEN JA, 1994, J MATER SCI-MATER M, V5, P284, DOI 10.1007/BF00122398
   JAURAND MC, 1987, J NATL CANCER I, V79, P797
   LEAKE ES, 1975, J RETICULOENDOTH SOC, V17, P370
   LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1
   LEENEN PJM, 1993, BLOOD CELL BIOCH, V5, P29
   LUOTO K, 1994, ENVIRON RES, V66, P198, DOI 10.1006/enrs.1994.1055
   MAROIS Y, 1993, BIOMATERIALS, V14, P255, DOI 10.1016/0142-9612(93)90115-I
   MCPHERSON GK, 1985, CLIN ORTHOP RELAT R, P186
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   OXLEY HR, 1993, BIOMATERIALS, V14, P1064, DOI 10.1016/0142-9612(93)90207-I
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   RASP FL, 1979, J RETICULOENDOTH SOC, V25, P101
   Robinson D, 1993, Agents Actions Suppl, V39, P231
   RUTHERFORD MS, 1993, J LEUKOCYTE BIOL, V53, P602
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SHIEH SJ, 1990, J BIOMED MATER RES, V24, P789, DOI 10.1002/jbm.820240702
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   THORENS B, 1987, CELL, V48, P671, DOI 10.1016/0092-8674(87)90245-5
   TRINKAUSRANDALL V, 1991, INVEST OPHTH VIS SCI, V32, P3245
   TRINKAUSRANDALL V, 1990, INVEST OPHTH VIS SCI, V31, P1321
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   VONSCHROEDER HP, 1991, J BIOMED MATER RES, V25, P329, DOI 10.1002/jbm.820250305
   WALD HL, 1993, BIOMATERIALS, V14, P270, DOI 10.1016/0142-9612(93)90117-K
   WYNN TA, 1992, CELL IMMUNOL, V140, P184, DOI 10.1016/0008-8749(92)90186-S
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 52
TC 42
Z9 45
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1996
VL 17
IS 21
BP 2077
EP 2086
DI 10.1016/0142-9612(96)00014-2
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA VM787
UT WOS:A1996VM78700009
PM 8902241
DA 2018-10-19
ER

PT J
AU Goodman, SL
   Sims, PA
   Albrecht, RM
AF Goodman, SL
   Sims, PA
   Albrecht, RM
TI Three-dimensional extracellular matrix textured biomaterials
SO BIOMATERIALS
LA English
DT Article
DE extracellular matrix; endothelial cells; biomimetic materials;
   three-dimensional texture; surface topography
ID CELLULAR TENSEGRITY; SURFACE TEXTURE; TISSUE; ADHESION; REORGANIZATION;
   MORPHOGENESIS; CYTOSKELETON; PP125(FAK); CHEMISTRY; AIR
AB Clinical and experimental investigations have reported that manufactured surface topographies have significant effects on cell adhesion and tissue integration. However, essentially all previously examined topographies bear little relation to cell adhesion substrates found in biological tissues. In vivo, many cells are adherent to extracellular matrices (ECM), which have an extremely complex 3-D topography in the micrometre to nanometre range. In addition, many studies indicate that micro- and nano-scale mechanical stresses generated by cell-matrix adhesion have significant effects on cellular phenotypic behaviour. In this report we describe methodology for the fabrication of topographic replicas of the subendothelial ECM topography with a biomedical polyurethane. Using three-dimensional high resolution scanning electron microscopy, accurate replication of subendothelial ECM topography from the macroscopic to the macromolecular scale is demonstrated. Bovine aortic endothelial cells cultured on the ECM replicas spread more rapidly and had a three-dimensional appearance and spread areas at confluence which appeared more like endothelial cells in native arteries, compared with cells cultured on untextured control surfaces. Since the fabrication process may be used with many different types of materials, including polymers of synthetic and biological origin, these biomimetic ECM-textured surfaces may find both research and clinical applications. (C) 1996 Elsevier Science Limited
RP Goodman, SL (reprint author), UNIV WISCONSIN,DEPT ANIM HLTH & BIOMED SCI,1655 LINDEN DR,MADISON,WI 53706, USA.
CR ALBRECHT RM, 1976, J MICROSC-OXFORD, V108, P21, DOI 10.1111/j.1365-2818.1976.tb01075.x
   BJORLING DE, 1992, J PHARMACOL TOXICOL, V28, P149, DOI 10.1016/1056-8719(92)90077-E
   BOYDE A, 1974, SCANNING ELECTRON MI, P277
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893
   CLARK P, 1991, J CELL SCI, V99, P73
   DIDISHEIM P, 1983, T AM SOC ART INT ORG, V29, P169
   GEISLER HP, 1991, NEW BIOL SYNTHETIC V
   Girard Peggy R., 1993, Frontiers of Medical and Biological Engineering, V5, P31
   Goodman S L, 1989, Scanning Microsc Suppl, V3, P285
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   GOODMAN SL, 1995, CELL MATER, V5, P15
   GOODMAN SL, 1990, COLLOIDAL GOLD METHO, P369
   GOODMAN SL, 1993, BIOMATERIALS, V14, P557
   GUIDOIN R, 1992, BIOMATERIALS, V13, P281, DOI 10.1016/0142-9612(92)90051-O
   HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993
   INGBER DE, 1993, CELL, V75, P1249, DOI 10.1016/0092-8674(93)90612-T
   INGBER DE, 1994, INT REV CYTOL, V150, P173
   INGBER DE, 1993, J CELL SCI, V104, P613
   INGBER DE, 1991, J CELL BIOL, V99, pS34
   MASER MD, 1977, J HISTOCHEM CYTOCHEM, V25, P247, DOI 10.1177/25.4.67137
   PAWLEY JB, 1992, ADV ELECT ELECT PHYS, P203
   RATNER BD, 1985, SURFACE INTERFACIAL, P373
   REITH EJ, 1977, ATLAS DESCRIPTIVE HI
   ROSLOWSKY M, 1991, European Journal of Pharmacology, V193, P293
   SEDLARIK KM, 1990, BIOMATERIALS, V11, P4, DOI 10.1016/0142-9612(90)90043-P
   SIMS PA, 1993, SCANNING MICROSCOPY, V7, P637
   SNOW J, 1981, T AM SOC ART INT ORG, V27, P485
   SZYCHER M, 1980, T AM SOC ART INT ORG, V26, P493
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   WECHEZAK AR, 1989, J CELL PHYSIOL, V139, P136, DOI 10.1002/jcp.1041390120
   Whalen R L, 1988, ASAIO Trans, V34, P887
   WILLIAMS SK, 1987, ANN NY ACAD SCI, V516, P154
NR 33
TC 79
Z9 87
U1 1
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1996
VL 17
IS 21
BP 2087
EP 2095
DI 10.1016/0142-9612(96)00016-6
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA VM787
UT WOS:A1996VM78700010
PM 8902242
DA 2018-10-19
ER

PT J
AU Kitano, H
   Kawabata, J
   Muramoto, T
AF Kitano, H
   Kawabata, J
   Muramoto, T
TI Polymer microspheres prepared with a macroinitiator .2. Sugar balls from
   2-methacryloyloxyethyl-D-glucopyranoside
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID LIPOPHILIC RADICAL INITIATOR; COAGULATION; LIPOSOMES
AB Macroinitiator was prepared by the coupling of the disuccinimidyl ester of 4,4'-azobis(cyanovaleric acid) with poly(methacryloyloxyethyl-D-glucopyranoside) (PMEGlc) with an amino group at its end. Styrene and divinylbenzene were copolymerized using the initiator in the presence of sodium dodecylsulfate. The polymer microspheres obtained have PMEGlc chains on their surfaces (''sugar balls''). Aggregation phenomena were observed when a solution of lectin (Con-A) was added to the suspension, due to a specific recognition of sugar residues on the microsphere by a tetrameric lectin molecule. A suspension of sugar balls could not be flocculated even upon addition of an aqueous 3M NaCl solution due to the thick diffuse layer composed of PMEGlc chains on their surfaces. The utility of macroinitiators to prepare various polymer materials which have biomedical functions on their surfaces is suggested.
RP Kitano, H (reprint author), TOYAMA UNIV,DEPT CHEM & BIOCHEM ENGN,TOYAMA 930,JAPAN.
CR BARAKAT I, 1994, MACROMOL SYMP, V88, P227, DOI 10.1002/masy.19940880118
   CHARREYRE MT, 1993, COLLOID POLYM SCI, V271, P668, DOI 10.1007/BF00652829
   EVERETT DH, 1988, BASIC PRINCIPLE COLL
   HASEGAWA M, 1992, THESIS KYOTO U
   HONIG EP, 1971, J COLLOID INTERF SCI, V36, P97, DOI 10.1016/0021-9797(71)90245-1
   Kitano H, 1996, MACROMOL CHEM PHYSIC, V197, P1721, DOI 10.1002/macp.1996.021970513
   KITANO H, 1991, MACROMOLECULES, V24, P42, DOI 10.1021/ma00001a007
   KITANO H, 1994, LANGMUIR, V10, P4131, DOI 10.1021/la00023a036
   KITANO H, 1995, BIOCONJUGATE CHEM, V6, P131, DOI 10.1021/bc00031a016
   LEE YC, 1994, METHODS ENZYMOLOGY, V242
   LICHTENBELT JW, 1974, J COLLOID INTERF SCI, V49, P281, DOI 10.1016/0021-9797(74)90363-4
   Napper DH, 1983, POLYM STABILIZATION
   OHNO K, 1995, BIOCONJUGATE CHEM, V6, P361, DOI 10.1021/bc00034a004
   QUIRK RP, 1995, RING OPENING POLYM, P263
   REVILLA J, 1995, POLYM ADVAN TECHNOL, V6, P55
   SHARON N, 1989, LECTINS
   TAKEUCHI S, 1993, MAKROMOL CHEM, V194, P551
   TAMAI H, 1987, J COLLOID INTERF SCI, V118, P176, DOI 10.1016/0021-9797(87)90446-2
   TAUER K, 1995, POLYM ADVAN TECHNOL, V6, P435, DOI 10.1002/pat.1995.220060703
   VANDENHUL HJ, 1968, J COLLOID INTERF SCI, V28, P336, DOI 10.1016/0021-9797(68)90139-2
   von Smoluchowski M, 1916, PHYS Z, V17, P557
   von Smoluchowski M, 1916, PHYS Z, V17, P585
   1992, TOYOBO ENZYME MANUAL
NR 23
TC 15
Z9 15
U1 0
U2 1
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD NOV
PY 1996
VL 197
IS 11
BP 3657
EP 3666
DI 10.1002/macp.1996.021971113
PG 10
WC Polymer Science
SC Polymer Science
GA VU056
UT WOS:A1996VU05600013
DA 2018-10-19
ER

PT J
AU Butterworth, MD
   Bell, SA
   Armes, SP
   Simpson, AW
AF Butterworth, MD
   Bell, SA
   Armes, SP
   Simpson, AW
TI Synthesis and characterization of polypyrrole-magnetite-silica particles
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE polypyrrole; conducting polymer; magnetite; silica; nanocomposite;
   superparamagnetism
ID COLLOIDAL NANOCOMPOSITES; BIOMEDICAL APPLICATIONS; COMPOSITES;
   POLYANILINE; MATRIX
AB The synthesis of colloidal polypyrrole-magnetite-silica nanocomposites is described. First, silica-coated magnetite particles were prepared by the aqueous deposition of silica onto ultrafine (5-20 nm) magnetite particles via controlled hydrolysis of sodium silicate, Then pyrrole was chemically polymerized using (NH4)(2)S2O8, H2O2/Fe3+/HCl, or FeCl3 oxidants in the presence of these silica-coated magnetite particles to yield colloidal dispersions of polypyrrole-magnetite-silica particles. The magnetite contents of these materials were as high as 17.5% by mass. Vibrating sample magnetometry measurements confirmed that these nanocomposites were superparamagnetic, with bulk saturation magnetization values of up to 10.9 emu g(-1). Disc centrifuge photosedimentometry was used to assess particle size and degree of dispersion, yielding weight-average particle diameters in the range 100-520 nm. Electron microscopy studies indicated a rather ill-defined particle morphology but provided some evidence for the magnetite component within the nanocomposites. Stable colloidal dispersions were obtained using the H2O2/Fe3+/HCl and (NH4)(2)S2O8, oxidants, whereas FeCl3-based syntheses yielded only flocculated particles or macroscopic precipitates under similar conditions. Solid-state electrical conductivities of nanocomposites synthesized using (NH4)(2)S2O8, H2O2/Fe3+/HCl, and FeCl3 were about 10(-3), 10(-2), and 10(-1) S cm(-1), respectively. (C) 1996 Academic Press, Inc.
C1 UNIV SUSSEX, SCH CHEM & MOL SCI, BRIGHTON BN1 9QJ, E SUSSEX, ENGLAND.
   UNIV SUSSEX, SCH ENGN, BRIGHTON BN1 9QJ, E SUSSEX, ENGLAND.
OI Armes, Steven/0000-0002-8289-6351
CR ARMES SP, 1987, SYNTHETIC MET, V20, P367
   ARSHADY R, 1993, BIOMATERIALS, V14, P5, DOI 10.1016/0142-9612(93)90015-T
   BIDAN G, 1994, ADV MATER, V6, P152, DOI 10.1002/adma.19940060213
   BUTTERWORTH MD, 1995, J COLLOID INTERF SCI, V174, P510, DOI 10.1006/jcis.1995.1418
   BUTTERWORTH MD, 1994, J CHEM SOC CHEM COMM, P2129, DOI 10.1039/c39940002129
   BUTTERWORTH MD, UNPUB
   FORDER C, 1993, J MATER CHEM, V3, P563, DOI 10.1039/jm9930300563
   FURUSAWA K, 1994, COLLOID POLYM SCI, V272, P1104, DOI 10.1007/BF00652379
   GILL M, 1992, J CHEM SOC CHEM COMM, P108, DOI 10.1039/c39920000108
   HALLING PJ, 1980, ENZYME MICROB TECH, V2, P2, DOI 10.1016/0141-0229(80)90002-2
   JARJAYES O, 1995, SYNTHETIC MET, V69, P343, DOI 10.1016/0379-6779(94)02477-G
   KANATZIDIS MG, 1989, J AM CHEM SOC, V111, P4139, DOI 10.1021/ja00193a078
   Kawaguchi H., 1993, BIOMEDICAL APPL POLY, P299
   KAWAI K, 1990, J ELECTROCHEM SOC, V137, P1793, DOI 10.1149/1.2086806
   LIU CF, 1993, POLYM J, V25, P363, DOI 10.1295/polymj.25.363
   MAEDA S, 1994, J MATER CHEM, V4, P935, DOI 10.1039/jm9940400935
   MAEDA S, 1995, CHEM MATER, V7, P171, DOI 10.1021/cm00049a026
   MAEDA S, 1993, J COLLOID INTERF SCI, V159, P257, DOI 10.1006/jcis.1993.1323
   MAEDA S, 1995, LANGMUIR, V11, P1899, DOI 10.1021/la00006a014
   MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188
   MEHROTRA V, 1991, J NON-CRYST SOLIDS, V136, P97, DOI 10.1016/0022-3093(91)90124-O
   NUSTAD K, 1990, NATO ADV SCI I C-MAT, V303, P517
   PARTCH R, 1991, J COLLOID INTERF SCI, V144, P27, DOI 10.1016/0021-9797(91)90234-Y
   PHILIPSE AP, 1994, LANGMUIR, V10, P92, DOI 10.1021/la00013a014
   SENNA M, 1975, COLLOID POLYM SCI, V273, P76
   UGELSTAD J, 1993, BLOOD PURIFICAT, V11, P349, DOI 10.1159/000170129
NR 26
TC 76
Z9 90
U1 1
U2 34
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD OCT 15
PY 1996
VL 183
IS 1
BP 91
EP 99
DI 10.1006/jcis.1996.0521
PG 9
WC Chemistry, Physical
SC Chemistry
GA VV314
UT WOS:A1996VV31400011
DA 2018-10-19
ER

PT J
AU Cheang, P
   Khor, KA
   Teoh, LL
   Tam, SC
AF Cheang, P
   Khor, KA
   Teoh, LL
   Tam, SC
TI Pulsed laser treatment of plasma-sprayed hydroxyapatite coatings
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; plasma spraying; microstructure; pulsed laser; pore
   network
AB Plasma-sprayed hydroxyapatite (HA) coatings have complex microstructures. There are often variations in phase, structure and chemical composition among the starting material and coating. Some of these changes may not be acceptable for biomedical applications. Attaining all the requirements for a functional coating in a single spraying process is not easily achieved. Additional post-treatment may be necessary. This study examines the use of a pulsed laser to enhance the coating characteristics of plasma-sprayed HA coatings. Preliminary results show the laser-treated coatings having a modified microstructure with crack networks and pores in the size range 5-30 mu m. The pores and cracks were quantified by an image analyser. The crack network is less significant in coatings that are treated at lower energy intensity and this could be interesting in that the laser can be used to alter the surface phase composition as well as the morphology. However, repetitive passes with the pulsed laser did not help to seal the cracks that formed. (C) 1996 Elsevier Science Limited
C1 NANYANG TECHNOL UNIV,SCH MECH & PROD ENGN,SINGAPORE 2263,SINGAPORE.
   NANYANG TECHNOL UNIV,SCH APPL SCI,SINGAPORE 2263,SINGAPORE.
   NANYANG TECHNOL UNIV,SCH EEE,SINGAPORE 2263,SINGAPORE.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR CHEANG P, 1995, J MATER PROCESS TECH, V48, P429, DOI 10.1016/0924-0136(94)01679-U
   CHEANG P, 1994, P 8 INT C BIOM ENG S, P530
   GROSS KA, 1990, THESIS MONASH U AUST
   IWAMOTO N, 1988, SURF COAT TECH, V34, P59, DOI 10.1016/0257-8972(88)90089-8
   JASIM KM, 1988, J MATER SCI LETT, V3, P1307
   Khor K. A., 1994, THERMAL SPRAY IND AP, P147
   KHOR KA, 1994, J THERM SPRAY TECHN, V3, P45, DOI 10.1007/BF02648998
   KHOR KA, 1992, CERAMICS ADDING VALU, P810
   KHOR KE, UNPUB
NR 9
TC 35
Z9 40
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1996
VL 17
IS 19
BP 1901
EP 1904
DI 10.1016/0142-9612(95)00146-8
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA VH744
UT WOS:A1996VH74400010
PM 8889071
DA 2018-10-19
ER

PT J
AU Lim, GK
   Wang, J
   Ng, SC
   Gan, LM
AF Lim, GK
   Wang, J
   Ng, SC
   Gan, LM
TI Processing of fine hydroxyapatite powders via an inverse microemulsion
   route
SO MATERIALS LETTERS
LA English
DT Article
DE hydroxyapatite; microemulsion; nanoparticles; processing; biomedical
   materials
ID CALCIUM HYDROXYAPATITE; PRECURSORS
AB A submicrometer-sized hydroxyapatite powder has been synthesized via an inverse microemulsion processing route, which uses cyclohexane as the oil phase, mixed poly(oxyethylene)(5) nonyl phenol ether (NP-5) and poly(oxyethylene)(9) nonyl phenol ether (NP-9) as the surfactant phase, and an aqueous CaCl2 solution as the water phase. In comparison with the hydroxyapatite powder prepared by directly reacting (NH4)(2)HPO4 with CaCl2 in an aqueous solution, the microemulsion processing route led to a significant refinement in the particle size, particle size distribution, and the degree of particle agglomeration. XRD phase analysis indicates that a high-purity crystalline hydroxyapatite powder was obtained when the microemulsion-derived precursor was calcined at 800 degrees C. In contrast, there existed impurity phases such as beta-Ca-3(PO4)(2) and CaO in the conventionally processed hydroxyapatite powder after calcination at various temperatures up to 1200 degrees C. This shows that the microemulsion processing route results in the formation of a more homogeneous ultrafine powder precursor than that obtained from the conventional processing route.
C1 NATL UNIV SINGAPORE,DEPT MAT SCI,SINGAPORE 119260,SINGAPORE.
   NATL UNIV SINGAPORE,DEPT PHYS,SINGAPORE 119260,SINGAPORE.
   NATL UNIV SINGAPORE,DEPT CHEM,SINGAPORE 119260,SINGAPORE.
CR BURGARD D, 1994, MATER RES SOC SYMP P, V346, P101
   DEPTULA A, 1992, J NON-CRYST SOLIDS, V147, P537, DOI 10.1016/S0022-3093(05)80672-6
   GAN LM, 1994, MATER CHEM PHYS, V37, P263, DOI 10.1016/0254-0584(94)90162-7
   GOBE M, 1983, J COLLOID INTERF SCI, V93, P293, DOI 10.1016/0021-9797(83)90411-3
   HATTORI T, 1990, J AM CERAM SOC, V73, P1803, DOI 10.1111/j.1151-2916.1990.tb09841.x
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1993, ADV SERIES CERAMICS, V1, pCH9
   HINGORANI S, 1995, J MATER RES, V10, P461, DOI 10.1557/JMR.1995.0461
   KANDORI K, 1995, CHEM MATER, V7, P26, DOI 10.1021/cm00049a007
   LANGE FF, 1989, J AM CERAM SOC, V72, P3, DOI 10.1111/j.1151-2916.1989.tb05945.x
   LANGEVIN D, 1988, ACCOUNTS CHEM RES, V21, P257
   LEE WE, 1994, CERAMIC MICROSTRUCTU, pCH1
   LIN CH, 1994, MATER RES SOC SYMP P, V346, P237
   MURRAY MGS, 1995, J MATER SCI, V30, P3661
   PUAJINDANETR S, 1994, BRIT CERAM T, V93, P96
   VALLETREGI M, 1994, J SOLID STATE CHEM, V112, P58, DOI 10.1006/jssc.1994.1264
   WANG J, 1993, 3 EUR CER, V1, P715
   ZHENG JM, 1992, AM CERAM SOC BULL, V71, P1410
NR 18
TC 80
Z9 93
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD OCT
PY 1996
VL 28
IS 4-6
BP 431
EP 436
DI 10.1016/0167-577X(96)00095-X
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA VQ345
UT WOS:A1996VQ34500034
DA 2018-10-19
ER

PT J
AU Rodriguez, AJ
   HerandezVelez, M
   RoqueMalherbe, R
   Aragon, EG
   OnateMartinez, J
AF Rodriguez, AJ
   HerandezVelez, M
   RoqueMalherbe, R
   Aragon, EG
   OnateMartinez, J
TI Synthesis and characterization of molecular sieve with AlPO4-5
   framework. Preliminary biomedical essays
SO MATERIALS LETTERS
LA English
DT Article
DE aluminophosphate; molecular sieve; hydrothermal synthesis; bioactive
   material; osseous implantation
ID CRYSTALLINE INORGANIC SOLIDS
AB A molecular sieve including Ca in AlPO4-5 framework was synthesized. The highly crystalline synthetic products were characterized by X-ray fluorescence analysis, X-ray diffraction and NH3 adsorption. Sterilized CaAPO-5 was implanted in powder form in alive animals and a preliminary evaluation of their bioactive properties was made by elementary preclinical tests.
C1 FAC FIS, ISP EJ VARONA, GRP ZEOLITAS & PROPIEDADES DIELECT SOLIDOS, MARIANAO 46022, LA HABANA, CUBA.
   UNIV POLITECN VALENCIA, CSIC, INST TECNOL QUIM, CH-8092 VALENCIA, SPAIN.
   SWISS FED INST TECHNOL, ETH ZENTRUM, LAB KRISTALLOG, ZURICH, SWITZERLAND.
CR Bering B.P., 1974, IAN SSSR KH, P2427
   CHOUDHARY VR, 1988, J CATAL, V111, P23, DOI 10.1016/0021-9517(88)90062-0
   Dubinin M. M, 1975, PROGR SURFACE MEMBRA, V9, P1
   GIER TE, 1991, NATURE, V349, P508, DOI 10.1038/349508a0
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   LOK BM, 1984, J AM CHEM SOC, V106, P6092, DOI 10.1021/ja00332a063
   MARTENS JA, 1994, STUD SURF SCI CATAL, V85, P653
   MONTES C, 1990, J PHYS CHEM-US, V94, P6431, DOI 10.1021/j100379a050
   ORTEGA R, UNPUB
   RIGUTTO MS, 1993, J MOL CATAL, V81, P77, DOI 10.1016/0304-5102(93)80024-O
   ROSS S, 1964, PHYSICAL ADSORPTION, P31
   THOMANN JM, 1990, CALCIFIED TISSUE INT, V46, P121, DOI 10.1007/BF02556096
   Wilson S. T, 1986, U.S. Patent, Patent No. [4,567,029, 4567029, 4,567,029A]
   WILSON ST, 1982, J AM CHEM SOC, V104, P1146, DOI 10.1021/ja00368a062
   ZENJI H, PARTICLE PACKED FIBE
NR 15
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD OCT
PY 1996
VL 28
IS 4-6
BP 507
EP 511
DI 10.1016/0167-577X(96)00105-X
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA VQ345
UT WOS:A1996VQ34500048
DA 2018-10-19
ER

PT J
AU Patriarca, M
AF Patriarca, M
TI The contribution of inductively coupled plasma mass spectrometry to
   biomedical research
SO MICROCHEMICAL JOURNAL
LA English
DT Article; Proceedings Paper
CT VII Italian/Hungarian Symposium on Spectrochemistry - Innovative
   Methodologies for Health and Environmental Protection
CY NOV 27-DEC 01, 1995
CL ROME, ITALY
ID TRACE-ELEMENT ABSORPTION; STABLE ISOTOPES; ICP-MS;
   LIQUID-CHROMATOGRAPHY; HUMAN-SERUM; MINERAL METABOLISM; IRON-ABSORPTION;
   LEC RATS; SPECIATION; COPPER
AB The most striking features of inductively coupled plasma mass spectrometry (ICP-MS) are its superior sensitivity for a wide range of elements and its capability to determine the isotope composition of a sample using less cumbersome pretreatment procedures than other mass spectrometry techniques. Both these capabilities have been exploited in biomedical research. The application of ICP-MS to samples of body fluids and tissues extends the investigation of reference values and biological role to elements present at the ultra-trace level, The availability of simplified methods for the determination of isotope ratios in biological samples allows a more extensive use of stable isotopes as tracers to study mineral metabolism in man, overcoming the restrictions due to safety concerns and short lifetime of radioisotopes. The high sample throughput of ICP-MS significantly increases the information available. for kinetic models in human nutrition and toxicology. By means of on-line coupling with chromatographic techniques, such information could be further extended to the speciation of minerals and their time-dependent biochemical transformations. Multielemental metabolic studies could be performed, taking advantage of the capability of ICP-MS for simultaneous determinations. Finally, the development of high accuracy methods based on isotopic dilution and ICP-MS is important to improve the reliability of analytical data and for the certification of reference and control materials. (C) 1996 Academic Press, Inc.
RP Patriarca, M (reprint author), IST SUPER SANITA,BIOCHIM CLIN LAB,VIALE REGINA ELENA 299,I-00161 ROME,ITALY.
RI PATRIARCA, MARINA/E-3680-2015
CR ABRAMS SA, 1994, J PEDIATR GASTR NUTR, V19, P151, DOI 10.1097/00005176-199408000-00003
   AGGARWAL SK, 1994, CRIT REV CL LAB SCI, V31, P35, DOI 10.3109/10408369409084673
   AMARASIRIWARDENA CJ, 1990, J ANAL ATOM SPECTROM, V5, P457, DOI 10.1039/ja9900500457
   BARNES RM, 1993, ANAL CHIM ACTA, V283, P115, DOI 10.1016/0003-2670(93)85214-5
   BARRETT JFR, 1992, CLIN SCI, V83, P213, DOI 10.1042/cs0830213
   BOWINS RJ, 1994, J ANAL ATOM SPECTROM, V9, P1233, DOI 10.1039/ja9940901233
   BYRDY FA, 1995, ENVIRON HEALTH PERSP, V103, P21, DOI 10.2307/3432006
   CORNELIS R, 1994, J ANAL ATOM SPECTROM, V9, P945, DOI 10.1039/ja9940900945
   CORNELIS R, 1993, ANAL CHIM ACTA, V283, P183, DOI 10.1016/0003-2670(93)85221-5
   CREWS HM, 1994, ANALYST, V119, P2491, DOI 10.1039/an9941902491
   DAMS R, 1994, BIOL TRACE ELEMENT R, P539
   DAVIDSSON L, 1994, ACTA PAEDIATR, V395, P38
   DEBIEVRE P, 1994, FRESEN J ANAL CHEM, V350, P277, DOI 10.1007/BF00322482
   DOUGLAS DJ, 1985, PROG ANAL ATOM SPECT, V8, P1
   FOMON SJ, 1989, PEDIATR RES, V26, P250, DOI 10.1203/00006450-198909000-00019
   FOMON SJ, 1988, PEDIATR RES, V24, P20, DOI 10.1203/00006450-198807000-00006
   GIESSMAN U, 1994, FRESEN J ANAL CHEM, V50, P186
   GRAY AL, 1985, SPECTROCHIM ACTA B, V40, P1525, DOI 10.1016/0584-8547(85)80176-2
   HILL SJ, 1993, J ANAL ATOM SPECTROM, V8, P499, DOI 10.1039/ja9930800499
   HORLICK G, 1987, INDUCTIVELY COUPLED, P361
   JANGHORBANI M, 1989, MIKROCHIM ACTA, V3, P315
   KIRLEW PW, 1996 WINT C PLASM SP
   LASZTITY A, 1995, J ANAL ATOM SPECTROM, V10, P505, DOI 10.1039/ja9951000505
   LEVENSON CW, 1994, ANAL BIOCHEM, V221, P243, DOI 10.1006/abio.1994.1408
   LU Q, 1996 WINT C PLASM SP
   LU QH, 1995, ANAL CHEM, V67, P2949, DOI 10.1021/ac00113a033
   LYON TDB, 1991, J ANAL ATOM SPECTROM, V6, P559, DOI 10.1039/ja9910600559
   LYON TDB, 1988, J ANAL ATOM SPECTROM, V3, P265, DOI 10.1039/ja9880300265
   Lyon TDB, 1996, MICROCHEM J, V54, P236, DOI 10.1006/mchj.1996.0099
   LYON TDB, 1990, J ANAL ATOM SPECTROM, V5, P135, DOI 10.1039/ja9900500135
   LYON TDB, 1992, FOOD CHEM, V43, P299, DOI 10.1016/0308-8146(92)90217-P
   LYON TDB, 1995, CLIN SCI, V8, P727
   MELLON FA, 1993, ANAL CHIM ACTA, V283, P190, DOI 10.1016/0003-2670(93)85222-6
   MICHALKE B, 1996 WINT C PLASM SP
   MOENS L, 1995, J RADIOAN NUCL CH AR, V192, P29, DOI 10.1007/BF02037733
   MOENS L, 1994, J ANAL ATOM SPECTROM, V9, P1075, DOI 10.1039/ja9940901075
   NUTTALL KL, 1995, ANN CLIN LAB SCI, V25, P264
   OGRA Y, 1995, RES COMMUN MOL PATH, V88, P196
   OLSON LK, 1995, SPECTROCHIM ACTA B, V50, P355, DOI 10.1016/0584-8547(94)00170-Z
   PASCHAL DC, 1995, J ANAL ATOM SPECTROM, V10, P67
   Patriarca M, 1996, J ANAL ATOM SPECTROM, V11, P297, DOI 10.1039/ja9961100297
   Patriarca M, 1996, MIKROCHIM ACTA, V123, P261, DOI 10.1007/BF01244399
   PATRIARCA M, 1995, 5 COMTOX S TOX CLIN
   PATRIARCA M, 1995, RECENT ADV PLASMA SO, P224
   SABBIONI E, 1994, SCI TOTAL ENVIRON, V158, P228
   Sandstrom B., 1993, Nutrition Research Reviews, V6, P71, DOI 10.1079/NRR19930007
   SCHRAMEL P, 1995, FRESEN J ANAL CHEM, V353, P115, DOI 10.1007/BF00322942
   SCHUETTE SA, 1992, J NUTR BIOCHEM, V3, P38, DOI 10.1016/0955-2863(92)90066-R
   SERFASS RE, 1986, ANAL CHIM ACTA, V188, P73, DOI 10.1016/S0003-2670(00)86031-6
   SERFASS RE, 1989, J NUTR, V119, P1661
   SEUBERT A, 1994, FRESEN J ANAL CHEM, V350, P210, DOI 10.1007/BF00322472
   SOLTANINESHAN MA, 1992, ISOTOPENPRAXIS, V28, P101, DOI 10.1080/00211919208050834
   SULAIMAN AB, 1996 WINT C PLASM SP
   SUZUKI KT, 1994, J INORG BIOCHEM, V54, P157, DOI 10.1016/0162-0134(94)80010-3
   SUZUKI KT, 1995, J CHROMATOGR B, V666, P13, DOI 10.1016/0378-4347(94)00561-I
   SUZUKI KT, 1995, RES COMMUN MOL PATH, V88, P187
   THOMPSON JJ, 1986, ANAL CHEM, V58, P2541, DOI 10.1021/ac00125a039
   TING BTG, 1987, SPECTROCHIM ACTA B, V42, P21, DOI 10.1016/0584-8547(87)80046-0
   TOMLINSON MJ, 1995, ANALYST, V120, P583, DOI 10.1039/an9952000583
   TOMLINSON MJ, 1994, J ANAL ATOM SPECTROM, V9, P957, DOI 10.1039/ja9940900957
   TYLER G, 1995, SPECTROSCOPY EUROPE, V7, P14
   Vanhaecke F, 1996, ANAL CHEM, V68, P567, DOI 10.1021/ac9507247
   VANHOE H, 1989, ANAL CHEM, V61, P1851, DOI 10.1021/ac00192a014
   VANHOE H, 1994, J ANAL ATOM SPECTROM, V9, P23, DOI 10.1039/ja9940900023
   VAUGHAN MA, 1990, CLIN CHEM, V27, P210
   VELA NP, 1993, ANAL CHEM, V65, pA585, DOI 10.1021/ac00061a002
   WATSON WS, 1995, 5 COMTOX S TOX CLIN
   WHITTAKER PG, 1992, J ANAL ATOM SPECTROM, V7, P109, DOI 10.1039/ja9920700109
   WHITTAKER PG, 1991, BRIT J NUTR, V65, P457, DOI 10.1079/BJN19910104
   YANG KL, 1995, ANAL CHIM ACTA, V307, P109, DOI 10.1016/0003-2670(95)00010-W
   YERGEY AL, 1994, ADV EXP MED BIOL, V352, P279
   ZIEGLER EE, 1989, J NUTR, V119, P1647
NR 72
TC 16
Z9 18
U1 0
U2 4
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0026-265X
J9 MICROCHEM J
JI Microchem J.
PD OCT
PY 1996
VL 54
IS 3
BP 262
EP 271
DI 10.1006/mchj.1996.0102
PG 10
WC Chemistry, Analytical
SC Chemistry
GA VT161
UT WOS:A1996VT16100011
DA 2018-10-19
ER

PT J
AU Jourlin, M
   Bertrand, C
   Coudert, JL
   Darsonville, F
   Gremillet, P
   Martinez, S
   Pinoli, JC
   Revol, C
   Trunde, F
AF Jourlin, M
   Bertrand, C
   Coudert, JL
   Darsonville, F
   Gremillet, P
   Martinez, S
   Pinoli, JC
   Revol, C
   Trunde, F
TI 3D imaging applications at the LISA laboratory during the last ten years
SO MICROSCOPY MICROANALYSIS MICROSTRUCTURES
LA English
DT Article; Proceedings Paper
CT 20th Annual Meeting of the French Section of the
   International-Society-for-Stereology
CY FEB, 1997
CL ECOLE NATL SUPER MINES, PARIS, FRANCE
SP Int Soc Stereol
HO ECOLE NATL SUPER MINES
ID TIME CONFOCAL MICROSCOPY; HUMAN SKIN; IN-VIVO
AB This article ambitiously aims at illustrating the tremendous potentialities offered by new imaging technologies (electron microscopy, confocal microscopy and atomic force microscopy...), that give access to either volumic or surfacic informations, and the necessity to create high-level tools and models that are essential for the treatment of the information provided by the sensors, as well from a mathematical point of view (modeling, interpolation, correlation, reconstruction...) as under the computing aspect (facettisation, smoothing, visualization... but also data structures adapted to the storage and use of voluminous files, parallel architectures...). Since ten years the LISA Laboratory has focused in the field of 3D imaging on the creation, development and implementation of such theoretical and practical tools. This article briefly presents the main works on image analysis at LISA Laboratory and especially illustrates by images the main successfully addressed three dimensional imaging applications. The overviewed examples concern the biomedical domain (biological cells, hairs, jaws, epidermis) and that of materials (textiles, concretes, aluminium alloys).
C1 LOREAL, LAB RECH AVANCEE, F-93600 AULNAY SOUS BOIS, FRANCE.
   FAC ODONTOL, F-69372 LYON 08, FRANCE.
   MISIS, F-42000 ST ETIENNE, FRANCE.
   PECHINEY, CTR RECH, F-38340 VOREPPE, FRANCE.
RP Jourlin, M (reprint author), ECOLE SUPER CHIM PHYS & ELECT, CNRS, EP0092, LAB IMAGE SIGNAL & ACOUST, 43 BLVD 11 NOVEMBRE 1918, F-69616 VILLEURBANNE, FRANCE.
CR BERTRAND C, 1994, SCANNING, V16, P150
   BERTRAND C, 1994, THESIS U SAINT ETIEN
   BRON C, 1990, J MICROSC-OXFORD, V157, P115, DOI 10.1111/j.1365-2818.1990.tb02952.x
   CORCUFF P, 1993, DERMATOLOGY, V186, P50, DOI 10.1159/000247302
   CORCUFF P, 1993, J SOC COSMET CHEM, V44, P1
   CORCUFF P, 1993, ARCH DERMATOL RES, V285, P475, DOI 10.1007/BF00376820
   DARSONVILLE F, 1994, SUIVI DYNAMIQUE PAYS
   FORTIN T, 1994, ENCY MED CHIR
   GREMILLET P, 1994, J MICROSC-OXFORD, V174, P31, DOI 10.1111/j.1365-2818.1994.tb04321.x
   GREMILLET P, 1995, P IEEE WORKSH NONL I, P819
   GREMILLET P, 1992, THESIS U SAINT ETIEN
   Gremillet Ph., 1991, Machine Vision and Applications, V4, P263, DOI 10.1007/BF01815303
   JOURLIN M, 1995, SIGNAL PROCESS, V41, P225, DOI 10.1016/0165-1684(94)00102-6
   JOURLIN M, 1987, ACTA STEREOL, V6, P651
   JOURLIN M, 1988, J MICROSC-OXFORD, V149, P21, DOI 10.1111/j.1365-2818.1988.tb04559.x
   MARTINEZ S, UNPUB 3 DIMENSIONAL
   MARTINEZ S, 1994, ETUDE DISTRIBUTION T
   MARTINEZ S, 1996, IN PRESS INT C 3D IM
   PINOLI JC, IN PRESS J MATH IMAG
   REVOL C, 1996, THESIS U SAINT ETIEN
   REVOL C, UNPUB NEW MINIMUM VA
   REVOL C, 1996, IN PRESS P 37 C SOC
NR 22
TC 1
Z9 1
U1 0
U2 1
PU EDP SCIENCES S A
PI LES ULIS CEDEX A
PA 17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A,
   FRANCE
SN 1154-2799
J9 MICROSC MICROANAL M
JI Microsc. Microanal. Microstruct.
PD OCT-DEC
PY 1996
VL 7
IS 5-6
BP 289
EP 295
DI 10.1051/mmm:1996124
PG 7
WC Microscopy; Spectroscopy
SC Microscopy; Spectroscopy
GA XH270
UT WOS:A1996XH27000003
OA Bronze
DA 2018-10-19
ER

PT J
AU Pang, Z
   Gu, XH
   Yekta, A
   Masoumi, Z
   Coll, JB
   Winnik, MA
   Manners, I
AF Pang, Z
   Gu, XH
   Yekta, A
   Masoumi, Z
   Coll, JB
   Winnik, MA
   Manners, I
TI Phosphorescent oxygen sensors utilizing sulfur-nitrogen-phosphorus
   polymer matrices
SO ADVANCED MATERIALS
LA English
DT Article
ID TRANSITION-METAL COMPLEXES; MOLECULAR RECOGNITION
AB Luminescent sensors based on composites comprising transition metal complexes immobilized in polymer matrices have attracted attention as oxygen sensors for both biomedical and barometric applications. Typically, phosphorescent dyes are dispersed in a polymer matrix of high gas permeability are used, Here, S-N-P polymers are used as a novel matrix material allowing the sensitivity of the sensors to be controlled over a wide range.
C1 UNIV TORONTO,DEPT CHEM,TORONTO,ON M5S 3H6,CANADA.
   ONTARIO LASER & LIGHTWAVE RES CTR,TORONTO,ON M5S 1A7,CANADA.
   DE HAVILLAND INC,DOWNSVIEW,ON M3K 1Y5,CANADA.
CR ALLCOCK HR, 1993, MACROMOLECULES, V26, P1493, DOI 10.1021/ma00059a003
   BACON JR, 1987, ANAL CHEM, V59, P2780, DOI 10.1021/ac00150a012
   Barlet P. N., 1993, SYNTHETIC MET, V61, P15
   BAUERLE P, 1993, ADV MATER, V5, P848, DOI 10.1002/adma.19930051113
   BONDI MCM, 1990, ANAL CHEM, V62, P2377
   CARRAWAY ER, 1991, ANAL CHEM, V63, P337, DOI 10.1021/ac00004a007
   Czarnik A. W., 1993, ACS S SERIES, V538
   DEMAS JN, 1991, ANAL CHEM, V63, pA829, DOI 10.1021/ac00017a001
   DIMARCO G, 1995, ADV MATER, V7, P468, DOI 10.1002/adma.19950070512
   DORN R, 1992, ADV MATER, V4, P464, DOI 10.1002/adma.19920040703
   Gouterman M., 1993, U. S. Patent, Patent No. [5,186,046, 5186046]
   GOUTERMAN M, 1995, WORKSH PRESS TEMP SH
   KAVANDI J, 1990, REV SCI INSTRUM, V61, P3341
   KLIMANT I, 1995, ANAL CHEM, V67, P3160, DOI 10.1021/ac00114a010
   LI XM, 1993, ANALYST, V118, P289, DOI 10.1039/an9931800289
   LIANG M, 1991, J AM CHEM SOC, V113, P4044, DOI 10.1021/ja00010a085
   LIEBMAN RA, 1989, CHEM BIOCH ENV SENSO, V1172
   MASOUMI Z, UNPUB
   MOSHAROV V, 1994, Patent No. 5307675
   NI YZ, 1992, MACROMOLECULES, V25, P7119, DOI 10.1021/ma00052a008
   Ni YZ, 1996, MACROMOLECULES, V29, P3401, DOI 10.1021/ma951611s
   PREININGER C, 1994, ANAL CHEM, V66, P1841, DOI 10.1021/ac00083a011
   SCHWAB SD, 1994, Patent No. 5359887
   SWAGER TM, 1994, ADV MATER, V6, P595, DOI 10.1002/adma.19940060717
   Yekta A, 1995, CAN J CHEM, V73, P2021, DOI 10.1139/v95-250
   ZHOU Q, 1995, J AM CHEM SOC, V117, P7017, DOI 10.1021/ja00131a031
NR 26
TC 37
Z9 37
U1 2
U2 10
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD SEP
PY 1996
VL 8
IS 9
BP 768
EP &
DI 10.1002/adma.19960080916
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA VG738
UT WOS:A1996VG73800015
DA 2018-10-19
ER

PT J
AU Sodhi, RNS
AF Sodhi, RNS
TI Application of surface analytical and modification techniques to
   biomaterial research
SO JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA
LA English
DT Article
DE adsorbate; biomaterial; plasma technique; SSIMS; surface modification;
   XPS
ID SCANNING-TUNNELING-MICROSCOPY; NEURONAL CELL ATTACHMENT; ATOMIC-FORCE
   MICROSCOPY; X-RAY PHOTOELECTRON; ADHESION; PLASMA;
   POLY(TETRAFLUOROETHYLENE); TEFLON; FILMS; POLYTETRAFLUOROETHYLENE
AB The development of suitable materials for biomedical applications requires a thorough understanding of the structure and chemistry of the solid-liquid interface when such a material is placed in the biological environment. The held is made complex by the diversity of materials used, the different applications one has to consider, and the complexity of the various biological environments the implanted material may find itself in. To understand the interactions which may occur, it is important to have information on the structure and composition of the top few atomic layers. Concepts from surface science, such as surface analysis and modification techniques prove to be valuable aids in the development of suitable biomaterials. These methods are not new or unique but are well established in other technologies. In this paper, several areas of surface modification techniques will be chosen to illustrate how they are being applied in the biomaterial field, stressing the interdisciplinary nature of the work as well as the surface analytical techniques involved.
RP Sodhi, RNS (reprint author), UNIV TORONTO,CTR BIOMAT,170 COLL ST,TORONTO,ON M5S 3E3,CANADA.
CR American Society for Testing and Materials (ASTM), 1992, ANN BOOK ASTM STAND, V11.04
   ANDERS PA, 1989, J APPL PHYS, V66, P3548
   Andrade J. D., 1985, SURFACE INTERFACIAL, V1, P105
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Beamson G., 1992, HIGH RESOLUTION XPS
   Briggs D., 1989, HDB STATIC SECONDARY
   BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9
   BUSSCHER HJ, 1991, CELL MATER, V1, P243
   CADMAN P, 1979, J MATER SCI, V14, P2672, DOI 10.1007/BF00610638
   CALLEN BW, 1995, J VAC SCI TECHNOL A, V13, P2023, DOI 10.1116/1.579647
   CALLEN BW, 1993, J BIOMED MATER RES, V27, P851, DOI 10.1002/jbm.820270703
   CALLEN BW, 1995, J BIOMED MATER RES, V29, P279, DOI 10.1002/jbm.820290302
   CALLEN BW, 1994, T 20 M SOC BIOM BOST, P342
   CASTNER DG, 1992, T 4 WORLD BIOM C BER, P194
   CHAKRABARTI N, 1988, MACROMOLECULES, V21, P3011, DOI 10.1021/ma00188a020
   CHANEY R, 1987, FRESEN Z ANAL CHEM, V329, P143, DOI 10.1007/BF00469126
   CHANG CA, 1987, APPL PHYS LETT, V51, P1236, DOI 10.1063/1.98741
   CLARK DT, 1986, J ELECTRON SPECTROSC, V41, P399, DOI 10.1016/0368-2048(86)85017-4
   CLARK DT, 1987, J POLYM SCI POL CHEM, V25, P2643, DOI 10.1002/pola.1987.080251002
   Clark DT, 1978, POLYM SURFACES, P185
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   DAVIES M, 1996, J ELECT SPECTROSC RE, V81, P249
   DAVIES MC, 1990, CRIT REV BIOCOMPAT, V5, P297
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P63
   Formichi M J, 1988, Ann Vasc Surg, V2, P14, DOI 10.1016/S0890-5096(06)60773-5
   GJERMO P, 1989, J DENT RES, V68, P1602
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   HANSMA PK, 1988, SCIENCE, V242, P209, DOI 10.1126/science.3051380
   HAQUE Y, 1986, J APPL POLYM SCI, V32, P4369, DOI 10.1002/app.1986.070320407
   JANSTA J, 1975, J APPL POLYM SCI, V19, P3201, DOI 10.1002/app.1975.070191206
   JOHANSSON C, 1989, J BIOMED ENG, V11, P3, DOI 10.1016/0141-5425(89)90158-1
   Johnston EE, 1996, J ELECTRON SPECTROSC, V81, P303, DOI 10.1016/0368-2048(95)02666-5
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   KNUTSON K, 1985, SURFACE INTERFACIAL, V1, P197
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LINDSAY SM, 1993, J VAC SCI TECHNOL A, V11, P808, DOI 10.1116/1.578309
   MAEUSLI PA, 1986, BIOL BIOMECHANICAL P, P57
   MCKEOWN NB, 1991, LANGMUIR, V7, P2146, DOI 10.1021/la00058a029
   MICHAEL R, 1986, J VAC SCI TECHNOL A, V4, P1861, DOI 10.1116/1.573778
   Morosoff N., 1990, PLASMA DEPOSITION TR, P1, DOI 10.1016/13978-0-12-200430-8.50007-5
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   RATNER BD, 1990, J VAC SCI TECHNOL A, V8, P2306, DOI 10.1116/1.576755
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   ROBERTS RF, 1976, J APPL POLYM SCI, V20, P255, DOI 10.1002/app.1976.070200121
   RYE RR, 1987, APPL SURF SCI, V29, P397, DOI 10.1016/0169-4332(87)90045-6
   RYE RR, 1990, LANGMUIR, V6, P338, DOI 10.1021/la00092a008
   Sabbatini L, 1996, J ELECTRON SPECTROSC, V81, P285, DOI 10.1016/0368-2048(95)02528-6
   SACHER E, 1988, SURFACE CHARACTERISA
   Sherwood PMA, 1996, J ELECTRON SPECTROSC, V81, P319, DOI 10.1016/0368-2048(95)02529-4
   SODHI RNS, 1992, J DENT RES, V71, P1493, DOI 10.1177/00220345920710080601
   SODHI RNS, 1992, T 4 WORLD BIOM C BER, P172
   VARGO TG, 1992, LANGMUIR, V8, P130, DOI 10.1021/la00037a025
   VARGO TG, 1995, J BIOMED MATER RES, V29, P767, DOI 10.1002/jbm.820290613
   VARGO TG, 1991, J POLYM SCI POL CHEM, V29, P555, DOI 10.1002/pola.1991.080290412
   WERTHEIMER MR, 1985, J VAC SCI TECHNOL A, V3, P2643, DOI 10.1116/1.572805
   ZHOU XL, 1990, J CHEM PHYS, V92, P5612, DOI 10.1063/1.458493
NR 60
TC 38
Z9 39
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0368-2048
J9 J ELECTRON SPECTROSC
JI J. Electron Spectrosc. Relat. Phenom.
PD SEP
PY 1996
VL 81
IS 3
BP 269
EP 284
DI 10.1016/0368-2048(95)02665-7
PG 16
WC Spectroscopy
SC Spectroscopy
GA VT919
UT WOS:A1996VT91900005
DA 2018-10-19
ER

PT J
AU Alonso, F
   Ugarte, JJ
   Sansom, D
   Viviente, JL
   Onate, JI
AF Alonso, F
   Ugarte, JJ
   Sansom, D
   Viviente, JL
   Onate, JI
TI Effects of ion implantation on Ti-6Al-4V on its frictional behaviour
   against UHMWPE
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 9th International Conference on Surface Modification of Metals by Ion
   Beams (SMMIB 95)
CY SEP 04-08, 1995
CL SAN SEBASTIAN, SPAIN
SP INASMET
DE carbon ion implantation; Ti-6Al-4V titanium alloy; hardness; friction
ID TITANIUM
AB The aim of this work was to study the effect of carbon ion implantation and a DLC coating on the friction response of Ti-6Al-4V/UHMWPE materials used for biomedical implants, and on the endurance of the protective oxide layer of the Ti alloy at increasing loads.
   Carbon implantation was carried out at doses ranging from 2 x 10(17) to 10 x 10(17) ions cm(-2) and energies from 75 to 180 keV. This implantation procedure produced a more than twofold improvement in hardness, as evaluated by a dynamic micro-indentation technique at increasing loads from 0.4 to 10 mN. Dry pin-on-disc tribological tests, using an UHMWPE pin, showed that some of the implantation treatments effectively protected the surface of the Ti alloy, without producing a break in the protective passive oxide layer and exhibited low friction values, similar to those obtained in DLC coatings. No direct correlation has been found, however, between the hardening induced by ion implantation and the improved tribological response. Formation of TiC precipitates could account for the hardening effect observed after carbon implantation and, in addition, implantation may cause stabilisation of the protective oxide layer on the titanium surface.
C1 UNIV BATH,SCH MAT SCI,BATH BA2 7AY,AVON,ENGLAND.
RP Alonso, F (reprint author), INASMET,CAMINO PORTUETXE 12,SAN SEBASTIAN 20009,SPAIN.
RI Onate, J. Ignacio/I-1555-2015
OI Onate de la Presa, Jose Ignacio/0000-0002-9078-4480
CR Alonso F, 1995, SURF COAT TECH, V74-75, P986, DOI 10.1016/0257-8972(95)08291-3
   BOLSTER RN, 1987, SURF COAT TECH, V33, P469, DOI 10.1016/0257-8972(87)90211-8
   CHEN A, 1991, WEAR MATERIALS, P667
   CLARKE LA, 1992, ASTM STP, V1144, P7
   Elder J. E., 1989, Surface Engineering, V5, P55
   HOHMUTH K, 1985, MATER SCI ENG, V69, P489, DOI 10.1016/0025-5416(85)90351-9
   Lausmaa J., 1991, Surface Engineering, V7, P311
   NASSER S, 1990, CLIN ORTHOPAEDICS, V261, P171
   OLIVER WC, 1984, METALL TRANS A, V15, P2221, DOI 10.1007/BF02647105
   ONATE JI, 1994, SURF COAT TECH, V65, P165, DOI 10.1016/S0257-8972(94)80025-1
   PIVIN JC, 1987, J MATER SCI, V22, P1087, DOI 10.1007/BF01103555
   RIEU J, 1992, SURFACE MODIFICATION, V5, P155
   SARITAS S, 1987, MATER SCI ENG, V90, P297, DOI 10.1016/0025-5416(87)90225-4
   SCHROER A, 1991, SURF COAT TECH, V47, P418, DOI 10.1016/0257-8972(91)90307-I
   SIOSHANSI P, 1987, NUCL INSTRUM METH B, V19-20, P204, DOI 10.1016/S0168-583X(87)80043-5
NR 15
TC 36
Z9 37
U1 0
U2 6
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP
PY 1996
VL 83
IS 1-3
BP 301
EP 306
DI 10.1016/0257-8972(96)02767-3
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA VE213
UT WOS:A1996VE21300053
DA 2018-10-19
ER

PT J
AU Marshall, KG
AF Marshall, KG
TI Prevention. How much harm? How much benefit? .4. The ethics of informed
   consent for preventive screening programs
SO CANADIAN MEDICAL ASSOCIATION JOURNAL
LA English
DT Article
ID PATIENT-PHYSICIAN PARTNERSHIP; HEALTH-CARE MANAGEMENT; BREAST-CANCER;
   PROSTATE-CANCER; OLDER WOMEN; MEDICINE; INTERVENTIONS; INFORMATION;
   ATTENDANCE; GUIDELINES
AB Preventive interventions may have few or unproven benefits, or they may even be harmful. Since three of the fundamental precepts of Western biomedical ethics are beneficence, non-maleficence and respect for individual autonomy, failure to obtain truly informed consent for many current preventive interventions may be unethical. However, there are many impediments to obtaining such consent. Physicians-need to be aware of an immense amount of up-to-date, complex information. It may be difficult for patients to assimilate this information, and there is rarely time for physicians to become informed and to inform their patients. Clinical practice guidelines may be helpful, but not all are based on evidence, and recommendations are often conflicting. Medical institutions, as well as individual clinicians, can help solve these dilemmas. Authors and journal editors can make a:commit ment to report and publish wall-referenced evidence-based guidelines. Organizations such as the Canadian Task Force on the Periodic Health Examination and the,US Preventive Services Task Force can develop balanced, evidence-based patient-information material. Faculty at all levels of medical education can increase their emphasis on the ethics of prevention. Individual clinicians should avoid making clinical decisions on the basis of relative reductions of morbidity or mortality, should use evidence-based clinical practice guidelines rather than those based on authority whenever possible, should make use of patient-information material and, most important, should have a consistent policy of obtaining informed consent from: patients before they participate in potentially harmful preventive programs.
RP Marshall, KG (reprint author), MCGILL UNIV,DEPT FAMILY MED,517 PINE AVE W,MONTREAL,PQ H3Y 1Y8,CANADA.
CR ANGELL M, 1994, NEW ENGL J MED, V331, P189, DOI 10.1056/NEJM199407213310309
   ANNAS GJ, 1992, J GERONTOL, V47, P121
   BAINES CJ, 1992, CAN MED ASSOC J, V146, P2147
   BATTISTA RN, 1995, J CLIN EPIDEMIOL, V48, P875, DOI 10.1016/0895-4356(94)00199-Z
   BAUM M, 1995, BRIT MED J, V310, P1003, DOI 10.1136/bmj.310.6985.1003
   BEAUCHAMP TL, 1989, MED ETHICS, P173
   BEISECKER AE, 1990, MED CARE, V28, P19, DOI 10.1097/00005650-199001000-00004
   BLACK WC, 1995, J NATL CANCER I, V87, P720, DOI 10.1093/jnci/87.10.720
   BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820
   BUTLER JA, 1993, J ROY SOC MED, V86, P341
   *CAN TASK FORC PER, 1994, CAN GUID CLIN PREV H
   *CAN TASK FORC PER, 1994, CAN GUID CLIN PREV H, P791
   CARRESE JA, 1995, JAMA-J AM MED ASSOC, V274, P826, DOI 10.1001/jama.274.10.826
   CASSEL CK, 1992, J GERONTOL, V47, P126
   COCHRANE AL, 1971, BRIT MED BULL, V27, P3, DOI 10.1093/oxfordjournals.bmb.a070810
   Collins J. H., 1995, J AM TAXATION ASS, V17, P1
   CONROY M, 1995, BRIT J GEN PRACT, V45, P371
   CSAJA R, 1994, ANN INTERN MED, V120, P602
   DEBER RB, 1994, CAN MED ASSOC J, V151, P423
   DEBER RB, 1994, CAN MED ASSOC J, V151, P171
   EDWARDS PJ, 1992, BMJ-BRIT MED J, V305, P267, DOI 10.1136/bmj.305.6848.267
   *FDN INF MED DEC M, 1994, PSA DEC WHAT YOU NEE
   FRENCH K, 1982, BRIT MED J, V285, P617, DOI 10.1136/bmj.285.6342.617
   GLODE LM, 1994, HOSP PRACT, V29, P10
   GOSTIN LO, 1995, JAMA-J AM MED ASSOC, V274, P844
   HAHN DL, 1993, J FAM PRACTICE, V37, P432
   HAYNES RB, 1993, ANN NY ACAD SCI, V703, P210, DOI 10.1111/j.1749-6632.1993.tb26350.x
   HOLLAND WW, 1993, BRIT MED J, V306, P1222, DOI 10.1136/bmj.306.6887.1222
   HUX JE, 1995, MED DECIS MAKING, V15, P152, DOI 10.1177/0272989X9501500208
   JEYAPRAGASAN M, 1878, CAN FAM PHYSICIAN, V39, P1878
   KRAHN M, 1991, ANN INTERN MED, V115, P248, DOI 10.7326/0003-4819-115-4-248
   LEE JM, 1993, NEW ENGL J MED, V328, P438, DOI 10.1056/NEJM199302113280613
   Lyon H. C.  Jr., 1989, Proceedings: The Thirteenth Annual Symposium on Computer Applications in Medical Care (Cat. No.89TH0286-5), P1043
   Mappes T. A., 1991, BIOMEDICAL ETHICS
   MARSHALL KG, 1993, CAN FAM PHYSICIAN, V39, P2385
   MCCORMICK J, 1988, LANCET, V2, P839
   MCCORMICK J, 1994, LANCET, V344, P390
   OHAGAN J, 1991, NZ MED J, V104, P122
   OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423
   ROBERTS MM, 1989, BRIT MED J, V299, P1153, DOI 10.1136/bmj.299.6708.1153
   ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32
   SCHAPIRA DV, 1993, CANCER, V71, P839, DOI 10.1002/1097-0142(19930201)71:3<839::AID-CNCR2820710329>3.0.CO;2-E
   SKRABANEK P, 1988, LANCET, V1, P1155
   SKRABANEK P, 1990, J MED ETHICS, V16, P187, DOI 10.1136/jme.16.4.187
   SKRABANEK P, 1994, DEATH HUMANE MED, P31
   SOX HC, 1994, NEW ENGL J MED, V330, P1589, DOI 10.1056/NEJM199406023302208
   STEPHENSON MJ, 1993, CAN FAM PHYSICIAN, V39, P745
   STRANDBERG TE, 1991, JAMA-J AM MED ASSOC, V266, P1225, DOI 10.1001/jama.266.9.1225
   *US PREV SERV TASK, 1989, ASS EFF 169 INT
   VEATCH RM, 1989, MED ETHICS
   Vevaina J R, 1993, Dis Mon, V39, P869
   WALDRON G, 1993, BRIT MED J, V307, P500, DOI 10.1136/bmj.307.6902.500-c
   WALSWORTHBELL JP, 1993, BRIT MED J, V307, P1495, DOI 10.1136/bmj.307.6917.1495-a
   WOOLF SH, 1995, NEW ENGL J MED, V333, P1401, DOI 10.1056/NEJM199511233332107
   WOOLF SH, 1993, ARCH INTERN MED, V153, P2646, DOI 10.1001/archinte.153.23.2646
   1994, BRIT MED J, V308, P313
   1994, BRIT MED J, V308, P308
NR 57
TC 27
Z9 27
U1 0
U2 1
PU CANADIAN MEDICAL ASSOCIATION
PI OTTAWA
PA 1867 ALTA VISTA DR, OTTAWA ON K1G 3Y6, CANADA
SN 0820-3946
J9 CAN MED ASSOC J
JI Can. Med. Assoc. J.
PD AUG 15
PY 1996
VL 155
IS 4
BP 377
EP 383
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA VC609
UT WOS:A1996VC60900020
PM 8752062
DA 2018-10-19
ER

PT J
AU Santin, M
   Huang, SJ
   Iannace, S
   Ambrosio, L
   Nicolais, L
   Peluso, G
AF Santin, M
   Huang, SJ
   Iannace, S
   Ambrosio, L
   Nicolais, L
   Peluso, G
TI Synthesis and characterization of a new interpenetrated
   poly(2-hydroxyethylmethacrylate)-gelatin composite polymer
SO BIOMATERIALS
LA English
DT Article
DE poly(2-hydroxyethylmethacrylate); gelatin; interpenetrating polymer
   network; biocompatibility; cell adhesion
ID IMPLANTATION; INVITRO; INVIVO
AB Poly(2-hydroxyethylmethacrylate) [poly(HEMA)] is a widely used biomaterial which does not allow cell adhesion and growth on its surface, limiting its use in biomedical applications in which cell cohesion is detrimental. We have prepared a poly(HEMA)-gelatin composite hydrogel using a sequential interpenetrating polymer network technique. The properties of this material were compared with poly(HEMA) freeze-dried sponges in terms of morphology, mechanical properties and biocompatibility. Moreover, in vivo biocompatibility experiments highlighted the occurrence of cellular interactions on the surface of the poly(HEMA)-gelatin interpenetrating polymer network, which are usually absent when unmodified poly(HEMA) hydrogels are implanted in the same host organism. These tests also showed a progressive gelatin degradation from the surface to the bulk of the poly(HEMA)-gelatin specimens during short-term (7 d) implantation. Finally, in vitro tests confirmed an improved ability of this composite to scaffold for the cells. (C) 1996 Elsevier Science Limited.
C1 CNR,INST PROT BIOCHEM & ENZYMOL,I-80072 ARCO,NAPLES,ITALY.
   UNIV CONNECTICUT,INST MAT SCI,STORRS,CT 06269.
   UNIV NAPLES,DEPT MAT & PROD ENGN,I-80125 NAPLES,ITALY.
OI AMBROSIO, LUIGI/0000-0002-8367-2405; Iannace,
   Salvatore/0000-0003-1487-4983
CR ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   AMUDESWARI S, 1984, EUR POLYM J, V20, P91, DOI 10.1016/0014-3057(84)90230-1
   ANDERSON JM, 1988, ASAIO, V11
   BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403
   CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A
   CIVERCHIAPEREZ L, 1980, P NATL ACAD SCI-BIOL, V77, P2064, DOI 10.1073/pnas.77.4.2064
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P65, DOI 10.1002/jbm.820080308
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   GORHAM SD, 1991, BIOMATERIALS NOVEL M
   JAYANTHI R, 1990, BIOMATERIALS, V11, P238
   KUMAR GS, 1981, J POLYM SCI POL CHEM, V9, P1265
   Pulapura S, 1992, J Biomater Appl, V6, P216, DOI 10.1177/088532829200600303
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   RICHES D, 1988, MOL CELLULAR BIOL WO
   SMETANA K, 1992, BIOMATERIALS, V13, P639, DOI 10.1016/0142-9612(92)90033-K
   Sperling L.H., 1981, INTERPENETRATING POL
   STOL M, 1991, BIOMATERIALS, V12, P454, DOI 10.1016/0142-9612(91)90142-W
   STOL M, 1985, BIOMATERIALS, V6, P193, DOI 10.1016/0142-9612(85)90009-2
   WOERLY S, 1990, BIOMATERIALS, V11, P97, DOI 10.1016/0142-9612(90)90123-8
   ZHAO QH, 1992, J BIOMED MATER RES, V26, P1019, DOI 10.1002/jbm.820260805
NR 21
TC 67
Z9 69
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1996
VL 17
IS 15
BP 1459
EP 1467
DI 10.1016/0142-9612(96)89769-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UZ139
UT WOS:A1996UZ13900001
PM 8853115
DA 2018-10-19
ER

PT J
AU Mitura, S
   Niedzielski, P
   Jachowicz, D
   Langer, M
   Marciniak, J
   Stanishevsky, A
   Tochitsky, E
   Louda, P
   Couvrat, P
   Denis, M
   Lourdin, P
AF Mitura, S
   Niedzielski, P
   Jachowicz, D
   Langer, M
   Marciniak, J
   Stanishevsky, A
   Tochitsky, E
   Louda, P
   Couvrat, P
   Denis, M
   Lourdin, P
TI Influence of carbon coatings origin on the properties important for
   biomedical application
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article
DE carbon coatings; plasma assisted CVD; biomaterials
ID RF DENSE-PLASMA; FILMS; DEPOSITION; CVD
AB The purpose of the present study was to investigate the properties of a carbon layer depending of the origin of applied methods. Quasiamorphous carbon coatings prepared by ion beam methane decomposition by RF dense plasma and vacuum pulsed are deposition were applied to stainless steel implants used in surgery. The studies of carbon films as coatings for implants in surgery were aimed on the investigations of biological resistance of implants, histopathological investigations using laboratory animals, tests of corrosion resistance, measurements of mechanical properties and a breakdown test in Tyrod solution.
   The comparison of the properties of the coating produced by these methods shows very good biotolerance and biocompatibility of all of the coatings. They are not corroded in physiological fluids. From the other side they have different properties, especially electrical and optical, and are not influenced on medical applications. The obtained results prove that the implants coated by all the methods mentioned are a very good material for medical use.
C1 SILESIAN TECH UNIV, INST MET, GLIWICE, POLAND.
   BELARUS ACAD SCI, PLASMOTEG ENGN CTR, MINSK 220141, BYELARUS.
   TECH UNIV LIBEREC, INST SCI MAT, LIBEREC 46117, CZECH REPUBLIC.
   ECOLE CATHOLIQUE ARTS MTIERS, F-69321 LYON 05, FRANCE.
RP Mitura, S (reprint author), TECH UNIV LODZ, INST MAT SCI & ENGN, STEFANOWSKIEGO 1, PL-90924 LODZ, POLAND.
RI Mitura, Stanislaw/L-6013-2014
OI Mitura, Stanislaw/0000-0001-9280-3748; Niedzielski,
   Piotr/0000-0002-6966-9154
CR ANGUS J, 1986, PLASMA DEPOSITED THI
   BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   CHANDRA L, 1995, DIAM RELAT MATER, V4, P852, DOI 10.1016/0925-9635(94)05255-7
   COOPER CV, 1994, DIAM RELAT MATER, V3, P534, DOI 10.1016/0925-9635(94)90219-4
   COUVRAT P, 1995, DIAM RELAT MATER, V4, P1251, DOI 10.1016/0925-9635(95)00307-X
   GRANT DM, 1992, DIAM RELAT MATER, V1, P727, DOI 10.1016/0925-9635(92)90198-W
   GRILL A, 1993, DIAM RELAT MATER, V2, P597, DOI 10.1016/0925-9635(93)90190-D
   KCHOLODNY AK, 1995, COMMUNICATION
   LETTINGTON AH, 1992, DIAM RELAT MATER, V1, P805, DOI 10.1016/0925-9635(92)90104-V
   Marciniak J., 1992, BIOMATERIALY CHIRURG
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MITURA S, 1991, SURF COAT TECH, V47, P106, DOI 10.1016/0257-8972(91)90273-Y
   MITURA S, 1995, DIAM RELAT MATER, V4, P302, DOI 10.1016/0925-9635(94)05203-4
   MITURA S, 1995, ADV SCI TECHNOLOGY, V6, P273
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   TOCHITSKY EI, 1991, SURF COAT TECH, V47, P522, DOI 10.1016/0257-8972(91)90320-V
   TOCHITSKY EI, 1991, SURF COAT TECH, V47, P292, DOI 10.1016/0257-8972(91)90294-7
   WEI RH, 1993, DIAM RELAT MATER, V2, P898, DOI 10.1016/0925-9635(93)90247-Y
   WILLIAMS DF, 1973, IMPLANTS SURG
NR 19
TC 24
Z9 24
U1 1
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
EI 1879-0062
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD AUG
PY 1996
VL 5
IS 10
BP 1185
EP 1188
DI 10.1016/0925-9635(95)00525-0
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA VH527
UT WOS:A1996VH52700018
DA 2018-10-19
ER

PT J
AU Francois, P
   Vaudaux, P
   Foster, TJ
   Lew, DP
AF Francois, P
   Vaudaux, P
   Foster, TJ
   Lew, DP
TI Host-bacteria interactions in foreign body infections
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article; Proceedings Paper
CT 4th International Conference on the Prevention of Infection (CIPI)
CY MAY 06-07, 1996
CL NICE, FRANCE
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; FIBRONECTIN-BINDING-PROTEINS; AUREUS
   COLLAGEN ADHESIN; CLUMPING FACTOR; LIGAND-BINDING; NUCLEOTIDE-SEQUENCE;
   MOLECULAR CHARACTERIZATION; FIBRINOGEN RECEPTOR; BONE SIALOPROTEIN;
   SEPTIC ARTHRITIS
AB Persistent staphylococcal infections are a major medical problem, especially when they occur on implanted materials or intravascular catheters. This review describes some of the recently discovered molecular mechanisms of Staphylococcus aureus attachment to host proteins coating biomedical implants. These interactions involve specific surface proteins, called bacterial adhesins, that recognize specific domains of host proteins deposited on indwelling devices, such as fibronectin, fibrinogen, or fibrin. Elucidation of molecular mechanisms of S aureus adhesion to the different host proteins may lead to the development of specific inhibitors blocking attachment of S aureus, which may decrease the risk of bacterial colonization of indwelling devices.
C1 UNIV HOSP,DIV INFECT DIS,CH-1211 GENEVA 14,SWITZERLAND.
   UNIV GENEVA,APPL PHYS GRP,GENEVA,SWITZERLAND.
   TRINITY COLL DUBLIN,DEPT MICROBIOL,MOYNE INST,DUBLIN,IRELAND.
FU Wellcome Trust
CR BISNO AL, 1994, INFECT ASS INDWELLIN, P398
   BODEN MK, 1994, MOL MICROBIOL, V12, P599, DOI 10.1111/j.1365-2958.1994.tb01046.x
   BOUCHENAKI N, 1990, ANTIMICROB AGENTS CH, V34, P21, DOI 10.1128/AAC.34.1.21
   CHEUNG AI, 1995, INFECT IMMUN, V63, P1914
   CHEUNG AL, 1990, J INFECT DIS, V161, P1177, DOI 10.1093/infdis/161.6.1177
   CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878
   Christensen Gordon D., 1994, P45
   CHUARD C, 1991, ANTIMICROB AGENTS CH, V35, P2611, DOI 10.1128/AAC.35.12.2611
   DELMI M, 1994, J ORTHOPAED RES, V12, P432, DOI 10.1002/jor.1100120316
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   FISCHER B, IN PRESS J ORTHOP RE
   FLOCK JI, 1987, EMBO J, V6, P2351, DOI 10.1002/j.1460-2075.1987.tb02511.x
   Foster T. J., 1994, P31
   FOSTER TJ, 1994, FEMS MICROBIOL LETT, V118, P199, DOI 10.1016/0378-1097(94)90504-5
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x
   GREENE C, IN PRESS MICROBIOLOG
   HERRMANN M, 1990, J CLIN INVEST, V86, P942
   HERRMANN M, 1991, INFECT IMMUN, V59, P279
   HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HOOK M, 1989, FIBRONECTIN, P295
   JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x
   JONSSON K, 1995, J BIOL CHEM, V270, P21457, DOI 10.1074/jbc.270.37.21457
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117
   KUYPERS JM, 1989, INFECT IMMUN, V57, P2306
   LIANG OD, 1993, BIOCHIM BIOPHYS ACTA, V1225, P57, DOI 10.1016/0925-4439(93)90122-H
   LINDBERG M, 1990, MOL BIOL STAPHYLOCOC, P343
   LOPES JD, 1985, SCIENCE, V229, P275, DOI 10.1126/science.3160113
   LUCET JC, 1990, ANTIMICROB AGENTS CH, V34, P2312, DOI 10.1128/AAC.34.12.2312
   MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x
   MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x
   MCGAVIN MJ, 1993, J BIOL CHEM, V268, P23946
   MCGAVIN MJ, 1991, J BIOL CHEM, V266, P8343
   MOREILLON P, 1995, INFECT IMMUN, V63, P4738
   MULLER E, 1993, J INFECT DIS, V168, P1211, DOI 10.1093/infdis/168.5.1211
   PARK PW, 1991, J BIOL CHEM, V266, P23399
   PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021
   PATTI JM, 1995, J BIOL CHEM, V270, P12005, DOI 10.1074/jbc.270.20.12005
   PATTI JM, 1992, J BIOL CHEM, V267, P4766
   PATTI JM, 1994, INFECT IMMUN, V62, P152
   PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177
   PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598
   RAJA RH, 1990, INFECT IMMUN, V58, P2593
   ROZALSKA B, 1994, APMIS, V102, P1
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   RYDEN C, 1989, EUR J BIOCHEM, V184, P331, DOI 10.1111/j.1432-1033.1989.tb15023.x
   SCHAAD HJ, 1994, ANTIMICROB AGENTS CH, V38, P1703, DOI 10.1128/AAC.38.8.1703
   SHIRO H, 1994, J INFECT DIS, V169, P1042, DOI 10.1093/infdis/169.5.1042
   SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699
   SWITALSKI LM, 1993, MOL MICROBIOL, V7, P99, DOI 10.1111/j.1365-2958.1993.tb01101.x
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   VAUDAUX P, 1992, J INFECT DIS, V166, P58, DOI 10.1093/infdis/166.1.58
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
   VAUDAUX PE, 1995, INFECT IMMUN, V63, P585
   Vaudaux Pierre E., 1994, P1
   WALDVOGEL FA, 1995, PRINCIPLES PRACTICE, P1754
   YACOUB A, 1994, EUR J BIOCHEM, V222, P919, DOI 10.1111/j.1432-1033.1994.tb18940.x
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   ZIMMERLI W, 1984, INFECT IMMUN, V46, P625
NR 63
TC 65
Z9 65
U1 0
U2 7
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086
SN 0899-823X
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD AUG
PY 1996
VL 17
IS 8
BP 514
EP 520
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA VE320
UT WOS:A1996VE32000008
PM 8875296
DA 2018-10-19
ER

PT J
AU Kato, K
   Matsumoto, G
   Karasawa, Y
   Niimura, N
   Matsubayashi, M
   Tsuruno, A
AF Kato, K
   Matsumoto, G
   Karasawa, Y
   Niimura, N
   Matsubayashi, M
   Tsuruno, A
TI Neutron radiography of thick hydrogenous materials with use of an
   imaging plate neutron detector
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 2nd International Topical Meeting on Neutron Radiography System Design
   and Characterization
CY NOV 12-18, 1995
CL RIKKYO UNIV, INST ATOM ENERGY, NAGASAKA, JAPAN
SP Inoue Fdn Sci, Atom Energy Soc Japan, Japanese Soc Non Destruct Inspect, Radiat Applicat Dev Assoc, Japan Atom Energy Res Inst, Tokai Estab, Rikkyo Univ, Inst Atom Energy
HO RIKKYO UNIV, INST ATOM ENERGY
DE neutron radiography; imaging plate; water; mouse
AB The value of the neutron mass attenuation coefficient of hydrogen being very high, it is extremely difficult to image normal size, living animals with neutron radiography. However, the authors suggest the possibility of applying neutron radiography for biomedical specimens. The organs in the breast, bones and cartilages in the extremities, and the tail of mice and rats were clearly imaged by neutron radiography with Gd foils as neutron converters and X-ray films. However, no contours of the organs in the mouse abdomen were visible with neutron radiography with an exposure time of 200 s.
   By adding Gd or Li compounds as neutron converters to imaging X-ray plates, imaging plates have been developed for neutron detectors. A trial using these imaging plates for neutron radiography of water-filled containers and the abdomen of mice was completed. The roundness of a 100 ml-beaker was imaged with a neutron exposure of 180 s. Obscure contours of the liver and kidneys of the mouse were imaged with a neutron exposure of 100 s.
C1 NAGOYA UNIV,FAC ENGN,NAGOYA,AICHI 460,JAPAN.
   JAPAN ATOM ENERGY RES INST,ADV SCI RES CTR,TOKAI,IBARAKI 31911,JAPAN.
   JAPAN ATOM ENERGY RES INST,RES REACTOR TECHNOL DEV DIV,TOKAI,IBARAKI 31911,JAPAN.
RP Kato, K (reprint author), INAZAWA CITY HOSP,INAZAWA,AICHI 492,JAPAN.
CR MATSUBAYASHI M, 1994, NEUTRON RADIOGRAPHY (4): INCLUDING RADIOSCOPY AND COMPLEMENTARY INSPECTION METHODS USING NEUTRONS, P415
   Matsumoto G., 1995, Medical Imaging Technology, V13, P885
   MATSUMOTO G, 1994, NEUTRON RADIOGRAPHY (4): INCLUDING RADIOSCOPY AND COMPLEMENTARY INSPECTION METHODS USING NEUTRONS, P333
   NIIMURA N, 1994, NUCL INSTRUM METH A, V349, P521, DOI 10.1016/0168-9002(94)91220-3
NR 4
TC 6
Z9 7
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD JUL 21
PY 1996
VL 377
IS 1
BP 123
EP 125
DI 10.1016/0168-9002(96)00129-5
PG 3
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA UY527
UT WOS:A1996UY52700029
DA 2018-10-19
ER

PT J
AU Bruce, PG
AF Bruce, PG
TI Rechargeable lithium batteries
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article
ID MANGANESE OXIDE CATHODE; INSERTION; LIMN2O4; EXTRACTION; SYSTEM
AB Much of materials electrochemistry represents a fusion of solid-state chemistry and electrochemistry. The commercial success of the world's first rechargeable lithium battery, introduced recently by Sony, is a triumph of materials electrochemistry. By developing radically new anodes, cathodes and electrolytes, a cell has been produced which can store three times the energy per unit weight and volume compared with conventional systems. This represents a revolution in battery technology. The Sony cell was developed in response to a demand from consumer electronic products such as camcorders. The future development of such products, e.g. mobile telephones and lap-top computers, of biomedical devices, such as the artificial heart, and of electric vehicles, is crucially dependent on developing advanced batteries. The markets for many of these devices are vast. The Sony cell is based on the rocking-chair concept and is composed of a carbon anode, LiCoO2 cathode and non-aqueous electrolyte. The advantages and disadvantages of the rocking-chair battery will be compared with those of the rechargeable lithium battery based on a lithium-metal anode. The Sony cell represents merely a first-generation lithium system. Future substantial improvements in performance will also rely on innovative materials electrochemistry. The search for new intercalation cathodes which can offer advantages compared with LiCoO2 are discussed. In particular, the development of new 3 and 4 V cathodes, based on LiMn2O4 spinel materials, is presented. These materials have a number of important advantages which make them attractive as the basis for a new generation of rechargeable lithium batteries. The new synthetic routes to the spinel materials are described, as are the structures, microstructures and electrochemical performance of these materials.
RP Bruce, PG (reprint author), UNIV ST ANDREWS, SCH CHEM, ST ANDREWS KY16 9ST, FIFE, SCOTLAND.
CR BARBOUX P, 1991, J SOLID STATE CHEM, V94, P185, DOI 10.1016/0022-4596(91)90231-6
   BRUCE PG, 1993, RSC 1 INT C MAT CHEM
   Dahn J. R., 1994, LITHIUM BATTERIES NE, P1
   DELMAS C, 1994, LITHIUM BATTERIES NE, P457
   GOODENOUGH JB, 1984, REV CHIM MINER, V21, P435
   HUANG HT, 1994, J ELECTROCHEM SOC, V141, pL76, DOI 10.1149/1.2055042
   HUANG HT, 1995, J POWER SOURCES, V54, P52, DOI 10.1016/0378-7753(94)02039-6
   HUANG HT, 1994, J ELECTROCHEM SOC, V141, pL106, DOI 10.1149/1.2055168
   Linden D., 1984, HDB BATTERIES FUEL C
   MIZUCHIMA K, 1980, MAT RES B, V17, P785
   MOMCHILOV A, 1993, J POWER SOURCES, V41, P305, DOI 10.1016/0378-7753(93)80048-T
   Nagaura T., 1990, 3 INT BATT SEM DEERF
   PISTOIA G, 1993, SOLID STATE IONICS, V66, P135, DOI 10.1016/0167-2738(93)90036-3
   TARASCON JM, 1993, ELECTROCHIM ACTA, V38, P1221, DOI 10.1016/0013-4686(93)80053-3
   THACKERAY MM, 1984, MATER RES BULL, V19, P179, DOI 10.1016/0025-5408(84)90088-6
   THACKERAY MM, 1992, J ELECTROCHEM SOC, V139, P363, DOI 10.1149/1.2069222
   THACKERAY MM, 1983, MATER RES BULL, V18, P461, DOI 10.1016/0025-5408(83)90138-1
   THOMAS MGS, 1985, SOLID STATE IONICS, V18, P794
   THOMAS MGSR, 1985, SOLID STATE IONICS, V17, P13, DOI 10.1016/0167-2738(85)90117-1
   Vetter K. J., 1966, ELECTROCHIM ACTA, V11, P401
NR 20
TC 40
Z9 40
U1 2
U2 15
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD JUL 15
PY 1996
VL 354
IS 1712
BP 1577
EP 1593
DI 10.1098/rsta.1996.0066
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA UZ217
UT WOS:A1996UZ21700008
DA 2018-10-19
ER

PT J
AU Yamamoto, Y
   Sefton, MV
AF Yamamoto, Y
   Sefton, MV
TI Hofmann degradation of acrylamide copolymer: Synthesis of amine
   functionalized thermoplastic hydrogel
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID POLYMER LATEX
AB The amine functionalization of an acrylamide copolymer was achieved via Hofmann degradation. The starting material, poly(acrylamide-co-methyl methacrylate), was synthesized by radical precipitation polymerization. Using this copolymer, Hofmann degradation at 0 degrees C in a water-dioxane mixture was done using sodium hypochlorite and NaOH. The resulting hydrogel could be dissolved in water-tetrahydrofuran mixtures, and the cast film had a water content of 73%. It was found that the conversion to primary amine was lower, and the extent of a side reaction was higher, compared to those of an acrylamide homopolymer. This was presumed to be due to the lack of the neighboring group effect among acrylamide units since it was a random copolymer. Further modification of this polymer by reacting the amine group is considered to obtain the desired properties for biomedical applications. (C) 1996 John Wiley & Sons, Inc.
C1 UNIV TORONTO,DEPT CHEM ENGN & APPL CHEM,TORONTO,ON M5S 1A4,CANADA.
   UNIV TORONTO,CTR BIOMAT,TORONTO,ON M5S 1A4,CANADA.
CR Badesso R. J., 1993, P AM CHEM SOC DIV PO, V69, P251
   BAINES FC, 1968, J POLYM SCI A1, V6, P2433, DOI 10.1002/pol.1968.150060901
   DAWSON DJ, 1976, J AM CHEM SOC, V98, P5996, DOI 10.1021/ja00435a036
   GREENLEY RZ, 1980, J MACROMOL SCI CHEM, VA14, P445, DOI 10.1080/00222338008081032
   HARLAND RS, 1993, J CONTROL RELEASE, V26, P157, DOI 10.1016/0168-3659(93)90184-7
   KAWAGUCHI H, 1984, J COLLOID INTERF SCI, V97, P465, DOI 10.1016/0021-9797(84)90318-7
   KAWAGUCHI H, 1981, J APPL POLYM SCI, V26, P2015, DOI 10.1002/app.1981.070260624
   MARCH J, 1985, ADV ORG CHEM, P983
   OHTSUKA Y, 1981, ACS SYM SER, P145
   RADHAKRISHNA AS, 1979, J ORG CHEM, V44, P1746, DOI 10.1021/jo01324a048
   REYNOLDS DD, 1947, J AM CHEM SOC, V69, P911, DOI 10.1021/ja01196a052
   SAINI G, 1971, MAKROMOLEKUL CHEM, V144, P235
   SEFTON MV, 1992, J CONTROL RELEASE, V19, P289, DOI 10.1016/0168-3659(92)90084-5
   SMETANA KJ, 1993, J BIOMED MATER RES, V24, P463
   TABAL H, 1989, EUR POLYM J, V25, P31
   TANAKA H, 1978, J POLYM SCI POL LETT, V16, P87, DOI 10.1002/pol.1978.130160205
   TANAKA H, 1979, J POLYM SCI POL CHEM, V17, P1239, DOI 10.1002/pol.1979.170170427
   TANAKA K, 1976, THIN SOLID FILMS, V33, P309, DOI 10.1016/0040-6090(76)90100-0
   VYAVAHARE N, 1994, J POLYM SCI POL CHEM, V32, P1271, DOI 10.1002/pola.1994.080320708
NR 19
TC 19
Z9 22
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUL 11
PY 1996
VL 61
IS 2
BP 351
EP 358
DI 10.1002/(SICI)1097-4628(19960711)61:2<351::AID-APP18>3.0.CO;2-6
PG 8
WC Polymer Science
SC Polymer Science
GA UR697
UT WOS:A1996UR69700018
DA 2018-10-19
ER

PT J
AU Goffeng, AR
   Holst, E
   Milsom, I
   Lindstedt, G
   Lundberg, PA
   Andersch, B
AF Goffeng, AR
   Holst, E
   Milsom, I
   Lindstedt, G
   Lundberg, PA
   Andersch, B
TI Fetal fibronectin and microorganisms in vaginal fluid of healthy
   pregnant women
SO ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
LA English
DT Article
DE fetal fibronectin; bacterial vaginosis; hydrogen peroxide-producing
   lactobacilli
ID BACTERIAL VAGINOSIS; PRETERM DELIVERY; GRAM STAIN; LACTOBACILLI;
   MICROFLORA; PREDICTOR; BIRTH; FLORA
AB Objective. To determine fetal fibronectin in vaginal fluid from healthy women during uncomplicated pregnancy and to investigate possible relationships to gestational age and the vaginal microflora.
   Materials and methods. Samples of vaginal fluid were collected for fetal fibronectin determination and for quantitative aerobic and anaerobic microbiological culture from 22 women followed longitudinally at 12, 28 and 37 weeks gestation and cross-sectionally in women at 12 weeks (n=10), 28 weeks (n=10), 37 weeks (n=10), and 39 weeks (n=30) gestation, respectively. Fetal fibronectin was determined by a quantitative enzyme immunoassay (Adeza Biomedical).
   Results. There were no significant differences between the concentrations of fetal fibronectin in vaginal secretions at any of the four measurement points (12, 28, 37 and 39 weeks gestation). Women with elevated fetal fibronectin concentration (greater than or equal to 0.05 mg/L) had less often hydrogen peroxide-producing facultative lactobacilli (p<0.0001), and more often bacterial vaginosis (p<0.02) and Peptostreptococcus species (p<0.002). Bacterial vaginosis (p<0.01) and Candida albicans (p<0.01) were more frequently found in women lacking hydrogen peroxide-producing lactobacilli.
   Conclusion. Fetal fibronectin in vaginal fluid was more associated with the vaginal microflora than with the gestational age of the pregnancy. Presence of hydrogen peroxide-producing lactobacilli seems to be the most important factor for a stable vaginal microflora.
C1 LUND UNIV,DEPT MED MICROBIOL,LUND,SWEDEN.
   GOTHENBURG UNIV,SAHLGRENS UNIV HOSP,DEPT CLIN CHEM & TRANSFUS MED,GOTHENBURG,SWEDEN.
RP Goffeng, AR (reprint author), EAST HOSP,DEPT OBSTET & GYNECOL,S-41685 GOTHENBURG,SWEDEN.
CR EKMAN G, 1995, ACTA OBSTET GYN SCAN, V74, P698, DOI 10.3109/00016349509021177
   ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251
   FEINBERG RF, 1991, AM J PATHOL, V138, P537
   HAY PE, 1994, BRIT J OBSTET GYNAEC, V101, P1048, DOI 10.1111/j.1471-0528.1994.tb13580.x
   HILLIER SL, 1992, OBSTET GYNECOL, V79, P369, DOI 10.1097/00006250-199203000-00008
   HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K
   HOLST E, 1994, J CLIN MICROBIOL, V32, P176
   KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94
   KURKI T, 1992, OBSTET GYNECOL, V80, P173
   LEESON S, 1993, BRIT J OBSTET GYNAEC, V100, P304, DOI 10.1111/j.1471-0528.1993.tb12968.x
   LOCKWOOD CJ, 1993, AM J OBSTET GYNECOL, V169, P798, DOI 10.1016/0002-9378(93)90008-7
   LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001
   MARTIUS J, 1988, OBSTET GYNECOL, V71, P89
   MCCARTHY PE, 1991, NEW ENGL J MED, V325, P727
   NAGEOTTE MP, 1994, AM J OBSTET GYNECOL, V170, P20
   REDONDOLOPEZ V, 1990, REV INFECT DIS, V12, P856
   SPIEGEL CA, 1983, J CLIN MICROBIOL, V18, P170
NR 17
TC 7
Z9 7
U1 0
U2 0
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0001-6349
J9 ACTA OBSTET GYN SCAN
JI Acta Obstet. Gynecol. Scand.
PD JUL
PY 1996
VL 75
IS 6
BP 520
EP 525
DI 10.3109/00016349609054664
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA UZ092
UT WOS:A1996UZ09200003
DA 2018-10-19
ER

PT J
AU Manner, I
   Alanen, A
   Komu, M
   Savunen, T
   Kantonen, I
   Ekfors, T
AF Manner, I
   Alanen, A
   Komu, M
   Savunen, T
   Kantonen, I
   Ekfors, T
TI MR imaging in the presence of small circular metallic implants -
   Assessment of thermal injuries
SO ACTA RADIOLOGICA
LA English
DT Article
DE MR; safety; foreign bodies; experimental
ID BIOMEDICAL IMPLANTS; POTENTIAL HAZARDS; DEVICES
AB Purpose: The thermal effects of MR imaging in the presence of circular nonferromagnetic metallic implants were studied in 6 rabbits.
   Material and Methods: A sternotomy was performed and fixed with stainless steel wires, and small titanium rings (diameter 3 mm) were placed on the surface of the ascending aorta and subcutaneous tissue of the thigh. Four of the rabbits were exposed to an imaging procedure with a 1.5 T scanner applying a T1-weighted spin-echo sequence and a gradient echo sequence. Two of the animals served as unexposed controls. Thirty-six hours after the exposure, tissues adjacent to the implants were examined histologically and compared with corresponding samples of the control animals.
   Results: In the area of the titanium rings, histologic analysis revealed slight inflammatory changes apparently caused by the operation. No evidence of thermal injury was found, suggesting that the presence of the rings does not contraindicate MR examinations. Necrosis was noted in all of the sternal specimens. This was probably postoperative, but it impaired the assessment of thermal injury in this area.
C1 TURKU UNIV,DEPT DIAGNOST RADIOL,FIN-20520 TURKU,FINLAND.
   TURKU UNIV,DEPT SURG,FIN-20520 TURKU,FINLAND.
   TURKU UNIV,DEPT PATHOL,FIN-20520 TURKU,FINLAND.
RP Manner, I (reprint author), TURKU UNIV HOSP,DIAGNOST IMAGING CTR,KIINAMYLLYNKATU 4-8,FIN-20520 TURKU,FINLAND.
CR BOTTOMLEY PA, 1985, MAGNET RESON MED, V2, P336, DOI 10.1002/mrm.1910020404
   BUDINGER TF, 1981, J COMPUT ASSIST TOMO, V5, P800, DOI 10.1097/00004728-198112000-00003
   DARSONVAL MA, 1993, ARCH PHYSL NORM PATH, V5, P401
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   FISCHER H, 1989, RADIOLOGY, V173, P382
   GANGAROSA RE, 1987, MAGN RESON IMAGING, V5, P287, DOI 10.1016/0730-725X(87)90006-3
   HASSLER M, 1986, Journal de Radiologie (Paris), V67, P661
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   Kanal E., 1988, MAGN RESON IMAGIN S1, V7, P106
   MARK AS, 1987, RADIOLOGY, V162, P311, DOI 10.1148/radiology.162.2.3797642
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   Schaefer D.J., 1988, BIOMEDICAL MAGNETIC, P553
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1994, RADIOLOGY, V192, P865, DOI 10.1148/radiology.192.3.8058962
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1987, RADIOLOGY, V163, P259, DOI 10.1148/radiology.163.1.3823445
   SHELLOCK FG, 1990, AM J ROENTGENOL, V154, P1229, DOI 10.2214/ajr.154.6.2110733
   SHELLOCK FG, 1987, RADIOLOGY, V167, P809
   Shellock FG, 1987, RADIOLOGY, V165, P150
   SOULEN RL, 1985, RADIOLOGY, V154, P705, DOI 10.1148/radiology.154.3.3969474
NR 21
TC 10
Z9 10
U1 0
U2 2
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0284-1851
J9 ACTA RADIOL
JI Acta Radiol.
PD JUL
PY 1996
VL 37
IS 4
BP 551
EP 554
PG 4
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA VA958
UT WOS:A1996VA95800015
PM 8688241
DA 2018-10-19
ER

PT J
AU Kishida, A
   Kato, S
   Ohmura, K
   Sugimura, K
   Akashi, M
AF Kishida, A
   Kato, S
   Ohmura, K
   Sugimura, K
   Akashi, M
TI Evaluation of biological responses to polymeric biomaterials by RT-PCR
   analysis .1. Study of IL-1 beta mRNA expression
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; macrophage; IL-I beta; mRNA; RT-PCR
ID BIOMEDICAL POLYMERS; MONOCYTES MACROPHAGES
AB In this study, we introduce a novel research methodology, the evaluation of mRNA expression of cells contacting with polymeric materials using reverse transcription-polymerase chain reaction (RT-PCR) analysis HL-60 was used as a model of the macrophages. The expression of interleukin-1 beta (IL-1 beta) mRNA, a cytokine secreted by macrophages, was selected to estimate the extent of inflammation. The expression of IL-1 beta mRNA in the HL60 cells cultured on various substrates and in Various conditions was studied. Expression of IL-1 beta could be successfully determined by RT-PGR analysis. A 48 h incubation period was necessary to clarify the expression of IL-1 beta mRNA. It became clear that lipopolysaccharide stimulation was not necessary in this analysis because of the high sensitivity of RT-PCR analysis. It is concluded that RT-PCR analysis is a powerful tool for studying cell-polymer interaction, and is a complementary method for ELISA. (C) 1996 Elsevier Science Limited
RP Kishida, A (reprint author), KAGOSHIMA UNIV,FAC ENGN,DEPT APPL CHEM & CHEM ENGN,1-21-40 KORIMOTO,KAGOSHIMA 890,JAPAN.
CR BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   FALCK P, 1995, BIOMATERIALS, V16, P61, DOI 10.1016/0142-9612(95)91097-I
   Ikada Y, 1986, J BIOACT COMPAT POL, V1, P32
   KISHIDA A, 1991, BIOMATERIALS, V12, P786, DOI 10.1016/0142-9612(91)90031-5
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NAGAHARA S, 1994, SOC POLYM SCI JAPAN, V23, P53
   NAKAJIMA T, 1993, J CLIN INVEST, V92, P186, DOI 10.1172/JCI116548
   TABATA Y, 1989, J COLLOID INTERF SCI, V127, P132, DOI 10.1016/0021-9797(89)90013-1
   TABATA Y, 1988, BIOMATERIALS, V9, P35
   TAMADA Y, 1986, POLYM MED, V2, P101
NR 17
TC 33
Z9 33
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1996
VL 17
IS 13
BP 1301
EP 1305
DI 10.1016/0142-9612(96)88675-3
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UT734
UT WOS:A1996UT73400006
PM 8805977
DA 2018-10-19
ER

PT J
AU Li, YJ
   Matthews, KH
   Chen, TM
   Wang, YF
   Kodama, M
   Nakaya, T
AF Li, YJ
   Matthews, KH
   Chen, TM
   Wang, YF
   Kodama, M
   Nakaya, T
TI Novel blood-compatible polyurethanes containing poly(butadiene) soft
   segments and phosphatidylcholine analogues for biomedical applications
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID PHOSPHOLIPID ANALOG; ALBUMIN ADSORPTION; SURFACE; CHAIN;
   PHOSPHORYLCHOLINE; BIOSTABILITY; COPOLYMERS; ADHESION; POLYMERS; BOND
AB New segmented polyurethanes (SPUs) based on stearyl and phosphatidylcholine analogues were synthesized. The soft segments used in this study were the poly(butadiene) (PBD) glycol, the hard segments of these SPUs were composed of 4,4'-methylenediphenyl diisocyanate (MDI), 2-[bis(2-hydroxyethyl)methylammonio]ethy stearylphosphate (BESP), and 1,4-butanediol (BD). The bulk and surface characterization was investigated by differential scanning calorimetry (DSC), X-ray diffraction, attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR), and contact angle measurements. The mechanical properties were investigated by dynamic viscoelasticity and tensile property experiments. The blood compatibilities of the new SPUs were evaluated by platelet-rich plasma (PRP) contact studies and viewed by scanning electron microscopy(SEM). The results show that this new material has good mechanical strength with an elongation at break of 252%, and the blood compatibilities of the SPUs have a great difference between the glass contact side and air-exposed side for the same cast films. The hot-pressed films, having same polyimide contact surface, show that the phospholipid SPU is a favorable surface in terms of platelet adhesion and that the morphology of adhered platelets undergoes a relatively low degree of variation. The clotting time of the cast films contacting with PRP was more than 240 s for the new polymers and 122 and 86 s for polystyrene and glass, respectively.
C1 OSAKA CITY UNIV,FAC ENGN,DEPT BIOAPPL CHEM,SUMIYOSHI KU,OSAKA 558,JAPAN.
   NATL INST ADV INTERDISCIPLINARY RES,BION DESIGN GRP,TSUKUBA,IBARAKI 305,JAPAN.
OI Matthews, Kerr/0000-0002-8503-7157
CR BORETOS JW, 1972, J BIOMED MATER RES, V6, P473, DOI 10.1002/jbm.820060513
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BORETOS JW, 1982, 8TH P ANN SOC BIOM, P24
   CHAPMAN D, 1984, Patent No. 199790
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   COURY AJ, 1984, ADV URETHANE SCI TEC, V9, P130
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DURANI AA, 1986, Patent No. 275293
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   EBERHART RC, 1987, ARTIF ORGANS, V11, P375
   ESTES GM, 1970, J MACROMOL SCI-REV M, VC  4, P313
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   Lelah M. D., 1986, POLYURETHANES MED
   LETOURNEUR D, 1991, J POLYM SCI POL CHEM, V29, P1367, DOI 10.1002/pola.1991.080291001
   LI YJ, 1995, MACROMOL CHEM PHYSIC, V196, P3143, DOI 10.1002/macp.1995.021961006
   LI YJ, 1995, MACROMOL RAPID COMM, V16, P253, DOI 10.1002/marc.1995.030160404
   LI YJ, IN PRESS BIOMATERIAL
   LI YJ, IN PRESS J BIOMATER
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   MARCONI W, 1994, MACROMOL CHEM PHYS, V195, P875, DOI 10.1002/macp.1994.021950306
   MCMILLIN CR, 1989, IEEE ENG MED BIO JUN, P30
   MUNRO MS, 1983, ASAIO J, V6, P65
   NAKAI S, 1977, MAKROMOL CHEM, V178, P2963
   NAKAYA T, 1987, KAGAKU, V42, P725
   NAKAYA T, 1986, Patent No. 207395
   OBRIEN DF, 1989, ENCY POLYM SCI ENG, V17, P108
   PITT WG, 1988, BIOMATERIALS, V9, P36, DOI 10.1016/0142-9612(88)90067-1
   Planck H, 1987, PROGR BIOMEDICAL ENG
   RAHMAN R, 1989, J POLYM SCI POL CHEM, V27, P2673, DOI 10.1002/pola.1989.080270815
   SAKURAI I, 1992, MACROMOLECULES, V25, P7256, DOI 10.1021/ma00052a029
   Saunders J. H., 1962, POLYURETHANES CHEM 1
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P195
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   STRIZINAR I, 1992, J BIOMED MATER RES, V26, P577
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
   TAKAHARA A, 1988, ARTIFICIAL HEART, V2, P19
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P635
   UMEDA T, 1982, MAKROMOL CHEM-RAPID, V3, P457
   VALENCIA GP, 1985, Patent No. 247114
   YAMADA M, 1995, MACROMOL RAPID COMM, V16, P25, DOI 10.1002/marc.1995.030160105
   YAMADA M, 1995, J MACROMOL SCI PURE, VA32, P1235, DOI 10.1080/10601329508009351
   YAMADA M, 1985, 50 SPRING M JPN CHEM, V2, P1582
   YAMADA M, 1986, 52 SPRING M JPN CHEM, V2, P793
NR 50
TC 39
Z9 40
U1 1
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD JUL
PY 1996
VL 8
IS 7
BP 1441
EP 1450
DI 10.1021/cm960014x
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA VA057
UT WOS:A1996VA05700018
DA 2018-10-19
ER

PT J
AU Thompson, JY
   Bayne, SC
   Swift, EJ
AF Thompson, JY
   Bayne, SC
   Swift, EJ
TI Dental materials citations .A. January to June 1996
SO DENTAL MATERIALS
LA English
DT Bibliography
AB Objective. A search was conducted to identify the denial materials publications that appeared in biomedical journals from January 1996 to June 1996 and to compare the frequency of citations among the different categories.
   Methods. The tables of contents of 16 primary journals and 48 secondary journals were examined to identify dental materials articles that were published from January to June 1996. These citations were divided into 17 categories and the numbers of citations in each category were compared. To assess the usefulness of the citation listing, a survey of Academy of Dental Materials subscribers was conducted (n= 153 of 382 or 40.1% have responded to date).
   Results. As in previous years, the greatest number of citations were found in categories of bonding (n=83) and resin-based restorative materials such as composites and resin-reinforced glass ionomers (n=80). Results of the reader survey indicated that 84.3% of the respondents have used the citations lists, and 95.4% feel that its publication should be continued.
   Significance. The literature compiled in this list serves to supplement the electronic indexing mechanisms so that academicians and researchers can have ready access to the current literature in the field of dental materials.
RP Thompson, JY (reprint author), UNIV N CAROLINA,SCH DENT,DEPT OPERAT DENT,CB 7450,BRAUER HALL,CHAPEL HILL,NC 27599, USA.
NR 0
TC 8
Z9 8
U1 0
U2 1
PU ACAD DENTAL MATERIALS
PI DALLAS
PA BAYLOR COLLEGE DENTISTRY, 3302 GASTON AVE, DALLAS, TX 75266-0677
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD JUL
PY 1996
VL 12
IS 4
BP 272
EP 286
DI 10.1016/S0109-5641(96)80034-0
PG 15
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA VQ333
UT WOS:A1996VQ33300009
PM 9002846
DA 2018-10-19
ER

PT J
AU Mitura, E
   Niedzielska, A
   Niedzielski, P
   Klimek, L
   Rylski, A
   Mitura, S
   Moll, J
   Pietrzykowski, W
AF Mitura, E
   Niedzielska, A
   Niedzielski, P
   Klimek, L
   Rylski, A
   Mitura, S
   Moll, J
   Pietrzykowski, W
TI The properties of carbon layers deposited onto titanium substrates
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th European Conference on Diamond, Diamond-like and Related Materials
   (Diamond Films 95)
CY SEP 10-15, 1995
CL BARCELONA, SPAIN
DE amorphous carbon; adhesion; biomaterial; biomedical applications;
   interface
ID RF DENSE-PLASMA; COATINGS; FILMS
AB Thin, hard, amorphous carbon layers, deposited using a dense r.f. methane plasma onto titanium substrate, were investigated. This includes an examination of the interface between the carbon layer and the substrate and the optimization of the process and its application.
   The substrates coated with carbon layers were analysed by Auger electron spectroscopy (AES) and scanning electron microscopy (SEM). Results of AES studies show that the surface layer, several thousand angstroms thick, consists of carbon. The carbon film passes smoothly into a thick layer (about 1 mu m) consisting of titanium carbide. The composition varies across the transitional layer between carbon and carbide regions. This coating structure ensures a high mechanical strength and very good adhesion to Ti substrates. These coatings also protect metal implants against corrosion, and protect man from a serious illness, metallosis.
   Preliminary,investigations in vivo and in vitro confirm the biocompatibility of the C/TiC/Ti system and its biointegration. In addition, investigations of the mechanical, anticorrosive and structural properties of the coatings, deposited using a dense methane plasma excited in an r.f. electric field, show that this can be a very good material to apply in cardiovascular surgery.
   The r.f. decomposition of methane seems to be a very convenient method for the production of superhard carbon coatings on Ti substrates for medical applications.
C1 TECH UNIV LODZ,INST MAT SCI & ENGN,PL-90924 LODZ,POLAND.
   MED ACAD LODZ,PAEDIAT CARDIAC SURG DEPT,PL-93338 LODZ,POLAND.
RP Mitura, E (reprint author), TECH UNIV LODZ,FAC PROC & ENVIRONM ENGN,WOLCZANSKA 175,PL-90924 LODZ,POLAND.
RI Mitura, Stanislaw/L-6013-2014; Klimek, Leszek/K-5958-2015
OI Mitura, Stanislaw/0000-0001-9280-3748; Klimek,
   Leszek/0000-0003-3617-8225; Niedzielski, Piotr/0000-0002-6966-9154
CR ANGUS J, 1986, PLASMA DEPOSITED THI
   CHUAN CC, 1974, CHARACTERIZATION SOL, P534
   COOPER CV, 1994, DIAM RELAT MATER, V3, P534, DOI 10.1016/0925-9635(94)90219-4
   COUVRAT P, 1995, DIAM RELAT MATER, V4, P1251, DOI 10.1016/0925-9635(95)00307-X
   GRIL A, 1994, DIAM RELAT MATER, V2, P597
   LETTINGTON AH, 1992, DIAM RELAT MATER, V1, P805, DOI 10.1016/0925-9635(92)90104-V
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MITURA S, 1991, SURF COAT TECH, V47, P106, DOI 10.1016/0257-8972(91)90273-Y
   MITURA S, 1995, DIAM RELAT MATER, V4, P302, DOI 10.1016/0925-9635(94)05203-4
   MITURA S, 1995, ADV SCI TECHNOLOGY, V6, P273
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   WEI R, 1994, DIAM RELAT MATER, V2, P898
NR 12
TC 19
Z9 20
U1 1
U2 14
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD JUL
PY 1996
VL 5
IS 9
BP 998
EP 1001
DI 10.1016/0925-9635(95)00469-6
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA VA325
UT WOS:A1996VA32500022
DA 2018-10-19
ER

PT J
AU Barnes, RM
AF Barnes, RM
TI Analytical plasma source mass spectrometry in biomedical research
SO FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 29th International Colloquium on Spectroscopy
CY AUG 27-SEP 01, 1995
CL LEIPZIG, GERMANY
ID ELEMENTAL SPECIATION; ANION-EXCHANGE; CHROMATOGRAPHY; LEAD;
   METALLOPORPHYRINS
AB The features of inductively coupled plasma-mass spectrometry (ICP-MS) that make it unique also make possible applications in biological chemistry and biomedical research that would be otherwise difficult or impossible. High sensitivity, characterized spectral interferences, rapid mass scanning, and individual isotope measurements are now combined with sophisticated sample preparation, separations, or stable isotope additions to achieve rapid semi-quantitative analysis, element speciation, and high accuracy. The semi-quantitative analysis of various materials, the separation and detection of macromolecules in blood and other tissues, and tracking of stable isotopes added either purposely or inadvertently to children are important applications of ICP-MS. Current functional limitations and obstacles and potential development areas also are examined.
RP Barnes, RM (reprint author), UNIV MASSACHUSETTS,LEDERLE GRAD RES CTR,DEPT CHEM,BOX 34510,AMHERST,MA 01003, USA.
CR ALLAIN P, 1992, BIOL MASS SPECTROM, V21, P141, DOI 10.1002/bms.1200210305
   AMARASIRIWARDEN.D, 1995, UNPUB APPL SPECTROSC
   ARAR EJ, 1992, ENVIRON SCI TECHNOL, V26, P1944, DOI 10.1021/es00034a010
   BACON JR, 1944, J ANAL ATOM SPECTROM, V9, pR267
   BARNES RM, 1993, ANAL CHIM ACTA, V283, P115, DOI 10.1016/0003-2670(93)85214-5
   BEARY ES, 1994, J ANAL ATOM SPECTROM, V9, P1363, DOI 10.1039/ja9940901363
   BEARY ES, 1994, ANAL CHEM, V66, P431, DOI 10.1021/ac00076a004
   BROWINS RJ, 1994, J ANAL ATOM SPECTROM, V9, P1233
   Cairns W. R. L., 1994, Analytical Proceedings, V31, P295, DOI 10.1039/ai9943100295
   CLELAND SL, 1994, J ANAL ATOM SPECTROM, V9, P975, DOI 10.1039/ja9940900975
   CORNELIS R, 1994, J ANAL ATOM SPECTROM, V9, P945, DOI 10.1039/ja9940900945
   CORNELIS R, 1993, ANAL CHIM ACTA, V283, P183, DOI 10.1016/0003-2670(93)85221-5
   CRESSER MS, 1995, J ANAL ATOM SPECTROM, V10, pR9, DOI 10.1039/ja995100009r
   CREWS HM, 1994, ANALYST, V119, P2491, DOI 10.1039/an9941902491
   CREWS HM, 1993, AM LAB, V25
   DAMS R, 1994, BIOL TRACE ELEM RES, V42, P539
   DAUVHY X, 1993, J CHROMATOGR SCI, V31, P416
   DEAN JR, 1994, J ANAL ATOM SPECTROM, V9, P615, DOI 10.1039/ja9940900615
   DEBIEVRE P, 1993, MASS SPECTROM REV, V12, P143, DOI 10.1002/mas.1280120302
   DEBIEVRE P, 1993, ANAL PROC, V30, P328
   DENOYER ER, 1995, ATOM SPECTROSC, V16, P1
   DONARD OFX, 1993, ENV ANAL TECHNIQUES, P549
   EVANS EH, 1993, J ANAL ATOM SPECTROM, V8, P1, DOI 10.1039/ja9930800001
   EVANS S, 1994, J ANAL ATOM SPECTROM, V9, P1249, DOI 10.1039/ja9940901249
   FELDMANN I, 1994, J ANAL ATOM SPECTROM, V9, P1007, DOI 10.1039/ja9940901007
   FORSTNER U, 1993, INT J ENVIRON AN CH, V51, P5, DOI 10.1080/03067319308027608
   GARCIAALONSO JI, 1993, ANAL CHIM ACTA, V283, P261, DOI 10.1016/0003-2670(93)85231-8
   GODLEWSKA B, 1993, CHEM ANAL-WARSAW, V38, P267
   GOOSSENS J, 1993, J ANAL ATOM SPECTROM, V8, P921, DOI 10.1039/ja9930800921
   GRAY AL, 1994, ANAL PROC, V31, P371
   GREGOIRE DC, 1994, J ANAL ATOM SPECTROM, V9, P393, DOI 10.1039/ja9940900393
   GRIEND CES, 1994, J CHROMATOGR A, V673, P299
   HALICZ L, 1994, SPECTROCHIM ACTA B, V49, P637, DOI 10.1016/0584-8547(94)80057-X
   HARALDSSON C, 1994, J ANAL ATOM SPECTROM, V9, P1229, DOI 10.1039/ja9940901229
   HEUMANN KG, 1994, J ANAL ATOM SPECTROM, V9, P1351, DOI 10.1039/ja9940901351
   HIGH KA, 1995, FRESEN J ANAL CHEM, V351, P393, DOI 10.1007/BF00322908
   HIGH KA, 1995, ANALYST, V120, P629, DOI 10.1039/an9952000629
   HILL SJ, 1993, J ANAL ATOM SPECTROM, V8, P499, DOI 10.1039/ja9930800499
   HOLLAND G, 1993, APPL PLASMA SOURCE M, V2
   HORLICK G, 1944, J ANAL ATOM SPECTROM, V9, P593
   HUANG CW, 1994, J ANAL ATOM SPECTROM, V9, P681
   INOUE Y, 1995, J ANAL ATOM SPECTROM, V10, P363, DOI 10.1039/ja9951000363
   JAKUBOWSKI N, 1994, J ANAL ATOM SPECTROM, V9, P193, DOI 10.1039/ja9940900193
   KRAUSE P, 1993, FRESEN J ANAL CHEM, V346, P324
   KUMAR U, 1994, J CHROMATOGR SCI, V32, P282, DOI 10.1093/chromsci/32.7.282
   LARSEN EH, 1994, J ANAL ATOM SPECTROM, V9, P1099, DOI 10.1039/ja9940901099
   LARSEN EH, 1993, J ANAL ATOM SPECTROM, V8, P1075, DOI 10.1039/ja9930801075
   LE SXC, 1994, ENVIRON SCI TECHNOL, V28, P1598, DOI 10.1021/es00058a010
   LIU Y, 1995, ANAL CHEM, V67, P2020, DOI 10.1021/ac00109a019
   LIU Y, 1993, HRC-J HIGH RES CHROM, V16, P717
   LORD CJ, 1994, J ANAL ATOM SPECTROM, V9, P599, DOI 10.1039/ja9940900599
   LU PL, 1993, ANAL CHIM ACTA, V284, P181, DOI 10.1016/0003-2670(93)80022-D
   LU QH, 1995, ANAL CHEM, V67, P2949, DOI 10.1021/ac00113a033
   MAURAS Y, 1993, CLIN CHIM ACTA, V218, P201, DOI 10.1016/0009-8981(93)90184-6
   MCKAY K, 1993, CANCER SURV, V17, P407
   MELLON FA, 1993, ANAL CHIM ACTA, V283, P190, DOI 10.1016/0003-2670(93)85222-6
   MOENS L, 1994, J ANAL ATOM SPECTROM, V9, P187, DOI 10.1039/ja9940900187
   MOENS L, 1994, J ANAL ATOM SPECTROM, V9, P1075, DOI 10.1039/ja9940901075
   MORITA M, 1994, ANAL CHEM, V66, P1588, DOI 10.1021/ac00081a038
   OLESIK JW, 1995, ANAL CHEM, V67, P1, DOI 10.1021/ac00097a003
   Pais Istvan, 1994, P73, DOI 10.1002/9783527615872.ch3
   Perry B. J., 1994, Analytical Proceedings, V31, P269, DOI 10.1039/ai9943100269
   PLATZNER I, 1994, J ANAL ATOM SPECTROM, V9, P719, DOI 10.1039/ja9940900719
   PRETORIUS W, 1993, HRC-J HIGH RES CHROM, V16, P157
   PRETORIUS WG, 1993, J CHROMATOGR, V646, P369, DOI 10.1016/0021-9673(93)83350-2
   REED NM, 1994, J ANAL ATOM SPECTROM, V9, P881, DOI 10.1039/ja9940900881
   ROTTMANN L, 1994, ANAL CHEM, V66, P3709, DOI 10.1021/ac00093a027
   ROTTMANN L, 1994, FRESEN J ANAL CHEM, V350, P221, DOI 10.1007/BF00322473
   SCHONEICH C, 1995, ANAL CHEM, V67, pR155, DOI 10.1021/ac00108a009
   SEUBERT A, 1994, FRESEN J ANAL CHEM, V350, P210, DOI 10.1007/BF00322472
   SHEPPARD BS, 1994, J ANAL ATOM SPECTROM, V9, P145, DOI 10.1039/ja9940900145
   SHUM SCK, 1993, ANAL CHEM, V65, P2972, DOI 10.1021/ac00069a006
   SMITH RD, 1993, ANAL CHEM, V65, pA574, DOI 10.1021/ac00061a001
   STROH A, 1993, ATOM SPECTROSC, V14, P141
   SUBRAMANIAN KNS, 1955, KINETIC MODELS TRACE
   TANNER SD, 1995, ATOM SPECTROSC, V16, P16
   TAYLOR A, 1994, J ANAL ATOM SPECTROM, V9, pR87, DOI 10.1039/ja994090087r
   TEMPLETON DM, 1994, SCI TOTAL ENVIRON, V148, P253, DOI 10.1016/0048-9697(94)90401-4
   THOMPSON JJ, 1993, J AOAC INT, V76, P1378
   THORMANN W, 1994, ELECTROPHORESIS, V15, P3, DOI 10.1002/elps.1150150103
   TITTES W, 1994, J ANAL ATOM SPECTROM, V9, P1015, DOI 10.1039/ja9940901015
   TOLG G, 1993, ANAL CHIM ACTA, V283, P3, DOI 10.1016/0003-2670(93)85206-Y
   TOMLINSON MJ, 1995, ANALYST, V120, P583, DOI 10.1039/an9952000583
   TOMLINSON MJ, 1994, J ANAL ATOM SPECTROM, V9, P657
   VANDECASTEELE C, 1993, J ANAL ATOM SPECTROM, V8, P781, DOI 10.1039/ja9930800781
   VANHOE H, 1993, J TRACE ELEM ELECT H, V7, P131
   VANHOE H, 1994, J ANAL ATOM SPECTROM, V9, P177, DOI 10.1039/ja9940900177
   VANHOE H, 1994, J ANAL ATOM SPECTROM, V9, P23, DOI 10.1039/ja9940900023
   VELA NP, 1993, ANAL CHEM, V65, pA585, DOI 10.1021/ac00061a002
   Vighi M, 1993, Ann Ist Super Sanita, V29, P209
   VOLLKOPF U, 1995, ATOM SPECTROSC, V16, P19
   WALDER AJ, 1993, ANAL SCI, V9, P675, DOI 10.2116/analsci.9.675
   WASTNEY ME, 1995, UNPUB AM J PHYSL
   WILLIAMS CA, 1995, ANALYST, V120, P341, DOI 10.1039/an9952000341
   WOLF RE, 1995, ATOM SPECTROSC, V16, P22
   XIAO G, 1994, J ANAL ATOM SPECTROM, V9, P509, DOI 10.1039/ja9940900509
   XU Y, 1995, ANAL CHEM, V67, pR436
   YAMASAKI S, 1994, MICROCHEM J, V49, P305, DOI 10.1006/mchj.1994.1042
   ZHAO Z, 1993, J CHROMATOGR-BIOMED, V615, P83, DOI 10.1016/0378-4347(93)80293-D
NR 99
TC 34
Z9 33
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0937-0633
J9 FRESEN J ANAL CHEM
JI Fresenius J. Anal. Chem.
PD JUL
PY 1996
VL 355
IS 5-6
BP 433
EP 441
PG 9
WC Chemistry, Analytical
SC Chemistry
GA UV610
UT WOS:A1996UV61000003
DA 2018-10-19
ER

PT J
AU Dang, MH
   Birchler, F
   Ruffieux, K
   Wintermantel, E
AF Dang, MH
   Birchler, F
   Ruffieux, K
   Wintermantel, E
TI Toxicity screening of biodegradable polymers .1. Selection and
   evaluation of cell culture test methods
SO JOURNAL OF ENVIRONMENTAL POLYMER DEGRADATION
LA English
DT Article
DE toxicity screening; biodegradable polymers; cell cultures; test with
   extract
AB A screening test method for potential toxicity of biodegradable plastics on humans and the environment was selected and evaluated with samples of cellulose acetate, Bionolle, polyhydroxybutyrate-co-valerate (Biopol), and polycaprolactone (Tone polymer). Among the standard in vitro tests using animal cell cultures for the evaluation of biomedical materials, the test by direct contact and the test with extract were examined. Qualitative and quantitative determinations of the cell viability and morphology indicate that the test with extracts can be easily performed, providing reproducible and comparable results for all materials. Using the cell culture test with the extract of sterile samples, an estimation of the toxicity of a new polymeric material can be obtained within a few weeks.
RP Dang, MH (reprint author), ETH ZURICH, CHAIR BIOCOMPATIBLE MAT SCI & ENGN, WAGISTR 23, SCHLIEREN, SWITZERLAND.
CR [Anonymous], ASTM STAND
   [Anonymous], ISO109935 5
   Matthews I. P., 1994, Clinical Materials, V15, P191, DOI 10.1016/0267-6605(94)90082-5
   Petitmermet M, 1995, BIOREMED SER, V3, P223
   WAN H, 1994, J MATER SCI-MATER M, V5, P154, DOI 10.1007/BF00053336
NR 5
TC 9
Z9 9
U1 0
U2 6
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1064-7546
J9 J ENVIRON POLYM DEGR
JI J. Environ. Polym. Degrad.
PD JUL
PY 1996
VL 4
IS 3
BP 197
EP 203
DI 10.1007/BF02067453
PG 7
WC Engineering, Environmental; Polymer Science
SC Engineering; Polymer Science
GA VC286
UT WOS:A1996VC28600006
DA 2018-10-19
ER

PT J
AU Miller, JM
   Dunn, B
   Valentine, JS
   Zink, JI
AF Miller, JM
   Dunn, B
   Valentine, JS
   Zink, JI
TI Synthesis conditions for encapsulating cytochrome c and catalase in SiO2
   sol-gel materials
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
ID GLUCOSE BIOSENSOR; SILICA-GEL; GLASSES; ENZYMES; IMMOBILIZATION
AB The encapsulation of biological molecules in sol-gel materials has led to the development of a new class of chemical and biomedical sensors. The influence of sol-gel synthesis conditions on the stability, chemical function, and enzymatic reactivity for horse heart cytochrome c and bovine liver catalase encapsulated in silica sol-gel materials was studied. The effects of synthesis pH, alcohol/alkoxide ratio, and buffer type were examined using UV-Vis absorption spectroscopy for cytochrome c-doped materials and gasometric analysis for assays of catalase in gels. In general, the behavior of the proteins encapsulated in silica gels mirrored their behavior in solution suggesting that the stability limiting factor for encapsulating these biological molecules is determined by the solution stability of the protein. In the case of catalase, the results indicate that the silica gel stabilizes the encapsulated enzyme to higher methanol concentrations.
C1 UNIV CALIF LOS ANGELES,DEPT MAT SCI & ENGN,LOS ANGELES,CA 90095.
   UNIV CALIF LOS ANGELES,DEPT CHEM & BIOCHEM,LOS ANGELES,CA 90095.
RI Valentine, Joan/B-6665-2008
OI Valentine, Joan/0000-0002-7174-925X
CR Adar F., 1978, PORPHYRINS A, P167
   AUDEBERT P, 1993, CHEM MATER, V5, P911, DOI 10.1021/cm00031a005
   AVNIR D, 1992, ACS SYM SER, V499, P384
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   BERNARDS TNM, 1991, J NON-CRYST SOLIDS, V134, P1, DOI 10.1016/0022-3093(91)90005-Q
   Bertini I., 1994, BIOINORG CHEM, P611
   BRAUN S, 1990, MATER LETT, V10, P1, DOI 10.1016/0167-577X(90)90002-4
   Brinker C. J., 1990, SOL GEL SCI PHYSICS, P97
   CHUNG KE, 1995, ANAL CHEM, V67, P1505, DOI 10.1021/ac00105a004
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   GLEZER V, 1993, J AM CHEM SOC, V115, P2533, DOI 10.1021/ja00059a072
   KLEIN LC, 1985, ANNU REV MATER SCI, V15, P227
   KLEIN LC, 1984, J NON-CRYST SOLIDS, V63, P23, DOI 10.1016/0022-3093(84)90383-1
   KUROKAWA Y, 1994, CARBOHYD POLYM, V23, P1, DOI 10.1016/0144-8617(94)90083-3
   KUROKAWA Y, 1993, BIOTECHNOL BIOENG, V42, P394, DOI 10.1002/bit.260420318
   LAN E, 1994, THESIS UCLA
   Lapange S., 1978, PHYSICOCHEMICAL ASPE, P331
   MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357
   NARANG U, 1994, CHEM MATER, V6, P1596, DOI 10.1021/cm00046a004
   NARANG U, 1994, ANAL CHEM, V66, P3139, DOI 10.1021/ac00091a023
   SCHONBAUM GR, 1976, OXIDATION REDUCTIO C, V13, P542
   TATSU Y, 1992, CHEM LETT, P1615, DOI 10.1246/cl.1992.1615
   Theorell H, 1941, J AM CHEM SOC, V63, P1804, DOI 10.1021/ja01852a005
   UNO T, 1984, BIOCHEMISTRY-US, V23, P6802, DOI 10.1021/bi00321a081
   Uo M., 1992, J CERAM SOC JPN, V100, P426
   VEGA AJ, 1989, J NON-CRYST SOLIDS, V111, P153, DOI 10.1016/0022-3093(89)90276-7
   VOET D, 1990, BIOCHEMISTRY
   WU SG, 1994, APPL BIOCHEM BIOTECH, V47, P11, DOI 10.1007/BF02788671
NR 29
TC 73
Z9 75
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD JUL
PY 1996
VL 202
IS 3
BP 279
EP 289
DI 10.1016/0022-3093(96)00191-3
PG 11
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA VF407
UT WOS:A1996VF40700010
DA 2018-10-19
ER

PT J
AU Hjelle, MA
   Bauer, MA
AF Hjelle, MA
   Bauer, MA
TI Characteristics of an ultrafiltered deionized water system used in the
   manufacture of implantable biomedical devices
SO JOURNAL OF THE INSTITUTE OF ENVIRONMENTAL SCIENCES
LA English
DT Article
DE ultrapure water; endotoxin; total oxidizable carbon (TOC); bacteria;
   deionized; ultrafilter (UF)
AB The purpose of this paper is to demonstrate the characteristics of an ultrafiltered deionized water system used in the manufacture of biomedical devices. The water system was designed to reduce product concerns with respect to ionic contamination, organic contamination, and microbial contamination. The goal of the system was to produce high-purity deionized water that exceeded the requirements of USP pure water and meet the manufacturing requirements of electronic device assembly. This goal was achieved by using a compact design, select materials of construction, and robust pretreatment to reduce the bur-den to the ultrafiltration system. Continuous supply is delivered to all points of use through balanced pressures within the system and without a bulk storage tank. System maintenance is reduced to routine daily monitoring and sanitization once per month. Detailed descriptions of the system design, system operating conditions, and variable data are included to demonstrate system performance.
RP Hjelle, MA (reprint author), MEDTRONIC INC,CHEM SERV,MINNEAPOLIS,MN, USA.
CR COLLENTRO WV, 1987, ULTRAPURE WATER, V4, P40
   LORCH W, 1981, HDB WATER PURIFICATI, P516
   1990, USP, V22
NR 3
TC 0
Z9 0
U1 0
U2 1
PU INST ENVIRONMENTAL SCI
PI MT PROSPECT
PA 940 E NORTHWEST HIGHWAY, MT PROSPECT, IL 60056
SN 1052-2883
J9 J INST ENVIRON SCI
JI J. Inst. Environ. Sci.
PD JUL-AUG
PY 1996
VL 39
IS 4
BP 40
EP 44
PG 5
WC Engineering, Environmental; Environmental Sciences; Instruments &
   Instrumentation
SC Engineering; Environmental Sciences & Ecology; Instruments &
   Instrumentation
GA VE846
UT WOS:A1996VE84600005
DA 2018-10-19
ER

PT J
AU Joziasse, CAP
   Veenstra, H
   Grijpma, DW
   Pennings, AJ
AF Joziasse, CAP
   Veenstra, H
   Grijpma, DW
   Pennings, AJ
TI On the chain stiffness of poly(lactide)s
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID RESORBABLE MATERIALS; CHEMICAL-STRUCTURE; MOLECULAR-WEIGHT;
   ENTANGLEMENT; POLYMERS; POLY(L-LACTIDE); POLYLACTIDE; DIMENSIONS;
   TRANSITION; FIXATION
AB Poly(lactide)s (PLAs) are well known hydrolytically degradable polymers, that are widely used for biomedical applications. However, the intrinsic brittle nature of poly(lactide)s is still poorly understood. The stiffness of a polymer chain, expressed as the characteristic ratio C-infinity plays an important role in the deformation mechanism of amorphous polymers. In order to investigate the effect of tacticity, high molecular weight poly(lactide) stereo-copolymers with D-lactide contents in the range 0-50 mol-% were synthesised. These polymers were used in light scattering and differential scanning calorimetry (DSC) experiments for the determination of the characteristic ratio C-infinity and glass transition temperature T-g. The results of the light scattering experiments in acetonitrile indicate that the characteristic ratio C-infinity for poly(lactide)s depends on the L/D-lactide ratio and increases with the tacticity of the polymer from 9.5 for racemic PDLLA to an estimated 11.8 for isotactic PLLA. These results are consistent with the observed brittle behaviour of poly(lactide) stereo-copolymers and agree well with predictions obtained from group contribution methods. The choice of the relevant bond length used for the calculation of the characteristic ratio from the scattering data is not as obvious as it may seem and remains a point of discussion. The tacticity of poly(lactide)s also influences the glass transition temperature, which varies from 54 degrees C for racemic to 63 degrees C for isotactic poly(lactide).
RP Joziasse, CAP (reprint author), UNIV GRONINGEN,DEPT POLYMER CHEM,NIJENBORGH 4,NL-9747 AG GRONINGEN,NETHERLANDS.
CR AHARONI SM, 1985, MACROMOLECULES, V18, P2624, DOI 10.1021/ma00154a045
   BAREISS RE, 1975, POLYM HDB
   BERSTED BH, 1979, J APPL POLYM SCI, V24, P37, DOI 10.1002/app.1979.070240105
   BOS RRM, 1989, INT J ORAL MAX SURG, V18, P365, DOI 10.1016/S0901-5027(89)80035-9
   BOYER RF, 1992, MACROMOLECULES, V25, P5326, DOI 10.1021/ma00046a034
   BRANT DA, 1969, MACROMOLECULES, V2, P228, DOI 10.1021/ma60009a003
   CUTRIGHT DE, 1971, J ORAL SURG, V29, P393
   FETTERS LJ, 1994, MACROMOLECULES, V27, P4639, DOI 10.1021/ma00095a001
   Flory PJ., 1969, STATISTICAL MECHANIC
   Freed KF, 1987, RENORMALIZATION GROU
   GENT AN, 1972, J POLYM SCI A2, V10, P571, DOI 10.1002/pol.1972.160100314
   GRIJPMA DW, 1994, POLYM ENG SCI, V34, P1674, DOI 10.1002/pen.760342205
   GRIJPMA DW, 1993, MAKROMOL CHEM-RAPID, V14, P155
   GRIJPMA DW, 1994, COLLOID POLYM SCI, V272, P1068, DOI 10.1007/BF00652375
   JOZIASSE CAP, 1994, POLYM BULL, V33, P599, DOI 10.1007/BF00296170
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9
   LEENSLAG JW, 1984, J APPL POLYM SCI, V39, P2829
   OROFINO TA, 1957, J CHEM PHYS, V26, P1067, DOI 10.1063/1.1743472
   PIETILA LO, COMMUNICATION
   PORTER RS, 1966, CHEM REV, V66, P1, DOI 10.1021/cr60239a001
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   TONELLI AE, 1969, MACROMOLECULES, V2, P225, DOI 10.1021/ma60009a002
   TURNER DT, 1982, POLYMER, V23, P626, DOI 10.1016/0032-3861(82)90106-9
   Van Krevelen D. W., 1976, PROPERTIES POLYM
   VANDEWITTE P, 1994, THESIS TWENTE U ENSC
   WOOL RP, 1993, MACROMOLECULES, V26, P1564, DOI 10.1021/ma00059a012
   WU S, 1989, J POLYM SCI POL PHYS, V27, P723, DOI 10.1002/polb.1989.090270401
   WU SH, 1992, POLYM ENG SCI, V32, P823, DOI 10.1002/pen.760321209
   WU SH, 1992, POLYM INT, V29, P229, DOI 10.1002/pi.4990290313
   YAMAKAWA H, 1971, MODERN THEORY POLYM
NR 32
TC 65
Z9 65
U1 2
U2 24
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD JUL
PY 1996
VL 197
IS 7
BP 2219
EP 2229
DI 10.1002/macp.1996.021970713
PG 11
WC Polymer Science
SC Polymer Science
GA VA040
UT WOS:A1996VA04000013
DA 2018-10-19
ER

PT J
AU Gallorini, M
   Apostoli, P
AF Gallorini, M
   Apostoli, P
TI Standard reference materials and data quality assurance in the
   biomedical analysis of trace elements
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article
DE biological standard reference materials; trace elements; human body
   fluids; quality assurance; biomarkers
ID EUROPEAN-COMMUNITY; REFERENCE VALUES; ITALIAN SUBJECTS; INHABITANTS;
   TISSUES; BLOOD
AB Accurate and precise analytical data of the concentrations of bio-analytes in bioclinical studies are of fundamental importance. Quality assurance procedures should always be performed to check the overall analytical work. This can be conveniently performed if appropriate standard reference materials with known concentrations of the analyte object of study are available. This paper underlines the key points related to the production and use of biological standard materials for trace element analysis. In particular, the present situation in the field of trace element determination in human biological fluids and the related problems are illustrated. The considerations given in this work may contribute to the preparation of the new biomarker standard materials.
C1 UNIV BRESCIA,INST OCCUPAT HLTH,BRESCIA,ITALY.
RP Gallorini, M (reprint author), UNIV PAVIA,CNR,CTR RADIOCHEM & ACTIVAT ANAL,PAVIA,ITALY.
CR Aitio A., 1981, QUALITY CONTROL OCCU
   [Anonymous], 1993, INT VOC BAS GEN TERM
   BUTTNER J, 1980, J CLIN CHEM CLIN BIO, V18, P855
   Buttner J., 1980, J CLIN CHEM CLIN BIO, V18, P69
   GLADNEY ES, 1982, NBS SPEC PUBL, P260
   IYENGAR GV, 1989, ELEMENTAL ANAL BIOL, V1
   MINOIA C, 1990, SCI TOTAL ENVIRON, V95, P89, DOI 10.1016/0048-9697(90)90055-Y
   MINOIA C, 1992, SCI TOTAL ENVIRON, V120, P63, DOI 10.1016/0048-9697(92)90216-F
   MURAMATSU Y, 1985, IAEARL128 INT AT EN
   *NIST STAND REF MA, 1991, SPECIAL PUBLICATION, V260
   Rennert O M, 1984, METABOLISM TRACE MET, VI
   RENNERT OM, 1984, METABOLISM TRACE MET, V2
   SABBIONI E, 1992, SCI TOTAL ENVIRON, V120, P39, DOI 10.1016/0048-9697(92)90215-E
   THOMPSON MB, 1986, MANAGING CONDUCT DAT, P199
   TORO EC, 1990, IAEA128 INT AT EN AG
   VERSIECK J, 1989, TRACE ELEMENTS HUMAN
   *WHO, 1984, PRINC PROC QUAL ASS
NR 17
TC 3
Z9 3
U1 0
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512
SN 0163-4984
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD JUN
PY 1996
VL 52
IS 3
BP 263
EP 272
DI 10.1007/BF02789167
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA UV440
UT WOS:A1996UV44000005
PM 8811283
DA 2018-10-19
ER

PT J
AU Tirrell, JG
   Tirrell, DA
AF Tirrell, JG
   Tirrell, DA
TI Synthesis of biopolymers: Proteins, polyesters, polysaccharides and
   polynucleotides
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
ID RECOMBINANT ESCHERICHIA-COLI; NEPHILA-CLAVIPES; CHEMOENZYMATIC
   SYNTHESIS; DRAGLINE SILK; CELLULOSE-II; DNA MOLECULE; BOMBYX-MORI;
   ACIDS; GENES; POLYPEPTIDES
AB The synthesis of proteins, polyesters, polysaccharides and polynucleotides can be adapted to produce new macromolecular materials. Proteins of designed sequence, and with specific chemical functions, conferred by the incorporation of unnatural amino acids, have been prepared in genetically engineered bacteria. Polyesters, useful as biodegradable thermoplastics, have been made in bacterial hosts, and more recently, in transgenic plants. Polysaccharides, made either chemically or enzymatically, are being explored for biomedical applications, and synthetic polynucleotides could eventually serve as scaffolds in the construction of nanoscale materials.
RP Tirrell, JG (reprint author), UNIV MASSACHUSETTS, DEPT POLYMER SCI & ENGN, AMHERST, MA 01003 USA.
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   BECKER MA, 1994, ACS SYM SER, V544, P252
   BECKER MA, 1994, ACS SYM SER, V544, P185
   Bruno FF, 1995, MACROMOLECULES, V28, P8881, DOI 10.1021/ma00130a028
   CABALLERO KP, 1995, INT J BIOL MACROMOL, V17, P86, DOI 10.1016/0141-8130(95)93522-Y
   CASE ST, 1994, ACS SYM SER, V544, P80
   CASE ST, 1994, ACS SYM SER, V544, P243
   CHEN XM, 1994, MACROMOL CHEM PHYSIC, V195, P3567, DOI 10.1002/macp.1994.021951105
   CHEN XM, 1995, MACROMOLECULES, V28, P6014, DOI 10.1021/ma00122a005
   COLGIN MA, 1995, SPIDER SILK BIOMATER, P1009
   CUNNIFF PM, 1994, ACS SYM SER, V544, P234
   Curley JM, 1996, MACROMOLECULES, V29, P1762, DOI 10.1021/ma951185a
   DEGUCHI Y, 1994, J MACROMOL SCI PURE, VA31, P1691, DOI 10.1080/10601329408545877
   DEKONING G, 1995, CAN J MICROBIOL, V41, P303, DOI 10.1139/m95-201
   Deming TJ, 1996, MACROMOLECULES, V29, P1442, DOI 10.1021/ma9510698
   DOI Y, 1995, MACROMOL SYMP, V98, P585, DOI 10.1002/masy.19950980150
   DOUGHERTY MJ, 1993, MACROMOLECULES, V26, P1779, DOI 10.1021/ma00059a045
   DU SM, 1995, J AM CHEM SOC, V117, P1194, DOI 10.1021/ja00109a002
   DU SM, 1995, BIOCHEMISTRY-US, V34, P673, DOI 10.1021/bi00002a035
   EGGINK G, 1995, CAN J MICROBIOL, V41, P14, DOI 10.1139/m95-163
   FAVIER V, 1995, MACROMOLECULES, V28, P6365, DOI 10.1021/ma00122a053
   FLAPAN E, 1995, J CHEM SOC CHEM COMM, P2249, DOI 10.1039/c39950002249
   FURUIKE T, 1995, MACROMOLECULES, V28, P7241, DOI 10.1021/ma00125a029
   HINMAN MB, 1994, ACS SYM SER, V544, P222
   KALOUSEK S, 1995, CAN J MICROBIOL, V41, P216, DOI 10.1139/m95-190
   Kamitakahara H, 1996, MACROMOLECULES, V29, P1119, DOI 10.1021/ma951454x
   KANG CK, 1995, BIOTECHNOL LETT, V17, P583, DOI 10.1007/BF00129382
   KATSURAYA K, 1995, MACROMOLECULES, V28, P6697, DOI 10.1021/ma00124a001
   KIM OY, 1995, CAN J MICROBIOL, V41, P32, DOI 10.1139/m95-165
   Kobayashi S, 1996, MACROMOLECULES, V29, P2698, DOI 10.1021/ma951552i
   KOTHAKOTA S, 1995, J AM CHEM SOC, V117, P536, DOI 10.1021/ja00106a064
   KOTHAKOTA S, 1995, J POLYM SCI POL CHEM, V33, P1267, DOI 10.1002/pola.1995.080330809
   KOYAMA N, 1995, BIOTECHNOL LETT, V17, P281, DOI 10.1007/BF01190637
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   LEE EY, 1995, APPL MICROBIOL BIOT, V42, P901
   LEE SY, 1995, CAN J MICROBIOL, V41, P207, DOI 10.1139/m95-189
   MAHONEY DV, 1994, ACS SYM SER, V544, P196
   MCGRATH KP, 1992, J AM CHEM SOC, V114, P727, DOI 10.1021/ja00028a048
   NAKAMURA S, 1994, ACS SYM SER, V544, P211
   NAWRATH C, 1994, P NATL ACAD SCI USA, V91, P12760, DOI 10.1073/pnas.91.26.12760
   ORFANIDOU CC, 1995, INT J BIOL MACROMOL, V17, P93, DOI 10.1016/0141-8130(95)93523-Z
   POIRIER Y, 1995, INT J BIOL MACROMOL, V17, P7, DOI 10.1016/0141-8130(95)93511-U
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   RAYMOND S, 1995, MACROMOLECULES, V28, P2096, DOI 10.1021/ma00110a051
   RAYMOND S, 1995, CARBOHYD RES, V277, P209, DOI 10.1016/0008-6215(95)00219-J
   RHIE HG, 1995, CAN J MICROBIOL, V41, P200, DOI 10.1139/m95-188
   RICH JO, 1995, BIOTECHNOL BIOENG, V45, P426, DOI 10.1002/bit.260450507
   SAMAIN E, 1995, CARBOHYD RES, V271, P217, DOI 10.1016/0008-6215(95)00022-L
   SMITH SV, 1993, MATER RES SOC SYMP P, V292, P93
   STUART ES, 1995, CAN J MICROBIOL, V41, P84, DOI 10.1139/m95-174
   WANG H, 1995, BIOCHEMISTRY-US, V34, P920, DOI 10.1021/bi00003a026
   YOSHIKAWA E, 1994, MACROMOLECULES, V27, P5471, DOI 10.1021/ma00097a029
NR 52
TC 5
Z9 5
U1 1
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
EI 1879-0348
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD JUN
PY 1996
VL 1
IS 3
BP 407
EP 411
DI 10.1016/S1359-0286(96)80033-7
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA VE415
UT WOS:A1996VE41500013
DA 2018-10-19
ER

PT J
AU Goodyer, PD
   Fothergill, JC
   Jones, NB
   Hanning, CD
AF Goodyer, PD
   Fothergill, JC
   Jones, NB
   Hanning, CD
TI The design of an optical fiber pressure transducer for use in the upper
   airways
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
ID SENSORS
AB The development of an optical fiber transducer for use in biomedical applications has been presented. The design was targeted for use in the upper airways of patients with sleep disorders stemming from partial or total occlusion of the airway, The transducer's preliminary specification was suited for that of upper airway manometry: a resolution of 10 Pa over the range +/-5 kPa, a single transducer being less than 0.94 mm in diameter. Amplitude modulated optical fiber sensors are susceptible to loss due to bending of the fiber care and cladding. The design of the transducer uses a series of three optical fibers, one emitting and two receiving, the combination of the two receiving optical fibers is used to reduce effects of light loss: a bend radios of 50 mm is typical for the insertion into the naso-pharynx. The transducer transduction element is a silicone gel coated with reflective titanium dioxide, the meniscus deforms under pressure and modulates the intensity of tight reflected back into the receiving optical fibers. The main disadvantage of optical fiber pressure transducers is their susceptibility to temperature drift. Temperature in the airway rarely changes more than 17 degrees C. The frequency of breathing and the high thermal mass of the catheter means that:temperature drift in this application is not significant, and, will cause an insignificant error of 12 Pa. The transducer is inexpensive to produce, and may he deemed disposable: approximately $20 in material costs (using current manufacturing techniques this can be halved). The system has the added advantage of being electrically, magnetically, and chemically passive. The potential For miniaturization is limited only by the mechanical strength of the optical fibers as mechanical problems associated with fragile elastic membranes do not apply.
C1 UNIV LEICESTER,DEPT ANAESTHESIA,LEICESTER LE1 7RH,LEICS,ENGLAND.
RP Goodyer, PD (reprint author), UNIV LEICESTER,DEPT ENGN,UNIV RD,LEICESTER LE1 7RH,LEICS,ENGLAND.
CR BERTHOLD JW, 1994, P 10 OPT FIBR SENS C, P182
   BOCK WJ, 1992, IEEE T INSTRUM MEAS, V41, P68, DOI 10.1109/19.126634
   GOODYER P, 1995, THESIS U LEICESTER, pCH5
   GOODYER PD, IN PRESS MED BIOL EN
   GUILLEMINAULT C, 1990, OBSTRUCTIVE SLEEP AP, pCH1
   HUDGEL DA, 1993, ENT J, V71, P42
   KOHL C, 1990, J AEROSOL SCI, V21, P415
   LEKHOLM A, 1968, MED BIOL ENG, V7, P333
   LIBO Y, 1991, SENSOR ACTUAT A-PHYS, V29, P29
   PAPAGEORGIOU G, 1988, SENSOR REV IFS PUBLI, V8, P19
   SKATVEDT O, 1994, ARCH DIS CHILD, V71, P138, DOI 10.1136/adc.71.2.138
   SKATVEDT O, 1992, LARYNGOSCOPE, V102, P1275, DOI 10.1288/00005537-199211000-00014
   TRACEY PM, 1991, IEEE T IND APPL, V27, P96, DOI 10.1109/28.67537
   WOLTHUIS RA, 1991, IEEE T BIO-MED ENG, V38, P974, DOI 10.1109/10.88443
NR 14
TC 12
Z9 12
U1 0
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD JUN
PY 1996
VL 43
IS 6
BP 600
EP 606
DI 10.1109/10.495279
PG 7
WC Engineering, Biomedical
SC Engineering
GA UM669
UT WOS:A1996UM66900006
PM 8987264
DA 2018-10-19
ER

PT J
AU Arru, P
   Rinaldi, S
   Stacchino, C
   Vallana, F
AF Arru, P
   Rinaldi, S
   Stacchino, C
   Vallana, F
TI Wear assessment in bileaflet heart valves
SO JOURNAL OF HEART VALVE DISEASE
LA English
DT Article; Proceedings Paper
CT International Symposium on Wear in Mechanical Heart Valve Prostheses
CY SEP   29, 1995
CL AARHUUS UNIV HOSP, WERNER, DENMARK
HO AARHUUS UNIV HOSP
ID BIOMEDICAL DEVICES; PROSTHESIS; EXPERIENCE; DESIGN
AB Sorin Biomedica has accumulated 20 years of experience in designing and manufacturing heart valves as well as in the development of turbostratic carbons, both as bulk coating (pyrolytic carbon, PyC) and as a thin film (Carbofilm).
   In designing a bileaflet valve, where hinges represent the most critical elements since wear occurs mainly at these points, we took into account: a) theoretical considerations on the geometry (flat-to-flat vs. curved-to-flat) of the coupling elements undergoing impact wear; b) kinematic coupling (sliding, rotation, rolling) between the moving parts in relation to friction wear; c) experimental wear rates of different material couples (PyC/PyC, metal/PyC) assessed by paying attention to test artifacts due to particle contamination; and d) wear mechanisms involving brittle fracture mechanics for bulk PyC and ductile fracture mode for metals.
   On the basis of the above evaluations a Carbofilm coated titanium alloy housing and PyC leaflets were developed for the Sorin Bicarbon valve. A flat-to-flat coupling between hinge stops and mating pivot surfaces for reducing the impact wear and a rolling action aimed at minimizing the friction wear were designed for the hinge.
   The Bicarbon long term durability has been assessed by accelerated wear tests conducted in comparison with clinically accepted bileaflet prostheses (CarboMedics and St. Jude Medical).
   The main results for the Bicarbon valve were, wear rates slightly lower or comparable to those found in the reference valves and wear morphology free from microfractures, while deep cracks associated with higher stress concentrations were detected on the PyC components of the reference valves. No mechanical failure or loss of functionality occurred up to 2,100 million cycles (equivalent of 52.5 years).
C1 SORIN BIOMED SPA,I-13040 SALUGGIA,ITALY.
CR AEBISCHER P, 1988, BIOMATERIALS, V9, P80, DOI 10.1016/0142-9612(88)90075-0
   ARRU P, 1994, INT J ARTIF ORGANS, V17, P280
   Arru P, 1987, HIGH TECH CERAMICS, P117
   BOKROS JC, 1977, CARBON, V15, P355
   BOKROS JC, 1992, REPLACEMENT CARDIAC, P21
   Burwell J.T.  Jr., 1957, Wear, V1, P119, DOI 10.1016/0043-1648(57)90005-4
   DISALVO C, 1994, J CARDIOVASC SURG, V35, P199
   *FDA, 1994, DRAFT REPLACEMENT
   HAUBOLD AD, 1978, BIOCOMPATIBILITY CLI, V2, P341
   Juvinall R. C., 1967, ENG CONSIDERATION ST
   MILANO A, 1992, J THORAC CARDIOV SUR, V103, P267
   Paccagnella A, 1986, J ARTIF ORGANS, V9, P115
   RITCHIE RO, 1990, J BIOMED MATER RES, V24, P189, DOI 10.1002/jbm.820240206
   Ritchie RO, 1996, J HEART VALVE DIS, V5, pS9
   SBARBATI R, 1991, INT J ARTIF ORGANS, V14, P491
   Shim H S, 1974, Biomater Med Devices Artif Organs, V2, P103
   SHIM HS, 1977, J BIOENG, V1, P223
   SHIM HS, 1978, J BIOENG, V2, P341
   SHIM HS, 1976, J BIOENG, V1, P45
   Thiene G, 1989, Eur J Cardiothorac Surg, V3, P65, DOI 10.1016/1010-7940(89)90014-6
   VALLANA F, 1993, CERAM INT, V19, P169, DOI 10.1016/0272-8842(93)90038-S
   Vallana F, 1992, ASAIO J, V38, pM600, DOI 10.1097/00002480-199207000-00107
   VITALE E, 1995, INT J ARTIF ORGANS, V18, P775
   1987, CARBOMEDICS DATA PHY
   1995, ISODIS5840ISOTC150SC
   1994, J HEART VALVE DIS S1, V3, pS1
NR 26
TC 7
Z9 8
U1 0
U2 2
PU I C R PUBLISHERS
PI NORTHWOOD
PA CRISPIN HOUSE, 12/A SOUTH APPROACH, MOOR PARK, NORTHWOOD, ENGLAND HA6
   2ET
SN 0966-8519
J9 J HEART VALVE DIS
JI J. Heart Valve Dis.
PD JUN
PY 1996
VL 5
SU 1
BP S133
EP S143
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA VH148
UT WOS:A1996VH14800020
PM 8803766
DA 2018-10-19
ER

PT J
AU Bergoc, RM
   Menossi, CA
   Caro, RA
AF Bergoc, RM
   Menossi, CA
   Caro, RA
TI Radioisotope methodology course: Radioprotection aspects
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-ARTICLES
LA English
DT Article; Proceedings Paper
CT International Conference on Isotopes
CY MAY 07-12, 1995
CL BEIJING, PEOPLES R CHINA
SP Amer Nucl Soc, Isotopes & Radiat Div, Brit Nucl Energy Soc, China Natl Nucl Corp, Chinese Chem Soc, European Nucl Soc, German Chem Soc, Nucl Chem Sect, Indian Nucl Soc, Int Isotope Soc, Japan Radioisotope Assoc, Korean Nucl Soc, Natl Nat Sci Fdn China, Nucl Soc Russia
AB Since 1962 a Radioisotopes Methodology Course is given annually at the School of Pharmacy and Biochemistry. Buenos Aires University, Argentina, where usually professionals of the biomedical area assists. The current program has 222 hours of training: 122 hours devoted to theoretical aspects and 100 hours to intensive practical work. The training in radioprotection include subjects as: definitions, dosimetrical magnitudes and units, dose rate, equivalent dose, effective dose, exposition, dosimetry of internal and external sources, shielding, classification of working conditions and areas, transportation of radioactive materials, instrumentation associated to radioprotection and many application excersises. A total of 1085 professionals have passed their examination. Percentage distribution according to different professions can be resumed as follows: 16.1 physicians, 65.1 biochemists, 0.7 engineers, 2.0 biologist and 16.1 from others professions such pharmacists, etc. The training in radioprotection throughout the whole program is oriented to consolidate the general knowledge on the subject independently from the previous universitary formation. We stress also the importance and differentiate the applications to biochemistry, principally those concerning the use of 125-I, as well as to nuclear medicine fundamentally through the utilisation of 99m-Tc generators.
C1 ARGENT NATL NUCL REGULATORY AUTHOR,BUENOS AIRES,DF,ARGENTINA.
RP Bergoc, RM (reprint author), UNIV BUENOS AIRES,SCH PHARM & BIOCHEM,RADIOISOTOPES LAB,BUENOS AIRES,DF,ARGENTINA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AKADEMIAI KIADO
PI BUDAPEST
PA PO BOX 245, H-1519 BUDAPEST, HUNGARY
SN 0236-5731
J9 J RADIOAN NUCL CH AR
JI J. Radioanal. Nucl. Chem.-Artic.
PD JUN
PY 1996
VL 206
IS 2
BP 257
EP 262
DI 10.1007/BF02039651
PG 6
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA VD127
UT WOS:A1996VD12700010
DA 2018-10-19
ER

PT J
AU Barrett, R
   Gross, RS
AF Barrett, R
   Gross, RS
TI Super-active shape-memory alloy composites
SO SMART MATERIALS & STRUCTURES
LA English
DT Article
ID GELS
AB A new type of very-low-stiffness super-active composite material is presented. This laminate uses shape-memory alloy (SMA) filaments which are embedded within a low-hardness silicone matrix. The purpose is to develop an active composite in which the local strains within the SMA actuator material will be approximately 1%, while the laminate strains will be at least an order of magnitude larger. This type of laminate will be useful for biomimetic, biomedical, surgical and prosthetic applications in which the very high stiffness and actuation strength of conventional SMA filaments are too great for biological tissues. A modified form of moment and force-balance analysis is used to model the performance of the super-active shape-memory alloy composite (SASMAC). The analytical models are used to predict the performance of a SASMAC pull-pull actuator which uses 10 mil diameter Tinel alloy K actuators embedded in a 0.10'' thick, 25 Durometer silicone matrix. The results of testing demonstrate that the laminate is capable of straining up to 10% with theory and experiment in good agreement. Fatigue testing was conducted on the actuator for 1000 cycles. Because the local strains within the SMA were kept to less than 1%, the element showed no degradation in performance.
C1 AUBURN UNIV,DEPT AEROSP ENGN,AUBURN,AL 36849.
CR DOI M, 1992, MACROMOL J, V29, P5504
   DUERIG TW, 1989, MRS INT M ADV MATS, V9, P581
   OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0
   PEI QB, 1993, SMART MATER STRUCT, V2, P1
   *RAYCH CORP MET DI, 1989, RAYCHEM TINEL SHAPE
   Segalman D. J., 1992, Smart Materials and Structures, V1, P95, DOI 10.1088/0964-1726/1/1/015
   Shahinpoor M., 1994, Smart Materials and Structures, V3, P367, DOI 10.1088/0964-1726/3/3/012
   SHIGA T, 1990, J APPL POLYM SCI, V39, P2305, DOI 10.1002/app.1990.070391110
   *SWISSM ADV MAT TE, 1992, SHAP MEM ACT
NR 9
TC 30
Z9 31
U1 0
U2 3
PU IOP PUBLISHING LTD
PI BRISTOL
PA TECHNO HOUSE, REDCLIFFE WAY, BRISTOL, ENGLAND BS1 6NX
SN 0964-1726
J9 SMART MATER STRUCT
JI Smart Mater. Struct.
PD JUN
PY 1996
VL 5
IS 3
BP 255
EP 260
DI 10.1088/0964-1726/5/3/003
PG 6
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA UW422
UT WOS:A1996UW42200003
DA 2018-10-19
ER

PT J
AU Stupar, J
   Dolinsek, F
AF Stupar, J
   Dolinsek, F
TI Determination of chromium, manganese, lead and cadmium in biological
   samples including hair using direct electrothermal atomic absorption
   spectrometry
SO SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY
LA English
DT Article
DE botanical samples; ETAAS; hair samples; slurry sampling; solid sampling
ID SLURRY ATOMIZATION; ENVIRONMENTAL-SAMPLES; MATRIX MODIFICATION; TANNERY
   WORKERS; PLANT MATERIALS; ERROR ANALYSIS; SCALP HAIR; FURNACE; COPPER;
   GFAAS
AB Direct analysis of solid samples employing a laboratory assembled electrothermal atomic absorption spectrometer is demonstrated to be a feasible approach for determination of trace elements in plant tissue and hair samples for special applications in plant physiology and biomedical research. As an example, the kinetics of Cr uptake by cabbage and its distribution have been measured as a function of chromium speciation in the nutrient solution. Further, longitudinal concentration gradients of Cr, Pb and Cd have been measured in hair of various population groups exposed to different levels of these elements in ambient and/or occupational environments. The techniques are validated for the determination of these trace elements by neutron activation analysis, dissolution atomic absorption spectrometry and by analysis of certified reference materials. Slurry sample introduction is found appropriate for routine trace element determination and in homogeneity testing. Direct sample introduction is indispensable in the analysis of very small (< 1 mg) tissue biopsy samples in the determination of trace element distributions.
RP Stupar, J (reprint author), JOZEF STEFAN INST,JAMOVA 39,LJUBLJANA 1111,SLOVENIA.
CR ALDER JF, 1976, ANAL CHIM ACTA, V587, P313
   BRADY DV, 1974, ATOM ABSORPT NEWSL, V13, P118
   CARRION N, 1988, J ANAL ATOM SPECTROM, V3, P479, DOI 10.1039/ja9880300479
   CHATTOPADHYAY A, 1974, TRACE SUBSTANCES ENV, V8, P31
   DOBROWOLSKI R, 1993, FRESEN J ANAL CHEM, V346, P1058, DOI 10.1007/BF00323716
   DOLINSEK F, 1991, J ANAL ATOM SPECTROM, V9, P653
   EBDON L, 1987, MICROCHEM J, V36, P207, DOI 10.1016/0026-265X(87)90155-X
   EBDON L, 1986, MICROCHEM J, V34, P340, DOI 10.1016/0026-265X(86)90129-3
   EBDON L, 1990, J ANAL ATOM SPECTROM, V5, P321, DOI 10.1039/ja9900500321
   EBDON L, 1987, J ANAL ATOM SPECTROM, V2, P317, DOI 10.1039/ja9870200317
   FAGIOLI F, 1986, ATOM SPECTROSC, V7, P49
   GARCIA IL, 1992, J ANAL ATOM SPECTROM, V7, P529, DOI 10.1039/ja9920700529
   HAMBIDGE KM, 1972, AM J CLIN NUTR, V25, P380
   HOENIG M, 1986, ANAL CHEM, V58, P2614, DOI 10.1021/ac00126a008
   HOLCOMBE JA, 1989, J ANAL ATOM SPECTROM, V4, P423, DOI 10.1039/ja9890400423
   JORDAN P, 1989, ATOM SPECTROSC, V10, P165
   KOPITO L, 1969, J AMER MED ASSOC, V209, P243, DOI 10.1001/jama.209.2.243
   KUMPULAINEN J, 1982, ANAL CHIM ACTA, V138, P361, DOI 10.1016/S0003-2670(01)85322-8
   LAHOUTI M, 1979, J SCI FOOD AGR, V30, P136, DOI 10.1002/jsfa.2740300207
   LVOV BV, 1988, J ANAL ATOM SPECTROM, V3, P9, DOI 10.1039/ja9880300009
   MAJIDI V, 1990, SPECTROCHIM ACTA B, V45, P753, DOI 10.1016/0584-8547(90)80054-M
   MILLERIHLI NJ, 1993, FRESEN J ANAL CHEM, V345, P482, DOI 10.1007/BF00326337
   MILLERIHLI NJ, 1994, J ANAL ATOM SPECTROM, V9, P1129, DOI 10.1039/ja9940901129
   MILLERIHLI NJ, 1992, ATOM SPECTROSC, V13, P1
   MILLERIHLI NJ, 1989, SPECTROCHIM ACTA B, V44, P1221, DOI 10.1016/0584-8547(89)80120-X
   MILLERIHLI NJ, 1990, FRESEN Z ANAL CHEM, V337, P771
   OLAYINKA KO, 1986, J ANAL ATOM SPECTROM, V1, P297, DOI 10.1039/ja9860100297
   RAMACHANDRAN V, 1980, J NUCL AGR BIOL, V9, P127
   RANDALL JA, 1989, BRIT J IND MED, V46, P171
   RENSHAW G D, 1973, Journal of Forensic Sciences, V18, P143
   RENSHAW GD, 1972, NATURE, V238, P162, DOI 10.1038/238162a0
   SANER G, 1984, BRIT J IND MED, V41, P263
   SHEWRY PR, 1974, J EXP BOT, V25, P785, DOI 10.1093/jxb/25.4.785
   SLAVIN W, 1989, TALANTA, V36, P171, DOI 10.1016/0039-9140(89)80092-X
   SLAVIN W, 1982, SPECTROCHIM ACTA B, V37, P955, DOI 10.1016/0584-8547(82)80113-4
   STAUBER JL, 1989, SCI TOTAL ENVIRON, V83, P85, DOI 10.1016/0048-9697(89)90007-7
NR 36
TC 37
Z9 37
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0584-8547
J9 SPECTROCHIM ACTA B
JI Spectroc. Acta Pt. B-Atom. Spectr.
PD JUN
PY 1996
VL 51
IS 7
BP 665
EP 683
DI 10.1016/0584-8547(96)01475-9
PG 19
WC Spectroscopy
SC Spectroscopy
GA UV738
UT WOS:A1996UV73800003
DA 2018-10-19
ER

PT J
AU Jen, AC
   Wake, MC
   Mikos, AG
AF Jen, AC
   Wake, MC
   Mikos, AG
TI Review: Hydrogels for cell immobilization
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Review
DE hydrogel; cell immobilization; surface adhesion; matrix entrapment;
   microencapsulation; immunoisolation; bioartificial organs
ID LONG-TERM REVERSAL; MICROENCAPSULATED ISLETS; RAT ISLETS; HEPATOCYTE
   FUNCTION; TRANSPLANTATION; TISSUE; MICROCAPSULES; ALGINATE;
   XENOTRANSPLANTATION; PHOTOPOLYMERIZATION
AB Hydrogels are being investigated for mammalian cell immobilization. Their material properties can be engineered for biocompatibility, selective permeability, mechanical and chemical stability, and other requirements as specified by the application including uniform cell distribution and a given membrane thickness or mechanical strength. These aqueous gels are attractive for analytical and tissue engineering applications and can be used with immobilization in therapies for various diseases as well as to generate bioartificial organs. Recent advances have broadened the use of hydrogel cell immobilization in biomedical fields. To provide an overview of available technology, this review surveys the current developments in immobilization of mammalian cells in hydrogels. Discussions cover hydrogel requirements for use in adhesion, matrix entrapment, and microencapsulation, the respective processing methods, as well as current applications. (C) 1996 John Wiley & Sons, Inc.
C1 RICE UNIV,COX LAB BIOMED ENGN,DEPT CHEM ENGN,HOUSTON,TX 77251.
   RICE UNIV,INST BIOSCI & BIOENGN,HOUSTON,TX 77251.
CR Aebisher P, 1993, FUNDAMENTALS ANIMAL, P197
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   AOMATSU Y, 1992, TRANSPLANT P, V24, P2922
   AUNG T, 1994, TRANSPLANT P, V26, P790
   Bell CL, 1995, ADV POLYM SCI, V122, P125
   BESSELINK GAJ, 1994, J BIOMAT SCI-POLYM E, V6, P675
   Chang T M, 1992, ASAIO J, V38, P128, DOI 10.1097/00002480-199204000-00013
   Christenson L, 1993, FUNDAMENTALS ANIMAL, P7
   CIMA L, 1994, ANN BIOMED ENG, V22, P184
   CORKHILL PH, 1993, J BIOMAT SCI-POLYM E, V4, P615, DOI 10.1163/156856293X00834
   DRUMHELLER PD, 1995, HDB BIOMEDICAL ENG, P1583
   FAN MY, 1990, DIABETES, V39, P519, DOI 10.2337/diabetes.39.4.519
   FRITSCHY WM, 1991, DIABETOLOGIA, V34, P542, DOI 10.1007/BF00400270
   Gibson LJ, 1988, CELLULAR SOLIDS STRU
   GOOSEN MFA, 1993, FUNDAMENTALS ANIMAL, P43
   GROBOILLOT A, 1994, CRIT REV BIOTECHNOL, V14, P75, DOI 10.3109/07388559409086963
   Kanda K, 1993, ASAIO J, V39, pM561
   KING G, 1993, FUNDAMENTALS ANIMAL, P1
   KOBAYASHI H, 1991, CURR EYE RES, V10, P899, DOI 10.3109/02713689109020325
   KOBAYASHI H, 1991, BIOMATERIALS, V12, P747, DOI 10.1016/0142-9612(91)90024-5
   KOEBE HG, 1994, XENOBIOTICA, V24, P95, DOI 10.3109/00498259409043224
   Kost J, 1986, HYDROGELS MED PHARM, V3, P95
   KRESTOW M, 1991, TRANSPLANTATION, V51, P651, DOI 10.1097/00007890-199103000-00021
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANZA RP, 1992, DIABETES, V41, P1503, DOI 10.2337/diabetes.41.12.1503
   LEE J, 1993, FASEB J, V7, P586
   LEVESQUE L, 1992, ENDOCRINOLOGY, V130, P644, DOI 10.1210/en.130.2.644
   LUM ZP, 1991, DIABETES, V40, P1511, DOI 10.2337/diabetes.40.11.1511
   LUM ZP, 1992, TRANSPLANTATION, V53, P1180, DOI 10.1097/00007890-199206000-00002
   LUNDBERG P, 1992, MAGN RESON MED, V25, P273, DOI 10.1002/mrm.1910250206
   MIKOS AG, 1994, BIOTECHNOL BIOENG, V43, P673, DOI 10.1002/bit.260430717
   Miwa H, 1993, ASAIO J, V39, pM273
   NYBERG SL, 1994, ANN SURG, V220, P59
   OXLEY HR, 1993, BIOMATERIALS, V14, P1064, DOI 10.1016/0142-9612(93)90207-I
   Park H., 1994, P INT S CONTR REL BI, V21, P21
   PARK K, 1993, BIODEGRADABLE HYDROG
   Park K., 1987, HYDROGELS MED PHARM, P151
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   Peppas N. A., 1986, HYDROGELS MED PHARM, P1
   PEPPAS NA, 1986, HYDROGELS MED PHARM, P57
   PLUNKETT ML, 1990, LAB INVEST, V62, P510
   PONCELET D, 1993, FUNDAMENTALS ANIMAL, P113
   RATNER B, 1986, HYDROGELS MED PHARM, P85
   Sato M, 1993, ASAIO J, V39, pM554
   SAWHNEY AS, 1993, BIOMATERIALS, V14, P1008, DOI 10.1016/0142-9612(93)90194-7
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SCHREZENMEIR J, 1992, TRANSPLANT P, V24, P2941
   SEFTON MV, 1993, ADV POLYM SCI, V107, P143
   SHATFORD RA, 1992, J SURG RES, V53, P549, DOI 10.1016/0022-4804(92)90253-V
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   SOONSHIONG P, 1992, TRANSPLANTATION, V54, P769, DOI 10.1097/00007890-199211000-00001
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   SOONSHIONG P, 1992, TRANSPLANT P, V24, P2946
   SOONSHIONG P, 1994, T SOC BIOMATER, V17, P356
   Stevenson WTK, 1993, FUNDAMENTALS ANIMAL, P143
   Sun A M, 1992, ASAIO J, V38, P125, DOI 10.1097/00002480-199204000-00012
   Sun AM, 1992, MICROCAPSULES NANOPA, P315
   Thomson R.C., 1995, MOL BIOL BIOTECHNOLO, P717
   ULUDAG H, 1990, BIOMATERIALS, V11, P708, DOI 10.1016/0142-9612(90)90032-L
   ULUDAG H, 1993, J BIOMED MATER RES, V27, P1213, DOI 10.1002/jbm.820271002
   WELLS GDM, 1993, BIOMATERIALS, V14, P615, DOI 10.1016/0142-9612(93)90181-Z
   WOERLY S, 1993, BIOMATERIALS, V14, P1056, DOI 10.1016/0142-9612(93)90205-G
   WOERLY S, 1990, BIOMATERIALS, V11, P97, DOI 10.1016/0142-9612(90)90123-8
   Yannas IV, 1995, ADV POLYM SCI, V122, P219
   Yuet P., 1993, FUNDAMENTALS ANIMAL, P79
NR 66
TC 351
Z9 357
U1 3
U2 128
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAY 20
PY 1996
VL 50
IS 4
BP 357
EP 364
DI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA UG326
UT WOS:A1996UG32600003
PM 18626984
DA 2018-10-19
ER

PT J
AU Iannace, S
   Ambrosio, L
   DAmore, A
   Nicolais, L
AF Iannace, S
   Ambrosio, L
   DAmore, A
   Nicolais, L
TI Nonlinear viscoelasticity of Hydrothane(R)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB The nonlinear viscoelastic behaviour of Hydrothane(R), a hydrophilic polyurethane used for biomedical applications, has been studied. The material has been tested in stress-relaxation experiments in a range of deformation up to 25%. Isochrone curves have been predicted by using the rubber elasticity theory and separating strain and time effect. Stress-strain curves obtained at different strain rates have been interpreted introducing strain rate dependent scaling factors.
C1 UNIV NAPLES FEDERICO II,INST COMPOSITE MAT TECHNOL,I-80125 NAPLES,ITALY.
RP Iannace, S (reprint author), UNIV NAPLES FEDERICO II,DEPT MAT & PROD ENGN,P TECCHIO 80,I-80125 NAPLES,ITALY.
OI AMBROSIO, LUIGI/0000-0002-8367-2405; Iannace,
   Salvatore/0000-0003-1487-4983
CR CHANG WV, 1977, J POLYM SCI POL PHYS, V15, P923, DOI 10.1002/pol.1977.180150601
   Doi M., 1986, THEORY POLYM DYNAMIC
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   Fung Y-C, 1993, BIOMECHANICS
   HAUT RC, 1972, J BIOMECH, V5, P423, DOI 10.1016/0021-9290(72)90001-2
   HAUT RC, 1993, ANTERIOR CRUCIATE LI
   IANNACE S, IN PRESS BIOMATERIAL
   LIN HC, 1987, ADV BIOENG, V3, P5
   Lodge A. S, 1964, ELASTIC LIQUIDS
   Matsuoka S., 1986, FAILURE PLASTICS
   OSAKI K, 1980, MACROMOLECULES, V13, P671, DOI 10.1021/ma60075a036
   RIVLIN RS, 1948, PHILOS TR R SOC S-A, V241, P379, DOI 10.1098/rsta.1948.0024
   ROLAND CM, 1989, RUBBER CHEM TECHNOL, V62, P880, DOI 10.5254/1.3536281
   SPERLING LH, 1986, INTRO PHYSICAL POLYM
   WAGNER MH, 1976, RHEOL ACTA, V15, P136, DOI 10.1007/BF01517505
   WILLIAMS G, 1970, T FARADAY SOC, V66, P80, DOI 10.1039/tf9706600080
   WOO SLY, 1981, J BIOMECH ENG-T ASME, V103, P293, DOI 10.1115/1.3138295
NR 17
TC 2
Z9 2
U1 0
U2 3
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 1996
VL 7
IS 5
BP 305
EP 307
DI 10.1007/BF00058572
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UL308
UT WOS:A1996UL30800012
DA 2018-10-19
ER

PT J
AU Bennett, LH
   Wang, PS
   Donahue, MJ
AF Bennett, LH
   Wang, PS
   Donahue, MJ
TI Artifacts in magnetic resonance imaging from metals
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 40th Annual Conference on Magnetism and Magnetic Materials
CY NOV 06-09, 1995
CL PHILADELPHIA, PA
SP Amer Inst Phys, IEEE, Magnet Soc, Minerals Met & Mat Soc, Amer Soc Testing & Mat, USN, Off Naval Res, Amer Ceram Soc
AB Metallic biomedical implants, such as aneurysm Clips, endoprostheses, and internal orthopedic devices give rise to artifacts in the magnetic resonance image (MRI) of patients. Such artifacts impair the information contained in the image in precisely the region of most interest, namely near the metallic device. Ferromagnetic materials are contraindicated because of the hazards associated with their movement during the MRI procedure. In less-magnetic metals, it has been suggested that the extent of the artifact is related to the magnetic susceptibility of the metal, but no systematic data appear to be available. When the susceptibility is sufficiently small, an additional artifact due to electrical conductivity is observed. We present an initial systematic study of MRI artifacts produced by two low susceptibility metals, titanium (relative permeability mu(r) approximate to 1.0002) and copper (mu(r) approximate to 0.99998), including experimental, theoretical, and computer simulation results. (C) 1996 American Institute of Physics.
RP Bennett, LH (reprint author), NATL INST STAND & TECHNOL,GAITHERSBURG,MD 20899, USA.
CR ALANEN A, 1995, ACTA RADIOL, V36, P92
   BRACEWELL RN, 1967, ASTROPHYS J, V150, P427, DOI 10.1086/149346
   CAMACHO CR, 1995, JMRI-J MAGN RESON IM, V5, P75, DOI 10.1002/jmri.1880050115
   LUCZNIK RP, 1993, RADIOLOGY, V187, P855
   Ludeke K M, 1985, Magn Reson Imaging, V3, P329, DOI 10.1016/0730-725X(85)90397-2
   MALKOI JA, 1989, RADIOLOGY, V143, P563
   PATTON JA, 1994, RADIOGRAPHICS, V14, P1083, DOI 10.1148/radiographics.14.5.7991815
   Wang P., UNPUB
   WANG PS, 1995, J MATER SCI, V30, P1069, DOI 10.1007/BF01178447
   WANG PS, 1995, J MATER SCI, V30, P1059, DOI 10.1007/BF01178445
NR 10
TC 37
Z9 37
U1 0
U2 18
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0021-8979
J9 J APPL PHYS
JI J. Appl. Phys.
PD APR 15
PY 1996
VL 79
IS 8
BP 4712
EP 4714
DI 10.1063/1.361649
PN 2A
PG 3
WC Physics, Applied
SC Physics
GA UG877
UT WOS:A1996UG87700087
DA 2018-10-19
ER

PT J
AU DeAza, PN
   Luklinska, ZB
   Anseau, M
   Guitian, F
   DeAza, S
AF DeAza, PN
   Luklinska, ZB
   Anseau, M
   Guitian, F
   DeAza, S
TI Morphological studies of pseudowollastonite for biomedical application
SO JOURNAL OF MICROSCOPY-OXFORD
LA English
DT Article
DE wollastonite; bioactivity; electron microscopy
ID SIMULATED BODY-FLUID; GLASS-CERAMICS; APATITE
AB Pseudowollastonite ceramic (psW) composed of CaO . SiO2 was found to be bioactive in a simulated body fluid environment. The chemical reaction initiated at the material surface resulted in hydroxyapatite (HA) formation. These bone-bonding properties are essential for securing the necessary physico-chemical integration of the material with living bone. Materials behaving in this way can be considered for potential biomedical application as bone tissue substitute for a natural bone repair or replacement as implant.
   A mechanism of hydroxyapatite formation on pseudowollastonite ceramics surface was investigated during exposure to a simulated body fluid (SBF) for a period of 3 weeks. Morphology and structure of the surface product and its original substrate was examined by thin-film X-ray diffraction, scanning electron microscopy and high-resolution transmission electron microscopy. HA crystals were found to form on an amorphous silica intermediate layer. (100) lattice planes of IIA were resolved and identified.
   Concentration of ions in the SBF and pH of the SBF were monitored throughout the exposure. Additional pH measurements were made at the interface of psW with SBF. The HA formation occurred when there was a sudden increase of pH from 7.25 to 10.5 at the interface of psW with SBF as a result of ionic exchange between 2H(+) and Ca2+ within the psW network. This ionic exchange transformed the psW crystals into an amorphous silica phase. The appropriate pH and the ion concentrations were essential for partial dissolution of the amorphous silica phase and subsequent precipitation of a Ca-P rich phase which then transformed to HA.
C1 UNIV LONDON QUEEN MARY & WESTFIELD COLL,DEPT MAT,IRC,LONDON E1 4NS,ENGLAND.
   UNIV LONDON LONDON HOSP,IRC BIOMED MAT,COLL MED,LONDON E1 2AD,ENGLAND.
   CSIC,INST CERAM & VIDRIO,MADRID,SPAIN.
RP DeAza, PN (reprint author), UNIV SANTIAGO DE COMPOSTELA,INST CERAM,CAMPUS SUR,SANTIAGO,SPAIN.
RI De Aza, Piedad/A-7621-2015
OI De Aza, Piedad/0000-0001-9316-4407
CR DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   DEAZA PN, 1995, MATERIALS CLIN APPL, P19
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   Gamble J. E., 1967, CHEM ANATOMY PHYSL P
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1990, HDB BIOACTIVE CERAMI, V1, P13
   HENCH LL, 1982, BIOMATERIALS INTERFA
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   KEREBEL B, 1976, J ULTRA MOL STRUCT R, V57, P266, DOI 10.1016/S0022-5320(76)80116-5
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   Kokubo T., 1993, INTRO BIOCERAMICS, P75
   KOKUBO T, 1986, 14 INT C GLASS, V2, P408
   KOKUBO T, 1987, YOGYO-KYOKAI-SHI, V95, P785
   LUKLINSKA ZB, 1992, BONE BONDING MAT, P73
   MERLOS A, 1991, P 5 C SENS THEIR APP, P127
   MIZUTANI S, 1970, SEDIMENTOLOGY, V15, P419, DOI 10.1111/j.1365-3091.1970.tb02193.x
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHTSUKI C, 1992, BIOCERAMICS, V5, P79
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   SPECTOR M, 1975, J MICROSC-OXFORD, V103, P55, DOI 10.1111/j.1365-2818.1975.tb04536.x
   Yamamuro T, 1988, Ann N Y Acad Sci, V523, P107, DOI 10.1111/j.1749-6632.1988.tb38505.x
   YAMAMURO T, 1990, BIOCERAMICS, V2, P361
   YAMAMURO T, 1989, BIOCERAMICS, V1, P175
   YOSHII S, 1988, J BIOMED MATER RES-A, V22, P327, DOI 10.1002/jbm.820221410
NR 29
TC 82
Z9 82
U1 0
U2 15
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc.-Oxf.
PD APR
PY 1996
VL 182
BP 24
EP 31
DI 10.1111/j.1365-2818.1996.tb04794.x
PN 1
PG 8
WC Microscopy
SC Microscopy
GA UG936
UT WOS:A1996UG93600003
PM 8632444
DA 2018-10-19
ER

PT J
AU Ektessabi, AM
   Otsuka, T
   Tsuboi, Y
   Horino, Y
   Mokuno, Y
   Fujii, K
   Albrektsson, T
   Sennerby, L
   Johansson, C
AF Ektessabi, AM
   Otsuka, T
   Tsuboi, Y
   Horino, Y
   Mokuno, Y
   Fujii, K
   Albrektsson, T
   Sennerby, L
   Johansson, C
TI Preliminary experimental results on mapping of the elemental
   distribution of the organic tissues surrounding titanium-alloy implants
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT VIIth International Conference on Particle Induced X-ray Emission and
   Its Analytical Applications
CY MAY 26-30, 1995
CL ABANO TERME, ITALY
SP Ist Nazl Fis Nucl, Italy, Univ Padova, Italy, Ruder Boskovic Inst, Croatia, Int Atom Energy Agcy, Austria
ID BIOMEDICAL APPLICATIONS; NUCLEAR MICROSCOPY
AB Titanium alloy (Ti-6Al-4V) is one of the most common materials which are used as orthopaedic and dental implants. In this paper, preliminary experimental results are presented on the measurement of distribution (mapping of X-ray intensities) of the constituent elements of the tissues as well as the released impurity elements in the organic tissues around a Ti-alloy implant. Micro-beam PIXE was carried out for the case of a Ti-6Al-4V implant which was inserted in tibial metaphysis of a rabbit for 12 weeks, using a Nissin high voltage accelerator. Maps of Ca and P clearly show the situation of bone formation and Ca concentration with respect to implant surface. The maps of K alpha intensities of Ti and Al are also obtained to investigate the possible release of these elements. In conclusion, application of micro-beam PIXE to mapping of the constituent and impurity elements around implants can be used as a powerful tool in clarifying the mechanism of osseo-integration, and release of impurity ions from the implants.
C1 KYOTO UNIV,FAC MED,KYOTO,JAPAN.
   AIST,OSAKA NATL RES INST,OSAKA,JAPAN.
   UNIV GOTHENBURG,INST SURG SCI,GOTHENBURG,SWEDEN.
RP Ektessabi, AM (reprint author), KYOTO UNIV,FAC ENGN,KYOTO,JAPAN.
CR CHOLEWA M, 1993, NUCL INSTRUM METH B, V77, P282, DOI 10.1016/0168-583X(93)95556-K
   EKTESSABI AM, 1994, INT J PIXE, V4, P81
   LINDH U, 1993, NUCL INSTRUM METH B, V77, P261, DOI 10.1016/0168-583X(93)95553-H
   MOKUNO Y, 1994, NUCL INSTRUM METH B, V85, P741, DOI 10.1016/0168-583X(94)95914-5
   MORETTO P, 1993, NUCL INSTRUM METH B, V77, P275, DOI 10.1016/0168-583X(93)95555-J
   VIS RD, 1988, SCANNING MICROSCOPY, V2, P977
   WATT F, 1993, NUCL INSTRUM METH B, V77, P249, DOI 10.1016/0168-583X(93)95552-G
NR 7
TC 24
Z9 24
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD APR
PY 1996
VL 109
BP 278
EP 283
DI 10.1016/0168-583X(95)00922-1
PG 6
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA UV444
UT WOS:A1996UV44400054
DA 2018-10-19
ER

PT J
AU Laurent, A
   Beaujeux, R
   Wassef, M
   Rufenacht, D
   Boschetti, E
   Merland, JJ
AF Laurent, A
   Beaujeux, R
   Wassef, M
   Rufenacht, D
   Boschetti, E
   Merland, JJ
TI Trisacryl gelatin microspheres for therapeutic embolization .1.
   Development and in vitro evaluation
SO AMERICAN JOURNAL OF NEURORADIOLOGY
LA English
DT Article
DE interventional materials, particles and microspheres
ID POLYVINYL-ALCOHOL; MITOMYCIN-C; CELLS; INJECTION; HYDROGELS; PARTICLES;
   INVITRO; CULTURE; KIDNEY
AB PURPOSE: To develop a precisely calibrated, perfectly spherical, stainable, soft, and implantable but nonresorbable particulate embolization material. METHODS: Calibrated particles with a trisacryl gelatin polymer core and hydrophilic surface characteristics were obtained by reversed emulsion synthesis followed by application of a wet-sieving technique. Particles were suspended in saline, bottled, and sterilized. Quality control included analysis of particle diameters before and after sieving and of suspension sterility and apyrogenicity. Particles were subsequently tested to ascertain their compatibility with commercially available microcatheters. RESULTS: The resulting embolization material consisted of spherical, stainable microspheres of medical grade with diameters ranging from 130 mu m to 1200 mu m. Sieving the suspension produced particle groups of homogeneous size (accuracy, +/- 20-100 mu m). At injection, the particles showed no tendency to build aggregates or to obstruct the microcatheters. CONCLUSION: Precisely calibrated and easy-to-use microspheres were obtained that satisfied the biomedical requirements for implantation as an embolization material.
C1 UNIV PARIS,CLAUDE BERNARD RES ASSOC,LAB INTERVENT NEURORADIOL,F-75252 PARIS,FRANCE.
   HOP LARIBOISIERE,DEPT PATHOL,F-75475 PARIS,FRANCE.
   SOC SEPRACOR IBF,VILLENEUVE GARENN,FRANCE.
   CTR RECH INTERVENT IMAGING,JOUY EN JOSAS,FRANCE.
CR BENITA S, 1986, J PHARM SCI, V9, P847
   BERGETHON PR, 1989, J CELL SCI, V92, P111
   BERTA P, 1986, FEBS LETT, V200, P27, DOI 10.1016/0014-5793(86)80504-X
   BROWN NE, 1977, J CHROMATOGR, V150, P101
   CASTANEDAZUNIGA WR, 1978, RADIOLOGY, V126, P783, DOI 10.1148/126.3.783
   Co C S, 1983, Radiat Med, V1, P268
   CORY RN, 1986, EUR J PHARMACOL, V131, P153, DOI 10.1016/0014-2999(86)90531-5
   DION JE, 1986, RADIOLOGY, V160, P717, DOI 10.1148/radiology.160.3.2426727
   DOMAS L, 1993, INNOV TECH BIOL MED, V14, P436
   FLANDROY P, 1990, NEURORADIOLOGY, V32, P311, DOI 10.1007/BF00593051
   FORSBERG JO, 1978, ACTA CHIR SCAND, V144, P275
   FUJIMOTO S, 1985, CANCER, V56, P2404, DOI 10.1002/1097-0142(19851115)56:10<2404::AID-CNCR2820561011>3.0.CO;2-C
   GUYOMARD S, 1985, ANN INST PASTEUR MIC, V136B, P49, DOI 10.1016/S0769-2609(85)80005-3
   HECQUET B, 1986, ANTICANCER RES, V6, P65
   HORAK D, 1986, BIOMATERIALS, V7, P188, DOI 10.1016/0142-9612(86)90100-6
   JACK CR, 1985, AM J NEURORADIOL, V6, P595
   KATO T, 1981, CANCER, V48, P674, DOI 10.1002/1097-0142(19810801)48:3<674::AID-CNCR2820480303>3.0.CO;2-E
   KERBER CW, 1978, AM J ROENTGENOL, V130, P1193, DOI 10.2214/ajr.130.6.1193
   LAURENT A, 1989, INNOV TECH BIOL MED, V10, P357
   LONGACRE JJ, 1972, PLAST RECONSTR SURG, V50, P618, DOI 10.1097/00006534-197212000-00019
   LUESSENHOP AJ, 1960, JAMA-J AM MED ASSOC, V172, P1153, DOI 10.1001/jama.1960.63020110001009
   MADOULE P, 1981, J RADIOL, V62, P457
   MAISONNEURA, 1990, FRENCH PHARMACOPEIA, P1
   MAISONNEURE, 1980, EUROPEAN PHARMACOPEI
   MILLERFAURES A, 1985, DEV BIOL STAND, V60, P209
   OBRENOVITCH A, 1982, BIOL CELL, V46, P249
   PRINZMETAL M, 1947, AM HEART J, V33, P420, DOI 10.1016/0002-8703(47)90090-2
   RAO VRK, 1991, J NEURORADIOLOGY, V18, P61
   RAZIEL A, 1980, AM J ROENTGENOL, V134, P404, DOI 10.2214/ajr.134.2.404
   REPA I, 1989, RADIOLOGY, V170, P395, DOI 10.1148/radiology.170.2.2911663
   RUSSELL EJ, 1987, RADIOLOGY, V165, P631, DOI 10.1148/radiology.165.3.3685342
   SPENLEHAUER G, 1989, BIOMATERIALS, V10, P557, DOI 10.1016/0142-9612(89)90063-X
   STOL M, 1985, BIOMATERIALS, V6, P193, DOI 10.1016/0142-9612(85)90009-2
   STRIDBECK H, 1984, INVEST RADIOL, V19, P179
   WRIGHT KC, 1982, RADIOLOGY, V142, P351, DOI 10.1148/radiology.142.2.6172809
NR 35
TC 111
Z9 120
U1 2
U2 12
PU AMER SOC NEURORADIOLOGY
PI OAK BROOK
PA 2210 MIDWEST RD, OAK BROOK, IL 60521
SN 0195-6108
J9 AM J NEURORADIOL
JI Am. J. Neuroradiol.
PD MAR
PY 1996
VL 17
IS 3
BP 533
EP 540
PG 8
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA UB139
UT WOS:A1996UB13900022
PM 8881250
DA 2018-10-19
ER

PT J
AU Cheang, P
   Khor, KA
AF Cheang, P
   Khor, KA
TI Addressing processing problems associated with plasma spraying of
   hydroxyapatite coatings
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; plasma spraying; microstructure; powder properties;
   bioactive phases
ID CALCIUM-PHOSPHATE; TITANIUM IMPLANTS
AB Biomedical coatings generally have to satisfy specific requirements such as a high degree of crystallinity (for positive biological responses), good coating adhesion and optimal porosity. These are necessary to enhance biocompatibility, accelerate post-operative healing and improve fixation. Thermal spray processes have been frequently used to deposit functionally active biomedical coatings, such as hydroxyapatite (HA), onto prosthetic implants. The benefits of HA materials in coated implants have been widely acknowledged, but the occurrence of several poor performances has generated concerns over the consistency and reliability of thermally sprayed HA coatings. Recent investigations using HA coatings have shown that process related variability has significant influence on coating characteristics such as phase composition, structure and chemical composition and performance such as bioresorption, degradation and bone apposition. Variation in process parameters such as powder morphology can induce microstructural and mechanical inconsistencies that have an effect on the service performance of the coating. In order to reach some acceptable level of reliability, it may be necessary to control existing variability in commercially available HA feedstock. In addition, certain opposing factors severely constrain the means to achieve the necessary coating conditions via thermal spraying alone; therefore, creating the need to introduce other innovative or secondary treatment stages to attain the desired results. This paper highlights some of the problems associated with plasma spray coating of HA and suggests that tailoring the powder feedstock morphology and properties through suitable conditioning processes can aid the deposition efficiency and produce an acceptable coating structure.
C1 NANYANG TECHNOL UNIV,SCH MECH & PROD ENGN,SINGAPORE 2263,SINGAPORE.
   NANYANG TECHNOL UNIV,SCH APPL SCI,SINGAPORE 2263,SINGAPORE.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR CAHN RW, 1993, MAT SCI TECHNOLOGY M, V14, P278
   CHEANG P, 1989, THESIS MONASH U AUST
   CHEANG P, 1994, P 8 INT C BIOM ENG S, P531
   CHEN JY, 1994, BIOMATERIALS, V15, P396, DOI 10.1016/0142-9612(94)90253-4
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   DEGROOT K, 1982, BIOCERAMICS CALCIUM
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   Gerdeman D. A., 1972, ARC PLASMA TECHNOLOG
   GROSS KA, 1990, THESIS MONASH U AUST
   GROSS KA, 1993, CHARACTERISATION PER, P256
   HEIDE H, 1987, P INT C HOT IS PRESS, P423
   JACHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KAY JF, 1992, DENTAL CLIN N AM, V38, P1
   Khor K. A., 1994, THERMAL SPRAY IND AP, P147
   KHOR KA, 1994, J THERM SPRAY TECHN, V3, P45, DOI 10.1007/BF02648998
   KHOR KA, 1994, P 8 INT C BIOM ENG S, P536
   KHOR KA, 1995, UNPUB J MAT P TECHNO
   KHOR KA, 1995, IN PRESS P 2 INT S A
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P909, DOI 10.1002/jbm.820280810
   LACEFIELD WR, 1988, MAT CHARACTERIZATION, P72
   MALMBERG S, 1993, J THERM SPRAY TECHN, V2, P339
   MANLEY MT, 1987, 33RD T ANN M ORTH RE, V12, P214
   MAXIAN SH, 1993, J BIOMED MATER RES, V27, P717, DOI 10.1002/jbm.820270604
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   RAVAGLIOLI A, 1992, BIOCERAMICS MAT PROP, P264
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   Tagai H, 1980, MECH PROPERTIES BIOM
   VARDELLE M, 1983, 10 INT THERM SPRAYIN, V80, P88
   YIP CS, 1995, P INT C MECH SOL MAT, VA, P191
   ZYMAN Z, 1993, BIOMATERIALS, V14, P225, DOI 10.1016/0142-9612(93)90027-Y
   1983, Patent No. 109049
NR 31
TC 166
Z9 174
U1 4
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1996
VL 17
IS 5
BP 537
EP 544
DI 10.1016/0142-9612(96)82729-3
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TY590
UT WOS:A1996TY59000009
PM 8991486
DA 2018-10-19
ER

PT J
AU Swift, EJ
   Thompson, JY
   Bayne, SC
AF Swift, EJ
   Thompson, JY
   Bayne, SC
TI Review of dental materials citations .B. July to December 1995
SO DENTAL MATERIALS
LA English
DT Article
AB Objective: A lag of many months occurs between journal issue publication and updates to electronic databases. The objective of this literature analysis was to identify and categorize all of the dental materials citations in biomedical journals that were published from July 1995 through December 1995.
   Methods: Seventeen primary and 51 secondary journals were searched using their tables of contents to detect and record dental materials publications from July to December of 1995. Those journals that were typically rich in dental materials articles were classified as primary ones. Citations were categorized into 17 topics and divided into subsections. The review excluded case reports, most literature related primarily to dental implants, and most articles on biomedical materials used outside of the field of general dentistry.
   Results. The greatest number of citations was related to topics of dentin bonding and resin-based restorative filling materials (composites and glass ionomers). There was no major change in the number of dental materials publications per year reported from 1993 (n = 786) to 1995 (n = 751).
   Significance: This citation list provides a comprehensive resource for use by academicians and researchers to bridge the gap between initial publication and access to electronic searching methods for major databases.
RP Swift, EJ (reprint author), UNIV N CAROLINA,SCH DENT,DEPT OPERAT DENT,CHAPEL HILL,NC 27599, USA.
CR BAYNE SC, 1995, DENT MATER, V11, P281, DOI 10.1016/0109-5641(95)80064-6
   BAYNE SC, 1994, DENT MATER, V10, P59, DOI 10.1016/0109-5641(94)90023-X
   Christensen G J, 1995, J Esthet Dent, V7, P228, DOI 10.1111/j.1708-8240.1995.tb00584.x
   JENDRESEN MD, 1993, J PROSTHET DENT, V70, P44, DOI 10.1016/0022-3913(93)90036-N
   JENDRESEN MD, 1995, J PROSTHET DENT, V74, P60, DOI 10.1016/S0022-3913(05)80231-8
   JENDRESEN MD, 1994, J PROSTHET DENT, V72, P39, DOI 10.1016/0022-3913(94)90214-3
   LLOYD CH, 1995, J DENT, V23, P67, DOI 10.1016/0300-5712(95)98973-7
   SWIFT EJ, 1995, DENT MATER, V11, P52, DOI 10.1016/0109-5641(95)80009-3
   VANNOORT R, 1993, J DENT, V21, P5, DOI 10.1016/0300-5712(93)90046-S
   VANNOORT R, 1994, J DENT, V22, P5, DOI 10.1016/0300-5712(94)90139-2
   1995, CLIN RES ASS NEWSLET, V19, P1
NR 11
TC 3
Z9 3
U1 0
U2 2
PU ACAD DENTAL MATERIALS
PI DALLAS
PA BAYLOR COLLEGE DENTISTRY, 3302 GASTON AVE, DALLAS, TX 75266-0677
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD MAR
PY 1996
VL 12
IS 2
BP 127
EP 141
PG 15
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA UD091
UT WOS:A1996UD09100009
PM 9002855
DA 2018-10-19
ER

PT J
AU Kaetsu, I
AF Kaetsu, I
TI Biomedical materials, devices and drug delivery systems by radiation
   techniques
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 8th Tihany Symposium on Radiation Chemistry
CY 1994
CL BALATONSZEPLAK, HUNGARY
AB The study of radiation polymerization in a super-cooled state started in 1966 and has been applied to the immobilization of biofunctional materials since 1973. In the last twenty years, application has been concentrated to the immobilization of drugs and hormones for the purpose of drug delivery systems. Very recently, the author has proposed a concept of environmental signal responsive chemical delivery system, as a new generation of controlled release and delivery systems. The study and development of materials, devices and systems is described. The signal responsive delivery system consists of a sensor part and a controlled delivery part. Therefore, the use of immobilization techniques for the biochip sensor and the hydrogel actuator has been investigated. As a future goal, systems for the brain research are to be designed and studied.
RP Kaetsu, I (reprint author), KINKI UNIV,FAC SCI & TECHNOL,DEPT NUCL ENGN,KOWAKAE 3-4-1,OSAKA 577,JAPAN.
CR KAETSU I, 1993, ADV POLYM SCI, V105, P81
   KAETSU I, 1972, J POLYM SCI A1, V10, P2203, DOI 10.1002/pol.1972.150100801
   KAETSU I, 1988, DRUG DEV IND PHARM, V14, P2519, DOI 10.3109/03639048809152030
   YOSHIDA M, 1979, J PHARM SCI, V68, P628, DOI 10.1002/jps.2600680531
NR 4
TC 16
Z9 16
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD MAR
PY 1996
VL 47
IS 3
BP 419
EP 424
DI 10.1016/0969-806X(95)00129-L
PG 6
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA TN378
UT WOS:A1996TN37800022
DA 2018-10-19
ER

PT J
AU Ando, H
   Watanabe, S
   Mori, S
   Wada, Y
   Tanada, M
   Suzuki, H
   Takagi, S
   Nagaoka, S
   Matsumoto, K
   Suzuki, T
   Ogasawara, K
   Ogawa, K
   Tsumura, K
AF Ando, H
   Watanabe, S
   Mori, S
   Wada, Y
   Tanada, M
   Suzuki, H
   Takagi, S
   Nagaoka, S
   Matsumoto, K
   Suzuki, T
   Ogasawara, K
   Ogawa, K
   Tsumura, K
TI Intracellular recordings from Xenopus oocyte by using telescience
   technique
SO ACTA ASTRONAUTICA
LA English
DT Article; Proceedings Paper
CT 46th International-Astronautical-Federation Congress
CY OCT 02-06, 1995
CL OSLO, NORWAY
SP Int Astronaut Federat
AB By using telescience techniques, we developed and tested a system for remotely conducting intracellular recordings, an indispensable method for biomedical studies. As a representative experiment we chose to study on the adenosine-induced responses of Xenopus oocyte. Experimental materials were placed in a room simulating an orbital laboratory. The experiment was controlled and monitored by a principal investigator (PI) from another room simulating a ground control room. The two rooms were connected by a telecommunication simulator that could impose the communication delay and limit the data transfer rate. The PI inserted one or two microelectrodes into an oocyte using remote control on the micro-manipulators and on the platform of microscope with stereoscopic pictures observed through a head mounted display. By inserting one electrode, we could successfully study the adenosine responses at various concentrations. Then, we tried to perform the ''voltage clamp'' recordings by inserting two electrodes into one oocyte. Though insertion of two electrodes was troublesome, we finally succeeded the voltage clamp recordings. Result indicate the usefulness of the telescience for conducting intracellular recordings in space.
RP Ando, H (reprint author), KOBE UNIV,SCH MED,DEPT PHYSIOL,KOBE,JAPAN.
CR LOTAN I, 1985, MOL PHARMACOL, V28, P170
   WATANABE S, 1994, ACTA ASTRONAUT, V33, P189, DOI 10.1016/0094-5765(94)90124-4
NR 2
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0094-5765
J9 ACTA ASTRONAUT
JI Acta Astronaut.
PD FEB-APR
PY 1996
VL 38
IS 4-8
BP 517
EP 523
DI 10.1016/0094-5765(96)00026-4
PG 7
WC Engineering, Aerospace
SC Engineering
GA VJ682
UT WOS:A1996VJ68200031
DA 2018-10-19
ER

PT J
AU DeLucas, LJ
AF DeLucas, LJ
TI International Space Station
SO ACTA ASTRONAUTICA
LA English
DT Article; Proceedings Paper
CT 46th International-Astronautical-Federation Congress
CY OCT 02-06, 1995
CL OSLO, NORWAY
SP Int Astronaut Federat
AB The International Space Station represents the largest scientific and technological cooperative program in history, drawing on the resources of thirteen nations. The early stages of construction will involve significant participation from the Russian Space Agency (RSA), numerous nations of the European Space Agency (ESA), and-the space agencies of Canada (CSA), Japan (NASDA) and the United States Space Agency (NASA). Its purpose is to place a unique, highly capable laboratory in lower orbit, where high value scientific research can be performed in microgravity; In addition to providing facilities where an international crew of six astronaut-scientists can live and work in space, it will provide important laboratory research facilities for performing basic research in life science, biomedical and material sciences, as well as space and engineering technology development which cannot be accomplished on Earth. The Space Station will be comprised of numerous interlocking components which are currently being constructed on Earth. Space Station will be assembled in orbit over a period of time and will provide several experimentation modules as well as habitation modules and interfaces for logistic modules. Including the four extensive solar rays from which it will draw electrical power, the Station will measure more than 300 feet wide by 200 feet long. This paper will present an overview of the various phases of construction of the Space Station and the planned science thought will be performed during the construction phase and after completion.
RP DeLucas, LJ (reprint author), UNIV ALABAMA,CTR MACROMOL CRYSTALLOG,BIRMINGHAM,AL 35294, USA.
NR 0
TC 5
Z9 5
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0094-5765
J9 ACTA ASTRONAUT
JI Acta Astronaut.
PD FEB-APR
PY 1996
VL 38
IS 4-8
BP 613
EP 619
DI 10.1016/0094-5765(96)00056-2
PG 7
WC Engineering, Aerospace
SC Engineering
GA VJ682
UT WOS:A1996VJ68200039
DA 2018-10-19
ER

PT J
AU Tangpasuthadol, V
   Shefer, A
   Hooper, KA
   Kohn, J
AF Tangpasuthadol, V
   Shefer, A
   Hooper, KA
   Kohn, J
TI Thermal properties and physical ageing behaviour of tyrosine-derived
   polycarbonates
SO BIOMATERIALS
LA English
DT Article
DE physical ageing; enthalpy relaxation kinetics; differential scanning
   calorimetry; tyrosine; polycarbonates
ID GLASS-TRANSITION TEMPERATURE; ENTHALPY RELAXATION; PSEUDO-POLY(AMINO
   ACIDS); AGING TEMPERATURE
AB Tyrosine-derived polycarbonates are new carbonate-amide copolymers. These materials have been suggested for use in medical applications, but their thermal properties and their enthalpy relaxation kinetics (physical ageing behaviour) have so far not been evaluated in detail. Since structure-property correlations involving enthalpy relaxation are rarely investigated for biomedical polymers, a series of four tyrosine-derived polycarbonates was used as a model system to study the effect of pendant chain length on the thermal properties and the enthalpy relaxation kinetics. The chemical structure of the test polymers was identical except for the length of their respective pendant chains. This feature facilitated the identification of structure-property correlations. Quantitative differential scanning calorimetry was utilized to determine the thermal properties and to measure enthalpy relaxation kinetics. The glass transition temperature of this family of polymers decreased from 93 to 52 degrees C when the length of the pendant chain was increased from two to eight carbon atoms. Successive additions of methylene groups to the pendant chain made a fairly constant contribution to lowering the glass transition temperature. For pendant chains of four or more methylene groups, the rate of enthalpy relaxation was independent of the number of methylene groups in the pendant chain. The enthalpy relaxation data were fitted to the Cowie-Ferguson model and the relaxation times obtained were about 90 min. Dynamic mechanical analysis was employed to study the viscoelastic properties. The available observations indicate that the polymers become more flexible with increasing length of the pendant chain. The results suggest that the length of the pendant chain can be used effectively to control important material properties in this series of polymers.
C1 RUTGERS STATE UNIV,DEPT CHEM,NEW BRUNSWICK,NJ 08903.
RI Tangpasuthadol, Varawut/F-9260-2010
FU NIGMS NIH HHS [GM39455]
CR ANDERSON JM, 1985, BIOCOMPATIBILITY TIS, V1, P67
   BAUWENSCROWET C, 1986, POLYMER, V27, P709, DOI 10.1016/0032-3861(86)90128-X
   Billmeyer FW, 1984, TXB POLYM SCI
   BRON S, 1993, POLYM MAT SCI ENG, V69, P37
   BRON S, 1993, IEEE 19 ANN NE BIOEN, P145
   CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   CHENG SZD, 1991, POLYMER, V32, P2053, DOI 10.1016/0032-3861(91)90172-F
   CLARSON SJ, 1985, POLYMER, V26, P930, DOI 10.1016/0032-3861(85)90140-5
   COFFEY D, 1992, S POLYM DEL SYST SPR
   COWIE JMG, 1989, MACROMOLECULES, V22, P2312, DOI 10.1021/ma00195a054
   COWIE JMG, 1989, MACROMOLECULES, V22, P2307, DOI 10.1021/ma00195a053
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   KOHN J, 1993, TRENDS POLYM SCI, V1, P206
   MONTSERRAT S, 1994, J POLYM SCI POL PHYS, V32, P509, DOI 10.1002/polb.1994.090320312
   PETHRICK RA, 1993, TRENDS POLYM SCI, V1, P226
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   SHEFER A, 1992, MACROMOLECULES, V25, P4036, DOI 10.1021/ma00041a028
   SPATOLA AF, 1983, CHEM BIOCH AMINO ACI, V7, P267
   STRUIK LCE, 1978, PHYSICAL AGING AMORP
   YOSHIDA H, 1982, J MACROMOL SCI PHYS, VB21, P565, DOI 10.1080/00222348208215191
   ZHOU J, 1994, 20 ANN M SOC BIOM BO, P371
NR 21
TC 15
Z9 16
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1996
VL 17
IS 4
BP 463
EP 468
DI 10.1016/0142-9612(96)89665-7
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TY460
UT WOS:A1996TY46000011
PM 8938243
DA 2018-10-19
ER

PT J
AU Ellis, RD
   Jankowski, TB
   Jasper, JE
   Abdul, A
AF Ellis, RD
   Jankowski, TB
   Jasper, JE
   Abdul, A
TI Gero-Informatics and the Internet: Locating gerontology information on
   the World Wide Web (WWW)
SO GERONTOLOGIST
LA English
DT Article
DE computer applications; electronic information; Internet; World Wide Web
AB The Internet, and in particular the World Wide Web (WWW), are growing at a tremendous rate. information useful to researchers and practitioners in gerontology is scattered and hard to locate, even for experts in the use of the WWW. In order to locate and organize access to this material, a WWW server was developed for gerontologists, using state-of-the-art Internet search techniques. This report provides background on the WWW, reasons for its growth, its potential usefulness to gerontologists, and the results of an exhaustive search of over 300 potential sites. Relevant information was discovered in 5 general categories of gerontology-related information: academic institutions, government agencies, biomedical and health research institutions, general interest sites and data archives.
C1 WAYNE STATE UNIV,DEPT IND & MFG ENGN,DETROIT,MI 48202.
RP Ellis, RD (reprint author), WAYNE STATE UNIV,INST GERONTOL,87 E FERRY,226 KNAPP BLDG,DETROIT,MI 48202, USA.
RI Ellis, Richard/A-5905-2009
OI Ellis, Richard/0000-0003-0435-8395
CR POST JA, 1995, AGEING INT, V22, P56
NR 1
TC 7
Z9 7
U1 0
U2 1
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 0016-9013
J9 GERONTOLOGIST
JI Gerontologist
PD FEB
PY 1996
VL 36
IS 1
BP 100
EP 105
DI 10.1093/geront/36.1.100
PG 6
WC Gerontology
SC Geriatrics & Gerontology
GA TV975
UT WOS:A1996TV97500018
PM 8932415
OA Bronze
DA 2018-10-19
ER

PT J
AU Xu, JW
   Gilson, DFR
   Butler, IS
   Stangel, I
AF Xu, JW
   Gilson, DFR
   Butler, IS
   Stangel, I
TI Effect of high external pressures on the vibrational spectra of
   biomedical materials: Calcium hydroxyapatite and calcium fluoroapatite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID TRANSFORM INFRARED-SPECTROSCOPY; LITHIUM HYDROXIDE; PHOSPHATE IONS;
   EARLY DEPOSITS; SOLID-PHASE; PO4 DOMAIN; APATITES; ENVIRONMENT;
   EVOLUTION; ENAMEL
AB Infrared and Raman spectra of the principal mineral component of human hard tissue, calcium hydroxyapatite, Ca-10(PO4)(6)(OH)(2), or HAP, and the analogous calcium fluoroapatite, Ca-10(PO4)(6)F-2, or FAP, have been recorded, using a diamond-anvil cell, at pressures ranging from ambient to 30 kbar. For FAP, the absence of any discontinuities in the slopes of the nu (cm(-1)) versus P (kbar) plots for the observed bands indicates that no pressure-induced structural transition occurs in this material throughout the pressure range investigated. For the internal vibrational modes of HAP, however, there are distinct breaks at similar to 20 kbar in the nu versus P plots, suggesting the occurrence of a structural change at this pressure. The OH stretching mode of HAP shifts to higher wave numbers with increasing pressure while the associated OH librational mode shifts in the opposite direction. The pressure-induced structural transition in HAP is reversible and occurs at similar to 22 kbar upon decompression. Further evidence for a structural change taking place at similar to 20 kbar was provided by a parallel pressure-tuning Raman study. Hydrogen bonding does not occur, or is very weak, in HAP. (C) 1996 John Wiley & Sons, Inc.
C1 MCGILL UNIV,DEPT CHEM,MONTREAL,PQ H3A 2K6,CANADA.
   MCGILL UNIV,FAC DENT,MONTREAL,PQ H3A 1A4,CANADA.
CR ADAMS DM, 1991, J PHYS CHEM-US, V95, P7064, DOI 10.1021/j100171a063
   ADAMS DM, 1991, J PHYS-CONDENS MAT, V3, P9503, DOI 10.1088/0953-8984/3/47/022
   ANDRESVERGES M, 1983, SPECTROCHIM ACTA A, V39, P1077, DOI 10.1016/0584-8539(83)80128-7
   BADDIEL CB, 1966, SPECTROCHIM ACTA, V22, P1407, DOI 10.1016/0371-1951(66)80133-9
   BUSING WR, 1957, J CHEM PHYS, V26, P563, DOI 10.1063/1.1743345
   DASARATHY H, 1993, J BIOMED MATER RES, V27, P477, DOI 10.1002/jbm.820270408
   de Groot K, 1988, Ann N Y Acad Sci, V523, P272
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   ELLIOTT JC, 1962, J DENT RES, V41, P1251
   ENGEL G, 1972, J SOLID STATE CHEM, V5, P28, DOI 10.1016/0022-4596(72)90004-7
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   GONZALEZDIAZ PF, 1977, J SOLID STATE CHEM, V22, P193, DOI 10.1016/0022-4596(77)90037-8
   HAMANN SD, 1975, AUST J CHEM, V28, P2567, DOI 10.1071/CH9752567
   IQBAL Z, 1977, J PHYS CHEM SOLIDS, V38, P923, DOI 10.1016/0022-3697(77)90132-9
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   KLEE WE, 1970, J INORG NUCL CHEM, V32, P1837, DOI 10.1016/0022-1902(70)80590-5
   KLUG DD, 1983, REV SCI INSTRUM, V54, P1205, DOI 10.1063/1.1137551
   KROBOK MP, 1994, J PHYS-CONDENS MAT, V6, P9789, DOI 10.1088/0953-8984/6/45/028
   KRUGER MB, 1989, J CHEM PHYS, V91, P5910, DOI 10.1063/1.457460
   LEUNG YC, 1990, SPECTROCHIM ACTA A, V46, P1453, DOI 10.1016/0584-8539(90)80059-8
   LIPPINCOTT ER, 1955, J CHEM PHYS, V23, P1099, DOI 10.1063/1.1742196
   MOON SH, 1974, J CHEM PHYS, V61, P48, DOI 10.1063/1.1681669
   Naray-Szabo S, 1930, Z KRISTALLOGR, V75, P387
   NORDQUIST WD, 1973, CALC TISS RES, V12, P30, DOI 10.1007/BF02013719
   PIERMARINI GJ, 1975, J APPL PHYS, V46, P2774, DOI 10.1063/1.321957
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   YOUNG R, 1974, CLIN ORTHOPAEDICS, V113, P249
NR 29
TC 20
Z9 20
U1 0
U2 13
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1996
VL 30
IS 2
BP 239
EP 244
DI 10.1002/(SICI)1097-4636(199602)30:2<239::AID-JBM14>3.0.CO;2-H
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UD181
UT WOS:A1996UD18100015
PM 9019489
DA 2018-10-19
ER

PT J
AU Simpson, ML
   Miller, JC
   Lowndes, DH
AF Simpson, ML
   Miller, JC
   Lowndes, DH
TI Laser technology at the Oak Ridge National Laboratory
SO JOURNAL OF LASER APPLICATIONS
LA English
DT Article
DE laser technology research; exchange; laser industry interaction; Oak
   Ridge National Laboratory
ID SUPERCONDUCTING THIN-FILMS; RESONANCE IONIZATION SPECTROSCOPY; HIGH-TC;
   GROWTH; DEPOSITION; ABLATION
AB Researchers at the Department of Energy (DOE) facilities at Oak Ridge perform a variety of basic and applied research involving lasers and laser technology, One of the major strengths at Oak Ridge is the combination of core capabilities in optical materials, optical diagnostics, and sensors, Communities benefiting from these core capabilities include environmental, biomedical, and industrial sponsors, Industry can interact with Oak Ridge in a variety of ways: with Cooperative Research and Development Agreements (CRADAs), through Work for Others (WFO) programs, and as User Center participants, Oak Ridge is also active in sponsoring workshops and symposia for industrial participants like the Optical Diagnostics in Manufacturing and Process Control symposium held in December 1993. In this paper, an overview of a selection of laser technologies residing at Oak Ridge is provided, Examples of the application of these technologies are given as well as overviews of several on-going CRADAs with industrial partners.
RP Simpson, ML (reprint author), OAK RIDGE NATL LAB,POB 2008,OAK RIDGE,TN 37831, USA.
CR ALLISON SW, 1988, P ICALEO
   CHEN CH, 1992, INT J GENOME RES, V1, P25
   CHEN CH, 1984, APPL PHYS LETT, V44, P640, DOI 10.1063/1.94861
   CHEUNG JT, 1988, CRIT REV SOLID STATE, V15, P63, DOI 10.1080/10408438808244625
   COMPTON RN, 1989, LASER APPL PHYSICAL
   DESAI SR, 1994, J CHEM PHYS, V101
   FORK DK, 1991, APPL PHYS LETT, V58, P2294, DOI 10.1063/1.104903
   FORK DK, 1990, APPL PHYS LETT, V57, P2504, DOI 10.1063/1.104181
   GARSIDE BK, 1988, P SOC PHOTO-OPT INS, V954, P670
   HURST GS, 1979, REV MOD PHYS, V51, P767, DOI 10.1103/RevModPhys.51.767
   INAM A, 1988, APPL PHYS LETT, V53, P908, DOI 10.1063/1.100155
   Jellison G. E.  Jr., 1993, Optical Materials, V2, P105, DOI 10.1016/0925-3467(93)90035-Y
   JELLISON GE, 1990, APPL OPTICS, V29, P959, DOI 10.1364/AO.29.000959
   KANAI M, 1989, APPL PHYS LETT, V54, P1802, DOI 10.1063/1.101269
   KANAI M, 1991, APPL PHYS LETT, V58, P771, DOI 10.1063/1.104543
   KERCEL SW, 1993, 12383 ORNL
   KERCEL SW, ULTRAHIGH HIGH SPEED, P60
   LEE LP, 1991, APPL PHYS LETT, V59, P3051, DOI 10.1063/1.105790
   LOWNDES DH, 1994, MODERN TOPICS GROWTH
   MCCAMY JW, 1993, APPL PHYS LETT, V63, P3008, DOI 10.1063/1.110267
   MILLER JC, 1991, LECT NOTES PHYSICS, V389
   MILLER JC, 1982, J CHEM PHYS, V76, P2056
   MILLER JC, 1994, AIP C P, V288
   MUHS JD, 1992, PHOTONICS, V98
   NORTON DP, 1991, PHYS REV LETT, V66, P1537, DOI 10.1103/PhysRevLett.66.1537
   NORTON DP, 1993, APPL PHYS LETT, V62, P1679, DOI 10.1063/1.109574
   NORTON DP, 1994, IN PRESS SCIENCE
   STEVENSON CL, 1993, APPL SPECTROSC, V47, P430, DOI 10.1366/0003702934334967
   STOREY JME, 1994, SPECTROSCOPY     AUG
   VODINH T, 1994, IN PRESS LASERS SURG
   WATTS W, 1992, APPL SPECTROSC, V46, P1235, DOI 10.1366/0003702924123953
   WOOD RF, 1984, SEMICONDUCTORS SEMIM, V23
   WU XD, 1988, APPL PHYS LETT, V52, P754, DOI 10.1063/1.99337
   WU XD, 1990, APPL PHYS LETT, V56, P1481, DOI 10.1063/1.103209
NR 34
TC 0
Z9 0
U1 0
U2 0
PU LASER INST AMER
PI ORLANDO
PA 12424 RESEARCH PARKWAY SUITE 125, ORLANDO, FL 32826
SN 1042-346X
J9 J LASER APPL
JI J. Laser Appl.
PD FEB
PY 1996
VL 8
IS 1
BP 55
EP 60
DI 10.2351/1.4745405
PG 6
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA UG055
UT WOS:A1996UG05500009
DA 2018-10-19
ER

PT J
AU Krajewski, A
   Ravaglioli, A
   Kirsch, M
   Biagini, G
   Solmi, R
   Belmonte, M
   Zucchini, C
   Gandolfi, MG
   Castaldini, C
   Rodriguez, L
   Giardino, R
   Mongiorgi, R
   Roncari, E
   Orlandi, L
AF Krajewski, A
   Ravaglioli, A
   Kirsch, M
   Biagini, G
   Solmi, R
   Belmonte, M
   Zucchini, C
   Gandolfi, MG
   Castaldini, C
   Rodriguez, L
   Giardino, R
   Mongiorgi, R
   Roncari, E
   Orlandi, L
TI Ceramic support for cell cultures
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HUMAN-ENDOTHELIAL-CELLS
AB Research was carried out on the use of ceramics as supports to host mammalian cells. The research was part of a programme whose priority was to study the possibility of using ceramics in the non-traditional sector of the biomedical field. The aim of the study was also to verify the suitability of particular types of ceramics dealt with in the literature for these applications. Among the different samples tested the cordieritic one proved to be very interesting, at least in relation to the cellular cultures considered. The chemical composition of the material is not, however, the only important aspect, since other parameters concur to make the hosting of cells highly acceptable. Of particular importance is the rugosity and porosity of the surface and its flaking, not only externally, but also in the pores.
C1 WITE GMBH,BERLIN,GERMANY.
   UNIV ANCONA,INST NORMAL HUMAN MORPHOL,FAC MED,ANCONA,ITALY.
   UNIV BOLOGNA,INST HISTOL,FAC MED,BOLOGNA,ITALY.
   UNIV TURIN,DEPT MED,TURIN,ITALY.
   UNIV BOLOGNA,DIV ESPERIMENTAL SURG,ORTHOPAED INST RIZZOLI,BOLOGNA,ITALY.
   UNIV BOLOGNA,DEPT HEARTH SCI,BOLOGNA,ITALY.
   UNIV BOLOGNA,FAC PHARM,BOLOGNA,ITALY.
   NATL INST STUDY & TREATMENT TUMOURS ONCOL C,MILAN,ITALY.
RP Krajewski, A (reprint author), ITALIAN NATL RES COUNCIL,INST TECHNOL RES,FAENZA,ITALY.
RI Mattioli-Belmonte, Monica/J-5861-2012
OI Gandolfi, Maria Giovanna/0000-0001-7793-6227; SOLMI,
   ROSSELLA/0000-0001-9122-8243
CR BERG GJ, 1988, ANIMAL CELL BIOTECHN, P321
   DEKKER A, 1991, J MATER SCI-MATER M, V2, P227, DOI 10.1007/BF00703376
   DELGUERRA SS, 1993, BIOMATERALI, V1, P29
   DEWOOD MA, 1993, CLIN CARDIOL, V16, P302, DOI 10.1002/clc.4960160404
   DUKE PJ, 1993, J CELL BIOCHEM, V51, P274, DOI 10.1002/jcb.240510306
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   KOLLER MR, 1993, BLOOD, V82, P378
   Martinetti R, 1993, P ECERS 3 MADR, V3, P17
   ONEILL C, 1986, CELL, V44, P489, DOI 10.1016/0092-8674(86)90470-8
   PARULEKAR SJ, 1992, INT REV CYTOL, V142, P145, DOI 10.1016/S0074-7696(08)62076-8
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VROUWENVELDER WCA, 1993, THESIS DRUKKERIJ SIN, P7
   WATSON PA, 1991, FASEB J, V5, P2013
   YAMAMOTO M, 1993, EXP CELL RES, V204, P121, DOI 10.1006/excr.1993.1016
NR 14
TC 4
Z9 5
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 1996
VL 7
IS 2
BP 99
EP 102
DI 10.1007/BF00058720
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UA904
UT WOS:A1996UA90400006
DA 2018-10-19
ER

PT J
AU Ishihara, K
   Fujiike, A
   Iwasaki, Y
   Kurita, K
   Nakabayashi, N
AF Ishihara, K
   Fujiike, A
   Iwasaki, Y
   Kurita, K
   Nakabayashi, N
TI Synthesis of polymers having a phospholipid polar group connected to a
   poly(oxyethylene) chain and their protein adsorption-resistance
   properties
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE phospholipid polymer; biomaterials; hydrogel; protein adsorption;
   surface modification; blood compatibility
ID PHOSPHORYLCHOLINE MOIETY; PHOSPHATIDYLCHOLINES; MEMBRANES; SURFACES;
   LIPIDS; PLASMA
AB New methacrylates having a phospholipid polar group which was connected to various lengths of poly(oxyethylene) chains to form a polymerizable group (MEOnPC) were synthesized. The MEOnPC could polymerize with n-butyl methacrylate (BMA) in ethanol using a conventional radical polymerization technique. The unit mole fraction of MEOnPC in the polymer corresponded to that in the feed monomer solution. The MEOnPC polymers were soluble in ethanol, insoluble in water, but swelled in water and became hydrated. On the surface of a poly(BMA) membrane coated with MEOnPC, the phosphorylcholine groups of the MEOnPC unit present were determined by x-ray photoelectron spectroscopy. As a fundamental evaluation for biomedical materials, adsorption of one of the plasma proteins, fibrinogen, on acrylic beads coated with the MEOnPC polymers was evaluated. The amount of fibrinogen adsorbed on the MEOnPC polymer was smaller than that on the original acrylic beads, poly(BMA) and poly(2-hydroxyethyl methacrylate). The increase in the MEOnPC unit mole fraction in the polymer showed more effective protein adsorption-resistant properties. (C) 1996 John Wiley & Sons, Inc.
C1 NIHON UNIV,COLL SCI & TECHNOL,DEPT IND CHEM,CHIYODA KU,TOKYO 101,JAPAN.
RP Ishihara, K (reprint author), TOKYO MED & DENT UNIV,INST MED & DENT ENGN,CHIYODA KU,2-3-10 KANDA SURUGADAI,TOKYO 101,JAPAN.
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR BAMFORD CH, 1992, VROMAN EFFECT
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   CAMPBELL EJ, 1994, ASAIO J, P853
   EDMUNDSON RS, 1962, CHEM IND-LONDON, P1828
   GENNIS RB, 1989, BIOMEMBRANES MOL STR
   GROS L, 1981, ANGEW CHEM INT EDIT, V20, P305, DOI 10.1002/anie.198103051
   HALL B, 1989, BIOMATERIALS, V10, P219, DOI 10.1016/0142-9612(89)90096-3
   HUPFER B, 1981, MACROMOL CHEM PHYS, V182, P247
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ISHIHARA K, 1991, SEITAI ZAIRYO, V9, P243
   IWASAKI Y, 1994, J BIOMAT SCI-POLYM E, V6, P447, DOI 10.1163/156856294X00437
   KADOMA Y, 1978, KOBUNSHI RONBUNSHU, V35, P423, DOI 10.1295/koron.35.423
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   LAMPARSKI H, 1993, J AM CHEM SOC, V115, P8096, DOI 10.1021/ja00071a022
   REGEN SL, 1981, BIOCHEM BIOPH RES CO, V101, P131, DOI 10.1016/S0006-291X(81)80020-4
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   SLACK SM, 1992, J BIOMED MATER RES, V26, P1633, DOI 10.1002/jbm.820261208
   SOLTYS CE, 1993, BIOCHEMISTRY-US, V32, P9545, DOI 10.1021/bi00088a005
   SUGIYAMA K, 1994, POLYM J, V26, P561, DOI 10.1295/polymj.26.561
   TANAKA S, 1994, MACROMOL RAPID COMM, V15, P319, DOI 10.1002/marc.1994.030150404
   UEDA T, 1995, J BIOMED MATER RES, V29, P381, DOI 10.1002/jbm.820290313
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   YU J, 1994, INT J ARTIF ORGANS, V17, P499
NR 31
TC 41
Z9 41
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JAN 30
PY 1996
VL 34
IS 2
BP 199
EP 205
DI 10.1002/(SICI)1099-0518(19960130)34:2<199::AID-POLA6>3.0.CO;2-P
PG 7
WC Polymer Science
SC Polymer Science
GA TM426
UT WOS:A1996TM42600010
DA 2018-10-19
ER

PT J
AU Whitley, JQ
   Kusy, RP
AF Whitley, JQ
   Kusy, RP
TI Reutilizing and retesting of parallel plate sensors in dielectric
   thermal analysis
SO THERMOCHIMICA ACTA
LA English
DT Article; Proceedings Paper
CT 23rd North-American-Thermal-Analysis-Society Conference
CY SEP 25-28, 1994
CL TORONTO, CANADA
SP N Amer Thermal Anal Soc
DE DETA; membrane; quality assurance; poly(vinyl chloride); loss factor;
   permittivity
ID ELECTRODES
AB One of the advantages of dielectric thermal analysis (DETA) is that the parallel plate sensors are disposable, thereby eliminating potentially time-consuming clean-up procedures. Nonetheless, sometimes the reusing of parallel plate sensors is desirable, for example, when the test material is limited, further processing is intended, or cyclic testing is required. In this experiment, multiple-run and single-run methodologies were performed, the former without unloading the ram, and the latter after unloading the ram, removing the specimen, and cleaning the sensor. A dummy biomedical membrane was cast from a tetrahydrofuran solution of highly plasticized poly(vinyl chloride). After running each DETA experiment at a heating rate of 3 degrees C min(-1) from -20 to +80 degrees C at 1, 10, and 100 Hz, no significant differences were observed for permittivities, loss factors, tan deltas, ion conductivities, or the membrane thicknesses at room temperature. When calibrated, sensor areas varied by +/-1%, and thermistor values varied by +/-0.5%. From comparative graphs, box-plots, and statistical analyses, the data confirm that parallel plate sensors can be reutilized for retesting with these biomedical membranes.
C1 UNIV N CAROLINA,DENT RES CTR,CHAPEL HILL,NC 27599.
CR AMBROSIUS EE, 1966, MECHANICAL MEASUREME, P56
   CRAGGS A, 1974, J CHEM EDUC, V51, P541, DOI 10.1021/ed051p541
   JOHNSON TA, 1990, AM J PHYSIOL, V258, pH1224
   LINDNER E, 1994, J BIOMED MATER RES, V28, P591, DOI 10.1002/jbm.820280509
   MCCRUM NG, 1991, ANELASTIC DIELECTRIC, pCH7
   MOORE CYRIL, 1964, BIOCHEM BIOPHYS RES COMMUN, V15, P562, DOI 10.1016/0006-291X(64)90505-4
   POURNOOR K, 1991, POLYMER, V32, P445, DOI 10.1016/0032-3861(91)90448-R
   SIMON MA, 1993, POLYMER, V34, P5106, DOI 10.1016/0032-3861(93)90255-9
   SIMON MA, 1995, IN PRESS J BIOMED MA
   SIMPSON RJ, 1988, AM HEART J, V116, P1663, DOI 10.1016/0002-8703(88)90791-0
   TOTH K, 1986, ANAL CHEM, V58, P2741, DOI 10.1021/ac00126a035
NR 11
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0040-6031
J9 THERMOCHIM ACTA
JI Thermochim. Acta
PD JAN 20
PY 1996
VL 272
BP 95
EP 103
DI 10.1016/0040-6031(95)02458-1
PG 9
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA TW691
UT WOS:A1996TW69100011
DA 2018-10-19
ER

PT B
AU Tsuruta, T
AF Tsuruta, T
BE Ogata, N
   Kim, SW
   Feijen, J
   Okano, T
TI New polymeric materials design for biomedical applications
SO ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY
   SYSTEMS
LA English
DT Proceedings Paper
CT 5th Iketani Conference on Biomedical Polymers
CY APR 18-22, 1995
CL KAGOSHIMA UNIV, KAGOSHIMA, JAPAN
SP Iketani Sci & Technol Fdn
HO KAGOSHIMA UNIV
DE materials design; polyamine copolymers; microdomain structure;
   conformational transition; inert surface
C1 SCI UNIV TOKYO,FAC ENGN,DEPT IND CHEM,SHINJUKU KU,TOKYO 162,JAPAN.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER-VERLAG
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO 113, JAPAN
BN 4-431-70163-X
PY 1996
BP 43
EP 47
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials; Pharmacology &
   Pharmacy
SC Engineering; Materials Science; Pharmacology & Pharmacy
GA BF14A
UT WOS:A1996BF14A00009
DA 2018-10-19
ER

PT B
AU Nakabayashi, N
AF Nakabayashi, N
BE Ogata, N
   Kim, SW
   Feijen, J
   Okano, T
TI Preparation of self-assembled biomimetic membranes and their functions
SO ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY
   SYSTEMS
LA English
DT Proceedings Paper
CT 5th Iketani Conference on Biomedical Polymers
CY APR 18-22, 1995
CL KAGOSHIMA UNIV, KAGOSHIMA, JAPAN
SP Iketani Sci & Technol Fdn
HO KAGOSHIMA UNIV
DE phospholipid; 2-Methacryloyloxyethyl phosphorylcholine;
   nonthrombogenicity; self-assembled biomimetic membrane; protein
   adsorption; hydrogel; biocompatibility; biomedical material
C1 TOKYO MED & DENT UNIV,INST MED & DENT ENGN,CHIYODA KU,TOKYO 101,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO 113, JAPAN
BN 4-431-70163-X
PY 1996
BP 193
EP 197
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials; Pharmacology &
   Pharmacy
SC Engineering; Materials Science; Pharmacology & Pharmacy
GA BF14A
UT WOS:A1996BF14A00036
DA 2018-10-19
ER

PT B
AU Kobayashi, K
   Usui, T
   Akaike, T
AF Kobayashi, K
   Usui, T
   Akaike, T
BE Ogata, N
   Kim, SW
   Feijen, J
   Okano, T
TI Artificial glycoconjugate polymers: Cell-specific biomedical materials
   using carbohydrates as recognition signals
SO ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY
   SYSTEMS
LA English
DT Proceedings Paper
CT 5th Iketani Conference on Biomedical Polymers
CY APR 18-22, 1995
CL KAGOSHIMA UNIV, KAGOSHIMA, JAPAN
SP Iketani Sci & Technol Fdn
HO KAGOSHIMA UNIV
C1 NAGOYA UNIV, FAC AGR SCI, NAGOYA, AICHI 46401, JAPAN.
   NAGOYA UNIV, FAC AGR SCI, NAGOYA, AICHI 46401, JAPAN.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER-VERLAG TOKYO
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO, 113, JAPAN
BN 4-431-70163-X
PY 1996
BP 215
EP 216
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials; Pharmacology &
   Pharmacy
SC Engineering; Materials Science; Pharmacology & Pharmacy
GA BF14A
UT WOS:A1996BF14A00043
DA 2018-10-19
ER

PT S
AU Zlatanovic, MD
   Kunosic, AM
   Belosevac, RB
   Popovic, NV
AF Zlatanovic, MD
   Kunosic, AM
   Belosevac, RB
   Popovic, NV
BE Uskokovic, DP
TI Plasma deposition of hard coatings - Duplex treatment
SO ADVANCED MATERIALS FOR HIGH TECHNOLOGY APPLICATIONS
SE Materials Science Forum
LA English
DT Article; Proceedings Paper
CT 1st Yugoslavian Advanced Materials Conference - Advanced Materials 95 on
   Challenges of Tomorrow
CY SEP 18-22, 1995
CL HERCEG NOVI, YUGOSLAVIA
DE hard coatings; plasma deposition; duplex treatment; plasma nitriding;
   TiN; TiAlN
ID COMPRESSIBILITY; TIN; STEEL
AB Various ion and plasma assisted techniques used for surface modification and formation of functional surface layers are extensively developed as a important part of plasma surface engineering (PSE), Besides many applications in electrical engineering, microelectronics, optoelectronics, optics, sensors and actuators, biomedical engineering and other fields for production of active surface elements, the use of plasma technique for synthesis of new materials and deposition of protective coatings on functional components is of increasing importance, In order to obtain various thermal and diffusion barriers, wear and corrosion resistant layers and surface structure with desired tribological properties, a wide range of materials in the form of coatings was obtained by using plasma technique. In many cases, wear resistant material was found to have high hardness so that a new class of surface protective layers known as hard coatings was developed. Further research in this field includes the formation of multicomponent, multilayer and composite structures, as well as superlattice with desired tribological properties. A composite surface: structure which consists of a hard coating deposited on plasma nitrided layer was considered and its principal properties analyzed.
C1 IMT, PLASMA TECHNOL CTR ETF, YU-11000 BELGRADE, YUGOSLAVIA.
   INST NUCL SCI, YU-11000 BELGRADE, YUGOSLAVIA.
RP Zlatanovic, MD (reprint author), FAC ELECT ENGN, BULEVAR REVOLUCIJE 73, YU-11000 BELGRADE, YUGOSLAVIA.
CR BARNETT SA, 1992, MAT PRECESSING, V7, P1
   COHEN ML, 1989, SCIENCE, V243, P547, DOI 10.1126/science.243.4890.547
   FELLA R, 1988, SURF COAT TECH, V36, P257, DOI 10.1016/0257-8972(88)90155-7
   GOBLE RJ, 1985, CAN MINERAL, V23, P273
   GREDIC T, 1993, THIN SOLID FILMS, V228, P261, DOI 10.1016/0040-6090(93)90612-S
   GREDIC T, 1993, SURF COAT TECH, V61, P338, DOI 10.1016/0257-8972(93)90249-N
   GREDIC T, 1992, SURF COAT TECH, V55, P502, DOI 10.1016/S0257-8972(07)80073-9
   HOLLECK H, 1990, SURF COAT TECH, V43-4, P245, DOI 10.1016/0257-8972(90)90078-Q
   HOLLECK H, 1989, METALL, V43, P614
   Holmberg K., 1994, COATING TRIBOLOGY
   HULTMANN L, 1993, ICMCTF 93 SAN DIEG
   KNITTLE E, 1989, NATURE, V337, P349, DOI 10.1038/337349a0
   LIU AY, 1990, PHYS REV B, V41, P10727, DOI 10.1103/PhysRevB.41.10727
   LIU AY, 1989, SCIENCE, V245, P841, DOI 10.1126/science.245.4920.841
   Matthews J. W., 1975, EPITAXIAL GROWTH
   ROBERTSON J, 1992, SURF COAT TECH, V50, P185, DOI 10.1016/0257-8972(92)90001-Q
   SHINN M, 1992, J MATER RES, V7, P901, DOI 10.1557/JMR.1992.0901
   SUN Y, 1991, MAT SCI ENG A-STRUCT, V140, P419, DOI 10.1016/0921-5093(91)90458-Y
   Zhogolev D. A., 1981, ZH STRUKT KHIM, V22, P46
   ZLATANOVIC M, 1994, SURF COAT TECH, V63, P35, DOI 10.1016/S0257-8972(05)80005-2
   ZLATANOVIC M, 1990, SURF COAT TECH, V41, P17, DOI 10.1016/0257-8972(90)90127-X
   ZLATANOVIC M, 1991, SURF COAT TECH, V48, P19, DOI 10.1016/0257-8972(91)90124-F
   ZLATANOVIC M, 1994, SURF COAT TECH, V64, P173, DOI 10.1016/0257-8972(94)90105-8
   ZLATANOVIC M, 1989, COAT TECH 89, P135
   ZLATANOVIC M, 1989, 2ND P ASM INT C ION, P99
   ZLATANOVIC M, 1991, 1 ASM HEAT TREAT SUR, P655
NR 26
TC 10
Z9 10
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 0-87849-731-5
J9 MATER SCI FORUM
PY 1996
VL 214
BP 179
EP 188
DI 10.4028/www.scientific.net/MSF.214.179
PG 10
WC Chemistry, Physical; Electrochemistry; Materials Science,
   Multidisciplinary; Metallurgy & Metallurgical Engineering; Materials
   Science, Characterization & Testing; Materials Science, Coatings &
   Films; Optics; Polymer Science
SC Chemistry; Electrochemistry; Materials Science; Metallurgy &
   Metallurgical Engineering; Optics; Polymer Science
GA BG35S
UT WOS:A1996BG35S00022
DA 2018-10-19
ER

PT B
AU Robare, EW
   Bugle, CM
   Davidson, JA
   Daigle, KP
AF Robare, EW
   Bugle, CM
   Davidson, JA
   Daigle, KP
BE Weiss, I
   Srinivasan, R
   Bania, PJ
   Eylon, D
   Semiatin, SL
TI Development of processing methods for Ti-13Nb-13Zr
SO ADVANCES IN THE SCIENCE AND TECHNOLOGY OF TITANIUM ALLOY PROCESSING
LA English
DT Proceedings Paper
CT International Symposium on Advances in the Science and Technology of
   Titanium Alloy Processing at the 125th TMS Annual Meeting and Exhibition
CY FEB 05-08, 1996
CL ANAHEIM, CA
SP TMS Titanium & Shaping & Forming Comm
ID LOW-MODULUS; ALLOY
AB Ti-13Nb-13Zr (Ti-13-13(TM)) is a new titanium alloy which has a unique combination of properties that may make it an attractive choice for a variety of applications. Originally developed for use in biomedical implants, this alloy combines a low elastic modulus, high strength, excellent hot and cold workability, superior corrosion resistance, and the ability to be surface hardened to improve wear properties.
   Research on this age-hardenable alloy has shown that the mechanical properties can be controlled over a significant range through hot working, heat treatment and cold working. The elastic modulus of Ti-13-13 can be varied between approximately 41 and 83 GPa, and strengths as high as 1330 MPa have been achieved. Some typical combinations of properties are presented.
   Further, the material does not seem to exhibit some of the typical processing difficulties encountered in some age-hardenable beta Ti alloys. For example, in wire drawing trials, Ti-13-13 yielded exceptionally good surface finish in the "as-drawn" condition with over 85% cold work. Some examples of processing behavior are discussed.
C1 Dynamet Inc, Res & Dev, Washington, PA 15302 USA.
RP Robare, EW (reprint author), Dynamet Inc, Res & Dev, 195 Museum Rd, Washington, PA 15302 USA.
CR DAIGLE KP, 1994, P 1994 INT C TIT PRO
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   GOODMAN SB, 1993, J APPL BIOMATER, V4, P331, DOI 10.1002/jab.770040407
   KOVACS P, 1995, ASTM STP, V1272
   MISHRA AK, 1995, ASTM STP, V1272
   POGGIE RA, 1996, MAT MANUFACTURING PR, V2
NR 6
TC 1
Z9 1
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-324-4
PY 1996
BP 283
EP 291
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BM47L
UT WOS:000078852200023
DA 2018-10-19
ER

PT J
AU Kanazawa, H
   Yamamoto, K
   Matsushima, Y
   Takai, N
   Kikuchi, A
   Sakurai, Y
   Okano, T
AF Kanazawa, H
   Yamamoto, K
   Matsushima, Y
   Takai, N
   Kikuchi, A
   Sakurai, Y
   Okano, T
TI Temperature-responsive chromatography using
   poly(N-isopropylacrylamide)-modified silica
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID CULTURED-CELLS; PERMEATION; RELEASE; MEMBRANES; POLYMERS; WATER
AB A new concept in chromatography is proposed that utilizes a temperature-responsive surface with a constant aqueous mobile phase. The surface of the silica stationary phase in high-performance liquid chromatography (HPLC) has been modified with temperature-responsive polymers to exhibit temperature-controlled hydrophilic/hydrophobic changes. Poly(N-isopropylacrylamide) (PIPAAm) was grafted onto (aminopropyl)silica using an activated esteramine coupling method. These grafted silica surfaces show hydrophilic properties at lower temperatures which, as temperature increases, transform to hydrophobic surface properties. The elution profile of five mixed steroids on an HPLC column packed with this material depends largely on the temperature of the aqueous mobile phase. Retention times increase with increasing temperature without any change in the eluent. Changes in the retention times of hydrophobic steroids were larger than those for hydrophilic steroids. The temperature-responsive interaction between PIPAAm-modified silica and these steroids is proposed to result from changes in the surface properties of the HPLC stationary phase by the transition of hydrophilic/hydrophobic surface-grafted IPAAm polymers. We demonstrate a novel and useful new chromatography system in which surface properties and the resulting function of the HPLC stationary phase are controlled by external temperature changes, This method should be effective in biological and biomedical separations of peptides and proteins using only aqueous mobile phases.
C1 TOKYO DENKI UNIV,FAC SCI & ENGN,SAITAMA 35003,JAPAN.
   TOKYO WOMENS MED COLL,INST BIOMED ENGN,SHINJUKU KU,TOKYO 162,JAPAN.
RP Kanazawa, H (reprint author), KYORITSU COLL PHARMACEUT SCI,MINATO KU,1-5-30 SHIBA KOEN,TOKYO 105,JAPAN.
RI Okano, Teruo/J-4028-2012
OI Kanazawa, Hideko/0000-0003-2550-470X
CR BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609
   BUCKMANN AF, 1981, MAKROMOL CHEM, V182, P1379
   FUJISHIGE S, 1989, J PHYS CHEM-US, V93, P3311, DOI 10.1021/j100345a085
   FUJISHIGE S, 1987, POLYM J, V19, P297, DOI 10.1295/polymj.19.297
   GAUR RK, 1989, ANAL BIOCHEM, V180, P253, DOI 10.1016/0003-2697(89)90426-0
   GEWEHR M, 1992, MAKROMOL CHEM, V193, P249
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   HOSOYA K, 1994, MACROMOLECULES, V27, P3973, DOI 10.1021/ma00092a042
   ISHIHARA K, 1984, J APPL POLYM SCI, V29, P211, DOI 10.1002/app.1984.070290119
   KANAZAWA H, 1993, 1ST P INT C INT MAT, P415
   KOPECEK J, 1971, J POLYM SCI A1, V9, P2801, DOI 10.1002/pol.1971.150091005
   LINDSAY S, 1992, HIGH PERFORMANCE LIQ, P302
   MATSUKATA M, 1994, J BIOCHEM-TOKYO, V116, P682, DOI 10.1093/oxfordjournals.jbchem.a124580
   MIRON T, 1982, ANAL BIOCHEM, V126, P433, DOI 10.1016/0003-2697(82)90540-1
   OKAHATA Y, 1986, MACROMOLECULES, V19, P493, DOI 10.1021/ma00156a049
   OKANO T, 1978, J APPL POLYM SCI, V22, P369, DOI 10.1002/app.1978.070220206
   OKANO T, 1990, J CONTROL RELEASE, V11, P255, DOI 10.1016/0168-3659(90)90138-J
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035
   TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P42, DOI 10.1021/bc00019a006
   TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P341, DOI 10.1021/bc00023a006
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   YOSHIDA R, 1991, J BIOMAT SCI-POLYM E, V3, P155, DOI 10.1163/156856291X00250
NR 25
TC 320
Z9 326
U1 5
U2 80
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD JAN 1
PY 1996
VL 68
IS 1
BP 100
EP 105
DI 10.1021/ac950359j
PG 6
WC Chemistry, Analytical
SC Chemistry
GA TN244
UT WOS:A1996TN24400018
PM 21619225
DA 2018-10-19
ER

PT J
AU Cosofret, VV
   Olson, WW
   Marzouk, SAM
   Erdosy, M
   Johnson, TA
   Buck, RP
AF Cosofret, VV
   Olson, WW
   Marzouk, SAM
   Erdosy, M
   Johnson, TA
   Buck, RP
TI Calcium selective polymeric membranes for microfabricated sensor arrays
SO ANALYTICAL LETTERS
LA English
DT Article
DE calcium planar microchemical sensor arrays; polymeric membranes;
   impedance analysis; blood interactions with sensor materials
ID PLASTICIZED POLYVINYL-CHLORIDE) PROPERTIES; VALINOMYCIN ELECTRODES; ION;
   FREQUENCY; ADHESION; MATRICES; LIFETIME
AB The potentiometric and impedance characteristics of various selective Ca2+ polymeric membranes are described and interpreted by theory and experiments for Ca2+ microfabricated sensor arrays. These are designed for further biomedical applications with an emphasis on potential in situ applications. The polymeric materials used in the present studies consist of either carboxylated PVC or aliphatic polyurethane. Both materials showed good adherence properties to the polyimide-coated Kapton substrate used in planar sensor fabrication. The impedance analysis, performed in the frequency range from 65,000 Hz to 0.1 Hz, revealed the bulk geometrical response at high frequencies. Measured R(bulk) corresponds to the unperturbed bulk resistance. That, in turn, depends on mobilities and concentrations of Ca2+ complex and mobile sites. Decreases in R(bulk) correlated well with sensor behavior during the preconditioning (hydration) period. Studies of blood interactions with these sensors proved that the main sensor characteristics (E(o), slope of the calibration curve, and reproducibility of response) are not significantly affected after 14 days of whole blood contact.
C1 UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27599.
RP Cosofret, VV (reprint author), UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599, USA.
RI Marzouk, Sayed/C-6155-2011
CR BUCK RP, 1982, ION SEL ELECTRODE RE, V4, P3
   CHA GS, 1991, ANAL CHEM, V63, P1666, DOI 10.1021/ac00017a003
   COSOFRET VV, 1995, ANAL CHEM, V67, P1647, DOI 10.1021/ac00106a001
   COSOFRET VV, 1994, ANAL LETT, V27, P3039, DOI 10.1080/00032719408000310
   COSOFRET VV, 1994, ANAL CHEM, V66, P3592, DOI 10.1021/ac00093a010
   COSOFRET VV, 1994, ANALYST, V119, P2283, DOI 10.1039/an9941902283
   COSOFRET VV, 1994, TALANTA, V41, P931, DOI 10.1016/0039-9140(94)E0106-2
   COSOFRET VV, IN PRESS ANAL CHIM A
   COSOFRET VV, IN PRESS TALANTA
   COSOFRET VV, IN PRESS POLYMERIC M
   COSOFRET VV, 1994, POLYM MAT SCI ENG, V70, P137
   CUTLER SG, 1978, POLYM PREPRS AM CHEM, V19, P330
   DINTEN O, 1991, ANAL CHEM, V63, P596, DOI 10.1021/ac00006a009
   DORAZIO P, 1992, ELECTROLYTES BLOOD G, V14, P21
   DURSELEN LFJ, 1988, ANAL CHEM, V60, P1455, DOI 10.1021/ac00165a021
   Gettes LS, 1992, HEART CARDIOVASCULAR, P2021
   HARRISON DJ, 1988, J ELECTROCHEM SOC, V135, P2473, DOI 10.1149/1.2095361
   HORVAI G, 1986, ANAL CHEM, V58, P2735, DOI 10.1021/ac00126a034
   HORVAI G, 1989, ION SELECTIVE ELECTR, P397
   LADENSON JH, 1983, ANAL P, V20, P554
   LEWENSTAM A, 1991, Analytical Proceedings, V28, P106
   LI XZ, 1990, SENSOR ACTUAT B-CHEM, V1, P275, DOI 10.1016/0925-4005(90)80215-L
   LINDNER E, 1993, J CHEM SOC FARADAY T, V89, P361, DOI 10.1039/ft9938900361
   LINDNER E, 1994, J BIOMED MATER RES, V28, P591, DOI 10.1002/jbm.820280509
   LINDNER E, 1988, ANAL CHEM, V60, P295, DOI 10.1021/ac00155a004
   LINDNER E, 1993, FRESEN J ANAL CHEM, V346, P584, DOI 10.1007/BF00321250
   LIU D, 1993, ANAL CHIM ACTA, V274, P37, DOI 10.1016/0003-2670(93)80602-H
   LUNDBERG RD, 1978, POLYM PREPR AM CHEM, V19, P310
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P153, DOI 10.1002/jbm.820200205
   MEIER PC, 1980, LIQUID MEMBRANE ION, P13
   OESCH U, 1986, CLIN CHEM, V32, P1448
   PUNGOR E, 1994, PURE APPL CHEM, V51, P1913
   STATCHWILL T, 1986, J ELECTROANAL CHEM, V202, P75
   TOTH K, 1986, ANAL CHEM, V58, P2741, DOI 10.1021/ac00126a035
   TREASURE JL, 1985, CONTINUOUS MEASUREME, P297
NR 35
TC 5
Z9 5
U1 0
U2 1
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0003-2719
J9 ANAL LETT
JI Anal. Lett.
PY 1996
VL 29
IS 5
BP 725
EP 743
PG 19
WC Chemistry, Analytical
SC Chemistry
GA UC492
UT WOS:A1996UC49200006
DA 2018-10-19
ER

PT J
AU Elbert, DL
   Hubbell, JA
AF Elbert, DL
   Hubbell, JA
TI Surface treatments of polymers for biocompatibility
SO ANNUAL REVIEW OF MATERIALS SCIENCE
LA English
DT Review
DE biomaterial; peptide; saccharide; hydrogel; poly(ethylene glycol)
ID SELF-ASSEMBLED MONOLAYERS; MONOCLONAL-ANTIBODY BINDING; BLOOD-CONTACTING
   PROPERTIES; NEURONAL CELL ATTACHMENT; PROTEIN ADSORPTION; POLY(ETHYLENE
   GLYCOL); EXTRACELLULAR-MATRIX; POLYETHYLENE OXIDE; POLYURETHANE
   SURFACES; PHOSPHOLIPID POLYMERS
AB Biological recognition mediates cell and tissue interactions with biomaterials, be the materials employed in a biotechnical environment in vitro or a biomedical environment in vivo. These interactions are typically mediated by proteins that have adsorbed to the biomaterial surface. The principles of protein adsorption and biological recognition are described. Polymer surface modifications to reduce protein adsorption upon biomaterial surfaces are summarized, as are modifications to enhance the irreversible adsorption of proteins. Using these approaches, it may be possible to reduce the extent to which the biomaterial surface and the protein-biomaterial surface are recognized by cells and tissues. Polymer surface modifications to incorporate oligopeptide-, saccharide-, and oligosaccharide-based receptor-binding sequences are described to enable direct binding of cells with the polymer surface. With use of these approaches, it is possible to endow an entirely synthetic material with the biological recognition characteristics of biological macromolecules.
RP Elbert, DL (reprint author), CALTECH,DIV CHEM & CHEM ENGN,PASADENA,CA 91125, USA.
RI Elbert, Donald/B-2040-2008; Hubbell, Jeffrey/A-9266-2008
OI Elbert, Donald/0000-0001-6480-9536; Hubbell, Jeffrey/0000-0003-0276-5456
CR ADACHI N, 1994, J BIOMAT SCI-POLYM E, V6, P463
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   AMIJI M, 1993, J COLLOID INTERF SCI, V155, P251, DOI 10.1006/jcis.1993.1031
   AMIJI MM, 1994, J APPL POLYM SCI, V52, P539, DOI 10.1002/app.1994.070520409
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   BROWN EJ, 1992, INFECT AGENT DIS, V1, P63
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   BURNS NL, 1995, LANGMUIR, V11, P2768, DOI 10.1021/la00007a070
   BYUN Y, 1994, J BIOMAT SCI-POLYM E, V6, P1
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   CHAIKOF EL, 1992, J BIOMED MATER RES, V26, P1163, DOI 10.1002/jbm.820260906
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   CHO CS, 1993, J BIOMED MATER RES, V27, P199, DOI 10.1002/jbm.820270209
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   CINNI E, 1993, BIOMATERIALS, V14, P588
   CLAPPER DL, 1994, J CELL BIOCHEM     S, V18, P283
   DAI WG, 1994, BIO-TECHNOL, V12, P797, DOI 10.1038/nbt0894-797
   DESAI NP, 1994, ABSTR PAP AM CHEM S, V207, P8
   DIMILLA PA, 1994, J AM CHEM SOC, V116, P2225, DOI 10.1021/ja00084a105
   DRUMHELLER PD, 1994, J POLYM SCI POL CHEM, V32, P2715, DOI 10.1002/pola.1994.080321412
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   DRUMMOND RK, 1991, BIOMATERIALS, V12, P356, DOI 10.1016/0142-9612(91)90002-R
   ESMON CT, 1995, FASEB J, V9, P946
   FENG L, 1995, J BIOMAT SCI-POLYM E, V7, P439, DOI 10.1163/156856295X00445
   FERGUSON GS, 1993, MACROMOLECULES, V26, P5870, DOI 10.1021/ma00074a007
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V50, P345, DOI 10.1002/app.1993.070500215
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   FUJIMOTO K, 1994, ACS SYM SER, V540, P228
   GEFFEN I, 1992, INT REV CYTOL, V137B, P181
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRASEL TG, 1990, J BIOMED MATER RES, V24, P605, DOI 10.1002/jbm.820240507
   GU YJ, 1994, CELL TRANSPLANT, V3, pS19
   GUIRE PE, 1993, Patent No. 5263992
   GUTSCHE AT, 1994, BIOTECHNOL BIOENG, V43, P801, DOI 10.1002/bit.260430815
   HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P401
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   HATANAKA K, 1993, MACROMOLECULES, V26, P1483, DOI 10.1021/ma00059a001
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   HORBETT TA, 1994, J BIOMAT SCI-POLYM E, V6, P15, DOI 10.1163/156856295X00724
   HUBBELL JA, 1993, CARDIOVASC PATHOL, V2, pS121
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HUBBELL JA, 1995, Patent No. 5462990
   HUMPHRIES MJ, 1990, J CELL SCI, V97, P585
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   INTVELD PJA, 1994, J POLYM SCI POL CHEM, V32, P1063, DOI 10.1002/pola.1994.080320608
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P1347, DOI 10.1002/jbm.820281113
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   KIAEI D, 1995, J BIOMED MATER RES, V29, P729, DOI 10.1002/jbm.820290609
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   KIM YJ, 1994, J APPL POLYM SCI, V54, P1863, DOI 10.1002/app.1994.070541209
   KISHIDA A, 1994, BIOMATERIALS, V15, P1170, DOI 10.1016/0142-9612(94)90238-0
   KOBAYASHI K, 1994, METHOD ENZYMOL, V247, P409
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LASIC DD, 1994, ANGEW CHEM INT EDIT, V33, P1685, DOI 10.1002/anie.199416851
   LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEES WJ, 1994, J MED CHEM, V37, P3419, DOI 10.1021/jm00046a027
   LELLAH MD, 1986, POLYURETHANES MED
   LI S, 1995, ABSTR PAP AM CHEM S, V209, P305
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   LLANOS GR, 1992, BIOMATERIALS, V13, P421, DOI 10.1016/0142-9612(92)90161-G
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   LOFAS S, 1995, PURE APPL CHEM, V67, P829, DOI 10.1351/pac199567050829
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   MASSIA SP, 1992, J BIOL CHEM, V267, P10133
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MATTHEWS KH, 1994, MAT SCI ENG C-BIOMIM, V2, P51, DOI 10.1016/0928-4931(94)90029-9
   MECHAM RP, 1991, ANNU REV CELL BIOL, V7, P71, DOI 10.1146/annurev.cb.07.110191.000443
   MERRILL EW, 1993, J BIOMAT SCI-POLYM E, V5, P1
   MOGHADDAM MJ, 1993, J POLYM SCI POL CHEM, V31, P1589, DOI 10.1002/pola.1993.080310629
   MOGHIMI SM, 1993, BIOCHIM BIOPHYS ACTA, V1179, P157, DOI 10.1016/0167-4889(93)90137-E
   MOSHER DF, 1993, CURR OPIN STRUC BIOL, V3, P214, DOI 10.1016/S0959-440X(05)80155-1
   NOJIRI C, 1992, J BIOMAT SCI-POLYM E, V4, P75
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   OSHEA GM, 1986, DIABETES, V35, P943, DOI 10.2337/diabetes.35.8.943
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   PARK KD, 1992, J BIOMED MATER RES, V26, P739, DOI 10.1002/jbm.820260605
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PLOW EF, 1995, FASEB J, V9, P939
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   REMPP P, 1991, POLYM PREPR-ACS, V32, P687
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RUOSLAHTI E, 1986, Patent No. 4578079
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   SCHAKENRAAD JM, 1992, CELL MATER, V2, P193
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P281
   SHOICHET MS, 1994, BIOTECHNOL BIOENG, V43, P563, DOI 10.1002/bit.260430705
   SILVER JH, 1995, J BIOMED MATER RES, V29, P535, DOI 10.1002/jbm.820290414
   SILVER JH, 1994, BIOMATERIALS, V15, P695, DOI 10.1016/0142-9612(94)90168-6
   SINGER II, 1988, J CELL BIOL, V106, P2171, DOI 10.1083/jcb.106.6.2171
   SINGER II, 1987, J CELL BIOL, V104, P573, DOI 10.1083/jcb.104.3.573
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   TERLINGEN JGA, 1992, J BIOMAT SCI-POLYM E, V4, P31
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   TSENG YC, 1995, BIOMATERIALS, V16, P963, DOI 10.1016/0142-9612(95)94902-W
   UCHIDA E, 1994, LANGMUIR, V10, P481, DOI 10.1021/la00014a023
   UCHIDA M, 1991, MACROMOLECULES, V24, P3238, DOI 10.1021/ma00011a031
   VANALSTINE JM, 1993, COLLOID SURFACE A, V77, P149, DOI 10.1016/0927-7757(93)80111-Q
   VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390
   WOJCIECHOWSKI P, 1991, Journal of Biomaterials Science Polymer Edition, V2, P203
   WOODHOUSE KA, 1994, J COLLOID INTERF SCI, V164, P40, DOI 10.1006/jcis.1994.1141
   WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P171, DOI 10.1016/0304-4157(92)90038-C
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   YANG Z, 1995, J AM CHEM SOC, V117, P4843, DOI 10.1021/ja00122a014
   YOON SC, 1990, MACROMOLECULES, V23, P4351, DOI 10.1021/ma00222a004
   YU XH, 1990, J APPL POLYM SCI, V41, P1777, DOI 10.1002/app.1990.070410734
NR 125
TC 388
Z9 391
U1 4
U2 152
PU ANNUAL REVIEWS INC
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139
SN 0084-6600
J9 ANNU REV MATER SCI
JI Annu. Rev. Mater. Sci.
PY 1996
VL 26
BP 365
EP 394
DI 10.1146/annurev.ms.26.080196.002053
PG 30
WC Materials Science, Multidisciplinary
SC Materials Science
GA VB465
UT WOS:A1996VB46500015
DA 2018-10-19
ER

PT J
AU Kalasinsky, VF
AF Kalasinsky, VF
TI Biomedical applications of infrared and Raman microscopy
SO APPLIED SPECTROSCOPY REVIEWS
LA English
DT Review
ID SINGLE LIVING CELLS; PYROPHOSPHATE DIHYDRATE DEPOSITION; FT-IR
   MICROSPECTROSCOPY; HUMAN BREAST TISSUES; SPECTROSCOPIC IDENTIFICATION;
   URINARY CALCULI; KIDNEY-STONE; SPATIAL-RESOLUTION; IMAGING MICROSCOPY;
   FOREIGN MATERIALS
RP Kalasinsky, VF (reprint author), ARMED FORCES INST PATHOL,DEPT ENVIRONM & TOXICOL PATHOL,WASHINGTON,DC 20306, USA.
CR ABRAHAM JL, 1979, SCIENCE, V206, P716, DOI 10.1126/science.493979
   ADAR F, 1988, MICROCHEM J, V38, P50, DOI 10.1016/0026-265X(88)90004-5
   ALBIN M, 1993, ANAL CHEM, V65, pA489, DOI 10.1021/ac00058a002
   ANDERSEN ME, 1981, ANAL CHEM, V53, P1772, DOI 10.1021/ac00235a013
   ASHER SA, 1993, ANAL CHEM, V65, pA59, DOI 10.1021/ac00052a715
   ASSELIN KJ, 1994, APPL SPECTROSC, V48, P699, DOI 10.1366/000370294774369009
   BAEK M, 1988, APPL SPECTROSC, V42, P1312, DOI 10.1366/0003702884430010
   BARAGA JJ, 1992, P NATL ACAD SCI USA, V89, P3473, DOI 10.1073/pnas.89.8.3473
   BARER R, 1949, NATURE, V163, P198, DOI 10.1038/163198a0
   BARRY B, 1982, J CELL BIOL, V94, P479, DOI 10.1083/jcb.94.2.479
   BARTICK EG, 1985, APPL SPECTROSC, V39, P885, DOI 10.1366/0003702854249961
   BENEDETTI E, 1986, APPL SPECTROSC, V40, P39, DOI 10.1366/0003702864815565
   BENEDETTI E, 1990, APPL SPECTROSC, V44, P1276, DOI 10.1366/000370290789619621
   BLAHA JJ, 1978, ANAL CHEM, V50, P892, DOI 10.1021/ac50029a018
   BLAHA JJ, 1981, VIB SPECTRA STRUCT, V10, P227
   BOT ACC, 1989, EXP EYE RES, V49, P161, DOI 10.1016/0014-4835(89)90086-9
   BROWN PR, 1990, ANAL CHEM, V62, pA995, DOI 10.1021/ac00218a001
   BUITEVELD H, 1984, APPL SPECTROSC, V38, P304, DOI 10.1366/0003702844555520
   CAI MZ, 1989, EXP EYE RES, V49, P531, DOI 10.1016/S0014-4835(89)80052-1
   CAMPION A, 1988, J AM CHEM SOC, V110, P408
   CASSIS LA, 1993, ANAL CHEM, V65, P1247, DOI 10.1021/ac00057a023
   CENTENO JA, 1993, APPL SPECTROSC, V47, P341, DOI 10.1366/0003702934066613
   CENTENO JA, 1992, LAB INVEST, V66, P123
   CENTENO JA, 1994, APPL SPECTROSC, V48, P569, DOI 10.1366/0003702944924745
   CENTENO JA, 1995, PLAST RECONSTR SURG, V20
   Chang RK, 1982, SURFACE ENHANCED RAM
   Chase DB, 1994, FOURIER TRANSFORM RA
   CHOO LP, 1993, BIOCHIM BIOPHYS ACTA, V1182, P333, DOI 10.1016/0925-4439(93)90078-F
   CLARK RJH, 1986, ADV INFRARED RAMAN S
   CLARKE RH, 1987, APPL OPTICS, V26, P3175, DOI 10.1364/AO.26.003175
   Coates V. J., 1953, J OPT SOC AM, V47, P984
   Colthup N. B., 1990, INTRO INFRARED RAMAN
   CRAMERS CA, 1988, CRIT REV ANAL CHEM, V20, P117, DOI 10.1080/00078988808048809
   DALTERIO RA, 1987, APPL SPECTROSC, V41, P241, DOI 10.1366/000370287774986732
   DALTERIO RA, 1986, APPL SPECTROSC, V40, P271, DOI 10.1366/0003702864509484
   DAUDON M, 1983, KIDNEY INT, V23, P842, DOI 10.1038/ki.1983.104
   DELAGE C, 1973, ARCH DERMATOL, V108, P104, DOI 10.1001/archderm.1973.01620220066018
   DELHAYE M, 1975, J RAMAN SPECTROSC, V3, P33, DOI 10.1002/jrs.1250030105
   DEMUL FFM, 1984, HUM PATHOL, V15, P1062, DOI 10.1016/S0046-8177(84)80250-6
   DHAMELINCOURT P, 1979, ANAL CHEM, V51, pA414, DOI 10.1021/ac50039a002
   DONG A, 1987, BIOCHEM BIOPH RES CO, V156, P752
   ETZ ES, 1979, SCANNING ELECTRON MI, V1, P67
   FABIAN H, 1993, APPL SPECTROSC, V47, P1513, DOI 10.1366/0003702934067469
   FABIAN H, 1993, VIB SPECTROSC, V4, P125, DOI 10.1016/0924-2031(93)87032-O
   FENTON JJ, 1995, ARCH PATHOL, V20
   FRANK CJ, 1994, ANAL CHEM, V66, P319, DOI 10.1021/ac00075a002
   FRANK CJ, 1993, APPL SPECTROSC, V47, P387, DOI 10.1366/0003702934334958
   FRICK R, 1973, BEITR PATHOL, V149, P39, DOI 10.1016/S0005-8165(73)80123-4
   GAYOU RM, 1979, PLAST RECONSTR SURG, V63, P700, DOI 10.1097/00006534-197905000-00015
   GERRARD DL, 1986, APPL SPECTROSC REV, V22, P251, DOI 10.1080/05704928608070179
   GERSON DJ, 1988, INFRARED MICROSPECTR, P73
   Grasselli J, 1981, CHEM APPL RAMAN SPEC
   Grasselli J. G., 1991, ANAL RAMAN SPECTROSC
   GRIFFITHS PR, 1986, FOURIER TRANSFORM IN
   HARDT NS, 1994, MODERN PATHOL, V7, P669
   HARTHCOCK MA, 1988, APPL SPECTROSC, V42, P449, DOI 10.1366/0003702884427780
   HARTHCOCK MA, 1988, INFRARED MICROSPECTR, P21
   HONG TDN, 1992, CLIN CHEM, V38, P292
   HUIZINGA A, 1989, EXP EYE RES, V48, P487, DOI 10.1016/0014-4835(89)90032-8
   Humecki H.J., 1995, PRACTICAL GUIDE INFR
   HUONG PV, 1991, ANAL RAMAN SPECTROSC, P397
   ISHIDA H, 1987, APPL SPECTROSC, V41, P407, DOI 10.1366/0003702874448779
   JOHNSON FR, UNPUB
   KALASINSKY KS, 1994, J ANAL TOXICOL, V18, P337, DOI 10.1093/jat/18.6.337
   KALASINSKY KS, 1993, FORENSIC SCI INT, V63, P253, DOI 10.1016/0379-0738(93)90278-I
   KATON JE, 1986, ANAL CHEM, V58, pA465, DOI 10.1021/ac00294a002
   KEEN CE, 1991, HISTOPATHOLOGY, V19, P529, DOI 10.1111/j.1365-2559.1991.tb01501.x
   KESSLER DA, 1992, NEW ENGL J MED, V326, P1713, DOI 10.1056/NEJM199206183262525
   KLUG DD, 1992, LASER SURG MED, V12, P13, DOI 10.1002/lsm.1900120105
   KODALI DR, 1991, APPL SPECTROSC, V45, P1310, DOI 10.1366/0003702914335878
   KODATI VR, 1990, APPL SPECTROSC, V44, P1134, DOI 10.1366/0003702904086470
   KODATI VR, 1993, APPL SPECTROSC, V47, P334, DOI 10.1366/0003702934066604
   KODATI VR, 1991, APPL SPECTROSC, V45, P581, DOI 10.1366/0003702914336859
   KODATI VR, 1990, APPL SPECTROSC, V44, P1408, DOI 10.1366/000370290789619405
   KODATI VR, 1990, APPL SPECTROSC, V44, P837, DOI 10.1366/0003702904087181
   KOSSOVSKY N, 1992, AM J CLIN PATHOL, V97, P34
   LEVIN IW, 1984, ADV INFRARED RAMAN S, V11, pCH1
   LEVINE SM, 1994, INT J DEV NEUROSCI, V12, P275, DOI 10.1016/0736-5748(94)90075-2
   LEVINE SM, 1994, AM J PATHOL, V145, P1041
   LEVINE SM, 1993, APPL SPECTROSC REV, V28, P385, DOI 10.1080/05704929308018117
   LEVINE SM, 1994, NEUROPROTOCOLS, V5, P63
   LEWIS EN, 1988, APPL SPECTROSC, V42, P1188, DOI 10.1366/0003702884429850
   LEWIS EN, 1995, APPL SPECTROSC, V49, P672, DOI 10.1366/0003702953964066
   LEWIS EN, 1988, ANAL CHEM, V60, P2658, DOI 10.1021/ac00175a002
   LOPPNOW GR, 1989, P NATL ACAD SCI USA, V86, P1515, DOI 10.1073/pnas.86.5.1515
   LUKE JL, UNPUB
   MARTOJA R, 1982, CR ACAD SCI III-VIE, V295, P369
   MARTOJA R, 1981, CR ACAD SCI III-VIE, V292, P857
   MAUGARS YM, 1994, J RHEUMATOL, V21, P573
   MCGILL N, 1991, LANCET, V337, P77, DOI 10.1016/0140-6736(91)90738-B
   MENDELSOHN R, 1989, CALCIFIED TISSUE INT, V44, P20, DOI 10.1007/BF02556236
   Messerschmidt R. G., 1988, INFRARED MICROSPECTR
   MESSERSCHMIDT RG, 1989, APPL SPECTROSC, V43, P11, DOI 10.1366/0003702894201761
   MESSERSCHMIDT RG, 1988, INFRARED MICROSPECTR, P1
   MORRIS HR, 1994, APPL SPECTROSC, V48, P857, DOI 10.1366/0003702944029820
   OLEARY TJ, 1989, APPL SPECTROSC, V43, P1095, DOI 10.1366/0003702894203994
   Osborne B. G., 1986, NEAR INFRARED SPECTR
   OZAKI Y, 1988, APPL SPECTROSC REV, V24, P259, DOI 10.1080/05704928808060459
   PALLISTER DM, 1994, APPL SPECTROSC, V48, P1277, DOI 10.1366/0003702944027480
   PELL RJ, 1993, APPL SPECTROSC, V47, P634, DOI 10.1366/0003702934067126
   PUPPELS GJ, 1991, EXP CELL RES, V195, P361, DOI 10.1016/0014-4827(91)90385-8
   PUPPELS GJ, 1991, BIOPHYS J, V60, P1046, DOI 10.1016/S0006-3495(91)82142-7
   PUPPELS GJ, 1993, APPL SPECTROSC, V47, P1256, DOI 10.1366/0003702934068017
   PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0
   REDD DCB, 1993, APPL SPECTROSC, V47, P787, DOI 10.1366/0003702934067072
   REFFNER JA, 1995, REV SCI INSTRUM, V66, P1298, DOI 10.1063/1.1145958
   Rochow TG, 1994, INTRO MICROSCOPY MEA
   ROSASCO GJ, 1975, APPL SPECTROSC, V29, P396, DOI 10.1366/000370275774455752
   ROSASCO GJ, 1975, SCIENCE, V190, P557, DOI 10.1126/science.190.4214.557
   ROSASCO GT, 1981, ADV INFRARED RAMAN S, V7, P223
   SCHMID ED, 1988, SPECTROSCOPY BIOL MO
   SCHRADER B, 1973, ANGEW CHEM INT EDIT, V12, P884, DOI 10.1002/anie.197308841
   SCHWAB SD, 1984, ANAL CHEM, V56, P2199, DOI 10.1021/ac00276a049
   SHEARER JC, 1983, ANAL CHEM, V55, pA874, DOI 10.1021/ac00259a002
   SHUNSHIN GD, 1993, INVEST OPHTH VIS SCI, V34, P3489
   SIEBINGA I, 1991, EXP EYE RES, V53, P233, DOI 10.1016/0014-4835(91)90079-T
   SMAHEL J, 1979, BRIT J PLAST SURG, V32, P35, DOI 10.1016/0007-1226(79)90058-4
   SMAHEL J, 1978, MATER TECHNOL, V6, P51
   Smith A., 1979, APPL INFRARED SPECTR
   SOMMER AJ, 1991, APPL SPECTROSC, V45, P1633, DOI 10.1366/0003702914335229
   SUDLOW K, 1991, CLIN CHIM ACTA, V203, P387, DOI 10.1016/0009-8981(91)90313-2
   SUREAU F, 1990, APPL SPECTROSC, V44, P1047, DOI 10.1366/0003702904086920
   Thomas GJ, 1986, BIOMOLECULAR STEREOD, VIV, P227
   TODD EA, 1994, APPL SPECTROSC, V48, P545, DOI 10.1366/0003702944924790
   TOMAZIC BB, 1987, SCANNING MICROSCOPY, V1, P95
   TREADO PJ, 1990, APPL SPECTROSC, V44, P1, DOI 10.1366/0003702904085714
   TREADO PJ, 1992, APPL SPECTROSC, V46, P553, DOI 10.1366/0003702924125032
   TREADO PJ, 1994, APPL SPECTROSC, V48, P607, DOI 10.1366/0003702944924899
   TUNGOL MW, 1993, APPL SPECTROSC, V47, P1655, DOI 10.1366/0003702934334552
   WALLON J, 1994, APPL SPECTROSC, V48, P190, DOI 10.1366/0003702944028542
   Wetzel D. L., 1993, SPECTROSCOPY, V8, P40
   WISHNOK JS, 1992, ANAL CHEM, V64, pA1126, DOI 10.1021/ac00047a002
   WONG PTT, 1990, APPL SPECTROSC, V44, P1715, DOI 10.1366/0003702904417481
   WONG PTT, 1993, APPL SPECTROSC, V47, P1830, DOI 10.1366/0003702934065885
   WONG PTT, 1991, P NATL ACAD SCI USA, V88, P10988, DOI 10.1073/pnas.88.24.10988
   WONG PTT, 1993, APPL SPECTROSC, V47, P1058, DOI 10.1366/0003702934415291
   WOPENKA B, 1987, ANAL CHEM, V59, P2165, DOI 10.1021/ac00144a034
   WOPENKA B, 1986, APPL SPECTROSC, V40, P144, DOI 10.1366/0003702864509592
   ZHENG SD, 1987, APPL SPECTROSC, V41, P696, DOI 10.1366/0003702874448661
NR 139
TC 28
Z9 28
U1 1
U2 7
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0570-4928
J9 APPL SPECTROSC REV
JI Appl. Spectrosc. Rev.
PY 1996
VL 31
IS 3
BP 193
EP 249
DI 10.1080/05704929608000570
PG 57
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA VK885
UT WOS:A1996VK88500002
DA 2018-10-19
ER

PT B
AU Rubio, M
AF Rubio, M
BE Burattini, E
   Balerna, A
TI Trace and ultra trace element analysis in biomedical materials
SO BIOMEDICAL APPLICATIONS OF SYNCHROTRON RADIATION
SE PROCEEDINGS OF THE INTERNATIONAL SCHOOL OF PHYSICS ENRICO FERMI
LA English
DT Proceedings Paper
CT 128th Course of the International-School-of-Physics-Enrico-Fermi -
   Biomedical Applications of Synchrotron Radiation
CY JUL 12-22, 1994
CL VARENNA, ITALY
SP Italian Phys Soc
C1 NATL UNIV CORDOBA,FAC MATEMAT ASTRON & FIS,RA-5000 CORDOBA,ARGENTINA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU I O S PRESS
PI AMSTERDAM
PA VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS
BN 90-5199-248-3
J9 P INT SCH PHYS
PY 1996
VL 128
BP 313
EP 332
PG 20
WC Physics, Condensed Matter; Radiology, Nuclear Medicine & Medical Imaging
SC Physics; Radiology, Nuclear Medicine & Medical Imaging
GA BF38L
UT WOS:A1996BF38L00018
DA 2018-10-19
ER

PT B
AU Denisov, NA
   Dets, SM
   Kravchenko, IV
AF Denisov, NA
   Dets, SM
   Kravchenko, IV
BE Croitoru, NI
   Frenz, M
   King, TA
   Pratesi, R
   Scheggi, AMV
   Seeger, S
   Wolfbeis, OS
   Katzir, A
TI Tapered fiber optics sensors for laser medicine
SO BIOMEDICAL SYSTEMS AND TECHNOLOGIES, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Systems and Technologies
CY SEP 08-10, 1996
CL VIENNA, AUSTRIA
SP Laser Vis, European Laser Assoc, Int Biomed Opt Soc, European Opt Soc, Soc Photo Opt Instrumentat Engineers, Commiss European Communities, Directorate Gen Sci Res & Dev
DE fiber optics sensor; tapered tip; light collector; optical coupling
AB Biomedical science and practical medicine need special techniques for reliable real-time remote detection and determination information from human tissue. Most applications of these techniques in interior organs are based on optical fibers which should not only be able to deliver excitation light with minimal loss but provide effective light gathering from tissue being under the test. As emitted from tissue optical signal is often weak especially if autofluorescence spectroscopy is chosen for diagnostics, an efficient collection by fiber optics probe became essential. The main part of proposed fiber optics probes is specially designed tapered tip with one nat surface and another spherical one. This tip operates as a collector, transmitter and coupler to deliver light to the tissue and backward to the detector simultaneously. To find geometrical dimensions of tips optimized for these purposes calculating formulas have been adduced. These optimized tips could collect fluorescence signal from biological sites in wide angular aperture region and could transport light without leakage on tapered surface. When delivery fibers are placed at the focal plane of tip spherical surface an efficient optical coupling with them is achieved. Ray tracing of the tapered tips has been performed on sapphire and quartz tip materials in air and in saline to determine the best sensor design.
RP Denisov, NA (reprint author), NATL ACAD SCI UKRAINE,DEPT OPT ENGN,UA-252056 KIEV,UKRAINE.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2330-0
J9 P SOC PHOTO-OPT INS
PY 1996
VL 2928
BP 165
EP 174
DI 10.1117/12.259958
PG 10
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Optics
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Optics
GA BG97A
UT WOS:A1996BG97A00019
DA 2018-10-19
ER

PT S
AU Tsuruta, T
AF Tsuruta, T
TI Contemporary topics in polymeric materials for biomedical applications
SO BIOPOLYMERS LIQUID CRYSTALLINE POLYMERS PHASE EMULSION
SE Advances in Polymer Science
LA English
DT Review
ID POLY(2-HYDROXYETHYL METHACRYLATE) POLYAMINE; POLYETHER
   POLY(URETHANEUREA) ELASTOMERS; SULFONATE-CONTAINING POLYURETHANES;
   LACTOSE-CARRYING POLYSTYRENE; POLY(ETHER URETHANE UREAS);
   BLOCK-COPOLYMER SURFACES; CELL ATTACHMENT ACTIVITY; PHOSPHOLIPID POLAR
   GROUP; SOFT SEGMENT CHEMISTRY; RANDOM NETWORK MODEL
AB Contemporary topics in polymeric materials for biomedical applications are reviewed, with the emphasis on the modes of interaction of water soluble polymers as well as their conjugates, and those of microdomain-structured polymers with proteins and cells. The nature of biocompatibility of these polymer surfaces is discussed in terms of the random-network concept of water molecules on the polymer surface. Several recent studies on biohybridized and biomimicking materials are also reviewed.
RP Tsuruta, T (reprint author), SCI UNIV TOKYO, FAC ENGN, DEPT IND CHEM, SHINJUKU KU, 1-2 KAGURAZAKA, TOKYO 162, JAPAN.
CR AKAIKE T, 1993, GASTROENTEROL JPN, V28, P45
   AKAIKE T, 1993, NEW FUNCTIONALITY B, P303
   Albertsson P. A., 1986, PARTITION CELL PARTI
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   ANDRADE JD, 1979, J COLLOID INTERF SCI, V72, P488, DOI 10.1016/0021-9797(79)90350-3
   BAMFORD CH, 1989, J BIOMAT SCI-POLYM E, V1, P1
   BEER JH, 1992, BLOOD, V79, P117
   BELCH AC, 1983, J CHEM PHYS, V78, P4817, DOI 10.1063/1.445416
   BERG JC, 1993, WETTABILITY, V49, P75
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   BIGELOW JC, 1989, J IMMUNOL METHODS, V117, P289, DOI 10.1016/0022-1759(89)90152-X
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   BROWN EJ, 1988, J EXP MED, V167, P777, DOI 10.1084/jem.167.3.777
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P255, DOI 10.1002/jbm.820270216
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   CHAIKOF EL, 1992, J BIOMED MATER RES, V26, P1163, DOI 10.1002/jbm.820260906
   CHEN GH, 1994, J BIOMAT SCI-POLYM E, V5, P371
   COLE CA, 1988, T 3 WORLD BIOM C, V11, P299
   COSTELLO CA, 1987, MACROMOLECULES, V20, P2819, DOI 10.1021/ma00177a030
   DEDHAR S, 1987, J CELL BIOL, V104, P585, DOI 10.1083/jcb.104.3.585
   DEJANA E, 1988, J CELL BIOL, V107, P1215, DOI 10.1083/jcb.107.3.1215
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DRAGO RS, 1987, INORG CHEM, V26, P9, DOI 10.1021/ic00248a003
   DRAGO RS, 1971, J AM CHEM SOC, V93, P6014, DOI 10.1021/ja00752a010
   DRUMHELLER PD, 1991, T 17 M SOC BIOM, V14, P239
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   FOWKES FM, 1990, J ADHES SCI TECHNOL, V4, P669, DOI 10.1163/156856190X00595
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   GOODMAN SL, 1993, J BIOMED MATER RES, V27, P683, DOI 10.1002/jbm.820270516
   GOTO M, 1994, J CONTROL RELEASE, V28, P223
   GRAINGER DW, 1990, J BIOMED MATER RES, V24, P403, DOI 10.1002/jbm.820240402
   GREEN JL, 1986, J PHYS CHEM-US, V90, P3958, DOI 10.1021/j100408a027
   GREEN JL, 1987, J CHEM PHYS, V86, P1841, DOI 10.1063/1.452136
   GRESHAM HD, 1989, J CELL BIOL, V108, P1935, DOI 10.1083/jcb.108.5.1935
   HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P401
   HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P579
   HARE DE, 1992, J CHEM PHYS, V96, P13, DOI 10.1063/1.462852
   HAUTANEN A, 1989, J BIOL CHEM, V264, P1437
   HAYMAN EG, 1985, J CELL BIOL, V100, P1948, DOI 10.1083/jcb.100.6.1948
   HERRING M, 1978, SURGERY, V84, P498
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   HIRANO Y, 1993, J BIOMAT SCI-POLYM E, V4, P235, DOI 10.1163/156856293X00546
   HIRANO Y, 1991, J BIOMED MATER RES, V25, P1523, DOI 10.1002/jbm.820251209
   HIRAO A, 1986, MACROMOLECULES, V19, P1294, DOI 10.1021/ma00159a002
   HOLMESFARLEY SR, 1988, LANGMUIR, V4, P921, DOI 10.1021/la00082a025
   Ikada Y., 1985, POLYM BIOMATERIALS, P135
   IMAI Y, 1972, KOBUNSHI, V21, P569
   IMAI Y, 1973, JPN J ARTIF ORGANS, V2, P95
   IMANISHI Y, 1988, J MACROMOL SCI CHEM, VA25, P555, DOI 10.1080/00222338808053384
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   ITO Y, 1991, J BIOMED MATER RES, V25, P1325, DOI 10.1002/jbm.820251102
   ITO Y, 1991, J BIOMED MATER RES, V25, P1347, DOI 10.1002/jbm.820251104
   JVAN S, 1991, J BIOMAT SCI-POLYM E, V2, P91
   KASUYA Y, 1993, J BIOMAT SCI-POLYM E, V4, P369, DOI 10.1163/156856293X00636
   KASUYA Y, 1994, J BIOMED MATER RES, V28, P397, DOI 10.1002/jbm.820280315
   KATAOKA K, 1980, J BIOMED MATER RES, V14, P817, DOI 10.1002/jbm.820140613
   KATAOKA K, 1988, BIOMATERIALS, V9, P218, DOI 10.1016/0142-9612(88)90087-7
   KATAOKA K, 1993, J CONTROL RELEASE, V24, P119
   KATAOKA K, 1982, BIOMATERIALS, V3, P237, DOI 10.1016/0142-9612(82)90026-6
   KATAOKA K, 1980, MAKROMOL CHEM, V181, P1363
   KATAOKA K, 1978, MAKROMOL CHEM, V179, P1121
   KATAOKA K, 1983, EUR POLYM J, V19, P979, DOI 10.1016/0014-3057(83)90060-5
   KATAOKA K, 1982, MAKROMOL CHEM-RAPID, V3, P275
   KATAOKA K, 1991, KOBUNSHI RONBUNSHU, V48, P201, DOI 10.1295/koron.48.201
   KIKUCHI A, 1993, J COLLOID INTERF SCI, V158, P10, DOI 10.1006/jcis.1993.1222
   KIKUCHI A, 1992, Japanese Journal of Artificial Organs, V21, P1212
   KIKUCHI A, 1992, J BIOMAT SCI-POLYM E, V3, P355, DOI 10.1163/156856292X00187
   KIKUCHI A, 1988, JPN J ARTIF ORGANS, V17, P487
   KIKUCHI A, 1991, POLYM ADVAN TECHNOL, V2, P245
   KIKUHCI A, 1993, ARTIFICIAL HEART, V4, P29
   KOBAYASHI A, 1994, J BIOMAT SCI-POLYM E, V6, P325, DOI 10.1163/156856295X00030
   KOBAYASHI A, 1992, J BIOMAT SCI-POLYM E, V3, P499, DOI 10.1163/156856292X00466
   Kobayashi Kazukiyo, 1994, P261
   KUGO K, 1994, J BIOMAT SCI-POLYM E, V5, P325, DOI 10.1163/156856294X00059
   KUGUMIYA T, 1992, J BIOACT COMPAT POL, V7, P337, DOI 10.1177/088391159200700403
   LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   LIN SC, 1991, J BIOMED MATER RES, V25, P791, DOI 10.1002/jbm.820250608
   LIU S Q, 1989, Journal of Biomaterials Science Polymer Edition, V1, P111
   LIU SQ, 1993, J BIOMED MATER RES, V27, P909, DOI 10.1002/jbm.820270710
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   LYMAN DJ, 1972, T AM SOC ART INT ORG, V18, P19
   MAEDA T, 1991, P 11 TAN C POL RES K, P45
   MAEDA Y, 1993, J PHYS CHEM-US, V97, P13903, DOI 10.1021/j100153a073
   MALCOLM GN, 1957, T FARADAY SOC, V53, P921, DOI 10.1039/tf9575300921
   MARUYAMA A, 1986, MAKROMOL CHEM, V187, P1895
   MARUYAMA A, 1988, J BIOMED MATER RES, V22, P555, DOI 10.1002/jbm.820220610
   MARUYAMA A, 1988, BIOMATERIALS, V9, P471, DOI 10.1016/0142-9612(88)90041-5
   MARUYAMA A, 1989, BIOMATERIALS, V10, P291, DOI 10.1016/0142-9612(89)90068-9
   MARUYAMA A, 1987, MAKROMOL CHEM-RAPID, V8, P27
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   MASSIA SP, 1991, T 17 M SOC BIOM, V14, P238
   MATSUDA T, 1989, T AM SOC ART INT ORG, V35, P677
   MATSUO ES, 1988, J CHEM PHYS, V89, P1695, DOI 10.1063/1.455115
   MIYAMOTO M, 1989, VOX SANG, V57, P164, DOI 10.1111/j.1423-0410.1989.tb00815.x
   MONJI N, 1994, J BIOMAT SCI-POLYM E, V5, P407, DOI 10.1163/156856294X00112
   MONJI N, 1988, T 3 WORLD BIOMATER C, V11, P298
   NABESHIMA Y, 1989, Journal of Biomaterials Science Polymer Edition, V1, P85
   NABESHIMA Y, 1987, POLYM J, V19, P593, DOI 10.1295/polymj.19.593
   NICOL A, 1992, J BIOMED MATER RES, V26, P393, DOI 10.1002/jbm.820260309
   NICOL A, 1993, J BIOMED MATER RES, V27, P801, DOI 10.1002/jbm.820270613
   NILSSON K, 1981, BIOCHEM BIOPH RES CO, V102, P449, DOI 10.1016/0006-291X(81)91541-2
   NISHIMURA T, 1980, MAKROMOL CHEM-RAPID, V1, P573
   NISHIMURA T, 1982, MAKROMOL CHEM, V183, P29
   NISHIMURA T, 1988, T 3 WORLD BIOM C, V11, P481
   NITADORI Y, 1979, MAKROMOL CHEM, V180, P1877
   NOGUCHI Y, 1991, J IMMUNOL, V146, P3599
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   NOJIRI C, 1992, J BIOMAT SCI-POLYM E, V4, P75
   NOJIRI C, 1993, ARTIFICIAL HEART, P53
   OHGAWARA H, 1994, CELL TRANSPLANT, V3, P83
   OHLSON S, 1978, FEBS LETT, V93, P5, DOI 10.1016/0014-5793(78)80792-3
   OKANO T, 1993, J BIOMED MATER RES, V27, P1519, DOI 10.1002/jbm.820271208
   OKANO T, 1978, J APPL POLYM SCI, V22, P369, DOI 10.1002/app.1978.070220206
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   OKANO T, 1977, NIPPON KAGAKU KAISHI, P88, DOI 10.1246/nikkashi.1977.88
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   OKANO T, 1979, JPN J ARTIF ORGANS, V8, P292
   OKANO T, 1994, JAPANESE TECHNOLOGY, V4, P67
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   OKKEMA AZ, 1991, J BIOMED MATER RES, V25, P1371, DOI 10.1002/jbm.820251106
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   PLOW EF, 1985, P NATL ACAD SCI USA, V82, P8057, DOI 10.1073/pnas.82.23.8057
   PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   RENIER M, 1993, J BIOMAT SCI-POLYM E, V5, P231
   RICE SA, 1981, J PHYS CHEM-US, V85, P1108, DOI 10.1021/j150609a009
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P39, DOI 10.1002/jbm.820260105
   SHAREFKIN JB, 1982, SURGERY, V92, P385
   SHIBATA S, 1990, DRUG DELIVERY SYSTEM, V7, P109
   SILVER JH, 1993, J BIOMED MATER RES, V27, P735, DOI 10.1002/jbm.820270606
   SILVER JH, 1993, J BIOMED MATER RES, V27, P1443, DOI 10.1002/jbm.820271111
   STANISLAWSKI L, 1993, J BIOMED MATER RES, V27, P619, DOI 10.1002/jbm.820270509
   STANLEY JC, 1982, SURGERY, V92, P994
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   STILLINGER FH, 1980, SCIENCE, V209, P451, DOI 10.1126/science.209.4455.451
   SUNAMOTO J, 1992, MACROMOLECULES, V25, P5665, DOI 10.1021/ma00047a017
   SUNAMOTO J, 1993, NEW FUNCTIONALITY MA, P203
   SUNG CSP, 1981, MACROMOLECULES, V14, P212, DOI 10.1021/ma50002a047
   Taira H., 1994, Japanese Journal of Artificial Organs, V23, P695
   TAKAHARA A, 1982, KOBUNSHI RONBUNSHU, V39, P203, DOI 10.1295/koron.39.203
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P1095, DOI 10.1002/jbm.820250905
   TAKAHARA A, 1993, J BIOMAT SCI-POLYM E, V5, P183
   TAKAHARA A, 1992, J BIOMED MATER RES, V26, P801, DOI 10.1002/jbm.820260609
   TAKAHARA A, 1992, KOBUNSHI RONBUNSHU, V49, P275, DOI 10.1295/koron.49.275
   TAKAHARA A, 1991, ARTIFICIAL HEART, V3, P77
   TAKEI YG, 1994, J BIOMAT SCI-POLYM E, V6, P149
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   TANAKA T, 1987, ENCY POLYM SCI ENG, V7, P514
   TANZAWA H, 1985, 1 JAP US WORKSH BIOM
   TANZAWA H, 1986, JPN J ARTIF ORGANS, V15, P16
   TERADA T, 1993, J PHYS CHEM-US, V97, P3619, DOI 10.1021/j100116a029
   TOBE S, 1992, BIOCHEM BIOPH RES CO, V184, P225, DOI 10.1016/0006-291X(92)91182-P
   TSURUTA T, 1990, MAKROMOL CHEM-M SYMP, V33, P243, DOI 10.1002/masy.19900330121
   TSURUTA T, 1987, MAKROMOL CHEM-M SYMP, V12, P323, DOI 10.1002/masy.19870120116
   TYLER BJ, 1993, J BIOMED MATER RES, V27, P327, DOI 10.1002/jbm.820270306
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   UEDA Y, 1990, THESIS SCI U TOKYO, P34
   VANDERLEI B, 1989, THORAC CARDIOV SURG, V37, P337, DOI 10.1055/s-2007-1020349
   WALTER H, 1977, METHODS CELL SEPARAT, V1, P307
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   WATER H, 1985, PARTITIONING AQUEOUS
   WILDEVUUR CRH, 1987, BIOMATERIALS, V8, P418, DOI 10.1016/0142-9612(87)90076-7
   WILKES GL, 1981, MACROMOLECULES, V14, P456, DOI 10.1021/ma50003a045
   WILLIAMS SK, 1987, ANN NY ACAD SCI, V516, P145, DOI 10.1111/j.1749-6632.1987.tb33037.x
   WILLIAMS SK, 1994, J BIOMED MATER RES, V28, P203, DOI 10.1002/jbm.820280210
   YAMADA N, 1992, Japanese Journal of Artificial Organs, V21, P206
   YAMADANOSAKA A, 1990, J APPL POLYM SCI, V39, P2443, DOI 10.1002/app.1990.070391117
   YAMADANOSAKA A, 1991, J APPL POLYM SCI, V43, P1165, DOI 10.1002/app.1991.070430617
   YOKOYAMA M, 1991, CANCER RES, V51, P3229
   YOKOYAMA M, 1990, J CONTROL RELEASE, V11, P269
   YOKOYAMA M, 1992, BIOCONJUGATE CHEM, V3, P295, DOI 10.1021/bc00016a007
   YOKOYAMA M, 1990, CANCER RES, V50, P1693
   YOSHIDA R, 1991, J BIOMAT SCI-POLYM E, V3, P155, DOI 10.1163/156856291X00250
   YOSHIDA R, 1994, J BIOMAT SCI-POLYM E, V6, P585, DOI 10.1163/156856294X00536
   YUE X, 1988, SURGERY, V103, P206
   YUI N, 1986, MAKROMOL CHEM, V187, P943
   YUI N, 1988, BIOMATERIALS, V9, P225, DOI 10.1016/0142-9612(88)90088-9
   YUI N, 1984, POLYM J, V16, P119, DOI 10.1295/polymj.16.119
   YUI N, 1986, J BIOMED MATER RES, V20, P929, DOI 10.1002/jbm.820200708
   YUI N, 1991, ARTIFICIAL HEART, V3, P23
NR 191
TC 90
Z9 91
U1 0
U2 13
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-60484-7
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 1996
VL 126
BP 1
EP 51
PG 51
WC Polymer Science
SC Polymer Science
GA BF45K
UT WOS:A1996BF45K00001
DA 2018-10-19
ER

PT J
AU Hess, T
   Stepanow, B
   Knopp, MV
AF Hess, T
   Stepanow, B
   Knopp, MV
TI Safety of intrauterine contraceptive devices during MR imaging
SO EUROPEAN RADIOLOGY
LA English
DT Article
DE MR safety; intrauterine contraceptive device; MR compatibility;
   biomedical materials
ID BIOMEDICAL IMPLANTS; METALLIC IMPLANTS; POTENTIAL HAZARDS;
   MAGNETIC-FIELDS
AB Three intrauterine contraceptive devices (IUD) were examined in an experimental in vitro set-up to test their MR compatibility: Multiload CU375, Nova T (containing copper and silver), and Gyne T. The devices were fixed in a polyacrylamide gel and exposed to the magnetic field and the radiofrequency (RF) of standard MR sequences (spin-echo, turbo-spin-echo, turboFLASH, and magnetization transfer prepared FLASH). The RF power of a turbo-spin-echo sequence was increased by a factor of 5. Temperatures of the IUDs and the gel were measured during the MR examination. No deflection of the IUDs exposed to the magnetic field of 1.5 Tesla was detected. Under normal imaging conditions no temperature increase could be observed. Using an increased RF power, a maximal temperature rise of 0.4 degrees C per examination was seen. no differences between the gel and the IUDs were observed, indicating that there is no specific heating of the tested IUDs.
RP Hess, T (reprint author), GERMAN CANC RES CTR,RES PROGRAM RADIOL DIAGNOST & THERAPY,NEUENHEIMER FELD 280,D-69120 HEIDELBERG,GERMANY.
CR BROWN MA, 1987, MAGN RESON IMAGING, V5, P443, DOI 10.1016/0730-725X(87)90378-X
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   GOLD JP, 1989, ANN THORAC SURG, V48, P643, DOI 10.1016/0003-4975(89)90780-7
   KAGETSU NJ, 1991, RADIOLOGY, V179, P505, DOI 10.1148/radiology.179.2.2014301
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   MARK AS, 1987, RADIOLOGY, V162, P311, DOI 10.1148/radiology.162.2.3797642
   MESGARZADEH M, 1985, SKELETAL RADIOL, V14, P205, DOI 10.1007/BF00355565
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   SHELLOCK FG, 1992, REV MAGN RESON IMAGI, V4, P21
NR 13
TC 12
Z9 12
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0938-7994
J9 EUR RADIOL
JI Eur. Radiol.
PY 1996
VL 6
IS 1
BP 66
EP 68
DI 10.1007/BF00619957
PG 3
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA TV240
UT WOS:A1996TV24000014
PM 8797953
DA 2018-10-19
ER

PT S
AU Fornaciari, G
   Capasso, L
AF Fornaciari, G
   Capasso, L
BE Spindler, K
   Wilfing, H
   RastbichlerZissernig, E
   zurNedden, D
   Nothdurfter, H
TI Natural and artificial 13th-19th century mummies in Italy
SO HUMAN MUMMIES: GLOBAL SURVEY OF THEIR STATUS AND THE TECHNIQUES OF
   CONSERVATION
SE MAN IN THE ICE
LA English
DT Proceedings Paper
CT International Mummy Symposium
CY SEP 15-17, 1993
CL INNSBRUCK, AUSTRIA
SP Univ Innsbruck, Inst Prehist & Early Hist, Univ Innsbruck, Inst Prehist Alpine Res
AB Numerous collections of mummies in Italy are unexpectedly distributed over che entire and in particular in the southern part of the country. Burials dare from medieval to modern times, with a higher incidence between the 17th and 19th centuries. The mummies are both artificial, chose submitted to the process of embalming and natural which represent che majority of the collections. Natural mummification was made easier by particular drainage methods of the cadaveric savage frequently used in the crypts of the churches, especially in southern Italy.
   The study of the natural mummies of the church of Santa Maria della Grazia in Comiso (Sicily, 18th-19th centuries) made possible the diagnosis of atherosclerosis, splenomegaly, tuberculosis, acariasis, colon diverticulosis, inguinal hernia and varicose ulcer.
   Examination of the natural and artificial mummies of he Abbey of S. Domenico Maggiore in Naples (15th-17th centuries) clarified the embalming methods of the Renaissance, allowing the diagnosis of two cases of infectious disease (smallpox and venereal syphilis) and two of neoplastic pathology (epithelioma and adenocarcinoma).
   The Italian mummies submitted to paleopathological studies have shown chat modern biomedical techniques, such as immunohistochemistry and electronmicroscopy, can be applied to this type of material, providing extremely interesting results for the history of diseases.
C1 UNIV PISA,SCH MED,INST PATHOL,I-56100 PISA,ITALY.
RI Wilfing, Harald/C-3918-2013
OI Wilfing, Harald/0000-0001-8591-2145
NR 0
TC 3
Z9 3
U1 0
U2 2
PU SPRINGER-VERLAG
PI VIENNA
PA MOLKERBASTEI 5, POSTFACH 367, A-1011 VIENNA, AUSTRIA
SN 0947-3483
BN 3-211-82659-9
J9 MAN IN ICE
PY 1996
VL 3
BP 195
EP 203
PG 9
WC Anthropology; Archaeology
SC Anthropology; Archaeology
GA BH13M
UT WOS:A1996BH13M00019
DA 2018-10-19
ER

PT S
AU Park, H
   Park, K
AF Park, H
   Park, K
BE Ottenbrite, RM
   Huang, SJ
   Park, K
TI Hydrogels in bioapplications
SO HYDROGELS AND BIODEGRADABLE POLYMERS FOR BIOAPPLICATIONS
SE ACS Symposium Series
LA English
DT Review
CT Symposium on Hydrogels and Biodegradable Polymers for Bioapplications,
   at the 208th National Meeting of the American-Chemical-Society
CY AUG 21-26, 1994
CL WASHINGTON, D.C.
SP Amer Chem Soc, Div Polym Chem Inc
ID PHASE-TRANSITION; DRUG DELIVERY; IMPLANT MATERIALS; GELS; GLUCOSE;
   MEMBRANES; IMMOBILIZATION; METHACRYLATE); TRANSPORT; BEHAVIOR
AB Research on hydrogels has been geared toward biomedical applications from the beginning due to their relatively high biocompatibility. Initially only the hydrophilic nature and the large swelling properties of hydrogels was explored. Continued research on hydrogels has resulted in the development of new types of hydrogels, such as environment-sensitive hydrogels, thermoplastic hydrogels, hydrogel foams, and sol-gel phase-reversible hydrogels. Application of hydrogels ranges from biomedical devices to solute separation. Examples of hydrogel applications in pharmaceutics, biomaterials, and biotechnology are briefly described.
C1 PURDUE UNIV, SCH PHARM, W LAFAYETTE, IN 47907 USA.
CR Aharoni S. M., 1992, SYNTHESIS CHARACTERI
   Albin G, 1990, PULSED SELF REGULATE, P159
   AMIYA T, 1987, MACROMOLECULES, V20, P1162, DOI 10.1021/ma00171a050
   BAE YH, 1991, PHARMACEUT RES, V8, P624, DOI 10.1023/A:1015860824953
   BRANNONPEPPAS L, 1991, CHEM ENG SCI, V46, P715, DOI 10.1016/0009-2509(91)80177-Z
   CAPOZZA RC, 1990, POLYM PREPRINTS, V31, P57
   CARLSON KH, 1993, J CATARACT REFR SURG, V19, P9, DOI 10.1016/S0886-3350(13)80272-6
   CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A
   CONSTANCE J, 1991, MECH ENG, V113, P51
   CORKHILL PH, 1989, BIOMATERIALS, V10, P3, DOI 10.1016/0142-9612(89)90002-1
   DARSOW U, 1995, J ALLERGY CLIN IMMUN, V95, P677, DOI 10.1016/S0091-6749(95)70172-9
   DAVIES ML, 1992, BIOMATERIALS, V13, P991, DOI 10.1016/0142-9612(92)90149-I
   De Rossi D., 1992, Journal of Intelligent Material Systems and Structures, V3, P75, DOI 10.1177/1045389X9200300105
   DeRossi D, 1991, POLYM GELS FUNDAMENT
   DONG LC, 1990, J CONTROL RELEASE, V13, P21, DOI 10.1016/0168-3659(90)90071-Z
   DREXLER KE, 1992, NANOSYSTEMS MOL MACH
   FEIL H, 1991, J MEMBRANE SCI, V64, P283, DOI 10.1016/0376-7388(91)80099-R
   GEHRKE SH, 1986, CHEM ENG SCI, V41, P2153, DOI 10.1016/0009-2509(86)87131-7
   GRAIVER D, 1993, BIOMATERIALS, V14, P465, DOI 10.1016/0142-9612(93)90150-Z
   GUENET JMM, 1992, THERMOREVERSIBLE GEL
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   HOFFMAN A S, 1987, Journal of Controlled Release, V6, P297, DOI 10.1016/0168-3659(87)90083-6
   HOOPER HH, 1990, MACROMOLECULES, V23, P1096, DOI 10.1021/ma00206a031
   HU YX, 1993, MACROMOLECULES, V26, P1761, DOI 10.1021/ma00059a041
   INOMATA H, 1992, LANGMUIR, V8, P687, DOI 10.1021/la00038a064
   ISHIHARA K, 1983, MAKROMOL CHEM-RAPID, V4, P327
   KAETSU I, 1992, RADIAT PHYS CHEM, V40, P157
   KINDLER DD, 1990, J APPL PHYSIOL, V69, P373
   KITANO S, 1992, J CONTROL RELEASE, V19, P162
   KITANO S, 1993, P 1 INT C INT MAT, P383
   KLUMB LA, 1993, J CONTROL RELEASE, V27, P95, DOI 10.1016/0168-3659(93)90214-P
   Kost J., 1990, PULSED SELF REGULATE
   KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0
   LACY PE, 1995, SCI AM, V273, P50, DOI 10.1038/scientificamerican0795-50
   LEE KK, 1990, CHEM ENG SCI, V45, P766, DOI 10.1016/0009-2509(90)87019-O
   LEE SJ, 1994, POLYM PREPRINTS, V35, P391
   LEE SJ, UNPUB J MOL REC
   LIU Y, 1994, EUR POLYM J, V30, P457, DOI 10.1016/0014-3057(94)90044-2
   MAMADA A, 1990, MACROMOLECULES, V23, P1517, DOI 10.1021/ma00207a046
   MARCHETTI M, 1989, SEPAR PURIF METHOD, V18, P177, DOI 10.1080/03602548908050923
   MAUBON AJ, 1994, RADIOLOGY, V193, P721, DOI 10.1148/radiology.193.3.7972813
   MIYAZAKI H, 1993, P 1 INT C INT MAT, P481
   MOLIN A, 1992, GYNECOL OBSTET INVES, V34, P12, DOI 10.1159/000292716
   MYERS RI, 1991, OPTOMETRY VISION SCI, V68, P776, DOI 10.1097/00006324-199110000-00003
   NETTI PA, 1993, BIOMATERIALS, V14, P1098, DOI 10.1016/0142-9612(93)90211-J
   NIGAM SC, 1988, BIOTECHNOL PROGR, V4, P166, DOI 10.1002/btpr.5420040307
   OHMINE I, 1982, J CHEM PHYS, V77, P5725, DOI 10.1063/1.443780
   OKUZAKI H, 1993, P 1 INT C INT MAT TE, P273
   Oxley H. R., 1993, Biomaterials, V14, P1065
   Park H., 1994, 20 ANN M SOC BIOM
   Park H., 1994, P INT S CONTR REL BI, V21, P21
   PARK K, 1993, BIODEGRADABLE HYDROG
   PARK TG, 1990, J BIOMED MATER RES, V24, P21, DOI 10.1002/jbm.820240104
   PARK TG, 1994, BIOTECHNOL PROGR, V10, P82, DOI 10.1021/bp00025a010
   Peppas N. A., 1987, HYDROGELS MED PHARM, V1-3
   PISHKO MV, 1991, ANAL CHEM, V63, P2268, DOI 10.1021/ac00020a014
   SAWAHATA K, 1990, J CONTROL RELEASE, V14, P253, DOI 10.1016/0168-3659(90)90165-P
   SHINO D, 1993, P 1 INT C INT MAT, P301
   SIEGEL RA, 1990, PULSED SELF REGULATE, pCH8
   STUDT T, 1995, R PLUS D MAGAZINE, P22
   STUDT T, 1992, R D MAG          APR, P55
   SUZUKI A, 1993, P 1 INT C INT MAT, P297
   SUZUKI M, 1989, KOBUNSHI RONBUNSHU, V46, P603, DOI 10.1295/koron.46.603
   TAKAGI T, 1993, P 1 INT C INT MAT
   TANAKA T, 1981, SCI AM, V244, P124, DOI 10.1038/scientificamerican0181-124
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   VASHEGHANIFARAHANI E, 1992, CHEM ENG SCI, V47, P31, DOI 10.1016/0009-2509(92)80197-K
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
NR 69
TC 38
Z9 40
U1 1
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3400-0
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 1996
VL 627
BP 2
EP 10
PG 9
WC Chemistry, Multidisciplinary; Mechanics
SC Chemistry; Mechanics
GA BF19C
UT WOS:A1996BF19C00001
DA 2018-10-19
ER

PT B
AU Petersen, K
AF Petersen, K
GP IEEE
TI Biomedical applications of MEMS
SO IEDM - INTERNATIONAL ELECTRON DEVICES MEETING, TECHNICAL DIGEST 1996
LA English
DT Proceedings Paper
CT 1996 International Electron Devices Meeting
CY DEC 08-11, 1996
CL SAN FRANCISCO, CA
SP IEEE Electron Devices Soc
AB Exploiting the materials and processing techniques developed for integrated circuits, silicon micromachining technology has been responsible for fundamental improvements in many, diverse fields of biomedicine. As blood pressure sensors, chemical sensors, micro-chemical reaction and analysis systems, and micro-fluidic control systems, the impact of micromachining on biomedical applications has already been impressive, but is only now poised for dramatic advances.
   This paper will review current state-of-the-art biomedical applications of micromachining technology such as pressure sensors and biochemical sensors. In addition, we will discuss significant new biomedical innovations on the horizon which make use of micromachining techniques and processes.
RP Petersen, K (reprint author), CEPHEID,SAN JOSE,CA, USA.
NR 0
TC 9
Z9 9
U1 0
U2 1
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
BN 0-7803-3394-2
PY 1996
BP 239
EP 242
DI 10.1109/IEDM.1996.553575
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BG98F
UT WOS:A1996BG98F00051
DA 2018-10-19
ER

PT J
AU Schimpf, PH
   Haynor, DR
   Kim, Y
AF Schimpf, PH
   Haynor, DR
   Kim, Y
TI Object-free adaptive meshing in highly heterogeneous 3-D domains
SO INTERNATIONAL JOURNAL OF BIO-MEDICAL COMPUTING
LA English
DT Article
DE numerical analysis; finite element; mesh generation; adaptive
ID FINITE-ELEMENT STRATEGY; REFINEMENT
AB Traditional approaches to the generation of finite element meshes are well suited for modeling the homogeneous or mildly heterogeneous domains presented by man-made objects, but are difficult to apply to the complex 3-D domains encountered in some biomedical applications. In this paper, we describe an adaptive algorithm that automates the modeling of these domains. The method differs from traditional approaches in that no explicit description is required of the boundaries between objects with dissimilar material properties. The algorithm uses images of the tissue class to build irregular meshes, and continuity is enforced by constraining the solution at irregular nodes. Local estimates of the error in the flux solution are used to refine the mesh. For an analytic problem with a rapid change along a spherical boundary, the adaptive method converges to a 1% voltage error using 25% of the degrees of freedom required by a uniform refinement, and to a 5% voltage gradient error using 11% of the degrees of freedom. For a defibrillation model in a pig thorax, the voltage gradient solution in the ventricles of the heart converges to within 5% of a uniform mesh solution using less than 8% of the memory and processing resources required by a uniform mesh, which has been the only practical alternative for subject-specific modeling.
C1 UNIV WASHINGTON,DEPT ELECT ENGN,SEATTLE,WA 98195.
   UNIV WASHINGTON,DEPT RADIOL,SEATTLE,WA 98195.
FU NHLBI NIH HHS [HL48814]
CR Axelsson O., 1984, FINITE ELEMENT SOLUT
   Bank R.E., 1983, SCI COMPUT, P3
   BATHE KJ, 1982, FINITE ELEMENT PROCE
   BESAG J, 1986, J ROY STAT SOC B MET, V48, P259
   BLILIE DE, 1991, P 13 C IEEE EMBS, V13, P772
   Burnett D., 1988, FINITE ELEMENT ANAL
   CAREY GF, 1988, INT J NUMER METH ENG, V26, P2607, DOI 10.1002/nme.1620261203
   DEMKOWICZ L, 1989, COMPUT METHOD APPL M, V77, P79, DOI 10.1016/0045-7825(89)90129-1
   DEMKOWICZ L, 1988, 8802 U TEX I COMP ME
   GEORGE P, 1991, AUTOMATIC MESH GENER
   HAGEMAN LA, 1981, APPLIED ITERATIVE ME, P138
   IMGRUND MC, 1991, P 3 INT C QUAL ASS S, P190
   Irons BM, 1972, MATH FDN FINITE ELEM, P557
   JORGENSON DB, 1995, IEEE T BIO-MED ENG, V42, P559, DOI 10.1109/10.387195
   JORGENSON DB, 1995, IEEE T BIO-MED ENG, V42, P172, DOI 10.1109/10.341830
   KELA A, 1987, ENG COMPUT, V4, P104
   KOCVARA M, 1993, INT J NUMER METH ENG, V36, P1703, DOI 10.1002/nme.1620361006
   MURAMATSU K, 1991, IEEE T MAGN, V27, P5211, DOI 10.1109/20.278790
   MURAMATSU K, 1993, IEEE T MAGN, V29, P1479, DOI 10.1109/20.250682
   ODEN JT, 1989, COMPUT METHOD APPL M, V77, P113, DOI 10.1016/0045-7825(89)90130-8
   RACHOWICZ W, 1989, COMPUT METHOD APPL M, V77, P181, DOI 10.1016/0045-7825(89)90131-X
   RHEINBOLDT WC, 1980, ACM T MATH SOFTWARE, V6, P166, DOI 10.1145/355887.355891
   SCHIMPF PH, 1995, MED BIOL ENG COMPUT, V33, P713, DOI 10.1007/BF02510792
   SHEPHARD MS, 1988, APPL MECH REV, V41, P169
   SHRINIDHI N, 1995, IN PRESS IEEE T BIOM
   STRANG G, 1972, MATH FDN FINITE ELEM, P689
   TAYLOR RL, 1986, INT J NUMER METH ENG, V22, P39, DOI 10.1002/nme.1620220105
   WHEELER MJ, 1989, P 2 INT C QUAL ASS S, P1
   Zienkiewicz O, 1989, FINITE ELEMENT METHO
   ZIENKIEWICZ OC, 1987, INT J NUMER METH ENG, V24, P337, DOI 10.1002/nme.1620240206
NR 30
TC 14
Z9 14
U1 0
U2 3
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0020-7101
J9 INT J BIOMED COMPUT
JI Int. J. Bio-Med. Comput.
PD JAN
PY 1996
VL 40
IS 3
BP 209
EP 225
DI 10.1016/0020-7101(95)01146-3
PG 17
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Theory & Methods; Engineering, Biomedical; Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA UB229
UT WOS:A1996UB22900006
PM 8666474
DA 2018-10-19
ER

PT S
AU Burg, KJL
   Shalaby, SW
AF Burg, KJL
   Shalaby, SW
BE Clough, RL
   Shalaby, SW
TI Radiation sterilization of medical devices and pharmaceuticals
SO IRRADIATION OF POLYMERS: FUNDAMENTALS AND TECHNOLOGICAL APPLICATIONS
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Irradiation of Polymers, at the 208th National Meeting of
   the American-Chemical-Society
CY AUG 21-26, 1994
CL WASHINGTON, DC
SP Amer Chem Soc, Div Polym Chem Inc
ID TENDON ALLOGRAFTS
AB The advantages of ionizing irradiation over traditional sterilization methods are overviewed and recent developments in the field are described. The effect of irradiation on synthetic polymers, natural materials, and pharmaceuticals is discussed, along with the advantages and disadvantages of irradiation on each of these systems. Biomedical materials have the stringent requirement of maintaining their integrity during sterilization as well as displaying short and long-term biocompatibility in the biological environment. In effect, a biomedical device or pharmaceutical product should maintain its chemical and physical properties through different stages of processing including terminal sterilization. Sterilization is a sensitive, critical step in this process.
C1 POLY MED INC,CTR APPL TECHNOL,PENDLETON,SC 29670.
RP Burg, KJL (reprint author), CLEMSON UNIV,DEPT BIOENGN,RHODES ENGN RES CTR 301,CLEMSON,SC 29634, USA.
CR ARTANDI C, 1959, NUCLEONICS, V17, P86
   *ASS ADV MED INSTR, 1984, GUID GAMM RAD STER M
   *ASS ADV MED INSTR, 1992, ST321991 ANSIAAMI
   BELKOFF SM, 1992, J ORTHOPAED RES, V10, P461, DOI 10.1002/jor.1100100320
   BRUCK SD, 1988, J BIOMED MAT RES APP, V32, P133
   CHAPIRO A, 1962, RAD CHEM POLYM SYSTE, V15, P341
   CHRISTENSEN EA, 1992, PRINCIPLES PRACTICE, P558
   DEDEYNE P, 1991, CONNECT TISSUE RES, V27, P51
   DZIEDZICGOCLAWS.A, 1991, CLIN ORTHOP RELAT R, V272, P30
   HANSEN J, 1994, MED DEVICE DIAGN MAY, P218
   *INT AT EN AG, 1967, RADIOSTERILIZATION M
   JACOBS PT, 1995, ACS S SEIRES
   MOACANIN J, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P183
   NAIR PD, 1988, BIOMATERIALS, V9, P335, DOI 10.1016/0142-9612(88)90029-4
   SHALABY SW, 1995, Patent No. 5422068
   STEINGER E, 1973, HDB DESINFEKTION STE, V2, P181
   VOLLAND C, 1994, J CONTROL RELEASE, V31, P293, DOI 10.1016/0168-3659(94)90012-4
NR 17
TC 7
Z9 7
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036
SN 0097-6156
BN 0-8412-3377-2
J9 ACS SYM SER
PY 1996
VL 620
BP 240
EP 245
PG 6
WC Chemistry, Multidisciplinary; Polymer Science
SC Chemistry; Polymer Science
GA BF03R
UT WOS:A1996BF03R00018
DA 2018-10-19
ER

PT J
AU Forstel, H
AF Forstel, H
TI Production and use of nitrogen-15 in German agricultural, biomedical and
   ecological research - A historical review
SO ISOTOPES IN ENVIRONMENTAL AND HEALTH STUDIES
LA English
DT Review
DE application; Germany; history; Leipzig; nitrogen 15; production; review
ID DIFFERENT COMPARTMENTS; ISOTOPE RATIOS
AB The history of production and application of the stable nitrogen isotope N-15 in Germany is mainly part of the history of the former Institute of Stable Isotopes, later a part of the Central Institute of Isotope and Radiation Research (Zentralinstitut fur Isotopen-und Strahlenforschung) in Leipzig. In 1956, after a relatively large fractionation during isotopic exchange in the system NO/HNO3, was reported by SPINDEL and TAYLOR, the construction of an isotope enrichment plant was planned and started work in 1958 on a laboratory scale. The prodution of N-15-labelled material in the institute started in 1960, followed in 1968 by the start of a separation plant in Wolfen as a branch of industrial fertilizer production. The economy was optimized by feeding back the N-15 decreased efflux to the fertilizer production line.
   The material produced was used for studies at home and abroad. Close contacts with the IAEA (International Atomic Energy Agency, Vienna) and the development of an easy-to-handle optical instrument for N-15 measurements were the basis for a wide application in agriculture and medicine.
   As a result of German reunification fertilizer production in Wolfen was stopped, and consequently the successful N-15 separation plant had to be closed. A broad spectrum of N-15-labelled compounds, however, is being produced also today in Berlin and is purchased by Chemotrade, Leipzig.
   In the Western part of the country stable isotopes were not produced, but could be purchased on the world market at prices far below the realistic economic costs. At that time research was not coordinated centrally, until the lack of common information was counteracted by the foundation of the Working Group on Stable Isotopes in Mainz in 1977. A similar group in Eastern Germany had been at work since 1959, but no direct contact between the two groups had existed for political reasons.
RP Forstel, H (reprint author), FORSCHUNGSZENTRUM JULICH, FORSCHUNGSZENTRUM, INST RADIOAGRON, POSTFACH 1913, D-52425 JULICH, GERMANY.
CR *ADL DDR, 1990, DAUERF
   *ADL DDR, 1987, FZ MUNCH METH ERG EI
   *ADL DDR, 1978, 155 ADL
   AMBERGER A, 1987, GEOCHIM COSMOCHIM AC, V51, P2699, DOI 10.1016/0016-7037(87)90150-5
   *ASTI, 1967, ARB STAB IS LEIPZ OC
   *ASTI, 1969, ARB STAB IS LEIPZ OC
   *ASTI, 1965, ARB STAB IS LEIPZ OC
   BIRKENFELD H, 1962, MASSENSPEKTROMETRISC
   BUCHMANN N, 1995, OECOLOGIA, V102, P361, DOI 10.1007/BF00329803
   DURKA W, 1994, NATURE, V372, P765, DOI 10.1038/372765a0
   FAUST H., 1962, Kernenergie, V5, P391
   FAUST H, 1993, ISOTOPENPRAXIS, V29, P289, DOI 10.1080/00211919308046699
   FAUST H, 1960, Z ANAL CHEM, V175, P9
   FAUST H, 1987, TAGUNGSBAND METHODEN, P3
   Faust H., 1981, ISOCOMMERZ GMBH BERL, V5, P1
   Faust H., 1981, METHODENKATALOG ZFI, V36, P1
   FAUST H, 1960, ISOTOPENTECHNIK, V1, P13
   FAUST H, 1964, ABH DTSCHN AKAD CGB, V7, P577
   FREYER HD, 1994, 1 RESULTS 15N 14N RA, P7
   GEBAUER G, 1994, PLANT SOIL, V164, P267, DOI 10.1007/BF00010079
   GEBAUER G, 1991, OECOLOGIA, V87, P198, DOI 10.1007/BF00325257
   GEBAUER G, 1993, ISOTOPENPRAXIS, V29, P35, DOI 10.1080/10256019308046133
   Hartig W., 1978, DDR MED REPORT, V7, P563
   HIRSCHBERG K, 1985, ZFL MITT LEIPZIG, V110, P4
   HUBNER G, 1970, ROLLE WASSERS BIOL S
   HUBNER H, 1976, STABILE ISOTOPE SCHR, V7, P1
   JONAS C, 1989, ZFL MITTEILUNGEN LEI, V150, P285
   JUNG K, 1985, EUR J NUCL MED, V11, P62
   KORSCHENS, 1992, DAUERFELDVERSUCHE NA
   KRELL E, 1958, HDB LABORATORIUMSDES
   KRELL E, 1976, ISOTOPENPRAXIS, V12, P188
   KRETZSCHMANN G, 1970, ISOTOPENPRAXIS, V6, P354
   KRUMBIEGEL P, 1985, EUR J NUCL MED, V11, P58
   KRUMBIEGEL P, 1991, Z KLIN MED, V46, P691
   KRUMBIEGEL P, 1992, STABLE ISOTOPE PHARM
   KRUMBIEGEL P, 1983, ISOCOMMERZ GMBH BERL, V13, P1
   KRUMBIEGEL P, 1970, ISOTOPIEEFFEKTE
   LATUS C, 1990, NATURWISSENSCHAFTEN, V77, P283, DOI 10.1007/BF01131225
   MEIER G, 1992, ISOTOPENPRAXIS, V28, P85, DOI 10.1080/00211919208050832
   REINHARDT R, 1983, ISOTOPENPRAXIS, V19, P208, DOI 10.1080/10256018308544887
   Schmidt H., 1989, P 5 WORK M IS NAT LE, P613
   SEGSCHNEIDER HJ, 1995, NEW PHYTOL, V131, P109, DOI 10.1111/j.1469-8137.1995.tb03060.x
   *TGL, 1990, 14466 DDR TGL
   *U BONN, 1991, 1 U BONN FAK BONN
   VOERKELIUS S, 1990, GESELLSCHAFT, V60, P361
   WETZEL H, 1989, ZFL MITT, V150
   1962, KERNENERGIE, V5, P208
   1995, ENV HLTH STUD, V31, P237
   1964, ABHANDL DTSCH AK CGB, P1
   1994, ISOT ENVIRON HEALT S, V30, P87
   1960, KERNENERGIE, V3, P815
   1993, ENV HLTH STUD, V29, P1
   1992, ISOT ENVIRON HEALT S, V28, P1
NR 53
TC 2
Z9 2
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1025-6016
J9 ISOT ENVIRON HEALT S
JI Isot. Environ. Health Stud.
PY 1996
VL 32
IS 1
BP 1
EP 13
DI 10.1080/10256019608036288
PG 13
WC Chemistry, Inorganic & Nuclear; Environmental Sciences
SC Chemistry; Environmental Sciences & Ecology
GA UL241
UT WOS:A1996UL24100001
DA 2018-10-19
ER

PT J
AU Iwasaki, Y
   Kurita, K
   Ishihara, K
   Nakabayashi, N
AF Iwasaki, Y
   Kurita, K
   Ishihara, K
   Nakabayashi, N
TI Effect of reduced protein adsorption on platelet adhesion at the
   phospholipid polymer surfaces
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE phospholipid polymer; blood compatibility; protein adsorption; platelet
   adhesion; nonthrombogenicity; lipid adsorption; gold-colloid
   immunoassay; biomimetic membrane
ID HUMAN PLASMA-PROTEINS; BLOOD COMPATIBILITY; POLAR GROUP;
   PHOSPHORYLCHOLINE MOIETY; GRAFT-COPOLYMERS; VASCULAR GRAFTS;
   HEMOCOMPATIBILITY; BIOMATERIALS; POLYURETHANE; WATER
AB We prepared polymers having a phospholipid polar group, poly[omega-methacryloxyloxyalkyl phosphorylcholine (MAPC)-co-n-butyl methacrylate (BMA)], as new biomedical materials and evaluated their blood compatibility with attention to protein adsorption and platelet adhesion. The total amount of proteins adsorbed on the polymer surface from human plasma was determined, and the distribution of adsorbed proteins on the plasma-contacting surface was analyzed. The amount of proteins adsorbed on every poly(MAPC-co-BMA) was small compared with that observed on polymers without the phospholipid polar group. However, there was no significant difference in the amount of adsorbed proteins on the poly(MAPC-co-BMA) even when the methylene chain length between the phospholipid polar group and the backbone in the MAPC moiety was altered. Platelet adhesion on the polymer surface from a platelet suspension in a buffered solution was evaluated with and without plasma treatment on the surface. When a rabbit platelet suspension was brought into contact with the poly(BMA) surface after treatment with plasma, many platelets adhered and aggregated. However, a reduced amount of platelet adhered on the poly(BMA) was found in the case of direct contact with the platelet suspension. On the other hand, the poly(MAPC-co-BMA)s could inhibit platelet adhesion under both conditions. Based on these results, it can be concluded that the proteins adsorbed on the surface play an important role in determining the platelet adhesion and suppression of the protein adsorption on the surface, which is one of the most significant ways of inhibiting platelet adhesion.
C1 TOKYO MED & DENT UNIV,INST MED & DENT ENGN,CHIYODA KU,TOKYO 101,JAPAN.
   NIHON UNIV,COLL SCI & TECHNOL,DEPT IND CHEM,CHIYODA KU,TOKYO 101,JAPAN.
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   BAMFORD CH, 1992, VROMAN EFFECT
   Brash JL, 1987, ACS S SERIES, V343
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   CAMPBELL EJ, 1992, MATER RES SOC SYMP P, V252, P229
   CHOLAKIS CH, 1991, J BIOMED MATER RES, V25, P791
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   HALL B, 1989, BIOMATERIALS, V10, P213
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   ISHIHARA K, 1994, J POLYM SCI POL CHEM, V32, P859, DOI 10.1002/pola.1994.080320507
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ISHIHARA K, 1993, NEW FUNCTIONALITY PO, VB, P233
   ISHIHARA K, 1991, SEITAI ZAIRYO, V9, P243
   ISHIHARA K, 1994, ACS SYM SER, V556, P353
   IWASAKI Y, 1994, J BIOMAT SCI-POLYM E, V6, P447, DOI 10.1163/156856294X00437
   KANO K, 1989, BIOMATERIALS, V10, P455
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   LYMAN DJ, 1970, THROMB DIATH HAEMO, V42, P109
   MOHAMMAD SF, 1986, T AM SOC ART INT ORG, V32, P323
   NAKABAYASHI N, 1991, POLYMERS AND BIOMATERIALS, P343
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   NOZAKI Y, 1984, JINKO ZOKI, V13, P1147
   OKANO T, 1978, POLYM J, V10, P233
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   PARK K, 1986, J COLLOID INTERF SCI, V111, P197, DOI 10.1016/0021-9797(86)90019-6
   PEPPAS NA, 1987, HYDROGELS MED PHARM, V3
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   TSURUTA T, 1992, POLYM MAT BIOMEDICAL
   UEDA T, 1995, J BIOMED MATER RES, V29, P381, DOI 10.1002/jbm.820290313
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   Yianni YP, 1992, STRUCTURAL DYNAMIC P, P187
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
   ZIATS NP, 1991, CELL MATER, V1, P73
NR 40
TC 48
Z9 50
U1 0
U2 9
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1996
VL 8
IS 2
BP 151
EP 163
DI 10.1163/156856296X00228
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA VW644
UT WOS:A1996VW64400007
PM 8957711
DA 2018-10-19
ER

PT J
AU Kartvelishvili, T
   Kvintradze, A
   Katsarava, R
AF Kartvelishvili, T
   Kvintradze, A
   Katsarava, R
TI Amino acid based bioanalogous polymers. Synthesis of novel poly(urethane
   amide)s based on N,N'-(trimethylenedioxydicarbonyl)bis(phenylalanine)
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID DERIVATIVES; ESTERS; ALPHA
AB The feasibility of synthesizing high-molecular-weight amino acid based bioanalogous polymers (AABBPs)-poly(urethane amide)s (PUA) - via polycondensation (PC) of dip-nitrophenyl ester of N,N'-(trimethylenedioxydicarbonyl)bis(L-phenylalanine) (3) with diamines or their derivatives under mild conditions in organic solvents was studied for the first time. A regular PUA (eta(red) = 1,53 dL/g) was obtained by PC of 3 with hexamethylenediamine. A dipeptide (Phe-Phe) containing regular poly(ester urethane amide) (eta(red) = 0,58 dL/g) was synthesized by PC of 3 with p-toluenesulfonic acid salt of bis(L-phenylalanine) 1,4-butylene diester. A tripeptide (Phe-Lys-Phe) containing PUA (eta(red) = 0,38 dL/g) with pendent ester groups was prepared via PC of 3 with N,N-bis(trimethylsilyl)-L-lysine methyl ester. These novel AABBPs which may be considered as structural analogs of AB type bioanalogous polymers - conventional poly(amino acids) are of interest in enzymology, immunology, pharmacology, and biotechnology (as materials for biomedical applications).
RP Kartvelishvili, T (reprint author), GEORGIAN ACAD SCI,INST MOLEC BIOL & BIOPHYS,14 L GOTUA STR,TBILISI 380060,REP OF GEORGIA.
CR ARABULI N, 1994, MACROMOL CHEM PHYSIC, V195, P2279, DOI 10.1002/macp.1994.021950633
   CLEAVER CS, 1955, J AM CHEM SOC, V77, P1544, DOI 10.1021/ja01611a042
   GARKUSHABOZHKO IP, 1982, ZH ORG KHIM+, V18, P2340
   HORT U, 1976, CONDENSATION MONOMER, P206
   KATSARAVA RD, 1993, MAKROMOL CHEM, V194, P3209
   KATSARAVA RD, 1985, MAKROMOL CHEM, V186, P939
   KATSARAVA RD, 1985, ACTA POLYM, V36, P29
   KHARADZE DP, 1994, VYSOKOMOL SOEDIN, V36, P1462
   KHURGIN YI, 1962, DOKL AKAD NAUK SSSR, V143, P629
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   LABSKY J, 1979, EUR POLYM J, V15, P167, DOI 10.1016/0014-3057(79)90203-9
   OLEINIK NM, 1980, ZH ORG KHIM+, V16, P1469
   SU CP, 1977, J POLYM SCI POL CHEM, V15, P185, DOI 10.1002/pol.1977.170150117
   SU CW, 1974, J AM CHEM SOC, V96, P1854, DOI 10.1021/ja00813a034
NR 14
TC 7
Z9 7
U1 0
U2 5
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD JAN
PY 1996
VL 197
IS 1
BP 249
EP 257
DI 10.1002/macp.1996.021970119
PG 9
WC Polymer Science
SC Polymer Science
GA TP173
UT WOS:A1996TP17300019
DA 2018-10-19
ER

PT J
AU Tokura, S
   Nishimura, SI
   Sakairi, N
   Nishi, N
AF Tokura, S
   Nishimura, SI
   Sakairi, N
   Nishi, N
TI Biological activities of biodegradable polysaccharide
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 5th SPSC International Polymer Conference on Challenges in Polymer
   Science and Technology
CY NOV 28-DEC 02, 1994
CL SENRI LIFE SCI CTR, SENRI, JAPAN
SP Soc Polym Sci, Japan
HO SENRI LIFE SCI CTR
ID CHITIN DERIVATIVES; MICE
AB A low toxicity of chitin was demonstrated to be mostly due to biodegradability and the fast metabolization of hydrolysate in animal body. Chitosan, a deacetylated derivative of chitin, is also known to be a biocompatible polymer in spite of a slight immunoadjuvant activity in animal body. Chitosan is easily regenerated to fiber, film, beads and non woven fabrics owing to its high solubility toward diluted aqueous organic acids such as formic acid, acetic acid, glutamic acid and ascorbic acid. The regeneration of chitin was achieved into fibers, gels, porous foams and non woven fabrics following to dissolution of chitin with formic acid or calcium chloride dihydrate saturated methanol. Chitin and its derivatives have been applied as biomedical materials due to remarkable advantages such as antimicrobial activity, acceleration of epidermal cell assembly, low toxicity, and biodegradability.
C1 HOKKAIDO UNIV,GRAD SCH SCI,SAPPORO,HOKKAIDO 060,JAPAN.
RP Tokura, S (reprint author), HOKKAIDO UNIV,GRAD SCH ENVIRONM EARTH SCI,SAPPORO,HOKKAIDO 060,JAPAN.
CR DOMSZY JG, 1985, MAKROMOL CHEM, V186, P1671
   HACKMAN RH, 1954, AUST J BIOL SCI, V7, P168, DOI 10.1071/BI9540168
   HIRANO S, 1976, CARBOHYD RES, V47, P315, DOI 10.1016/S0008-6215(00)84198-1
   MINAMI S, 1991, ADV CHITIN CHITOSAN, P61
   NISHIMURA K, 1985, VACCINE, V3, P379, DOI 10.1016/0264-410X(85)90127-6
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   OKAMOTO Y, 1993, J VET MED SCI, V55, P743, DOI 10.1292/jvms.55.743
   TOKURA S, 1983, POLYM J, V15, P485, DOI 10.1295/polymj.15.485
   TOKURA S, 1993, ACS SYM SER, V520, P351
   TOKURA S, 1979, POLYM J, V11, P781, DOI 10.1295/polymj.11.781
   TOKURA S, UNPUB CARBOHYDR POLY
   URAKI Y, 1993, CARBOHYD POLYM, V20, P139, DOI 10.1016/0144-8617(93)90089-M
   WATANABE K, 1992, CARBOHYD POLYM, V17, P29, DOI 10.1016/0144-8617(92)90020-Q
   YANO H, 1985, Mie Medical Journal, V35, P53
NR 14
TC 42
Z9 44
U1 0
U2 6
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JAN
PY 1996
VL 101
BP 389
EP 396
DI 10.1002/masy.19961010144
PG 8
WC Polymer Science
SC Polymer Science
GA TP172
UT WOS:A1996TP17200043
DA 2018-10-19
ER

PT J
AU Khor, KA
   Cheang, P
AF Khor, KA
   Cheang, P
TI Effects of feedstock and laser post-spray treatment on plasma sprayed
   bioceramic coatings
SO MATERIALS AND MANUFACTURING PROCESSES
LA English
DT Article
ID HYDROXYAPATITE COATINGS; PARAMETERS
AB Hydroxyapatite (HA) is a bioactive material with Ca to P ratio similar to that of natural bone. This can encourage early bonding between bony tissues and the implant surface. Plasma spraying is efficient in coating HA onto biomedical implants. However, the biocompatibility of hydroxyapatite (HA) changes after plasma spraying. This paper reports the preparation and characterization of HA coatings using different feedstocks; calcined HA (CHA) that has angular geometry, and spray dried HA (SDHA) that is predominantly spherical in shape. The results indicates that the state of the starting powder adversely influences the coating characteristics.;Both types of HA, calcined and crushed HA powders and spray dried HA powders, are plasma sprayed on steel substrates to produce HA coatings. The results indicate that particle cohesion, size range and thermal treatment during thermal spray processing alter the phase and structure of the as-sprayed coatings. Post-spray treatment by pulsed lasers is performed on the coatings to modify the surface characteristics and phase composition of the surface layer. This, in addition, may be necessary to produce a dense and well-bonded coating having the desired biocompatible properties. Laser treatments show overall melting of the HAcoating to yield a smooth surface. However, the presence of crack networks is undesirable.
C1 NANYANG TECHNOL UNIV,SCH MECH & PROD ENGN,SINGAPORE 639798,SINGAPORE.
   NANYANG TECHNOL UNIV,SCH APPL SCI,SINGAPORE 639798,SINGAPORE.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR ANTONIO JA, 1992, J BONE JOINT SURG AM, V74, P995
   BOSTMAN O, 1989, CLIN ORTHOPAEDICS, V238, P195
   BROWN SR, 1994, J MATER SCI-MATER M, V5, P756, DOI 10.1007/BF00120371
   CHEANG P, 1995, J MATER PROCESS TECH, V48, P429, DOI 10.1016/0924-0136(94)01679-U
   CHEANG P, 1995, HIGH TEMPERATURE SOC, V1, P181
   DEBRUIJN JD, 1995, J BIOMED MATER RES, V29, P89, DOI 10.1002/jbm.820290113
   DORFMAN MR, 1986, P ITSC 86 MONTR CAN, P241
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   JARCHO M, 1980, J BIOMEDICAL MAT RES, V14, P713
   JARCHO M, 1981, CLIN ORTHOPAEDICS, V285, P102
   KHOR KA, 1994, J THERM SPRAY TECHN, V3, P45, DOI 10.1007/BF02648998
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   LUGSCHEIDER E, 1992, INT ADV COATINGS TEC, P967
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   MURYAMA M, 1995, J BIOMEDICAL MAT RES, V29, P329
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   VARDELLE M, 1993, J THERM SPRAY TECHN, V2, P79
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   YANG CY, 1995, J MATER SCI-MATER M, V6, P249, DOI 10.1007/BF00120267
NR 19
TC 0
Z9 0
U1 0
U2 0
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 1042-6914
J9 MATER MANUF PROCESS
JI Mater. Manuf. Process.
PY 1996
VL 11
IS 5
BP 869
EP 882
DI 10.1080/10426919608947533
PG 14
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA VP325
UT WOS:A1996VP32500010
DA 2018-10-19
ER

PT B
AU Serafetinides, AA
AF Serafetinides, AA
BE Atanasov, PA
TI Short pulse laser beam interactions with polymers biocompatible
   materials and tissue
SO NINTH INTERNATIONAL SCHOOL ON QUANTUM ELECTRONICS: LASERS-PHYSICS AND
   APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 9th International School on Quantum Electronics - Lasers-Physics and
   Applications
CY SEP 16-20, 1996
CL VARNA, BULGARIA
SP Bulgarian Acad Sci, Inst Electr, Soc Photo Opt Instrumentat Engineers, Soc Photo Opt Instrumentat Engineers, Bulgaria Chapter, Int Sci Org Zond
DE ablation; tissue ablation; polymers ablation; picoseconds ablation;
   femtoseconds ablation
AB Pulsed laser beams, of very short duration, appear to be very promising tools for polymer surface processing. Recently we have studied the interaction of picosecond and femtosecond laser radiation in the visible region of the spectrum with synthetic polymer films and we have compared these studies with our similar studies nab nanosecond duration laser radiation.
   Biocompatible polymers have been extensively used for sutures, vascular grafts or bone and other hard tissue replacements. The use of surgical lasers for intervention on biocompatible material - tissue interfaces has attracted a great deal of interest, as both the high intensity, short pulse duration lasers and the prosthetic biomaterials are in increasing use. Our recent ablation studies, using ultrashort laser pulses, of biocompatible materials, are described in this article.
   Lasers were introduced in medical research in the early sixties but the laser beam ability to remove efficiently and safely soft or hard tissue, the lateral thermal damage and the final surface characteristics are still under investigation In the past few years, pulse mid-infrared lasers have attracted much attention because they operate at wavelengths where soft or hard tissue, try virtue of their water or water and hydroxyapatite content respectively, exhibit strong absorption restricting residual thermal damage to a relatively small zone. Recently we have investigated the interaction of short pulse laser radiation of picosecond and femtosecond duration with soft and hard tissue, as this unexplored field is expected to be a potential alternative in powerful laser processing of biomedical structures.
   The experimental results obtained, including ablation rates, ablation wavelength dependence, pulse duration dependence, fluence dependence, etc. are presented These results are discussed according to simple theoretical models of laser energy absorption and the possible mechanisms of ultrashort pulse laser ablation, which in some cases involves multiphoton photodissociation processes. Finally, the design characteristics of the lasers employed in our experiments, are stated briefly.
RP Serafetinides, AA (reprint author), NATL TECH UNIV ATHENS,DEPT PHYS,LASER & APPLICAT LAB,ZOGRAFOU CAMPUS,GR-15773 ATHENS,GREECE.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2466-8
J9 P SOC PHOTO-OPT INS
PY 1996
VL 3052
BP 111
EP 123
DI 10.1117/12.262907
PG 3
WC Optics; Physics, Applied
SC Optics; Physics
GA BH07B
UT WOS:A1996BH07B00010
DA 2018-10-19
ER

PT J
AU Shintani, H
AF Shintani, H
TI Formation and elution of toxic compounds from sterilized medical
   products: Toxic compound formation from irradiated products
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
ID POLY(ETHER URETHANE UREA); BIOMEDICAL APPLICATIONS; GAMMA-RAY;
   POLYURETHANES; 4,4'-METHYLENEDIANILINE; DEGRADATION;
   4,4'-DIAMINODIPHENYLMETHANE; BIODEGRADATION; MUTAGENICITY
AB No formation of MDA was observed in chain-extended thermoplastic polyurethane (PU) when sterilized by autoclave or gamma-ray irradiation. No formation of MDA was observed in nonchain-extended thermoplastic PU when sterilized by gamma-ray irradiation. Less than 1 ppm MDA was produced in nonchain-extended thermoplastic PU sterilized by autoclave sterilization. Autoclave sterilization did not produce MDA in thermosetting PU potting material. MDA formation in potting material was promoted by gamma-ray irradiation and increased with increasing irradiation at a quadratic equation of regression. MDA formation at 100 kGy irradiation is a few ppm and <1 ppm at 25 kGy irradiation, therefore the potential risk to human recipients was not significant. The elution of compounds other than MDA from potting material was more problematic. Solvent extracts from potting material presented mutagenicity in the absence of metabolic activity. MDA presented mutagenicity in the presence of metabolic activity, therefore MDA was not the mutagenic trigger. The chemical and biological characteristics of the specific mutagens required to identify in a further study. Negative promotion of MDA formation and a lesser presence of mutagen in autoclave sterilized potting material indicated that autoclave sterilization was preferable.
RP Shintani, H (reprint author), NATL INST HLTH SCI,DEPT MED DEVICES,SETAGAYA KU,1-18-1 KAMIYOGA,TOKYO 158,JAPAN.
CR BRUCK SD, 1988, J BIOMED MATER RES-A, V22, P133, DOI 10.1002/jbm.820221306
   COCKER J, 1988, J ANAL TOXICOL, V12, P9, DOI 10.1093/jat/12.1.9
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   CUNNINGHAM ML, 1990, CHEM RES TOXICOL, V3, P159
   DARBY TD, 1978, TOXICOL APPL PHARM, V46, P449, DOI 10.1016/0041-008X(78)90090-X
   DEICHMANN WB, 1978, TOXICOLOGY, V11, P185, DOI 10.1016/S0300-483X(78)91089-2
   ERNES DA, 1983, ANAL CHEM, V55, P408, DOI 10.1021/ac00253a062
   FROMMELT H, 1987, MAKROMOL CHEM-M SYMP, V12, P281, DOI 10.1002/masy.19870120114
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   Gogolewski S., 1991, TRENDS POLYM SCI, V1, P47
   GOHLKE R, 1974, INT ARCH ARBEITSMED, V32, P217, DOI 10.1007/BF00539338
   GOLBERG L, 1986, HAZARD ASSESSMENT ET
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   HO T, 1979, ENVIRON MUTAGEN, V1, P167
   Hu C. B., 1980, AM CHEM SOC DIV POLY, V21, P156
   Huff J. E., 1983, PROGR CLIN BIOL RES, V141, P347
   KOPELMAN H, 1966, BMJ-BRIT MED J, V1, P514, DOI 10.1136/bmj.1.5486.514
   Kopelman H., 1966, Q J MED, V53, P553
   LAI YC, 1991, J APPL POLYM SCI, V42, P3173, DOI 10.1002/app.1991.070421210
   LAMB JC, 1986, J TOXICOL ENV HEALTH, V18, P325, DOI 10.1080/15287398609530874
   LELAH MD, 1987, POLYURETHANES MED
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MAZZU AL, 1984, J BIOMED MATER RES, V18, P961, DOI 10.1002/jbm.820180810
   MCGILL DB, 1974, NEW ENGL J MED, V291, P278, DOI 10.1056/NEJM197408082910604
   Mizutani H., 1960, HDB PLASTIC MANUFACT
   NYSTROM B, 1991, AM J MED, V91, pS264, DOI 10.1016/0002-9343(91)90379-C
   O'Mara M. M., 1984, PROG BIOMED ENG, V1, P83
   OKAMURA S, 1969, RAD CHEM POLYM SYSTE, V15
   PETROVIC ZS, 1984, J APPL POLYM SCI, V29, P1031, DOI 10.1002/app.1984.070290401
   Phus S. K., 1987, J BIOMED MATER RES, V21, P231
   PLUDRO G, 1969, ACTA POL PHARM, V26, P353
   RAO TK, 1982, ARCH TOXICOL, V49, P185, DOI 10.1007/BF00347866
   Ratner B. D., 1983, PHYSICOCHEMICAL ASPE, P969
   RATNER BD, 1981, ACS SYM SER, V162, P371
   SHINTANI H, 1989, J ANAL TOXICOL, V13, P354, DOI 10.1093/jat/13.6.354
   SHINTANI H, 1990, J APPL POLYM SCI, V41, P661, DOI 10.1002/app.1990.070410316
   SHINTANI H, 1989, FRESEN Z ANAL CHEM, V333, P637, DOI 10.1007/BF00496937
   SHINTANI H, 1991, J BIOMED MATER RES, V25, P1275, DOI 10.1002/jbm.820251008
   SHINTANI H, 1995, J APPL POLYM SCI, V42, P1979
   Shintani H, 1994, OHIO SCI WORKBOOKS P
   SHINTANI H, 1995, IN PRESS J RAD STERI
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STEINHOFF D, 1970, NATURWISSENSCHAFTEN, V57, P247, DOI 10.1007/BF01010277
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   WALL LA, 1955, J POLYM SCI, V17, P141, DOI 10.1002/pol.1955.120178318
   Williams N., 1974, NEW ENGL J MED, V291, P1256
   YOSHII F, 1985, J APPL POLYM SCI, V30, P3339, DOI 10.1002/app.1985.070300816
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
NR 48
TC 8
Z9 8
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JAN
PY 1996
VL 47
IS 1
BP 139
EP 148
DI 10.1016/0969-806X(94)00135-7
PG 10
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA TC695
UT WOS:A1996TC69500026
DA 2018-10-19
ER

PT J
AU Fareed, J
AF Fareed, J
TI Current trends in antithrombotic drug and device development
SO SEMINARS IN THROMBOSIS AND HEMOSTASIS
LA English
DT Article
DE antithrombotic drugs; heparin; hirudin; antiplatelet; biotechnology
ID MOLECULAR MARKERS; HEPARIN FRACTIONS; ANTICOAGULANT-THERAPY; VEIN
   THROMBOSIS; PERSPECTIVES; ACTIVATION; FRAGMENTS; HIRUDIN
AB During the past decade, many significant developments in the clinical management of thrombotic and vascular disorders have occurred. In particular, several newer approaches for the prophylactic and therapeutic management of such disorders as venous thrombosis, acute myocardial infarction, and stroke have been introduced. This has been possible because of the understanding of the molecular mechanisms involved in the thrombogenic process, which plays a key role in the pathophysiology of thrombotic and vascular disorders. With the increased knowledge of the pathophysiology of thrombosis have come advances in drug treatment possibilities. Advances in biotechnology and separation techniques have contributed to the development of many newer antithrombotic, anticoagulant, and thrombolytic drugs. Many new drugs and devices based on newer concepts are currently being tested in various clinical trials. Hirudin, hirulog, GPIIb/IIIa targeting antibodies, and tissue factor pathway inhibitor are some examples. From these current developments, it can be appreciated that antithrombotic drugs represent a wide spectrum of natural, synthetic, semisynthetic, and biotechnology-produced agents with marked differences in chemical composition, physicochemical properties, biochemical actions, and pharmacologic effects. The use of physical means to treat thrombotic disorders and advanced means of drug delivery add to the expanding nature of treatment, The endogenous actions of the antithrombotic drugs are quite complex. It is no longer valid to assume that an antithrombotic drug must produce an anticoagulant action in blood, as do the classical heparin and oral anticoagulants. Many of these new drugs do not produce any alteration of currently measurable blood-clotting parameters, yet they are effective therapeutic agents because of their interactions with the elements of the blood and the vasculature. Another perspective is that several of these agents require endogenous transformation to become active products. Therefore, it becomes important to rely on the pharmacodynamic actions of these agents rather than on other in vitro characteristics to assess potency or efficacy. Hematologic and vascular modulation play a key role in the mediation of the antithrombotic actions of these drugs, involving red cells, white cells, platelets, endothelial cells, and blood;proteins. Thus, an optimal antithrombotic drug approach will include the targeting of ail possible sites involved in thrombogenesis. Antithrombotic and anticoagulant drugs will also be useful in the development of such biomedical devices as stents and other vascular support material. Polytherapeutic approaches utilizing combinations of drugs may turn out to be the most effective in the management of thrombotic disorders.
C1 LOYOLA UNIV, MED CTR, DEPT PHARMACOL, MAYWOOD, IL 60153 USA.
RP Fareed, J (reprint author), LOYOLA UNIV, MED CTR, DEPT PATHOL, 2160 S 1ST AVE, MAYWOOD, IL 60153 USA.
CR FAREED J, 1985, SEMIN THROMB HEMOST, V11, P227, DOI 10.1055/s-2007-1004380
   FAREED J, 1980, CLIN CHEM, V26, P1380
   FAREED J, 1983, SEMIN THROMB HEMOST, V9, P355
   FAREED J, 1989, SEMIN THROMB HEMOST, V15, P230, DOI 10.1055/s-2007-1002710
   FAREED J, 1984, NOUV REV FR HEMATOL, V26, P267
   FAREED J, 1985, SEMIN THROMB HEMOST, V11, P1, DOI 10.1055/s-2007-1004350
   FAREED J, 1983, CLIN CHEM, V29, P1641
   FAREED J, 1986, SEMIN THROMB HEMOST, V12, P102, DOI 10.1055/s-2007-1003542
   FAREED J, 1986, MED J AUSTRALIA, V144, pHS21
   FAREED J, 1981, PERSPECTIVES HEMOSTA, P310
   FAREED J, 1983, SEMIN THROMB HEMOST, V9, P379
   FAREED J, 1986, THROMBOSIS HEMORRHAG, P83
   FAREED J, 1983, SEMIN THROMB HEMOST, V8, P288
   HULL R, 1983, ARCH INTERN MED, V143, P2061, DOI 10.1001/archinte.143.11.2061
   LAGERSTEDT CI, 1985, LANCET, V2, P515
   MARKWARDT F, 1986, ANN NY ACAD SCI, V485, P204, DOI 10.1111/j.1749-6632.1986.tb34582.x
   MARKWARDT F, 1985, BIOMED BIOCHIM ACTA, V44, P1007
   MARKWARDT F, 1988, PHARMAZIE, V43, P202
   MESSMORE HL, 1984, SEMIN THROMB HEMOST, V10, P264, DOI 10.1055/s-2007-1004431
   PETITTI DB, 1986, AM J MED, V81, P255, DOI 10.1016/0002-9343(86)90260-3
   SUAREZ CR, 1984, SEMIN THROMB HEMOST, V10, P280, DOI 10.1055/s-2007-1004433
   SUMMARIA L, 1988, AM SURGEON, V54, P156
   ULUTIN ON, 1986, THROMBOSIS HEMORRHAG, P101
   WALENGA JM, 1986, CRC CR REV CL LAB SC, V22, P361
   WALENGA JM, 1983, SEMIN THROMB HEMOST, V9, P346
   1988, LANCET, V13, P349
NR 26
TC 10
Z9 10
U1 1
U2 2
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0094-6176
EI 1098-9064
J9 SEMIN THROMB HEMOST
JI Semin. Thromb. Hemost.
PY 1996
VL 22
SU 1
BP 3
EP 8
PG 6
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA UV124
UT WOS:A1996UV12400002
PM 8807721
DA 2018-10-19
ER

PT J
AU Chan, CM
   Ko, TM
   Hiraoka, H
AF Chan, CM
   Ko, TM
   Hiraoka, H
TI Polymer surface modification by plasmas and photons
SO SURFACE SCIENCE REPORTS
LA English
DT Review
ID GLOW-DISCHARGE POLYMERIZATION; AMMONIA GASEOUS PLASMA; EXCIMER LASER
   ABLATION; LOW-TEMPERATURE-PLASMA; ION MASS-SPECTROMETRY; OXYGEN PLASMA;
   PLATELET-ADHESION; POLY(METHYL METHACRYLATE); ENZYME-IMMOBILIZATION;
   INTRAOCULAR LENSES
AB Polymers have been applied successfully in fields such as adhesion, biomaterials, protective coatings, friction and wear, composites, microelectronic devices, and thin-film technology. In general, special surface properties with regard to chemical composition, hydrophilicity, roughness, crystallinity, conductivity, lubricity, and cross-linking density are required for the success of these applications. Polymers very often do not possess the surface properties needed for these applications. However, they have excellent bulk physical and chemical properties, are inexpensive, and are easy to process. For these reasons, surface modification techniques which can transform these inexpensive materials into highly valuable finished products have become an important part of the plastics and many other industries. In recent years, many advances have been made in developing surface treatments to alter the chemical and physical properties of polymer surfaces without affecting bulk properties. Common surface modification techniques include treatments by flame, corona, plasmas, photons, electron beams, ion beams, X-rays, and gamma-rays.
   Plasma treatment is probably the most versatile surface treatment technique. Different types of gases such as argon, oxygen, nitrogen, fluorine, carbon dioxide, and water can produce the unique surface properties required by various applications. For example, oxygen-plasma treatment can increase the surface energy of polymers, whereas fluorine-plasma treatment can decrease the surface energy and improve the chemical inertness. Cross-linking at a polymer surface can be introduced by an inert-gas plasma. Modification by plasma treatment is usually confined to the top several hundred angstroms and does not affect the bulk properties. The main disadvantage of this technique is that it requires a vacuum system, which increases the cost of operation.
   Thin polymer films with unique chemical and physical properties are produced by plasma polymerization. This technology is still in its infancy, and the plasma chemical process is not fully understood. The films are prepared by vapor phase deposition and can be formed on practically any substrate with good adhesion between the film and the substrate. These films, which are usually highly cross-linked and pinhole-free, have very good barrier properties. Such films find great potential in biomaterial applications and in the microelectronics industry.
   Very high-power microwave-driven mercury lamps are available, and they are used in UV-hardening of photoresist patterns for image stabilization at high temperatures. Other applications of UV irradiation include surface photo-oxidation, increase of hydrophilicity, and photocuring of paintings.
   Pulsed UV-lasers are used in surface modification in many areas. Pulsed UV-laser irradiation can produce submicron periodic linear and dot patterns on polymer surfaces without photomask. These interference patterns can be used to increase surface roughness of inert polymers for improved adhesion. These images can also be transferred to silicon surfaces by reactive ion etching. Pulsed laser beams can be applied to inert polymer surfaces for increased hydrophilicity and wettability. Polymer surfaces treated by pulsed UV-laser irradiation can be positively or negatively charged to enhance chemical reactivity and processability. Pulsed UV-laser exposures with high fluence give rise to photoablation with a clean wall profile. There are many other practical applications of laser photoablation, including via-hole fabrication, and diamond-film deposition. The present review discusses all these current applications, especially in the biomedical and microelectronics areas.
C1 HONG KONG UNIV SCI & TECHNOL, DEPT CHEM, KOWLOON, HONG KONG.
RP Chan, CM (reprint author), HONG KONG UNIV SCI & TECHNOL, DEPT CHEM ENGN, KOWLOON, HONG KONG.
CR ALLING E, 1985, P SOC PHOTO-OPT INST, V539, P194
   ASFARDJANI K, 1991, J APPL POLYM SCI, V43, P271, DOI 10.1002/app.1991.070430206
   BACHMANN F, 1990, EUR MAT RES SOC 1990
   BAIK KH, 1994, J PHOTOPOLYM SCI TEC, V7, P517
   BIEG KW, 1980, SOL ENERG MATER, V3, P301, DOI 10.1016/0165-1633(80)90068-4
   BIRCH AD, 1983, MICROELECTRON MANUF, V6, P20
   BLAIS PD, 1983, P SOC PHOTO-OPT INS, V333, P20
   BOLLE M, 1993, J APPL PHYS, V73, P3516, DOI 10.1063/1.352957
   BRADLEY A, 1975, ANAL CHEM, V47, P1838, DOI 10.1021/ac60361a044
   BRENNAN WJ, 1991, POLYMER, V32, P1527, DOI 10.1016/0032-3861(91)90436-M
   BRINEN JS, 1991, SURF INTERFACE ANAL, V17, P63, DOI 10.1002/sia.740170202
   Chan C. M, 1994, POLYM SURFACE MODIFI
   CHAPPELL PJC, 1991, SURF INTERFACE ANAL, V17, P143, DOI 10.1002/sia.740170305
   CHEN KS, 1982, J APPL POLYM SCI, V27, P4655, DOI 10.1002/app.1982.070271212
   CHO DL, 1990, J APPL POLYM SCI, V41, P1373, DOI 10.1002/app.1990.070410702
   CHO DL, 1988, J APPL POLYM SCI APP, V42, P139
   CHUANG TJ, 1988, APPL PHYS A-MATER, V45, P277, DOI 10.1007/BF00617932
   CLARK DT, 1979, J POLYM SCI POL CHEM, V17, P957, DOI 10.1002/pol.1979.170170404
   CLARK DT, 1975, J POLYM SCI POL CHEM, V13, P857, DOI 10.1002/pol.1975.170130408
   CLARK DT, 1979, J POLYM SCI POL CHEM, V17, P1317, DOI 10.1002/pol.1979.170170507
   CLARK DT, 1987, J POLYM SCI POL CHEM, V25, P2643, DOI 10.1002/pola.1987.080251002
   CLARK DT, 1980, J POLYM SCI POL CHEM, V18, P27, DOI 10.1002/pol.1980.170180103
   CLARK DT, 1977, J POLYM SCI POL CHEM, V15, P2321, DOI 10.1002/pol.1977.170151004
   CLARK DT, 1978, J POLYM SCI POL CHEM, V16, P911, DOI 10.1002/pol.1978.170160506
   Clark DT, 1978, POLYM SURFACES, P185
   COBURN JW, 1979, IBM J RES DEV, V23, P33, DOI 10.1147/rd.231.0033
   COLLINS GCS, 1973, EUR POLYM J, V9, P1173, DOI 10.1016/0014-3057(73)90120-1
   CORN S, 1991, J ADHES SCI TECHNOL, V5, P239, DOI 10.1163/156856191X00170
   d'Agostino R., 1990, PLASMA DEPOSITION TR, P95
   d'Agostino R, 1982, PLASMA CHEM PLASMA P, V2, P213
   DAGOSTINO R, 1983, J APPL PHYS, V54, P1284, DOI 10.1063/1.332193
   DAUTARTAS MF, 1987, J ELECTROANAL CHEM, V219, P71, DOI 10.1016/0022-0728(87)85032-5
   DEMURA M, 1992, BIOMATERIALS, V13, P276, DOI 10.1016/0142-9612(92)90050-X
   DONOHOE KG, 1979, J APPL POLYM SCI, V23, P2591, DOI 10.1002/app.1979.070230905
   EGITTO FD, 1990, PURE APPL CHEM, V62, P1699, DOI 10.1351/pac199062091699
   EPAILLARD F, 1989, J APPL POLYM SCI, V38, P887, DOI 10.1002/app.1989.070380510
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   Evans J.R.G., 1987, J ADHES SCI TECHNOL, V1, P291
   FAKES DW, 1988, SURF INTERFACE ANAL, V13, P233, DOI 10.1002/sia.740130411
   FOERCH R, 1991, J ADHES SCI TECHNOL, V5, P549, DOI 10.1163/156856191X00747
   FOERCH R, 1990, J APPL POLYM SCI, V40, P1903, DOI 10.1002/app.1990.070401109
   FOERCH R, 1990, J POLYM SCI POL CHEM, V28, P803, DOI 10.1002/pola.1990.080280409
   FUKUMURA H, 1991, APPL PHYS A-MATER, V53, P255, DOI 10.1007/BF00324261
   GARFINKLE AM, 1984, T AM SOC ART INT ORG, V30, P432
   GERENSER LJ, 1993, J ADHES SCI TECHNOL, V7, P10
   GEUSKENS G, 1978, EUR POLYM J, V14, P291, DOI 10.1016/0014-3057(78)90051-4
   GIROUX TA, 1991, J APPL POLYM SCI, V43, P145, DOI 10.1002/app.1991.070430112
   GOMBOTZ WR, 1988, J APPL POLYM SCI APP, V42, P285
   GRANT JL, 1988, J VAC SCI TECHNOL A, V6, P2213, DOI 10.1116/1.575013
   GRIFFING BF, 1983, P SOC PHOTO-OPT INS, V394, P33
   HANSEN RH, 1966, J POLYM SCI POL LETT, V4, P203, DOI 10.1002/pol.1966.110040309
   HASIRCI N, 1987, J APPL POLYM SCI, V34, P2457, DOI 10.1002/app.1987.070340710
   HASIRCI N, 1987, J APPL POLYM SCI, V34, P1135, DOI 10.1002/app.1987.070340322
   HETTLICH HJ, 1991, BIOMATERIALS, V12, P521, DOI 10.1016/0142-9612(91)90153-2
   HIRAOKA H, 1989, J VAC SCI TECHNOL B, V7, P1760, DOI 10.1116/1.584453
   HIRAOKA H, 1981, J ELECTROCHEM SOC, V128, P2645, DOI 10.1149/1.2127321
   HIRAOKA H, 1981, J VAC SCI TECHNOL, V19, P1132, DOI 10.1116/1.571183
   HIRAOKA H, 1994, APPL PHYS LETT, V64, P563, DOI 10.1063/1.111104
   Hiraoka H., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V771, P174
   Hiraoka H., 1987, Microelectronic Engineering, V6, P407, DOI 10.1016/0167-9317(87)90066-9
   HIRAOKA H, 1994, JPN J APPL PHYS 1, V33, P7135, DOI 10.1143/JJAP.33.7135
   HIRAOKA H, 1991, MATER RES SOC SYMP P, V227, P329, DOI 10.1557/PROC-227-329
   Hiraoka H, 1989, PHOTOCHEMISTRY SOLID, P448
   HIRAOKA H, 1994, MAT MANUF PROCESSES, V9, P467
   HIRAOKA H, UNPUB MICROGRAPH TAK
   HIRAOKA H, 1989, PHOTOCHEMISTRY SOLID
   HIRAOKA H, 1984, P 10 INT C EL ION BE, P171
   HIRAOKA H, 1987, 172 M EL SOC OCT 19
   HIRAOKA H, 1993, JPN J APPL PHYS, V32, P6182
   HIROTSU T, 1980, J ADHESION, V11, P57, DOI 10.1080/00218468008078904
   HO CP, 1988, J BIOMED MATER RES, V22, P919, DOI 10.1002/jbm.820221007
   HO CP, 1990, J APPL POLYM SCI, V39, P1541, DOI 10.1002/app.1990.070390712
   HOFFMAN AS, 1988, J APPL POLYM SCI APP, V42, P251
   HOLLAHAN JR, 1969, J APPL POLYM SCI, V13, P807, DOI 10.1002/app.1969.070130419
   HSIEH YL, 1989, J APPL POLYM SCI, V38, P1719, DOI 10.1002/app.1989.070380911
   HULT A, 1985, MACROMOLECULES, V18, P1804, DOI 10.1021/ma00152a003
   INAGAKI N, 1983, J APPL POLYM SCI, V28, P3629, DOI 10.1002/app.1983.070281204
   INAGAKI N, 1990, J ADHES SCI TECHNOL, V4, P99, DOI 10.1163/156856190X00126
   INAGAKI N, 1989, J ADHES SCI TECHNOL, V3, P637, DOI 10.1163/156856189X00461
   INAGAKI N, 1986, J POLYM SCI POL LETT, V24, P447, DOI 10.1002/pol.1986.140240903
   INAGAKI N, 1985, J APPL POLYM SCI, V30, P3385, DOI 10.1002/app.1985.070300821
   INAGAKI N, 1987, J POLYM SCI POL CHEM, V25, P1803, DOI 10.1002/pola.1987.080250709
   INAGAKI N, 1984, POLYM BULL, V12, P437
   Inagaki N., 1982, INT J ADHES ADHES, V2, P169
   INOUE H, 1990, J APPL POLYM SCI, V41, P1815, DOI 10.1002/app.1990.070410737
   INYAMA Y, 1988, J APPL POLYM SCI APP, V42, P97
   ISHIKAWA Y, 1985, MAKROMOL CHEM-RAPID, V6, P495
   ITO H, 1982, SPE REG TECH C ELL N
   KATNANI AD, 1989, J ADHES SCI TECHNOL, V3, P441, DOI 10.1163/156856189X00326
   KAWAKAMI M, 1988, BIOTECHNOL BIOENG, V32, P369, DOI 10.1002/bit.260320316
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   KIAEI D, 1992, RADIAT PHYS CHEM, V39, P463
   KNICKMEYER WW, 1974, J APPL POLYM SCI, V18, P301, DOI 10.1002/app.1974.070180126
   KNOP A, 1979, CHEM APPLICATION PHE
   KO TM, 1993, BIOMATERIALS, V14, P657
   KO TM, 1993, J APPL POLYM SCI, V47, P1601, DOI 10.1002/app.1993.070470908
   KO TM, 1993, J COLLOID INTERF SCI, V156, P207, DOI 10.1006/jcis.1993.1101
   KO TM, 1994, FRONTIERS OF POLYMERS AND ADVANCED MATERIALS, P439
   KO TM, 1991, THESIS U WISCONSIN M
   KUMAGAI H, 1993, J APPL PHYS, V73, P1971, DOI 10.1063/1.353161
   LAI JY, 1989, J APPL POLYM SCI, V37, P1465, DOI 10.1002/app.1989.070370603
   LAOHAROJANAPHAND P, 1990, J APPL POLYM SCI, V40, P369, DOI 10.1002/app.1990.070400306
   LATSCH S, 1994, MATER RES SOC S P, V312, P239
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LIEPINS R, 1981, J VAC SCI TECHNOL, V18, P1218, DOI 10.1116/1.570897
   LOH IH, 1987, POLYM ENG SCI, V27, P861, DOI 10.1002/pen.760271115
   LUB J, 1989, J POLYM SCI POL CHEM, V27, P4035, DOI 10.1002/pola.1989.080271213
   LUB J, 1989, POLYMER, V30, P40, DOI 10.1016/0032-3861(89)90380-7
   LUB J, 1989, POLYMER, V30, P35
   MA WHL, 1980, Patent No. 4187331
   MACDONALD SA, 1985, P SPE REGIONAL TECHN, P177
   MARCHANT RE, 1988, J APPL POLYM SCI APP, V42, P125
   MATIENZO LJ, 1988, J VAC SCI TECHNOL A, V6, P950, DOI 10.1116/1.575037
   MATZAKIS M, 1980, MICR ENG P AMST, P439
   McColgin W. C., 1988, Proceedings of the SPIE - The International Society for Optical Engineering, V920, P260
   MOMOSE Y, 1988, J APPL POLYM SCI APP, V42, P49
   MORITA S, 1979, J POLYM SCI POL CHEM, V17, P2775, DOI 10.1002/pol.1979.170170914
   MORITA S, 1985, PURE APPL CHEM, V57, P1277, DOI 10.1351/pac198557091277
   MORITZ H, 1978, Patent No. 4104070
   MORRA M, 1989, J COLLOID INTERF SCI, V132, P504, DOI 10.1016/0021-9797(89)90264-6
   MORRA M, 1990, SURF INTERFACE ANAL, V16, P412, DOI 10.1002/sia.740160186
   MORRA M, 1990, J COLLOID INTERF SCI, V137, P11, DOI 10.1016/0021-9797(90)90038-P
   MOSHONOV A, 1980, J APPL POLYM SCI, V25, P771, DOI 10.1002/app.1980.070250506
   MUNRO HS, 1988, J COATING TECHNOL, V60, P41
   MUNRO HS, 1987, POLYM COMMUN, V28, P339
   MURATSUGU M, 1991, J COLLOID INTERF SCI, V147, P378, DOI 10.1016/0021-9797(91)90170-D
   MUTLU M, 1991, J MATER CHEM, V1, P447, DOI 10.1039/jm9910100447
   NAKAJIMA K, 1979, J APPL POLYM SCI, V23, P2627, DOI 10.1002/app.1979.070230908
   NAKAYAMA Y, 1988, J POLYM SCI POL CHEM, V26, P559, DOI 10.1002/pola.1988.080260219
   NIEHUIS E, 1989, SURF INTERFACE ANAL, V14, P135, DOI 10.1002/sia.740140307
   NIINO H, 1989, APPL PHYS LETT, V55, P510, DOI 10.1063/1.101863
   NIINO H, 1993, APPL PHYS LETT, V63, P3527, DOI 10.1063/1.110091
   NIINO H, 1989, APPL PHYS LETT, V54, P2159, DOI 10.1063/1.101154
   NIINO H, 1992, APPL PHYS LETT, V60, P2697, DOI 10.1063/1.106877
   OCCHIELLO E, 1988, POLYMER, V29, P2277, DOI 10.1016/0032-3861(88)90122-X
   OCCHIELLO E, 1989, J PHYS D APPL PHYS, V22, P983, DOI 10.1088/0022-3727/22/7/018
   OCCHIELLO E, 1991, J APPL POLYM SCI, V42, P2045, DOI 10.1002/app.1991.070420732
   OHKUBO J, 1990, J APPL POLYM SCI, V41, P349, DOI 10.1002/app.1990.070410127
   OKOSHI M, 1992, J MATER RES, V7, P1912, DOI 10.1557/JMR.1992.1912
   OSADA Y, 1987, THIN SOLID FILMS, V151, P71, DOI 10.1016/0040-6090(87)90010-1
   PETRAT FM, 1994, SURF INTERFACE ANAL, V21, P274, DOI 10.1002/sia.740210503
   PITTS J, 1964, PHOTOCHEMISTRY, P686
   PRATT KJ, 1989, J BIOMED MATER RES, V23, P1131, DOI 10.1002/jbm.820231004
   RENEKER DH, 1976, J MACROMOL SCI CHEM, VA 10, P599, DOI 10.1080/00222337608061202
   Roland B., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V771, P69
   Sanchez Urrutia M., 1988, J APPL POLYM SCI APP, V42, P305
   SCHONHORN H, 1967, J APPL POLYM SCI, V11, P1461, DOI 10.1002/app.1967.070110809
   SHAW JM, 1989, J VAC SCI TECHNOL B, V7, P1709, DOI 10.1116/1.584444
   SHEN M, 1979, ACS S SER, V108
   SHEN MS, 1992, J ADHES SCI TECHNOL, V6, P995
   SIMIONESCU BC, 1981, POLYM BULL, V4, P415, DOI 10.1007/BF00254973
   SIPEHIA R, 1988, J BIOMED MATER RES, V22, P417, DOI 10.1002/jbm.820220505
   SIPEHIA R, 1986, BIOMATERIALS, V7, P471, DOI 10.1016/0142-9612(86)90038-4
   SIPEHIA R, 1982, BIOMATER ARTIF CELL, V10, P229, DOI 10.3109/10731198209118783
   SOWELL RR, 1972, J ADHESION, V4, P15, DOI 10.1080/00218467208072207
   SPIERTZ E, 1984, MICROCIRCUIT WENG, V68, P1
   SRINIVASAN R, 1994, N-HOLLAND D, P137
   STERRETT TL, 1992, J MATER SCI-MATER M, V3, P402, DOI 10.1007/BF00701235
   STROBEL M, 1987, J POLYM SCI POL CHEM, V25, P1295, DOI 10.1002/pola.1987.080250508
   STROBEL M, 1987, J POLYM SCI POL CHEM, V25, P3343, DOI 10.1002/pola.1987.080251213
   STROBEL M, 1985, J POLYM SCI POL CHEM, V23, P1125, DOI 10.1002/pol.1985.170230417
   STROM DR, 1986, SEMICOND INT     MAY
   SUHR H, 1988, PLASMA CHEM PLASMA P, V8, P9, DOI 10.1007/BF01016927
   TANIGAWA S, 1991, J ADHES SCI TECHNOL, V5, P543, DOI 10.1163/156856191X00738
   TERLINGEN JGA, 1993, J COLLOID INTERF SCI, V155, P55, DOI 10.1006/jcis.1993.1009
   THOMPSON LF, 1972, J APPL POLYM SCI, V16, P1179, DOI 10.1002/app.1972.070160512
   THOMPSON LF, 1972, J APPL POLYM SCI, V16, P2317, DOI 10.1002/app.1972.070160912
   THOMPSON LF, 1972, J APPL POLYM SCI, V16, P2291, DOI 10.1002/app.1972.070160911
   TRAN CNB, 1989, J COLLOID INTERF SCI, V132, P373, DOI 10.1016/0021-9797(89)90252-X
   URY MG, 1983, OPTICAL MICROLITHOGR, V344, P241
   *USH EL, 1994, UER20172
   VANDERLAAN JS, 1991, INT J ARTIF ORGANS, V14, P661
   VARGO TG, 1989, J POLYM SCI POL CHEM, V27, P1267, DOI 10.1002/pola.1989.080270413
   VARGO TG, 1988, POLYM PREP-ACS, V2, P303
   VOLLENBROEK FA, 1983, POLYM ENG SCI, V23, P925, DOI 10.1002/pen.760231702
   WANG D, 1991, J APPL POLYM SCI, V42, P233, DOI 10.1002/app.1991.070420128
   WERTHEIMER MR, 1981, J APPL POLYM SCI, V26, P2087, DOI 10.1002/app.1981.070260630
   YADUSA H, 1977, J APPL POLYM, V21, P3167
   YAGI T, 1982, J APPL POLYM SCI, V27, P4019, DOI 10.1002/app.1982.070271032
   YAMAGISHI FG, 1981, THIN SOLID FILMS, V84, P427, DOI 10.1016/0040-6090(81)90183-8
   YAMAGISHI FG, 1991, THIN SOLID FILMS, V202, P39, DOI 10.1016/0040-6090(91)90539-A
   YAO YG, 1993, J ADHES SCI TECHNOL, V7, P63
   YASUDA H, 1977, J POLYM SCI POL CHEM, V15, P991, DOI 10.1002/pol.1977.170150420
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P415, DOI 10.1002/pol.1978.170160212
   YASUDA H, 1977, J APPL POLYM SCI, V21, P3179, DOI 10.1002/app.1977.070211128
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P313, DOI 10.1002/pol.1978.170160201
   YASUDA H, 1973, J APPL POLYM SCI, V17, P137, DOI 10.1002/app.1973.070170111
   YASUDA H, 1977, J APPL POLYM SCI, V21, P3139, DOI 10.1002/app.1977.070211124
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P2587, DOI 10.1002/pol.1978.170161013
   Yasuda H., 1985, PLASMA POLYM
   YASUDA HK, 1990, PURE APPL CHEM, V63, P1689
   YASUDA T, 1988, J POLYM SCI POL PHYS, V26, P1781, DOI 10.1002/polb.1988.090260817
   YASUDA T, 1988, J POLYM SCI POL PHYS, V26, P2061, DOI 10.1002/polb.1988.090261004
   YEH YS, 1986, J POLYM SCI POL CHEM, V24, P3233, DOI 10.1002/pola.1986.080241208
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
   YOUNG JF, 1983, PHYS REV B, V27, P1155, DOI 10.1103/PhysRevB.27.1155
NR 196
TC 317
Z9 317
U1 16
U2 200
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5729
J9 SURF SCI REP
JI Surf. Sci. Rep.
PY 1996
VL 24
IS 1-2
BP 3
EP 54
PG 52
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA UU393
UT WOS:A1996UU39300001
DA 2018-10-19
ER

PT J
AU Grosset, DG
   Georgiadis, D
   Kelman, AW
   Cowburn, P
   Stirling, S
   Lees, KR
   Faichney, A
   Mallinson, A
   Quin, R
   Bone, I
   Pettigrew, L
   Brodie, E
   MacKay, T
   Wheatley, DJ
AF Grosset, DG
   Georgiadis, D
   Kelman, AW
   Cowburn, P
   Stirling, S
   Lees, KR
   Faichney, A
   Mallinson, A
   Quin, R
   Bone, I
   Pettigrew, L
   Brodie, E
   MacKay, T
   Wheatley, DJ
TI Detection of microemboli by transcranial Doppler ultrasound
SO TEXAS HEART INSTITUTE JOURNAL
LA English
DT Article
DE cerebral arteries ultrasonography; cerebral embolism and thrombosis
   ultrasonography; heart valve prosthesis; ultrasonography, Doppler,
   transcranial
ID PROSTHETIC CARDIAC VALVES; ARTERY BYPASS-SURGERY; CARDIOPULMONARY
   BYPASS; INTRACRANIAL EMBOLI; CAROTID DISEASE; BJORK-SHILEY; SIGNALS
AB Doppler ultrasound detection of abnormally high-pitched signals within the arterial waveform offers a new method for diagnosis, and potentially for prediction, of embolic complications in at-risk patients. The nature of Doppler ''microembolic'' signals is of particular interest in patients with prosthetic heart valves, where a high prevalence of these signals is observed Monitoring the middle cerebral artery with 2-MHz transcranial Doppler ultrasound (TC-2000 Nicolet Biomedical; Warwick, UK), we looked for microemboli signals in 150 patients (95 women and 55 men), and found I or more signals during a 30-min recording in 89% of 70 patients with Bjork-Shiley valves (principally monostrut), 54% of 50 patients with Medtronic-Hall valves, and 50% of 30 patients with Carpentier-Edwards valves (p < 0.001, chi(2)). In the patients with Bjork-Shiley valves, the mean number of signals per hour was 59 (range, 42-86; 95% confidence interval), which was significantly higher than the mean in patients with Medtronic-Hall and Carpentier-Edwards valves (1.5 [range, 0.5-2.5] and 1 [range, 0-5.3], respectively; both p < 0.04, multiple comparisons, Bonferroni correction). In the patients undergoing serial pre- and postoperative studies, the causative role of the valve implant was emphasized. There was no correlation between the number of emboli signals and a prior history of neurologic deficit, cardiac rhythm, previous cardiac surgery, or the intensity of oral anticoagulation, in patients with prosthetic heart valves. In Bjork-Shiley patients, dual (mitral and aortic) valves were associated with more signals than were single valves. In Medtronic-Hall patients, the signal count was greater for valves in the aortic position than it was for valves in the mitral position. Comparative studies of Doppler emboli signals in other clinical settings suggest a difference in composition or size of the underlying material between prosthetic valve patients and patients with carotid stenosis. These studies also suggest that the signals are of gaseous origin in valve patients. The clinical significance of continuing microembolism remains to be determined.
RP Grosset, DG (reprint author), SO GEN HOSP,INST NEUROL SCI,DEPT NEUROL,GLASGOW G51 4TF,LANARK,SCOTLAND.
CR AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769
   BLOOMFIELD P, 1986, CIRCULATION, V73, P1213, DOI 10.1161/01.CIR.73.6.1213
   Brown M M, 1994, J Heart Valve Dis, V3, P126
   CORTINA JM, 1986, J THORAC CARDIOV SUR, V91, P174
   DITULLIO M, 1993, STROKE, V24, P1020, DOI 10.1161/01.STR.24.7.1020
   GEORGIADIS D, 1993, STROKE, V24, P1664, DOI 10.1161/01.STR.24.11.1664
   GEORGIADIS D, 1994, STROKE, V25, P1211, DOI 10.1161/01.STR.25.6.1211
   GEORGIADIS D, 1994, EUR J VASCULAR SURG, V8, P309, DOI 10.1016/S0950-821X(05)80147-1
   GEORGIADIS D, 1994, STROKE, V25, P587, DOI 10.1161/01.STR.25.3.587
   GLEN SK, 1995, UNDERSEA HYPERBAR M, V22, P129
   Grosset D G, 1994, J Heart Valve Dis, V3, P128
   GROSSET DG, 1994, STROKE, V25, P382, DOI 10.1161/01.STR.25.2.382
   GROSSET DG, 1993, STROKE, V24, P1922, DOI 10.1161/01.STR.24.12.1922
   GROSSET DG, 1994, EUR J CARDIO-THORAC, V8, P63, DOI 10.1016/1010-7940(94)90092-2
   GROSSET DG, 1993, 5 M NEUR RES GROUP W
   GROSSET DG, 1995, 9 INT CER HEM S 1995
   HARRISON MJG, 1990, STROKE, V21, P1512, DOI 10.1161/str.21.10.1512a
   MacArthur K J, 1988, Eur J Cardiothorac Surg, V2, P143, DOI 10.1016/1010-7940(88)90062-0
   Mackay T G, 1995, J Heart Valve Dis, V4, P414
   MARKUS H, 1993, LANCET, V341, P784, DOI 10.1016/0140-6736(93)90561-T
   ORSINELLI DA, 1994, AM HEART J, V128, P990, DOI 10.1016/0002-8703(94)90599-1
   PADAYACHEE TS, 1987, ANN THORAC SURG, V44, P298, DOI 10.1016/S0003-4975(10)62077-2
   PUGSLEY W, 1994, STROKE, V25, P1393, DOI 10.1161/01.STR.25.7.1393
   PUGSLEY W, 1990, VASCULAR SURG, V24, P34, DOI 10.1177/153857449002400107
   SIEBLER M, 1993, BRAIN, V116, P1005, DOI 10.1093/brain/116.5.1005
   SIEBLER M, 1992, STROKE, V23, P1652, DOI 10.1161/01.STR.23.11.1652
   Spencer M P, 1969, Ann Thorac Surg, V8, P489
   SPENCER MP, 1969, JOM-J OCCUP MED, V11, P238
   SPENCER MP, 1992, TRANSCRANIAL DOPPLER, P215
   TEGELER CH, 1990, J CARDIOVASC TECHNOL, V9, P283
NR 30
TC 15
Z9 15
U1 0
U2 2
PU TEXAS HEART INST
PI HOUSTON
PA PO BOX 20345, HOUSTON, TX 77225-0345
SN 0730-2347
J9 TEX HEART I J
JI Tex. Heart Inst. J.
PY 1996
VL 23
IS 4
BP 289
EP 292
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA VY292
UT WOS:A1996VY29200009
PM 8969029
DA 2018-10-19
ER

PT B
AU Parthasarathi, S
   Tittmann, BR
AF Parthasarathi, S
   Tittmann, BR
BE Nair, CGK
   Raj, B
   Nurthy, CRL
   Jayakumar, T
TI Emerging applications of acoustic microscopy
SO TRENDS IN NDE SCIENCE AND TECHNOLOGY - PROCEEDINGS OF THE 14TH WORLD
   CONFERENCE ON NDT (14TH WCNDT), VOLS 1-5
LA English
DT Proceedings Paper
CT 14th World Conference on NDT - Trends in NDE Science and Technology
   (14th WCNDT)
CY DEC 08-13, 1996
CL NEW DELHI, INDIA
SP Int Comm NDT, Indian Soc Non Destruct Testing
DE acoustic microscopy; bond strength; coatings; films characterization
AB This paper reports on emerging applications of acoustic microscopy techniques for the quantitative characterization of coatings and films. Single and multi-layer films coatings are ideal materials in a variety of semiconductor, optical, display, biomedical and aerospace applications. As with any engineered structure, the properties of the coatings and their adhesion to each other and to the substrate are of critical importance. Theoretical models of wave propagation indicate the Rayleigh wave velocity at high frequencies are sensitive to the properties of coatings and their interface condition and could be used potentially to characterize the same.
RP Parthasarathi, S (reprint author), PENN STATE UNIV,DEPT ENGN SCI & MECH,227 HAMMOND BLDG,UNIVERSITY PK,PA 16802, USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU A A BALKEMA
PI ROTTERDAM
PA PO BOX 1675, 3000 BR ROTTERDAM, NETHERLANDS
BN 90-5410-740-5
PY 1996
BP 227
EP 230
PG 4
WC Materials Science, Characterization & Testing
SC Materials Science
GA BH40Q
UT WOS:A1996BH40Q00039
DA 2018-10-19
ER

PT J
AU Causon, DM
AF Causon, DM
TI An efficient front-tracking algorithm for multi-component flow
   calculations with biomedical applications
SO ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND MECHANIK
LA English
DT Article; Proceedings Paper
CT 3rd International Congress on Industrial and Applied Mathematics (ICIAM
   95)
CY JUL 03-07, 1995
CL HAMBURG, GERMANY
SP Gesell Angew Math & Mech
ID SCHEMES; GODUNOV
AB A hybrid front-tracking algorithm has been developed for applications to shock wave propagation in gas/gas and gas/water media. The hybrid scheme resolves shock waves and rarefactions accurately and material fronts have aero width. The method is being used to study planar shock wave interaction with a gas bubble in water with applications to extracorporeal shock wave lithotripsy.
RP Causon, DM (reprint author), MANCHESTER METROPOLITAN UNIV,CTR MATH MODELING & FLOW ANAL,CHESTER ST,MANCHESTER M1 5GD,LANCS,ENGLAND.
RI Causon, Derek/H-4948-2012
CR GLIMM J, 1955, COMMUN PUR APPL MATH, P697
   HARTEN A, 1983, SIAM REV, V25, P35, DOI 10.1137/1025002
   KARNI S, 1994, J COMPUT PHYS, V112, P31, DOI 10.1006/jcph.1994.1080
   TAKAYAMA K, 1993, JPN J APPL PHYS 1, V32, P2192, DOI 10.1143/JJAP.32.2192
   VAN LEER B, 1984, SIAM J SCI STAT COMP, V5, P1, DOI 10.1137/0905001
NR 5
TC 4
Z9 4
U1 0
U2 1
PU AKADEMIE VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0044-2267
J9 Z ANGEW MATH MECH
JI Z. Angew. Math. Mech.
PY 1996
VL 76
SU 1
BP 371
EP 372
PG 2
WC Mathematics, Applied; Mechanics
SC Mathematics; Mechanics
GA VG254
UT WOS:A1996VG25400105
DA 2018-10-19
ER

PT J
AU Langer, R
AF Langer, R
TI Biomaterials and biomedical engineering
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article; Proceedings Paper
CT Symposium on Frontiers of Chemical Engineering Science, Commemorating
   the 50th Anniversary of Chemical Engineering Science
CY MAR 23-25, 1995
CL MIT, CAMBRIDGE, MA
SP Elsevier Sci Ltd, MIT, Dept Chem Engn
HO MIT
ID CONTROLLED-RELEASE POLYMER; DRUG-CARRIER MATRICES; BIOERODIBLE
   POLYANHYDRIDES; POLYSILOXANE NETWORKS; POLY(ETHYLENE OXIDE); POTENTIAL
   TREATMENT; HYDROGELS; DELIVERY; INVITRO; BLOOD
AB The current status and future prospects of biomaterials, in the context of chemical engineering science and biomedical engineering, is examined. Research on artificial organs, controlled drug delivery systems, tissue engineering, materials for minimally invasive surgery, medical contrast imaging agents, gene therapy, immobilized enzyme bioreactors, and biosensors is evaluated. Techniques for assessing the performance of biomaterials are considered. The role of new types of materials, not yet used in medicine, such as electrically conducting polymers, is discussed. Finally, an analysis of future educational and training issues in biomaterials in the context of chemical engineering is provided.
RP Langer, R (reprint author), MIT,DEPT CHEM ENGN,CAMBRIDGE,MA 02139, USA.
CR ANDERSON JL, 1978, J PHYS CHEM-US, V82, P608, DOI 10.1021/j100494a022
   BALLAL G, 1985, CHEM ENG SCI, V40, P1477, DOI 10.1016/0009-2509(85)80089-0
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Bissell M J, 1987, J Cell Sci Suppl, V8, P327
   BRAZEL CS, 1994, MATER RES SOC SYMP P, V331, P211
   BREM H, 1991, J NEUROSURG, V74, P441, DOI 10.3171/jns.1991.74.3.0441
   BREM H, 1989, SELECT CANCER THER, V5, P55, DOI 10.1089/sct.1989.5.55
   BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6
   BREM H, 1988, AM ASS NEUROL SURG, P349
   Brenner H., 1993, MACROTRANSPORT PROCE
   BRITTON R A, 1968, Journal of Biomedical Materials Research, V2, P429, DOI 10.1002/jbm.820020403
   CHAIKOF EL, 1990, J COLLOID INTERF SCI, V137, P340, DOI 10.1016/0021-9797(90)90410-P
   CHANDRASAKARAN SK, J PHARM SCI, V71, P1399
   COHEN S, 1990, J AM CHEM SOC, V112, P7832, DOI 10.1021/ja00177a074
   COLTON C K, 1971, Journal of Biomedical Materials Research, V5, P459, DOI 10.1002/jbm.820050504
   COLTON C K, 1970, Chemical Engineering Progress Symposium Series, V66, P85
   Colton C. K., 1987, UREMIA THERAPY TECHN, P187
   COLTON CK, 1971, AICHE J, V17, P800, DOI 10.1002/aic.690170408
   COLTON CK, 1975, J LAB CLIN MED, V85, P355
   COLTON CK, 1981, KIDNEY, V2, P2425
   CONTARD P, 1993, J INVEST DERMATOL, V100, P35, DOI 10.1111/1523-1747.ep12349952
   CROOKS CA, 1990, J BIOMED MATER RES, V24, P1241, DOI 10.1002/jbm.820240908
   CUSSLER EL, CHEM ENG SCI, V38, P2027
   DACOSTA VS, 1980, J COLLOID INTERF SCI, V76, P594
   DEEN WM, 1994, P INT S COPNTROL REL, V21, P103
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   DOMB AJ, 1988, MACROMOLECULES, V21, P1925, DOI 10.1021/ma00185a008
   DOMB AJ, 1987, J POLYM SCI POL CHEM, V25, P3373, DOI 10.1002/pola.1987.080251217
   DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043
   EDWARDS DA, 1994, J PHARM SCI, V83, P1315, DOI 10.1002/jps.2600830925
   FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0
   FREED LE, 1994, BIOTECHNOL BIOENG, V43, P605, DOI 10.1002/bit.260430710
   FREED LE, 1994, BIOTECHNOL BIOENG, V43, P597, DOI 10.1002/bit.260430709
   GIFFORD GH, 1976, J BIOMED MATER RES, V10, P857, DOI 10.1002/jbm.820100605
   GOTCH FA, 1972, NIH72103 DEP HLTH ED
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Hansbrough John F., 1992, Journal of Burn Care and Rehabilitation, V13, P519, DOI 10.1097/00004630-199209000-00004
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59
   HSIEH DST, 1983, J PHARM SCI, V72, P17, DOI 10.1002/jps.2600720105
   HUBBELL JA, 1995, CHEM ENG NEWS, V73, P42, DOI 10.1021/cen-v073n011.p042
   KHARE AR, 1993, J BIOMAT SCI-POLYM E, V4, P275, DOI 10.1163/156856293X00564
   KLEIN E, 1977, J MEMBRANE SCI, V2, P349, DOI 10.1016/S0376-7388(00)83262-7
   KOST J, 1991, ADV DRUG DELIVER REV, V6, P19
   LABEQUE R, 1993, P NATL ACAD SCI USA, V90, P3476, DOI 10.1073/pnas.90.8.3476
   LANGER R, 1982, SCIENCE, V217, P261, DOI 10.1126/science.7089564
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   Langer R, 1995, Tissue Eng, V1, P151, DOI 10.1089/ten.1995.1.151
   LANGER R, 1983, J MACROMOL SCI R M C, VC23, P61, DOI 10.1080/07366578308079439
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LARSON RG, 1977, NATURE, V268, P409, DOI 10.1038/268409a0
   LAURENCIN CT, 1993, J ORTHOPAED RES, V11, P256, DOI 10.1002/jor.1100110213
   LAVIN A, 1985, SCIENCE, V230, P543, DOI 10.1126/science.4048947
   LEONARD EF, 1960, T AM SOC ART INT ORG, V6, P33
   LEONARD EF, 1974, 74605 DEP HLTH ED WE
   LEONARD EF, 1959, T NY ACAD SCI, V21, P585
   LEONG KW, 1986, J BIOMED MATER RES, V20, P51, DOI 10.1002/jbm.820200106
   LEONG KW, 1987, MACROMOLECULES, V20, P705, DOI 10.1021/ma00170a001
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   LIGHTFOOT EN, 1974, TRANSPORT PHENOMENA
   MCGRATH KP, 1992, J AM CHEM SOC, V114, P727, DOI 10.1021/ja00028a048
   MERRILL EW, 1970, J APPL PHYSIOL, V29, P723
   MERRILL EW, 1966, T AM SOC ART INT ORG, V12, P139
   MERRILL EW, 1992, POLYETHYLENE GLYCOL, P199
   MERRILL EW, 1982, J AM SOC ARTIF INT O, V6, P60
   MICHAELS A S, 1985, Journal of Controlled Release, V2, P405, DOI 10.1016/0168-3659(85)90062-8
   MICHAELS AS, 1975, AICHE J, V21, P985, DOI 10.1002/aic.690210522
   MICHAELS AS, 1976, PURE APPL CHEM, V46, P193, DOI 10.1351/pac197646020193
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   PEKALA RW, 1986, BIOMATERIALS, V7, P372, DOI 10.1016/0142-9612(86)90008-6
   Peppas N. A., 1984, J CONTROL RELEASE, V5, P23
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PEPPAS NA, 1994, J CONTROL RELEASE, V31, P271
   PISHKO MV, 1991, ANAL CHEM, V63, P2268, DOI 10.1021/ac00020a014
   POWELL EM, 1990, BRAIN RES, V515, P309, DOI 10.1016/0006-8993(90)90612-F
   PREIS I, 1979, J IMMUNOL METHODS, V28, P193, DOI 10.1016/0022-1759(79)90341-7
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   REMPP P, 1990, POLYM PREPR AM CHEM, V31, P215
   Rhine W.D., 1980, CONTROLLED RELEASE B, P177
   ROBERTSON C, ADV CHEM ENG, V16
   SALTZMAN WM, 1993, CRIT REV THER DRUG, V10, P111
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SHAH N, 1986, CHEM ENG SCI, V41, P283, DOI 10.1016/0009-2509(86)87009-9
   SIMONS M, 1992, NATURE, V359, P67, DOI 10.1038/359067a0
   SULLIVAN SJ, 1991, SCIENCE, V252, P718, DOI 10.1126/science.2024124
   SUNG C, 1990, POLYMER, V31, P556, DOI 10.1016/0032-3861(90)90402-K
   SWEENEY LM, IN PRESS TOXIC VITRO
   TAMADA JA, 1993, P NATL ACAD SCI USA, V90, P552, DOI 10.1073/pnas.90.2.552
   TAMARGO RJ, 1988, J BIOMED MATER RES, V23, P253
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   VUNJAKNOVAKOVIC G, IN PRESS AICHE J
   WHEATLEY MA, 1990, BIOMATERIALS, V11, P713, DOI 10.1016/0142-9612(90)90033-M
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   YARMUSH ML, 1993, CRIT REV THER DRUG, V10, P197
   ZHOU XH, 1994, BBA-BIOMEMBRANES, V1189, P195, DOI 10.1016/0005-2736(94)90066-3
NR 96
TC 52
Z9 53
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0009-2509
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC
PY 1995
VL 50
IS 24
BP 4109
EP 4121
DI 10.1016/0009-2509(95)00226-X
PG 13
WC Engineering, Chemical
SC Engineering
GA TP497
UT WOS:A1995TP49700032
DA 2018-10-19
ER

PT J
AU Ciardelli, G
   Saad, B
   Hirt, T
   Keiser, O
   Neuenschwander, P
   Uhlschmid, GK
AF Ciardelli, G
   Saad, B
   Hirt, T
   Keiser, O
   Neuenschwander, P
   Uhlschmid, GK
TI Phagocytosis and biodegradation of short-chain poly[(R)-3-hydroxybutyric
   acid] particles in macrophage cell line
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 12th European Conference on Biomaterials
CY SEP 10-13, 1995
CL OPORTO, PORTUGAL
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; DEGRADATION; INVIVO;
   POLY(EPSILON-CAPROLACTONE); POLY(3-HYDROXYBUTYRATE); PHB
AB The biocompatibility a nd the degradation mechanisms of block co-polyurethanes containing crystallizable telechelic poly [(R)-3-hydroxybutyric acid] (PHB) segments have found recently growing interest for the possible biomedical applications of these new materials. The random hydrolytic cleavage of the amorphous part of these polymers might result, in vivo, in the production of small crystalline particles of low molecular weight PHB that could then undergo phagocytosis and biodegradation inside phagosomes. To test this possibility, a fluorescent-labelled PHB segment was synthesized, precipitated in the form of crystalline particles, and used for an in vitro investigation of its interaction with macrophage cell line. Light and fluorescence microscopy performed in the present study clearly show that the fluorescent particles are well internalized in phagosomes already after 1 h of incubation. The number of phagocytized particles decreases notably after 8 days of incubation. A quantitative determination of the time dependence of the phagocytosis was obtained through laser cytometry and fluorescence-activated cell sorting (FAGS). Fluorescence spectroscopy and high-performance liquid chromatography (HPLC) analysis of extracts of cell supernatants revealed the presence of supposed degradation products of PHB after 8 days of incubation, suggesting that macrophages could degrade low molecular weight PHB.
C1 UNIV ZURICH HOSP,DEPT SURG,DIV RES,CH-8091 ZURICH,SWITZERLAND.
RP Ciardelli, G (reprint author), ETH ZURICH,INST POLYMERS,CH-8092 ZURICH,SWITZERLAND.
OI Saad, Bashar/0000-0003-4052-2279; Ciardelli,
   Gianluca/0000-0003-0199-1427
CR CIARDELLI G, UNPUB
   GIILDING DK, 1981, BIOCOMPATIBILITY CLI, V2, P209
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   HIRT T, UNPUB
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   KORSATKO W, 1983, PHARM IND, V45, P1004
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   SAAD B, IN PRESS J MATER SCI
   SAITO T, 1991, BIOMATERIALS, V12, P309, DOI 10.1016/0142-9612(91)90039-D
   TABATA Y, 1988, J BIOMED MATER RES, V22, P837, DOI 10.1002/jbm.820221002
   TABATA Y, 1990, ADV POLYM SCI, V94, P108
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
NR 13
TC 15
Z9 15
U1 0
U2 2
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1995
VL 6
IS 12
BP 725
EP 730
DI 10.1007/BF00134308
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TM616
UT WOS:A1995TM61600011
DA 2018-10-19
ER

PT J
AU Ianno, NJ
   Dillon, RO
   Ali, A
   Ahmad, A
AF Ianno, NJ
   Dillon, RO
   Ali, A
   Ahmad, A
TI Deposition of diamond-like carbon on a titanium biomedical alloy
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 22nd International Conference on Metallurgical Coatings and Thin Films
   (ICMCTF 1995)
CY APR 25-29, 1995
CL SAN DIEGO, CA
SP Amer Vacuum Soc, Vacuum Met & Thin Films Div
DE adhesion; carbon; physical vapour deposition; plasma processing and
   deposition
AB Much of the orthopedic community now believe that the long-term failure of total hip and knee prostheses is directly or indirectly due to the production of wear particles, particularly polyethylene wear particles which are produced at the articulating interface between the metal component and the high molecular weight plastic component. Therefore, a friction and wear reducing coating on the metal component, which is also biocompatible, should reduce the production of the polyethylene wear particles and dramatically extend hip-implant life. Diamondlike carbon (DLC), with its extreme smoothness, hardness, low coefficient of friction, and biocompatibility is an excellent candidate for such an application. One of the key issues that may limit the utility of DLC in this application is the adhesion of this material to common biomedical alloys. We will show that high adhesion strength between sputter-deposited DLC and a silicon-coated titanium biomedical alloy can be easily achieved.
RP Ianno, NJ (reprint author), UNIV NEBRASKA, DEPT ELECT ENGN, CTR MICROELECTR & OPT MAT RES, LINCOLN, NE 68588 USA.
CR BOX GEP, 1978, STATISTICS EXPT, P306
   Davies O. L., 1971, DESIGN ANAL IND EXPT
   FRANKS J, 1989, J VAC SCI TECHNOL A, V7, P2307, DOI 10.1116/1.575933
   GRILL A, 1990, IBM J RES DEV, V34, P849, DOI 10.1147/rd.346.0849
   HARRIS SJ, 1993, SURF COAT TECH, V62, P550, DOI 10.1016/0257-8972(93)90298-3
   HARRIS WH, 1994, ACTA ORTHOP SCAND, V65, P113, DOI 10.3109/17453679408993734
   LEE HJ, 1992, SURF COAT TECH, V55, P552, DOI 10.1016/S0257-8972(07)80081-8
   MAA JS, 1979, THIN SOLID FILMS, V64, P439, DOI 10.1016/0040-6090(79)90328-6
   MAKOVICKA T, 1993, F0863091C0047 WRIG L
   MIYOSHI K, 1992, SURF COAT TECH, V55, P428, DOI 10.1016/S0257-8972(07)80061-2
   MURARKA SP, 1983, SILICIDES VLSI APPLI, pCH4
   VANGURP GJ, 1979, J APPL PHYS, V50, P6915, DOI 10.1063/1.325843
NR 12
TC 37
Z9 38
U1 0
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD DEC 1
PY 1995
VL 270
IS 1-2
BP 275
EP 278
DI 10.1016/0040-6090(95)06710-8
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA TM187
UT WOS:A1995TM18700052
DA 2018-10-19
ER

PT J
AU KO, WH
AF KO, WH
TI PACKAGING OF MICROFABRICATED DEVICES AND SYSTEMS
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Review
DE PACKAGING; MICROSENSORS; MICROACTUATORS; MICROFABRICATED DEVICES;
   MICROSYSTEMS
ID SENSORS
AB All devices and systems need to be packaged for applications. For microfabricated devices or systems the packaging is an essential part of the design, not an after-thought. The functions of packaging are: (i) to protect the devices from the environment, and (ii) to protect the environment from the device operation. At present, there is no generally applicable packaging method for all microdevices, but there are basic principles useful in packaging design. This article outlines the fundamental requirements, design considerations, and packaging techniques for sensors and microsystems, with selected examples, and suggested references. The protection of the device includes: (i) electrical isolation and passivation of leads and device structures from the penetration of moisture and ions; sealing techniques and hermeticity measurements are important aspects; (ii) mechanical protection to ensure structural integrity and dimensional stability; (iii) thermal and optical isolation, and (iv) chemical and biological isolation and protection. It is also necessary to protect the environment from the device materials and device operation, so that no undesirable reaction with or contamination of the environment occurs. This is especially important for devices used in biomedical, pharmaceutical and food processing. Biocompatibility and contamination must be considered as factors in the design. Successful packaging design requires the integration of knowledge of materials, device characteristics, packaging and evaluation techniques. It remains as a challenge in the MEMS field for engineers.
C1 CASE WESTERN RESERVE UNIV,CTR ELECTR DESIGN,CLEVELAND,OH 44106.
RP KO, WH (reprint author), CASE WESTERN RESERVE UNIV,DEPT ELECT ENGN & APPL PHYS,EUCLID AVE,CLEVELAND,OH 44106, USA.
CR BARD AJ, 1992, PURE APPL CHEM, V64, P185, DOI 10.1351/pac199264020185
   CLINE HE, 1978, J APPL PHYS, V49, P2412, DOI 10.1063/1.325082
   EDEN JG, 1986, IEEE CIRCUITS DEVICE, V2, P18, DOI 10.1109/MCD.1986.6311766
   EHRLICH DJ, 1982, IEEE T COMPONENTS HY, V1, P520
   ESASHI M, 1990, SENSOR ACTUAT A-PHYS, V23, P1048, DOI 10.1016/0924-4247(90)87087-Y
   ESASHI M, 1990, SENSOR ACTUAT A-PHYS, V21, P931
   FUNG CD, 1985, MICROMACHINING MICRO
   HANNEBORG A, 1991, JAN IEEE WORKSH MICR, P92
   HOFFERINS HL, 1991, JUN TRANSD 91 SAN FR, P986
   Ko W.H., 1983, IEEE ENG MED BIO MAR, V2, P22
   Ko W. H., 1985, MICROMACHINING MICRO
   LEE YS, 1982, IEEE T ELECTRON DEV, V29, P42, DOI 10.1109/T-ED.1982.20656
   LEE YS, 1982, IEEE T ELECTRON DEV, V29, P48
   LESKY JB, 1985, DEC IEEE INT EL DEV, P684
   MATISOFF BS, 1990, HDB ELECTRONICS PACK
   NEUMAN MR, 1982, MED PROG TECHNOL, V9, P95
   REICHL H, 1991, SENSOR ACTUAT A-PHYS, V25, P63
   SENTURIA SD, 1989, ELECTRONIC DEVICE PA
   SERAPHIM DP, 1989, PRINCIPLES ELECTRONI
   SHLICHTA PJ, 1988, NASA TECH BRIEFS, V12, P84
   SMITH RL, 1989, FUNDAMENTALS GENERAL, V1, pCH4
   SOORIAJUMAR K, 1993, JUN TRANSD 93 YOK, P191
   Spiering V. L., 1991, TRANSDUCERS '91. 1991 International Conference on Solid-State Sensors and Actuators. Digest of Technical Papers (Cat. No.91CH2817-5), P982, DOI 10.1109/SENSOR.1991.149055
   TIEN Z, 1992, FARADAY DISCUSS, V94
   VANDENVLEKKERT HH, 1990, SENSOR ACTUAT B-CHEM, V1, P395, DOI 10.1016/0925-4005(90)80237-T
   VONGUTFELD RJ, 1982, APPL PHYS LETT, V40, P352, DOI 10.1063/1.93069
   WOLF S, 1990, SILICON PROCESSING V, V2, P176
   WONG ASH, 1985, THESIS CASE W RESERV
   ZIAIE B, 1993, JUN INT C SOL STAT S, P266
   1990, ENG MATERIALS HDB, V3
   1987, METHOD, V1014
   1988, JEDEC22A109 EL IND A
NR 32
TC 32
Z9 34
U1 1
U2 13
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD NOV 30
PY 1995
VL 42
IS 3
BP 169
EP 175
DI 10.1016/0254-0584(95)01573-6
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA TF280
UT WOS:A1995TF28000003
DA 2018-10-19
ER

PT J
AU MASIULANIS, B
   CALUSINSKI, G
   MARJANSKI, W
   KOTSCHY, M
   JURKOWSKI, P
   GORALCZYK, B
   STANISZEWSKAKUS, J
   SOLSKI, L
   KRZEMIENDABROWSKA, A
AF MASIULANIS, B
   CALUSINSKI, G
   MARJANSKI, W
   KOTSCHY, M
   JURKOWSKI, P
   GORALCZYK, B
   STANISZEWSKAKUS, J
   SOLSKI, L
   KRZEMIENDABROWSKA, A
TI INVESTIGATION ON SUITABILITY OF POLY(URETHANEIMIDES) AS BIOMATERIALS
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID POLYIMIDE FILMS; WATER
AB The mechanical properties of poly(urethaneimides) (PUI) were compared with known biomedical polyurethanes. The resistance of PUI to extraction with hexane and water and to sterilization with ethylene oxide or water vapor was stated. Water sorption and the permeability of water vapor, oxygen, and carbon dioxide through PUI foils were investigated. In blood compatibility, the PUI foils were similar to cellulose material Cuprophane, used in dialysis. Preliminary in vivo testing of PUI implanted in rats indicated good biocompatibility of this polymer. (C) 1995 John Wiley & Sons, Inc.
C1 MED ACAD BYDGOSZCZ,DEPT PATHOPHYSIOL,PL-85094 BYDGOSZCZ,POLAND.
   MED ACAD WROCLAW,CHAIR SURG TRAUMATOL,DEPT EXPTL SURG & BIOMAT RES,PL-50326 WROCLAW,POLAND.
RP MASIULANIS, B (reprint author), GDANSK TECH UNIV,FAC CHEM,PL-80952 GDANSK,POLAND.
CR BAMFORD CH, 1992, POLYM MED, P57
   CHARLES HK, 1984, POLYIMIDES, V2, P1139
   EASTMOND GC, 1993, POLYMER, V34, P667, DOI 10.1016/0032-3861(93)90571-Q
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V49, P815, DOI 10.1002/app.1993.070490507
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   GOSEY MT, 1985, POLYM PERMEABILITY, P309
   HABAL MB, 1987, ADV BIOMEDICAL PLYME, P27
   HACHISUKA H, 1991, J POLYM SCI POL PHYS, V29, P11, DOI 10.1002/polb.1991.090290103
   ILLINGER IL, 1974, PERMEABILITY PLASTIC, P183
   JURKOWSKI P, 1993, UNPUBLISHED REPORT
   KIM SW, 1990, POLIMERY, V11, P401
   KOMATSUZAKI S, 1992, J APPL POLYM SCI APP, V50, P309
   LAWANDY SN, 1980, ELASTOMERICS, V10, P43
   LIM BS, 1993, J POLYM SCI POL PHYS, V31, P545, DOI 10.1002/polb.1993.090310505
   MARJANSKI W, 1986, ZESZ NAUK POLITECHNI, V57
   MASIULANIS B, 1985, J APPL POLYM SCI, V30, P2731, DOI 10.1002/app.1985.070300702
   MASIULANIS B, 1987, J APPL POLYM SCI, V34, P1941, DOI 10.1002/app.1987.070340512
   MASIULANIS B, 1987, Patent No. 140428
   MASIULANIS B, 1993, POLIMERY, V8, P414
   MOYLAN CR, 1991, J POLYM SCI POL PHYS, V29, P87, DOI 10.1002/polb.1991.090290111
   OKANO T, 1992, J BIOMED MATER RES, V26, P801
   Rogers C. E., 1985, POLYM PERMEABILITY, P11, DOI DOI 10.1007/978-94-009-4858-72
   SAHER E, 1981, J APPL POLYM SCI, V26, P679
   STANISZEWSKAKUS J, 1994, UNPUBLISHED REPORT
   Tock R. W., 1983, ADV POLYM TECHNOL, V3, P223
   UKIBAYRAM K, 1992, POLYMER, V23, P2084
   ULRICH H, 1984, POLYURETHANES BIOMED, P175
   WARD RS, 1984, POLYURETHANES BIOMED, P191
   WROBLEWSKI DA, 1988, APPLIED BIOACTIVE PO, P281
NR 29
TC 5
Z9 5
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD NOV 28
PY 1995
VL 58
IS 9
BP 1441
EP 1454
DI 10.1002/app.1995.070580905
PG 14
WC Polymer Science
SC Polymer Science
GA TB510
UT WOS:A1995TB51000005
DA 2018-10-19
ER

PT J
AU DELANGE, PJ
   MAHY, JWG
AF DELANGE, PJ
   MAHY, JWG
TI TOF-SIMS AND XPS INVESTIGATIONS OF FIBERS, COATINGS AND BIOMEDICAL
   MATERIALS
SO FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 8th Conference on Applied Surface Analysis
CY SEP 05-08, 1994
CL KAISERSLAUTERN, GERMANY
ID RAY PHOTOELECTRON-SPECTROSCOPY; WOOD
AB The use of ToF-SIMS and XPS in industrial research is demonstrated by a number of applications of surface analysis within Akzo Nobel: surface treatment of carbon fibers, adhesion activation of aramid fibers, weathering and protection of wood, surfactant adsorption on pigments, grafting of polypropylene with acrylic monomers and treatment of a perfluorinated membrane with an amphiphile. The examples illustrate the broad use of these techniques on non-conducting organic and polymeric materials.
RP DELANGE, PJ (reprint author), AKZO NOBEL CENT RES,DEPT ANALYT & ENVIRONM CHEM,POB 9300,6800 SB ARNHEM,NETHERLANDS.
CR ALEXANDER MR, 1994, CARBON, V32, P785, DOI 10.1016/0008-6223(94)90034-5
   AMEEN AP, 1993, POLYMER, V34, P1795, DOI 10.1016/0032-3861(93)90418-A
   ANDREWS MC, 1995, COMPOSITE INTERFACES
   DELANGE PJ, 1992, SURF INTERFACE ANAL, V19, P397, DOI 10.1002/sia.740190174
   DELANGE PJ, 1994, SURF INTERFACE ANAL, V22, P502, DOI 10.1002/sia.7402201106
   DELANGE PJ, 1993, I PHYS C SER, V130, P439
   DONNET JB, 1990, CARBON FIBRES
   Dorris GM, 1978, CELLUL CHEM TECHNOL, V12, P9
   FEIST WC, 1984, CHEM SOLID WOOD, pCH11
   GARTON A, 1985, J POLYM SCI POL CHEM, V23, P1031, DOI 10.1002/pol.1985.170230408
   HON DNS, 1984, J APPL POLYM SCI, V29, P2777, DOI 10.1002/app.1984.070290908
   MAHY J, 1994, SURF INTERFACE ANAL, V21, P1, DOI 10.1002/sia.740210102
   MAHY J, 1994, COMPOSITES, V25, P653, DOI 10.1016/0010-4361(94)90198-8
   MAHY JWG, 1991, INTERFACIAL PHENOMENA IN COMPOSITE MATERIALS 91, P45
   MUKHERJEE AK, 1983, J MACROMOL SCI CHEM, VA19, P1069, DOI 10.1080/00222338308081086
   MUKHERJEE AK, 1985, J APPL POLYM SCI, V30, P2655, DOI 10.1002/app.1985.070300628
   VANSTRAATENNIJE.WF, 1993, LANGMUIR, V9, P1657
   WAUGH AR, 1987, J PHYS-PARIS, V48, P577, DOI 10.1051/jphyscol:1987694
NR 18
TC 14
Z9 14
U1 0
U2 6
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0937-0633
J9 FRESEN J ANAL CHEM
JI Fresenius J. Anal. Chem.
PD NOV-DEC
PY 1995
VL 353
IS 5-8
BP 487
EP 493
DI 10.1007/BF00321308
PG 7
WC Chemistry, Analytical
SC Chemistry
GA TH385
UT WOS:A1995TH38500001
DA 2018-10-19
ER

PT J
AU Mammel, KA
   Kaplan, DW
AF Mammel, KA
   Kaplan, DW
TI Research consent by adolescent minors and Institutional Review Boards
SO JOURNAL OF ADOLESCENT HEALTH
LA English
DT Article
DE consent; confidentiality; Institutional Review Boards; adolescents;
   research
ID BIOMEDICAL-RESEARCH; CHILDREN
AB Purpose: A national survey of institutional review boards (IRBs) was conducted to determine: (1) the current practices of IRBs concerning consent for adolescent miners; and (2) the existence of support for changes in the federal regulations for research on adolescents.
   Methods: Six hundred surveys were mailed in two waves to all IRE chairs in the United States, with the exception of highly specialized institutions. The survey consisted of three sections. Section 1 assessed demographic data, such as institution type; presence of personnel trained in adolescent health; and number of protocols involving adolescents reviewed annually. Section 2 presented a series of twelve scenarios for which respondents stated whether their IRE would waive parental consent under present federal regulations. These scenarios varied the sensitivity of information and procedural invasiveness, and ranged from simple satisfaction surveys to experimental drug treatment for AIDS. Section 3 assessed whether respondents would recommend changes in current federal regulations that would enable adolescent miners to provide their own consent to research participation. To this end, respondents indicated whether minor consent alone is sufficient or if parental consent should be required for 10 general research categories that paralleled the level of invasiveness of the scenarios presented in Section 2.
   Results: Two hundred and thirty-three surveys (39%) were returned and 183 (30%) were fully scorable. Within group comparisons for IRBs were conducted using Chi-square statistics. Seventy percent of respondent IRBs required parental consent for all research on miners, and IRBs reviewing more than 10 adolescent protocols per year were less likely to require parental consent (p <.01). Responses did not differ by institution type or presence of personnel trained in adolescent health. Fifty-two percent of respondent IRBs required parental consent for a simple satisfaction survey, and only 29% of IRBs would waive parental consent for an anonymous HIV seroprevalence study. Over one-half of IRBs supported changes in regulations that would enable miners to provide informed self-consent for seven of 10 general research categories: anonymous surveys (supported by 93%), research involving sensitive material if nothing more than survey (89%) or venipuncture (53%) were involved, and research on diseases for which miners may consent to treatment including survey (93%), venipuncture (68%), or medication approved for use in pediatric patients (57%).
   Conclusion: Even though IRBs practice under the same federal regulations there is a broad spectrum of interpretation. Considerable support exists for changing the guidelines for certain categories of research involving adolescents. Federal regulations need to be clarified for meaningful and necessary research on adolescents to take place.
C1 UNIV COLORADO,CHILDRENS HOSP,HLTH SCI CTR,DEPT PEDIAT,ADOLESCENT MED SECT,DENVER,CO 80218.
CR BROOME ME, 1992, RES NURS HEALTH, V15, P147, DOI 10.1002/nur.4770150209
   *DHEW, 1977, OS770004 PUBL
   GRISSO T, 1992, SOCIAL RES CHILDREN
   GRODIN MA, 1988, PEDIATR CLIN N AM, V35, P1389
   Holder Angela R, 1981, IRB, V3, P5, DOI 10.2307/3563513
   MORRISSEY JM, 1986, CONSENT CONFIDENTIAL, P91
   MOSS HB, 1979, CANCER, V43, P1549
   MUNIR K, 1992, J AM ACAD CHILD PSY, V31, P408, DOI 10.1097/00004583-199205000-00005
   SCHULTZ AL, 1975, WESTERN J MED, V123, P76
   SEVERSON H, 1989, PREV MED, V18, P267, DOI 10.1016/0091-7435(89)90074-1
   SUSMAN EJ, 1992, J PEDIATR-US, V121, P547, DOI 10.1016/S0022-3476(05)81142-4
   TARNOWSKI KJ, 1990, PEDIATRICS, V85, P58
   THOMPSON RA, 1990, CHILD DEV, V61, P1
   Thurber F W, 1992, J Pediatr Nurs, V7, P165
   WEITHORN LA, 1982, CHILD DEV, V53, P1589, DOI 10.2307/1130087
   Weithorn Lois A, 1983, IRB, V5, P1, DOI 10.2307/3563792
NR 16
TC 42
Z9 42
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 1054-139X
J9 J ADOLESCENT HEALTH
JI J. Adolesc. Health
PD NOV
PY 1995
VL 17
IS 5
BP 323
EP 330
DI 10.1016/1054-139X(95)00176-S
PG 8
WC Psychology, Developmental; Public, Environmental & Occupational Health;
   Pediatrics
SC Psychology; Public, Environmental & Occupational Health; Pediatrics
GA TK532
UT WOS:A1995TK53200010
PM 8924437
DA 2018-10-19
ER

PT J
AU SHAMES, B
   FOX, JG
   DEWHURST, F
   YAN, LL
   SHEN, ZL
   TAYLOR, NS
AF SHAMES, B
   FOX, JG
   DEWHURST, F
   YAN, LL
   SHEN, ZL
   TAYLOR, NS
TI IDENTIFICATION OF WIDESPREAD HELICOBACTER-HEPATICUS INFECTION IN FECES
   IN COMMERCIAL MOUSE COLONIES BY CULTURE AND PCR ASSAY
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID CAMPYLOBACTER-CINAEDI; DNA
AB The identification of a new murine pathogen, Helicobacter hepaticus, and its association with chronic active hepatitis and liver tumors prompted an evaluation of the prevalence of H, hepaticus in commercially available mice. Of the 28 different strains or stocks, totaling 160 mice from four major commercial vendors, cultured for H. hepaticus, 100% of mice from two outbred strains from one vendor were infected with H. hepaticus, whereas of 13 inbred mouse strains from another vendor were infected, This high prevalence of H, hepaticus established a need for a rapid and reproducible, noninvasive assay for the screening of colony-maintained mice being used for biomedical research. The culturing of fecal material by using 0.45-mu m-pore-size filtration for H. hepaticus consistently yielded reproducible results but required extended periods of time (1 to 3 weeks) to obtain a definitive answer. Although it is rapid, the use of a direct PCR-based detection assay with fecal specimens is restricted by inhibitory agents. To circumvent these inhibitory agents and to augment our H. hepaticus culture technique, we have developed a novel PCR system in which the bacteria are isolated from fecal material in the presence of polyvinylpyropyrollidone and lysed by treatment with Chelex 100. The PCR is performed with Tth polymerase supplemented with a polymerase enhancer. By this PCR method, 24 H. hepaticus culture-positive and 30 H. hepaticus culture-negative fecal samples were correctly identified, Moreover, two samples which were PCR positive and culture negative initially were positive by both methods upon retesting of fresh material, Southern blot hybridizations and sequencing of PCR products showed them to be H, hepaticus specific. A comparison of results obtained under identical conditions indicated a 100-fold increase in sensitivity with Tth polymerase over Tag polymerase. This PCR method can be used as a noninvasive means of rapidly screening large numbers of colony mice for H. hepaticus.
C1 MIT,DIV COMPARAT MED,CAMBRIDGE,MA 02139.
   FORSYTH DENT CTR,DEPT MOLEC GENET,BOSTON,MA 02115.
FU NCRR NIH HHS [RR07036, RR01046]; OFP OPHS HHS [RFPS 94-69]
CR ATLAS RM, 1993, HDB METHODS AQUATIC, P261
   BATTLES JK, 1995, J CLIN MICROBIOL, V33, P1344
   Bej Asim K., 1994, P219
   Bej Asim K., 1994, P327
   COVER TL, 1995, ASM NEWS, V61, P21
   DELAMBALLERIE X, 1992, RES MICROBIOL, V143, P785, DOI 10.1016/0923-2508(92)90107-Y
   FLORES BM, 1990, INFECT IMMUN, V58, P3947
   FOLTZ CJ, 1995, ANTIMICROB AGENTS CH, V39, P1292, DOI 10.1128/AAC.39.6.1292
   FOX JG, 1995, J CLIN MICROBIOL, V33, P445
   FOX JG, 1994, J CLIN MICROBIOL, V32, P1238
   FOX JG, 1993, BIOL CLIN PRACTICE, P407
   FOX JW, UNPUB
   GEBHART CJ, 1989, J CLIN MICROBIOL, V27, P1692
   Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31
   HIU PJ, 1992, BIOTECHNOL GENET ENG, V10, P343
   JIANG X, 1992, Journal of Clinical Microbiology, V30, P2529
   LEE A, 1992, INT J SYST BACTERIOL, V42, P27, DOI 10.1099/00207713-42-1-27
   Mahbubani Meena H., 1994, P307
   OCHERT AS, 1994, PCR METH APPL, V3, P365
   PANACCIO M, 1991, NUCLEIC ACIDS RES, V19, P1151, DOI 10.1093/nar/19.5.1151
   Panaccio Michael, 1994, P151
   Poli F, 1993, PCR Methods Appl, V2, P356
   SAYLER GS, 1990, ANNU REV MICROBIOL, V44, P625
   SCHAUER DB, 1993, J CLIN MICROBIOL, V31, P2709
   SOLNICK JV, 1993, INFECT AG DIS, V1, P294
   STEFFAN RJ, 1988, APPL ENVIRON MICROB, V54, P2908
   VANZWET AA, 1994, J CLINMICROBIOL, V32, P1343
   WARD JM, 1994, J NATL CANCER I, V86, P1222, DOI 10.1093/jnci/86.16.1222
   WIDJOJOATMODJO MN, 1992, J CLIN MICROBIOL, V30, P3195
NR 29
TC 151
Z9 160
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0095-1137
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD NOV
PY 1995
VL 33
IS 11
BP 2968
EP 2972
PG 5
WC Microbiology
SC Microbiology
GA TA461
UT WOS:A1995TA46100033
PM 8576355
DA 2018-10-19
ER

PT J
AU Rosiak, JM
   Ulanski, P
   Rzeznicki, A
AF Rosiak, JM
   Ulanski, P
   Rzeznicki, A
TI Hydrogels for biomedical purposes
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Ionizing Radiation and Polymers (IRaP94)
CY NOV 14-19, 1994
CL QUADELOUPE, FRANCE
SP INSERM, Minist Def, Minist DOM TOM, Minist Enseignement Super & Rech, Minist Environm, Soc Francaise Phys, Soc Francaise Chim
ID CROSS-LINKING; POLYMERS
AB Medical advances that have prolonged the average life span have generated more needs for new materials that can be used as tissue and organ replacements, drug delivery systems or components of devices related to therapy and diagnosis. One of the most promising class of such materials seems to be hydrogels. Taking poly(ethylene oxide) - PEO as an example of hydrogel-forming polymers the mechanism of formation and decay of its macroradicals in aqueous solution was discussed. The influence of scavengers as well as concentration of PEO solution on the formation of gel has been shown. Short description of technologies of some hydrogel biomaterials obtained by means of radiation technique was given.
RP Rosiak, JM (reprint author), TECH UNIV LODZ,INST APPL RADIAT CHEM,WROBLEWSKIEGO 15,PL-93590 LODZ,POLAND.
RI Ulanski, Piotr/S-9103-2018
OI Ulanski, Piotr/0000-0002-4310-3574
CR BEHZADI A, 1970, BERICH BUNSEN GESELL, V74, P649
   BORGWARDT U, 1969, MAKROMOLEKUL CHEM, V127, P176
   INOUE K, 1992, PANCREAS, V7, P562, DOI 10.1097/00006676-199209000-00009
   MATHESON MS, 1973, J PHYS CHEM-US, V77, P2420, DOI 10.1021/j100639a011
   OLEJNICZAK J, 1991, RADIAT PHYS CHEM, V37, P499
   ROSIAK J, 1990, RADIAT PHYS CHEM, V36, P747
   Rosiak J, 1989, Polim Med, V19, P93
   Rosiak J., 1989, Patent US, Patent No. [4871490 A, 4871490, 4,871,490]
   ULANSKI P, 1994, J RADIOAN NUCL CH LE, V186, P315, DOI 10.1007/BF02162615
   ULANSKI P, 1994, MACROMOL CHEM PHYSIC, V195, P1443, DOI 10.1002/macp.1994.021950427
   ULANSKI P, 1994, IN PRESS RAD PHYS CH
NR 11
TC 40
Z9 41
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD NOV
PY 1995
VL 105
IS 1-4
BP 335
EP 339
DI 10.1016/0168-583X(95)00550-1
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA TM152
UT WOS:A1995TM15200070
DA 2018-10-19
ER

PT J
AU MATSUURA, Y
   ABEL, T
   HARRINGTON, JA
AF MATSUURA, Y
   ABEL, T
   HARRINGTON, JA
TI OPTICAL-PROPERTIES OF SMALL-BORE HOLLOW GLASS WAVE-GUIDES
SO APPLIED OPTICS
LA English
DT Article
DE HOLLOW WAVE-GUIDES; INFRARED FIBERS; BIOMEDICAL OPTICS
ID WAVE-GUIDES; TRANSMISSION; LOSSES; ATTENUATION; DELIVERY; FIBERS
AB Hollow glass waveguides with a 250-mu m i.d. have been fabricated with a liquid-phase deposition technique that uses silica tubing as a base material. The losses of the 250-mu m-bore guide measured at CO2 laser wavelengths are as low as 2.0 dB/m. The straight losses for the hollow guides are in good agreement with theoretically predicted losses as a result of the nearly ideal structure of the guides. It is also shown that the guides have low bending losses, a nearly pure-mode delivery, and good high-power laser transmission. By proper design of the dielectric thickness, the guide is also able to deliver Er:YAG laser energy with a low loss of 1.2 dB/m for the 320-mu m-bore waveguide. Because the hollow glass waveguide is very flexible and robust, it is quite suitable for medical applications.
RP MATSUURA, Y (reprint author), RUTGERS STATE UNIV,FIBER OPT MAT RES PROGRAM,BRETT & BOWSER RD,POB 909,PISCATAWAY,NJ 08855, USA.
RI matsuura, yuji/M-6457-2016
OI matsuura, yuji/0000-0002-4722-7654
CR ABE S, 1991, IEEE T MICROW THEORY, V39, P230, DOI 10.1109/22.102965
   ABEL T, 1994, OPT LETT, V19, P1034, DOI 10.1364/OL.19.001034
   CROITORU N, 1990, APPL OPTICS, V29, P1805, DOI 10.1364/AO.29.001805
   CROITORU N, 1990, Patent No. 4930863
   DAHAN R, 1992, MATER RES BULL, V27, P761, DOI 10.1016/0025-5408(92)90084-D
   DAHAN R, 1994, P SOC PHOTO-OPT INS, V2131, P35, DOI 10.1117/12.180762
   GANNOT I, 1994, P SOC PHOTO-OPT INS, V2084, P66
   GREGORY CC, 1993, APPL OPTICS, V32, P5302, DOI 10.1364/AO.32.005302
   HALL DR, 1977, J APPL PHYS, V48, P1212, DOI 10.1063/1.323761
   HARRINGTON JA, 1990, OPT LETT, V15, P541, DOI 10.1364/OL.15.000541
   HARRINGTON JA, 1990, SPIE MILESTONE SE MS, V9, P409
   HARRINGTON JA, 1990, SPIE MILESTONE SE MS, V9, P527
   KATO Y, 1993, P SOC PHOTO-OPT INST, V2131, P66
   MARCATILI EAJ, 1964, AT&T TECH J, V43, P1783, DOI 10.1002/j.1538-7305.1964.tb04108.x
   MATSUURA Y, 1994, ELECTRON LETT, V30, P1688, DOI 10.1049/el:19941124
   MATSUURA Y, 1989, J OPT SOC AM A, V6, P423, DOI 10.1364/JOSAA.6.000423
   MATSUURA Y, 1993, APPL OPTICS, V32, P6598, DOI 10.1364/AO.32.006598
   MIYAGI M, 1984, J LIGHTWAVE TECHNOL, V2, P116, DOI 10.1109/JLT.1984.1073590
   MIYAGI M, 1990, APPL OPTICS, V29, P367, DOI 10.1364/AO.29.000367
   MIYAGI M, 1981, APPL OPTICS, V20, P1221, DOI 10.1364/AO.20.001221
   Schweig B., 1973, MIRRORS GUIDE MANUFA
NR 21
TC 101
Z9 103
U1 3
U2 13
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036
SN 0003-6935
J9 APPL OPTICS
JI Appl. Optics
PD OCT 20
PY 1995
VL 34
IS 30
BP 6842
EP 6847
DI 10.1364/AO.34.006842
PG 6
WC Optics
SC Optics
GA RZ268
UT WOS:A1995RZ26800008
PM 21060543
DA 2018-10-19
ER

PT J
AU COSOFRET, VV
   ERDOSY, M
   JOHNSON, TA
   BELLINGER, DA
   BUCK, RP
   ASH, RB
   NEUMAN, MR
AF COSOFRET, VV
   ERDOSY, M
   JOHNSON, TA
   BELLINGER, DA
   BUCK, RP
   ASH, RB
   NEUMAN, MR
TI ELECTROANALYTICAL AND SURFACE CHARACTERIZATION OF ENCAPSULATED
   IMPLANTABLE MEMBRANE PLANAR MICROSENSORS
SO ANALYTICA CHIMICA ACTA
LA English
DT Article
DE SENSORS; ENCAPSULATED POLYMERIC MEMBRANES; BIOCOMPATIBLE POLYMERS;
   IMPLANTABLE SENSORS
ID SOLVENT POLYMERIC MEMBRANES; ELECTROCHEMICAL DETECTOR; SYNTHETIC
   HYDROGELS; TRANSPORT PROCESSES; ELECTRODES; SENSORS
AB The selective polymeric membranes of planar microsensors sensitive to inorganic analytes of biomedical interest (e.g., H+, K+), fabricated on a flexible polyimide (Kapton(R) DuPont) substrate using a combination of thin-film, thick-film and packaging technologies, were encapsulated with a biocompatible polymeric material such as poly(2-hydroxyethylmethacrylate) (poly-HEMA), The electroanalytical characteristics pf these sensors (linear activity ranges, slopes of the calibration curves, response times, membrane resistances, and selectivities) are not significantly different when compared with those of non-coated membrane sensors. The encapsulated membrane electrodes show improved analytical characteristics after exposure to whole blood samples for specified periods of time. The long-term stability of the membranes for in vivo use was investigated by the cage implant system; the membrane biostability and cell adhesion, at 1, 3, 7, and 14 days of subcutaneous implantation in Sprague-Dawley rats, were evaluated by scanning electron microscopy.
C1 UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599.
   UNIV N CAROLINA,SCH MED,CHAPEL HILL,NC 27599.
   N CAROLINA STATE UNIV,DEPT ELECT & COMP ENGN,RALEIGH,NC 27695.
   CASE WESTERN RESERVE UNIV,METROHLTH MED CTR,DEPT OBSTET GYNECOL,CLEVELAND,OH 44109.
CR AMMANN D, 1985, ANAL CHIM ACTA, V171, P119, DOI 10.1016/S0003-2670(00)84189-6
   BILBRUCK J, 1993, INT J PHARM, V99, P293, DOI 10.1016/0378-5173(93)90372-M
   CLARK LC, 1988, METHOD ENZYMOL, V137, P68
   COSOFRET VV, 1992, J ELECTROANAL CHEM, V327, P137, DOI 10.1016/0022-0728(92)80142-Q
   COSOFRET VV, 1995, ANAL CHEM, V67, P1647, DOI 10.1021/ac00106a001
   COSOFRET VV, 1993, J ELECTROANAL CHEM, V345, P169, DOI 10.1016/0022-0728(93)80477-Y
   COSOFRET VV, 1994, ANALYST, V119, P2283, DOI 10.1039/an9941902283
   COSOFRET VV, 1994, TALANTA, V41, P931, DOI 10.1016/0039-9140(94)E0106-2
   COSOFRET VV, IN PRESS POLYM MATER
   COSOFRET VV, 1994, ANAL LETT, V27, P15
   DAVIES ML, 1991, SELECT ELECTR REV, V13, P159
   DINTEN O, 1991, ANAL CHEM, V63, P596, DOI 10.1021/ac00006a009
   DURSELEN LFJ, 1988, ANAL CHEM, V60, P1455, DOI 10.1021/ac00165a021
   GADZEKPO VPY, 1986, ANALYST, V111, P567, DOI 10.1039/an9861100567
   HAMILTON CJ, 1988, POLYMER, V29, P1879, DOI 10.1016/0032-3861(88)90406-5
   ISHII K, 1993, CONCURRENT ENG AUTOM, P19
   KO WH, 1985, IMPLANTABLE SENSORS, P259
   KUSY RP, 1994, POLYMER, V35, P2141, DOI 10.1016/0032-3861(94)90241-0
   KUSY RP, 1994, J MATER SCI LETT, V13, P849, DOI 10.1007/BF00273227
   LINDNER E, 1993, J CHEM SOC FARADAY T, V89, P361, DOI 10.1039/ft9938900361
   LINDNER E, 1993, TALANTA, V40, P957, DOI 10.1016/0039-9140(93)80151-G
   LINDNER E, 1993, FRESEN J ANAL CHEM, V346, P584, DOI 10.1007/BF00321250
   LINDNER E, 1994, DIAGNOSTIC BIOSENSOR, P149
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P53
   MCKINLEY BA, 1981, CRIT CARE MED, V9, P333, DOI 10.1097/00003246-198104000-00011
   MEIER PC, 1980, MED BIOL APPLICATION, P13
   MURPHY SM, 1988, POLYMER, V29, P1887, DOI 10.1016/0032-3861(88)90407-7
   OESCH U, 1980, ANAL CHEM, V52, P692, DOI 10.1021/ac50054a024
   OESCH U, 1986, CLIN CHEM, V32, P1448
   POTJEKAMLOTH K, 1989, SENSOR ACTUATOR, V18, P415, DOI 10.1016/0250-6874(89)87047-7
   Pungor E., 1977, PURE APPL CHEM, V51, P1913
   REICHERT WM, 1992, MAT SCI TECHNOL, V14, P303
   SEPRAPHIM DP, 1989, PRINCIPLES ELECTRONI
   SHICHIRI M, 1987, GBF MONOGR, V10, P95
   SHIMADA K, 1980, MED BIOL ENG COMPUT, V18, P741, DOI 10.1007/BF02441899
   SITTAMPALAM G, 1983, ANAL CHEM, V55, P1608, DOI 10.1021/ac00260a039
   UEDA N, 1987, GBF MONOGR, V10, P265
   WANG J, 1985, ANAL CHEM, V57, P1536, DOI 10.1021/ac00285a010
NR 38
TC 12
Z9 12
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0003-2670
J9 ANAL CHIM ACTA
JI Anal. Chim. Acta
PD OCT 10
PY 1995
VL 314
IS 1-2
BP 1
EP 11
DI 10.1016/0003-2670(95)00260-7
PG 11
WC Chemistry, Analytical
SC Chemistry
GA RZ263
UT WOS:A1995RZ26300001
DA 2018-10-19
ER

PT J
AU CHEN, LQ
   YUDE, Z
   DU, XQ
   WANG, QZ
   ZHANG, ZQ
AF CHEN, LQ
   YUDE, Z
   DU, XQ
   WANG, QZ
   ZHANG, ZQ
TI BIOMEDICAL MATERIAL FOR SUTURELESS ESOPHAGOGASTROSTOMY - ANALYSIS OF 31
   CASES
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
AB The results of 31 cases of sutureless esophagogastrostomy by intraluminal elastic circular ligation (IECL) with the biodegradable supporting tube were reported. The fate of the supporting tube could be tracked satisfactorily by X-ray, The tube-dislodge time was 15.03 +/- 2.23 days and unaffected by the size of supporting tube or the site of anastomosis, The supporting tube could be safely absorbed or partially discharged through the alimentary tract. IECL, with the merits of saving time, anastomosing tightly and leaving no suture materials in the anastomotic site, can be expected to further reduce the incidence of anastomotic leakage and provide references for other gastrointestinal anastomosis.
RP CHEN, LQ (reprint author), HEBEI MED COLL,AFFILIATED HOSP 4,DEPT THORAC SURG,SHIJIAZHUANG 050011,PEOPLES R CHINA.
CR PING YM, 1982, CHINESE J ONCOL, V4, P36
   ZHANG X, 1988, CHIN J EXP SURG, V5, P170
   ZHANG YD, 1988, CHINESE J ONCOL, V10, P224
   ZHANG YD, 1982, CHINESE J ONCOL, V4, P5
   ZHANG YD, 1989, CHINESE J SURG, V27, P369
NR 5
TC 2
Z9 2
U1 0
U2 0
PU CHINESE MEDICAL ASSOCIATION
PI BEIJING
PA 42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD OCT
PY 1995
VL 108
IS 10
BP 750
EP 753
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA TF113
UT WOS:A1995TF11300008
PM 8565660
DA 2018-10-19
ER

PT J
AU Nair, PD
AF Nair, PD
TI Currently practised sterilization methods - Some inadvertent
   consequences
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE sterilization methods; biomedical polymers; polyesters; biocompatibility
ID ETHYLENE-OXIDE; DEGRADATION; PROSTHESES; INVITRO; GRAFTS
AB Currently used sterilization techniques such as ethylene oxide, gamma irradiation, and steam sterilization could introduce inadvertent consequences, especially in polymeric materials. These could have far-reaching effects on the biocompatibility of the materials. Some of these consequences are reviewed and a typical example of the effect of steam sterilization on the properties and biocompatibility of polyethylene terephthalate is discussed.
C1 SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,TRIVANDRUM 695012,KERALA,INDIA.
CR BAQUEY C, 1987, BIOMATERIALS, V8, P185, DOI 10.1016/0142-9612(87)90061-5
   BERGER K, 1981, ANN SURG, V193, P477
   BRUCK S D, 1971, Journal of Biomedical Materials Research, V5, P139, DOI 10.1002/jbm.820050303
   Chapiro A., 1962, RAD CHEM POLYM SYSTE
   CHRISTENSEN EA, 1967, S RADIOSTERILIZATION
   CHU CC, 1983, J BIOMED MATER RES, V17, P1029, DOI 10.1002/jbm.820170612
   CLARKE CP, 1966, J SURG, P36
   CONWAY PF, 1979, BRIT J SURG, V66, P262, DOI 10.1002/bjs.1800660414
   Dempsey D J, 1989, J Biomater Appl, V3, P454
   EHLRENBERG L, 1974, MUTAT RES, V24, P84
   FREEMAN MAR, 1960, J HYG-CAMBRIDGE, P337
   GUIDOIN R, 1985, BIOMATERIALS, V6, P122, DOI 10.1016/0142-9612(85)90075-4
   GUMARGALIEVA KZ, 1982, BIOMATERIALS, V3, P177, DOI 10.1016/0142-9612(82)90008-4
   Habermann V, 1985, Arch Toxicol Suppl, V8, P458
   JAYABALAN M, 1986, ANGEW MAKROMOL CHEM, V142, P51, DOI 10.1002/apmc.1986.051420104
   JAYABALAN M, 1989, BIOMATERIALS, V10, P33, DOI 10.1016/0142-9612(89)90006-9
   JAYABALAN M, 1986, 5TH P SO BIOM ENG C, P344
   JAYABALAN M, 1991, BIOMED, V11, P7
   LUDWIG K, 1988, OPHTHALMIC RES, V20, P304, DOI 10.1159/000266732
   MARLOWE DE, 1987, J PHARM SCI, V76, P333, DOI 10.1002/jps.2600760414
   MAZZU AL, 1984, J BIOMED MATER RES, V18, P961, DOI 10.1002/jbm.820180810
   MELBERG SG, 1988, DIABETIC MED, V5, P243, DOI 10.1111/j.1464-5491.1988.tb00977.x
   NAIR P D, 1990, Clinical Materials, V5, P43, DOI 10.1016/0267-6605(90)90070-C
   NAIR PD, 1984, BIOMATERIALS, V5, P305, DOI 10.1016/0142-9612(84)90079-6
   NAIR PD, 1988, BIOMATERIALS, V9, P335, DOI 10.1016/0142-9612(88)90029-4
   NAIR PD, UNPUB STUDIES CYTOXI
   OLEARY RK, 1968, J PHARM SCI, V57, P12, DOI 10.1002/jps.2600570102
   REUTER A, 1969, APPL MICROBIOL, V18, P1057
   ROSE R M, 1984, Journal of Orthopaedic Research, V2, P393, DOI 10.1002/jor.1100020412
   SAWYER PN, 1979, J BIOMED MATER RES, V13, P937, DOI 10.1002/jbm.820130611
   SHINTANI H, 1989, J ANAL TOXICOL, V13, P354, DOI 10.1093/jat/13.6.354
   Shumnes E., 1984, CONTACT DERMATITIS, V10, P240
   SPENLEHAUER G, 1989, BIOMATERIALS, V10, P557, DOI 10.1016/0142-9612(89)90063-X
   Szycher M., 1991, BLOOD COMPATIBLE MAT, P87
   Takesawa S, 1987, Nephrol Dial Transplant, V1, P254
   TURNER DT, 1973, RAD CHEM MACROMOLECU, pCH8
   VINCE DG, 1991, BIOMATERIALS, V12, P731, DOI 10.1016/0142-9612(91)90021-2
   VINK P, 1986, BIOMATERIALS, V7, P225, DOI 10.1016/0142-9612(86)90108-0
   WALL LA, 1955, J POLYM SCI, V17, P141, DOI 10.1002/pol.1955.120178318
NR 39
TC 51
Z9 51
U1 1
U2 17
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD OCT
PY 1995
VL 10
IS 2
BP 121
EP 135
DI 10.1177/088532829501000203
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TQ684
UT WOS:A1995TQ68400003
PM 8618206
DA 2018-10-19
ER

PT J
AU KAETSU, I
AF KAETSU, I
TI RADIATION SYNTHESIS AND FABRICATION FOR BIOMEDICAL APPLICATIONS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 9th International Meeting on Radiation Processing
CY SEP 11-16, 1994
CL ISTANBUL, TURKEY
DE RADIATION POLYMERIZATION; CROSS-LINKING; GRAFTING; IMMOBILIZATION;
   BIOMEDICAL MATERIALS; BIOMEDICAL APPLICATIONS; DRUG DELIVERY SYSTEMS;
   SIGNAL RESPONSIVE CHEMICAL DELIVERY SYSTEMS
ID IMMOBILIZATION
AB Radiation synthesis and fabrication techniques can make various specific forms and structures of materials enhancedly which are useful for biomedical applications, Those materials are a porous gel and membrane, an interpenetrating networked(IPN) hydrogel, a heterogeneous surface phase membrane,an ultra-thin membrane, a biofunctional laminate and an ultra-fine particle. Radiation techniques can attach various biofunctionalities to those materials effectively by means of immobilization of biofunctional components such as enzymes,proteins,hormones,drugs:,microbial cells and tissue cells, It is convenient that the immobilization can be finished at the same time as the synthesis and fabrication in many cases, The applications to bioreactors,biosensors, artificial organs, drug delivery systems and recently to signal responsive chemical delivery systems, have been studied and developed based on those techniques.
RP KAETSU, I (reprint author), KINKI UNIV,FAC SCI & TECHNOL,DEPT NUCL ENGN,KOWAKAE 3-4-1,OSAKA,OSAKA 577,JAPAN.
CR KAETSU I, 1993, ADV POLYM SCI, V105, P81
   KAETSU I, 1985, RADIAT PHYS CHEM, V25, P517, DOI 10.1016/0146-5724(85)90131-1
   KAETSU I, 1981, RADIAT PHYS CHEM, V18, P343, DOI 10.1016/0146-5724(81)90086-8
NR 3
TC 18
Z9 18
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD OCT-DEC
PY 1995
VL 46
IS 4-6
BP 1025
EP 1030
DI 10.1016/0969-806X(95)00314-N
PN 2
PG 6
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA TD120
UT WOS:A1995TD12000021
DA 2018-10-19
ER

PT J
AU BURGESS, LW
AF BURGESS, LW
TI ABSORPTION-BASED SENSORS
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article; Proceedings Paper
CT 2nd European Conference on Optical Chemical Sensors and Biosensors
   (EUROPT(R)ODE II)
CY APR 19-21, 1994
CL FLORENCE, ITALY
DE ABSORPTION; CHEMICAL SENSORS
AB Many chemical sensors based on fiber optics and absorption spectroscopy have been reported in applications ranging from biomedical and environmental monitoring to industrial process control. In these diverse applications, the analyte can be probed directly, by measuring its intrinsic absorption, or by incorporating some transduction mechanism such as a reagent chemistry to enhance sensitivity and selectivity. Physical and performance requirements are placed on a device depending on its intended use. In applications such as chemical process monitoring, survivability and the assurance of the long-term quality of the analytical data are paramount. The above needs have resulted in devices that now employ multivariate data analysis, complex sampling interfaces, and reagent renewal mechanisms. The response from such systems can provide information not only about target analyte(s), but can also signal the presence of interferences, and may potentially be used to follow ser,sor degradation. Examples are given of devices currently being investigated along with a discussion of some of the remaining material, chemical, and optical challenges.
RP BURGESS, LW (reprint author), UNIV WASHINGTON,CTR PROC ANALYT CHEM,BG-10,SEATTLE,WA 98195, USA.
CR ANGEL S, 1989, SPIE P, V1172, P115
   BERMAN RJ, 1990, ANAL CHEM, V62, P2066, DOI 10.1021/ac00218a003
   BERMAN RJ, 1990, SPIE P, V1368, P45
   BERMAN RJ, 1989, SPIE P, V1172, P206
   HENSHAW JM, 1993, THESIS U WASHINGTON
   LIN ZH, 1994, ANAL CHEM, V66, P2552, DOI 10.1021/ac00087a021
   POLANYI ML, 1962, REV SCI INSTRUM, V33, P1050, DOI 10.1063/1.1717679
   Sanchez E., 1990, J CHEMOMETR, V4, P29, DOI DOI 10.1002/CEM.1180040105
   Sanchez E, 1988, J CHEMOMETR, V2, P265
   WEI W, 1992, ANAL CHEM, V64, P22
   Wilson B. E., 1989, J CHEMOMETR, V3, P493
NR 11
TC 13
Z9 13
U1 1
U2 1
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD OCT
PY 1995
VL 29
IS 1-3
BP 10
EP 15
DI 10.1016/0925-4005(95)01657-0
PG 6
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA TD753
UT WOS:A1995TD75300003
DA 2018-10-19
ER

PT J
AU WALSH, D
   MANN, S
AF WALSH, D
   MANN, S
TI FABRICATION OF HOLLOW POROUS SHELLS OF CALCIUM-CARBONATE FROM
   SELF-ORGANIZING MEDIA
SO NATURE
LA English
DT Article
AB A RICH variety of elaborate microscopic skeletal structures composed of inorganic materials are produced in nature(1). Such complex, three-dimensional structures, if produced synthetically, could find important applications as light-weight ceramics, catalyst supports, biomedical implants and robust membranes for high-temperature separation technology. Here we describe a method for synthesizing hollow porous shells of crystalline calcium carbonate (aragonite) that resemble the coccospheres of certain marine algae. We show that thin cellular frameworks of either mesoporous or macroporous aragonite can be formed from oil-water-surfactant microemulsions supersaturated with calcium bicarbonate, with the pore size determined by the relative concentrations of water and oil. Using micrometre-sized polystyrene beads as the substrate for the microemulsion, hollow spherical shells of the honeycomb architecture can be produced. We propose that these cellular frameworks originate from rapid mineralization of aragonite, with a self-organized foam of oil droplets acting as a structural template, and suggest that similar processes could be of general importance in materials chemistry.
C1 UNIV BATH,SCH CHEM,BATH BA2 7AY,AVON,ENGLAND.
RI Mann, Stephen/D-1332-2012
OI Mann, Stephen/0000-0003-3012-8964; Walsh, Dominic/0000-0002-8693-6808
CR KITANO Y, 1962, J GEOPHYS RES, V67, P4873, DOI 10.1029/JZ067i012p04873
   KRESGE CT, 1992, NATURE, V2359, P710
   SCHRIVEN LE, 1960, NATURE, V187, P186
   Sebba F., 1987, FOAMS BILIQUID FOAMS
   THOMPSON DW, 1952, GROWTH FORM, V2, P645
   WALSH D, 1994, SCIENCE, V264, P1576, DOI 10.1126/science.264.5165.1576
   WATZKE HJ, 1994, ADV COLLOID INTERFAC, V50, P1, DOI 10.1016/0001-8686(94)80021-9
   WIDAWSKI G, 1994, NATURE, V369, P387, DOI 10.1038/369387a0
   Winter A., 1994, COCCOLITHOPHORES
NR 9
TC 392
Z9 400
U1 7
U2 151
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA 4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF
SN 0028-0836
J9 NATURE
JI Nature
PD SEP 28
PY 1995
VL 377
IS 6547
BP 320
EP 323
DI 10.1038/377320a0
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA RX111
UT WOS:A1995RX11100049
DA 2018-10-19
ER

PT J
AU GROTH, T
   CAMPBELL, EJ
   HERRMANN, K
   SEIFERT, B
AF GROTH, T
   CAMPBELL, EJ
   HERRMANN, K
   SEIFERT, B
TI APPLICATION OF ENZYME IMMUNOASSAYS FOR TESTING HEMOCOMPATIBILITY OF
   BIOMEDICAL POLYMERS
SO BIOMATERIALS
LA English
DT Article
DE POLYMERS; PLATELET ADHESION ACTIVATION; FIBRINOGEN ADSORPTION;
   MONOCLONAL ANTIBODIES; ENZYME IMMUNOASSAY
ID INTEGRIN ALPHA-IIB-BETA-3; PLATELET ACTIVATION; MONOCLONAL-ANTIBODY;
   HUMAN-FIBRINOGEN; CELL-ADHESION; GAMMA-CHAIN; SURFACES; BLOOD
AB In this study enzyme immunoassays are presented for the assessment of platelet adhesion/activation and fibrinogen adsorption/conformation. The estimation of platelet adhesion and activation was performed with two enzyme immunoassays (EIAs) using monoclonal antibodies directed against CD42b (GP Ib) and CD 62 (GMP 140 or P-Selectin). The applicability of EIA was first demonstrated in microtitre plates coated with fibrinogen. The thrombogenic substrate showed that platelet adhesion and activation reached a plateau level within 30 min. The use of EIA for testing biomaterials was demonstrated with polymeric reference materials where a differentiation of materials with respect to adhesion and activation was achieved. To validate the EIA scanning electron microscopy was applied and confirmed the different extent of adhesion and activation of platelets on reference materials. In addition, polyurethaneureas, based on 4,4'-diphenylmethane diisocyanate and polytetramethylene glycols, with different hard segment content and composition were investigated. It was found that both adhesion and activation were not simply dependent on the hard segment content but also on the hard segment composition. To get more insight into the mechanism of this process, two EIAs for the binding of fibrinogen using polyclonal and monoclonal antibodies were developed. There it was shown that the adhesion and activation of platelets on polyurethaneureas was not simply dependent on the total amount of adsorbed fibrinogen but rather on its conformation, indicated by the binding of the monoclonal antibody directed vs the gamma-chain of fibrinogen.
C1 HUMBOLDT UNIV BERLIN,SCH DENT,D-10098 BERLIN,GERMANY.
   HUMBOLDT UNIV BERLIN,SCH MED,INST ROENTGENDIAGNOST INTERVENT RADIOL,D-10098 BERLIN,GERMANY.
   BIOCOMPATIBLES LTD,UXBRIDGE UB8 3PQ,MIDDX,ENGLAND.
RI Seifert, Barbara/K-7569-2012
OI Groth, Thomas/0000-0001-6647-9657
CR ABSOLOM DR, 1988, J BIOMED MATER RES, V22, P215, DOI 10.1002/jbm.820220306
   ALTANKOV G, 1990, HAEMATOLOGIA, V23, P239
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   CAMPBELL EJ, 1992, MRS S P TISSUE INDUC, P229
   CASTNER DG, 1992, REFERENCE MATERIALS, P173
   DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B
   ELOY R, 1987, THROMB RES, V47, P223
   GEMMELL CH, 1992, 24TH T WORLD BIOM C, P470
   GENTRY PA, 1992, J COMP PATHOL, V107, P243, DOI 10.1016/0021-9975(92)90002-C
   GOODALL AH, 1991, BLOOD COAGUL FIBRIN, V2, P377, DOI 10.1097/00001721-199104000-00024
   GROTH T, 1992, J BIOMAT SCI-POLYM E, V3, P285, DOI 10.1163/156856292X00385
   GROTH T, 1992, BIOMATERIAL TISSUE I, V10, P247
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   HSULIN SC, 1984, J BIOL CHEM, V259, P9121
   HYNES RO, 1991, THROMB HAEMOSTASIS, V66, P40
   KIEFFER N, 1993, ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS, P15
   KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028
   LAMM W, 1993, REFERENCE MATERIALS
   LEMM W, 1992, REFERENCE MATERIALS OF THE EUROPEAN COMMUNITIES, P173
   MARMUR A, 1986, J COLLOID INTERF SCI, V114, P261, DOI 10.1016/0021-9797(86)90260-2
   MCEVER RP, 1984, J BIOL CHEM, V259, P9799
   MISSIRLIS Y, 1992, REFERENCE MATERIALS OF THE EUROPEAN COMMUNITIES, P157
   MOHRI H, 1993, THROMB HAEMOSTASIS, V69, P490
   MULVIHILL JN, 1993, ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS, P69
   MUSTARD JF, 1987, ANN NY ACAD SCI, V516, P12
   PODIAS A, 1994, J BIOMAT SCI-POLYM E, V6, P399
   POOT A, 1993, TEST PROCEDURES BLOO, P229
   SADACOSTA V, 1991, J COLLOID INTERF SCI, V80, P445
   SAKARIASSEN KS, 1988, THROMB HAEMOSTASIS, V60, P392
   SALZMAN EW, 1987, ANN NY ACAD SCI, V516, P184
   SALZMAN EW, 1987, HEMOSTASIS THROMBOSI, P1335
   SHATTIL SJ, 1993, THROMB HAEMOSTASIS, V70, P224
   SIXMA JJ, 1991, J BIOMAT SCI-POLYM E, V3, P17
   SREENIVASAN K, 1991, Clinical Materials, V7, P27, DOI 10.1016/0267-6605(91)90053-I
NR 34
TC 42
Z9 45
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 1995
VL 16
IS 13
BP 1009
EP 1015
DI 10.1016/0142-9612(95)94909-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RM797
UT WOS:A1995RM79700008
PM 8580253
DA 2018-10-19
ER

PT J
AU OKANO, T
   KIKUCHI, A
   SAKURAI, Y
   TAKEI, Y
   OGATA, N
AF OKANO, T
   KIKUCHI, A
   SAKURAI, Y
   TAKEI, Y
   OGATA, N
TI TEMPERATURE-RESPONSIVE POLY(N-ISOPROPYLACRYLAMIDE) AS A MODULATOR FOR
   ALTERATION OF HYDROPHILIC HYDROPHOBIC SURFACE-PROPERTIES TO CONTROL
   ACTIVATION INACTIVATION OF PLATELETS
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 3rd European Symposium on Controlled Drug Delivery
CY APR 04-06, 1994
CL NOORDWIJK, NETHERLANDS
SP 3M Medica GmbH, Germany, Astra Arcus AB, Sweden, Astra Hassle AB, Sweden, Ciba Geigy Ltd, US, Insutech Inc, US, Medisorb Technol Int LP, US, N V Organon Akzo Nobel, Netherlands, Pronova Biopolym a s, Norway, Rhone Poulenc Rorer SA, France, Sandoz Pharma Ltd, Switzerland, Yamanouchi Europe B V, Netherlands
DE POLY (N-ISOPROPYLACRYLAMIDE) (PIPAAM); PIPAAM-GRAFTED SURFACE; CONTACT
   ANGLE; TEMPERATURE-MODULATED SURFACE PROPERTY CHANGES; PLATELET
   ACTIVATION
ID DRUG PERMEATION; CULTURED-CELLS; SKIN LAYERS; POLYMER; HYDROGELS;
   SWITCHES; RELEASE; WATER; POLYSTYRENE; IMMUNOASSAY
AB Our research is directed toward development and fundamental studies of biomedically relevant modulation systems using the temperature-responsive polymer, poly(N-isopropylacrylamide) (PIPAAm) functionalized with a carboxyl end group, as the switching element. This material has been attached to both biomolecules and solid surfaces to create new, modified bioconjugates and grafted surfaces, respectively. PIPAAm was used to introduce a reversible switching function correlated to hydration-dehydration changes of polymer chains in response to changes in temperature, The introduction of PIPAAm chains onto polymer surfaces is intended to impart temperature-responsive surface property changes, These surfaces were prepared using either PIPAAm with a terminal carboxyl end group or random copolymers of IPAAm with acrylic acid. The effects of graft conformation on the dynamics of grafted PIPAAm species were investigated by means of aqueous dynamic contact angle measurement. Each PIPAAm-grafted surface showed completely hydrophilic nature below 20 degrees C, however, these surfaces become hydrophobic above their critical temperature. The extent of hydrophobic property for multipoint-grafted surfaces was small compared to that of the terminally grafted surface. These hydrophilic/hydrophobic surface property changes affect the platelet contact activation. The increase in cytoplasmic [Ca2+](i) in platelets was observed only when PIPAAm grafted surface become hydrophobic, The feasibility of cell activation/inactivation control by temperature-modulated surface changes is attractive as modulator for biomedical systems and this strategy may lead to development of new 'intelligent materials' with specific temperature-modulated surface properties.
C1 SOPHIA UNIV,FAC SCI & TECHNOL,DEPT CHEM,CHIYODA KU,TOKYO 102,JAPAN.
RP OKANO, T (reprint author), TOKYO WOMENS MED COLL,INST BIOMED ENGN,SHINJUKU KU,8-1 KAWADACHO,TOKYO 162,JAPAN.
RI Okano, Teruo/J-4028-2012
CR Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481
   BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609
   CHEN JP, 1990, BIOMATERIALS, V11, P631, DOI 10.1016/0142-9612(90)90020-Q
   COLE CA, 1987, ACS SYM SER, V350, P245
   DETTRE RH, 1964, J PHYS CHEM-US, V69, P1507
   DONG L C, 1986, Journal of Controlled Release, V4, P223, DOI 10.1016/0168-3659(86)90006-4
   FREITAS RFS, 1987, CHEM ENG SCI, V42, P97, DOI 10.1016/0009-2509(87)80213-0
   GAUR RK, 1989, ANAL BIOCHEM, V180, P253, DOI 10.1016/0003-2697(89)90426-0
   GEHRKE SH, 1993, ADV POLYM SCI, V110, P81
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   JOHNSON RE, 1964, J PHYS CHEM-US, V68, P1744, DOI 10.1021/j100789a012
   MATSUKATA M, 1994, J BIOCHEM-TOKYO, V116, P682, DOI 10.1093/oxfordjournals.jbchem.a124580
   MONJI N, 1987, APPL BIOCHEM BIOTECH, V14, P107, DOI 10.1007/BF02798429
   MONJI N, 1990, BIOCHEM BIOPH RES CO, V172, P652, DOI 10.1016/0006-291X(90)90724-2
   OKANO T, 1978, J APPL POLYM SCI, V22, P369, DOI 10.1002/app.1978.070220206
   OKANO T, 1990, J CONTROL RELEASE, V11, P255, DOI 10.1016/0168-3659(90)90138-J
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   OKANO T, 1990, PULSED SELF REGULATE, P17
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   PARK TG, 1993, J BIOMAT SCI-POLYM E, V4, P493
   SMITH L, 1982, J APPL POLYM SCI, V26, P1269
   Starks C. M., 1974, FREE RADICAL TELOMER
   TAKEI YG, 1994, J BIOMAT SCI-POLYM E, V6, P149
   TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035
   TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P42, DOI 10.1021/bc00019a006
   TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P341, DOI 10.1021/bc00023a006
   TAKEI YG, 1995, IN PRESS BIOMATERIAL
   WANG KL, 1993, ADV POLYM SCI, V110, P67
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   YOSHIDA R, 1991, J BIOMAT SCI-POLYM E, V3, P155, DOI 10.1163/156856291X00250
   YOSHIDA R, 1992, J BIOMAT SCI-POLYM E, V3, P243, DOI 10.1163/156856292X00150
   YUI N, 1993, J BIOMAT SCI-POLYM E, V4, P199, DOI 10.1163/156856293X00528
NR 36
TC 80
Z9 85
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD SEP
PY 1995
VL 36
IS 1-2
BP 125
EP 133
DI 10.1016/0168-3659(95)00054-C
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA RV908
UT WOS:A1995RV90800012
DA 2018-10-19
ER

PT J
AU ILZHOEFER, JR
   BROOM, BC
   NEPA, SM
   VOGLER, EA
   KHAN, SA
   SPONTAK, RJ
AF ILZHOEFER, JR
   BROOM, BC
   NEPA, SM
   VOGLER, EA
   KHAN, SA
   SPONTAK, RJ
TI EVIDENCE OF HIERARCHICAL ORDER IN AN AMPHIPHILIC GRAFT TERPOLYMER GEL
SO JOURNAL OF PHYSICAL CHEMISTRY
LA English
DT Letter
ID MICROPHASE SEPARATION; BLOCK-COPOLYMER; SUSPENSIONS; POLYMERS; GELATION;
   RHEOLOGY; MELTS; POINT
AB Graft terpolymers consist of a polymer backbone onto which are grafted two series of chemically dissimilar sidechains. Depending on monomer incompatibility, such terpolymers either order into periodic morphologies or remain microscopically mixed. Addition of a small quantity (<2 wt%) of dibenzylidene sorbitol, a small-molecule gelling agent which self-associates through hydrogen bonding, to a homogeneous (i.e., disordered) amphiphilic graft terpolymer results in a physical gel that exhibits two levels of structural organization. In this initial study, we report on the nature and evolution of such hierarchical order. Interactions between the gellant and terpolymer result in the formation of a fine percolation network comprised of fibrillar strands measuring 10-20 nm in diameter, as determined from scanning electron micrographs. Amorphous micrometer-size spherules, similar in appearance to crystalline spherulites, subsequently develop through nucleation. Dynamic theological measurements reveal that these two distinct levels of microstructural organization are (i) responsible for deformation mechanisms manifested at different strain levels and (ii) recoverable upon mechanical and thermal recycling. These polymer-rich gels constitute a new family of responsive materials which show promise in biomedical applications.
C1 N CAROLINA STATE UNIV, DEPT MAT SCI & ENGN, RALEIGH, NC 27695 USA.
   N CAROLINA STATE UNIV, DEPT CHEM ENGN, RALEIGH, NC 27695 USA.
   BECTON DICKINSON INC, DEPT POLYMER SCI & TECHNOL, RES TRIANGLE PK, NC 27709 USA.
CR ARANGUREN MI, 1992, J RHEOL, V36, P1165, DOI 10.1122/1.550306
   BATES FS, 1990, ANNU REV PHYS CHEM, V41, P525, DOI 10.1146/annurev.pc.41.100190.002521
   Bird R.B., 1987, DYNAMICS POLYM LIQUI, V1
   COVIELLO T, 1992, MACROMOLECULES, V25, P1011, DOI 10.1021/ma00028a082
   CUVELIER G, 1990, MAKROMOL CHEM-M SYMP, V40, P23, DOI 10.1002/masy.19900400105
   EISA T, 1993, BIOMATERIALS, V14, P755, DOI 10.1016/0142-9612(93)90040-9
   FRAAIJE JGEM, 1993, J CHEM PHYS, V99, P9202, DOI 10.1063/1.465536
   FREDRICKSON GH, 1987, J CHEM PHYS, V87, P697, DOI 10.1063/1.453566
   FREDRICKSON GH, 1992, PHYSICS POLYM SURFAC, pCH1
   GARBASSI F, 1994, POLYM SURFACES PHYSI, P285
   GIDO SP, 1993, MACROMOLECULES, V26, P2636, DOI 10.1021/ma00062a040
   HASHIMOTO T, 1989, SPRINGER SERIES CHEM, V51, P2
   HOLDEN G, 1987, THERMOPLASTIC ELASTO, P481
   ILZHOEFER JR, IN PRESS MICROSC RES
   ILZHOEFER JR, IN PRESS LANGMUIR
   KHAN SA, 1994, CHEM MATER, V6, P2359, DOI 10.1021/cm00048a023
   KHAN SA, 1993, J RHEOL, V37, P1225, DOI 10.1122/1.550378
   KHAN SA, 1992, RHEOL ACTA, V31, P151, DOI 10.1007/BF00373237
   KILPATRICK PK, 1994, ACS SYM SER, V578, P229
   KOBAYASHI T, 1989, HIHON REOROJI GAKKAI, V17, P155
   LAURER JH, UNPUB MACROMOLECULES
   LEIBLER L, 1980, MACROMOLECULES, V13, P1602, DOI 10.1021/ma60078a047
   MCCALL PC, 1988, Patent No. 86832092
   MITRA D, 1988, J APPL POLYM SCI, V36, P387, DOI 10.1002/app.1988.070360211
   MITRA D, 1988, POLYMER, V29, P1990, DOI 10.1016/0032-3861(88)90172-3
   MOGI Y, 1992, MACROMOLECULES, V25, P5408, DOI 10.1021/ma00046a043
   MULLER T, 1989, COLLOID POLYM SCI, V267, P230, DOI 10.1007/BF01410580
   PRUDHOMME RK, 1990, ELECTRONIC MATERIALS, P838
   RUSSELL TP, 1994, NATURE, V368, P729, DOI 10.1038/368729a0
   SHIBAYAMA M, 1982, MACROMOLECULES, V15, P274, DOI 10.1021/ma00230a015
   STADLER R, 1995, MACROMOLECULES, V28, P3080, DOI 10.1021/ma00113a010
   TENIJENHUIS K, 1989, MACROMOLECULES, V22, P411
   Thierry A., 1992, PROG COLLOID POLYM S, V87, P28
   TOHYAMA K, 1981, NATURE, V289, P813, DOI 10.1038/289813a0
   UTRACKI LA, 1990, POLYM ALLOYS BLENDS, P117
   WIDAWSKI G, 1994, NATURE, V369, P387, DOI 10.1038/369387a0
   YANG MC, 1986, J RHEOL, V30, P1015, DOI 10.1122/1.549892
NR 37
TC 21
Z9 21
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-3654
J9 J PHYS CHEM-US
JI J. Phys. Chem.
PD AUG 10
PY 1995
VL 99
IS 32
BP 12069
EP 12071
DI 10.1021/j100032a002
PG 3
WC Chemistry, Physical
SC Chemistry
GA RN706
UT WOS:A1995RN70600002
DA 2018-10-19
ER

PT J
AU BOOS, KS
   RUDOLPHI, A
   VIELHAUER, S
   WALFORT, A
   LUBDA, D
   EISENBEISS, F
AF BOOS, KS
   RUDOLPHI, A
   VIELHAUER, S
   WALFORT, A
   LUBDA, D
   EISENBEISS, F
TI ALKYL-DIOL SILICA (ADS) - RESTRICTED ACCESS PRECOLUMN PACKINGS FOR
   DIRECT-INJECTION AND COUPLED-COLUMN CHROMATOGRAPHY OF BIOFLUIDS
SO FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY
LA English
DT Article
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; CLEANUP; HPLC
AB The direct and repetitive injection of untreated biological fluids (e.g. hemolyzed blood, plasma, serum, cell culture and tissue homogenates) onto an HPLC-system and the subsequent analysis of low-molecular weight compounds (e.g. drugs, xenobiotics, metabolites) is rendered possible by a coupled-column configuration and special precolumn packings. For this purpose a new family of chemically and enzymatically tailored reversed-phase packing materials have been prepared. The LC-integrated sample clean-up with these restricted access (bimodal) phases is based on the complete nonadsorptive size exclusion of macromolecules (e.g. proteins) and on the simultaneous dynamic partitioning of the target molecules, The bonded phase which exclusively covers the internal pore surface of a glyceryl-modified silica is a butyryl-(C-4), capryloyl-(C-8) or stearoyl-(C-18) moiety. These ligands allow a classical reversed-phase or ion-pair chromatography during the sample work-up step. The capacity of the n-alkyl phase is comparable with conventional silica based RP-materials. The broad hydrophobic retentive capability of these packings allows the extraction of a wide variety of compounds of biomedical interest. The electroneutral and hydrophilic particle exterior (glyceryl-residues) was generated using either soluble or immobilized enzymes (lipase, esterase) which cleave the fatty acid esters exclusively at the outer surface. Unwanted macromolecular components of a sample (e.g. proteins) are quantitatively eluted in the void volume due to the restricted access given by the pore size (6 nm) and the nonadsorptive external diol coverage. The lifetime of a precolumn (25 x 4 mm I.D.) packed with these novel bimodal, i.e. RP-SEC phases exceeds more than 200 injections of 500 mu l plasma. In addition to the synthesis, this paper describes an application of each of these Alkyl-Diol Silica (ADS) precolumn packings in fully automated coupled-column HPLC systems for the analysis of drugs and endogenous compounds in different biological matrices.
C1 E MERCK AG,D-64271 DARMSTADT,GERMANY.
RP BOOS, KS (reprint author), UNIV HOSP MUNICH,INST CLIN CHEM,POB 701260,D-81312 MUNICH,GERMANY.
CR ANDERSON DJ, 1993, ANAL CHEM, V65, pR434
   [Anonymous], 1980, ANAL CHEM, V52, P2242
   BOOS KS, 1988, J CHROMATOGR, V456, P93, DOI 10.1016/0021-9673(86)80009-7
   BOOS KS, 1991, Patent No. 4130475
   HAGINAKA J, 1991, TRAC-TREND ANAL CHEM, V10, P17, DOI 10.1016/0165-9936(91)85040-X
   HAGINAKA J, 1989, ANAL CHEM, V61, P2445, DOI 10.1021/ac00196a024
   HUBER JFK, 1973, J CHROMATOGR, V83, P267, DOI 10.1016/S0021-9673(00)97044-4
   IMAI H, 1989, ANAL SCI, V5, P389, DOI 10.2116/analsci.5.389
   KIMATA K, 1991, J CHROMATOGR, V558, P19, DOI 10.1016/0021-9673(91)80108-S
   MEISER BM, 1994, TRANSPLANTATION, V57, P563
   OOSTERKAMP AJ, 1994, J CHROMATOGR B, V653, P55, DOI 10.1016/0378-4347(93)E0405-F
   OOSTERKAMP AJ, 1994, ANAL CHEM, V66, P4295, DOI 10.1021/ac00095a028
   PINKERTON TC, 1991, J CHROMATOGR, V544, P13, DOI 10.1016/S0021-9673(01)83975-3
   RUDOLPHI A, 1995, J PHARMACEUT BIOMED, V13, P615, DOI 10.1016/0731-7085(95)01317-E
   SHIHABI ZK, 1988, J LIQ CHROMATOGR, V11, P1579, DOI 10.1080/01483918808076722
   UNGER KK, 1991, CHROMATOGRAPHIA, V31, P507, DOI 10.1007/BF02262398
   VIELHAUER S, 1995, J CHROMATOGR B, V666, P315, DOI 10.1016/0378-4347(94)00578-S
   WESTERLUND D, 1987, CHROMATOGRAPHIA, V24, P155, DOI 10.1007/BF02688478
   YU Z, 1994, 5TH INT S PHARM BIOM, P117
NR 19
TC 106
Z9 106
U1 0
U2 18
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0937-0633
J9 FRESEN J ANAL CHEM
JI Fresenius J. Anal. Chem.
PD AUG
PY 1995
VL 352
IS 7-8
BP 684
EP 690
DI 10.1007/BF00323048
PG 7
WC Chemistry, Analytical
SC Chemistry
GA RR550
UT WOS:A1995RR55000014
DA 2018-10-19
ER

PT J
AU KOBAYASHI, E
   MATSUMOTO, S
   DOI, H
   YONEYAMA, T
   HAMANAKA, H
AF KOBAYASHI, E
   MATSUMOTO, S
   DOI, H
   YONEYAMA, T
   HAMANAKA, H
TI MECHANICAL-PROPERTIES OF THE BINARY TITANIUM-ZIRCONIUM ALLOYS AND THEIR
   POTENTIAL FOR BIOMEDICAL MATERIALS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID TI
AB Mechanical properties of titanium-zirconium binary alloys were investigated in order to reveal their possible use for new biomedical materials and to collect useful data for alloy design through a hardness test, a tensile test, and optical microscopy. The hardness of the alloy containing 50% zirconium was approximately 2.5 times as large as the hardness of pure titanium and pure zirconium. Tensile tests showed a similar tendency. No changes between hardness of as cast specimens and as homogenized specimens were observed, nor were changes in microstructures noted. Comparisons between the Ti-6Al-4V alloy and the Ti-Zr-6Al-4V alloy indicated that a titanium-zirconium alloy could provide a base material for a new biomedical alloy. From these results, it was concluded that new alloys for biomedical materials should be designed as titanium-zirconium base alloys. (C) 1995 John Wiley and Sons, Inc.
C1 TOKYO INST POLYTECH,DEPT IND CHEM,ATSUGI,KANAGAWA 24303,JAPAN.
RP KOBAYASHI, E (reprint author), TOKYO MED & DENT UNIV,INST MED & DENT ENGN,CHIYODA KU,2-3-10 KANDA SURUGADAI,TOKYO 101,JAPAN.
CR Douglass D.L, 1963, ATOM ENERGY REV, V3, P71
   ETCHU Y, 1992, J JPN SOC DENT MAT D, V11, P270
   FLEISCHER RL, 1963, ACTA METALL MATER, V11, P203, DOI 10.1016/0001-6160(63)90213-X
   FRIEDEL J, 1964, DISLOCATIONS, P351
   HAMANAKA H, 1989, J DENT RES, V68, P1529, DOI 10.1177/00220345890680111201
   IMGRAM AG, 1962, J LESS-COMMON MET, V4, P217, DOI 10.1016/0022-5088(62)90068-1
   MOTT NF, 1947, STRENGTH SOLIDS
   Murray J. L., 1987, PHASE DIAGRAMS BINAR, P340
   OKUNO O, 1985, J JPN SOC DENT MAT D, V4, P408
   SUZUKI T, 1967, PHYSICS STRENGTH PLA
   SUZUKI T, 1967, DISLOCATION DYNAMICS
   TAKAHASHI M, 1994, UNPUB
   Yamamoto Y., 1989, Shimadzu Review, V46, P63
   Yoneyama T, 1992, Dent Mater J, V11, P1
   YONEYAMA T, 1993, J BIOMED MATER RES, V27, P399, DOI 10.1002/jbm.820270313
   YONEYAMA T, 1994, J JPN DENT MAT DEVIC, V13, P213
   Yoneyama T, 1993, J JPN SOC BIOMATER, V11, P71
NR 17
TC 128
Z9 134
U1 2
U2 47
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1995
VL 29
IS 8
BP 943
EP 950
DI 10.1002/jbm.820290805
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RL619
UT WOS:A1995RL61900004
PM 7593037
DA 2018-10-19
ER

PT J
AU BURNY, F
   DONKERWOLCKE, M
   MUSTER, D
AF BURNY, F
   DONKERWOLCKE, M
   MUSTER, D
TI BIOMATERIALS EDUCATION - A CHALLENGE FOR MEDICINE AND INDUSTRY IN THE
   LATE 1990S
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT 1st European-Material-Research-Society Symposium on Advanced Materials
   Education
CY MAY 24-26, 1994
CL STRASBOURG, FRANCE
SP European Mat Res Soc
DE BIOMATERIALS; EDUCATION; INDUSTRY; UNIVERSITY
AB To treat diseases or disabilities, medicine and surgery use drugs and/or biomaterials. Devices used in the biomedical sector are often classified as a single sector (biomedical devices) which in reality comprises different market niches requiring appropriate R&D approaches. Throughout Europe, many biomaterials experts participate in formal or informal networks and existing protocols in research. The networks were reinforced by the creation of national and European Meetings, the support of the EC in projects such as Brite Euram. The interdisciplinary nature of the teaching is critical; permanent education and in-job training are imperatives. University researchers in materials science should spin off ideas into campus companies or small industries. A proposal was made for a European Advanced Course on Biomaterials, leading to the degree of Master of Science. A cooperative effort must be chartered, in which leaders in business help the educational system produce the technically literate person that the 21st century will demand.
C1 UNIV STRASBOURG 1,CHRU,LEED BIOMAT,STRASBOURG,FRANCE.
RP BURNY, F (reprint author), FREE UNIV BRUSSELS,HOP ERASME,DEPT ORTHOPED & TRAUMATOL,BRUSSELS,BELGIUM.
CR BLACK J, 1992, J APPL BIOMATER, V3, P231, DOI 10.1002/jab.770030311
   BORETOS JW, 1984, CONT BIOMATERIAL
   DESAHAGUN, 1938, HIST GENERAL COSAS N
   GUIBAL P, 1903, THESIS PARIS
   HALL CW, 1971, J BIOMED MATER RES 1, V2, P1
   LAMBOTTE A, 1935, NOUVELLES MED ILLUST, V22, P1
   RICHE M, 1925, B MEM SOC CHIR PARIS, P11
   SUTTON NG, 1935, MED J AUSTRALIA, V2, P611
   WILLEMS, 1992, EUROPEAN MARKET BIOM
   Williams D. F., 1987, DEFINITIONS BIOMATER
   1982, CONSENSUS DEV C BETH
NR 11
TC 9
Z9 9
U1 0
U2 2
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD AUG 1
PY 1995
VL 199
IS 1
BP 53
EP 59
DI 10.1016/0921-5093(95)09907-7
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA RU806
UT WOS:A1995RU80600010
DA 2018-10-19
ER

PT J
AU TABATA, Y
   SATO, S
   OMICHI, H
AF TABATA, Y
   SATO, S
   OMICHI, H
TI 2ND INTERNATIONAL-SYMPOSIUM ON RADIATION TECHNOLOGY IN BIOMEDICAL
   MATERIALS - PREFACE
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Editorial Material
NR 0
TC 3
Z9 3
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD AUG
PY 1995
VL 46
IS 2
BP 157
EP 157
DI 10.1016/0969-806X(95)90037-M
PG 1
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA RK077
UT WOS:A1995RK07700001
DA 2018-10-19
ER

PT J
AU BAYNE, SC
   SWIFT, EJ
   THOMPSON, JY
AF BAYNE, SC
   SWIFT, EJ
   THOMPSON, JY
TI REVIEW OF DENTAL MATERIALS CITATIONS .A. JANUARY TO JUNE 1995
SO DENTAL MATERIALS
LA English
DT Review
AB Objective: Electronic databases are an excellent resource for identifying relevant references for research and education projects. However, these databases are not yet a substitute for direct inspection of the literature because: (a) there still is a lag of many months between journal issue publication and updates of the database, and (b) most databases selectively report a portion of the entire literature. The objective was to identify and categorize all the dental materials citations in biomedical journals that were published from January 1995 through June 1995.
   Methods: Seventeen primary and 56 secondary dental journals were manually searched via their tables of contents to detect dental materials publications from January to June of 1995. Denial materials citations were categorized into 17 major sections and further divided into several subsections. The review excluded case reports and literature primarily related to dental implants or biomedical materials outside of dentistry.
   Results: Three hundred-sixty-nine citations were identified. The greatest number of citations were associated with dentin bonding, composites, and glass ionomers. There was no significant increase in dental materials publications vs. the number reported for 1994.
   Significance: This list provides a comprehensive source for review by academicians and researchers to bridge the gap between initial publication and electronic citation.
RP BAYNE, SC (reprint author), UNIV N CAROLINA,SCH DENT,DEPT OPERAT DENT,CHAPEL HILL,NC 27599, USA.
CR AIDA M, 1995, J PROSTHET DENT, V73, P464, DOI 10.1016/S0022-3913(05)80076-9
   AKINMADE AO, 1995, BIOMATERIALS, V16, P149, DOI 10.1016/0142-9612(95)98279-N
   Al-Waheidi E M, 1995, Quintessence Int, V26, P385
   ANASTASSIADOU V, 1995, DENT MATER, V11, P182, DOI 10.1016/0109-5641(95)80015-8
   ANDERSSON OH, 1995, J MATER SCI-MATER M, V6, P242, DOI 10.1007/BF00146863
   ANDERSSONWENCKE.IE, 1995, ASDC J DENT CHILD, V62, P197
   ANUSAVICE KJ, 1995, DENT MATER, V11, P102, DOI 10.1016/0109-5641(95)80042-5
   ARIMA T, 1995, J PROSTHET DENT, V73, P55, DOI 10.1016/S0022-3913(05)80273-2
   ARITA IH, 1995, J MATER SCI MAT MED, V6, P9
   ASMUSSEN E, 1995, J DENT RES, V74, P715, DOI 10.1177/00220345950740021501
   BALES DJ, 1991, CURR OPIN DENT, V1, P253
   BALES DJ, 1992, CURR OPIN DENT, V2, P183
   BALES DJ, 1991, CURR OPIN DENT, V1, P245
   Balevi B, 1995, Oral Health, V85, P29
   BARNETT ML, 1995, J DENT RES, V74, P1129, DOI 10.1177/00220345950740041401
   BASKETTER D, 1995, CONTACT DERMATITIS, V32, P65, DOI 10.1111/j.1600-0536.1995.tb00748.x
   BAUMGARDNER KR, 1995, J AM DENT ASSOC, V126, P351, DOI 10.14219/jada.archive.1995.0180
   BAYNE SC, 1994, DENT MATER, V10, P59, DOI 10.1016/0109-5641(94)90023-X
   Beckett H, 1995, Quintessence Int, V26, P217
   BENAMAR A, 1995, J ORAL REHABIL, V22, P101, DOI 10.1111/j.1365-2842.1995.tb00242.x
   BERDOUSES E, 1995, J DENT RES, V74, P1185, DOI 10.1177/00220345950740050701
   BERRY TG, 1995, AM J DENT, V8, P122
   Berte J J, 1995, J Prosthodont, V4, P129, DOI 10.1111/j.1532-849X.1995.tb00328.x
   Bester S P, 1995, Int J Prosthodont, V8, P46
   BICHACHO N, 1995, OPER DENT, V20, P68
   Binon P P, 1995, Int J Prosthodont, V8, P162
   BISHARA SE, 1995, ANGLE ORTHOD, V65, P117
   Blight S J, 1995, Br J Orthod, V22, P35
   Bott B, 1995, J Esthet Dent, V7, P110, DOI 10.1111/j.1708-8240.1995.tb00727.x
   BRAEM MJA, 1995, DENT MATER, V11, P137, DOI 10.1016/0109-5641(95)80049-2
   BRANTLEY WA, 1995, DENT MATER, V11, P154, DOI 10.1016/0109-5641(95)80011-5
   Briseno B, 1995, Quintessence Int, V26, P361
   Bruce G J, 1995, Compend Contin Educ Dent, V16, P180
   BRUZE M, 1995, CONTACT DERMATITIS, V32, P156, DOI 10.1111/j.1600-0536.1995.tb00806.x
   Buch D, 1995, Int J Prosthodont, V8, P285
   Burke F J, 1995, Quintessence Int, V26, P293
   BURROW MF, 1995, J DENT, V23, P41, DOI 10.1016/0300-5712(95)90659-6
   CAFRUNY WA, 1995, AM J DENT, V8, P152
   CAMPS J, 1995, DENT MATER, V11, P177, DOI 10.1016/0109-5641(95)80014-X
   CARVALHO RM, 1995, AM J DENT, V8, P128
   CERNAVIN I, 1995, AUST DENT J, V40, P79, DOI 10.1111/j.1834-7819.1995.tb03120.x
   Chadwick S M, 1995, Br J Orthod, V22, P113
   Chadwick S M, 1995, Br J Orthod, V22, P29
   CHAI TI, 1995, J PROSTHET DENT, V73, P534, DOI 10.1016/S0022-3913(05)80112-X
   Chan DCN, 1995, QUINTESSENCE INT, V26, P57
   Chirtoc M, 1995, Int J Prosthodont, V8, P259
   Cho E, 1995, Quintessence Int, V26, P351
   CHO GC, 1995, J PROSTHET DENT, V73, P419, DOI 10.1016/S0022-3913(05)80068-X
   CHRISTENSEN GJ, 1995, J AM DENT ASSOC, V126, P781, DOI 10.14219/jada.archive.1995.0274
   CHRISTENSEN GJ, 1995, J AM DENT ASSOC, V126, P503, DOI 10.14219/jada.archive.1995.0215
   CIPRIANO TM, 1995, J PROSTHET DENT, V73, P8, DOI 10.1016/S0022-3913(05)80265-3
   Cohen B I, 1995, Oral Health, V85, P7
   Cohen B I, 1995, J Esthet Dent, V7, P174, DOI 10.1111/j.1708-8240.1995.tb00574.x
   Cohen B I, 1995, Compend Contin Educ Dent, V16, P630
   Cornell D F, 1995, J Esthet Dent, V7, P81, DOI 10.1111/j.1708-8240.1995.tb00566.x
   Counts A L, 1995, J Prosthodont, V4, P3, DOI 10.1111/j.1532-849X.1995.tb00306.x
   Croll T P, 1995, Quintessence Int, V26, P121
   Croll Theodore P., 1995, ASDC (American Society of Dentistry for Children) Journal of Dentistry for Children, V62, P17
   Cunningham J L, 1995, Int J Prosthodont, V8, P69
   CZERW RJ, 1995, OPER DENT, V20, P58
   DARIEL MP, 1995, DENT MATER, V11, P211
   DARR AH, 1995, J ORAL REHABIL, V22, P43, DOI 10.1111/j.1365-2842.1995.tb00209.x
   Davis B A, 1995, J Prosthodont, V4, P111, DOI 10.1111/j.1532-849X.1995.tb00325.x
   DEGROOD ME, 1995, J ENDODONT, V21, P65, DOI 10.1016/S0099-2399(06)81097-6
   DEHOFF PH, 1995, DENT MATER, V11, P126, DOI 10.1016/0109-5641(95)80047-6
   DENISSEN H, 1995, J MATER SCI-MATER M, V6, P35, DOI 10.1007/BF00121245
   DERAND T, 1995, DENT MATER, V11, P93, DOI 10.1016/0109-5641(95)80040-9
   DERHAMI K, 1995, OPER DENT, V20, P100
   DIAZARNOLD AM, 1995, AM J DENT, V8, P134
   DIAZARNOLD AM, 1995, DENT MATER, V11, P96, DOI 10.1016/0109-5641(95)80041-7
   Dietschi D, 1995, Quintessence Int, V26, P127
   DIXON DL, 1995, J PROSTHET DENT, V73, P510, DOI 10.1016/S0022-3913(05)80108-8
   Dominici J T, 1995, J Prosthodont, V4, P101, DOI 10.1111/j.1532-849X.1995.tb00324.x
   DONACHIE MA, 1995, J DENT, V23, P157, DOI 10.1016/0300-5712(95)93573-K
   Downing A, 1995, Br J Orthod, V22, P41
   DRIESSENS FCM, 1995, J MATER SCI-MATER M, V6, P272, DOI 10.1007/BF00120270
   DYSON JE, 1995, AUST DENT J, V40, P50, DOI 10.1111/j.1834-7819.1995.tb05615.x
   ECONOMIDES N, 1995, J ENDODONT, V21, P122, DOI 10.1016/S0099-2399(06)80436-X
   EICK JD, 1995, J DENT RES, V74, P1246, DOI 10.1177/00220345950740060201
   EIDE R, 1995, ACTA ODONTOL SCAND, V53, P12, DOI 10.3109/00016359509005937
   ELBADRAWY WA, 1995, J PROSTHET DENT, V73, P515, DOI 10.1016/S0022-3913(05)80109-X
   Ergas R P, 1995, Pediatr Dent, V17, P204
   Fanning D E, 1995, Gen Dent, V43, P256
   FEILZER AJ, 1995, DENT MATER, V11, P186, DOI 10.1016/0109-5641(95)80016-6
   FIELD MJ, 1995, J AM DENT ASSOC, V126, P191, DOI 10.14219/jada.archive.1995.0144
   FISCHMAN SL, 1995, J DENT RES, V74, P1117
   FISCHMAN SL, 1995, J DENT RES, V74, P1116
   FLINT GN, 1995, CONTACT DERMATITIS, V32, P218, DOI 10.1111/j.1600-0536.1995.tb00672.x
   FRANCHI M, 1995, J MATER SCI-MATER M, V6, P187, DOI 10.1007/BF00146853
   FRANCHI M, 1995, QUINTESSENCE INT, V26, P431
   FRIEDL KH, 1995, OPER DENT, V20, P34
   FRIEDL KH, 1995, OPER DENT, V20, P74
   FUJISHIMA A, 1995, DENT MATER, V11, P82, DOI 10.1016/0109-5641(95)80038-7
   Futatsuki M, 1995, J Clin Pediatr Dent, V19, P99
   Garcia-Godoy F, 1995, J Clin Pediatr Dent, V19, P181
   Gegauff A G, 1995, Int J Prosthodont, V8, P62
   GEMALMAZ D, 1995, J PROSTHET DENT, V73, P49
   GERZINA TM, 1995, J DENT RES, V74, P369, DOI 10.1177/00220345950740011301
   GILMOUR ASM, 1995, J PROSTHET DENT, V73, P569, DOI 10.1016/S0022-3913(05)80118-0
   GIORDANO RA, 1995, J PROSTHET DENT, V73, P411, DOI 10.1016/S0022-3913(05)80067-8
   GIRAY CB, 1995, AUST DENT J, V40, P43, DOI 10.1111/j.1834-7819.1995.tb05613.x
   GIVAN DA, 1995, J PROSTHET DENT, V73, P377
   GLUSKIN AH, 1995, J ENDODONT, V21, P33, DOI 10.1016/S0099-2399(06)80554-6
   Godder Benjamin, 1995, General Dentistry, V43, P252
   GOLDBERG M, 1995, J DENT, V23, P15, DOI 10.1016/0300-5712(95)90655-2
   GOLDSTEIN RE, 1995, J AM DENT ASSOC, V126, P761, DOI 10.14219/jada.archive.1995.0271
   GRANCHI D, 1995, ORAL SURG ORAL MED O, V79, P359, DOI 10.1016/S1079-2104(05)80230-6
   GRIPPO JO, 1995, J AM DENT ASSOC, V126, P619, DOI 10.14219/jada.archive.1995.0241
   GROSSMAN ES, 1995, J PROSTHET DENT, V73, P199, DOI 10.1016/S0022-3913(05)80162-3
   GROSSMAN ES, 1995, J PROSTHET DENT, V73, P290, DOI 10.1016/S0022-3913(05)80208-2
   Gruythuysen R. J. M., 1995, ASDC (American Society of Dentistry for Children) Journal of Dentistry for Children, V62, P22
   Guzman A, 1995, Int J Prosthodont, V8, P179
   GWINNETT AJ, 1995, AM J DENT, V8, P109
   HALBACH S, 1995, J DENT RES, V74, P1103, DOI 10.1177/00220345950740041101
   HARRINGTON E, 1995, J ORAL REHABIL, V22, P377, DOI 10.1111/j.1365-2842.1995.tb00788.x
   HASEGAWA T, 1995, J PROSTHET DENT, V73, P432, DOI 10.1016/S0022-3913(05)80071-X
   HATA G, 1995, J ENDODONT, V21, P167, DOI 10.1016/S0099-2399(06)80559-5
   Haug S P, 1995, J Prosthodont, V4, P11, DOI 10.1111/j.1532-849X.1995.tb00308.x
   HAUTANIEMI JA, 1995, J MATER SCI-MATER M, V6, P46, DOI 10.1007/BF00121247
   HAYAKAWA T, 1995, DENT MATER, V11, P221
   Hembree J H Jr, 1995, Quintessence Int, V26, P145
   Henderson B, 1995, J Can Dent Assoc, V61, P429
   HILL R, 1995, J MATER SCI-MATER M, V6, P311, DOI 10.1007/BF00120298
   HIMEL VT, 1995, J ENDODONT, V21, P142, DOI 10.1016/S0099-2399(06)80440-1
   HINOURA K, 1995, OPER DENT, V20, P30
   HISATSUNE K, 1995, J MATER SCI-MATER M, V6, P284, DOI 10.1007/BF00120272
   HOLTAN JR, 1995, OPER DENT, V20, P94
   HOLTAN JR, 1995, J AM DENT ASSOC, V126, P611, DOI 10.14219/jada.archive.1995.0240
   HONG YH, 1995, EUR J ORTHODONT, V17, P121, DOI 10.1093/ejo/17.2.121
   Hosoya Y, 1995, J Clin Pediatr Dent, V19, P185
   HOTTA M, 1995, J ORAL REHABIL, V22, P197, DOI 10.1111/j.1365-2842.1995.tb01564.x
   HOVAV S, 1995, OPER DENT, V20, P63
   HTANG A, 1995, DENT MATER, V11, P7, DOI 10.1016/0109-5641(95)80002-6
   HUNTER AR, 1995, OPER DENT, V20, P2
   Hurzeler M B, 1995, Int J Prosthodont, V8, P142
   HUTTON JE, 1995, J PROSTHET DENT, V73, P126, DOI 10.1016/S0022-3913(05)80150-7
   IMAZATO S, 1995, J DENT, V23, P177, DOI 10.1016/0300-5712(95)93576-N
   IMBERY TA, 1995, J AM DENT ASSOC, V126, P753, DOI 10.14219/jada.archive.1995.0270
   IMBERY TA, 1995, AM J DENT, V8, P117
   INDRANI DJ, 1995, DENT MATER, V11, P201, DOI 10.1016/0109-5641(95)80019-0
   INOKOSHI S, 1995, OPER DENT, V20, P111
   IVANOVSKI S, 1995, DENT MATER, V11, P19, DOI 10.1016/0109-5641(95)80004-2
   JACOBSEN T, 1995, DENT MATER, V11, P132, DOI 10.1016/0109-5641(95)80048-4
   JAGGER DC, 1995, J ORAL REHABIL, V22, P275, DOI 10.1111/j.1365-2842.1995.tb00086.x
   JAGGER DC, 1995, J ORAL REHABIL, V22, P349, DOI 10.1111/j.1365-2842.1995.tb00784.x
   JANDA R, 1995, BIOMATERIALS, V16, P209, DOI 10.1016/0142-9612(95)92119-Q
   JENDRESEN MD, 1993, J PROSTHET DENT, V70, P44, DOI 10.1016/0022-3913(93)90036-N
   JENDRESEN MD, 1995, J PROSTHET DENT, V74, P60, DOI 10.1016/S0022-3913(05)80231-8
   JENDRESEN MD, 1994, J PROSTHET DENT, V72, P39, DOI 10.1016/0022-3913(94)90214-3
   JEPSON NJA, 1995, J DENT, V23, P123, DOI 10.1016/0300-5712(95)98979-D
   JOHANSSON BI, 1995, DENT MATER, V11, P41, DOI 10.1016/0109-5641(95)80007-7
   Johnston W M, 1995, Int J Prosthodont, V8, P79
   JONTELL M, 1995, J DENT RES, V74, P1162, DOI 10.1177/00220345950740050401
   Jou G L, 1995, J Clin Orthod, V29, P184
   KALACHANDRA S, 1995, J MATER SCI-MATER M, V6, P218, DOI 10.1007/BF00146859
   KAPLOWITZ GJ, 1995, J AM DENT ASSOC, V126, P486, DOI 10.14219/jada.archive.1995.0212
   KARLSSON S, 1995, J ORAL REHABIL, V22, P9, DOI 10.1111/j.1365-2842.1995.tb00204.x
   KARLZENREUTERVI.G, 1995, ASDC J DENT CHILD, V62, P108
   KELLY JR, 1995, DENT MATER, V11, P103, DOI 10.1016/0109-5641(95)80043-3
   KELLY JR, 1995, J DENT RES, V74, P1253, DOI 10.1177/00220345950740060301
   KELSEY WP, 1995, QUINTESSENCE INT, V26, P15
   KERN M, 1995, J DENT, V23, P47, DOI 10.1016/0300-5712(95)90660-A
   KERN M, 1995, J PROSTHET DENT, V73, P240, DOI 10.1016/S0022-3913(05)80200-8
   Kern M, 1995, J Prosthodont, V4, P16, DOI 10.1111/j.1532-849X.1995.tb00309.x
   KEROSUO H, 1995, ANGLE ORTHOD, V65, P111
   Keyf Filiz, 1995, Journal of Nihon University School of Dentistry, V37, P1
   KINNEY JH, 1995, J DENT RES, V74, P1179, DOI 10.1177/00220345950740050601
   Kocadereli I, 1995, J Clin Pediatr Dent, V19, P127
   KONONEN M, 1995, J PROSTHET DENT, V73, P4, DOI 10.1016/S0022-3913(05)80264-1
   KOPPANG R, 1995, J PROSTHET DENT, V73, P486, DOI 10.1016/S0022-3913(05)80080-0
   KOTSIOMITI E, 1995, J ORAL REHABIL, V22, P135, DOI 10.1111/j.1365-2842.1995.tb00247.x
   KOVARIK RE, 1995, AM J DENT, V8, P145
   KREJCI I, 1995, DENT MATER, V11, P34, DOI 10.1016/0109-5641(95)80006-9
   KVAM K, 1995, BIOMATERIALS, V16, P73, DOI 10.1016/0142-9612(95)91099-K
   LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317
   LARMOUR CJ, 1995, J DENT, V23, P37, DOI 10.1016/0300-5712(95)90658-5
   Laurell K A, 1995, Quintessence Int, V26, P139
   Lee Charles Q., 1995, General Dentistry, V43, P158
   LEE SY, 1995, J DENT, V23, P27, DOI 10.1016/0300-5712(95)90657-4
   LEEMPOEL PJB, 1995, J ORAL REHABIL, V22, P327, DOI 10.1111/j.1365-2842.1995.tb00780.x
   Lefebvre C A, 1995, Int J Prosthodont, V8, P122
   LEINFELDER KF, 1995, J AM DENT ASSOC, V126, P663, DOI 10.14219/jada.archive.1995.0247
   LENZ J, 1995, J APPL BIOMATER, V6, P55, DOI 10.1002/jab.770060108
   LEUNG YC, 1995, DENT MATER, V11, P191, DOI 10.1016/0109-5641(95)80017-4
   LIAO WM, 1995, J ORAL REHABIL, V22, P67
   LIBERMAN R, 1995, J ORAL REHABIL, V22, P445, DOI 10.1111/j.1365-2842.1995.tb00799.x
   Libman W J, 1995, Int J Prosthodont, V8, P155
   Liebenberg W H, 1995, J Esthet Dent, V7, P155, DOI 10.1111/j.1708-8240.1995.tb00572.x
   Liebenberg William H., 1995, General Dentistry, V43, P50
   Lim P F, 1995, Int J Prosthodont, V8, P117
   LIN JHC, 1995, J ORAL REHABIL, V22, P331, DOI 10.1111/j.1365-2842.1995.tb00781.x
   LLOYD CH, 1995, J DENT, V23, P67, DOI 10.1016/0300-5712(95)98973-7
   Loney R W, 1995, Int J Prosthodont, V8, P247
   LONNROTH EC, 1995, SWED DENT J, V19, P55
   LORSCHEIDER FL, 1995, FASEB J, V9, P504
   LUEBKE NH, 1995, J ENDODONT, V21, P259, DOI 10.1016/S0099-2399(06)80993-3
   LYGRE H, 1995, ACTA ODONTOL SCAND, V53, P75, DOI 10.3109/00016359509005950
   Lyzak W A, 1995, J Prosthodont, V4, P133, DOI 10.1111/j.1532-849X.1995.tb00329.x
   LYZAK WA, 1995, GEN DENT, V43, P49
   MACHIDA T, 1995, J ENDODONT, V21, P88, DOI 10.1016/S0099-2399(06)81102-7
   MACKERT JR, 1995, J DENT RES, V74, P1259, DOI 10.1177/00220345950740060401
   MACPHERSON LC, 1995, BRIT DENT J, V178, P341, DOI 10.1038/sj.bdj.4808760
   MAFFEZZOLI A, 1995, J MATER SCI-MATER M, V6, P155, DOI 10.1007/BF00120292
   MAFFEZZOLI A, 1995, J MATER SCI-MATER M, V6, P161, DOI 10.1007/BF00120293
   MAIR LH, 1995, J DENT, V23, P107, DOI 10.1016/0300-5712(95)98976-A
   Manga R K, 1995, Gen Dent, V43, P241
   MANTON DJ, 1995, AUST DENT J, V40, P22, DOI 10.1111/j.1834-7819.1995.tb05608.x
   Matasa C G, 1995, J Clin Orthod, V29, P16
   MATSUMURA H, 1995, J PROSTHET DENT, V73, P386, DOI 10.1016/S0022-3913(05)80336-1
   MATSUMURA H, 1995, J PROSTHET DENT, V73, P233, DOI 10.1016/S0022-3913(05)80199-4
   MAY KB, 1995, J PROSTHET DENT, V73, P428, DOI 10.1016/S0022-3913(05)80070-8
   Mazzeo N, 1995, Pediatr Dent, V17, P112
   McCracken MS, 1995, QUINTESSENCE INT, V26, P21
   McEvoy S A, 1995, J Esthet Dent, V7, P104, DOI 10.1111/j.1708-8240.1995.tb00726.x
   Mclean J W, 1995, J Esthet Dent, V7, P141, DOI 10.1111/j.1708-8240.1995.tb00570.x
   MECHOLSKY JJ, 1995, DENT MATER, V11, P113, DOI 10.1016/0109-5641(95)80045-X
   MECHOLSKY JJ, 1995, DENT MATER, V11, P111, DOI 10.1016/0109-5641(95)80044-1
   MEECHAN JG, 1995, J ORAL MAXIL SURG, V53, P284, DOI 10.1016/0278-2391(95)90226-0
   MEHTA S, 1995, BIOMATERIALS, V16, P97, DOI 10.1016/0142-9612(95)98269-K
   MEIARS JR, 1995, AM J DENT, V8, P80
   MEIJERING AC, 1995, J DENT, V23, P21, DOI 10.1016/0300-5712(95)90656-3
   MENG CL, 1995, ANGLE ORTHOD, V65, P209
   MERCURI LG, 1995, J ORAL MAXIL SURG, V53, P106, DOI 10.1016/0278-2391(95)90381-X
   MERTZFAIRHURST EJ, 1995, ASDC J DENT CHILD, V62, P97
   Meyenberg K H, 1995, J Esthet Dent, V7, P73, DOI 10.1111/j.1708-8240.1995.tb00565.x
   Millett D T, 1995, Br J Orthod, V22, P161
   Millstein P L, 1995, Int J Prosthodont, V8, P129
   MISERENDINO LJ, 1995, J ENDODONT, V21, P83, DOI 10.1016/S0099-2399(06)81101-5
   MITCHELL CA, 1995, BIOMATERIALS, V16, P11, DOI 10.1016/0142-9612(95)91090-L
   MIXSON JM, 1995, AM J DENT, V8, P5
   Mizrahi E, 1995, J Clin Orthod, V29, P268
   MOHSEN NM, 1995, J ORAL REHABIL, V22, P183, DOI 10.1111/j.1365-2842.1995.tb01562.x
   MOHSEN NM, 1995, J ORAL REHABIL, V22, P213, DOI 10.1111/j.1365-2842.1995.tb01566.x
   Moore B. Keith, 1995, General Dentistry, V43, P176
   Morand J M, 1995, Quintessence Int, V26, P389
   Moseley H C, 1995, Br J Orthod, V22, P23
   MOSHONOV J, 1995, ORAL SURG ORAL MED O, V79, P221, DOI 10.1016/S1079-2104(05)80287-2
   Mount G J, 1995, Int Dent J, V45, P135
   MUNKSGAARD EC, 1995, AM J DENT, V8, P137
   MUSIKANT BL, 1995, J ORAL REHABIL, V22, P435, DOI 10.1111/j.1365-2842.1995.tb00797.x
   NAKABAYASHI N, 1995, AM J DENT, V8, P37
   NERY S, 1995, J DENT, V23, P55, DOI 10.1016/0300-5712(95)90661-Z
   NIEMZ MH, 1995, J DENT RES, V74, P1194, DOI 10.1177/00220345950740050801
   Nikaido T, 1995, Quintessence Int, V26, P221
   NIKOLAI RJ, 1995, DENT MATER, V11, P169, DOI 10.1016/0109-5641(95)80013-1
   Noie F, 1995, Int J Prosthodont, V8, P51
   OCONNOR RP, 1995, J ENDODONT, V21, P74, DOI 10.1016/S0099-2399(06)81099-X
   Oda Yutaka, 1995, Bulletin of Tokyo Dental College, V36, P1
   Oesterle L J, 1995, J Clin Orthod, V29, P31
   OSBORNE JW, 1995, OPER DENT, V20, P26
   Owens B M, 1995, Compend Contin Educ Dent, V16, P557
   PAMEIJER CH, 1995, AM J DENT, V8, P140
   PAMEIJER CH, 1995, AM J DENT, V8, P43
   PANAGIOTOUNI E, 1995, J PROSTHET DENT, V73, P578, DOI 10.1016/S0022-3913(05)80120-9
   PANG IC, 1995, J PROSTHET DENT, V73, P17, DOI 10.1016/S0022-3913(05)80267-7
   PANITVISAI P, 1995, J ENDODONT, V21, P57
   PARKER HH, 1995, J DENT, V23, P113, DOI 10.1016/0300-5712(95)98977-B
   PASHLEY DH, 1995, DENT MATER, V11, P117, DOI 10.1016/0109-5641(95)80046-8
   PATERSON FM, 1995, J DENT, V23, P137, DOI 10.1016/0300-5712(95)93570-R
   Patton L L, 1995, Gen Dent, V43, P22
   PAULUZZI P, 1995, CONTACT DERMATITIS, V32, P123, DOI 10.1111/j.1600-0536.1995.tb00772.x
   PERCINOTO C, 1995, AM J DENT, V8, P20
   PEUTZFELDT A, 1995, ACTA ODONTOL SCAND, V53, P29, DOI 10.3109/00016359509005941
   Phoenix R D, 1995, Int J Prosthodont, V8, P187
   PIDAPARTI RMV, 1995, J BIOMED MATER RES, V29, P309, DOI 10.1002/jbm.820290305
   Piddock V, 1995, Int J Prosthodont, V8, P280
   POHL L, 1995, ACTA ODONTOL SCAND, V53, P44, DOI 10.3109/00016359509005944
   Polyzois G L, 1995, J Prosthodont, V4, P38, DOI 10.1111/j.1532-849X.1995.tb00313.x
   Polyzois G L, 1995, Int J Prosthodont, V8, P150
   Polyzois G L, 1995, Compend Contin Educ Dent, V16, P230
   POLYZOIS GL, 1995, J BIOMATER APPL, V9, P355, DOI 10.1177/088532829500900403
   POWELL LV, 1995, OPER DENT, V20, P7
   Powers J M, 1995, J Prosthodont, V4, P28, DOI 10.1111/j.1532-849X.1995.tb00311.x
   PRIEST G, 1995, INT J PERIODONT REST, V15, P239
   PRIYAWAN R, 1995, J MATER SCI-MATER M, V6, P1, DOI 10.1007/BF00121237
   PURK JH, 1995, J DENT, V8, P75
   RITTER JE, 1995, DENT MATER, V11, P147, DOI 10.1016/0109-5641(95)80051-4
   RITTER JE, 1995, DENT MATER, V11, P142, DOI 10.1016/0109-5641(95)80050-6
   ROSSOMANDO KJ, 1995, DENT MATER, V11, P47, DOI 10.1016/0109-5641(95)80008-5
   ROULET JF, 1995, J DENT RES, V74, P381, DOI 10.1177/00220345950740011501
   Rubinstein S, 1995, J Esthet Dent, V7, P167, DOI 10.1111/j.1708-8240.1995.tb00573.x
   SAMET N, 1995, J PROSTHET DENT, V73, P457, DOI 10.1016/S0022-3913(05)80075-7
   SANCHEZ E, 1995, J AM DENT ASSOC, V126, P359, DOI 10.14219/jada.archive.1995.0181
   SANO H, 1995, J DENT RES, V74, P1093, DOI 10.1177/00220345950740041001
   SANO H, 1995, OPER DENT, V20, P18
   Sato Y, 1995, Int J Prosthodont, V8, P73
   SCHMALZ G, 1995, J PROSTHET DENT, V73, P392, DOI 10.1016/S0022-3913(05)80337-3
   SCHMITT SM, 1995, J PROSTHET DENT, V73, P280, DOI 10.1016/S0022-3913(05)80206-9
   Seghi R R, 1995, Int J Prosthodont, V8, P239
   SEKA W, 1995, J DENT RES, V74, P1086, DOI 10.1177/00220345950740040901
   SENDA A, 1995, OPER DENT, V20, P51
   SEPPA L, 1995, EUR J ORAL SCI, V103, P182, DOI 10.1111/j.1600-0722.1995.tb00022.x
   Shanthala B M, 1995, J Clin Pediatr Dent, V19, P121
   SHINKAI K, 1995, AM J DENT, V8, P149
   SHORTALL AC, 1995, J ORAL REHABIL, V22, P337, DOI 10.1111/j.1365-2842.1995.tb00782.x
   SIDHU SK, 1995, AM J DENT, V8, P59
   Sinha P K, 1995, J Clin Orthod, V29, P97
   SIPAHIER M, 1995, QUINTESSENCE INT, V26, P37
   SIPAHIER M, 1995, QUINTESSENCE INT, V26, P43
   SJOGREN G, 1995, ACTA ODONTOL SCAND, V53, P24, DOI 10.3109/00016359509005940
   SMALES RJ, 1995, AUST DENT J, V40, P171, DOI 10.1111/j.1834-7819.1995.tb05632.x
   SMART ER, 1995, BRIT DENT J, V178, P108, DOI 10.1038/sj.bdj.4808663
   Sohmura T, 1995, Int J Prosthodont, V8, P252
   SORENSEN JA, 1995, EUR J ORAL SCI, V103, P186, DOI 10.1111/j.1600-0722.1995.tb00023.x
   SORENSEN JA, 1995, EUR J ORAL SCI, V103, P116, DOI 10.1111/j.1600-0722.1995.tb00128.x
   Spranger H, 1995, Quintessence Int, V26, P149
   Staninec M, 1995, Gen Dent, V43, P278
   Sterrett J, 1995, J Can Dent Assoc, V61, P412
   STRYDOM C, 1995, AM J DENT, V8, P93
   SULJAK JP, 1995, J DENT, V23, P171, DOI 10.1016/0300-5712(95)93575-M
   SUZUKI S, 1995, AM J DENT, V8, P83
   Swift E J Jr, 1995, Quintessence Int, V26, P95
   SWIFT EJ, 1995, DENT MATER, V11, P196, DOI 10.1016/0109-5641(95)80018-2
   SWIFT EJ, 1995, DENT MATER, V11, P52, DOI 10.1016/0109-5641(95)80009-3
   SYVERUD M, 1995, DENT MATER, V11, P14, DOI 10.1016/0109-5641(95)80003-4
   TAIRA M, 1995, J MATER SCI-MATER M, V6, P197, DOI 10.1007/BF00146855
   TAIRA M, 1995, J MATER SCI-MATER M, V6, P5, DOI 10.1007/BF00121238
   TAIRA M, 1995, J MATER SCI-MATER M, V6, P167, DOI 10.1007/BF00120294
   TAIRA Y, 1995, DENT MATER, V11, P2, DOI 10.1016/0109-5641(95)80001-8
   TAIRA Y, 1995, J ORAL REHABIL, V22, P409, DOI 10.1111/j.1365-2842.1995.tb00793.x
   Tay F.R., 1995, QUINTESSENCE INT, V26, P63
   TAY FR, 1995, J DENT RES, V74, P1168, DOI 10.1177/00220345950740050501
   TAY FR, 1995, AM J DENT, V8, P105
   Ten Cate J. M., 1995, Journal of Dental Research, V74, P1266
   TENBOSCH JJ, 1995, J DENT RES, V74, P374, DOI 10.1177/00220345950740011401
   THONEMANN B, 1995, DENT MATER, V11, P161, DOI 10.1016/0109-5641(95)80012-3
   Thordrup M, 1995, Int J Prosthodont, V8, P233
   TORABINEJAD M, 1995, J ENDODONT, V21, P109, DOI 10.1016/S0099-2399(06)80433-4
   TORABINEJAD M, 1995, J ENDODONT, V21, P295, DOI 10.1016/S0099-2399(06)81004-6
   TORBJORNER A, 1995, J PROSTHET DENT, V73, P439, DOI 10.1016/S0022-3913(05)80072-1
   TRIOLO PT, 1995, OPER DENT, V20, P46
   Tripodakis A P, 1995, Int J Prosthodont, V8, P265
   TUNTIPRAWON M, 1995, AUST DENT J, V40, P17, DOI 10.1111/j.1834-7819.1995.tb05607.x
   TYAS MJ, 1995, AUST DENT J, V40, P167, DOI 10.1111/j.1834-7819.1995.tb05631.x
   UNTERBRINK GL, 1995, J DENT, V23, P183, DOI 10.1016/0300-5712(95)93577-O
   UTER W, 1995, CONTACT DERMATITIS, V32, P135, DOI 10.1111/j.1600-0536.1995.tb00802.x
   Valderrama S, 1995, Int J Prosthodont, V8, P29
   VALLITTU PK, 1995, ACTA ODONTOL SCAND, V53, P99, DOI 10.3109/00016359509005954
   VALLITTU PK, 1995, J ORAL REHABIL, V22, P257, DOI 10.1111/j.1365-2842.1995.tb00083.x
   Van Zeghbroeck L, 1995, J Esthet Dent, V7, P49
   Van Zeghbroeck L, 1995, J Esthet Dent, V7, P59
   VANLANDUYT P, 1995, J MATER SCI-MATER M, V6, P8, DOI 10.1007/BF00121239
   VANMEERBEEK B, 1995, DENT MATER, V11, P87, DOI 10.1016/0109-5641(95)80039-5
   VANNOORT R, 1993, J DENT, V21, P5, DOI 10.1016/0300-5712(93)90046-S
   VANNOORT R, 1994, J DENT, V22, P5, DOI 10.1016/0300-5712(94)90139-2
   Vickery J M, 1995, Int J Prosthodont, V8, P221
   Waggoner W F, 1995, Pediatr Dent, V17, P36
   WAGNER WC, 1995, J PROSTHET DENT, V73, P471, DOI 10.1016/S0022-3913(05)80077-0
   WAKASA K, 1995, J ORAL REHABIL, V22, P371, DOI 10.1111/j.1365-2842.1995.tb00787.x
   WAKASA K, 1995, J MATER SCI-MATER M, V6, P29, DOI 10.1007/BF00121243
   WARD MT, 1995, OPER DENT, V20, P106
   WARFVINGE K, 1995, BRIT DENT J, V178, P149, DOI 10.1038/sj.bdj.4808684
   Wataha J C, 1995, Int J Prosthodont, V8, P9
   Wataha J C, 1995, Int J Prosthodont, V8, P228
   WATANABE I, 1995, J PROSTHET DENT, V73, P299, DOI 10.1016/S0022-3913(05)80209-4
   WATKINS JH, 1995, DENT MATER, V11, P24, DOI 10.1016/0109-5641(95)80005-0
   WATTS DC, 1995, AM J DENT, V8, P15
   Weesner B W Jr, 1995, Compendium, V16, P88
   WELLER RN, 1995, INT ENDOD J, V28, P86, DOI 10.1111/j.1365-2591.1995.tb00164.x
   WESTERHOFF B, 1995, J ORAL REHABIL, V22, P121, DOI 10.1111/j.1365-2842.1995.tb00245.x
   WHITE RR, 1995, DENT MATER, V11, P208
   WHITE SN, 1995, J ENDODONT, V21, P9, DOI 10.1016/S0099-2399(06)80549-2
   WHITEHEAD SA, 1995, J ORAL REHABIL, V22, P421, DOI 10.1111/j.1365-2842.1995.tb00795.x
   WHITTERS CJ, 1995, J DENT, V23, P145, DOI 10.1016/0300-5712(95)93571-I
   WILDERSMITH P, 1995, ORAL SURG ORAL MED O, V79, P685, DOI 10.1016/S1079-2104(05)80300-2
   Williamson R T, 1995, Quintessence Int, V26, P413
   WILLIAMSON RT, 1995, J PROSTHET DENT, V73, P400, DOI 10.1016/S0022-3913(05)80338-5
   WILSON NHF, 1995, AM J DENT, V8, P99
   WISCOVITCH JG, 1995, J ENDODONT, V21, P43, DOI 10.1016/S0099-2399(06)80556-X
   Wiskott H W, 1995, Int J Prosthodont, V8, P105
   YOKOI K, 1995, J DENT, V23, P117, DOI 10.1016/0300-5712(95)98978-C
   YOSHIMINE Y, 1995, ORAL SURG ORAL MED O, V79, P351, DOI 10.1016/S1079-2104(05)80229-X
   YU H, 1995, J DENT, V23, P101, DOI 10.1016/0300-5712(95)98975-9
   ZACHRISSON BU, 1995, ANGLE ORTHOD, V65, P35
   ZAKI HS, 1995, J PROSTHET DENT, V73, P1, DOI 10.1016/S0022-3913(05)80263-X
   Ziebert A J, 1995, J Prosthodont, V4, P33, DOI 10.1111/j.1532-849X.1995.tb00312.x
   ZWETCHKENBAUM S, 1995, J PROSTHET DENT, V73, P525, DOI 10.1016/S0022-3913(05)80110-6
   1995, J ENDODONT, V21, P13
NR 378
TC 4
Z9 4
U1 1
U2 3
PU ACAD DENTAL MATERIALS
PI DALLAS
PA BAYLOR COLLEGE DENTISTRY, 3302 GASTON AVE, DALLAS, TX 75266-0677
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD JUL
PY 1995
VL 11
IS 4
BP 281
EP 293
DI 10.1016/0109-5641(95)80064-6
PG 13
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA TH837
UT WOS:A1995TH83700012
PM 8621053
DA 2018-10-19
ER

PT J
AU PARTY, E
   GERSHEY, EL
AF PARTY, E
   GERSHEY, EL
TI A REVIEW OF SOME AVAILABLE RADIOACTIVE AND NONRADIOACTIVE SUBSTITUTES
   FOR USE IN BIOMEDICAL-RESEARCH
SO HEALTH PHYSICS
LA English
DT Review
DE WASTE MANAGEMENT; WASTE DISPOSAL; S-35; BIOASSAY
AB The unavailability of disposal facilities for long-lived low-level radioactive waste (LLRW), expense associated with its disposal, and, for some generators, limitation of space to decay short half-life radioactive materials has prompted the search for alternatives to radiochemical techniques. Some of these alternatives are presented below.
RP PARTY, E (reprint author), ROCKEFELLER UNIV, 1230 YORK AVE, NEW YORK, NY 10021 USA.
CR BARINAGA M, 1993, SCIENCE, V260, P750, DOI 10.1126/science.8484114
   EVANS MR, 1992, NATURE, V358, P520, DOI 10.1038/358520a0
   HATFULL GF, 1994, ASM NEWS, V60, P255
   HOWARD GC, 1993, METHODS NONRADIOACTI
   PARTY E, 1989, HEALTH PHYS, V56, P571
   Stewart G. S. A. B., 1993, ASM News (Washington), V59, P241
   ZAGURSKY RJ, 1991, BIOTECHNIQUES, V11, P36
NR 7
TC 7
Z9 7
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD JUL
PY 1995
VL 69
IS 1
BP 1
EP 5
DI 10.1097/00004032-199507000-00001
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA RF830
UT WOS:A1995RF83000001
PM 7790201
DA 2018-10-19
ER

PT J
AU NAVARRO, A
   GARCIAGARDUNO, M
   VAZQUEZPOLO, G
   ALVAREZCASTILLO, A
   CASTANO, VM
   MARTINEZ, E
AF NAVARRO, A
   GARCIAGARDUNO, M
   VAZQUEZPOLO, G
   ALVAREZCASTILLO, A
   CASTANO, VM
   MARTINEZ, E
TI STUDIES ON THE STABILITY OF A STYRENE-BUTADIENE COPOLYMER FOR USE IN
   BIOMEDICAL APPLICATIONS
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
ID DEGRADATION
AB Two samples of commercially-available styrene-butadiene block copolymers (SBC) were tested for suitability for use in biomedical applications. A 30% sample and a 40% sample of styrene-containing polymers with very similar molecular weights (approximately 300,000) were characterized before and after being placed in a physiological serum for a period of six months. SEM, FTIR, and atomic absorption spectroscopy were used to characterize the polymers. Scanning and transmission electron micrographs showed that the SBC's morphology was clearly affected by the serum. A difference was observed with the higher styrene-containing polymer which showed no degradation of the elastomeric portion of the copolymer, whereas the 30% sample showed that considerable degradation occurred in this area. Atomic absorption results showed a clear difference in the capability of both materials to absorb K+, Na+ and Ca++ ions with a clear advantage for the 40% styrene-containing material. FTIR results indicate that both polymer samples degraded in the serum, showing loss of both the polystyrene and polybutadiene portions, as well as oxidation of the double bonds in the latter.
C1 UNIV NACL AUTONOMA MEXICO,INST FIS,MEXICO CITY 01000,DF,MEXICO.
   IND NEGROMEX SA CV,MEXICO CITY 11700,DF,MEXICO.
   UNIV NACL AUTONOMA MEXICO,FAC ODONTOL,UNIDAD INVEST & POSGRADO,MEXICO CITY 01000,DF,MEXICO.
RI Castano, Victor/C-1696-2018
CR BRANNONPEPPAS L, 1992, J CONTROL RELEASE, V20, P201, DOI 10.1016/0168-3659(92)90122-8
   BRANNONPEPPAS L, 1994, J BIOMAT SCI-POLYM E, V5, P339, DOI 10.1163/156856294X00068
   CASTANO VM, 1994, POLYM BULL, V32, P693, DOI 10.1007/BF00973921
   CASTANO VM, 1991, MATER LETT, V12, P199, DOI 10.1016/0167-577X(91)90174-5
   GROBE GL, 1986, MATER RES SOC S P, P55
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HSIVE GH, 1993, J BIOMAT SCI-POLYM E, V5, P205
   ISAACS PA, 1981, ELASTOMERICS     APR, P26
   MCGRATH JE, 1981, ACS POLYM S SER, V166
   MERRILL EW, 1993, J BIOMAT SCI-POLYM E, V5, P1
   Morton M., 1983, ANIONIC POLYM PRINCI
   RENIER M, 1993, J BIOMAT SCI-POLYM E, V5, P231
   RODRIGUEZ R, 1992, MATER LETT, V12, P448, DOI 10.1016/0167-577X(92)90212-3
   WILLIAMS JL, 1988, TPE, P203
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
NR 15
TC 1
Z9 1
U1 0
U2 1
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 1995
VL 10
IS 3
BP 258
EP 272
DI 10.1177/088391159501000305
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA RN672
UT WOS:A1995RN67200005
DA 2018-10-19
ER

PT J
AU SHINTANI, H
AF SHINTANI, H
TI FORMATION AND ELUTION OF TOXIC COMPOUNDS FROM STERILIZED MEDICAL
   PRODUCTS - METHYLENEDIANILINE FORMATION IN POLYURETHANE
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE MEDICAL DEVICE; POLYURETHANE; 4,4'-METHYLENEDIANILINE; MDA; GAMMA-RAY
   IRRADIATION; AUTOCLAVE STERILIZATION; MUTAGENICITY TEST
ID SOLID-PHASE EXTRACTION; POLY(ETHER URETHANE UREA); BIOMEDICAL
   APPLICATIONS; LIQUID-CHROMATOGRAPHY; DENTAL MATERIALS; HPLC ANALYSIS;
   GAMMA-RAY; 4,4'-METHYLENEDIANILINE; DEGRADATION;
   4,4'-DIAMINODIPHENYLMETHANE
AB The formation of a toxic and carcinogenic compound, methylenedianiline (MDA), in sterilized medical use polyurethane (PU) is discussed. Due to good biocompatibility and biostability, PU is widely used for blood-containing devices. There are two types of PU currently available for medical use. One is chain-extended thermoplastic PU the other is thermosetting PU used for potting material connecting fibers and modules in artificial dialyzers and plasma separators. Both gamma-ray irradiation and autoclave sterilization are predominantly used for the sterilization of these devices. MDA formation in sterilized PUs by gamma-ray irradiation and by autoclave treatment is compared. The Delany clause in the USA prohibits the manufacture of medical devices producing any toxic compound during fabrication and sterilization, therefore, the formation and elution of MDA and other toxic compounds should be seriously considered. Although MDA formation at a concentration of a few to a few hundred ppb in autoclaved chain-extended thermoplastic PU has been reported, there have been no papers describing MDA formation in autoclaved thermosetting PU potting material, or describing MDA and thermosetting PU. We elected to determine whether MDA was in fact produced in PUs sterilized by gamma-ray irradiation or by autoclave sterilization. Our objective was to estimate the risk factor to the human patients or recipient. Our conclusion is to confirm which sterilization of gamma-ray or autoclave is more appropriate. No formation of MDA was observed in autoclaved thermosetting PU potting material at 121 degrees C for 60 min. A few ppm of MDA was formed in irradiated potting material. MDA formation increased with increasing irradiation doses. MDA formed in irradiated potting material at 2.5 Mrad (less than one ppm) is not a significant risk to the recipient. The estimated cancer causing risk factor when absorbing one mg MDA/kg body weight/day is 0.29. Twenty-nine persons per 100 persons exhibit a cancer potential. More importantly, our experimental evidence indicated that serum extracts from irradiated potting material contained unknown compounds other than MDA, The presence of these compounds is considerably more significant and toxic. When tested, these compounds proved to be mutagenic in the absence of metabolic activity, thus promoting a need to identify and study further. Compounds indicating mutagenicity increased with increasing irradiation. Small amounts of mutagenic compounds were determined in extract from autoclaved potting material, smaller than that by gamma-ray irradiation. Therefore, autoclave sterilization is more appropriate, providing materials can withstand the process. Mutagenicity and cytotoxicity tests of the solvent extract from thermoplastic PU are also discussed, as is a pretreatment method of liquid-liquid extraction and the solid-phase extraction of serum MDA prior to HPLC analysis.
C1 NATL INST HLTH SCI,DEPT MED DEVICES,SETAGAYA KU,TOKYO 158,JAPAN.
CR BOWMAN MC, 1978, J ASSOC OFF ANA CHEM, V61, P1253
   BRUCK SD, 1988, J BIOMED MATER RES-A, V22, P133, DOI 10.1002/jbm.820221306
   COCKER J, 1988, J ANAL TOXICOL, V12, P9, DOI 10.1093/jat/12.1.9
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   CUNNINGHAM ML, 1990, CHEM RES TOXICOL, V3, P157, DOI 10.1021/tx00014a012
   DARBY TD, 1978, TOXICOL APPL PHARM, V46, P449, DOI 10.1016/0041-008X(78)90090-X
   DEICHMANN WB, 1978, TOXICOLOGY, V11, P185, DOI 10.1016/S0300-483X(78)91089-2
   DYER E, 1964, J POLYM SCI A2, P1
   ERNES DA, 1983, ANAL CHEM, V55, P408, DOI 10.1021/ac00253a062
   FROMMELT H, 1987, MAKROMOL CHEM-M SYMP, V12, P281, DOI 10.1002/masy.19870120114
   FURUKAWA M, 1980, J CHROMATOGR, V198, P212, DOI 10.1016/S0021-9673(00)80113-2
   GARDNER J, 1986, INTRO STERILIZATION
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   Gogolewski S., 1991, TRENDS POLYM SCI, V1, P47
   GOHLKE R, 1974, INT ARCH ARBEITSMED, V32, P217, DOI 10.1007/BF00539338
   GOLDBERG L, 1986, HAZARD ASSESSMENT ET
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   HO T, 1979, ENVIRON MUTAGEN, V1, P167
   Hu C. B., 1980, AM CHEM SOC DIV POLY, V21, P156
   Huff J. E., 1983, PROGR CLIN BIOL RES, V141, P347
   HUNTER SK, 1982, T AM SOC ART INT ORG, V28, P473
   KOPELMAN H, 1966, BMJ-BRIT MED J, V1, P514, DOI 10.1136/bmj.1.5486.514
   Kopelman H., 1966, Q J MED, V53, P553
   LAI YC, 1991, J APPL POLYM SCI, V42, P3173, DOI 10.1002/app.1991.070421210
   LAMB JC, 1986, J TOXICOL ENV HEALTH, V18, P325, DOI 10.1080/15287398609530874
   LELAH MD, 1987, POLYURETHANES MED
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MAZZU AL, 1984, J BIOMED MATER RES, V18, P961, DOI 10.1002/jbm.820180810
   MCGILL DB, 1974, NEW ENGL J MED, V291, P278, DOI 10.1056/NEJM197408082910604
   MEEHAN E, 1990, MAR PITTSB C NEW YOR
   Mizutani H., 1960, HDB PLASTIC MANUFACT
   NYSTROM B, 1991, AM J MED, V91, pS264, DOI 10.1016/0002-9343(91)90379-C
   O'Mara M. M., 1984, PROG BIOMED ENG, V1, P83
   OKAMURA S, 1969, SERIES MONOGRAPHS SC, V15
   PETROVIC ZS, 1984, J APPL POLYM SCI, V29, P1031, DOI 10.1002/app.1984.070290401
   Phus S. K., 1987, J BIOMED MATER RES, V21, P231
   PLUDRO G, 1969, ACTA POL PHARM, V26, P353
   RAO TK, 1982, ARCH TOXICOL, V49, P185, DOI 10.1007/BF00347866
   Ratner B. D., 1983, PHYSICOCHEMICAL ASPE, P969
   RATNER BD, 1981, ACS SYM SER, V162, P371
   SHINTANI H, 1989, J ANAL TOXICOL, V13, P354, DOI 10.1093/jat/13.6.354
   SHINTANI H, 1991, J ANAL TOXICOL, V15, P198, DOI 10.1093/jat/15.4.198
   SHINTANI H, 1991, J APPL POLYM SCI, V42, P1979, DOI 10.1002/app.1991.070420723
   SHINTANI H, 1990, J APPL POLYM SCI, V41, P661, DOI 10.1002/app.1990.070410316
   SHINTANI H, 1992, J CHROMATOGR, V600, P93, DOI 10.1016/0021-9673(92)85442-V
   SHINTANI H, 1992, J LIQ CHROMATOGR, V15, P1315, DOI 10.1080/10826079208018290
   SHINTANI H, 1989, FRESEN Z ANAL CHEM, V333, P637, DOI 10.1007/BF00496937
   SHINTANI H, 1993, J ANAL TOXICOL, V17, P73, DOI 10.1093/jat/17.2.73
   SHINTANI H, 1991, J BIOMED MATER RES, V25, P1275, DOI 10.1002/jbm.820251008
   SHINTANI H, 1991, J RAD STERIL, V3, P92
   SHINTANI H, 1991, OHIO SCI WORKBOOKS P
   SHINTANI H, 1991, 8TH DAN S CHROM WARS
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STEINHOFF D, 1970, NATURWISSENSCHAFTEN, V57, P247, DOI 10.1007/BF01010277
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   TORTORETO M, 1983, J CHROMATOGR, V262, P367, DOI 10.1016/S0021-9673(01)88122-X
   WALL LA, 1955, J POLYM SCI, V17, P141, DOI 10.1002/pol.1955.120178318
   Williams N., 1974, NEW ENGL J MED, V291, P1256
   YOSHII F, 1985, J APPL POLYM SCI, V30, P3339, DOI 10.1002/app.1985.070300816
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
   1982, NTP81143 NAT TOX PRO
   1984, FED REGISTER, V49, P46293
NR 62
TC 26
Z9 26
U1 0
U2 4
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 1995
VL 10
IS 1
BP 23
EP 58
DI 10.1177/088532829501000102
PG 36
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RN468
UT WOS:A1995RN46800001
PM 7473051
DA 2018-10-19
ER

PT J
AU FRIENDS, GD
   KUNZLER, JF
   OZARK, RM
AF FRIENDS, GD
   KUNZLER, JF
   OZARK, RM
TI RECENT ADVANCES IN THE DESIGN OF POLYMERS FOR CONTACT-LENSES
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 35th IUPAC International Symposium on Macromolecules (MACROAKRON 94)
CY JUL 11-19, 1994
CL UNIV AKRON, AKRON, OH
SP Int Union Pure & Appl Chem
HO UNIV AKRON
ID BIOMEDICAL APPLICATIONS; HYDROGELS
AB Three approaches for the design of polymers for extended wear contact lenses possessing high oxygen permeability are described. These approaches include the design of high strength, high water content hydrogels, the design of low water content fluorosilicone based materials and the design of hydrogels based on methacrylate end capped hydrophilic side chain siloxanes.
C1 BAUSCH & LOMB INC,DIV CONTACT LENS,DEPT CHEM & POLYMER DEV,ROCHESTER,NY 14692.
CR Boretos J W, 1971, J Biomed Mater Res, V5, P373, DOI 10.1002/jbm.820050408
   Brandrup J., 1989, POLYM HDB
   CHANG SH, 1980, Patent No. 4182822
   Chromecek RC, 1984, US Patent, Patent No. 4436887
   COX I, BAUSCH LOMB CLIN DAT
   DROBNIC J, 1977, USE POLYM MED B, V1
   DUNCAN R, 1983, BIOCHIM BIOPHYS ACTA, V755, P518, DOI 10.1016/0304-4165(83)90258-1
   FRIENDS G, 1994, ACS SYM SER, V540, P76
   FRIENDS G, 1992, J BIOMEDICAL MATERIA, V50, P59
   HART DE, 1986, OPHTHALMOLOGY, V93, P495
   Ho C. P., 1987, POLYM MAT SCI ENG, V56, P705
   HOLDEN BA, 1983, INVEST OPHTH VIS SCI, V24, P218
   HOLDEN BA, 1984, INVEST OPHTH VIS SCI, V25, P1161
   KAGANOV AL, 1976, J BIOMED MATER RES, V10, P1, DOI 10.1002/jbm.820100102
   Keogh P., 1981, U. S. Pat., Patent No. [4,260,725, 4260725]
   KEOGH PL, 1979, BIOMATER ARTIF CELL, V7, P307, DOI 10.3109/10731197909117586
   Kleiner E., 1979, US Patent, Patent No. [4,136,250, 4136250]
   KOPECEK J, 1982, MACROMOLECULES, P305
   KUDELA V, 1987, ENCY POLYM SCI ENG, V7, P783
   LAI Y, 1993, KIRKOTHMER ENCY CHEM, V7, P191
   LAI YC, 1991, J APPL POLYM SCI, V42, P3173, DOI 10.1002/app.1991.070421210
   MINARIK L, 1989, CLAO Journal, V15, P185
   MUELLER KF, 1986, Patent No. 4605712
   ORSBORN G N, 1988, CLAO Journal, V14, P81
   Peppas N A, 1981, Contact Intraocul Lens Med J, V7, P300
   RATNER B, 1988, COMPREHENSIVE POLYM, V7, P222
   RUSCIO DV, 1993, POLYM PREP AM CHEM S, V69, P221
   SARVER M, 1981, AM J OPTOM PHYSL OPT, V58, P387
   Schoessler JP, 1983, INT CONTACT LENS CLI, V10, P148
   TIGHE BJ, 1986, BRIT POLYM J, V18, P8, DOI 10.1002/pi.4980180104
NR 30
TC 22
Z9 22
U1 2
U2 11
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 1995
VL 98
BP 619
EP 631
DI 10.1002/masy.19950980153
PG 13
WC Polymer Science
SC Polymer Science
GA RZ124
UT WOS:A1995RZ12400042
DA 2018-10-19
ER

PT J
AU KIM, YD
   LEE, BK
   JEON, EJ
   SHIN, YC
   KIM, SC
AF KIM, YD
   LEE, BK
   JEON, EJ
   SHIN, YC
   KIM, SC
TI HYDROPHILIC-HYDROPHOBIC INTERPENETRATING POLYMER NETWORKS AND
   DICYANATE-BASED SEMI-IPN MATERIALS
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 35th IUPAC International Symposium on Macromolecules (MACROAKRON 94)
CY JUL 11-19, 1994
CL UNIV AKRON, AKRON, OH
SP Int Union Pure & Appl Chem
HO UNIV AKRON
AB Hydrophilic-hydrophobic IPN materials of poly(acrylic acid)poly(styrene-co-acrylonitrile) were synthesized and the pervaporation characteristics of the IPN membranes were evaluated for the separation of ethanol/water mixture. Hydrophilic-hydrophobic IPN materials of polyurethane-polystyrene were synthesized and the blood compatibility of the IPN's were measured for the biomedical application. Dicyanate-engineering plastics semi-IPN's were prepared and the morphology and mechanical properties were evaluated for the high temperature composite matrix materials.
C1 KOREA ADV INST SCI & TECHNOL,DEPT CHEM ENGN,TAEJON 305701,SOUTH KOREA.
CR JEON EJ, 1992, J MEMBRANE SCI, V70, P193, DOI 10.1016/0376-7388(92)80105-S
   SHIN YC, IN PRESS J BIOMATERI
   SHIN YC, 1992, POLYMER, V16, P520
NR 3
TC 2
Z9 2
U1 0
U2 2
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 1995
VL 98
BP 665
EP 672
DI 10.1002/masy.19950980157
PG 8
WC Polymer Science
SC Polymer Science
GA RZ124
UT WOS:A1995RZ12400045
DA 2018-10-19
ER

PT J
AU CHIELLINI, E
   SOLARO, R
AF CHIELLINI, E
   SOLARO, R
TI MULTIFUNCTIONAL BIOERODIBLE BIODEGRADABLE POLYMERIC MATERIALS
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 35th IUPAC International Symposium on Macromolecules (MACROAKRON 94)
CY JUL 11-19, 1994
CL UNIV AKRON, AKRON, OH
SP Int Union Pure & Appl Chem
HO UNIV AKRON
ID ALKYL VINYL ETHERS; CATIONIC POLYMERIZATION; CONTROLLED RELEASE;
   EPSILON-CAPROLACTONE; DELTA-VALEROLACTONE; POLYLACTONES; FORMULATION;
   MECHANISM
AB As a part of our continuing interest in the preparation of multifunctional polymeric materials and evaluation of their potential in biomedical and environmental field, a survey on new polymeric systems susceptible to bioerosion and/or biodegradation attack is presented. In particular attention has been focused on the preparation and characterization of the following classes of polymeric materials: 1) hydroxyl-containing polyesters; 2) functionalized cyclodextrins; 3) hydrophilic polymers containing carboxylic groups; 4) hydrogels for the release of phytodrugs; 5) hybrid polymeric materials; 6) synthetic and semisynthetic polyfunctional polymeric materials for the removal of uremic toxins. A few examples of the use of these polymers in the controlled release of drugs and as coadjuvants in the chronic renal failure treatment will be also presented.
RP CHIELLINI, E (reprint author), UNIV PISA,DEPT CHEM & IND CHEM,VIA RISORGIMENTO 35,I-56126 PISA,ITALY.
CR AKELAH A, 1985, J POLYM MATER, V2, P149
   ANDERSON JM, 1986, ADV DRUG DELIVERY SY
   BACCI L, 1995, THESIS U PISA
   Baer E, 1939, J BIOL CHEM, V128, P463
   BAILY WPJ, 1983, CHEM TECHNOLOGY WATE, P249
   BARSOTTI G, IN PRESS P IKETANI C
   BRAUNS U, 1985, Patent No. 149197
   BRAUNS U, 1985, Patent No. 3346123
   BRESCHI MC, 1995, 1ST S FRONT BIOM POL, P31
   CANTONI G, 1995, 3RD INT S POL ADV TE, P150
   CHIELLINI E, 1992, MAKROMOL CHEM-M SYMP, V54-5, P483, DOI 10.1002/masy.19920540136
   CHIELLINI E, 1992, J CONTROL RELEASE, V22, P273, DOI 10.1016/0168-3659(92)90102-W
   CHIELLINI E, 1992, J BIOACT COMPAT POL, V7, P161, DOI 10.1177/088391159200700204
   CHIELLINI E, 1994, J BIOACT COMPAT POL, V9, P152, DOI 10.1177/088391159400900203
   CHIELLINI E, 1995, 1ST S FRONT MED POL, P12
   CHIELLINI E, 1995, 3RD INT S POL ADV TE, P250
   CHIELLINI E, 1990, Patent No. 1242214
   CHIELLINI E, 1995, 1ST S FRONT BIOM POL, P30
   CHIELLINI E, 1991, Patent No. 8304858
   CHIELLINI E, 1991, Patent No. 830497
   CHIELLINI E, UNPUB J ENV POLYM DE
   CHIELLINI E, 1995, 3RD INT S POL ADV TE, P251
   CHIELLINI E, 1990, Patent No. 17714
   Chiellini E, 1990, J BIOACT COMPAT POLY, V5, P16
   CHIELLINI E, 1990, Patent No. 17713
   CHIELLINI E, 1989, POLYM MED SURGERY
   CHIELLINI E, 1991, Patent No. 260
   CHIELLINI E, 1992, Patent No. 830172
   CHIELLINI E, 1983, GEBEM MED, V1
   CHIELLINI EE, 1995, IKETANI C IKETANI, P73
   Ching C, 1993, BIODEGRADABLE POLYM
   DANTONE S, 1992, NEW POLYM MAT, V3, P223
   DeRossi D, 1991, POLYM GELS FUNDAMENT
   DOSSI E, 1994, GNOSEIS S, V1, P120
   DOSSI E, 1994, GNOSEIS S, V1, P118
   DOSSI E, 1993, BIOMATERIALI, V7, P111
   FINCH CA, 1985, CHEM TECHNOLOGY WATE
   FONTANILLE M, 1989, COMPREHENIVE POLYM S, V3, pCH25
   FRIEDMAN EA, 1974, 7TH P ANN CONTR C BE, P98
   GARDER DL, 1971, T AM SOC ART INT ORG, V17, P329
   GEBELEIN GC, 1985, BIOACTIVE POLYM SYST
   GIANNASI D, 1994, GNOSEIS, V1, P114
   GIORDANO C, 1974, 7TH P ANN CONTR C BE, P97
   Gregory J., 1983, CHEM TECHNOLOGY WATE, P307
   HALL HK, 1958, J AM CHEM SOC, V80, P6409, DOI 10.1021/ja01556a060
   HALSALL TG, 1947, J CHEM SOC, P1427, DOI 10.1039/jr9470001427
   INOUE S, 1972, J ORGANOMET CHEM, V39, P11, DOI 10.1016/S0022-328X(00)88899-3
   IRIE T, 1989, CARBOHYD RES, V192, P167, DOI 10.1016/0008-6215(89)85176-6
   ISSA R, 1991, J CONTROL RELEASE, V17, P113
   JEANES A, 1950, J AM CHEM SOC, V72, P2655, DOI 10.1021/ja01162a086
   JEDLINSKI Z, 1992, MAKROMOL CHEM-M SYMP, V60, P235, DOI 10.1002/masy.19920600121
   JING SB, 1950, CHEM EXPRESS, V72, P2655
   Jun Hae Sang, 1994, Journal of Environmental Polymer Degradation, V2, P9, DOI 10.1007/BF02073482
   KRICHELDORF HR, 1987, MACROMOLECULES, V20, P2050, DOI 10.1021/ma00175a002
   KRICHELDORF HR, 1986, MAKROMOL CHEM, V187, P1611
   KRICHELDORF HR, 1988, MAKROMOL CHEM, V189, P317
   KRICHELDORF HR, 1986, MAKROMOL CHEM, V187, P771
   KRICHELDORF HR, 1989, EUR POLYM J, V25, P585, DOI 10.1016/0014-3057(89)90010-4
   KYDONEUS AF, 1980, CONTROLLED RELEASE T
   MAYER JM, 1994, TRENDS POLYM SCI, V2, P227
   MORGANTII F, 1994, CNOSEIS S, V1, P116
   Napper D. H., 1983, CHEM TECHNOLOGY WATE, P233
   NIR MM, 1993, PLAST ENG, P75
   Peppas N. A., 1987, HYDROGELS MED PHARM, V2
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1
   PEPPAS NA, 1987, HYDROGELS MED PHARM, V3
   PITHA J, 1990, CARBOHYD RES, V200, P429, DOI 10.1016/0008-6215(90)84208-C
   PITHA J, 1985, J PHARM SCI, V75, P987
   PITHA J, 1988, J BIOACT COMPAT POLY, V3, P157
   REHAB A, 1991, J BIOACT COMPAT POL, V6, P52, DOI 10.1177/088391159100600105
   REHAB A, 1990, J CONTROL RELEASE, V13, P1
   REPPE W, 1956, LIEBIGS ANN CHEM, V60, P84
   RUSSO PS, 1987, ACS S SER, V350
   SCHMIDT U, 1980, ANGEW CHEM INT EDIT, V19, P198, DOI 10.1002/anie.198001981
   SOLARO R, 1983, J APPL POLYM SCI, V28, P3651, DOI 10.1002/app.1983.070281206
   SOLARO R, 1991, REACT POLYM, V14, P21, DOI 10.1016/0923-1137(91)90244-I
   SOLARO R, 1993, J BIOACT COMPAT POL, V8, P236, DOI 10.1177/088391159300800303
   SOLARO R, UNPUB EUR POLYM J
   SOLARO R, 1991, SYNTHETIC POLYM DRUG, P71
   SOLARO R, 1993, CHIM IND-MILAN, V75, P535
   SPARKS RE, 1972, T AM SOC ART INT ORG, V18, P458
   Stahl G.A., 1986, WATER SOLUBLE POLYM
   TAYLOR GT, 1989, PHARMACEUT RES, V6, P641, DOI 10.1023/A:1015922019038
   TOKIWA Y, 1981, J APPL POLYM SCI, V26, P441, DOI 10.1002/app.1981.070260206
   TSUDA T, 1965, MAKROMOLEKUL CHEM, V86, P304
   TSURUTA T, 1989, COMPREHENSIVE POLYM, V3, pCH31
   YOUNG DM, 1956, ACS PREP, V16, P108
   1959, Patent No. 2914556
   1983, ISP2550029R INT SPEC
   1957, Patent No. 2809208
NR 90
TC 14
Z9 14
U1 2
U2 4
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 1995
VL 98
BP 803
EP 824
DI 10.1002/masy.19950980168
PG 22
WC Polymer Science
SC Polymer Science
GA RZ124
UT WOS:A1995RZ12400054
DA 2018-10-19
ER

PT J
AU RATNER, BD
AF RATNER, BD
TI ADVANCES IN THE ANALYSIS OF SURFACES OF BIOMEDICAL INTEREST
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
ID ION MASS-SPECTROMETRY; X-RAY PHOTOELECTRON; ANGLE-DEPENDENT XPS; POLYMER
   SURFACES; DEPTH PROFILES; POLY(METHYL METHACRYLATE); MULTIVARIATE DATA;
   ELECTRON-SPECTRA; SOLID-SURFACES; PROTEIN FILMS
AB Materials used in biomedical applications often function based upon their surface properties, Thus, understanding their surfaces is critical to the design and engineering of new biomaterials and medical devices, Modern surface analysis tools have been developed largely around the needs for the microelectronics and petrochemicals industries, where durable, inorganic surfaces are studied, This paper examines how surface analysis methods can be applied to biomaterials which are typically hydrated and fragile, In particular, vacuum compatibility, sample damage, the aqueous/solid interface; spatial information, buried interfaces, chemical complexity and correlation with bio-reactivity will be addressed,
C1 UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
RP RATNER, BD (reprint author), UNIV WASHINGTON,CTR BIOENGN,BF-10,SEATTLE,WA 98195, USA.
CR AKHTER S, 1988, APPL SURF SCI, V35, P241, DOI 10.1016/0169-4332(88)90053-0
   BEEBE KR, 1987, ANAL CHEM, V59, pA1007, DOI 10.1021/ac00144a725
   BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111
   BRIGGS D, 1986, SURF INTERFACE ANAL, V9, P391
   BRIGGS D, 1984, SURF INTERFACE ANAL, V6, P184, DOI 10.1002/sia.740060407
   BUCHWALTER LP, 1990, J VAC SCI TECHNOL A, V8, P781, DOI 10.1116/1.576917
   BUSSING TD, 1985, J VAC SCI TECHNOL A, V3, P1973, DOI 10.1116/1.572910
   CALDWELL SJ, 1990, THESIS U WASHINGTON
   CASTNER DG, 1988, SURFACE CHARACTERIZA, P65
   CHANEY R, 1987, FRESEN Z ANAL CHEM, V329, P143, DOI 10.1007/BF00469126
   CHANG SK, 1977, MED PROG TECHNOL, V5, P57
   CHANG SK, 1977, 51ST COLL SURF SCI S
   CHILKOTI A, 1992, SURF INTERFACE ANAL, V18, P604, DOI 10.1002/sia.740180807
   CHILKOTI A, 1993, ANAL CHEM, V65, P1736, DOI 10.1021/ac00061a017
   CHILKOTI A, IN PRESS ANAL CHEM
   CHRISTIE OHJ, 1987, CHEMOMETR INTELL LAB, V2, P53, DOI 10.1016/0169-7439(87)80085-0
   DAVIES MC, 1990, CRIT REV BIOCOMPAT, V5, P297
   FERRIS JP, 1992, SCIENCE, V257, P1387, DOI 10.1126/science.1529338
   FISHER KA, 1976, P NATL ACAD SCI USA, V73, P173, DOI 10.1073/pnas.73.1.173
   GELADI P, 1986, ANAL CHIM ACTA, V185
   Geladi P., 1988, J CHEMOMETR, V2, P231, DOI DOI 10.1002/CEM.1180020403
   GILDING DK, 1980, BIOMATERIALS, V1, P163, DOI 10.1016/0142-9612(80)90040-X
   HANSON SR, 1982, ADV BIOMATER, V3, P519
   HARKER LA, 1979, J CLIN INVEST, V64, P559, DOI 10.1172/JCI109494
   Hart Dean E., 1993, CLAO (Contact Lens Association of Ophthalmologists) Journal, V19, P169
   HEARN MJ, 1986, SURF INTERFACE ANAL, V9, P411
   HOOK KJ, 1987, MACROMOLECULES, V20, P2112, DOI 10.1021/ma00175a011
   JURS PC, 1986, SCIENCE, V232, P1219, DOI 10.1126/science.3704647
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KARGACIN ME, 1986, ANAL CHEM, V58, P2300, DOI 10.1021/ac00124a041
   KNOBLER CM, 1990, ADV CHEM PHYS, V77, P397, DOI 10.1002/9780470141267.ch7
   LAIBINIS PE, 1991, SCIENCE, V254, P981, DOI 10.1126/science.254.5034.981
   LEWIS KB, 1993, J COLLOID INTERF SCI, V158, P77
   LINNER JG, 1986, J HISTOCHEM CYTOCHEM, V34, P1123, DOI 10.1177/34.9.2426340
   MACKENZIE AP, 1972, SCANNING ELECTRON MI, P273
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   MELLINGER M, 1987, CHEMOMETR INTELL LAB, V2, P29, DOI 10.1016/0169-7439(87)80083-7
   MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203
   MOZES N, 1989, COLLOID SURFACE, V42, P313
   NAKAHAMA S, 1994, UNPUB
   NEUMANN AW, 1979, J POLY SCI        PS, V66, P391
   PAYNTER RW, 1981, SURF INTERFACE ANAL, V3, P186, DOI 10.1002/sia.740030410
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PAYNTER RW, 1985, SURFACE INTERFACIAL, V2, P189
   PEREZLUNA VH, 1994, J BIOMED MATER RES, V28, P1111, DOI 10.1002/jbm.820281002
   PEREZLUNA VH, 1993, 19TH T ANN M SOC BIO, P281
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RATNER BD, 1981, J COLLOID INTERF SCI, V83, P630, DOI 10.1016/0021-9797(81)90358-1
   RATNER BD, IN PRESS BIOMATERIAL
   ROBERTS GG, 1990, LANGMUIRBLODGETT FIL
   ROUXHET PG, 1994, COLLOID SURFACE, V2, P348
   RUGGIERO F, 1984, EUR J CELL BIOL, V35, P49
   SMITH GC, 1992, SURF INTERFACE ANAL, V19, P175, DOI 10.1002/sia.740190134
   STENGER DA, 1992, J AM CHEM SOC, V114, P8435, DOI 10.1021/ja00048a013
   STICKLE WF, 1990, J VAC SCI TECHNOL A, V8, P2217, DOI 10.1116/1.577040
   STICKLE WF, 1992, J VAC SCI TECHNOL A, V10, P2806, DOI 10.1116/1.577914
   THOMAS EV, 1994, ANAL CHEM, V66, pA795, DOI 10.1021/ac00087a002
   TYLER BJ, 1989, SURF INTERFACE ANAL, V14, P443, DOI 10.1002/sia.740140804
   VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508
   Vickerman J. C., 1989, SECONDARY ION MASS S
   VOGEL V, 1991, ANNU REV MATER SCI, V21, P515
   WILSON IH, 1989, J VAC SCI TECHNOL A, V7, P2840, DOI 10.1116/1.576155
   WOJCIECHOWSKI PW, 1993, COLLOID SURFACE B, V1, P107, DOI 10.1016/0927-7765(93)80041-V
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   YASUDA H, 1978, J BIOMED MATER RES, V12, P701, DOI 10.1002/jbm.820120510
   YIH RS, 1987, J ELECTRON SPECTROSC, V43, P61, DOI 10.1016/0368-2048(87)80019-1
   ZANDVLIET HJW, 1992, SECONDARY ION MASS S, P3
   ZASADZINSKI JAN, 1987, CHEM ENG COMMUN, V52, P283, DOI 10.1080/00986448708911873
NR 68
TC 43
Z9 44
U1 1
U2 12
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JUL
PY 1995
VL 23
IS 7-8
BP 521
EP 528
DI 10.1002/sia.740230712
PG 8
WC Chemistry, Physical
SC Chemistry
GA RH941
UT WOS:A1995RH94100011
DA 2018-10-19
ER

PT J
AU MIYATA, T
   MORIZANE, M
   NAKAMAE, K
   OKUMURA, M
   KINOMURA, K
AF MIYATA, T
   MORIZANE, M
   NAKAMAE, K
   OKUMURA, M
   KINOMURA, K
TI PROPERTIES OF BIOMEDICAL PRESSURE-SENSITIVE ADHESIVE COPOLYMER FILMS
   WITH PENDANT MONOSACCHARIDES
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID AMIDE TYPE; POLYMERS; POLY(VINYLSACCHARIDE)S; POLYMERIZATION
AB Glucosyloxyethyl methacrylate (GEMA) was copolymerized with butyl acrylate (BA) for the preparation of a biomedical pressure-sensitive adhesive with pendant monosaccharides, for possible use in medical applications. The measurements of 180 degrees peel strength, ball tack, and holding power for the GEMA-BA copolymer films revealed that the film at the GEMA content of 5 mol % has excellent pressure-sensitive adhesive properties. Protein adsorption onto the GEMA-BA copolymer film hardly occurred due to very low interfacial free energy between its surface and water. Release profiles of vitamin B-12 from the GEMA-BA copolymer film suggests that it is useful as a material for a transdermal therapeutic system. (C) 1995 John Wiley and Sons, Inc.
C1 KOBE UNIV,FAC ENGN,NADA KU,KOBE 657,JAPAN.
   NIPPON FINE CHEM CO LTD,TAKASAGO,HYOGO 676,JAPAN.
CR BLACK WAP, 1968, MAKROMOL CHEM, V117, P210
   CARPINO LA, 1976, MAKROMOL CHEM, V177, P1631
   Chien Y. W., 1987, CONTROLLED DRUG DELI, P523
   CHIEN YW, 1987, CONTROLLED RELEASE T, P281
   Chien YW., 1982, NOVEL DRUG DELIVERY, P149
   FOWKES FM, 1962, J PHYS CHEM-US, V66, P382, DOI 10.1021/j100808a524
   FOWKES FM, 1963, J PHYS CHEM-US, V67, P2538, DOI 10.1021/j100806a008
   GAINSLY M, 1954, ADHESION ADHESIVES F, P127
   HORI Y, 1980, SETTYAKU HDB
   IKADA Y, 1984, ADV POLYM SCI, V57, P103
   KITAZAWA S, 1990, CHEM LETT, P1733, DOI 10.1246/cl.1990.1733
   KLEIN J, 1987, MAKROMOL CHEM, V188, P1217
   KLEIN J, 1989, MAKROMOL CHEM, V190, P2527
   KLEIN J, 1985, MAKROMOL CHEM-RAPID, V6, P675
   KOBAYASHI A, 1986, MAKROMOL CHEM-RAPID, V7, P645
   KOBAYASHI K, 1987, NIPPON KAGAKU KAISHI, P575, DOI 10.1246/nikkashi.1987.575
   KOBAYASHI K, 1988, J MACROMOL SCI CHEM, VA25, P655, DOI 10.1080/00222338808053391
   KOBAYASHI K, 1985, KOBUNSHI RONBUNSHU, V42, P719, DOI 10.1295/koron.42.719
   MIYATA T, 1994, MACROMOL CHEM PHYSIC, V195, P3597, DOI 10.1002/macp.1994.021951107
   NAKAMAE K, 1994, MACROMOL CHEM PHYSIC, V195, P2663, DOI 10.1002/macp.1994.021950733
   NAKAMAE K, 1993, MAKROMOL CHEM-RAPID, V14, P413
   NAKAMAE K, 1994, MACROMOL CHEM PHYSIC, V195, P1953, DOI 10.1002/macp.1994.021950606
   NAKAMAE K, 1990, J ADHES SOC JPN, V26, P128
   NAKAMAE K, 1990, J ADHES SOC JPN, V26, P100
   OKUMURA M, 1990, 57H NAT M CHEM SOC J
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   PAYNTER RW, 1984, POLYM BIOMATERIALS, P121
   PAYNTER RW, 1985, SURFACE INTERFACIAL, V2, P189
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   TANIGAWA S, 1991, J ADHES SCI TECHNOL, V51, P543
   VIENTH WR, 1991, DIFFUSION POLYM PRIN, P215
   WHISTLER RL, 1950, J AM CHEM SOC, V72, P2299
   Z0237 JAP IND STAND
NR 33
TC 7
Z9 7
U1 1
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 20
PY 1995
VL 56
IS 12
BP 1615
EP 1623
DI 10.1002/app.1995.070561212
PG 9
WC Polymer Science
SC Polymer Science
GA QY973
UT WOS:A1995QY97300012
DA 2018-10-19
ER

PT J
AU DMITRIEV, SN
   OGANESSIAN, YT
   STARODUB, GY
   SHISHKIN, SV
   BUKLANOV, GV
   KHARITONOV, YP
   NOVGORODOV, AF
   YUSHKEVICH, YV
   NEWTON, D
   TALBOT, RJ
AF DMITRIEV, SN
   OGANESSIAN, YT
   STARODUB, GY
   SHISHKIN, SV
   BUKLANOV, GV
   KHARITONOV, YP
   NOVGORODOV, AF
   YUSHKEVICH, YV
   NEWTON, D
   TALBOT, RJ
TI ULTRA-PURE PU-236 AND PU-237 FOR ENVIRONMENTAL AND BIOMEDICAL-RESEARCH
SO APPLIED RADIATION AND ISOTOPES
LA English
DT Article
AB Isotopically pure Pu-236 (>99.999% by activity) has been produced by irradiating U (95% U-235) With He-4 ions and refining the product by electromagnetic mass separation. Further developments in the production of Pu-237 are also reported, giving material containing, by activity, only 3 x 10(-6)% Pu-236 and probably only similar to 10(-5)% Pu-238.
C1 AEA TECHNOL,BIOMED RES,DIDCOT OX11 0RA,OXON,ENGLAND.
RP DMITRIEV, SN (reprint author), DUBNA JOINT NUCL RES INST,DUBNA 141980,RUSSIA.
CR DMITRIEV SN, 1993, APPL RADIAT ISOTOPES, V44, P1097, DOI 10.1016/0969-8043(93)90112-N
   EFURD DW, 1991, RADIOCHIM ACTA, V54, P159
   ELLIS YA, 1979, PHYS REV C, V20, P799, DOI 10.1103/PhysRevC.20.799
   KALINNIKOV VG, 1992, NUCL INSTRUM METH B, V70, P62, DOI 10.1016/0168-583X(92)95910-J
   PERELYGIN VP, 1993, HEAVY ION PHYSICS, P375
   TALBOT RJ, 1994, APPL RADIAT ISOTOPES, V45, P743, DOI 10.1016/0969-8043(94)90123-6
   TALBOT RJ, 1993, HEALTH PHYS, V65, P41, DOI 10.1097/00004032-199307000-00006
   VANDENBOSCH R, 1958, PHYS REV, V111, P1358, DOI 10.1103/PhysRev.111.1358
   WARNER AJ, 1994, RADIAT PROT DOSIM, V55, P61, DOI 10.1093/oxfordjournals.rpd.a082376
   1983, ANN ICRP, V11, P13
   1982, IONIZING RAD SORUCES
NR 11
TC 13
Z9 13
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0969-8043
J9 APPL RADIAT ISOTOPES
JI Appl. Radiat. Isot.
PD MAY
PY 1995
VL 46
IS 5
BP 307
EP 309
DI 10.1016/0969-8043(94)00134-L
PG 3
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
SC Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA RA525
UT WOS:A1995RA52500006
DA 2018-10-19
ER

PT J
AU ZHANG, LL
   XIONG, CD
   DENG, XM
AF ZHANG, LL
   XIONG, CD
   DENG, XM
TI BIODEGRADABLE POLYESTER BLENDS FOR BIOMEDICAL APPLICATION
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; PEO/PLA BLOCK COPOLYMERS;
   POLYMERS; DEGRADATION; ACID); POLY(EPSILON-CAPROLACTONE); SURGERY; PHB
AB A new family of bioabsorbable materials suitable for biomedical applications was designed and prepared by means of blending of some available polyesters to develop new biodegradable materials tailored for different requirements. Multiphase polymer blends containing poly(d, l-lactide) (PLA), poly(epsilon-caprolactone) (PCL), poly(d, l-lactide-co-poly(ethylene glycol) (PELA), poly(epsilon-caprolactone)-co-poly(ethylene glycol) (PECL), and poly(beta-hydroxybutyrate) (PHB), PLA/PCL, PELA/PECL, PHB/PLA, PHB/PELA, PHB/PCL, and PHB/PECL blends were respectively investigated. It was found that PLA/PCL, PHB, and PHB/PLA and PHB/PCL blends were seemingly immiscible, with their morphology and hydrolytic behavior were determined by the composition of the blends. On the other hand, the miscibility of PELA/PECL, PHB/PELA, and PHB/PECL blends was improved by using PELA and/or PECL block copolymers that contained poly(ethylene glycol) (PEG) as compatibilizer. The blends showed to a certain extent miscibility, fine phase morphology, and fast hydrolysis. (C) 1995 John Wiley and Sons, Inc.
C1 ACAD SINICA,CHENGDU INST ORGAN CHEM,CHENGDU 610041,PEOPLES R CHINA.
CR CHA Y, 1990, BIOMATERIALS, V11, P108, DOI 10.1016/0142-9612(90)90124-9
   CHANG R-K, 1986, Pharmaceutical Technology, V10, P32
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   DAVE P, 1990, POLYM MATER SCI ENG, V63, P726
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   DOLLINGER HM, 1990, ACS POLYM PREPR, V31, P429
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GRECO P, 1989, POLYMER, V30, P1475, DOI 10.1016/0032-3861(89)90219-X
   HELLER J, 1989, ADV BIOMED POLYM WOR, P31
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   HOLLINGER JO, 1983, J BIOMED MATER RES, V17, P71, DOI 10.1002/jbm.820170107
   HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   Lisuardi A., 1992, POLYM MATER SCI ENG, V67, P298
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1981, BIOMATERIALS, V2, P215
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   VAINIONPAA S, 1989, PROG POLYM SCI, V14, P679, DOI 10.1016/0079-6700(89)90013-0
   XU RP, 1991, POLYM BIOMATERIALS, V3, P285
   YASIN M, 1989, BIOMATERIALS, V10, P400, DOI 10.1016/0142-9612(89)90132-4
   YOUNES H, 1987, J BIOMED MATER RES, V21, P1301, DOI 10.1002/jbm.820211103
   ZHANG LL, 1992, AUG NAT S POL CHANGC, P1013
NR 25
TC 89
Z9 96
U1 0
U2 27
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD APR 4
PY 1995
VL 56
IS 1
BP 103
EP 112
DI 10.1002/app.1995.070560114
PG 10
WC Polymer Science
SC Polymer Science
GA QL998
UT WOS:A1995QL99800014
DA 2018-10-19
ER

PT J
AU TANG, LP
   EATON, JW
AF TANG, LP
   EATON, JW
TI INFLAMMATORY RESPONSES TO BIOMATERIALS
SO AMERICAN JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Review
DE BIOMATERIALS; FIBRINOGEN; INFLAMMATION
ID TOTAL HIP-REPLACEMENT; SYNOVIAL-LIKE MEMBRANE; BONE-CEMENT INTERFACE;
   GEL BREAST IMPLANTS; 10-YEAR FOLLOW-UP; COMPLEMENT ACTIVATION;
   SILICONE-GEL; INVIVO BIOCOMPATIBILITY; POLYMERIC BIOMATERIALS; PROTEIN
   ADSORPTION
AB Implanted biomedical devices are of increasing importance in modern medical care. However, surprisingly little is known of the factors that determine biocompatibility of the materials used in these devices. These materials, although generally inert and non-toxic, can mediate a variety of adverse reactions, including inflammation, fibrosis, coagulation, and infection. This brief review focuses on the inflammatory responses (including fibrosis) that commonly occur around implanted biomaterials. Host proteins that spontaneously associate with implant surfaces are important determinants of the acute inflammatory response. In this regard, adsorbed fibrinogen appears particularly pro-inflammatory. Chronic inflammatory processes, in many cases in response to fragments of implanted biomaterials, may cause implant failure. In the case of silicone-filled mammary prostheses, the extravasation of silicone gel has been held responsible for a number of complications, including silicone granuloma, synovitis, connective-tissue disease, and lymphadenopathy. In some instances, material-mediated inflammatory responses may even cause degradation of the material itself (via oxidative products released by implant-associated inflammatory cells). Overall, there is insufficient knowledge of the determinants and mechanisms of host: implant responses. A clear understanding of tissue:biomaterial interactions will be required both to explain the pathogenesis of many implant-mediated complications and to aid in the development of more biocompatible materials for implantable devices.
C1 ALBANY MED COLL,DEPT PATHOL & LAB MED,DIV EXPTL PATHOL,ALBANY,NY 12208.
CR ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158
   ASPLUND O, 1984, PLAST RECONSTR SURG, V73, P270, DOI 10.1097/00006534-198402000-00022
   ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAKER JL, 1982, PLAST RECONSTR SURG, V69, P56, DOI 10.1097/00006534-198269010-00008
   BARKER DE, 1978, PLAST RECONSTR SURG, V61, P836, DOI 10.1097/00006534-197861060-00002
   BENJAMIN E, 1982, DIAGN HISTOPATHOL, V5, P133
   BENOIT FM, 1993, J BIOMED MATER RES, V27, P1341, DOI 10.1002/jbm.820271014
   BLOEBAUM RD, 1993, J ARTHROPLASTY, V8, P195
   BLOEBAUM RD, 1994, CLIN ORTHOPAEDICS, V298, P19
   BOMMER J, 1981, LANCET, V1, P1314
   BOMMER J, 1981, NEW ENGL J MED, V305, P1077, DOI 10.1056/NEJM198110293051809
   BRODY GS, 1977, PLAST RECONSTR SURG, V60, P615, DOI 10.1097/00006534-197710000-00020
   CAPOZZI A, 1981, PLAST RECONSTR SURG, V68, P512, DOI 10.1097/00006534-198110000-00006
   CAPOZZI A, 1978, PLAST RECONSTR SURG, V62, P302, DOI 10.1097/00006534-197808000-00038
   CHAN SC, 1991, CLIN CHEM, V37, P756
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   CHEUNG AK, 1989, KIDNEY INT, V36, P257, DOI 10.1038/ki.1989.188
   CHINN JA, 1992, J BIOMED MATER RES, V16, P757
   CHRISTIE AJ, 1977, JAMA-J AM MED ASSOC, V237, P1463, DOI 10.1001/jama.237.14.1463
   CHUANG HYK, 1980, THROMB RES, V19, P1, DOI 10.1016/0049-3848(80)90398-9
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   DAYER JM, 1979, J CLIN INVEST, V64, P1386, DOI 10.1172/JCI109596
   DIGBY JM, 1982, HAND, V14, P326, DOI 10.1016/S0072-968X(82)80069-7
   DOMANSKIS EJ, 1976, PLAST RECONSTR SURG, V58, P689, DOI 10.1097/00006534-197612000-00006
   DOOR LD, 1990, CLIN ORTHOPAEDICS, V261, P82
   EDMOND JA, 1980, PLAST RECONSTR SURG, V66, P478
   EHRLICH HP, 1983, J CELL PHYSIOL, V116, P345, DOI 10.1002/jcp.1041160312
   EISENBERG HV, 1977, PLAST RECONSTR SURG, V59, P849, DOI 10.1097/00006534-197706000-00024
   ENDO LP, 1987, SEMIN ARTHRITIS RHEU, V17, P112, DOI 10.1016/0049-0172(87)90033-3
   EYSSEN JE, 1984, PLAST RECONSTR SURG, V73, P415, DOI 10.1097/00006534-198403000-00013
   GABRIELSE, 1994, NEW ENGL J MED, V330, P1697
   GOLDRING S R, 1985, Arthritis and Rheumatism, V28, pS36
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1986, ARTHRITIS RHEUM-US, V29, P836, DOI 10.1002/art.1780290704
   GOLDRING SR, 1988, NONCEMENTED TOTAL HI, P35
   GORDON M, 1982, J BONE JOINT SURG AM, V64, P574, DOI 10.2106/00004623-198264040-00013
   GUIDOIN R, 1984, ANN THORAC SURG, V37, P457, DOI 10.1016/S0003-4975(10)61131-9
   HANDEL N, 1991, PLAST RECONSTR SURG, V88, P475, DOI 10.1097/00006534-199109000-00015
   HENSON PM, 1975, J CLIN INVEST, V56, P1053, DOI 10.1172/JCI108152
   HERZLINGER GA, 1980, T AM SOC ART INT ORG, V26, P165
   HOGQUIST KA, 1991, J IMMUNOL, V147, P2181
   HOLTROP ME, 1982, CALCIFIED TISSUE INT, V34, P488, DOI 10.1007/BF02411290
   HOWIE DW, 1992, T ORTHOP RES SOC, V17, P344
   HUANG TT, 1978, PLAST RECONSTR SURG, V61, P277, DOI 10.1097/00006534-197802000-00026
   ITO N, 1969, CANCER RES, V29, P1137
   JASTY M, 1990, J BONE JOINT SURG BR, V72, P63
   JASTY M, 1991, J BONE JOINT SURG BR, V73, P551
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   JASTY M, 1992, CLIN ORTHOP RELAT R, V285, P116
   JENNINGS DA, 1991, ANN PLAS SURG, V27, P553, DOI 10.1097/00000637-199112000-00007
   KAUFMAN RL, 1985, J RHEUMATOL, V12, P1066
   KOSSOVSKY N, 1994, ARCH PATHOL LAB MED, V118, P686
   KOTTKEMARCHANT K, 1987, J BIOMED MATER RES, V21, P379, DOI 10.1002/jbm.820210310
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LEONG ASY, 1982, NEW ENGL J MED, V306, P135, DOI 10.1056/NEJM198201213060303
   LEONG ASY, 1981, LANCET, V1, P889
   LEONG ASY, 1981, LANCET, V2, P210
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P37, DOI 10.1002/jbm.820200105
   Mason J, 1981, Arch Dermatol, V117, P366
   MATHIESEN EB, 1991, J BONE JOINT SURG BR, V73, P569
   MCCAULEY RL, 1990, J SURG RES, V49, P103, DOI 10.1016/0022-4804(90)90118-L
   MCDONALD MD, 1995, J BIOMED MATER RES, V29, P1, DOI 10.1002/jbm.820290102
   MELMED EP, 1988, PLAST RECONSTR SURG, V82, P285, DOI 10.1097/00006534-198808000-00013
   MONTANDOND, 1979, PLAST RECONSTR SURG, V63, P719
   MULROY RD, 1990, J BONE JOINT SURG BR, V72, P757
   MUNDY GR, 1977, SCIENCE, V196, P1109
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   PARFREY PS, 1981, LANCET, V1, P1101
   PHUA SK, 1987, J BIOMED MATER RES, V21, P231, DOI 10.1002/jbm.820210207
   PICHA GJ, 1990, PLAST RECONSTR SURG, V85, P903, DOI 10.1097/00006534-199006000-00011
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   ROSTOKER W, 1978, J BIOMED MATER RES, V12, P317, DOI 10.1002/jbm.820120306
   Rudolph R, 1980, Ann Plast Surg, V4, P14
   SCHMALZRIED TP, 1991, CLIN ORTHOP RELAT R, V274, P60
   SEDEL L, 1992, ARCH ORTHOP TRAUM SU, V111, P255, DOI 10.1007/BF00571519
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SHEPARD AD, 1984, J VASC SURG, V1, P829, DOI 10.1067/mva.1984.avs0010829
   SILVER RM, 1993, ARCH DERMATOL, V129, P63, DOI 10.1001/archderm.129.1.63
   SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4
   SPILIZEWSKI K L, 1985, Journal of Controlled Release, V2, P197, DOI 10.1016/0168-3659(85)90045-8
   STAUFFER RN, 1982, J BONE JOINT SURG AM, V64, P983, DOI 10.2106/00004623-198264070-00003
   STEINBACH BG, 1993, RADIOGRAPHICS, V13, P95, DOI 10.1148/radiographics.13.1.8426939
   SUTHERLAND CJ, 1982, J BONE JOINT SURG AM, V64, P970, DOI 10.2106/00004623-198264070-00002
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TANG L, 1995, IN PRESS 21ST ANN M
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TRAVIS WD, 1985, HUM PATHOL, V16, P19, DOI 10.1016/S0046-8177(85)80209-4
   VARGA J, 1989, ANN INTERN MED, V111, P377, DOI 10.7326/0003-4819-111-5-377
   VISTNES LM, 1977, PLAST RECONSTR SURG, V59, P31, DOI 10.1097/00006534-197701000-00005
   WICKHAM MG, 1978, SCIENCE, V199, P437, DOI 10.1126/science.619466
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WINDING O, 1988, SCAND J PLAST RECONS, V22, P127, DOI 10.3109/02844318809072383
   WOLF CF, 1981, INT J ARTIF ORGANS, V5, P277
   WORSING RA, 1982, J BONE JOINT SURG AM, V64, P581, DOI 10.2106/00004623-198264040-00014
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
NR 100
TC 289
Z9 295
U1 1
U2 83
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQUARE, PHILADELPHIA, PA 19106
SN 0002-9173
J9 AM J CLIN PATHOL
JI Am. J. Clin. Pathol.
PD APR
PY 1995
VL 103
IS 4
BP 466
EP 471
PG 6
WC Pathology
SC Pathology
GA QQ628
UT WOS:A1995QQ62800018
PM 7726145
DA 2018-10-19
ER

PT J
AU WANG, IW
   ANDERSON, JM
   JACOBS, MR
   MARCHANT, RE
AF WANG, IW
   ANDERSON, JM
   JACOBS, MR
   MARCHANT, RE
TI ADHESION OF STAPHYLOCOCCUS-EPIDERMIDIS TO BIOMEDICAL POLYMERS -
   CONTRIBUTIONS OF SURFACE THERMODYNAMICS AND HEMODYNAMIC SHEAR CONDITIONS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID PROSTHETIC VASCULAR GRAFTS; PLASMA-PROTEINS; ADHERENCE; BIOMATERIALS;
   FIBRONECTIN; FIBRINOGEN; PRINCIPLES; ADSORPTION; ALBUMIN
AB Adhesion studies of Staphylococcus epidermidis RP62A were conducted using a rotating disk system to determine the roles of surface physicochemistry and topographies under physiologic shear conditions. Six materials were investigated: biomedical reference polyethylene and polydimethylsiloxane; argon plasma-treated reference polyethylene (Ar-PE); Silastic(R); expanded polytetrafluoroethylene; and woven Dacron. All of the polymers except Dacron demonstrated reduced bacterial adhesion with increasing shear stress. Argon plasma treatment of polyethylene reduced the level of staphylococcal adhesion. Adsorption of human plasma proteins effected significantly lower numbers of adherent bacteria. The lowest adhesion was observed for Ar-PE in 1% human plasma protein solution, whereas Dacron had the highest number of adherent bacteria. The high adhesion on Dacron was attributed to increased bacterial flux caused by topography-induced turbulent flow and physical entrapment of the bacteria in the fiber interstices. The results indicate that the driving force for S. epidermidis adhesion is strongly influenced by substrate physicochemistry, but this may be dominated by physical forces such as shear and turbulence. (C) 1995 John Wiley & Sons, Inc.
C1 CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106.
FU NHLBI NIH HHS [HL-47300]
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   ANDRADE JD, 1985, INTERFACIAL ASPECTS
   BENTON ER, 1966, J FLUID MECH, V24, P781, DOI 10.1017/S0022112066001009
   BRUNSTEDT MR, 1994, 20TH ANN M SOC BIOM
   COTTONARO CN, 1981, ASAIO T, V27, P391
   DAILY JW, 1960, T ASME             D, V82, P217
   DANILICH MJ, 1992, J BIOMAT SCI-POLYM E, V3, P195, DOI 10.1163/156856292X00123
   EASMON CSF, 1990, PRINCIPLES BACTERIOL, V2, P161
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   FERREIROS CM, 1989, FEMS MICROBIOL LETT, V160, P89
   FLETCHER M, 1982, APPL ENVIRON MICROB, V44, P184
   GILBERT P, 1991, J APPL BACTERIOL, V71, P72
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   GRIESLER HP, 1991, NEW BIOL SYNTHETIC V
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Levich V. G., 1962, PHYSICOCHEMICAL HYDR
   LOCCI R, 1980, ZENTRALBL BAKTERIO B, V173, P300
   LUDWICKA A, 1984, POLYM BIOMATERIALS, P241
   MALANGONI MA, 1993, J SURG RES, V54, P168, DOI 10.1006/jsre.1993.1027
   MARCHANT RE, 1989, J POLYM SCI POL CHEM, V27, P881, DOI 10.1002/pola.1989.080270314
   MULLER E, 1991, INFECT IMMUN, V59, P3323
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   OBRIEN T, 1992, BRIT J SURG, V79, P1262, DOI 10.1002/bjs.1800791205
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   SCHMITT DD, 1986, J VASC SURG, V3, P732, DOI 10.1067/mva.1986.avs0030732
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   SIVERHUS DJ, 1990, SURGERY, V107, P613
   SNOOKS SJ, 1988, J VASC SURG, V7, P538, DOI 10.1067/mva.1988.avs0070538
   SUGARMAN B, 1982, INFECTION, V10, P9, DOI 10.1007/BF01640828
   SZYCHER M, 1991, HIGH PERFORMANCE BIO, P1
   TENNEKES H, 1972, 1ST COURSE TURBULENC
   TIMMERMAN CP, 1991, INFECT IMMUN, V59, P187
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   WHEAT RW, 1992, ZINSSER MICROBIOLOGY, P8
   YATES SG, 1978, ANN SURG, V188, P611, DOI 10.1097/00000658-197811000-00005
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 39
TC 47
Z9 47
U1 1
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 1995
VL 29
IS 4
BP 485
EP 493
DI 10.1002/jbm.820290408
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QP943
UT WOS:A1995QP94300007
PM 7622533
DA 2018-10-19
ER

PT J
AU GREIL, P
AF GREIL, P
TI ACTIVE-FILLER-CONTROLLED PYROLYSIS OF PRECERAMIC POLYMERS
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID SILICON-CARBIDE FIBER; HIGH-TENSILE STRENGTH; CERAMIC FIBERS; OXYCARBIDE
   GLASSES; ORGANOMETALLIC POLYMERS; POLYCARBOSILANE FIBER; SIC FIBER;
   PRECURSOR; NITRIDE; CONVERSION
AB Manufacturing of bulk ceramic components from materials in the system Si-Me-C-N-O (Me Ti, Cr, V, Mo, Si, B, CrSi2, MoSi2, etc.) from preceramic organosilicon polymers-such as poly(carbosilanes), poly(silazanes), or poly(siloxanes)-has become possible by incorporating reactive filler particles into the liquid or solid polymer precursor. During pyrolytic decomposition of the polymer matrix, the filler particles react with carbon from the polymer precursor or nitrogen from the reaction gas atmosphere to form new (oxy)carbide or (oxy)nitride phases embedded in a nanocrystalline SI-O-C(-N) matrix. The selective expansion encountered in the filler phase reaction can be used to compensate for the polymer shrinkage upon pyrolytic conversion. The formation of a transient pore network between 400 degrees and 1000 degrees C is governed by the polymer decomposition as well as the filler particle reaction kinetics, Thus, the properties of the oxycarbonitride composite materials can be tailored by controlling the microstructures of the polymer-derived matrix phase, the filler network, and the residual porosity. Near-net-shape forming of bulk ceramic components, even with complex geometry, is possible, making novel applications of polymer-derived bulk materials in biomedical, electrical, and mechanical fields highly interesting.
RP GREIL, P (reprint author), UNIV ERLANGEN NURNBERG,DEPT MAT SCI GLASS & CERAM,D-91058 ERLANGEN,GERMANY.
CR Ainger FW, 1960, SPECIAL CERAMICS, V661, P168
   ATWELL WH, 1991, INORGANIC AND ORGANOMETALLIC OLIGOMERS AND POLYMERS, P147
   AYLETT BJ, 1968, ORGANOMET CHEM REV A, V3, P151
   BABONNEAU F, 1990, J MATER SCI, V25, P3664, DOI 10.1007/BF00575402
   BALDUS HP, 1992, MATER RES SOC SYMP P, V271, P821, DOI 10.1557/PROC-271-821
   BANEY RH, 1979, Patent No. 2021545
   BANEY RH, 1982, Patent No. 4310651
   BARIN I., 1989, THERMOCHEMICAL DATA
   BELOT V, 1992, J POLYM SCI POL CHEM, V30, P613, DOI 10.1002/pola.1992.080300413
   BLUM YD, 1989, J MATER SCI, V24, P1707, DOI 10.1007/BF01105695
   BOUILLON E, 1991, J MATER SCI, V26, P1517, DOI 10.1007/BF00544661
   BOULLION E, 1991, J MATER SCI, V26, P1333
   BURNS GT, 1989, J AM CERAM SOC, V72, P333, DOI 10.1111/j.1151-2916.1989.tb06129.x
   Chantrell PG, 1965, SPECIAL CERAMICS, V67
   COOKE TF, 1991, J AM CERAM SOC, V74, P2959, DOI 10.1111/j.1151-2916.1991.tb04289.x
   CZEKAJ CL, 1990, J AM CERAM SOC, V73, P352, DOI 10.1111/j.1151-2916.1990.tb06518.x
   Emsley R. J. P., 1990, British Ceramic Proceedings, P139
   ERNY T, 1993, J AM CERAM SOC, V76, P207, DOI 10.1111/j.1151-2916.1993.tb03709.x
   FRITZ G, 1956, Z ANORG ALLG CHEM, V286, P149, DOI 10.1002/zaac.19562860307
   GALASSO F, 1966, APPL PHYS LETT, V9, P37, DOI 10.1063/1.1754590
   GERMAN RM, 1987, INT J POWDER METALL, V23, P237
   GREIL P, 1992, MATER RES SOC SYMP P, V274, P155, DOI 10.1557/PROC-274-155
   Greil P., 1990, Journal of the European Ceramic Society, V6, P53, DOI 10.1016/0955-2219(90)90035-E
   GREIL P, 1991, J MATER SCI, V27, P1053
   GREIL P, 1991, CERAMIC T, V19, P43
   HASEGAWA Y, 1983, J MATER SCI, V18, P3633, DOI 10.1007/BF00540736
   HASEGAWA Y, 1980, J MATER SCI, V15, P720, DOI 10.1007/BF00551739
   HASEGAWA Y, 1989, J MATER SCI, V24, P1177
   HASEGAWA Y, 1986, J MATER SCI, V21, P321, DOI 10.1007/BF01144739
   HATAKEYAMA F, 1990, J AM CERAM SOC, V73, P2107, DOI 10.1111/j.1151-2916.1990.tb05278.x
   HURWITZ FI, 1993, J MATER SCI, V28, P6622, DOI 10.1007/BF00356406
   HURWITZ FI, 1989, CERAM ENG SCI P, V10, P750
   ICHIKAWA H, 1987, J MATER SCI LETT, V6, P420, DOI 10.1007/BF01756783
   ISHIKAWA T, 1992, J MATER SCI, V27, P6627, DOI 10.1007/BF01165946
   JAMET J, 1984, CERAM ENG SCI P, V5, P677
   JOHNSON SM, 1988, J AM CERAM SOC, V71, pC132
   KOMEYA K, 1986, J NONCRYST SOLIDS, V83, P208
   LAFFON C, 1989, J MATER SCI, V24, P1503, DOI 10.1007/BF02397093
   LAINE RM, 1987, POLYM PREPR, V28, P393
   Lavedrine A., 1991, Journal of the European Ceramic Society, V8, P221, DOI 10.1016/0955-2219(91)90098-K
   LEGROW GE, 1987, AM CERAM SOC BULL, V66, P363
   LEVENSPIEL O, 1972, CHEM REACTION ENG
   LIPOWITZ J, 1991, AM CERAM SOC BULL, V70, P1888
   LIPOWITZ J, 1990, J MATER SCI, V25, P2118, DOI 10.1007/BF01045776
   PEUCKERT M, 1990, ADV MATER, V2, P398, DOI 10.1002/adma.19900020903
   PORTE L, 1989, J MATER SCI, V24, P271, DOI 10.1007/BF00660966
   POUSKOULELI G, 1989, CERAM INT, V15, P213, DOI 10.1016/0272-8842(89)90041-2
   RAHN JA, 1990, MATER RES SOC SYMP P, V171, P31
   RENLUND GM, 1991, J MATER RES, V6, P2723, DOI 10.1557/JMR.1991.2723
   RENLUND GM, 1991, J MATER RES, V6, P2716, DOI 10.1557/JMR.1991.2716
   RENLUND GM, 1989, THESIS RENSSELAER PO
   RICE RW, 1983, AM CERAM SOC BULL, V62, P889
   RIEDEL R, 1992, NATURE, V355, P355
   SASAKI Y, 1987, J MATER SCI, V22, P443, DOI 10.1007/BF01160751
   SAWYER LC, 1987, J AM CERAM SOC, V70, P798, DOI 10.1111/j.1151-2916.1987.tb05631.x
   SCHWARTZ KB, 1988, ADV CERAM MATER, V3, P320
   SCHWARTZ KB, 1986, MATER RES SOC S P, V73, P407
   Seibold M., 1993, Journal of the European Ceramic Society, V11, P105, DOI 10.1016/0955-2219(93)90041-O
   SEIBOLD M, 1990, ADV MATER PROCESS, V1, P641
   SEYFERTH D, 1992, J AM CERAM SOC, V75, P1300, DOI 10.1111/j.1151-2916.1992.tb05578.x
   SEYFERTH D, 1991, J AM CERAM SOC, V74, P2687, DOI 10.1111/j.1151-2916.1991.tb06824.x
   SEYFERTH D, 1990, J AM CERAM SOC, V73, P2131, DOI 10.1111/j.1151-2916.1990.tb05286.x
   SEYFERTH D, 1983, J AM CERAM SOC, V66, pC13
   SEYFERTH D, 1984, J AM CERAM SOC, V67, pC132
   SEYFERTH D, 1986, SCI CERAMIC CHEM PRO, P354
   SEYFERTH D, 1987, ACS SYM SER, V360, P143
   SHELDON BW, 1992, J AM CERAM SOC, V75, P677, DOI 10.1111/j.1151-2916.1992.tb07858.x
   SHILLING CL, 1983, AM CERAM SOC B, V62, P912
   SINCLAIR RA, 1984, MATER RES SOC S P, V32, P387
   SINGH AK, 1992, MATER RES SOC SYMP P, V271, P795, DOI 10.1557/PROC-271-795
   SIRIEIX F, 1990, COMPOS SCI TECHNOL, V37, P7, DOI 10.1016/0266-3538(90)90089-N
   SONG YC, 1988, J MATER SCI, V23, P1911, DOI 10.1007/BF01115750
   SORARU GD, 1990, J MATER SCI, V25, P3886, DOI 10.1007/BF00582455
   SUTTOR D, 1995, CERAMIC T, V51, P211
   TAKI T, 1988, J MATER SCI LETT, V7, P209, DOI 10.1007/BF01730172
   TAKI T, 1987, J MATER SCI LETT, V6, P826, DOI 10.1007/BF01729026
   TAWANCY HM, 1992, J MATER SCI, V27, P1061, DOI 10.1007/BF01197661
   Toreki W., 1992, CERAM ENG SCI P, V13, P198
   Verbeek W, 1974, Ger Pat, Patent No. 2236078
   Verbeek W, 1974, U.S. Patent, Patent No. 3853567
   Verbeek W., 1973, Ger. Pat, Patent No. 2218960
   WALKER BE, 1983, AM CERAM SOC BULL, V62, P916
   WEST R, 1983, AM CERAM SOC BULL, V62, P899
   WEST R, 1984, ULTRASTRUCTURE PROCE, P235
   WHITE DA, 1987, ADV CERAM MATER, V2, P45
   WILLS RR, 1983, AM CERAM SOC BULL, V62, P904
   WINTER G, 1975, Patent No. 3892583
   Winter G, 1974, Ger Pat, Patent No. 2243527
   WU MJ, 1992, MACROMOLECULES, V25, P1840
   WYNNE KJ, 1984, ANNU REV MATER SCI, V14, P297, DOI 10.1146/annurev.ms.14.080184.001501
   YAJIMA S, 1978, NATURE, V273, P525, DOI 10.1038/273525a0
   YAJIMA S, 1981, AM CERAM SOC BULL, V60, P253
   YAJIMA S, 1981, J MATER SCI, V16, P1349, DOI 10.1007/BF01033851
   YAJIMA S, 1976, NATURE, V261, P683, DOI 10.1038/261683a0
   YAJIMA S, 1977, NATURE, V266, P521, DOI 10.1038/266521a0
   YAJIMA S, 1978, J MATER SCI, V13, P2569, DOI 10.1007/BF02402743
   YAJIMA S, 1983, AM CERAM SOC BULL, V62, P893
   YAJIMA S, 1957, CHEM LETT, V9, P931
   YU YF, 1986, MATER RES SOC S P, V73, P559
   ZHANG H, 1990, J AM CERAM SOC, V73, P958, DOI 10.1111/j.1151-2916.1990.tb05143.x
NR 100
TC 307
Z9 326
U1 1
U2 64
PU AMER CERAMIC SOC 735 CERAMIC PLACE
PI WESTERVILLE
PA PO BOX 6136, WESTERVILLE, OH 43081-6136
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD APR
PY 1995
VL 78
IS 4
BP 835
EP 848
DI 10.1111/j.1151-2916.1995.tb08404.x
PG 14
WC Materials Science, Ceramics
SC Materials Science
GA QT907
UT WOS:A1995QT90700001
DA 2018-10-19
ER

PT J
AU CALLEN, BW
   LOWENBERG, BF
   LUGOWSKI, S
   SODHI, RNS
   DAVIES, JE
AF CALLEN, BW
   LOWENBERG, BF
   LUGOWSKI, S
   SODHI, RNS
   DAVIES, JE
TI NITRIC-ACID PASSIVATION OF TI6AL4V REDUCES THICKNESS OF SURFACE OXIDE
   LAYER AND INCREASES TRACE-ELEMENT RELEASE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID DENTAL IMPLANT MATERIALS; PREPARATIVE PROCEDURES; CITRIC-ACID;
   WHOLE-BLOOD; ALUMINUM; TITANIUM; BRAIN; BONE; ABSORPTION; INHIBITION
AB Passivation of Ti6Al4V and cpTi implants using methods based on the ASTM-F86 nitric acid protocol are used with the intention of reducing their surface reactivity, and consequently the corrosion potential, in the highly corrosive biologic milieu. The ASTM-F86 passivation protocol was originally developed for surgical implants made of stainless steel and chrome cobalt alloy. Using X-ray photoelectron spectroscopy (XPS) to examine the effect of nitric acid passivation on the surface oxide layer of mill-annealed Ti6Al4V and cpTi, we have found that such treatment actually reduced the oxide thickness on the alloy while having no significant effect on the pure metal. These results correlated with observations obtained using graphite furnace atomic absorption spectrophotometry (GFAAS) to detect trace element release from solid, mill-annealed, Ti6Al4V and cpTi into serum-containing culture medium. We detected significantly greater levels of Ti, Al, and V in the presence of passivated compared to nonpassivated Ti6Al4V. In contrast, nitric acid passivation did not influence Ti release from mill-annealed cpTi. These results, derived from two mill-annealed Ti-based metals, would indicate that reexamination of ASTM-F86-based passivation protocols with respect to Ti6Al4V should be considered in view of the widespread use of this alloy for biomedical devices. (C) 1995 John Wiley & Sons, Inc.
RP CALLEN, BW (reprint author), UNIV TORONTO,CTR BIOMAT,170 COLL ST,TORONTO,ON M5S 1A1,CANADA.
CR ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402
   ASK M, 1988, APPL SURF SCI, V35, P283
   BIANCO PD, 1993, 19TH ANN M SOC BIOM
   BLUMENTHAL NC, 1984, CALCIFIED TISSUE INT, V36, P439, DOI 10.1007/BF02405357
   BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   BRUNEEL N, 1988, J BIOMED MATER RES, V22, P203, DOI 10.1002/jbm.820220305
   DUCHEYNE P, 1984, J BIOMED MATER RES, V18, P293, DOI 10.1002/jbm.820180306
   FLENDRIG JA, 1976, LANCET, V1, P1235
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   JACOBS JJ, 1993, 19TH ANN M SOC BIOM
   JERVIS TR, 1993, METALL TRANS A, V24, P215, DOI 10.1007/BF02669618
   Johansson CB, 1992, EUR J EXP MUSCULOSKE, V1, P161
   KIRSCHBAUM BB, 1989, AM J MED SCI, V279, P9
   LAUSMAA J, 1985, BIOMATERIALS, V6, P23, DOI 10.1016/0142-9612(85)90033-X
   LAUSMAA J, 1986, MAT RES S P, V35, P351
   LOWENBERG BF, 1994, J MATER SCI-MATER M, V5, P467, DOI 10.1007/BF00058985
   LUGOWSKI S, 1987, J BIOMED MATER RES, V21, P657, DOI 10.1002/jbm.820210510
   LUGOWSKI S, 1987, TRACE ELEM MED, V4, P28
   MAEUSLI PA, 1986, BIOL BIOMECHANICAL P, P57
   MASSEY RC, 1989, ALUMINUM FOOD ENV
   MURALEEDHARAN TM, 1992, THIN SOLID FILMS, V221, P104, DOI 10.1016/0040-6090(92)90802-I
   OSBORN JF, 1990, CLIN IMPLANT MAT, P73
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   ROSTOKER W, 1974, J BIOMED MATER RES, V8, P407, DOI 10.1002/jbm.820080609
   SHAM TK, 1979, CHEM PHYS LETT, V68, P426, DOI 10.1016/0009-2614(79)87231-0
   SLANINA P, 1985, ACTA PHARMACOL TOX, V56, P331
   SLANINA P, 1984, FOOD CHEM TOXICOL, V22, P391, DOI 10.1016/0278-6915(84)90369-7
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1045, DOI 10.1002/jbm.820250902
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   SMITH DC, 1989, ORAL IMPLANTOLOGY BI, P185
   SMITH GK, 1981, SYSTEMIC ASPECTS BIO, V2, P1
   SODHI RNS, 1994, J VAC SCI TECHNOL A, V12, P267, DOI 10.1116/1.578899
   SODHI RNS, 1991, J VAC SCI TECHNOL A, V9, P1329, DOI 10.1116/1.577621
   SOLAR RJ, 1978, ASTM684 SPEC TECHN P
   VANATTEKUM PMTM, 1977, J ELECTRON SPECTROSC, V11, P363, DOI 10.1016/0368-2048(77)80013-3
   VANDERVOET GB, 1991, HISTO CYTOCHEMISTRY, P235
   VANGINKEL MF, 1993, J LAB CLIN MED, V121, P453
   WILLS MR, 1983, LANCET, V2, P49
   WROBEL K, 1993, TRACE ELEM MED, V10, P97
   1992, ANN BOOK ASTM STANDA
NR 40
TC 71
Z9 71
U1 1
U2 18
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR
PY 1995
VL 29
IS 3
BP 279
EP 290
DI 10.1002/jbm.820290302
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QJ437
UT WOS:A1995QJ43700001
PM 7615579
DA 2018-10-19
ER

PT J
AU HOLCOMB, WF
AF HOLCOMB, WF
TI RADIATION SAFETY TRAINING-PROGRAM AT THE NATIONAL-INSTITUTES-OF-HEALTH
SO MILITARY MEDICINE
LA English
DT Article
AB At the U.S. Public Health Service's National Institutes of Health (NIH), one of the world's largest biomedical and clinical research institutions, 70 to 80% of all research is performed using radiation or radioactive materials. To maintain a safe environment and minimize risks to the health and safety of the employees, patients, visitors, and the surrounding community, a radiation protection program is required. Under U.S. Nuclear Regulatory Commission licenses and NIH policies, the Radiation Safety Branch (RSB), Division of Safety, administers a comprehensive radiation safety program covering over 3,500 NIH laboratories and some 7,000 laboratory and ancillary staff workers. The NIH radiation protection program provides for the effective supervision, control, and monitoring of all radioactive materials and radiation sources at NIH, This includes activities such as radiation exposure monitoring, laboratory inspections, waste management, consulting, environmental monitoring, and training, Training is considered an integral part of the radiation safety program, RSB offers an extensive training program with over 20 different training courses each year, For example, in 1993 some 6,700 employees attended 243 classes.
RP HOLCOMB, WF (reprint author), NIH,DIV SAFETY,RADIAT SAFETY BRANCH,BLDG 10,BETHESDA,MD 20892, USA.
NR 0
TC 1
Z9 1
U1 0
U2 2
PU ASSN MILITARY SURG US
PI BETHESDA
PA 9320 OLD GEORGETOWN RD, BETHESDA, MD 20814
SN 0026-4075
J9 MIL MED
JI Milit. Med.
PD MAR
PY 1995
VL 160
IS 3
BP 115
EP 120
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA QY950
UT WOS:A1995QY95000006
PM 7783932
DA 2018-10-19
ER

PT J
AU DILL, A
   BROWN, P
   CIAMBRONE, D
   RAKOWSKI, W
AF DILL, A
   BROWN, P
   CIAMBRONE, D
   RAKOWSKI, W
TI THE MEANING AND PRACTICE OF SELF-CARE BY OLDER ADULTS - A QUALITATIVE
   ASSESSMENT
SO RESEARCH ON AGING
LA English
DT Article
ID SYMPTOMS; ILLNESS; BEHAVIOR; CULTURE; PEOPLE
AB Drawing on material from qualitative interviews, this article examines self-care as a response to physical symptoms commonly experienced by older people.  The analysis indicates that older persons approach, interpret, and treat their symptoms within both biomedical and psychosocial frameworks.  Self-care responses appear to be learned early in life, reinforced throughout the life cycle, and formed in consultation with professional as well as lay persons.  Symptom responses reflect and reinforce the meaning of social relations in individuals' lives, providing a symbolic medium for the assessment of present and past relationships, cross-generational connections, and past troubles and issues of personal identity.  Findings suggest that categorizing sources of care into professional, informal, or self overly simplifies the symptom experience of older adults.  Self-care goes beyond the acknowledgement of discomfort and subsequent treatment of symptoms; it involves the representation and interpretation of the self.
C1 BROWN UNIV,DEPT COMMUNITY HLTH,PROVIDENCE,RI 02912.
   BROWN UNIV,CTR GERONTOL & HLTH CARE RES,PROVIDENCE,RI 02912.
RP DILL, A (reprint author), BROWN UNIV,DEPT SOCIOL,BOX 1916,PROVIDENCE,RI 02912, USA.
CR BRODY EM, 1981, J AM GERIATR SOC, V29, P442, DOI 10.1111/j.1532-5415.1981.tb01746.x
   BURY M, 1991, SOCIOL HEALTH ILL, V13, P451, DOI 10.1111/j.1467-9566.1991.tb00522.x
   Chappell N L, 1988, Compr Gerontol B, V2, P92
   CHAPPELL NL, 1987, HLTH AGING SOCIOLOGI, P159
   Charmaz K., 1991, GOOD DAYS BAD DAYS S
   DEAN K, 1981, SOC SCI MED-MED SOC, V15, P673, DOI 10.1016/0271-7123(81)90091-2
   DEAN K, 1986, SOC SCI MED, V22, P275, DOI 10.1016/0277-9536(86)90076-6
   Dean K., 1992, AGING HLTH BEHAV, P27
   EWING KP, 1990, ETHOS, V18, P251, DOI 10.1525/eth.1990.18.3.02a00020
   Fitzpatrick R., 1984, EXPERIENCE ILLNESS, P11
   Gergen K. J., 1983, STUDIES SOCIAL IDENT, P254
   Gochman DS, 1988, HLTH BEHAV EMERGING, P149
   HAUG M, 1984, NOV ANN M GER SOC AM
   HAUG MR, 1989, SOC SCI MED, V29, P171, DOI 10.1016/0277-9536(89)90165-2
   HENNESSY CH, 1989, J AGING STUD, V3, P39, DOI 10.1016/0890-4065(89)90024-8
   KLEINMAN A, 1988, ILLNESS NARRATIVES
   LEVENTHAL EA, 1986, J AM GERIATR SOC, V34, P185
   Levin LS, 1976, SELF CARE LAY INITIA
   LUBORSKY MR, 1993, GERONTOLOGIST, V33, P445, DOI 10.1093/geront/33.4.445
   Mishler E., 1981, SOCIAL CONTEXTS HLTH
   PROHASKA TR, 1987, HEALTH PSYCHOL, V6, P495, DOI 10.1037//0278-6133.6.6.495
   Register C., 1987, LIVING CHRONIC ILLNE
   SEGALL A, 1989, SOC SCI MED, V29, P153, DOI 10.1016/0277-9536(89)90163-9
   SEGALL A, 1991, ADV MED SOCIOLOGY, V2, P115
   Starr P, 1982, SOCIAL TRANSFORMATIO
   VERBRUGGE LM, 1987, MED CARE, V25, P539, DOI 10.1097/00005650-198706000-00008
   WILLIAMS G, 1984, SOCIOLOGY HLTH ILLNE, V6, P176
   Young K, 1989, TEXTS IDENTITY, P152
   ZOLA IK, 1973, SOC SCI MED, V7, P677, DOI 10.1016/0037-7856(73)90002-4
NR 29
TC 22
Z9 22
U1 0
U2 2
PU SAGE PUBL INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320
SN 0164-0275
J9 RES AGING
JI Res. Aging
PD MAR
PY 1995
VL 17
IS 1
BP 8
EP 41
DI 10.1177/0164027595171002
PG 34
WC Gerontology
SC Geriatrics & Gerontology
GA QH650
UT WOS:A1995QH65000002
DA 2018-10-19
ER

PT J
AU POGHOSSIAN, AS
AF POGHOSSIAN, AS
TI USING THE SITE-BINDING MODEL FOR AN EXPLANATION OF THE BLOOD
   COMPATIBILITY OF SOME MATERIALS USED IN BIOMEDICAL SENSORS
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article; Proceedings Paper
CT 5th International Meeting on Chemical Sensors
CY JUL 11-14, 1994
CL ROME, ITALY
DE BIOMEDICAL SENSORS; BLOOD COMPATIBILITY; SITE-BINDING MODEL
ID INTERFACE; OPERATION; SYSTEM
AB Blood clotting time is the most obvious indication of the biological incompatibility of materials that are in contact with blood. The results of the investigation of blood clotting time are presented for 12 different materials that are widely used in biomedical chemical-sensor technology. The most important factors that define the antithrombogenic properties of materials are the surface-state charges and electrochemical phenomena taking place at the solid-state-blood interface. Using the site-binding model, a mechanism that can explain the high antithrombogenic properties of some materials is proposed and discussed.
RP POGHOSSIAN, AS (reprint author), STATE ENGN UNIV ARMENIA,TERIAN 105,YEREVAN 375009,ARMENIA.
CR BOUSSE L, 1983, IEEE T ELECTRON DEV, V30, P1263, DOI 10.1109/T-ED.1983.21284
   KOBLOV LF, 1975, METHODS APPARATUS IN, P96
   MANEBU C, 1982, POLYM MED APPLICATIO, P248
   MATSUO T, 1979, IEEE T ELECTRON DEV, V26, P1856, DOI 10.1109/T-ED.1979.19780
   MEIXNER LK, 1992, SENSOR ACTUAT B-CHEM, V6, P315, DOI 10.1016/0925-4005(92)80077-B
   SIU WM, 1979, IEEE T ELECTRON DEV, V26, P1805, DOI 10.1109/T-ED.1979.19690
   TORBICZ W, 1992, SENSOR ACTUAT B-CHEM, V7, P565, DOI 10.1016/0925-4005(92)80365-5
   VANKERKHOF JC, 1994, SENSOR ACTUAT B-CHEM, V18, P56, DOI 10.1016/0925-4005(94)87056-X
   WILLIAMS DF, 1978, IMPLANT SURGERY, P552
   YATES DE, 1974, J CHEM SOC FARAD T 1, V70, P1807, DOI 10.1039/f19747001807
NR 10
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD MAR
PY 1995
VL 24
IS 1-3
BP 159
EP 161
DI 10.1016/0925-4005(95)85034-1
PG 3
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA RM959
UT WOS:A1995RM95900032
DA 2018-10-19
ER

PT J
AU SUK, WA
AF SUK, WA
TI THE NIEHS SUPERFUND BASIC RESEARCH-PROGRAM - OVERVIEW AND AREAS OF
   FUTURE-RESEARCH DIRECTIONS
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Proceedings Paper
CT Joint US/Mexico Conference on Fate, Transport and Interactions of Metals
CY APR 14-16, 1993
CL TUCSON, AZ
DE NIEHS; HAZARDOUS SUBSTANCES; INTERDISCIPLINARY; BASIC RESEARCH; BIOLOGIC
   MARKERS; METALS; MIXTURES OF CHEMICALS; TECHNOLOGY TRANSFER
AB The National Institute of Environmental Health Sciences' Superfund Basic Research Program is currently funding 142 separate research projects within 18 programs encompassing 29 universities and institutions around the United States. The research under this program covers a wide range of interdisciplinary science from both the biomedical and nonbiomedical perspectives. This is a unique program of technology-driven research. Nonetheless, there are some areas of research that should be investigated or investigated further, should funds become available. Environmental health risk posed by the location of Superfund sites may be distributed inequitably across socioeconomic status and racial groups. Since one in five children now lives below the poverty line, an important aspect of environmental equity must be the investigation of the health effects of environmental factors on children. The multidisciplinary investigation of the effects of hazardous substance exposure on children is an area that needs much research due to the fact that most of the toxicologic data available are based on adults and animals. This program is funding 27 projects on ecologic damage posed by hazardous wastes. Much more research is needed in the investigation of toxic effects on natural succession of ecosystems as well as on their effects on biodiversity to further our understanding of the food web in the role of bioavailability in human health, and to examine the bioaccumulation of these chemicals as it relates to their fate and transport. This program is researching and developing many innovative technologies for detecting, assessing, and reducing toxic materials in the environment. As these products are developed through basic research, it becomes necessary to design a technology-transfer strategy for this program to handle the unique problems associated with transferring multidisciplinary technology from basic research to applied research and eventually to technology demonstrations and commercialization. Two areas of prime consideration are biologically based risk assessment and bioremediation. Presently, more than half of hazardous waste remediation is done via incineration. Additional funding will allow for investigating innovative technologies in incineration, to augment studies on the health effects of exposure to toxic combustion by-products, and to develop real-time monitors for hazardous waste incinerator emissions. From a public health perspective, this technology may allow for the destruction of environmental hazardous wastes such that potential human health effects are ameliorated, or indeed prevented, specifically by reducing the amount and toxicity of hazardous substances.
RP SUK, WA (reprint author), NIEHS, POB 12233, RES TRIANGLE PK, NC 27709 USA.
NR 0
TC 2
Z9 2
U1 1
U2 6
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD FEB
PY 1995
VL 103
SU 1
BP 3
EP 5
DI 10.2307/3432001
PG 3
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA QP391
UT WOS:A1995QP39100001
PM 7621795
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU BOZSAI, G
   MELEGH, M
AF BOZSAI, G
   MELEGH, M
TI APPLICATION OF THE TRANSVERSELY HEATED GRAPHITE ATOMIZER TO THE
   DETERMINATION OF TRACE-METALS IN ENVIRONMENTAL AND BIOMEDICAL SAMPLES
SO MICROCHEMICAL JOURNAL
LA English
DT Article; Proceedings Paper
CT 6th Hungaro/Italian Symposium on Spectrochemistry: Advances in
   Environmental Sciences
CY AUG 23-27, 1993
CL LILLAFURED, HUNGARY
SP EOTVOS LORAND TUDOMANYEGYETEM, BUDAPEST, IST SUPER SANITA, ROME
ID ABSORPTION SPECTROMETRY; FURNACE; INTERFERENCE; SELENIUM
AB A transversely heated graphite atomizer (THGA) with longitudinal Zeeman background correction was used for the determination of silver, nickel, cobalt, and chromium in water and human urine samples. The performance of the new type furnace was compared with that of a conventional ''Massmann''-type atomizer. The gas phase and covolatilization interferences of chloride and sulfate matrices in the determination of silver in water observed in the conventional furnace were successfully eliminated using the THGA technique. Detection limits for nickel, cobalt, and chromium were significantly improved using the new atomizer. The results of the determination of trace elements in standard reference materials showed good agreement with the certified or informative values. (C) 1995 Academic Press, Inc.
C1 INST ENVIRONM MANAGEMENT,H-1518 BUDAPEST,HUNGARY.
RP BOZSAI, G (reprint author), NATL INST HYG,POB 64,H-1966 BUDAPEST,HUNGARY.
CR BOZSAI G, 1990, TALANTA, V37, P545, DOI 10.1016/0039-9140(90)80195-L
   DELOOSVOLLEBREG.MT, 1988, SPECTROCHIM ACTA B, V43, P1147
   FRECH W, 1982, SPECTROCHIM ACTA B, V37, P1021, DOI 10.1016/0584-8547(82)80031-1
   FRECH W, 1985, PROG ANAL ATOM SPECT, V8, P257
   FRECH W, 1986, ANAL CHEM, V58, P1973, DOI 10.1021/ac00122a013
   MINOIA C, 1992, APPLICATION ZEEMAN G
   SHUTTLER I, 1992, ATOM SPECTROSC, V13, P174
   WELZ B, 1992, J ANAL ATOM SPECTROM, V7, P505, DOI 10.1039/ja9920700505
NR 8
TC 9
Z9 9
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495
SN 0026-265X
J9 MICROCHEM J
JI Microchem J.
PD FEB-APR
PY 1995
VL 51
IS 1-2
BP 39
EP 45
DI 10.1006/mchj.1995.1007
PG 7
WC Chemistry, Analytical
SC Chemistry
GA QK537
UT WOS:A1995QK53700006
DA 2018-10-19
ER

PT J
AU ALI, SAM
   HOURSTON, DJ
   MANZOOR, K
   WILLIAMS, DF
AF ALI, SAM
   HOURSTON, DJ
   MANZOOR, K
   WILLIAMS, DF
TI THE STABILITY OF POLY(ETHER URETHANE) POLYDIMETHYLSILOXANE
   INTERPENETRATING POLYMER NETWORKS
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID IMPLANTABLE DEVICES; DEGRADATION; MECHANISMS
AB Interpenetrating polymer networks (IPNs) are a special type of polymer blend consisting of two polymer networks synthesized and/or cross-linked independently within each other. One potential approach for the preparation of composite materials from polymers having desirable physical characteristics obtained by modifying their surfaces with physiologically acceptable polymers involves IPN technology. An IPN based on a poly(ether urethane) and polydimethylsiloxane has been synthesized and characterized using optical microscopy, dynamic mechanical analysis, and scanning electron microscopy. The stability of poly(ether urethane)/polydimethylsiloxane composites were studied in hydroxyl radical aqueous solutions over 30 weeks. The data suggest that these composites have good potential for biomedical applications. (C) 1995 John Wiley & Sons, Inc.
C1 ROYAL LIVERPOOL UNIV HOSP,DEPT CLIN ENGN,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND.
   LOUGHBOROUGH UNIV TECHNOL,INST POLYMER TECHNOL & MAT ENGN,LOUGHBOROUGH LE11 3TU,LEICS,ENGLAND.
   UNIV LANCASTER,CTR POLYMER,LANCASTER LA1 4YA,ENGLAND.
CR ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   ALI SAM, 1994, J APPL POLYM SCI, V51, P1389, DOI 10.1002/app.1994.070510805
   ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   ALI SAM, 1994, BIOMATERIALS, V15, P779, DOI 10.1016/0142-9612(94)90032-9
   ARKLES BC, 1983, MED DEVICE DIAGN IND, V5, P66
   ARKLES BC, 1983, POLYM MAT SCI ENG, V49, P6
   Baier R., 1977, ANN NY ACAD SCI, V17, P283
   DWIGHT DW, 1979, POLYM PREPR AM CHEM, V20, P702
   EBDIB HR, 1988, POLYMER, V29, P1079
   EBDON JR, 1984, POLYMER, V25, P1633, DOI 10.1016/0032-3861(84)90159-9
   EBDON JR, 1986, POLYMER, V27, P1807, DOI 10.1016/0032-3861(86)90280-6
   EBDON JR, 1986, ADV CHEM SERIES, V211
   HELMER JD, 1969, J APPL POLYM SCI, V13, P2112
   KLEIN PG, 1982, THESIS LANCASTER U L
   LEE CL, 1969, POLYM PREPR AM CHEM, V10, P1311
   LEGRAND DG, 1970, POLYM PREPR AM CHEM, V11, P442
   MANZOOR K, 1994, THESIS LANCASTER U L
   OMALLY JJ, 1977, POLYM PREPR, V18, P11
   WARD RS, 1980, ORG COAT PLAST CHEM, V42, P227
NR 19
TC 8
Z9 9
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JAN 31
PY 1995
VL 55
IS 5
BP 733
EP 740
DI 10.1002/app.1995.070550509
PG 8
WC Polymer Science
SC Polymer Science
GA QC555
UT WOS:A1995QC55500009
DA 2018-10-19
ER

PT S
AU Piel, H
AF Piel, H
BE DewHughes, D
TI Future prospects of applied superconductivity in Europe
SO APPLIED SUPERCONDUCTIVITY 1995, VOLS. 1 AND 2: VOL 1: PLENARY TALKS AND
   HIGH CURRENT APPLICATIONS; VOL 2: SMALL SCALE APPLICATIONS
SE INSTITUTE OF PHYSICS CONFERENCE SERIES
LA English
DT Article; Proceedings Paper
CT 2nd European Conference on Applied Superconductivity (EUCAS 1995)
CY JUL 03-06, 1995
CL EDINBURGH, SCOTLAND
SP Ansaldo Energia, BICC Cent Tech Unit, City Edinburgh Dist Council, Cookson, Dept Trade & Ind, European Mat Res Soc, Engn & Phys Sci Res Council, GEC Alsthom NV, Lothian & Edinburgh Enterprise Ltd, Merck Ind Chem, NKT Res Ctr, Oxford Instruments, Quantum Design, Natl Grid Co plc, Royal Soc, Royal Soc Edinburgh, Brit Cryogen Council, Inst Elect Engn
AB This contribution is a personal view of the current state and the future evolution of applied superconductivity with a specific focus on the European scene. It is approached by giving some examples from the history of applied superconductivity and by sketching the present market for products using superconducting components. Today's superconducting NMR, MRI and SQUID systems and the large scale projects of the near future, especially in the field of particle accelerators and energy technology, are exclusively based on metallic superconductors. The High Temperature Superconductors (HTS) still have a long way to go before they will have a noticeable impact on the superconductivity market, but quite a few practical uses of high Tc components are beginning to take shape. HTS bulk materials in the form of current leads are the first products which are used in commercial systems. The fabrication and application of HTS Josephson junctions is progressing and may find uses in the fields of biomedical research and non destructive evaluation. ITS wires and tapes are being tested in cryogen free or very high field magnets and in energy technology. One particular application area which is carrying much hope for the introduction of HTS materials to present technology will be described in more detail. It is the practical use of superconductors in high frequency fields. Epitaxial HTS films are expected to have their first wide spread use in mobile communication and rf signal sensing. In closing the early activities of a new European organization called CONECTUS are introduced. Tn this context an updated forecast of the size of the future superconductivity world market will be given.
RP Piel, H (reprint author), BERG UNIV GESAMTHSCH WUPPERTAL,INST SCI MAT,D-42097 WUPPERTAL,GERMANY.
CR Cavallari G., 1994, P EPAC 94, P2042
   ELIAS LR, 1976, PHYS REV LETT, V36, P71
   FAIRBANK WM, 1949, PHYS REV, V76, P1106, DOI 10.1103/PhysRev.76.1106
   FOLTYN SR, 1995, P INT WORKSHOP SUPER
   GRUNDER H, COMMUNICATION
   HEINRICHS H, 1995, APPLIED SUPERCONDUCT, V1, P627
   IJIMA Y, 1993, J APPL PHYS, V74, P1905
   KOMAREK P, 1995, APPLIED SUPERCONDUCT, V1, P9
   LEROY D, P ASC 94
   London H, 1934, NATURE, V133, P497, DOI 10.1038/133497b0
   MATTHIAS BT, 1954, PHYS REV, V95, P1435, DOI 10.1103/PhysRev.95.1435
   MAXWELL E, 1948, PHYS REV, V74, P1234
   PIPPARD AB, 1947, P ROY SOC LOND A MAT, V191, P371
   ROSNER CH, COMMUNICATION
   SATO KI, 1995, UNPUB PHYSICA B
   SCHWETTMANN HA, 1988, NEAR ZERO, P376
   WOOD M, P ASC 94
NR 17
TC 5
Z9 5
U1 0
U2 7
PU IOP PUBLISHING LTD
PI BRISTOL
PA TECHNO HOUSE, REDCLIFFE WAY, BRISTOL, ENGLAND BS1 6NX
SN 0951-3248
BN 0-7503-0348-4
J9 INST PHYS CONF SER
PY 1995
VL 148
BP 1
EP 8
PG 8
WC Physics, Applied; Physics, Condensed Matter
SC Physics
GA BE67G
UT WOS:A1995BE67G00001
DA 2018-10-19
ER

PT J
AU LABOW, RS
   ERFLE, DJ
   SANTERRE, JP
AF LABOW, RS
   ERFLE, DJ
   SANTERRE, JP
TI NEUTROPHIL-MEDIATED DEGRADATION OF SEGMENTED POLYURETHANES
SO BIOMATERIALS
LA English
DT Article
DE NEUTROPHILS; CELL CULTURE; ELASTASE; POLYURETHANES; DEGRADATION
ID BIOMATERIALS; ACTIVATION
AB The biostability of polyurethanes was evaluated using a human neutrophil cell culture. The polymers were synthesized with C-14 radiolabelled components incorporated into the polyurethane chain and the amount of radiolabel released during exposure to cells and medium was used as a marker for material degradation. The effect of diisocyanate, soft segment and chain extender chemistry on the susceptibility of polymer degradation was examined. All polymers showed a release of material into the tissue culture medium which was unrelated to the cells. A significant cell-dependent release of radiolabel-containing material was found from one of the polymers (a polyester urea-urethane, TDI/ PCL/ED) which increased linearly up to 96 h. The polyether-containing polyurethanes showed no significant cell-mediated degradation under similar conditions as measured by radiolabel release. Scanning electron microscopy (SEM) showed that the cells adhered to the different polyurethanes. However, no effect of neutrophils on polymer structure could be detected by this technique. The cellular response to each polymer was evaluated by measuring release of elastase-like activity (ELA) into the tissue culture media. After 24 h TDI/PCL/ED showed the highest levels of ELA in the tissue culture medium. When TDI/PCL/ED was incubated with commercial elastase in vitro, a significant release of radiolabel was found which was comparable to the amount of radiolabelled material released from this polymer in contact with the neutrophils in culture. No significant amount of radiolabel was released from the corresponding polyether material (TDI/PTMO/ED) under similar conditions. This study has identified one enzymatic activity (elastase) as a possible contributor to the deterioration of biomedical implants in vivo in that the polymer which elicited the greatest response of ELA also showed release of radiolabel when incubated with elastase in vitro. The use of a live cell culture system to assess the susceptibility of polyurethanes to degradation has provided a significant step forward in understanding the mechanism of biodegradation.
C1 UNIV OTTAWA,DEPT BIOCHEM,OTTAWA,ON,CANADA.
RP LABOW, RS (reprint author), UNIV OTTAWA,OTTAWA CIVIC HOSP,INST HEART,DIV CARDIOVASC DIVICES,1053 CARLING AVE,OTTAWA,ON K1Y 4E9,CANADA.
CR BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   FAYMONVILLE ME, 1991, J THORAC CARDIOV SUR, V102, P309
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   JANOFF A, 1969, BIOCHEM J, V114, P157, DOI 10.1042/bj1140157
   KELLEY JL, 1987, EXP MOL PATHOL, V46, P266, DOI 10.1016/0014-4800(87)90049-9
   KRAUSE TJ, 1993, J BIOMED MATER RES, V27, P65, DOI 10.1002/jbm.820270109
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Lelah M. D., 1986, POLYURETHANES MED
   PAPATHEOFANIS FJ, 1991, J BIOMED MATER RES, V25, P761, DOI 10.1002/jbm.820250606
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   RIGDON RH, 1975, CRIT REV FOOD SCI NU, V7, P435
   ROULIS M, 1990, ARTERIOSCLEROSIS, V10, P246
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   SANTERRE JP, 1994, IN PRESS J BIOMED MA, V28
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P1059, DOI 10.1016/0142-9612(92)90138-E
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   Thoma R J, 1987, J Biomater Appl, V1, P449
   WACHTFOGEL YT, 1987, BLOOD, V69, P324
NR 20
TC 47
Z9 48
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 1995
VL 16
IS 1
BP 51
EP 59
DI 10.1016/0142-9612(95)91096-H
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QB054
UT WOS:A1995QB05400008
PM 7718693
DA 2018-10-19
ER

PT S
AU Scranton, AB
   Rangarajan, B
   Klier, J
AF Scranton, AB
   Rangarajan, B
   Klier, J
BE Peppas, NA
   Langer, RS
TI Biomedical applications of polyelectrolytes
SO BIOPOLYMERS II
SE Advances in Polymer Science
LA English
DT Review
ID GLASS-IONOMER CEMENTS; MODEL MEMBRANE SYSTEMS; SHEAR BOND STRENGTH;
   POLY(METHACRYLIC ACID) GELS; POLY-ELECTROLYTE COMPLEXES; CONTROLLED DRUG
   DELIVERY; PHOSPHOLIPID VESICLE MEMBRANES; GLUCOSE-SENSITIVE MEMBRANES;
   WATER-SOLUBLE COPOLYMERS; PRE-IRRADIATION METHOD
AB Polyelectrolytes are used in a variety of biomedical systems, including dental adhesives and restorations; controlled release devices; polymeric drugs, prodrugs, and adjuvants; and biocompatible materials. This article provides a review of biomedical applications of polyelectrolytes with emphasis on recent developments. For completeness, an overview of the methods for polyelectrolyte synthesis is provided along with a description of the unique properties of polyelectrolyte solutions, gels, and complexes which make them useful in biomedical applications. The discussion of dental materials focuses on the recent developments in glass-ionomer cements and novel organic polyelectrolyte adhesives since these materials are replacing the traditional zinc carboxylates. The section on controlled release applications includes a brief overview of recent developments in the mature areas of coatings, matrices and binders; and provides more in-depth discussions of the advanced responsive, bioadhesive, and liposomal systems that have emerged in recent years. Finally, descriptions of the recent work in polyelectrolytes as biocompatible materials as well as drugs or prodrugs are provided.
C1 DOW CHEM CO USA, CENT RES, ADV POLYMER SYST LAB, MIDLAND, MI 48640 USA.
RP Scranton, AB (reprint author), MICHIGAN STATE UNIV, DEPT CHEM ENGN, E LANSING, MI 48824 USA.
CR AGABEYOGLU IT, 1986, DRUG DEV IND PHARM, V12, P569, DOI 10.3109/03639048609048029
   AKASHI M, 1990, ADV POLYM SCI, V97, P107
   Akelah A., 1990, FUNCTIONALIZED POLYM
   ALBIN G, 1985, Journal of Controlled Release, V2, P153, DOI 10.1016/0168-3659(85)90041-0
   Albin G, 1990, PULSED SELF REGULATE, P159
   ALBIN G W, 1987, Journal of Controlled Release, V6, P267, DOI 10.1016/0168-3659(87)90081-2
   ALEKSEEV KV, 1991, NOVEL DRUG FORMULATI, P59
   ALEXANDROWICZ Z, 1963, J POLYM SCI PART A, V1, P3231, DOI 10.1002/pol.1963.100011017
   ALEYAMMA AJ, 1990, BIOMIMETIC POLYMERS, P191
   ALEYAMMA AJ, 1988, POLYM MATER SCI ENG, V59, P692
   ALHAIQUE F, 1985, J PHARM PHARMACOL, V37, P310, DOI 10.1111/j.2042-7158.1985.tb05072.x
   ALICO KV, 1984, MAKROMOL CHEM-RAPID, V5, P345
   Amsel L.P., 1984, PHARM TECH, V8, P28
   ANBAR M, 1971, J DENT RES, V50, P778, DOI 10.1177/00220345710500033801
   ANBAR M, 1974, J DENT RES, V53, P879, DOI 10.1177/00220345740530041901
   ANDERSON JM, 1985, CRC CRITICAL REV BIO, P111
   ANDRADE JK, 1987, T AM SOC ART INT ORG, V83, P75
   ARMSTRONG RW, 1969, ENCYCLOPEDIA POLYMER, V10, P781
   ARTURSSON P, 1989, Advanced Drug Delivery Reviews, V3, P165, DOI 10.1016/0169-409X(89)90009-4
   ASMUSSEN E, 1991, J DENT RES, V70, P1290, DOI 10.1177/00220345910700091101
   ASMUSSEN E, 1993, J DENT RES, V72, P558, DOI 10.1177/00220345930720030101
   AZORI M, 1986, MAKROMOL CHEM, V187, P303
   AZZUOLI G, 1987, BIOMATERIALS, V8, P61, DOI 10.1016/0142-9612(87)90032-9
   BABA M, 1990, ANTIMICROB AGENTS CH, V34, P134, DOI 10.1128/AAC.34.1.134
   BAJORAS G, 1986, POLYM J, V18, P955, DOI 10.1295/polymj.18.955
   BAMFORD CH, 1983, EUR POLYM J, V19, P1027, DOI 10.1016/0014-3057(83)90068-X
   BANSLEBEN DA, 1985, POLYM PREPRINTS, V26, P106
   BARBUCCI R, 1991, J CONTROL RELEASE, V17, P79, DOI 10.1016/0168-3659(91)90133-X
   BARBUCCI R, 1987, ADV BIOMEDICAL POLYM, P259
   BARKHORDAR R A, 1988, Journal of Dental Research, V67, P263
   BARRY TI, 1979, J DENT RES, V58, P1072, DOI 10.1177/00220345790580030801
   BARTELS T, 1981, J POLYM SCI POL CHEM, V19, P127, DOI 10.1002/pol.1981.170190113
   BAUDUIN G, 1981, MAKROMOL CHEM, V182, P773
   Bayne S C, 1992, Adv Dent Res, V6, P65
   BEKTUROV E, 1980, ADV POLYM SCI, V41, P100
   Ben-Amar A, 1989, Am J Dent, V2, P175
   BENOIT H, 1954, J PHYS CHEM-US, V57, P958
   BENVENUTI M, 1989, DEV HEMATOL, V23, P259
   BERG HJ, 1988, J DENT RES, V67, P280
   BILLINGTON RW, 1990, BRIT DENT J, V169, P164, DOI 10.1038/sj.bdj.4807311
   Billmeyer FW, 1984, TXB POLYM SCI
   BLAGOJEVIC B, 1989, AUST DENT J, V33, P320
   BLANCHON S, 1991, INT J PHARM, V72, P1, DOI 10.1016/0378-5173(91)90374-W
   BODDE HE, 1990, J CONTROL RELEASE, V13, P225, DOI 10.1016/0168-3659(90)90012-I
   BORDEN KA, 1988, MACROMOLECULES, V21, P2649, DOI 10.1021/ma00186a059
   BORDEN KA, 1987, MACROMOLECULES, V20, P454, DOI 10.1021/ma00168a046
   BORUE VY, 1988, MACROMOLECULES, V21, P3240
   BOTTENBERG P, 1991, J PHARM PHARMACOL, V43, P457, DOI 10.1111/j.2042-7158.1991.tb03514.x
   BOUSSOUIRA B, 1987, J MACROMOL SCI CHEM, VA24, P137, DOI 10.1080/00222338708068127
   Bowen R L, 1992, Adv Dent Res, V6, P44
   Bowen R L, 1987, Int Dent J, V37, P158
   BOWEN RL, 1985, INT DENT J, V35, P155
   BOWEN RL, 1984, IND ENG CHEM PROD RD, V23, P78, DOI 10.1021/i300013a015
   BRACKETT WW, 1992, J PROSTHET DENT, V67, P59, DOI 10.1016/0022-3913(92)90050-K
   BRACKETT WW, 1989, J PROSTHET DENT, V62, P261, DOI 10.1016/0022-3913(89)90328-4
   BRADY JE, 1984, J AM CHEM SOC, V106, P4279, DOI 10.1021/ja00327a044
   Brannon-Peppas L., 1990, ABSORBENT POLYM TECH, V8, P45, DOI DOI 10.1016/B978-0-444-88654-5.50008-X
   BRANNONPEPPAS L, 1989, J CONTROL RELEASE, V8, P267, DOI 10.1016/0168-3659(89)90048-5
   BREMECKER KD, 1984, J PHARM SCI, V73, P548, DOI 10.1002/jps.2600730429
   BROOK I M, 1991, Clinical Materials, V7, P295, DOI 10.1016/0267-6605(91)90073-O
   BROOK IM, 1992, BIOMATERIALS, V13, P721, DOI 10.1016/0142-9612(92)90134-A
   BRUCK SD, 1988, CRIT REV THER DRUG, V5, P171
   BRUNE D, 1982, SCAND J DENT RES, V90, P409
   BRUNE D, 1984, SCAND J DENT RES, V92, P156
   BRYDSON JA, 1982, PLASTIC MATERIALS
   BUCHHOLZ FL, 1990, ABSORBENT POLYM TECH, P23
   BURAIE AN, 1991, ALEXANDRIA J PHARM S, V5, P37
   BURGESS DJ, 1991, POLYM PREPR, V32, P600
   BUTLER GB, 1991, ACS SYM SER, V467, P25
   BUTTON GL, 1985, J PROSTHET DENT, V53, P34, DOI 10.1016/0022-3913(85)90060-5
   CANDAU F, 1986, COLLOID POLYM SCI, V264, P676, DOI 10.1007/BF01469528
   CAPAN Y, 1989, PHARM IND, V51, P443
   CARRALE CE, 1982, ACS S SER, V186
   Chang R K, 1988, J Biomater Appl, V3, P80, DOI 10.1177/088532828800300104
   CHANG R-K, 1987, Pharmaceutical Technology, V11, P64
   CHANG RK, 1990, PHARM TECH, V14, P62
   CHEN RS, 1989, J ADHES SCI TECHNOL, V3, P49, DOI 10.1163/156856189X00047
   CHIEN YW, 1990, MED RES REV, V10, P477, DOI 10.1002/med.2610100405
   CHIEN YW, 1983, DRUG DEV IND PHARM, V9, P497, DOI 10.3109/03639048309044691
   CHIGIRA H, 1991, DENT MATER, V7, P103, DOI 10.1016/0109-5641(91)90054-3
   CHIGIRA H, 1988, JPN J CONSERV DENT, V31, P667
   CHITNIS VS, 1991, DRUG DEV IND PHARM, V17, P879, DOI 10.3109/03639049109040824
   CHOULIS NH, 1975, J PHARM SCI, V64, P1033, DOI 10.1002/jps.2600640634
   CHUNG DW, 1986, J AM CHEM SOC, V108, P5823, DOI 10.1021/ja00279a026
   COLOMBO P, 1993, ADV DRUG DELIVER REV, V11, P37, DOI 10.1016/0169-409X(93)90026-Z
   COOK WD, 1982, BIOMATERIALS, V3, P232, DOI 10.1016/0142-9612(82)90025-4
   COOK WD, 1983, BIOMATERIALS, V4, P85, DOI 10.1016/0142-9612(83)90045-5
   COOLEY RL, 1991, J PROSTHET DENT, V66, P773, DOI 10.1016/0022-3913(91)90413-Q
   CRAIG DQM, 1992, P INT S CONTROL REL, V19, P260
   CRAIG RG, 1983, DENTAL MATERIALS PRO
   CRANFIELD M, 1982, J DENT, V10, P333, DOI 10.1016/0300-5712(82)90028-8
   Crim G A, 1993, Am J Dent, V6, P192
   CRIM GA, 1993, J PROSTHET DENT, V69, P561, DOI 10.1016/0022-3913(93)90281-R
   CRISP S, 1974, J DENT RES, V53, P1414, DOI 10.1177/00220345740530062001
   CRISP S, 1979, J DENT, V7, P304, DOI 10.1016/0300-5712(79)90143-X
   CRISP S, 1974, J DENT RES, V53, P1408, DOI 10.1177/00220345740530061901
   CRISP S, 1976, J DENT RES, V55, P1023, DOI 10.1177/00220345760550060401
   CULBERTSON BM, 1985, ENCY POLYM SCI ENG, V11, P740
   Davis E L, 1993, Am J Dent, V6, P127
   DAVIS M, 1986, INT J PHARM, V28, P157, DOI 10.1016/0378-5173(86)90241-3
   DAVIS MB, 1986, DRUG DEV IND PHARM, V12, P1419, DOI 10.3109/03639048609065869
   DAVIS RM, 1984, THESIS PRINCETON U P
   Davison CJ, 1990, J BIOACT COMPAT POL, V5, P267, DOI 10.1177/088391159000500303
   De Moor C.P., 1989, P INT S CONTROLLED R, V16, P157
   DEGROOT K, 1980, J DENT RES, V59, P1493, DOI 10.1177/00220345800590090601
   DeSchepper E J, 1989, Am J Dent, V2, P51
   DEVLIN BP, 1986, MACROMOLECULES, V19, P2465, DOI 10.1021/ma00163a028
   DEVLIN BP, 1987, POLYM PREPRINTS, V28
   DEVRIES ME, 1988, J BIOMED MATER RES, V22, P1023, DOI 10.1002/jbm.820221106
   DILTS WE, 1985, J PROSTHET DENT, V53, P505, DOI 10.1016/0022-3913(85)90635-3
   DOMINQUEZ L, 1987, MAKROMOL CHEM-RAPID, V8, P151
   DONARUMA LG, 1980, ANIONIC POLYM DRUGS, V1
   DONG C, 1991, J CONTROL RELEASE, V17, P217, DOI 10.1016/0168-3659(91)90140-9
   DRAGAN S, 1981, J POLYM SCI POL CHEM, V19, P2869, DOI 10.1002/pol.1981.170191120
   DRAGAN S, 1991, POLYM BULL, V27, P17, DOI 10.1007/BF00296319
   DUMITRIU S, 1992, POLYM MED, P115
   Dumitriu S, 1990, J BIOACT COMPAT POL, V5, P310, DOI 10.1177/088391159000500307
   DUNN RL, 1991, ACS SYM SER, V469, P11
   DURRANI MJ, 1992, P INT S CONTROL REL, V19, P811
   Eick J D, 1992, Quintessence Int, V23, P43
   ELLIS J, 1991, POLYM INT, V24, P221, DOI 10.1002/pi.4990240404
   ELLIS J, 1990, J MATER SCI LETT, V9, P1058, DOI 10.1007/BF00727876
   ELLIS J, 1991, Clinical Materials, V7, P341, DOI 10.1016/0267-6605(91)90079-U
   EUM KM, 1989, MACROMOLECULES, V22, P2755, DOI 10.1021/ma00196a038
   FERRITTO MS, 1988, MACROMOLECULES, V21, P3117, DOI 10.1021/ma00188a036
   FERRUTI P, 1985, POLYMER, V26, P1336, DOI 10.1016/0032-3861(85)90309-X
   FERRUTI P, 1984, ADV POLYM SCI, V58, P55
   FINI A, 1987, MAKROMOL CHEM, V188, P1959
   FIRESTONE BA, 1988, POLYM COMMUN, V29, P204
   FIXMAN M, 1978, MACROMOLECULES, V11, P863, DOI 10.1021/ma60065a004
   FIXMAN M, 1982, J CHEM PHYS, V76, P6346, DOI 10.1063/1.443039
   FORSS H, 1990, SCAND J DENT RES, V98, P173
   FORSTEN L, 1977, SCAND J DENT RES, V85, P503
   FORSTEN L, 1991, SCAND J DENT RES, V99, P241
   FOUGNOT C, 1984, BIOMATERIALS, V5, P94, DOI 10.1016/0142-9612(84)90008-5
   FOUGNOT C, 1979, ANN BIOMED ENG, V7, P441, DOI 10.1007/BF02364220
   FOUGNOT C, 1979, ANN BIOMED ENG, V7, P429, DOI 10.1007/BF02364219
   FUKUMORI Y, 1988, CHEM PHARM BULL, V36, P4927
   Garcia-Godoy F, 1988, Am J Dent, V1, P97
   Garcia-Godoy F, 1991, Am J Dent, V4, P223
   Garcia-Godoy F, 1992, Am J Dent, V5, P283
   Gebelein C.G., 1987, ADV BIOMEDICAL POLYM, P277
   GEKKO K, 1981, J BIOCHEM-TOKYO, V90, P39, DOI 10.1093/oxfordjournals.jbchem.a133468
   GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023
   GHANEM A, 1980, PHARM ACTA HELV, V55, P61
   GIESELMAN MB, 1992, MACROMOLECULES, V25, P4832, DOI 10.1021/ma00044a056
   GLASS JE, 1989, ACS DIVISION POLYM C, V30, P387
   GOETHALS EJ, 1980, POLYM AMINES AMMONIU
   GRAHAM NB, 1986, NATO ASI SERIES E, V106, P170
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   GREENLEY RZ, 1991, ACS SYM SER, V469, P213
   GREENWALD HL, 1980, HDB WATER SOLUBLE GU, P17
   GRIGNON J, 1980, J APPL POLYM SCI, V25, P2829, DOI 10.1002/app.1980.070251215
   Grodzinsky AJ, 1990, PULSED SELF REGULATE, P47
   GROSS JR, 1990, ABSORBENT POLYM TECH, P3
   Gross L., 1966, CHEM PHYSICS IONIC S, P361
   GUMOWSKI F, 1987, Pharmaceutical Technology, V11, P28
   GURNY R, 1987, Journal of Controlled Release, V6, P367, DOI 10.1016/0168-3659(87)90090-3
   Haddad D, 1992, Am J Dent, V5, P286
   HAN DK, 1991, J BIOMED MATER RES, V25, P561, DOI 10.1002/jbm.820250502
   HARADA J, 1992, ACS SYM SER, V480, P80
   HARIHARAN D, 1992, P INT S CONTR REL BI, V19, P367
   HARRIS D, 1990, BIOMATERIALS, V11, P652, DOI 10.1016/0142-9612(90)90023-J
   HARRIS D, 1990, J CONTROL RELEASE, V12, P55, DOI 10.1016/0168-3659(90)90183-T
   HARRIS D, 1990, J CONTROL RELEASE, V12, P45, DOI 10.1016/0168-3659(90)90182-S
   HASA J, 1975, J POLYM SCI POL PHYS, V13, P263, DOI 10.1002/pol.1975.180130204
   HASA J, 1975, J POLYM SCI POL PHYS, V13, P253, DOI 10.1002/pol.1975.180130203
   HASEGAWA T, 1989, DENT MATER, V5, P150, DOI 10.1016/0109-5641(89)90002-X
   HASSAN RM, 1993, J APPL POLYM SCI, V47, P1649, DOI 10.1002/app.1993.070470912
   HATIBOVICKOFMAN S, 1991, SWED DENT J, V15, P253
   Hayakawa T, 1988, Dent Mater J, V7, P19
   HELLER J, 1993, CRIT REV THER DRUG, V10, P253
   HELMUS MN, 1984, J BIOMED MATER RES, V18, P165, DOI 10.1002/jbm.820180207
   HERMANS JJ, 1948, RECL TRAV CHIM PAY B, V67, P761
   HEWLETT ER, 1991, J PROSTHET DENT, V66, P767, DOI 10.1016/0022-3913(91)90412-P
   HEYS RJ, 1991, J DENT RES, V70, P55, DOI 10.1177/00220345910700010901
   Hicks M J, 1986, Quintessence Int, V17, P527
   Hicks M J, 1992, Am J Dent, V5, P329
   HIGUCHI S, 1986, MACROMOLECULES, V19, P2263, DOI 10.1021/ma00162a026
   HILL RG, 1988, J DENT RES, V67, P1446, DOI 10.1177/00220345880670120101
   HILL RG, 1989, J MATER SCI, V24, P363, DOI 10.1007/BF00660982
   HILL RG, 1991, J MATER SCI, V26, P67, DOI 10.1007/BF00576034
   HINOURA K, 1991, J DENT RES, V70, P1542, DOI 10.1177/00220345910700121301
   HIRANO S, 1987, ADV BIOMEDICAL POLYM, P285
   HODD KA, 1976, BRIT POLYM J, V8, P131, DOI 10.1002/pi.4980080405
   Horbett T.A., 1984, POLYM BIOMATERIALS, P193
   HORBETT TA, 1983, POLYM PREPR-ACS, V24, P34
   HSU YG, 1991, MAKROMOL CHEM, V192, P999
   HUNKELER D, 1992, ACS SYM SER, V480, P24
   IDOL WK, 1986, J MEMBRANE SCI, V28, P269, DOI 10.1016/S0376-7388(00)82039-6
   IHATA J, 1988, J POLYM SCI POL CHEM, V26, P167, DOI 10.1002/pola.1988.080260116
   IHATA J, 1988, J POLYM SCI POL CHEM, V26, P177, DOI 10.1002/pola.1988.080260117
   IHATA J, 1988, J POLYM SCI POL CHEM, V26, P187, DOI 10.1002/pola.1988.080260118
   Iioka A, 1989, Dent Mater J, V8, P236
   Ikada Y., 1984, POLYM BIOMATERIALS, P135
   IMAI Y, 1991, J DENT RES, V70, P1088, DOI 10.1177/00220345910700071401
   IMENSON AP, 1983, 2ND GUMS STAB FOOD I, V2, P189
   ISHIGAKI I, 1982, J APPL POLYM SCI, V27, P1033, DOI 10.1002/app.1982.070270322
   ISHIGAKI I, 1982, J APPL POLYM SCI, V27, P1043, DOI 10.1002/app.1982.070270323
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P937, DOI 10.1002/jbm.820260708
   ISHIHARA K, 1984, POLYM J, V16, P647, DOI 10.1295/polymj.16.647
   ISHIHARA K, 1986, J POLYM SCI POL LETT, V24, P413, DOI 10.1002/pol.1986.140240809
   ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   ISHIHARA K, 1989, J BIOMED MATER RES, V23, P1475, DOI 10.1002/jbm.820231209
   ISHIHARA K, 1983, MAKROMOL CHEM-RAPID, V4, P327
   Ishihara K., 1988, P INT S CONTROLLED R, V15, P168
   ITO H, 1986, J APPL POLYM SCI, V31, P2491, DOI 10.1002/app.1986.070310810
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   ITO Y, 1989, J CONTROL RELEASE, V10, P195, DOI 10.1016/0168-3659(89)90063-1
   ITO Y, 1990, POLYMER, V31, P2157, DOI 10.1016/0032-3861(90)90090-L
   ITO Y, 1986, J BIOMED MATER RES, V20, P1139, DOI 10.1002/jbm.820200807
   ITO Y, 1986, J BIOMED MATER RES, V20, P1017, DOI 10.1002/jbm.820200715
   ITO Y, 1992, SYNTHESIS BIOCOMPOSI, P137
   ITO Y, 1984, POLYM PREPAR JPN, V33, P2163
   IWATA H, 1988, J MEMBRANE SCI, V38, P185, DOI 10.1016/S0376-7388(00)80879-0
   Iwata H., 1988, P INT S CONTR REL BI, V15, P170
   JOHNSON M, 1985, EUR POLYM J, V21, P147, DOI 10.1016/0014-3057(85)90045-X
   JOHNSTON AD, 1989, J DENT RES, V68, P1337, DOI 10.1177/00220345890680091001
   JONCK L M, 1992, Clinical Materials, V9, P85, DOI 10.1016/0267-6605(92)90053-V
   JONCK LM, 1989, CLIN MATER, V4, P85
   JOZEFOWICZ M, 1985, AM SOC ARTIF INTERN, V8, P218
   Kabanov V., 1984, MACROMOL CHEM S, P259
   KABANOV VA, 1986, MAKROMOL CHEM-M SYMP, V1, P101, DOI 10.1002/masy.19860010110
   KABRA B, 1989, POLYM PREPR, V30, P490
   KATAOKA K, 1979, MAKROMOL CHEM, V180, P65
   KATAOKA K, 1980, MAKROMOL CHEM, V181, P1363
   Katchalsky A., 1966, CHEM PHYSICS IONIC S, P295
   KATO A, 1983, BIORHEOLOGY, V20, P593
   Kato A, 1984, J Microencapsul, V1, P105, DOI 10.3109/02652048409038514
   KATO A, 1985, POLYM MATER SCI ENG, V53, P654
   KATO A, 1987, ADV BIOMEDICAL POLYM, P285
   KATO A, 1987, POLYM SCI TECHNOL, V35, P299
   KAWASHIMA Y, 1991, INT J PHARM, V75, P25, DOI 10.1016/0378-5173(91)90247-L
   KAWASHIMA Y, 1985, J PHARM SCI, V74, P264, DOI 10.1002/jps.2600740308
   KAZANSKII KS, 1992, ADV POLYM SCI, V104, P97
   KHOKHLOV AR, 1982, POLYMER, V23, P1742, DOI 10.1016/0032-3861(82)90116-1
   KHOKHLOV AR, 1980, J PHYS A-MATH GEN, V13, P979, DOI 10.1088/0305-4470/13/3/030
   KHOSLA R, 1987, J PHARM PHARMACOL, V39, P47, DOI 10.1111/j.2042-7158.1987.tb07161.x
   KIKUCHI Y, 1988, B CHEM SOC JPN, V61, P2943, DOI 10.1246/bcsj.61.2943
   KIKUCHI Y, 1988, J APPL POLYM SCI, V35, P259, DOI 10.1002/app.1988.070350119
   KIKUCHI Y, 1980, MAKROMOL CHEM-RAPID, V1, P253
   KIM S W, 1985, Critical Reviews in Biocompatibility, V1, P229
   KIMBALL GE, 1957, J PHYS CHEM-US, V56, P47
   KINOSHITA T, 1983, J MACROMOL SCI PHYS, VB22, P1, DOI 10.1080/00222348308215489
   KISLALIOGLU MS, 1991, J PHARM SCI, V80, P799, DOI 10.1002/jps.2600800820
   KIYOMURA M, 1987, J JPN DENT MATER, V6, P719
   KLIER J, 1990, MACROMOLECULES, V23, P4944, DOI 10.1021/ma00225a011
   KOBAYASHI S, 1983, MAKROMOL CHEM, V184, P793
   KOKUBO T, 1991, J CONTROL RELEASE, V17, P69
   KONAK C, 1989, POLYMER, V30, P677, DOI 10.1016/0032-3861(89)90154-7
   KONO K, 1990, J MEMBRANE SCI, V50, P85, DOI 10.1016/S0376-7388(00)80888-1
   KONO K, 1990, BIOCHEMISTRY-US, V29, P3631, DOI 10.1021/bi00467a007
   KORSHAK VV, 1985, ENVIRON PROT ENG, V11, P103
   KOST J, 1985, J BIOMED MATER RES, V19, P1117, DOI 10.1002/jbm.820190920
   KOST J, 1991, ADV DRUG DELIVER REV, V6, P19
   KOTIN L, 1961, J AM CHEM SOC, V83, P1026, DOI 10.1021/ja01466a003
   KOTZ J, 1992, ACTA POLYM, V43, P193, DOI 10.1002/actp.1992.010430401
   KOTZ J, 1991, ACTA POLYM, V42, P28, DOI 10.1002/actp.1991.010420109
   KOTZ J, 1993, MAKROMOL CHEM, V194, P397
   KOU JH, 1988, PHARMACEUT RES, V5, P592, DOI 10.1023/A:1015998131160
   KRABBENDAM CA, 1987, J DENT, V15, P77, DOI 10.1016/0300-5712(87)90004-2
   KUDO S, 1992, MAKROMOL CHEM-RAPID, V13, P545
   KULKARNI PV, 1990, J MACROMOL SCI R M C, V30, P364
   KWON GS, 1991, J COLLOID INTERF SCI, V143, P501, DOI 10.1016/0021-9797(91)90283-E
   KWON IC, 1991, J CONTROL RELEASE, V17, P149, DOI 10.1016/0168-3659(91)90054-H
   KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0
   LEHMANN K, 1984, ACTA PHARM FENN, V93, P55
   LEHMANN K, 1989, CHEM APPL PROPERTIES, P153
   LEHMANN K, 1985, P INT S CONTROLLED R, V12, P361
   Leung S. H., 1988, J CONTROL RELEASE, V5, P223
   LEVI M, 1989, POLYM THEIR PROPERTI, P379
   LI FM, 1991, J BIOACT COMPAT POL, V6, P142, DOI 10.1177/088391159100600203
   LI SP, 1991, DRUG DEV IND PHARM, V17, P1655
   LIFSON S, 1957, J CHEM PHYS, V27, P700, DOI 10.1063/1.1743817
   LIN A, 1992, J DENT RES, V71, P1836, DOI 10.1177/00220345920710111401
   LIN SY, 1991, PHARMACEUT RES, V8, P1137, DOI 10.1023/A:1015850301214
   LINAKIS JG, 1992, PHARMACOL TOXICOL, V70, P38, DOI 10.1111/j.1600-0773.1992.tb00422.x
   Lindeque B. G. P., 1993, Clinical Materials, V14, P49, DOI 10.1016/0267-6605(93)90047-B
   LIPPMAN N, 1988, Journal of Dental Research, V67, P263
   LONGER MA, 1985, J PHARM SCI, V74, P406, DOI 10.1002/jps.2600740408
   Lynch E, 1989, J Ir Dent Assoc, V35, P66
   MACHIDA Y, 1979, CHEM PHARM BULL, V27, P93
   MAEDA M, 1991, ANN NY ACAD SCI, V618, P362, DOI 10.1111/j.1749-6632.1991.tb27256.x
   MAEDA M, 1988, J AM CHEM SOC, V110, P7455, DOI 10.1021/ja00230a028
   MAEDA M, 1984, J AM CHEM SOC, V106, P250, DOI 10.1021/ja00313a049
   MAKSIMENKO OO, 1990, VYSOKOMOL SOEDIN A+, V32, P2362
   MALAVASIC T, 1986, J MACROMOL SCI CHEM, VA23, P853, DOI 10.1080/00222338608069477
   MALLEY I, 1987, DRUG DEV IND PHARM, V13, P67, DOI 10.3109/03639048709040156
   MANDEL M, 1984, ANGEW MAKROMOL CHEM, V123, P63, DOI 10.1002/apmc.1984.051230103
   MANDEL M, 1988, ENCY POLYM SCI ENG, V11, P739
   MANNING GS, 1972, ANNU REV PHYS CHEM, V23, P117, DOI 10.1146/annurev.pc.23.100172.001001
   MANNING GS, 1969, J CHEM PHYS, V51, P934, DOI 10.1063/1.1672158
   MANNING GS, 1965, J CHEM PHYS, V43, P4250, DOI 10.1063/1.1696682
   MANNING GS, 1969, J CHEM PHYS, V51, P924, DOI 10.1063/1.1672157
   MANNING MC, 1989, PHARM RES-DORDR, V6, P903, DOI 10.1023/A:1015929109894
   MANSEN AE, 1981, CANCER RES, V16, P329
   MARCOS BP, 1991, J CONTROL RELEASE, V17, P267
   MARGAU M, 1981, 3RD P MISAO, V5, P504
   MAUZAC M, 1984, BIOMATERIALS, V5, P301, DOI 10.1016/0142-9612(84)90078-4
   MAUZAC M, 1982, BIOMATERIALS, V3, P221, DOI 10.1016/0142-9612(82)90023-0
   MAYS JW, 1990, POLYM COMMUN, V31, P170
   MCCAGHREN RA, 1990, J DENT RES, V69, P40, DOI 10.1177/00220345900690010601
   MCCOMB D, 1987, J DENT RES, V66, P1025, DOI 10.1177/00220345870660050601
   MCCORMICK CL, 1991, ACS SYM SER, V467, P2
   MCCORMICK CL, 1992, MACROMOLECULES, V25, P1201, DOI 10.1021/ma00030a001
   MCGINTY JW, 1989, AQUEOUS POLYM COATIN, P317
   MCLEAN JW, 1985, BRIT DENT J, V158, P410, DOI 10.1038/sj.bdj.4805621
   MERRILL EW, 1987, ANN NY ACAD SCI, V516, P196, DOI 10.1111/j.1749-6632.1987.tb33041.x
   MERYON SD, 1984, INT ENDOD J, V17, P16, DOI 10.1111/j.1365-2591.1984.tb00373.x
   MESHALI MM, 1993, INT J PHARM, V89, P177, DOI 10.1016/0378-5173(93)90241-7
   MIDDLETON JC, 1989, POLYM PREPR AM CHEM, V30, P348
   MILLER RM, 1985, ESAO P, V12, P466
   MISRA DN, 1988, LANGMUIR, V4, P953, DOI 10.1021/la00082a029
   MISRA DN, 1989, J DENT RES, V68, P42, DOI 10.1177/00220345890680010601
   MISRA DN, 1987, J BIOMED MATER RES, V21, P1329, DOI 10.1002/jbm.820211105
   MITRA SB, 1991, J DENT RES, V70, P72, DOI 10.1177/00220345910700011201
   MITRA SB, 1991, J DENT RES, V70, P75, DOI 10.1177/00220345910700011301
   MOJON P, 1992, J DENT RES, V71, P1633, DOI 10.1177/00220345920710091701
   MORA M, 1992, J CONTROL RELEASE, V18, P153, DOI 10.1016/0168-3659(92)90184-S
   MORIMOTO K, 1987, J PHARMACOBIO-DYNAM, V10, P85, DOI 10.1248/bpb1978.10.85
   MORIMOTO K, 1985, J PHARM PHARMACOL, V37, P134, DOI 10.1111/j.2042-7158.1985.tb05024.x
   MORIMOTO K, 1982, INT J PHARM, V12, P107
   MORIMOTO Y, 1992, J CONTROL RELEASE, V18, P113
   MORTNY KS, 1988, J BIOMATERIALS APPLI, V3
   MUNKSGAARD EC, 1985, J DENT RES, V64, P1409, DOI 10.1177/00220345850640121801
   MUQBILL R, 1979, J POLYM SCI POL LETT, V17, P369, DOI 10.1002/pol.1979.130170607
   MURAMATSU N, 1983, J BIOMED MATER RES, V17, P959, DOI 10.1002/jbm.820170607
   MURTHY K S, 1986, Pharmaceutical Technology, V10, P46
   NAGAI T, 1993, ADV DRUG DELIVER REV, V11, P179, DOI 10.1016/0169-409X(93)90032-Y
   NAKABAYASHI N, 1982, J BIOMED MATER RES, V16, P265, DOI 10.1002/jbm.820160307
   NAKABAYASHI N, 1988, KOBUNSHI RONBUNSHU, V45, P91, DOI 10.1295/koron.45.91
   NAKABAYASHI N, 1984, CRIT REV BIOCOMPAT, V1, P25
   NAKABAYASHI N, 1981, REP I MED DENT ENG, V15, P37
   NAKANO M, 1980, INT J PHARM, V4, P291
   NAVARRO A, 1991, STP HARM SCI, V1, P151
   NEMEC JW, 1988, ENCY POLYM SCI ENG, P211
   Neve A D, 1993, Clin Mater, V12, P113, DOI 10.1016/0267-6605(93)90059-G
   Neve A D, 1992, Clin Mater, V9, P13, DOI 10.1016/0267-6605(92)90005-E
   NEVE AD, 1992, CLIN MATER, V9, P21
   Nicholson J.W., 1991, CLIN MATER, V7, P289, DOI 10.1016/0267-6605(91)90072-N
   NICHOLSON JW, 1988, J DENT RES, V67, P1451, DOI 10.1177/00220345880670120201
   NICOLAI T, 1989, MACROMOLECULES, V22, P438, DOI 10.1021/ma00191a080
   ODIAN G, 1991, PRINCIPLES POLYM
   ODIJK T, 1978, J POLYM SCI POL PHYS, V16, P627, DOI 10.1002/pol.1978.180160405
   ODIJK T, 1977, J POLYM SCI POL PHYS, V15, P477, DOI 10.1002/pol.1977.180150307
   Oilo G, 1992, Adv Dent Res, V6, P50
   OKAHATA Y, 1984, J CHEM SOC CHEM COMM, P519, DOI 10.1039/c39840000519
   OKAHATA Y, 1987, MACROMOLECULES, V20, P15, DOI 10.1021/ma00167a004
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P668, DOI 10.1016/0142-9612(91)90115-Q
   OKKEMA AZ, 1988, MATER RES SOC S P, V110, P91
   OKOR RS, 1991, J CONTROL RELEASE, V16, P349, DOI 10.1016/0168-3659(91)90012-3
   OMICHI H, 1986, J APPL POLYM SCI, V32, P4827, DOI 10.1002/app.1986.070320505
   ORACESKA B, 1992, P INT S CONTROL REL, V19, P198
   OSADA Y, 1981, J POLYM SCI POL LETT, V19, P303, DOI 10.1002/pol.1981.130190605
   OSADA Y, 1993, PROG POLYM SCI, V18, P187, DOI 10.1016/0079-6700(93)90025-8
   OSADA Y, 1991, J MACROMOL SCI CHEM, VA28, P1189, DOI 10.1080/00222339108054092
   OSADA Y, 1986, J MEMBRANE SCI, V27, P327, DOI 10.1016/0376-7388(86)80003-5
   OSADA Y, 1987, ADV POLYM SCI, V82, P1
   OSADA Y, 1994, TRENDS POLYM SCI, V2, P61
   OSAWA F, 1954, J POLYM SCI, V13, P93, DOI 10.1002/pol.1954.120136808
   Osborne J W, 1990, Am J Dent, V3, P40
   OSBORNE JW, 1986, DENT MATER, V2, P147, DOI 10.1016/S0109-5641(86)80023-9
   OSTERWALD HP, 1985, PHARM RES-DORDR, V1, P14
   OTTENBRITE RM, 1985, ANN NY ACAD SCI, V446, P160, DOI 10.1111/j.1749-6632.1985.tb18398.x
   OTTENBRITE RM, 1985, BIOACTIVE POLYM SYST, P514
   OTTENBRITE RM, 1983, POLYM SCI TECHNOL PO, V23, P3
   OTTENBRITE RM, 1978, POLYM DRUGS, P263
   OTTENBRITE RM, 1984, ANTICANCER INTERFERO, P247
   OZTURK SS, 1988, PHARMACEUT RES, V5, P550, DOI 10.1023/A:1015937912504
   Panarin E. F., 1985, MAKROMOL CHEM S, V9, P25, DOI [10.1002/macp.1985.020091985104, DOI 10.1002/MACP.1985.020091985104]
   PARK H, 1985, Journal of Controlled Release, V2, P47, DOI 10.1016/0168-3659(85)90032-X
   PARK K, 1984, INT J PHARM, V19, P107, DOI 10.1016/0378-5173(84)90154-6
   Park K., 1984, RECENT ADV DRUG DELI, P163
   PEARSON G J, 1991, Clinical Materials, V7, P325, DOI 10.1016/0267-6605(91)90076-R
   PEARSON GJ, 1987, DENT MATER, V3, P275, DOI 10.1016/S0109-5641(87)80087-8
   PEARSON GJ, 1989, DENT MATER, V5, P10, DOI 10.1016/0109-5641(89)90084-5
   PEFFERKORN E, 1982, BIOPOLYMERS, V21, P1451, DOI 10.1002/bip.360210713
   PEPPAS N A, 1985, Journal of Controlled Release, V2, P257, DOI 10.1016/0168-3659(85)90050-1
   Peppas N. A., 1986, HYDROGELS MED PHARM, VI, P1
   PEPPAS NA, 1993, ADV DRUG DELIVER REV, V11, P1, DOI 10.1016/0169-409X(93)90025-Y
   PERNER T, 1987, BRIT POLYM J, V19, P181, DOI 10.1002/pi.4980190210
   Petrak K, 1986, J BIOACT COMPAT POL, V1, P202
   PHILIPP B, 1989, PROG POLYM SCI, V14, P91, DOI 10.1016/0079-6700(89)90018-X
   PHILIPP B, 1991, POLYM NEWS, V16, P106
   PHILIPP B, 1980, ACTA POLYM, V31, P654
   PHILIPP B, 1980, ACTA POLYM, V31, P592
   PHILLIPS RW, 1982, SKINNERS SCI DENTAL
   PITT CG, 1986, PHARM INT, V88
   POWIS DR, 1982, J DENT RES, V61, P1416, DOI 10.1177/00220345820610120801
   PRADNY M, 1986, POLYM BULL, V16, P195, DOI 10.1007/BF00955491
   PRADNY M, 1990, MAKROMOL CHEM, V191, P1887
   PRATI C, 1992, DENT MATER, V8, P21, DOI 10.1016/0109-5641(92)90048-H
   PRATI C, 1991, Clinical Materials, V8, P137, DOI 10.1016/0267-6605(91)90022-8
   PROSSER HJ, 1982, J BIOMED MATER RES, V16, P431, DOI 10.1002/jbm.820160411
   PRUDHOMME RK, 1993, P ACS POLYM MATERIAL, V69, P527
   PUJOLFORTIN ML, 1991, MACROMOLECULES, V24, P4523, DOI 10.1021/ma00016a007
   RAGHUNATHAN Y, 1981, J PHARM SCI, V70, P379, DOI 10.1002/jps.2600700409
   RATH NC, 1984, CHEM-BIOL INTERACT, V48, P339, DOI 10.1016/0009-2797(84)90144-3
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   REGEN SL, 1984, J AM CHEM SOC, V106, P2446, DOI 10.1021/ja00320a043
   RETIEF DH, 1984, CARIES RES, V18, P250, DOI 10.1159/000260773
   RODRIGUES F, 1982, PRINCIPLES POLYM SYS
   ROZIER A, 1989, INT J PHARM, V57, P163, DOI 10.1016/0378-5173(89)90305-0
   RUBINSTEIN A, 1992, INT J PHARM, V84, P141, DOI 10.1016/0378-5173(92)90054-6
   RUSSEL WB, 1982, J POLYM SCI POL PHYS, V20, P1233, DOI 10.1002/pol.1982.180200710
   RYSER HJP, 1980, CANCER, V45, P1207, DOI 10.1002/1097-0142(19800315)45:5+<1207::AID-CNCR2820451327>3.0.CO;2-M
   RYTTING JH, 1991, P PROGRAM INT S CONT, V18, P115
   SALAMONE JC, 1980, J POLYM SCI POL CHEM, V18, P2983, DOI 10.1002/pol.1980.170181008
   SALAMONE JC, 1978, POLYMER, V19, P1157, DOI 10.1016/0032-3861(78)90064-2
   SALAMONE JC, 1982, POLYMER, V23, P843, DOI 10.1016/0032-3861(82)90144-6
   SALAMONE JC, 1985, J POLYM SCI POL LETT, V23, P655, DOI 10.1002/pol.1985.130231210
   SALAMONE JC, 1986, J POLYM SCI POL SYM, P187
   SALAMONE JC, 1974, J POLYM SCI POL SYM, P51
   SALAMONE JC, 1991, J MACROMOL SCI CHEM, VA28, P225, DOI 10.1080/00222339108052097
   SALAMONE JC, 1988, WATER SOLUBLE POLYM, P181
   SALIB N, 1983, PHARM IND, V45, P902
   SAMSONOV GV, 1992, ADV POLYM SCI, V104, P1
   SANADA T, 1986, J BIOMED MATER RES, V20, P1179, DOI 10.1002/jbm.820200809
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P1003, DOI 10.1002/jbm.820260804
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P39, DOI 10.1002/jbm.820260105
   SARAI K, 1991, ANTICANCER RES, V11, P957
   SATO T, 1986, J BIOACT COMP POLYM, V1, P445
   SAWAHATA K, 1990, J CONTROL RELEASE, V14, P253, DOI 10.1016/0168-3659(90)90165-P
   SAWYER PN, SURFACE CHARGE THROM, V416, P561
   SCHERER W, 1989, OPER DENT, V14, P82
   Scherer W, 1989, Am J Dent, V2, P355
   SCHOO HFM, 1992, MACROMOLECULES, V25, P1633, DOI 10.1021/ma00032a002
   SCHOSSELER F, 1991, MACROMOLECULES, V24, P225, DOI 10.1021/ma00001a035
   SCHROEDER UKO, 1989, MACROMOLECULES, V22, P765, DOI 10.1021/ma00192a042
   SCHULZ RC, 1989, MAKROMOL CHEM-M SYMP, V26, P221, DOI 10.1002/masy.19890260123
   SEDEREL LC, 1981, J BIOMED MATER RES, V15, P819, DOI 10.1002/jbm.820150606
   SEDEREL LC, 1983, BIOMATERIALS, V4, P210, DOI 10.1016/0142-9612(83)90013-3
   SEKI K, 1984, MACROMOLECULES, V17, P1692, DOI 10.1021/ma00139a009
   SHATAYEVA LK, 1979, J APPL POLYM SCI, V23, P2245, DOI 10.1002/app.1979.070230803
   SHIBUTA R, 1986, J BIOMED MATER RES, V20, P971, DOI 10.1002/jbm.820200712
   SIEGEL RA, 1988, J CONTROL RELEASE, V8, P179, DOI 10.1016/0168-3659(88)90044-2
   SIEGEL RA, 1988, MACROMOLECULES, V21, P3254, DOI 10.1021/ma00189a021
   SIEGEL RA, 1988, P INT S CONTROLLED R, V15, P164
   SIEGEL RA, 1990, PULSED SELF REGULATE, P129
   SILVER J, 1990, POLYM PREPR, V31, P222
   SKORODINSKAYA AM, 1984, KHIM FARM ZH+, V18, P283
   SMART JD, 1989, INT J PHARM, V53, P79, DOI 10.1016/0378-5173(89)90365-7
   Smith D C, 1968, Br Dent J, V124, P381
   SOUTO C, 1992, 6TH C INT TECHN PHAR, V3, P349
   SOUTO C, 1991, INT J PHARMACEUT, V67, P113
   Stanley H R, 1992, Adv Dent Res, V6, P55
   STIGTER D, 1975, J COLLOID INTERF SCI, V53, P296, DOI 10.1016/0021-9797(75)90016-8
   STRAUSS UP, 1959, J AM CHEM SOC, V81, P5295, DOI 10.1021/ja01529a012
   SUMAMOTO J, 1983, POLYM MED, P157
   SUMAMOTO J, 1985, CRC CRIT R THER DRUG, V2, P117
   SUNAMOTO J, 1988, CHEM LETT, P1781, DOI 10.1246/cl.1988.1781
   SUZUKI M, 1991, J DENT RES, V70, P1092, DOI 10.1177/00220345910700071501
   SUZUKI M, 1987, J RAMAN SPECTROSC, V18, P315, DOI 10.1002/jrs.1250180503
   SUZUKI S, 1990, J BIOMED MATER RES, V24, P1091, DOI 10.1002/jbm.820240811
   SWARTZ ML, 1984, J DENT RES, V63, P158, DOI 10.1177/00220345840630021301
   SWIFT EJ, 1989, AM J DENT, V2, P358
   Tagami J, 1987, Dent Mater J, V6, P201
   TAKAHATA H, 1990, CHEM PHARM BULL, V38, P2556
   Takeyama M, 1978, J JPN SOC DENT APPAR, V19, P179
   TAKIGAWA DY, 1985, MACROMOLECULES, V18, P338, DOI 10.1021/ma00145a006
   TALUKDAR MM, 1991, P INT S CONTROL REL, V18, P247
   TANAKA T, 1988, J DENT RES, V67, P1376, DOI 10.1177/00220345880670110301
   TANAKA T, 1988, J PROSTHET DENT, V60, P271, DOI 10.1016/0022-3913(88)90267-3
   TANI N, 1980, CONTROLLED RELEASE P, P79
   TAYLOR LD, 1986, J POLYM SCI POL LETT, V24, P287, DOI 10.1002/pol.1986.140240609
   TIRRELL DA, 1985, MACROMOLECULES, V18, P1512, DOI 10.1021/ma00149a027
   TIRRELL DA, 1990, PULSED SELF REGULATE, P109
   TJAN AHL, 1991, J PROSTHET DENT, V66, P602, DOI 10.1016/0022-3913(91)90437-2
   TOBIAS RS, 1985, INT ENDOD J, V18, P161, DOI 10.1111/j.1365-2591.1985.tb00435.x
   TOUMBA KJ, 1993, CARIES RES, V27, P43, DOI 10.1159/000261601
   TRIJASSON P, 1990, MAKROMOL CHEM-M SYMP, V35-6, P141, DOI 10.1002/masy.19900350111
   TSAI MF, 1984, J POLYM SCI POL CHEM, V22, P2523, DOI 10.1002/pol.1984.170221019
   TSAI MF, 1984, ION EXCH TECHNOL, P533
   TSUCHIDA E, 1982, ADV POLYM SCI, V45, P1
   TUMOKO U, 1991, KONBUNSHI RONBUNSHU, V48, P289
   UCHIDA K, 1992, P INT S CONTROL REL, V19, P381
   Um C M, 1992, Quintessence Int, V23, P209
   URYO T, 1991, POLYM SCI SER C, V2, P989
   VALENTINE JR, 1982, POLYM PREPR, V29, P446
   VANDERDOES L, 1980, J POLYM SCI POL LETT, V18, P53, DOI 10.1002/pol.1980.130180110
   VANDERDOES L, 1986, DEV HEMATOL IMMUNOL, V14, P215
   VANMEERBEEK B, 1993, J DENT RES, V72, P495, DOI 10.1177/00220345930720020501
   VENZ S, 1993, J DENT RES, V72, P582, DOI 10.1177/00220345930720030501
   VERBEECK RMH, 1993, J DENT RES, V72, P577, DOI 10.1177/00220345930720030401
   VINK H, 1981, MACROMOL CHEM PHYS, V182, P279
   WALLES WE, 1990, ACS SYM SER, V423, P266
   WANDREY C, 1985, ACTA POLYM, V36, P100, DOI 10.1002/actp.1985.010360209
   WANG T, 1991, J DENT RES, V70, P59, DOI 10.1177/00220345910700011001
   Wasson E A, 1993, Clin Mater, V12, P181, DOI 10.1016/0267-6605(93)90070-N
   WASSON EA, 1990, BRIT POLYM J, V23, P179, DOI 10.1002/pi.4980230129
   WASSON EA, 1993, J DENT RES, V72, P481, DOI 10.1177/00220345930720020201
   WATANABE F, 1988, J DENT RES, V67, P479, DOI 10.1177/00220345880670020901
   WEBB RE, 1991, J DENT RES, V70, P211, DOI 10.1177/00220345910700031101
   WEISS AM, 1986, AICHE S SER 82, V250, P85
   WEN S, 1991, J APPL POLYM SCI, V42, P1399, DOI 10.1002/app.1991.070420524
   WEN S, 1991, J APPL POLYM SCI, V43, P205, DOI 10.1002/app.1991.070430119
   WHITE SN, 1992, J PROSTHET DENT, V67, P156, DOI 10.1016/0022-3913(92)90447-I
   WILLIAMS JA, 1989, J ORAL REHABIL, V16, P475, DOI 10.1111/j.1365-2842.1989.tb01368.x
   WILSON AD, 1973, Patent No. 1316129
   WILLIAMS JA, 1991, J ORAL REHABIL, V18, P163, DOI 10.1111/j.1365-2842.1991.tb00044.x
   Wilson A D, 1990, Int J Prosthodont, V3, P425
   WILSON A D, 1991, Clinical Materials, V7, P275, DOI 10.1016/0267-6605(91)90070-V
   WILSON AD, 1983, J DENT RES, V62, P590, DOI 10.1177/00220345830620051801
   WILSON AD, 1985, BIOMATERIALS, V6, P431, DOI 10.1016/0142-9612(85)90107-3
   WILSON AD, 1980, IND ENG CHEM PROD RD, V19, P263, DOI 10.1021/i360074a027
   WILSON AD, 1978, CHEM SOC REV, V7, P265, DOI 10.1039/cs9780700265
   WILSON AD, 1977, J DENT, V5, P117, DOI 10.1016/0300-5712(77)90070-7
   WILSON AD, 1984, BRIT DENT J, V157, P449, DOI 10.1038/sj.bdj.4805517
   WILSON AD, 1988, GLASS IONOMER CEMENT, P134
   WILSON C, 1988, INT J PANCREATOL, V3, P273
   Wilson M A, 1991, Clin Mater, V7, P15, DOI 10.1016/0267-6605(91)90051-G
   WOOD D, 1991, Clinical Materials, V7, P301, DOI 10.1016/0267-6605(91)90074-P
   WOOD D, 1991, BIOMATERIALS, V12, P164, DOI 10.1016/0142-9612(91)90195-G
   XI T, 1991, Clinical Materials, V8, P43
   XI T, 1990, C MRS INT S P, V3, P483
   YAMAKAWA H, 1971, MODERN THEORY POLYM
   Yamauchi J., 1986, J JPN DENT MATER, V5, P144
   YANG YJ, 1991, J ORG CHEM, V56, P4300, DOI 10.1021/jo00013a043
   YIN YL, 1992, ACS SYM SER, V480, P91
   YOSHIDA M, 1991, RADIAT PHYS CHEM, V38, P7
   ZIDAN O, 1987, J DENT RES, V66, P716, DOI 10.1177/00220345870660030201
   ZUELLIGSINGER R, 1992, J DENT RES, V71, P1842, DOI 10.1177/00220345920710111501
NR 523
TC 57
Z9 57
U1 1
U2 24
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-58788-8
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 1995
VL 122
BP 1
EP 54
PG 54
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA BE58P
UT WOS:A1995BE58P00001
DA 2018-10-19
ER

PT S
AU Bell, CL
   Peppas, NA
AF Bell, CL
   Peppas, NA
BE Peppas, NA
   Langer, RS
TI Biomedical membranes from hydrogels and interpolymer complexes
SO BIOPOLYMERS II
SE Advances in Polymer Science
LA English
DT Review
ID TEMPERATURE-SENSITIVE GELS; INTERPENETRATING POLYMER NETWORKS; BLENDS
   INVOLVING POLYMERS; EQUILIBRIUM SWELLING BEHAVIOR; LABELED POLY(ETHYLENE
   GLYCOL); VOLUME-PHASE-TRANSITIONS; POLY(ACRYLIC ACID); POLY(METHACRYLIC
   ACID); SOLUTE DIFFUSION; POLYELECTROLYTE COMPLEXES
AB Biomedical applications of hydrogel membranes require understanding of their structural characteristics and diffusive behavior. Thus, the subject of this review is the analysis of the response of such biomembranes to their surrounding environment. This responsive behavior may be due to the presence of certain functional groups along the polymer chains or specific interactions between polymer chains (complexation). This behavior is particularly important in the use of these physiologically responsive materials in membrane applications. We begin with an introduction to the structural characteristics and behavior of hydrogel membranes followed by a discussion of the types of environmentally responsive behavior seen with hydrogels. The subject of interpolymer complexation is then treated with emphasis on complexation due to hydrogen bonding and how this type of behavior may be used to produce responsive membranes. Finally, the theories of transport in membranes are reviewed.
C1 PURDUE UNIV, SCH CHEM ENGN, W LAFAYETTE, IN 47907 USA.
CR ADACHI H, 1982, POLYM J, V14, P985, DOI 10.1295/polymj.14.985
   ANDERSON JL, 1974, BIOPHYS J, V14, P130, DOI 10.1016/S0006-3495(74)70005-4
   ANNAKA M, 1992, MACROMOLECULES, V25, P4826, DOI 10.1021/ma00044a054
   ANTIPINA AD, 1972, VYSOKOMOL SOEDIN A, V14, P941
   BAE YH, 1989, J CONTROL RELEASE, V9, P271, DOI 10.1016/0168-3659(89)90096-5
   BAILEY FE, 1964, J POLYM SCI PART A, V2, P845, DOI 10.1002/pol.1964.100020221
   BARANOVSKY V, 1991, EUR POLYM J, V27, P643, DOI 10.1016/0014-3057(91)90149-I
   BEKTUROV EA, 1981, ADV POLYM SCI, V41, P99
   BELL CL, 1994, THESIS PURDUE U
   BELTRAN S, 1990, J CHEM PHYS, V92, P2061, DOI 10.1063/1.458039
   BELTRAN S, 1991, MACROMOLECULES, V24, P549, DOI 10.1021/ma00002a032
   BIMENDINA LA, 1974, VYSOKOMOL SOEDIN A+, V16, P2810
   BOKIAS G, 1994, MACROMOLECULES, V27, P427, DOI 10.1021/ma00080a016
   BORDEN KA, 1987, MACROMOLECULES, V20, P454, DOI 10.1021/ma00168a046
   Brannon-Peppas L., 1990, ABSORBENT POLYM TECH, V8, P45, DOI DOI 10.1016/B978-0-444-88654-5.50008-X
   BRANNONPEPPAS L, 1991, CHEM ENG SCI, V46, P715, DOI 10.1016/0009-2509(91)80177-Z
   BRANNONPEPPAS L, 1989, J CONTROL RELEASE, V8, P267, DOI 10.1016/0168-3659(89)90048-5
   BRANNONPEPPAS L, 1991, INT J PHARM, V70, P53, DOI 10.1016/0378-5173(91)90163-I
   BRANNONPEPPAS L, 1991, J CONTROL RELEASE, V16, P319, DOI 10.1016/0168-3659(91)90009-3
   BRANNONPEPPAS L, 1988, POLYM BULL, V20, P285
   BRANNONPEPPAS L, 1990, ABSORBENT POLYM TECH, P67
   BRENNER H, 1977, J COLLOID INTERF SCI, V58, P312, DOI 10.1016/0021-9797(77)90147-3
   BROMBERG LE, 1991, J MEMBRANE SCI, V62, P117, DOI 10.1016/0376-7388(91)80056-C
   BROMBERG LE, 1991, J MEMBRANE SCI, V62, P131, DOI 10.1016/0376-7388(91)80057-D
   BURZAK K, 1994, BIOMATERIALS, V15, P231
   CHATTERJEE SK, 1991, POLYM COMMUN, V32, P473
   CHATTERJEE SK, 1989, J POLYM SCI POL CHEM, V27, P3855, DOI 10.1002/pola.1989.080271125
   CHATTERJEE SK, 1991, POLYM COMMUN, V32, P220
   CHEN HL, 1982, MACROMOLECULES, V15, P1445, DOI 10.1021/ma00233a047
   CHUNG DJ, 1992, J CONTROL RELEASE, V18, P45
   COLE CA, 1987, ACS SYM SER, V350, P245
   Crank J, 1975, MATH DIFFUSION
   DAOUST H, 1990, POLYMER, V31, P1946, DOI 10.1016/0032-3861(90)90021-P
   DEEN WM, 1987, AICHE J, V33, P1409, DOI 10.1002/aic.690330902
   DOI M, 1992, MACROMOLECULES, V25, P5504, DOI 10.1021/ma00046a058
   DONG LC, 1992, J CONTROL RELEASE, V19, P171
   DONG LC, 1982, ACS S SERIES REVERSI, P237
   DRUMMOND RK, 1989, MACROMOLECULES, V22, P3816, DOI 10.1021/ma00199a059
   DUBIN SB, 1967, P NATL ACAD SCI USA, V57, P1164, DOI 10.1073/pnas.57.5.1164
   DUBROVSKII SA, 1992, POLYM BULL, V29, P587, DOI 10.1007/BF00296722
   FEIL H, 1992, MACROMOLECULES, V25, P5528, DOI 10.1021/ma00046a063
   FEIL H, 1991, J MEMBRANE SCI, V64, P283, DOI 10.1016/0376-7388(91)80099-R
   FERGUSON J, 1968, EUR POLYM J, V4, P343, DOI 10.1016/0014-3057(68)90022-0
   FIRESTONE BA, 1988, POLYM COMMUN, V29, P204
   Flory P. J. E., 1956, PRINCIPLES POLYM CHE
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   FLYNN GL, 1974, J PHARM SCI-US, V63, P479, DOI 10.1002/jps.2600630403
   FREITAS RFS, 1987, CHEM ENG SCI, V42, P97, DOI 10.1016/0009-2509(87)80213-0
   GALLI AJ, 1983, J CHEM PHYS, V79, P2411, DOI 10.1063/1.446048
   GEHRKE SH, 1989, CHEM ENG SCI, V44, P559, DOI 10.1016/0009-2509(89)85032-8
   GLADDEN JK, 1953, J AM CHEM SOC, V75, P3900, DOI 10.1021/ja01112a008
   GUTOWSKA A, 1992, J CONTROL RELEASE, V22, P95, DOI 10.1016/0168-3659(92)90194-V
   HARIHARAN D, 1993, THESIS PURDUE U W LA
   HARLAND RS, 1987, POLYM BULL, V18, P553
   HELLER J, 1990, J CONTROL RELEASE, V13, P295, DOI 10.1016/0168-3659(90)90019-P
   HEMKER DJ, 1990, MACROMOLECULES, V23, P4411, DOI 10.1021/ma00222a014
   HEMKER DJ, 1987, MACROMOLECULES, V23, P4404
   HIROTSU S, 1987, J CHEM PHYS, V87, P1392, DOI 10.1063/1.453267
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   HOOPER HH, 1990, MACROMOLECULES, V23, P1096, DOI 10.1021/ma00206a031
   HORBETT TA, 1984, RECENT ADV DRUG DELI, P209
   HORSKY J, 1987, POLYM COMMUN, V29, P110
   IRIE M, 1986, MACROMOLECULES, V19, P2476, DOI 10.1021/ma00164a003
   IRIE M, 1986, MACROMOLECULES, V19, P2890, DOI 10.1021/ma00165a040
   ISHIHARA K, 1984, POLYM J, V16, P647, DOI 10.1295/polymj.16.647
   ISHIHARA K, 1986, J POLYM SCI POL LETT, V24, P413, DOI 10.1002/pol.1986.140240809
   ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   ITO Y, 1992, MACROMOLECULES, V25, P7313, DOI 10.1021/ma00052a037
   ITO Y, 1989, J CONTROL RELEASE, V10, P195, DOI 10.1016/0168-3659(89)90063-1
   JEON SH, 1988, J POLYM SCI POL CHEM, V26, P1419, DOI 10.1002/pola.1988.080260514
   JEUN SH, 1989, J POLYM SCI C, V27, P161
   KABRA BG, 1991, POLYM COMMUN, V32, P322
   KALYUZHNAYA RI, 1976, VYSOKOMOL SOEDIN A+, V18, P71
   KALYUZHNAYA RI, 1975, VYSOKOMOL SOEDIN A+, V17, P2786
   KATCHALSKY A, 1949, EXPERIENTIA, V5, P319, DOI 10.1007/BF02172636
   KATCHALSKY A, 1950, J POLYM SCI, V5, P283, DOI 10.1002/pol.1950.120050302
   KATCHALSKY A, 1955, J POLYM SCI, V15, P68
   KATCHALSKY A, 1949, J POLYM SCI, V4, P393
   Khare A. R., 1991, POLYM NEWS, V16, P230
   KHARE AR, 1993, POLYMER, V34, P4736, DOI 10.1016/0032-3861(93)90710-R
   KHOKHLOV AR, 1993, MAKROMOL CHEM-THEOR, V2, P169
   KHOKHLOV AR, 1992, MACROMOLECULES, V25, P4779, DOI 10.1021/ma00044a045
   KIM JT, 1991, IND ENG CHEM RES, V29, P1008
   KIM OK, 1993, MACROMOLECULES, V26, P379, DOI 10.1021/ma00054a018
   KIM S W, 1990, Journal of Controlled Release, V11, P193
   KIM SW, 1990, WATER POLYM, P347
   KLIER J, 1990, MACROMOLECULES, V23, P4944, DOI 10.1021/ma00225a011
   KOKUFUTA E, 1991, MACROMOLECULES, V24, P1605, DOI 10.1021/ma00007a024
   KONAK C, 1989, POLYMER, V30, P677, DOI 10.1016/0032-3861(89)90154-7
   KONO K, 1993, J MEMBRANE SCI, V76, P233, DOI 10.1016/0376-7388(93)85220-Q
   KOPYLOVA YM, 1987, VYSOKOMOL SOEDIN A+, V29, P517
   KOVAC J, 1978, MACROMOLECULES, V11, P362, DOI 10.1021/ma60062a016
   KUDELA V, 1985, ENCY POLYM SCI TECHN, P783
   KUHN W, 1950, NATURE, V165, P514, DOI 10.1038/165514a0
   LEE JY, 1988, MACROMOLECULES, V21, P346, DOI 10.1021/ma00180a011
   LEE JY, 1988, MACROMOLECULES, V21, P954, DOI 10.1021/ma00182a019
   LICHKUS AM, 1988, MACROMOLECULES, V21, P2636, DOI 10.1021/ma00186a054
   LIU GJ, 1991, MACROMOLECULES, V24, P68, DOI 10.1021/ma00001a011
   MALONE DM, 1978, CHEM ENG SCI, V33, P1429, DOI 10.1016/0009-2509(78)85192-6
   MARCHETTI M, 1990, MACROMOLECULES, V23, P1760, DOI 10.1021/ma00208a034
   MATUSZEWSKACZERWIK J, 1988, POLYM BULL, V19, P149, DOI 10.1007/BF00257008
   NICOLI D, 1983, MACROMOLECULES, V16, P887, DOI 10.1021/ma00240a011
   NIELSEN LE, 1974, MECHANICAL PROPERTIE, V1, P39
   NISHI S, 1985, MACROMOLECULES, V18, P1519, DOI 10.1021/ma00150a001
   NISHI S, 1989, POLYM J, V21, P393, DOI 10.1295/polymj.21.393
   OHMINE I, 1982, J CHEM PHYS, V77, P5725, DOI 10.1063/1.443780
   OHNO H, 1978, MAKROMOL CHEM, V179, P755
   OKANO T, 1990, J CONTROL RELEASE, V11, P255, DOI 10.1016/0168-3659(90)90138-J
   OPPERMANN W, 1992, ACS SYM SER, V480, P159
   OSADA Y, 1981, J POLYM SCI POL LETT, V19, P303, DOI 10.1002/pol.1981.130190605
   OSADA Y, 1979, J POLYM SCI POL CHEM, V17, P3485, DOI 10.1002/pol.1979.170171107
   OSADA Y, 1986, J MEMBRANE SCI, V27, P327, DOI 10.1016/0376-7388(86)80003-5
   OSADA Y, 1976, J POLYM SCI POL LETT, V14, P129, DOI 10.1002/pol.1976.130140302
   OSADA Y, 1980, J POLYM SCI POL LETT, V18, P281, DOI 10.1002/pol.1980.130180407
   OSADA Y, 1987, ADV POLYM SCI, V82, P2
   OTAKE K, 1989, J CHEM PHYS, V91, P1345, DOI 10.1063/1.457157
   OYAMA HT, 1987, MACROMOLECULES, V20, P474, DOI 10.1021/ma00169a002
   OYAMA HT, 1987, MACROMOLECULES, V20, P1839, DOI 10.1021/ma00174a024
   PAPISOV IM, 1974, VYSOKOMOL SOEDIN A+, V16, P1133
   PARK SM, 1989, J POLYM SCI POL CHEM, V27, P4109, DOI 10.1002/pola.1989.080271218
   PARK TG, 1992, J APPL POLYM SCI, V46, P659, DOI 10.1002/app.1992.070460413
   PEIFFER DG, 1985, POLYMER, V26, P1058, DOI 10.1016/0032-3861(85)90229-0
   PEPPAS NA, 1985, J APPL POLYM SCI, V30, P2589, DOI 10.1002/app.1985.070300623
   PEPPAS NA, 1991, J BIOACT COMPAT POL, V6, P241, DOI 10.1177/088391159100600303
   PEPPAS NA, 1991, J CONTROL RELEASE, V16, P203, DOI 10.1016/0168-3659(91)90044-E
   PEPPAS NA, 1993, ADV DRUG DELIVER REV, V11, P1, DOI 10.1016/0169-409X(93)90025-Y
   PEPPAS NA, 1983, J MEMBRANE SCI, V15, P275, DOI 10.1016/S0376-7388(00)82304-2
   PEPPAS NA, 1983, J MEMBRANE SCI, V16, P361, DOI 10.1016/S0376-7388(00)81321-6
   PEPPAS NA, 1994, J APPL POLYM SCI, V52, P763, DOI 10.1002/app.1994.070520606
   PEPPAS NA, 1986, HYDROGELS MED PHARM, V1, P28
   Peppas NA, 1984, CHEM ENG COMMUN, V30, P291, DOI 10.1080/00986448408911134
   REINHART CT, 1984, J MEMBRANE SCI, V18, P227, DOI 10.1016/S0376-7388(00)85036-X
   SAMSONOV GV, 1979, VYSOKOMOL SOEDIN A+, V21, P723
   SATOMATSUO E, 1992, NATURE, V358, P482
   SCRANTON AB, 1991, J POLYM SCI B
   SHIGA T, 1993, J APPL POLYM SCI, V47, P113, DOI 10.1002/app.1993.070470114
   SHINKAI S, 1981, J AM CHEM SOC, V103, P111, DOI 10.1021/ja00391a021
   SIEGEL RA, 1988, MACROMOLECULES, V21, P3254, DOI 10.1021/ma00189a021
   SIEGEL RA, 1990, PULSED SELF REGULATE, P129
   SIEGEL RA, 1988, J CONTROL RELEASE, V8, P79
   SMITH FG, 1980, J COLLOID INTERF SCI, V78, P444, DOI 10.1016/0021-9797(80)90584-6
   SOUTAR I, 1990, MACROMOLECULES, V23, P5170, DOI 10.1021/ma00226a027
   STAIKOS G, 1991, MAKROMOL CHEM, V192, P2649
   STEINBERG IZ, 1966, NATURE, V210, P568, DOI 10.1038/210568a0
   TANAKA T, 1979, POLYMER, V20, P1404, DOI 10.1016/0032-3861(79)90281-7
   TIRRELL D A, 1987, Journal of Controlled Release, V6, P15, DOI 10.1016/0168-3659(87)90060-5
   TRANK SJ, 1987, CHEM ENG SCI, V42, P381, DOI 10.1016/0009-2509(87)85070-4
   TRELOAR LRG, 1975, PHYSICS RUBBER ELAST
   TSUCHIDA E, 1982, ADV POLYM SCI, V45, P1
   VANDEGRAMPEL HT, 1992, J POLYM SCI POL CHEM, V30, P787, DOI 10.1002/pola.1992.080300508
   YASUDA H, 1971, J MACROMOL SCI PHYS, VB  5, P111, DOI 10.1080/00222347108212523
   YASUDA H, 1969, MAKROMOLEKUL CHEM, V125, P108
   YASUDA H, 1968, MAKROMOL CHEM, V118, P19
   YASUDA H, 1969, MAKROMOLEKUL CHEM, V126, P177
   YOSHIDA R, 1992, J BIOMAT SCI-POLYM E, V3, P243, DOI 10.1163/156856292X00150
   ZRINYI M, 1987, POLYMER, V28, P1139, DOI 10.1016/0032-3861(87)90256-4
NR 156
TC 134
Z9 137
U1 0
U2 29
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-58788-8
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 1995
VL 122
BP 125
EP 175
PG 51
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA BE58P
UT WOS:A1995BE58P00003
DA 2018-10-19
ER

PT J
AU TRELOAR, PH
   CHRISTIE, IM
   VADGAMA, PM
AF TRELOAR, PH
   CHRISTIE, IM
   VADGAMA, PM
TI ENGINEERING THE RIGHT MEMBRANES FOR ELECTRODES AT THE BIOLOGICAL
   INTERFACE - SOLVENT-CAST AND ELECTROPOLYMERIZED
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article; Proceedings Paper
CT 2nd CEC Workshop on Bioelectronics: Interfacing Biology with Electronics
CY NOV, 1993
CL FRANKFURT, GERMANY
SP COMMISS EUROPEAN COMMUNITIES
DE AMPEROMETRY; ENZYME ELECTRODE; MEMBRANE; PERMSELECTIVE; BIOCOMPATIBLE;
   DIAMOND-LIKE CARBON; CELLULOSE ACETATE; POLYVINYL CHLORIDE; PHENOL
ID GLUCOSE ENZYME ELECTRODE; SELECTIVITY; BIOSENSORS; BARRIER; PHENOLS;
   BLOOD
AB A generic approach to adapting many sensors to the rigours of biomedical measurement is to protect appropriate components with selective solute discriminating membrane layers. Our work has utilised external barrier membranes for mass transport control to enzyme electrodes in order to adapt their behaviour to requisite clinical ranges; these membranes have had the additional important effect of reducing surface deposition of colloid and other material on electrode surfaces. Internal membranes, especially those interposed between the enzyme layer and the working electrode of an amperometric sensor, have been found by us to be remarkably important in determining sensor operational stability. This paper will review such membrane materials, including coating technologies, and suggest appropriate directions for future work.
RP TRELOAR, PH (reprint author), UNIV MANCHESTER,HOPE HOSP,DEPT MED,CLIN BIOCHEM SECT,ECCLES OLD RD,SALFORD M6 8HD,LANCS,ENGLAND.
CR Blum L., 1991, BIOSENSORS PRINCIPLE
   BORESTOS JW, 1973, CONCISE GUIDE BIOMED, P11
   CHRISTIE I, 1993, ANAL CHIM ACTA, V272, P145, DOI 10.1016/0003-2670(93)80386-Y
   CHRISTIE IM, 1993, ANAL CHIM ACTA, V274, P191, DOI 10.1016/0003-2670(93)80465-W
   CHRISTIE IM, 1992, ANAL CHIM ACTA, V269, P65, DOI 10.1016/0003-2670(92)85134-R
   CHRISTIE IM, 1991, Patent No. 91054064
   CHURCHOUSE SJ, 1986, BIOSENSORS, V2, P325, DOI 10.1016/0265-928X(86)85022-2
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   DESAI MA, 1993, SCAND J CLIN LAB INV, V53, P53, DOI 10.3109/00365519309090679
   EVANS AC, 1991, SURF COAT TECH, V47, P662, DOI 10.1016/0257-8972(91)90338-W
   FRANKS J, 1989, J VAC SCI TECHNOL A, V7, P2307, DOI 10.1116/1.575933
   GORTON L, 1990, ANAL CHIM ACTA, V223, P23
   HIGSON SPJ, 1993, ANAL CHIM ACTA, V271, P125, DOI 10.1016/0003-2670(93)80559-4
   KAMIZAWA C, 1972, B CHEM SOC JPN, V45, P2964, DOI 10.1246/bcsj.45.2964
   KHEDR MGA, 1979, CHEM-ING-TECH, V51, P756, DOI 10.1002/cite.330510719
   KOOCHAKI Z, 1991, J MEMBRANE SCI, V57, P83, DOI 10.1016/S0376-7388(00)81164-3
   MATSUURA T, 1971, J APPL POLYM SCI, V15, P2905, DOI 10.1002/app.1971.070151202
   MULLEN WH, 1986, ANAL CHIM ACTA, V183, P59, DOI 10.1016/0003-2670(86)80074-5
   PALLESCHI G, 1986, ANAL BIOCHEM, V159, P114, DOI 10.1016/0003-2697(86)90315-5
   REYNOLDS ER, 1992, BIOSENSORS CHEM SENS, P186
   ROFF WJ, 1971, FIBRES FILMS PLASTIC, P463
   TANG LX, 1990, ANAL CHIM ACTA, V232, P357, DOI 10.1016/S0003-2670(00)81254-4
   THEWS G, 1960, ARCH GES PHYSIOL, V271, P227
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Turner A. P. F., 1987, BIOSENSORS FUNDAMENT
NR 25
TC 25
Z9 25
U1 0
U2 7
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD, OXON, ENGLAND OX5 1GB
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PY 1995
VL 10
IS 1-2
BP 195
EP 201
DI 10.1016/0956-5663(95)96806-A
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA QK937
UT WOS:A1995QK93700019
PM 7734119
DA 2018-10-19
ER

PT J
AU Kohn, DH
AF Kohn, DH
TI Acoustic emission and nondestructive evaluation of biomaterials and
   tissues
SO CRITICAL REVIEWS IN BIOMEDICAL ENGINEERING
LA English
DT Review
DE acoustic emission; biomaterials; bone; implants; fatigue; damage; damage
   accumulation; wave
ID QUANTITATIVE COMPUTED-TOMOGRAPHY; ULTRASONIC WAVE-PROPAGATION; VIBRATION
   TESTING INSITU; X-RAY ABSORPTIOMETRY; HUMAN CORTICAL BONE; SINGLE
   PHOTON-ABSORPTIOMETRY; FATIGUE DAMAGE ACCUMULATION; TI-6AL-4V IMPLANT
   ALLOY; EMBEDDED OPTICAL FIBER; POROUS COATED IMPLANTS
AB Acoustic emission (AE) is an acoustic wave generated by the release of energy from localized sources in a material subjected to an externally applied stimulus. This technique may be used nondestructively to analyze tissues, materials, and biomaterial/tissue interfaces. Applications of AE include use as an early warning tool for detecting tissue and material defects and incipient failure, monitoring damage progression, predicting failure, characterizing failure mechanisms, and serving as a tool to aid in understanding material properties and structure-function relations. All these applications may be performed in real time.
   This review discusses general principles of AE monitoring and the use of the technique in 3 areas of importance to biomedical engineering: (1) analysis of biomaterials, (2) analysis of tissues, and (3) analysis of tissue/biomaterial interfaces. Focus in these areas is on detection sensitivity, methods of signal analysis in both the time and frequency domains, the relationship between acoustic signals and microstructural phenomena, and the uses of the technique in establishing a relationship between signals and failure mechanisms.
C1 UNIV MICHIGAN, BIOENGN PROGRAM, ANN ARBOR, MI 48109 USA.
RP Kohn, DH (reprint author), UNIV MICHIGAN, SCH DENT, DEPT BIOL & MAT SCI, ANN ARBOR, MI 48109 USA.
RI CHEN, Jiangang/A-1549-2011
FU NIAMS NIH HHS [5-P60-AR20557]; NCRR NIH HHS [2-SO7-RR05321]
CR ABDELSALAM S, 1990, INT J FRACTURE, V45, P311, DOI 10.1007/BF00036274
   ABENDSCHEIN W, 1970, CLIN ORTHOP RELAT R, P294
   ABENDSCHEIN WF, 1972, J TRAUM, V12, P297, DOI 10.1097/00005373-197204000-00005
   ALREJA V, 1985, P 5 INT C TIT DTSCH, P933
   AN HS, 1994, SPINE, V19, P2358, DOI 10.1097/00007632-199410150-00019
   ANAST G T, 1958, Am J Phys Med, V37, P157
   ASHMAN RB, 1990, J BIOMECH, V23, P941, DOI 10.1016/0021-9290(90)90359-B
   ASHMAN RB, 1987, J BIOMECH, V20, P979, DOI 10.1016/0021-9290(87)90327-7
   ASHMAN RB, 1988, J BIOMECH, V21, P177, DOI 10.1016/0021-9290(88)90167-4
   ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   AWERBUCH J, 1988, ASTM STP, V964, P121
   BACHMANN V, 1976, J TEST EVAL, V4, P257
   BAKUCKAS JG, 1987, ISTFA ADV MAT S ASM, P33
   BARAN DT, 1988, CALCIFIED TISSUE INT, V43, P138, DOI 10.1007/BF02571310
   BARTLETT ML, 1987, C P FAT, P87
   BASSIM NM, 1981, ACOUSTIC EMISSION, P139
   BAXTER WJ, 1990, J TEST EVAL, V18, P430
   BAXTER WJ, 1977, RES TECHNIQUES NONDE, V3, P395
   Beattie AG., 1983, J ACOUSTIC EMISSION, V2, P95
   BEHIRI JC, 1980, J MATER SCI, V15, P1841, DOI 10.1007/BF00550605
   BENTZEN SM, 1987, J BIOMECH, V20, P743, DOI 10.1016/0021-9290(87)90053-4
   Bereiter-Hahn J., 1989, Acoustical Imaging. Vol.17, P27
   BERNDT CC, 1985, J ENG GAS TURB POWER, V107, P142, DOI 10.1115/1.3239674
   BERNDT CC, 1984, ULTRASTRUCTURE PROCE, P524
   BILGRAM R, 1985, P 5 INT C TIT DTSCH, P955
   BONFIELD W, 1982, J BIOMED ENG, V4, P23, DOI 10.1016/0141-5425(82)90022-X
   BONFIELD W, 1976, J BIOMECH, V9, P131, DOI 10.1016/0021-9290(76)90151-2
   BONSE U, 1991, J MATER SCI, V26, P4076
   BOWLES CO, 1992, J MATER SCI, V27, P5756
   BRASSOW F, 1982, EUR J RADIOL, V2, P99
   BRIGGS GAD, 1985, INTRO SCANNING ACOUS
   BRIGHTON CT, 1979, ELECTRICAL PROPERTIE
   Broek D., 1984, ELEMENTARY ENG FRACT
   Buck O., 1989, MRS Bulletin, V14, P44
   BURR DB, 1985, J BIOMECH, V18, P189, DOI 10.1016/0021-9290(85)90204-0
   CALER WE, 1989, J BIOMECH, V22, P625, DOI 10.1016/0021-9290(89)90013-4
   Callaghan J J, 1992, J Arthroplasty, V7, P495, DOI 10.1016/S0883-5403(05)80223-2
   CANN CE, 1985, BONE, V6, P1, DOI 10.1016/8756-3282(85)90399-0
   CARTER DR, 1976, J BIOMECH, V9, P27, DOI 10.1016/0021-9290(76)90136-6
   CARTER DR, 1981, J BIOMECH, V14, P461, DOI 10.1016/0021-9290(81)90096-8
   CARTER DR, 1981, ACTA ORTHOP SCAND, V52, P481, DOI 10.3109/17453678108992136
   CARTER DR, 1976, J BIOMECH, V9, P211, DOI 10.1016/0021-9290(76)90006-3
   CARTER DR, 1977, J BIOMECH, V10, P325, DOI 10.1016/0021-9290(77)90005-7
   CAZENEUVE C, 1990, J MATER SCI, V25, P1902, DOI 10.1007/BF01045740
   CHANCY G, 1985, P 5 INT C TIT DTSCH, P1891
   CHEN IIH, 1987, J BIOMECH, V20, P523, DOI 10.1016/0021-9290(87)90252-1
   CHEN PS, 1984, EXP MECH, V24, P342
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   CHRISTENSEN AB, 1986, J BIOMECH, V19, P53, DOI 10.1016/0021-9290(86)90108-9
   CODY DD, 1991, SPINE, V16, P146
   COGNARD J, 1990, J ADHESION, V32, P45, DOI 10.1080/00218469008030179
   COLLIER RJ, 1982, J BIOMECH, V15, P545, DOI 10.1016/0021-9290(82)90067-7
   CORNELISSEN M, 1987, J BIOMECH, V20, P333, DOI 10.1016/0021-9290(87)90041-8
   CORNELISSEN P, 1986, J BIOMECH, V19, P551, DOI 10.1016/0021-9290(86)90128-4
   CRAIG RG, 1993, RESTORATIVE DENTAL M
   CULNANE AH, 1991, J MATER SCI LETT, V10, P333, DOI 10.1007/BF00719700
   CURREY JD, 1984, MECHANICAL ADAPTATIO
   CURTIS GJ, 1975, NON-DESTRUCT TEST, V8, P249, DOI 10.1016/0029-1021(75)90045-6
   DAI YZ, 1991, INT J FATIGUE, V13, P227, DOI 10.1016/0142-1123(91)90246-U
   DANIEL BL, 1994, INVEST RADIOL, V29, P933, DOI 10.1097/00004424-199410000-00012
   DAVIES JP, 1993, T SOC BIOMAT, V19, P244
   DELAVEAUX R, 1991, MATER EVAL, V49, P1042
   DOHERTY WP, 1974, J BIOMECH, V7, P559, DOI 10.1016/0021-9290(74)90090-6
   DOWLING NE, 1985, ASTM STAND NEWS, V13, P44
   DROUILLAR TF, 1983, 1 INT S AC EM REINF, P1
   DROUILLARD TF, 1988, MATER EVAL, V46, P174
   DROUILLARD TF, 1990, J ACOUSTIC EMISSION, V9, P45
   DROUILLARD TF, 1986, J ACOUSTIC EMISSION, V5, P120
   DUNEGAN HL, 1971, MATER RES STANDARD, V11, P21
   DURAY SJ, 1995, J DENT RES, V74, P184
   ELIAS JJ, 1993, 1993 BIOENG C LA BED, V24, P327
   ESSES SI, 1989, J BONE MINER RES, V4, P715
   EYRES KS, 1993, J BONE JOINT SURG BR, V75, P358
   FAH D, 1988, J BIOMECH, V21, P975, DOI 10.1016/0021-9290(88)90136-4
   FARAH JW, 1973, J BIOMECH, V6, P511, DOI 10.1016/0021-9290(73)90009-2
   FEINSTEIN L, 1975, P 10 S NDE, P143
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   FIG LM, 1990, ARCH OTOLARYNGOL, V116, P191
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   FIROOZNIA H, 1986, RADIOLOGY, V159, P737, DOI 10.1148/radiology.159.3.3704152
   FIROOZNIA H, 1984, CT-J COMPUT TOMOGR, V8, P99
   FISCHER RA, 1986, J BIOMECH, V19, P119, DOI 10.1016/0021-9290(86)90142-9
   FLORIANI LP, 1967, SURG FORUM, V18, P48
   FRANK EH, 1991, T ORTHOP RES SOC, V16, P74
   FRIESEL M, 1984, METALL TRANS A, V15, P1849, DOI 10.1007/BF02664898
   FRIESEL MA, 1984, MATER SCI ENG, V68, P107, DOI 10.1016/0025-5416(84)90248-9
   Frost H.M., 1960, H FORD HOSP B, V8, P25
   FROST HM, 1966, BONE DYNAMICS OSTEOP
   FUHRMANN J, 1993, J APPL POLYM SCI, V48, P2123, DOI 10.1002/app.1993.070481207
   FUJII Y, 1994, BONE MINER, V25, P93, DOI 10.1016/S0169-6009(08)80251-6
   GALLAGHER C, 1985, J COMPUT ASSIST TOMO, V9, P634, DOI 10.1097/00004728-198505000-00075
   GAO XJ, 1988, PROGR ACOUSTIC EMISS, V4, P201
   GAO XJ, 1986, PROGR ACOUSTIC EMISS, V3, P263
   GARDNER TN, 1992, J BIOMECH, V25, P1265, DOI 10.1016/0021-9290(92)90282-6
   GEORGE TF, 1992, J APPL BIOMATER, V3, P29, DOI 10.1002/jab.770030106
   GERLANC M, 1975, CLIN ORTHOP RELAT R, V111, P175
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GREENFIELD GB, 1991, RADIOGRAPHICS, V11, P611, DOI 10.1148/radiographics.11.4.1887116
   GREENFIELD MA, 1992, MED PHYS, V19, P1349, DOI 10.1118/1.596769
   HAMSTAD MA, 1986, EXP MECH, V26, P7, DOI 10.1007/BF02319949
   HANAGUD S, 1977, P IEEE ULTR S, P242
   HANAGUD S, 1974, P IEEE ULTR S, P77
   HARP JH, 1994, CLIN ORTHOP RELAT R, V301, P42
   HARRIS DO, 1974, EXP MECH, V14, P71, DOI 10.1007/BF02323130
   HARRIS DO, 1971, ASTM STP, V505, P238
   Hartbower C. E., 1973, Engineering Fracture Mechanics, V5, P765, DOI 10.1016/0013-7944(73)90050-7
   HASEGAWA K, 1993, BONE, V14, P737, DOI 10.1016/8756-3282(93)90205-O
   HAWORTH WL, 1979, FATIGUE ENG MATER, V1, P351, DOI 10.1111/j.1460-2695.1979.tb00392.x
   HAYES WC, 1991, RADIOL CLIN N AM, V29, P1
   HEANEY RP, 1989, JAMA-J AM MED ASSOC, V261, P2986, DOI 10.1001/jama.261.20.2986
   HEIPLE CR, 1981, ACOUSTIC EMISSION, P14
   HEROUX P, 1994, ANN BIOMED ENG, V22, P328, DOI 10.1007/BF02368239
   HIGHT TK, 1980, J BIOMECH, V13, P139, DOI 10.1016/0021-9290(80)90188-8
   HONEYCOMBE RWK, 1988, PLASTIC DEFORMATION
   HORN CA, 1965, J COLL RADIOL AUSTRA, V9, P165
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   HVID I, 1989, J BIOMECH, V22, P837, DOI 10.1016/0021-9290(89)90067-5
   Irwin GR, 1957, J APPL MECH, V24, P361, DOI DOI 10.1111/J.1460-2695.2012.01707.X
   JACKSON P, 1990, J MATER SCI LETT, V9, P1165, DOI 10.1007/BF00721878
   JANES GC, 1993, J BONE JOINT SURG BR, V75, P914
   JASTY M, 1991, J BONE JOINT SURG BR, V73, P551
   JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014
   JEE WSS, 1990, ANAT REC, V227, P418, DOI 10.1002/ar.1092270405
   JENG JS, 1989, J ACOUSTIC EMISSION, V8, pS268
   JONSSON U, 1984, ACTA ORTHOP SCAND, V55, P441, DOI 10.3109/17453678408992391
   JURIST JM, 1970, PHYS MED BIOL, V15, P417, DOI 10.1088/0031-9155/15/3/002
   JURIST JM, 1973, J BIOMECH, V6, P331, DOI 10.1016/0021-9290(73)90093-6
   KANEKO T, 1986, J BIOMED MATER RES, V20, P169, DOI 10.1002/jbm.820200206
   KANEKO T, 1991, BIOMATERIALS, V12, P555, DOI 10.1016/0142-9612(91)90050-K
   KANNATEYASIBU E, 1987, J MECH SYS SIG P, V1, P333
   KATZ JL, 1993, J BIOMECH ENG-T ASME, V115, P543, DOI 10.1115/1.2895537
   KATZ Y, 1970, INT J FRACT MECH, V6, P219
   KAUFMAN JJ, 1993, J BONE MINER RES, V8, P517
   KENNEDY JR, 1982, SCRIPTA METALL MATER, V16, P525, DOI 10.1016/0036-9748(82)90263-0
   KEYAK JH, 1994, J BIOMED MATER RES, V28, P1329, DOI 10.1002/jbm.820281111
   KHALIL TB, 1981, J SOUND VIB, V75, P417, DOI 10.1016/0022-460X(81)90387-4
   KIM HC, 1994, J MAT RES, V9
   KIM KH, 1994, J DENT RES, V73, P499, DOI 10.1177/00220345940730020301
   KIM KH, 1991, ENG FRACT MECH, V40, P811, DOI 10.1016/0013-7944(91)90238-V
   KISHI T, 1980, TITANIUM 80 SCI TECH, P1709
   KISHI T, 1985, TITANIUM SCI TECHNOL, P2039
   KISHI T, 1984, PROGR ACOUSTIC EMISS, V2, P547
   KLINE RA, 1990, J ENG MATER-T ASME, V112, P218, DOI 10.1115/1.2903310
   KNETS LV, 1975, MEKH POLIM, V4, P685
   KNODO S, 1985, DENT MATER J, V4, P81
   KOENEMAN J, 1990, J APPL BIOMATER, V1, P79, DOI 10.1002/jab.770010110
   KOHLES SS, 1994, J BIOMECH, V27, P137, DOI 10.1016/0021-9290(94)90202-X
   KOHN DH, 1992, J BIOMED MATER RES, V26, P19, DOI 10.1002/jbm.820260104
   KOHN DH, 1990, J BIOMED MATER RES, V24, P1483, DOI 10.1002/jbm.820241106
   KOHN DH, 1992, J MATER SCI, V27, P3133, DOI 10.1007/BF01116003
   KOHN DH, 1994, MED PROG TECHNOL, V20, P169
   KOHN DH, 1992, J MATER SCI, V27, P1633, DOI 10.1007/BF00542927
   KOHN DH, 1992, 1992 ADV BIOENGINEER, V27, P297
   KOHN DH, 1995, HDB ADV MAT TESTING, P593
   KOHN DH, 1989, TITANIUM SCI TECHNOL, P789
   KONDO S, 1992, J DENT RES, V71, P558
   KONONEN M, 1991, DENT MATER, V7, P211, DOI 10.1016/0109-5641(91)90046-2
   KRASNOW AZ, 1987, J NUCL MED, V28, P1268
   KRAUYA UE, 1978, MEKH POLIM, V7, P109
   KROGER H, 1995, ACTA ORTHOP SCAND, V66, P47, DOI 10.3109/17453679508994639
   KUPPERMAN DS, 1990, J ENG MATER-T ASME, V112, P198, DOI 10.1115/1.2903307
   Kushibiki J., 1987, IEEE 1987 Ultrasonics Symposium Proceedings (Cat. No.87CH2492-7), P837
   KWON OY, 1990, J ACOUSTIC EMISSION, V9, P123
   KWON SJ, 1985, P IEEE ULTR S, P864
   LAKES R, 1986, J BIOMED ENG, V8, P143, DOI 10.1016/0141-5425(86)90049-X
   LANG SB, 1970, IEEE T BIO-MED ENG, VBM17, P101, DOI 10.1109/TBME.1970.4502706
   LANG SM, 1988, J BONE JOINT SURG AM, V70A, P1531, DOI 10.2106/00004623-198870100-00013
   LANKFORD J, 1991, J MATER SCI, V26, P1131
   LAWRENCE JM, 1991, T ORTHOP RES SOC, V16, P518
   LAYTON MW, 1988, ARTHRITIS RHEUM, V31, P1400, DOI 10.1002/art.1780311109
   LEAITY GP, 1984, FAT FRACT ENG MAT ST, V12, P271
   LEE SY, 1995, J DENT RES, V74, P184
   LEICHTER I, 1992, BIOMATERIALS, V13, P478, DOI 10.1016/0142-9612(92)90170-S
   LEWIS JL, 1975, J BIOMECH, V8, P17, DOI 10.1016/0021-9290(75)90039-1
   LEWIS JL, 1975, J BONE JOINT SURG AM, V57, P576
   LI SX, 1984, MATER EVAL, V42, P1020
   LI XJ, 1990, ANAT REC, V227, P12, DOI 10.1002/ar.1092270103
   LICHT T, 1979, 2 TECH REV
   LIEBETRAU R, 1993, J OTOLARYNGOL, V22, P249
   LINGARD S, 1993, WEAR, V162, P597, DOI 10.1016/0043-1648(93)90548-Z
   LINGARD S, 1984, WEAR, V96, P75, DOI 10.1016/0043-1648(84)90105-4
   LOTZ JC, 1990, J COMPUT ASSIST TOMO, V14, P107, DOI 10.1097/00004728-199001000-00020
   LOWET G, 1993, J BIOMECH, V26, P689, DOI 10.1016/0021-9290(93)90032-A
   MA BT, 1990, POLYM COMPOSITE, V11, P211, DOI 10.1002/pc.750110403
   MAISL M, 1990, J ENG MATER-T ASME, V112, P223, DOI 10.1115/1.2903311
   MARGOLIN H, 1980, TITANIUM 80 SCI TECH, P169
   MARKEL MD, 1992, AM J VET RES, V53, P2105
   MARKEL MD, 1990, ACTA ORTHOP SCAND, V61, P487, DOI 10.3109/17453679008993569
   MARTIN B, 1992, J ORTHOP RES, V10, P818, DOI 10.1002/jor.1100100611
   MARTIN RB, 1982, J BIOMECH, V15, P137
   Martin RB, 1989, STRUCTURE FUNCTION A
   MASLOUHI A, 1989, J ACOUSTIC EMISSION, V8, pS292
   MATTHEWS JR, 1981, ACOUSTIC EMISSION
   MAZESS RB, 1989, ANN BIOMED ENG, V17, P177, DOI 10.1007/BF02368026
   MCBROOM RJ, 1985, J BONE JOINT SURG AM, V67A, P1206, DOI 10.2106/00004623-198567080-00010
   MCCABE F, 1991, J BONE MINER RES, V6, P53
   MCCARTHY RN, 1990, J BIOMECH, V23, P1139, DOI 10.1016/0021-9290(90)90006-O
   MCGUIRE SM, 1993, J MATER RES, V8, P2216, DOI 10.1557/JMR.1993.2216
   MCKELVIE ML, 1991, PHYS MED BIOL, V36, P1331, DOI 10.1088/0031-9155/36/10/003
   MEDRANO RE, 1993, REV SCI INSTRUM, V64, P250, DOI 10.1063/1.1144446
   MELANITIS N, 1990, J MATER SCI, V25, P5081, DOI 10.1007/BF00580133
   MELTON LJ, 1993, J BONE MINER RES, V8, P1227
   MEUNIER A, 1988, J ORTHOPAED RES, V6, P770, DOI 10.1002/jor.1100060521
   Mielke W., 1990, Journal of Acoustic Emission, V9, P103
   MOORTHY V, 1991, FAT FRACT STEEL CONC
   MORRIS RA, 1975, P 10 S NDE, P90
   MOSEKILDE L, 1989, BONE, V10, P465, DOI 10.1016/8756-3282(89)90080-X
   MURPHY KA, 1992, APPL OPTICS, V31, P431, DOI 10.1364/AO.31.000431
   MURRAY IPC, 1989, SKELETAL RADIOL, V18, P493, DOI 10.1007/BF00351747
   MYERS ER, 1991, CALCIFIED TISSUE INT, V49, P292, DOI 10.1007/BF02556221
   *NASA, 1992, NASA TECH BRIEFS
   *NASA, 1993, NASA TECH BRIEFS, V17, P22
   *NASA, 1992, YASA TECH BRIEFS, V16, P62
   NETRAVALI AN, 1989, COMPOS SCI TECHNOL, V34, P289, DOI 10.1016/0266-3538(89)90001-8
   NETRAVALI AN, 1989, COMPOS SCI TECHNOL, V35, P13, DOI 10.1016/0266-3538(89)90068-7
   NETZ P, 1979, ACTA ORTHOP SCAND S, V176
   NICHOLLS PJ, 1981, MED BIOL ENG COMPUT, V19, P416, DOI 10.1007/BF02441305
   OBRIEN WJ, 1977, DENTAL MATERIALS REV, P123
   OCCHIELLO E, 1989, COMPOS SCI TECHNOL, V36, P133, DOI 10.1016/0266-3538(89)90084-5
   OHIRA T, 1980, 5TH P INT AE S, P137
   OHTA A, 1977, INT J FRACTURE, V13, P289
   OHTA A, 1977, ENG FRACT MECH, V9, P307
   OKAWAI H, 1989, ACOUST IMAGING, P192
   ONO K, 1979, FUNDAMENTALS ACOUSTI, P167
   ORTOFT G, 1993, BONE, V14, P667, DOI 10.1016/8756-3282(93)90090-W
   OVERGAARD K, 1992, CALCIFIED TISSUE INT, V50, P30, DOI 10.1007/BF00297294
   PAPAZLAN JM, 1992, J ENG MAT TECH, V114, P399
   PECK SD, 1989, J DENT RES, V68, P107, DOI 10.1177/00220345890680020201
   PELKER RR, 1985, J BIOMECH, V18, P745, DOI 10.1016/0021-9290(85)90049-1
   PELKER RR, 1983, J BIOMECH, V16, P481, DOI 10.1016/0021-9290(83)90062-3
   PETERS A, 1982, MED BIOL ENG COMPUT, V20, pN8
   POLEKSIC L, 1993, SKELETAL RADIOL, V22, P577
   POLIAKOFF SJ, 1989, T ORTHOP RES SOC, V14, P483
   POLLOCK AA, 1981, INT ADV NONDESTRUCTI, V7, P215
   PULS MP, 1991, METALL TRANS A, V22, P2327, DOI 10.1007/BF02664999
   PUSKAR A, 1993, ULTRASONICS, V31, P61, DOI 10.1016/0041-624X(93)90034-W
   QUINTEN A, 1989, MAT SCI ENG A-STRUCT, V122, P15, DOI 10.1016/0921-5093(89)90764-8
   RAGHAVENDRO MN, 1989, J ACOUSTIC EMISSION, V8, pS284
   RAJAN DS, 1989, J ACSOUSTIC EMISSION, V8, pS297
   RAYMAKERS JA, 1986, SKELETAL RADIOL, V15, P191, DOI 10.1007/BF00354059
   ROSENQVIST R, 1986, J BONE JOINT SURG AM, V68A, P538, DOI 10.2106/00004623-198668040-00009
   RUBIN CT, 1987, J BIOMECH, V20, P723, DOI 10.1016/0021-9290(87)90038-8
   SACHSE W, 1991, ASTM STP, V1077
   SAFAI S, 1979, AM CERAM SOC BULL, V58, P624
   SAFAI S, 1980, 9 INT THERM SPRAY C, P129
   SAHA S, 1977, IEEE T BIO-MED ENG, V24, P508, DOI 10.1109/TBME.1977.326161
   SAHA S, 1977, J BIOMECH, V10, P393, DOI 10.1016/0021-9290(77)90015-X
   SCHAFFLER MB, 1990, BONE, V11, P321, DOI 10.1016/8756-3282(90)90087-F
   SCHAFFLER MB, 1989, BONE, V10, P207, DOI 10.1016/8756-3282(89)90055-0
   SCHAFFLER MB, 1994, BONE, V15, P483, DOI 10.1016/8756-3282(94)90271-2
   SCHMIDT J, 1994, MED BIOL ENG COMPUT, V32, P258, DOI 10.1007/BF02512520
   SCHUBIGER O, 1986, NEURORADIOLOGY, V28, P93, DOI 10.1007/BF00327878
   SCHUSTER J, 1990, J COMPOS TECH RES, V12, P52
   SEITZ P, 1987, J BONE JOINT SURG BR, V69, P407
   SHANKAR NR, 1982, CERAM ENG SCI P, V3, P772
   SHANKAR NR, 1983, 10 INT THERM SPRAYIN, P41
   SHIMAISHIN OA, 1976, MAT EVOL, V34, P137
   Sklarczyk C., 1992, Journal of the European Ceramic Society, V9, P427, DOI 10.1016/0955-2219(92)90103-K
   SMITH MD, 1992, CLIN ORTHOPAEDICS, V283, P244
   SMITH PA, 1990, COMPOS SCI TECHNOL, V38, P85, DOI 10.1016/0266-3538(90)90073-E
   SNYDER SM, 1991, J ORTHOPAED RES, V9, P422, DOI 10.1002/jor.1100090315
   SONSTEGARD DA, 1976, J BIOMECH, V9, P689, DOI 10.1016/0021-9290(76)90170-6
   SPIEGL PV, 1975, J BIOMECH, V8, P213, DOI 10.1016/0021-9290(75)90027-5
   SRIKANTH V, 1994, J MATER SCI, V29, P3363, DOI 10.1007/BF00356686
   STEELE CR, 1988, J BIOMECH ENG-T ASME, V110, P87, DOI 10.1115/1.3108423
   STEPHENS RR, 1988, REV SCI INSTRUM, V59, P1412, DOI 10.1063/1.1139679
   STEWART A, 1994, CALCIFIED TISSUE INT, V54, P466, DOI 10.1007/BF00334324
   SUGIYAMA H, 1989, CLIN ORTHOP RELAT R, V249, P122
   SULIMAN AA, 1993, J DENT RES, V72, P1532, DOI 10.1177/00220345930720111201
   SUNDARESAN MJ, 1994, J COMPOS TECH RES, V16, P127
   TANAKA H, 1975, SCRIPTA METALL MATER, V9, P777, DOI 10.1016/0036-9748(75)90239-2
   TATENTO H, 1989, ACOUST IMAGING, P125
   TAVAKOLI MB, 1991, PHYS MED BIOL, V36, P1529, DOI 10.1088/0031-9155/36/11/012
   THOMAS RA, 1977, P IEEE ULTR S, P237
   THOMPSN DO, 1986, REV PROGR NONDESTRUC
   THOMPSON RB, 1975, P 10 S NDE, P98
   THOMPSON RB, 1990, J TEST EVAL, V18, P421
   THOMSEN JJ, 1990, J BIOMECH, V23, P215, DOI 10.1016/0021-9290(90)90013-S
   Tiitto K., 1989, Nondestructive Testing Communications, V5, P27, DOI 10.1080/02780898908952952
   TSURUTA H, 1980, P 5 INT AE S JAP SOC, P175
   TURNER CH, 1991, CALCIFIED TISSUE INT, V49, P116, DOI 10.1007/BF02565132
   ULREN L, 1990, J ADHESION, V31, P117, DOI 10.1080/00218469008048220
   VANBERKUM FNR, 1989, J BONE MINER RES, V4, P679
   VANBUSKIRK WC, 1986, J MATER SCI, V21, P2759, DOI 10.1007/BF00551484
   VANBUSKIRK WC, 1981, J BIOMECH ENG-T ASME, V103, P67, DOI 10.1115/1.3138262
   VANDERPERRE G, 1983, J BIOMECH ENG-T ASME, V105, P244, DOI 10.1115/1.3138412
   VANDERSCHUEREN D, 1993, CALCIFIED TISSUE INT, V53, P342, DOI 10.1007/BF01351841
   VANROERMUND PM, 1987, SKELETAL RADIOL, V16, P52, DOI 10.1007/BF00349929
   VARY A, 1991, MATER EVAL, V49, P581
   VARY A, 1991, AM SOC TEST MATER, V1077, P95, DOI 10.1520/STP19087S
   VERPOEST I, 1981, FATIGUE ENG MATER ST, V3, P203
   VIANO D, 1976, J BIOMECH, V9, P703, DOI 10.1016/0021-9290(76)90172-X
   VIKSTROM M, 1989, COMPOS STRUCT, V13, P49, DOI 10.1016/0263-8223(89)90072-X
   Wadley H. N. G., 1980, International Metals Reviews, V25, P41
   WAGNER L, 1989, TITANIUM SCI TECHNOL
   WAITE SR, 1990, COMPOSITES, V21, P148, DOI 10.1016/0010-4361(90)90007-J
   WAITE SR, 1990, COMPOSITES, V21, P225, DOI 10.1016/0010-4361(90)90237-Q
   WAKAYAMA S, 1985, P 2 INT C AC EM, pS278
   WALKER D, 1991, IEEE ENG MED BIOL C, V13, P2107
   WALTER A, 1984, BIOMATERIALS BIOMECH, P55
   WALTER A, 1986, MATER RES SOC S P, V55, P181
   WEHRLI FW, 1993, CALCIFIED TISSUE INT, V53, pS162, DOI 10.1007/BF01673429
   WEI RP, 1981, ASTM STP, V738, P103
   WELLS JG, 1985, BIOMATERIALS, V6, P218, DOI 10.1016/0142-9612(85)90016-X
   WEVERS M, 1991, AM SOC TEST MATER, V1077, P416, DOI 10.1520/STP19111S
   WHITE SP, 1989, PROSTHETIC HIP JOINT
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, V258, P108
   WIOLAND M, 1993, J NUCL MED, V34, P1410
   WISHART JM, 1993, BRIT J RADIOL, V66, P435, DOI 10.1259/0007-1285-66-785-435
   WOLFARTH D, 1990, J APPL BIOMATER, V1, P3, DOI 10.1002/jab.770010103
   WOLTERS J, 1986, 2 INT S AC EM REINF, P29
   WONG ATC, 1976, J BIOMECH, V9, P813, DOI 10.1016/0021-9290(76)90189-5
   WONG FY, 1983, J BIOMECH, V16, P849, DOI 10.1016/0021-9290(83)90009-X
   WOOH SC, 1990, J ENG MATER-T ASME, V112, P175, DOI 10.1115/1.2903304
   WRIGHT TM, 1983, J BIOMECH ENG-T ASME, V105, P20, DOI 10.1115/1.3138379
   WRIGHT TM, 1976, J BIOMED MATER RES, V10, P637, DOI 10.1002/jbm.820100420
   WRIGHT TM, 1981, J BIOMECH, V14, P405, DOI 10.1016/0021-9290(81)90058-0
   WRIGHT TM, 1977, J BIOMECH, V10, P419, DOI 10.1016/0021-9290(77)90019-7
   WRIGHT TM, 1978, MATER EVAL, P37
   WRIGHT TM, 1981, 1981 BIOM S ASME NEW, P237
   WRIGHT TM, 1988, NONDESTRUCTIVE TESTI, V5, P447
   YAMAGUCHI K, 1991, AM SOC TEST MATER, V1077, P123, DOI 10.1520/STP19089S
   YAMAKI T, 1986, SURG NEUROL, V26, P551, DOI 10.1016/0090-3019(86)90338-1
   YAMAMOTO S, 1992, J MATER RES, V7, P2240, DOI 10.1557/JMR.1992.2240
   YEE BGW, 1973, TITANIUM SCI TECHNOL, P707
   YOON HS, 1976, J BIOMECH, V9, P459, DOI 10.1016/0021-9290(76)90089-0
   YOON HS, 1976, J BIOMECH, V9, P407, DOI 10.1016/0021-9290(76)90118-4
   YOON HS, 1980, P IEEE ULTR S, P1067
   YUYAMA S, 1982, PROGR ACOUSTIC EMISS, P126
   ZHU ZM, 1982, PROGR ACOUSTIC EMISS, P366
   ZIMMERMAN MC, 1989, J ORTHOP RES, V7, P607, DOI 10.1002/jor.1100070420
   ZIMMERMAN MC, 1990, IEEE T BIO-MED ENG, V37, P433, DOI 10.1109/10.55634
   ZIMMERMAN MC, 1994, J BIOMED MATER RES, V28, P931, DOI 10.1002/jbm.820280812
   ZIMMERMAN RA, 1987, NEURORADIOLOGY, V29, P246, DOI 10.1007/BF00451761
   ZIOUPOS P, 1994, J MATER SCI, V29, P978, DOI 10.1007/BF00351420
   ZIOUPOS P, 1994, MED ENG PHYS, V16, P203, DOI 10.1016/1350-4533(94)90039-6
   ZUMING Z, 1984, PROGR ACOUSTIC EMISS, V2, P218
   1983, 1 INT S AC EM REINF
   1976, 2 INT S AC EM REINF
NR 340
TC 9
Z9 9
U1 1
U2 14
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 0278-940X
EI 1943-619X
J9 CRIT REV BIOMED ENG
JI Crit. Rev. Biomed. Eng.
PY 1995
VL 23
IS 3-4
BP 221
EP 306
DI 10.1615/CritRevBiomedEng.v23.i3-4.20
PG 86
WC Engineering, Biomedical
SC Engineering
GA VA999
UT WOS:A1995VA99900002
PM 8853951
DA 2018-10-19
ER

PT J
AU SWIFT, EJ
   BAYNE, SC
   MARKER, VA
   FORD, KY
AF SWIFT, EJ
   BAYNE, SC
   MARKER, VA
   FORD, KY
TI REVIEW OF THE 1994 DENTAL MATERIALS LITERATURE
SO DENTAL MATERIALS
LA English
DT Review
AB Objectives. Electronic databases provide strong support for research and education literature searches. However, there is still some lag in time between publication and updates of the database. The objective of this summary was to identify and categorize the 1994 dental materials scientific literature that dealt with restorative dentistry.
   Methods. Seventeen primary journals were manually searched via the Tables of Contents and 88 secondary journals were manually or electronically searched. Dental materials citations were categorized into 15 major sections and several subsections, excluding case reports and literature primarily related to dental implants or biomedical materials outside of dentistry.
   Results. Nearly twelve hundred citations were identified, the largest number being associated with composites and glass ionomers.
   Significance. This list provides a comprehensive source for review by academicians and researchers to bridge the gap between initial publication and electronic citation.
C1 BAYLOR COLL DENT, DEPT BIOMAT SCI, DALLAS, TX 75246 USA.
RP SWIFT, EJ (reprint author), UNIV N CAROLINA, SCH DENT, DEPT OPERAT DENT, CHAPEL HILL, NC 27599 USA.
CR Abdullah H., 1994, Clinical Materials, V16, P15, DOI 10.1016/0267-6605(94)90087-6
   Abuasi H A, 1994, Eur J Prosthodont Restor Dent, V2, P117
   Adair Steven M., 1994, Pediatric Dentistry, V16, P410
   ADAMS AM, 1994, INT ENDOD J, V27, P171, DOI 10.1111/j.1365-2591.1994.tb00250.x
   Adams D, 1994, Adv Dent Res, V8, P291
   ALBERT K, 1994, BIO-MED MATER ENG, V4, P199
   ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0
   ALBERTS B, 1994, SCIENCE, V266, P1660, DOI 10.1126/science.7992048
   Aldana L, 1994, Int J Prosthodont, V7, P473
   ALHADAINY HA, 1994, J ENDODONT, V20, P449, DOI 10.1016/S0099-2399(06)80036-1
   Allen W R, 1994, J Dent Assoc S Afr, V49, P331
   ALLENBY CF, 1994, CONTACT DERMATITIS, V30, P135, DOI 10.1111/j.1600-0536.1994.tb00693.x
   Almajed I, 1994, J Clin Pediatr Dent, V19, P19
   ALPER J, 1994, SCIENCE, V263, P324, DOI 10.1126/science.8278805
   ALTIERI JV, 1994, J PROSTHET DENT, V71, P16, DOI 10.1016/0022-3913(94)90249-6
   AMBJORNSEN E, 1994, DENT MATER, V10, P107, DOI 10.1016/0109-5641(94)90049-3
   AMORY C, 1994, DENT MATER, V10, P203, DOI 10.1016/0109-5641(94)90033-7
   ANDERSSON B, 1994, INT J ORAL MAXILLOF, V9, P665
   ANDERSSON L, 1994, SWED DENT J S, V56
   ANDERSSON OH, 1994, BIOMATERIALS, V15, P882, DOI 10.1016/0142-9612(94)90111-2
   ANDREOPOULOS AG, 1994, J PROSTHET DENT, V72, P462, DOI 10.1016/0022-3913(94)90115-5
   Andrews P B, 1994, J Can Dent Assoc, V60, P976
   Angmar-Mansson B, 1994, Adv Dent Res, V8, P75
   ANSELME K, 1994, CELL MATER, V4, P113
   ANUSAVICE KJ, 1994, DENT MATER, V10, P141, DOI 10.1016/0109-5641(94)90055-8
   ANUSAVICE KJ, 1994, DENT MATER, V10, P230, DOI 10.1016/0109-5641(94)90066-3
   Aoba T, 1994, Adv Dent Res, V8, P66
   APPLETON J, 1994, SCANNING MICROSCOPY, V8, P711
   ARAKI K, 1994, J ENDODONT, V20, P67, DOI 10.1016/S0099-2399(06)81183-0
   Arnold T J, 1994, Compendium, V15, P780
   ARTACHOPERULA E, 1994, J MICROSC-OXFORD, V173, P73, DOI 10.1111/j.1365-2818.1994.tb03429.x
   ARVIER JF, 1994, BRIT J ORAL MAX SURG, V32, P276, DOI 10.1016/0266-4356(94)90046-9
   ASAOKA K, 1994, J DENT RES, V73, P1539, DOI 10.1177/00220345940730090901
   ASSAEL LA, 1994, J ORAL MAXIL SURG, V52, P757, DOI 10.1016/0278-2391(94)90495-2
   ASSIF D, 1994, J PROSTHET DENT, V71, P565, DOI 10.1016/0022-3913(94)90438-3
   ATCHISON WD, 1994, FASEB J, V8, P622
   ATTAL JP, 1994, DENT MATER, V10, P259, DOI 10.1016/0109-5641(94)90071-X
   ATTIN T, 1994, OPER DENT, V19, P110
   AVOURIS P, 1994, SCIENCE, V264, P942, DOI 10.1126/science.264.5161.942
   Awad M A, 1994, J Can Dent Assoc, V60, P318
   BAGLEY A, 1994, OPER DENT, V19, P97
   Bahn S L, 1994, Compendium, V15, P825
   BALES DJ, 1991, CURR OPIN DENT, V1, P253
   BALES DJ, 1992, CURR OPIN DENT, V2, P183
   BALES DJ, 1991, CURR OPIN DENT, V1, P245
   BALL P, 1994, NATURE, V367, P323, DOI 10.1038/367323a0
   BANKS PA, 1994, EUR J ORTHODONT, V16, P19, DOI 10.1093/ejo/16.1.19
   BAPNA MS, 1994, J ORAL REHABIL, V21, P577, DOI 10.1111/j.1365-2842.1994.tb01172.x
   BARAN G, 1994, J DENT RES, V73, P1450, DOI 10.1177/00220345940730080901
   Baratieri L N, 1994, Quintessence Int, V25, P749
   Barber H D, 1994, Compendium, V15, P1392
   BARBOSA SV, 1994, J ENDODONT, V20, P6, DOI 10.1016/S0099-2399(06)80018-X
   Barclay C W, 1994, Eur J Prosthodont Restor Dent, V3, P5
   Barkmeier W W, 1994, Am J Dent, V7, P175
   Barkmeier W W, 1994, Am J Dent, V7, P239
   BARNES DM, 1994, OPER DENT, V19, P133
   Barreto L C, 1994, J Clin Pediatr Dent, V19, P31
   Barsby M J, 1994, J Can Dent Assoc, V60, P435
   BASSI G, 1994, BRIT DENT J, V177, P248, DOI 10.1038/sj.bdj.4808576
   Basson N J, 1994, J Dent Assoc S Afr, V49, P339
   BAUMBERGER T, 1994, NATURE, V367, P544, DOI 10.1038/367544a0
   BAYNE SC, 1994, DENT MATER, V10, P11, DOI 10.1016/0109-5641(94)90016-7
   BAYNE SC, 1994, J AM DENT ASSOC, V125, P687, DOI 10.14219/jada.archive.1994.0113
   BAYNE SC, 1994, DENT MATER, V10, P59, DOI 10.1016/0109-5641(94)90023-X
   BEAN TA, 1994, J BIOMED MATER RES, V28, P59, DOI 10.1002/jbm.820280108
   Bearn D R, 1994, Quintessence Int, V25, P321
   Bebermeyer R D, 1994, Quintessence Int, V25, P209
   Becker W, 1994, Int J Oral Maxillofac Implants, V9, P31
   BECKER W, 1994, INT J ORAL MAXILLOF, V9, P305
   Bell R B, 1994, J Esthet Dent, V6, P129, DOI 10.1111/j.1708-8240.1994.tb00846.x
   BELVEDERE PC, 1994, NW DENT          MAR, P19
   Ben-Amar A, 1994, Am J Dent, V7, P141
   BENBASSAT H, 1994, CELL MATER, V4, P37
   BERGLUND A, 1992, SWED DENT J S, V85
   BERGMAN B, 1994, SWED DENT J, V18, P25
   BERKSUN S, 1994, J PROSTHET DENT, V71, P423, DOI 10.1016/0022-3913(94)90109-0
   Berry E A, 1994, J Prosthodont, V3, P126, DOI 10.1111/j.1532-849X.1994.tb00141.x
   BERRY EA, 1994, OPER DENT, V19, P122
   BERRY FA, 1994, AM J DENT, V7, P333
   BERRY TG, 1994, J AM DENT ASSOC, V125, P392, DOI 10.14219/jada.archive.1994.0053
   BEUF O, 1994, DENT MATER, V10, P265, DOI 10.1016/0109-5641(94)90072-8
   Beyerle M P, 1994, Int J Prosthodont, V7, P234
   BILLAS IML, 1994, SCIENCE, V265, P1682, DOI 10.1126/science.265.5179.1682
   BISHARA SE, 1994, ANGLE ORTHOD, V64, P277
   BLOCK MS, 1994, J ORAL MAXIL SURG, V52, P937, DOI 10.1016/S0278-2391(10)80074-6
   BLOOM NS, 1994, NATURE, V367, P694, DOI 10.1038/367694a0
   Blumenthal N M, 1994, Ill Dent J, V63, P35
   BLUMENTHAL NM, 1994, DENT J, V63, P35
   Blunden R E, 1994, Br J Orthod, V21, P125
   BOGERT TR, 1994, ORAL HLTH, V84, P35
   Borem L M, 1994, Quintessence Int, V25, P283
   Botha C T, 1994, J Dent Assoc S Afr, V49, P201
   BOTTON G, 1994, J MICROSC-OXFORD, V173, P9, DOI 10.1111/j.1365-2818.1994.tb03424.x
   BOURKE AM, 1994, J DENT, V22, P242, DOI 10.1016/0300-5712(94)90123-6
   BOUVIER M, 1994, CELL MATER, V4, P135
   BOWEN WH, 1994, J DENT RES, V73, P1773, DOI 10.1177/00220345940730111501
   BOYD KS, 1994, INT ENDOD J, V27, P330, DOI 10.1111/j.1365-2591.1994.tb00278.x
   Boyd R L, 1994, Int Dent J, V44, P119
   BOYEN PJ, 1994, ORAL IMPLANTOLOGY, V20, P227
   Boyer D B, 1994, Am J Dent, V7, P91
   Brackett W W, 1994, Int J Prosthodont, V7, P13
   BRACKETT WW, 1994, OPER DENT, V19, P106
   BRAEM M, 1994, J DENT, V22, P97, DOI 10.1016/0300-5712(94)90010-8
   BRAEM MJA, 1994, J BIOMED MATER RES, V28, P1397, DOI 10.1002/jbm.820281203
   BREEDING LC, 1994, J PROSTHET DENT, V71, P31, DOI 10.1016/0022-3913(94)90252-6
   BRIDGEMAN AM, 1994, AUST DENT J, V39, P279, DOI 10.1111/j.1834-7819.1994.tb05562.x
   Briggs P, 1994, Eur J Prosthodont Restor Dent, V3, P51
   BROCKHURST PJ, 1994, AUST DENT J, V39, P33, DOI 10.1111/j.1834-7819.1994.tb05544.x
   BROWN RC, 1994, J ENDODONT, V20, P288, DOI 10.1016/S0099-2399(06)80818-6
   Brown Ronald S., 1994, General Dentistry, V42, P242
   BROWNE RM, 1994, J DENT, V22, pS21, DOI 10.1016/0300-5712(94)90035-3
   Browning G C, 1994, Quintessence Int, V25, P787
   Bryant A W, 1994, J Prosthodont, V3, P96, DOI 10.1111/j.1532-849X.1994.tb00135.x
   BRYANT RW, 1994, AUST DENT J, V39, P77, DOI 10.1111/j.1834-7819.1994.tb01377.x
   BUNKER BC, 1994, SCIENCE, V264, P48, DOI 10.1126/science.264.5155.48
   Burgess J, 1994, J Esthet Dent, V6, P207, DOI 10.1111/j.1708-8240.1994.tb00861.x
   Burke F J, 1994, Quintessence Int, V25, P335
   Burke F J, 1994, Quintessence Int, V25, P269
   Burke F J, 1994, Int Dent J, V44, P195
   BURKE FJT, 1994, BRIT DENT J, V176, P251, DOI 10.1038/sj.bdj.4808428
   BURKE FM, 1994, J DENT, V22, P283, DOI 10.1016/0300-5712(94)90061-2
   BURNS T, 1994, J DENT, V22, P273, DOI 10.1016/0300-5712(94)90056-6
   BURROW MF, 1994, J DENT RES, V73, P522, DOI 10.1177/00220345940730020701
   BURROW MF, 1994, DENT MATER, V10, P241, DOI 10.1016/0109-5641(94)90068-X
   BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293
   BUTTERMANN GR, 1994, J BIOMECH, V27, P1087, DOI 10.1016/0021-9290(94)90225-9
   Buyukyilmaz S, 1994, Int J Prosthodont, V7, P372
   CAI H, 1994, SCIENCE, V266, P1551, DOI 10.1126/science.266.5190.1551
   CALISKAN MK, 1994, INT ENDOD J, V27, P163, DOI 10.1111/j.1365-2591.1994.tb00247.x
   CALLIS PD, 1994, J ENDODONT, V20, P555, DOI 10.1016/S0099-2399(06)80072-5
   CALVERT P, 1994, NATURE, V367, P119, DOI 10.1038/367119a0
   CAMPS J, 1994, DENT MATER, V10, P210, DOI 10.1016/0109-5641(94)90034-5
   Cardoso A C, 1994, Quintessence Int, V25, P835
   CARMAN JE, 1994, J ENDODONT, V20, P571, DOI 10.1016/S0099-2399(06)80078-6
   Cassidy M, 1994, Dent Update, V21, P196
   CASSINELLI C, 1994, J BIOMED MATER RES, V28, P1427, DOI 10.1002/jbm.820281207
   CASTANO P, 1994, J MICROSC-OXFORD, V175, P229, DOI 10.1111/j.1365-2818.1994.tb03489.x
   Castellani D, 1994, Int J Prosthodont, V7, P149
   CASTELLANI D, 1994, J PROSTHET DENT, V72, P360, DOI 10.1016/0022-3913(94)90554-1
   CASTRO GW, 1994, OPER DENT, V19, P194
   CATTANILORENTE MA, 1994, DENT MATER, V10, P37, DOI 10.1016/0109-5641(94)90020-5
   Cavicchia F., 1994, INT J ORAL MAXILLOF, V9, P711
   CERNAVIN I, 1994, AUST DENT J, V39, P28, DOI 10.1111/j.1834-7819.1994.tb05543.x
   CHADWICK RG, 1994, BRIT DENT J, V176, P17, DOI 10.1038/sj.bdj.4808350
   CHADWICK RG, 1994, J DENT, V22, P364, DOI 10.1016/0300-5712(94)90090-6
   CHADWICK RG, 1994, J ORAL REHABIL, V21, P533, DOI 10.1111/j.1365-2842.1994.tb01167.x
   Chai J, 1994, J Prosthodont, V3, P134, DOI 10.1111/j.1532-849X.1994.tb00143.x
   Chai J, 1994, Int J Prosthodont, V7, P155
   Chain M C, 1994, Am J Dent, V7, P195
   CHAN DCN, 1994, AM J DENT, V7, P322
   CHAN KC, 1994, J PROSTHET DENT, V72, P420, DOI 10.1016/0022-3913(94)90563-0
   CHAN MFWY, 1994, J DENT, V22, P292, DOI 10.1016/0300-5712(94)90062-0
   CHANDLER JE, 1994, J DENT RES, V73, P1554, DOI 10.1177/00220345940730091101
   Chappell R P, 1994, Quintessence Int, V25, P359
   Chappell R P, 1994, Quintessence Int, V25, P851
   CHAPPELL RP, 1994, J PROSTHET DENT, V72, P183, DOI 10.1016/0022-3913(94)90078-7
   Charlton D G, 1994, Am J Dent, V7, P47
   CHARLTON DG, 1994, OPER DENT, V19, P154
   Checchi L, 1994, Quintessence Int, V25, P647
   CHEN JY, 1994, BIOMATERIALS, V15, P396, DOI 10.1016/0142-9612(94)90253-4
   CHENG AC, 1994, J PROSTHET DENT, V72, P8, DOI 10.1016/0022-3913(94)90208-9
   CHENG PT, 1994, CELL MATER, V4, P299
   CHESTNUTT IG, 1994, BRIT DENT J, V177, P125, DOI 10.1038/sj.bdj.4808525
   CHEUNG LK, 1994, J ORAL MAXIL SURG, V52, P373, DOI 10.1016/0278-2391(94)90440-5
   Chiche G J, 1994, Compendium, V15, P328
   CHIGIRA H, 1994, J DENT RES, V73, P1088, DOI 10.1177/00220345940730051101
   CHIGIRA H, 1994, DENT MATER, V10, P363, DOI 10.1016/0109-5641(94)90060-4
   CHRISTENSEN GJ, 1994, J AM DENT ASSOC, V125, P193, DOI 10.14219/jada.archive.1994.0269
   CHRISTENSEN GJ, 1994, J AM DENT ASSOC, V125, P1257, DOI 10.14219/jada.archive.1994.0156
   CHRISTENSEN GJ, 1994, ORAL HLTH, V84, P43
   CHRISTENSEN GJ, 1994, J AM DENT ASSOC, V125, P305
   CHRISTENSEN GJ, 1994, ORAL HLTH, V84, P47
   CHRISTERSSON C, 1991, SWED DENT J, V77
   CHUNG KH, 1994, DENT MATER, V10, P325, DOI 10.1016/0109-5641(94)90041-8
   Ciamponi A L, 1994, Quintessence Int, V25, P599
   CIEPLAK M, 1994, SCIENCE, V265, P1209, DOI 10.1126/science.265.5176.1209
   Clark D C, 1994, J Can Dent Assoc, V60, P711
   Cobo J M, 1994, J Clin Orthod, V28, P600
   Cochran David, 1994, Int J Oral Maxillofac Implants, V9, P289
   Cohen B D, 1994, Dent Update, V21, P57
   Cohen B I, 1994, J Prosthodont, V3, P53, DOI 10.1111/j.1532-849X.1994.tb00126.x
   Cohen B I, 1994, Oral Health, V84, P7
   COHEN J, 1994, SCIENCE, V264, P1534, DOI 10.1126/science.8202707
   COLLETT AR, 1994, AUST DENT J, V39, P298, DOI 10.1111/j.1834-7819.1994.tb05566.x
   CONCEICAO EN, 1994, J PROSTHET DENT, V71, P303, DOI 10.1016/0022-3913(94)90472-3
   Cooney P V, 1994, J Can Dent Assoc, V60, P140
   CORBIN SB, 1994, J AM DENT ASSOC, V125, P381, DOI 10.14219/jada.archive.1994.0055
   COX CF, 1994, J AM DENT ASSOC, V125, P823, DOI 10.14219/jada.archive.1994.0205
   Coyne B M, 1994, Eur J Prosthodont Restor Dent, V3, P87
   CRAIG RG, 1994, OPER DENT, V19, P138
   Crawford P R, 1994, N Y State Dent J, V60, P80
   Crim G A, 1994, Quintessence Int, V25, P781
   Crispin B J, 1994, Compendium, V15, P294
   CROLL TP, 1994, J DENT CHILD, V61, P246
   CROLL TP, 1994, ORAL HLTH, V84, P45
   CROLL TP, 1994, J CLIN ORTHOD, V28, P265
   CSERNA A, 1994, J PROSTHET DENT, V71, P387, DOI 10.1016/0022-3913(94)90100-7
   DACULSI G, 1994, CELL MATER, V4, P63
   Dahl B L, 1994, Quintessence Int, V25, P561
   DANIN J, 1994, INT ENDOD J, V27, P257, DOI 10.1111/j.1365-2591.1994.tb00265.x
   DARBAR UR, 1994, J DENT, V22, P259, DOI 10.1016/0300-5712(94)90054-X
   DARDICK I, 1994, MICROSC RES TECHNIQ, V27, P46, DOI 10.1002/jemt.1070270104
   DARLING M, 1994, BIOMATERIALS, V15, P299, DOI 10.1016/0142-9612(94)90055-8
   DAUTELMORAZIN A, 1994, J ENDODONT, V20, P531, DOI 10.1016/S0099-2399(06)80066-X
   David A T, 1994, Indian J Dent Res, V5, P101
   David S B, 1994, Compendium, V15, P810
   Davidson C L, 1994, J Esthet Dent, V6, P223, DOI 10.1111/j.1708-8240.1994.tb00863.x
   Davidson C L, 1994, Am J Dent, V7, P111
   Davidson D F, 1994, J Can Dent Assoc, V60, P301
   Davis B A, 1994, J Prosthodont, V3, P31, DOI 10.1111/j.1532-849X.1994.tb00122.x
   Davis B K, 1994, Int J Prosthodont, V7, P227
   Davis D M, 1994, Dent Update, V21, P15
   de Freitas A R, 1994, Quintessence Int, V25, P419
   DEGEE AJ, 1994, INT ENDOD J, V27, P239
   DEGROOT K, 1994, ORAL IMPLANTOLOGY, V20, P232
   DEHOFF PH, 1994, DENT MATER, V10, P178, DOI 10.1016/0109-5641(94)90029-9
   DEKKER A, 1994, CELL MATER, V4, P101
   DELCOURT MO, 1994, SCANNING MICROSCOPY, V8, P449
   DELLABONA A, 1994, J DENT, V22, P103, DOI 10.1016/0300-5712(94)90012-4
   DEMENEZES LFS, 1994, ANGLE ORTHOD, V64, P383
   DESAEYTIJD C, 1994, EUR J ORTHODONT, V16, P541, DOI 10.1093/ejo/16.6.541
   Devlin H., 1994, Clinical Materials, V16, P111, DOI 10.1016/0267-6605(94)90105-8
   DEWALD JP, 1994, J PROSTHET DENT, V71, P394, DOI 10.1016/0022-3913(94)90102-3
   DHUMMARUNGRONG S, 1994, J DENT CHILD, V61, P17
   DICKENSVENZ SH, 1994, DENT MATER, V10, P100, DOI 10.1016/0109-5641(94)90048-5
   Dickerson W G, 1994, J Can Dent Assoc, V60, P687
   Dietschi D, 1994, Quintessence Int, V25, P659
   DIETSCHI D, 1994, DENT MATER, V10, P353, DOI 10.1016/0109-5641(94)90059-0
   DIJKMAN GEHM, 1994, SCAND J DENT RES, V102, P144
   DIONYSOPOULOS P, 1994, OPER DENT, V19, P183
   DISHMAN MV, 1994, DENT MATER, V10, P33, DOI 10.1016/0109-5641(94)90019-1
   Dixon D L, 1994, Int J Prosthodont, V7, P129
   DIXON DL, 1994, J PROSTHET DENT, V72, P457, DOI 10.1016/0022-3913(94)90114-7
   DIXON DL, 1994, J PROSTHET DENT, V71, P316, DOI 10.1016/0022-3913(94)90474-X
   Donly K, 1994, Quintessence Int, V25, P355
   Donly K J, 1994, Am J Dent, V7, P275
   DOOTZ ER, 1994, J PROSTHET DENT, V71, P379, DOI 10.1016/0022-3913(94)90098-1
   DORNEY B, 1994, AUST DENT J, V39, P372, DOI 10.1111/j.1834-7819.1994.tb03109.x
   DORTMANS LJMG, 1994, J BIOMECH ENG-T ASME, V116, P373, DOI 10.1115/1.2895746
   dos Santos J Jr, 1994, Compendium, V15, P230
   Douglas C W, 1994, Adv Dent Res, V8, P254
   DOYLE RJ, 1994, CELL MATER, V4, P91
   DRORY MD, 1994, SCIENCE, V263, P1753, DOI 10.1126/science.263.5154.1753
   du Preez I C, 1994, J Dent Assoc S Afr, V49, P61
   Duckworth R M, 1994, Adv Dent Res, V8, P202
   Duke E S, 1994, Compendium, V15, P864
   DUKE ES, 1994, AM J DENT, V7, P307
   DUNN J, 1994, J CALIF DENT ASS APR, P73
   DUPOIRIEUX L, 1994, INT J ORAL MAX SURG, V23, P395, DOI 10.1016/S0901-5027(05)80028-1
   EAKLE WS, 1994, J PROSTHET DENT, V72, P351, DOI 10.1016/0022-3913(94)90552-5
   EBERHART M, 1994, SCIENCE, V265, P332, DOI 10.1126/science.265.5170.332
   EDELMANN L, 1994, SCANNING MICROSCOPY, V8, P551
   Edgar W M, 1994, Adv Dent Res, V8, P239
   Edge M J, 1994, J Prosthodont, V3, P130, DOI 10.1111/j.1532-849X.1994.tb00142.x
   EHRNFORD LE, 1994, SWED DENT J, V18, P207
   EHUDIN DZ, 1994, J PROSTHET DENT, V71, P165, DOI 10.1016/0022-3913(94)90026-4
   EIDE R, 1994, SCAND J DENT RES, V102, P76
   Eidenbenz S, 1994, Int J Prosthodont, V7, P134
   EKFELDT A, 1989, SWED DENT J S, V65
   ELCHARKAWI HG, 1994, J PROSTHET DENT, V72, P614, DOI 10.1016/0022-3913(94)90294-1
   Elhabashy A, 1994, Am J Dent, V7, P50
   ELIADES G, 1994, J DENT, V22, P73, DOI 10.1016/0300-5712(94)90004-3
   Ellwood R, 1994, Int Dent J, V44, P628
   ELMOWAFY OM, 1994, OPER DENT, V19, P11
   ELMOWAFY OM, 1994, J DENT, V22, P33
   ELMOWAFY OM, 1994, OPER DENT, V19, P176
   Endo K, 1994, Dent Mater J, V13, P228
   ENG JH, 1994, J DENT RES, V73, P1050
   ENGLUND GS, 1994, J DENT RES, V73, P620
   ENTWISTLE A, 1994, J MICROSC-OXFORD, V175, P238, DOI 10.1111/j.1365-2818.1994.tb03490.x
   EPSTEIN J, 1994, ORAL SURG ORAL MED O, V77, P242, DOI 10.1016/0030-4220(94)90292-5
   Erickson R L, 1994, Am J Dent, V7, P279
   Erickson R L, 1994, J Esthet Dent, V6, P227, DOI 10.1111/j.1708-8240.1994.tb00864.x
   ERICSON D, 1994, SCAND J DENT RES, V102, P244
   EUFINGER H, 1994, INT J ORAL MAX SURG, V23, P399
   FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553
   FARINA M, 1994, J MICROSC-OXFORD, V173, P1, DOI 10.1111/j.1365-2818.1994.tb03423.x
   FARNAN I, 1994, SCIENCE, V265, P1206, DOI 10.1126/science.265.5176.1206
   FAVA LRG, 1994, INT ENDOD J, V27, P47, DOI 10.1111/j.1365-2591.1994.tb00229.x
   Fehling A W, 1994, J Prosthodont, V3, P256, DOI 10.1111/j.1532-849X.1994.tb00164.x
   FEIFEL H, 1994, INT J ORAL MAX SURG, V23, P104, DOI 10.1016/S0901-5027(05)80603-4
   FEJERESKOV O, 1994, INT DENT J, V44, P169
   Fejerskov O, 1994, Int Dent J, V44, P139
   FEJERSKOV O, 1994, ADV DENT RES, V5, P15
   Feldens E G, 1994, J Clin Pediatr Dent, V18, P187
   Fernandez E., 1994, Clinical Materials, V16, P99, DOI 10.1016/0267-6605(94)90103-1
   Ferracane J L, 1994, Am J Dent, V7, P103
   FERRACANE JL, 1994, J ORAL REHABIL, V21, P441, DOI 10.1111/j.1365-2842.1994.tb01158.x
   FERRACANE JL, 1994, DENT MATER, V10, P92, DOI 10.1016/0109-5641(94)90047-7
   Ferrari M, 1994, Quintessence Int, V25, P861
   FERRARI M, 1994, J PROSTHET DENT, V71, P404, DOI 10.1016/0022-3913(94)90104-X
   Ferrari M, 1994, Quintessence Int, V25, P621
   Ferrari M, 1994, Am J Dent, V7, P217
   FERRARI M, 1994, INT J PERIODONT REST, V14, P273
   FERRO KJ, 1994, J PROSTHET DENT, V71, P462, DOI 10.1016/0022-3913(94)90183-X
   Fettig R H, 1994, J Oral Implantol, V20, P42
   Filler S J, 1994, Am J Dent, V7, P85
   Finger W J, 1994, Am J Dent, V7, P35
   Fischman Steven A., 1994, Pediatric Dentistry, V16, P368
   Fitchie James G., 1994, General Dentistry, V42, P54
   FITTING HJ, 1994, SCANNING MICROSCOPY, V8, P165
   FLAITZ CM, 1994, J DENT CHILD, V61, P21
   FLAM F, 1994, SCIENCE, V266, P215, DOI 10.1126/science.266.5183.215
   FLORES DA, 1994, ANGLE ORTHOD, V64, P283
   FORD TRP, 1994, J ENDODONT, V20, P381
   FOREMAN FJ, 1994, J AM DENT ASSOC, V125, P182, DOI 10.14219/jada.archive.1994.0270
   FORSTEN L, 1994, AUST DENT J, V39, P339, DOI 10.1111/j.1834-7819.1994.tb03102.x
   Forsten L, 1994, J Esthet Dent, V6, P216, DOI 10.1111/j.1708-8240.1994.tb00862.x
   FORTIN D, 1994, DENT MATER, V10, P253, DOI 10.1016/0109-5641(94)90070-1
   FORTIN D, 1994, AM J DENT, V7, P315
   Forward G C, 1994, Adv Dent Res, V8, P208
   FOSTER LV, 1994, BRIT DENT J, V177, P89, DOI 10.1038/sj.bdj.4808518
   FOWLER CS, 1994, OPER DENT, V19, P47
   Fox N A, 1994, Br J Orthod, V21, P33
   Franchi M, 1994, Quintessence Int, V25, P577
   FRANKEL MS, 1994, J DENT RES, V73, P1759, DOI 10.1177/00220345940730111301
   Freedman G, 1994, J Can Dent Assoc, V60, P695
   FRIEDL KH, 1994, OPER DENT, V19, P228
   FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071
   FROST HM, 1994, ANGLE ORTHOD, V64, P175
   Fujisawa S, 1994, Dent Mater J, V13, P251
   FURUZONO T, 1993, J BIOMAT SCI-POLYM E, V5, P89
   Futatsuki M, 1994, J Clin Pediatr Dent, V18, P191
   Gaffar A, 1994, Int Dent J, V44, P63
   Gagnon F, 1994, J Prosthodont, V3, P228, DOI 10.1111/j.1532-849X.1994.tb00160.x
   Gaintantzopoulou M D, 1994, Am J Dent, V7, P39
   Galan D, 1994, J Can Dent Assoc, V60, P422
   GALE MS, 1994, J DENT, V22, P370, DOI 10.1016/0300-5712(94)90091-4
   GALUN EA, 1994, J PROSTHET DENT, V72, P424, DOI 10.1016/0022-3913(94)90564-9
   GALVAN DA, 1994, J ENDODONT, V20, P83, DOI 10.1016/S0099-2399(06)81187-8
   Garberoglio P, 1994, Quintessence Int, V25, P49
   GARCIABARBERO AE, 1994, DENT MATER, V10, P83, DOI 10.1016/0109-5641(94)90045-0
   GAREY DJ, 1994, J PROSTHET DENT, V71, P124, DOI 10.1016/0022-3913(94)90019-1
   Garg A K, 1994, Implant Soc, V5, P11
   GAULKER IA, 1994, INT J PROSTHODONT, V7, P258
   GAYLE FW, 1994, SCIENCE, V266, P1015, DOI 10.1126/science.266.5187.1015
   GEISGERSTORFER J, 1994, J DENT, V22, P247, DOI 10.1016/0300-5712(94)90124-4
   GELBARD S, 1994, J PROSTHET DENT, V71, P1, DOI 10.1016/0022-3913(94)90246-1
   GEORGOPOULOU M, 1994, INT ENDOD J, V27, P139, DOI 10.1111/j.1365-2591.1994.tb00243.x
   GERSCHMAN JA, 1994, AUST DENT J, V39, P353, DOI 10.1111/j.1834-7819.1994.tb03105.x
   GERZINA TM, 1994, J ORAL REHABIL, V21, P463, DOI 10.1111/j.1365-2842.1994.tb01160.x
   GEWIRTH AA, 1994, MICROS RES TECH, V27, P268
   Ghalichebaf M, 1994, Compendium, V15, P473
   GHANI F, 1994, J ORAL REHABIL, V21, P631
   Ghani S H, 1994, Br J Orthod, V21, P239
   Ghani S H, 1994, Br J Orthod, V21, P375
   GHAZALI SE, 1989, SWED DENT J S, V59
   GILBERT JL, 1994, DENT MATER, V10, P134, DOI 10.1016/0109-5641(94)90054-X
   GILHEANY PA, 1994, J ENDODONT, V20, P22, DOI 10.1016/S0099-2399(06)80022-1
   GILLETT GR, 1994, J DENT RES, V73, P1766, DOI 10.1177/00220345940730111401
   Gilpatrick R O, 1994, Quintessence Int, V25, P573
   GIORDANO RA, 1994, J PROSTHET DENT, V71, P468, DOI 10.1016/0022-3913(94)90184-8
   GLASSMAN GD, 1994, ORAL HLTH, V84, P13
   Godder B, 1994, Am J Dent, V7, P74
   GOLDBERG M, 1994, J DENT, V22, pS25, DOI 10.1016/0300-5712(94)90036-1
   GOLDSTEIN RE, 1994, J AM DENT ASSOC, V125, P1447, DOI 10.14219/jada.archive.1994.0215
   GOLDSTEIN RE, 1994, J AM DENT ASSOC, V125, P551, DOI 10.14219/jada.archive.1994.0077
   GOLDSTEIN RE, 1994, J CALIF DENT ASS SEP, P23
   Goracci G, 1994, Quintessence Int, V25, P627
   Gough M, 1994, Dent Update, V21, P203
   Granstrom G, 1994, INT J ORAL MAXILLOF, V9, P653
   Graves S L, 1994, Aust Prosthodont J, V8, P31
   Gray G B, 1994, Eur J Prosthodont Restor Dent, V2, P131
   GREER AL, 1994, NATURE, V368, P688, DOI 10.1038/368688a0
   GRIGGS JA, 1994, DENT MATER, V10, P314, DOI 10.1016/0109-5641(94)90039-6
   Grobler S R, 1994, J Dent Assoc S Afr, V49, P67
   Grogono A L, 1994, Am J Dent, V7, P89
   GRYNPAS MD, 1994, CELL MATER, V4, P287
   GUBA CJ, 1994, OPER DENT, V19, P146
   GUCKENBERGER R, 1994, SCIENCE, V266, P1538, DOI 10.1126/science.7985024
   Gugushe T S, 1994, J Dent Assoc S Afr, V49, P209
   Gwinnett A J, 1994, Am J Dent, V7, P144
   Gwinnett A J, 1994, Quintessence Int, V25, P687
   Gwinnett A J, 1994, Quintessence Int, V25, P215
   Gwinnett A J, 1994, Am J Dent, V7, P243
   Gwinnett A J, 1994, Am J Dent, V7, P57
   GWINNETT AJ, 1994, DENT MATER, V10, P150
   GWINNETT AJ, 1994, AM J DENT, V7, P312
   HADAVI F, 1994, J PROSTHET DENT, V72, P250, DOI 10.1016/0022-3913(94)90337-9
   HALL G, 1994, SWED DENT J, V18, P29
   Hall H D, 1994, J Okla Dent Assoc, V85, P20
   HALLETT KB, 1994, AUST DENT J, V39, P292, DOI 10.1111/j.1834-7819.1994.tb05565.x
   Hallgren A, 1994, Br J Orthod, V21, P23
   HAMULA W, 1994, ORAL HLTH, V84, P43
   HAN CH, 1994, INT J ORAL MAXILLOF, V9, P698
   Hanawa T, 1994, Dent Mater J, V13, P164
   HANKINSON JA, 1994, INT J PERIODONT REST, V14, P139
   HANKS CT, 1994, J ORAL REHABIL, V21, P475, DOI 10.1111/j.1365-2842.1994.tb01162.x
   HARDEE MW, 1994, J ENDODONT, V20, P377, DOI 10.1016/S0099-2399(06)80294-3
   HARKIN T, 1994, FASEB J, V8, P1215
   Harnick D J, 1994, J Gen Orthod, V5, P11
   HARRIGAN TP, 1994, J BIOMECH, V27, P323, DOI 10.1016/0021-9290(94)90008-6
   HARRIS DE, 1994, NATURE, V367, P713, DOI 10.1038/367713a0
   Harris I R, 1994, Int J Prosthodont, V7, P348
   HASE JC, 1993, SWED DENT J S, V89
   Hasegawa T, 1994, Am J Dent, V7, P212
   HATTON JF, 1994, J ENDODONT, V20, P580, DOI 10.1016/S0099-2399(06)80080-4
   HAUDRECHY P, 1994, CONTACT DERMATITIS, V31, P249, DOI 10.1111/j.1600-0536.1994.tb01997.x
   Haveman C W, 1994, Am J Dent, V7, P247
   Hayakawa I, 1994, Int J Prosthodont, V7, P339
   Hayakawa Tohru, 1994, Journal of Nihon University School of Dentistry, V36, P52
   HAYASHI Y, 1994, ORAL SURG ORAL MED O, V77, P623, DOI 10.1016/0030-4220(94)90323-9
   HEIFETZ SB, 1994, J CALIF DENT ASS MAR, P49
   HEINZ DL, 1994, SCIENCE, V264, P279, DOI 10.1126/science.264.5156.279
   HELLGREN K, 1994, SWED DENT J, V18, P9
   HELSINGEN AL, 1994, INT J ORAL MAXILLOF, V9, P422
   HENG YM, 1994, J MICROSC-OXFORD, V173, P79, DOI 10.1111/j.1365-2818.1994.tb03430.x
   HENNEQUIN M, 1994, J ENDODONT, V20, P551, DOI 10.1016/S0099-2399(06)80071-3
   HERO H, 1994, CELL MATER, V4, P409
   HIDAKA S, 1994, J BIOMED MATER RES, V28, P175, DOI 10.1002/jbm.820280206
   HIGA RK, 1994, INT ENDOD J, V27, P252, DOI 10.1111/j.1365-2591.1994.tb00264.x
   Hilton T J, 1994, Int J Prosthodont, V7, P424
   Hirano S, 1994, Dent Mater J, V13, P214
   HO MH, 1994, J PROSTHET DENT, V72, P367, DOI 10.1016/0022-3913(94)90555-X
   Hoad-Reddick G, 1994, Eur J Prosthodont Restor Dent, V3, P61
   HOGLUND AC, 1994, ACTA ODONTOL SCAND, V52, P140
   HOLGER SKM, 1994, INT J ORAL MAXILLOF, V9, P689
   Holt R D, 1994, Int Dent J, V44, P331
   HOLTAN JR, 1994, OPER DENT, V19, P189
   HOLTAN JR, 1994, J DENT, V22, P92, DOI 10.1016/0300-5712(94)90008-6
   Hondrum S O, 1994, Int J Prosthodont, V7, P517
   HORSTEDBINDSLEV P, 1994, J DENT, V22, pS29, DOI 10.1016/0300-5712(94)90037-X
   Hosoya Y, 1994, J Clin Pediatr Dent, V18, P115
   Hosseini A, 1994, Quintessence Int, V25, P567
   HOTTA M, 1994, J ORAL REHABIL, V21, P679
   HOTTA M, 1994, OPER DENT, V19, P42
   HOTZ G, 1994, INT J ORAL MAX SURG, V23, P413, DOI 10.1016/S0901-5027(05)80033-5
   Houpt M, 1994, Quintessence Int, V25, P155
   Hulterstrom M, 1994, INT J ORAL MAXILLOF, V9, P449
   Hum S K, 1994, Oral Health, V84, P9
   HUME WR, 1994, J ORAL REHABIL, V21, P469, DOI 10.1111/j.1365-2842.1994.tb01161.x
   HUMMEL SK, 1994, J PROSTHODONT, V3, P107
   HUNT PR, 1994, J ESTHET DENT, V6, P191
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   Iimuro F T, 1994, Dent Mater J, V13, P76
   Ikemi T, 1994, Dent Mater J, V13, P1
   ILBAY SG, 1994, J ORAL REHABIL, V21, P103, DOI 10.1111/j.1365-2842.1994.tb01129.x
   IMAI Y, 1994, DENT MATER, V10, P275, DOI 10.1016/0109-5641(94)90074-4
   Imai Y, 1994, Dent Mater J, V13, P190
   Imai Y, 1994, Dent Mater J, V13, P66
   IMAZATO S, 1994, J DENT RES, V73, P1641, DOI 10.1177/00220345940730100901
   IMFELD K, 1994, ADV DENT RES, V8, P225
   Ingram G S, 1994, Adv Dent Res, V8, P158
   Inoue M, 1994, Am J Dent, V7, P161
   IRELAND AJ, 1994, EUR J ORTHODONT, V16, P27, DOI 10.1093/ejo/16.1.27
   ISAKSSON S, 1992, SWED DENT J S, V84
   ISHIKAWA K, 1994, DENT MATER, V10, P26, DOI 10.1016/0109-5641(94)90018-3
   ISHIKAWA K, 1994, J DENT RES, V73, P1197, DOI 10.1177/00220345940730061101
   Ishikawa K, 1994, Dent Mater J, V13, P182
   Ishikawa-Nagai S, 1994, Int J Prosthodont, V7, P50
   ITO K, 1994, SCIENCE, V263, P66, DOI 10.1126/science.263.5143.66
   Itoh H, 1994, Dent Mater J, V13, P25
   Jackley G A, 1994, J Prosthodont, V3, P16, DOI 10.1111/j.1532-849X.1994.tb00119.x
   JAGGER DC, 1994, J PROSTHET DENT, V72, P320, DOI 10.1016/0022-3913(94)90347-6
   JAMALUDDIN A, 1994, J ORAL REHABIL, V21, P649
   JEANSONNE MJ, 1994, J ENDODONT, V20, P276, DOI 10.1016/S0099-2399(06)80815-0
   JENDRESEN MD, 1993, J PROSTHET DENT, V70, P44, DOI 10.1016/0022-3913(93)90036-N
   JENDRESEN MD, 1994, J PROSTHET DENT, V72, P39, DOI 10.1016/0022-3913(94)90214-3
   JENKINS WMM, 1994, J DENT, V22, P108, DOI 10.1016/0300-5712(94)90013-2
   JEPSON NJA, 1994, BRIT DENT J, V177, P11, DOI 10.1038/sj.bdj.4808489
   JIN CM, 1994, SCIENCE, V263, P68, DOI 10.1126/science.263.5143.68
   Johansson P, 1994, INT J ORAL MAXILLOF, V9, P279
   Johnson A, 1994, Int J Prosthodont, V7, P35
   JOHNSON ME, 1994, OPER DENT, V19, P205
   JOKSTAD A, 1994, ACTA ODONTOL SCAND, V52, P234, DOI 10.3109/00016359409029052
   Jokstad A, 1994, Quintessence Int, V25, P101
   JONES DW, 1994, BRIT DENT J, V177, P159
   Jones M L, 1994, Br J Orthod, V21, P133
   Joyston-Bechal S., 1994, DENT UPDATE, V21, P366
   JUNIPER RP, 1994, BRIT J ORAL MAX SURG, V32, P71, DOI 10.1016/0266-4356(94)90130-9
   JUSKAITIS R, 1994, J MICROSC-OXFORD, V176, P188, DOI 10.1111/j.1365-2818.1994.tb03514.x
   KAISER J, 1994, SCIENCE, V265, P1365, DOI 10.1126/science.8073269
   KAISER J, 1994, SCIENCE, V265, P2010, DOI 10.1126/science.265.5181.2010
   KALFAS S, 1989, SWED DENT J S, V63
   Kamegai Akihide, 1994, Bio-Medical Materials and Engineering, V4, P291
   KAMPOSIORA P, 1994, J PROSTHET DENT, V71, P435, DOI 10.1016/0022-3913(94)90179-1
   Kanca J 3rd, 1994, J Esthet Dent, V6, P286
   KANERVA L, 1994, CONTACT DERMATITIS, V31, P299, DOI 10.1111/j.1600-0536.1994.tb02023.x
   KANIWA MA, 1994, CONTACT DERMATITIS, V30, P20, DOI 10.1111/j.1600-0536.1994.tb00723.x
   KANIWA MA, 1994, CONTACT DERMATITIS, V30, P26, DOI 10.1111/j.1600-0536.1994.tb00724.x
   KAPLAN BA, 1994, J PROSTHET DENT, V71, P603, DOI 10.1016/0022-3913(94)90445-6
   KAPLOWITZ GJ, 1994, J ENDODONT, V20, P109, DOI 10.1016/S0099-2399(06)80052-X
   1994, PEDIATR DENT, V16, P56
   1994, J DENT ASSOC S AFR, V49, P358
   1994, ORAL HLTH, V84, P47
   1994, PEDIATR DENT, V16, P25
   1994, ORTHOD REV       SEP, P7
   1994, CINCINNATI DENT SOC, V63, P30
   1994, ORTHOD REV       JUL, P8
   1994, J DENT EDUC, V58, P433
   1994, ORAL REV         MAR, P10
   1994, ORAL HLTH, V84, P45
   1994, ORTHOD REV       MAR, P10
   1994, ORTHOD REV       JAN, P11
   1994, CINCINNATI DENT SCH, V63, P30
   1994, J DENT EDUC, V58, P424
   1994, J AM DENT ASSOC, V125, P1591
   1994, PEDIATR DENT, V16, P31
   1994, J DENT EDUC, V58, P26
   1994, J DENT EDUC, V58, P261
   FORTIN D, 1995, AM J DENT, V8, P201
   Karkazis H C, 1994, Eur J Prosthodont Restor Dent, V2, P109
   KARLSSON S, 1994, ACTA ODONTOL SCAND, V52, P290, DOI 10.3109/00016359409029041
   KATONA TR, 1994, J DENT RES, V73, P1470, DOI 10.1177/00220345940730081201
   KATSIKAS NG, 1994, DENT MATER, V10, P2, DOI 10.1016/0109-5641(94)90014-0
   KAWAGUCHI M, 1994, J DENT RES, V73, P516, DOI 10.1177/00220345940730020601
   KAWAHARA LK, 1994, J CALIF DENT ASS JUN, P55
   Kawai K, 1994, Quintessence Int, V25, P53
   Kawakami M, 1994, Am J Dent, V7, P53
   KAWANO F, 1994, J PROSTHET DENT, V72, P599, DOI 10.1016/0022-3913(94)90292-5
   KAWANO F, 1994, J PROSTHET DENT, V72, P393, DOI 10.1016/0022-3913(94)90559-2
   KAWASAKI M, 1994, SCIENCE, V266, P1540, DOI 10.1126/science.266.5190.1540
   KELLER EE, 1994, J ORAL MAXIL SURG, V52, P438, DOI 10.1016/0278-2391(94)90335-2
   KELLETT M, 1994, J DENT, V22, P208, DOI 10.1016/0300-5712(94)90108-2
   KENDALL K, 1994, SCIENCE, V263, P1720, DOI 10.1126/science.263.5154.1720
   KENR M, 1994, J PROSTHET DENT, V71, P453
   KENYON CM, 1994, J MICROSC-OXFORD, V176, P152, DOI 10.1111/j.1365-2818.1994.tb03509.x
   KERN M, 1994, DENT MATER, V10, P19, DOI 10.1016/0109-5641(94)90017-5
   KERN M, 1994, J DENT, V22, P300, DOI 10.1016/0300-5712(94)90067-1
   KERN M, 1994, J PROSTHET DENT, V71, P251, DOI 10.1016/0022-3913(94)90463-4
   Kidd E A, 1994, Dent Update, V21, P323
   KILDAL KK, 1994, ACTA ODONTOL SCAND, V52, P315, DOI 10.3109/00016359409029044
   KILPATRICK NM, 1994, J DENT, V22, P182, DOI 10.1016/0300-5712(94)90203-8
   KIM HJ, 1994, BIO-MED MATER ENG, V4, P171
   KIM KH, 1994, J DENT RES, V73, P499, DOI 10.1177/00220345940730020301
   King A W, 1994, Northwest Dent Res, V4, P11
   KING AWC, 1994, J PROSTHET DENT, V72, P314, DOI 10.1016/0022-3913(94)90346-8
   King B B, 1994, J Prosthodont, V3, P219, DOI 10.1111/j.1532-849X.1994.tb00159.x
   Kingman A, 1994, Adv Dent Res, V8, P56
   KINNEY JH, 1994, SCANNING MICROSCOPY, V8, P197
   Kjaerheim V, 1994, Adv Dent Res, V8, P302
   Kleerekoper M, 1994, Adv Dent Res, V8, P32
   Knight G M, 1994, Quintessence Int, V25, P97
   KNOBLER CM, 1994, NATURE, V369, P15, DOI 10.1038/369015a0
   Knoernschild K L, 1994, Int J Prosthodont, V7, P22
   Kobayashi S, 1994, Int Dent J, V44, P641
   KOMATSU H, 1994, J AM DENT ASSOC, V125, P543, DOI 10.14219/jada.archive.1994.0082
   KOMORI T, 1994, J ORAL MAXIL SURG, V52, P516, DOI 10.1016/0278-2391(94)90356-5
   Kon M, 1994, Dent Mater J, V13, P47
   Kon M, 1994, Dent Mater J, V13, P138
   KONONEN M, 1994, J BIOMED MATER RES, V28, P1027, DOI 10.1002/jbm.820280907
   Koroluk Lorne, 1994, Pediatric Dentistry, V16, P276
   KOTSIOMITI E, 1994, J PROSTHET DENT, V71, P511, DOI 10.1016/0022-3913(94)90192-9
   Koutsi V., 1994, Pediatric Dentistry, V16, P29
   KRAFFT T, 1994, INT J ORAL MAX SURG, V23, P418, DOI 10.1016/S0901-5027(05)80034-7
   Kraut J M, 1994, J Clin Orthod, V28, P50
   KREJCI I, 1994, J PROSTHET DENT, V72, P233, DOI 10.1016/0022-3913(94)90335-2
   Krejci I, 1994, Quintessence Int, V25, P403
   KREJCI I, 1994, J DENT RES, V73, P1228, DOI 10.1177/00220345940730061501
   Krejci I, 1994, Quintessence Int, V25, P199
   Krejci I, 1994, Am J Dent, V7, P27
   KREJCI I, 1994, DENT MATER, V10, P331, DOI 10.1016/0109-5641(94)90042-6
   KREULEN CM, 1994, J DENT CHILD, V61, P29
   KREULEN CM, 1994, J DENT CHILD, V61, P192
   KRUFT MAB, 1994, J BIOMED MATER RES, V28, P1259, DOI 10.1002/jbm.820281103
   Kupietzky Ari, 1994, Pediatric Dentistry, V16, P340
   Kuroe K, 1994, J Clin Orthod, V28, P347
   KURTZ KS, 1994, J DENT RES, V73, P1130, DOI 10.1177/00220345940730060101
   Kutay O, 1994, Eur J Prosthodont Restor Dent, V2, P123
   KUTAY O, 1994, J PROSTHET DENT, V71, P525, DOI 10.1016/0022-3913(94)90194-5
   Ladizesky N H, 1994, Int J Prosthodont, V7, P307
   LAFONT J, 1994, CELL MATER, V4, P219
   Lagerlof F, 1994, Adv Dent Res, V8, P229
   LAIBLE JP, 1994, J BIOMECH ENG-T ASME, V116, P19, DOI 10.1115/1.2895699
   LAND MF, 1994, J PROSTHET DENT, V72, P4, DOI 10.1016/0022-3913(94)90207-0
   Laney W R, 1994, Int J Oral Maxillofac Implants, V9, P49
   LANOUE KF, 1994, FASEB J, V8, P132
   LARSON TD, 1994, NW DENT          JUL, P21
   LARSSON KS, 1994, J DENT, V22, pS12
   LATTA MA, 1994, J PROSTHET DENT, V72, P189, DOI 10.1016/0022-3913(94)90079-5
   Laufer B Z, 1994, Int J Prosthodont, V7, P247
   LAVERGNE JL, 1994, J MICROSC-OXFORD, V174, P195, DOI 10.1111/j.1365-2818.1994.tb03467.x
   Lavigne S E, 1994, Int J Oral Maxillofac Implants, V9, P156
   LAWLER A, 1994, SCIENCE, V266, P1315, DOI 10.1126/science.7973716
   LAWN BR, 1994, SCIENCE, V263, P1114, DOI 10.1126/science.263.5150.1114
   Leake J L, 1994, J Can Dent Assoc, V60, P1066
   LEE SY, 1994, J DENT, V22, P352, DOI 10.1016/0300-5712(94)90088-4
   LEE SY, 1994, J DENT, V22, P175, DOI 10.1016/0300-5712(94)90202-X
   LEFEBVRE CA, 1994, J PROSTHET DENT, V72, P644, DOI 10.1016/0022-3913(94)90298-4
   LEFEBVRE CA, 1994, J PROSTHET DENT, V71, P178, DOI 10.1016/0022-3913(94)90028-0
   Legnani P, 1994, Quintessence Int, V25, P435
   Leinfelder K F, 1994, J Esthet Dent, V6, P177, DOI 10.1111/j.1708-8240.1994.tb00855.x
   Leinfelder K F, 1994, Compendium, V15, P1398
   LEINFELDER KF, 1994, J AM DENT ASSOC, V125, P292, DOI 10.14219/jada.archive.1994.0029
   LEINFELDER KF, 1994, J AM DENT ASSOC, V125, P586, DOI 10.14219/jada.archive.1994.0066
   LEINFELDER KF, 1994, J AM DENT ASSOC, V125, P65, DOI 10.14219/jada.archive.1994.0016
   LEINFELDER KF, 1994, ORAL HLTH, V84, P31
   Leong D, 1994, Int J Prosthodont, V7, P440
   LESOT H, 1994, CELL MATER, V4, P199
   LEUNG SF, 1994, INT ENDOD J, V27, P39, DOI 10.1111/j.1365-2591.1994.tb00227.x
   LEVARTOVSKY S, 1994, J PROSTHET DENT, V72, P481, DOI 10.1016/0022-3913(94)90118-X
   LEVI E, 1994, J MED STATE DENT ASS, V37, P11
   Levine R A, 1994, Compendium, V15, P528
   LEVITCH LC, 1994, J DENT, V22, P195, DOI 10.1016/0300-5712(94)90107-4
   LEW D, 1994, J ORAL MAXIL SURG, V52, P952, DOI 10.1016/S0278-2391(10)80078-3
   LEWINSTEIN I, 1994, J ENDODONT, V20, P61, DOI 10.1016/S0099-2399(06)81181-7
   Lewis D W, 1994, J Can Dent Assoc, V60, P1050
   LI JG, 1994, ACTA ODONTOL SCAND, V52, P209, DOI 10.3109/00016359409029048
   LIBERMAN R, 1994, J ORAL REHABIL, V21, P87, DOI 10.1111/j.1365-2842.1994.tb01127.x
   Liebenberg W H, 1994, J Can Dent Assoc, V60, P289
   Liebenberg W H, 1994, J Can Dent Assoc, V60, P701
   LIN CP, 1994, J DENT RES, V73, P1072, DOI 10.1177/00220345940730050901
   LIN CP, 1994, J BIOMECH, V27, P1037, DOI 10.1016/0021-9290(94)90220-8
   LINDBERG NE, 1994, ACTA ODONTOL SCAND, V52, P219, DOI 10.3109/00016359409029050
   Linden J J, 1994, Am J Dent, V7, P31
   Linehan A D, 1994, J Prosthodont, V3, P88, DOI 10.1111/j.1532-849X.1994.tb00134.x
   LIPHARDT M, 1994, SCIENCE, V263, P367, DOI 10.1126/science.263.5145.367
   LLOYD CH, 1994, DENT MATER, V10, P128, DOI 10.1016/0109-5641(94)90053-1
   Loney R W, 1994, Int J Prosthodont, V7, P362
   LONG DKM, 1994, NW DENT RES, V4, P13
   LoPresti J T, 1994, N Y State Dent J, V60, P39
   LOS SA, 1994, OPER DENT, V19, P169
   Low D, 1994, Dent Mater J, V13, P103
   Loyola-Rodriguez Juan P., 1994, Pediatric Dentistry, V16, P346
   LOZADA JL, 1994, ORAL IMPLANTOLOGY, V20, P315
   Lui J L, 1994, Quintessence Int, V25, P313
   LUI JL, 1994, OPER DENT, V19, P165
   LUMLEY PJ, 1994, J DENT, V22, P376, DOI 10.1016/0300-5712(94)90093-0
   Lund P S, 1994, J Prosthodont, V3, P2, DOI 10.1111/j.1532-849X.1994.tb00116.x
   LUNDIN S, 1990, SWED DENT J S, V73
   LUOMANEN M, 1994, SCAND J DENT RES, V102, P223
   Lygidakis N A, 1994, J Clin Pediatr Dent, V19, P23
   LYGRE H, 1994, ACTA ODONTOL SCAND, V52, P150, DOI 10.3109/00016359409027589
   LYMAN CE, 1994, J MICROSC-OXFORD, V176, P85, DOI 10.1111/j.1365-2818.1994.tb03503.x
   LYNCH A, 1994, J DENT RES, V73, P1778, DOI 10.1177/00220345940730111601
   MACDONALD A, 1994, J ENDODONT, V20, P598, DOI 10.1016/S0099-2399(06)80085-3
   MACKERT JR, 1994, J DENT RES, V73, P1221, DOI 10.1177/00220345940730061401
   Mackie I C, 1994, Dent Update, V21, P192
   MacPherson Jeff R., 1994, General Dentistry, V42, P310
   Maeda Y, 1994, Int J Prosthodont, V7, P17
   MAHARAJ G, 1994, BIO-MED MATER ENG, V4, P193
   MAHLER DB, 1994, J DENT RES, V73, P1663, DOI 10.1177/00220345940730101201
   MAHLER DB, 1994, J AM DENT ASSOC, V125, P282, DOI 10.14219/jada.archive.1994.0038
   MAHMOOD S, 1994, AUST DENT J, V39, P15, DOI 10.1111/j.1834-7819.1994.tb05539.x
   MAIR LH, 1994, BR J ORAL MAXILLO SU, V32, P91
   Mangum Frank I. Jr., 1994, General Dentistry, V42, P304
   Margolis Maureen Quirk, 1994, Pediatric Dentistry, V16, P200
   MARIANI T, 1994, J MICROSC-OXFORD, V176, P121, DOI 10.1111/j.1365-2818.1994.tb03506.x
   MARINI E, 1994, CELL MATER, V4, P231
   Marks R G, 1994, Int Dent J, V44, P275
   Marlin G M, 1994, Compendium, V15, P628
   MARSHALL E, 1994, SCIENCE, V265, P20, DOI 10.1126/science.8016650
   MARSHALL E, 1994, SCIENCE, V265, P314, DOI 10.1126/science.8023150
   MARSHALL E, 1994, SCIENCE, V265, P1651, DOI 10.1126/science.265.5179.1651
   MARSHALL E, 1994, SCIENCE, V265, P467, DOI 10.1126/science.8036487
   MARSHALL E, 1994, SCIENCE, V263, P747
   Mason P N, 1994, Quintessence Int, V25, P499
   MATSUI Y, 1994, INT J ORAL MAXILLOF, V9, P397
   MATSUKAWA S, 1994, DENT MATER, V10, P343, DOI 10.1016/0109-5641(94)90057-4
   Matsumura H, 1994, Quintessence Int, V25, P425
   MATSUYA Y, 1994, BIOMATERIALS, V15, P307, DOI 10.1016/0142-9612(94)90056-6
   MATTHEW IR, 1994, ORAL SURG ORAL MED O, V77, P456, DOI 10.1016/0030-4220(94)90223-2
   Mattie P A, 1994, J Prosthodont, V3, P213, DOI 10.1111/j.1532-849X.1994.tb00158.x
   MATTSSON U, 1994, ACTA ODONTOL SCAND, V52, P86, DOI 10.3109/00016359409029060
   MAYWALD M, 1994, SCANNING MICROSCOPY, V8, P181
   MCCABE JF, 1994, BRIT DENT J, V176, P333, DOI 10.1038/sj.bdj.4808447
   MCCOMB D, 1994, J PROSTHET DENT, V72, P517, DOI 10.1016/0022-3913(94)90125-2
   McConnell R J, 1994, J Can Dent Assoc, V60, P49
   MCCONNELL RJ, 1994, J IR DENT ASS, V40, P2
   MCCORD JF, 1994, AUST DENT J, V39, P365, DOI 10.1111/j.1834-7819.1994.tb03107.x
   McGuckin R S, 1994, Quintessence Int, V25, P791
   McIntyre F M, 1994, Int J Prosthodont, V7, P461
   MCKINLEY IB, 1994, J ENDODONT, V20, P558, DOI 10.1016/S0099-2399(06)80073-7
   McLean J W, 1994, Quintessence Int, V25, P587
   McLean J W, 1994, J Esthet Dent, V6, P195, DOI 10.1111/j.1708-8240.1994.tb00860.x
   MEADE C, 1994, SCIENCE, V264, P1558, DOI 10.1126/science.264.5165.1558
   MEECHAN JG, 1994, BRIT J ORAL MAX SURG, V32, P91, DOI 10.1016/0266-4356(94)90135-X
   MELSEN B, 1994, EUR J ORTHODONT, V16, P531, DOI 10.1093/ejo/16.6.531
   MENDOZA DB, 1994, J PROSTHET DENT, V72, P591, DOI 10.1016/0022-3913(94)90290-9
   MERICSKESTERN R, 1994, CLIN ORAL IMPLAN RES, V5, P9, DOI 10.1034/j.1600-0501.1994.050102.x
   MERRILL EW, 1993, J BIOMAT SCI-POLYM E, V5, P1
   MERVIS J, 1994, SCIENCE, V265, P731, DOI 10.1126/science.265.5173.731-a
   MERVIS J, 1994, SCIENCE, V263, P165, DOI 10.1126/science.263.5144.165
   Mesaros A J Jr, 1994, Am J Dent, V7, P137
   MESKIN LH, 1994, J AM DENT ASSOC, V125, P234, DOI 10.14219/jada.archive.1994.0044
   METZ JE, 1994, J PROSTHET DENT, V71, P13, DOI 10.1016/0022-3913(94)90248-8
   METZ JE, 1994, ORAL HLTH, V84, P27
   MEYER JM, 1994, J DENT, V22, P131, DOI 10.1016/0300-5712(94)90195-3
   MILES DA, 1994, J ENDODONT, V20, P538, DOI 10.1016/S0099-2399(06)80068-3
   Miles P G, 1994, J Clin Orthod, V28, P74
   MILLER RG, 1994, J DENT RES, V73, P1457, DOI 10.1177/00220345940730081001
   Miller S, 1994, Int Dent J, V44, P83
   MILLETT DT, 1994, EUR J ORTHODONT, V16, P203, DOI 10.1093/ejo/16.3.203
   MILLSTEIN PL, 1994, J PROSTHET DENT, V71, P400, DOI 10.1016/0022-3913(94)90103-1
   MISCH C, 1994, J MICHIGAN DENT ASS, V76, P40
   Misch C E, 1994, Compendium, V15, P1344
   Misch C E, 1994, J Oral Implantol, V20, P100
   MISCH CM, 1994, ORAL HLTH, V84, P29
   MITCHELL CA, 1994, DENT MATER, V10, P88, DOI 10.1016/0109-5641(94)90046-9
   Mitchell L, 1994, Br J Orthod, V21, P79
   Mitchem J C, 1994, Am J Dent, V7, P232
   MITRA SB, 1994, DENT MATER, V10, P78, DOI 10.1016/0109-5641(94)90044-2
   Miyazaki K, 1994, Dent Mater J, V13, P9
   MJOR IA, 1994, J DENT, V22, pS3, DOI 10.1016/0300-5712(94)90031-0
   Mohite U H, 1994, Int J Prosthodont, V7, P479
   MOLIN M, 1990, SWED DENT J S, V71
   MOLINARI JA, 1994, KY DENT J, V45, P13
   MOMOI Y, 1994, BRIT DENT J, V176, P91, DOI 10.1038/sj.bdj.4808379
   MONGKOLNAM P, 1994, DENT MATER, V10, P196, DOI 10.1016/0109-5641(94)90032-9
   MOORHEAD JE, 1994, DENT MATER, V10, P45, DOI 10.1016/0109-5641(94)90021-3
   MORA GP, 1994, J BIOMED MATER RES, V28, P189, DOI 10.1002/jbm.820280208
   MORFIS A, 1994, ORAL SURG ORAL MED O, V77, P172, DOI 10.1016/0030-4220(94)90281-X
   MORI T, 1994, AUST DENT J, V39, P348, DOI 10.1111/j.1834-7819.1994.tb03104.x
   MOSELEY JP, 1994, J PROSTHET DENT, V71, P532, DOI 10.1016/0022-3913(94)90195-3
   MOSHONOV J, 1994, J ENDODONT, V20, P90, DOI 10.1016/S0099-2399(06)81189-1
   MOSS JP, 1994, DENT UPDATE, V21, P386
   MOSSINGHOFF GJ, 1994, FASEB J, V8, P1214
   Mount G J, 1994, Am J Dent, V7, P286
   MOUNT GJ, 1994, J OKLAHOMA DENT ASS, V85, P26
   MUELLER HJ, 1994, J ORAL REHABIL, V21, P699
   MULDER FM, 1994, NATURE, V367, P716, DOI 10.1038/367716a0
   Murakami S, 1994, Dent Mater J, V13, P240
   MURALI SR, 1994, CELL MATER, V4, P337
   MURATA H, 1994, J ORAL REHABIL, V21, P145, DOI 10.1111/j.1365-2842.1994.tb01133.x
   MUTLU G, 1994, J PROSTHET DENT, V71, P186, DOI 10.1016/0022-3913(94)90029-9
   MYERS JL, 1994, J PROSTHODONT, V3, P149
   Myers M L, 1994, Int J Prosthodont, V7, P549
   Myers M L, 1994, Int J Prosthodont, V7, P253
   MYERS TD, 1994, J CALIF DENT ASS SEP, P41
   Nagahara K, 1994, Int J Oral Maxillofac Implants, V9, P41
   NAKAYAMA M, 1994, BIO-MED MATER ENG, V4, P105
   NANCI A, 1994, CELL MATER, V4, P1
   Nancollas G H, 1994, Adv Dent Res, V8, P307
   NANCOLLAS GH, 1994, ORAL IMPLANTOLOGY, V20, P221
   Nasman Margareta, 1994, Pediatric Dentistry, V16, P217
   NATHANSON D, 1994, J AM DENT ASSOC, V125, P421, DOI 10.14219/jada.archive.1994.0052
   NAVAZESH M, 1994, J CALIF DENT ASS MAR, P62
   Nel J C, 1994, J Esthet Dent, V6, P282, DOI 10.1111/j.1708-8240.1994.tb00870.x
   NEL JC, 1994, J DENT ASSOC S AFR, V49, P143
   Nelson Linda P., 1994, Pediatric Dentistry, V16, P18
   Newman G V, 1994, J Clin Orthod, V28, P396
   NEWMAN RC, 1994, SCIENCE, V263, P1708, DOI 10.1126/science.263.5154.1708
   NICOUD JF, 1994, SCIENCE, V263, P636, DOI 10.1126/science.263.5147.636
   NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650
   NIEDERAUER GG, 1994, BIOMATERIALS, V15, P342, DOI 10.1016/0142-9612(94)90246-1
   NIKAWA H, 1994, J PROSTHET DENT, V72, P657, DOI 10.1016/0022-3913(94)90300-X
   Nilson H, 1994, Int J Prosthodont, V7, P115
   NISHIHARA K, 1994, BIO-MED MATER ENG, V4, P151
   Nomoto R, 1994, Dent Mater J, V13, P198
   NORDBO H, 1994, J DENT, V22, P342, DOI 10.1016/0300-5712(94)90085-X
   Nordstrom E. G., 1994, Bio-Medical Materials and Engineering, V4, P309
   NORTHEAST SE, 1994, J DENT, V22, P252, DOI 10.1016/0300-5712(94)90126-0
   Nuckles D B, 1994, Quintessence Int, V25, P829
   Nunn J H, 1994, Int Dent J, V44, P165
   O'Brien W J, 1994, Int J Prosthodont, V7, P56
   O'Mullane D M, 1994, Int Dent J, V44, P257
   O'Mullane D M, 1994, Adv Dent Res, V8, P181
   OBERG S, 1994, INT J ORAL MAX SURG, V23, P110, DOI 10.1016/S0901-5027(05)80604-6
   OBRIEN WJ, 1994, J PROSTHET DENT, V72, P414, DOI 10.1016/0022-3913(94)90562-2
   Ochi S, 1994, Implant Dent, V3, P159, DOI 10.1097/00008505-199409000-00003
   OGAARD B, 1994, ADV DENT RES, V8, P1900
   OHMOTO K, 1994, J PROSTHET DENT, V71, P319, DOI 10.1016/0022-3913(94)90475-8
   OKABE T, 1994, J DENT RES, V73, P1711, DOI 10.1177/00220345940730110601
   OKAMOTO Y, 1994, J BIOMED MATER RES, V28, P1403, DOI 10.1002/jbm.820281204
   OKUZAKI H, 1994, J BIOMAT SCI-POLYM E, V5, P485, DOI 10.1163/156856294X00167
   OLIN PS, 1994, J PROSTHET DENT, V71, P625, DOI 10.1016/0022-3913(94)90449-9
   OLSEN FK, 1994, J ENDODONT, V20, P389, DOI 10.1016/S0099-2399(06)80297-9
   OLSSON S, 1994, J DENT RES, V73, P33, DOI 10.1177/00220345940730010501
   OLVERA N, 1994, DENT MATER, V10, P122, DOI 10.1016/0109-5641(94)90052-3
   Ophaug R, 1994, Adv Dent Res, V8, P87
   OSBORNE JW, 1994, AM J DENT, V7, P337
   OSTMAN PO, 1994, SCAND J DENT RES, V102, P172
   Otogoto Jun-Ichi, 1994, Journal of Nihon University School of Dentistry, V36, P209
   OWADALLY ID, 1994, INT ENDOD J, V27, P227, DOI 10.1111/j.1365-2591.1994.tb00260.x
   Ozata F, 1994, Quintessence Int, V25, P181
   OZDEN AN, 1994, J PROSTHET DENT, V72, P85
   PALMQVIST S, 1994, J PROSTHET DENT, V71, P245, DOI 10.1016/0022-3913(94)90462-6
   Palomo F, 1994, Int Dent J, V44, P75
   PAMEIJER CH, 1994, SWED DENT J, V18, P59
   PAMEIJER CH, 1991, SWED DENT J S, V80
   Pang I C, 1994, Northwest Dent Res, V4, P15
   PANG IC, 1994, J PROSTHET DENT, V72, P177, DOI 10.1016/0022-3913(94)90077-9
   Papathanasiou A G, 1994, Pediatr Dent, V16, P282
   PARISSIS N, 1994, AUST DENT J, V39, P184, DOI 10.1111/j.1834-7819.1994.tb03090.x
   PARSELL DE, 1994, DENT MATER, V10, P167, DOI 10.1016/0109-5641(94)90027-2
   Pascoe L., 1994, Pediatric Dentistry, V16, P193
   Paulillo L A, 1994, Am J Dent, V7, P153
   PAULILLO LAM, 1994, AM J DENT, V7, P345
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PERA P, 1994, J PROSTHET DENT, V72, P585, DOI 10.1016/0022-3913(94)90289-5
   Perdigao J, 1994, Am J Dent, V7, P149
   Perdigao J, 1994, Quintessence Int, V25, P327
   Perdigao J, 1994, Int Dent J, V44, P349
   PERDIGAO J, 1994, J DENT RES, V73, P44, DOI 10.1177/00220345940730010601
   Perdigao J, 1994, Am J Dent, V7, P81
   Perrin C, 1994, Quintessence Int, V25, P603
   PETERSSON LG, 1994, SWED DENT J, V18, P69
   PEUTZFELDT A, 1994, SCAND J DENT RES, V102, P73
   PEUTZFELDT A, 1994, J DENT RES, V73, P511, DOI 10.1177/00220345940730020501
   PEUTZFELDT A, 1994, ACTA ODONTOL SCAND, V52, P51, DOI 10.3109/00016359409096376
   PEUTZFELDT A, 1994, J DENT RES, V73, P1657, DOI 10.1177/00220345940730101101
   Philip D S, 1994, J Can Dent Assoc, V60, P682
   Phillips KM, 1994, INT J ORAL MAXILLOF, V9, P533
   Piattelli A, 1994, Int J Oral Maxillofac Implants, V9, P163
   PICHE PW, 1994, J BIOMED MATER RES, V28, P603, DOI 10.1002/jbm.820280510
   PIERPONT WF, 1994, OPER DENT, V19, P211
   PIGNO MA, 1994, J PROSTHET DENT, V71, P295, DOI 10.1016/0022-3913(94)90470-7
   PILO R, 1994, DENT MATER, V10, P338, DOI 10.1016/0109-5641(94)90056-6
   PIMIENTA C, 1994, CELL MATER, V4, P379
   PINHOLT EM, 1994, CLIN ORAL IMPLAN RES, V5, P213, DOI 10.1034/j.1600-0501.1994.050404.x
   PISKIN E, 1994, J BIOMAT SCI-POLYM E, V5, P451, DOI 10.1163/156856294X00149
   Pissiotis A, 1994, Eur J Prosthodont Restor Dent, V3, P55
   PISSIOTIS E, 1994, J ENDODONT, V20, P118, DOI 10.1016/S0099-2399(06)80055-5
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Polyzois G. L., 1994, Clinical Materials, V16, P21, DOI 10.1016/0267-6605(94)90088-4
   Polyzois G L, 1994, Spec Care Dentist, V14, P26, DOI 10.1111/j.1754-4505.1994.tb01092.x
   POLYZOIS GL, 1994, J PROSTHET DENT, V71, P500, DOI 10.1016/0022-3913(94)90190-2
   POLYZOIS GL, 1994, J PROSTHET DENT, V71, P505, DOI 10.1016/0022-3913(94)90191-0
   Poolthong S, 1994, Dent Mater J, V13, P220
   POWELL LV, 1994, OPER DENT, V19, P70
   POWERS MP, 1994, J ORAL MAXIL SURG, V52, P904, DOI 10.1016/S0278-2391(10)80064-3
   PRADO C, 1994, AM J DENT, V7, P304
   PRATI C, 1994, J ENDODONT, V20, P174, DOI 10.1016/S0099-2399(06)80330-4
   PRATI C, 1994, J DENT, V22, P49, DOI 10.1016/0300-5712(94)90147-3
   PRATI C, 1994, J DENT, V22, P83, DOI 10.1016/0300-5712(94)90005-1
   PRESTON JD, 1994, INT J PROSTHODONT, V7, P399
   Price C A, 1994, Aust Prosthodont J, V8, P47
   PROMBONAS A, 1994, J PROSTHET DENT, V72, P95, DOI 10.1016/0022-3913(94)90218-6
   Proskin Howard M., 1994, Journal of Clinical Dentistry, V5, P19
   PSARRAS V, 1994, SWED DENT J, V18, P15
   QUEGUINER I, 1994, ORAL SURG ORAL MED O, V77, P90, DOI 10.1016/S0030-4220(06)80114-3
   Quirynen M, 1994, Int J Oral Maxillofac Implants, V9, P71
   Rankin K. Vendrell, 1994, Pediatric Dentistry, V16, P117
   RATLEDGE DK, 1994, J PROSTHET DENT, V72, P194, DOI 10.1016/0022-3913(94)90080-9
   RAVISHANKARA AR, 1994, SCIENCE, V263, P71, DOI 10.1126/science.263.5143.71
   RAVNHOLT G, 1994, J DENT, V22, P169, DOI 10.1016/0300-5712(94)90201-1
   RAZZOOG ME, 1994, J PROSTHET DENT, V72, P453, DOI 10.1016/0022-3913(94)90113-9
   RECLARU L, 1994, J DENT, V22, P159, DOI 10.1016/0300-5712(94)90200-3
   REEH ES, 1994, DENT MATER, V10, P247, DOI 10.1016/0109-5641(94)90069-8
   REID JS, 1994, J DENT CHILD, V61, P255
   REINHARDT JW, 1994, OPER DENT, V19, P217
   Retief D H, 1994, Int Dent J, V44, P19
   RETIEF DH, 1994, AM J DENT, V7, P43
   Rix A M, 1994, Am J Dent, V7, P131
   Rizoiu I M, 1994, Compendium, V15, P110
   ROBINSON PB, 1994, J PROSTHET DENT, V71, P390, DOI 10.1016/0022-3913(94)90101-5
   Rolla G, 1994, Int Dent J, V44, P99
   Rolla G, 1994, Adv Dent Res, V8, P272
   Rosen S, 1994, J Dent Educ, V58, P836
   Rossmann J A, 1994, Tex Dent J, V111, P17
   ROZAJZL WF, 1994, AM J DENT, V7, P319
   Rozier R G, 1994, Adv Dent Res, V8, P39
   RUBIE DC, 1994, SCIENCE, V264, P1445, DOI 10.1126/science.264.5164.1445
   Rueggeberg F A, 1994, Int J Prosthodont, V7, P159
   RUEGGEBERG FA, 1994, OPER DENT, V19, P26
   RUEGGEBERG FA, 1994, J PROSTHET DENT, V72, P406, DOI 10.1016/0022-3913(94)90561-4
   RUEGGEBERG FA, 1994, DENT MATER, V10, P282, DOI 10.1016/0109-5641(94)90076-0
   Russell D A, 1994, Int J Prosthodont, V7, P7
   Russell R R, 1994, Adv Dent Res, V8, P285
   RYDEN H, 1994, SWED DENT J, V18, P35
   SADAMORI S, 1994, J PROSTHET DENT, V72, P19, DOI 10.1016/0022-3913(94)90210-0
   SADOUN M, 1994, DENT MATER, V10, P185, DOI 10.1016/0109-5641(94)90030-2
   Sain D R, 1994, J Clin Orthod, V28, P522
   SAKAKI T, 1994, J PROSTHET DENT, V71, P552, DOI 10.1016/0022-3913(94)90436-7
   Salama F S, 1994, J Clin Pediatr Dent, V19, P35
   Salama Fouad S., 1994, Pediatric Dentistry, V16, P424
   SALONGA JP, 1994, J PROSTHET DENT, V72, P582, DOI 10.1016/0022-3913(94)90288-7
   SANO H, 1994, J DENT RES, V73, P1205, DOI 10.1177/00220345940730061201
   SANO H, 1994, DENT MATER, V10, P236, DOI 10.1016/0109-5641(94)90067-1
   SANO H, 1994, OPER DENT, V19, P59
   SANTOS AC, 1994, OPER DENT, V19, P2
   SARRETT DC, 1994, DENT MATER, V10, P6, DOI 10.1016/0109-5641(94)90015-9
   Satoh Y, 1994, J Nihon Univ Sch Dent, V36, P40
   SAUNDERS WP, 1994, J ENDODONT, V20, P155, DOI 10.1016/S0099-2399(06)80325-0
   SAUTIER JM, 1994, CELL MATER, V4, P357
   Scannapieco F A, 1994, J Dent Educ, V58, P843
   Scheie A A, 1994, Adv Dent Res, V8, P246
   SCHERRER SS, 1994, DENT MATER, V10, P172, DOI 10.1016/0109-5641(94)90028-0
   SCHLIEPHAKE H, 1994, INT J ORAL MAX SURG, V23, P300, DOI 10.1016/S0901-5027(05)80115-8
   SCHMALZ G, 1994, J ENDODONT, V20, P592, DOI 10.1016/S0099-2399(06)80083-X
   SCHMALZ G, 1994, J DENT, V22, pS6, DOI 10.1016/0300-5712(94)90032-9
   SCHMALZ G, 1994, DENT MATER, V10, P304, DOI 10.1016/0109-5641(94)90038-8
   Schulein T M, 1994, J Dent Educ, V58, P411
   Schultz J S, 1994, Adv Dent Res, V8, P100
   Schwabacher W B, 1994, J Prosthodont, V3, P188, DOI 10.1111/j.1532-849X.1994.tb00153.x
   Schwartz R S, 1994, Int J Prosthodont, V7, P418
   SCULLY MO, 1994, SCIENCE, V263, P337, DOI 10.1126/science.263.5145.337
   SCURRIA MS, 1994, J PROSTHET DENT, V71, P174, DOI 10.1016/0022-3913(94)90027-2
   SEACHRIST L, 1994, SCIENCE, V264, P499, DOI 10.1126/science.8160006
   SEATON P, 1994, J PROSTHET DENT, V71, P237, DOI 10.1016/0022-3913(94)90461-8
   Sekiya K, 1994, Dent Mater J, V13, P36
   Serra M C, 1994, Am J Dent, V7, P203
   SERVICE RF, 1994, SCIENCE, V264, P1532, DOI 10.1126/science.264.5165.1532
   SERVICE RF, 1994, SCIENCE, V264, P510, DOI 10.1126/science.264.5158.510
   Sethi A, 1994, Dent Update, V21, P52
   SHACKLETON JL, 1994, J PROSTHET DENT, V71, P23, DOI 10.1016/0022-3913(94)90250-X
   SHAH RM, 1994, J DENT RES, V73, P1783, DOI 10.1177/00220345940730111701
   Shapira J, 1994, Spec Care Dentist, V14, P158, DOI 10.1111/j.1754-4505.1994.tb01124.x
   Shazad N, 1994, Eur J Prosthodont Restor Dent, V3, P33
   Shearer A C, 1994, Int J Prosthodont, V7, P167
   Shellis R P, 1994, Int Dent J, V44, P263
   SHEN CY, 1994, DENT MATER, V10, P190, DOI 10.1016/0109-5641(94)90031-0
   Shinkai K, 1994, Quintessence Int, V25, P767
   SHINKAI K, 1994, J AM DENT ASSOC, V125, P1467, DOI 10.14219/jada.archive.1994.0214
   SHIROTA T, 1994, ORAL IMPLANTOLOGY, V20, P307
   Sidhu S K, 1994, Am J Dent, V7, P115
   Sidhu S K, 1994, Quintessence Int, V25, P797
   Siervo S, 1994, Quintessence Int, V25, P773
   Siervo S, 1994, Int J Prosthodont, V7, P434
   SIM C, 1994, DENT MATER, V10, P278, DOI 10.1016/0109-5641(94)90075-2
   Sim T P, 1994, Quintessence Int, V25, P505
   Simonsen R J, 1994, J Dent Educ, V58, P855
   SMALES RJ, 1994, AUST DENT J, V39, P344, DOI 10.1111/j.1834-7819.1994.tb03103.x
   SMITH DC, 1994, J DENT, V22, P121, DOI 10.1016/0300-5712(94)90017-5
   Smith I, 1994, Int Dent J, V44, P71
   SMITH MA, 1994, J ENDODONT, V20, P18, DOI 10.1016/S0099-2399(06)80021-X
   Smith T B, 1994, J Prosthodont, V3, P138, DOI 10.1111/j.1532-849X.1994.tb00144.x
   SOH G, 1994, J ORAL REHABIL, V21, P411, DOI 10.1111/j.1365-2842.1994.tb01155.x
   SOHOEL H, 1994, SCAND J DENT RES, V102, P126
   Sonis A L, 1994, J Clin Orthod, V28, P93
   Sonis A L, 1994, J Clin Orthod, V28, P293
   SOUSA JP, 1994, BIOMATERIALS, V15, P821, DOI 10.1016/0142-9612(94)90037-X
   Souto M, 1994, Am J Dent, V7, P122
   Souza M H, 1994, Am J Dent, V7, P67
   Spieler E L, 1994, Compendium, V15, P310
   STACKHOUSE JA, 1994, J PROSTHET DENT, V71, P209, DOI 10.1016/0022-3913(94)90035-3
   STAMWESTERVELD EB, 1994, CONTACT DERMATITIS, V31, P1, DOI 10.1111/j.1600-0536.1994.tb01894.x
   STASSEN LFA, 1994, BRIT J ORAL MAX SURG, V32, P83, DOI 10.1016/0266-4356(94)90133-3
   STEA S, 1994, J BIOMED MATER RES, V28, P319, DOI 10.1002/jbm.820280306
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Steflik D E, 1994, J Oral Implantol, V20, P8
   STEFLIK DE, 1994, ORAL IMPLANTOLOGY, V20, P201
   STEFLIK DE, 1994, ORAL IMPLANTOLOGY, V20, P198
   STEIN JM, 1994, ANGLE ORTHOD, V64, P291
   Stephen K W, 1994, Adv Dent Res, V8, P185
   Stephen K W, 1994, Int Dent J, V44, P287
   STEVENS BH, 1994, J ENDODONT, V20, P246, DOI 10.1016/S0099-2399(06)80287-6
   STONE R, 1994, SCIENCE, V264, P204, DOI 10.1126/science.8146648
   STORIE DJ, 1994, ANGLE ORTHOD, V64, P199
   STRUTZ JM, 1994, J PROSTHET DENT, V72, P128, DOI 10.1016/0022-3913(94)90068-X
   SULIMAN AH, 1994, J PROSTHET DENT, V71, P7, DOI 10.1016/0022-3913(94)90247-X
   Summitt J B, 1994, Quintessence Int, V25, P251
   SUTOW EJ, 1994, J ORAL REHABIL, V21, P553, DOI 10.1111/j.1365-2842.1994.tb01169.x
   SUTTER F, 1994, CLIN ORAL IMPLAN RES, V5, P164, DOI 10.1034/j.1600-0501.1994.050307.x
   Suzuki S, 1994, Quintessence Int, V25, P59
   Swartz M L, 1994, J Clin Orthod, V28, P208
   Swift E J Jr, 1994, Int J Prosthodont, V7, P356
   SWITZER JA, 1994, SCIENCE, V264, P1573, DOI 10.1126/science.264.5165.1573
   Taira Y, 1994, Dent Mater J, V13, P155
   Tajima K, 1994, Dent Mater J, V13, P206
   TAM LE, 1994, J DENT RES, V73, P607, DOI 10.1177/00220345940730030601
   TAM LE, 1994, J DENT RES, V73, P1530, DOI 10.1177/00220345940730090801
   TAMARESELVY K, 1994, DENT MATER, V10, P290, DOI 10.1016/0109-5641(94)90036-1
   Tanaka Hajime, 1994, Journal of Nihon University School of Dentistry, V36, P135
   Tanaka J, 1994, Dent Mater J, V13, P55
   TANG LP, 1994, CELL MATER, V4, P429
   Tani C, 1994, Dent Mater J, V13, P131
   Tani Y, 1994, Dent Mater J, V13, P174
   TAY FR, 1994, J DENT RES, V73, P629, DOI 10.1177/00220345940730030801
   TAY FR, 1994, CELL MATER, V4, P317
   TAYAPONGSAK P, 1994, J ORAL MAXIL SURG, V52, P161, DOI 10.1016/0278-2391(94)90401-4
   Taylor D F, 1994, Am J Dent, V7, P167
   ten Cate J M, 1994, Adv Dent Res, V8, P125
   TENHUISEN KS, 1994, J DENT RES, V73, P598, DOI 10.1177/00220345940730030501
   Terata R, 1994, Dent Mater J, V13, P148
   THOMPSON GA, 1994, J PROSTHET DENT, V72, P651, DOI 10.1016/0022-3913(94)90299-2
   THOMPSON JY, 1994, J DENT RES, V73, P505, DOI 10.1177/00220345940730020401
   Thoms L M, 1994, Int J Prosthodont, V7, P403
   THORDRUP M, 1994, SCAND J DENT RES, V102, P186
   THORDRUP M, 1994, J DENT, V22, P147, DOI 10.1016/0300-5712(94)90198-8
   Thrash W J, 1994, Int Dent J, V44, P107
   THURMOND JW, 1994, J PROSTHET DENT, V72, P355, DOI 10.1016/0022-3913(94)90553-3
   Thylstrup A, 1994, Adv Dent Res, V8, P144
   Thyne Gerard M., 1994, New Zealand Dental Journal, V90, P56
   Tipton D F, 1994, J Clin Orthod, V28, P718
   TITLEY K, 1995, AM J DENT, V8, P224
   Titley K, 1994, Am J Dent, V7, P190
   TITLEY K, 1994, ORAL HLTH, V84, P3
   Toledano M, 1994, AM J DENT, V7, P328
   TONNER RIM, 1994, EUR J ORTHODONT, V16, P409, DOI 10.1093/ejo/16.5.409
   TONNER RIM, 1994, EUR J ORTHODONT, V16, P421, DOI 10.1093/ejo/16.5.421
   TORABINEJAD M, 1994, J ENDODONT, V20, P159, DOI 10.1016/S0099-2399(06)80326-2
   TORONTALI M, 1994, CELL MATER, V4, P125
   Touyz L Z, 1994, J Can Dent Assoc, V60, P454
   Triana R, 1994, Am J Dent, V7, P252
   Triana R T, 1994, J Clin Pediatr Dent, V18, P109
   TRUHLAR MR, 1994, J PROSTHET DENT, V71, P517, DOI 10.1016/0022-3913(94)90193-7
   TSCHAKALOFF A, 1994, INT J ORAL MAX SURG, V23, P443, DOI 10.1016/S0901-5027(05)80043-8
   TSU R, 1994, NATURE, V369, P442, DOI 10.1038/369442a0
   TSUCHIYA H, 1994, J PROSTHET DENT, V71, P618, DOI 10.1016/0022-3913(94)90448-0
   Tsujimoto Y, 1994, J Nihon Univ Sch Dent, V36, P199
   TSUMIMOTO Y, 1994, J NIHON U SCH DENT, V36, P199
   TUOVINEN V, 1994, J ORAL MAXIL SURG, V52, P931, DOI 10.1016/S0278-2391(10)80072-2
   TURNER CH, 1994, FASEB J, V8, P875
   Tyas M J, 1994, Int Dent J, V44, P303
   Tyas M J, 1994, Am J Dent, V7, P77
   TYAS MJ, 1994, AUST DENT J, V39, P220, DOI 10.1111/j.1834-7819.1994.tb04780.x
   TYAS MJ, 1994, AUST DENT J, V39, P188, DOI 10.1111/j.1834-7819.1994.tb03091.x
   TYLER MW, 1994, OPER DENT, V19, P116
   TYLKA DF, 1994, J PROSTHET DENT, V72, P121, DOI 10.1016/0022-3913(94)90067-1
   UCTASLI S, 1994, J ORAL REHABIL, V21, P565, DOI 10.1111/j.1365-2842.1994.tb01171.x
   Ulukapi Isin, 1994, Journal of Nihon University School of Dentistry, V36, P266
   UNGERSBOCK A, 1994, BIOMED MATER ENG, V4, P347
   Uno S, 1994, Dent Mater J, V13, P19
   UNSAL E, 1994, CELL MATER, V4, P309
   VALENZUELA VS, 1994, OPER DENT, V19, P91
   VALLITTU PK, 1994, J PROSTHET DENT, V72, P639, DOI 10.1016/0022-3913(94)90297-6
   VALLITTU PK, 1994, J PROSTHET DENT, V71, P613, DOI 10.1016/0022-3913(94)90447-2
   VALLITTU PK, 1994, J PROSTHET DENT, V71, P607, DOI 10.1016/0022-3913(94)90446-4
   VALLITTU PK, 1994, DENT MATER, V10, P116, DOI 10.1016/0109-5641(94)90051-5
   VALLITTU PK, 1994, J PROSTHET DENT, V72, P289, DOI 10.1016/0022-3913(94)90342-5
   van der Merwe W J, 1994, J Dent Assoc S Afr, V49, P11
   van der Vyver P J, 1994, J Dent Assoc S Afr, V49, P355
   van Putten M C Jr, 1994, J Prosthodont, V3, P79
   van Rensburg S D, 1994, J Dent Assoc S Afr, V49, P127
   VANDERSTEEN AFW, 1994, J MICROSC-OXFORD, V175, P21
   Vandewalle K S, 1994, Int J Prosthodont, V7, P315
   VANDIJKEN JWV, 1994, ACTA ODONTOL SCAND, V52, P368, DOI 10.3109/00016359409029034
   VANDIJKEN JWV, 1994, J DENT, V22, P265, DOI 10.1016/0300-5712(94)90055-8
   VANDIJKEN JWV, 1994, DENT MATER, V10, P319, DOI 10.1016/0109-5641(94)90040-X
   VANDKJKEN JWV, 1994, 6 YEAR EVALUATION DI
   VANKEKEN PE, 1994, SCIENCE, V264, P1437, DOI 10.1126/science.264.5164.1437
   VANKIJKEN JWV, 1994, J DENT, V22, P265
   VANMEERBEEK B, 1994, J ORAL REHABIL, V21, P57
   VANMEERBEEK B, 1994, J DENT, V22, P141, DOI 10.1016/0300-5712(94)90197-X
   VANMEERBEEK B, 1994, J DENT RES, V73, P1690, DOI 10.1177/00220345940730110401
   VANNOORT R, 1993, J DENT, V21, P5, DOI 10.1016/0300-5712(93)90046-S
   VANNOORT R, 1994, J DENT, V22, P5, DOI 10.1016/0300-5712(94)90139-2
   Vargas M A, 1994, Am J Dent, V7, P187
   VARGAS MA, 1994, OPER DENT, V19, P224
   VARGAS MA, 1994, AM J DENT, V7, P325
   Varpio M., 1994, Pediatric Dentistry, V16, P107
   VEIEN NK, 1994, CONTACT DERMATITIS, V30, P210, DOI 10.1111/j.1600-0536.1994.tb00645.x
   VEIGA MM, 1994, NATURE, V368, P816, DOI 10.1038/368816a0
   Venezie Ronald D., 1994, Pediatric Dentistry, V16, P433
   VENHOVEN BAM, 1994, BIOMATERIALS, V15, P1152, DOI 10.1016/0142-9612(94)90235-6
   Venkateswarlu P, 1994, Adv Dent Res, V8, P80
   VERDE MARL, 1994, J PROSTHET DENT, V71, P339
   VERZIJDEN CWGJM, 1994, J DENT, V22, P29, DOI 10.1016/0300-5712(94)90140-6
   VERZIJDEN CWGJM, 1994, J DENT RES, V73, P529, DOI 10.1177/00220345940730020801
   VIGUIE G, 1994, J PROSTHET DENT, V72, P245, DOI 10.1016/0022-3913(94)90336-0
   VIJAYARAGHAVAN TV, 1994, FLEXURAL BEHAVIOR VI
   VIVORY JL, 1994, SCIENCE, V264, P112
   von Fraunhofer J A, 1994, Int J Prosthodont, V7, P120
   Wakabayashi Y, 1994, Int J Prosthodont, V7, P302
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   WALSH LJ, 1994, DENT MATER, V10, P162, DOI 10.1016/0109-5641(94)90026-4
   WALSHAW PR, 1994, J DENT RES, V73, P1079, DOI 10.1177/00220345940730051001
   WALTER M, 1994, J DENT, V22, P346, DOI 10.1016/0300-5712(94)90086-8
   WALTON JN, 1994, J PROSTHET DENT, V71, P283, DOI 10.1016/0022-3913(94)90468-5
   Wang R, 1994, Int J Prosthodont, V7, P43
   WANG WN, 1994, ANGLE ORTHOD, V64, P377
   WANG XA, 1994, INT J ORAL MAX SURG, V23, P115
   WARFVINGE G, 1994, J DENT, V22, pS16, DOI 10.1016/0300-5712(94)90034-5
   WARFVINGE G, 1994, SCAND J DENT RES, V102, P34
   WASSELL RW, 1994, J DENT RES, V73, P1546, DOI 10.1177/00220345940730091001
   WATAHA JC, 1994, J ORAL REHABIL, V21, P453, DOI 10.1111/j.1365-2842.1994.tb01159.x
   WATAHA JC, 1994, DENT MATER, V10, P298, DOI 10.1016/0109-5641(94)90037-X
   WATAHA JC, 1994, DENT MATER, V10, P156, DOI 10.1016/0109-5641(94)90025-6
   WATANABE I, 1994, J DENT, V22, P67, DOI 10.1016/0300-5712(94)90001-9
   WATANABE I, 1994, DENT MATER, V10, P369, DOI 10.1016/0109-5641(94)90061-2
   WATANABE I, 1994, BONDING GROUND DENTI, P1212
   Watson R M, 1994, Dent Update, V21, P8
   WATSON TF, 1994, BRIT DENT J, V176, P227, DOI 10.1038/sj.bdj.4808410
   Watts A, 1994, Eur J Prosthodont Restor Dent, V3, P27
   WATTS DC, 1994, J DENT, V22, P154, DOI 10.1016/0300-5712(94)90199-6
   WATTS DC, 1994, J DENT, V22, P112, DOI 10.1016/0300-5712(94)90014-0
   WELLER RN, 1994, INT ENDOD J, V27, P299, DOI 10.1111/j.1365-2591.1994.tb00272.x
   Wendt S L Jr, 1994, Am J Dent, V7, P207
   WENKING A, 1994, INT J PROSTHODONT, V7, P532
   White D J, 1994, Adv Dent Res, V8, P166
   WHITE JM, 1994, J DENT RES, V73, P1560, DOI 10.1177/00220345940730091201
   White K C, 1994, Quintessence Int, V25, P259
   White S N, 1994, J Esthet Dent, V6, P267, DOI 10.1111/j.1708-8240.1994.tb00868.x
   WHITE SN, 1994, J PROSTHET DENT, V71, P333, DOI 10.1016/0022-3913(94)90090-6
   WHITE SN, 1994, J PROSTHET DENT, V71, P257, DOI 10.1016/0022-3913(94)90464-2
   WHITE SN, 1994, DENT MATER, V10, P52, DOI 10.1016/0109-5641(94)90022-1
   WHITE SN, 1994, J CALIF DENT ASS MAR, P55
   WHITE SN, 1994, J CALIF DENT ASS AUG, P39
   Whitford G M, 1994, Adv Dent Res, V8, P5
   WIDSTROM E, 1994, SWED DENT J, V18, P1
   WILLIAMS JA, 1994, BIOMATERIALS, V15, P1008, DOI 10.1016/0142-9612(94)90082-5
   Williams P, 1994, J Can Dent Assoc, V60, P299
   WILLIAMS RM, 1994, FASEB J, V8, P804
   Williams V D, 1994, Am J Dent, V7, P184
   WILLIAMSON DL, 1994, J PROSTHET DENT, V72, P635, DOI 10.1016/0022-3913(94)90296-8
   Wilson J, 1994, Eur J Prosthodont Restor Dent, V2, P137
   WILSON PR, 1994, J PROSTHET DENT, V71, P560, DOI 10.1016/0022-3913(94)90437-5
   WILSON T, 1994, J MICROSC-OXFORD, V175, P1, DOI 10.1111/j.1365-2818.1994.tb04782.x
   Wilson T G Jr, 1994, Tex Dent J, V111, P7
   WINKLER MM, 1994, DENT MATER, V10, P222, DOI 10.1016/0109-5641(94)90065-5
   WISKOTT HWA, 1994, DENT MATER, V10, P215
   WONG WS, 1994, J ENDODONT, V20, P595, DOI 10.1016/S0099-2399(06)80084-1
   WOOLFORD MJ, 1994, J DENT, V22, P360, DOI 10.1016/0300-5712(94)90089-2
   WRANGSJO K, 1994, CONTACT DERMATITIS, V30, P102, DOI 10.1111/j.1600-0536.1994.tb00572.x
   WRANGSJO K, 1994, CONTACT DERMATITIS, V30, P139, DOI 10.1111/j.1600-0536.1994.tb00694.x
   Wright Kelly J., 1994, Pediatric Dentistry, V16, P102
   WRIGHT RS, 1994, ORAL HLTH, V84, P11
   Wu J C, 1994, Int J Prosthodont, V7, P209
   Wu J C, 1994, Aust Prosthodont J, V8, P55
   WU MK, 1994, INT ENDOD J, V27, P304, DOI 10.1111/j.1365-2591.1994.tb00273.x
   WYLIE SG, 1994, J DENT RES, V73, P1684, DOI 10.1177/00220345940730110301
   XU S, 1994, J MICROSC-OXFORD, V173, P199, DOI 10.1111/j.1365-2818.1994.tb03442.x
   XU W, 1994, SCANNING MICROSCOPY, V8, P499
   YAMADA S, 1994, CELL MATER, V4, P347
   Yan J, 1994, J Prosthet Dent, V71, P289, DOI 10.1016/0022-3913(94)90469-3
   YANAGA M, 1994, DENT MATER J, V13, P89
   Yanagawa T, 1994, Am J Dent, V7, P157
   YGUELHENRY S, 1994, J ENDODONT, V20, P367, DOI 10.1016/S0099-2399(06)80292-X
   YOSHIDA K, 1994, J DENT, V22, P296, DOI 10.1016/0300-5712(94)90064-7
   YOSHIDA K, 1994, J DENT, V22, P57, DOI 10.1016/0300-5712(94)90149-X
   YOSHIDA K, 1994, INT J ORAL MAXILLOF, V9, P719
   Yoshinari M, 1994, Int J Prosthodont, V7, P329
   YOU ZH, 1994, J ORAL MAXIL SURG, V52, P1293, DOI 10.1016/0278-2391(94)90052-3
   YOUNG L, 1994, J PROSTHET DENT, V71, P575, DOI 10.1016/0022-3913(94)90440-5
   Youngs G, 1994, Spec Care Dentist, V14, P68, DOI 10.1111/j.1754-4505.1994.tb01104.x
   YUNUS N, 1994, J ORAL REHABIL, V21, P641
   ZIOUPOS P, 1994, J BIOMECH, V27, P993, DOI 10.1016/0021-9290(94)90272-0
   Zografakis M A, 1994, Eur J Prosthodont Restor Dent, V2, P101
NR 1109
TC 5
Z9 5
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JAN
PY 1995
VL 11
IS 1
BP 52
EP 77
DI 10.1016/0109-5641(95)80009-3
PG 26
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA RV700
UT WOS:A1995RV70000009
PM 7498609
DA 2018-10-19
ER

PT J
AU ANDERSON, JM
   ZIATS, NP
   AZEEZ, A
   BRUNSTEDT, MR
   STACK, S
   BONFIELD, TL
AF ANDERSON, JM
   ZIATS, NP
   AZEEZ, A
   BRUNSTEDT, MR
   STACK, S
   BONFIELD, TL
TI PROTEIN ADSORPTION AND MACROPHAGE ACTIVATION ON POLYDIMETHYLSILOXANE AND
   SILICONE-RUBBER
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE BIOCOMPATIBILITY; POLYDIMETHYLSILOXANE; SILICONE RUBBER; PROTEIN
   ADSORPTION; MONOCYTE MACROPHAGE ACTIVATION
ID CONNECTIVE-TISSUE DISEASE; HUMAN PLASMA-PROTEINS; BIO-MEDICAL POLYMERS;
   BIOMEDICAL POLYMERS; INTERLEUKIN-1 GENERATION; MONOCYTES MACROPHAGES;
   BREAST IMPLANTS; VASCULAR GRAFTS; FACTOR-XII; STIMULATION
AB Static and dynamic human blood adsorption studies on polydimethylsiloxane, PDMS, and silicone rubber show that these materials are similar, but not identical, in their protein adsorption behavior. Fibrinogen, immunoglobulin G, and albumin were the predominant proteins identified on the material surfaces with fibronectin, Hageman factor (factor XII), and factor VIII/vWF adsorbing at intermediate levels. While the protein adsorption characteristics for the two materials were similar, higher levels of the respective proteins were identified on silicone rubber compared to PDMS. Monocytes/macrophages incubated on PDMS, silicone rubber and low density polyethylene, LDPE, with or without protein adsorption produced variable levels of IL-I beta, IL-6 and TNF-alpha dependent on the polymer and adsorbed protein. PDMS showed lower levels of the cytokines when compared to the polystyrene control and polyethylene. Protein preadsorption on the PDMS, polystyrene, and LDPE surfaces showed lower levels of cytokines when compared to the respective quantities produced with no protein adsorption suggesting a passivating effect by the protein adsorption phenomenon on monocyte/macrophage activation. Preadsorption of IgG, fibrinogen or fibronectin decreased the quantitative expression of IL-1 beta but increased the functional activity in the thymocyte proliferation assay indicating the presence of monocyte/macrophage activation products which either downregulated the activity of IL-1 beta or upregulated thymocyte proliferation in an independent fashion.
RP ANDERSON, JM (reprint author), CASE WESTERN RESERVE UNIV,INST PATHOL,2085 ADELBERT RD,CLEVELAND,OH 44106, USA.
FU NHLBI NIH HHS [HL-33849, HL-48771]
CR BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P525
   BRASH JL, 1988, BLOOD, V71, P932
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   DUNN KW, 1992, BRIT J PLAST SURG, V45, P315, DOI 10.1016/0007-1226(92)90060-B
   FENSKE NA, 1993, ARCH DERMATOL, V129, P97, DOI 10.1001/archderm.129.1.97
   HORBETT TA, 1993, CARDIOVASC PATHOL S, V2, P173
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT, P183
   KOSSOVSKY N, 1987, CRIT REV BIOCOMPAT, V3, P53
   KRANE SM, 1985, COLLAGEN REL RES, V5, P99
   LEVIER RR, 1993, PLAST RECONSTR SURG, V92, P163
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NEMECEK JAR, 1993, SOUTH MED J, V86, P932
   NERAD JL, 1992, J LEUK BIOL, V52
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   SCALCH L, 1991, BIOCHEM BIOPH RES CO, V174, P885
   SILVER RM, 1993, ARCH DERMATOL, V129, P63, DOI 10.1001/archderm.129.1.63
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   VROMAN L, 1987, SEMIN THROMB HEMOST, V13, P79, DOI 10.1055/s-2007-1003477
   VROMAN L, 1980, BLOOD, V55, P156
   VROMAN L, 1971, FED PROC, V30, P1494
   WAHL SM, 1988, J IMMUNOL, V140, P3026
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
   ZIATS NP, 1991, CELL MATER, V1, P73
NR 31
TC 77
Z9 77
U1 0
U2 16
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1995
VL 7
IS 2
BP 159
EP 169
DI 10.1163/156856295X00670
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA QZ524
UT WOS:A1995QZ52400007
PM 7654630
DA 2018-10-19
ER

PT J
AU KASUGA, T
   INOUE, T
   TSUJI, K
   OTA, Y
   ABE, Y
AF KASUGA, T
   INOUE, T
   TSUJI, K
   OTA, Y
   ABE, Y
TI PREPARATION OF POROUS CERAMICS WITH CALCIUM METAPHOSPHATE FIBER SKELETON
   FOR BIOMEDICAL USE
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Note
ID PHOSPHATE GLASS-CERAMICS; INTERFACE; BONE
AB High-strength calcium metaphosphate fibers for biomedical applications are extracted from crystallized products of calcium ultraphosphate glasses by aqueous leaching. In the present work, new types of porous ceramics with a skeleton composed of the crystalline fibers are prepared by heating the fibrous products extracted. The fibers in the ceramic are interlinked to each other by glassy phases formed during the heating. This porous material has a large porosity of >60%. The surface of the skeleton can be successfully converted into new calcium phosphate phases such as apatite by heating the porous material treated with a molten salt mixture of CaCl2Ca(NO3)(2).
C1 YABASHI IND CO LTD,OGAKI,GIFU 50322,JAPAN.
RP KASUGA, T (reprint author), NAGOYA INST TECHNOL,DEPT MAT SCI & ENGN,NAGOYA,AICHI 466,JAPAN.
CR ABE Y, 1982, J AM CERAM SOC, V65, pC189
   ABE Y, 1987, PHOSPHORUS SULFUR, V30, P337, DOI 10.1080/03086648708080589
   ABE Y, 1984, J AM CERAM SOC, V67, pC142
   ABE Y, 1983, ORTHOPAED CERAM IMPL, V3, P49
   ABE Y, 1990, HDB BIOACTIVE CERAMI, V1, P109
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   KASUGA T, 1992, NIPPON SERAM KYO GAK, V100, P1088
   KASUGA T, 1993, PHOSPHORUS SULFUR, V76, P247
   KASUGA T, 1992, PHOSPHORUS RES B, V2, P17
   KLEIN CPAT, 1987, BIOMATERIALS, V8, P234, DOI 10.1016/0142-9612(87)90071-8
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P362, DOI 10.1016/0142-9612(84)90036-X
   NAGASE M, 1992, BIOMATERIALS, V13, P172, DOI 10.1016/0142-9612(92)90067-X
   Ota Y., UNPUB
   WHITTINGHAM S, 1975, TISSUE ANTIGENS, V6, P23
NR 15
TC 18
Z9 18
U1 0
U2 0
PU AMER CERAMIC SOC 735 CERAMIC PLACE
PI WESTERVILLE
PA PO BOX 6136, WESTERVILLE, OH 43081-6136
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD JAN
PY 1995
VL 78
IS 1
BP 245
EP 247
PG 3
WC Materials Science, Ceramics
SC Materials Science
GA QD720
UT WOS:A1995QD72000042
DA 2018-10-19
ER

PT J
AU Bruns, M
   Schlesinger, R
   KleweNebenius, H
   Baumann, H
   Becht, R
   Ache, HJ
AF Bruns, M
   Schlesinger, R
   KleweNebenius, H
   Baumann, H
   Becht, R
   Ache, HJ
TI Development of Na+-sensitive membranes based on sputtered Na-Al-Si
   glasses
SO MIKROCHIMICA ACTA
LA English
DT Article
DE Na-sensitive glass membranes; RF magnetron sputtering; surface analysis;
   depth profiles; capacitance
ID ISFETS
AB Na+-sensitive microdevices are of increasing interest for integration in microanalytical systems e.g. for biomedical applications or for industrial process control. In order to produce ultra thin Na+-sensitive layers with fixed and reproducible composition and, in particular, defined Na concentration by means of RF sputtering, an off-axis geometry of a magnetron with cylindrical target was chosen for minimizing back-sputtering effects from the already deposited material. With this inverted cylindrical magnetron (ICM) it was possible to obtain reproducible and controllable sodium aluminosilicate glass layers on semiconductor substrates. Several surface and thin layer analytical techniques were applied for characterization of the membranes and for stoichiometry control. Especially by the non-destructive nuclear reaction analysis method a constant Na profile throughout the glass layer and - together with AES depth profiles the diffusion barrier effect of an Si3N4 interface layer could be verified. Electrochemical measurements proved Nernstian sensitivity down to 10(-4) M Na+ in solutions of pH 7, supporting sufficient stability and reproducibility of the sputtered Na+-sensitive layers.
C1 UNIV FRANKFURT,INST KERNPHYS,D-60486 FRANKFURT,GERMANY.
RP Bruns, M (reprint author), KERNFORSCHUNGSZENTRUM KARLSRUHE GMBH,INST RADIOCHEM,POB 3640,D-76021 KARLSRUHE,GERMANY.
RI Bruns, Michael/K-9073-2013
OI Bruns, Michael/0000-0002-0462-3948
CR ABE H, 1979, IEEE T ELECTRON DEV, V26, P1939, DOI 10.1109/T-ED.1979.19799
   BERGVELD P, 1988, ANAL BIOMEDICAL APPL, P91
   BYCHKOV E, 1994, SOLID STATE IONICS, V74, P165, DOI 10.1016/0167-2738(94)90207-0
   CRENS R, 1992, SOLID STATE IONICS 1, V53, P641
   DAVIES LE, 1978, HDB AUGER ELECTRON S
   EISENMAN G, 1967, GLASS ELECT HYDROGEN, pCH9
   ENDT PM, 1967, NUCL PHYS A, V105, P139
   ENDT PM, 1967, NUCL PHYS A, V105, P53
   Geerk J., 1989, Material Science Reports, V4, P193, DOI 10.1016/S0920-2307(89)80003-9
   HOFFMANN W, 1994, P MU TAS 94 WORKSHOP, P215
   ITO T, 1988, IEEE T ELECTRON DEV, V35, P56, DOI 10.1109/16.2415
   KLEIN M, 1989, SENSOR ACTUATOR, V17, P203, DOI 10.1016/0250-6874(89)80081-2
   LANFORD WA, 1979, J NON-CRYST SOLIDS, V33, P249, DOI 10.1016/0022-3093(79)90053-X
   MACDONALD JR, 1987, IMPEDANCE SPECTROSCO, P243
   MCCAUGHAN DV, 1974, P IEEE, V62, P1237
   PHAM MT, 1993, SENSOR ACTUAT B-CHEM, V13, P746
   SCHADE K, 1981, HALBLEITERTECHNOLOGI, V1, pCH13
   SCHLESINGER R, 1995, UNPUB J ANAL CHE JUL
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   SMETS BMJ, 1983, FRESEN Z ANAL CHEM, V314, P285, DOI 10.1007/BF00516821
   WAGNER CD, 1982, J VAC SCI TECHNOL, V21, P933, DOI 10.1116/1.571870
NR 21
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER-VERLAG WIEN
PI VIENNA
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA
SN 0026-3672
J9 MIKROCHIM ACTA
JI Mikrochim. Acta
PY 1995
VL 121
IS 1-4
BP 73
EP 85
DI 10.1007/BF01248242
PG 13
WC Chemistry, Analytical
SC Chemistry
GA TN601
UT WOS:A1995TN60100006
DA 2018-10-19
ER

PT B
AU Tandon, RP
AF Tandon, RP
GP IEEE
TI Materials in biomedical engineering: Potential and issues
SO PROCEEDING OF THE FIRST REGIONAL CONFERENCE - IEEE ENGINEERING IN
   MEDICINE & BIOLOGY SOCIETY AND 14TH CONFERENCE OF THE BIOMEDICAL
   ENGINEERING SOCIETY OF INDIA
LA English
DT Proceedings Paper
CT 1st Regional Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society/14th Conference of the
   Biomedical-Engineering-Society-of-India
CY FEB 15-18, 1995
CL NEW DELHI, INDIA
SP IEEE, Engn Med & Biol Soc, Biomed Engn Soc India
C1 NATL PHYS LAB,NEW DELHI 110012,INDIA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
BN 0-7803-2711-X
PY 1995
BP 417
EP 418
PG 2
WC Engineering, Biomedical
SC Engineering
GA BG01B
UT WOS:A1995BG01B00204
DA 2018-10-19
ER

PT J
AU REID, G
   BUSSCHER, HJ
   SHARMA, S
   MITTELMAN, MW
   MCINTYRE, S
AF REID, G
   BUSSCHER, HJ
   SHARMA, S
   MITTELMAN, MW
   MCINTYRE, S
TI SURFACE-PROPERTIES OF CATHETERS, STENTS AND BACTERIA ASSOCIATED WITH
   URINARY-TRACT INFECTIONS
SO SURFACE SCIENCE REPORTS
LA English
DT Review
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; TRANSFORM INFRARED-SPECTROSCOPY; HUMAN
   UROEPITHELIAL CELLS; ESCHERICHIA-COLI STRAINS; ACETYL-D-GLUCOSAMINE;
   TOXIC SHOCK SYNDROME; HYDROPHOBIC PROPERTIES; COMPETITIVE-EXCLUSION;
   POULTRY LACTOBACILLI; MICROBIAL ADHESION
AB Applications of surface and physico-chemical techniques to the clinical setting, in particular related to the urogenital tract, have been sporadic, often concentrating on aspects of biocompatibility and interactions of blood cells with materials.  In an era where billions of such devices are implanted annually, it is important to utilize such techniques to improve our understanding of material-host interactions.  In an effort to encourage further such interactive investigations, this review will illustrate some practical biomedical examples where utilization of sophisticated surface-science techniques has provided valuable insight into interfacial events between host components, micro-organisms and material surfaces.  Techniques to reduce bacterial infection and encrustations will be discussed, and suggestions given for future lines of enquiry.
C1 UNIV GRONINGEN,MAT TECH LAB,9700 AB GRONINGEN,NETHERLANDS.
   UNIV WESTERN ONTARIO,DEPT MICROBIOL & IMMUNOL,LONDON,ON N6A 3K7,CANADA.
   UNIV WESTERN ONTARIO,DIV UROL,LONDON,ON N6A 3K7,CANADA.
   UNIV WESTERN ONTARIO,DEPT CHEM,LONDON,ON N6A 3K7,CANADA.
   UNIV TORONTO HOSP,CTR INFECT & BIOMAT RES,TORONTO,ON,CANADA.
CR BATICH C, 1984, T ANN M SOC BIOMATER, P31
   BEAVERS EM, 1985, Patent No. 791021
   BERKLEY SF, 1987, JAMA-J AM MED ASSOC, V258, P917, DOI 10.1001/jama.258.7.917
   BIALKOWSKAHOBRZ.H, 1990, J CLIN MICROBIOL, V28, P269
   BOSKEY AL, 1992, CELL MATER, V2, P209
   Bremer P. J., 1991, Biofouling, V3, P89
   BRINKMAN E, 1991, BIOMATERIALS, V12, P63, DOI 10.1016/0142-9612(91)90134-V
   BRUCE AW, 1974, CAN MED ASSOC J, V111, P238
   BRUCE AW, 1988, CAN J MICROBIOL, V34, P339, DOI 10.1139/m88-062
   BRUCE AW, 1973, CAN MED ASSOC J, V108, P973
   Bruce AW, 1992, INT UROGYNECOL J, V3, P22, DOI DOI 10.1007/BF00372644
   BUSSCHER HJ, 1994, COLLOID SURFACE B, V2, P73, DOI 10.1016/0927-7765(94)80020-0
   BUSSCHER HJ, 1990, SURF INTERFACE ANAL, V15, P344, DOI 10.1002/sia.740150508
   CHAN RCY, 1985, INFECT IMMUN, V47, P84
   CHAN RCY, 1984, J UROLOGY, V131, P596, DOI 10.1016/S0022-5347(17)50512-1
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P59
   COOK RL, 1988, CURR MICROBIOL, V17, P159, DOI 10.1007/BF01573472
   COSTERTON JW, 1992, INT BIODETER BIODEGR, V30, P123
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   COX AJ, 1989, UROL RES, V17, P353, DOI 10.1007/BF00510524
   COX AJ, 1988, BRIT J UROL, V61, P156, DOI 10.1111/j.1464-410X.1988.tb05067.x
   COX AJ, 1987, BIOMATERIALS, V8, P500, DOI 10.1016/0142-9612(87)90089-5
   CUPERUS PL, 1993, J COLLOID INTERF SCI, V156, P319, DOI 10.1006/jcis.1993.1118
   CUPERUS PL, 1994, UNPUB J ANTIMICROB C
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DAVIES MC, 1989, SURF INTERFACE ANAL, V14, P115, DOI 10.1002/sia.740140304
   DUGUID IG, 1992, J ANTIMICROB CHEMOTH, V30, P791, DOI 10.1093/jac/30.6.791
   Duncan-Hewitt W., 1990, MICROBIAL CELL SURFA, P39
   EISEN A, 1989, MICROBIAL ECOL, V17, P17, DOI 10.1007/BF02025590
   Fleer A, 1989, J Invest Surg, V2, P391, DOI 10.3109/08941938909018264
   Fletcher M., 1985, BACTERIAL ADHESION M, P339
   FOERCH R, 1990, J POLYM SCI POL CHEM, V28, P193, DOI 10.1002/pola.1990.080280114
   GEERTSEMADOORNB.GI, 1994, J MICROBIOL METH, V19, P269
   GRIFFITH PR, 1986, FOURIER TRANSFORM IN
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HACKER J, 1985, INFECT IMMUN, V47, P434
   HAGBERG L, 1981, INFECT IMMUN, V31, P564
   HEARN MJ, 1987, SURF INTERFACE ANAL, V10, P384, DOI 10.1002/sia.740100803
   HOBOT JA, 1991, MICROBIAL CELL SURFA, P127
   HULTGREN SJ, 1985, INFECT IMMUN, V50, P370
   IP WF, 1989, BIOMATERIALS, V10, P313, DOI 10.1016/0142-9612(89)90071-9
   JACOBSON SH, 1989, J INFECTION, V19, P17, DOI 10.1016/S0163-4453(89)94746-4
   JAMES AM, 1991, MICROBIAL CELL SURFA, P221
   KALLENIUS G, 1980, FEMS MICROBIOL LETT, V9, P297
   KIST ML, 1990, INFECT IMMUN, V58, P695
   Klotz SA, 1990, MICROBIAL CELL SURFA, P107
   KORHONEN TK, 1984, J BACTERIOL, V159, P762
   Kunin CM, 1987, DETECTION PREVENTION, P245
   LATRACHE H, 1994, COLLOID SURFACE B, V2, P47, DOI 10.1016/0927-7765(94)80017-0
   Marshall K.C., 1985, BACTERIAL ADHESION M, P133
   MCGROARTY J A, 1988, Microbial Ecology in Health and Disease, V1, P215
   MCGROARTY JA, 1988, CAN J MICROBIOL, V34, P974, DOI 10.1139/m88-171
   MCLEAN RJC, 1988, CRC CR REV MICROBIOL, V16, P37, DOI 10.3109/10408418809104467
   MCLEAN RJC, 1985, INFECT IMMUN, V49, P805
   MCMURDO MET, 1992, J EPIDEMIOL COMMUN H, V46, P222, DOI 10.1136/jech.46.3.222
   MILLSAP K, 1994, APPL ENVIRON MICROB, V60, P1867
   MITTELMAN MW, 1990, MICROBIAL ECOL, V19, P269, DOI 10.1007/BF02017171
   NAGAOKA S, 1990, BIOMATERIALS, V11, P419, DOI 10.1016/0142-9612(90)90098-B
   Naumann D., 1992, MODERN TECHNIQUES RA, P43
   NIVENS DE, 1993, J MICROBIOL METH, V17, P199, DOI 10.1016/0167-7012(93)90047-L
   PERE A, 1985, J GEN MICROBIOL, V131, P1705
   RATNER BD, 1980, J BIOMED MATER RES, V14, P665, DOI 10.1002/jbm.820140512
   RATNER BD, 1994, COLLOID SURFACE B, V2, P333, DOI 10.1016/0927-7765(94)80048-0
   RATNER BD, 1988, PROG BIOMED ENG, V5, P87
   REID G, 1994, ANTIMICROB AGENTS CH, V38, P1490, DOI 10.1128/AAC.38.7.1490
   REID G, 1985, INFECT IMMUN, V49, P320
   REID G, 1989, COLLOID SURFACE, V42, P299
   REID G, 1992, CELL MATER, V2, P253
   REID G, 1988, MICROBIAL ECOL, V16, P241, DOI 10.1007/BF02011698
   REID G, 1990, CLIN MICROBIOL REV, V3, P335
   REID G, 1984, NEW ZEAL MED J, V97, P439
   REID G, 1994, PARAPLEGIA, V32, P468, DOI 10.1038/sc.1994.74
   REID G, 1992, APPL ENVIRON MICROB, V58, P1549
   REID G, 1987, J UROLOGY, V138, P330, DOI 10.1016/S0022-5347(17)43137-5
   REID G, 1993, COLLOID SURFACE B, V1, P9, DOI 10.1016/0927-7765(93)80012-N
   REID G, 1987, REV INFECT DIS, V9, P470
   REID G, 1994, J BIOMED MATER RES, V28, P731, DOI 10.1002/jbm.820280610
   REID G, 1993, J MATER SCI-MATER M, V4, P17, DOI 10.1007/BF00122972
   REID G, 1988, CAN J MICROBIOL, V34, P344, DOI 10.1139/m88-063
   REID G, 1988, CURR MICROBIOL, V17, P151, DOI 10.1007/BF01573471
   REID G, 1993, CELL MATER, V3, P171
   REID G, 1994, SURF INTERFACE ANAL, V21, P581, DOI 10.1002/sia.740210812
   REID G, 1994, LANCET, V244, P1229
   REID G, 1995, IN PRESS MICROECOL T
   REID G, 1994, BIOINTERFACES, V2, P377
   RHEN M, 1986, J BACTERIOL, V168, P1234, DOI 10.1128/jb.168.3.1234-1242.1986
   ROBERTS JA, 1990, J UROLOGY, V144, P264, DOI 10.1016/S0022-5347(17)39428-4
   ROSENBERG M, 1986, ADV MICROB ECOL, V9, P353
   SCHAKENRAAD JM, 1989, BIOFOULING, V1, P193
   SCHAMBERGER PC, 1994, COLLOID SURFACE B, V2, P209, DOI 10.1016/0927-7765(94)80036-7
   STEADMAN R, 1989, BIOCHIM BIOPHYS ACTA, V1013, P21, DOI 10.1016/0167-4889(89)90122-5
   STICKLER D, 1991, EUR J CLIN MICROBIOL, V10, P157, DOI 10.1007/BF01964448
   SUCI PA, 1994, ANTIMICROB AGENTS CH, V38, P2125, DOI 10.1128/AAC.38.9.2125
   TIERNO PM, 1989, REV INFECT DIS, V11, pS182, DOI 10.1093/clinids/11.Supplement_1.S182
   TIERNO PM, 1985, CONTRACEPTION, V31, P185, DOI 10.1016/0010-7824(85)90033-2
   TOMECZEK L, 1992, FEMS MICROBIOL LETT, V94, P101
   TRAORE R, 1994, COLLOID SURFACE B, V2, P111, DOI 10.1016/0927-7765(94)80025-1
   UYAMA Y, 1991, BIOMATERIALS, V12, P71, DOI 10.1016/0142-9612(91)90135-W
   VAISANEN V, 1982, LANCET, V1, P1192
   VAISANENRHEN V, 1983, FEBS LETT, V159, P233, DOI 10.1016/0014-5793(83)80453-0
   VANDERMEI HC, 1989, BIOCHIM BIOPHYS ACTA, V991, P395, DOI 10.1016/0304-4165(89)90063-9
   VANDERMEI HC, 1988, COLLOID SURFACE, V32, P297, DOI 10.1016/0166-6622(88)80024-6
   VANDERMEI HC, 1987, J MICROBIOL METH, V6, P277, DOI 10.1016/0167-7012(87)90065-0
   VANDERMEI HC, 1989, APPL ENVIRON MICROB, V55, P2806
   VANDERWALL E, 1992, LANCET, V339, P946
   Wadstrom T., 1990, MICROBIAL CELL SURFA, P315
   WICKEN AJ, 1985, BACTERIAL ADHESION M, P45
NR 107
TC 23
Z9 23
U1 2
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5729
J9 SURF SCI REP
JI Surf. Sci. Rep.
PY 1995
VL 21
IS 7
BP 251
EP 273
DI 10.1016/0167-5729(94)00006-9
PG 23
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA QK685
UT WOS:A1995QK68500001
DA 2018-10-19
ER

PT J
AU AMBROSIO, L
   NICHOLAIS, L
AF AMBROSIO, L
   NICHOLAIS, L
TI PAPERS PRESENTED AT THE INTERNATIONAL-CONFERENCE ON MATERIALS FOR
   BIOMEDICAL APPLICATIONS, CAPRI, NAPLES, ITALY, 6-11-JUNE-1993
SO BIOMATERIALS
LA English
DT Editorial Material
C1 UNIV NAPLES,DEPT MAT & PROD ENGN,I-80125 NAPLES,ITALY.
   UNIV LECCE,DEPT MAT SCI,I-73100 LECCE,ITALY.
   UNIV NAPLES,INTERDISCIPLINARY RES CTR BIOMED MAT,I-80125 NAPLES,ITALY.
RP AMBROSIO, L (reprint author), CNR,INST COMPOSITE MAT TECHNOL,P TECHIO,NAPLES,ITALY.
OI AMBROSIO, LUIGI/0000-0002-8367-2405
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 1994
VL 15
IS 15
BP 1195
EP 1195
DI 10.1016/0142-9612(94)90268-2
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PY723
UT WOS:A1994PY72300001
DA 2018-10-19
ER

PT J
AU GIUSTI, P
   LAZZERI, L
   DEPETRIS, S
   PALLA, M
   CASCONE, MG
AF GIUSTI, P
   LAZZERI, L
   DEPETRIS, S
   PALLA, M
   CASCONE, MG
TI COLLAGEN-BASED NEW BIOARTIFICIAL POLYMERIC MATERIALS
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT International Conference on Materials for Biomedical Applications
CY JUN 06-11, 1993
CL CAPRI, ITALY
SP ASSING SPA, CNR, EASTMAN CHEM EUROPE, ITALPRO SPA, MTS SYST, UNIV NAPLES FEDERICO II
DE BIOMATERIALS; COLLAGEN; POLY(VINYL ALCOHOL); POLY(ACRYLIC ACID); POLYMER
   BLENDS; THERMOMECHANICAL CHARACTERIZATION
AB Bioartificial polymeric materials, based on blends of biological and synthetic polymers, have been proposed as new materials for applications in the biomedical field. They should usefully combine the biocompatibility of the biological component with the physical and mechanical properties of the synthetic component. Blends of collagen with either poly(vinyl alcohol) or poly(acrylic acid) have been prepared by mixing aqueous solutions of the two polymers. Differential scanning calorimetry and dynamic mechanical thermal analysis has been carried out to investigate the miscibility properties of the polymers and the mechanical behaviour of the blends.
C1 CNR,CTR STUDIES ION POLYMERIZAT,I-56126 PISA,ITALY.
RP GIUSTI, P (reprint author), UNIV PISA,DEPT CHEM ENGN,VIA DIOTISALVI 2,I-56126 PISA,ITALY.
CR BARBER JM, 1992, J ENVIRON PERMITTING, V1, P59
   GIUSTI P, IN PRESS MAKROMOL CH
   GIUSTI P, 1991, 4TH EUR S BIOM IND R, P31
   GIUSTI P, 1989, 1ST P MED SCH SCI TE, P715
   GIUSTI P, 1991, 2ND JOINT SOV UN IT, P37
   GIUSTI P, 1989, 1ST P PAC POL C MAU, P137
   GIUSTI P, 1991, FEB INT S POL MAT AU, P491
   JOOS U, 1978, 71ST BES SCI M 3RD C
   PARKANY M, 1984, MACROMOLECULAR BIOMA, P911
   Paul D. R., 1988, ENCY POLYMER SCI ENG, V12, P399
   PUHL W, 1978, 71ST BES SCI M 3RD C
   SARTI B, 1992, THESIS U BOLOGNA ITA
   SHINODA K, 1976, POLYM J, V8, P202, DOI 10.1295/polymj.8.202
NR 13
TC 69
Z9 74
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 1994
VL 15
IS 15
BP 1229
EP 1233
DI 10.1016/0142-9612(94)90274-7
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PY723
UT WOS:A1994PY72300007
PM 7703319
DA 2018-10-19
ER

PT J
AU LAZZERI, L
   BARBANI, N
   CASCONE, MG
   LUPINACCI, D
   GIUSTI, P
   LAUS, M
AF LAZZERI, L
   BARBANI, N
   CASCONE, MG
   LUPINACCI, D
   GIUSTI, P
   LAUS, M
TI PHYSICOCHEMICAL AND MECHANICAL CHARACTERIZATION OF HYDROGELS OF
   POLY(VINYL ALCOHOL) AND HYALURONIC-ACID
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB Hydrogels are three-dimensional polymeric networks very similar to biological tissues and potentially useful as soft tissue substitutes and drug delivery systems.  Many synthetic polymers can be used to make hydrogels:  poly(vinyl alcohol) is widely employed to make hydrogels for biomedical applications.  Improvements in the biocompatibility characteristics of synthetic materials could be achieved by the addition of biological macromolecules.  The resulting materials named ''bioartifical polymeric materials'' could possess the good mechanical properties of the synthetic component and adequate biocompatibility due to the biological component.  We have used poly(vinyl alcohol) to make hydrogels containing various amounts of hyaluronic acid.  These bioartificial materials were studied to investigate the effect of the presence of the hyaluronic acid on the structural properties of the hydrogels.  Thermal, mechanical, morphological and X-ray analyses were performed.  A close correspondence between the network consistency and the degree of crystallinity developed in the matrix suggested that the hyaluronic acid, when its content is about 20%, could provide heterogeneous crystallization nuclei for poly(vinyl alcohol) thus increasing the crystallization degree, and consequently, the storage modulus.
C1 UNIV BOLOGNA,DIPARTIMENTO CHIM IND & MAT,I-40136 BOLOGNA,ITALY.
RP LAZZERI, L (reprint author), UNIV PISA,DIPARTIMENTO INGN CHIM,VIA DIOTISALVI 2,I-56126 PISA,ITALY.
OI Laus, Michele/0000-0002-4296-3732
CR GIUSTI P, 1993, TRENDS POLYM SCI, V1, P261
   GUISTI P, 1993, J MATER SCI-MATER M, V4, P538
   LAZZERI L, 1992, 4TH P WORLD BIOM C B, P462
   Nambu M, 1982, Japanese Patent Kokai, Patent No. [57/130543, 130543]
   PEPPAS NA, 1986, HYDROGELS MED PHARM, V3, P109
   SBARBATI R, IN PRESS J MATER SCI
   SWANN DA, 1991, BIOMATERIALS NOVEL M, pCH6
NR 7
TC 31
Z9 31
U1 0
U2 3
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1994
VL 5
IS 12
BP 862
EP 867
DI 10.1007/BF01172026
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QB102
UT WOS:A1994QB10200006
DA 2018-10-19
ER

PT J
AU BOER, GJ
AF BOER, GJ
TI ETHICAL GUIDELINES FOR THE USE OF HUMAN EMBRYONIC OR FETAL TISSUE FOR
   EXPERIMENTAL AND CLINICAL NEUROTRANSPLANTATION AND RESEARCH
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE NECTAR; ETHICAL GUIDELINES; HUMAN FETAL TISSUE; NEUROTRANSPLANTATION
ID ADRENAL-MEDULLARY TRANSPLANTATION; ADVANCED PARKINSONS-DISEASE; RIGHT
   CAUDATE-NUCLEUS; DOPAMINE NEURONS; NEURAL TRANSPLANTATION; BRAIN; ISSUES
AB Recently a Network of European CNS Transplantation And Restoration (NECTAR) has been founded, aimed at a concerted effort to develop efficient, reliable, safe and ethically acceptable transplantation therapies for neurodegenerative diseases, in particular Parkinson's and Huntington's disease. Owing to the use of human fetal brain tissue in such studies, usually obtained from elective abortions, ethical concerns have been focused on the relation ship between abortion and transplantation activities. There is no uniform code on the retrieval and use of human embryonal or fetal material for experimental and clinical research or application in Europe, NECTAR has therefore formulated self-restraining ethical guidelines for its European member groups. These guidelines consist of a series of restrictions intended to-prevent the use of grafts from encouraging induced abortions and to maintain high standards of respect for life and human dignity. In order to support applications for human embryonal or fetal neurotransplantation studies of NECTAR member groups to local or national medico-ethical committees, and to stimulate the goal of obtaining European legislation on this issue, the guidelines are here presented. They are followed by extensive explanatory notes. Only in this public manner can the lines of thought behind these NECTAR guidelines be addressed critically by those working in the fields of biomedical ethics and legislation as well by politicians and the general public.
C1 NETHERLANDS INST BRAIN RES,GRAD SCH NEUROSCI AMSTERDAM,1105 AZ AMSTERDAM,NETHERLANDS.
CR ALLEN GS, 1989, ARCH NEUROL-CHICAGO, V46, P487, DOI 10.1001/archneur.1989.00520410021016
   BACKLUND EO, 1985, FERNSTROM F SERIES, P551
   BEAUCHAMP TL, 1989, PRINCIPLES BIOMEDICA
   BJORKLUND A, 1983, ACTA PHYSL SCAND S, V522, P1
   BOER GJ, 1991, NOTES DISCUSSION ETH
   BOPP J, 1988, REPORT HUMAN FETAL T, V1, P45
   BRUNDIN P, 1986, EXP BRAIN RES, V65, P235
   BURNELL GM, 1987, J PSYCHOL, V121, P71, DOI 10.1080/00223980.1987.9712645
   Burtchaell James Tunstead, 1988, IRB, V10, P7, DOI 10.2307/3564625
   CAPRON AM, 1976, BIOMEDICAL ETHICS LA, P489
   FARIA G, 1985, SOC WORK HEALTH CARE, V11, P85, DOI 10.1300/J010v11n01_06
   FRANKOWSKI SJ, 1987, ABORTION PROTECTION
   FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202
   GARRY DJ, 1992, NEW ENGL J MED, V327, P1592, DOI 10.1056/NEJM199211263272211
   GASH DM, 1985, NEUROBIOL AGING, V6, P131, DOI 10.1016/0197-4580(85)90031-4
   GOETZ CG, 1989, NEW ENGL J MED, V320, P337, DOI 10.1056/NEJM198902093200601
   GREELY HT, 1989, NEW ENGL J MED, V320, P1093, DOI 10.1056/NEJM198904203201624
   HANSEN JT, 1989, SCIENCE, V246, P775, DOI 10.1126/science.2683082
   HENDERSON BTH, 1991, ARCH NEUROL-CHICAGO, V48, P822, DOI 10.1001/archneur.1991.00530200062020
   HOFFER BJ, 1991, TRENDS NEUROSCI, V14, P384, DOI 10.1016/0166-2236(91)90168-T
   ISACSON O, 1991, INTRACEREBRAL TRANSP, P245
   Jacobson M., 1991, DEV NEUROBIOLOGY
   JIANG N, 1987, ACTA ACAD MED SHANGH, V14, P1
   Jones D Gareth, 1991, Bioethics, V5, P23, DOI 10.1111/j.1467-8519.1991.tb00142.x
   KING P, 1988, CLIN RES, V36, P205
   KOLARIK J, 1988, ACTIV NERV SUPER, V30, P155
   KOLLER WC, 1987, HDB PARKINSONS DISEA
   LAWLER SD, 1981, J CLIN PATHOL, V34, P240, DOI 10.1136/jcp.34.3.240
   LENNETTE EH, 1988, LABORATORY DIAGNOSIS, V2
   LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529
   LINDVALL O, 1992, ANN NEUROL, V31, P155, DOI 10.1002/ana.410310206
   LOZANO JJL, 1991, RESTOR NEUROL, V4, P87
   MACDONALD AS, 1990, TRANSPLANT P, V22, P1030
   MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402
   MADRAZO I, 1991, INTRACEREBRAL TRANSP, V4, P123
   MAHOWALD MB, 1988, CLIN RES, V36, P220
   MAY WF, 1990, TRANSPLANT P, V22, P985
   MCCULLAGH PM, 1987, FOETUS TRANSPLANT DO
   MCLAREN A, 1989, CAHBIREF1 COUNC EUR
   MOLINA H, 1991, RES NEUROL, V4, P99
   MOLLISON PL, 1987, BLOOD TRANSFUSION CL, P764
   NOLAN K, 1990, TRANSPLANT P, V22, P1028
   O'Rahilly R., 1987, DEV STAGES HUMAN EMB
   OLSON L, 1988, DISCUSSION NEUROSCIE, V5
   RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266
   ROBERTSON JA, 1990, TRANSPLANT P, V22, P1025
   ROBERTSON JA, 1988, 6 HAST CTR REP
   SLADEK JR, 1988, SCIENCE, V240, P1386, DOI 10.1126/science.3375820
   SPENCER DD, 1992, NEW ENGL J MED, V327, P1541, DOI 10.1056/NEJM199211263272201
   WALTERS L, 1988, CLIN RES, V36, P209
   WARREN MA, 1975, TODAYS MORAL PROBLEM, P120
   WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203
   WOODS L, 1993, DIAGNOSTIC PATHOLOGY, P573
   YEZZI R, 1980, MED ETHICS THINKING
   1990, B WORLD MED ASS  FEB, P8
   1984, RECOMMENDATION USE E
   1972, USE FETUSES FETAL MA
   1988, REPORT HUMAN FETAL T
   1988, REPORT SCI RES RELAT
   1984, ADVICE DONATION USES
   1986, USE HUMAN EMBRYOS FO
   1993, NEW PROGRAM NECTAR N
   1989, REPORT USE HUMAN EMB
   1990, STATEMENT INTRACEREB
   1989, CM762
   1988, LANCET, V1, P1119
   1992, 1ST REPORT
   1993, 1991 1992 DUTCH COMM
   1990, JAMA-J AM MED ASSOC, V263, P565
   1989, USE HUMAN EMBRYOS FO
NR 70
TC 85
Z9 86
U1 1
U2 7
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0340-5354
J9 J NEUROL
JI J. Neurol.
PD DEC
PY 1994
VL 242
IS 1
BP 1
EP 13
DI 10.1007/BF00920568
PG 13
WC Clinical Neurology
SC Neurosciences & Neurology
GA PU855
UT WOS:A1994PU85500001
PM 7897446
DA 2018-10-19
ER

PT J
AU BRON, WE
AF BRON, WE
TI FROM COLOR-CENTERS TO COHERENT PHONON STATES
SO JOURNAL OF PHYSICS AND CHEMISTRY OF SOLIDS
LA English
DT Article
DE SEMICONDUCTORS; RAMAN SPECTROSCOPY; COLOR CENTERS; PHONONS
ID DIFFUSION; DYNAMICS
AB I trace the progression of scientific steps which start with color centers in alkali halides and end with my current research on the coherent generation and dephasing of vibrations in solids. It was Art Nowick who started me off along a series of ever more sophisticated experimental methods with which it has become possible to understand the temporal, spectral, and spatial response of insulators, semiconductors, superconductors, metals and biomedical tissues, to various forms of excitations. Among the observed phenomena are crystal field splitting of atomic states in ionic materials; localized and extended phonon states in alkaline-earth halides, and other insulators; spectral, spatial and temporally resolved phonon transport in various materials, the generation of coherent phonon and polariton states in semiconductors, and the dephasing of the coherent states and the observations of a long sought after long-lived phonon state.
RP BRON, WE (reprint author), UNIV CALIF IRVINE,DEPT PHYS,IRVINE,CA 92717, USA.
CR BILZ H, 1979, PHONON DISPERSION RE, P104
   BRON WE, 1965, PHYS REV, V139, pA233, DOI 10.1103/PhysRev.139.A233
   BRON WE, 1982, PHYS REV LETT, V49, P209, DOI 10.1103/PhysRevLett.49.209
   BRON WE, 1978, PHYS REV LETT, V40, P1459, DOI 10.1103/PhysRevLett.40.1459
   BRON WE, 1992, ULTRASHORT PROCESSES, P101
   DIPPOLITO JP, 1973, THESIS INDIANA U BLO
   FOURIER J, 1822, THEORIE ANAL CHALEUR
   KAZAKOVTSEV DV, 1978, JETP LETT+, V27, P181
   KAZAKOVTSEV DV, 1979, PHYS STATUS SOLIDI B, V96, P117, DOI 10.1002/pssb.2220960109
   KAZAKOVTSEV DV, 1981, J LOW TEMP PHYS, V45, P49, DOI 10.1007/BF00661142
   KAZAKOVTZEV DV, PISMA ESKP TEOR FIZ, V27, P194
   KLEMENS PG, 1966, PHYS REV, V38, P4573
   MARIS HJ, 1970, J ACOUST SOC AM, V50, P812
   MAUL MK, 1969, J APPL PHYS, V40, P2822, DOI 10.1063/1.1658082
   Orbach R., 1964, Physics, V1, P91
   Placzek G., 1934, HDB RADIOLOGIE
   QU J, 1993, PHYS REV B, V48, P6720, DOI 10.1103/PhysRevB.48.6720
   RHEE BK, 1986, PHYS REV B, V34, P7107, DOI 10.1103/PhysRevB.34.7107
   VONGUTFIELD RJ, 1964, PHYS REV LETT, V12, P641, DOI 10.1103/PhysRevLett.12.641
NR 19
TC 0
Z9 0
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0022-3697
J9 J PHYS CHEM SOLIDS
JI J. Phys. Chem. Solids
PD DEC
PY 1994
VL 55
IS 12
BP 1381
EP 1391
DI 10.1016/0022-3697(94)90565-7
PG 11
WC Chemistry, Multidisciplinary; Physics, Condensed Matter
SC Chemistry; Physics
GA QL009
UT WOS:A1994QL00900003
DA 2018-10-19
ER

PT J
AU SCHWERTNER, HA
AF SCHWERTNER, HA
TI PATENTING MEDICAL INVENTIONS
SO MILITARY MEDICINE
LA English
DT Article
AB Medical, dental, nursing, and biomedical personnel often perform critical research that can lead to patents.  Similarly, patentable discoveries can be made during the normal course of medical practice, e.g., the development of new biocompatible polymers, improved dental materials, new or modified catheters, new laboratory diagnostic tests, and improved medical devices.  Many inventions may not be patented in federal organizations due to the lack of information available on the patenting process.  In this article, the financial benefits that can be derived from patenting inventions are discussed, as well as the different types of patents that can be obtained, the conditions for patentability, bars or restrictions to obtaining a patent, the importance of proper record keeping, and the steps to take toward getting an invention patented.
RP SCHWERTNER, HA (reprint author), WILFORD HALL USAF MED CTR,RDL,CLIN INVEST DIRECTORATE,1255 WILFORD HALL LOOP,LACKLAND AFB,TX 78236, USA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU ASSN MILITARY SURG US
PI BETHESDA
PA 9320 OLD GEORGETOWN RD, BETHESDA, MD 20814
SN 0026-4075
J9 MIL MED
JI Milit. Med.
PD DEC
PY 1994
VL 159
IS 12
BP 729
EP 732
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA QK573
UT WOS:A1994QK57300002
PM 7723995
DA 2018-10-19
ER

PT J
AU KWIATEK, WM
AF KWIATEK, WM
TI BIOMEDICAL APPLICATIONS OF SYNCHROTRON X-RAY-FLUORESCENCE
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 2nd International School and Symposium on Synchrotron Radiation in
   Natural Science
CY MAY 18-26, 1994
CL JASZOWIEC, POLAND
SP COMMISS EUROPEAN COMMUNITIES, STATE COMM SCI RES, POLISH ACAD SCI, INST PHYS, JAGIELONIAN UNIV, INST PHYS, POLISH ACAD SCI, COMM PHYS, POLISH ACAD SCI, COMM CRYSTALLOG, POLISH ACAD SCI, INST PHYS CHEM, REG LAB PHYSICOCHEM ANAL, JAGIELLONIAN UNIV, RES, DOCTORQ CO, APRIL BUSINESS COMP CO
ID RADIATION; SRIXE
AB Since the exact role of trace elements in living organisms is still not very well known, it is a need of a careful analysis and study on trace element distributions in various bio-medical materials. The conventional techniques such as X-ray fluorescence, proton-induced X-ray emission, atomic absorption spectrophotometry do not always give precise determination, especially in microstructures areas. Since synchrotron radiation is very powerful and gives the opportunity to work with micro-beams the synchrotron radiation induced X-ray emission technique has been recently developed. Due to many properties of synchrotron radiation it becomes a very useful tool in science. In this paper a characterization of different apparatus for a trace element analysis as well as several applications are described to show the usefulness of the synchrotron radiation induced X-ray emission.
RP KWIATEK, WM (reprint author), H NIEWODNICZANSKI INST NUCL PHYS,RADZIKOWSKIEGO 152,PL-31342 KRAKOW,POLAND.
CR BAKIR F, 1976, B WORLD HEALTH ORGAN, V53, P87
   BUTTKEWITZ A, 1990, HASYLAB PROGR REPORT, P577
   IYENGAR GV, 1978, ELEMENTAL COMPOSITIO
   JAKSIC M, 1991, NUCL INSTRUM METH B, V56-7, P699, DOI 10.1016/0168-583X(91)95007-Z
   JONES KW, 1992, HDB XRAY SPECTROMETR, P441
   KWIATEK WM, 1990, NUCL INSTRUM METH B, V50, P347, DOI 10.1016/0168-583X(90)90380-D
   KWIATEK WM, 1992, NUCL INSTRUM METH B, V68, P122, DOI 10.1016/0168-583X(92)96062-4
   KWIATEK WM, 1992, ACTA PHYS POL A, V82, P263, DOI 10.12693/APhysPolA.82.263
   MURAKAMI M, 1973, Nature (London), V245, P153, DOI 10.1038/245153a0
   PROHASKA JR, 1987, PHYSIOL REV, V67, P858
   ROSE J, 1983, TRACE ELEMNTS HLTH
   SCOTT R, 1980, UROL RES, V8, P167
   VALKOVIC V, 1990, IAEA300 TECH DOC
NR 13
TC 10
Z9 10
U1 0
U2 2
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, 02-668 WARSAW, POLAND
SN 0587-4246
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD NOV
PY 1994
VL 86
IS 5
BP 695
EP 703
DI 10.12693/APhysPolA.86.695
PG 9
WC Physics, Multidisciplinary
SC Physics
GA PR749
UT WOS:A1994PR74900004
OA Bronze
DA 2018-10-19
ER

PT J
AU GRIJPMA, DW
   VANHOFSLOT, RDA
   SUPER, H
   NIJENHUIS, AJ
   PENNINGS, AJ
AF GRIJPMA, DW
   VANHOFSLOT, RDA
   SUPER, H
   NIJENHUIS, AJ
   PENNINGS, AJ
TI RUBBER TOUGHENING OF POLY(LACTIDE) BY BLENDING AND BLOCK
   COPOLYMERIZATION
SO POLYMER ENGINEERING AND SCIENCE
LA English
DT Article
ID POLY(L-LACTIC ACID); RESORBABLE MATERIALS; FRACTURE FIXATION; L-LACTIDE;
   POLYLACTIDE; PLATES; SCREWS; POLYMERIZATION; DEGRADATION
AB Copolymers of L-lactide with 15 or more mole % D-lactide are amorphous, noncrystallizable hydrolytically degradable materials. These glassy materials are brittle in tension and bending. To make these materials suitable for use as load-bearing devices in biomedical applications, toughness has to be enhanced. This is effectively accomplished by introducing a separate degradable rubber phase in the amorphous matrix. Several approaches have been explored: solution blending and coprecipitation of trimethylene carbonate and epsilon-caprolactone rubbers and poly(lactide), preparation of ABA triblock copolymers and blending of ABA block copolymers with the amorphous poly(lactide) matrix. In all cases very tough materials could be prepared. These materials are easily processable by compression molding at relatively low temperatures.
C1 UNIV GRONINGEN,DEPT POLYMER CHEM,9747 AG GRONINGEN,NETHERLANDS.
CR AGRAWAL CM, 1992, BIOMATERIALS, V13, P176, DOI 10.1016/0142-9612(92)90068-Y
   BOS RRM, 1987, J ORAL MAXIL SURG, V45, P751, DOI 10.1016/0278-2391(87)90194-7
   BOS RRM, 1989, INT J ORAL MAX SURG, V18, P365, DOI 10.1016/S0901-5027(89)80035-9
   BOYLE WJ, 1988, Patent No. 5664
   BRANDRUP J, POLYM HDB
   BRODE GL, 1972, J MACROMOL SCI CHEM, VA  6, P1109, DOI 10.1080/10601327208056888
   Bucknall C. B., 1977, TOUGHENED PLASTICS
   Carothers WH, 1930, J AM CHEM SOC, V52, P314, DOI 10.1021/ja01364a045
   CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   CHA Y, 1990, BIOMATERIALS, V11, P108, DOI 10.1016/0142-9612(90)90124-9
   COHN D, 1989, BIOMATERIALS, V10, P466
   GORDA KR, 1991, POLYM COMMUN, V23, P25
   GRIJPMA DW, 1991, POLYM BULL, V25, P335, DOI 10.1007/BF00316903
   GRIJPMA DW, IN PRESS MAKROMOL CH
   GRIJPMA DW, 1991, POLYM B, V29, P571
   KINLOCH AJ, 1983, FRACTURE BEHAVIOUR P
   KRICHELDORF HR, 1987, J MACROMOL SCI CHEM, VA24, P1345, DOI 10.1080/00222338708076950
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9
   LEENSLAG JW, 1987, MAKROMOL CHEM, V188, P1809
   LI SM, 1990, J MATER SCI-MATER M, V1, P198, DOI 10.1007/BF00701077
   LIPINSKY ES, 1986, CHEM ENG PROG, V82, P26
   MAJOLA A, 1992, J MATER SCI-MATER M, V3, P43, DOI 10.1007/BF00702943
   Manson J. A., 1976, POLYM BLENDS COMPOSI
   MARK HF, 1988, ENCY POLYM SCI TECHN, V1, P648
   MIGLIARESI C, 1991, J APPL POLYM SCI, V43, P83, DOI 10.1002/app.1991.070430109
   NAKAMURA T, 1989, J BIOMED MATER RES, V23, P1115, DOI 10.1002/jbm.820231003
   NIJENHUIS AJ, 1992, MACROMOLECULES, V25, P6419, DOI 10.1021/ma00050a006
   NIJENHUIS AJ, 1991, POLYM BULL, V26, P71, DOI 10.1007/BF00299350
   ROZEMA FR, 1991, THESIS U GRONINGEN N
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   SCHINDLER A, 1982, J POLYM SCI POL CHEM, V20, P319, DOI 10.1002/pol.1982.170200206
   Schindler A, 1977, CONT TOPICS POLYM SC, V2, P251
   Sinclair R. G., 1977, US Patent, Patent No. [4057537, 4 057 537]
   SINCLAIR RG, 1977, Patent No. 4045418
   SINCLAIR RG, 1989, Patent No. 1521
   Van Krevelen D. W., 1976, PROPERTIES POLYM
   VERT M, 1981, MAKROMOL CHEM S, V5, P30, DOI DOI 10.1002/MACP.1981.020051981103
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
   1971, HDB CHEM PHYSICS, pC765
NR 42
TC 119
Z9 120
U1 2
U2 27
PU SOC PLASTICS ENG INC
PI BROOKFIELD CENTER
PA 14 FAIRFIELD DR, BROOKFIELD CENTER, CT 06804-0403
SN 0032-3888
J9 POLYM ENG SCI
JI Polym. Eng. Sci.
PD NOV
PY 1994
VL 34
IS 22
BP 1674
EP 1684
DI 10.1002/pen.760342205
PG 11
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA PU107
UT WOS:A1994PU10700004
DA 2018-10-19
ER

PT J
AU AITON, JF
AF AITON, JF
TI THE WORLDWIDE WEB - AN INTERFACE BETWEEN RESEARCH AND TEACHING IN
   BIOINFORMATICS
SO DISEASE MARKERS
LA English
DT Review
AB The rapid expansion occurring in World-Wide Web activity is beginning to make the concepts of 'global hypermedia' and 'universal document readership' realistic objectives of the new revolution in information technology. One consequence of this increase in usage is that educators and students are becoming more aware of the diversity of the knowledge base which can be accessed via the Internet. Although computerised databases and information services have long played a key role in bioinformatics these same resources can also be used to provide core materials for teaching and learning. The large datasets and archives that have been compiled for biomedical research can be enhanced with the addition of a variety of multimedia elements (images, digital videos, animation etc.). The use of this digitally stored information in structured and self-directed learning environments is likely to increase as activity across World-Wide Web increases.
RP AITON, JF (reprint author), UNIV ST ANDREWS,SCH BIOL & MED SCI,ST ANDREWS KY16 9TS,FIFE,SCOTLAND.
NR 0
TC 7
Z9 8
U1 0
U2 0
PU ASFRA
PI EDAM
PA VOORHAVEN 33, 1135 BL EDAM, NETHERLANDS
SN 0278-0240
J9 DIS MARKERS
JI Dis. Markers
PD OCT
PY 1994
VL 12
IS 1
BP 3
EP 10
DI 10.1155/1994/412976
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental; Pathology
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine; Pathology
GA PN077
UT WOS:A1994PN07700001
PM 7842629
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU KASEMO, B
   LAUSMAA, J
AF KASEMO, B
   LAUSMAA, J
TI MATERIAL-TISSUE INTERFACES - THE ROLE OF SURFACE-PROPERTIES AND
   PROCESSES
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Proceedings Paper
CT Workshop on Biopersistence of Respirable Synthetic Fibers and Minerals
CY SEP 07-09, 1992
CL LYON, FRANCE
SP INT AGCY RES CANC, INSERM, CNRS
DE SURFACE; INTERFACE; METAL OXIDE; BIOMOLECULES; WATER; IONS; CELL
   MEMBRANE; BIOMATERIALS
ID IMPLANT MATERIALS; OXIDE-FILMS; TITANIUM; BIOMATERIAL; ADSORPTION
AB The introduction of a foreign material into living tissue-intentionally as in biomedical applications (implants, protheses, drugs) or unintentionally as when minerals or fibers are inhaled-results in the creation of interfaces between the material and the surrounding tissue. This article identifies and discusses the possible role of material surface properties and molecular processes occurring at such interfaces. For kinetic and thermodynamic reasons, surfaces are different from the corresponding bulk of the material, and contain reactive (unsaturated) bonds, which in turn lead to the formation of surface reactive layers (e.g., surface oxides on metals) and adsorbed contamination layers. The encounter with the biological environment leads to further surface reactions modifying the surface, and to the adsorption of water, ions, and biomolecules, which are continuously exchanged. The exact nature of the dynamic, adsorbed water, ions, and biomolecule coating in turn influences the behavior of cells approaching the material surface, and hence the tissue response.
RP KASEMO, B (reprint author), CHALMERS UNIV TECHNOL,DEPT APPL PHYS,S-41296 GOTHENBURG,SWEDEN.
CR ANDRADE JD, 1985, PROTEIN ADSORPTION S, V2
   ASK M, 1990, J MATER RES, V5, P1662, DOI 10.1557/JMR.1990.1662
   ASK M, 1988, APPL SURF SCI, V35, P283
   BRANEMARK PI, 1985, TISSUE INTEGRATED PR
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   HEALY KE, 1992, J BIOMED MATER RES, V26, P319, DOI 10.1002/jbm.820260305
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KASEMO B, 1991, BONE-BIOMATERIAL INTERFACE, P19
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KASEMO B, 1988, SURFACE CHARACTERIZA, P1
   KING DA, 1983, CHEM PHYSICS HETEROG, V1
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LAUSMAA J, 1991, THESIS GOTHENBURG
   Luckey H. A., 1983, ASTM SPECIAL TECHNIC, V796
   LUNDSTROM I, 1985, ORAL INTERACTIONS RE, P9
   MAEUSLI PA, 1986, BIOL BIOMECHANICAL P, P57
   McQueen D, 1982, CLIN APPL BIOMATERIA, P179
   RADEGRAN G, 1991, J ELECTRON MICR TECH, V19, P99, DOI 10.1002/jemt.1060190110
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   WILLIAMS DF, 1977, J MED ENG TECHNOL, V1, P266, DOI 10.3109/03091907709162192
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
NR 27
TC 114
Z9 116
U1 0
U2 9
PU NATL INST ENVIRON HEALTH SCI
PI RES TRIANGLE PK
PA PO BOX 12233, RES TRIANGLE PK, NC 27709
SN 0091-6765
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD OCT
PY 1994
VL 102
SU 5
BP 41
EP 45
DI 10.2307/3432057
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA PT108
UT WOS:A1994PT10800009
PM 7882954
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU CUBEDDU, R
   MUSOLINO, M
   PIFFERI, A
   TARONI, P
   VALENTINI, G
AF CUBEDDU, R
   MUSOLINO, M
   PIFFERI, A
   TARONI, P
   VALENTINI, G
TI TIME-RESOLVED REFLECTANCE - A SYSTEMATIC STUDY FOR APPLICATION TO THE
   OPTICAL CHARACTERIZATION OF TISSUES
SO IEEE JOURNAL OF QUANTUM ELECTRONICS
LA English
DT Article
ID ULTRASHORT LASER-PULSES; RANDOM-MEDIA; LIGHT-SCATTERING; TURBID TISSUES;
   TRANSMITTANCE; SPECTROSCOPY; PROPAGATION; PROFILES; DESCRIBE; PHANTOM
AB In principle, the measurement of the time-resolved diffuse reflectance, as interpreted on the basis of the diffusion theory, allows us to determine the optical properties (absorption coefficient mu(a) and transport scattering coefficient mu's) of biological materials noninvasively.  A system for time-resolved reflectance measurements and its performances are described in detail.  An extensive experimental work and a computer simulation characterized the influence of mu(a), mu's, and observation distance on the measurement, and allowed to determine the ranges of mu(a) and mu's which can be measured reliably (and which include most of the values of interest in biomedical applications).  Moreover, on the basis of the experimental and computer work, the optimal experimental parameters can be determined in various situations.  The results presented are general and can be extended to different systems of measurement.
RP CUBEDDU, R (reprint author), POLITECN MILAN,CEQSE,CNR,PIAZZA L DA VINCI 32,I-20133 MILAN,ITALY.
RI Pifferi, Antonio/C-4688-2012; Taroni, Paola/C-4709-2012
OI Pifferi, Antonio/0000-0002-2261-2089; Taroni, Paola/0000-0001-7486-0001;
   Valentini, Gianluca/0000-0002-6340-3021
CR ARNFIELD MR, 1990, PHOTOCHEM PHOTOBIOL, V51, P667
   Berne B. J., 1975, DYNAMIC LIGHT SCATTE
   DUDERSTADT JJ, 1976, NUCL REACTOR ANAL, P140
   FERRARI M, 1992, J PHOTOCH PHOTOBIO B, V16, P141, DOI 10.1016/1011-1344(92)80005-G
   FLOCK ST, 1992, LASER SURG MED, V12, P510, DOI 10.1002/lsm.1900120510
   ISHIMARU A, 1978, WAVE PROPAGATION SCA, P175
   JACQUES SL, 1989, APPL OPTICS, V28, P2223, DOI 10.1364/AO.28.002223
   JACQUES SL, 1989, IEEE T BIO-MED ENG, V36, P1155, DOI 10.1109/10.42109
   LIU F, 1993, OPT LETT, V18, P432, DOI 10.1364/OL.18.000432
   MADSEN SJ, 1992, APPL OPTICS, V31, P3509, DOI 10.1364/AO.31.003509
   MADSEN SJ, 1992, PHYS MED BIOL, V37, P985, DOI 10.1088/0031-9155/37/4/012
   PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331
   PREUSS L E, 1986, Photochemistry and Photobiology, V43, p32S
   VANSTAVEREN HJ, 1991, APPL OPTICS, V30, P4507, DOI 10.1364/AO.30.004507
   WHITEHURST C, 1990, Lasers in Medical Science, V5, P395, DOI 10.1007/BF02032597
   WILSON BC, 1990, IEEE J QUANTUM ELECT, V26, P2186, DOI 10.1109/3.64355
   WILSON BC, 1987, PHOTOCHEM PHOTOBIOL, V46, P601, DOI 10.1111/j.1751-1097.1987.tb04820.x
   WILSON BC, 1985, PHOTOCHEM PHOTOBIOL, V42, P153, DOI 10.1111/j.1751-1097.1985.tb01554.x
   WILSON BC, 1988, PHOTON MIGRATION TIS, P25
   YOO KM, 1990, PHYS REV LETT, V65, P2210, DOI 10.1103/PhysRevLett.65.2210
   YOO KM, 1990, J OPT SOC AM B, V7, P1685, DOI 10.1364/JOSAB.7.001685
   YOO KM, 1989, APPL OPTICS, V28, P2343, DOI 10.1364/AO.28.002343
   YOO KM, 1990, PHYS REV LETT, V64, P2647, DOI 10.1103/PhysRevLett.64.2647
NR 23
TC 56
Z9 56
U1 0
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9197
J9 IEEE J QUANTUM ELECT
JI IEEE J. Quantum Electron.
PD OCT
PY 1994
VL 30
IS 10
BP 2421
EP 2430
DI 10.1109/3.328616
PG 10
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA PM813
UT WOS:A1994PM81300030
DA 2018-10-19
ER

PT J
AU RUDOLPH, AS
AF RUDOLPH, AS
TI BIOMATERIAL BIOTECHNOLOGY USING SELF-ASSEMBLED LIPID MICROSTRUCTURES
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE SELF-ASSEMBLY; LIPIDS; BLOOD SUBSTITUTES; CONTROLLED RELEASE; MONOLAYER
   FORMATION
ID LIPOSOME-ENCAPSULATED HEMOGLOBIN; BLOOD SUBSTITUTE
AB Lipids are a class of molecules which self-assemble into a variety of phase-dependent morphologies. We have employed self-assembled lipid microstructures in the development of a number of biomedical material applications. The blood substitute, liposome encapsulated hemoglobin, is being investigated for the in vivo delivery of hemoglobin without many of the inherent toxicities associated with the delivery of free hemoglobin. This investigation is currently focused on demonstrations of efficacy in stressed animal models and on the safety of administering this material in models of sepsis. The synthetic modification of phospholipids to include photopolymerizable moieties such as diacetylenes has resulted in the spontaneous self-assembly of a hollow microcylinder which we are investigating for the controlled release of growth factors in soft tissue regeneration. Self-assembled monolayers are also being explored for the ability to surface modify biomaterials for improved cell adhesion. Photolithographic techniques have been combined with monolayer deposition to fabricate coplanar patterns of cell adhesion and inhibiting moieties. This results in the ability to spatially control the adhesion of cells to biomaterial surfaces. These cell patterns can form the basis for understanding two- and three-dimensional cellular events on the biomaterial surface and for the fabrication of improved cell-based biocompatible surfaces. The spontaneous self-assembly of lipids to form structures of biotechnological interest presents a unique opportunity to exploit this class of molecules for biomaterial applications. (C) 1994 Wiley-Liss, Inc.(*)
RP RUDOLPH, AS (reprint author), USN,RES LAB,CTR BIOMOLEC SCI & ENGN,CODE 6900,WASHINGTON,DC 20375, USA.
CR ALLEN T, 1992, LIPOSOME TECHNOLOGY, V3, P59
   Bangham A. D., 1983, LIPOSOME LETT
   JULIANO RL, 1980, LIPOSOMES IMMUNOBIOL, P49
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   LINDBLOM G, 1989, BIOCHIM BIOPHYS ACTA, V988, P221, DOI 10.1016/0304-4157(89)90020-8
   LUZATTI V, 1968, NATURE, V73, P7304
   OSTRO MJ, 1989, AM J HOSP PHARM, V46, P1576
   OSTRO MJ, 1987, LIPOSOMES BIOPHYSICS
   PRICE RR, 1993, J MICROENCAPSUL, V10, P215, DOI 10.3109/02652049309104387
   RABINOVICI R, 1993, J TRAUMA, V35, P121, DOI 10.1097/00005373-199307000-00019
   RUDOLPH AS, 1991, P NATL ACAD SCI USA, V88, P10976, DOI 10.1073/pnas.88.23.10976
   RUDOLPH AS, 1992, BIOMATERIALS, V13, P1085, DOI 10.1016/0142-9612(92)90141-A
   RUDOLPH AS, 1991, NATURE, V352, P52, DOI 10.1038/352052a0
   RUDOLPH AS, 1988, CRYOBIOLOGY, V25, P277, DOI 10.1016/0011-2240(88)90036-3
   RUDOLPH AS, 1989, BIOTECHNOLOGICAL APP, V110, P305
   SCHNUR JM, 1987, THIN SOLID FILMS, V152, P181, DOI 10.1016/0040-6090(87)90416-0
   SPARGO BJ, 1992, MATER RES SOC SYMP P, V252, P285
   Tanford C., 1980, HYDROPHOBIC EFFECT
   YAGER P, 1984, MOL CRYST LIQ CRYST, V106, P371, DOI 10.1080/00268948408071454
NR 19
TC 25
Z9 27
U1 0
U2 9
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD OCT
PY 1994
VL 56
IS 2
BP 183
EP 187
DI 10.1002/jcb.240560211
PG 5
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA PJ445
UT WOS:A1994PJ44500010
PM 7829578
DA 2018-10-19
ER

PT J
AU ANDREOPOULOS, AG
   THEOPHANIDES, T
AF ANDREOPOULOS, AG
   THEOPHANIDES, T
TI DEGRADABLE PLASTICS - A SMART APPROACH TO VARIOUS APPLICATIONS
SO JOURNAL OF ELASTOMERS AND PLASTICS
LA English
DT Review
DE ATR-FT-IR; BIODEGRADATION; BIOMEDICAL POLYMERS; FT-IR; PHOTODEGRADATION;
   SPECTROPHOTOMETRY
ID LOW-MOLECULAR-WEIGHT; FUNCTIONAL-GROUP FORMATION; ULTRA-VIOLET
   DEGRADATION; LACTIC-ACID OLIGOMER; PHOTO-OXIDATION; RESORBABLE
   MATERIALS; INVITRO DEGRADATION; POLY(L-LACTIC ACID); POLYETHYLENE FILMS;
   SURFACE-LAYER
AB The suitability of photodegradation and biodegradation technologies for specialty applications is discussed. The research on degradable polymers is reviewed with emphasis on the processes of photooxidation, photostabilization and photosensitization. The degradation mechanisms, reaction products, analytical procedures and additives are discussed. Also, recent developments on biodegradable materials are reported, including composites of commodity plastics with starch, polymers of alpha-hydroxyacids, etc. Biomedical plastic based on lactic acid homopolymers or copolymers are another important field because of their versatility, which allows for successful product design. Typical applications are screws and plates used as implants for bone fixation or drug carriers. After the completion of a certain treatment, these materials degrade in the human body and do not require surgical retrieval.
C1 NATL TECH UNIV ATHENS, DEPT CHEM ENGN, RADIAT CHEM & BIOSPECT LAB, GR-15780 ATHENS, GREECE.
RP ANDREOPOULOS, AG (reprint author), NATL TECH UNIV ATHENS, DEPT CHEM ENGN, SPECIAL CHEM TECHNOL LAB, 9 IROON POLYTECH STR, GR-15780 ATHENS, GREECE.
CR ADAM C, 1990, POLYM DEGRAD STABIL, V27, P85, DOI 10.1016/0141-3910(90)90099-S
   ALBERTSSON AC, 1988, ACTA POLYM, V39, P95, DOI 10.1002/actp.1988.010390118
   ALBERTSSON AC, 1990, PROG POLYM SCI, V15, P177, DOI 10.1016/0079-6700(90)90027-X
   AMINABHAVI TM, 1990, POLYM-PLAST TECHNOL, V29, P235, DOI 10.1080/03602559008049843
   ANDRADY AL, 1990, J APPL POLYM SCI, V39, P363, DOI 10.1002/app.1990.070390213
   ANDREOPOULOS AG, 1993, IN PRESS POLYM TESTI
   ANDREOPOULOS AG, IN PRESS CLIN MATERI
   ANGIVTSEVA TG, 1990, INT POLYM SCI TECHN, V17, P55
   AVGOUSTAKIS K, 1991, INT J PHARM, V70, P77, DOI 10.1016/0378-5173(91)90166-L
   BARTUS J, 1989, POLYM DEGRAD STABIL, V26, P43, DOI 10.1016/0141-3910(89)90027-X
   BECK LR, 1979, NEW LONG ACTING INJE, V5, P545
   BELLENGER V, 1990, POLYM DEGRAD STABIL, V28, P53, DOI 10.1016/0141-3910(90)90051-8
   BODMEIER R, 1989, INT J PHARM, V51, P1, DOI 10.1016/0378-5173(89)90068-9
   BODMEIER R, 1989, J PHARM SCI, V78, P819, DOI 10.1002/jps.2600781008
   BOSE AK, 1989, 1989 POL LAM COAT C, P427
   BOTTENBERG P, 1991, P INT CONTROL REL BI, V18, P631
   BOUSQUET JA, 1987, POLYM DEGRAD STABIL, V18, P163, DOI 10.1016/0141-3910(87)90029-2
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   BRUHN BW, 1991, P INT CONTROL REL BI, V18, P668
   BURFIELD DR, 1988, MAKROMOL CHEM, V189, P523
   CACIARI I, 1990, MACPLAS, V15, P54
   CARLSSON DJ, 1987, J APPL POLYM SCI, V33, P875, DOI 10.1002/app.1987.070330316
   CASTELEYN PP, 1992, J BONE JOINT SURG BR, V74, P858
   CASTILLO F, 1990, POLYM DEGRAD STABIL, V27, P1, DOI 10.1016/0141-3910(90)90092-L
   CHANDRA R, 1990, J MACROMOL SCI R M C, VC30, P155
   COFFIN MD, 1992, PHARMACEUT RES, V9, P200, DOI 10.1023/A:1018981222092
   COGHLAN A, 1990, NEW SCI, V125, P36
   CORDONNIER M, 1987, PLAST RUB PROC APPL, V8, P23
   DEMIRDERE A, 1991, EUR J PHARM BIOPHARM, V37, P42
   DO CH, 1987, J POLYM SCI POL CHEM, V25, P2301, DOI 10.1002/pola.1987.080250826
   DOI Y, 1990, MACROMOLECULES, V23, P26, DOI 10.1021/ma00203a006
   DUNN RL, 1991, P INT CONTROL REL BI, V18, P465
   EBI GC, 1990, J POLYM SCI POL CHEM, V28, P3533, DOI 10.1002/pola.1990.080281301
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   FERNANDI MJ, 1989, FEB P SPE REG TECHN, P525
   FRASER RK, 1992, J BONE JOINT SURG BR, V74, P929
   FUKUZAKI H, 1990, EUR POLYM J, V26, P1273, DOI 10.1016/0014-3057(90)90139-U
   FUZESSERY S, 1990, C P, P151
   GAUVIN P, 1987, MAKROMOL CHEM, V188, P1815
   GENTA I, 1991, P INT CONTROL REL BI, V18, P676
   GEORGE DI, 1988, MAY POL PROC APPL BU, P271
   GOHEEN SM, 1991, J APPL POLYM SCI, V42, P2691, DOI 10.1002/app.1991.070421007
   GRECO P, 1989, POLYMER, V30, P1475, DOI 10.1016/0032-3861(89)90219-X
   GUGUMUS F, 1990, ANGEW MAKROMOL CHEM, V182, P111, DOI 10.1002/apmc.1990.051820108
   GUGUMUS F, 1990, ANGEW MAKROMOL CHEM, V182, P85, DOI 10.1002/apmc.1990.051820107
   GUGUMUS F, 1990, ANGEW MAKROMOL CHEM, V176, P27, DOI 10.1002/apmc.1990.051760102
   GUILLET JE, 1973, 3RD TECHN C PHOT
   HON DNS, 1986, POLYM PHOTOCHEM, V7, P299, DOI 10.1016/0144-2880(86)90057-6
   Huang Jan-Chan, 1990, ADV POLYM TECHNOL, V10, P23
   IMASAKA K, 1990, MAKROMOL CHEM, V191, P2077
   Jian L., 1991, POLYM DEGRAD STABIL, V31, P1
   JIAN L, 1991, POLYM DEGRADAT STABI, V28, P335
   JOUAN X, 1991, J POLYM SCI POL CHEM, V29, P685, DOI 10.1002/pola.1991.080290510
   KABOTA H, 1990, POLYM DEGRADAT STABI, V29, P207
   KANESAWA Y, 1990, MAKROMOL CHEM-RAPID, V11, P679
   KISHIDA A, 1990, J CONTROL RELEASE, V13, P83, DOI 10.1016/0168-3659(90)90077-7
   KLEMCHUK PP, 1990, POLYM DEGRAD STABIL, V27, P183, DOI 10.1016/0141-3910(90)90108-J
   KOMITOV P, 1989, POLYM DEGRADAT STABI, V4, P303
   Labana S. S., 1976, ULTRAVIOLET LIGHT IN
   LACOSTE J, 1988, MAKROMOL CHEM, V189, P651
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9
   LEENSLAG JW, 1987, MAKROMOL CHEM, V188, P1809
   LEENSLAG JW, 1987, POLYM COMMUN, V28, P92
   Lenz R W, 1989, Chinese Journal of Polymer Science, V7, P289
   LUCAS PC, 1989, POLYM DEGRAD STABIL, V26, P203, DOI 10.1016/0141-3910(89)90073-6
   LUCAS PC, 1988, POLYM DEGRAD STABIL, V22, P175, DOI 10.1016/0141-3910(88)90040-7
   LUCKI J, 1986, POLYMER, V27, P1193, DOI 10.1016/0032-3861(86)90007-8
   LUOMA GA, 1986, J APPL POLYM SCI, V32, P577
   MAJORANA P, 1991, C P
   MCCANN B, 1990, PLAST NEWS, V2, P7
   MEAD D, 1988, MAY POL PROC APPL BU, P291
   MIMELAUT VJ, 1988, C P, P333
   Mingbo H., 1987, POLYM DEGRAD STABIL, V18, P321
   MONTGOMERY M, 1991, MAT EDGE, V27, P6
   NAZARI G, 1989, POLIPLASTI PLAST RIN, V37, P46
   OMELCZUK MO, 1992, PHARMACEUT RES, V9, P26, DOI 10.1023/A:1018967424392
   OSAWA Z, 1986, POLYM PHOTOCHEM, V7, P337, DOI 10.1016/0144-2880(86)90002-3
   OTAKE Y, 1991, NIPPON GOMU KYAKAISH, V64, P688
   PARK TG, 1992, PHARMACEUT RES, V9, P37, DOI 10.1023/A:1018971525301
   PERRONE C, 1989, POLIPLASTI PLAST RIN, V37, P38
   PFEIL A, 1991, INT POLYM SCI TECHN, V18, P1
   PFEIL A, 1990, GUMMI FAS KUNST, V43, P180
   PHILAJAMAKI O, 1992, J BONE JOINT SURG BR, V74, P853
   PHILIPPART JL, 1990, MAKROMOL CHEM, V190, P413
   PHUA SK, 1987, J BIOMED MATER RES, V21, P231, DOI 10.1002/jbm.820210207
   PIELICHOWSKI J, 1988, MUANYAG GUMI, V25, P190
   PITT CG, 1981, BIOMATERIALS, V2, P215
   PRAMANICK D, 1987, POLYM BULL, V18, P311
   QURESHI FS, 1990, J POLYM ENG, V9, P302
   Ranby B., 1975, PHOTODEGRADATION PHO
   REDPATH AE, 1988, MAY POL PROC APPL BU, P305
   REK V, 1989, POLYM DEGRAD STABIL, V24, P399, DOI 10.1016/0141-3910(89)90051-7
   REK V, 1986, POLYM PHOTOCHEM, V7, P273, DOI 10.1016/0144-2880(86)90055-2
   ROOM R, 1985, NEW TRENDS PHOTOCHEM, P147
   SACHAROW S, 1991, PAPER FILM FOIL CONV, V65, P58
   SASTRE R, 1990, J POLYM SCI POL CHEM, V28, P3661, DOI 10.1002/pola.1990.080281312
   SCHOOLENBERG GE, 1991, POLYMER, V32, P438, DOI 10.1016/0032-3861(91)90447-Q
   SCHOOLENBERG GE, 1991, POLYMER, V32, P432, DOI 10.1016/0032-3861(91)90446-P
   SEVERINI F, 1988, POLYM DEGRAD STABIL, V22, P185, DOI 10.1016/0141-3910(88)90041-9
   SEVERINI F, 1988, POLYM DEGRADAT STABI, V22, P79
   SHIH C, 1984, BIOMATERIALS, V5, P237, DOI 10.1016/0142-9612(84)90022-X
   SUBOCZ J, 1989, POLYM DEGRAD STABIL, V24, P335, DOI 10.1016/0141-3910(89)90044-X
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   THAYER A, 1990, CHEM ENG NEWS, V68, P7, DOI 10.1021/cen-v068n026.p007
   THOMAS RH, 1990, POLYM NEWS, V15, P246
   TICE TR, 1991, P INT CONTROL REL BI, V18, P467
   TORIKAI A, 1990, J APPL POLYM SCI, V40, P1673
   TROJAN M, 1990, POLYM DEGRAD STABIL, V28, P275, DOI 10.1016/0141-3910(90)90068-I
   VAIDERGORIN EYL, 1987, POLYM DEGRAD STABIL, V18, P329, DOI 10.1016/0141-3910(87)90019-X
   WADA R, 1990, J PHARM SCI, V79, P919, DOI 10.1002/jps.2600791016
   WASSERBAUER R, 1990, BIOMATERIALS, V11, P36, DOI 10.1016/0142-9612(90)90049-V
   WASSERBAUER R, 1987, PLASTY KAUC, V24, P169
   WEI GX, 1991, J BONE JOINT SURG BR, V73, P246
   WELCH WF, 1987, APPL SPECTROSC, V41, P853, DOI 10.1366/0003702874448201
   WELLAND EL, 1989, POLYM COMMUN, V30, P302
   WOOTTON AB, 1988, PIGM RESIN TECHNOL, V17, P4
   YASSIN AA, 1990, J MACROMOL SCI R M C, VC30, P491, DOI 10.1080/07366579008050916
   ZWIERS RJM, 1983, POLYMER, V24, P167, DOI 10.1016/0032-3861(83)90128-3
   1989, EUROPEAN PLASTICS NE, V38
   1971, Patent No. 2119855
   1990, MPI, V134
   1991, NEW MAT JAP      APR, P10
   1968, Patent No. 1128793
   1971, Patent No. 2120336
NR 125
TC 17
Z9 17
U1 3
U2 24
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0095-2443
EI 1530-8006
J9 J ELASTOM PLAST
JI J. Elastomer Plast.
PD OCT
PY 1994
VL 26
IS 4
BP 308
EP 326
DI 10.1177/009524439402600401
PG 19
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA PJ420
UT WOS:A1994PJ42000001
DA 2018-10-19
ER

PT J
AU DRUM, DA
   BULLEY, M
AF DRUM, DA
   BULLEY, M
TI MEDICAL WASTE-DISPOSAL
SO JOURNAL OF THE AIR & WASTE MANAGEMENT ASSOCIATION
LA English
DT Article
AB Medical (biomedical) wastes pose numerous potential health and safety hazards.  In addition to their infectious and toxic characteristics, the highly variable and inconsistent nature of medical waste streams has increased public concern about storage, treatment, transportation, and ultimate disposal.
   In recent years, techniques have been developed to reduce human exposure to the toxic and infectious components of medical wastes.  The most commonly used techniques include internal segregation, containment, and incineration.  Other common techniques include grinding, shredding, and disinfection, e.g., autoclaving and chemical treatment followed by landfilling.
   Of all the available technologies for medical waste treatment and disposal, incineration has been found to be the most effective method overall for destroying infectious and toxic material, volume reduction, and weight reduction in the medical waste stream.  Incineration destroys the broadest variety of medical waste constituents and can recover energy from the medical waste stream.  Incineration also is an appropriate alternative to burial of human pathological remains.
C1 AUCKLAND EPA LTD,AUCKLAND,NEW ZEALAND.
RP DRUM, DA (reprint author), BUUTLER CTY COMMUNITY COLL,BUTLER,PA 16003, USA.
CR BARTHOLOMEW P, 1994, 87TH ANN M EXH AIR W
   BOROWSKY AR, 1993, 86TH ANN M EXH AIR W
   CHANG TJ, 1991, 84TH ANN M EXH AIR W
   CROSS FL, 1993, 86TH ANN M EXH AIR W
   CROSS FL, 1990, INFECTIOUS WASTE MAN
   DRUM DA, 1993, REGULATORY ANAL MED
   GLASSER H, 1991, J AIR WASTE MANAGE, V41, P1180, DOI 10.1080/10473289.1991.10466913
   GREEN A, 1993, 86TH ANN M EXH AIR W
   HASSELRIIS F, 1994, 87TH ANN M EXH AIR W
   HASSELRIIS F, 1991, 84TH ANN M AIR WAST
   HASSELRIIS F, 1992, ASME NATIONAL WASTE
   HYLAND RG, 1994, 87TH ANN M EXH AIR W
   HYLAND RG, 1993, 86TH ANN M EXH AIR W
   JORDAN JW, 1994, 87TH ANN M EXH AIR W
   KONHEIM CS, 1994, 87TH ANN M EXH AIR W
   KONHEIM CS, 1993, 86TH ANN M EXH AIR W
   LAUBER JD, 1990, 83RD ANN M EXH AIR W
   LEE CC, 1991, 84TH ANN M EXH AIR W
   LERNER BJ, 1993, 86TH ANN M EXH AIR W
   LINDSEY WB, 1992, 85TH ANN M EXH AIR W
   MARRACK D, 1994, 87TH ANN M EXH AIR W
   1990, FINDING PRESCRIPTION
   1990, US EPA530SW90087A
   1992, STUDY NONBURN TECHNO
   1991, REPORT ASSESSMENT OP
   1990, EPA530SW90051A OFF W
   EPA625491030, P10
   1993, SOLID WASTE MANAGEME, pD207
NR 28
TC 11
Z9 11
U1 0
U2 9
PU AIR & WASTE MANAGEMENT ASSOC
PI PITTSBURGH
PA PO BOX 2861, PITTSBURGH, PA 15230
SN 1047-3289
J9 J AIR WASTE MANAGE
JI J. Air Waste Manage. Assoc.
PD OCT
PY 1994
VL 44
IS 10
BP 1176
EP 1179
PG 4
WC Engineering, Environmental; Environmental Sciences; Meteorology &
   Atmospheric Sciences
SC Engineering; Environmental Sciences & Ecology; Meteorology & Atmospheric
   Sciences
GA PP907
UT WOS:A1994PP90700002
DA 2018-10-19
ER

PT J
AU SULLIVAN, PK
   SMITH, JF
   ROZZELLE, AA
AF SULLIVAN, PK
   SMITH, JF
   ROZZELLE, AA
TI CRANIO-ORBITAL RECONSTRUCTION - SAFETY AND IMAGE QUALITY OF METALLIC
   IMPLANTS ON CT AND MRI SCANNING
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID BIOMEDICAL IMPLANTS; FRACTURES; MANAGEMENT; FIXATION
AB A study was undertaken to evaluate the safety of magnetic resonance imaging (MRI) of metallic implants used in cranio-orbital reconstruction (stainless steel wire and titanium and Vitallium plates) and also to compare the degree of artifact created on computed tomographic (CT) scanning and MRI by each material.
   Samples of each material were tested for deflection (movement) in a 1.5-T MRI field and for temperature change under conditions simulating a clinical MRI scan. None of the materials exhibited any deflection, and none exhibited any significant temperature change compared with water.
   Standardized bars of each material and commonly used, commercially available titanium and Vitallium implants (plates, mesh) were evaluated for artifact. On blinded evaluation by three radiologists and on quantitative computer analysis of the CT images, the stainless steel produced the most artifact on both CT scan and MRI, followed by the Vitallium, with the least artifact caused by titanium. All the titanium images were felt to be acceptable to detect orbital pathology, while only the images with the thinnest Vitallium (micromesh) implant were acceptable.
C1 RHODE ISL HOSP,PROVIDENCE,RI 02902.
RP SULLIVAN, PK (reprint author), BROWN UNIV,SCH MED,DIV PLAST SURG,235 PLAIN ST,SUITE 502,PROVIDENCE,RI 02905, USA.
CR ANTONYSHYN O, 1989, ANN PLAS SURG, V22, P220, DOI 10.1097/00000637-198903000-00009
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   GLASSMAN RD, 1990, PLAST RECONSTR SURG, V86, P1103, DOI 10.1097/00006534-199012000-00009
   JACKSON IT, 1989, CLIN PLAST SURG, V16, P77
   LEIPZIGER LS, 1992, CLIN PLAST SURG, V19, P167
   NGUYEN PN, 1992, CLIN PLAST SURG, V19, P87
   PHILLIPS JH, 1988, PLAST RECONSTR SURG, V82, P872, DOI 10.1097/00006534-198811000-00023
   ROHRICH RJ, 1992, CLIN PLAST SURG, V19, P149
   SARGENT LA, 1991, PLAST RECONSTR SURG, V88, P31, DOI 10.1097/00006534-199107000-00006
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   Shellock FG, 1987, RADIOLOGY, V165, P150
   SILVERMAN PM, 1986, COMPUT RADIOL, V10, P37, DOI 10.1016/0730-4862(86)90017-X
   SOULEN RL, 1985, RADIOLOGY, V154, P705, DOI 10.1148/radiology.154.3.3969474
   YAREMCHUK MJ, 1992, CLIN PLAST SURG, V19, P113
NR 16
TC 62
Z9 65
U1 0
U2 2
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0032-1052
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD OCT
PY 1994
VL 94
IS 5
BP 589
EP 596
DI 10.1097/00006534-199410000-00004
PG 8
WC Surgery
SC Surgery
GA PK556
UT WOS:A1994PK55600004
PM 7938281
DA 2018-10-19
ER

PT J
AU ALLCOCK, HR
AF ALLCOCK, HR
TI CROSS-LINKING REACTIONS FOR THE CONVERSION OF POLYPHOSPHAZENES INTO
   USEFUL MATERIALS
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID INTERPENETRATING POLYMER NETWORKS; PHOSPHORUS-NITROGEN COMPOUNDS;
   THERMAL TRANSITION BEHAVIOR; SIDE GROUPS; LINKABLE POLYPHOSPHAZENE;
   CYCLIC PHOSPHAZENES; CARRIER MOLECULES; BOND-CLEAVAGE; HYDROGELS;
   POLY<BIS(TRIFLUOROETHOXY)PHOSPHAZENE>
AB The conversion of phosphazene high polymers to useful materials depends on the development of methods to cross-link the macromolecular chains. A number of crosslinking routes have been used including chemical, photochemical, and high-energy radiation techniques. The relationship of the cross-linking processes to electrochemical, electrooptical, elastomer, structural, membrane, surface, and biomedical properties is discussed.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,UNIVERSITY PK,PA 16802, USA.
CR Allcock H. R., 1990, CONT POLYM CHEM
   ALLCOCK HR, 1993, MACROMOLECULES, V26, P11, DOI 10.1021/ma00053a002
   ALLCOCK HR, 1972, INORG CHEM, V11, P2584, DOI 10.1021/ic50117a003
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P4179, DOI 10.1021/ma00201a008
   ALLCOCK HR, 1980, POLYMER, V21, P673, DOI 10.1016/0032-3861(80)90327-4
   ALLCOCK HR, 1992, BIOMATERIALS, V13, P857, DOI 10.1016/0142-9612(92)90179-R
   ALLCOCK HR, 1977, J AM CHEM SOC, V99, P3984, DOI 10.1021/ja00454a016
   ALLCOCK HR, 1992, MACROMOLECULES, V25, P5573, DOI 10.1021/ma00047a002
   ALLCOCK HR, 1988, BIOMATERIALS, V9, P509, DOI 10.1016/0142-9612(88)90046-4
   ALLCOCK HR, 1986, MACROMOLECULES, V19, P1508, DOI 10.1021/ma00160a003
   ALLCOCK HR, 1980, MACROMOLECULES, V13, P1332, DOI 10.1021/ma60078a002
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P75, DOI 10.1021/ma00191a015
   ALLCOCK HR, 1992, CHEM MATER, V4, P296, DOI 10.1021/cm00020a015
   ALLCOCK HR, 1985, MACROMOLECULES, V18, P1330, DOI 10.1021/ma00148a050
   ALLCOCK HR, 1988, ACS SYM SER, V360, P250
   ALLCOCK HR, 1966, INORG CHEM, V5, P1716, DOI 10.1021/ic50044a017
   ALLCOCK HR, 1966, INORG CHEM, V5, P1709, DOI 10.1021/ic50044a016
   ALLCOCK HR, 1990, CHEM MATER, V2, P425, DOI 10.1021/cm00010a021
   ALLCOCK HR, 1977, INORG CHEM, V16, P3362, DOI 10.1021/ic50178a081
   ALLCOCK HR, 1993, CHEM MATER, V5, P1307, DOI 10.1021/cm00033a021
   ALLCOCK HR, 1974, MACROMOLECULES, V7, P284, DOI 10.1021/ma60039a006
   ALLCOCK HR, 1992, CHEM MATER, V4, P775, DOI 10.1021/cm00022a007
   ALLCOCK HR, 1972, MACROMOLECULES, V5, P231, DOI 10.1021/ma60026a026
   ALLCOCK HR, 1985, INORG CHEM, V24, P2656, DOI 10.1021/ic00211a015
   ALLCOCK HR, 1983, ORGANOMETALLICS, V2, P267, DOI 10.1021/om00074a011
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P1000, DOI 10.1021/ma00005a006
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1975, MACROMOLECULES, V8, P377, DOI 10.1021/ma60046a001
   ALLCOCK HR, 1991, CHEM MATER, V3, P442, DOI 10.1021/cm00015a017
   ALLCOCK HR, 1985, CHEM ENG NEWS, V63, P22, DOI 10.1021/cen-v063n011.p022
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P993, DOI 10.1021/ma00005a005
   ALLCOCK HR, 1979, J AM CHEM SOC, V101, P606, DOI 10.1021/ja00497a021
   ALLCOCK HR, 1992, CHEM MATER, V4, P769, DOI 10.1021/cm00022a006
   ALLCOCK HR, 1994, MACROMOLECULES, V27, P3131, DOI 10.1021/ma00090a003
   ALLCOCK HR, 1985, MACROMOLECULES, V18, P1340, DOI 10.1021/ma00148a051
   ALLCOCK HR, 1991, CHEM MATER, V3, P1120, DOI 10.1021/cm00018a032
   ALLCOCK HR, 1994, BIOMATERIALS, V15, P502, DOI 10.1016/0142-9612(94)90015-9
   ALLCOCK HR, 1988, BIOMATERIALS, V9, P500, DOI 10.1016/0142-9612(88)90045-2
   ALLCOCK HR, 1974, MACROMOLECULES, V7, P571, DOI 10.1021/ma60041a007
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P2024, DOI 10.1021/ma00008a048
   ALLCOCK HR, 1994, MACROMOLECULES, V27, P3125, DOI 10.1021/ma00090a002
   ALLCOCK HR, 1993, MACROMOLECULES, V26, P1493, DOI 10.1021/ma00059a003
   ALLCOCK HR, 1992, J INORG ORGANOMET P, V2, P197
   ALLCOCK HR, 1992, RING OPENING POLYM, P217
   ALLCOCKI HR, 1994, ADV MATER, V6, P101
   ANDRIANOV AK, 1993, J CONTROL RELEASE, V27, P69, DOI 10.1016/0168-3659(93)90058-D
   ANDRIANOV AK, 1993, POLYM PREPR AM CHEM, V34, P233
   ARMAND MB, 1986, ANNU REV MATER SCI, V16, P245, DOI 10.1146/annurev.ms.16.080186.001333
   BABIC D, 1986, RADIAT PHYS CHEM, V28, P169
   BANO MC, 1991, BIO-TECHNOL, V9, P468, DOI 10.1038/nbt0591-468
   BENNETT JL, 1989, CHEM MATER, V1, P14
   BLONSKY PM, 1986, SOLID STATE IONICS, V18-9, P258, DOI 10.1016/0167-2738(86)90123-2
   BLONSKY PM, 1984, J AM CHEM SOC, V106, P6854, DOI 10.1021/ja00334a071
   COHEN S, 1990, J AM CHEM SOC, V112, P7832, DOI 10.1021/ja00177a074
   COHEN S, 1992, PCT INT APPL, P45
   DEGENNES PG, 1983, PHYS TODAY       JUN, P33
   DEMBEK AA, 1990, CHEM MATER, V2, P97, DOI 10.1021/cm00008a005
   DESPER CR, 1976, MACROMOLECULES, V9, P424, DOI 10.1021/ma60051a008
   DHALLUM G, 1992, MACROMOLECULES, V625, P1254
   DODGE JA, 1990, J AM CHEM SOC, V112, P1268, DOI 10.1021/ja00159a070
   DUBOIS RA, 1986, ORGANOMETALLICS, V5, P460, DOI 10.1021/om00134a012
   DUBOIS RA, 1984, ORGANOMETALLICS, V3, P649, DOI 10.1021/om00082a032
   Fieldhouse J. W., 1980, U.S. Patent, Patent No. [4,226,840, 4226840]
   FLINDT EP, 1977, Z ANORG ALLG CHEM, V428, P204, DOI 10.1002/zaac.19774280125
   Flory P.J., 1969, PRINCIPLES POLYM CHE
   FRANZ U, 1993, MACROMOLECULES, V26, P3723, DOI 10.1021/ma00066a036
   GETTLEMAN L, 1985, POLYM MAT SCI ENG, V53, P770
   HABER CM, 1960, P CHEM SOC LONDON, P219
   HERRING DL, 1960, CHEM IND-LONDON, P717
   KOJIMA M, 1989, POLYMER, V30, P1856, DOI 10.1016/0032-3861(89)90358-3
   KOJIMA M, 1989, POLYMER, V30, P579, DOI 10.1016/0032-3861(89)90138-9
   MANNERS I, 1989, J AM CHEM SOC, V111, P5478, DOI 10.1021/ja00196a071
   MANNERS I, 1989, J AM CHEM SOC, V111, P3067, DOI 10.1021/ja00190a052
   Mark J. E., 1992, INORGANIC POLYM, P272
   MONTAGUE RA, 1990, J AM CHEM SOC, V112, P6721, DOI 10.1021/ja00174a047
   NAPIERALA M, 1994, WORK CARRIED OUT PEN
   NEILSON RH, 1988, CHEM REV, V88, P541, DOI 10.1021/cr00085a005
   NEILSON RH, 1987, MACROMOLECULES, V20, P910, DOI 10.1021/ma00171a002
   NELSON CE, UNPUB
   NELSON CJ, 1991, CHEM MATER, V3, P786, DOI 10.1021/cm00017a010
   OBRIEN JP, 1979, MACROMOLECULES, V12, P108, DOI 10.1021/ma60067a023
   PACIOREK RH, 1965, INORG CHEM, V4, P1767
   PENTON HR, 1986, KAUT GUMMI KUNSTST, V39, P301
   ROSE SH, 1968, J POLYM SCI POL LETT, V6, P837, DOI 10.1002/pol.1968.110061203
   SCHNEIDER NS, 1978, ORG POL S NEW ORL 19, P271
   SENNETT MS, 1983, POLYM MAT SCI ENG, V49, P297
   SHRIVER DF, 1985, CHEM ENG NEWS, V63, P20
   SINGLER RE, 1982, ACS SYM SER, V193, P229
   Sperling L.H., 1981, INTERPENETRATING POL
   SPERLING LH, 1988, CHEMTECH, V18, P104
   Tate D.P., 1974, J POLYM SCI POLYM S, V48, P33
   TONGE JS, 1987, P S LITHIUM BATTERIE, V1, P533
   VISSCHER KB, 1990, MACROMOLECULES, V23, P4885, DOI 10.1021/ma00224a022
   WELKER MF, 1994, ACS SYM SER, V537, P293
   Wright P. V., 1975, British Polymer Journal, V7, P319, DOI 10.1002/pi.4980070505
   WRIGHT PV, 1976, J POLYM SCI POL PHYS, V14, P955, DOI 10.1002/pol.1976.180140516
   1985, ECNY POLYM SCI ENG, V1
NR 97
TC 98
Z9 100
U1 2
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD SEP
PY 1994
VL 6
IS 9
BP 1476
EP 1491
DI 10.1021/cm00045a003
PG 16
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA PG435
UT WOS:A1994PG43500003
DA 2018-10-19
ER

PT J
AU YAPARPALVI, R
   LOYALKA, SK
   TOMPSON, RV
AF YAPARPALVI, R
   LOYALKA, SK
   TOMPSON, RV
TI PRODUCTION OF SPHERICAL ZRO2-Y2O3 AND ZNO PARTICLES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID SPRAY PYROLYSIS METHOD; EVAPORATIVE DECOMPOSITION; POWDER; BIOCERAMICS;
   CERAMICS
AB In recent years substantial effort has been focused on the use of engineered ceramics for biomedical applications. To produce ceramic components with reliable and reproducible properties for such speciality applications, it is necessary to use high-purity raw material powders with specific properties. Fine ceramic particles having specific shapes and sizes are also required for conducting biocompatibility experiments. This article reports on the laboratory scale production, in an aerosol reactor, of spherical, submicron zirconia (partially stabilized by yttria; ZrO2-Y2O3) and zinc oxide (ZnO) particles by the thermal decomposition of mists generated from aqueous solutions of inorganic metal salt precursors. The particles produced were characterized by scanning electron microscopy, X-ray diffraction, and Fourier transform infrared spectroscopy. (C) 1994 John Wiley and Sons, Inc.
C1 UNIV MISSOURI,COLL ENGN,PARTICULATE SYST RES CTR,COLUMBIA,MO 65211.
CR Brook R., 1984, NEW SCI, P13
   CHRISTEL P, 1991, ANN NY ACAD SCI, V523, P235
   DION I, 1993, BIOMATERIALS, V14, P107, DOI 10.1016/0142-9612(93)90218-Q
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   GARDNER TJ, 1984, AM CERAM SOC BULL, V63, P1498
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   ISHIZAWA H, 1986, AM CERAM SOC BULL, V65, P1399
   JOHNSON DW, 1981, AM CERAM SOC BULL, V60, P221
   LANGE FF, 1989, J AM CERAM SOC, V72, P3, DOI 10.1111/j.1151-2916.1989.tb05945.x
   MATIJEVIC E, 1985, ANNU REV MATER SCI, V15, P483
   NONMAN RD, 1964, J DENT RES, V43, P252
   PRATSINIS SE, 1989, CHEM ENG PROG    MAY, P62
   RICE RW, 1990, AICHE J, V36, P481, DOI 10.1002/aic.690360402
   SPROSON DW, 1986, CERAM INT, V12, P3, DOI 10.1016/S0272-8842(86)80003-7
   STJOHN KR, 1992, ASTM PUBLICATION STP, V1144
   TAKIGAWA K, 1990, BRIT CERAM TRANS J, V89, P82
   VINCENZINI P, 1982, 2ND P INT S BIOC LIG
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   1987, POWDER DIFFRACTION F
NR 19
TC 13
Z9 13
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1994
VL 28
IS 9
BP 1087
EP 1093
DI 10.1002/jbm.820280914
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PE101
UT WOS:A1994PE10100013
PM 7814436
DA 2018-10-19
ER

PT J
AU VANWACHEM, PB
   VANLUYN, MJA
   BLAAUW, EH
   RAATJES, D
   CAHALAN, PT
   HENDRIKS, M
AF VANWACHEM, PB
   VANLUYN, MJA
   BLAAUW, EH
   RAATJES, D
   CAHALAN, PT
   HENDRIKS, M
TI INCIDENCE OF INFECTION IN IMPLANTED POLYURETHANE TUBING SEGMENTS
   SERIALLY INJECTED WITH STAPHYLOCOCCI
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FOREIGN-BODY INFECTION; BACTERIAL ADHERENCE; PATHOGENESIS; ADHESION;
   POLYMERS; THERAPY
AB One of the major clinical complications in the biomedical application of synthetic materials is the incidence of implant-associated infections. Such infections are very often induced by Staphylococcus aureus. To obtain information on tissue reactions and minimal bacterial challenge needed to create an infection related to untreated implant surfaces, we injected polyurethane tubing segments with a series of Staphylococcus aureus. The segments were subcutaneously implanted in rats. Implantation periods varied from 2, 5 and 10 days to 3 weeks. Specimen were evaluated using light and transmission electron microscopy. At least 0.25 x 10(4) of Staphylococci aureus were needed to clearly recognize that bacteria had been injected in the polyurethane tubing segments. The evidence was indirect, showing high infiltration and activation of neutrophils and macrophages, but not bacteria. Furthermore, 0.25 x 10(6) S. aureus were needed to induce a persistent specific inflammatory reaction with high concentrations of lymphocytes, i.e. mainly plasma-cells, at 3 weeks. The results indicate that this model functioned well to obtain the wanted information. Results are discussed with respect to (a-) specific inflammatory reactions occurring with (bacterial-challenged) biomaterials. Ultimately, our goal is to develop infection-resistant materials, for which the in vivo model developed may be used to qualify the processed materials
C1 UNIV GRONINGEN HOSP,DEPT HOSP EPIDEMIOL,9713 EZ GRONINGEN,NETHERLANDS.
   MEDTRON BAKKEN RES CTR BV,6201 MP MAASTRICHT,NETHERLANDS.
RP VANWACHEM, PB (reprint author), UNIV GRONINGEN,CELL BIOL & ELECTRON MICROSCOPY LAB,OOSTERSINGEL 69-2,9713 EZ GRONINGEN,NETHERLANDS.
CR ABBAS AK, 1991, CELLULAR MOL IMMUNOL
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   ANWAR H, 1992, ANTIMICROB AGENTS CH, V36, P1347, DOI 10.1128/AAC.36.7.1347
   BISNO AL, 1989, INFECTIONS ASS INDWE
   Black J., 1992, BIOL PERFORMANCE MAT
   Brostoff J., 1991, CLIN IMMUNOLOGY
   CHRISTENSEN GD, 1987, ZBL BAKT S, V16, P103
   COLOMB G, 1991, J BIOMED MATER RES, V25, P937
   COSTERTON JW, 1984, REV INFECT DIS, V6, pS608, DOI 10.1093/clinids/6.Supplement_3.S608
   CRISTINA AG, 1987, BIOMATERIALS, V8, P423
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   JANSEN B, 1990, PROGRESS IN BIOMEDICAL POLYMERS, P347
   JANSEN B, 1990, ADV BIOMAT, V9, P117
   JOHNSON GM, 1987, ZENTRALBLATT BAKTE S, V16, P33
   PLANCK H, 1984, POLYURETHANES BIOMED
   REED WP, 1978, J CHRON DIS, V31, P67, DOI 10.1016/0021-9681(78)90091-7
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   SHETH NK, 1985, LANCET, V2, P1266
   SHETH NK, 1987, ZBL BAKT S, V16, P177
   VANDERMEER JB, 1992, NETH J MED, V40, P244
   von Recum A F, 1989, J Invest Surg, V2, P351, DOI 10.3109/08941938909018260
   WALDVOGEL FA, 1990, PRINCIPLES PRACTICE, P1489
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 27
TC 7
Z9 7
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 628
EP 634
DI 10.1007/BF00120344
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500013
DA 2018-10-19
ER

PT J
AU SALOMONI, A
   TUCCI, A
   ESPOSITO, L
   STAMENKOVIC, I
AF SALOMONI, A
   TUCCI, A
   ESPOSITO, L
   STAMENKOVIC, I
TI FORMING AND SINTERING OF MULTIPHASE BIOCERAMICS
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB Composite bioceramic materials could find use in a wide range of biomedical applications; however, their processing technologies are quite complex or not sufficiently developed. In order to eliminate deleterious influences of powder inhomogeneities and to reduce the machining time of final components, a novel procedure for multiphase powders using wet pretreatment and direct forming of green bodies having the desired geometries was studied. During the experimental work alumina, yttria-stabilized zirconia, and their mixtures were used. The forming of discs and femoral heads was done by pressure casting of aqueous suspensions of powders. The measurements of physical, mechanical and tribological properties of sintered samples were performed; the results obtained showed the effectiveness of the process since the property values approached those of similar materials actually on the market, while requiring less machining labour.
RP SALOMONI, A (reprint author), CTR CERAM,VIA MARTELLI 26,I-40138 BOLOGNA,ITALY.
CR ESPOSITO L, 1993, 3RD P EUR CER C, V3, P301
   NIIHARA K, 1982, J MATER SCI LETT, V1, P13, DOI 10.1007/BF00724706
   SALOMONI A, 1992, CERAMIC T, V26, P178
   TSUKUMA K, 1985, J AM CERAM SOC, V68, pC4
   1992, MAY P INT S HIP PROS
NR 5
TC 19
Z9 19
U1 0
U2 4
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 651
EP 653
DI 10.1007/BF00120349
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500018
DA 2018-10-19
ER

PT J
AU TANZI, MC
   MANTERO, S
   FREDDI, G
   MOTTA, A
   SADA, A
   PELUSO, G
AF TANZI, MC
   MANTERO, S
   FREDDI, G
   MOTTA, A
   SADA, A
   PELUSO, G
TI CYTOCOMPATIBILITY OF 2 SEGMENTED BIOMEDICAL POLYURETHANES
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB In this work the proliferation of mitogen-activated human T lymphocytes, and human endothelial cells (HEC) adhesion and growth have been evaluated in vitro with two segmented polyurethanes (SPUs) having different chemical structure: Pellethane 2363-80A, a poly-ether-urethane, and Corethane 55D, a polycarbonate-urethane. The effect of the two SPUs on phytohemoagglutinin (PHA)-induced T-cells proliferation was analysed by evaluating both morphological changes of the lympho-monocyte system with scanning electron microscopy (SEM), and the perturbation of cell cycle progression with a cytofluorimetric technique. Results showed that, although the PHA stimulation of T-cells cultured on Corethane was sufficient to induce entry into the cell cycle, as evidenced by an increase in RNA content, the DNA synthesis appeared similar to that of unstimulated cultures. On the other hand, there was a significant increase of the DNA and RNA content in the culture performed in the presence of Pellethane, as in the case of PHA-stimulated control cultures. Moreover, in comparison with Pellethane, a strong decrease in monocyte attachment and spreading was observed on Corethane; with lymphocytes scattered around the monocytes, and not attached to them as in the case of Pellethane. In the experiment with HEC, the cells were directly seeded on the materials, and the number of cells attached after 4 and 72 h culture was then evaluated, the former reading being a measure for cell adhesion, the latter indicating the capacity of the cells to proliferate. Although both SPUs allowed a HEC adhesion lower than the positive control, it was possible to confirm that Pellethane well supports cell proliferation, whereas Corethane is less prone to promote cell growth
C1 STN SPERIMENTALE SETA,I-20133 MILAN,ITALY.
   CNR,INST BIOCHIM PROT ENZIMOL,I-80100 ARCO,ITALY.
RP TANZI, MC (reprint author), POLITECN MILAN,DIPARTIMENTO BIOINGN,PZZA L VINCI 32,I-20133 MILAN,ITALY.
RI Mantero, Sara/F-6587-2013; Tanzi, Maria Cristina/I-4620-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633; MANTERO,
   SARA/0000-0002-1264-0465; Motta, Antonella/0000-0003-4893-6863
CR Lelah M. D., 1986, POLYURETHANES MED
   MERRITT K, 1986, TECHNIQUES BIOCOMPAT, V2, P123
   MOLLER G, 1989, IMMUNOL REV, V11, P1
   PINCHUK L, 1993, 19TH T ANN M SOC BIO, V16, P22
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   SZYCHER M, 1991, BLOOD COMPATIBLE MAT, P42
   Tanzi M. C., 1993, Clinical Materials, V12, P17, DOI 10.1016/0267-6605(93)90023-Z
   TERADA N, 1991, J IMMUNOL, V147, P698
   WILLIAMS DF, 1986, TECHNIQUES BIOCOMPAT, V2, pCH4
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 10
TC 2
Z9 2
U1 0
U2 5
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 705
EP 710
DI 10.1007/BF00120361
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500030
DA 2018-10-19
ER

PT J
AU WITTWER, C
   DEVLIN, AJ
   HATTON, PV
   BROOK, IM
   DOWNES, S
AF WITTWER, C
   DEVLIN, AJ
   HATTON, PV
   BROOK, IM
   DOWNES, S
TI THE RELEASE OF SERUM-PROTEINS AND DYE FROM GLASS-IONOMER (POLYALKENOATE)
   AND ACRYLIC CEMENTS - A PILOT-STUDY
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OTOLOGIC SURGERY; INVITRO
AB Glass ionomer cements (GICs) are composite materials with the potential for use as improved bone substitutes and cements. The hydrophilic nature of the GIC matrix may confer the ability to release therapeutic agents after surgical implantation which would aid the development of GICs for wider biomedical application. Acrylic and GIC were loaded (5% w/w> with either a model dye or high molecular weight proteins and eluted in vitro over 84 days to study simulated drug release. Serum proteins were also adsorbed on to the surface of acrylic and two different GICs and desorption measured over six days. GIC was a suitable matrix for simple dye and protein release, protein release being greater from the GIC than from the acrylic cement. Selective desorption from the two different GICs studied was noted indicating GICs may be formulated to release specific drugs or proteins.
C1 ROYAL NATL ORTHOPAED HOSP,INST ORTHOPAED,IRC BIOMED MAT,STANMORE HA7 4LP,MIDDX,ENGLAND.
RP WITTWER, C (reprint author), UNIV SHEFFIELD,SCH CLIN DENT,BIOMAT GRP,CLAREMONT CRESCENT,SHEFFIELD S10 2TA,S YORKSHIRE,ENGLAND.
OI Hatton, Paul/0000-0001-5234-1104
CR BABIGHIAN G, 1992, J LARYNGOL OTOL, V106, P954, DOI 10.1017/S0022215100121450
   BAKER AS, 1988, J BONE JOINT SURG AM, V70A, P1551, DOI 10.2106/00004623-198870100-00015
   Barnes C, 1934, PHYSICS-J GEN APPL P, V5, P4, DOI 10.1063/1.1745209
   BROOK IM, 1985, BIOMATERIALS, V6, P281, DOI 10.1016/0142-9612(85)90027-4
   BROOK IM, 1992, BIOMATERIALS, V13, P721, DOI 10.1016/0142-9612(92)90134-A
   BROOK IM, 1986, BIOL BIOMECHANICAL P, V6, P251
   BUCHOLZ HW, 1979, RECENT ADV ORTHOPAED, V3, P61
   Crank J., 1975, MATH DIFFUSION, P238
   DOWNES S, 1991, Clinical Materials, V7, P227, DOI 10.1016/0267-6605(91)90063-L
   DOWNES S, 1989, CLIN MATER, V4, P109
   DOWNES S, 1990, CLIN ORTHOP REL, V252, P293
   HATTON PV, 1992, BRIT DENT J, V173, P275, DOI 10.1038/sj.bdj.4808026
   HATTON PV, 1992, ADV BIOMAT, V10, P331
   JONCK L M, 1990, Clinical Materials, V6, P323, DOI 10.1016/0267-6605(90)90052-W
   JOSEFSSON G, CLIN ORTHOP RELAT R, V253, P174
   RAMSDEN RT, 1992, J LARYNGOL OTOL, V106, P949, DOI 10.1017/S0022215100121449
NR 16
TC 4
Z9 4
U1 0
U2 0
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 711
EP 714
DI 10.1007/BF00120362
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500031
DA 2018-10-19
ER

PT J
AU PELUSO, G
   PETILLO, O
   AMBROSIO, L
   NICOLAIS, L
AF PELUSO, G
   PETILLO, O
   AMBROSIO, L
   NICOLAIS, L
TI POLYETHERIMIDE AS BIOMATERIAL - PRELIMINARY IN-VITRO AND IN-VIVO
   BIOCOMPATIBILITY TESTING
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NYLON WOOL; PATHOGENESIS; FIBER
AB During the last few years, on the basis of their physico-chemical characteristics, thermoplastic materials, already used in several advanced industries, have become very attractive candidates for biomedical applications as matrix for composite femoral stems and bone plates. In the present study, the biocompatibility of a thermoplastic material, polyetherimide (PEI), was investigated both in vivo, and in vitro. Our results show that PEI did not elicit any toxic response in cell culture testing. It was possible to grow on PEI surfaces not only 3T3 fibroblasts but also human endothelial cells (HEC) from human umbilical cord, with no apparent deleterious effects on the cell viability. The attachment, spreading, and growth of cells on PEI material was followed with respect to time. Both the number of adhering HEC, and the spreading area of individual cells, increased as a function of time. The hydrogen peroxide-sensitive dye DCFH-DA was used to examine the functional activity of cells adherent to PEI or control material implants. PEI material did not induce significant DCFH oxidation until day 14, when levels of DCFH oxidation were significantly higher than observed with PDMS negative control, but lower than those observed on Pellethane positive control.
C1 UNIV NAPLES FEDERICO II,DEPT MAT & PROD ENGN,I-80125 NAPLES,ITALY.
   UNIV NAPLES FEDERICO II,CNR,INST COMPOSITE MAT TECHNOL,I-80125 NAPLES,ITALY.
RP PELUSO, G (reprint author), CNR,INST PROT BIOCHEM & ENZYMOL,VIA TOIANO 6,I-80072 ARCO,ITALY.
OI AMBROSIO, LUIGI/0000-0002-8367-2405
CR BASS DA, 1983, J IMMUNOL, V130, P1910
   HAGGERTY HS, 1989, ACTA OTO-LARYNGOL, V107, P13, DOI 10.3109/00016488909127474
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KESTON AS, 1965, ANAL BIOCHEM, V11, P1, DOI 10.1016/0003-2697(65)90034-5
   KLOCK JC, 1977, J CLIN INVEST, V60, P1183, DOI 10.1172/JCI108871
   KLOCK JC, 1976, BLOOD, V48, P149
   PELUSO G, 1991, BIOMATERIALS, V12, P231, DOI 10.1016/0142-9612(91)90205-O
   PELUSO G, 1991, Clinical Materials, V8, P99, DOI 10.1016/0267-6605(91)90016-9
   RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3
   ROBINSON JP, 1988, J LEUKOCYTE BIOL, V43, P304
   STRAIT LH, 1991, MAY T SOC BIOM SCOOT
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
   ZIATS NP, 1989, BIOMATERIALS, V9, P5
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 14
TC 31
Z9 31
U1 1
U2 12
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 738
EP 742
DI 10.1007/BF00120367
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500036
DA 2018-10-19
ER

PT J
AU KISHIDA, A
   UENO, Y
   FUKUDOME, N
   YASHIMA, E
   MARUYAMA, I
   AKASHI, M
AF KISHIDA, A
   UENO, Y
   FUKUDOME, N
   YASHIMA, E
   MARUYAMA, I
   AKASHI, M
TI IMMOBILIZATION OF HUMAN THROMBOMODULIN ONTO POLY(ETHER URETHANE UREA)
   FOR DEVELOPING ANTITHROMBOGENIC BLOOD-CONTACTING MATERIALS
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Molecular Aspects of Biomaterials
   (BIOINTERACTIONS 93)
CY AUG 29-SEP 01, 1993
CL NOORDWIJKERHOUT, NETHERLANDS
DE THROMBOMODULIN; POLY(ETHER URETHANE UREA); IMMOBILIZATION;
   ANTITHROMBOGENICITY; PLATELET ADHESION
ID ANTICOAGULANT ACTIVITY; HEPARIN; COPOLYMERS
AB Thrombomodulin (TM) is a newly described endothelial cell-associated protein that functions as a potent natural anticoagulant by converting thrombin from a procoagulant protease to an anticoagulant. In this study, focussing on the application of TM for biomedical materials, recombinant human TM (hTM) was immobilized onto the polymers for medical use, and the evaluation of their antithrombogenicity and the interaction with platelets were investigated. As the base polymer for immobilization reaction, poly(ether urethane urea)(PEUU), which was reported to have good blood compatibility, was used. hTM-immobilized PEUU showed superior antithrombogenic activity, such as the prolongation of plasma recalcification time and the inhibition of thrombin-induced platelet aggregation, though the amount of immobilized hTM was very small (i.e. less than 1 mu g/cm(2)). Platelet adhesions onto hTM-immobilized PEUU were not observed. These results show that the immobilization of hTM does not change the native good blood compatibility of PEUU, but provides excellent anticoagulant activity.
C1 KAGOSHIMA UNIV,FAC ENGN,DEPT APPL CHEM & CHEM ENGN,KAGOSHIMA 890,JAPAN.
   NATL COLL TECHNOL,DEPT IND CHEM,MIYAKONOJO,MIYAZAKI,JAPAN.
   KAGOSHIMA UNIV,FAC MED,DEPT CLIN LAB MED,KAGOSHIMA 890,JAPAN.
RI Yashima, Eiji/H-5380-2011
OI Yashima, Eiji/0000-0001-6307-198X
CR AKASHI M, 1992, BIOCONJUGATE CHEM, V3, P363, DOI 10.1021/bc00017a002
   AKASHI M, 1989, J BIOACT COMPAT POL, V4, P4
   CLARKE JH, 1993, J BIOL CHEM, V268, P6309
   EBERT CD, 1982, J BIOMED MATER RES, V16, P629, DOI 10.1002/jbm.820160510
   ISHIHARA K, 1993, BIOMEDICAL APPL POLY, P89
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   ITO Y, 1986, J BIOMED MATER RES, V20, P1017, DOI 10.1002/jbm.820200715
   JOHANSSON AC, 1974, BIOCHIM BIOPHYS ACTA, V370, P339, DOI 10.1016/0005-2744(74)90094-1
   KAWAUCHI H, 1969, J BIOCHEM-TOKYO, V66, P783, DOI 10.1093/oxfordjournals.jbchem.a129208
   KITANO H, 1982, J APPL BIOCHEM, V4, P434
   KULIK EA, 1993, BIOMATERIALS, V14, P763, DOI 10.1016/0142-9612(93)90041-Y
   LOK BK, 1983, J COLLOID INTERF SCI, V91, P87, DOI 10.1016/0021-9797(83)90316-8
   MORI Y, 1978, T AM SOC ART INT ORG, V24, P736
   OSHIRO T, 1980, ARTIF ORGANS, V4, P58
   OSHIRO T, 1988, METHOD ENZYMOL, V137, P529
   SALEM HH, 1984, J BIOL CHEM, V259, P2246
   SENATORE F, 1986, J BIOMED MATER RES, V20, P177, DOI 10.1002/jbm.820200207
   SHIRAI T, 1988, J BIOCHEM-TOKYO, V103, P281, DOI 10.1093/oxfordjournals.jbchem.a122261
   VULIC I, 1988, J POLYM SCI POL CHEM, V26, P381, DOI 10.1002/pola.1988.080260204
   YAGI K, 1989, CHEM PHARM BULL, V37, P732
   YAMADA H, 1981, BIOCHEMISTRY-US, V20, P4836, DOI 10.1021/bi00520a005
   ZUSHI M, 1989, J BIOL CHEM, V264, P10351
NR 22
TC 42
Z9 43
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1994
VL 15
IS 10
BP 848
EP 852
DI 10.1016/0142-9612(94)90041-8
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PC347
UT WOS:A1994PC34700018
PM 7986950
DA 2018-10-19
ER

PT J
AU DIEDERICH, F
   ISAACS, L
   PHILP, D
AF DIEDERICH, F
   ISAACS, L
   PHILP, D
TI SYNTHESES, STRUCTURES, AND PROPERTIES OF METHANOFULLERENES
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID BUCKMINSTERFULLERENE C60; FULLERENE DERIVATIVES; VALENCE TAUTOMERISM;
   C-60; CHEMISTRY; FULLEROIDS; SPECTROSCOPY; INHIBITION; EPOXIDE; ADDUCTS
AB The chemistry of the fullerenes has been extensively explored - this review focuses specifically on the methanofullerenes. A comprehensive coverage of the known methanofullerene syntheses is presented. This is followed by a discussion of the electronic structure of the methanofullerenes which is based on experimental and computational studies. Lastly, we discuss the further functionalization of the methanofullerenes and their possible applications in materials and biomedical sciences.
RP DIEDERICH, F (reprint author), ETH ZURICH,ORGAN CHEM LAB,UNIV STR 16,CH-8092 ZURICH,SWITZERLAND.
RI Isaacs, Lyle/B-4472-2009
OI Isaacs, Lyle/0000-0002-4079-332X
CR AN YZ, 1994, J ORG CHEM, V59, P2927, DOI 10.1021/jo00090a006
   ANDERSON HL, 1994, IN PRESS ANGEW CHEM, V33
   ARBOGAST JW, 1991, J PHYS CHEM-US, V95, P11, DOI 10.1021/j100154a006
   ARNZ R, 1991, ANGEW CHEM INT EDIT, V30, P683, DOI 10.1002/anie.199106831
   BALCH AL, 1991, INORG CHEM, V30, P3980, DOI 10.1021/ic00021a003
   Billups W. E., 1993, BUCKMINSTERFULLERENE
   BINGEL C, 1993, CHEM BER-RECL, V126, P1957, DOI 10.1002/cber.19931260829
   CREEGAN KM, 1992, J AM CHEM SOC, V114, P1103, DOI 10.1021/ja00029a058
   DIEDERICH F, 1992, ACCOUNTS CHEM RES, V25, P119, DOI 10.1021/ar00015a004
   DIEDERICH F, 1991, SCIENCE, V252, P548, DOI 10.1126/science.252.5005.548
   DIEDERICH F, 1994, J CHEM SOC PERK T 2, P391, DOI 10.1039/p29940000391
   DIEDERICH F, 1994, NATURE, V369, P199, DOI 10.1038/369199a0
   DIXON DA, 1992, J PHYS CHEM-US, V96, P6107, DOI 10.1021/j100194a001
   ELEMES Y, 1992, ANGEW CHEM INT EDIT, V31, P351, DOI 10.1002/anie.199203511
   FAGAN PJ, 1991, SCIENCE, V252, P1160, DOI 10.1126/science.252.5009.1160
   FRIEDMAN SH, 1993, J AM CHEM SOC, V115, P6506, DOI 10.1021/ja00068a005
   FRYDMAN L, 1990, J AM CHEM SOC, V112, P6472, DOI 10.1021/ja00174a003
   GUNTHER H, 1973, ANGEW CHEM INT EDIT, V12, P570, DOI 10.1002/anie.197305701
   GUNTHER H, 1975, PURE APPL CHEM, V44, P807, DOI 10.1351/pac197544040807
   GUNTHER H, 1970, TETRAHEDRON LETT, P5173
   HADDON RC, 1993, SCIENCE, V261, P1545, DOI 10.1126/science.261.5128.1545
   HAWKINS JM, 1990, J ORG CHEM, V55, P6250, DOI 10.1021/jo00313a009
   HIRSCH A, 1994, ANGEW CHEM INT EDIT, V33, P437, DOI 10.1002/anie.199404371
   HIRSCH A, 1993, ANGEW CHEM INT EDIT, V32, P1138, DOI 10.1002/anie.199311381
   HOFFMANN R, 1970, TETRAHEDRON LETT, P2907
   ISAACS L, 1993, HELV CHIM ACTA, V76, P1231, DOI 10.1002/hlca.19930760310
   ISAACS L, 1993, HELV CHIM ACTA, V76, P2454, DOI 10.1002/hlca.19930760705
   KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0
   KROTO HW, 1987, NATURE, V329, P529, DOI 10.1038/329529a0
   KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0
   MATSUZAWA N, 1992, J PHYS CHEM-US, V96, P7594, DOI 10.1021/j100198a021
   NALWA HS, 1993, ADV MATER, V5, P341, DOI 10.1002/adma.19930050504
   OSTERODT J, 1993, CHEM BER-RECL, V126, P2331, DOI 10.1002/cber.19931261023
   PRATO M, 1993, J AM CHEM SOC, V115, P7876, DOI 10.1021/ja00070a043
   PRATO M, 1993, J ORG CHEM, V58, P5578, DOI 10.1021/jo00073a004
   PRATO M, 1993, J AM CHEM SOC, V115, P8479, DOI 10.1021/ja00071a080
   RAGHAVACHARI K, 1993, CHEM PHYS LETT, V209, P223, DOI 10.1016/0009-2614(93)80097-9
   SHI S, 1992, J AM CHEM SOC, V114, P10656, DOI 10.1021/ja00052a083
   SIJBESMA R, 1993, J AM CHEM SOC, V115, P6510, DOI 10.1021/ja00068a006
   SKIEBE A, 1994, J CHEM SOC CHEM COMM, P335, DOI 10.1039/c39940000335
   SMITH AB, 1993, J AM CHEM SOC, V115, P5829, DOI 10.1021/ja00066a063
   SUZUKI T, 1992, J AM CHEM SOC, V114, P7301, DOI 10.1021/ja00044a055
   SUZUKI T, 1992, J AM CHEM SOC, V114, P7300, DOI 10.1021/ja00044a054
   SUZUKI T, 1991, SCIENCE, V254, P1186, DOI 10.1126/science.254.5035.1186
   TAYLOR R, 1992, J CHEM SOC PERK T 2, P3, DOI 10.1039/p29920000003
   TAYLOR R, 1993, NATURE, V363, P685, DOI 10.1038/363685a0
   TAYLOR R, 1991, TETRAHEDRON LETT, V32, P3731, DOI 10.1016/S0040-4039(00)79780-2
   TAYLOR R, 1993, PHILOS T ROY SOC A, V343, P87, DOI 10.1098/rsta.1993.0043
   TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064
   TOKUYAMA H, 1993, TETRAHEDRON LETT, V34, P7429, DOI 10.1016/S0040-4039(00)60144-2
   TSUDA M, 1993, TETRAHEDRON LETT, V34, P6911, DOI 10.1016/S0040-4039(00)91828-8
   VASELLA A, 1992, ANGEW CHEM INT EDIT, V31, P1388, DOI 10.1002/anie.199213881
   VOGEL E, 1980, ISRAEL J CHEM, V20, P215
   VOGEL E, 1993, PURE APPL CHEM, V65, P143, DOI 10.1351/pac199365010143
   VOGEL E, 1982, ANGEW CHEM S, P1882
   VOGEL E, 1969, PURE APPL CHEM, V20, P237
   VOGEL E, 1967, SPEC PUBL CHEM SOC, V21, P113
   WILSON SR, 1993, J CHEM SOC CHEM COMM, P784, DOI 10.1039/c39930000784
   WOOLEY KL, 1993, J AM CHEM SOC, V115, P9836, DOI 10.1021/ja00074a075
   WUDL F, 1992, ACCOUNTS CHEM RES, V25, P157, DOI 10.1021/ar00015a009
NR 60
TC 181
Z9 181
U1 0
U2 39
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK MILTON ROAD, CAMBRIDGE, CAMBS, ENGLAND
   CB4 4WF
SN 0306-0012
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PD AUG
PY 1994
VL 23
IS 4
BP 243
EP 255
DI 10.1039/cs9942300243
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA PH102
UT WOS:A1994PH10200003
DA 2018-10-19
ER

EF